,category,over_represented_pvalue,under_represented_pvalue,numDEInCat,numInCat,term,ontology,foreground_genes
3708,GO:0007275,1.23556318712873e-12,1,65,4496,multicellular organism development,BP,ARX;CRLF1;USH1C;SCIN;LTF;CLDN11;ZIC2;DSG2;EYA2;FGFR3;CAMK2A;CDH19;DCX;SOX10;FA2H;SLC17A7;MAG;CAV2;AHR;EFNB3;BVES;COL9A1;OTX1;CHD5;PPL;TRIM67;GJB6;PACSIN1;MYRF;PRKCG;PCDH8;GPNMB;ENPP2;MOG;ST8SIA2;HAPLN1;EGFR;GFRA1;GRID2;SPOCK1;GJA1;NRGN;ACAN;DMTN;EDIL3;CSMD3;CTHRC1;LMO1;SCN9A;GJB1;IRX2;SGCD;NPTX1;KNDC1;DMRT2;UGT8;GPC6;CNTN2;SLITRK2;CCK;HAPLN4;APOD;MYT1;MBP;SMOC1
13195,GO:0048731,1.36161031562746e-12,1,61,3992,system development,BP,ARX;CRLF1;USH1C;SCIN;LTF;CLDN11;ZIC2;DSG2;FGFR3;CAMK2A;DCX;SOX10;FA2H;SLC17A7;MAG;CAV2;AHR;EFNB3;BVES;COL9A1;OTX1;CHD5;PPL;TRIM67;GJB6;PACSIN1;MYRF;PRKCG;PCDH8;GPNMB;ENPP2;MOG;ST8SIA2;HAPLN1;EGFR;GFRA1;GRID2;SPOCK1;GJA1;NRGN;ACAN;DMTN;CSMD3;CTHRC1;LMO1;GJB1;IRX2;SGCD;NPTX1;KNDC1;DMRT2;UGT8;GPC6;CNTN2;SLITRK2;CCK;HAPLN4;APOD;MYT1;MBP;SMOC1
13255,GO:0048856,1.72455075914381e-11,1,66,4897,anatomical structure development,BP,ARX;CRLF1;USH1C;SCIN;LTF;CLDN11;ZIC2;DSG2;EYA2;FGFR3;CAMK2A;CDH19;DCX;SOX10;FA2H;SLC17A7;MAG;CAV2;AHR;EFNB3;BVES;COL9A1;OTX1;CHD5;PPL;TRIM67;GJB6;PACSIN1;MYRF;PRKCG;PCDH8;GPNMB;ENPP2;MOG;ST8SIA2;FBN3;HAPLN1;EGFR;GFRA1;GRID2;SPOCK1;GJA1;NRGN;ACAN;DMTN;EDIL3;CSMD3;CTHRC1;LMO1;SCN9A;GJB1;IRX2;SGCD;NPTX1;KNDC1;DMRT2;UGT8;GPC6;CNTN2;SLITRK2;CCK;HAPLN4;APOD;MYT1;MBP;SMOC1
3748,GO:0007399,1.46673453449669e-10,0.999999999971625,41,2088,nervous system development,BP,ARX;USH1C;CLDN11;ZIC2;CAMK2A;DCX;SOX10;FA2H;SLC17A7;MAG;EFNB3;OTX1;CHD5;TRIM67;PACSIN1;MYRF;PRKCG;PCDH8;MOG;ST8SIA2;HAPLN1;EGFR;GFRA1;GRID2;SPOCK1;GJA1;NRGN;ACAN;CSMD3;CTHRC1;GJB1;NPTX1;KNDC1;UGT8;CNTN2;SLITRK2;CCK;HAPLN4;APOD;MYT1;MBP
8459,GO:0032502,1.51777032798943e-10,0.999999999968075,67,5253,developmental process,BP,ARX;CRLF1;USH1C;SCIN;LTF;CLDN11;ZIC2;DSG2;EYA2;FGFR3;CAMK2A;CDH19;DCX;SOX10;FA2H;SLC17A7;MAG;CAV2;AHR;EFNB3;BVES;COL9A1;OTX1;CHD5;PPL;TRIM67;GJB6;PACSIN1;MYRF;PRKCG;PCDH8;GPNMB;ENPP2;MOG;ST8SIA2;FBN3;HAPLN1;EGFR;GFRA1;GRID2;SPOCK1;GJA1;NRGN;ACAN;DMTN;EDIL3;CSMD3;CTHRC1;LMO1;SCN9A;GJB1;IRX2;SGCD;NPTX1;KNDC1;DMRT2;UGT8;GPC6;CNTN2;PRAME;SLITRK2;CCK;HAPLN4;APOD;MYT1;MBP;SMOC1
3759,GO:0007417,5.04800179835444e-09,0.999999999038359,24,870,central nervous system development,BP,ARX;ZIC2;DCX;SOX10;FA2H;SLC17A7;MAG;OTX1;CHD5;MYRF;MOG;HAPLN1;EGFR;GRID2;SPOCK1;NRGN;ACAN;NPTX1;KNDC1;UGT8;CNTN2;HAPLN4;APOD;MBP
8458,GO:0032501,6.67142954149779e-09,0.999999998042347,68,5878,multicellular organismal process,BP,ARX;CRLF1;USH1C;SCIN;NOS2;LTF;CLDN11;ZIC2;DSG2;EYA2;FGFR3;CAMK2A;CDH19;CACNG4;DCX;SOX10;FA2H;SLC17A7;MAG;CAV2;AHR;EFNB3;BVES;COL9A1;OTX1;CHD5;PPL;TRIM67;GJB6;PACSIN1;MYRF;PRKCG;PCDH8;GPNMB;ENPP2;MOG;ST8SIA2;HAPLN1;EGFR;GFRA1;GRID2;SPOCK1;GJA1;NRGN;ACAN;DMTN;EDIL3;CSMD3;CTHRC1;LMO1;KCNJ4;SCN9A;GJB1;IRX2;SGCD;NPTX1;KNDC1;DMRT2;UGT8;GPC6;CNTN2;SLITRK2;CCK;HAPLN4;APOD;MYT1;MBP;SMOC1
7035,GO:0022610,1.45721823782782e-08,0.999999996763291,27,1163,biological adhesion,BP,LTF;CLDN11;DSG2;CDH19;ICAM5;MAG;EFNB3;BVES;PCDH8;GPNMB;MOG;HAPLN1;EGFR;GRID2;SPOCK1;ABI3BP;ACAN;DMTN;EDIL3;SUSD5;CNTN2;HAPLN4;APOD;HLA-DRB1;MBP;HLA-DRB5;COL28A1
11664,GO:0044459,4.45392996916726e-08,0.999999987095377,39,2392,plasma membrane part,CC,DSG2;CA11;FGFR3;CAMK2A;CDH19;CACNG4;ICAM5;MAG;CAV2;EFNB3;SLC38A1;BVES;SLC30A3;GJB6;PACSIN1;PRKCG;PCDH8;GPNMB;ENPP2;MOG;GPR17;EGFR;GFRA1;GRID2;GJA1;KCNJ6;DMTN;KCNJ4;SCN9A;GJB1;SGCD;RGS6;GPC6;CNTN2;ANKS1B;FPR3;HLA-DRB1;HLA-DRB5;KLRC2
3622,GO:0007155,5.54542008915311e-08,0.99999998713893,26,1156,cell adhesion,BP,CLDN11;DSG2;CDH19;ICAM5;MAG;EFNB3;BVES;PCDH8;GPNMB;MOG;HAPLN1;EGFR;GRID2;SPOCK1;ABI3BP;ACAN;DMTN;EDIL3;SUSD5;CNTN2;HAPLN4;APOD;HLA-DRB1;MBP;HLA-DRB5;COL28A1
7005,GO:0022010,6.35400531150539e-08,0.999999999206306,5,17,central nervous system myelination,BP,SOX10;FA2H;MAG;MYRF;CNTN2
8297,GO:0032291,6.35400531150539e-08,0.999999999206306,5,17,axon ensheathment in central nervous system,BP,SOX10;FA2H;MAG;MYRF;CNTN2
2824,GO:0005886,9.70040369340875e-08,0.999999968159887,54,4229,plasma membrane,CC,USH1C;SCIN;NOS2;CLDN11;DSG2;CA11;FGFR3;CAMK2A;CDH19;CACNG4;SLC17A7;ICAM5;MAG;CAV2;EFNB3;SLC38A1;BVES;SLC30A3;ATP10B;PPL;GJB6;PACSIN1;PRKCG;PCDH8;GPNMB;ENPP2;MOG;GPR17;EGFR;GFRA1;GRID2;GJA1;KCNJ6;DMTN;CSMD3;KCNJ4;SCN9A;GJB1;SGCD;NPTX1;UGT8;RIN1;RGS6;GPC6;CNTN2;ANKS1B;PRAME;SLITRK2;FPR3;HLA-DRB1;DAPK1;MBP;HLA-DRB5;KLRC2
16611,GO:0071944,2.22463738041054e-07,0.999999924597967,54,4325,cell periphery,CC,USH1C;SCIN;NOS2;CLDN11;DSG2;CA11;FGFR3;CAMK2A;CDH19;CACNG4;SLC17A7;ICAM5;MAG;CAV2;EFNB3;SLC38A1;BVES;SLC30A3;ATP10B;PPL;GJB6;PACSIN1;PRKCG;PCDH8;GPNMB;ENPP2;MOG;GPR17;EGFR;GFRA1;GRID2;GJA1;KCNJ6;DMTN;CSMD3;KCNJ4;SCN9A;GJB1;SGCD;NPTX1;UGT8;RIN1;RGS6;GPC6;CNTN2;ANKS1B;PRAME;SLITRK2;FPR3;HLA-DRB1;DAPK1;MBP;HLA-DRB5;KLRC2
7721,GO:0031175,1.00668047444328e-06,0.999999762529729,21,885,neuron projection development,BP,ARX;USH1C;CAMK2A;MAG;EFNB3;TRIM67;PACSIN1;EGFR;GFRA1;GRID2;SPOCK1;GJA1;CSMD3;CTHRC1;NPTX1;KNDC1;UGT8;CNTN2;SLITRK2;CCK;APOD
4564,GO:0009653,1.33193884624993e-06,0.999999564337235,36,2334,anatomical structure morphogenesis,BP,ARX;USH1C;LTF;EYA2;FGFR3;CAMK2A;CDH19;SOX10;MAG;EFNB3;BVES;COL9A1;OTX1;GJB6;PACSIN1;PCDH8;GPNMB;ENPP2;FBN3;EGFR;GFRA1;GRID2;GJA1;DMTN;CTHRC1;IRX2;NPTX1;KNDC1;DMRT2;UGT8;GPC6;CNTN2;SLITRK2;CCK;APOD;MBP
3706,GO:0007272,1.53479517940222e-06,0.999999880371993,8,113,ensheathment of neurons,BP,CLDN11;SOX10;FA2H;MAG;MYRF;UGT8;CNTN2;MBP
4056,GO:0008366,1.53479517940222e-06,0.999999880371993,8,113,axon ensheathment,BP,CLDN11;SOX10;FA2H;MAG;MYRF;UGT8;CNTN2;MBP
18033,GO:0098797,3.23548128269248e-06,0.999999373853035,15,532,plasma membrane protein complex,CC,CDH19;CACNG4;GJB6;EGFR;GRID2;GJA1;KCNJ6;KCNJ4;SCN9A;GJB1;SGCD;RGS6;CNTN2;HLA-DRB1;HLA-DRB5
5118,GO:0014003,3.86420757556106e-06,0.999999872194327,5,38,oligodendrocyte development,BP,SOX10;FA2H;MAG;MYRF;CNTN2
2635,GO:0005578,5.821575460916e-06,0.999999054806852,12,337,proteinaceous extracellular matrix,CC,COL9A1;FBN3;HAPLN1;SPOCK1;ABI3BP;ACAN;CTHRC1;GPC6;SLITRK2;HAPLN4;SMOC1;COL28A1
13049,GO:0048468,5.90048142332473e-06,0.999998075976204,30,1841,cell development,BP,ARX;USH1C;LTF;CAMK2A;SOX10;FA2H;MAG;CAV2;EFNB3;BVES;CHD5;TRIM67;PACSIN1;MYRF;EGFR;GFRA1;GRID2;SPOCK1;GJA1;DMTN;CSMD3;CTHRC1;SGCD;NPTX1;KNDC1;UGT8;CNTN2;SLITRK2;CCK;APOD
7003,GO:0022008,5.95635147405189e-06,0.999998193890621,26,1439,neurogenesis,BP,ARX;USH1C;CAMK2A;DCX;SOX10;FA2H;MAG;EFNB3;CHD5;TRIM67;PACSIN1;MYRF;EGFR;GFRA1;GRID2;SPOCK1;GJA1;CSMD3;CTHRC1;NPTX1;KNDC1;UGT8;CNTN2;SLITRK2;CCK;APOD
13149,GO:0048666,7.03949597954749e-06,0.999998105744735,21,1002,neuron development,BP,ARX;USH1C;CAMK2A;MAG;EFNB3;TRIM67;PACSIN1;EGFR;GFRA1;GRID2;SPOCK1;GJA1;CSMD3;CTHRC1;NPTX1;KNDC1;UGT8;CNTN2;SLITRK2;CCK;APOD
7629,GO:0031012,7.76008380661461e-06,0.999998587412299,13,425,extracellular matrix,CC,COL9A1;FBN3;HAPLN1;SPOCK1;ABI3BP;ACAN;EDIL3;CTHRC1;GPC6;SLITRK2;HAPLN4;SMOC1;COL28A1
2623,GO:0005540,8.27504143281091e-06,0.999999831609146,4,19,hyaluronic acid binding,MF,HAPLN1;ACAN;SUSD5;HAPLN4
13774,GO:0051239,1.342498583091e-05,0.999995117403657,35,2551,regulation of multicellular organismal process,BP,ARX;SCIN;NOS2;LTF;DSG2;CACNG4;SOX10;FA2H;MAG;EFNB3;BVES;TRIM67;PACSIN1;MYRF;GPNMB;ENPP2;MOG;EGFR;GRID2;SPOCK1;GJA1;DMTN;CSMD3;CTHRC1;LMO1;KCNJ4;KNDC1;DMRT2;GPC6;CNTN2;SLITRK2;CCK;APOD;MBP;SMOC1
10780,GO:0042552,1.53088131382448e-05,0.999998658879864,7,111,myelination,BP,SOX10;FA2H;MAG;MYRF;UGT8;CNTN2;MBP
13178,GO:0048699,1.93883717096032e-05,0.999993940031472,24,1346,generation of neurons,BP,ARX;USH1C;CAMK2A;DCX;SOX10;MAG;EFNB3;CHD5;TRIM67;PACSIN1;EGFR;GFRA1;GRID2;SPOCK1;GJA1;CSMD3;CTHRC1;NPTX1;KNDC1;UGT8;CNTN2;SLITRK2;CCK;APOD
13265,GO:0048869,2.02373359388079e-05,0.9999919594695,44,3636,cellular developmental process,BP,ARX;USH1C;SCIN;LTF;ZIC2;DSG2;EYA2;FGFR3;CAMK2A;CDH19;DCX;SOX10;FA2H;MAG;CAV2;EFNB3;BVES;CHD5;PPL;TRIM67;PACSIN1;MYRF;GPNMB;ENPP2;EGFR;GFRA1;GRID2;SPOCK1;GJA1;DMTN;CSMD3;CTHRC1;LMO1;SGCD;NPTX1;KNDC1;UGT8;CNTN2;PRAME;SLITRK2;CCK;APOD;MYT1;SMOC1
17948,GO:0098609,2.9159477000798e-05,0.999993154976295,15,647,cell-cell adhesion,BP,CLDN11;DSG2;CDH19;ICAM5;MAG;EFNB3;BVES;PCDH8;GPNMB;EGFR;GRID2;DMTN;HLA-DRB1;MBP;HLA-DRB5
7182,GO:0030154,3.21456502608069e-05,0.999987073171038,42,3453,cell differentiation,BP,ARX;USH1C;SCIN;LTF;ZIC2;DSG2;EYA2;FGFR3;CAMK2A;DCX;SOX10;FA2H;MAG;CAV2;EFNB3;BVES;CHD5;PPL;TRIM67;PACSIN1;MYRF;GPNMB;EGFR;GFRA1;GRID2;SPOCK1;GJA1;DMTN;CSMD3;CTHRC1;LMO1;SGCD;NPTX1;KNDC1;UGT8;CNTN2;PRAME;SLITRK2;CCK;APOD;MYT1;SMOC1
11637,GO:0044425,3.6975438727634e-05,0.999984417270336,55,5327,membrane part,CC,LTF;CLDN11;DSG2;CA11;FGFR3;CAMK2A;CDH19;CACNG4;SOX10;FA2H;SLC17A7;ICAM5;MAG;CAV2;EFNB3;SLC38A1;BVES;SLC30A3;ATP10B;GJB6;PACSIN1;MYRF;PRKCG;PCDH8;GPNMB;ENPP2;MOG;ST8SIA2;GPR17;GALNT13;EGFR;GFRA1;GRID2;GJA1;KCNJ6;DMTN;CSMD3;MGAT5B;KCNJ4;SCN9A;GJB1;SGCD;SUSD5;UGT8;RPRML;RGS6;GALNT9;GPC6;CNTN2;ANKS1B;SLITRK2;FPR3;HLA-DRB1;HLA-DRB5;KLRC2
18453,GO:0120039,3.82586565854886e-05,0.999990802663383,15,611,plasma membrane bounded cell projection morphogenesis,BP,ARX;CAMK2A;MAG;EFNB3;PACSIN1;ENPP2;EGFR;GFRA1;GJA1;NPTX1;KNDC1;UGT8;CNTN2;SLITRK2;CCK
13257,GO:0048858,3.88137779452239e-05,0.999990656944693,15,612,cell projection morphogenesis,BP,ARX;CAMK2A;MAG;EFNB3;PACSIN1;ENPP2;EGFR;GFRA1;GJA1;NPTX1;KNDC1;UGT8;CNTN2;SLITRK2;CCK
7205,GO:0030182,4.02638762189755e-05,0.999987398858047,22,1223,neuron differentiation,BP,ARX;USH1C;CAMK2A;MAG;EFNB3;CHD5;TRIM67;PACSIN1;EGFR;GFRA1;GRID2;SPOCK1;GJA1;CSMD3;CTHRC1;NPTX1;KNDC1;UGT8;CNTN2;SLITRK2;CCK;APOD
6890,GO:0021782,4.3628451286913e-05,0.999996481547566,6,92,glial cell development,BP,SOX10;FA2H;MAG;MYRF;EGFR;CNTN2
7130,GO:0030054,4.90669130144661e-05,0.999984832215771,21,1169,cell junction,CC,SCIN;CLDN11;DSG2;FGFR3;CAMK2A;CDH19;SLC17A7;CAV2;BVES;SLC30A3;PPL;GJB6;PACSIN1;PRKCG;PCDH8;EGFR;GRID2;GJA1;KCNJ4;GJB1;ANKS1B
8774,GO:0032990,5.05737755226112e-05,0.999987527656639,15,630,cell part morphogenesis,BP,ARX;CAMK2A;MAG;EFNB3;PACSIN1;ENPP2;EGFR;GFRA1;GJA1;NPTX1;KNDC1;UGT8;CNTN2;SLITRK2;CCK
18451,GO:0120036,6.00642225889266e-05,0.999980187697753,23,1351,plasma membrane bounded cell projection organization,BP,ARX;USH1C;CAMK2A;MAG;EFNB3;TRIM67;PACSIN1;ENPP2;EGFR;GFRA1;GRID2;SPOCK1;GJA1;DMTN;CSMD3;CTHRC1;NPTX1;KNDC1;UGT8;CNTN2;SLITRK2;CCK;APOD
2846,GO:0005922,6.35646951902751e-05,0.999999026013933,3,14,connexin complex,CC,GJB6;GJA1;GJB1
7734,GO:0031224,6.44697853849954e-05,0.999972633859201,46,4199,intrinsic component of membrane,CC,CLDN11;DSG2;FGFR3;CDH19;CACNG4;FA2H;SLC17A7;ICAM5;MAG;CAV2;EFNB3;SLC38A1;BVES;SLC30A3;ATP10B;GJB6;MYRF;PCDH8;GPNMB;ENPP2;MOG;ST8SIA2;GPR17;GALNT13;EGFR;GFRA1;GRID2;GJA1;KCNJ6;CSMD3;MGAT5B;KCNJ4;SCN9A;GJB1;SGCD;SUSD5;UGT8;RPRML;GALNT9;GPC6;CNTN2;SLITRK2;FPR3;HLA-DRB1;HLA-DRB5;KLRC2
11916,GO:0045202,6.6217889180468e-05,0.999981667053392,17,828,synapse,CC,USH1C;CAMK2A;CACNG4;SLC17A7;SLC30A3;PACSIN1;PRKCG;PCDH8;EGFR;GRID2;SPOCK1;NRGN;DMTN;KCNJ4;CNTN2;ANKS1B;CCK
5658,GO:0016021,7.60279766801286e-05,0.999967584678309,45,4090,integral component of membrane,CC,CLDN11;DSG2;FGFR3;CDH19;CACNG4;FA2H;SLC17A7;ICAM5;MAG;CAV2;EFNB3;SLC38A1;BVES;SLC30A3;ATP10B;GJB6;MYRF;PCDH8;GPNMB;ENPP2;MOG;ST8SIA2;GPR17;GALNT13;EGFR;GRID2;GJA1;KCNJ6;CSMD3;MGAT5B;KCNJ4;SCN9A;GJB1;SGCD;SUSD5;UGT8;RPRML;GALNT9;GPC6;CNTN2;SLITRK2;FPR3;HLA-DRB1;HLA-DRB5;KLRC2
7114,GO:0030030,8.19733665397308e-05,0.999972360788062,23,1381,cell projection organization,BP,ARX;USH1C;CAMK2A;MAG;EFNB3;TRIM67;PACSIN1;ENPP2;EGFR;GFRA1;GRID2;SPOCK1;GJA1;DMTN;CSMD3;CTHRC1;NPTX1;KNDC1;UGT8;CNTN2;SLITRK2;CCK;APOD
13540,GO:0050877,8.65445608534514e-05,0.999976479022078,16,800,nervous system process,BP,USH1C;ZIC2;CACNG4;SOX10;SLC17A7;MAG;GJB6;MYRF;PRKCG;EGFR;GRID2;NRGN;SCN9A;CNTN2;CCK;MBP
7969,GO:0031643,9.13323039325391e-05,0.999998440332955,3,13,positive regulation of myelination,BP,SOX10;MAG;MYRF
7847,GO:0031406,9.24525383816338e-05,0.99998908543603,7,170,carboxylic acid binding,MF,NOS2;MAG;ST8SIA2;HAPLN1;ACAN;SUSD5;HAPLN4
11095,GO:0043177,0.000104828707854907,0.99998736669794,7,172,organic acid binding,MF,NOS2;MAG;ST8SIA2;HAPLN1;ACAN;SUSD5;HAPLN4
11569,GO:0044304,0.00010810592657532,0.999992543075353,5,62,main axon,CC,MAG;SPOCK1;CNTN2;CCK;MBP
2825,GO:0005887,0.000113008171360836,0.99996187964733,22,1382,integral component of plasma membrane,CC,FGFR3;CACNG4;ICAM5;MAG;CAV2;EFNB3;SLC38A1;SLC30A3;PCDH8;GPNMB;ENPP2;GPR17;EGFR;GRID2;GJA1;KCNJ6;KCNJ4;SCN9A;GPC6;CNTN2;FPR3;KLRC2
13232,GO:0048812,0.000116091330841615,0.999970634277071,14,597,neuron projection morphogenesis,BP,ARX;CAMK2A;MAG;EFNB3;PACSIN1;EGFR;GFRA1;GJA1;NPTX1;KNDC1;UGT8;CNTN2;SLITRK2;CCK
326,GO:0000902,0.000126475748872607,0.999961622574387,18,939,cell morphogenesis,BP,ARX;CAMK2A;CDH19;MAG;EFNB3;BVES;PACSIN1;ENPP2;EGFR;GFRA1;GJA1;DMTN;NPTX1;KNDC1;UGT8;CNTN2;SLITRK2;CCK
2622,GO:0005539,0.000134550050981237,0.999983110931432,7,173,glycosaminoglycan binding,MF,LTF;GPNMB;HAPLN1;ABI3BP;ACAN;SUSD5;HAPLN4
2484,GO:0005201,0.00016798340029841,0.999987219963521,5,66,extracellular matrix structural constituent,MF,COL9A1;FBN3;HAPLN1;ACAN;HAPLN4
20808,GO:1905867,0.000172007965898349,0.999999391182703,2,4,epididymis development,BP,GJA1;GJB1
1370,GO:0003008,0.000190790783636277,0.999933077956192,22,1444,system process,BP,USH1C;NOS2;ZIC2;DSG2;CACNG4;SOX10;SLC17A7;MAG;BVES;GJB6;MYRF;PRKCG;EGFR;GRID2;GJA1;NRGN;KCNJ4;SCN9A;SGCD;CNTN2;CCK;MBP
5657,GO:0016020,0.000191990979884034,0.999914474462587,68,7580,membrane,CC,USH1C;SCIN;NOS2;LTF;CLDN11;DSG2;CA11;FGFR3;CAMK2A;CDH19;CACNG4;SOX10;FA2H;SLC17A7;ICAM5;MAG;CAV2;EFNB3;SLC38A1;BVES;SLC30A3;CHD5;ATP10B;PPL;GJB6;PACSIN1;MYRF;PRKCG;PCDH8;GPNMB;ENPP2;MOG;ST8SIA2;GPR17;GALNT13;EGFR;GFRA1;GRID2;GJA1;NRGN;KCNJ6;SNX22;DMTN;CSMD3;MGAT5B;KCNJ4;SCN9A;GJB1;SGCD;NPTX1;SUSD5;UGT8;RIN1;RPRML;RGS6;GALNT9;GPC6;MX2;CNTN2;ANKS1B;PRAME;SLITRK2;FPR3;HLA-DRB1;DAPK1;MBP;HLA-DRB5;KLRC2
7736,GO:0031226,0.000194241972298194,0.999931777569259,22,1436,intrinsic component of plasma membrane,CC,FGFR3;CACNG4;ICAM5;MAG;CAV2;EFNB3;SLC38A1;SLC30A3;PCDH8;GPNMB;ENPP2;GPR17;EGFR;GRID2;GJA1;KCNJ6;KCNJ4;SCN9A;GPC6;CNTN2;FPR3;KLRC2
18003,GO:0098742,0.000231907186244737,0.999968206550251,7,164,cell-cell adhesion via plasma-membrane adhesion molecules,BP,CLDN11;DSG2;CDH19;MAG;PCDH8;GRID2;MBP
13482,GO:0050793,0.000271664010918288,0.999889963563976,29,2200,regulation of developmental process,BP,ARX;SCIN;LTF;FGFR3;SOX10;MAG;EFNB3;BVES;TRIM67;PACSIN1;MYRF;GPNMB;ENPP2;EGFR;GRID2;SPOCK1;GJA1;DMTN;CSMD3;CTHRC1;LMO1;KNDC1;DMRT2;GPC6;CNTN2;PRAME;SLITRK2;MBP;SMOC1
5169,GO:0014069,0.000274734858399488,0.99995445821595,8,221,postsynaptic density,CC,CAMK2A;CACNG4;PRKCG;GRID2;SPOCK1;NRGN;DMTN;ANKS1B
18264,GO:0099572,0.000283223904755135,0.999952832674381,8,222,postsynaptic specialization,CC,CAMK2A;CACNG4;PRKCG;GRID2;SPOCK1;NRGN;DMTN;ANKS1B
13186,GO:0048709,0.000284743749433767,0.999975436279752,5,87,oligodendrocyte differentiation,BP,SOX10;FA2H;MAG;MYRF;CNTN2
10993,GO:0043005,0.000286880936940936,0.999903766580317,19,1134,neuron projection,CC,USH1C;CAMK2A;DCX;SLC17A7;MAG;SLC30A3;PACSIN1;PRKCG;PCDH8;GRID2;SPOCK1;NRGN;NPTX1;KNDC1;CNTN2;ANKS1B;CCK;APOD;MBP
18030,GO:0098794,0.000290369244232909,0.999933367937775,11,430,postsynapse,CC,CAMK2A;CACNG4;SLC17A7;PRKCG;PCDH8;GRID2;SPOCK1;NRGN;DMTN;KCNJ4;ANKS1B
8292,GO:0032286,0.000298422960017282,0.999998605691008,2,4,central nervous system myelin maintenance,BP,FA2H;MYRF
8289,GO:0032279,0.000320381715216877,0.99994563065299,8,226,asymmetric synapse,CC,CAMK2A;CACNG4;PRKCG;GRID2;SPOCK1;NRGN;DMTN;ANKS1B
18143,GO:0098984,0.000344941622907689,0.999940794644539,8,229,neuron to neuron synapse,CC,CAMK2A;CACNG4;PRKCG;GRID2;SPOCK1;NRGN;DMTN;ANKS1B
5114,GO:0012506,0.000349078572994477,0.999901305729345,14,725,vesicle membrane,CC,NOS2;CAMK2A;CACNG4;SLC17A7;CAV2;SLC30A3;ATP10B;PACSIN1;EGFR;NRGN;SNX22;KCNJ4;HLA-DRB1;HLA-DRB5
2845,GO:0005921,0.00036145327410081,0.999989262287525,3,23,gap junction,CC,GJB6;GJA1;GJB1
11662,GO:0044456,0.000361560010359349,0.999897441439815,14,697,synapse part,CC,CAMK2A;CACNG4;SLC17A7;SLC30A3;PACSIN1;PRKCG;PCDH8;GRID2;SPOCK1;NRGN;DMTN;KCNJ4;ANKS1B;CCK
4618,GO:0009888,0.000385787709978106,0.999854260715857,23,1600,tissue development,BP,ARX;CRLF1;USH1C;SCIN;LTF;DSG2;EYA2;FGFR3;SOX10;FA2H;CAV2;BVES;PPL;PCDH8;GPNMB;EGFR;GJA1;CTHRC1;IRX2;SGCD;DMRT2;GPC6;APOD
8773,GO:0032989,0.000390235749525235,0.999869591746015,18,1030,cellular component morphogenesis,BP,ARX;CAMK2A;CDH19;MAG;EFNB3;BVES;PACSIN1;ENPP2;EGFR;GFRA1;GJA1;DMTN;NPTX1;KNDC1;UGT8;CNTN2;SLITRK2;CCK
7091,GO:0023052,0.000399324365129128,0.99981083609819,53,5421,signaling,BP,CRLF1;NOS2;LTF;DSG2;EYA2;FGFR3;CAMK2A;CACNG4;DCX;SOX10;SLC17A7;CAV2;AHR;EFNB3;BVES;CHD5;TRIM67;PRKCG;PCDH8;GPNMB;ENPP2;MOG;GPR17;EGFR;GFRA1;GRID2;SPOCK1;GJA1;NRGN;DMTN;PHKG1;CTHRC1;KCNJ4;SCN9A;GJB1;NPTX1;KNDC1;SUSD5;RIN1;RGS6;GPC6;MX2;CNTN2;PRAME;CCK;FPR3;APOD;HLA-DRB1;DAPK1;MBP;HLA-DRB5;SMOC1;KLRC2
623,GO:0001764,0.000435062303061502,0.99994571310209,6,130,neuron migration,BP,ARX;DCX;SPOCK1;GJA1;CNTN2;CCK
7454,GO:0030665,0.000455640340125146,0.999956249811479,5,99,clathrin-coated vesicle membrane,CC,SLC17A7;EGFR;NRGN;HLA-DRB1;HLA-DRB5
13071,GO:0048513,0.000462007629406547,0.999796116383787,34,2884,animal organ development,BP,ARX;CRLF1;USH1C;SCIN;LTF;ZIC2;DSG2;FGFR3;SOX10;FA2H;SLC17A7;CAV2;BVES;COL9A1;OTX1;CHD5;PPL;GJB6;GPNMB;EGFR;GRID2;GJA1;NRGN;DMTN;CTHRC1;LMO1;IRX2;SGCD;KNDC1;GPC6;CNTN2;APOD;MBP;SMOC1
6950,GO:0021895,0.00048249936545722,0.999984241250489,3,22,cerebral cortex neuron differentiation,BP,ARX;CHD5;CNTN2
7972,GO:0031646,0.000487463954289399,0.99998394960756,3,23,positive regulation of neurological system process,BP,SOX10;MAG;MYRF
7254,GO:0030246,0.000497757930397589,0.999922038118675,7,222,carbohydrate binding,MF,MAG;ENPP2;GALNT13;ACAN;GALNT9;CNTN2;KLRC2
2608,GO:0005516,0.000542180414203609,0.999914138937075,7,183,calmodulin binding,MF,NOS2;CAMK2A;EGFR;NRGN;PHKG1;DAPK1;MBP
6925,GO:0021853,0.000566408307510373,0.999995753012524,2,5,cerebral cortex GABAergic interneuron migration,BP,ARX;CNTN2
20452,GO:1904936,0.000566408307510373,0.999995753012524,2,5,interneuron migration,BP,ARX;CNTN2
10572,GO:0042127,0.000631552682170317,0.999767497431248,20,1403,regulation of cell proliferation,BP,ARX;CRLF1;SCIN;NOS2;LTF;FGFR3;SOX10;FA2H;CAV2;AHR;CHD5;GJB6;GPNMB;EGFR;GJA1;CTHRC1;LMO1;PRAME;CCK;APOD
18450,GO:0120035,0.000669091657296183,0.999818257097639,12,561,regulation of plasma membrane bounded cell projection organization,BP,USH1C;MAG;EFNB3;TRIM67;PACSIN1;ENPP2;GRID2;SPOCK1;DMTN;CSMD3;KNDC1;CNTN2
17771,GO:0097458,0.000672190707886162,0.999745509913689,21,1418,neuron part,CC,USH1C;CAMK2A;CACNG4;DCX;SLC17A7;MAG;SLC30A3;PACSIN1;PRKCG;PCDH8;GRID2;SPOCK1;NRGN;DMTN;NPTX1;KNDC1;CNTN2;ANKS1B;CCK;APOD;MBP
5816,GO:0016328,0.000679197155142604,0.999951687481426,4,56,lateral plasma membrane,CC,DSG2;BVES;GJA1;GJB1
6949,GO:0021894,0.000692635533230459,0.99999374382026,2,6,cerebral cortex GABAergic interneuron development,BP,ARX;CNTN2
7817,GO:0031344,0.000768271992490639,0.999787916293696,12,570,regulation of cell projection organization,BP,USH1C;MAG;EFNB3;TRIM67;PACSIN1;ENPP2;GRID2;SPOCK1;DMTN;CSMD3;KNDC1;CNTN2
3621,GO:0007154,0.000838580825440041,0.999586680909295,52,5433,cell communication,BP,CRLF1;NOS2;LTF;DSG2;EYA2;FGFR3;CAMK2A;CACNG4;DCX;SOX10;SLC17A7;CAV2;AHR;EFNB3;CHD5;TRIM67;GJB6;PRKCG;PCDH8;GPNMB;ENPP2;MOG;GPR17;EGFR;GFRA1;GRID2;SPOCK1;GJA1;NRGN;DMTN;PHKG1;CTHRC1;SCN9A;GJB1;NPTX1;KNDC1;SUSD5;RIN1;RGS6;GPC6;MX2;CNTN2;PRAME;CCK;FPR3;APOD;HLA-DRB1;DAPK1;MBP;HLA-DRB5;SMOC1;KLRC2
941,GO:0002227,0.000872102525374879,0.999989466147264,2,12,innate immune response in mucosa,BP,NOS2;LTF
7450,GO:0030659,0.000883345364887749,0.999737821098437,13,706,cytoplasmic vesicle membrane,CC,CAMK2A;CACNG4;SLC17A7;CAV2;SLC30A3;ATP10B;PACSIN1;EGFR;NRGN;SNX22;KCNJ4;HLA-DRB1;HLA-DRB5
7970,GO:0031644,0.000885079193957844,0.999932014898087,4,64,regulation of neurological system process,BP,SOX10;MAG;MYRF;CCK
6981,GO:0021953,0.000917891205823955,0.999867230008633,6,161,central nervous system neuron differentiation,BP,ARX;CHD5;GRID2;SPOCK1;KNDC1;CNTN2
2148,GO:0004683,0.000958039171063741,0.999959443916366,3,28,calmodulin-dependent protein kinase activity,MF,CAMK2A;PHKG1;DAPK1
9009,GO:0033555,0.000989586862920363,0.999921571214016,4,66,multicellular organismal response to stress,BP,PRKCG;GJA1;SCN9A;CCK
21157,GO:2000026,0.00102545328483284,0.999582054683333,23,1706,regulation of multicellular organismal development,BP,SCIN;LTF;SOX10;MAG;EFNB3;TRIM67;PACSIN1;MYRF;GPNMB;ENPP2;EGFR;GRID2;SPOCK1;GJA1;CSMD3;CTHRC1;LMO1;KNDC1;DMRT2;GPC6;CNTN2;SLITRK2;MBP
18032,GO:0098796,0.00104624844054656,0.999640950228114,16,1047,membrane protein complex,CC,LTF;CDH19;CACNG4;GJB6;EGFR;GRID2;GJA1;KCNJ6;KCNJ4;SCN9A;GJB1;SGCD;RGS6;CNTN2;HLA-DRB1;HLA-DRB5
6846,GO:0021684,0.00106338670617053,0.999987396515299,2,7,cerebellar granular layer formation,BP,GRID2;KNDC1
6862,GO:0021707,0.00106338670617053,0.999987396515299,2,7,cerebellar granule cell differentiation,BP,GRID2;KNDC1
11471,GO:0044057,0.00108266828478291,0.99972864895801,10,462,regulation of system process,BP,DSG2;CACNG4;SOX10;MAG;BVES;MYRF;EGFR;GJA1;KCNJ4;CCK
3701,GO:0007267,0.00118203155515178,0.999540955050271,20,1434,cell-cell signaling,BP,NOS2;FGFR3;CAMK2A;CACNG4;SOX10;SLC17A7;EFNB3;PRKCG;PCDH8;GPNMB;EGFR;GRID2;GJA1;NRGN;CTHRC1;GJB1;NPTX1;GPC6;CNTN2;MBP
11925,GO:0045216,0.00130507355049456,0.999758891315558,7,224,cell-cell junction organization,BP,DSG2;CDH19;GJA1;DMTN;GJB1;UGT8;APOD
17939,GO:0098590,0.00138054514301252,0.999513273616175,16,967,plasma membrane region,CC,DSG2;CA11;CAMK2A;CACNG4;CAV2;BVES;GJB6;PACSIN1;PRKCG;PCDH8;EGFR;GRID2;GJA1;DMTN;KCNJ4;ANKS1B
1355,GO:0002931,0.00139748961455595,0.999931863643923,3,32,response to ischemia,BP,CAMK2A;BVES;GJA1
10822,GO:0042613,0.00142133018885832,0.999977531742677,2,14,MHC class II protein complex,CC,HLA-DRB1;HLA-DRB5
6913,GO:0021826,0.00147612600650671,0.999978531352825,2,8,substrate-independent telencephalic tangential migration,BP,ARX;CNTN2
6916,GO:0021830,0.00147612600650671,0.999978531352825,2,8,interneuron migration from the subpallium to the cortex,BP,ARX;CNTN2
6921,GO:0021843,0.00147612600650671,0.999978531352825,2,8,substrate-independent telencephalic tangential interneuron migration,BP,ARX;CNTN2
18277,GO:0099612,0.00155115775090694,0.999977727148002,2,7,protein localization to axon,BP,UGT8;CNTN2
9087,GO:0033691,0.00155731853520119,0.999976725159721,2,8,sialic acid binding,MF,MAG;ST8SIA2
16247,GO:0071346,0.00168674301732451,0.999780993350576,5,145,cellular response to interferon-gamma,BP,NOS2;CAMK2A;HLA-DRB1;DAPK1;HLA-DRB5
2503,GO:0005243,0.00175220831476421,0.999970772850533,2,10,gap junction channel activity,MF,GJA1;GJB1
7967,GO:0031641,0.00176290238341757,0.999906398948645,3,34,regulation of myelination,BP,SOX10;MAG;MYRF
13074,GO:0048518,0.00178753233292313,0.999084745607504,48,5037,positive regulation of biological process,BP,ARX;CRLF1;SCIN;NOS2;LTF;ZIC2;EYA2;FGFR3;CAMK2A;CACNG4;SOX10;TOX3;MAG;CAV2;AHR;EFNB3;BVES;SLC30A3;OTX1;CHD5;TRIM67;PACSIN1;MYRF;PRKCG;GPNMB;ENPP2;MOG;GPR17;EGFR;GRID2;GJA1;NRGN;ABI3BP;DMTN;EDIL3;CTHRC1;LMO1;KNDC1;DMRT2;CNTN2;PRAME;SLITRK2;CCK;FPR3;HLA-DRB1;DAPK1;MBP;HLA-DRB5
6845,GO:0021683,0.00184809801180185,0.999969004494256,2,9,cerebellar granular layer morphogenesis,BP,GRID2;KNDC1
6947,GO:0021892,0.00186185763962474,0.999967969191406,2,10,cerebral cortex GABAergic interneuron differentiation,BP,ARX;CNTN2
1637,GO:0003823,0.00192532765628425,0.999892957050362,3,45,antigen binding,MF,HLA-DRB1;HLA-DRB5;KLRC2
4659,GO:0010001,0.0020088899030824,0.999660226891817,6,190,glial cell differentiation,BP,SOX10;FA2H;MAG;MYRF;EGFR;CNTN2
13442,GO:0050730,0.00205994610961776,0.999649515570664,6,202,regulation of peptidyl-tyrosine phosphorylation,BP,CRLF1;FGFR3;ENPP2;EGFR;DMTN;CCK
7168,GO:0030133,0.00207660534613951,0.999526199091486,8,354,transport vesicle,CC,FGFR3;SLC17A7;CAV2;SLC30A3;NRGN;NPTX1;HLA-DRB1;HLA-DRB5
5780,GO:0016264,0.00214388579498042,0.999960368629026,2,10,gap junction assembly,BP,GJA1;GJB1
2839,GO:0005911,0.00214995299291341,0.999455081339048,9,399,cell-cell junction,CC,CLDN11;DSG2;CDH19;BVES;PPL;GJB6;PRKCG;GJA1;GJB1
7457,GO:0030669,0.0021557581457679,0.999875850206772,3,41,clathrin-coated endocytic vesicle membrane,CC,EGFR;HLA-DRB1;HLA-DRB5
3553,GO:0007009,0.00217899827580775,0.99978510248443,4,73,plasma membrane organization,BP,FA2H;CAV2;PACSIN1;MYRF
5455,GO:0015467,0.00218931318123231,0.999959093750865,2,10,G-protein activated inward rectifier potassium channel activity,MF,KCNJ6;KCNJ4
9086,GO:0033690,0.00220851085672404,0.999957832472643,2,11,positive regulation of osteoblast proliferation,BP,LTF;CTHRC1
3761,GO:0007420,0.00222236764160095,0.999303011159455,12,649,brain development,BP,ARX;ZIC2;SLC17A7;OTX1;CHD5;EGFR;GRID2;NRGN;KNDC1;CNTN2;APOD;MBP
4635,GO:0009931,0.00222918579235674,0.999957963503318,2,10,calcium-dependent protein serine/threonine kinase activity,MF,CAMK2A;PRKCG
8477,GO:0032536,0.00255115521116847,0.999947569598301,2,11,regulation of cell projection size,BP,USH1C;CNTN2
6317,GO:0018210,0.00259135043393308,0.999629512205216,5,131,peptidyl-threonine modification,BP,CAMK2A;GALNT13;DMTN;PHKG1;GALNT9
9292,GO:0034341,0.00263310978778382,0.999620605400446,5,163,response to interferon-gamma,BP,NOS2;CAMK2A;HLA-DRB1;DAPK1;HLA-DRB5
12149,GO:0045739,0.00264782767273273,0.999835852044486,3,42,positive regulation of DNA repair,BP,EYA2;PRKCG;EGFR
4997,GO:0010857,0.00268149717544474,0.999943469916348,2,11,calcium-dependent protein kinase activity,MF,CAMK2A;PRKCG
3702,GO:0007268,0.00269176443994627,0.99918285866038,11,598,chemical synaptic transmission,BP,CAMK2A;CACNG4;SLC17A7;PRKCG;PCDH8;EGFR;GRID2;NRGN;NPTX1;CNTN2;MBP
18106,GO:0098916,0.00269176443994627,0.99918285866038,11,598,anterograde trans-synaptic signaling,BP,CAMK2A;CACNG4;SLC17A7;PRKCG;PCDH8;EGFR;GRID2;NRGN;NPTX1;CNTN2;MBP
1037,GO:0002385,0.0027000851180142,0.999939180070359,2,18,mucosal immune response,BP,NOS2;LTF
17610,GO:0097154,0.00270948139971363,0.999941768939973,2,12,GABAergic neuron differentiation,BP,ARX;CNTN2
15114,GO:0061024,0.0027993084307175,0.999051421015325,13,803,membrane organization,BP,EYA2;CAMK2A;CACNG4;FA2H;CAV2;ATP10B;PACSIN1;MYRF;EGFR;SGCD;MX2;CNTN2;MBP
18242,GO:0099537,0.00281666396064088,0.999139818064448,11,601,trans-synaptic signaling,BP,CAMK2A;CACNG4;SLC17A7;PRKCG;PCDH8;EGFR;GRID2;NRGN;NPTX1;CNTN2;MBP
7455,GO:0030666,0.00284197856225125,0.999583773278471,5,151,endocytic vesicle membrane,CC,CAMK2A;CACNG4;EGFR;HLA-DRB1;HLA-DRB5
18241,GO:0099536,0.00286430944327085,0.999123330349482,11,602,synaptic signaling,BP,CAMK2A;CACNG4;SLC17A7;PRKCG;PCDH8;EGFR;GRID2;NRGN;NPTX1;CNTN2;MBP
9285,GO:0034330,0.00286942228525035,0.999389576332524,7,256,cell junction organization,BP,DSG2;CDH19;GJA1;DMTN;GJB1;UGT8;APOD
2481,GO:0005198,0.00291440490876473,0.999162171651685,10,587,structural molecule activity,MF,CLDN11;CAV2;BVES;COL9A1;PPL;FBN3;HAPLN1;ACAN;HAPLN4;MBP
5876,GO:0016477,0.00293194691689026,0.998850302006778,17,1193,cell migration,BP,ARX;DCX;SOX10;MAG;BVES;GPNMB;ENPP2;EGFR;SPOCK1;GJA1;DMTN;CTHRC1;GPC6;CNTN2;CCK;FPR3;APOD
1439,GO:0003161,0.00294714291867895,0.999933879408623,2,12,cardiac conduction system development,BP,DSG2;BVES
11122,GO:0043218,0.00300671374933161,0.999931055798752,2,13,compact myelin,CC,MAG;MBP
10493,GO:0040011,0.00305398440412406,0.998709124345154,20,1518,locomotion,BP,ARX;DCX;SOX10;MAG;CAV2;EFNB3;BVES;GPNMB;ENPP2;EGFR;GFRA1;SPOCK1;GJA1;DMTN;CTHRC1;GPC6;CNTN2;CCK;FPR3;APOD
327,GO:0000904,0.00312847960068004,0.998976401694462,12,659,cell morphogenesis involved in differentiation,BP,ARX;CAMK2A;MAG;EFNB3;BVES;GFRA1;DMTN;NPTX1;KNDC1;CNTN2;SLITRK2;CCK
2422,GO:0005102,0.00325150652759527,0.998711187106075,17,1300,signaling receptor binding,MF,CRLF1;NOS2;CAMK2A;ICAM5;MAG;EFNB3;GPNMB;MOG;EGFR;GFRA1;GJA1;DMTN;EDIL3;CTHRC1;ANKS1B;PRAME;CCK
11118,GO:0043209,0.00330942711670023,0.999497482879014,5,158,myelin sheath,CC,CLDN11;MAG;PACSIN1;CNTN2;MBP
5587,GO:0015868,0.0033805122484106,0.999916887426706,2,14,purine ribonucleotide transport,BP,GJA1;GJB1
9364,GO:0034443,0.00338654221782054,1,1,1,negative regulation of lipoprotein oxidation,BP,APOD
14872,GO:0060588,0.00338654221782054,1,1,1,negative regulation of lipoprotein lipid oxidation,BP,APOD
6843,GO:0021681,0.00346997398743897,0.999914377047903,2,13,cerebellar granular layer development,BP,GRID2;KNDC1
8191,GO:0032095,0.0034751402800743,0.999911434203299,2,17,regulation of response to food,BP,PRKCG;CCK
952,GO:0002251,0.00351836708390637,0.999908415060829,2,20,organ or tissue specific immune response,BP,NOS2;LTF
4898,GO:0010721,0.0035247761868135,0.999221065878118,7,277,negative regulation of cell development,BP,LTF;SOX10;MAG;EFNB3;SPOCK1;DMTN;CNTN2
10820,GO:0042611,0.00354095409392676,0.999906827932558,2,22,MHC protein complex,CC,HLA-DRB1;HLA-DRB5
14676,GO:0060322,0.0035574938829116,0.998816832812338,12,688,head development,BP,ARX;ZIC2;SLC17A7;OTX1;CHD5;EGFR;GRID2;NRGN;KNDC1;CNTN2;APOD;MBP
7276,GO:0030282,0.00365824479468421,0.999580562469853,4,93,bone mineralization,BP,LTF;FGFR3;GPNMB;GJA1
2773,GO:0005798,0.00385375161664634,0.999393412220067,5,162,Golgi-associated vesicle,CC,PACSIN1;GJA1;NRGN;HLA-DRB1;HLA-DRB5
5092,GO:0010975,0.00387751577419858,0.998925451249399,9,427,regulation of neuron projection development,BP,MAG;EFNB3;TRIM67;PACSIN1;GRID2;SPOCK1;CSMD3;KNDC1;CNTN2
7452,GO:0030662,0.00391460236826203,0.999381570535318,5,162,coated vesicle membrane,CC,SLC17A7;EGFR;NRGN;HLA-DRB1;HLA-DRB5
5584,GO:0015865,0.0039990874995947,0.999891939655347,2,15,purine nucleotide transport,BP,GJA1;GJB1
6316,GO:0018209,0.00403788259131916,0.999085060284667,7,285,peptidyl-serine modification,BP,CAMK2A;PRKCG;GALNT13;EGFR;DMTN;PHKG1;GALNT9
10069,GO:0035988,0.00404373340679108,0.999891018416545,2,14,chondrocyte proliferation,BP,LTF;FGFR3
17897,GO:0097755,0.00406487296738405,0.999704310727328,3,50,positive regulation of blood vessel diameter,BP,NOS2;EGFR;GJA1
7451,GO:0030660,0.00419411306395735,0.999498931173467,4,105,Golgi-associated vesicle membrane,CC,GJA1;NRGN;HLA-DRB1;HLA-DRB5
10984,GO:0042995,0.00427631472146648,0.99803708419454,23,1861,cell projection,CC,USH1C;SCIN;CAMK2A;DCX;SLC17A7;MAG;BVES;SLC30A3;PACSIN1;PRKCG;PCDH8;GRID2;SPOCK1;NRGN;DMTN;SCN9A;NPTX1;KNDC1;CNTN2;ANKS1B;CCK;APOD;MBP
9644,GO:0035249,0.00428499632181293,0.999487215536582,4,88,synaptic transmission, glutamatergic,BP,CACNG4;SLC17A7;EGFR;GRID2
14125,GO:0051899,0.00440149221722773,0.999469132906962,4,89,membrane depolarization,BP,CACNG4;GJA1;SCN9A;CCK
7052,GO:0022829,0.00458081408432014,0.999865483425175,2,17,wide pore channel activity,MF,GJA1;GJB1
3632,GO:0007165,0.00474457937058631,0.997427122616588,46,4994,signal transduction,BP,CRLF1;NOS2;LTF;EYA2;FGFR3;CAMK2A;CACNG4;DCX;SOX10;SLC17A7;CAV2;AHR;EFNB3;CHD5;TRIM67;PRKCG;GPNMB;ENPP2;MOG;GPR17;EGFR;GFRA1;GRID2;SPOCK1;GJA1;NRGN;DMTN;PHKG1;CTHRC1;KNDC1;SUSD5;RIN1;RGS6;GPC6;MX2;CNTN2;PRAME;CCK;FPR3;APOD;HLA-DRB1;DAPK1;MBP;HLA-DRB5;SMOC1;KLRC2
7082,GO:0023023,0.00488273939630354,0.999849628754742,2,20,MHC protein complex binding,MF,HLA-DRB1;KLRC2
12617,GO:0046718,0.00505787619598442,0.999363071728377,4,105,viral entry into host cell,BP,CAV2;EFNB3;MOG;EGFR
6860,GO:0021700,0.00506204728287867,0.998965220123814,6,228,developmental maturation,BP,LTF;FGFR3;SOX10;SLC17A7;GJA1;CNTN2
9284,GO:0034329,0.00512496992708022,0.998950499398648,6,215,cell junction assembly,BP,CDH19;GJA1;DMTN;GJB1;UGT8;APOD
10816,GO:0042605,0.00531439007930625,0.999828372127701,2,21,peptide antigen binding,MF,HLA-DRB1;HLA-DRB5
14121,GO:0051895,0.005314721162498,0.999833776555894,2,15,negative regulation of focal adhesion assembly,BP,DMTN;APOD
11970,GO:0045334,0.00540799728169421,0.999562153344626,3,57,clathrin-coated endocytic vesicle,CC,EGFR;HLA-DRB1;HLA-DRB5
5472,GO:0015633,0.00558760885892521,1,1,1,zinc-transporting ATPase activity,MF,SLC30A3
7171,GO:0030136,0.00560635090406706,0.99903545026838,5,168,clathrin-coated vesicle,CC,SLC17A7;EGFR;NRGN;HLA-DRB1;HLA-DRB5
7011,GO:0022029,0.00567010962737792,0.999535725709604,3,49,telencephalon cell migration,BP,ARX;EGFR;CNTN2
11121,GO:0043217,0.00576649039275498,0.999813449295455,2,14,myelin maintenance,BP,FA2H;MYRF
10743,GO:0042471,0.00577720840534326,0.999244457377027,4,106,ear morphogenesis,BP,USH1C;OTX1;GJB6;CTHRC1
12116,GO:0045667,0.00579329547129607,0.999241914154494,4,105,regulation of osteoblast differentiation,BP,LTF;GJA1;CTHRC1;SMOC1
7183,GO:0030155,0.0058823958774977,0.998130832143551,10,582,regulation of cell adhesion,BP,EFNB3;GPNMB;SPOCK1;ABI3BP;DMTN;EDIL3;APOD;HLA-DRB1;MBP;HLA-DRB5
21298,GO:2000287,0.00592788341776725,1,1,1,positive regulation of myotome development,BP,DMRT2
21300,GO:2000290,0.00592788341776725,1,1,1,regulation of myotome development,BP,DMRT2
19684,GO:1903392,0.00607208006908467,0.99979512256067,2,16,negative regulation of adherens junction organization,BP,DMTN;APOD
8906,GO:0033212,0.00620540180041202,1,1,1,iron assimilation,BP,LTF
8907,GO:0033214,0.00620540180041202,1,1,1,iron assimilation by chelation and transport,BP,LTF
10862,GO:0042710,0.00620540180041202,1,1,1,biofilm formation,BP,LTF
11458,GO:0044010,0.00620540180041202,1,1,1,single-species biofilm formation,BP,LTF
11625,GO:0044407,0.00620540180041202,1,1,1,single-species biofilm formation in or on host organism,BP,LTF
18636,GO:1900159,0.00620540180041202,1,1,1,positive regulation of bone mineralization involved in bone maturation,BP,LTF
18651,GO:1900190,0.00620540180041202,1,1,1,regulation of single-species biofilm formation,BP,LTF
18652,GO:1900191,0.00620540180041202,1,1,1,negative regulation of single-species biofilm formation,BP,LTF
18675,GO:1900228,0.00620540180041202,1,1,1,regulation of single-species biofilm formation in or on host organism,BP,LTF
18676,GO:1900229,0.00620540180041202,1,1,1,negative regulation of single-species biofilm formation in or on host organism,BP,LTF
21313,GO:2000308,0.00620540180041202,1,1,1,negative regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,LTF
4958,GO:0010812,0.00627531778220516,0.999466200885744,3,51,negative regulation of cell-substrate adhesion,BP,SPOCK1;DMTN;APOD
17768,GO:0097453,0.00628226100447324,1,1,1,mesaxon,CC,MAG
20856,GO:1990015,0.00628226100447324,1,1,1,ensheathing process,CC,MAG
13150,GO:0048667,0.0062874011583634,0.997983738624734,10,537,cell morphogenesis involved in neuron differentiation,BP,ARX;CAMK2A;MAG;EFNB3;GFRA1;NPTX1;KNDC1;CNTN2;SLITRK2;CCK
764,GO:0001949,0.0063190301653662,1,1,1,sebaceous gland cell differentiation,BP,FA2H
17077,GO:0080132,0.0063190301653662,1,1,1,fatty acid alpha-hydroxylase activity,MF,FA2H
18829,GO:1901215,0.00634466830448427,0.99887507434118,5,175,negative regulation of neuron death,BP,CRLF1;TOX3;MAG;PRKCG;GPNMB
8929,GO:0033268,0.00645954939086145,0.99977657413811,2,15,node of Ranvier,CC,SPOCK1;CNTN2
16389,GO:0071556,0.0065047990057845,0.999763954417156,2,25,integral component of lumenal side of endoplasmic reticulum membrane,CC,HLA-DRB1;HLA-DRB5
17921,GO:0098553,0.0065047990057845,0.999763954417156,2,25,lumenal side of endoplasmic reticulum membrane,CC,HLA-DRB1;HLA-DRB5
17787,GO:0097489,0.00658016336976338,1,1,1,multivesicular body, internal vesicle lumen,CC,EGFR
8198,GO:0032102,0.00665996980873539,0.998556673419933,6,258,negative regulation of response to external stimulus,BP,LTF;GPR17;GRID2;GJA1;CCK;APOD
6942,GO:0021885,0.00669475213372411,0.999416626856675,3,52,forebrain cell migration,BP,ARX;EGFR;CNTN2
10540,GO:0042063,0.00672635880390502,0.998540194112359,6,244,gliogenesis,BP,SOX10;FA2H;MAG;MYRF;EGFR;CNTN2
10700,GO:0042391,0.00676916448431836,0.998120235982615,8,398,regulation of membrane potential,BP,DSG2;CACNG4;SLC17A7;BVES;GRID2;GJA1;SCN9A;CCK
12626,GO:0046777,0.00687962793164343,0.998501369487103,6,225,protein autophosphorylation,BP,FGFR3;CAMK2A;PRKCG;GPNMB;EGFR;DAPK1
20044,GO:1904106,0.00690591522613922,1,1,1,protein localization to microvillus,BP,USH1C
9177,GO:0034103,0.00691106915422006,0.99938840739779,3,58,regulation of tissue remodeling,BP,GPNMB;EGFR;GJA1
17560,GO:0097060,0.00691176898284755,0.998269388871599,7,299,synaptic membrane,CC,CAMK2A;CACNG4;PRKCG;PCDH8;GRID2;KCNJ4;ANKS1B
16073,GO:0070977,0.00694281201084864,0.999750728694571,2,15,bone maturation,BP,LTF;FGFR3
12118,GO:0045669,0.00695363471294204,0.999384023013081,3,56,positive regulation of osteoblast differentiation,BP,LTF;GJA1;CTHRC1
3458,GO:0006862,0.00698355965429555,0.999741349057704,2,20,nucleotide transport,BP,GJA1;GJB1
7732,GO:0031214,0.0070166591725036,0.999029068868478,4,112,biomineral tissue development,BP,LTF;FGFR3;GPNMB;GJA1
1099,GO:0002505,0.00703973145242911,0.999987691444052,1,2,antigen processing and presentation of polysaccharide antigen via MHC class II,BP,HLA-DRB1
1100,GO:0002506,0.00703973145242911,0.999987691444052,1,2,polysaccharide assembly with MHC class II protein complex,BP,HLA-DRB1
15520,GO:0065006,0.00703973145242911,0.999987691444052,1,2,protein-carbohydrate complex assembly,BP,HLA-DRB1
16541,GO:0071823,0.00703973145242911,0.999987691444052,1,2,protein-carbohydrate complex subunit organization,BP,HLA-DRB1
6917,GO:0021831,0.00705506001649306,1,1,1,embryonic olfactory bulb interneuron precursor migration,BP,ARX
4136,GO:0008489,0.00709051352011535,1,1,1,UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity,MF,UGT8
12780,GO:0047263,0.00709051352011535,1,1,1,N-acylsphingosine galactosyltransferase activity,MF,UGT8
7449,GO:0030658,0.00711473311946816,0.998702512436568,5,184,transport vesicle membrane,CC,SLC17A7;SLC30A3;NRGN;HLA-DRB1;HLA-DRB5
7778,GO:0031295,0.00716567551544085,0.999354594650095,3,67,T cell costimulation,BP,EFNB3;HLA-DRB1;HLA-DRB5
14492,GO:0060047,0.00717256777598925,0.998421975893178,6,248,heart contraction,BP,DSG2;CACNG4;BVES;GJA1;KCNJ4;SGCD
3874,GO:0008068,0.00717351635490516,1,1,1,extracellularly glutamate-gated chloride channel activity,MF,SLC17A7
17742,GO:0097401,0.00717351635490516,1,1,1,synaptic vesicle lumen acidification,BP,SLC17A7
6766,GO:0021533,0.00724121489889648,0.999730716981645,2,17,cell differentiation in hindbrain,BP,GRID2;KNDC1
1524,GO:0003294,0.00729242666018069,1,1,1,atrial ventricular junction remodeling,BP,GJA1
4711,GO:0010232,0.00729242666018069,1,1,1,vascular transport,BP,GJA1
4856,GO:0010645,0.00729242666018069,1,1,1,regulation of cell communication by chemical coupling,BP,GJA1
4862,GO:0010652,0.00729242666018069,1,1,1,positive regulation of cell communication by chemical coupling,BP,GJA1
14564,GO:0060156,0.00729242666018069,1,1,1,milk ejection reflex,BP,GJA1
13078,GO:0048522,0.00732361929637843,0.995952303297023,42,4509,positive regulation of cellular process,BP,CRLF1;SCIN;NOS2;LTF;ZIC2;EYA2;FGFR3;CAMK2A;CACNG4;SOX10;TOX3;MAG;CAV2;AHR;EFNB3;BVES;OTX1;CHD5;TRIM67;PACSIN1;MYRF;PRKCG;GPNMB;ENPP2;GPR17;EGFR;GRID2;GJA1;NRGN;DMTN;CTHRC1;LMO1;KNDC1;DMRT2;CNTN2;PRAME;SLITRK2;CCK;HLA-DRB1;DAPK1;MBP;HLA-DRB5
7777,GO:0031294,0.00734530997047427,0.999332173556459,3,68,lymphocyte costimulation,BP,EFNB3;HLA-DRB1;HLA-DRB5
14763,GO:0060429,0.00735212855707123,0.99709225475571,14,996,epithelium development,BP,ARX;CRLF1;USH1C;DSG2;SOX10;FA2H;PPL;PCDH8;EGFR;GJA1;CTHRC1;IRX2;DMRT2;GPC6
13266,GO:0048870,0.00737038285300511,0.996819447731043,17,1309,cell motility,BP,ARX;DCX;SOX10;MAG;BVES;GPNMB;ENPP2;EGFR;SPOCK1;GJA1;DMTN;CTHRC1;GPC6;CNTN2;CCK;FPR3;APOD
14011,GO:0051674,0.00737038285300511,0.996819447731043,17,1309,localization of cell,BP,ARX;DCX;SOX10;MAG;BVES;GPNMB;ENPP2;EGFR;SPOCK1;GJA1;DMTN;CTHRC1;GPC6;CNTN2;CCK;FPR3;APOD
18711,GO:1900383,0.00737386216583069,1,1,1,regulation of synaptic plasticity by receptor localization to synapse,BP,ANKS1B
15339,GO:0061564,0.00746524209514977,0.997707616317109,9,471,axon development,BP,ARX;MAG;EFNB3;GFRA1;NPTX1;CNTN2;SLITRK2;CCK;APOD
3577,GO:0007043,0.00752566899371693,0.998938378880783,4,108,cell-cell junction assembly,BP,CDH19;GJA1;GJB1;UGT8
7170,GO:0030135,0.00756862953463168,0.998315109464408,6,259,coated vesicle,CC,SLC17A7;PACSIN1;EGFR;NRGN;HLA-DRB1;HLA-DRB5
4540,GO:0009605,0.00757065006102878,0.99645077568915,21,1859,response to external stimulus,BP,ARX;NOS2;LTF;MAG;EFNB3;PPL;GJB6;PRKCG;GPNMB;ENPP2;GPR17;EGFR;GFRA1;GRID2;GJA1;DMTN;MX2;CNTN2;CCK;FPR3;APOD
3697,GO:0007263,0.00757361292910202,0.999706325612005,2,21,nitric oxide mediated signal transduction,BP,NOS2;EGFR
8200,GO:0032104,0.00757726862154074,0.999704125907687,2,23,regulation of response to extracellular stimulus,BP,PRKCG;CCK
8203,GO:0032107,0.00757726862154074,0.999704125907687,2,23,regulation of response to nutrient levels,BP,PRKCG;CCK
19169,GO:1902178,0.00758792757660356,1,1,1,fibroblast growth factor receptor apoptotic signaling pathway,BP,FGFR3
1377,GO:0003015,0.00766100763817794,0.998290786079088,6,251,heart process,BP,DSG2;CACNG4;BVES;GJA1;KCNJ4;SGCD
11746,GO:0044788,0.00778654302092788,0.999694893951627,2,20,modulation by host of viral process,BP,LTF;CAV2
8197,GO:0032101,0.00778747293547516,0.997419759148932,10,643,regulation of response to external stimulus,BP,NOS2;LTF;PRKCG;GPR17;EGFR;GRID2;GJA1;DMTN;CCK;APOD
11306,GO:0043523,0.00780648927320191,0.998544215400745,5,184,regulation of neuron apoptotic process,BP,CRLF1;TOX3;MAG;PRKCG;GRID2
2126,GO:0004653,0.00781065671415018,0.999694785790251,2,19,polypeptide N-acetylgalactosaminyltransferase activity,MF,GALNT13;GALNT9
6326,GO:0018243,0.00781065671415018,0.999694785790251,2,19,protein O-linked glycosylation via threonine,BP,GALNT13;GALNT9
2477,GO:0005178,0.00792429704364735,0.998864835425158,4,111,integrin binding,MF,ICAM5;GPNMB;EGFR;EDIL3
3948,GO:0008194,0.00800036895428787,0.998849389595582,4,118,UDP-glycosyltransferase activity,MF,GALNT13;MGAT5B;UGT8;GALNT9
12057,GO:0045595,0.0080013100428513,0.996361911584806,19,1540,regulation of cell differentiation,BP,SCIN;LTF;SOX10;MAG;EFNB3;TRIM67;PACSIN1;EGFR;GRID2;SPOCK1;GJA1;DMTN;CSMD3;CTHRC1;LMO1;KNDC1;CNTN2;PRAME;SMOC1
2502,GO:0005242,0.0080958740498234,0.999676301831977,2,20,inward rectifier potassium channel activity,MF,KCNJ6;KCNJ4
5390,GO:0015267,0.00817472751410727,0.997654799194418,8,407,channel activity,MF,CACNG4;SLC17A7;GRID2;GJA1;KCNJ6;KCNJ4;SCN9A;GJB1
7048,GO:0022803,0.00817472751410727,0.997654799194418,8,407,passive transmembrane transporter activity,MF,CACNG4;SLC17A7;GRID2;GJA1;KCNJ6;KCNJ4;SCN9A;GJB1
4956,GO:0010810,0.00835173605397508,0.998418197548064,5,174,regulation of cell-substrate adhesion,BP,SPOCK1;ABI3BP;DMTN;EDIL3;APOD
2414,GO:0005088,0.00847679325015072,0.998069543436073,6,234,Ras guanyl-nucleotide exchange factor activity,MF,FGFR3;CAMK2A;EGFR;GFRA1;KNDC1;RIN1
17585,GO:0097110,0.00852024696374341,0.999186526877429,3,58,scaffold protein binding,MF,CAV2;GRID2;GJA1
7261,GO:0030260,0.0086083385931792,0.998735009283466,4,121,entry into host cell,BP,CAV2;EFNB3;MOG;EGFR
11626,GO:0044409,0.0086083385931792,0.998735009283466,4,121,entry into host,BP,CAV2;EFNB3;MOG;EGFR
14084,GO:0051806,0.0086083385931792,0.998735009283466,4,121,entry into cell of other organism involved in symbiotic interaction,BP,CAV2;EFNB3;MOG;EGFR
14091,GO:0051828,0.0086083385931792,0.998735009283466,4,121,entry into other organism involved in symbiotic interaction,BP,CAV2;EFNB3;MOG;EGFR
6325,GO:0018242,0.00862452710031814,0.999643658619496,2,20,protein O-linked glycosylation via serine,BP,GALNT13;GALNT9
9516,GO:0034752,0.00863588548173332,1,1,1,cytosolic aryl hydrocarbon receptor complex,CC,AHR
9517,GO:0034753,0.00863588548173332,1,1,1,nuclear aryl hydrocarbon receptor complex,CC,AHR
19746,GO:1903522,0.00865419225469416,0.998018246071778,6,258,regulation of blood circulation,BP,DSG2;CACNG4;BVES;EGFR;GJA1;KCNJ4
14164,GO:0051960,0.00875358542402688,0.996727426343105,12,765,regulation of nervous system development,BP,SOX10;MAG;EFNB3;TRIM67;PACSIN1;MYRF;GRID2;SPOCK1;CSMD3;KNDC1;CNTN2;SLITRK2
6857,GO:0021697,0.00882290610452854,0.999632725527901,2,19,cerebellar cortex formation,BP,GRID2;KNDC1
7966,GO:0031640,0.00890793001726073,0.999613207866659,2,34,killing of cells of other organism,BP,NOS2;LTF
11611,GO:0044364,0.00890793001726073,0.999613207866659,2,34,disruption of cells of other organism,BP,NOS2;LTF
18828,GO:1901214,0.00894677097706574,0.997936237996427,6,264,regulation of neuron death,BP,CRLF1;TOX3;MAG;PRKCG;GPNMB;GRID2
3633,GO:0007166,0.00899233410428054,0.995379210527037,27,2588,cell surface receptor signaling pathway,BP,CRLF1;NOS2;LTF;EYA2;FGFR3;CAMK2A;CACNG4;SOX10;SLC17A7;CAV2;EFNB3;MOG;GPR17;EGFR;GFRA1;GRID2;DMTN;CTHRC1;SUSD5;GPC6;MX2;CNTN2;FPR3;APOD;HLA-DRB1;DAPK1;HLA-DRB5
7173,GO:0030139,0.00902318969107198,0.99791403578059,6,274,endocytic vesicle,CC,LTF;CAMK2A;CACNG4;EGFR;HLA-DRB1;HLA-DRB5
3353,GO:0006688,0.00927268835186649,0.999599222414898,2,22,glycosphingolipid biosynthetic process,BP,ST8SIA2;UGT8
471,GO:0001503,0.00933572151429142,0.997522533713449,7,342,ossification,BP,LTF;FGFR3;GPNMB;EGFR;GJA1;CTHRC1;SMOC1
19067,GO:1901889,0.00942233868911631,0.999592378609455,2,20,negative regulation of cell junction assembly,BP,DMTN;APOD
16160,GO:0071206,0.00948493690287458,1,1,1,establishment of protein localization to juxtaparanode region of axon,BP,CNTN2
541,GO:0001618,0.0095674584224048,0.999044098719492,3,64,virus receptor activity,MF,EFNB3;MOG;EGFR
18382,GO:0104005,0.0095674584224048,0.999044098719492,3,64,hijacked molecular function,MF,EFNB3;MOG;EGFR
14646,GO:0060284,0.00964344952749441,0.996347361623037,12,782,regulation of cell development,BP,LTF;SOX10;MAG;EFNB3;TRIM67;PACSIN1;GRID2;SPOCK1;DMTN;CSMD3;KNDC1;CNTN2
551,GO:0001649,0.0100056451855648,0.998017278441008,5,191,osteoblast differentiation,BP,LTF;GPNMB;GJA1;CTHRC1;SMOC1
4004,GO:0008283,0.0100323033589328,0.995245787449246,20,1764,cell proliferation,BP,ARX;CRLF1;SCIN;NOS2;LTF;FGFR3;SOX10;FA2H;CAV2;AHR;CHD5;GJB6;GPNMB;EGFR;GJA1;CTHRC1;LMO1;PRAME;CCK;APOD
2500,GO:0005234,0.0105430592303656,0.999518487848353,2,19,extracellularly glutamate-gated ion channel activity,MF,SLC17A7;GRID2
3821,GO:0007610,0.010549268273033,0.996573413506254,9,523,behavior,BP,SLC17A7;EFNB3;PRKCG;EGFR;GJA1;NRGN;SCN9A;CNTN2;CCK
13228,GO:0048799,0.0105573944037602,0.999517491378283,2,19,animal organ maturation,BP,LTF;FGFR3
19007,GO:1901681,0.0105669153157512,0.997876134134136,5,204,sulfur compound binding,MF,LTF;GSTM1;GPNMB;ABI3BP;GPC6
14541,GO:0060122,0.0106318475292063,0.999504991421814,2,23,inner ear receptor cell stereocilium organization,BP,USH1C;CTHRC1
21195,GO:2000098,0.0106784931751972,0.999971626148871,1,2,negative regulation of smooth muscle cell-matrix adhesion,BP,APOD
9360,GO:0034439,0.0107985652906773,0.999970982699798,1,2,lipoprotein lipid oxidation,BP,APOD
9363,GO:0034442,0.0107985652906773,0.999970982699798,1,2,regulation of lipoprotein oxidation,BP,APOD
10592,GO:0042160,0.0107985652906773,0.999970982699798,1,2,lipoprotein modification,BP,APOD
10593,GO:0042161,0.0107985652906773,0.999970982699798,1,2,lipoprotein oxidation,BP,APOD
14871,GO:0060587,0.0107985652906773,0.999970982699798,1,2,regulation of lipoprotein lipid oxidation,BP,APOD
7133,GO:0030057,0.0109730997039396,0.999486073127049,2,20,desmosome,CC,DSG2;PPL
13650,GO:0051049,0.0110030741800512,0.994830070811547,19,1627,regulation of transport,BP,SCIN;NOS2;CAMK2A;CACNG4;BVES;SLC30A3;PACSIN1;PRKCG;EGFR;GJA1;KCNJ6;DMTN;KCNJ4;SCN9A;MX2;CCK;APOD;DAPK1;MBP
12297,GO:0046013,0.0110198436542875,0.99996977789678,1,2,regulation of T cell homeostatic proliferation,BP,LMO1
9084,GO:0033688,0.0110494571083668,0.999475107012767,2,23,regulation of osteoblast proliferation,BP,LTF;CTHRC1
13775,GO:0051240,0.0111790566099966,0.994951314901373,17,1389,positive regulation of multicellular organismal process,BP,ARX;SCIN;LTF;SOX10;MAG;TRIM67;PACSIN1;MYRF;ENPP2;EGFR;GRID2;GJA1;DMTN;CTHRC1;DMRT2;SLITRK2;MBP
17197,GO:0090066,0.0114623662413835,0.996509356581682,8,448,regulation of anatomical structure size,BP,USH1C;SCIN;NOS2;MAG;EGFR;GJA1;DMTN;CNTN2
11307,GO:0043524,0.0114730867702924,0.998165147987394,4,131,negative regulation of neuron apoptotic process,BP,CRLF1;TOX3;MAG;PRKCG
13185,GO:0048708,0.0114815530063692,0.998771921545922,3,67,astrocyte differentiation,BP,MAG;EGFR;CNTN2
21391,GO:2000405,0.0115198165551094,0.999966964906683,1,2,negative regulation of T cell migration,BP,APOD
21712,GO:2001022,0.0116739492906086,0.998741187656636,3,72,positive regulation of response to DNA damage stimulus,BP,EYA2;PRKCG;EGFR
18445,GO:0120025,0.0117060229331673,0.994275115986639,21,1793,plasma membrane bounded cell projection,CC,USH1C;CAMK2A;DCX;SLC17A7;MAG;BVES;SLC30A3;PACSIN1;PRKCG;PCDH8;GRID2;SPOCK1;NRGN;DMTN;NPTX1;KNDC1;CNTN2;ANKS1B;CCK;APOD;MBP
491,GO:0001533,0.0117091294986934,0.999423481329422,2,25,cornified envelope,CC,DSG2;PPL
13676,GO:0051094,0.0117529510498923,0.994926442548374,15,1157,positive regulation of developmental process,BP,ARX;SCIN;LTF;SOX10;MAG;TRIM67;PACSIN1;MYRF;ENPP2;GRID2;GJA1;DMTN;CTHRC1;DMRT2;SLITRK2
16807,GO:0072272,0.0117694802886189,0.999965513094761,1,2,proximal/distal pattern formation involved in metanephric nephron development,BP,IRX2
10289,GO:0036477,0.0117861410715163,0.995616111448371,11,721,somatodendritic compartment,CC,CACNG4;PRKCG;PCDH8;GRID2;NRGN;KNDC1;CNTN2;ANKS1B;CCK;APOD;MBP
17530,GO:0097013,0.0119909543660576,0.999952297516518,1,3,phagocytic vesicle lumen,CC,LTF
10994,GO:0043006,0.0120571204667998,0.999963801505508,1,2,activation of phospholipase A2 activity by calcium-mediated signaling,BP,EGFR
3845,GO:0008015,0.0120824659749719,0.996285524718415,8,458,blood circulation,BP,NOS2;DSG2;CACNG4;BVES;EGFR;GJA1;KCNJ4;SGCD
5112,GO:0012501,0.0121825288649493,0.994111836838289,20,1816,programmed cell death,BP,CRLF1;SCIN;LTF;DSG2;EYA2;FGFR3;CAMK2A;SOX10;TOX3;MAG;AHR;PPL;GJB6;PRKCG;EGFR;GRID2;GJA1;PRAME;CCK;DAPK1
12233,GO:0045907,0.0121997450337493,0.999384804302015,2,26,positive regulation of vasoconstriction,BP,EGFR;GJA1
3969,GO:0008219,0.0122286797960454,0.993992218288854,21,1940,cell death,BP,CRLF1;SCIN;LTF;DSG2;EYA2;FGFR3;CAMK2A;SOX10;TOX3;MAG;AHR;PPL;GJB6;PRKCG;GPNMB;EGFR;GRID2;GJA1;PRAME;CCK;DAPK1
10582,GO:0042137,0.0122766029367164,0.999962467429464,1,2,sequestering of neurotransmitter,BP,SLC17A7
4481,GO:0009311,0.0124663023579838,0.998622346053281,3,73,oligosaccharide metabolic process,BP,ST8SIA2;GALNT13;GALNT9
9866,GO:0035637,0.012498548317746,0.997384366289706,5,190,multicellular organismal signaling,BP,DSG2;CACNG4;GJA1;KCNJ4;SCN9A
12155,GO:0045745,0.0125416256806568,0.999356914081155,2,27,positive regulation of G-protein coupled receptor protein signaling pathway,BP,CAV2;CNTN2
13870,GO:0051402,0.0125919253962271,0.997357112971381,5,207,neuron apoptotic process,BP,CRLF1;TOX3;MAG;PRKCG;GRID2
12654,GO:0046849,0.012643508950687,0.998595981220016,3,72,bone remodeling,BP,EGFR;GJA1;CTHRC1
11634,GO:0044421,0.0126560497133353,0.993131252244834,30,3280,extracellular region part,CC,CRLF1;SCIN;LTF;CLDN11;DSG2;SLC38A1;COL9A1;PPL;GSTM1;ENPP2;FBN3;HAPLN1;EGFR;GFRA1;SPOCK1;GJA1;ABI3BP;ACAN;EDIL3;CTHRC1;GPC6;SLITRK2;CCK;HAPLN4;APOD;HLA-DRB1;CPNE4;HLA-DRB5;SMOC1;COL28A1
1375,GO:0003013,0.012773898508331,0.996033775607462,8,462,circulatory system process,BP,NOS2;DSG2;CACNG4;BVES;EGFR;GJA1;KCNJ4;SGCD
14846,GO:0060548,0.0128244885124712,0.994947861071406,12,891,negative regulation of cell death,BP,CRLF1;LTF;EYA2;FGFR3;SOX10;TOX3;MAG;PRKCG;GPNMB;EGFR;PRAME;DAPK1
13116,GO:0048598,0.012835923076788,0.9956940971601,9,539,embryonic morphogenesis,BP,USH1C;EYA2;OTX1;GJB6;PCDH8;GJA1;CTHRC1;IRX2;MBP
12983,GO:0048265,0.012851043634795,0.99933408942439,2,26,response to pain,BP,PRKCG;SCN9A
3518,GO:0006952,0.0132200258606592,0.994209627991255,15,1305,defense response,BP,NOS2;LTF;CAMK2A;GPR17;EGFR;GJA1;SCN9A;MX2;CCK;FPR3;APOD;HLA-DRB1;DAPK1;HLA-DRB5;KLRC2
20083,GO:1904207,0.0132814106541321,0.999956049601664,1,2,regulation of chemokine (C-C motif) ligand 2 secretion,BP,MBP
20084,GO:1904209,0.0132814106541321,0.999956049601664,1,2,positive regulation of chemokine (C-C motif) ligand 2 secretion,BP,MBP
2377,GO:0005006,0.0133960930138868,0.999955284702823,1,2,epidermal growth factor-activated receptor activity,MF,EGFR
1443,GO:0003165,0.0134032382418524,0.999955236826311,1,2,Purkinje myocyte development,BP,DSG2
16196,GO:0071260,0.013456869248556,0.998468724806152,3,76,cellular response to mechanical stimulus,BP,MAG;EGFR;GJA1
16928,GO:0072535,0.0134691952299421,0.999954793664376,1,2,tumor necrosis factor (ligand) superfamily member 11 production,BP,LTF
21312,GO:2000307,0.0134691952299421,0.999954793664376,1,2,regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,LTF
9083,GO:0033687,0.013487004585576,0.999283231447071,2,26,osteoblast proliferation,BP,LTF;CTHRC1
14685,GO:0060333,0.0135168212839282,0.998456129882946,3,83,interferon-gamma-mediated signaling pathway,BP,CAMK2A;HLA-DRB1;HLA-DRB5
18547,GO:1900015,0.0135472397619713,0.999276726174571,2,27,regulation of cytokine production involved in inflammatory response,BP,NOS2;APOD
13219,GO:0048771,0.0135895923390972,0.997715104435177,4,135,tissue remodeling,BP,GPNMB;EGFR;GJA1;CTHRC1
2171,GO:0004714,0.013606513254046,0.998452651311353,3,64,transmembrane receptor protein tyrosine kinase activity,MF,FGFR3;EFNB3;EGFR
635,GO:0001777,0.0137006083083487,0.99993767681693,1,3,T cell homeostatic proliferation,BP,LMO1
18634,GO:1900157,0.0137064075145108,0.999953181677129,1,2,regulation of bone mineralization involved in bone maturation,BP,LTF
19024,GO:1901731,0.0137413721782493,0.999952941668398,1,2,positive regulation of platelet aggregation,BP,DMTN
20312,GO:1904685,0.0137860810368477,0.999952633872126,1,2,positive regulation of metalloendopeptidase activity,BP,MBP
2749,GO:0005770,0.0138196161698345,0.997029830092478,5,219,late endosome,CC,SLC30A3;EGFR;GJA1;HLA-DRB1;HLA-DRB5
11136,GO:0043235,0.0138985121244642,0.996016140503226,7,351,receptor complex,CC,FGFR3;CACNG4;AHR;EGFR;GFRA1;GRID2;KLRC2
15854,GO:0070560,0.0139275863987267,0.999951653024156,1,2,protein secretion by platelet,BP,DMTN
15785,GO:0070435,0.0139353168640783,0.999951599148616,1,2,Shc-EGFR complex,CC,EGFR
8190,GO:0032094,0.0140268579781647,0.999231624079929,2,31,response to food,BP,PRKCG;CCK
4922,GO:0010750,0.0141720555868922,0.999949934624769,1,2,positive regulation of nitric oxide mediated signal transduction,BP,EGFR
1041,GO:0002399,0.0142351273298902,0.999924320921599,1,4,MHC class II protein complex assembly,BP,HLA-DRB1
2633,GO:0005576,0.014304626110303,0.992001858887887,33,3750,extracellular region,CC,CRLF1;SCIN;LTF;CLDN11;DSG2;CA11;FGFR3;SLC38A1;COL9A1;PPL;GSTM1;ENPP2;FBN3;HAPLN1;EGFR;GFRA1;SPOCK1;GJA1;ABI3BP;ACAN;EDIL3;CTHRC1;CREG2;GPC6;SLITRK2;CCK;HAPLN4;APOD;HLA-DRB1;CPNE4;HLA-DRB5;SMOC1;COL28A1
4854,GO:0010643,0.0144396679880518,0.999948018892511,1,2,cell communication by chemical coupling,BP,GJA1
11665,GO:0044463,0.0144479951606626,0.99343894841695,16,1252,cell projection part,CC,USH1C;MAG;BVES;PACSIN1;PRKCG;PCDH8;GRID2;SPOCK1;NRGN;DMTN;KNDC1;CNTN2;ANKS1B;CCK;APOD;MBP
18452,GO:0120038,0.0144479951606626,0.99343894841695,16,1252,plasma membrane bounded cell projection part,CC,USH1C;MAG;BVES;PACSIN1;PRKCG;PCDH8;GRID2;SPOCK1;NRGN;DMTN;KNDC1;CNTN2;ANKS1B;CCK;APOD;MBP
16283,GO:0071393,0.0145231515696468,0.999947413851427,1,2,cellular response to progesterone stimulus,BP,SOX10
9490,GO:0034702,0.0146649045250849,0.996236092725586,6,273,ion channel complex,CC,CACNG4;GRID2;KCNJ6;KCNJ4;SCN9A;CNTN2
8392,GO:0032425,0.0146855898012718,0.999946226484119,1,2,positive regulation of mismatch repair,BP,PRKCG
13187,GO:0048710,0.0146870531887428,0.999181930044355,2,27,regulation of astrocyte differentiation,BP,MAG;CNTN2
15792,GO:0070458,0.0147097556910054,0.999928124706883,1,3,cellular detoxification of nitrogen compound,BP,GSTM1
3754,GO:0007409,0.014750935563139,0.995302691262287,8,435,axonogenesis,BP,ARX;MAG;EFNB3;GFRA1;NPTX1;CNTN2;SLITRK2;CCK
16089,GO:0070997,0.0147704720026618,0.996200214340945,6,295,neuron death,BP,CRLF1;TOX3;MAG;PRKCG;GPNMB;GRID2
17558,GO:0097058,0.0148166040967341,0.999927073206554,1,3,CRLF-CLCF1 complex,CC,CRLF1
12667,GO:0046875,0.0148351565819312,0.999169314987217,2,27,ephrin receptor binding,MF,EFNB3;ANKS1B
7083,GO:0023024,0.015009346113136,0.999925156981212,1,3,MHC class I protein complex binding,MF,KLRC2
16974,GO:0072604,0.015026391908489,0.999151170447607,2,28,interleukin-6 secretion,BP,NOS2;MBP
8398,GO:0032431,0.0150811553844587,0.999924436662015,1,3,activation of phospholipase A2 activity,BP,EGFR
6941,GO:0021884,0.0154011933285607,0.999120482231184,2,27,forebrain neuron development,BP,ARX;CNTN2
2359,GO:0004982,0.015459589500558,0.999920583192664,1,3,N-formyl peptide receptor activity,MF,FPR3
3837,GO:0007628,0.0156177311049197,0.999103550387551,2,26,adult walking behavior,BP,EFNB3;CNTN2
5395,GO:0015276,0.0157541820216499,0.997234472565524,4,131,ligand-gated ion channel activity,MF,SLC17A7;GRID2;KCNJ6;KCNJ4
7054,GO:0022834,0.0157541820216499,0.997234472565524,4,131,ligand-gated channel activity,MF,SLC17A7;GRID2;KCNJ6;KCNJ4
14727,GO:0060384,0.0157736602603498,0.999092058444625,2,25,innervation,BP,PRKCG;NPTX1
14261,GO:0052548,0.0158225475661929,0.995863173870349,6,335,regulation of endopeptidase activity,BP,LTF;SPOCK1;CCK;DAPK1;MBP;COL28A1
15060,GO:0060931,0.0158469977737801,0.999937347656379,1,2,sinoatrial node cell development,BP,BVES
11033,GO:0043066,0.015902610464299,0.993818132114888,11,807,negative regulation of apoptotic process,BP,CRLF1;LTF;EYA2;FGFR3;SOX10;TOX3;MAG;PRKCG;EGFR;PRAME;DAPK1
13443,GO:0050731,0.0159869146176136,0.99717598336484,4,148,positive regulation of peptidyl-tyrosine phosphorylation,BP,CRLF1;FGFR3;ENPP2;CCK
7795,GO:0031315,0.0160736857192931,0.999935534909881,1,2,extrinsic component of mitochondrial outer membrane,CC,SOX10
3503,GO:0006928,0.0160776568705021,0.992004156845181,20,1741,movement of cell or subcellular component,BP,ARX;DSG2;DCX;SOX10;MAG;EFNB3;BVES;GPNMB;ENPP2;EGFR;GFRA1;SPOCK1;GJA1;DMTN;CTHRC1;GPC6;CNTN2;CCK;FPR3;APOD
13048,GO:0048408,0.0160997812910479,0.999913844558475,1,3,epidermal growth factor binding,MF,EGFR
20280,GO:1904613,0.0161346277747402,0.999935043131442,1,2,cellular response to 2,3,7,8-tetrachlorodibenzodioxine,BP,AHR
2605,GO:0005509,0.0163075598206317,0.994306933431933,9,553,calcium ion binding,MF,SCIN;DSG2;CDH19;PCDH8;ENPP2;FBN3;SPOCK1;EDIL3;SMOC1
19383,GO:1902732,0.0163459033768437,0.999911180327437,1,3,positive regulation of chondrocyte proliferation,BP,LTF
2289,GO:0004874,0.0163464961014933,0.999933318774745,1,2,aryl hydrocarbon receptor activity,MF,AHR
12058,GO:0045596,0.0163546990798665,0.994286394560097,9,575,negative regulation of cell differentiation,BP,LTF;SOX10;MAG;EFNB3;EGFR;SPOCK1;DMTN;CNTN2;PRAME
3762,GO:0007422,0.0164222241401168,0.997989953497971,3,73,peripheral nervous system development,BP,SOX10;FA2H;UGT8
1119,GO:0002534,0.0164271945874644,0.999023892273193,2,30,cytokine production involved in inflammatory response,BP,NOS2;APOD
7381,GO:0030507,0.0164719409455448,0.999029991074478,2,25,spectrin binding,MF,USH1C;DMTN
16485,GO:0071695,0.0164787555939775,0.997066301474384,4,137,anatomical structure maturation,BP,LTF;FGFR3;GJA1;CNTN2
13675,GO:0051093,0.0164851529087364,0.993558815341242,11,775,negative regulation of developmental process,BP,LTF;FGFR3;SOX10;MAG;EFNB3;EGFR;SPOCK1;GJA1;DMTN;CNTN2;PRAME
12171,GO:0045778,0.0166376316301515,0.997950279710248,3,78,positive regulation of ossification,BP,LTF;GJA1;CTHRC1
17151,GO:0086075,0.0167006086148957,0.999930385860467,1,2,gap junction channel activity involved in cardiac conduction electrical coupling,MF,GJA1
10613,GO:0042221,0.0168250310214622,0.990414583257113,34,3737,response to chemical,BP,ARX;CRLF1;NOS2;LTF;DSG2;FGFR3;CAMK2A;SOX10;SLC17A7;CAV2;AHR;EFNB3;SLC30A3;GJB6;PRKCG;GSTM1;GPNMB;ENPP2;FBN3;GPR17;EGFR;GFRA1;GJA1;DMTN;SCN9A;MX2;CNTN2;CCK;FPR3;APOD;HLA-DRB1;DAPK1;MBP;HLA-DRB5
15251,GO:0061337,0.0169264926137305,0.996962495351182,4,137,cardiac conduction,BP,DSG2;CACNG4;GJA1;KCNJ4
2750,GO:0005771,0.0169625830370521,0.998967364967555,2,35,multivesicular body,CC,EGFR;GJA1
19376,GO:1902722,0.017046407655142,0.999903373712909,1,3,positive regulation of prolactin secretion,BP,EGFR
3846,GO:0008016,0.0171152165910089,0.996119643655314,5,218,regulation of heart contraction,BP,DSG2;CACNG4;BVES;GJA1;KCNJ4
21194,GO:2000097,0.0171172502608039,0.999902565774727,1,3,regulation of smooth muscle cell-matrix adhesion,BP,APOD
17492,GO:0090659,0.0171220030746157,0.998966130506958,2,27,walking behavior,BP,EFNB3;CNTN2
11036,GO:0043069,0.0173006278446763,0.993190021925818,11,818,negative regulation of programmed cell death,BP,CRLF1;LTF;EYA2;FGFR3;SOX10;TOX3;MAG;PRKCG;EGFR;PRAME;DAPK1
9491,GO:0034703,0.017429924140743,0.9960331777927,5,204,cation channel complex,CC,CACNG4;KCNJ6;KCNJ4;SCN9A;CNTN2
9026,GO:0033590,0.0174904073141927,0.999898254067885,1,3,response to cobalamin,BP,EGFR
5731,GO:0016167,0.0175307974488085,0.999923260200569,1,2,glial cell-derived neurotrophic factor receptor activity,MF,GFRA1
13507,GO:0050829,0.0176473731464595,0.998895064736843,2,42,defense response to Gram-negative bacterium,BP,NOS2;LTF
3629,GO:0007162,0.0179315512035704,0.995885705755243,5,222,negative regulation of cell adhesion,BP,GPNMB;SPOCK1;DMTN;APOD;MBP
6612,GO:0019732,0.0179337393487122,0.999879696393817,1,4,antifungal humoral response,BP,LTF
7189,GO:0030162,0.0180200172299378,0.993597744596359,9,633,regulation of proteolysis,BP,LTF;TRIM67;PRKCG;SPOCK1;CNTN2;CCK;DAPK1;MBP;COL28A1
14172,GO:0051968,0.0181475759315277,0.99886770883209,2,28,positive regulation of synaptic transmission, glutamatergic,BP,CACNG4;EGFR
20725,GO:1905576,0.0183423969417208,0.999888056813025,1,3,ganglioside GT1b binding,MF,MAG
6379,GO:0018916,0.0185733232962342,0.999870927236175,1,4,nitrobenzene metabolic process,BP,GSTM1
3763,GO:0007423,0.0186666451933541,0.993792917621116,8,476,sensory organ development,BP,USH1C;SLC17A7;OTX1;GJB6;EGFR;GJA1;CTHRC1;SMOC1
9515,GO:0034751,0.0186837854500896,0.99988383302115,1,3,aryl hydrocarbon receptor complex,CC,AHR
2637,GO:0005581,0.018778457857181,0.99757940012694,3,78,collagen trimer,CC,COL9A1;CTHRC1;COL28A1
6856,GO:0021696,0.0188237422196369,0.998802595178204,2,28,cerebellar cortex morphogenesis,BP,GRID2;KNDC1
1441,GO:0003163,0.0192375864392529,0.99987681336558,1,3,sinoatrial node development,BP,BVES
15053,GO:0060921,0.0192375864392529,0.99987681336558,1,3,sinoatrial node cell differentiation,BP,BVES
18987,GO:1901655,0.0192822910051495,0.997486018877928,3,83,cellular response to ketone,BP,SOX10;AHR;EGFR
1039,GO:0002396,0.0193256689994559,0.999850943807041,1,5,MHC protein complex assembly,BP,HLA-DRB1
5525,GO:0015748,0.0193681270394692,0.997470613265247,3,83,organophosphate ester transport,BP,ATP10B;GJA1;GJB1
12801,GO:0047391,0.0193763149939906,0.999875022387739,1,3,alkylglycerophosphoethanolamine phosphodiesterase activity,MF,ENPP2
5669,GO:0016043,0.0195780574706784,0.988230881060402,48,5560,cellular component organization,BP,ARX;USH1C;SCIN;DSG2;EYA2;CAMK2A;CDH19;CACNG4;FA2H;TOX3;SLC17A7;ICAM5;MAG;CAV2;EFNB3;BVES;COL9A1;CHD5;ATP10B;PPL;TRIM67;PACSIN1;MYRF;PRKCG;ENPP2;HAPLN1;EGFR;GFRA1;GRID2;SPOCK1;GJA1;ABI3BP;ACAN;DMTN;CSMD3;CTHRC1;GJB1;SGCD;NPTX1;KNDC1;UGT8;MX2;CNTN2;SLITRK2;CCK;APOD;HLA-DRB1;MBP
9825,GO:0035585,0.0195852677899652,0.999904118832648,1,2,calcium-mediated signaling using extracellular calcium source,BP,DMTN
15979,GO:0070836,0.0196135496573876,0.999871929483128,1,3,caveola assembly,BP,CAV2
754,GO:0001937,0.0197865439696591,0.998700768721278,2,31,negative regulation of endothelial cell proliferation,BP,CAV2;GJA1
14010,GO:0051673,0.0199004978805958,0.999841907559393,1,5,membrane disruption in other organism,BP,LTF
13479,GO:0050789,0.019960727069043,0.98855079552051,74,9666,regulation of biological process,BP,ARX;CRLF1;USH1C;SCIN;NOS2;LTF;ZIC2;DSG2;EYA2;FGFR3;CAMK2A;CACNG4;DCX;SOX10;FA2H;TOX3;SLC17A7;ICAM5;MAG;CAV2;AHR;EFNB3;BVES;SLC30A3;OTX1;CHD5;TRIM67;GJB6;PACSIN1;MYRF;PRKCG;GPNMB;ENPP2;MOG;FBN3;GPR17;EGFR;GFRA1;GRID2;SPOCK1;GJA1;NRGN;ABI3BP;KCNJ6;DMTN;EDIL3;PHKG1;CSMD3;CTHRC1;LMO1;KCNJ4;SCN9A;IRX2;KNDC1;DMRT2;SUSD5;RIN1;RGS6;GPC6;MX2;CNTN2;PRAME;SLITRK2;CCK;FPR3;APOD;HLA-DRB1;MYT1;DAPK1;MBP;HLA-DRB5;SMOC1;KLRC2;COL28A1
7943,GO:0031589,0.0201292566256908,0.994454969318705,6,295,cell-substrate adhesion,BP,BVES;SPOCK1;ABI3BP;DMTN;EDIL3;APOD
7176,GO:0030144,0.0201543799852247,0.999864735875194,1,3,alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity,MF,MGAT5B
12113,GO:0045664,0.0201839739512834,0.992694174890923,9,566,regulation of neuron differentiation,BP,MAG;EFNB3;TRIM67;PACSIN1;GRID2;SPOCK1;CSMD3;KNDC1;CNTN2
19294,GO:1902495,0.020189067660493,0.994434804836358,6,295,transmembrane transporter complex,CC,CACNG4;GRID2;KCNJ6;KCNJ4;SCN9A;CNTN2
9669,GO:0035282,0.0203103461075489,0.997299776403017,3,83,segmentation,BP,PCDH8;IRX2;DMRT2
14575,GO:0060168,0.0203236909378072,0.999862443091988,1,3,positive regulation of adenosine receptor signaling pathway,BP,CNTN2
7021,GO:0022407,0.020333227509223,0.994379969283602,6,336,regulation of cell-cell adhesion,BP,EFNB3;GPNMB;DMTN;HLA-DRB1;MBP;HLA-DRB5
17595,GO:0097120,0.0204199191284348,0.998634505614227,2,32,receptor localization to synapse,BP,CACNG4;ANKS1B
6028,GO:0016757,0.0205008025567389,0.995129808929722,5,240,transferase activity, transferring glycosyl groups,MF,ST8SIA2;GALNT13;MGAT5B;UGT8;GALNT9
19066,GO:1901888,0.0205218238789391,0.997263300347569,3,80,regulation of cell junction assembly,BP,GJA1;DMTN;APOD
2650,GO:0005594,0.0208211584253701,0.999855593923093,1,3,collagen type IX trimer,CC,COL9A1
17383,GO:0090317,0.0211208606081707,0.998554505998288,2,36,negative regulation of intracellular protein transport,BP,DMTN;APOD
4594,GO:0009790,0.0214608931671874,0.990913086395933,12,888,embryo development,BP,USH1C;EYA2;SOX10;OTX1;GJB6;PCDH8;EGFR;GJA1;CTHRC1;IRX2;DMRT2;MBP
16680,GO:0072086,0.0214611720756533,0.99982745686686,1,4,specification of loop of Henle identity,BP,IRX2
564,GO:0001662,0.0215819379592038,0.998507731687173,2,35,behavioral fear response,BP,GJA1;CCK
933,GO:0002209,0.0215819379592038,0.998507731687173,2,35,behavioral defense response,BP,GJA1;CCK
2286,GO:0004869,0.0216792075833391,0.998487900368403,2,41,cysteine-type endopeptidase inhibitor activity,MF,LTF;SPOCK1
14260,GO:0052547,0.0217155353217047,0.993905865251877,6,358,regulation of peptidase activity,BP,LTF;SPOCK1;CCK;DAPK1;MBP;COL28A1
6410,GO:0019065,0.021733405826374,0.999842597399536,1,3,receptor-mediated endocytosis of virus by host cell,BP,CAV2
17051,GO:0075509,0.021733405826374,0.999842597399536,1,3,endocytosis involved in viral entry into host cell,BP,CAV2
9030,GO:0033594,0.0218299929720512,0.999821447283704,1,4,response to hydroxyisoflavone,BP,EGFR
5415,GO:0015319,0.0218854953433968,0.999840375624301,1,3,sodium:inorganic phosphate symporter activity,MF,SLC17A7
20940,GO:1990351,0.0219175576621479,0.99384460620769,6,303,transporter complex,CC,CACNG4;GRID2;KCNJ6;KCNJ4;SCN9A;CNTN2
8391,GO:0032423,0.0221464419078164,0.999836526985608,1,3,regulation of mismatch repair,BP,PRKCG
7191,GO:0030165,0.022205425919015,0.996947648544921,3,82,PDZ domain binding,MF,GRID2;GJA1;KCNJ4
767,GO:0001953,0.0222659389052571,0.998443496220905,2,31,negative regulation of cell-matrix adhesion,BP,DMTN;APOD
7058,GO:0022839,0.0223579408836973,0.993692401090398,6,305,ion gated channel activity,MF,CACNG4;SLC17A7;GRID2;KCNJ6;KCNJ4;SCN9A
3877,GO:0008076,0.0224266227200561,0.996902424457515,3,86,voltage-gated potassium channel complex,CC,KCNJ6;KCNJ4;CNTN2
14018,GO:0051693,0.0225010909262728,0.998418250801232,2,31,actin filament capping,BP,SCIN;DMTN
19874,GO:1903763,0.0225172997114066,0.99983097760379,1,3,gap junction channel activity involved in cell communication by electrical coupling,MF,GJA1
11087,GO:0043168,0.0225461342865891,0.987530803601571,26,2524,anion binding,MF,SCIN;NOS2;LTF;FGFR3;CAMK2A;MAG;BVES;CHD5;ATP10B;PACSIN1;PRKCG;GSTM1;GPNMB;ST8SIA2;HAPLN1;EGFR;NRGN;ABI3BP;SNX22;ACAN;PHKG1;SUSD5;GPC6;MX2;HAPLN4;DAPK1
13251,GO:0048852,0.0226680881819467,0.999828694498542,1,3,diencephalon morphogenesis,BP,OTX1
16806,GO:0072268,0.0226848682469278,0.999807118510828,1,4,pattern specification involved in metanephros development,BP,IRX2
10744,GO:0042472,0.0227017345963423,0.996849156238046,3,87,inner ear morphogenesis,BP,USH1C;OTX1;CTHRC1
13135,GO:0048640,0.0227441161162434,0.996842620625911,3,85,negative regulation of developmental growth,BP,FGFR3;MAG;GJA1
11426,GO:0043932,0.0227672549648407,0.99980570810892,1,4,ossification involved in bone remodeling,BP,CTHRC1
11788,GO:0044877,0.0227852445724469,0.990653435789607,11,804,protein-containing complex binding,MF,USH1C;SCIN;LTF;ICAM5;GPNMB;EGFR;ABI3BP;DMTN;EDIL3;HLA-DRB1;KLRC2
3053,GO:0006282,0.0229307736159837,0.996803734099528,3,89,regulation of DNA repair,BP,EYA2;PRKCG;EGFR
3822,GO:0007611,0.0229700866539615,0.994386537272322,5,223,learning or memory,BP,SLC17A7;PRKCG;EGFR;NRGN;CNTN2
2029,GO:0004517,0.02297305962611,0.999824029584915,1,3,nitric-oxide synthase activity,MF,NOS2
7056,GO:0022836,0.0232098799126863,0.993396054773003,6,308,gated channel activity,MF,CACNG4;SLC17A7;GRID2;KCNJ6;KCNJ4;SCN9A
20466,GO:1904970,0.0232422217435995,0.999819859805452,1,3,brush border assembly,BP,USH1C
20279,GO:1904612,0.0232881041578802,0.999819144085931,1,3,response to 2,3,7,8-tetrachlorodibenzodioxine,BP,AHR
7178,GO:0030148,0.0235875561344482,0.996674594145039,3,92,sphingolipid biosynthetic process,BP,FA2H;ST8SIA2;UGT8
13490,GO:0050804,0.0236132150360111,0.993253633645378,6,316,modulation of chemical synaptic transmission,BP,CAMK2A;CACNG4;EGFR;GRID2;NRGN;CNTN2
18208,GO:0099177,0.0236132150360111,0.993253633645378,6,316,regulation of trans-synaptic signaling,BP,CAMK2A;CACNG4;EGFR;GRID2;NRGN;CNTN2
11086,GO:0043167,0.024054186422744,0.985310813090045,48,5495,ion binding,MF,SCIN;NOS2;LTF;ZIC2;DSG2;EYA2;FGFR3;CAMK2A;CDH19;FA2H;MAG;BVES;COL9A1;CHD5;ATP10B;TRIM67;PACSIN1;PRKCG;GSTM1;PCDH8;GPNMB;ENPP2;ST8SIA2;FBN3;GALNT13;HAPLN1;EGFR;SPOCK1;NRGN;ABI3BP;SNX22;ACAN;EDIL3;PHKG1;LMO1;MGAT5B;SCN9A;NPTX1;VAT1L;DMRT2;SUSD5;GALNT9;GPC6;MX2;HAPLN4;MYT1;DAPK1;SMOC1
10813,GO:0042596,0.0241371025024805,0.99822462386926,2,37,fear response,BP,GJA1;CCK
4942,GO:0010771,0.0243293770280261,0.996534313196782,3,86,negative regulation of cell morphogenesis involved in differentiation,BP,MAG;EFNB3;DMTN
6449,GO:0019199,0.0243643444012383,0.996534020635433,3,79,transmembrane receptor protein kinase activity,MF,FGFR3;EFNB3;EGFR
896,GO:0002141,0.0244009541657369,0.999801345305102,1,3,stereocilia ankle link,CC,USH1C
897,GO:0002142,0.0244009541657369,0.999801345305102,1,3,stereocilia ankle link complex,CC,USH1C
11774,GO:0044854,0.0244929864841876,0.999774971450033,1,4,plasma membrane raft assembly,BP,CAV2
11777,GO:0044857,0.0244929864841876,0.999774971450033,1,4,plasma membrane raft organization,BP,CAV2
14574,GO:0060167,0.0245230970745439,0.999774414920456,1,4,regulation of adenosine receptor signaling pathway,BP,CNTN2
4482,GO:0009312,0.0246230560039375,0.998167583101554,2,38,oligosaccharide biosynthetic process,BP,GALNT13;GALNT9
14594,GO:0060199,0.0246632462907617,0.999771815422662,1,4,clathrin-sculpted glutamate transport vesicle,CC,SLC17A7
14597,GO:0060203,0.0246632462907617,0.999771815422662,1,4,clathrin-sculpted glutamate transport vesicle membrane,CC,SLC17A7
13448,GO:0050748,0.0249756750970789,0.999765966294537,1,4,negative regulation of lipoprotein metabolic process,BP,APOD
5124,GO:0014012,0.0250521738620251,0.999748931355216,1,5,peripheral nervous system axon regeneration,BP,APOD
18060,GO:0098839,0.0251573815934398,0.998120352462669,2,32,postsynaptic density membrane,CC,CACNG4;GRID2
8497,GO:0032570,0.0253188985047016,0.998083815115166,2,40,response to progesterone,BP,DSG2;SOX10
2158,GO:0004698,0.0253273631469149,0.999785884014803,1,3,calcium-dependent protein kinase C activity,MF,PRKCG
19670,GO:1903367,0.0254012358110903,0.999741849072967,1,5,positive regulation of fear response,BP,GJA1
21704,GO:2000987,0.0254012358110903,0.999741849072967,1,5,positive regulation of behavioral fear response,BP,GJA1
18986,GO:1901654,0.0254169355491871,0.9948292281578,4,172,response to ketone,BP,DSG2;SOX10;AHR;EGFR
21115,GO:1990911,0.0255409306189903,0.99975519370968,1,4,response to psychosocial stress,BP,PRKCG
9832,GO:0035594,0.0256220492220684,0.999753627652663,1,4,ganglioside binding,MF,MAG
13461,GO:0050767,0.0257642920807383,0.989719359503497,10,687,regulation of neurogenesis,BP,SOX10;MAG;EFNB3;TRIM67;PACSIN1;GRID2;SPOCK1;CSMD3;KNDC1;CNTN2
17786,GO:0097487,0.0258269918927566,0.999749648587053,1,4,multivesicular body, internal vesicle,CC,EGFR
3673,GO:0007215,0.0258613210180295,0.996230486417744,3,85,glutamate receptor signaling pathway,BP,CACNG4;GRID2;DAPK1
12174,GO:0045785,0.0258695874151098,0.99244800402553,6,352,positive regulation of cell adhesion,BP,EFNB3;ABI3BP;DMTN;EDIL3;HLA-DRB1;HLA-DRB5
15376,GO:0061628,0.0259774832979271,0.999774683793834,1,3,H3K27me3 modified histone binding,MF,CHD5
11891,GO:0045163,0.0263429519695691,0.999768260647958,1,3,clustering of voltage-gated potassium channels,BP,CNTN2
16657,GO:0072047,0.0264590458054003,0.999719778533034,1,5,proximal/distal pattern formation involved in nephron development,BP,IRX2
16679,GO:0072081,0.0264590458054003,0.999719778533034,1,5,specification of nephron tubule identity,BP,IRX2
11231,GO:0043394,0.0264737983716929,0.997961704507862,2,34,proteoglycan binding,MF,GPNMB;GPC6
6287,GO:0018108,0.0264893811269392,0.992228335819809,6,334,peptidyl-tyrosine phosphorylation,BP,CRLF1;FGFR3;ENPP2;EGFR;DMTN;CCK
21568,GO:2000672,0.0265020441515609,0.999736314129134,1,4,negative regulation of motor neuron apoptotic process,BP,CRLF1
9183,GO:0034112,0.0265342972534032,0.999735668268053,1,4,positive regulation of homotypic cell-cell adhesion,BP,DMTN
18286,GO:0099634,0.0266274987072001,0.997946290445911,2,33,postsynaptic specialization membrane,CC,CACNG4;GRID2
7273,GO:0030278,0.0268290538827344,0.994453251393655,4,167,regulation of ossification,BP,LTF;GJA1;CTHRC1;SMOC1
4652,GO:0009986,0.0269377891934824,0.989745500870714,9,632,cell surface,CC,LTF;DSG2;FGFR3;CDH19;MOG;EGFR;GFRA1;CNTN2;HLA-DRB1
16446,GO:0071638,0.0269648413250578,0.999708901994738,1,5,negative regulation of monocyte chemotactic protein-1 production,BP,APOD
2411,GO:0005085,0.0270771534879444,0.992021889401028,6,305,guanyl-nucleotide exchange factor activity,MF,FGFR3;CAMK2A;EGFR;GFRA1;KNDC1;RIN1
7525,GO:0030835,0.0271193969806002,0.997884925583042,2,34,negative regulation of actin filament depolymerization,BP,SCIN;DMTN
10919,GO:0042802,0.0271686192027572,0.986678807398881,16,1486,identical protein binding,MF,NOS2;CLDN11;FGFR3;CAMK2A;CDH19;SOX10;TOX3;MAG;CAV2;PACSIN1;GSTM1;EGFR;GJB1;DMRT2;CNTN2;DAPK1
6806,GO:0021587,0.0272062037724302,0.997874524854069,2,34,cerebellum morphogenesis,BP,GRID2;KNDC1
14539,GO:0060119,0.027241462987584,0.997865041189971,2,36,inner ear receptor cell development,BP,USH1C;CTHRC1
13531,GO:0050865,0.0273185554265087,0.991014734451505,7,464,regulation of cell activation,BP,AHR;EFNB3;GPNMB;DMTN;LMO1;HLA-DRB1;HLA-DRB5
6319,GO:0018212,0.0274280898922076,0.99188811294843,6,337,peptidyl-tyrosine modification,BP,CRLF1;FGFR3;ENPP2;EGFR;DMTN;CCK
13780,GO:0051249,0.0275277261645092,0.991846313688195,6,370,regulation of lymphocyte activation,BP,AHR;EFNB3;GPNMB;LMO1;HLA-DRB1;HLA-DRB5
3858,GO:0008038,0.0275683040239774,0.99783697214921,2,32,neuron recognition,BP,EFNB3;CNTN2
1413,GO:0003104,0.0276082487231361,0.999713706176344,1,4,positive regulation of glomerular filtration,BP,GJA1
11921,GO:0045211,0.0276338005132641,0.992914524867414,5,229,postsynaptic membrane,CC,CACNG4;PCDH8;GRID2;KCNJ4;ANKS1B
8930,GO:0033269,0.0276601272992699,0.999712622817772,1,4,internode region of axon,CC,MBP
13109,GO:0048585,0.0276937310994024,0.986390288073818,16,1434,negative regulation of response to stimulus,BP,LTF;EYA2;FGFR3;SOX10;CAV2;TRIM67;GPR17;EGFR;GRID2;GJA1;CTHRC1;RGS6;PRAME;CCK;APOD;DAPK1
12616,GO:0046717,0.027700063387595,0.995842674228514,3,99,acid secretion,BP,NOS2;SLC17A7;CCK
17087,GO:0080184,0.0277654190624736,0.999691258377814,1,5,response to phenylpropanoid,BP,EGFR
9493,GO:0034705,0.0278155279867041,0.995823647078248,3,93,potassium channel complex,CC,KCNJ6;KCNJ4;CNTN2
6872,GO:0021759,0.0279785434400315,0.999705928113438,1,4,globus pallidus development,BP,ARX
9432,GO:0034617,0.0279980593279052,0.999705515254367,1,4,tetrahydrobiopterin binding,MF,NOS2
19770,GO:1903556,0.0282420068164039,0.997724691319796,2,45,negative regulation of tumor necrosis factor superfamily cytokine production,BP,LTF;GPNMB
6029,GO:0016758,0.0283248687514784,0.994042539980452,4,175,transferase activity, transferring hexosyl groups,MF,GALNT13;MGAT5B;UGT8;GALNT9
13873,GO:0051410,0.028343624123772,0.999678188937158,1,5,detoxification of nitrogen compound,BP,GSTM1
7711,GO:0031133,0.0283730445146534,0.999697525504338,1,4,regulation of axon diameter,BP,CNTN2
16191,GO:0071253,0.0284435679634696,0.999696010778868,1,4,connexin binding,MF,GJA1
7031,GO:0022603,0.0285299987961581,0.987406330259594,12,943,regulation of anatomical structure morphogenesis,BP,MAG;EFNB3;BVES;GPNMB;ENPP2;DMTN;CTHRC1;KNDC1;DMRT2;GPC6;CNTN2;MBP
4630,GO:0009913,0.0286421816190488,0.993956021106453,4,173,epidermal cell differentiation,BP,USH1C;DSG2;FA2H;PPL
15144,GO:0061055,0.0286909579511855,0.999690666974653,1,4,myotome development,BP,DMRT2
9863,GO:0035633,0.028721592113004,0.999690001974611,1,4,maintenance of permeability of blood-brain barrier,BP,MBP
5125,GO:0014013,0.0287569522709337,0.995622598309119,3,98,regulation of gliogenesis,BP,SOX10;MAG;CNTN2
8397,GO:0032430,0.0287932504947009,0.99966783634602,1,5,positive regulation of phospholipase A2 activity,BP,EGFR
11644,GO:0044433,0.0288565539554477,0.986064821537808,15,1360,cytoplasmic vesicle part,CC,LTF;CAMK2A;CACNG4;SLC17A7;CAV2;SLC30A3;ATP10B;PACSIN1;EGFR;GJA1;NRGN;SNX22;KCNJ4;HLA-DRB1;HLA-DRB5
12655,GO:0046850,0.0289443823044927,0.997651571460204,2,38,regulation of bone remodeling,BP,EGFR;GJA1
15234,GO:0061302,0.0289915945621676,0.999663216778749,1,5,smooth muscle cell-matrix adhesion,BP,APOD
15056,GO:0060926,0.029075954090349,0.999682257007189,1,4,cardiac pacemaker cell development,BP,BVES
18550,GO:1900019,0.0291203164357111,0.999681280605077,1,4,regulation of protein kinase C activity,BP,EGFR
18551,GO:1900020,0.0291203164357111,0.999681280605077,1,4,positive regulation of protein kinase C activity,BP,EGFR
7013,GO:0022037,0.0291895757142655,0.995536635714222,3,92,metencephalon development,BP,OTX1;GRID2;KNDC1
13242,GO:0048839,0.0292501181622655,0.99379145084944,4,165,inner ear development,BP,USH1C;OTX1;GJB6;CTHRC1
9157,GO:0034056,0.0295574564728392,0.999671578160778,1,4,estrogen response element binding,MF,TOX3
5177,GO:0014706,0.0296068031019633,0.991090501576544,6,329,striated muscle tissue development,BP,DSG2;EYA2;CAV2;BVES;GJA1;SGCD
1502,GO:0003254,0.029663021675811,0.99755894046999,2,39,regulation of membrane depolarization,BP,GJA1;CCK
11642,GO:0044431,0.0298940324032377,0.987210919764299,11,849,Golgi apparatus part,CC,CAV2;ST8SIA2;GALNT13;EGFR;GJA1;ACAN;MGAT5B;GALNT9;GPC6;HLA-DRB1;HLA-DRB5
3347,GO:0006682,0.0300634094537737,0.999637694644975,1,5,galactosylceramide biosynthetic process,BP,UGT8
6526,GO:0019375,0.0300634094537737,0.999637694644975,1,5,galactolipid biosynthetic process,BP,UGT8
13462,GO:0050768,0.0304007789851312,0.992003108800375,5,245,negative regulation of neurogenesis,BP,SOX10;MAG;EFNB3;SPOCK1;CNTN2
6802,GO:0021575,0.0304663258041859,0.997461870446168,2,37,hindbrain morphogenesis,BP,GRID2;KNDC1
19388,GO:1902743,0.0304915101380184,0.997455942049285,2,38,regulation of lamellipodium organization,BP,ENPP2;DMTN
4216,GO:0008637,0.0305084987740346,0.995237181700582,3,114,apoptotic mitochondrial changes,BP,EYA2;CAMK2A;CCK
7353,GO:0030424,0.0305554885524637,0.988855796528747,8,514,axon,CC,SLC17A7;MAG;PACSIN1;SPOCK1;NRGN;CNTN2;CCK;MBP
9686,GO:0035326,0.0305718348946207,0.995234896687591,3,99,enhancer binding,MF,ARX;SOX10;AHR
9594,GO:0035093,0.0310503419716269,0.999637331736188,1,4,spermatogenesis, exchange of chromosomal proteins,BP,CHD5
13529,GO:0050863,0.0311201678154788,0.991752999689306,5,283,regulation of T cell activation,BP,EFNB3;GPNMB;LMO1;HLA-DRB1;HLA-DRB5
14569,GO:0060161,0.0311373695324357,0.999635282262173,1,4,positive regulation of dopamine receptor signaling pathway,BP,CAV2
9981,GO:0035821,0.031316064040499,0.995061088951849,3,115,modification of morphology or physiology of other organism,BP,NOS2;LTF;CAV2
12933,GO:0048167,0.0314285513055338,0.993180336451661,4,164,regulation of synaptic plasticity,BP,CAMK2A;GRID2;NRGN;CNTN2
4686,GO:0010107,0.0314799661352637,0.997325355992446,2,39,potassium ion import,BP,KCNJ6;KCNJ4
2537,GO:0005315,0.0314883977350273,0.999626956233055,1,4,inorganic phosphate transmembrane transporter activity,MF,SLC17A7
12665,GO:0046873,0.0315688401114346,0.989308925459078,7,412,metal ion transmembrane transporter activity,MF,CACNG4;SLC17A7;SLC38A1;SLC30A3;KCNJ6;KCNJ4;SCN9A
6896,GO:0021795,0.0316525108085074,0.997305487669535,2,38,cerebral cortex cell migration,BP,ARX;EGFR
1031,GO:0002376,0.0316598723520196,0.982409682746436,23,2461,immune system process,BP,SCIN;NOS2;LTF;CAMK2A;ICAM5;MAG;AHR;EFNB3;BVES;GPNMB;ENPP2;MOG;GPR17;DMTN;LMO1;MX2;FPR3;APOD;HLA-DRB1;DAPK1;MBP;HLA-DRB5;KLRC2
10604,GO:0042177,0.0317848695990547,0.994965882785286,3,105,negative regulation of protein catabolic process,BP,NOS2;PRKCG;EGFR
3498,GO:0006915,0.0321032333708724,0.983306708099581,18,1746,apoptotic process,BP,CRLF1;SCIN;LTF;EYA2;FGFR3;CAMK2A;SOX10;TOX3;MAG;AHR;GJB6;PRKCG;EGFR;GRID2;GJA1;PRAME;CCK;DAPK1
1442,GO:0003164,0.0321664394566605,0.999584872481123,1,5,His-Purkinje system development,BP,DSG2
3833,GO:0007623,0.0323981279851917,0.992896534896312,4,178,circadian rhythm,BP,NOS2;AHR;PRKCG;EGFR
15052,GO:0060920,0.0324214197494862,0.999578220586856,1,5,cardiac pacemaker cell differentiation,BP,BVES
17381,GO:0090315,0.0326649984034965,0.999571816091201,1,5,negative regulation of protein targeting to membrane,BP,DMTN
2436,GO:0005127,0.0327503425630467,0.999569560537025,1,5,ciliary neurotrophic factor receptor binding,MF,CRLF1
11525,GO:0044218,0.0327713094042243,0.999569005487051,1,5,other organism cell membrane,CC,LTF
11554,GO:0044279,0.0327713094042243,0.999569005487051,1,5,other organism membrane,CC,LTF
16550,GO:0071840,0.0328397176440088,0.9794454045078,48,5763,cellular component organization or biogenesis,BP,ARX;USH1C;SCIN;DSG2;EYA2;CAMK2A;CDH19;CACNG4;FA2H;TOX3;SLC17A7;ICAM5;MAG;CAV2;EFNB3;BVES;COL9A1;CHD5;ATP10B;PPL;TRIM67;PACSIN1;MYRF;PRKCG;ENPP2;HAPLN1;EGFR;GFRA1;GRID2;SPOCK1;GJA1;ABI3BP;ACAN;DMTN;CSMD3;CTHRC1;GJB1;SGCD;NPTX1;KNDC1;UGT8;MX2;CNTN2;SLITRK2;CCK;APOD;HLA-DRB1;MBP
12103,GO:0045654,0.0328550238759838,0.999548903958792,1,6,positive regulation of megakaryocyte differentiation,BP,SCIN
913,GO:0002175,0.0333316489982077,0.999581671834947,1,4,protein localization to paranode region of axon,BP,UGT8
894,GO:0002139,0.0334993689415959,0.999577420759155,1,4,stereocilia coupling link,CC,USH1C
2284,GO:0004866,0.0335952960782016,0.994552661763691,3,120,endopeptidase inhibitor activity,MF,LTF;SPOCK1;COL28A1
11160,GO:0043269,0.0336510165808331,0.987492680924841,8,554,regulation of ion transport,BP,CAMK2A;CACNG4;GJA1;KCNJ6;KCNJ4;SCN9A;CCK;DAPK1
4957,GO:0010811,0.0337090878258999,0.994542369563587,3,101,positive regulation of cell-substrate adhesion,BP,ABI3BP;DMTN;EDIL3
18029,GO:0098793,0.0337294778437023,0.989533028187375,6,355,presynapse,CC,CAMK2A;SLC17A7;SLC30A3;PACSIN1;PCDH8;CCK
21567,GO:2000671,0.0338036269716462,0.999541228715743,1,5,regulation of motor neuron apoptotic process,BP,CRLF1
8928,GO:0033267,0.0338672048811744,0.989484098130264,6,338,axon part,CC,MAG;PACSIN1;SPOCK1;CNTN2;CCK;MBP
13622,GO:0051015,0.0338828142040909,0.992474605220824,4,164,actin filament binding,MF,USH1C;SCIN;EGFR;DMTN
8082,GO:0031902,0.0338992538386605,0.994488523746838,3,114,late endosome membrane,CC,SLC30A3;HLA-DRB1;HLA-DRB5
10766,GO:0042531,0.0340550913248148,0.996959903097183,2,48,positive regulation of tyrosine phosphorylation of STAT protein,BP,CRLF1;FGFR3
4921,GO:0010749,0.0342501045974445,0.999528942753159,1,5,regulation of nitric oxide mediated signal transduction,BP,EGFR
17723,GO:0097367,0.0343666861886066,0.981183824317207,21,1979,carbohydrate derivative binding,MF,NOS2;LTF;FGFR3;CAMK2A;MAG;BVES;CHD5;ATP10B;PRKCG;GPNMB;ST8SIA2;HAPLN1;EGFR;ABI3BP;ACAN;PHKG1;SUSD5;GPC6;MX2;HAPLN4;DAPK1
14034,GO:0051716,0.0344320530514789,0.978330521614196,50,6151,cellular response to stimulus,BP,CRLF1;NOS2;LTF;EYA2;FGFR3;CAMK2A;CACNG4;DCX;SOX10;SLC17A7;MAG;CAV2;AHR;EFNB3;CHD5;TRIM67;GJB6;PRKCG;GSTM1;GPNMB;ENPP2;MOG;FBN3;GPR17;EGFR;GFRA1;GRID2;SPOCK1;GJA1;NRGN;DMTN;PHKG1;CTHRC1;KNDC1;SUSD5;RIN1;RGS6;GPC6;MX2;CNTN2;PRAME;CCK;FPR3;APOD;HLA-DRB1;DAPK1;MBP;HLA-DRB5;SMOC1;KLRC2
10034,GO:0035926,0.034611612473616,0.999518874301385,1,5,chemokine (C-C motif) ligand 2 secretion,BP,MBP
5148,GO:0014047,0.0346755387119972,0.99689053753454,2,41,glutamate secretion,BP,SLC17A7;CCK
6284,GO:0018105,0.0347387347178451,0.99053218018495,5,254,peptidyl-serine phosphorylation,BP,CAMK2A;PRKCG;EGFR;DMTN;PHKG1
2581,GO:0005436,0.0347834831906794,0.999514049604368,1,5,sodium:phosphate symporter activity,MF,SLC17A7
5416,GO:0015321,0.0347834831906794,0.999514049604368,1,5,sodium-dependent phosphate transmembrane transporter activity,MF,SLC17A7
5067,GO:0010941,0.0352706453824145,0.982125880293921,16,1515,regulation of cell death,BP,CRLF1;SCIN;LTF;EYA2;FGFR3;CAMK2A;SOX10;TOX3;MAG;PRKCG;GPNMB;EGFR;GRID2;PRAME;CCK;DAPK1
1118,GO:0002532,0.0354691787113034,0.99676547284304,2,47,production of molecular mediator involved in inflammatory response,BP,NOS2;APOD
10974,GO:0042981,0.0355019748491962,0.982381517305618,15,1390,regulation of apoptotic process,BP,CRLF1;SCIN;LTF;EYA2;FGFR3;CAMK2A;SOX10;TOX3;MAG;PRKCG;EGFR;GRID2;PRAME;CCK;DAPK1
13550,GO:0050890,0.0355384164181464,0.990255996305977,5,253,cognition,BP,SLC17A7;PRKCG;EGFR;NRGN;CNTN2
14837,GO:0060537,0.0357660577582095,0.988750978744308,6,343,muscle tissue development,BP,DSG2;EYA2;CAV2;BVES;GJA1;SGCD
14728,GO:0060385,0.0358095767491655,0.999484737188699,1,5,axonogenesis involved in innervation,BP,NPTX1
13099,GO:0048562,0.0358313427830858,0.990149880804972,5,266,embryonic organ morphogenesis,BP,USH1C;OTX1;GJB6;GJA1;CTHRC1
4808,GO:0010572,0.0358892681398848,0.999482424188472,1,5,positive regulation of platelet activation,BP,DMTN
2151,GO:0004689,0.0359199732300901,0.999481531586548,1,5,phosphorylase kinase activity,MF,PHKG1
2867,GO:0005964,0.0359199732300901,0.999481531586548,1,5,phosphorylase kinase complex,CC,PHKG1
6692,GO:0019898,0.0361494024468921,0.990039757158438,5,264,extrinsic component of membrane,CC,CDH19;SOX10;CAV2;GFRA1;RGS6
5652,GO:0016012,0.0364130735875551,0.99944511611646,1,6,sarcoglycan complex,CC,SGCD
18721,GO:1900449,0.0365153931730282,0.9966298830981,2,42,regulation of glutamate receptor signaling pathway,BP,CACNG4;DAPK1
7735,GO:0031225,0.0365675753590983,0.993872089446622,3,121,anchored component of membrane,CC,GFRA1;GPC6;CNTN2
469,GO:0001501,0.0366570823748776,0.987183147321749,7,447,skeletal system development,BP,SCIN;LTF;FGFR3;HAPLN1;ACAN;DMRT2;HAPLN4
4060,GO:0008376,0.03675001003263,0.99659103381535,2,44,acetylgalactosaminyltransferase activity,MF,GALNT13;GALNT9
14022,GO:0051701,0.0368747630020342,0.991577925467845,4,188,interaction with host,BP,CAV2;EFNB3;MOG;EGFR
18122,GO:0098943,0.0369273885686137,0.999413080641723,1,7,neurotransmitter receptor transport, postsynaptic endosome to lysosome,BP,CACNG4
15184,GO:0061135,0.0369954132994397,0.993768708493579,3,126,endopeptidase regulator activity,MF,LTF;SPOCK1;COL28A1
9674,GO:0035296,0.0370636502306503,0.993763707777289,3,112,regulation of tube diameter,BP,NOS2;EGFR;GJA1
17892,GO:0097746,0.0370636502306503,0.993763707777289,3,112,regulation of blood vessel diameter,BP,NOS2;EGFR;GJA1
4174,GO:0008544,0.0371366748773363,0.989691537232148,5,272,epidermis development,BP,USH1C;DSG2;FA2H;PPL;EGFR
2378,GO:0005007,0.0373165205605399,0.999440108212012,1,5,fibroblast growth factor-activated receptor activity,MF,FGFR3
19669,GO:1903365,0.0373854723478402,0.999398320020396,1,7,regulation of fear response,BP,GJA1
21657,GO:2000822,0.0373854723478402,0.999398320020396,1,7,regulation of behavioral fear response,BP,GJA1
18271,GO:0099601,0.0376692249976386,0.996458713953579,2,44,regulation of neurotransmitter receptor activity,BP,CACNG4;DAPK1
4782,GO:0010518,0.037735910035734,0.996446414265062,2,45,positive regulation of phospholipase activity,BP,FGFR3;EGFR
18726,GO:1900454,0.0377500822151614,0.999426919340815,1,5,positive regulation of long term synaptic depression,BP,GRID2
11034,GO:0043067,0.0377733279382796,0.981098201893968,15,1402,regulation of programmed cell death,BP,CRLF1;SCIN;LTF;EYA2;FGFR3;CAMK2A;SOX10;TOX3;MAG;PRKCG;EGFR;GRID2;PRAME;CCK;DAPK1
2399,GO:0005047,0.0379153802053557,0.999398020968974,1,6,signal recognition particle binding,MF,LTF
7125,GO:0030046,0.0380189623550257,0.999418661699126,1,5,parallel actin filament bundle assembly,BP,USH1C
7576,GO:0030900,0.0381189720080022,0.987829364245343,6,347,forebrain development,BP,ARX;OTX1;CHD5;EGFR;NRGN;CNTN2
9184,GO:0034113,0.0381201292851883,0.996387920748822,2,46,heterotypic cell-cell adhesion,BP,DSG2;MBP
10621,GO:0042246,0.0382187314939141,0.996364290046996,2,50,tissue regeneration,BP,GJA1;APOD
11747,GO:0044789,0.0382259845762328,0.99941226290297,1,5,modulation by host of viral release from host cell,BP,CAV2
11748,GO:0044791,0.0382259845762328,0.99941226290297,1,5,positive regulation by host of viral release from host cell,BP,CAV2
9941,GO:0035749,0.0384239142214434,0.999381637897379,1,6,myelin sheath adaxonal region,CC,MAG
15521,GO:0065007,0.0384741705033551,0.976991307181569,76,10209,biological regulation,BP,ARX;CRLF1;USH1C;SCIN;NOS2;LTF;ZIC2;DSG2;EYA2;FGFR3;CAMK2A;CACNG4;DCX;SOX10;FA2H;TOX3;SLC17A7;ICAM5;MAG;CAV2;AHR;EFNB3;SLC38A1;BVES;SLC30A3;OTX1;CHD5;ATP10B;TRIM67;GJB6;PACSIN1;MYRF;PRKCG;GPNMB;ENPP2;MOG;FBN3;GPR17;EGFR;GFRA1;GRID2;SPOCK1;GJA1;NRGN;ABI3BP;KCNJ6;DMTN;EDIL3;PHKG1;CSMD3;CTHRC1;LMO1;KCNJ4;SCN9A;IRX2;KNDC1;DMRT2;SUSD5;RIN1;RGS6;GPC6;MX2;CNTN2;PRAME;SLITRK2;CCK;FPR3;APOD;HLA-DRB1;MYT1;DAPK1;MBP;HLA-DRB5;SMOC1;KLRC2;COL28A1
7354,GO:0030425,0.038505047754604,0.985311997948429,8,541,dendrite,CC,PRKCG;PCDH8;GRID2;NRGN;KNDC1;ANKS1B;CCK;APOD
15793,GO:0070459,0.0385336484641825,0.999360505020892,1,7,prolactin secretion,BP,EGFR
11566,GO:0044300,0.0386616672621731,0.999398680246382,1,5,cerebellar mossy fiber,CC,SLC17A7
17763,GO:0097447,0.0386705831462497,0.98523636099801,8,542,dendritic tree,CC,PRKCG;PCDH8;GRID2;NRGN;KNDC1;ANKS1B;CCK;APOD
16268,GO:0071374,0.0386722526566578,0.999398348278902,1,5,cellular response to parathyroid hormone stimulus,BP,GJA1
7349,GO:0030414,0.0389184459933109,0.993315009505434,3,125,peptidase inhibitor activity,MF,LTF;SPOCK1;COL28A1
19287,GO:1902475,0.0390682443965096,0.9962538541626,2,44,L-alpha-amino acid transmembrane transport,BP,SLC17A7;SLC38A1
21797,GO:2001205,0.0395657468006631,0.999369991850546,1,5,negative regulation of osteoclast development,BP,LTF
13511,GO:0050839,0.0396414094713959,0.985905203423629,7,459,cell adhesion molecule binding,MF,DSG2;CDH19;ICAM5;PPL;GPNMB;EGFR;EDIL3
9433,GO:0034618,0.0397259783417415,0.999338671552432,1,6,arginine binding,MF,NOS2
14717,GO:0060373,0.0398080252773014,0.999362188371759,1,5,regulation of ventricular cardiac muscle cell membrane depolarization,BP,GJA1
2039,GO:0004528,0.0398173125283822,0.999335602614187,1,6,phosphodiesterase I activity,MF,ENPP2
8474,GO:0032532,0.0399861233511723,0.999329911365197,1,6,regulation of microvillus length,BP,USH1C
21388,GO:2000402,0.0399922320580714,0.999310778632416,1,7,negative regulation of lymphocyte migration,BP,APOD
9994,GO:0035860,0.0400399606867647,0.999354672280216,1,5,glial cell-derived neurotrophic factor receptor signaling pathway,BP,GFRA1
4839,GO:0010626,0.040129716677324,0.999351751637393,1,5,negative regulation of Schwann cell proliferation,BP,SOX10
14165,GO:0051961,0.0402108894113074,0.988601479727284,5,264,negative regulation of nervous system development,BP,SOX10;MAG;EFNB3;SPOCK1;CNTN2
13107,GO:0048583,0.040269446326126,0.975484369752381,32,3621,regulation of response to stimulus,BP,CRLF1;NOS2;LTF;EYA2;FGFR3;CAMK2A;CACNG4;SOX10;ICAM5;CAV2;CHD5;TRIM67;PRKCG;GPNMB;MOG;FBN3;GPR17;EGFR;GRID2;GJA1;DMTN;CTHRC1;RGS6;GPC6;CNTN2;PRAME;CCK;FPR3;APOD;HLA-DRB1;DAPK1;HLA-DRB5
21731,GO:2001046,0.0403425712145228,0.999317813127884,1,6,positive regulation of integrin-mediated signaling pathway,BP,DMTN
2504,GO:0005244,0.0403515748327863,0.990525049961103,4,179,voltage-gated ion channel activity,MF,CACNG4;KCNJ6;KCNJ4;SCN9A
7053,GO:0022832,0.0403515748327863,0.990525049961103,4,179,voltage-gated channel activity,MF,CACNG4;KCNJ6;KCNJ4;SCN9A
3623,GO:0007156,0.0404241459508943,0.992986949108669,3,93,homophilic cell adhesion via plasma membrane adhesion molecules,BP,DSG2;CDH19;PCDH8
11114,GO:0043203,0.0404511677545935,0.999294741276331,1,7,axon hillock,CC,CCK
15605,GO:0070141,0.0407100156858688,0.999305226484274,1,6,response to UV-A,BP,EGFR
5933,GO:0016576,0.0407379240989147,0.999304265715392,1,6,histone dephosphorylation,BP,EYA2
11749,GO:0044793,0.0407946484375361,0.999302310856142,1,6,negative regulation by host of viral process,BP,LTF
17155,GO:0086083,0.0408179930511033,0.999329132363177,1,5,cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication,MF,DSG2
6855,GO:0021695,0.0408247375125042,0.995990793094391,2,44,cerebellar cortex development,BP,GRID2;KNDC1
21341,GO:2000343,0.0408378501540033,0.999266289310762,1,8,positive regulation of chemokine (C-X-C motif) ligand 2 production,BP,MBP
10341,GO:0038023,0.04083889330096,0.982389759306718,10,817,signaling receptor activity,MF,FGFR3;AHR;EFNB3;GPR17;EGFR;GFRA1;GRID2;GPC6;FPR3;KLRC2
14529,GO:0060089,0.04083889330096,0.982389759306718,10,817,molecular transducer activity,MF,FGFR3;AHR;EFNB3;GPR17;EGFR;GFRA1;GRID2;GPC6;FPR3;KLRC2
7032,GO:0022604,0.0409712840118682,0.985332876578836,7,441,regulation of cell morphogenesis,BP,MAG;EFNB3;BVES;ENPP2;DMTN;KNDC1;CNTN2
17912,GO:0098532,0.0409941042449644,0.999275526489871,1,7,histone H3-K27 trimethylation,BP,CHD5
20509,GO:1905050,0.0412080372933541,0.999267883208528,1,7,positive regulation of metallopeptidase activity,BP,MBP
10982,GO:0042989,0.0413118472635013,0.999227836508072,1,10,sequestering of actin monomers,BP,SCIN
4823,GO:0010604,0.0415077418458422,0.975612129135135,26,2755,positive regulation of macromolecule metabolic process,BP,ARX;CRLF1;LTF;ZIC2;EYA2;FGFR3;SOX10;TOX3;CAV2;AHR;BVES;OTX1;TRIM67;MYRF;PRKCG;GPNMB;ENPP2;EGFR;GJA1;LMO1;KNDC1;DMRT2;CNTN2;CCK;DAPK1;MBP
10920,GO:0042803,0.0415097683707289,0.982919478630151,9,727,protein homodimerization activity,MF,NOS2;CAMK2A;CDH19;TOX3;MAG;CAV2;GSTM1;GJB1;DMRT2
13092,GO:0048546,0.0416058558197749,0.995868696670981,2,45,digestive tract morphogenesis,BP,SOX10;EGFR
9663,GO:0035272,0.041717991482501,0.995845771998475,2,47,exocrine system development,BP,SOX10;EGFR
2499,GO:0005231,0.0418657358761426,0.995825841899519,2,46,excitatory extracellular ligand-gated ion channel activity,MF,SLC17A7;GRID2
7524,GO:0030834,0.0418664361248223,0.995831743947292,2,44,regulation of actin filament depolymerization,BP,SCIN;DMTN
15685,GO:0070268,0.0418676721366994,0.995808116758525,2,53,cornification,BP,DSG2;PPL
19507,GO:1903012,0.0419818463118026,0.9992398965021,1,7,positive regulation of bone development,BP,LTF
19897,GO:1903800,0.0420081801631036,0.999238934683249,1,7,positive regulation of production of miRNAs involved in gene silencing by miRNA,BP,EGFR
12483,GO:0046476,0.0421008361507745,0.999235545596327,1,7,glycosylceramide biosynthetic process,BP,UGT8
68,GO:0000139,0.0421620814746238,0.982606473403518,9,681,Golgi membrane,CC,CAV2;ST8SIA2;GALNT13;EGFR;GJA1;MGAT5B;GALNT9;HLA-DRB1;HLA-DRB5
9593,GO:0035092,0.0423294782134872,0.999248357975038,1,6,sperm chromatin condensation,BP,CHD5
13543,GO:0050880,0.0424049385464671,0.992472133179087,3,120,regulation of blood vessel size,BP,NOS2;EGFR;GJA1
3424,GO:0006801,0.0424099741785829,0.995719735382517,2,55,superoxide metabolic process,BP,NOS2;EGFR
4940,GO:0010769,0.0424511778247824,0.987791908037002,5,259,regulation of cell morphogenesis involved in differentiation,BP,MAG;EFNB3;DMTN;KNDC1;CNTN2
727,GO:0001895,0.0426496225627996,0.995691207152617,2,51,retina homeostasis,BP,USH1C;LTF
9615,GO:0035150,0.0429690284618422,0.992331431854635,3,121,regulation of tube size,BP,NOS2;EGFR;GJA1
20956,GO:1990405,0.0431790231283962,0.999217615512701,1,6,protein antigen binding,MF,KLRC2
2290,GO:0004875,0.0435099128068827,0.999183061713824,1,7,complement receptor activity,MF,FPR3
14127,GO:0051901,0.0438511644531577,0.999153022263603,1,8,positive regulation of mitochondrial depolarization,BP,CCK
18125,GO:0098953,0.0439608877395594,0.999148741902856,1,8,receptor diffusion trapping,BP,CACNG4
18134,GO:0098970,0.0439608877395594,0.999148741902856,1,8,postsynaptic neurotransmitter receptor diffusion trapping,BP,CACNG4
18283,GO:0099628,0.0439608877395594,0.999148741902856,1,8,neurotransmitter receptor diffusion trapping,BP,CACNG4
1715,GO:0003958,0.0440001068453049,0.999187306975954,1,6,NADPH-hemoprotein reductase activity,MF,NOS2
11347,GO:0043583,0.0440410975340885,0.989361617547069,4,191,ear development,BP,USH1C;OTX1;GJB6;CTHRC1
5651,GO:0016011,0.0444058554985212,0.999148768396271,1,7,dystroglycan complex,CC,SGCD
6405,GO:0019058,0.0444085513094131,0.987060338483605,5,291,viral life cycle,BP,LTF;CAV2;EFNB3;MOG;EGFR
5743,GO:0016198,0.0445588209342976,0.99916634798951,1,6,axon choice point recognition,BP,EFNB3
6303,GO:0018193,0.0448014598890369,0.978171693416392,13,1143,peptidyl-amino acid modification,BP,CRLF1;NOS2;FGFR3;CAMK2A;CHD5;PRKCG;ENPP2;GALNT13;EGFR;DMTN;PHKG1;GALNT9;CCK
2761,GO:0005785,0.0449173977267628,0.999110962961345,1,8,signal recognition particle receptor complex,CC,LTF
9186,GO:0034115,0.0449834155777565,0.999108324684677,1,8,negative regulation of heterotypic cell-cell adhesion,BP,MBP
15875,GO:0070587,0.0449834155777565,0.999108324684677,1,8,regulation of cell-cell adhesion involved in gastrulation,BP,MBP
13732,GO:0051173,0.0449966753573701,0.973556776663142,25,2654,positive regulation of nitrogen compound metabolic process,BP,CRLF1;NOS2;LTF;ZIC2;EYA2;FGFR3;SOX10;TOX3;CAV2;AHR;OTX1;TRIM67;MYRF;PRKCG;GPNMB;ENPP2;EGFR;GJA1;LMO1;KNDC1;DMRT2;CNTN2;CCK;DAPK1;MBP
20449,GO:1904929,0.0450206587848502,0.999148817981886,1,6,coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway,MF,GPC6
1312,GO:0002862,0.045086050575616,0.999090192047566,1,9,negative regulation of inflammatory response to antigenic stimulus,BP,GPR17
9446,GO:0034638,0.0453476688822313,0.999093696469602,1,8,phosphatidylcholine catabolic process,BP,ENPP2
12036,GO:0045545,0.0453641191540071,0.999135660792636,1,6,syndecan binding,MF,GPNMB
10765,GO:0042509,0.0454134177504768,0.9952401429114,2,56,regulation of tyrosine phosphorylation of STAT protein,BP,CRLF1;FGFR3
5781,GO:0016266,0.0455286155166748,0.99524191934161,2,48,O-glycan processing,BP,GALNT13;GALNT9
11117,GO:0043208,0.0456447719066714,0.999100164643172,1,7,glycosphingolipid binding,MF,MAG
2603,GO:0005506,0.0457833024387119,0.991615300443858,3,129,iron ion binding,MF,NOS2;LTF;FA2H
14166,GO:0051962,0.045895605576593,0.983160233862313,7,458,positive regulation of nervous system development,BP,SOX10;MAG;TRIM67;PACSIN1;MYRF;GRID2;SLITRK2
4545,GO:0009612,0.0459755965673038,0.988739407018127,4,195,response to mechanical stimulus,BP,MAG;PPL;EGFR;GJA1
16159,GO:0071205,0.0460689311735361,0.999143553550529,1,5,protein localization to juxtaparanode region of axon,BP,CNTN2
8360,GO:0032387,0.0460974793939297,0.995128813722679,2,56,negative regulation of intracellular transport,BP,DMTN;APOD
13199,GO:0048738,0.0461147858223674,0.988701428580558,4,184,cardiac muscle tissue development,BP,DSG2;BVES;GJA1;SGCD
17550,GO:0097049,0.0461958103541581,0.999078105408615,1,7,motor neuron apoptotic process,BP,CRLF1
4837,GO:0010624,0.0462469557455331,0.999101369556425,1,6,regulation of Schwann cell proliferation,BP,SOX10
12737,GO:0046983,0.0462901649440399,0.978002057322829,12,1103,protein dimerization activity,MF,CRLF1;NOS2;CAMK2A;CDH19;TOX3;MAG;CAV2;AHR;GSTM1;EGFR;GJB1;DMRT2
5115,GO:0012507,0.0464719422731188,0.995065257253454,2,57,ER to Golgi transport vesicle membrane,CC,HLA-DRB1;HLA-DRB5
5205,GO:0014807,0.0465042217364997,0.999065640294647,1,7,regulation of somitogenesis,BP,DMRT2
4000,GO:0008277,0.0465443499883493,0.99142598056796,3,123,regulation of G-protein coupled receptor protein signaling pathway,BP,CAV2;RGS6;CNTN2
14031,GO:0051712,0.0466584702543767,0.999025032497484,1,9,positive regulation of killing of cells of other organism,BP,NOS2
14537,GO:0060113,0.0466974696362814,0.995051645948946,2,48,inner ear receptor cell differentiation,BP,USH1C;CTHRC1
4006,GO:0008285,0.0467636073071619,0.981455034088399,8,608,negative regulation of cell proliferation,BP,SCIN;SOX10;CAV2;CHD5;GJB6;GPNMB;GJA1;APOD
5175,GO:0014704,0.0468478691898773,0.995030151691732,2,47,intercalated disc,CC,DSG2;GJA1
13593,GO:0050957,0.0468960119812855,0.999075725236251,1,6,equilibrioception,BP,USH1C
7772,GO:0031284,0.0468970893182482,0.999030118246585,1,8,positive regulation of guanylate cyclase activity,BP,NOS2
13197,GO:0048733,0.0470755759644999,0.999068565700274,1,6,sebaceous gland development,BP,FA2H
1641,GO:0003828,0.0471223854036683,0.999066694698516,1,6,alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity,MF,ST8SIA2
3430,GO:0006811,0.0471476929442603,0.975686951249044,15,1404,ion transport,BP,NOS2;LTF;CAMK2A;CACNG4;SLC17A7;SLC38A1;SLC30A3;ATP10B;GRID2;GJA1;KCNJ6;KCNJ4;SCN9A;CCK;DAPK1
4617,GO:0009887,0.0471535443259381,0.978296954991345,11,905,animal organ morphogenesis,BP,USH1C;LTF;FGFR3;COL9A1;OTX1;GJB6;EGFR;GJA1;CTHRC1;IRX2;GPC6
7109,GO:0030020,0.0472713423829083,0.999060728064936,1,6,extracellular matrix structural constituent conferring tensile strength,MF,COL9A1
7527,GO:0030837,0.0473320126015668,0.994938276858108,2,51,negative regulation of actin filament polymerization,BP,SCIN;DMTN
20310,GO:1904683,0.0475388757013534,0.999049963066356,1,6,regulation of metalloendopeptidase activity,BP,MBP
11869,GO:0045121,0.0477493728913625,0.985812791118771,5,285,membrane raft,CC,MAG;CAV2;BVES;EGFR;GJA1
7123,GO:0030042,0.0477878925596746,0.994874977350024,2,47,actin filament depolymerization,BP,SCIN;DMTN
2649,GO:0005593,0.0478187568567293,0.999038634287148,1,6,FACIT collagen trimer,CC,COL9A1
17150,GO:0086073,0.0478739411812761,0.999036392506044,1,6,bundle of His cell-Purkinje myocyte adhesion involved in cell communication,BP,DSG2
13555,GO:0050896,0.0479392228741499,0.969014299504677,57,7357,response to stimulus,BP,ARX;CRLF1;NOS2;LTF;DSG2;EYA2;FGFR3;CAMK2A;CACNG4;DCX;SOX10;SLC17A7;ICAM5;MAG;CAV2;AHR;EFNB3;BVES;SLC30A3;CHD5;PPL;TRIM67;GJB6;PRKCG;GSTM1;GPNMB;ENPP2;MOG;FBN3;GPR17;EGFR;GFRA1;GRID2;SPOCK1;GJA1;NRGN;DMTN;PHKG1;CTHRC1;SCN9A;KNDC1;SUSD5;RIN1;RGS6;GPC6;MX2;CNTN2;PRAME;CCK;FPR3;APOD;HLA-DRB1;DAPK1;MBP;HLA-DRB5;SMOC1;KLRC2
6286,GO:0018107,0.0479514749784994,0.991074659787939,3,112,peptidyl-threonine phosphorylation,BP,CAMK2A;DMTN;PHKG1
14097,GO:0051851,0.0480664452553117,0.994800829066905,2,57,modification by host of symbiont morphology or physiology,BP,LTF;CAV2
7247,GO:0030235,0.0480814858883847,0.999000557931902,1,7,nitric-oxide synthase regulator activity,MF,EGFR
7849,GO:0031410,0.0481085704985905,0.97296364824293,20,2073,cytoplasmic vesicle,CC,LTF;FGFR3;CAMK2A;CACNG4;SLC17A7;CAV2;SLC30A3;ATP10B;PACSIN1;GPNMB;ST8SIA2;EGFR;GJA1;NRGN;SNX22;DMTN;KCNJ4;NPTX1;HLA-DRB1;HLA-DRB5
2287,GO:0004871,0.0481964092433993,0.976258871792538,13,1181,signal transducer activity,MF,FGFR3;SLC17A7;AHR;EFNB3;GPR17;EGFR;GFRA1;GRID2;GJA1;RGS6;GPC6;FPR3;KLRC2
18071,GO:0098857,0.0483957246824626,0.985567609302353,5,286,membrane microdomain,CC,MAG;CAV2;BVES;EGFR;GJA1
6938,GO:0021879,0.0484802708245752,0.994746953370933,2,51,forebrain neuron differentiation,BP,ARX;CNTN2
12507,GO:0046513,0.0485655474381815,0.994724395557001,2,54,ceramide biosynthetic process,BP,ST8SIA2;UGT8
19148,GO:1902108,0.0485734266593631,0.99471120564944,2,59,regulation of mitochondrial membrane permeability involved in apoptotic process,BP,EYA2;CAMK2A
16319,GO:0071447,0.0485822217417002,0.998958478066036,1,8,cellular response to hydroperoxide,BP,DAPK1
2769,GO:0005794,0.0486274841301057,0.974818057600428,15,1379,Golgi apparatus,CC,FGFR3;CAV2;MYRF;ST8SIA2;GALNT13;EGFR;GJA1;KCNJ6;ACAN;MGAT5B;CREG2;GALNT9;GPC6;HLA-DRB1;HLA-DRB5
14591,GO:0060193,0.048711303394633,0.994699862831222,2,54,positive regulation of lipase activity,BP,FGFR3;EGFR
2285,GO:0004867,0.0487152703830969,0.994685135042787,2,60,serine-type endopeptidase inhibitor activity,MF,SPOCK1;COL28A1
10605,GO:0042178,0.048772189601236,0.998920698389286,1,10,xenobiotic catabolic process,BP,GSTM1
17875,GO:0097708,0.0488118288324627,0.972521032997918,20,2076,intracellular vesicle,CC,LTF;FGFR3;CAMK2A;CACNG4;SLC17A7;CAV2;SLC30A3;ATP10B;PACSIN1;GPNMB;ST8SIA2;EGFR;GJA1;NRGN;SNX22;DMTN;KCNJ4;NPTX1;HLA-DRB1;HLA-DRB5
7010,GO:0022028,0.0488769593601019,0.998995182352742,1,6,tangential migration from the subventricular zone to the olfactory bulb,BP,ARX
11597,GO:0044341,0.0489390147818077,0.998964236491846,1,7,sodium-dependent phosphate transport,BP,SLC17A7
6474,GO:0019229,0.0490240155913773,0.994652555203379,2,52,regulation of vasoconstriction,BP,EGFR;GJA1
8659,GO:0032808,0.0490920416638828,0.998957685394322,1,7,lacrimal gland development,BP,SOX10
3696,GO:0007260,0.0491470064877517,0.994616451757024,2,58,tyrosine phosphorylation of STAT protein,BP,CRLF1;FGFR3
1054,GO:0002430,0.0492785849806456,0.998928113757068,1,8,complement receptor mediated signaling pathway,BP,FPR3
3346,GO:0006681,0.049535284759606,0.998916808388066,1,8,galactosylceramide metabolic process,BP,UGT8
6525,GO:0019374,0.049535284759606,0.998916808388066,1,8,galactolipid metabolic process,BP,UGT8
17974,GO:0098657,0.0495524400665087,0.978936253978725,9,706,import into cell,BP,CACNG4;ICAM5;CAV2;SLC38A1;PACSIN1;PRKCG;ENPP2;RIN1;CNTN2
4034,GO:0008328,0.0496194323588043,0.994560853243537,2,49,ionotropic glutamate receptor complex,CC,CACNG4;GRID2
5127,GO:0014015,0.0498540880717099,0.994506077038309,2,54,positive regulation of gliogenesis,BP,SOX10;MAG
4623,GO:0009893,0.050004219991067,0.969823129424996,27,2947,positive regulation of metabolic process,BP,ARX;CRLF1;NOS2;LTF;ZIC2;EYA2;FGFR3;SOX10;TOX3;CAV2;AHR;BVES;OTX1;TRIM67;MYRF;PRKCG;GPNMB;ENPP2;EGFR;GJA1;LMO1;KNDC1;DMRT2;CNTN2;CCK;DAPK1;MBP
9861,GO:0035630,0.0500448298672473,0.998916422530489,1,7,bone mineralization involved in bone maturation,BP,LTF
4781,GO:0010517,0.0501262302972385,0.994465205502798,2,52,regulation of phospholipase activity,BP,FGFR3;EGFR
7981,GO:0031659,0.0502386014354057,0.998907930788987,1,7,positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,EGFR
12114,GO:0045665,0.0502708473238647,0.987330893256797,4,196,negative regulation of neuron differentiation,BP,MAG;EFNB3;SPOCK1;CNTN2
3953,GO:0008201,0.0502759608262077,0.990444409866695,3,130,heparin binding,MF,LTF;GPNMB;ABI3BP
12455,GO:0046427,0.0503595825003975,0.99440935446396,2,58,positive regulation of JAK-STAT cascade,BP,CRLF1;FGFR3
17985,GO:0098700,0.0503973494698001,0.998878399387155,1,8,neurotransmitter loading into synaptic vesicle,BP,SLC17A7
16231,GO:0071320,0.0506095612082074,0.994395223553795,2,48,cellular response to cAMP,BP,AHR;DMTN
7770,GO:0031282,0.0506970305022184,0.99884714918502,1,9,regulation of guanylate cyclase activity,BP,NOS2
16135,GO:0071107,0.0507227013967668,0.998886568075775,1,7,response to parathyroid hormone,BP,GJA1
7023,GO:0022409,0.0507464902089012,0.98715610678591,4,224,positive regulation of cell-cell adhesion,BP,EFNB3;DMTN;HLA-DRB1;HLA-DRB5
17093,GO:0086002,0.0511320984260694,0.994312717309469,2,46,cardiac muscle cell action potential involved in contraction,BP,DSG2;GJA1
13621,GO:0051014,0.051213900158594,0.998841388699212,1,8,actin filament severing,BP,SCIN
21384,GO:2000394,0.0514033975957994,0.998856172579547,1,7,positive regulation of lamellipodium morphogenesis,BP,ENPP2
15104,GO:0061004,0.051416015605764,0.998813887237872,1,9,pattern specification involved in kidney development,BP,IRX2
16658,GO:0072048,0.051416015605764,0.998813887237872,1,9,renal system pattern specification,BP,IRX2
15874,GO:0070586,0.0514985781173168,0.998810036815872,1,9,cell-cell adhesion involved in gastrulation,BP,MBP
20432,GO:1904894,0.051593474185305,0.994193272991997,2,59,positive regulation of STAT cascade,BP,CRLF1;FGFR3
13039,GO:0048387,0.0516201244249153,0.998822747988677,1,8,negative regulation of retinoic acid receptor signaling pathway,BP,PRAME
19506,GO:1903011,0.0517696273018966,0.998839646264504,1,7,negative regulation of bone development,BP,LTF
13256,GO:0048857,0.0518069432706079,0.994163552010615,2,56,neural nucleus development,BP,ARX;MBP
5349,GO:0015179,0.0520053542827712,0.994137338171123,2,53,L-amino acid transmembrane transporter activity,MF,SLC17A7;SLC38A1
10852,GO:0042670,0.0520954908460928,0.99880074172843,1,8,retinal cone cell differentiation,BP,USH1C
12528,GO:0046549,0.0520954908460928,0.99880074172843,1,8,retinal cone cell development,BP,USH1C
18081,GO:0098878,0.0523552539353755,0.994082343883997,2,51,neurotransmitter receptor complex,CC,CACNG4;GRID2
11174,GO:0043295,0.0524644327317959,0.998736902083438,1,11,glutathione binding,MF,GSTM1
5506,GO:0015711,0.0525941995310088,0.98184853241635,6,399,organic anion transport,BP,NOS2;SLC17A7;SLC38A1;ATP10B;GJA1;CCK
7586,GO:0030913,0.0527186140782243,0.998796259551128,1,7,paranodal junction assembly,BP,UGT8
11587,GO:0044327,0.0530047518221454,0.998758069536433,1,8,dendritic spine head,CC,NRGN
7677,GO:0031090,0.0530566566215071,0.968531498681931,24,2671,organelle membrane,CC,NOS2;LTF;CAMK2A;CACNG4;SOX10;FA2H;SLC17A7;CAV2;SLC30A3;ATP10B;PACSIN1;ST8SIA2;GALNT13;EGFR;GJA1;NRGN;SNX22;DMTN;MGAT5B;KCNJ4;GALNT9;MX2;HLA-DRB1;HLA-DRB5
624,GO:0001765,0.0530644675518867,0.998735803474264,1,9,membrane raft assembly,BP,CAV2
8396,GO:0032429,0.0532009825594481,0.998748760382597,1,8,regulation of phospholipase A2 activity,BP,EGFR
11899,GO:0045178,0.0532024338613564,0.993940150204647,2,49,basal part of cell,CC,CLDN11;EGFR
1206,GO:0002694,0.0533084155425651,0.981533378073495,6,431,regulation of leukocyte activation,BP,AHR;EFNB3;GPNMB;LMO1;HLA-DRB1;HLA-DRB5
13193,GO:0048729,0.0533762128494729,0.978267044118478,8,590,tissue morphogenesis,BP,EYA2;SOX10;PCDH8;EGFR;GJA1;CTHRC1;IRX2;GPC6
6946,GO:0021891,0.0535469979220914,0.99875772176347,1,7,olfactory bulb interneuron development,BP,ARX
21339,GO:2000341,0.0535690763517828,0.998695553337782,1,10,regulation of chemokine (C-X-C motif) ligand 2 production,BP,MBP
2910,GO:0006027,0.0535892950520737,0.993858148844568,2,53,glycosaminoglycan catabolic process,BP,ACAN;GPC6
10417,GO:0038166,0.0536083951005746,0.998709481223188,1,9,angiotensin-activated signaling pathway,BP,CAMK2A
14029,GO:0051709,0.0536250400560344,0.998692798268303,1,10,regulation of killing of cells of other organism,BP,NOS2
14715,GO:0060371,0.0538134751963832,0.998745192931917,1,7,regulation of atrial cardiac muscle cell membrane depolarization,BP,GJA1
1568,GO:0003373,0.0539420099808097,0.998739126715188,1,7,dynamin family protein polymerization involved in membrane fission,BP,MX2
1569,GO:0003374,0.0539420099808097,0.998739126715188,1,7,dynamin family protein polymerization involved in mitochondrial fission,BP,MX2
5150,GO:0014049,0.0539533290043369,0.99871274022678,1,8,positive regulation of glutamate secretion,BP,CCK
17126,GO:0086042,0.0539791499568118,0.998737371105966,1,7,cardiac muscle cell-cardiac muscle cell adhesion,BP,DSG2
17938,GO:0098589,0.0540028868597635,0.98340104879904,5,294,membrane region,CC,MAG;CAV2;BVES;EGFR;GJA1
12476,GO:0046467,0.0540539736754472,0.98942178814795,3,134,membrane lipid biosynthetic process,BP,FA2H;ST8SIA2;UGT8
5122,GO:0014010,0.0543097191472627,0.998721690089807,1,7,Schwann cell proliferation,BP,SOX10
11535,GO:0044241,0.0544511957657959,0.998668148550889,1,9,lipid digestion,BP,ARX
13104,GO:0048568,0.0545482751650756,0.981007223721954,6,396,embryonic organ development,BP,USH1C;OTX1;GJB6;EGFR;GJA1;CTHRC1
7857,GO:0031424,0.0545953278598971,0.99365139502329,2,63,keratinization,BP,DSG2;PPL
18548,GO:1900016,0.0547618625118979,0.998652744966933,1,9,negative regulation of cytokine production involved in inflammatory response,BP,APOD
14023,GO:0051702,0.0548210325739678,0.993615335756689,2,61,interaction with symbiont,BP,LTF;CAV2
10755,GO:0042490,0.054930465376149,0.993618034443778,2,53,mechanoreceptor differentiation,BP,USH1C;CTHRC1
1194,GO:0002682,0.0553828314723327,0.972135657178301,13,1276,regulation of immune system process,BP,SCIN;LTF;ICAM5;AHR;EFNB3;GPNMB;MOG;GPR17;LMO1;FPR3;APOD;HLA-DRB1;HLA-DRB5
11368,GO:0043621,0.0555871527721216,0.993506088388473,2,51,protein self-association,MF,DMTN;CNTN2
9210,GO:0034145,0.0555953651505329,0.9986109709027,1,9,positive regulation of toll-like receptor 4 signaling pathway,BP,LTF
2487,GO:0005216,0.0556478953056011,0.980534757216778,6,380,ion channel activity,MF,CACNG4;SLC17A7;GRID2;KCNJ6;KCNJ4;SCN9A
19748,GO:1903524,0.0556583681033102,0.993465897117145,2,60,positive regulation of blood circulation,BP,EGFR;GJA1
809,GO:0002009,0.0557496883240175,0.978646872663705,7,496,morphogenesis of an epithelium,BP,SOX10;PCDH8;EGFR;GJA1;CTHRC1;IRX2;GPC6
14551,GO:0060135,0.0557703550424338,0.993459560929311,2,55,maternal process involved in female pregnancy,BP,DSG2;GJA1
12215,GO:0045862,0.0558633671370153,0.982657498993113,5,320,positive regulation of proteolysis,BP,TRIM67;CNTN2;CCK;DAPK1;MBP
12934,GO:0048168,0.0559689792400525,0.993433180592261,2,52,regulation of neuronal synaptic plasticity,BP,CAMK2A;CNTN2
1578,GO:0003407,0.0561707130065845,0.993392982800718,2,53,neural retina development,BP,USH1C;SLC17A7
414,GO:0001094,0.0565316973697221,0.99856326568539,1,9,TFIID-class transcription factor binding,MF,AHR
15545,GO:0070050,0.0566919344473032,0.998537275092381,1,10,neuron cellular homeostasis,BP,SLC17A7
4452,GO:0009247,0.0569961562885482,0.993210484309859,2,64,glycolipid biosynthetic process,BP,ST8SIA2;UGT8
4005,GO:0008284,0.0572041220502824,0.975012665620595,9,755,positive regulation of cell proliferation,BP,CRLF1;LTF;FGFR3;SOX10;CAV2;EGFR;CTHRC1;PRAME;CCK
8192,GO:0032096,0.0575940252140107,0.998474850939048,1,11,negative regulation of response to food,BP,CCK
8195,GO:0032099,0.0575940252140107,0.998474850939048,1,11,negative regulation of appetite,BP,CCK
3461,GO:0006865,0.0577612976153257,0.988401840898533,3,126,amino acid transport,BP,SLC17A7;SLC38A1;CCK
6702,GO:0019911,0.0578067615441345,0.998478527696916,1,10,structural constituent of myelin sheath,MF,MBP
8311,GO:0032310,0.0581769251433202,0.998458759859583,1,10,prostaglandin secretion,BP,NOS2
7984,GO:0031665,0.0584494971155832,0.998444120291924,1,10,negative regulation of lipopolysaccharide-mediated signaling pathway,BP,LTF
18754,GO:1900750,0.0587691622512971,0.998398271109998,1,12,oligopeptide binding,MF,GSTM1
10658,GO:0042308,0.0588419975365774,0.998422915147968,1,10,negative regulation of protein import into nucleus,BP,APOD
20268,GO:1904590,0.0588419975365774,0.998422915147968,1,10,negative regulation of protein import,BP,APOD
16333,GO:0071466,0.0588476984141698,0.988073898621916,3,145,cellular response to xenobiotic stimulus,BP,AHR;GSTM1;EGFR
14567,GO:0060159,0.0591369346028122,0.998426195104533,1,9,regulation of dopamine receptor signaling pathway,BP,CAV2
17143,GO:0086065,0.0592454117540509,0.992826443959939,2,52,cell communication involved in cardiac conduction,BP,DSG2;GJA1
9527,GO:0034765,0.0592781164888237,0.978934358354223,6,401,regulation of ion transmembrane transport,BP,CACNG4;GJA1;KCNJ6;KCNJ4;SCN9A;DAPK1
7057,GO:0022838,0.0597815091058397,0.978715123570717,6,389,substrate-specific channel activity,MF,CACNG4;SLC17A7;GRID2;KCNJ6;KCNJ4;SCN9A
18853,GO:1901264,0.0597882253947676,0.992686837038753,2,64,carbohydrate derivative transport,BP,GJA1;GJB1
15161,GO:0061088,0.0598126590823877,0.998389599202295,1,9,regulation of sequestering of zinc ion,BP,SLC30A3
17920,GO:0098552,0.0598593119990511,0.978669555144973,6,425,side of membrane,CC,CAV2;MOG;GFRA1;RGS6;HLA-DRB1;HLA-DRB5
3508,GO:0006935,0.0598709889937994,0.976695833037525,7,526,chemotaxis,BP,ARX;EFNB3;GPNMB;ENPP2;GFRA1;CNTN2;FPR3
14119,GO:0051893,0.0598828871938274,0.992702345234777,2,53,regulation of focal adhesion assembly,BP,DMTN;APOD
17231,GO:0090109,0.0598828871938274,0.992702345234777,2,53,regulation of cell-substrate junction assembly,BP,DMTN;APOD
17523,GO:0097001,0.0599062523378075,0.998364678974277,1,10,ceramide binding,MF,MAG
10672,GO:0042330,0.0601586891954256,0.9765586152575,7,527,taxis,BP,ARX;EFNB3;GPNMB;ENPP2;GFRA1;CNTN2;FPR3
2595,GO:0005488,0.0610259212564111,0.967505006795125,89,12653,binding,MF,ARX;CRLF1;USH1C;SCIN;NOS2;LTF;CLDN11;ZIC2;DSG2;EYA2;FGFR3;CAMK2A;CDH19;DCX;SOX10;FA2H;TOX3;ICAM5;MAG;CAV2;AHR;EFNB3;SLC38A1;BVES;COL9A1;SLC30A3;OTX1;CHD5;ATP10B;PPL;TRIM67;PACSIN1;MYRF;PRKCG;GSTM1;PCDH8;GPNMB;ENPP2;MOG;ST8SIA2;FBN3;GALNT13;HAPLN1;EGFR;GFRA1;GRID2;SPOCK1;GJA1;NRGN;ABI3BP;KCNJ6;SNX22;ACAN;DMTN;EDIL3;PHKG1;CTHRC1;LMO1;MGAT5B;KCNJ4;SCN9A;GJB1;IRX2;SGCD;NPTX1;VAT1L;KNDC1;DMRT2;SUSD5;RIN1;CREG2;RGS6;GALNT9;GPC6;MX2;CNTN2;ANKS1B;PRAME;CCK;HAPLN4;APOD;HLA-DRB1;MYT1;CPNE4;DAPK1;MBP;HLA-DRB5;SMOC1;KLRC2
3485,GO:0006897,0.0611905831914172,0.974375180276601,8,629,endocytosis,BP,CACNG4;ICAM5;CAV2;PACSIN1;PRKCG;ENPP2;RIN1;CNTN2
4510,GO:0009410,0.0612234239418045,0.983529029906357,4,235,response to xenobiotic stimulus,BP,AHR;PRKCG;GSTM1;EGFR
12125,GO:0045685,0.061269082450511,0.992411506716238,2,61,regulation of glial cell differentiation,BP,MAG;CNTN2
20070,GO:1904181,0.061322364627533,0.99828551300763,1,10,positive regulation of membrane depolarization,BP,CCK
1406,GO:0003093,0.0620720778613528,0.998242825422459,1,10,regulation of glomerular filtration,BP,GJA1
4870,GO:0010663,0.0624088852948409,0.998244984376858,1,9,positive regulation of striated muscle cell apoptotic process,BP,CAMK2A
4873,GO:0010666,0.0624088852948409,0.998244984376858,1,9,positive regulation of cardiac muscle cell apoptotic process,BP,CAMK2A
15522,GO:0065008,0.0624486461720947,0.960936550059208,29,3311,regulation of biological quality,BP,USH1C;SCIN;NOS2;LTF;DSG2;EYA2;CAMK2A;CACNG4;SLC17A7;MAG;SLC38A1;BVES;SLC30A3;ATP10B;GJB6;PRKCG;GPR17;EGFR;GRID2;GJA1;NRGN;DMTN;LMO1;SCN9A;CNTN2;SLITRK2;CCK;FPR3;MBP
16606,GO:0071936,0.0629476980227129,0.998241544544054,1,8,coreceptor activity involved in Wnt signaling pathway,MF,GPC6
618,GO:0001756,0.0629910975322699,0.992089959513318,2,57,somitogenesis,BP,PCDH8;DMRT2
2909,GO:0006026,0.063051427674543,0.992071528340961,2,59,aminoglycan catabolic process,BP,ACAN;GPC6
9287,GO:0034332,0.0630869128385859,0.986882184531645,3,121,adherens junction organization,BP,CDH19;DMTN;APOD
17291,GO:0090197,0.0632404242049798,0.998175229351497,1,10,positive regulation of chemokine secretion,BP,MBP
8207,GO:0032119,0.0636681983910238,0.998131842112274,1,11,sequestering of zinc ion,BP,SLC30A3
8543,GO:0032642,0.0638148871451987,0.991898643208608,2,67,regulation of chemokine production,BP,APOD;MBP
5586,GO:0015867,0.063972412601537,0.998132213097098,1,10,ATP transport,BP,GJA1
16421,GO:0071605,0.0641891045976256,0.998085263606291,1,12,monocyte chemotactic protein-1 production,BP,APOD
16445,GO:0071637,0.0641891045976256,0.998085263606291,1,12,regulation of monocyte chemotactic protein-1 production,BP,APOD
5186,GO:0014731,0.0642940612954136,0.99820128235627,1,7,spectrin-associated cytoskeleton,CC,DMTN
13832,GO:0051336,0.0643226810991162,0.967793176074643,12,1106,regulation of hydrolase activity,BP,LTF;FGFR3;CAV2;BVES;EGFR;SPOCK1;RIN1;RGS6;CCK;DAPK1;MBP;COL28A1
10699,GO:0042383,0.0643491778930841,0.986507563856654,3,124,sarcolemma,CC,CAV2;BVES;SGCD
7375,GO:0030500,0.0643683277154941,0.991809028715207,2,60,regulation of bone mineralization,BP,LTF;GJA1
6901,GO:0021800,0.0645422233157324,0.998150161035876,1,8,cerebral cortex tangential migration,BP,ARX
13141,GO:0048646,0.0645866241501179,0.968663260788194,11,937,anatomical structure formation involved in morphogenesis,BP,EYA2;PCDH8;GPNMB;ENPP2;GRID2;CTHRC1;IRX2;KNDC1;DMRT2;UGT8;APOD
5549,GO:0015807,0.0646201034796936,0.991759091707392,2,60,L-amino acid transport,BP,SLC17A7;SLC38A1
19064,GO:1901880,0.064875783268323,0.99172213224582,2,56,negative regulation of protein depolymerization,BP,SCIN;DMTN
7799,GO:0031325,0.0650186774657528,0.960230704962163,25,2752,positive regulation of cellular metabolic process,BP,CRLF1;NOS2;LTF;ZIC2;EYA2;FGFR3;SOX10;TOX3;CAV2;AHR;BVES;OTX1;TRIM67;MYRF;PRKCG;GPNMB;ENPP2;EGFR;LMO1;KNDC1;DMRT2;CNTN2;CCK;DAPK1;MBP
19009,GO:1901685,0.0651960107128673,0.997965358713017,1,18,glutathione derivative metabolic process,BP,GSTM1
19010,GO:1901687,0.0651960107128673,0.997965358713017,1,18,glutathione derivative biosynthetic process,BP,GSTM1
520,GO:0001574,0.0652592728847057,0.998055343271672,1,10,ganglioside biosynthetic process,BP,ST8SIA2
13050,GO:0048469,0.0656594769215059,0.986096017871173,3,142,cell maturation,BP,SOX10;GJA1;CNTN2
18270,GO:0099590,0.0658589259156113,0.997999385215779,1,11,neurotransmitter receptor internalization,BP,CACNG4
2486,GO:0005215,0.0659125431438722,0.966867415930647,12,1089,transporter activity,MF,CACNG4;SLC17A7;SLC38A1;SLC30A3;ATP10B;GRID2;GJA1;KCNJ6;KCNJ4;SCN9A;GJB1;APOD
11124,GO:0043220,0.0659285555996094,0.998014735599755,1,10,Schmidt-Lanterman incisure,CC,MAG
13057,GO:0048484,0.0659527401993619,0.998013260180216,1,10,enteric nervous system development,BP,SOX10
16848,GO:0072341,0.0660807027853708,0.991443740501323,2,68,modified amino acid binding,MF,SCIN;GSTM1
19683,GO:1903391,0.0661740971766253,0.991462665258962,2,56,regulation of adherens junction organization,BP,DMTN;APOD
7578,GO:0030902,0.0663418600228567,0.985909408770243,3,129,hindbrain development,BP,OTX1;GRID2;KNDC1
12686,GO:0046902,0.0666112374743471,0.991331415695357,2,70,regulation of mitochondrial membrane permeability,BP,EYA2;CAMK2A
21750,GO:2001135,0.0667117265414686,0.997991257869,1,9,regulation of endocytic recycling,BP,BVES
8282,GO:0032272,0.0668081713995242,0.991310726445123,2,63,negative regulation of protein polymerization,BP,SCIN;DMTN
1380,GO:0003018,0.0669098950126881,0.98572127342898,3,143,vascular process in circulatory system,BP,NOS2;EGFR;GJA1
8697,GO:0032879,0.0671452392797969,0.959846772492655,22,2357,regulation of localization,BP,SCIN;NOS2;DSG2;CAMK2A;CACNG4;BVES;SLC30A3;PACSIN1;PRKCG;GPNMB;ENPP2;EGFR;GJA1;KCNJ6;DMTN;KCNJ4;SCN9A;MX2;CCK;APOD;DAPK1;MBP
16949,GO:0072567,0.0672829110244069,0.997893753821644,1,12,chemokine (C-X-C motif) ligand 2 production,BP,MBP
5543,GO:0015800,0.0673268910757112,0.991218605963888,2,59,acidic amino acid transport,BP,SLC17A7;CCK
3219,GO:0006527,0.0673918793529113,0.997903930946169,1,11,arginine catabolic process,BP,NOS2
4761,GO:0010469,0.0674050532470088,0.977921541965407,5,393,regulation of signaling receptor activity,BP,CRLF1;CACNG4;GPNMB;CCK;DAPK1
6935,GO:0021872,0.0679194967010882,0.991090909646148,2,61,forebrain generation of neurons,BP,ARX;CNTN2
3818,GO:0007605,0.0680444007982186,0.985392625568656,3,133,sensory perception of sound,BP,USH1C;GJB6;MBP
16669,GO:0072070,0.0680456927184408,0.997883445218279,1,10,loop of Henle development,BP,IRX2
4859,GO:0010648,0.068153251111202,0.964599529415129,13,1234,negative regulation of cell communication,BP,LTF;EYA2;FGFR3;SOX10;CAV2;TRIM67;EGFR;GRID2;CTHRC1;RGS6;PRAME;APOD;DAPK1
15612,GO:0070161,0.0683129220400286,0.972611936790411,7,522,anchoring junction,CC,DSG2;FGFR3;CDH19;CAV2;PPL;EGFR;GJA1
15320,GO:0061515,0.0684369338726364,0.990981545579952,2,62,myeloid cell development,BP,LTF;DMTN
12704,GO:0046934,0.0687564451514126,0.990919170605182,2,61,phosphatidylinositol-4,5-bisphosphate 3-kinase activity,MF,FGFR3;EGFR
1357,GO:0002934,0.0690853998605336,0.997843760484385,1,9,desmosome organization,BP,DSG2
15618,GO:0070167,0.0692204534794783,0.990816760517015,2,63,regulation of biomineral tissue development,BP,LTF;GJA1
7093,GO:0023057,0.0695123764627633,0.963781447816767,13,1238,negative regulation of signaling,BP,LTF;EYA2;FGFR3;SOX10;CAV2;TRIM67;EGFR;GRID2;CTHRC1;RGS6;PRAME;APOD;DAPK1
5826,GO:0016358,0.069595597962667,0.980495500331033,4,206,dendrite development,BP,CAMK2A;PACSIN1;CSMD3;KNDC1
5094,GO:0010977,0.0697000048867588,0.984888736578246,3,134,negative regulation of neuron projection development,BP,MAG;EFNB3;SPOCK1
3520,GO:0006954,0.0697388035909748,0.97189379422829,7,589,inflammatory response,BP,NOS2;GPR17;EGFR;GJA1;SCN9A;FPR3;APOD
17094,GO:0086003,0.0697651698896755,0.990729561878845,2,56,cardiac muscle cell contraction,BP,DSG2;GJA1
11624,GO:0044406,0.0698137081721146,0.997748472257006,1,11,adhesion of symbiont to host,BP,LTF
17290,GO:0090196,0.069861421241425,0.997745352158694,1,11,regulation of chemokine secretion,BP,MBP
5430,GO:0015370,0.0698829915173103,0.990693306741461,2,59,solute:sodium symporter activity,MF,SLC17A7;SLC38A1
7073,GO:0022890,0.0699027096388157,0.971829411529329,7,517,inorganic cation transmembrane transporter activity,MF,CACNG4;SLC17A7;SLC38A1;SLC30A3;KCNJ6;KCNJ4;SCN9A
5072,GO:0010950,0.0699309062085256,0.984793562698292,3,154,positive regulation of endopeptidase activity,BP,CCK;DAPK1;MBP
15183,GO:0061134,0.070126639941294,0.984728421861981,3,159,peptidase regulator activity,MF,LTF;SPOCK1;COL28A1
8201,GO:0032105,0.0702971951987677,0.997682417387538,1,13,negative regulation of response to extracellular stimulus,BP,CCK
8204,GO:0032108,0.0702971951987677,0.997682417387538,1,13,negative regulation of response to nutrient levels,BP,CCK
15587,GO:0070106,0.0706005401428818,0.997696735493533,1,11,interleukin-27-mediated signaling pathway,BP,CRLF1
786,GO:0001973,0.0710580966278341,0.997647365046542,1,12,adenosine receptor signaling pathway,BP,CNTN2
21796,GO:2001204,0.0712001050066464,0.997679815952986,1,10,regulation of osteoclast development,BP,LTF
790,GO:0001977,0.0712606026827821,0.997633752802742,1,12,renal system process involved in regulation of blood volume,BP,GJA1
13648,GO:0051047,0.0712905363900637,0.976295374835739,5,342,positive regulation of secretion,BP,SCIN;EGFR;GJA1;CCK;MBP
453,GO:0001206,0.0713666544033828,0.997696943165017,1,9,transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding,MF,ARX
8632,GO:0032780,0.0713736384580907,0.997609916578478,1,13,negative regulation of ATPase activity,BP,LTF
14169,GO:0051965,0.0714212395891359,0.990371712566839,2,59,positive regulation of synapse assembly,BP,GRID2;SLITRK2
13465,GO:0050771,0.0715862976260809,0.99033315217788,2,60,negative regulation of axonogenesis,BP,MAG;EFNB3
7062,GO:0022843,0.0717027958985422,0.984276894085317,3,132,voltage-gated cation channel activity,MF,CACNG4;KCNJ6;KCNJ4
4702,GO:0010181,0.0720140364394207,0.997602276079186,1,11,FMN binding,MF,NOS2
5298,GO:0015077,0.0720403437113981,0.975980772375805,5,329,monovalent inorganic cation transmembrane transporter activity,MF,SLC17A7;SLC38A1;KCNJ6;KCNJ4;SCN9A
13467,GO:0050773,0.0720886066547778,0.984165530972294,3,127,regulation of dendrite development,BP,PACSIN1;CSMD3;KNDC1
13736,GO:0051179,0.0726794627678495,0.951452025720502,45,5638,localization,BP,ARX;USH1C;SCIN;NOS2;LTF;DSG2;EYA2;CAMK2A;CACNG4;DCX;SOX10;SLC17A7;ICAM5;MAG;CAV2;SLC38A1;BVES;SLC30A3;ATP10B;PACSIN1;PRKCG;GPNMB;ENPP2;EGFR;GRID2;SPOCK1;GJA1;KCNJ6;SNX22;DMTN;CTHRC1;KCNJ4;SCN9A;GJB1;UGT8;RIN1;GPC6;MX2;CNTN2;ANKS1B;CCK;FPR3;APOD;DAPK1;MBP
10603,GO:0042176,0.0728829704458959,0.975617550322495,5,333,regulation of protein catabolic process,BP,NOS2;TRIM67;PRKCG;EGFR;GJA1
8515,GO:0032602,0.0729329993522372,0.990004127694487,2,74,chemokine production,BP,APOD;MBP
3190,GO:0006486,0.0730794798196206,0.979162200403858,4,234,protein glycosylation,BP,ST8SIA2;GALNT13;MGAT5B;GALNT9
11247,GO:0043413,0.0730794798196206,0.979162200403858,4,234,macromolecule glycosylation,BP,ST8SIA2;GALNT13;MGAT5B;GALNT9
13483,GO:0050794,0.073109390950635,0.951947747308302,68,9109,regulation of cellular process,BP,ARX;CRLF1;USH1C;SCIN;NOS2;LTF;ZIC2;DSG2;EYA2;FGFR3;CAMK2A;CACNG4;DCX;SOX10;FA2H;TOX3;SLC17A7;MAG;CAV2;AHR;EFNB3;BVES;SLC30A3;OTX1;CHD5;TRIM67;GJB6;PACSIN1;MYRF;PRKCG;GPNMB;ENPP2;MOG;FBN3;GPR17;EGFR;GFRA1;GRID2;SPOCK1;GJA1;NRGN;DMTN;PHKG1;CSMD3;CTHRC1;LMO1;IRX2;KNDC1;DMRT2;SUSD5;RIN1;RGS6;GPC6;MX2;CNTN2;PRAME;SLITRK2;CCK;FPR3;APOD;HLA-DRB1;MYT1;DAPK1;MBP;HLA-DRB5;SMOC1;KLRC2;COL28A1
14593,GO:0060198,0.0731254504620031,0.997506501857809,1,12,clathrin-sculpted vesicle,CC,SLC17A7
2173,GO:0004716,0.0732291086908389,0.997573390029174,1,9,signal transducer, downstream of receptor, with protein tyrosine kinase activity,MF,EGFR
8736,GO:0032930,0.0736596328979587,0.997452141570423,1,13,positive regulation of superoxide anion generation,BP,EGFR
11009,GO:0043025,0.0738169785268892,0.972286029682573,6,425,neuronal cell body,CC,NRGN;KNDC1;CNTN2;CCK;APOD;MBP
475,GO:0001508,0.0738174136187028,0.98362454301747,3,129,action potential,BP,DSG2;GJA1;SCN9A
9810,GO:0035567,0.0738260303394369,0.983592159627946,3,150,non-canonical Wnt signaling pathway,BP,CAMK2A;CTHRC1;GPC6
365,GO:0000980,0.0738810039660211,0.989823610560503,2,66,RNA polymerase II distal enhancer sequence-specific DNA binding,MF,ARX;SOX10
13699,GO:0051128,0.0740010910753068,0.955677315273907,21,2210,regulation of cellular component organization,BP,USH1C;SCIN;MAG;CAV2;EFNB3;BVES;TRIM67;PACSIN1;PRKCG;ENPP2;EGFR;GRID2;SPOCK1;GJA1;DMTN;CSMD3;KNDC1;CNTN2;SLITRK2;CCK;APOD
3814,GO:0007600,0.0740566182115388,0.972164597375454,6,451,sensory perception,BP,USH1C;ZIC2;GJB6;SCN9A;CCK;MBP
7215,GO:0030198,0.0743190503118591,0.975012758418406,5,306,extracellular matrix organization,BP,ICAM5;COL9A1;HAPLN1;ABI3BP;ACAN
2844,GO:0005916,0.0744205090541184,0.997461998984176,1,10,fascia adherens,CC,GJA1
13446,GO:0050746,0.0744208608869958,0.997416089475636,1,12,regulation of lipoprotein metabolic process,BP,APOD
10675,GO:0042340,0.0744535120984782,0.997434659490887,1,11,keratan sulfate catabolic process,BP,ACAN
2480,GO:0005184,0.0745933495043232,0.997311848999915,1,20,neuropeptide hormone activity,MF,CCK
13773,GO:0051238,0.0746841056133256,0.997364530744377,1,14,sequestering of metal ion,BP,SLC30A3
17471,GO:0090596,0.0747504309073683,0.978530533812704,4,227,sensory organ morphogenesis,BP,USH1C;OTX1;GJB6;CTHRC1
14317,GO:0052813,0.0750340585835586,0.989581270532328,2,64,phosphatidylinositol bisphosphate kinase activity,MF,FGFR3;EGFR
3352,GO:0006687,0.0752698293844577,0.989516738309042,2,68,glycosphingolipid metabolic process,BP,ST8SIA2;UGT8
13492,GO:0050806,0.0755313855044866,0.983068784925081,3,140,positive regulation of synaptic transmission,BP,CACNG4;EGFR;NRGN
11140,GO:0043242,0.075821894644197,0.989417223029449,2,62,negative regulation of protein complex disassembly,BP,SCIN;DMTN
3772,GO:0007494,0.0759321886095621,0.9973302216021,1,11,midgut development,BP,EGFR
12989,GO:0048278,0.0759364008508945,0.989368175469596,2,69,vesicle docking,BP,CAV2;BVES
18027,GO:0098791,0.0764869542022364,0.964662886433355,9,765,Golgi subcompartment,CC,CAV2;ST8SIA2;GALNT13;EGFR;GJA1;MGAT5B;GALNT9;HLA-DRB1;HLA-DRB5
10660,GO:0042310,0.0766347943341285,0.989221394279255,2,67,vasoconstriction,BP,EGFR;GJA1
3778,GO:0007501,0.076635076884333,0.997239006486809,1,13,mesodermal cell fate specification,BP,EYA2
9180,GO:0034109,0.0767919765542132,0.989186815141136,2,67,homotypic cell-cell adhesion,BP,DSG2;DMTN
3334,GO:0006665,0.0769884427564952,0.982592521249284,3,150,sphingolipid metabolic process,BP,FA2H;ST8SIA2;UGT8
4934,GO:0010763,0.077001009542429,0.997253395176553,1,11,positive regulation of fibroblast migration,BP,DMTN
6769,GO:0021536,0.077019105354745,0.989127176697669,2,70,diencephalon development,BP,ARX;OTX1
17153,GO:0086080,0.0770819715660796,0.997274389351249,1,10,protein binding involved in heterotypic cell-cell adhesion,MF,DSG2
11559,GO:0044291,0.0772360242710105,0.98910705811069,2,62,cell-cell contact zone,CC,DSG2;GJA1
11528,GO:0044224,0.0773670908292588,0.997253882211507,1,10,juxtaparanode region of axon,CC,CNTN2
556,GO:0001654,0.0774535696766301,0.973642980705,5,318,eye development,BP,USH1C;SLC17A7;EGFR;GJA1;SMOC1
13075,GO:0048519,0.0775436065028732,0.948734029318018,37,4543,negative regulation of biological process,BP,ARX;CRLF1;SCIN;NOS2;LTF;ZIC2;EYA2;FGFR3;SOX10;TOX3;MAG;CAV2;AHR;EFNB3;CHD5;TRIM67;GJB6;PACSIN1;PRKCG;GPNMB;GPR17;EGFR;GRID2;SPOCK1;GJA1;DMTN;CTHRC1;LMO1;IRX2;RGS6;CNTN2;PRAME;CCK;APOD;DAPK1;MBP;COL28A1
17346,GO:0090277,0.0776169118019815,0.988975251870866,2,77,positive regulation of peptide hormone secretion,BP,EGFR;GJA1
6770,GO:0021537,0.0776566742025916,0.97741225762095,4,225,telencephalon development,BP,ARX;EGFR;NRGN;CNTN2
7521,GO:0030828,0.0778713894819053,0.997116966700131,1,15,positive regulation of cGMP biosynthetic process,BP,NOS2
11352,GO:0043588,0.0778909789936069,0.977313948091012,4,234,skin development,BP,DSG2;FA2H;PPL;EGFR
14589,GO:0060191,0.0781925865563024,0.988867034895554,2,70,regulation of lipase activity,BP,FGFR3;EGFR
8293,GO:0032287,0.0781989667660708,0.997227404266993,1,9,peripheral nervous system myelin maintenance,BP,FA2H
5738,GO:0016188,0.078316533487899,0.997157294006461,1,11,synaptic vesicle maturation,BP,SLC17A7
17463,GO:0090559,0.0785285469935229,0.988774729924694,2,76,regulation of membrane permeability,BP,EYA2;CAMK2A
7682,GO:0031095,0.078659730957102,0.997194123277267,1,9,platelet dense tubular network membrane,CC,DMTN
11898,GO:0045177,0.0786607425461559,0.973111108919537,5,322,apical part of cell,CC,USH1C;DSG2;GJB6;EGFR;GJA1
4648,GO:0009968,0.0789355904899342,0.959118175688555,12,1142,negative regulation of signal transduction,BP,LTF;EYA2;FGFR3;SOX10;CAV2;TRIM67;EGFR;CTHRC1;RGS6;PRAME;APOD;DAPK1
19523,GO:1903037,0.0789974356016686,0.976863648067526,4,261,regulation of leukocyte cell-cell adhesion,BP,EFNB3;GPNMB;HLA-DRB1;HLA-DRB5
21382,GO:2000392,0.0792163447978693,0.997090580190752,1,11,regulation of lamellipodium morphogenesis,BP,ENPP2
14489,GO:0060044,0.0792652393863056,0.997063271566947,1,12,negative regulation of cardiac muscle cell proliferation,BP,GJA1
6945,GO:0021889,0.0792940652326777,0.99708478041356,1,11,olfactory bulb interneuron differentiation,BP,ARX
5081,GO:0010960,0.0793301540054485,0.99711053788333,1,10,magnesium ion homeostasis,BP,EGFR
3782,GO:0007512,0.0794824057717467,0.997046910363316,1,12,adult heart development,BP,GJA1
15569,GO:0070085,0.0795370000908021,0.976666547371041,4,241,glycosylation,BP,ST8SIA2;GALNT13;MGAT5B;GALNT9
5516,GO:0015732,0.0797015199511683,0.997010120886935,1,13,prostaglandin transport,BP,NOS2
12984,GO:0048266,0.0798502303253178,0.997019091755548,1,12,behavioral response to pain,BP,SCN9A
21729,GO:2001044,0.0798623239135744,0.996997858921532,1,13,regulation of integrin-mediated signaling pathway,BP,DMTN
5817,GO:0016331,0.0798948989058355,0.981667674292113,3,143,morphogenesis of embryonic epithelium,BP,PCDH8;CTHRC1;IRX2
5317,GO:0015114,0.0799356419587692,0.997036676166164,1,11,phosphate ion transmembrane transporter activity,MF,SLC17A7
13925,GO:0051503,0.0802989353427532,0.996964435017201,1,13,adenine nucleotide transport,BP,GJA1
14170,GO:0051966,0.0804867956373717,0.988377225365086,2,63,regulation of synaptic transmission, glutamatergic,BP,CACNG4;EGFR
18801,GO:1901137,0.0807647559023715,0.964147016696771,8,685,carbohydrate derivative biosynthetic process,BP,NOS2;ST8SIA2;GALNT13;ACAN;MGAT5B;UGT8;GALNT9;GPC6
2498,GO:0005230,0.0807704888942261,0.988297755511709,2,67,extracellular ligand-gated ion channel activity,MF,SLC17A7;GRID2
9658,GO:0035265,0.0808304406267515,0.981366783166277,3,141,organ growth,BP,ARX;FGFR3;GJA1
7085,GO:0023026,0.0809563277334284,0.996866803581337,1,16,MHC class II protein complex binding,MF,HLA-DRB1
18553,GO:1900025,0.0811537768801838,0.996919421236963,1,12,negative regulation of substrate adhesion-dependent cell spreading,BP,DMTN
10499,GO:0040017,0.0813232554289445,0.968699383883159,6,449,positive regulation of locomotion,BP,CAV2;BVES;GPNMB;ENPP2;EGFR;DMTN
7259,GO:0030258,0.0819636086673286,0.97570964767948,4,243,lipid modification,BP,FGFR3;FA2H;EGFR;APOD
7096,GO:0030001,0.0821108652848883,0.961527876830763,9,772,metal ion transport,BP,CAMK2A;CACNG4;SLC17A7;SLC38A1;SLC30A3;GJA1;KCNJ6;KCNJ4;SCN9A
13252,GO:0048853,0.0821656221714141,0.996819381690819,1,13,forebrain morphogenesis,BP,OTX1
11750,GO:0044794,0.0833244648923708,0.996727574304923,1,13,positive regulation by host of viral process,BP,CAV2
8476,GO:0032535,0.0834267888302309,0.970987767721428,5,335,regulation of cellular component size,BP,USH1C;SCIN;MAG;DMTN;CNTN2
17289,GO:0090195,0.0835010540881819,0.996713465925809,1,13,chemokine secretion,BP,MBP
8570,GO:0032682,0.0835039781231555,0.996663280145914,1,16,negative regulation of chemokine production,BP,APOD
6982,GO:0021954,0.0836465846583537,0.987638649091577,2,67,central nervous system neuron development,BP,ARX;CNTN2
20507,GO:1905048,0.0836649045958128,0.996700347267341,1,13,regulation of metallopeptidase activity,BP,MBP
7684,GO:0031099,0.0838589690677564,0.980345181779288,3,160,regeneration,BP,EGFR;GJA1;APOD
8473,GO:0032530,0.084047626231735,0.996692104776083,1,12,regulation of microvillus organization,BP,USH1C
17450,GO:0090527,0.0843329592538446,0.996696028144691,1,11,actin filament reorganization,BP,DMTN
6160,GO:0017014,0.0844587158911581,0.996636408868302,1,13,protein nitrosylation,BP,NOS2
6290,GO:0018119,0.0844587158911581,0.996636408868302,1,13,peptidyl-cysteine S-nitrosylation,BP,NOS2
13591,GO:0050954,0.0848400197817396,0.980037307265589,3,147,sensory perception of mechanical stimulus,BP,USH1C;GJB6;MBP
6471,GO:0019226,0.0851238561160481,0.987294812892134,2,67,transmission of nerve impulse,BP,CACNG4;SCN9A
17898,GO:0097756,0.0852264055561513,0.987256139541862,2,71,negative regulation of blood vessel diameter,BP,EGFR;GJA1
3945,GO:0008191,0.085422167714947,0.996520775863379,1,15,metalloendopeptidase inhibitor activity,MF,SPOCK1
11849,GO:0045087,0.0856040987630744,0.961512383006424,8,742,innate immune response,BP,NOS2;LTF;CAMK2A;MX2;HLA-DRB1;DAPK1;HLA-DRB5;KLRC2
6611,GO:0019731,0.0856451404722417,0.996425068798526,1,22,antibacterial humoral response,BP,LTF
14550,GO:0060134,0.0857029488093317,0.996558317261511,1,12,prepulse inhibition,BP,GRID2
5116,GO:0012510,0.0857050508385267,0.996514689798215,1,14,trans-Golgi network transport vesicle membrane,CC,NRGN
5980,GO:0016653,0.0858447320865797,0.996523250866622,1,13,oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor,MF,NOS2
17251,GO:0090148,0.0858787840326607,0.996543944754854,1,12,membrane fission,BP,MX2
13321,GO:0050321,0.086242767128423,0.996490396662137,1,13,tau-protein kinase activity,MF,PHKG1
12922,GO:0048143,0.0862738813971657,0.996511537167482,1,12,astrocyte activation,BP,EGFR
14149,GO:0051938,0.086334511856702,0.996506550160412,1,12,L-glutamate import,BP,SLC17A7
20137,GO:1904321,0.0863506635812038,0.996533310302236,1,11,response to forskolin,BP,AHR
20138,GO:1904322,0.0863506635812038,0.996533310302236,1,11,cellular response to forskolin,BP,AHR
5700,GO:0016101,0.0866800314325026,0.986894089569147,2,77,diterpenoid metabolic process,BP,EGFR;GPC6
13188,GO:0048711,0.0868145137188508,0.996422348613148,1,14,positive regulation of astrocyte differentiation,BP,MAG
18724,GO:1900452,0.0868344098472165,0.996465291937648,1,12,regulation of long term synaptic depression,BP,GRID2
2771,GO:0005796,0.0869461572049536,0.986847126966926,2,72,Golgi lumen,CC,ACAN;GPC6
743,GO:0001921,0.0873171395258648,0.996400919429258,1,13,positive regulation of receptor recycling,BP,BVES
2050,GO:0004551,0.0873936701102825,0.996339779919163,1,16,nucleotide diphosphatase activity,MF,ENPP2
17092,GO:0086001,0.0874409123599539,0.986765533883615,2,63,cardiac muscle cell action potential,BP,DSG2;GJA1
5344,GO:0015171,0.0875231081035011,0.986709974733374,2,72,amino acid transmembrane transporter activity,MF,SLC17A7;SLC38A1
5301,GO:0015081,0.0876238645953523,0.979117356338017,3,139,sodium ion transmembrane transporter activity,MF,SLC17A7;SLC38A1;SCN9A
12173,GO:0045780,0.0877262685999518,0.996366539625352,1,13,positive regulation of bone resorption,BP,EGFR
12657,GO:0046852,0.0877262685999518,0.996366539625352,1,13,positive regulation of bone remodeling,BP,EGFR
2663,GO:0005614,0.0879727878678773,0.996370403020562,1,12,interstitial matrix,CC,ABI3BP
8734,GO:0032928,0.088241217532261,0.996267237812585,1,16,regulation of superoxide anion generation,BP,EGFR
13079,GO:0048523,0.0882513678472345,0.941455155849892,34,4114,negative regulation of cellular process,BP,ARX;CRLF1;SCIN;LTF;ZIC2;EYA2;FGFR3;SOX10;TOX3;MAG;CAV2;AHR;EFNB3;CHD5;TRIM67;GJB6;PACSIN1;PRKCG;GPNMB;EGFR;GRID2;SPOCK1;GJA1;DMTN;CTHRC1;LMO1;IRX2;RGS6;CNTN2;PRAME;APOD;DAPK1;MBP;COL28A1
1544,GO:0003333,0.0883134315517875,0.986524819925037,2,71,amino acid transmembrane transport,BP,SLC17A7;SLC38A1
7519,GO:0030826,0.0885375204641066,0.996227394854988,1,17,regulation of cGMP biosynthetic process,BP,NOS2
7843,GO:0031402,0.0886456720581205,0.996313703616937,1,12,sodium ion binding,MF,SCN9A
15119,GO:0061029,0.0887776876026423,0.99627741160676,1,13,eyelid development in camera-type eye,BP,EGFR
13037,GO:0048385,0.0889542858649047,0.996222009321144,1,15,regulation of retinoic acid receptor signaling pathway,BP,PRAME
9558,GO:0035004,0.0889808667450326,0.986372264441225,2,69,phosphatidylinositol 3-kinase activity,MF,FGFR3;EGFR
10772,GO:0042537,0.0889879487118859,0.996175414092913,1,18,benzene-containing compound metabolic process,BP,GSTM1
14376,GO:0055001,0.0892046262358114,0.978566418960031,3,148,muscle cell development,BP,CAV2;BVES;SGCD
16479,GO:0071682,0.0892454662130483,0.996141313544669,1,19,endocytic vesicle lumen,CC,LTF
17573,GO:0097090,0.0892909571592389,0.996258902618354,1,12,presynaptic membrane organization,BP,CNTN2
11053,GO:0043112,0.0893489955899015,0.978502255846625,3,158,receptor metabolic process,BP,CACNG4;BVES;CNTN2
8909,GO:0033218,0.0894359972958796,0.97268171338518,4,271,amide binding,MF,MAG;GSTM1;HLA-DRB1;HLA-DRB5
5074,GO:0010952,0.0895433809037588,0.978419055515453,3,171,positive regulation of peptidase activity,BP,CCK;DAPK1;MBP
1928,GO:0004364,0.0895474512368108,0.996071095024059,1,24,glutathione transferase activity,MF,GSTM1
855,GO:0002070,0.0895863847789103,0.996186185318089,1,14,epithelial cell maturation,BP,GJA1
13844,GO:0051349,0.0895873472198565,0.996167116210362,1,15,positive regulation of lyase activity,BP,NOS2
12214,GO:0045861,0.0896648824470651,0.972586679305448,4,273,negative regulation of proteolysis,BP,LTF;PRKCG;SPOCK1;COL28A1
3486,GO:0006898,0.0899050454064731,0.972503110732859,4,253,receptor-mediated endocytosis,BP,CACNG4;CAV2;ENPP2;CNTN2
13840,GO:0051345,0.089935262558656,0.959146259823314,8,680,positive regulation of hydrolase activity,BP,FGFR3;CAV2;EGFR;RIN1;RGS6;CCK;DAPK1;MBP
5149,GO:0014048,0.0903201975942699,0.996122356793965,1,14,regulation of glutamate secretion,BP,CCK
8897,GO:0033194,0.0903317373667664,0.996085160238211,1,16,response to hydroperoxide,BP,DAPK1
5297,GO:0015075,0.0903600937483301,0.956842512971722,9,783,ion transmembrane transporter activity,MF,CACNG4;SLC17A7;SLC38A1;SLC30A3;GRID2;GJA1;KCNJ6;KCNJ4;SCN9A
7518,GO:0030825,0.0904669997589592,0.996058284969131,1,17,positive regulation of cGMP metabolic process,BP,NOS2
8161,GO:0032045,0.0904879029397313,0.996130049754681,1,13,guanyl-nucleotide exchange factor complex,CC,KNDC1
3742,GO:0007379,0.0905294332898651,0.996084668826134,1,15,segment specification,BP,IRX2
6839,GO:0021675,0.0905462979365958,0.985990068787215,2,70,nerve development,BP,PRKCG;NPTX1
5280,GO:0015020,0.0905713804775508,0.99610038244148,1,14,glucuronosyltransferase activity,MF,UGT8
4951,GO:0010801,0.0905724007509913,0.996100293053361,1,14,negative regulation of peptidyl-threonine phosphorylation,BP,DMTN
7979,GO:0031657,0.0906302143637194,0.99609522615899,1,14,regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,EGFR
15308,GO:0061478,0.0908428131087861,0.996125396510233,1,12,response to platelet aggregation inhibitor,BP,AHR
13509,GO:0050832,0.0909178304802612,0.9959552759118,1,23,defense response to fungus,BP,LTF
11889,GO:0045161,0.0910288660719213,0.996109227650281,1,12,neuronal ion channel clustering,BP,CNTN2
14161,GO:0051957,0.0910564540510046,0.9960577645948,1,14,positive regulation of amino acid transport,BP,CCK
7681,GO:0031094,0.0911434134915943,0.996130556632904,1,11,platelet dense tubular network,CC,DMTN
11108,GO:0043197,0.0915170438996687,0.977774724990773,3,148,dendritic spine,CC,GRID2;NRGN;ANKS1B
8194,GO:0032098,0.0916733781748242,0.995924771697382,1,19,regulation of appetite,BP,CCK
8506,GO:0032588,0.0923676918269747,0.985512931388182,2,79,trans-Golgi network membrane,CC,HLA-DRB1;HLA-DRB5
3715,GO:0007289,0.0924124842988181,0.995937352986818,1,14,spermatid nucleus differentiation,BP,CHD5
17830,GO:0097581,0.0926194333979027,0.985478990294082,2,71,lamellipodium organization,BP,ENPP2;DMTN
8931,GO:0033270,0.0926216329718397,0.995969381056507,1,12,paranode region of axon,CC,MAG
19172,GO:1902188,0.0926684100446324,0.995894100798966,1,15,positive regulation of viral release from host cell,BP,CAV2
13069,GO:0048511,0.0926868886140121,0.971356359240865,4,254,rhythmic process,BP,NOS2;AHR;PRKCG;EGFR
7169,GO:0030134,0.0927425661816148,0.985408415272803,2,83,COPII-coated ER to Golgi transport vesicle,CC,HLA-DRB1;HLA-DRB5
3841,GO:0007635,0.0928973726754727,0.995917406675095,1,13,chemosensory behavior,BP,PRKCG
13776,GO:0051241,0.0932246179961526,0.953348463251115,10,946,negative regulation of multicellular organismal process,BP,LTF;SOX10;MAG;EFNB3;GPNMB;EGFR;SPOCK1;GJA1;CNTN2;APOD
2299,GO:0004888,0.0934391506903629,0.957193117283467,8,719,transmembrane signaling receptor activity,MF,FGFR3;EFNB3;GPR17;EGFR;GFRA1;GRID2;FPR3;KLRC2
7090,GO:0023051,0.0935979097557601,0.93951846277488,27,3154,regulation of signaling,BP,CRLF1;NOS2;LTF;EYA2;FGFR3;CAMK2A;CACNG4;SOX10;CAV2;BVES;CHD5;TRIM67;GPNMB;GPR17;EGFR;GRID2;GJA1;NRGN;DMTN;CTHRC1;RGS6;GPC6;CNTN2;PRAME;CCK;APOD;DAPK1
7769,GO:0031281,0.0937075834042384,0.995781651265396,1,16,positive regulation of cyclase activity,BP,NOS2
9208,GO:0034143,0.0937920528503947,0.995792112103072,1,15,regulation of toll-like receptor 4 signaling pathway,BP,LTF
1127,GO:0002544,0.0938422324948317,0.995753225163091,1,17,chronic inflammatory response,BP,GJA1
13518,GO:0050852,0.094323970853012,0.976754136792485,3,182,T cell receptor signaling pathway,BP,MOG;HLA-DRB1;HLA-DRB5
19895,GO:1903798,0.0944180531573458,0.99575582183023,1,14,regulation of production of miRNAs involved in gene silencing by miRNA,BP,EGFR
11574,GO:0044309,0.0949478419450347,0.976580125261709,3,150,neuron spine,CC,GRID2;NRGN;ANKS1B
17147,GO:0086069,0.0950121682375109,0.995725909486194,1,13,bundle of His cell to Purkinje myocyte communication,BP,DSG2
14625,GO:0060253,0.0953923802642537,0.995666147013078,1,14,negative regulation of glial cell proliferation,BP,SOX10
1311,GO:0002861,0.0955198641781718,0.995569167277087,1,19,regulation of inflammatory response to antigenic stimulus,BP,GPR17
6691,GO:0019897,0.0956347591480139,0.976324769311873,3,159,extrinsic component of plasma membrane,CC,CDH19;CAV2;RGS6
13388,GO:0050670,0.0956720237268041,0.97628123040306,3,182,regulation of lymphocyte proliferation,BP,AHR;GPNMB;LMO1
7158,GO:0030122,0.0957907312225578,0.995629203655959,1,14,AP-2 adaptor complex,CC,EGFR
9185,GO:0034114,0.0958829120482213,0.995563066885139,1,17,regulation of heterotypic cell-cell adhesion,BP,MBP
15030,GO:0060850,0.0961136970188058,0.995558155263448,1,16,regulation of transcription involved in cell fate commitment,BP,CHD5
3425,GO:0006805,0.0961260812439529,0.984538464051052,2,92,xenobiotic metabolic process,BP,AHR;GSTM1
11105,GO:0043194,0.0965583669183265,0.995612736434849,1,12,axon initial segment,CC,CCK
8743,GO:0032944,0.0969327947144712,0.975835047268092,3,183,regulation of mononuclear cell proliferation,BP,AHR;GPNMB;LMO1
16724,GO:0072148,0.0970426077406232,0.995489761876466,1,15,epithelial cell fate commitment,BP,ARX
15142,GO:0061053,0.0973076286468476,0.984298485879136,2,73,somite development,BP,PCDH8;DMRT2
4044,GO:0008344,0.0975681901925974,0.984220752388516,2,76,adult locomotory behavior,BP,EFNB3;CNTN2
12561,GO:0046625,0.0980444516610089,0.995374484019326,1,16,sphingolipid binding,MF,MAG
7069,GO:0022857,0.0981429429016915,0.950406821130497,10,921,transmembrane transporter activity,MF,CACNG4;SLC17A7;SLC38A1;SLC30A3;GRID2;GJA1;KCNJ6;KCNJ4;SCN9A;GJB1
7818,GO:0031345,0.0981969461279123,0.975420449724195,3,158,negative regulation of cell projection organization,BP,MAG;EFNB3;SPOCK1
7865,GO:0031434,0.0982743899960244,0.984074024493114,2,68,mitogen-activated protein kinase kinase binding,MF,FGFR3;EGFR
594,GO:0001710,0.0983729721579458,0.995325178733895,1,17,mesodermal cell fate commitment,BP,EYA2
10490,GO:0040008,0.0986325579372182,0.95692031009081,7,589,regulation of growth,BP,ARX;FGFR3;MAG;EGFR;SPOCK1;GJA1;PRAME
13439,GO:0050727,0.0992699087334248,0.96857055686023,4,283,regulation of inflammatory response,BP,NOS2;GPR17;EGFR;APOD
3649,GO:0007186,0.0993599318083061,0.953857589959221,8,761,G-protein coupled receptor signaling pathway,BP,CAMK2A;CAV2;ENPP2;GPR17;RGS6;CNTN2;CCK;FPR3
13778,GO:0051247,0.099385145271741,0.943950954271554,14,1452,positive regulation of protein metabolic process,BP,CRLF1;LTF;FGFR3;CAV2;TRIM67;GPNMB;ENPP2;EGFR;GJA1;KNDC1;CNTN2;CCK;DAPK1;MBP
13533,GO:0050867,0.0994512553344116,0.96849197883197,4,285,positive regulation of cell activation,BP,EFNB3;DMTN;HLA-DRB1;HLA-DRB5
20561,GO:1905208,0.0994577206952786,0.995281473908003,1,14,negative regulation of cardiocyte differentiation,BP,EGFR
5821,GO:0016338,0.0996338317876494,0.995186154943522,1,18,calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules,BP,CLDN11
8393,GO:0032426,0.0996804000607666,0.995236400110913,1,15,stereocilium tip,CC,USH1C
2301,GO:0004896,0.0997056346140066,0.983652061470038,2,82,cytokine receptor activity,MF,GPR17;GFRA1
7577,GO:0030901,0.0998696652744548,0.983609696507853,2,82,midbrain development,BP,OTX1;MBP
4032,GO:0008324,0.0999088908212123,0.956235068672754,7,570,cation transmembrane transporter activity,MF,CACNG4;SLC17A7;SLC38A1;SLC30A3;KCNJ6;KCNJ4;SCN9A
20405,GO:1904861,0.100188048543672,0.995237985098577,1,13,excitatory synapse assembly,BP,GRID2
14607,GO:0060219,0.100411265558587,0.995164927330815,1,15,camera-type eye photoreceptor cell differentiation,BP,USH1C
2535,GO:0005313,0.100592509700218,0.99517106300765,1,14,L-glutamate transmembrane transporter activity,MF,SLC17A7
5345,GO:0015172,0.100592509700218,0.99517106300765,1,14,acidic amino acid transmembrane transporter activity,MF,SLC17A7
3376,GO:0006721,0.100759499888773,0.98336953271622,2,85,terpenoid metabolic process,BP,EGFR;GPC6
15470,GO:0061844,0.10077573581278,0.994961077087723,1,30,antimicrobial humoral immune response mediated by antimicrobial peptide,BP,LTF
2835,GO:0005901,0.101038270247179,0.983340397929136,2,73,caveola,CC,CAV2;BVES
726,GO:0001894,0.101201059905678,0.97432623965823,3,170,tissue homeostasis,BP,USH1C;LTF;EGFR
16036,GO:0070920,0.101240781454456,0.995083137146739,1,15,regulation of production of small RNA involved in gene silencing by RNA,BP,EGFR
1407,GO:0003094,0.101387233601516,0.995068622922472,1,15,glomerular filtration,BP,GJA1
3579,GO:0007045,0.10150717749814,0.983227165233464,2,71,cell-substrate adherens junction assembly,BP,DMTN;APOD
12906,GO:0048041,0.10150717749814,0.983227165233464,2,71,focal adhesion assembly,BP,DMTN;APOD
19063,GO:1901879,0.101578330236263,0.983199899013133,2,73,regulation of protein depolymerization,BP,SCIN;DMTN
13076,GO:0048520,0.101580588339218,0.99499248136225,1,18,positive regulation of behavior,BP,GJA1
19014,GO:1901701,0.102352523038522,0.947855446029211,10,950,cellular response to oxygen-containing compound,BP,NOS2;LTF;CAMK2A;SOX10;CAV2;AHR;GJB6;EGFR;DMTN;DAPK1
14099,GO:0051861,0.10245452837658,0.994921279448576,1,17,glycolipid binding,MF,MAG
3755,GO:0007411,0.102670934430005,0.967157229954025,4,236,axon guidance,BP,ARX;EFNB3;GFRA1;CNTN2
7164,GO:0030128,0.10277809577958,0.994929671822254,1,15,clathrin coat of endocytic vesicle,CC,EGFR
5073,GO:0010951,0.1028700218902,0.97369934968261,3,187,negative regulation of endopeptidase activity,BP,LTF;SPOCK1;COL28A1
21710,GO:2001020,0.103267571790651,0.973575765513208,3,171,regulation of response to DNA damage stimulus,BP,EYA2;PRKCG;EGFR
15908,GO:0070663,0.103654915840191,0.973410932458294,3,189,regulation of leukocyte proliferation,BP,AHR;GPNMB;LMO1
9824,GO:0035584,0.103715795563207,0.99479294800899,1,17,calcium-mediated signaling using intracellular calcium source,BP,DMTN
14394,GO:0055022,0.103781249653129,0.99480591051425,1,16,negative regulation of cardiac muscle tissue growth,BP,GJA1
15181,GO:0061117,0.103781249653129,0.99480591051425,1,16,negative regulation of heart growth,BP,GJA1
412,GO:0001091,0.104078880071568,0.994775477015288,1,16,RNA polymerase II basal transcription factor binding,MF,AHR
3341,GO:0006672,0.104423001143907,0.982410095092188,2,84,ceramide metabolic process,BP,ST8SIA2;UGT8
17272,GO:0090177,0.104566890368617,0.994748012441674,1,15,establishment of planar polarity involved in neural tube closure,BP,CTHRC1
16677,GO:0072079,0.104975011713122,0.994645280166752,1,18,nephron tubule formation,BP,IRX2
17784,GO:0097485,0.104983492959649,0.966155985782009,4,238,neuron projection guidance,BP,ARX;EFNB3;GFRA1;CNTN2
8781,GO:0033002,0.105025184730691,0.972939330320613,3,167,muscle cell proliferation,BP,EGFR;GJA1;APOD
13536,GO:0050870,0.105186670521366,0.972852318574139,3,187,positive regulation of T cell activation,BP,EFNB3;HLA-DRB1;HLA-DRB5
14700,GO:0060349,0.105344248916907,0.982182743305161,2,79,bone morphogenesis,BP,LTF;FGFR3
17247,GO:0090136,0.10591153381668,0.994609266419168,1,15,epithelial cell-cell adhesion,BP,BVES
14126,GO:0051900,0.106042253918576,0.99453361347397,1,18,regulation of mitochondrial depolarization,BP,CCK
1398,GO:0003071,0.106233876070918,0.994513436806878,1,18,renal system process involved in regulation of systemic arterial blood pressure,BP,GJA1
10758,GO:0042493,0.106262349807545,0.947524718398413,9,869,response to drug,BP,NOS2;DSG2;SOX10;SLC17A7;AHR;PRKCG;EGFR;GJA1;APOD
9367,GO:0034446,0.106264150356611,0.981936699102485,2,79,substrate adhesion-dependent cell spreading,BP,BVES;DMTN
3342,GO:0006677,0.106340097102636,0.994502235697171,1,18,glycosylceramide metabolic process,BP,UGT8
730,GO:0001906,0.106910793156829,0.981686630128823,2,105,cell killing,BP,NOS2;LTF
8124,GO:0031982,0.106988323443874,0.928689594441278,30,3801,vesicle,CC,SCIN;NOS2;LTF;CLDN11;DSG2;FGFR3;CAMK2A;CACNG4;SLC17A7;CAV2;SLC38A1;SLC30A3;ATP10B;PPL;PACSIN1;GPNMB;ST8SIA2;EGFR;GFRA1;GJA1;NRGN;SNX22;DMTN;EDIL3;KCNJ4;NPTX1;APOD;HLA-DRB1;CPNE4;HLA-DRB5
862,GO:0002080,0.107088750626394,0.994441563264857,1,17,acrosomal membrane,CC,CAV2
6476,GO:0019233,0.107525508499233,0.981578675474021,2,84,sensory perception of pain,BP,SCN9A;CCK
3626,GO:0007159,0.10761460793344,0.964961219549877,4,290,leukocyte cell-cell adhesion,BP,EFNB3;GPNMB;HLA-DRB1;HLA-DRB5
8453,GO:0032496,0.107724308475188,0.964909397136165,4,295,response to lipopolysaccharide,BP,NOS2;LTF;GJB6;GJA1
7955,GO:0031623,0.108075689606116,0.981426220358277,2,85,receptor internalization,BP,CACNG4;CNTN2
17647,GO:0097205,0.10846404893435,0.994316342720602,1,16,renal filtration,BP,GJA1
519,GO:0001573,0.108598998961558,0.994280354824608,1,17,ganglioside metabolic process,BP,ST8SIA2
10536,GO:0042056,0.10876993634071,0.994183439138964,1,22,chemoattractant activity,MF,GPNMB
9524,GO:0034762,0.108885912605624,0.954772107767683,6,472,regulation of transmembrane transport,BP,CACNG4;GJA1;KCNJ6;KCNJ4;SCN9A;DAPK1
18285,GO:0099632,0.108971866720433,0.994220911823479,1,18,protein transport within plasma membrane,BP,CACNG4
18287,GO:0099637,0.108971866720433,0.994220911823479,1,18,neurotransmitter receptor transport,BP,CACNG4
13698,GO:0051127,0.10907163242767,0.994275769295628,1,15,positive regulation of actin nucleation,BP,SCIN
2157,GO:0004697,0.109520194138995,0.99422758493948,1,15,protein kinase C activity,MF,PRKCG
5575,GO:0015849,0.10971557197306,0.964054079274754,4,269,organic acid transport,BP,NOS2;SLC17A7;SLC38A1;CCK
12708,GO:0046942,0.10971557197306,0.964054079274754,4,269,carboxylic acid transport,BP,NOS2;SLC17A7;SLC38A1;CCK
3662,GO:0007200,0.110042119666335,0.980861199762092,2,94,phospholipase C-activating G-protein coupled receptor signaling pathway,BP,GPR17;FPR3
7279,GO:0030285,0.11007704295416,0.994120257246605,1,17,integral component of synaptic vesicle membrane,CC,SLC17A7
11030,GO:0043062,0.110291147736417,0.958353219950937,5,352,extracellular structure organization,BP,ICAM5;COL9A1;HAPLN1;ABI3BP;ACAN
2627,GO:0005545,0.110335455928928,0.994139470351001,1,15,1-phosphatidylinositol binding,MF,SCIN
15079,GO:0060973,0.111022383068547,0.994016651929821,1,17,cell migration involved in heart development,BP,BVES
12639,GO:0046823,0.111080314957794,0.993972332243199,1,19,negative regulation of nucleocytoplasmic transport,BP,APOD
3431,GO:0006812,0.111167174445994,0.942445766843331,10,966,cation transport,BP,CAMK2A;CACNG4;SLC17A7;SLC38A1;SLC30A3;GJA1;KCNJ6;KCNJ4;SCN9A;DAPK1
4853,GO:0010642,0.111220839737693,0.994017374782235,1,16,negative regulation of platelet-derived growth factor receptor signaling pathway,BP,APOD
13489,GO:0050803,0.111396092742586,0.970585735201843,3,158,regulation of synapse structure or activity,BP,SLC17A7;GRID2;SLITRK2
10103,GO:0036035,0.111500011631533,0.993986653304172,1,16,osteoclast development,BP,LTF
5075,GO:0010954,0.112338940718833,0.993850306073219,1,18,positive regulation of protein processing,BP,CNTN2
18019,GO:0098772,0.112772908959852,0.935086905231509,14,1531,molecular function regulator,MF,CRLF1;LTF;FGFR3;CAMK2A;CACNG4;GPNMB;EGFR;GFRA1;SPOCK1;KNDC1;RIN1;RGS6;CCK;COL28A1
2105,GO:0004622,0.113056749020901,0.993769743904847,1,18,lysophospholipase activity,MF,ENPP2
11425,GO:0043931,0.113131505204783,0.993862273513179,1,14,ossification involved in bone maturation,BP,LTF
2837,GO:0005903,0.113189446640485,0.980038582881548,2,80,brush border,CC,USH1C;SCIN
437,GO:0001158,0.113244164778718,0.980003794243439,2,85,enhancer sequence-specific DNA binding,MF,ARX;SOX10
4758,GO:0010466,0.113634172927796,0.969682346693991,3,194,negative regulation of peptidase activity,BP,LTF;SPOCK1;COL28A1
18102,GO:0098911,0.11390457466134,0.993776221855815,1,14,regulation of ventricular cardiac muscle cell action potential,BP,DSG2
8126,GO:0031984,0.114072476387323,0.934219781901071,14,1491,organelle subcompartment,CC,LTF;FA2H;CAV2;ATP10B;MYRF;ST8SIA2;GALNT13;EGFR;GJA1;MGAT5B;GJB1;GALNT9;HLA-DRB1;HLA-DRB5
4801,GO:0010562,0.114246622483676,0.94053290830083,10,971,positive regulation of phosphorus metabolic process,BP,CRLF1;NOS2;LTF;FGFR3;CAV2;GPNMB;ENPP2;EGFR;KNDC1;CCK
12259,GO:0045937,0.114246622483676,0.94053290830083,10,971,positive regulation of phosphate metabolic process,BP,CRLF1;NOS2;LTF;FGFR3;CAV2;GPNMB;ENPP2;EGFR;KNDC1;CCK
17697,GO:0097320,0.114373966005118,0.993641716395125,1,17,plasma membrane tubulation,BP,PACSIN1
11563,GO:0044297,0.114582992366257,0.951747259876539,6,487,cell body,CC,NRGN;KNDC1;CNTN2;CCK;APOD;MBP
12694,GO:0046916,0.11492092161172,0.979488510721787,2,99,cellular transition metal ion homeostasis,BP,LTF;SLC30A3
16334,GO:0071467,0.115258095977116,0.993499974970331,1,19,cellular response to pH,BP,GJA1
12482,GO:0046475,0.11536926161209,0.993487151876588,1,19,glycerophospholipid catabolic process,BP,ENPP2
13700,GO:0051129,0.115460779441985,0.947620029857821,7,599,negative regulation of cellular component organization,BP,SCIN;MAG;EFNB3;PACSIN1;SPOCK1;DMTN;APOD
708,GO:0001871,0.115543702252579,0.993467003317793,1,19,pattern binding,MF,ENPP2
7255,GO:0030247,0.115543702252579,0.993467003317793,1,19,polysaccharide binding,MF,ENPP2
21629,GO:2000778,0.115669668903674,0.993452433471131,1,19,positive regulation of interleukin-6 secretion,BP,MBP
14167,GO:0051963,0.115705505465085,0.979345672684777,2,77,regulation of synapse assembly,BP,GRID2;SLITRK2
6686,GO:0019886,0.11578371165185,0.979262265078112,2,93,antigen processing and presentation of exogenous peptide antigen via MHC class II,BP,HLA-DRB1;HLA-DRB5
12556,GO:0046620,0.115858495217441,0.979280673768029,2,82,regulation of organ growth,BP,ARX;GJA1
3176,GO:0006468,0.116111122218738,0.930534196713021,16,1712,protein phosphorylation,BP,CRLF1;LTF;FGFR3;CAMK2A;CAV2;PRKCG;GPNMB;ENPP2;EGFR;GFRA1;DMTN;PHKG1;KNDC1;CCK;DAPK1;MBP
482,GO:0001518,0.116133780964746,0.993524576973725,1,14,voltage-gated sodium channel complex,CC,SCN9A
3217,GO:0006525,0.116263558122465,0.993365853501886,1,20,arginine metabolic process,BP,NOS2
14111,GO:0051882,0.116322076264228,0.993359024316525,1,20,mitochondrial depolarization,BP,CCK
8423,GO:0032461,0.116661282070688,0.993303281939016,1,21,positive regulation of protein oligomerization,BP,CCK
10565,GO:0042110,0.116701865402518,0.955145510119874,5,403,T cell activation,BP,EFNB3;GPNMB;LMO1;HLA-DRB1;HLA-DRB5
2523,GO:0005283,0.117066283833088,0.993331902111939,1,17,amino acid:sodium symporter activity,MF,SLC38A1
10623,GO:0042249,0.117102797143796,0.993327647428898,1,17,establishment of planar polarity of embryonic epithelium,BP,CTHRC1
3444,GO:0006835,0.117155301181583,0.978908380552536,2,83,dicarboxylic acid transport,BP,SLC17A7;CCK
14087,GO:0051817,0.117243457663876,0.978857065855175,2,90,modification of morphology or physiology of other organism involved in symbiotic interaction,BP,LTF;CAV2
3435,GO:0006817,0.117279238144787,0.993307067789792,1,17,phosphate ion transport,BP,SLC17A7
16998,GO:0072673,0.11731458961603,0.993302940496754,1,17,lamellipodium morphogenesis,BP,ENPP2
8280,GO:0032270,0.117366312640908,0.933370921804493,13,1363,positive regulation of cellular protein metabolic process,BP,CRLF1;LTF;FGFR3;CAV2;TRIM67;GPNMB;ENPP2;EGFR;KNDC1;CNTN2;CCK;DAPK1;MBP
12059,GO:0045597,0.117455679853415,0.940783579588983,9,831,positive regulation of cell differentiation,BP,SCIN;LTF;SOX10;MAG;TRIM67;PACSIN1;GJA1;DMTN;CTHRC1
19033,GO:1901798,0.11746753751931,0.993224606993456,1,20,positive regulation of signal transduction by p53 class mediator,BP,CHD5
11113,GO:0043202,0.117908903501765,0.978677602127685,2,87,lysosomal lumen,CC,ACAN;GPC6
9828,GO:0035588,0.117951147759273,0.993150991610425,1,21,G-protein coupled purinergic receptor signaling pathway,BP,CNTN2
2509,GO:0005249,0.118028770033639,0.978654865249829,2,84,voltage-gated potassium channel activity,MF,KCNJ6;KCNJ4
2376,GO:0005005,0.118107101965766,0.993210065100885,1,17,transmembrane-ephrin receptor activity,MF,EFNB3
17345,GO:0090276,0.118139152856479,0.967969455861205,3,181,regulation of peptide hormone secretion,BP,NOS2;EGFR;GJA1
15703,GO:0070300,0.118307153922174,0.993163794919399,1,18,phosphatidic acid binding,MF,NRGN
19525,GO:1903039,0.118362291007212,0.967861586284188,3,196,positive regulation of leukocyte cell-cell adhesion,BP,EFNB3;HLA-DRB1;HLA-DRB5
5814,GO:0016324,0.11847744532223,0.960131285162921,4,265,apical plasma membrane,CC,DSG2;GJB6;EGFR;GJA1
751,GO:0001934,0.118809062928215,0.939952361158687,9,852,positive regulation of protein phosphorylation,BP,CRLF1;LTF;FGFR3;CAV2;GPNMB;ENPP2;EGFR;KNDC1;CCK
9747,GO:0035455,0.119202264862603,0.993018357687549,1,20,response to interferon-alpha,BP,MX2
13464,GO:0050770,0.119255452270391,0.967568879687806,3,162,regulation of axonogenesis,BP,MAG;EFNB3;CNTN2
19505,GO:1903010,0.119555338891664,0.993015412327104,1,18,regulation of bone development,BP,LTF
6740,GO:0020037,0.119923011569179,0.978057747842187,2,99,heme binding,MF,NOS2;FA2H
6469,GO:0019221,0.11993389989321,0.94505694503965,7,686,cytokine-mediated signaling pathway,BP,CRLF1;NOS2;CAMK2A;GPR17;MX2;HLA-DRB1;HLA-DRB5
15942,GO:0070734,0.119939307068482,0.992948542881416,1,19,histone H3-K27 methylation,BP,CHD5
17391,GO:0090330,0.120385846778428,0.992915758435106,1,18,regulation of platelet aggregation,BP,DMTN
1094,GO:0002495,0.120461328450581,0.977910700949462,2,96,antigen processing and presentation of peptide antigen via MHC class II,BP,HLA-DRB1;HLA-DRB5
2571,GO:0005385,0.120481698562605,0.992883131536519,1,19,zinc ion transmembrane transporter activity,MF,SLC30A3
4857,GO:0010646,0.120920769155562,0.919933643405662,26,3103,regulation of cell communication,BP,CRLF1;NOS2;LTF;EYA2;FGFR3;CAMK2A;CACNG4;SOX10;CAV2;CHD5;TRIM67;GPNMB;GPR17;EGFR;GRID2;GJA1;NRGN;DMTN;CTHRC1;RGS6;GPC6;CNTN2;PRAME;CCK;APOD;DAPK1
9193,GO:0034123,0.12094586888614,0.99280779027303,1,20,positive regulation of toll-like receptor signaling pathway,BP,LTF
7459,GO:0030672,0.121048922907036,0.97776008701132,2,90,synaptic vesicle membrane,CC,SLC17A7;SLC30A3
18218,GO:0099501,0.121048922907036,0.97776008701132,2,90,exocytic vesicle membrane,CC,SLC17A7;SLC30A3
17937,GO:0098588,0.121107049549823,0.926037598297508,17,1879,bounding membrane of organelle,CC,LTF;CAMK2A;CACNG4;SOX10;SLC17A7;CAV2;SLC30A3;ST8SIA2;GALNT13;EGFR;GJA1;NRGN;DMTN;MGAT5B;GALNT9;HLA-DRB1;HLA-DRB5
12606,GO:0046697,0.121172087774095,0.992799414472751,1,19,decidualization,BP,GJA1
4868,GO:0010661,0.12127408133841,0.992787003199032,1,19,positive regulation of muscle cell apoptotic process,BP,CAMK2A
10876,GO:0042734,0.121490403777653,0.977686724655694,2,77,presynaptic membrane,CC,CAMK2A;PCDH8
489,GO:0001530,0.121822452386622,0.992652656078531,1,23,lipopolysaccharide binding,MF,LTF
20171,GO:1904385,0.121845029774252,0.992697921933456,1,20,cellular response to angiotensin,BP,CAMK2A
821,GO:0002027,0.122079695390104,0.977474558827564,2,86,regulation of heart rate,BP,DSG2;BVES
7983,GO:0031664,0.12224794575877,0.992630743913701,1,21,regulation of lipopolysaccharide-mediated signaling pathway,BP,LTF
18171,GO:0099072,0.122298791309099,0.992642145619099,1,20,regulation of postsynaptic membrane neurotransmitter receptor levels,BP,CACNG4
2170,GO:0004713,0.122698262008081,0.966207230651516,3,169,protein tyrosine kinase activity,MF,FGFR3;EFNB3;EGFR
18186,GO:0099095,0.122906745438235,0.992608740705827,1,18,ligand-gated anion channel activity,MF,SLC17A7
7516,GO:0030823,0.123136810956919,0.99250434276903,1,22,regulation of cGMP metabolic process,BP,NOS2
21315,GO:2000310,0.123181281472495,0.992574893019223,1,18,regulation of NMDA receptor activity,BP,DAPK1
3550,GO:0007006,0.123201816868371,0.977087783330062,2,103,mitochondrial membrane organization,BP,EYA2;CAMK2A
1098,GO:0002504,0.123223738599358,0.977099353625949,2,97,antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,HLA-DRB1;HLA-DRB5
18693,GO:1900273,0.123373977529137,0.992603604936128,1,16,positive regulation of long-term synaptic potentiation,BP,NRGN
4009,GO:0008289,0.12355457830071,0.943003130741116,7,622,lipid binding,MF,SCIN;LTF;MAG;PACSIN1;NRGN;SNX22;APOD
2167,GO:0004709,0.123711519454324,0.977036508645837,2,77,MAP kinase kinase kinase activity,MF,FGFR3;EGFR
19013,GO:1901700,0.124073074384466,0.928884810854572,13,1404,response to oxygen-containing compound,BP,NOS2;LTF;DSG2;CAMK2A;SOX10;CAV2;AHR;GJB6;EGFR;GJA1;DMTN;APOD;DAPK1
14456,GO:0060004,0.124200410231175,0.992448534869028,1,18,reflex,BP,GJA1
5404,GO:0015294,0.124642235328629,0.976728715556538,2,84,solute:cation symporter activity,MF,SLC17A7;SLC38A1
9288,GO:0034333,0.125073503658737,0.976614424683593,2,81,adherens junction assembly,BP,DMTN;APOD
14664,GO:0060307,0.12531849939186,0.992308620207683,1,18,regulation of ventricular cardiac muscle cell membrane repolarization,BP,GJA1
7167,GO:0030132,0.125320464889518,0.992285566253392,1,19,clathrin coat of coated pit,CC,EGFR
19649,GO:1903319,0.125534753611784,0.992237926966064,1,20,positive regulation of protein maturation,BP,CNTN2
18513,GO:0140103,0.125698726999762,0.992217142462629,1,20,catalytic activity, acting on a glycoprotein,MF,MGAT5B
5938,GO:0016581,0.125914150281026,0.992259271287859,1,17,NuRD complex,CC,CHD5
17457,GO:0090545,0.125914150281026,0.992259271287859,1,17,CHD-type complex,CC,CHD5
11350,GO:0043586,0.125969581425629,0.99220348066269,1,19,tongue development,BP,EGFR
945,GO:0002237,0.126271656149271,0.956499669594876,4,311,response to molecule of bacterial origin,BP,NOS2;LTF;GJB6;GJA1
6782,GO:0021549,0.12657504057141,0.976149141326173,2,85,cerebellum development,BP,GRID2;KNDC1
3746,GO:0007389,0.126922834521655,0.949965350190182,5,390,pattern specification process,BP,OTX1;PCDH8;GJA1;IRX2;DMRT2
7935,GO:0031579,0.127032991466089,0.992010523296162,1,22,membrane raft organization,BP,CAV2
11232,GO:0043395,0.127229771164971,0.992066325894361,1,18,heparan sulfate proteoglycan binding,MF,GPC6
1610,GO:0003705,0.127500412344642,0.975847213576668,2,91,transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding,MF,ARX;SOX10
16402,GO:0071577,0.127895451613915,0.991935881759409,1,20,zinc ion transmembrane transport,BP,SLC30A3
3195,GO:0006491,0.128047540465658,0.991961450645102,1,18,N-glycan processing,BP,ST8SIA2
4640,GO:0009952,0.128709139203487,0.963784468221376,3,183,anterior/posterior pattern specification,BP,OTX1;PCDH8;DMRT2
13440,GO:0050728,0.128836714853896,0.975412299086926,2,100,negative regulation of inflammatory response,BP,GPR17;APOD
4057,GO:0008373,0.12925282900934,0.991759466183934,1,20,sialyltransferase activity,MF,ST8SIA2
17798,GO:0097503,0.12925282900934,0.991759466183934,1,20,sialylation,BP,ST8SIA2
21815,GO:2001237,0.129340382462061,0.975276461657575,2,95,negative regulation of extrinsic apoptotic signaling pathway,BP,EYA2;DAPK1
21536,GO:2000637,0.129388210589858,0.991741760919229,1,20,positive regulation of gene silencing by miRNA,BP,EGFR
13051,GO:0048471,0.129546452342279,0.939534483985799,7,626,perinuclear region of cytoplasm,CC,NOS2;CAV2;PACSIN1;PRKCG;EGFR;DMTN;APOD
9804,GO:0035556,0.129567094434928,0.915831963323435,22,2545,intracellular signal transduction,BP,CRLF1;NOS2;LTF;FGFR3;CAMK2A;DCX;CAV2;AHR;CHD5;TRIM67;PRKCG;GPNMB;GPR17;EGFR;GFRA1;GJA1;DMTN;PHKG1;KNDC1;RGS6;DAPK1;MBP
13561,GO:0050905,0.12959362333085,0.975230892072011,2,87,neuromuscular process,BP,USH1C;GRID2
2578,GO:0005416,0.130224439319856,0.991654115809831,1,19,amino acid:cation symporter activity,MF,SLC38A1
2374,GO:0005003,0.130240796433736,0.991651965931771,1,19,ephrin receptor activity,MF,EFNB3
16907,GO:0072507,0.130270610667321,0.948223152722236,5,408,divalent inorganic cation homeostasis,BP,SLC30A3;GPR17;EGFR;GJA1;FPR3
10489,GO:0040007,0.131103277146468,0.932340018114876,9,854,growth,BP,ARX;FGFR3;SOX10;MAG;EGFR;SPOCK1;GJA1;PRAME;APOD
8707,GO:0032892,0.131207662746798,0.99146302998558,1,22,positive regulation of organic acid transport,BP,CCK
3464,GO:0006869,0.131387140276944,0.954117038566314,4,286,lipid transport,BP,NOS2;CAV2;ATP10B;APOD
11265,GO:0043457,0.131571898310866,0.991432954800472,1,21,regulation of cellular respiration,BP,NOS2
19910,GO:1903828,0.131741545851871,0.974543239344465,2,95,negative regulation of cellular protein localization,BP,DMTN;APOD
5650,GO:0016010,0.131836716465805,0.991418095158327,1,20,dystrophin-associated glycoprotein complex,CC,SGCD
17496,GO:0090665,0.131836716465805,0.991418095158327,1,20,glycoprotein complex,CC,SGCD
3663,GO:0007202,0.131997083975899,0.99135735519736,1,22,activation of phospholipase C activity,BP,EGFR
473,GO:0001505,0.132041763600236,0.953809680158539,4,283,regulation of neurotransmitter levels,BP,NOS2;CAMK2A;SLC17A7;SLC38A1
21649,GO:2000810,0.13218713935733,0.991371237738826,1,20,regulation of bicellular tight junction assembly,BP,GJA1
10997,GO:0043010,0.132323571044754,0.953685333534885,4,274,camera-type eye development,BP,USH1C;SLC17A7;EGFR;GJA1
13964,GO:0051591,0.132752582527795,0.974251612030228,2,90,response to cAMP,BP,AHR;DMTN
847,GO:0002062,0.13329625584992,0.974087956242011,2,89,chondrocyte differentiation,BP,SCIN;FGFR3
9179,GO:0034105,0.133337987709671,0.991176289379725,1,22,positive regulation of tissue remodeling,BP,EGFR
3375,GO:0006720,0.133410970988012,0.974000864085076,2,103,isoprenoid metabolic process,BP,EGFR;GPC6
19311,GO:1902533,0.133525522633866,0.930809398859266,9,897,positive regulation of intracellular signal transduction,BP,CRLF1;LTF;FGFR3;CAV2;CHD5;GPNMB;GPR17;EGFR;GJA1
1584,GO:0003416,0.133659867053346,0.991151724242242,1,21,endochondral bone growth,BP,FGFR3
547,GO:0001637,0.134326085207185,0.991007685512162,1,24,G-protein coupled chemoattractant receptor activity,MF,GPR17
2335,GO:0004950,0.134326085207185,0.991007685512162,1,24,chemokine receptor activity,MF,GPR17
18648,GO:1900181,0.1343443610177,0.991058488424677,1,21,negative regulation of protein localization to nucleus,BP,APOD
13108,GO:0048584,0.134608629459134,0.916465740839452,17,1967,positive regulation of response to stimulus,BP,CRLF1;LTF;EYA2;FGFR3;CAV2;CHD5;PRKCG;GPNMB;MOG;GPR17;EGFR;GJA1;DMTN;CNTN2;FPR3;HLA-DRB1;HLA-DRB5
10781,GO:0042554,0.134627551263238,0.990966225665072,1,24,superoxide anion generation,BP,EGFR
6225,GO:0017134,0.134842989300673,0.990990245681009,1,21,fibroblast growth factor binding,MF,FGFR3
9247,GO:0034220,0.135842480916684,0.926805014602161,10,980,ion transmembrane transport,BP,CACNG4;SLC17A7;SLC38A1;SLC30A3;GRID2;GJA1;KCNJ6;KCNJ4;SCN9A;DAPK1
14558,GO:0060148,0.136451006853137,0.990768308663774,1,21,positive regulation of posttranscriptional gene silencing,BP,EGFR
14513,GO:0060071,0.136583068197275,0.973000992301795,2,106,Wnt signaling pathway, planar cell polarity pathway,BP,CTHRC1;GPC6
7856,GO:0031420,0.136828434397903,0.990762401399323,1,19,alkali metal ion binding,MF,SCN9A
1053,GO:0002429,0.13730813002776,0.951257922335523,4,318,immune response-activating cell surface receptor signaling pathway,BP,MOG;FPR3;HLA-DRB1;HLA-DRB5
17228,GO:0090103,0.137527343108927,0.990597842906864,1,22,cochlea morphogenesis,BP,CTHRC1
7212,GO:0030194,0.137715626214867,0.990552790598555,1,23,positive regulation of blood coagulation,BP,DMTN
18571,GO:1900048,0.137715626214867,0.990552790598555,1,23,positive regulation of hemostasis,BP,DMTN
9567,GO:0035025,0.137926524428307,0.99054171565987,1,22,positive regulation of Rho protein signal transduction,BP,GPR17
13133,GO:0048638,0.138142890681404,0.950893581508809,4,278,regulation of developmental growth,BP,ARX;FGFR3;MAG;GJA1
13647,GO:0051046,0.138209504989571,0.93443203338404,7,652,regulation of secretion,BP,SCIN;NOS2;CAMK2A;EGFR;GJA1;CCK;MBP
5414,GO:0015318,0.138226391392319,0.930863576044974,8,740,inorganic molecular entity transmembrane transporter activity,MF,CACNG4;SLC17A7;SLC38A1;SLC30A3;GRID2;KCNJ6;KCNJ4;SCN9A
12658,GO:0046854,0.138369358374093,0.972492181384614,2,91,phosphatidylinositol phosphorylation,BP,FGFR3;EGFR
839,GO:0002052,0.138492315555803,0.990505139867679,1,20,positive regulation of neuroblast proliferation,BP,SOX10
4163,GO:0008528,0.138991186966808,0.972218252640266,2,113,G-protein coupled peptide receptor activity,MF,GPR17;FPR3
6707,GO:0019932,0.139212598143654,0.95035517391378,4,298,second-messenger-mediated signaling,BP,NOS2;AHR;EGFR;DMTN
14409,GO:0055065,0.13951126628446,0.937995752665018,6,536,metal ion homeostasis,BP,LTF;SLC30A3;GPR17;EGFR;GJA1;FPR3
15747,GO:0070374,0.13966786417057,0.959251141030366,3,196,positive regulation of ERK1 and ERK2 cascade,BP,FGFR3;GPNMB;EGFR
8568,GO:0032680,0.139861417969859,0.971958656347954,2,107,regulation of tumor necrosis factor production,BP,LTF;GPNMB
11643,GO:0044432,0.13994931197522,0.921848163389432,11,1172,endoplasmic reticulum part,CC,LTF;FA2H;COL9A1;ATP10B;MYRF;EGFR;GJA1;GJB1;HLA-DRB1;HLA-DRB5;COL28A1
6168,GO:0017025,0.14005994745016,0.990185664265658,1,25,TBP-class protein binding,MF,AHR
741,GO:0001919,0.140581389214148,0.990163941136068,1,22,regulation of receptor recycling,BP,BVES
3317,GO:0006643,0.141158035745178,0.958611309775837,3,204,membrane lipid metabolic process,BP,FA2H;ST8SIA2;UGT8
12688,GO:0046906,0.141472020074555,0.971439202033667,2,108,tetrapyrrole binding,MF,NOS2;FA2H
555,GO:0001653,0.141534179729908,0.971401256017395,2,114,peptide receptor activity,MF,GPR17;FPR3
17270,GO:0090175,0.141575323360961,0.971405957511888,2,108,regulation of establishment of planar polarity,BP,CTHRC1;GPC6
17105,GO:0086014,0.142351506864041,0.990009364572831,1,18,atrial cardiac muscle cell action potential,BP,GJA1
17115,GO:0086026,0.142351506864041,0.990009364572831,1,18,atrial cardiac muscle cell to AV node cell signaling,BP,GJA1
17144,GO:0086066,0.142351506864041,0.990009364572831,1,18,atrial cardiac muscle cell to AV node cell communication,BP,GJA1
10890,GO:0042755,0.142798669473313,0.989787255694994,1,25,eating behavior,BP,CCK
8854,GO:0033137,0.143146527701438,0.989771413547437,1,23,negative regulation of peptidyl-serine phosphorylation,BP,DMTN
21073,GO:1990776,0.143202999081157,0.989763116390079,1,23,response to angiotensin,BP,CAMK2A
3442,GO:0006829,0.143288368485544,0.98975056659217,1,23,zinc ion transport,BP,SLC30A3
2143,GO:0004674,0.143336827159574,0.935849034080206,6,474,protein serine/threonine kinase activity,MF,FGFR3;CAMK2A;PRKCG;EGFR;PHKG1;DAPK1
7172,GO:0030137,0.143395943365639,0.989699256669911,1,25,COPI-coated vesicle,CC,PACSIN1
366,GO:0000981,0.143799627266736,0.921609156938727,10,1002,RNA polymerase II transcription factor activity, sequence-specific DNA binding,MF,ARX;ZIC2;SOX10;TOX3;AHR;OTX1;MYRF;IRX2;DMRT2;MYT1
456,GO:0001223,0.144241671025346,0.989677229134248,1,20,transcription coactivator binding,MF,AHR
2765,GO:0005789,0.144352029345284,0.923920798689071,9,930,endoplasmic reticulum membrane,CC,LTF;FA2H;ATP10B;MYRF;EGFR;GJA1;GJB1;HLA-DRB1;HLA-DRB5
17384,GO:0090322,0.144370362281216,0.989524205652687,1,27,regulation of superoxide metabolic process,BP,EGFR
16204,GO:0071276,0.144387952563069,0.989461771570397,1,32,cellular response to cadmium ion,BP,EGFR
7539,GO:0030855,0.145017695940649,0.934858648903351,6,525,epithelial cell differentiation,BP,ARX;USH1C;DSG2;FA2H;PPL;GJA1
7550,GO:0030867,0.145030014615117,0.989411756759221,1,28,rough endoplasmic reticulum membrane,CC,LTF
13503,GO:0050820,0.145086024254506,0.989465491765033,1,24,positive regulation of coagulation,BP,DMTN
16975,GO:0072606,0.145636743496074,0.989349366773153,1,26,interleukin-8 secretion,BP,NOS2
3436,GO:0006820,0.14579004643785,0.934415859067033,6,523,anion transport,BP,NOS2;SLC17A7;SLC38A1;ATP10B;GJA1;CCK
3578,GO:0007044,0.145949976123158,0.970070299309296,2,87,cell-substrate junction assembly,BP,DMTN;APOD
8538,GO:0032635,0.146006269535607,0.96997575447604,2,105,interleukin-6 production,BP,NOS2;MBP
12678,GO:0046887,0.14608908441011,0.969931862747181,2,110,positive regulation of hormone secretion,BP,EGFR;GJA1
12638,GO:0046822,0.146133571761261,0.969964325315957,2,97,regulation of nucleocytoplasmic transport,BP,MX2;APOD
19769,GO:1903555,0.146190940207022,0.969898401129985,2,110,regulation of tumor necrosis factor superfamily cytokine production,BP,LTF;GPNMB
2352,GO:0004970,0.146286469092663,0.989401918829941,1,19,ionotropic glutamate receptor activity,MF,GRID2
8541,GO:0032640,0.146373843477157,0.969838276503353,2,110,tumor necrosis factor production,BP,LTF;GPNMB
2141,GO:0004672,0.146477494617797,0.929506944736243,7,596,protein kinase activity,MF,FGFR3;CAMK2A;EFNB3;PRKCG;EGFR;PHKG1;DAPK1
21390,GO:2000404,0.146633898725465,0.989169544404041,1,28,regulation of T cell migration,BP,APOD
18074,GO:0098868,0.14663793245201,0.989251741077778,1,23,bone growth,BP,FGFR3
10654,GO:0042303,0.146716123552478,0.969768893877067,2,98,molting cycle,BP,FA2H;EGFR
10833,GO:0042633,0.146716123552478,0.969768893877067,2,98,hair cycle,BP,FA2H;EGFR
5675,GO:0016051,0.146736800119827,0.956236125853634,3,203,carbohydrate biosynthetic process,BP,GALNT13;PHKG1;GALNT9
10670,GO:0042327,0.146811674652958,0.922347833580897,9,891,positive regulation of phosphorylation,BP,CRLF1;LTF;FGFR3;CAV2;GPNMB;ENPP2;EGFR;KNDC1;CCK
16908,GO:0072509,0.146819499491299,0.989224343365163,1,23,divalent inorganic cation transmembrane transporter activity,MF,SLC30A3
7092,GO:0023056,0.146904709136993,0.911623379231427,14,1565,positive regulation of signaling,BP,CRLF1;LTF;FGFR3;CACNG4;CAV2;BVES;CHD5;GPNMB;GPR17;EGFR;GJA1;NRGN;DMTN;CNTN2
18051,GO:0098827,0.147043570366027,0.922188536395189,9,934,endoplasmic reticulum subcompartment,CC,LTF;FA2H;ATP10B;MYRF;EGFR;GJA1;GJB1;HLA-DRB1;HLA-DRB5
3887,GO:0008092,0.147207115484626,0.922106158348603,9,839,cytoskeletal protein binding,MF,USH1C;SCIN;CDH19;DCX;PACSIN1;EGFR;GJA1;DMTN;MX2
11773,GO:0044853,0.147270495064513,0.96960779932197,2,93,plasma membrane raft,CC,CAV2;BVES
8294,GO:0032288,0.14760021525572,0.989176646131589,1,20,myelin assembly,BP,UGT8
11043,GO:0043090,0.147714163552646,0.989110203756749,1,22,amino acid import,BP,SLC17A7
17635,GO:0097191,0.147799090742516,0.955773713235213,3,206,extrinsic apoptotic signaling pathway,BP,EYA2;FGFR3;DAPK1
13517,GO:0050851,0.14784390329659,0.955733613873049,3,220,antigen receptor-mediated signaling pathway,BP,MOG;HLA-DRB1;HLA-DRB5
667,GO:0001818,0.147849003500076,0.955741448244467,3,213,negative regulation of cytokine production,BP,LTF;GPNMB;APOD
1367,GO:0003002,0.148213986919525,0.945929751407077,4,304,regionalization,BP,OTX1;PCDH8;IRX2;DMRT2
19390,GO:1902745,0.148505767724623,0.98898975915447,1,22,positive regulation of lamellipodium organization,BP,ENPP2
666,GO:0001817,0.14864986082927,0.932748397383826,6,561,regulation of cytokine production,BP,NOS2;LTF;GPNMB;MOG;APOD;MBP
18282,GO:0099625,0.148847500330653,0.988937546863073,1,22,ventricular cardiac muscle cell membrane repolarization,BP,GJA1
9636,GO:0035239,0.149297026278931,0.923975986246445,8,732,tube morphogenesis,BP,SOX10;GPNMB;ENPP2;EGFR;GJA1;CTHRC1;IRX2;APOD
3921,GO:0008150,0.149322472269137,0.933306952346845,96,14255,biological_process,BP,ARX;CRLF1;USH1C;SCIN;NOS2;LTF;CLDN11;ZIC2;DSG2;EYA2;FGFR3;CAMK2A;CDH19;CACNG4;DCX;SOX10;FA2H;TOX3;SLC17A7;ICAM5;MAG;CAV2;AHR;EFNB3;SLC38A1;BVES;COL9A1;SLC30A3;OTX1;CHD5;ATP10B;PPL;TRIM67;GJB6;PACSIN1;MYRF;PRKCG;GSTM1;PCDH8;GPNMB;ENPP2;MOG;ST8SIA2;FBN3;GPR17;GALNT13;HAPLN1;EGFR;GFRA1;GRID2;SPOCK1;GJA1;NRGN;ABI3BP;KCNJ6;SNX22;ACAN;DMTN;EDIL3;PHKG1;CSMD3;CTHRC1;LMO1;MGAT5B;KCNJ4;SCN9A;GJB1;IRX2;SGCD;NPTX1;VAT1L;KNDC1;DMRT2;SUSD5;UGT8;RIN1;RGS6;GALNT9;GPC6;MX2;CNTN2;ANKS1B;PRAME;SLITRK2;CCK;FPR3;HAPLN4;APOD;HLA-DRB1;MYT1;DAPK1;MBP;HLA-DRB5;SMOC1;KLRC2;COL28A1
9181,GO:0034110,0.149388500459049,0.988832732993464,1,23,regulation of homotypic cell-cell adhesion,BP,DMTN
13913,GO:0051482,0.149999206080069,0.988682552317597,1,26,positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway,BP,GPR17
3757,GO:0007413,0.150379510262444,0.98875289938072,1,20,axonal fasciculation,BP,CNTN2
18396,GO:0106030,0.150379510262444,0.98875289938072,1,20,neuron projection fasciculation,BP,CNTN2
4548,GO:0009620,0.150768897022214,0.988470740366278,1,33,response to fungus,BP,LTF
18280,GO:0099623,0.150788174531505,0.988638554492477,1,22,regulation of cardiac muscle cell membrane repolarization,BP,GJA1
4851,GO:0010640,0.150872686468202,0.988625438033608,1,22,regulation of platelet-derived growth factor receptor signaling pathway,BP,APOD
8512,GO:0032594,0.151096853191441,0.988511395967823,1,26,protein transport within lipid bilayer,BP,CACNG4
3196,GO:0006493,0.151156276530284,0.968290215992825,2,99,protein O-linked glycosylation,BP,GALNT13;GALNT9
13655,GO:0051054,0.151477056474101,0.954185292777279,3,201,positive regulation of DNA metabolic process,BP,EYA2;PRKCG;EGFR
12581,GO:0046651,0.151606787591774,0.954095961290237,3,222,lymphocyte proliferation,BP,AHR;GPNMB;LMO1
6609,GO:0019725,0.151684287869267,0.922449573161527,8,805,cellular homeostasis,BP,NOS2;LTF;SLC17A7;SLC30A3;GJB6;GPR17;GJA1;FPR3
15673,GO:0070252,0.151789338373956,0.968095069068229,2,95,actin-mediated cell contraction,BP,DSG2;GJA1
13428,GO:0050714,0.151806430959788,0.954031355682283,3,207,positive regulation of protein secretion,BP,EGFR;GJA1;MBP
14856,GO:0060571,0.152498332271346,0.988290883377704,1,26,morphogenesis of an epithelial fold,BP,EGFR
6191,GO:0017075,0.153117020906657,0.988274174277875,1,22,syntaxin-1 binding,MF,DAPK1
17142,GO:0086064,0.153347513760354,0.988237778595854,1,22,cell communication by electrical coupling involved in cardiac conduction,BP,GJA1
17927,GO:0098563,0.153506291779503,0.988130913563908,1,26,intrinsic component of synaptic vesicle membrane,CC,SLC17A7
9895,GO:0035690,0.154173180628929,0.942933910925019,4,313,cellular response to drug,BP,NOS2;SOX10;AHR;EGFR
2516,GO:0005261,0.154182194166496,0.942959951782089,4,285,cation channel activity,MF,CACNG4;KCNJ6;KCNJ4;SCN9A
10969,GO:0042974,0.154513639023236,0.988029308779977,1,23,retinoic acid receptor binding,MF,PRAME
7743,GO:0031234,0.154559473908529,0.967116708891704,2,105,extrinsic component of cytoplasmic side of plasma membrane,CC,CAV2;RGS6
3472,GO:0006882,0.154753214686983,0.987845804834079,1,32,cellular zinc ion homeostasis,BP,SLC30A3
8742,GO:0032943,0.15486440495582,0.952661640078784,3,224,mononuclear cell proliferation,BP,AHR;GPNMB;LMO1
16494,GO:0071706,0.155299094310556,0.96683283175951,2,114,tumor necrosis factor superfamily cytokine production,BP,LTF;GPNMB
6162,GO:0017016,0.155425340247156,0.928838792647858,6,486,Ras GTPase binding,MF,FGFR3;CAMK2A;EGFR;GFRA1;KNDC1;RIN1
2878,GO:0005980,0.155676511719066,0.987842890130113,1,23,glycogen catabolic process,BP,PHKG1
8853,GO:0033135,0.155953776668784,0.966640779100276,2,105,regulation of peptidyl-serine phosphorylation,BP,EGFR;DMTN
5555,GO:0015813,0.15603481997675,0.987785141856152,1,23,L-glutamate transmembrane transport,BP,SLC17A7
8472,GO:0032528,0.156148577092796,0.987766777308149,1,23,microvillus organization,BP,USH1C
11239,GO:0043403,0.156241851611805,0.987673708228331,1,27,skeletal muscle tissue regeneration,BP,GJA1
12453,GO:0046425,0.156472182192001,0.966448193730619,2,109,regulation of JAK-STAT cascade,BP,CRLF1;FGFR3
13792,GO:0051261,0.156543718561218,0.966476782592143,2,96,protein depolymerization,BP,SCIN;DMTN
1252,GO:0002757,0.156746888763958,0.933978169854183,5,447,immune response-activating signal transduction,BP,LTF;MOG;FPR3;HLA-DRB1;HLA-DRB5
19754,GO:1903532,0.156747429509841,0.941619973504594,4,322,positive regulation of secretion by cell,BP,EGFR;GJA1;CCK;MBP
3521,GO:0006955,0.157001723588034,0.904447568590482,14,1692,immune response,BP,NOS2;LTF;CAMK2A;ICAM5;ENPP2;MOG;GPR17;MX2;FPR3;HLA-DRB1;DAPK1;MBP;HLA-DRB5;KLRC2
7304,GO:0030318,0.157205846341882,0.98761963402153,1,22,melanocyte differentiation,BP,SOX10
9142,GO:0033993,0.157534549906861,0.918732430402963,8,815,response to lipid,BP,NOS2;LTF;DSG2;SOX10;AHR;GJB6;EGFR;GJA1
9645,GO:0035250,0.157614412260882,0.987449449756365,1,27,UDP-galactosyltransferase activity,MF,UGT8
13487,GO:0050801,0.157614837141953,0.922682374686422,7,676,ion homeostasis,BP,LTF;SLC30A3;GPR17;EGFR;GJA1;CCK;FPR3
8291,GO:0032281,0.15798149916078,0.987389108424697,1,27,AMPA glutamate receptor complex,CC,CACNG4
20430,GO:1904892,0.15818980333676,0.965852999141018,2,110,regulation of STAT cascade,BP,CRLF1;FGFR3
10602,GO:0042175,0.158225223267456,0.914907480364796,9,947,nuclear outer membrane-endoplasmic reticulum membrane network,CC,LTF;FA2H;ATP10B;MYRF;EGFR;GJA1;GJB1;HLA-DRB1;HLA-DRB5
5813,GO:0016323,0.158233203595423,0.95122225264115,3,191,basolateral plasma membrane,CC,CA11;EGFR;KCNJ4
10834,GO:0042634,0.158383092943384,0.987359781429874,1,25,regulation of hair cycle,BP,FA2H
7410,GO:0030552,0.158412460470279,0.987398253462259,1,23,cAMP binding,MF,BVES
12580,GO:0046649,0.158808231322915,0.926803000020374,6,568,lymphocyte activation,BP,AHR;EFNB3;GPNMB;LMO1;HLA-DRB1;HLA-DRB5
21316,GO:2000311,0.159249888020008,0.987237663443838,1,24,regulation of AMPA receptor activity,BP,CACNG4
8310,GO:0032309,0.159577768708536,0.987108224426456,1,28,icosanoid secretion,BP,NOS2
3665,GO:0007205,0.159629421099356,0.987153773807624,1,25,protein kinase C-activating G-protein coupled receptor signaling pathway,BP,CCK
14398,GO:0055026,0.159640098364102,0.98715200129336,1,25,negative regulation of cardiac muscle tissue development,BP,GJA1
2657,GO:0005604,0.159699080531568,0.965429873103752,2,88,basement membrane,CC,SMOC1;COL28A1
9827,GO:0035587,0.159957332910758,0.987029277076077,1,29,purinergic receptor signaling pathway,BP,CNTN2
18185,GO:0099094,0.159978128386257,0.96528639171659,2,97,ligand-gated cation channel activity,MF,KCNJ6;KCNJ4
7497,GO:0030804,0.160340612541953,0.986923896954906,1,32,positive regulation of cyclic nucleotide biosynthetic process,BP,NOS2
772,GO:0001958,0.160687483311654,0.986977494324643,1,25,endochondral ossification,BP,FGFR3
10124,GO:0036075,0.160687483311654,0.986977494324643,1,25,replacement ossification,BP,FGFR3
15130,GO:0061041,0.160710403836092,0.964984719514704,2,108,regulation of wound healing,BP,GJA1;DMTN
766,GO:0001952,0.161008705667121,0.9649226296743,2,98,regulation of cell-matrix adhesion,BP,DMTN;APOD
1750,GO:0004012,0.161065568748173,0.987042952044075,1,20,phospholipid-translocating ATPase activity,MF,ATP10B
14411,GO:0055069,0.161211720892286,0.986764741424748,1,33,zinc ion homeostasis,BP,SLC30A3
10996,GO:0043009,0.161288744988732,0.925353579756446,6,527,chordate embryonic development,BP,SOX10;PCDH8;EGFR;GJA1;CTHRC1;DMRT2
777,GO:0001964,0.161748521989829,0.986821066233867,1,24,startle response,BP,GRID2
18037,GO:0098801,0.162025395041234,0.986714181981953,1,27,regulation of renal system process,BP,GJA1
21209,GO:2000116,0.162106069886624,0.949421934568851,3,227,regulation of cysteine-type endopeptidase activity,BP,LTF;CCK;DAPK1
753,GO:0001936,0.162335443901937,0.964427413462769,2,105,regulation of endothelial cell proliferation,BP,CAV2;GJA1
4333,GO:0009101,0.162421764851863,0.93872429131338,4,310,glycoprotein biosynthetic process,BP,ST8SIA2;GALNT13;MGAT5B;GALNT9
609,GO:0001736,0.162667186192419,0.964266614371141,2,117,establishment of planar polarity,BP,CTHRC1;GPC6
3631,GO:0007164,0.162667186192419,0.964266614371141,2,117,establishment of tissue polarity,BP,CTHRC1;GPC6
12120,GO:0045671,0.163002098428822,0.986609372590198,1,24,negative regulation of osteoclast differentiation,BP,LTF
12557,GO:0046621,0.163091089433065,0.986594276217091,1,24,negative regulation of organ growth,BP,GJA1
4455,GO:0009251,0.163122437371059,0.986588956216351,1,24,glucan catabolic process,BP,PHKG1
11142,GO:0043244,0.16319335202223,0.964161221708727,2,97,regulation of protein complex disassembly,BP,SCIN;DMTN
9207,GO:0034142,0.163304939342568,0.986479233046649,1,28,toll-like receptor 4 signaling pathway,BP,LTF
14158,GO:0051954,0.163696520142406,0.986412224161593,1,28,positive regulation of amine transport,BP,CCK
6294,GO:0018146,0.163956324793108,0.986404287582669,1,26,keratan sulfate biosynthetic process,BP,ACAN
13036,GO:0048384,0.164020976169978,0.986356568255658,1,28,retinoic acid receptor signaling pathway,BP,PRAME
5484,GO:0015672,0.164463366781111,0.929670150983055,5,436,monovalent inorganic cation transport,BP,SLC17A7;SLC38A1;KCNJ6;KCNJ4;SCN9A
4309,GO:0009065,0.164904323785788,0.986204427964242,1,28,glutamine family amino acid catabolic process,BP,NOS2
7161,GO:0030125,0.165301660463223,0.986172923613611,1,26,clathrin vesicle coat,CC,EGFR
5012,GO:0010876,0.165541081165477,0.937101381954916,4,316,lipid localization,BP,NOS2;CAV2;ATP10B;APOD
12664,GO:0046872,0.165959619321665,0.883500209999527,30,3657,metal ion binding,MF,SCIN;NOS2;LTF;ZIC2;DSG2;EYA2;CAMK2A;CDH19;FA2H;COL9A1;CHD5;ATP10B;TRIM67;PRKCG;PCDH8;ENPP2;FBN3;GALNT13;SPOCK1;ACAN;EDIL3;LMO1;MGAT5B;SCN9A;NPTX1;VAT1L;DMRT2;GALNT9;MYT1;SMOC1
13239,GO:0048821,0.16633562111293,0.985956003764917,1,28,erythrocyte development,BP,DMTN
12250,GO:0045926,0.167244192597447,0.947096710785529,3,218,negative regulation of growth,BP,FGFR3;MAG;GJA1
8109,GO:0031954,0.167534604206364,0.985805732483323,1,25,positive regulation of protein autophosphorylation,BP,GPNMB
11169,GO:0043280,0.16818673786915,0.962284665474919,2,122,positive regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,CCK;DAPK1
3433,GO:0006814,0.168231099882941,0.94668212258031,3,197,sodium ion transport,BP,SLC17A7;SLC38A1;SCN9A
3333,GO:0006664,0.168464267718812,0.962197896790153,2,118,glycolipid metabolic process,BP,ST8SIA2;UGT8
19736,GO:1903509,0.168464267718812,0.962197896790153,2,118,liposaccharide metabolic process,BP,ST8SIA2;UGT8
2552,GO:0005343,0.168842102220269,0.985554096985062,1,26,organic acid:sodium symporter activity,MF,SLC38A1
14417,GO:0055076,0.169114978991463,0.961946637122963,2,123,transition metal ion homeostasis,BP,LTF;SLC30A3
11538,GO:0044247,0.169326400749768,0.985490200046058,1,25,cellular polysaccharide catabolic process,BP,PHKG1
14623,GO:0060251,0.169401349726602,0.985476920927787,1,25,regulation of glial cell proliferation,BP,SOX10
2908,GO:0006024,0.169531902432989,0.961871695980766,2,103,glycosaminoglycan biosynthetic process,BP,ACAN;GPC6
12647,GO:0046834,0.17018090996105,0.961636898485351,2,103,lipid phosphorylation,BP,FGFR3;EGFR
4872,GO:0010665,0.170289262533514,0.985257482379556,1,28,regulation of cardiac muscle cell apoptotic process,BP,CAMK2A
6922,GO:0021846,0.170479926670924,0.985285104823027,1,25,cell proliferation in forebrain,BP,ARX
5171,GO:0014072,0.170544236736205,0.985177486301988,1,30,response to isoquinoline alkaloid,BP,PRKCG
11167,GO:0043278,0.170544236736205,0.985177486301988,1,30,response to morphine,BP,PRKCG
735,GO:0001912,0.170793692138585,0.985102516681382,1,32,positive regulation of leukocyte mediated cytotoxicity,BP,NOS2
13201,GO:0048741,0.170921007389852,0.985163347360164,1,27,skeletal muscle fiber development,BP,CAV2
15906,GO:0070661,0.171469383289182,0.945119344058969,3,235,leukocyte proliferation,BP,AHR;GPNMB;LMO1
13696,GO:0051125,0.171964774155559,0.984975382505765,1,27,regulation of actin nucleation,BP,SCIN
2841,GO:0005913,0.173230250681627,0.960516672173949,2,105,cell-cell adherens junction,CC,CDH19;GJA1
1198,GO:0002686,0.173490166194134,0.984597955542636,1,33,negative regulation of leukocyte migration,BP,APOD
1276,GO:0002793,0.173676106397895,0.944106225213669,3,225,positive regulation of peptide secretion,BP,EGFR;GJA1;MBP
1262,GO:0002768,0.173886186791633,0.93268273841718,4,347,immune response-regulating cell surface receptor signaling pathway,BP,MOG;FPR3;HLA-DRB1;HLA-DRB5
17750,GO:0097421,0.173924051890833,0.98453236698331,1,32,liver regeneration,BP,EGFR
14159,GO:0051955,0.174031823041302,0.984579543464876,1,28,regulation of amino acid transport,BP,CCK
14521,GO:0060079,0.174268426119871,0.960135373999689,2,105,excitatory postsynaptic potential,BP,SLC17A7;GRID2
134,GO:0000272,0.174385877413748,0.984555988231504,1,26,polysaccharide catabolic process,BP,PHKG1
4816,GO:0010591,0.174890090535636,0.984441833324469,1,27,regulation of lamellipodium assembly,BP,DMTN
11115,GO:0043204,0.175412908142983,0.959675296480285,2,114,perikaryon,CC,KNDC1;CCK
9494,GO:0034706,0.175494450342427,0.984428762036005,1,23,sodium channel complex,CC,SCN9A
3857,GO:0008037,0.176077969840703,0.959428978762394,2,114,cell recognition,BP,EFNB3;CNTN2
2759,GO:0005783,0.176117806231746,0.890632433554782,14,1645,endoplasmic reticulum,CC,LTF;FGFR3;FA2H;COL9A1;ATP10B;MYRF;EGFR;GJA1;GJB1;CREG2;APOD;HLA-DRB1;HLA-DRB5;COL28A1
18798,GO:1901099,0.176221558869714,0.984106615576811,1,32,negative regulation of signal transduction in absence of ligand,BP,EYA2
21818,GO:2001240,0.176221558869714,0.984106615576811,1,32,negative regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,EYA2
13143,GO:0048660,0.176310399976174,0.95934274923847,2,114,regulation of smooth muscle cell proliferation,BP,EGFR;APOD
6996,GO:0021987,0.176510983159342,0.959316063274697,2,103,cerebral cortex development,BP,ARX;EGFR
2789,GO:0005834,0.176798166287447,0.983984128720873,1,33,heterotrimeric G-protein complex,CC,RGS6
20636,GO:1905360,0.176798166287447,0.983984128720873,1,33,GTPase complex,CC,RGS6
4653,GO:0009987,0.176958215659052,0.89342425241712,90,13224,cellular process,BP,ARX;CRLF1;USH1C;SCIN;NOS2;LTF;CLDN11;ZIC2;DSG2;EYA2;FGFR3;CAMK2A;CDH19;CACNG4;DCX;SOX10;FA2H;TOX3;SLC17A7;ICAM5;MAG;CAV2;AHR;EFNB3;BVES;COL9A1;SLC30A3;OTX1;CHD5;ATP10B;PPL;TRIM67;GJB6;PACSIN1;MYRF;PRKCG;GSTM1;PCDH8;GPNMB;ENPP2;MOG;ST8SIA2;FBN3;GPR17;GALNT13;HAPLN1;EGFR;GFRA1;GRID2;SPOCK1;GJA1;NRGN;ABI3BP;KCNJ6;ACAN;DMTN;PHKG1;CSMD3;CTHRC1;LMO1;MGAT5B;KCNJ4;SCN9A;GJB1;IRX2;SGCD;NPTX1;KNDC1;DMRT2;SUSD5;UGT8;RIN1;RGS6;GALNT9;GPC6;MX2;CNTN2;PRAME;SLITRK2;CCK;FPR3;APOD;HLA-DRB1;MYT1;DAPK1;MBP;HLA-DRB5;SMOC1;KLRC2;COL28A1
20690,GO:1905476,0.177599798980658,0.983898770001983,1,29,negative regulation of protein localization to membrane,BP,DMTN
14622,GO:0060249,0.17770586498372,0.930658020788915,4,333,anatomical structure homeostasis,BP,USH1C;LTF;SLC17A7;EGFR
9673,GO:0035295,0.177899230216825,0.901793172860634,9,895,tube development,BP,CRLF1;SOX10;GPNMB;ENPP2;EGFR;GJA1;CTHRC1;IRX2;APOD
7139,GO:0030072,0.178045935561997,0.942060584533573,3,219,peptide hormone secretion,BP,NOS2;EGFR;GJA1
2907,GO:0006023,0.178106833464653,0.958703417217492,2,107,aminoglycan biosynthetic process,BP,ACAN;GPC6
19907,GO:1903825,0.178142290903226,0.958690176581984,2,107,organic acid transmembrane transport,BP,SLC17A7;SLC38A1
20501,GO:1905039,0.178142290903226,0.958690176581984,2,107,carboxylic acid transmembrane transport,BP,SLC17A7;SLC38A1
11318,GO:0043539,0.178197793342421,0.983751303804308,1,31,protein serine/threonine kinase activator activity,MF,LTF
4061,GO:0008378,0.178256056900574,0.983740301569814,1,31,galactosyltransferase activity,MF,UGT8
11968,GO:0045332,0.178490701332759,0.983873202384535,1,23,phospholipid translocation,BP,ATP10B
13397,GO:0050680,0.178639508422591,0.958495417068566,2,109,negative regulation of epithelial cell proliferation,BP,CAV2;GJA1
16501,GO:0071715,0.178806563946738,0.983636149204068,1,31,icosanoid transport,BP,NOS2
18949,GO:1901571,0.178806563946738,0.983636149204068,1,31,fatty acid derivative transport,BP,NOS2
5348,GO:0015175,0.179499936420698,0.983539981684259,1,29,neutral amino acid transmembrane transporter activity,MF,SLC38A1
4596,GO:0009792,0.179989857131967,0.914029420127303,6,545,embryo development ending in birth or egg hatching,BP,SOX10;PCDH8;EGFR;GJA1;CTHRC1;DMRT2
4933,GO:0010762,0.180276028001131,0.983412056782924,1,28,regulation of fibroblast migration,BP,DMTN
14999,GO:0060795,0.180288932573176,0.983353921405769,1,31,cell fate commitment involved in formation of primary germ layer,BP,EYA2
2847,GO:0005923,0.180562218483641,0.957782406974016,2,107,bicellular tight junction,CC,CLDN11;BVES
2508,GO:0005248,0.180687239342688,0.983459282830932,1,23,voltage-gated sodium channel activity,MF,SCN9A
5625,GO:0015931,0.180967186756412,0.940670232155361,3,220,nucleobase-containing compound transport,BP,GJA1;GJB1;MX2
11392,GO:0043679,0.181004588507371,0.957577220451432,2,116,axon terminus,CC,PACSIN1;CCK
10741,GO:0042462,0.181217616487421,0.983232039927882,1,28,eye photoreceptor cell development,BP,USH1C
12147,GO:0045737,0.181343248056306,0.983135190771158,1,32,positive regulation of cyclin-dependent protein serine/threonine kinase activity,BP,EGFR
13777,GO:0051246,0.181675135621283,0.878233972650618,20,2450,regulation of protein metabolic process,BP,CRLF1;NOS2;LTF;FGFR3;CAV2;TRIM67;PRKCG;GPNMB;ENPP2;EGFR;SPOCK1;GJA1;DMTN;KNDC1;CNTN2;CCK;APOD;DAPK1;MBP;COL28A1
4869,GO:0010662,0.181983973855487,0.983045673837509,1,30,regulation of striated muscle cell apoptotic process,BP,CAMK2A
3067,GO:0006298,0.182130683778362,0.983017335979748,1,30,mismatch repair,BP,PRKCG
12292,GO:0045995,0.182289334450725,0.957124946565876,2,108,regulation of embryonic development,BP,DMRT2;MBP
16385,GO:0071549,0.182801603040093,0.982852927569338,1,32,cellular response to dexamethasone stimulus,BP,EGFR
3001,GO:0006182,0.182841740963752,0.982861819464087,1,31,cGMP biosynthetic process,BP,NOS2
13965,GO:0051592,0.182864271790193,0.956888925726044,2,112,response to calcium ion,BP,EGFR;DMTN
4499,GO:0009395,0.182879621291609,0.982854459356683,1,31,phospholipid catabolic process,BP,ENPP2
19170,GO:1902186,0.183077992258477,0.982852838276208,1,29,regulation of viral release from host cell,BP,CAV2
14009,GO:0051668,0.183249921416084,0.956742216193475,2,112,localization within membrane,BP,CACNG4;ANKS1B
7546,GO:0030863,0.183273339333945,0.956785736354935,2,101,cortical cytoskeleton,CC,NOS2;DMTN
8741,GO:0032941,0.183382776076893,0.982723966035502,1,33,secretion by tissue,BP,GJA1
18554,GO:1900026,0.183435272678606,0.982746301841726,1,31,positive regulation of substrate adhesion-dependent cell spreading,BP,DMTN
10809,GO:0042592,0.183588484022158,0.887104577917761,13,1500,homeostatic process,BP,USH1C;NOS2;LTF;SLC17A7;SLC30A3;GJB6;GPR17;EGFR;GJA1;DMTN;LMO1;CCK;FPR3
4866,GO:0010659,0.18389746146879,0.982674076206962,1,30,cardiac muscle cell apoptotic process,BP,CAMK2A
13142,GO:0048659,0.184199293115231,0.956359471860203,2,117,smooth muscle cell proliferation,BP,EGFR;APOD
17955,GO:0098632,0.184701746550016,0.982498416927323,1,31,cell-cell adhesion mediator activity,MF,DSG2
2518,GO:0005267,0.184718104162621,0.95616503060383,2,116,potassium channel activity,MF,KCNJ6;KCNJ4
16496,GO:0071709,0.184828038563874,0.982554504641748,1,27,membrane assembly,BP,CAV2
7174,GO:0030140,0.184927624999269,0.982472226298361,1,30,trans-Golgi network transport vesicle,CC,NRGN
17379,GO:0090313,0.184962004873387,0.982447241595881,1,31,regulation of protein targeting to membrane,BP,DMTN
9240,GO:0034204,0.185022910224344,0.982594933861783,1,24,lipid translocation,BP,ATP10B
7006,GO:0022011,0.185047082986323,0.982561907930682,1,25,myelination in peripheral nervous system,BP,FA2H
8298,GO:0032292,0.185047082986323,0.982561907930682,1,25,peripheral nervous system axon ensheathment,BP,FA2H
13018,GO:0048333,0.185075146907708,0.982443218040866,1,30,mesodermal cell differentiation,BP,EYA2
713,GO:0001881,0.185321383779722,0.982394741333774,1,30,receptor recycling,BP,BVES
7166,GO:0030131,0.185323788183364,0.982413830484225,1,29,clathrin adaptor complex,CC,EGFR
725,GO:0001893,0.185510673529669,0.982357426966897,1,30,maternal placenta development,BP,GJA1
14651,GO:0060292,0.185515163773326,0.98239715145119,1,28,long term synaptic depression,BP,GRID2
14142,GO:0051930,0.185723661807482,0.982297013296889,1,31,regulation of sensory perception of pain,BP,CCK
14143,GO:0051931,0.185723661807482,0.982297013296889,1,31,regulation of sensory perception,BP,CCK
472,GO:0001504,0.185783894646462,0.982303492447212,1,30,neurotransmitter uptake,BP,SLC38A1
13782,GO:0051251,0.186036130400144,0.938194962431822,3,243,positive regulation of lymphocyte activation,BP,EFNB3;HLA-DRB1;HLA-DRB5
19370,GO:1902692,0.186495060309982,0.98222653691123,1,27,regulation of neuroblast proliferation,BP,SOX10
11871,GO:0045124,0.186797041824608,0.982102721692778,1,30,regulation of bone resorption,BP,EGFR
4855,GO:0010644,0.18708883625041,0.982108924302626,1,27,cell communication by electrical coupling,BP,GJA1
7075,GO:0022898,0.187387905532807,0.937582003608493,3,218,regulation of transmembrane transporter activity,BP,CACNG4;GJA1;DAPK1
10756,GO:0042491,0.187397605469897,0.982003137997773,1,29,inner ear auditory receptor cell differentiation,BP,USH1C
10574,GO:0042129,0.187489915932399,0.955037240928195,2,133,regulation of T cell proliferation,BP,GPNMB;LMO1
10501,GO:0040019,0.187661673597764,0.981950476561339,1,29,positive regulation of embryonic development,BP,DMRT2
10879,GO:0042742,0.187823015403133,0.954868305159159,2,147,defense response to bacterium,BP,NOS2;LTF
4793,GO:0010543,0.188125356933162,0.981837648735624,1,30,regulation of platelet activation,BP,DMTN
5266,GO:0014904,0.188165456094207,0.981829614100353,1,30,myotube cell development,BP,CAV2
1259,GO:0002764,0.188266434014969,0.915869890897698,5,476,immune response-regulating signaling pathway,BP,LTF;MOG;FPR3;HLA-DRB1;HLA-DRB5
19123,GO:1902042,0.188387643376848,0.981716118583589,1,34,negative regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,DAPK1
15611,GO:0070160,0.188599031352221,0.954695282590992,2,110,occluding junction,CC,CLDN11;BVES
9634,GO:0035235,0.188615697953519,0.981829697989254,1,26,ionotropic glutamate receptor signaling pathway,BP,GRID2
8775,GO:0032991,0.189259993045457,0.863186710932554,34,4539,protein-containing complex,CC,CRLF1;USH1C;SCIN;LTF;FGFR3;CDH19;CACNG4;DCX;CAV2;AHR;COL9A1;CHD5;GJB6;EGFR;GFRA1;GRID2;GJA1;KCNJ6;PHKG1;CTHRC1;KCNJ4;SCN9A;GJB1;SGCD;KNDC1;RGS6;MX2;CNTN2;APOD;HLA-DRB1;MBP;HLA-DRB5;KLRC2;COL28A1
13673,GO:0051091,0.189666544360672,0.936456581451854,3,226,positive regulation of DNA binding transcription factor activity,BP,LTF;ZIC2;CAMK2A
19944,GO:1903900,0.190245346048144,0.953992614377655,2,125,regulation of viral life cycle,BP,LTF;CAV2
2539,GO:0005319,0.190463793248679,0.953938389015764,2,117,lipid transporter activity,MF,ATP10B;APOD
7807,GO:0031333,0.190537265248298,0.953905543827867,2,118,negative regulation of protein complex assembly,BP,SCIN;DMTN
10674,GO:0042339,0.190537990891797,0.981331482969709,1,31,keratan sulfate metabolic process,BP,ACAN
16015,GO:0070888,0.190957049476379,0.981246132284047,1,31,E-box binding,MF,AHR
10641,GO:0042277,0.191069184313063,0.93574706289961,3,239,peptide binding,MF,GSTM1;HLA-DRB1;HLA-DRB5
5824,GO:0016342,0.191217492545654,0.981255601528061,1,28,catenin complex,CC,CDH19
4642,GO:0009954,0.191747217903157,0.981066266344666,1,32,proximal/distal pattern formation,BP,IRX2
18093,GO:0098901,0.192292311769801,0.981114667736889,1,25,regulation of cardiac muscle cell action potential,BP,DSG2
11331,GO:0043552,0.19246810626271,0.980956362127129,1,30,positive regulation of phosphatidylinositol 3-kinase activity,BP,FGFR3
3549,GO:0007005,0.192501251605023,0.91332458792679,5,513,mitochondrion organization,BP,EYA2;CAMK2A;CAV2;MX2;CCK
10880,GO:0042743,0.192501532445193,0.980796582467162,1,40,hydrogen peroxide metabolic process,BP,EGFR
11892,GO:0045165,0.192626957586852,0.93500899964408,3,223,cell fate commitment,BP,ARX;EYA2;CHD5
2425,GO:0005109,0.192916168941124,0.980808289797245,1,33,frizzled binding,MF,CTHRC1
19445,GO:1902904,0.193001396609032,0.952946594943739,2,116,negative regulation of supramolecular fiber organization,BP,SCIN;DMTN
3467,GO:0006875,0.193070106407262,0.913010469383808,5,472,cellular metal ion homeostasis,BP,LTF;SLC30A3;GPR17;GJA1;FPR3
14108,GO:0051879,0.193673190658809,0.980669107177925,1,32,Hsp90 protein binding,MF,AHR
4762,GO:0010470,0.194162137766046,0.980567572254881,1,32,regulation of gastrulation,BP,MBP
7816,GO:0031343,0.194534026995289,0.980397702135298,1,38,positive regulation of cell killing,BP,NOS2
12674,GO:0046883,0.195136337871775,0.933751608591835,3,232,regulation of hormone secretion,BP,NOS2;EGFR;GJA1
14424,GO:0055085,0.195165702922441,0.880905720508736,12,1347,transmembrane transport,BP,CACNG4;SLC17A7;SLC38A1;SLC30A3;GRID2;GJA1;KCNJ6;DMTN;KCNJ4;SCN9A;GJB1;DAPK1
752,GO:0001935,0.195380904058408,0.951991776681024,2,119,endothelial cell proliferation,BP,CAV2;GJA1
4865,GO:0010658,0.195402253544899,0.980308761582174,1,32,striated muscle cell apoptotic process,BP,CAMK2A
10539,GO:0042060,0.195539479402213,0.911538097909416,5,459,wound healing,BP,PRKCG;EGFR;GJA1;DMTN;APOD
16282,GO:0071392,0.195616752417711,0.980245862296555,1,33,cellular response to estradiol stimulus,BP,EGFR
7792,GO:0031312,0.195872066929952,0.980210229153471,1,32,extrinsic component of organelle membrane,CC,SOX10
14663,GO:0060306,0.196091960835961,0.980225600863323,1,29,regulation of membrane repolarization,BP,GJA1
12586,GO:0046658,0.196100436639191,0.980081832064097,1,37,anchored component of plasma membrane,CC,GPC6
11088,GO:0043169,0.196308641042077,0.859229989978599,30,3736,cation binding,MF,SCIN;NOS2;LTF;ZIC2;DSG2;EYA2;CAMK2A;CDH19;FA2H;COL9A1;CHD5;ATP10B;TRIM67;PRKCG;PCDH8;ENPP2;FBN3;GALNT13;SPOCK1;ACAN;EDIL3;LMO1;MGAT5B;SCN9A;NPTX1;VAT1L;DMRT2;GALNT9;MYT1;SMOC1
13111,GO:0048589,0.196341827012383,0.903809607789223,6,542,developmental growth,BP,ARX;FGFR3;SOX10;MAG;GJA1;APOD
15491,GO:0061900,0.196616004858282,0.980072964056641,1,31,glial cell activation,BP,EGFR
3695,GO:0007259,0.196743870061517,0.951424509327932,2,125,JAK-STAT cascade,BP,CRLF1;FGFR3
6232,GO:0017147,0.197325626219096,0.979923137218603,1,31,Wnt-protein binding,MF,CTHRC1
5001,GO:0010863,0.197683619868038,0.979847321570184,1,31,positive regulation of phospholipase C activity,BP,EGFR
17465,GO:0090568,0.197735156339948,0.979879487700109,1,29,nuclear transcriptional repressor complex,CC,CHD5
17871,GO:0097696,0.198526057745365,0.950706269405265,2,126,STAT cascade,BP,CRLF1;FGFR3
11731,GO:0044764,0.198770323043672,0.979577979214369,1,33,multi-organism cellular process,BP,LTF
6882,GO:0021772,0.199391570315772,0.979504661642908,1,30,olfactory bulb development,BP,ARX
3873,GO:0008066,0.199583928754844,0.979536612133151,1,27,glutamate receptor activity,MF,GRID2
17306,GO:0090218,0.199896047816485,0.979355395071433,1,32,positive regulation of lipid kinase activity,BP,FGFR3
11277,GO:0043486,0.199959393762477,0.979218080548664,1,40,histone exchange,BP,CHD5
11588,GO:0044331,0.200074928954243,0.979316940472486,1,32,cell-cell adhesion mediated by cadherin,BP,CDH19
7820,GO:0031347,0.200459485951149,0.901143861467346,6,622,regulation of defense response,BP,NOS2;LTF;GPR17;EGFR;GJA1;APOD
19891,GO:1903793,0.200470151928432,0.9791952603646,1,34,positive regulation of anion transport,BP,CCK
17879,GO:0097718,0.200761134665262,0.97921065609907,1,30,disordered domain specific binding,MF,GJA1
8421,GO:0032459,0.200968082447522,0.979054926169639,1,36,regulation of protein oligomerization,BP,CCK
7760,GO:0031267,0.201321362921952,0.900647041234157,6,528,small GTPase binding,MF,FGFR3;CAMK2A;EGFR;GFRA1;KNDC1;RIN1
7232,GO:0030216,0.201337492633287,0.949570385546052,2,126,keratinocyte differentiation,BP,DSG2;PPL
5117,GO:0014002,0.201552866670776,0.979018023078248,1,31,astrocyte development,BP,EGFR
14493,GO:0060048,0.201669833378793,0.949468722802856,2,118,cardiac muscle contraction,BP,DSG2;GJA1
5547,GO:0015804,0.201727302626868,0.978940810572907,1,33,neutral amino acid transport,BP,SLC38A1
1060,GO:0002437,0.20178658616684,0.978833968575085,1,39,inflammatory response to antigenic stimulus,BP,GPR17
5403,GO:0015293,0.201789932118249,0.949424426056096,2,117,symporter activity,MF,SLC17A7;SLC38A1
3394,GO:0006749,0.20199665914625,0.978709336688125,1,46,glutathione metabolic process,BP,GSTM1
5145,GO:0014044,0.202005674765508,0.978989661236643,1,28,Schwann cell development,BP,FA2H
16861,GO:0072359,0.202058132678265,0.885131279525871,9,916,circulatory system development,BP,DSG2;AHR;BVES;GPNMB;ENPP2;EGFR;GJA1;SGCD;APOD
6415,GO:0019076,0.202406801484805,0.978792894588686,1,33,viral release from host cell,BP,CAV2
10016,GO:0035890,0.202406801484805,0.978792894588686,1,33,exit from host,BP,CAV2
10017,GO:0035891,0.202406801484805,0.978792894588686,1,33,exit from host cell,BP,CAV2
14204,GO:0052126,0.202406801484805,0.978792894588686,1,33,movement in host environment,BP,CAV2
14214,GO:0052192,0.202406801484805,0.978792894588686,1,33,movement in environment of other organism involved in symbiotic interaction,BP,CAV2
686,GO:0001838,0.202572027821899,0.949101736899232,2,118,embryonic epithelial tube formation,BP,CTHRC1;IRX2
4477,GO:0009306,0.202633105211788,0.907230908617919,5,474,protein secretion,BP,NOS2;EGFR;GJA1;DMTN;MBP
665,GO:0001816,0.203039628004466,0.899493479475929,6,618,cytokine production,BP,NOS2;LTF;GPNMB;MOG;APOD;MBP
14518,GO:0060076,0.203298090177738,0.978683585968311,1,29,excitatory synapse,CC,SLC17A7
12023,GO:0045494,0.203529577659649,0.978587359674387,1,31,photoreceptor cell maintenance,BP,USH1C
610,GO:0001738,0.203549787583951,0.948646347603339,2,132,morphogenesis of a polarized epithelium,BP,CTHRC1;GPC6
18279,GO:0099622,0.204051081140299,0.978452163421166,1,32,cardiac muscle cell membrane repolarization,BP,GJA1
20017,GO:1904031,0.204403900395879,0.97830268119622,1,36,positive regulation of cyclin-dependent protein kinase activity,BP,EGFR
21292,GO:2000279,0.205261508146101,0.978185093062452,1,32,negative regulation of DNA biosynthetic process,BP,GJA1
6997,GO:0021988,0.205335449418343,0.978189768989808,1,31,olfactory lobe development,BP,ARX
12169,GO:0045776,0.20568095128668,0.978019412345282,1,36,negative regulation of blood pressure,BP,NOS2
13060,GO:0048487,0.205800837558178,0.977992717488824,1,36,beta-tubulin binding,MF,GJA1
4469,GO:0009268,0.205808561947206,0.977990996910778,1,36,response to pH,BP,GJA1
6000,GO:0016709,0.205841723969741,0.977983609368575,1,36,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen,MF,NOS2
21387,GO:2000401,0.205950618313744,0.977901043148303,1,40,regulation of lymphocyte migration,BP,APOD
18073,GO:0098862,0.206161946788753,0.947630472458556,2,118,cluster of actin-based cell projections,CC,USH1C;SCIN
8363,GO:0032391,0.206275132654582,0.977960072412162,1,32,photoreceptor connecting cilium,CC,USH1C
12595,GO:0046683,0.206623954342235,0.947417742808973,2,123,response to organophosphorus,BP,AHR;DMTN
17096,GO:0086005,0.207099839719927,0.977844739957905,1,29,ventricular cardiac muscle cell action potential,BP,DSG2
11012,GO:0043029,0.207272698772677,0.97764758673354,1,37,T cell homeostasis,BP,LMO1
1195,GO:0002683,0.20761287299825,0.914026733133031,4,368,negative regulation of immune system process,BP,LTF;GPNMB;GPR17;APOD
17110,GO:0086019,0.207916890091889,0.977662164621865,1,29,cell-cell signaling involved in cardiac conduction,BP,GJA1
13586,GO:0050931,0.208029182105028,0.977567718337047,1,32,pigment cell differentiation,BP,SOX10
21737,GO:2001056,0.208305048001674,0.946667513000241,2,137,positive regulation of cysteine-type endopeptidase activity,BP,CCK;DAPK1
18040,GO:0098805,0.208370677806249,0.868749597926058,13,1513,whole membrane,CC,CAMK2A;CACNG4;SOX10;SLC17A7;MAG;CAV2;BVES;SLC30A3;EGFR;GJA1;NRGN;HLA-DRB1;HLA-DRB5
6610,GO:0019730,0.208631530334224,0.97713053039858,1,58,antimicrobial humoral response,BP,LTF
7494,GO:0030801,0.208938302603398,0.977190192347901,1,43,positive regulation of cyclic nucleotide metabolic process,BP,NOS2
18691,GO:1900271,0.208986096630665,0.977373887394946,1,31,regulation of long-term synaptic potentiation,BP,NRGN
7202,GO:0030176,0.208986889446618,0.946383735686101,2,137,integral component of endoplasmic reticulum membrane,CC,HLA-DRB1;HLA-DRB5
881,GO:0002102,0.2090382985924,0.9773402902889,1,32,podosome,CC,SCIN
18009,GO:0098751,0.209068178443193,0.977355355862777,1,31,bone cell development,BP,LTF
11483,GO:0044091,0.209114524753328,0.977323060313048,1,32,membrane biogenesis,BP,CAV2
9345,GO:0034405,0.209296270833417,0.977261412352457,1,33,response to fluid shear stress,BP,GJA1
8377,GO:0032409,0.209643305105493,0.926418074621509,3,231,regulation of transporter activity,BP,CACNG4;GJA1;DAPK1
3445,GO:0006836,0.210004685657039,0.926237847556051,3,228,neurotransmitter transport,BP,CAMK2A;SLC17A7;SLC38A1
18694,GO:1900274,0.210254120211195,0.97704389451,1,33,regulation of phospholipase C activity,BP,EGFR
12127,GO:0045687,0.210535978855721,0.976907805308619,1,37,positive regulation of glial cell differentiation,BP,MAG
40,GO:0000082,0.210899870162781,0.925752710440538,3,240,G1/S transition of mitotic cell cycle,BP,CAMK2A;GPNMB;EGFR
15303,GO:0061462,0.210998148517039,0.97683599795923,1,35,protein localization to lysosome,BP,CACNG4
20531,GO:1905114,0.211282074919037,0.894185716614219,6,583,cell surface receptor signaling pathway involved in cell-cell signaling,BP,CAMK2A;SOX10;SLC17A7;GRID2;CTHRC1;GPC6
19752,GO:1903530,0.211359160821062,0.894122022887146,6,607,regulation of secretion by cell,BP,NOS2;CAMK2A;EGFR;GJA1;CCK;MBP
5126,GO:0014014,0.211378347562662,0.9767313132313,1,36,negative regulation of gliogenesis,BP,SOX10
5456,GO:0015485,0.212226123086111,0.976519502976868,1,37,cholesterol binding,MF,APOD
3765,GO:0007435,0.21232421174131,0.976550061102931,1,34,salivary gland morphogenesis,BP,EGFR
17003,GO:0072678,0.213121634754206,0.976240050022791,1,42,T cell migration,BP,APOD
9578,GO:0035051,0.213201947935045,0.944694336728998,2,118,cardiocyte differentiation,BP,BVES;EGFR
13101,GO:0048565,0.21323354307155,0.944662335585914,2,122,digestive tract development,BP,SOX10;EGFR
17972,GO:0098655,0.214289683070137,0.885949605573316,7,719,cation transmembrane transport,BP,CACNG4;SLC17A7;SLC30A3;KCNJ6;KCNJ4;SCN9A;DAPK1
2632,GO:0005575,0.214371311763854,0.946030219720017,99,14935,cellular_component,CC,ARX;CRLF1;USH1C;SCIN;NOS2;LTF;CLDN11;ZIC2;DSG2;CA11;EYA2;FGFR3;CAMK2A;CDH19;CACNG4;DCX;SOX10;FA2H;TOX3;SLC17A7;ICAM5;MAG;CAV2;AHR;EFNB3;SLC38A1;BVES;COL9A1;SLC30A3;OTX1;CHD5;ATP10B;PPL;TRIM67;GJB6;PACSIN1;MYRF;PRKCG;GSTM1;PCDH8;GPNMB;ENPP2;MOG;ST8SIA2;FBN3;GPR17;GALNT13;HAPLN1;EGFR;GFRA1;GRID2;SPOCK1;GJA1;NRGN;ABI3BP;KCNJ6;SNX22;ACAN;DMTN;EDIL3;PHKG1;CSMD3;CTHRC1;LMO1;MGAT5B;KCNJ4;SCN9A;GJB1;IRX2;SGCD;NPTX1;KNDC1;DMRT2;SUSD5;UGT8;RIN1;CREG2;RPRML;RGS6;GALNT9;GPC6;MX2;CNTN2;ANKS1B;PRAME;SLITRK2;CCK;FPR3;HAPLN4;APOD;HLA-DRB1;MYT1;CPNE4;DAPK1;MBP;HLA-DRB5;SMOC1;KLRC2;COL28A1
14420,GO:0055080,0.215471460155727,0.891433262686113,6,613,cation homeostasis,BP,LTF;SLC30A3;GPR17;EGFR;GJA1;FPR3
5281,GO:0015026,0.215553510115063,0.975762005396447,1,36,coreceptor activity,MF,GPC6
5822,GO:0016339,0.215699497682112,0.975785867301423,1,33,calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules,BP,CDH19
18259,GO:0099565,0.215750126444586,0.943605333174891,2,120,chemical synaptic transmission, postsynaptic,BP,SLC17A7;GRID2
3670,GO:0007212,0.216056889216846,0.975609922096515,1,38,dopamine receptor signaling pathway,BP,CAV2
7022,GO:0022408,0.216365892754339,0.943279629919208,2,135,negative regulation of cell-cell adhesion,BP,GPNMB;MBP
6874,GO:0021762,0.216816485771426,0.975414856020691,1,39,substantia nigra development,BP,MBP
13674,GO:0051092,0.217068635943451,0.942979481932589,2,135,positive regulation of NF-kappaB transcription factor activity,BP,LTF;CAMK2A
5121,GO:0014009,0.217498207235531,0.975341410384439,1,34,glial cell proliferation,BP,SOX10
954,GO:0002253,0.217635529848675,0.897931913534971,5,504,activation of immune response,BP,LTF;MOG;FPR3;HLA-DRB1;HLA-DRB5
7409,GO:0030551,0.217691938585876,0.975295511275377,1,34,cyclic nucleotide binding,MF,BVES
7376,GO:0030501,0.217990856867222,0.975224599805459,1,34,positive regulation of bone mineralization,BP,LTF
13762,GO:0051223,0.218026754654757,0.889756488825861,6,611,regulation of protein transport,BP,NOS2;EGFR;GJA1;DMTN;APOD;MBP
13919,GO:0051494,0.218055049301924,0.942593745103243,2,126,negative regulation of cytoskeleton organization,BP,SCIN;DMTN
13145,GO:0048662,0.218072210850504,0.975116566771854,1,39,negative regulation of smooth muscle cell proliferation,BP,APOD
1293,GO:0002832,0.218238676263656,0.975092772068135,1,38,negative regulation of response to biotic stimulus,BP,LTF
9592,GO:0035091,0.218242340084959,0.921956462474874,3,224,phosphatidylinositol binding,MF,SCIN;NRGN;SNX22
11571,GO:0044306,0.219025386137035,0.942155994137377,2,131,neuron projection terminus,CC,PACSIN1;CCK
16741,GO:0072175,0.219043253736646,0.942169461812755,2,126,epithelial tube formation,BP,CTHRC1;IRX2
7737,GO:0031227,0.219064778653935,0.942101260915888,2,141,intrinsic component of endoplasmic reticulum membrane,CC,HLA-DRB1;HLA-DRB5
7390,GO:0030517,0.219398786498956,0.974889109445065,1,34,negative regulation of axon extension,BP,MAG
2629,GO:0005547,0.219580002981871,0.974867016357961,1,33,phosphatidylinositol-3,4,5-trisphosphate binding,MF,NRGN
19520,GO:1903034,0.220810880740975,0.941381748096586,2,132,regulation of response to wounding,BP,GJA1;DMTN
12693,GO:0046915,0.220911406094562,0.974468348774152,1,37,transition metal ion transmembrane transporter activity,MF,SLC30A3
7127,GO:0030048,0.22108211428869,0.941328009086617,2,118,actin filament-based movement,BP,DSG2;GJA1
8419,GO:0032456,0.221134419782097,0.974472140252426,1,34,endocytic recycling,BP,BVES
130,GO:0000266,0.22134483201445,0.974421335828278,1,34,mitochondrial fission,BP,MX2
13974,GO:0051602,0.221419802487541,0.974311770598201,1,39,response to electrical stimulus,BP,GJB6
15620,GO:0070169,0.221639869072008,0.974329579882574,1,35,positive regulation of biomineral tissue development,BP,LTF
14123,GO:0051897,0.221913567298791,0.940908039564882,2,131,positive regulation of protein kinase B signaling,BP,FGFR3;EGFR
2534,GO:0005310,0.222298863717188,0.974169743598537,1,35,dicarboxylic acid transmembrane transporter activity,MF,SLC17A7
13611,GO:0050999,0.222453930476217,0.974060326140447,1,39,regulation of nitric-oxide synthase activity,BP,EGFR
12156,GO:0045746,0.222561602020333,0.974034069282419,1,39,negative regulation of Notch signaling pathway,BP,EGFR
3783,GO:0007517,0.222925809532374,0.905132757685098,4,344,muscle organ development,BP,CAV2;BVES;GJA1;SGCD
4676,GO:0010043,0.223038450229725,0.973788942513652,1,49,response to zinc ion,BP,SLC30A3
8591,GO:0032720,0.223170796054873,0.973826505203636,1,43,negative regulation of tumor necrosis factor production,BP,GPNMB
11175,GO:0043296,0.224000911720556,0.940039722153209,2,122,apical junction complex,CC,CLDN11;BVES
18237,GO:0099529,0.224131586446578,0.973722372082045,1,35,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential,MF,GRID2
20134,GO:1904315,0.224131586446578,0.973722372082045,1,35,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential,MF,GRID2
4858,GO:0010647,0.224260220287711,0.856702278277896,13,1558,positive regulation of cell communication,BP,CRLF1;LTF;FGFR3;CACNG4;CAV2;CHD5;GPNMB;GPR17;EGFR;GJA1;NRGN;DMTN;CNTN2
162,GO:0000323,0.224367272058829,0.885554808100736,6,626,lytic vacuole,CC,SLC30A3;GJA1;ACAN;GPC6;HLA-DRB1;HLA-DRB5
2743,GO:0005764,0.224367272058829,0.885554808100736,6,626,lysosome,CC,SLC30A3;GJA1;ACAN;GPC6;HLA-DRB1;HLA-DRB5
4625,GO:0009895,0.224737957714317,0.918474675110399,3,242,negative regulation of catabolic process,BP,NOS2;PRKCG;EGFR
20338,GO:1904724,0.225005351285358,0.973283274221801,1,51,tertiary granule lumen,CC,LTF
21546,GO:2000648,0.225206505715715,0.973458026530413,1,35,positive regulation of stem cell proliferation,BP,SOX10
16773,GO:0072210,0.225316417425413,0.973410983937279,1,36,metanephric nephron development,BP,IRX2
644,GO:0001786,0.225706527707221,0.97329565019478,1,37,phosphatidylserine binding,MF,SCIN
4634,GO:0009925,0.225778925033395,0.973360339783029,1,33,basal plasma membrane,CC,EGFR
3826,GO:0007616,0.226522194815976,0.973153831481611,1,34,long-term memory,BP,SLC17A7
2160,GO:0004702,0.227527398899449,0.938517499248288,2,117,signal transducer, downstream of receptor, with serine/threonine kinase activity,MF,FGFR3;EGFR
510,GO:0001558,0.227579653937614,0.902340563208994,4,365,regulation of cell growth,BP,MAG;EGFR;SPOCK1;GJA1
4897,GO:0010720,0.22788029541908,0.891484123959946,5,461,positive regulation of cell development,BP,SOX10;MAG;TRIM67;PACSIN1;DMTN
18018,GO:0098771,0.228345076342116,0.882903272085306,6,624,inorganic ion homeostasis,BP,LTF;SLC30A3;GPR17;EGFR;GJA1;FPR3
740,GO:0001917,0.228388343518941,0.97264657104609,1,36,photoreceptor inner segment,CC,USH1C
14488,GO:0060043,0.228483498245616,0.972622703348512,1,36,regulation of cardiac muscle cell proliferation,BP,GJA1
16189,GO:0071248,0.228790822621527,0.937850744019863,2,141,cellular response to metal ion,BP,EGFR;DMTN
6659,GO:0019838,0.229096685591238,0.937768666624846,2,128,growth factor binding,MF,FGFR3;EGFR
9684,GO:0035315,0.229191936881081,0.972444646698092,1,36,hair cell differentiation,BP,USH1C
13253,GO:0048854,0.2296973412,0.972337944411816,1,35,brain morphogenesis,BP,OTX1
16384,GO:0071548,0.230126564216269,0.972120074115337,1,41,response to dexamethasone,BP,EGFR
13789,GO:0051258,0.230452202681246,0.915383901763412,3,250,protein polymerization,BP,SCIN;DMTN;MX2
633,GO:0001775,0.230485813159035,0.860863307804366,10,1199,cell activation,BP,LTF;AHR;EFNB3;PRKCG;GPNMB;EGFR;DMTN;LMO1;HLA-DRB1;HLA-DRB5
14520,GO:0060078,0.230623921378853,0.937103607115809,2,125,regulation of postsynaptic membrane potential,BP,SLC17A7;GRID2
13763,GO:0051224,0.23062396197727,0.937027827640487,2,143,negative regulation of protein transport,BP,DMTN;APOD
13422,GO:0050708,0.230894462847305,0.900347008343725,4,371,regulation of protein secretion,BP,NOS2;EGFR;GJA1;MBP
14449,GO:0055123,0.231853787310202,0.936531153891861,2,130,digestive system development,BP,SOX10;EGFR
13653,GO:0051052,0.231909189437095,0.899751534459568,4,358,regulation of DNA metabolic process,BP,EYA2;PRKCG;EGFR;GJA1
10402,GO:0038128,0.232104063189487,0.971667122923254,1,38,ERBB2 signaling pathway,BP,EGFR
3764,GO:0007431,0.232134652791229,0.971659297599957,1,38,salivary gland development,BP,EGFR
11769,GO:0044843,0.232943779802768,0.914026061374316,3,252,cell cycle G1/S phase transition,BP,CAMK2A;GPNMB;EGFR
7398,GO:0030534,0.233109629046503,0.935972710977099,2,129,adult behavior,BP,EFNB3;CNTN2
722,GO:0001890,0.233155468165883,0.935921621101036,2,136,placenta development,BP,EGFR;GJA1
15260,GO:0061351,0.233535021523084,0.935790892168965,2,127,neural precursor cell proliferation,BP,ARX;SOX10
13834,GO:0051339,0.233736861846266,0.97119576818399,1,41,regulation of lyase activity,BP,NOS2
17954,GO:0098631,0.234012434025927,0.97114103937242,1,40,cell adhesion mediator activity,MF,DSG2
13731,GO:0051172,0.234196535986349,0.841002010092419,17,2098,negative regulation of nitrogen compound metabolic process,BP,ARX;NOS2;LTF;ZIC2;SOX10;AHR;PRKCG;EGFR;SPOCK1;GJA1;DMTN;LMO1;IRX2;PRAME;APOD;DAPK1;COL28A1
11633,GO:0044420,0.234224166499626,0.935549880259135,2,114,extracellular matrix component,CC,SMOC1;COL28A1
7767,GO:0031279,0.234596886945633,0.970973142879787,1,41,regulation of cyclase activity,BP,NOS2
4646,GO:0009966,0.234864301571987,0.833859251536453,22,2820,regulation of signal transduction,BP,CRLF1;LTF;EYA2;FGFR3;CACNG4;SOX10;CAV2;CHD5;TRIM67;GPNMB;GPR17;EGFR;GJA1;DMTN;CTHRC1;RGS6;GPC6;CNTN2;PRAME;CCK;APOD;DAPK1
4949,GO:0010799,0.234988194882523,0.970924092349877,1,38,regulation of peptidyl-threonine phosphorylation,BP,DMTN
1273,GO:0002790,0.235253764795352,0.886711056847799,5,505,peptide secretion,BP,NOS2;EGFR;GJA1;DMTN;MBP
21817,GO:2001239,0.23526346696197,0.970754465242912,1,44,regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,EYA2
6473,GO:0019228,0.235361867802425,0.970911856732229,1,34,neuronal action potential,BP,SCN9A
13779,GO:0051248,0.235391172232293,0.861196877394465,9,1027,negative regulation of protein metabolic process,BP,NOS2;LTF;PRKCG;EGFR;SPOCK1;DMTN;APOD;DAPK1;COL28A1
362,GO:0000977,0.235410234366898,0.878160242306735,6,608,RNA polymerase II regulatory region sequence-specific DNA binding,MF,ARX;SOX10;TOX3;AHR;OTX1;DMRT2
17095,GO:0086004,0.236013516058872,0.970767226084529,1,33,regulation of cardiac muscle cell contraction,BP,DSG2
1087,GO:0002478,0.236379010931178,0.934371154628373,2,163,antigen processing and presentation of exogenous peptide antigen,BP,HLA-DRB1;HLA-DRB5
11553,GO:0044275,0.236643530332296,0.970474177149579,1,39,cellular carbohydrate catabolic process,BP,PHKG1
8738,GO:0032934,0.236702575924754,0.970424087376406,1,41,sterol binding,MF,APOD
18220,GO:0099504,0.236962214180549,0.934241959807817,2,127,synaptic vesicle cycle,BP,SLC17A7;PACSIN1
8359,GO:0032386,0.237631487040579,0.896269111260489,4,371,regulation of intracellular transport,BP,BVES;DMTN;MX2;APOD
2551,GO:0005342,0.237702500815377,0.933860116257363,2,137,organic acid transmembrane transporter activity,MF,SLC17A7;SLC38A1
12709,GO:0046943,0.237702500815377,0.933860116257363,2,137,carboxylic acid transmembrane transporter activity,MF,SLC17A7;SLC38A1
12888,GO:0048018,0.237770438834438,0.911277236778824,3,320,receptor ligand activity,MF,CRLF1;GPNMB;CCK
3664,GO:0007204,0.237774992026289,0.911372347730332,3,255,positive regulation of cytosolic calcium ion concentration,BP,GPR17;GJA1;FPR3
1208,GO:0002696,0.238356127311462,0.911016737927786,3,275,positive regulation of leukocyte activation,BP,EFNB3;HLA-DRB1;HLA-DRB5
18127,GO:0098960,0.238579288349217,0.970004143449979,1,37,postsynaptic neurotransmitter receptor activity,MF,GRID2
5801,GO:0016303,0.238708394281518,0.969970065246383,1,37,1-phosphatidylinositol-3-kinase activity,MF,FGFR3
13056,GO:0048483,0.238794529281298,0.969927269424031,1,38,autonomic nervous system development,BP,SOX10
14486,GO:0060041,0.238803610837401,0.933403189924298,2,127,retina development in camera-type eye,BP,USH1C;SLC17A7
17369,GO:0090303,0.238954986568935,0.969814122100361,1,42,positive regulation of wound healing,BP,DMTN
16246,GO:0071345,0.23908549908196,0.863175034790074,8,951,cellular response to cytokine stimulus,BP,CRLF1;NOS2;CAMK2A;GPR17;MX2;HLA-DRB1;DAPK1;HLA-DRB5
11552,GO:0044273,0.239117508732859,0.969771018979566,1,42,sulfur compound catabolic process,BP,ACAN
383,GO:0001012,0.239215912859415,0.875577059020196,6,611,RNA polymerase II regulatory region DNA binding,MF,ARX;SOX10;TOX3;AHR;OTX1;DMRT2
13380,GO:0050661,0.239799664172705,0.969558989447741,1,44,NADP binding,MF,NOS2
16671,GO:0072073,0.239881080656874,0.932895793188818,2,130,kidney epithelium development,BP,CRLF1;IRX2
616,GO:0001754,0.240120960590477,0.969575547738536,1,38,eye photoreceptor cell differentiation,BP,USH1C
13754,GO:0051205,0.240127961918218,0.969443305030382,1,46,protein insertion into membrane,BP,EGFR
17159,GO:0086091,0.240426957940684,0.969558547475583,1,35,regulation of heart rate by cardiac conduction,BP,DSG2
20457,GO:1904950,0.240689769474862,0.932453556581416,2,147,negative regulation of establishment of protein localization,BP,DMTN;APOD
18835,GO:1901224,0.240753262643578,0.96931945323824,1,43,positive regulation of NIK/NF-kappaB signaling,BP,EGFR
10740,GO:0042461,0.240891424652925,0.969370213750223,1,38,photoreceptor cell development,BP,USH1C
10538,GO:0042059,0.241027918874858,0.969278478990657,1,41,negative regulation of epidermal growth factor receptor signaling pathway,BP,EGFR
3967,GO:0008217,0.24131802994468,0.932164410866878,2,147,regulation of blood pressure,BP,NOS2;GJA1
7687,GO:0031103,0.241369545667447,0.969204525785025,1,40,axon regeneration,BP,APOD
6031,GO:0016765,0.242257108837422,0.968778379330909,1,54,transferase activity, transferring alkyl or aryl (other than methyl) groups,MF,GSTM1
3556,GO:0007015,0.242458159485089,0.893329579062421,4,359,actin filament organization,BP,USH1C;SCIN;PACSIN1;DMTN
19858,GO:1903727,0.242779904855424,0.968790707835357,1,42,positive regulation of phospholipid metabolic process,BP,FGFR3
13220,GO:0048786,0.243176817729785,0.968847165493413,1,34,presynaptic active zone,CC,SLC17A7
20560,GO:1905207,0.24337703820591,0.968682835020027,1,39,regulation of cardiocyte differentiation,BP,EGFR
12183,GO:0045806,0.243741130571066,0.968483983081959,1,45,negative regulation of endocytosis,BP,PACSIN1
17216,GO:0090087,0.243776475818945,0.872447297672861,6,639,regulation of peptide transport,BP,NOS2;EGFR;GJA1;DMTN;APOD;MBP
947,GO:0002244,0.244003266230706,0.930883963437449,2,158,hematopoietic progenitor cell differentiation,BP,BVES;LMO1
8388,GO:0032420,0.244096636127751,0.96848795397664,1,39,stereocilium,CC,USH1C
16173,GO:0071222,0.244136514974719,0.930845994435418,2,151,cellular response to lipopolysaccharide,BP,NOS2;LTF
21096,GO:1990841,0.244220680324531,0.968474180667,1,38,promoter-specific chromatin binding,MF,SOX10
3809,GO:0007595,0.244524582864536,0.968391678252187,1,38,lactation,BP,GJA1
9923,GO:0035725,0.244604066900912,0.930721149689867,2,129,sodium ion transmembrane transport,BP,SLC17A7;SCN9A
4332,GO:0009100,0.245140936328557,0.891660862229023,4,371,glycoprotein metabolic process,BP,ST8SIA2;GALNT13;MGAT5B;GALNT9
21165,GO:2000045,0.245503822433138,0.930232108083925,2,145,regulation of G1/S transition of mitotic cell cycle,BP,GPNMB;EGFR
3823,GO:0007612,0.245526478272845,0.930291998999846,2,129,learning,BP,NRGN;CNTN2
14377,GO:0055002,0.245537820215303,0.930267501872232,2,133,striated muscle cell development,BP,CAV2;BVES
2664,GO:0005615,0.245609575185184,0.825032533495408,22,3093,extracellular space,CC,CRLF1;SCIN;LTF;CLDN11;DSG2;SLC38A1;PPL;ENPP2;EGFR;GFRA1;SPOCK1;GJA1;ABI3BP;EDIL3;CTHRC1;GPC6;SLITRK2;CCK;APOD;HLA-DRB1;CPNE4;HLA-DRB5
4932,GO:0010761,0.245852286022033,0.968029841129008,1,38,fibroblast migration,BP,DMTN
21814,GO:2001236,0.246263304694617,0.929873701963877,2,146,regulation of extrinsic apoptotic signaling pathway,BP,EYA2;DAPK1
12207,GO:0045843,0.246536247715747,0.967767297857873,1,42,negative regulation of striated muscle tissue development,BP,GJA1
10556,GO:0042098,0.246566659410586,0.929688819907127,2,158,T cell proliferation,BP,GPNMB;LMO1
3758,GO:0007416,0.246603991768396,0.929826139484517,2,122,synapse assembly,BP,GRID2;SLITRK2
3526,GO:0006968,0.246921424069919,0.967558932829223,1,49,cellular defense response,BP,KLRC2
6684,GO:0019884,0.247273703938738,0.929329278162349,2,167,antigen processing and presentation of exogenous antigen,BP,HLA-DRB1;HLA-DRB5
17543,GO:0097035,0.247374491178772,0.96763370313127,1,37,regulation of membrane lipid distribution,BP,ATP10B
6308,GO:0018198,0.247531084100757,0.967445172804124,1,45,peptidyl-cysteine modification,BP,NOS2
10779,GO:0042551,0.247590904719286,0.967532137186348,1,39,neuron maturation,BP,CNTN2
5139,GO:0014037,0.247602382317983,0.967593705955311,1,36,Schwann cell differentiation,BP,FA2H
2169,GO:0004712,0.248024781945821,0.967374343317636,1,41,protein serine/threonine/tyrosine kinase activity,MF,PRKCG
417,GO:0001098,0.248396111296869,0.967236951478918,1,43,basal transcription machinery binding,MF,AHR
418,GO:0001099,0.248396111296869,0.967236951478918,1,43,basal RNA polymerase II transcription machinery binding,MF,AHR
15745,GO:0070372,0.249236556210045,0.904962513295442,3,260,regulation of ERK1 and ERK2 cascade,BP,FGFR3;GPNMB;EGFR
16264,GO:0071364,0.249280184868031,0.967064388523313,1,39,cellular response to epidermal growth factor stimulus,BP,EGFR
4547,GO:0009617,0.249307296971283,0.889018556231589,4,424,response to bacterium,BP,NOS2;LTF;GJB6;GJA1
8705,GO:0032890,0.249375118284898,0.966981733908383,1,42,regulation of organic acid transport,BP,CCK
11330,GO:0043551,0.250088302474937,0.966819512641965,1,40,regulation of phosphatidylinositol 3-kinase activity,BP,FGFR3
7821,GO:0031348,0.250104502048725,0.928049590373219,2,151,negative regulation of defense response,BP,GPR17;APOD
13444,GO:0050732,0.250179422341256,0.96672381849637,1,44,negative regulation of peptidyl-tyrosine phosphorylation,BP,DMTN
12322,GO:0046068,0.250188753146935,0.96675465729917,1,42,cGMP metabolic process,BP,NOS2
3680,GO:0007223,0.25038058628305,0.96677860239122,1,38,Wnt signaling pathway, calcium modulating pathway,BP,CAMK2A
13914,GO:0051489,0.250732286054001,0.966659352440849,1,39,regulation of filopodium assembly,BP,DMTN
7523,GO:0030833,0.250857155365645,0.927708809136625,2,147,regulation of actin filament polymerization,BP,SCIN;DMTN
1257,GO:0002762,0.25116187140531,0.966500030063173,1,41,negative regulation of myeloid leukocyte differentiation,BP,LTF
8107,GO:0031952,0.251330846034713,0.966491597513611,1,39,regulation of protein autophosphorylation,BP,GPNMB
19034,GO:1901799,0.251778064369393,0.96627473745589,1,44,negative regulation of proteasomal protein catabolic process,BP,PRKCG
2849,GO:0005925,0.251899587295742,0.887444932315467,4,381,focal adhesion,CC,FGFR3;CAV2;EGFR;GJA1
21832,GO:2001257,0.251976329536283,0.927202758135746,2,141,regulation of cation channel activity,BP,CACNG4;DAPK1
13131,GO:0048635,0.25218979601778,0.966175132485524,1,43,negative regulation of muscle organ development,BP,GJA1
17100,GO:0086009,0.252198730364542,0.966227393264347,1,40,membrane repolarization,BP,GJA1
16904,GO:0072503,0.253558747487271,0.886392013880761,4,392,cellular divalent inorganic cation homeostasis,BP,SLC30A3;GPR17;GJA1;FPR3
12736,GO:0046982,0.254329234459739,0.885895760117305,4,403,protein heterodimerization activity,MF,CRLF1;CAV2;AHR;EGFR
16994,GO:0072666,0.25442358767054,0.965558826518991,1,42,establishment of protein localization to vacuole,BP,CACNG4
9627,GO:0035196,0.254599732449404,0.965546684628015,1,40,production of miRNAs involved in gene silencing by miRNA,BP,EGFR
13624,GO:0051017,0.25461128326953,0.925955643695567,2,139,actin filament bundle assembly,BP,USH1C;DMTN
15347,GO:0061572,0.25461128326953,0.925955643695567,2,139,actin filament bundle organization,BP,USH1C;DMTN
13061,GO:0048488,0.254885739425393,0.965485664404283,1,39,synaptic vesicle endocytosis,BP,PACSIN1
684,GO:0001836,0.255055731786274,0.965208459603765,1,54,release of cytochrome c from mitochondria,BP,CCK
2753,GO:0005775,0.25519962567172,0.925612970013852,2,154,vacuolar lumen,CC,ACAN;GPC6
2848,GO:0005924,0.255260033594576,0.88533128481644,4,384,cell-substrate adherens junction,CC,FGFR3;CAV2;EGFR;GJA1
13233,GO:0048813,0.255444249296358,0.925610638246456,2,128,dendrite morphogenesis,BP,CAMK2A;KNDC1
12909,GO:0048066,0.255458402256083,0.965263051804786,1,42,developmental pigmentation,BP,SOX10
18552,GO:1900024,0.255510433890938,0.965213262582842,1,44,regulation of substrate adhesion-dependent cell spreading,BP,DMTN
21239,GO:2000179,0.255606046336134,0.965259142769475,1,40,positive regulation of neural precursor cell proliferation,BP,SOX10
9614,GO:0035148,0.255860981790516,0.925352266796907,2,140,tube formation,BP,CTHRC1;IRX2
11798,GO:0045010,0.255861476269704,0.965096168794018,1,45,actin nucleation,BP,SCIN
19093,GO:1901981,0.25592426820278,0.925330932393128,2,138,phosphatidylinositol phosphate binding,MF,SCIN;NRGN
19057,GO:1901862,0.256325691478069,0.964978976597443,1,44,negative regulation of muscle tissue development,BP,GJA1
19556,GO:1903115,0.256679121836774,0.964993876957676,1,38,regulation of actin filament-based movement,BP,DSG2
5172,GO:0014074,0.256688853040667,0.924958864004397,2,139,response to purine-containing compound,BP,AHR;DMTN
454,GO:0001221,0.256745193148153,0.964932044411664,1,40,transcription cofactor binding,MF,AHR
12598,GO:0046686,0.256752340993668,0.964697632159213,1,56,response to cadmium ion,BP,EGFR
13470,GO:0050776,0.257468464198068,0.855695697236157,7,828,regulation of immune response,BP,LTF;ICAM5;MOG;GPR17;FPR3;HLA-DRB1;HLA-DRB5
9649,GO:0035254,0.258015991895547,0.964565133549038,1,40,glutamate receptor binding,MF,CAMK2A
2828,GO:0005891,0.258308396846197,0.964501529609074,1,39,voltage-gated calcium channel complex,CC,CACNG4
11833,GO:0045071,0.258736874307357,0.964204339993843,1,49,negative regulation of viral genome replication,BP,LTF
12503,GO:0046503,0.258752954413922,0.964213693060048,1,48,glycerolipid catabolic process,BP,ENPP2
11645,GO:0044437,0.259552275127941,0.870659473657917,5,525,vacuolar part,CC,SLC30A3;ACAN;GPC6;HLA-DRB1;HLA-DRB5
7842,GO:0031401,0.26020421378645,0.842740312739365,9,1036,positive regulation of protein modification process,BP,CRLF1;LTF;FGFR3;CAV2;GPNMB;ENPP2;EGFR;KNDC1;CCK
14487,GO:0060042,0.260672251092538,0.963770890194659,1,41,retina morphogenesis in camera-type eye,BP,USH1C
7131,GO:0030055,0.26095391171212,0.881722505215231,4,387,cell-substrate junction,CC,FGFR3;CAV2;EGFR;GJA1
17219,GO:0090090,0.261004985048704,0.922784600976789,2,160,negative regulation of canonical Wnt signaling pathway,BP,SOX10;CTHRC1
8316,GO:0032330,0.26236764869213,0.963252146255688,1,42,regulation of chondrocyte differentiation,BP,SCIN
11485,GO:0044093,0.262462395900472,0.826917936126265,13,1577,positive regulation of molecular function,BP,NOS2;LTF;ZIC2;FGFR3;CAMK2A;CAV2;EGFR;CTHRC1;RIN1;RGS6;CCK;DAPK1;MBP
15643,GO:0070201,0.262507483648257,0.859427153141018,6,653,regulation of establishment of protein localization,BP,NOS2;EGFR;GJA1;DMTN;APOD;MBP
16170,GO:0071219,0.262540877270082,0.922037880320737,2,159,cellular response to molecule of bacterial origin,BP,NOS2;LTF
733,GO:0001910,0.262608813984284,0.963025041842433,1,52,regulation of leukocyte mediated cytotoxicity,BP,NOS2
12874,GO:0048002,0.262704254083333,0.921905772670711,2,175,antigen processing and presentation of peptide antigen,BP,HLA-DRB1;HLA-DRB5
1274,GO:0002791,0.26274756282576,0.880567331024557,4,397,regulation of peptide secretion,BP,NOS2;EGFR;GJA1;MBP
17227,GO:0090102,0.26357981328286,0.962873868008573,1,43,cochlea development,BP,CTHRC1
17978,GO:0098662,0.264244359103431,0.858212069656659,6,637,inorganic cation transmembrane transport,BP,CACNG4;SLC17A7;SLC30A3;KCNJ6;KCNJ4;SCN9A
7194,GO:0030168,0.264301510597632,0.921212556529473,2,149,platelet activation,BP,PRKCG;DMTN
16286,GO:0071396,0.264551251311719,0.867289629387858,5,514,cellular response to lipid,BP,NOS2;LTF;SOX10;AHR;EGFR
7982,GO:0031663,0.264633732528429,0.962461366958298,1,49,lipopolysaccharide-mediated signaling pathway,BP,LTF
1600,GO:0003682,0.265733193184466,0.866504137447063,5,494,chromatin binding,MF,ARX;ZIC2;SOX10;TOX3;EGFR
12535,GO:0046579,0.265819913446339,0.962168402767206,1,45,positive regulation of Ras protein signal transduction,BP,GPR17
3785,GO:0007519,0.266067116862502,0.920346538606865,2,148,skeletal muscle tissue development,BP,CAV2;BVES
16299,GO:0071417,0.266900065797972,0.865708448112015,5,496,cellular response to organonitrogen compound,BP,CAMK2A;CAV2;AHR;EGFR;DMTN
11416,GO:0043902,0.266955011926034,0.919867660604283,2,158,positive regulation of multi-organism process,BP,NOS2;CAV2
3624,GO:0007157,0.267082705882508,0.961824120825201,1,43,heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules,BP,GRID2
7296,GO:0030308,0.267480311282873,0.919622518109692,2,154,negative regulation of cell growth,BP,MAG;GJA1
8389,GO:0032421,0.267714853975576,0.961614249800113,1,44,stereocilium bundle,CC,USH1C
13573,GO:0050918,0.267839989794597,0.961479832973963,1,50,positive chemotaxis,BP,GPNMB
8623,GO:0032768,0.267941726348425,0.961463359011684,1,49,regulation of monooxygenase activity,BP,EGFR
2505,GO:0005245,0.268790272984456,0.961346912247467,1,41,voltage-gated calcium channel activity,MF,CACNG4
2840,GO:0005912,0.268901886219525,0.86433251975959,5,508,adherens junction,CC,FGFR3;CDH19;CAV2;EGFR;GJA1
942,GO:0002228,0.269577285453491,0.960922334404104,1,52,natural killer cell mediated immunity,BP,KLRC2
8592,GO:0032722,0.269609896066067,0.960939905208977,1,50,positive regulation of chemokine production,BP,MBP
20689,GO:1905475,0.269704209910678,0.918519972659426,2,153,regulation of protein localization to membrane,BP,EGFR;DMTN
7646,GO:0031050,0.270697937298061,0.96072355465572,1,43,dsRNA fragmentation,BP,EGFR
16035,GO:0070918,0.270697937298061,0.96072355465572,1,43,production of small RNA involved in gene silencing by RNA,BP,EGFR
617,GO:0001755,0.271300215299452,0.960483447672962,1,46,neural crest cell migration,BP,SOX10
17712,GO:0097345,0.271321866077063,0.960372578425498,1,53,mitochondrial outer membrane permeabilization,BP,EYA2
12925,GO:0048146,0.271338365403673,0.960438811139146,1,48,positive regulation of fibroblast proliferation,BP,EGFR
7155,GO:0030119,0.271354575220637,0.960484242391787,1,45,AP-type membrane coat adaptor complex,CC,EGFR
12902,GO:0048037,0.2713720999352,0.874978032464265,4,433,cofactor binding,MF,NOS2;FA2H;GSTM1;CREG2
15992,GO:0070849,0.271386826043794,0.960511856131242,1,43,response to epidermal growth factor,BP,EGFR
14303,GO:0052742,0.272116572146632,0.960286907713557,1,43,phosphatidylinositol kinase activity,MF,FGFR3
6035,GO:0016773,0.272430127781107,0.844854381848992,7,720,phosphotransferase activity, alcohol group as acceptor,MF,FGFR3;CAMK2A;EFNB3;PRKCG;EGFR;PHKG1;DAPK1
12670,GO:0046879,0.272437009213346,0.891475240557371,3,274,hormone secretion,BP,NOS2;EGFR;GJA1
11061,GO:0043123,0.273220648744134,0.916729331061125,2,160,positive regulation of I-kappaB kinase/NF-kappaB signaling,BP,LTF;GJA1
5300,GO:0015079,0.273313245034915,0.91672696358331,2,149,potassium ion transmembrane transporter activity,MF,KCNJ6;KCNJ4
12558,GO:0046622,0.273361731864565,0.959881948904574,1,44,positive regulation of organ growth,BP,ARX
3566,GO:0007029,0.273385006830838,0.959838300886925,1,46,endoplasmic reticulum organization,BP,CAV2
15523,GO:0065009,0.273657063546987,0.801687564628236,22,2919,regulation of molecular function,BP,CRLF1;NOS2;LTF;ZIC2;FGFR3;CAMK2A;CACNG4;CAV2;BVES;GPNMB;EGFR;GFRA1;SPOCK1;GJA1;CTHRC1;KNDC1;RIN1;RGS6;CCK;DAPK1;MBP;COL28A1
2625,GO:0005543,0.273859731854473,0.873422938457042,4,379,phospholipid binding,MF,SCIN;PACSIN1;NRGN;SNX22
6695,GO:0019901,0.27394149531805,0.85133002823453,6,620,protein kinase binding,MF,FGFR3;DCX;MAG;CAV2;EGFR;GJA1
19407,GO:1902806,0.274104038631468,0.916299082364197,2,156,regulation of cell cycle G1/S phase transition,BP,GPNMB;EGFR
7403,GO:0030545,0.274391439075396,0.890203274247512,3,343,receptor regulator activity,MF,CRLF1;GPNMB;CCK
9820,GO:0035580,0.274658582867571,0.959274101264793,1,58,specific granule lumen,CC,LTF
2478,GO:0005179,0.274868816529074,0.959113773556816,1,68,hormone activity,MF,CCK
12017,GO:0045453,0.27487876153976,0.95933871439101,1,48,bone resorption,BP,EGFR
7220,GO:0030203,0.275000362007059,0.915888396894963,2,146,glycosaminoglycan metabolic process,BP,ACAN;GPC6
11541,GO:0044255,0.275044681803967,0.836645109598499,8,951,cellular lipid metabolic process,BP,FGFR3;FA2H;ENPP2;ST8SIA2;EGFR;UGT8;GPC6;APOD
15977,GO:0070830,0.275659235720788,0.95911053008803,1,47,bicellular tight junction assembly,BP,GJA1
3797,GO:0007565,0.275763577393097,0.915455115388238,2,157,female pregnancy,BP,DSG2;GJA1
1595,GO:0003674,0.276013074496675,0.847794560174338,95,14275,molecular_function,MF,ARX;CRLF1;USH1C;SCIN;NOS2;LTF;CLDN11;ZIC2;DSG2;EYA2;FGFR3;CAMK2A;CDH19;CACNG4;DCX;SOX10;FA2H;TOX3;SLC17A7;ICAM5;MAG;CAV2;AHR;EFNB3;SLC38A1;BVES;COL9A1;SLC30A3;OTX1;CHD5;ATP10B;PPL;TRIM67;PACSIN1;MYRF;PRKCG;GSTM1;PCDH8;GPNMB;ENPP2;MOG;ST8SIA2;FBN3;GPR17;GALNT13;HAPLN1;EGFR;GFRA1;GRID2;SPOCK1;GJA1;NRGN;ABI3BP;KCNJ6;SNX22;ACAN;DMTN;EDIL3;PHKG1;CTHRC1;LMO1;MGAT5B;KCNJ4;SCN9A;GJB1;IRX2;SGCD;NPTX1;VAT1L;KNDC1;DMRT2;SUSD5;UGT8;RIN1;CREG2;RGS6;GALNT9;GPC6;MX2;CNTN2;ANKS1B;PRAME;CCK;FPR3;HAPLN4;APOD;HLA-DRB1;MYT1;CPNE4;DAPK1;MBP;HLA-DRB5;SMOC1;KLRC2;COL28A1
12692,GO:0046914,0.277228052502873,0.835005211623744,8,926,transition metal ion binding,MF,NOS2;LTF;FA2H;TRIM67;PRKCG;ENPP2;VAT1L;MYT1
2294,GO:0004879,0.277672808057879,0.958511372265852,1,45,nuclear receptor activity,MF,AHR
17911,GO:0098531,0.277672808057879,0.958511372265852,1,45,transcription factor activity, direct ligand regulated sequence-specific DNA binding,MF,AHR
2876,GO:0005978,0.277730845109136,0.958512207765635,1,44,glycogen biosynthetic process,BP,PHKG1
4454,GO:0009250,0.277730845109136,0.958512207765635,1,44,glucan biosynthetic process,BP,PHKG1
13548,GO:0050885,0.277976293723716,0.958454631396781,1,43,neuromuscular process controlling balance,BP,USH1C
19522,GO:1903036,0.278024484564069,0.958315312703093,1,50,positive regulation of response to wounding,BP,DMTN
10656,GO:0042306,0.278124247049832,0.958332288464782,1,47,regulation of protein import into nucleus,BP,APOD
16223,GO:0071310,0.278473162213108,0.803264311822978,18,2351,cellular response to organic substance,BP,CRLF1;NOS2;LTF;FGFR3;CAMK2A;SOX10;CAV2;AHR;GJB6;FBN3;GPR17;EGFR;GJA1;DMTN;MX2;HLA-DRB1;DAPK1;HLA-DRB5
3088,GO:0006338,0.278840090044919,0.913884023244181,2,158,chromatin remodeling,BP,TOX3;CHD5
10575,GO:0042130,0.279046245272405,0.957975050822978,1,51,negative regulation of T cell proliferation,BP,GPNMB
5282,GO:0015030,0.279182078147965,0.957903283368942,1,53,Cajal body,CC,ANKS1B
5113,GO:0012505,0.279840743043123,0.790057632370397,29,3945,endomembrane system,CC,LTF;FGFR3;FA2H;SLC17A7;CAV2;COL9A1;SLC30A3;ATP10B;PACSIN1;MYRF;ST8SIA2;GALNT13;EGFR;GJA1;NRGN;KCNJ6;ACAN;DMTN;MGAT5B;GJB1;NPTX1;CREG2;GALNT9;GPC6;MX2;APOD;HLA-DRB1;HLA-DRB5;COL28A1
15744,GO:0070371,0.280330777871424,0.886738555897232,3,276,ERK1 and ERK2 cascade,BP,FGFR3;GPNMB;EGFR
19150,GO:1902110,0.280491070112263,0.957457336780629,1,55,positive regulation of mitochondrial membrane permeability involved in apoptotic process,BP,EYA2
14838,GO:0060538,0.280697677074935,0.912947981878041,2,154,skeletal muscle organ development,BP,CAV2;BVES
2541,GO:0005326,0.281158223819941,0.957381121134354,1,46,neurotransmitter transporter activity,MF,SLC17A7
14422,GO:0055082,0.281956227107074,0.845527412687265,6,674,cellular chemical homeostasis,BP,LTF;SLC30A3;GJB6;GPR17;GJA1;FPR3
10131,GO:0036092,0.2821095016247,0.957113545401288,1,44,phosphatidylinositol-3-phosphate biosynthetic process,BP,FGFR3
7095,GO:0023061,0.282406005151527,0.867792216579993,4,397,signal release,BP,NOS2;CAMK2A;EGFR;GJA1
15579,GO:0070098,0.282766810292417,0.956631388457178,1,63,chemokine-mediated signaling pathway,BP,GPR17
3780,GO:0007507,0.282799426562535,0.85475197013459,5,490,heart development,BP,DSG2;BVES;EGFR;GJA1;SGCD
11329,GO:0043550,0.283090423694248,0.956739339524521,1,47,regulation of lipid kinase activity,BP,FGFR3
14701,GO:0060350,0.28324619059675,0.956688832249559,1,47,endochondral bone morphogenesis,BP,FGFR3
15504,GO:0061971,0.28324619059675,0.956688832249559,1,47,replacement bone morphogenesis,BP,FGFR3
13485,GO:0050796,0.283908558798774,0.911282511703621,2,156,regulation of insulin secretion,BP,NOS2;GJA1
13267,GO:0048871,0.283961178981131,0.8845340039376,3,277,multicellular organismal homeostasis,BP,USH1C;LTF;EGFR
7686,GO:0031102,0.28428615715924,0.956316195084997,1,49,neuron projection regeneration,BP,APOD
19547,GO:1903078,0.284352506534224,0.956329156242398,1,47,positive regulation of protein localization to plasma membrane,BP,EGFR
14483,GO:0060038,0.284388404015851,0.956335890660275,1,46,cardiac muscle cell proliferation,BP,GJA1
14393,GO:0055021,0.284506745374352,0.956278878481343,1,47,regulation of cardiac muscle tissue growth,BP,GJA1
6607,GO:0019722,0.28517563031275,0.910637557811181,2,153,calcium-mediated signaling,BP,EGFR;DMTN
16184,GO:0071241,0.285223604565109,0.910571696879988,2,163,cellular response to inorganic substance,BP,EGFR;DMTN
17078,GO:0080134,0.285627433168708,0.818691419701344,10,1232,regulation of response to stress,BP,NOS2;LTF;EYA2;CAMK2A;PRKCG;GPR17;EGFR;GJA1;DMTN;APOD
7122,GO:0030041,0.285736536774018,0.910312488873822,2,161,actin filament polymerization,BP,SCIN;DMTN
12101,GO:0045652,0.285784769812165,0.955750074799573,1,54,regulation of megakaryocyte differentiation,BP,SCIN
7098,GO:0030003,0.286205082621953,0.852318707590555,5,547,cellular cation homeostasis,BP,LTF;SLC30A3;GPR17;GJA1;FPR3
18800,GO:1901136,0.286218044507363,0.91004236032002,2,166,carbohydrate derivative catabolic process,BP,ACAN;GPC6
2725,GO:0005741,0.286266019582888,0.910028703324366,2,163,mitochondrial outer membrane,CC,SOX10;GJA1
14110,GO:0051881,0.286400304925074,0.955484180939582,1,59,regulation of mitochondrial membrane potential,BP,CCK
13911,GO:0051480,0.286510874174471,0.882969419649192,3,281,regulation of cytosolic calcium ion concentration,BP,GPR17;GJA1;FPR3
12150,GO:0045740,0.286619812844198,0.95551926699509,1,51,positive regulation of DNA replication,BP,EGFR
10133,GO:0036094,0.287043741335908,0.796119541847742,18,2242,small molecule binding,MF,NOS2;FGFR3;CAMK2A;MAG;BVES;CHD5;ATP10B;PRKCG;ST8SIA2;HAPLN1;EGFR;ACAN;PHKG1;SUSD5;MX2;HAPLN4;APOD;DAPK1
2873,GO:0005975,0.287341206851217,0.851525620585647,5,541,carbohydrate metabolic process,BP,ST8SIA2;GALNT13;PHKG1;GALNT9;APOD
4631,GO:0009914,0.288055020903583,0.882018816626767,3,283,hormone transport,BP,NOS2;EGFR;GJA1
3636,GO:0007169,0.288061059577018,0.841108249916374,6,645,transmembrane receptor protein tyrosine kinase signaling pathway,BP,FGFR3;CAV2;EFNB3;EGFR;GFRA1;APOD
19369,GO:1902686,0.289583446022786,0.954451673799999,1,57,mitochondrial outer membrane permeabilization involved in programmed cell death,BP,EYA2
7154,GO:0030118,0.290232960517663,0.954370792009473,1,48,clathrin coat,CC,EGFR
13396,GO:0050679,0.290354908530256,0.907904939020264,2,158,positive regulation of epithelial cell proliferation,BP,CAV2;EGFR
4554,GO:0009636,0.290673411081608,0.862236290654771,4,442,response to toxic substance,BP,AHR;GSTM1;SCN9A;MBP
3429,GO:0006810,0.29086683540436,0.778638700763994,32,4422,transport,BP,SCIN;NOS2;LTF;EYA2;CAMK2A;CACNG4;SLC17A7;ICAM5;CAV2;SLC38A1;BVES;SLC30A3;ATP10B;PACSIN1;PRKCG;ENPP2;EGFR;GRID2;GJA1;KCNJ6;SNX22;DMTN;KCNJ4;SCN9A;GJB1;RIN1;MX2;CNTN2;CCK;APOD;DAPK1;MBP
7814,GO:0031341,0.291102771346169,0.953905884082039,1,60,regulation of cell killing,BP,NOS2
13512,GO:0050840,0.291193222010803,0.954049357612407,1,48,extracellular matrix binding,MF,SMOC1
15830,GO:0070527,0.291589584986053,0.953849219189501,1,52,platelet aggregation,BP,DMTN
12536,GO:0046580,0.29179115894017,0.953886546029993,1,46,negative regulation of Ras protein signal transduction,BP,TRIM67
14854,GO:0060563,0.291914210337885,0.953772212145223,1,50,neuroepithelial cell differentiation,BP,USH1C
13382,GO:0050663,0.292029523831243,0.906977002033356,2,169,cytokine secretion,BP,NOS2;MBP
3849,GO:0008021,0.292429949546958,0.906776165022382,2,166,synaptic vesicle,CC,SLC17A7;SLC30A3
4867,GO:0010660,0.292774737008198,0.953449556801463,1,52,regulation of muscle cell apoptotic process,BP,CAMK2A
13196,GO:0048732,0.293007624523203,0.860721093388359,4,396,gland development,BP,SOX10;FA2H;EGFR;GJA1
18092,GO:0098900,0.29310110545865,0.953487073616847,1,44,regulation of action potential,BP,DSG2
3513,GO:0006941,0.293183674675436,0.906412950979761,2,157,striated muscle contraction,BP,DSG2;GJA1
4583,GO:0009749,0.293418032131381,0.906267621143105,2,162,response to glucose,BP,GJB6;GJA1
13484,GO:0050795,0.293446779415133,0.953191875255282,1,54,regulation of behavior,BP,GJA1
7565,GO:0030888,0.293827807537513,0.953048231222868,1,55,regulation of B cell proliferation,BP,AHR
7503,GO:0030810,0.294432876348662,0.952828519879901,1,56,positive regulation of nucleotide biosynthetic process,BP,NOS2
18707,GO:1900373,0.294432876348662,0.952828519879901,1,56,positive regulation of purine nucleotide biosynthetic process,BP,NOS2
20267,GO:1904589,0.294676672101099,0.952820221034205,1,51,regulation of protein import,BP,APOD
13395,GO:0050678,0.294709941606712,0.87791721845356,3,277,regulation of epithelial cell proliferation,BP,CAV2;EGFR;GJA1
2397,GO:0005044,0.294956397852849,0.952759173305823,1,49,scavenger receptor activity,MF,ENPP2
7495,GO:0030802,0.295959322120712,0.952280238486902,1,58,regulation of cyclic nucleotide biosynthetic process,BP,NOS2
2519,GO:0005272,0.29598928032582,0.95252934664652,1,43,sodium channel activity,MF,SCN9A
20621,GO:1905330,0.297461091472668,0.904073459202558,2,171,regulation of morphogenesis of an epithelium,BP,CTHRC1;GPC6
9966,GO:0035794,0.297687135456251,0.951672696632106,1,59,positive regulation of mitochondrial membrane permeability,BP,EYA2
4059,GO:0008375,0.298139399532232,0.951600175276897,1,53,acetylglucosaminyltransferase activity,MF,MGAT5B
13493,GO:0050807,0.298198337452706,0.903776071933786,2,148,regulation of synapse organization,BP,GRID2;SLITRK2
7319,GO:0030335,0.298755220319887,0.856816913695235,4,409,positive regulation of cell migration,BP,GPNMB;ENPP2;EGFR;DMTN
363,GO:0000978,0.298842922458549,0.856767428758046,4,401,RNA polymerase II proximal promoter sequence-specific DNA binding,MF,SOX10;TOX3;AHR;OTX1
10280,GO:0036465,0.299110345300488,0.951350470907186,1,48,synaptic vesicle recycling,BP,PACSIN1
20772,GO:1905710,0.299261422009073,0.951114533990093,1,60,positive regulation of membrane permeability,BP,EYA2
16165,GO:0071214,0.299263567780227,0.875048652978987,3,288,cellular response to abiotic stimulus,BP,MAG;EGFR;GJA1
18381,GO:0104004,0.299263567780227,0.875048652978987,3,288,cellular response to environmental stimulus,BP,MAG;EGFR;GJA1
11551,GO:0044272,0.299299635680728,0.903099347354214,2,167,sulfur compound biosynthetic process,BP,GSTM1;ACAN
3470,GO:0006879,0.29950310503211,0.951069124269742,1,57,cellular iron ion homeostasis,BP,LTF
12018,GO:0045454,0.299646955557263,0.950945291456493,1,63,cell redox homeostasis,BP,NOS2
2906,GO:0006022,0.299933203083764,0.902799181837803,2,157,aminoglycan metabolic process,BP,ACAN;GPC6
13272,GO:0048878,0.300062625841594,0.817490010144179,8,961,chemical homeostasis,BP,LTF;SLC30A3;GJB6;GPR17;EGFR;GJA1;CCK;FPR3
16357,GO:0071496,0.300093365848047,0.874521337322691,3,291,cellular response to external stimulus,BP,MAG;EGFR;GJA1
11895,GO:0045171,0.30011365925184,0.950899620885777,1,54,intercellular bridge,CC,GSTM1
2747,GO:0005768,0.300243248141033,0.823995987483781,7,810,endosome,CC,SLC30A3;PACSIN1;ST8SIA2;EGFR;GJA1;HLA-DRB1;HLA-DRB5
19122,GO:1902041,0.300410053914008,0.950781322696941,1,55,regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,DAPK1
18833,GO:1901222,0.300609331518777,0.950711746648821,1,55,regulation of NIK/NF-kappaB signaling,BP,EGFR
4054,GO:0008360,0.300651812034176,0.902424446358965,2,154,regulation of cell shape,BP,BVES;DMTN
3465,GO:0006873,0.30149768387792,0.841455651031558,5,558,cellular ion homeostasis,BP,LTF;SLC30A3;GPR17;GJA1;FPR3
3871,GO:0008064,0.302253989372958,0.901504072864016,2,166,regulation of actin polymerization or depolymerization,BP,SCIN;DMTN
18814,GO:1901185,0.302754990965267,0.949990004619932,1,53,negative regulation of ERBB signaling pathway,BP,EGFR
4582,GO:0009746,0.30315175794692,0.901015757369094,2,166,response to hexose,BP,GJB6;GJA1
2277,GO:0004857,0.303234611632322,0.872497924092266,3,314,enzyme inhibitor activity,MF,LTF;SPOCK1;COL28A1
4715,GO:0010256,0.303601398175445,0.853533548308696,4,391,endomembrane system organization,BP,FA2H;CAV2;PACSIN1;MYRF
4039,GO:0008333,0.304057620409711,0.949546658731748,1,52,endosome to lysosome transport,BP,CACNG4
6212,GO:0017112,0.304186439736697,0.949518230345926,1,51,Rab guanyl-nucleotide exchange factor activity,MF,RIN1
7156,GO:0030120,0.304513968761604,0.949352561725914,1,54,vesicle coat,CC,EGFR
11651,GO:0044445,0.30455916560251,0.900066985388174,2,227,cytosolic part,CC,AHR;APOD
5604,GO:0015893,0.304762604260586,0.900102120508901,2,175,drug transport,BP,SLC17A7;GJA1
19946,GO:1903902,0.304858752264306,0.949214802297417,1,55,positive regulation of viral life cycle,BP,CAV2
13590,GO:0050953,0.30488762912447,0.900064430865912,2,167,sensory perception of light stimulus,BP,USH1C;ZIC2
4671,GO:0010038,0.305131660882036,0.871312305932075,3,304,response to metal ion,BP,SLC30A3;EGFR;DMTN
1604,GO:0003690,0.305592199153349,0.819918483443974,7,793,double-stranded DNA binding,MF,ARX;SOX10;TOX3;AHR;OTX1;EGFR;DMRT2
12119,GO:0045670,0.306391846336281,0.948716907883365,1,52,regulation of osteoclast differentiation,BP,LTF
5805,GO:0016310,0.306791422578236,0.783342249295493,16,2076,phosphorylation,BP,CRLF1;LTF;FGFR3;CAMK2A;CAV2;PRKCG;GPNMB;ENPP2;EGFR;GFRA1;DMTN;PHKG1;KNDC1;CCK;DAPK1;MBP
13658,GO:0051057,0.30808509438899,0.948110183386977,1,52,positive regulation of small GTPase mediated signal transduction,BP,GPR17
19531,GO:1903051,0.308431077106651,0.947921465417667,1,56,negative regulation of proteolysis involved in cellular protein catabolic process,BP,PRKCG
82,GO:0000165,0.308720362036654,0.817501356115474,7,824,MAPK cascade,BP,FGFR3;CAMK2A;CAV2;GPNMB;EGFR;GFRA1;MBP
6776,GO:0021543,0.308827447905033,0.897956932459067,2,154,pallium development,BP,ARX;EGFR
7522,GO:0030832,0.308938336228872,0.897837924619691,2,167,regulation of actin filament length,BP,SCIN;DMTN
1633,GO:0003779,0.309012469639977,0.849825986597746,4,380,actin binding,MF,USH1C;SCIN;EGFR;DMTN
749,GO:0001932,0.309013523004426,0.800042088569779,10,1227,regulation of protein phosphorylation,BP,CRLF1;LTF;FGFR3;CAV2;GPNMB;ENPP2;EGFR;DMTN;KNDC1;CCK
8148,GO:0032024,0.309038056022512,0.947659814011987,1,59,positive regulation of insulin secretion,BP,GJA1
13481,GO:0050792,0.30907699135859,0.897719014466948,2,178,regulation of viral process,BP,LTF;CAV2
7051,GO:0022824,0.309289083851447,0.94769403362322,1,51,transmitter-gated ion channel activity,MF,GRID2
7055,GO:0022835,0.309289083851447,0.94769403362322,1,51,transmitter-gated channel activity,MF,GRID2
4864,GO:0010657,0.309313966863163,0.947617967335794,1,55,muscle cell apoptotic process,BP,CAMK2A
12878,GO:0048008,0.310050521003068,0.947476592801773,1,48,platelet-derived growth factor receptor signaling pathway,BP,APOD
4661,GO:0010008,0.310327070726707,0.848856154255258,4,425,endosome membrane,CC,SLC30A3;EGFR;HLA-DRB1;HLA-DRB5
1489,GO:0003229,0.310369277578658,0.947321705351444,1,50,ventricular cardiac muscle tissue development,BP,DSG2
5949,GO:0016597,0.310548538112088,0.947140247446944,1,57,amino acid binding,MF,NOS2
10494,GO:0040012,0.311087637472038,0.815688458358537,7,802,regulation of locomotion,BP,CAV2;BVES;GPNMB;ENPP2;EGFR;DMTN;APOD
21224,GO:2000147,0.311322993488626,0.848171681045334,4,420,positive regulation of cell motility,BP,GPNMB;ENPP2;EGFR;DMTN
15981,GO:0070838,0.312208218963197,0.847570908808816,4,409,divalent metal ion transport,BP,CAMK2A;CACNG4;SLC30A3;GJA1
16167,GO:0071216,0.312638848803706,0.89574140570736,2,178,cellular response to biotic stimulus,BP,NOS2;LTF
13627,GO:0051020,0.312911404187332,0.822683824778126,6,622,GTPase binding,MF,FGFR3;CAMK2A;EGFR;GFRA1;KNDC1;RIN1
16993,GO:0072665,0.313028943209858,0.94628108931457,1,54,protein localization to vacuole,BP,CACNG4
8539,GO:0032637,0.313135123137148,0.946139753885243,1,61,interleukin-8 production,BP,NOS2
16277,GO:0071385,0.313213283533805,0.946166465800119,1,57,cellular response to glucocorticoid stimulus,BP,EGFR
13758,GO:0051216,0.313393515865194,0.895376101077835,2,164,cartilage development,BP,SCIN;FGFR3
9174,GO:0034097,0.314160641910975,0.806427411529855,8,1030,response to cytokine,BP,CRLF1;NOS2;CAMK2A;GPR17;MX2;HLA-DRB1;DAPK1;HLA-DRB5
12634,GO:0046794,0.314269372421213,0.945792931315857,1,56,transport of virus,BP,CAV2
12516,GO:0046530,0.31486656324344,0.945639383620534,1,52,photoreceptor cell differentiation,BP,USH1C
13205,GO:0048747,0.315024215412408,0.945599555914472,1,51,muscle fiber development,BP,CAV2
9273,GO:0034284,0.315493689168967,0.894170935507584,2,171,response to monosaccharide,BP,GJB6;GJA1
1196,GO:0002684,0.315520904828707,0.812222035740635,7,882,positive regulation of immune system process,BP,SCIN;LTF;EFNB3;MOG;FPR3;HLA-DRB1;HLA-DRB5
3677,GO:0007219,0.315773880178763,0.894017633587845,2,170,Notch signaling pathway,BP,EGFR;SUSD5
956,GO:0002260,0.315935609905839,0.9451181409095,1,60,lymphocyte homeostasis,BP,LMO1
14755,GO:0060420,0.316115906989389,0.945159202643499,1,53,regulation of heart growth,BP,GJA1
16910,GO:0072511,0.316201719455037,0.844783039024579,4,412,divalent inorganic cation transport,BP,CAMK2A;CACNG4;SLC30A3;GJA1
12699,GO:0046928,0.316437495017253,0.945057644745178,1,52,regulation of neurotransmitter secretion,BP,CAMK2A
20164,GO:1904377,0.316660055622044,0.944957061074959,1,53,positive regulation of protein localization to cell periphery,BP,EGFR
8729,GO:0032922,0.316950831913939,0.944904760128686,1,50,circadian regulation of gene expression,BP,AHR
763,GO:0001947,0.316991131818711,0.944799989588766,1,55,heart looping,BP,GJA1
19011,GO:1901698,0.318061519128353,0.80336886177877,8,957,response to nitrogen compound,BP,CAMK2A;CAV2;AHR;PRKCG;GSTM1;EGFR;GJA1;DMTN
17101,GO:0086010,0.318199973457006,0.944549647188478,1,45,membrane depolarization during action potential,BP,SCN9A
7116,GO:0030032,0.31885102304493,0.944138845868161,1,53,lamellipodium assembly,BP,DMTN
3428,GO:0006809,0.31901098966408,0.943997525610891,1,58,nitric oxide biosynthetic process,BP,NOS2
13494,GO:0050808,0.319645136395132,0.862052992420365,3,263,synapse organization,BP,GRID2;CNTN2;SLITRK2
13771,GO:0051235,0.319677694850335,0.861977830816421,3,286,maintenance of location,BP,SCIN;SLC17A7;SLC30A3
9191,GO:0034121,0.319763051553301,0.943729710038681,1,57,regulation of toll-like receptor signaling pathway,BP,LTF
10371,GO:0038083,0.320260015801212,0.943627286773898,1,52,peptidyl-tyrosine autophosphorylation,BP,EGFR
369,GO:0000987,0.320877345806299,0.841498074364247,4,414,proximal promoter sequence-specific DNA binding,MF,SOX10;TOX3;AHR;OTX1
11176,GO:0043297,0.321256871062362,0.943181171962724,1,56,apical junction assembly,BP,GJA1
1368,GO:0003006,0.321663660757013,0.826770554435965,5,554,developmental process involved in reproduction,BP,CHD5;EGFR;GJA1;GJB1;DMRT2
11023,GO:0043044,0.32182932670916,0.942876201593697,1,62,ATP-dependent chromatin remodeling,BP,CHD5
2630,GO:0005548,0.322377450863513,0.942825881577626,1,52,phospholipid transporter activity,MF,ATP10B
17917,GO:0098542,0.322623554371704,0.859954524524411,3,337,defense response to other organism,BP,NOS2;LTF;MX2
4544,GO:0009611,0.322823675667738,0.825905865728924,5,562,response to wounding,BP,PRKCG;EGFR;GJA1;DMTN;APOD
18496,GO:0140056,0.32411256968582,0.889285704453065,2,170,organelle localization by membrane tethering,BP,CAV2;BVES
13659,GO:0051058,0.324224509628441,0.942121502569495,1,52,negative regulation of small GTPase mediated signal transduction,BP,TRIM67
11654,GO:0044448,0.324354392940633,0.889206706964143,2,157,cell cortex part,CC,NOS2;DMTN
7838,GO:0031397,0.324466884471852,0.941882046860355,1,61,negative regulation of protein ubiquitination,BP,PRKCG
17001,GO:0072676,0.324666721373713,0.94170699104388,1,69,lymphocyte migration,BP,APOD
3740,GO:0007369,0.324965569033857,0.888822716428376,2,164,gastrulation,BP,EYA2;MBP
13160,GO:0048678,0.325521224043973,0.941462687263558,1,62,response to axon injury,BP,APOD
11267,GO:0043462,0.325575539512654,0.941345887340508,1,70,regulation of ATPase activity,BP,LTF
11370,GO:0043624,0.325718902063442,0.888257766406214,2,199,cellular protein complex disassembly,BP,SCIN;DMTN
10003,GO:0035869,0.326131858236999,0.941285042765759,1,58,ciliary transition zone,CC,USH1C
2751,GO:0005773,0.326329614123154,0.812410907672277,6,715,vacuole,CC,SLC30A3;GJA1;ACAN;GPC6;HLA-DRB1;HLA-DRB5
7948,GO:0031594,0.326412768293568,0.941243325301969,1,54,neuromuscular junction,CC,SPOCK1
16276,GO:0071384,0.326663379891742,0.941035212629212,1,61,cellular response to corticosteroid stimulus,BP,EGFR
361,GO:0000976,0.32686799378391,0.812020304131051,6,679,transcription regulatory region sequence-specific DNA binding,MF,ARX;SOX10;TOX3;AHR;OTX1;DMRT2
97,GO:0000186,0.32698803423689,0.941039314284655,1,53,activation of MAPKK activity,BP,EGFR
4628,GO:0009898,0.327157569102461,0.887534074561602,2,170,cytoplasmic side of plasma membrane,CC,CAV2;RGS6
15752,GO:0070382,0.327898776598808,0.887065164910713,2,180,exocytic vesicle,CC,SLC17A7;SLC30A3
13463,GO:0050769,0.32795824147712,0.836494084702149,4,404,positive regulation of neurogenesis,BP,SOX10;MAG;TRIM67;PACSIN1
13799,GO:0051272,0.328412636542117,0.836134522027906,4,431,positive regulation of cellular component movement,BP,GPNMB;ENPP2;EGFR;DMTN
15134,GO:0061045,0.329159331582401,0.940078890816071,1,60,negative regulation of wound healing,BP,GJA1
15273,GO:0061371,0.330387694242257,0.9396286292506,1,58,determination of heart left/right asymmetry,BP,GJA1
19119,GO:1902036,0.330864837442693,0.939195251213296,1,79,regulation of hematopoietic stem cell differentiation,BP,LMO1
10856,GO:0042698,0.330871807794068,0.939407657860794,1,60,ovulation cycle,BP,EGFR
11479,GO:0044087,0.330996939914814,0.800144195258827,7,806,regulation of cellular component biogenesis,BP,SCIN;GRID2;GJA1;DMTN;SLITRK2;CCK;APOD
3752,GO:0007405,0.331503207052622,0.93927778306604,1,53,neuroblast proliferation,BP,SOX10
13198,GO:0048736,0.331728216605865,0.884908166922714,2,164,appendage development,BP,GJA1;SMOC1
14579,GO:0060173,0.331728216605865,0.884908166922714,2,164,limb development,BP,GJA1;SMOC1
14156,GO:0051952,0.332250730759234,0.938807637072714,1,64,regulation of amine transport,BP,CCK
15125,GO:0061035,0.332624896071079,0.938780654262719,1,56,regulation of cartilage development,BP,SCIN
14122,GO:0051896,0.332969122605654,0.884138545901446,2,174,regulation of protein kinase B signaling,BP,FGFR3;EGFR
9582,GO:0035064,0.332990011180545,0.938636181237996,1,56,methylated histone binding,MF,CHD5
18488,GO:0140034,0.332990011180545,0.938636181237996,1,56,methylation-dependent protein binding,MF,CHD5
6682,GO:0019882,0.333186253644417,0.883898024466347,2,206,antigen processing and presentation,BP,HLA-DRB1;HLA-DRB5
4647,GO:0009967,0.333488636248439,0.775686654682689,11,1422,positive regulation of signal transduction,BP,CRLF1;LTF;FGFR3;CAV2;CHD5;GPNMB;GPR17;EGFR;GJA1;DMTN;CNTN2
12388,GO:0046209,0.334099557816308,0.938115798331601,1,61,nitric oxide metabolic process,BP,NOS2
12652,GO:0046847,0.334425837811225,0.938102420209405,1,54,filopodium assembly,BP,DMTN
8119,GO:0031968,0.334894725658301,0.882980345156719,2,181,organelle outer membrane,CC,SOX10;GJA1
8744,GO:0032945,0.335786894138293,0.937399533487301,1,64,negative regulation of mononuclear cell proliferation,BP,GPNMB
13390,GO:0050672,0.335786894138293,0.937399533487301,1,64,negative regulation of lymphocyte proliferation,BP,GPNMB
5800,GO:0016301,0.336341165369243,0.795922300840035,7,784,kinase activity,MF,FGFR3;CAMK2A;EFNB3;PRKCG;EGFR;PHKG1;DAPK1
8613,GO:0032755,0.336502443846535,0.937112348830263,1,64,positive regulation of interleukin-6 production,BP,MBP
2628,GO:0005546,0.337023615513865,0.936960703095083,1,60,phosphatidylinositol-4,5-bisphosphate binding,MF,SCIN
586,GO:0001701,0.337299397887329,0.850263178991057,3,293,in utero embryonic development,BP,SOX10;EGFR;GJA1
16684,GO:0072091,0.337932302518418,0.936643630972696,1,57,regulation of stem cell proliferation,BP,SOX10
14699,GO:0060348,0.338029982300157,0.881189679447845,2,167,bone development,BP,LTF;FGFR3
11714,GO:0044706,0.338383954047647,0.88090810858566,2,184,multi-multicellular organism process,BP,DSG2;GJA1
5612,GO:0015914,0.338629227323261,0.936345138660211,1,58,phospholipid transport,BP,ATP10B
7046,GO:0022626,0.338864631867759,0.935773594158064,1,114,cytosolic ribosome,CC,APOD
18038,GO:0098802,0.339275571602536,0.880419548908848,2,174,plasma membrane receptor complex,CC,CACNG4;GRID2
13770,GO:0051234,0.340509773577363,0.734800800341895,32,4516,establishment of localization,BP,SCIN;NOS2;LTF;EYA2;CAMK2A;CACNG4;SLC17A7;ICAM5;CAV2;SLC38A1;BVES;SLC30A3;ATP10B;PACSIN1;PRKCG;ENPP2;EGFR;GRID2;GJA1;KCNJ6;SNX22;DMTN;KCNJ4;SCN9A;GJB1;RIN1;MX2;CNTN2;CCK;APOD;DAPK1;MBP
2853,GO:0005938,0.341106527599244,0.847715332135687,3,280,cell cortex,CC,SCIN;NOS2;DMTN
6677,GO:0019867,0.341524407887602,0.879042948878849,2,183,outer membrane,CC,SOX10;GJA1
7204,GO:0030178,0.341820195528464,0.878828936765724,2,193,negative regulation of Wnt signaling pathway,BP,SOX10;CTHRC1
2405,GO:0005057,0.342192057564879,0.878737329118408,2,162,signal transducer activity, downstream of receptor,MF,FGFR3;EGFR
12478,GO:0046470,0.34262559747389,0.934546655241582,1,70,phosphatidylcholine metabolic process,BP,ENPP2
8278,GO:0032268,0.343087335315508,0.750101145160917,17,2288,regulation of cellular protein metabolic process,BP,CRLF1;LTF;FGFR3;CAV2;TRIM67;PRKCG;GPNMB;ENPP2;EGFR;SPOCK1;DMTN;KNDC1;CNTN2;CCK;DAPK1;MBP;COL28A1
16852,GO:0072347,0.343197485734044,0.934388369947947,1,64,response to anesthetic,BP,PRKCG
13651,GO:0051050,0.343826412330178,0.789910061157017,7,856,positive regulation of transport,BP,SCIN;CAMK2A;SLC30A3;EGFR;GJA1;CCK;MBP
10875,GO:0042733,0.344090593465955,0.934080352880056,1,60,embryonic digit morphogenesis,BP,GJA1
7078,GO:0023014,0.34417158869226,0.789635254025198,7,852,signal transduction by protein phosphorylation,BP,FGFR3;CAMK2A;CAV2;GPNMB;EGFR;GFRA1;MBP
16205,GO:0071277,0.344274964386882,0.934020614042722,1,59,cellular response to calcium ion,BP,DMTN
12197,GO:0045833,0.344762994704482,0.933714181591753,1,66,negative regulation of lipid metabolic process,BP,APOD
10350,GO:0038034,0.345167042069178,0.933533436429489,1,67,signal transduction in absence of ligand,BP,EYA2
17636,GO:0097192,0.345167042069178,0.933533436429489,1,67,extrinsic apoptotic signaling pathway in absence of ligand,BP,EYA2
7020,GO:0022406,0.346080973594875,0.876323308083915,2,179,membrane docking,BP,CAV2;BVES
2609,GO:0005518,0.346362485376569,0.933172274435678,1,58,collagen binding,MF,ABI3BP
5673,GO:0016049,0.346583467889969,0.822982158553471,4,437,cell growth,BP,MAG;EGFR;SPOCK1;GJA1
870,GO:0002088,0.346621771478259,0.933047135859639,1,59,lens development in camera-type eye,BP,GJA1
5238,GO:0014855,0.346891374828412,0.932934770960158,1,59,striated muscle cell proliferation,BP,GJA1
13458,GO:0050764,0.346921816886408,0.932789846630981,1,68,regulation of phagocytosis,BP,PRKCG
21738,GO:2001057,0.3473885539189,0.93264900048185,1,64,reactive nitrogen species metabolic process,BP,NOS2
10557,GO:0042100,0.348154773557911,0.932273596734248,1,68,B cell proliferation,BP,AHR
16014,GO:0070887,0.348220690553345,0.740132858139711,20,2789,cellular response to chemical stimulus,BP,CRLF1;NOS2;LTF;FGFR3;CAMK2A;SOX10;CAV2;AHR;GJB6;GSTM1;FBN3;GPR17;EGFR;GJA1;DMTN;MX2;FPR3;HLA-DRB1;DAPK1;HLA-DRB5
21812,GO:2001234,0.349096034858464,0.874428108161867,2,197,negative regulation of apoptotic signaling pathway,BP,EYA2;DAPK1
11435,GO:0043967,0.349561728594328,0.931766821613095,1,62,histone H4 acetylation,BP,CHD5
15909,GO:0070664,0.350237997835166,0.931396106052159,1,68,negative regulation of leukocyte proliferation,BP,GPNMB
1428,GO:0003143,0.350956246679231,0.931193795560716,1,61,embryonic heart tube morphogenesis,BP,GJA1
591,GO:0001707,0.351095340882925,0.931118941238073,1,62,mesoderm formation,BP,EYA2
7113,GO:0030029,0.351419851519756,0.79287527725717,6,674,actin filament-based process,BP,USH1C;SCIN;DSG2;PACSIN1;GJA1;DMTN
14689,GO:0060337,0.351643733130293,0.930762667629056,1,71,type I interferon signaling pathway,BP,MX2
16258,GO:0071357,0.351643733130293,0.930762667629056,1,71,cellular response to type I interferon,BP,MX2
11414,GO:0043900,0.352568721016983,0.839723900757101,3,339,regulation of multi-organism process,BP,NOS2;LTF;CAV2
7140,GO:0030073,0.352569295157579,0.872361433718587,2,183,insulin secretion,BP,NOS2;GJA1
19945,GO:1903901,0.352666949998929,0.930351701703957,1,69,negative regulation of viral life cycle,BP,LTF
12208,GO:0045844,0.353126992194892,0.930287984001601,1,60,positive regulation of striated muscle tissue development,BP,GJA1
13132,GO:0048636,0.353126992194892,0.930287984001601,1,60,positive regulation of muscle organ development,BP,GJA1
12282,GO:0045981,0.353138192939829,0.930113675959767,1,72,positive regulation of nucleotide metabolic process,BP,NOS2
18732,GO:1900544,0.353138192939829,0.930113675959767,1,72,positive regulation of purine nucleotide metabolic process,BP,NOS2
11959,GO:0045296,0.353474359567976,0.839151698653021,3,309,cadherin binding,MF,CDH19;PPL;EGFR
11170,GO:0043281,0.354103908288715,0.87134192212381,2,204,regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,CCK;DAPK1
4712,GO:0010243,0.354175097719005,0.781565806084421,7,855,response to organonitrogen compound,BP,CAMK2A;CAV2;AHR;PRKCG;EGFR;GJA1;DMTN
3923,GO:0008154,0.354606837664474,0.871094166665019,2,187,actin polymerization or depolymerization,BP,SCIN;DMTN
8740,GO:0032940,0.355292523391672,0.761804177745515,10,1322,secretion by cell,BP,SCIN;NOS2;LTF;CAMK2A;SLC17A7;EGFR;GJA1;DMTN;CCK;MBP
19667,GO:1903363,0.355929534955016,0.928978698763344,1,67,negative regulation of cellular protein catabolic process,BP,PRKCG
16180,GO:0071230,0.35611361959417,0.928990357551073,1,61,cellular response to amino acid stimulus,BP,EGFR
14387,GO:0055013,0.356244972101187,0.928986381765631,1,58,cardiac muscle cell development,BP,BVES
11040,GO:0043085,0.356358809083863,0.760916451307163,10,1274,positive regulation of catalytic activity,BP,NOS2;LTF;FGFR3;CAV2;EGFR;RIN1;RGS6;CCK;DAPK1;MBP
19530,GO:1903050,0.356419930853832,0.869964162512685,2,190,regulation of proteolysis involved in cellular protein catabolic process,BP,TRIM67;PRKCG
11417,GO:0043903,0.356484022230201,0.869884350195279,2,201,regulation of symbiosis, encompassing mutualism through parasitism,BP,LTF;CAV2
16259,GO:0071359,0.356522589051431,0.928797444687455,1,62,cellular response to dsRNA,BP,EGFR
150,GO:0000302,0.356780277154864,0.869684248802592,2,206,response to reactive oxygen species,BP,EGFR;APOD
2748,GO:0005769,0.356820369856515,0.836823874585907,3,307,early endosome,CC,ST8SIA2;EGFR;GJA1
4308,GO:0009064,0.357336912604073,0.928343025341601,1,69,glutamine family amino acid metabolic process,BP,NOS2
732,GO:0001909,0.35750999527792,0.928184510610942,1,76,leukocyte mediated cytotoxicity,BP,NOS2
17976,GO:0098660,0.357788445251805,0.787787793831714,6,710,inorganic ion transmembrane transport,BP,CACNG4;SLC17A7;SLC30A3;KCNJ6;KCNJ4;SCN9A
14853,GO:0060562,0.358201739834362,0.835874649736793,3,299,epithelial tube morphogenesis,BP,GJA1;CTHRC1;IRX2
7685,GO:0031100,0.35845921420431,0.927842305213747,1,70,animal organ regeneration,BP,EGFR
9088,GO:0033692,0.358680230804097,0.927878652488953,1,61,cellular polysaccharide biosynthetic process,BP,PHKG1
7211,GO:0030193,0.358714555764074,0.927744082155032,1,69,regulation of blood coagulation,BP,DMTN
18569,GO:1900046,0.358714555764074,0.927744082155032,1,69,regulation of hemostasis,BP,DMTN
19058,GO:1901863,0.358766447399518,0.927841133071902,1,61,positive regulation of muscle tissue development,BP,GJA1
5568,GO:0015837,0.358919409368204,0.927629055014694,1,71,amine transport,BP,CCK
139,GO:0000287,0.359912878426232,0.867816963424842,2,185,magnesium ion binding,MF,EYA2;ATP10B
56,GO:0000118,0.360217235009756,0.927225415291478,1,60,histone deacetylase complex,CC,CHD5
3527,GO:0006970,0.361010420076218,0.926781423865293,1,66,response to osmotic stress,BP,EGFR
19651,GO:1903321,0.362305657672971,0.926155794280645,1,70,negative regulation of protein modification by small protein conjugation or removal,BP,PRKCG
7750,GO:0031253,0.362481282598824,0.8328716654201,3,296,cell projection membrane,CC,BVES;PACSIN1;DMTN
13017,GO:0048332,0.362587601922024,0.926117356505515,1,64,mesoderm morphogenesis,BP,EYA2
7286,GO:0030295,0.362616239701608,0.926045626250626,1,68,protein kinase activator activity,MF,LTF
486,GO:0001523,0.362701105263999,0.925981111201092,1,70,retinoid metabolic process,BP,GPC6
11648,GO:0044440,0.363447274161853,0.81042055066964,4,461,endosomal part,CC,SLC30A3;EGFR;HLA-DRB1;HLA-DRB5
16529,GO:0071804,0.363601048817285,0.865518803667567,2,183,cellular potassium ion transport,BP,KCNJ6;KCNJ4
16530,GO:0071805,0.363601048817285,0.865518803667567,2,183,potassium ion transmembrane transport,BP,KCNJ6;KCNJ4
4574,GO:0009725,0.363947234762391,0.773585836959284,7,876,response to hormone,BP,NOS2;DSG2;CAMK2A;SOX10;CAV2;EGFR;GJA1
2775,GO:0005802,0.364082663197083,0.865191266255653,2,189,trans-Golgi network,CC,HLA-DRB1;HLA-DRB5
13790,GO:0051259,0.364119280131163,0.809905041920453,4,469,protein complex oligomerization,BP,CAV2;GJA1;GJB1;CCK
2820,GO:0005882,0.364151817397293,0.925379664772895,1,67,intermediate filament,CC,GJA1
19856,GO:1903725,0.364232508409907,0.925358492869948,1,66,regulation of phospholipid metabolic process,BP,FGFR3
11732,GO:0044766,0.364377991455649,0.925251114352876,1,69,multi-organism transport,BP,CAV2
19333,GO:1902579,0.364377991455649,0.925251114352876,1,69,multi-organism localization,BP,CAV2
21057,GO:1990748,0.365515122520798,0.924557621059654,1,86,cellular detoxification,BP,GSTM1
3836,GO:0007626,0.365892118525312,0.864103261177434,2,177,locomotory behavior,BP,EFNB3;CNTN2
10853,GO:0042692,0.366085818399809,0.830296141011814,3,306,muscle cell differentiation,BP,CAV2;BVES;SGCD
4824,GO:0010605,0.366165829054413,0.729816848596816,17,2346,negative regulation of macromolecule metabolic process,BP,ARX;NOS2;LTF;ZIC2;SOX10;AHR;PRKCG;EGFR;SPOCK1;GJA1;DMTN;LMO1;IRX2;PRAME;APOD;DAPK1;COL28A1
4580,GO:0009743,0.366377476440953,0.863732784581777,2,192,response to carbohydrate,BP,GJB6;GJA1
13472,GO:0050778,0.366401259320296,0.79260865344361,5,631,positive regulation of immune response,BP,LTF;MOG;FPR3;HLA-DRB1;HLA-DRB5
6694,GO:0019900,0.36661141064581,0.780719467766329,6,695,kinase binding,MF,FGFR3;DCX;MAG;CAV2;EGFR;GJA1
8281,GO:0032271,0.366858518619786,0.863424692198231,2,193,regulation of protein polymerization,BP,SCIN;DMTN
7235,GO:0030219,0.367479836145364,0.923850993972539,1,70,megakaryocyte differentiation,BP,SCIN
5978,GO:0016651,0.36787476841409,0.923410632207976,1,97,oxidoreductase activity, acting on NAD(P)H,MF,NOS2
9492,GO:0034704,0.367996700843121,0.923794746939157,1,59,calcium channel complex,CC,CACNG4
21207,GO:2000113,0.368709952868312,0.750417705112895,10,1278,negative regulation of cellular macromolecule biosynthetic process,BP,ARX;ZIC2;SOX10;AHR;EGFR;GJA1;LMO1;IRX2;PRAME;DAPK1
11096,GO:0043178,0.369073090923763,0.923146671863529,1,69,alcohol binding,MF,APOD
18926,GO:1901532,0.369174114489137,0.922892790989005,1,88,regulation of hematopoietic progenitor cell differentiation,BP,LMO1
11106,GO:0043195,0.370005149619879,0.92275374188287,1,67,terminal bouton,CC,CCK
9291,GO:0034340,0.370325007641946,0.922502077417072,1,75,response to type I interferon,BP,MX2
17926,GO:0098562,0.370676014489129,0.861007248889358,2,191,cytoplasmic side of membrane,CC,CAV2;RGS6
448,GO:0001190,0.372221462774716,0.921792830219435,1,64,transcriptional activator activity, RNA polymerase II transcription factor binding,MF,SOX10
5135,GO:0014032,0.372299835673334,0.921694830536014,1,68,neural crest cell development,BP,SOX10
21094,GO:1990837,0.373002636255302,0.775531003063075,6,715,sequence-specific double-stranded DNA binding,MF,ARX;SOX10;TOX3;AHR;OTX1;DMRT2
615,GO:0001750,0.373033806920134,0.921389363541335,1,66,photoreceptor outer segment,CC,USH1C
290,GO:0000792,0.37348786251591,0.921150950378987,1,68,heterochromatin,CC,CHD5
14606,GO:0060218,0.373609421507115,0.920858803946443,1,89,hematopoietic stem cell differentiation,BP,LMO1
13501,GO:0050818,0.373999426654109,0.920847289908362,1,73,regulation of coagulation,BP,DMTN
11632,GO:0044419,0.374260457956799,0.774451537514883,6,809,interspecies interaction between organisms,BP,NOS2;LTF;CAV2;EFNB3;MOG;EGFR
12091,GO:0045638,0.375301526207156,0.920247112924545,1,73,negative regulation of myeloid cell differentiation,BP,LTF
11522,GO:0044215,0.375761461432562,0.920074932524265,1,70,other organism,CC,LTF
11523,GO:0044216,0.375761461432562,0.920074932524265,1,70,other organism cell,CC,LTF
11524,GO:0044217,0.375761461432562,0.920074932524265,1,70,other organism part,CC,LTF
14396,GO:0055024,0.375995880282606,0.920026228095109,1,66,regulation of cardiac muscle tissue development,BP,GJA1
5606,GO:0015908,0.376229045193467,0.919844613400665,1,71,fatty acid transport,BP,NOS2
13836,GO:0051341,0.377353893952878,0.919246234380396,1,77,regulation of oxidoreductase activity,BP,EGFR
7385,GO:0030512,0.378671041890659,0.918783208042634,1,66,negative regulation of transforming growth factor beta receptor signaling pathway,BP,CAV2
21076,GO:1990782,0.379160601318604,0.918538637601428,1,67,protein tyrosine kinase binding,MF,GJA1
13557,GO:0050900,0.379984172966804,0.820200611752176,3,357,leukocyte migration,BP,MAG;FPR3;APOD
2013,GO:0004497,0.380542415123539,0.917778469942423,1,75,monooxygenase activity,MF,NOS2
13391,GO:0050673,0.380707797554637,0.819737116916455,3,323,epithelial cell proliferation,BP,CAV2;EGFR;GJA1
14390,GO:0055017,0.381314664957104,0.917527633781067,1,67,cardiac muscle tissue growth,BP,GJA1
14139,GO:0051924,0.381455806772069,0.85401571986632,2,199,regulation of calcium ion transport,BP,CAMK2A;GJA1
13183,GO:0048705,0.38157514941139,0.853965833872738,2,192,skeletal system morphogenesis,BP,LTF;FGFR3
13491,GO:0050805,0.381583136905694,0.917417174768891,1,66,negative regulation of synaptic transmission,BP,GRID2
1400,GO:0003073,0.381756663919502,0.917232060105586,1,73,regulation of systemic arterial blood pressure,BP,GJA1
3910,GO:0008134,0.381777424129264,0.780440508621726,5,593,transcription factor binding,MF,EYA2;SOX10;AHR;ENPP2;PRAME
14380,GO:0055006,0.382612989516672,0.916982382438166,1,63,cardiac cell development,BP,BVES
16676,GO:0072078,0.382711952559303,0.916852181775063,1,68,nephron tubule morphogenesis,BP,IRX2
4022,GO:0008306,0.383276874139173,0.916600234512315,1,67,associative learning,BP,NRGN
19521,GO:1903035,0.38426010981808,0.916058577920508,1,72,negative regulation of response to wounding,BP,GJA1
11042,GO:0043087,0.384693164762709,0.794211423443339,4,435,regulation of GTPase activity,BP,CAV2;BVES;RIN1;RGS6
4209,GO:0008625,0.385096227199882,0.915594700205435,1,77,extrinsic apoptotic signaling pathway via death domain receptors,BP,DAPK1
9577,GO:0035050,0.38533059749452,0.915591658085648,1,69,embryonic heart tube development,BP,GJA1
12090,GO:0045637,0.385360301902011,0.851450176472067,2,200,regulation of myeloid cell differentiation,BP,SCIN;LTF
4409,GO:0009190,0.385408420336144,0.915457818843601,1,76,cyclic nucleotide biosynthetic process,BP,NOS2
14281,GO:0052652,0.385408420336144,0.915457818843601,1,76,cyclic purine nucleotide metabolic process,BP,NOS2
19917,GO:1903845,0.385688397283956,0.915436111452518,1,68,negative regulation of cellular response to transforming growth factor beta stimulus,BP,CAV2
592,GO:0001708,0.38635171471739,0.915031828861054,1,74,cell fate specification,BP,EYA2
13144,GO:0048661,0.387148149935916,0.91467672762335,1,72,positive regulation of smooth muscle cell proliferation,BP,EGFR
3321,GO:0006650,0.388310782095515,0.814143340441503,3,331,glycerophospholipid metabolic process,BP,FGFR3;ENPP2;EGFR
14413,GO:0055072,0.388380463698084,0.914016722536397,1,77,iron ion homeostasis,BP,LTF
2875,GO:0005977,0.38906161276,0.913814058996844,1,68,glycogen metabolic process,BP,PHKG1
19012,GO:1901699,0.389484363080161,0.77424039619989,5,586,cellular response to nitrogen compound,BP,CAMK2A;CAV2;AHR;EGFR;DMTN
13261,GO:0048864,0.389529209974794,0.913527346348654,1,72,stem cell development,BP,SOX10
12092,GO:0045639,0.389804233930841,0.91336620649274,1,74,positive regulation of myeloid cell differentiation,BP,SCIN
12924,GO:0048145,0.390292965314493,0.913102478532062,1,76,regulation of fibroblast proliferation,BP,EGFR
6458,GO:0019209,0.3903921803893,0.913080639275377,1,74,kinase activator activity,MF,LTF
14445,GO:0055117,0.391091684549647,0.912813130938825,1,69,regulation of cardiac muscle contraction,BP,DSG2
7492,GO:0030799,0.391121733073602,0.912650001856373,1,80,regulation of cyclic nucleotide metabolic process,BP,NOS2
2744,GO:0005765,0.391330659644923,0.811897842323364,3,336,lysosomal membrane,CC,SLC30A3;HLA-DRB1;HLA-DRB5
18068,GO:0098852,0.391330659644923,0.811897842323364,3,336,lytic vacuole membrane,CC,SLC30A3;HLA-DRB1;HLA-DRB5
8855,GO:0033138,0.391419828648517,0.912553623805232,1,76,positive regulation of peptidyl-serine phosphorylation,BP,EGFR
2767,GO:0005791,0.391556883666197,0.912403880982929,1,83,rough endoplasmic reticulum,CC,LTF
18484,GO:0140029,0.391939471504532,0.912299829936534,1,76,exocytic process,BP,DMTN
2838,GO:0005905,0.391947579057017,0.912445073903561,1,66,clathrin-coated pit,CC,EGFR
16682,GO:0072088,0.391973883611497,0.912367414917221,1,70,nephron epithelium morphogenesis,BP,IRX2
4667,GO:0010033,0.392063243382166,0.700835672417879,20,2846,response to organic substance,BP,CRLF1;NOS2;LTF;DSG2;FGFR3;CAMK2A;SOX10;CAV2;AHR;GJB6;PRKCG;FBN3;GPR17;EGFR;GJA1;DMTN;MX2;HLA-DRB1;DAPK1;HLA-DRB5
2038,GO:0004527,0.392075833648987,0.912273643731518,1,73,exonuclease activity,MF,ENPP2
16968,GO:0072593,0.392215593975484,0.846844599112963,2,215,reactive oxygen species metabolic process,BP,NOS2;EGFR
4152,GO:0008514,0.392359575343183,0.846811875738807,2,198,organic anion transmembrane transporter activity,MF,SLC17A7;SLC38A1
5134,GO:0014031,0.392413270761034,0.912122868213755,1,72,mesenchymal cell development,BP,SOX10
12145,GO:0045732,0.393644188387476,0.845951562088385,2,198,positive regulation of protein catabolic process,BP,TRIM67;GJA1
2514,GO:0005254,0.39400152831985,0.911358438639303,1,71,chloride channel activity,MF,SLC17A7
133,GO:0000271,0.394162336246567,0.911310220444218,1,69,polysaccharide biosynthetic process,BP,PHKG1
2942,GO:0006073,0.394466723535565,0.911160403941967,1,69,cellular glucan metabolic process,BP,PHKG1
11469,GO:0044042,0.394466723535565,0.911160403941967,1,69,glucan metabolic process,BP,PHKG1
18544,GO:1900006,0.394608697048896,0.911158128986223,1,65,positive regulation of dendrite development,BP,PACSIN1
12923,GO:0048144,0.394897623837305,0.910833721638304,1,77,fibroblast proliferation,BP,EGFR
515,GO:0001568,0.395250581814328,0.769559361019233,5,583,blood vessel development,BP,AHR;GPNMB;ENPP2;GJA1;APOD
12257,GO:0045935,0.395579914450822,0.718212388807469,12,1589,positive regulation of nucleobase-containing compound metabolic process,BP,NOS2;ZIC2;EYA2;SOX10;TOX3;AHR;OTX1;MYRF;PRKCG;EGFR;LMO1;DMRT2
2596,GO:0005496,0.395683686125097,0.910445132405858,1,77,steroid binding,MF,APOD
5907,GO:0016528,0.396188824879565,0.910326245894349,1,68,sarcoplasm,CC,SPOCK1
5679,GO:0016055,0.396311518118903,0.785064907625942,4,471,Wnt signaling pathway,BP,CAMK2A;SOX10;CTHRC1;GPC6
21371,GO:2000379,0.396321557833989,0.910116329554934,1,78,positive regulation of reactive oxygen species metabolic process,BP,EGFR
8462,GO:0032507,0.396409387725598,0.91015447479685,1,72,maintenance of protein location in cell,BP,SCIN
14027,GO:0051707,0.396500493551345,0.768460704618832,5,679,response to other organism,BP,NOS2;LTF;GJB6;GJA1;MX2
11060,GO:0043122,0.396984158402467,0.843664432004359,2,208,regulation of I-kappaB kinase/NF-kappaB signaling,BP,LTF;GJA1
2836,GO:0005902,0.397174033381085,0.909774854082209,1,72,microvillus,CC,USH1C
18010,GO:0098754,0.397276850397902,0.909425135278459,1,100,detoxification,BP,GSTM1
7144,GO:0030099,0.398322881773699,0.806661968427249,3,344,myeloid cell differentiation,BP,SCIN;LTF;DMTN
11116,GO:0043207,0.398403967320234,0.766902714744596,5,681,response to external biotic stimulus,BP,NOS2;LTF;GJB6;GJA1;MX2
11477,GO:0044070,0.398469373680126,0.90911487014668,1,73,regulation of anion transport,BP,CCK
18944,GO:1901566,0.398478210296437,0.715604890175058,12,1757,organonitrogen compound biosynthetic process,BP,NOS2;FA2H;GSTM1;ST8SIA2;GALNT13;EGFR;ACAN;MGAT5B;UGT8;GALNT9;GPC6;DAPK1
11339,GO:0043565,0.398576373500131,0.736709292724882,8,1019,sequence-specific DNA binding,MF,ARX;SOX10;TOX3;AHR;OTX1;MYRF;IRX2;DMRT2
569,GO:0001669,0.398654059721443,0.908929935603338,1,80,acrosomal vesicle,CC,CAV2
11481,GO:0044089,0.399036262616687,0.782917947822707,4,464,positive regulation of cellular component biogenesis,BP,SCIN;GRID2;SLITRK2;CCK
3205,GO:0006508,0.399256333923376,0.719107778866535,11,1519,proteolysis,BP,LTF;TRIM67;MYRF;PRKCG;SPOCK1;ACAN;CNTN2;CCK;DAPK1;MBP;COL28A1
3838,GO:0007631,0.399273713210708,0.908596121173883,1,82,feeding behavior,BP,CCK
18540,GO:0198738,0.399284771047049,0.782709356296134,4,473,cell-cell signaling by wnt,BP,CAMK2A;SOX10;CTHRC1;GPC6
13081,GO:0048525,0.399640091079067,0.908436073685118,1,80,negative regulation of viral process,BP,LTF
19146,GO:1902106,0.399655520612,0.908479455136136,1,76,negative regulation of leukocyte differentiation,BP,LTF
3499,GO:0006919,0.400751787616537,0.90780923929015,1,86,activation of cysteine-type endopeptidase activity involved in apoptotic process,BP,CCK
15881,GO:0070603,0.401377888316157,0.907655716707186,1,73,SWI/SNF superfamily-type complex,CC,CHD5
16648,GO:0072028,0.401615742459584,0.907550703224304,1,72,nephron morphogenesis,BP,IRX2
14650,GO:0060291,0.402299256850515,0.907236800115873,1,70,long-term synaptic potentiation,BP,NRGN
15250,GO:0061333,0.402606968358532,0.907049916173287,1,72,renal tubule morphogenesis,BP,IRX2
634,GO:0001776,0.402805140747631,0.90683999833247,1,80,leukocyte homeostasis,BP,LMO1
3455,GO:0006855,0.403332037607947,0.906682567504463,1,72,drug transmembrane transport,BP,SLC17A7
3808,GO:0007589,0.403618885182793,0.90646554205245,1,77,body fluid secretion,BP,GJA1
13379,GO:0050660,0.404407927677201,0.90606414485161,1,77,flavin adenine dinucleotide binding,MF,NOS2
5136,GO:0014033,0.40469219565009,0.905946859485856,1,75,neural crest cell differentiation,BP,SOX10
10786,GO:0042562,0.405374942713396,0.905507544211766,1,82,hormone binding,MF,EGFR
21237,GO:2000177,0.40543186314811,0.905629434268622,1,71,regulation of neural precursor cell proliferation,BP,SOX10
568,GO:0001667,0.405625720710304,0.801168351157075,3,332,ameboidal-type cell migration,BP,SOX10;ENPP2;DMTN
11831,GO:0045069,0.406950885497101,0.904711845159548,1,81,regulation of viral genome replication,BP,LTF
39,GO:0000079,0.407057991636626,0.904632847061067,1,83,regulation of cyclin-dependent protein serine/threonine kinase activity,BP,EGFR
11245,GO:0043410,0.407453206661913,0.776181890312831,4,482,positive regulation of MAPK cascade,BP,FGFR3;CAV2;GPNMB;EGFR
10537,GO:0042058,0.407687745802701,0.904384560264942,1,77,regulation of epidermal growth factor receptor signaling pathway,BP,EGFR
18799,GO:1901135,0.407691610106524,0.72877518622509,8,1114,carbohydrate derivative metabolic process,BP,NOS2;ST8SIA2;GALNT13;ACAN;MGAT5B;UGT8;GALNT9;GPC6
4627,GO:0009897,0.40799096547699,0.836119271206502,2,214,external side of plasma membrane,CC,MOG;GFRA1
12491,GO:0046488,0.408224380671668,0.836008625725273,2,201,phosphatidylinositol metabolic process,BP,FGFR3;EGFR
8932,GO:0033273,0.409064168308024,0.903598028807797,1,83,response to vitamin,BP,EGFR
5642,GO:0015980,0.409244995764279,0.835154237061778,2,244,energy derivation by oxidation of organic compounds,BP,NOS2;PHKG1
6233,GO:0017148,0.410518933780529,0.834401418891708,2,205,negative regulation of translation,BP,EGFR;DAPK1
14754,GO:0060419,0.410733483147482,0.902851921430331,1,74,heart growth,BP,GJA1
15071,GO:0060964,0.410928224409601,0.902630479168573,1,83,regulation of gene silencing by miRNA,BP,EGFR
18558,GO:1900034,0.411390186474831,0.902495438996114,1,75,regulation of cellular response to heat,BP,CAMK2A
5401,GO:0015291,0.411434203629545,0.833794001851863,2,198,secondary active transmembrane transporter activity,MF,SLC17A7;SLC38A1
9445,GO:0034637,0.411453348408342,0.902462534780938,1,75,cellular carbohydrate biosynthetic process,BP,PHKG1
14693,GO:0060341,0.411687854327901,0.743335018170787,6,760,regulation of cellular localization,BP,CAMK2A;BVES;EGFR;DMTN;MX2;APOD
19316,GO:1902554,0.411721031996469,0.902254393094702,1,80,serine/threonine protein kinase complex,CC,PHKG1
11282,GO:0043491,0.413771272358172,0.832125323775851,2,207,protein kinase B signaling,BP,FGFR3;EGFR
3493,GO:0006909,0.414073829884681,0.831871794754047,2,218,phagocytosis,BP,ICAM5;PRKCG
11161,GO:0043270,0.415051527473393,0.831201132608836,2,214,positive regulation of ion transport,BP,CAMK2A;CCK
7302,GO:0030316,0.415147388579761,0.900511756507243,1,76,osteoclast differentiation,BP,LTF
755,GO:0001938,0.415354632290502,0.900374181115236,1,78,positive regulation of endothelial cell proliferation,BP,CAV2
13841,GO:0051346,0.415608853541937,0.793453576453994,3,364,negative regulation of hydrolase activity,BP,LTF;SPOCK1;COL28A1
10668,GO:0042325,0.416274131745546,0.70884728510422,10,1340,regulation of phosphorylation,BP,CRLF1;LTF;FGFR3;CAV2;GPNMB;ENPP2;EGFR;DMTN;KNDC1;CCK
8689,GO:0032870,0.416407937028268,0.752041390189829,5,621,cellular response to hormone stimulus,BP,CAMK2A;SOX10;CAV2;EGFR;GJA1
15115,GO:0061025,0.416505165265026,0.830175839953831,2,215,membrane fusion,BP,CAV2;MX2
19288,GO:1902476,0.416717409471038,0.899696589567786,1,75,chloride transmembrane transport,BP,SLC17A7
5471,GO:0015631,0.417225759323222,0.792295017127373,3,319,tubulin binding,MF,DCX;GJA1;MX2
13759,GO:0051219,0.417456531922238,0.899319716367393,1,74,phosphoprotein binding,MF,TOX3
2675,GO:0005643,0.418053824497502,0.898972039472241,1,76,nuclear pore,CC,MX2
7145,GO:0030100,0.41954998219276,0.828026082773711,2,215,regulation of endocytosis,BP,PACSIN1;PRKCG
13091,GO:0048545,0.419590365336932,0.790382780833274,3,355,response to steroid hormone,BP,DSG2;SOX10;EGFR
3627,GO:0007160,0.421253902400194,0.826905428934416,2,194,cell-matrix adhesion,BP,DMTN;APOD
3432,GO:0006813,0.421490915983151,0.826680178335577,2,207,potassium ion transport,BP,KCNJ6;KCNJ4
4797,GO:0010558,0.422083618148624,0.703649898751725,10,1339,negative regulation of macromolecule biosynthetic process,BP,ARX;ZIC2;SOX10;AHR;EGFR;GJA1;LMO1;IRX2;PRAME;DAPK1
11204,GO:0043331,0.422211098645163,0.896715525288336,1,78,response to dsRNA,BP,EGFR
19545,GO:1903076,0.422350429034183,0.896612618141785,1,80,regulation of protein localization to plasma membrane,BP,EGFR
19694,GO:1903409,0.422493127268762,0.896496462675547,1,83,reactive oxygen species biosynthetic process,BP,NOS2
10581,GO:0042136,0.422543641334407,0.896469170524418,1,83,neurotransmitter biosynthetic process,BP,NOS2
7819,GO:0031346,0.423075016895097,0.787725093968651,3,326,positive regulation of cell projection organization,BP,TRIM67;PACSIN1;ENPP2
14557,GO:0060147,0.425286089679122,0.894944042169515,1,86,regulation of posttranscriptional gene silencing,BP,EGFR
15073,GO:0060966,0.425286089679122,0.894944042169515,1,86,regulation of gene silencing by RNA,BP,EGFR
3806,GO:0007586,0.425340339157457,0.894869159632018,1,90,digestion,BP,ARX
3514,GO:0006942,0.425382623398441,0.894981764847589,1,79,regulation of striated muscle contraction,BP,DSG2
760,GO:0001944,0.425799917563869,0.744143181920098,5,607,vasculature development,BP,AHR;GPNMB;ENPP2;GJA1;APOD
2103,GO:0004620,0.426411303654294,0.894366498947411,1,83,phospholipase activity,MF,ENPP2
20015,GO:1904029,0.426777313557208,0.894105771834402,1,88,regulation of cyclin-dependent protein kinase activity,BP,EGFR
3191,GO:0006487,0.427820636032501,0.893521884620083,1,89,protein N-linked glycosylation,BP,MGAT5B
7528,GO:0030838,0.427836881907282,0.893524273170904,1,88,positive regulation of actin filament polymerization,BP,SCIN
7041,GO:0022617,0.428289139522086,0.893404945868878,1,78,extracellular matrix disassembly,BP,ACAN
15884,GO:0070613,0.42909900779705,0.892852638154826,1,86,regulation of protein processing,BP,CNTN2
3466,GO:0006874,0.430371802864401,0.78190937879606,3,361,cellular calcium ion homeostasis,BP,GPR17;GJA1;FPR3
13260,GO:0048863,0.43044753531879,0.82015593457053,2,233,stem cell differentiation,BP,SOX10;LMO1
13119,GO:0048609,0.430480925317593,0.740126883605678,5,651,multicellular organismal reproductive process,BP,CLDN11;DSG2;CHD5;EGFR;GJA1
8380,GO:0032412,0.431221932336233,0.819667328110797,2,213,regulation of ion transmembrane transporter activity,BP,CACNG4;DAPK1
759,GO:0001942,0.431482849715104,0.891596993349504,1,81,hair follicle development,BP,EGFR
17703,GO:0097327,0.431772821274039,0.891395992533545,1,84,response to antineoplastic agent,BP,EGFR
11736,GO:0044772,0.431894286248073,0.756189636209511,4,515,mitotic cell cycle phase transition,BP,USH1C;CAMK2A;GPNMB;EGFR
13534,GO:0050868,0.432198936258317,0.891121646365509,1,87,negative regulation of T cell activation,BP,GPNMB
13268,GO:0048872,0.432391168602581,0.818772735607321,2,225,homeostasis of number of cells,BP,DMTN;LMO1
724,GO:0001892,0.432460802794735,0.891052751563852,1,81,embryonic placenta development,BP,EGFR
19666,GO:1903362,0.432611950754092,0.818630476555257,2,220,regulation of cellular protein catabolic process,BP,TRIM67;PRKCG
7798,GO:0031324,0.432934107889319,0.671650241450776,16,2239,negative regulation of cellular metabolic process,BP,ARX;LTF;ZIC2;SOX10;AHR;PRKCG;EGFR;SPOCK1;GJA1;DMTN;LMO1;IRX2;PRAME;APOD;DAPK1;COL28A1
2968,GO:0006112,0.43482070955502,0.889746682830435,1,80,energy reserve metabolic process,BP,PHKG1
18020,GO:0098773,0.435711730143751,0.889217731758616,1,82,skin epidermis development,BP,EGFR
18959,GO:1901606,0.436456943919169,0.888633727201539,1,96,alpha-amino acid catabolic process,BP,NOS2
16860,GO:0072358,0.436673886050787,0.734860869412786,5,615,cardiovascular system development,BP,AHR;GPNMB;ENPP2;GJA1;APOD
21158,GO:2000027,0.436788120331871,0.815539508980301,2,231,regulation of organ morphogenesis,BP,CTHRC1;GPC6
10342,GO:0038024,0.437291055754058,0.88835440879978,1,80,cargo receptor activity,MF,ENPP2
3534,GO:0006979,0.437317930518051,0.776326679389276,3,390,response to oxidative stress,BP,EGFR;APOD;DAPK1
19647,GO:1903317,0.437623169945404,0.888061135148525,1,88,regulation of protein maturation,BP,CNTN2
15299,GO:0061448,0.437629562837175,0.814976934410838,2,216,connective tissue development,BP,SCIN;FGFR3
8460,GO:0032504,0.438301920367036,0.733422943496695,5,659,multicellular organism reproduction,BP,CLDN11;DSG2;CHD5;EGFR;GJA1
13961,GO:0051588,0.438956673620771,0.8873541396236,1,84,regulation of neurotransmitter transport,BP,CAMK2A
8760,GO:0032970,0.439292710189532,0.7748253603945,3,346,regulation of actin filament-based process,BP,SCIN;DSG2;DMTN
2513,GO:0005253,0.439400328837004,0.887114942975997,1,83,anion channel activity,MF,SLC17A7
558,GO:0001656,0.439781481801611,0.886925509620322,1,81,metanephros development,BP,IRX2
21210,GO:2000117,0.439857482584197,0.886711980420025,1,95,negative regulation of cysteine-type endopeptidase activity,BP,LTF
7018,GO:0022404,0.44019473719341,0.886661834344859,1,83,molting cycle process,BP,EGFR
7019,GO:0022405,0.44019473719341,0.886661834344859,1,83,hair cycle process,BP,EGFR
19843,GO:1903706,0.442709208214105,0.77199549587887,3,387,regulation of hemopoiesis,BP,SCIN;LTF;LMO1
460,GO:0001227,0.443120271938716,0.810907391289113,2,219,transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding,MF,ARX;IRX2
13234,GO:0048814,0.444206575043747,0.884446038767593,1,77,regulation of dendrite morphogenesis,BP,KNDC1
8188,GO:0032092,0.444628764129263,0.884098526935772,1,84,positive regulation of protein binding,BP,CTHRC1
3881,GO:0008081,0.444906743914963,0.883965276479962,1,82,phosphoric diester hydrolase activity,MF,ENPP2
12883,GO:0048013,0.445352889001585,0.883639446264917,1,87,ephrin receptor signaling pathway,BP,EFNB3
4541,GO:0009607,0.445667270577876,0.727012516359238,5,717,response to biotic stimulus,BP,NOS2;LTF;GJB6;GJA1;MX2
5314,GO:0015108,0.445949690279111,0.883360033630854,1,82,chloride transmembrane transporter activity,MF,SLC17A7
13441,GO:0050729,0.447419827093378,0.882301168120057,1,99,positive regulation of inflammatory response,BP,EGFR
9264,GO:0034249,0.447430647020625,0.807682438771458,2,221,negative regulation of cellular amide metabolic process,BP,EGFR;DAPK1
14415,GO:0055074,0.448110194705821,0.767642645744986,3,371,calcium ion homeostasis,BP,GPR17;GJA1;FPR3
8117,GO:0031966,0.450691832231871,0.740273919337075,4,618,mitochondrial membrane,CC,SOX10;GJA1;NRGN;MX2
7895,GO:0031490,0.450718308921754,0.880461578695524,1,90,chromatin DNA binding,MF,ZIC2
7822,GO:0031349,0.451435429672339,0.764885277489896,3,394,positive regulation of defense response,BP,LTF;EGFR;GJA1
19524,GO:1903038,0.452765590003701,0.879202586379601,1,94,negative regulation of leukocyte cell-cell adhesion,BP,GPNMB
14141,GO:0051928,0.453163305808194,0.878977460458037,1,93,positive regulation of calcium ion transport,BP,CAMK2A
17634,GO:0097190,0.453316492510871,0.738094268230475,4,552,apoptotic signaling pathway,BP,EYA2;FGFR3;CCK;DAPK1
16989,GO:0072659,0.453692740080007,0.802962718867574,2,220,protein localization to plasma membrane,BP,PACSIN1;EGFR
8746,GO:0032947,0.453723506062891,0.878817477329222,1,80,protein-containing complex scaffold activity,MF,CAV2
12687,GO:0046903,0.45405431592084,0.674543841665868,10,1426,secretion,BP,SCIN;NOS2;LTF;CAMK2A;SLC17A7;EGFR;GJA1;DMTN;CCK;MBP
2483,GO:0005200,0.454631086926061,0.878150569631724,1,89,structural constituent of cytoskeleton,MF,PPL
7424,GO:0030594,0.454914521775132,0.877981198797355,1,89,neurotransmitter receptor activity,MF,GRID2
7808,GO:0031334,0.455022684142716,0.801906258800599,2,232,positive regulation of protein complex assembly,BP,SCIN;CCK
17253,GO:0090150,0.455117431569679,0.801678664324549,2,285,establishment of protein localization to membrane,BP,EGFR;DMTN
16678,GO:0072080,0.455999405590796,0.87738457672556,1,85,nephron tubule development,BP,IRX2
20162,GO:1904375,0.456427545048534,0.877087419042448,1,88,regulation of protein localization to cell periphery,BP,EGFR
19338,GO:1902600,0.456956556753581,0.876540794224361,1,110,proton transmembrane transport,BP,SLC17A7
3110,GO:0006368,0.457120185632921,0.876564842240912,1,97,transcription elongation from RNA polymerase II promoter,BP,SOX10
13652,GO:0051051,0.457614229195904,0.759804250405734,3,391,negative regulation of transport,BP,PACSIN1;DMTN;APOD
18943,GO:1901565,0.458881564931749,0.683081043149821,8,1129,organonitrogen compound catabolic process,BP,NOS2;TRIM67;PRKCG;ENPP2;EGFR;GJA1;ACAN;GPC6
5265,GO:0014902,0.459162233920326,0.875438336212935,1,88,myotube differentiation,BP,CAV2
9361,GO:0034440,0.459339139640466,0.875224003480224,1,97,lipid oxidation,BP,APOD
13672,GO:0051090,0.459362810389826,0.758382965957926,3,376,regulation of DNA binding transcription factor activity,BP,LTF;ZIC2;CAMK2A
17886,GO:0097731,0.459754980926098,0.875092394249263,1,87,9+0 non-motile cilium,CC,USH1C
17888,GO:0097733,0.459754980926098,0.875092394249263,1,87,photoreceptor cell cilium,CC,USH1C
6178,GO:0017053,0.459805953795439,0.875132891343988,1,82,transcriptional repressor complex,CC,CHD5
13998,GO:0051651,0.459861811809311,0.875014274155788,1,88,maintenance of location in cell,BP,SCIN
4192,GO:0008593,0.460015549876402,0.874895214684152,1,90,regulation of Notch signaling pathway,BP,EGFR
21179,GO:2000060,0.460312257392,0.874714972968343,1,90,positive regulation of ubiquitin-dependent protein catabolic process,BP,TRIM67
7389,GO:0030516,0.46051422375708,0.874702968429289,1,82,regulation of axon extension,BP,MAG
8505,GO:0032587,0.460536326310937,0.874645542160297,1,85,ruffle membrane,CC,PACSIN1
13761,GO:0051222,0.461382784975648,0.756693721028776,3,382,positive regulation of protein transport,BP,EGFR;GJA1;MBP
691,GO:0001843,0.462069531243823,0.873711376853257,1,85,neural tube closure,BP,CTHRC1
15093,GO:0060993,0.462410293082196,0.873489075528614,1,86,kidney morphogenesis,BP,IRX2
6699,GO:0019905,0.462520343980502,0.87340800834371,1,87,syntaxin binding,MF,DAPK1
14887,GO:0060606,0.463329626009141,0.87292622646026,1,86,tube closure,BP,CTHRC1
12251,GO:0045927,0.463453973992656,0.795465061029331,2,224,positive regulation of growth,BP,ARX;EGFR
5382,GO:0015238,0.463835480834331,0.872549671141427,1,91,drug transmembrane transporter activity,MF,SLC17A7
8279,GO:0032269,0.464137594654606,0.686801602758857,7,974,negative regulation of cellular protein metabolic process,BP,LTF;PRKCG;EGFR;SPOCK1;DMTN;DAPK1;COL28A1
8565,GO:0032675,0.464538376730033,0.872046827029019,1,97,regulation of interleukin-6 production,BP,MBP
18813,GO:1901184,0.464551096695529,0.872122283558018,1,90,regulation of ERBB signaling pathway,BP,EGFR
15249,GO:0061326,0.464674107098547,0.872086377701859,1,87,renal tubule development,BP,IRX2
10887,GO:0042752,0.465459106196224,0.871549846289877,1,91,regulation of circadian rhythm,BP,PRKCG
19458,GO:1902936,0.466548752258482,0.870888891833779,1,90,phosphatidylinositol bisphosphate binding,MF,SCIN
3687,GO:0007249,0.466948324145945,0.79268811548095,2,241,I-kappaB kinase/NF-kappaB signaling,BP,LTF;GJA1
22,GO:0000041,0.466987646083121,0.870500344849871,1,100,transition metal ion transport,BP,SLC30A3
6714,GO:0019955,0.467345215741663,0.870322101045508,1,96,cytokine binding,MF,CRLF1
7902,GO:0031503,0.467536803376467,0.792257791725905,2,233,protein-containing complex localization,BP,CACNG4;ANKS1B
5166,GO:0014066,0.467869903768079,0.870095708948652,1,88,regulation of phosphatidylinositol 3-kinase signaling,BP,EGFR
3434,GO:0006816,0.468016752015818,0.751171683828113,3,368,calcium ion transport,BP,CAMK2A;CACNG4;GJA1
4840,GO:0010628,0.468221672920228,0.651791953492059,12,1676,positive regulation of gene expression,BP,ARX;ZIC2;SOX10;TOX3;AHR;OTX1;MYRF;EGFR;GJA1;LMO1;DMRT2;CNTN2
19449,GO:1902911,0.469401955217829,0.869076408451683,1,93,protein kinase complex,CC,PHKG1
8470,GO:0032526,0.469456557632173,0.869006681090802,1,96,response to retinoic acid,BP,GJA1
3713,GO:0007286,0.469815039662781,0.868771113843866,1,97,spermatid development,BP,CHD5
11546,GO:0044264,0.470420135449199,0.86850434630206,1,88,cellular polysaccharide metabolic process,BP,PHKG1
18647,GO:1900180,0.471388781580462,0.86783144193607,1,93,regulation of protein localization to nucleus,BP,APOD
11271,GO:0043473,0.471777588758792,0.867586945087085,1,93,pigmentation,BP,SOX10
15014,GO:0060828,0.472583062856747,0.788264673598661,2,243,regulation of canonical Wnt signaling pathway,BP,SOX10;CTHRC1
4626,GO:0009896,0.472884114804063,0.747069790881847,3,365,positive regulation of catabolic process,BP,TRIM67;GJA1;DAPK1
6468,GO:0019220,0.472914019228208,0.651848759820089,11,1549,regulation of phosphate metabolic process,BP,CRLF1;NOS2;LTF;FGFR3;CAV2;GPNMB;ENPP2;EGFR;DMTN;KNDC1;CCK
13429,GO:0050715,0.473050943532387,0.866703286589855,1,100,positive regulation of cytokine secretion,BP,MBP
13080,GO:0048524,0.473413164372336,0.866474266302532,1,100,positive regulation of viral process,BP,CAV2
21215,GO:2000134,0.473801895811422,0.866273144977135,1,96,negative regulation of G1/S transition of mitotic cell cycle,BP,GPNMB
4595,GO:0009791,0.475078059534322,0.865624971068126,1,84,post-embryonic development,BP,SCN9A
2752,GO:0005774,0.475726131156852,0.744611840692188,3,388,vacuolar membrane,CC,SLC30A3;HLA-DRB1;HLA-DRB5
11258,GO:0043434,0.477532117660628,0.743083847292497,3,382,response to peptide hormone,BP,CAMK2A;CAV2;GJA1
11734,GO:0044770,0.477674264123544,0.716922230285026,4,545,cell cycle phase transition,BP,USH1C;CAMK2A;GPNMB;EGFR
559,GO:0001657,0.477919540681884,0.863699647637532,1,92,ureteric bud development,BP,CRLF1
5662,GO:0016032,0.479033752725595,0.697433082866588,5,736,viral process,BP,LTF;CAV2;EFNB3;MOG;EGFR
7801,GO:0031327,0.479101807379445,0.651197367666888,10,1402,negative regulation of cellular biosynthetic process,BP,ARX;ZIC2;SOX10;AHR;EGFR;GJA1;LMO1;IRX2;PRAME;DAPK1
1256,GO:0002761,0.479348212933812,0.862732318290164,1,96,regulation of myeloid leukocyte differentiation,BP,LTF
17356,GO:0090287,0.479551715670173,0.782782964428014,2,230,regulation of cellular response to growth factor stimulus,BP,CAV2;FBN3
7153,GO:0030117,0.480117303117809,0.862236706455261,1,96,membrane coat,CC,EGFR
13052,GO:0048475,0.480117303117809,0.862236706455261,1,96,coated membrane,CC,EGFR
10742,GO:0042470,0.480124298088329,0.86217515627318,1,101,melanosome,CC,GPNMB
13218,GO:0048770,0.480124298088329,0.86217515627318,1,101,pigment granule,CC,GPNMB
11168,GO:0043279,0.481213129551305,0.861528589628866,1,96,response to alkaloid,BP,PRKCG
8871,GO:0033157,0.481338261165488,0.781315493720713,2,240,regulation of intracellular protein transport,BP,DMTN;APOD
18433,GO:0110053,0.481911758893001,0.780870208198575,2,236,regulation of actin filament organization,BP,SCIN;DMTN
21291,GO:2000278,0.482555703371307,0.860657892742292,1,96,regulation of DNA biosynthetic process,BP,GJA1
13118,GO:0048608,0.482718833987631,0.738645051128922,3,379,reproductive structure development,BP,EGFR;GJA1;GJB1
1376,GO:0003014,0.482797263246205,0.860500867476191,1,96,renal system process,BP,GJA1
9423,GO:0034599,0.483177171814483,0.779777594723525,2,258,cellular response to oxidative stress,BP,EGFR;DAPK1
19408,GO:1902807,0.483251965052246,0.860169636008826,1,99,negative regulation of cell cycle G1/S phase transition,BP,GPNMB
21601,GO:2000736,0.483493757543384,0.859854629587263,1,115,regulation of stem cell differentiation,BP,LMO1
16729,GO:0072163,0.484767620977418,0.859253715181992,1,93,mesonephric epithelium development,BP,CRLF1
16730,GO:0072164,0.484767620977418,0.859253715181992,1,93,mesonephric tubule development,BP,CRLF1
4173,GO:0008543,0.484785428502802,0.859180254582578,1,98,fibroblast growth factor receptor signaling pathway,BP,FGFR3
20456,GO:1904949,0.484802241996484,0.8592055640277,1,95,ATPase complex,CC,CHD5
17977,GO:0098661,0.48501399123841,0.859119207044017,1,91,inorganic anion transmembrane transport,BP,SLC17A7
13713,GO:0051146,0.485504613993403,0.77799588479801,2,231,striated muscle cell differentiation,BP,CAV2;BVES
5130,GO:0014020,0.485612577545236,0.858713706739484,1,92,primary neural tube formation,BP,CTHRC1
13733,GO:0051174,0.486249625506124,0.639225181249757,11,1563,regulation of phosphorus metabolic process,BP,CRLF1;NOS2;LTF;FGFR3;CAV2;GPNMB;ENPP2;EGFR;DMTN;KNDC1;CCK
9693,GO:0035335,0.486590675133717,0.858058376609641,1,93,peptidyl-tyrosine dephosphorylation,BP,EYA2
11326,GO:0043547,0.486783908281568,0.735171507648069,3,362,positive regulation of GTPase activity,BP,CAV2;RIN1;RGS6
13073,GO:0048515,0.486944815569167,0.857717626592714,1,102,spermatid differentiation,BP,CHD5
15301,GO:0061458,0.487089523754991,0.734865948740224,3,382,reproductive system development,BP,EGFR;GJA1;GJB1
13072,GO:0048514,0.487472427325153,0.708243899814946,4,513,blood vessel morphogenesis,BP,GPNMB;ENPP2;GJA1;APOD
4307,GO:0009063,0.489095929103517,0.85621486717877,1,110,cellular amino acid catabolic process,BP,NOS2
3437,GO:0006821,0.489384241974495,0.856188241835669,1,95,chloride transport,BP,SLC17A7
2822,GO:0005884,0.489439332794143,0.856126812980014,1,97,actin filament,CC,DMTN
7234,GO:0030218,0.489468899896719,0.856060358550923,1,101,erythrocyte differentiation,BP,DMTN
2179,GO:0004725,0.490018568216954,0.855780196765517,1,94,protein tyrosine phosphatase activity,MF,EYA2
3575,GO:0007041,0.490092832978637,0.855744029094817,1,93,lysosomal transport,BP,CACNG4
850,GO:0002065,0.490203280035665,0.855607518308322,1,98,columnar/cuboidal epithelial cell differentiation,BP,USH1C
10365,GO:0038061,0.490239969530148,0.855392496933904,1,117,NIK/NF-kappaB signaling,BP,EGFR
13797,GO:0051270,0.490931842069663,0.672846851099906,6,811,regulation of cellular component movement,BP,DSG2;GPNMB;ENPP2;EGFR;DMTN;APOD
16275,GO:0071383,0.491016470128843,0.773490236392305,2,238,cellular response to steroid hormone stimulus,BP,SOX10;EGFR
2724,GO:0005740,0.491238633675238,0.704719307511448,4,654,mitochondrial envelope,CC,SOX10;GJA1;NRGN;MX2
672,GO:0001823,0.491685348199767,0.854644853659578,1,96,mesonephros development,BP,CRLF1
6034,GO:0016772,0.492089582822032,0.660973246046902,7,934,transferase activity, transferring phosphorus-containing groups,MF,FGFR3;CAMK2A;EFNB3;PRKCG;EGFR;PHKG1;DAPK1
3685,GO:0007229,0.493092316971985,0.85372956709984,1,94,integrin-mediated signaling pathway,BP,DMTN
13530,GO:0050864,0.493375524715122,0.853399418647189,1,106,regulation of B cell activation,BP,AHR
4620,GO:0009890,0.493713841786987,0.637335507180476,10,1422,negative regulation of biosynthetic process,BP,ARX;ZIC2;SOX10;AHR;EGFR;GJA1;LMO1;IRX2;PRAME;DAPK1
7918,GO:0031532,0.494036337386505,0.853021513236876,1,100,actin cytoskeleton reorganization,BP,DMTN
11519,GO:0044212,0.495335288230373,0.668749479262482,6,810,transcription regulatory region DNA binding,MF,ARX;SOX10;TOX3;AHR;OTX1;DMRT2
7840,GO:0031399,0.495639446457218,0.630253462592344,11,1575,regulation of protein modification process,BP,CRLF1;LTF;FGFR3;CAV2;PRKCG;GPNMB;ENPP2;EGFR;DMTN;KNDC1;CCK
5170,GO:0014070,0.495717555478093,0.668375466191619,6,837,response to organic cyclic compound,BP,DSG2;SOX10;AHR;PRKCG;EGFR;DMTN
9510,GO:0034728,0.496241409319486,0.851363243934139,1,117,nucleosome organization,BP,CHD5
399,GO:0001067,0.496739329461366,0.667438037440794,6,811,regulatory region nucleic acid binding,MF,ARX;SOX10;TOX3;AHR;OTX1;DMRT2
12165,GO:0045765,0.497745743679767,0.767930925312454,2,245,regulation of angiogenesis,BP,GPNMB;ENPP2
1609,GO:0003700,0.498682388727507,0.632590534554112,10,1401,DNA binding transcription factor activity,MF,ARX;ZIC2;SOX10;TOX3;AHR;OTX1;MYRF;IRX2;DMRT2;MYT1
12489,GO:0046486,0.499469485126731,0.724011409897721,3,396,glycerolipid metabolic process,BP,FGFR3;ENPP2;EGFR
11032,GO:0043065,0.49968447532102,0.697161318136715,4,561,positive regulation of apoptotic process,BP,SCIN;CAMK2A;CCK;DAPK1
17973,GO:0098656,0.500222193987597,0.765918398775972,2,234,anion transmembrane transport,BP,SLC17A7;SLC38A1
3447,GO:0006839,0.500747700326334,0.765335689473659,2,277,mitochondrial transport,BP,EYA2;CAMK2A
6416,GO:0019079,0.501824949938066,0.84765738727687,1,106,viral genome replication,BP,LTF
7986,GO:0031667,0.504131274677212,0.719844386885244,3,416,response to nutrient levels,BP,PRKCG;EGFR;CCK
6152,GO:0016999,0.504564725299016,0.845606670066372,1,123,antibiotic metabolic process,BP,EGFR
4775,GO:0010508,0.50473509685303,0.845753297641688,1,97,positive regulation of autophagy,BP,DAPK1
4841,GO:0010629,0.504770161011497,0.62145340749593,11,1630,negative regulation of gene expression,BP,ARX;NOS2;ZIC2;SOX10;AHR;EGFR;GJA1;LMO1;IRX2;PRAME;DAPK1
5798,GO:0016298,0.504782168197705,0.84562512746549,1,105,lipase activity,MF,ENPP2
1292,GO:0002831,0.505253411191928,0.845255369676905,1,109,regulation of response to biotic stimulus,BP,LTF
11863,GO:0045111,0.505256037606644,0.845342064286827,1,101,intermediate filament cytoskeleton,CC,GJA1
14381,GO:0055007,0.505351730783071,0.84536546353442,1,94,cardiac muscle cell differentiation,BP,BVES
6161,GO:0017015,0.50562701420634,0.845121221014364,1,98,regulation of transforming growth factor beta receptor signaling pathway,BP,CAV2
16294,GO:0071407,0.50566055643507,0.691736743842907,4,530,cellular response to organic cyclic compound,BP,SOX10;AHR;EGFR;DMTN
15075,GO:0060968,0.505697459037664,0.844978262016726,1,106,regulation of gene silencing,BP,EGFR
14707,GO:0060359,0.506204729282882,0.844625087172917,1,106,response to ammonium ion,BP,PRKCG
15279,GO:0061387,0.507986327911658,0.843501536367586,1,96,regulation of extent of cell growth,BP,MAG
13701,GO:0051130,0.508246292849476,0.63684966291761,8,1121,positive regulation of cellular component organization,BP,SCIN;TRIM67;PACSIN1;ENPP2;GRID2;DMTN;SLITRK2;CCK
9176,GO:0034101,0.508608124391083,0.84291270646364,1,109,erythrocyte homeostasis,BP,DMTN
13113,GO:0048593,0.508779277637328,0.842919682727609,1,98,camera-type eye morphogenesis,BP,USH1C
2874,GO:0005976,0.509278735387978,0.842556271107418,1,99,polysaccharide metabolic process,BP,PHKG1
16634,GO:0072009,0.509334787906699,0.842516883165319,1,99,nephron epithelium development,BP,IRX2
11035,GO:0043068,0.509478509614357,0.688181844730355,4,567,positive regulation of programmed cell death,BP,SCIN;CAMK2A;CCK;DAPK1
4622,GO:0009892,0.509481801154734,0.596193014756048,17,2548,negative regulation of metabolic process,BP,ARX;NOS2;LTF;ZIC2;SOX10;AHR;PRKCG;EGFR;SPOCK1;GJA1;DMTN;LMO1;IRX2;PRAME;APOD;DAPK1;COL28A1
11149,GO:0043254,0.50976590618542,0.714835352287657,3,402,regulation of protein complex assembly,BP,SCIN;DMTN;CCK
4624,GO:0009894,0.509910716045406,0.655017766301496,6,852,regulation of catabolic process,BP,NOS2;TRIM67;PRKCG;EGFR;GJA1;DAPK1
9542,GO:0034968,0.509932642234469,0.842135515695034,1,96,histone lysine methylation,BP,CHD5
11905,GO:0045185,0.510144387067674,0.841910409610055,1,102,maintenance of protein location,BP,SCIN
4572,GO:0009719,0.510514485706254,0.621186062212302,10,1435,response to endogenous stimulus,BP,NOS2;DSG2;FGFR3;CAMK2A;SOX10;CAV2;AHR;EGFR;GJA1;DMTN
16239,GO:0071333,0.510993639529382,0.841243576750585,1,108,cellular response to glucose stimulus,BP,GJB6
19916,GO:1903844,0.511223223263763,0.84117357741008,1,100,regulation of cellular response to transforming growth factor beta stimulus,BP,CAV2
11963,GO:0045321,0.511502754520786,0.642524041892941,7,1066,leukocyte activation,BP,LTF;AHR;EFNB3;GPNMB;LMO1;HLA-DRB1;HLA-DRB5
11111,GO:0043200,0.511792704677942,0.840722825329355,1,104,response to amino acid,BP,EGFR
17226,GO:0090101,0.512835572125423,0.840019183450677,1,101,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,CAV2
11005,GO:0043021,0.512961298154171,0.83983882506997,1,109,ribonucleoprotein complex binding,MF,LTF
8332,GO:0032355,0.5140335239103,0.839025156003258,1,114,response to estradiol,BP,EGFR
19844,GO:1903707,0.515293762146558,0.8381250643367,1,114,negative regulation of hemopoiesis,BP,LTF
689,GO:0001841,0.515587070915933,0.838070507595464,1,100,neural tube formation,BP,CTHRC1
20458,GO:1904951,0.515973323229446,0.709212694286165,3,417,positive regulation of establishment of protein localization,BP,EGFR;GJA1;MBP
5057,GO:0010927,0.516453679721301,0.837516472318232,1,95,cellular component assembly involved in morphogenesis,BP,UGT8
16237,GO:0071331,0.51729746835961,0.836727861942158,1,110,cellular response to hexose stimulus,BP,GJB6
19755,GO:1903533,0.517683677040044,0.836409172492787,1,114,regulation of protein targeting,BP,DMTN
20691,GO:1905477,0.5179289637798,0.83627309690905,1,110,positive regulation of protein localization to membrane,BP,EGFR
815,GO:0002020,0.520786562547606,0.834204922832121,1,110,protease binding,MF,MBP
16235,GO:0071326,0.520913439599535,0.834102140228668,1,111,cellular response to monosaccharide stimulus,BP,GJB6
3309,GO:0006633,0.521390584045864,0.833676778328084,1,119,fatty acid biosynthetic process,BP,FA2H
12198,GO:0045834,0.521408640747282,0.833752453173535,1,110,positive regulation of lipid metabolic process,BP,FGFR3
3050,GO:0006275,0.522454372741641,0.83302308567183,1,107,regulation of DNA replication,BP,EGFR
8698,GO:0032880,0.523573683522283,0.64196591897358,6,864,regulation of protein localization,BP,NOS2;EGFR;GJA1;DMTN;APOD;MBP
21075,GO:1990778,0.523616289833343,0.745955990463006,2,251,protein localization to cell periphery,BP,PACSIN1;EGFR
3318,GO:0006644,0.524387550367513,0.70154685364869,3,414,phospholipid metabolic process,BP,FGFR3;ENPP2;EGFR
7662,GO:0031072,0.525326314558106,0.830884396835863,1,110,heat shock protein binding,MF,AHR
3739,GO:0007368,0.526616445357709,0.829955049607013,1,108,determination of left/right symmetry,BP,GJA1
2755,GO:0005777,0.526820699837831,0.829664153068984,1,122,peroxisome,CC,NOS2
10798,GO:0042579,0.526820699837831,0.829664153068984,1,122,microbody,CC,NOS2
3800,GO:0007568,0.52704080342514,0.74291209909706,2,267,aging,BP,GJB6;APOD
7318,GO:0030334,0.527556227463457,0.652312343329876,5,697,regulation of cell migration,BP,GPNMB;ENPP2;EGFR;DMTN;APOD
1436,GO:0003158,0.527711734892511,0.829167671946596,1,106,endothelium development,BP,GJA1
13781,GO:0051250,0.528708055392865,0.828310702082832,1,117,negative regulation of lymphocyte activation,BP,GPNMB
12534,GO:0046578,0.528771415127697,0.741527039927661,2,232,regulation of Ras protein signal transduction,BP,TRIM67;GPR17
19532,GO:1903052,0.529079647145641,0.828084920377013,1,112,positive regulation of proteolysis involved in cellular protein catabolic process,BP,TRIM67
14289,GO:0052689,0.52922339345645,0.827889718145352,1,121,carboxylic ester hydrolase activity,MF,ENPP2
11971,GO:0045335,0.529295163732212,0.827864172960298,1,118,phagocytic vesicle,CC,LTF
12252,GO:0045930,0.52951430881604,0.740697540861644,2,281,negative regulation of mitotic cell cycle,BP,GPNMB;EGFR
8125,GO:0031983,0.531409091622882,0.738946654554288,2,311,vesicle lumen,CC,LTF;EGFR
13471,GO:0050777,0.531501628072569,0.82621559704842,1,118,negative regulation of immune response,BP,GPR17
8283,GO:0032273,0.531612215333995,0.826152270144186,1,116,positive regulation of protein polymerization,BP,SCIN
3775,GO:0007498,0.532174094209077,0.825772039204578,1,112,mesoderm development,BP,EYA2
18539,GO:0150034,0.53255664830289,0.738106520857968,2,253,distal axon,CC,PACSIN1;CCK
16683,GO:0072089,0.532605641106692,0.825540222703125,1,104,stem cell proliferation,BP,SOX10
5770,GO:0016247,0.533502218582052,0.824683573372295,1,121,channel regulator activity,MF,CACNG4
2434,GO:0005125,0.533840951891601,0.824224677983223,1,148,cytokine activity,MF,CRLF1
671,GO:0001822,0.534285499933591,0.736601371812731,2,246,kidney development,BP,CRLF1;IRX2
7394,GO:0030522,0.53472425538439,0.736174049654025,2,256,intracellular receptor signaling pathway,BP,AHR;PRAME
9626,GO:0035195,0.535256597443846,0.823426576190663,1,114,gene silencing by miRNA,BP,EGFR
5093,GO:0010976,0.535395414241147,0.735623272592894,2,244,positive regulation of neuron projection development,BP,TRIM67;PACSIN1
3098,GO:0006354,0.535812215048483,0.822927257529477,1,122,DNA-templated transcription, elongation,BP,SOX10
11623,GO:0044403,0.535864498274154,0.644251418000958,5,786,symbiont process,BP,LTF;CAV2;EFNB3;MOG;EGFR
1140,GO:0002576,0.536519941874974,0.822417827136466,1,119,platelet degranulation,BP,DMTN
6269,GO:0018022,0.536528584600647,0.822576446542361,1,104,peptidyl-lysine methylation,BP,CHD5
4406,GO:0009187,0.536745226497386,0.822286356755227,1,115,cyclic nucleotide metabolic process,BP,NOS2
11268,GO:0043467,0.536788495445569,0.822330328013629,1,108,regulation of generation of precursor metabolites and energy,BP,NOS2
19737,GO:1903510,0.537175964012759,0.8220355257302,1,108,mucopolysaccharide metabolic process,BP,ACAN
4963,GO:0010817,0.537785449119031,0.689089128256405,3,436,regulation of hormone levels,BP,NOS2;EGFR;GJA1
3824,GO:0007613,0.539274164580222,0.820482522179885,1,104,memory,BP,SLC17A7
7246,GO:0030234,0.539452948427727,0.626543969349839,6,895,enzyme regulator activity,MF,LTF;EGFR;SPOCK1;RIN1;RGS6;COL28A1
13541,GO:0050878,0.540501485232889,0.686560466300503,3,424,regulation of body fluid levels,BP,PRKCG;GJA1;DMTN
7142,GO:0030097,0.540974324443578,0.639325996215756,5,744,hemopoiesis,BP,SCIN;LTF;BVES;DMTN;LMO1
13184,GO:0048706,0.541434700864075,0.818695835576153,1,115,embryonic skeletal system development,BP,DMRT2
3993,GO:0008270,0.541688309618333,0.638654085019975,5,715,zinc ion binding,MF,TRIM67;PRKCG;ENPP2;VAT1L;MYT1
8770,GO:0032984,0.542244321540164,0.729324296750363,2,294,protein-containing complex disassembly,BP,SCIN;DMTN
1872,GO:0004252,0.543805313318677,0.816706196737768,1,132,serine-type endopeptidase activity,MF,LTF
17885,GO:0097730,0.543979904090562,0.816770937594463,1,111,non-motile cilium,CC,USH1C
6238,GO:0017156,0.544884554906857,0.816091109282506,1,109,calcium ion regulated exocytosis,BP,SCIN
2764,GO:0005788,0.545366718034245,0.726585601863842,2,267,endoplasmic reticulum lumen,CC,COL9A1;COL28A1
4655,GO:0009991,0.545589663690167,0.681723470135295,3,444,response to extracellular stimulus,BP,PRKCG;EGFR;CCK
18883,GO:1901342,0.546264628774252,0.72576762892819,2,268,regulation of vasculature development,BP,GPNMB;ENPP2
4301,GO:0009057,0.546341290509323,0.599630192847703,8,1229,macromolecule catabolic process,BP,NOS2;TRIM67;PRKCG;EGFR;GJA1;ACAN;PHKG1;GPC6
16233,GO:0071322,0.546581217337788,0.814659172014487,1,119,cellular response to carbohydrate stimulus,BP,GJB6
7036,GO:0022612,0.54759285145664,0.813964148048781,1,110,gland morphogenesis,BP,EGFR
15146,GO:0061061,0.548074065403659,0.651685087948696,4,556,muscle structure development,BP,CAV2;BVES;GJA1;SGCD
588,GO:0001704,0.548275982124881,0.813428055768606,1,110,formation of primary germ layer,BP,EYA2
3525,GO:0006959,0.549475272394655,0.812114656336798,1,154,humoral immune response,BP,LTF
4612,GO:0009855,0.550194357638432,0.811849948117036,1,116,determination of bilateral symmetry,BP,GJA1
20035,GO:1904062,0.550419348825739,0.721963716332657,2,273,regulation of cation transmembrane transport,BP,CACNG4;DAPK1
4599,GO:0009799,0.552393856173845,0.810096436589124,1,117,specification of symmetry,BP,GJA1
5741,GO:0016192,0.553759359289982,0.568526286991828,12,1807,vesicle-mediated transport,BP,SCIN;LTF;CACNG4;ICAM5;CAV2;BVES;PACSIN1;PRKCG;ENPP2;DMTN;RIN1;CNTN2
9625,GO:0035194,0.554195076899645,0.808630129186995,1,120,posttranscriptional gene silencing by RNA,BP,EGFR
3307,GO:0006629,0.555231848956083,0.590757564501954,8,1238,lipid metabolic process,BP,FGFR3;FA2H;ENPP2;ST8SIA2;EGFR;UGT8;GPC6;APOD
3847,GO:0008017,0.555249994184831,0.71763546438834,2,243,microtubule binding,MF,DCX;MX2
576,GO:0001678,0.555614004780049,0.807484123929181,1,121,cellular glucose homeostasis,BP,GJB6
13860,GO:0051384,0.558276099588485,0.805265430392771,1,129,response to glucocorticoid,BP,EGFR
5860,GO:0016441,0.558524358377433,0.805139852070168,1,121,posttranscriptional gene silencing,BP,EGFR
13730,GO:0051171,0.558680046967269,0.524883202549223,35,5276,regulation of nitrogen compound metabolic process,BP,ARX;CRLF1;NOS2;LTF;ZIC2;EYA2;FGFR3;CAMK2A;SOX10;TOX3;CAV2;AHR;OTX1;CHD5;TRIM67;MYRF;PRKCG;GPNMB;ENPP2;EGFR;SPOCK1;GJA1;DMTN;LMO1;IRX2;KNDC1;DMRT2;CNTN2;PRAME;CCK;APOD;MYT1;DAPK1;MBP;COL28A1
5745,GO:0016202,0.559969317986635,0.804032433006692,1,115,regulation of striated muscle tissue development,BP,GJA1
4007,GO:0008286,0.560716724610111,0.803392351489573,1,118,insulin receptor signaling pathway,BP,CAV2
6708,GO:0019933,0.560801877868821,0.803252898576092,1,125,cAMP-mediated signaling,BP,AHR
13158,GO:0048675,0.561101309884328,0.803208249070672,1,107,axon extension,BP,MAG
10578,GO:0042133,0.561331183527384,0.802850828403009,1,122,neurotransmitter metabolic process,BP,NOS2
11969,GO:0045333,0.56223892415611,0.801809501300598,1,162,cellular respiration,BP,NOS2
11283,GO:0043492,0.563104402151494,0.801547446198302,1,109,ATPase activity, coupled to movement of substances,MF,ATP10B
939,GO:0002224,0.563113862719319,0.801364741548044,1,125,toll-like receptor signaling pathway,BP,LTF
18485,GO:0140030,0.563283317283652,0.801352504441365,1,113,modification-dependent protein binding,MF,CHD5
12224,GO:0045892,0.564911380140772,0.59006895035552,7,1044,negative regulation of transcription, DNA-templated,BP,ARX;ZIC2;SOX10;AHR;LMO1;IRX2;PRAME
13130,GO:0048634,0.564911625518772,0.799970075175843,1,117,regulation of muscle organ development,BP,GJA1
72,GO:0000149,0.565883307097526,0.799126671862938,1,121,SNARE binding,MF,DAPK1
11600,GO:0044344,0.566112811462168,0.798907076126728,1,124,cellular response to fibroblast growth factor stimulus,BP,FGFR3
6697,GO:0019903,0.566352838675445,0.798792437178247,1,116,protein phosphatase binding,MF,EGFR
12225,GO:0045893,0.566623521588172,0.571842142667487,9,1329,positive regulation of transcription, DNA-templated,BP,ZIC2;SOX10;TOX3;AHR;OTX1;MYRF;EGFR;LMO1;DMRT2
19735,GO:1903508,0.566623521588172,0.571842142667487,9,1329,positive regulation of nucleic acid-templated transcription,BP,ZIC2;SOX10;TOX3;AHR;OTX1;MYRF;EGFR;LMO1;DMRT2
19365,GO:1902680,0.567562933417957,0.570888906713475,9,1330,positive regulation of RNA biosynthetic process,BP,ZIC2;SOX10;TOX3;AHR;OTX1;MYRF;EGFR;LMO1;DMRT2
19056,GO:1901861,0.56761390964771,0.797737279610929,1,117,regulation of muscle tissue development,BP,GJA1
14627,GO:0060255,0.567698423509035,0.515218917647861,36,5463,regulation of macromolecule metabolic process,BP,ARX;CRLF1;NOS2;LTF;ZIC2;EYA2;FGFR3;CAMK2A;SOX10;TOX3;CAV2;AHR;BVES;OTX1;CHD5;TRIM67;MYRF;PRKCG;GPNMB;ENPP2;EGFR;SPOCK1;GJA1;DMTN;LMO1;IRX2;KNDC1;DMRT2;CNTN2;PRAME;CCK;APOD;MYT1;DAPK1;MBP;COL28A1
4669,GO:0010035,0.568715713390244,0.659384674036536,3,464,response to inorganic substance,BP,SLC30A3;EGFR;DMTN
3639,GO:0007173,0.569252003977859,0.796353765605761,1,119,epidermal growth factor receptor signaling pathway,BP,EGFR
5068,GO:0010942,0.569442435734435,0.630596578064921,4,614,positive regulation of cell death,BP,SCIN;CAMK2A;CCK;DAPK1
7501,GO:0030808,0.569868323301788,0.795759210206417,1,127,regulation of nucleotide biosynthetic process,BP,NOS2
18705,GO:1900371,0.569868323301788,0.795759210206417,1,127,regulation of purine nucleotide biosynthetic process,BP,NOS2
13654,GO:0051053,0.569879133734176,0.795852642601951,1,117,negative regulation of DNA metabolic process,BP,GJA1
16628,GO:0072001,0.570280830489189,0.703483937123902,2,262,renal system development,BP,CRLF1;IRX2
4845,GO:0010634,0.570535028458951,0.795272125803012,1,120,positive regulation of epithelial cell migration,BP,ENPP2
11661,GO:0044455,0.571833595792365,0.793809026519991,1,170,mitochondrial membrane part,CC,SOX10
5165,GO:0014065,0.572264822281118,0.793866225197168,1,116,phosphatidylinositol 3-kinase signaling,BP,EGFR
17656,GO:0097223,0.572533593786475,0.793454079187663,1,135,sperm part,CC,CAV2
18984,GO:1901652,0.572781204437434,0.655418546291027,3,441,response to peptide,BP,CAMK2A;CAV2;GJA1
9427,GO:0034605,0.573478049937746,0.792790388468261,1,121,cellular response to heat,BP,CAMK2A
5997,GO:0016705,0.575863074322559,0.790693339470149,1,129,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen,MF,NOS2
4511,GO:0009411,0.575984524953693,0.790590214590318,1,129,response to UV,BP,EGFR
3810,GO:0007596,0.57643294217034,0.697504784788168,2,292,blood coagulation,BP,PRKCG;DMTN
3294,GO:0006612,0.576660901226657,0.789688548445134,1,177,protein targeting to membrane,BP,DMTN
21222,GO:2000145,0.576673130366968,0.603869401431011,5,739,regulation of cell motility,BP,GPNMB;ENPP2;EGFR;DMTN;APOD
16269,GO:0071375,0.576841880392978,0.697146460231455,2,281,cellular response to peptide hormone stimulus,BP,CAMK2A;CAV2
16183,GO:0071236,0.577244447455712,0.789527789217692,1,128,cellular response to antibiotic,BP,AHR
16514,GO:0071774,0.579021328378504,0.788009817624137,1,128,response to fibroblast growth factor,BP,FGFR3
16493,GO:0071705,0.579224354137989,0.538558365994943,13,2055,nitrogen compound transport,BP,NOS2;CACNG4;SLC17A7;SLC38A1;EGFR;GJA1;SNX22;DMTN;GJB1;MX2;CCK;APOD;MBP
13480,GO:0050790,0.579335269174001,0.538452498978592,13,2006,regulation of catalytic activity,BP,NOS2;LTF;FGFR3;CAV2;BVES;EGFR;SPOCK1;RIN1;RGS6;CCK;DAPK1;MBP;COL28A1
957,GO:0002262,0.579894056492593,0.78721537998139,1,133,myeloid cell homeostasis,BP,DMTN
14512,GO:0060070,0.579964960564407,0.694099077419615,2,292,canonical Wnt signaling pathway,BP,SOX10;CTHRC1
3571,GO:0007034,0.580118580078227,0.787118644402111,1,123,vacuolar transport,BP,CACNG4
487,GO:0001525,0.580496266884451,0.647769769127132,3,432,angiogenesis,BP,GPNMB;ENPP2;APOD
13500,GO:0050817,0.580799715402786,0.693284777819945,2,294,coagulation,BP,PRKCG;DMTN
17079,GO:0080135,0.580874754614048,0.619116599002814,4,602,regulation of cellular response to stress,BP,EYA2;CAMK2A;PRKCG;EGFR
2421,GO:0005096,0.581446820869673,0.692766341330641,2,262,GTPase activator activity,MF,RIN1;RGS6
7311,GO:0030326,0.583115444692888,0.784544700318474,1,122,embryonic limb morphogenesis,BP,GJA1
9605,GO:0035113,0.583115444692888,0.784544700318474,1,122,embryonic appendage morphogenesis,BP,GJA1
6217,GO:0017124,0.583695538863052,0.784052734796005,1,121,SH3 domain binding,MF,GJA1
4200,GO:0008610,0.584337913549458,0.615578125294169,4,624,lipid biosynthetic process,BP,FGFR3;FA2H;ST8SIA2;UGT8
3813,GO:0007599,0.584755613926838,0.68942838504511,2,297,hemostasis,BP,PRKCG;DMTN
13084,GO:0048534,0.584898245540114,0.595453661636896,5,782,hematopoietic or lymphoid organ development,BP,SCIN;LTF;BVES;DMTN;LMO1
8081,GO:0031901,0.585923196144032,0.78205220507011,1,127,early endosome membrane,CC,EGFR
1207,GO:0002695,0.586113573793938,0.781785483734804,1,138,negative regulation of leukocyte activation,BP,GPNMB
17357,GO:0090288,0.586717676624165,0.781388548306941,1,124,negative regulation of cellular response to growth factor stimulus,BP,CAV2
6710,GO:0019935,0.586761316121037,0.781253798783827,1,134,cyclic-nucleotide-mediated signaling,BP,AHR
3290,GO:0006606,0.587696645759366,0.780490547110613,1,128,protein import into nucleus,BP,APOD
3081,GO:0006323,0.588403384976072,0.779745813328792,1,142,DNA packaging,BP,CHD5
2517,GO:0005262,0.588631415679959,0.779849733101765,1,112,calcium channel activity,MF,CACNG4
5508,GO:0015718,0.589160739697743,0.779156219195358,1,133,monocarboxylic acid transport,BP,NOS2
721,GO:0001889,0.589429329241124,0.778938110768489,1,131,liver development,BP,EGFR
16263,GO:0071363,0.589774468565705,0.610055482533004,4,597,cellular response to growth factor stimulus,BP,FGFR3;CAV2;FBN3;EGFR
11415,GO:0043901,0.590309720992914,0.778057252646638,1,143,negative regulation of multi-organism process,BP,LTF
5928,GO:0016571,0.590709067809351,0.777899554350421,1,122,histone methylation,BP,CHD5
4550,GO:0009628,0.591880588968078,0.562470886453888,7,1095,response to abiotic stimulus,BP,NOS2;CAMK2A;MAG;PPL;GJB6;EGFR;GJA1
16356,GO:0071495,0.593240278574941,0.552005911584043,8,1205,cellular response to endogenous stimulus,BP,FGFR3;CAMK2A;SOX10;CAV2;AHR;EGFR;GJA1;DMTN
7556,GO:0030879,0.593294992124374,0.775583016376023,1,124,mammary gland development,BP,GJA1
19668,GO:1903364,0.593537496227438,0.775296352280847,1,131,positive regulation of cellular protein catabolic process,BP,TRIM67
14894,GO:0060627,0.593980464953717,0.634123835269856,3,451,regulation of vesicle-mediated transport,BP,BVES;PACSIN1;PRKCG
21177,GO:2000058,0.595956375203464,0.773095417900039,1,135,regulation of ubiquitin-dependent protein catabolic process,BP,TRIM67
1197,GO:0002685,0.597628496779897,0.771405801717757,1,159,regulation of leukocyte migration,BP,APOD
17757,GO:0097435,0.598905354051054,0.600652826770992,4,588,supramolecular fiber organization,BP,USH1C;SCIN;PACSIN1;DMTN
15106,GO:0061008,0.599029192298199,0.770334873432689,1,134,hepaticobiliary system development,BP,EGFR
9430,GO:0034614,0.599658964878738,0.76965426532693,1,147,cellular response to reactive oxygen species,BP,EGFR
420,GO:0001101,0.600917953107931,0.673380100213445,2,307,response to acid chemical,BP,EGFR;GJA1
19734,GO:1903507,0.601732878738684,0.552215873622739,7,1081,negative regulation of nucleic acid-templated transcription,BP,ARX;ZIC2;SOX10;AHR;LMO1;IRX2;PRAME
8114,GO:0031960,0.602028174158632,0.767506070131069,1,146,response to corticosteroid,BP,EGFR
15513,GO:0062013,0.602736431387738,0.766883011054614,1,143,positive regulation of small molecule metabolic process,BP,NOS2
14444,GO:0055114,0.602811421561886,0.576854855630411,5,870,oxidation-reduction process,BP,NOS2;FA2H;PHKG1;VAT1L;APOD
19364,GO:1902679,0.602962359515731,0.550927317105713,7,1083,negative regulation of RNA biosynthetic process,BP,ARX;ZIC2;SOX10;AHR;LMO1;IRX2;PRAME
21369,GO:2000377,0.603215091310765,0.766428653373417,1,145,regulation of reactive oxygen species metabolic process,BP,EGFR
16631,GO:0072006,0.604827030864349,0.765114528001189,1,127,nephron development,BP,IRX2
3544,GO:0006997,0.605078079412448,0.764833044571413,1,132,nucleus organization,BP,CHD5
13421,GO:0050707,0.605353066411587,0.764456668102796,1,146,regulation of cytokine secretion,BP,MBP
3052,GO:0006281,0.607338993645539,0.620320967450055,3,475,DNA repair,BP,EYA2;PRKCG;EGFR
3419,GO:0006790,0.610652825997645,0.663429477745342,2,331,sulfur compound metabolic process,BP,GSTM1;ACAN
15970,GO:0070820,0.610748076023928,0.759402468794008,1,152,tertiary granule,CC,LTF
4148,GO:0008509,0.611203828611502,0.662960206947126,2,297,anion transmembrane transporter activity,MF,SLC17A7;SLC38A1
16491,GO:0071702,0.61128397596429,0.498475191442846,15,2399,organic substance transport,BP,NOS2;CACNG4;SLC17A7;CAV2;SLC38A1;ATP10B;EGFR;GJA1;SNX22;DMTN;GJB1;MX2;CCK;APOD;MBP
3101,GO:0006357,0.611396529765006,0.505141942790234,13,2015,regulation of transcription by RNA polymerase II,BP,ARX;ZIC2;SOX10;TOX3;AHR;OTX1;CHD5;MYRF;EGFR;LMO1;IRX2;DMRT2;MYT1
410,GO:0001085,0.611731681158738,0.758596637732121,1,138,RNA polymerase II transcription factor binding,MF,AHR
3510,GO:0006937,0.612289635568597,0.758037875864539,1,142,regulation of muscle contraction,BP,DSG2
2322,GO:0004930,0.612539858667549,0.661453491362602,2,347,G-protein coupled receptor activity,MF,GPR17;FPR3
3975,GO:0008236,0.613608596293898,0.756680340762796,1,157,serine-type peptidase activity,MF,LTF
10799,GO:0042581,0.613835615117335,0.756510239558941,1,151,specific granule,CC,LTF
9565,GO:0035023,0.613953042471983,0.756661653740692,1,123,regulation of Rho protein signal transduction,BP,GPR17
7797,GO:0031323,0.61421974120476,0.467364483807573,36,5530,regulation of cellular metabolic process,BP,ARX;CRLF1;NOS2;LTF;ZIC2;EYA2;FGFR3;CAMK2A;SOX10;TOX3;CAV2;AHR;BVES;OTX1;CHD5;TRIM67;MYRF;PRKCG;GPNMB;ENPP2;EGFR;SPOCK1;GJA1;DMTN;LMO1;IRX2;KNDC1;DMRT2;CNTN2;PRAME;CCK;APOD;MYT1;DAPK1;MBP;COL28A1
13634,GO:0051028,0.614461816101423,0.756036961719847,1,137,mRNA transport,BP,MX2
7643,GO:0031047,0.61464405767912,0.755837549061438,1,140,gene silencing by RNA,BP,EGFR
3330,GO:0006661,0.617585222472616,0.753083844999287,1,136,phosphatidylinositol biosynthetic process,BP,FGFR3
3266,GO:0006575,0.617865629976511,0.752629657721909,1,159,cellular modified amino acid metabolic process,BP,GSTM1
7119,GO:0030036,0.61786836442094,0.580730713960505,4,595,actin cytoskeleton organization,BP,USH1C;SCIN;PACSIN1;DMTN
5930,GO:0016573,0.617973720108751,0.7527041461815,1,137,histone acetylation,BP,CHD5
2792,GO:0005840,0.618149157756438,0.752024591223836,1,228,ribosome,CC,APOD
13112,GO:0048592,0.619981921360237,0.750832791589202,1,132,eye morphogenesis,BP,USH1C
18150,GO:0099003,0.621739656568813,0.749123453369195,1,134,vesicle-mediated transport in synapse,BP,PACSIN1
15991,GO:0070848,0.621757971603592,0.576555278032892,4,621,response to growth factor,BP,FGFR3;CAV2;FBN3;EGFR
7295,GO:0030307,0.622064113909604,0.748735917509352,1,142,positive regulation of cell growth,BP,EGFR
3634,GO:0007167,0.62433550758015,0.539570033101865,6,923,enzyme linked receptor protein signaling pathway,BP,FGFR3;CAV2;EFNB3;EGFR;GFRA1;APOD
6248,GO:0017171,0.62480262507765,0.745935806461777,1,161,serine hydrolase activity,MF,LTF
19529,GO:1903047,0.625320275961582,0.553036295984169,5,802,mitotic cell cycle process,BP,USH1C;CAMK2A;CAV2;GPNMB;EGFR
6351,GO:0018393,0.625775089242469,0.745156607640143,1,140,internal peptidyl-lysine acetylation,BP,CHD5
7190,GO:0030163,0.626359623209656,0.551916149222964,5,806,protein catabolic process,BP,NOS2;TRIM67;PRKCG;EGFR;GJA1
2616,GO:0005525,0.626616775701687,0.646811007684402,2,335,GTP binding,MF,MX2;DAPK1
8748,GO:0032956,0.62701060934367,0.646478387846717,2,305,regulation of actin cytoskeleton organization,BP,SCIN;DMTN
3421,GO:0006796,0.627018082308125,0.47415827677976,18,2851,phosphate-containing compound metabolic process,BP,CRLF1;NOS2;LTF;EYA2;FGFR3;CAMK2A;CAV2;PRKCG;GPNMB;ENPP2;EGFR;GFRA1;DMTN;PHKG1;KNDC1;CCK;DAPK1;MBP
18261,GO:0099568,0.627199140546685,0.599393534890688,3,439,cytoplasmic region,CC,SCIN;NOS2;DMTN
3862,GO:0008047,0.627210656667748,0.599336011331343,3,465,enzyme activator activity,MF,LTF;RIN1;RGS6
19845,GO:1903708,0.627296431019003,0.743577366784006,1,151,positive regulation of hemopoiesis,BP,SCIN
4941,GO:0010770,0.627577354038918,0.74346428095469,1,133,positive regulation of cell morphogenesis involved in differentiation,BP,DMTN
3703,GO:0007269,0.627858831658048,0.743139361677456,1,138,neurotransmitter secretion,BP,CAMK2A
18292,GO:0099643,0.627858831658048,0.743139361677456,1,138,signal release from synapse,BP,CAMK2A
18447,GO:0120032,0.628432451777424,0.742548954807401,1,141,regulation of plasma membrane bounded cell projection assembly,BP,DMTN
19444,GO:1902903,0.629280130724949,0.64406596210106,2,308,regulation of supramolecular fiber organization,BP,SCIN;DMTN
13729,GO:0051170,0.630182079806045,0.740758401191112,1,149,import into nucleus,BP,APOD
7152,GO:0030111,0.630264293678922,0.642988582570807,2,319,regulation of Wnt signaling pathway,BP,SOX10;CTHRC1
5469,GO:0015629,0.63065291262355,0.595651502460534,3,454,actin cytoskeleton,CC,SCIN;DMTN;DAPK1
13785,GO:0051254,0.63102811388549,0.504599126321951,9,1398,positive regulation of RNA metabolic process,BP,ZIC2;SOX10;TOX3;AHR;OTX1;MYRF;EGFR;LMO1;DMRT2
19909,GO:1903827,0.631111339036806,0.595120624657623,3,476,regulation of cellular protein localization,BP,EGFR;DMTN;APOD
3509,GO:0006936,0.631301849705824,0.641889985085237,2,317,muscle contraction,BP,DSG2;GJA1
1110,GO:0002520,0.631356139603422,0.546514977146066,5,821,immune system development,BP,SCIN;LTF;BVES;DMTN;LMO1
8483,GO:0032550,0.631746748010055,0.64135971356196,2,338,purine ribonucleoside binding,MF,MX2;DAPK1
17070,GO:0080090,0.631863411592487,0.44940547307238,35,5408,regulation of primary metabolic process,BP,ARX;CRLF1;NOS2;LTF;ZIC2;EYA2;FGFR3;CAMK2A;SOX10;TOX3;CAV2;AHR;OTX1;CHD5;TRIM67;MYRF;PRKCG;GPNMB;ENPP2;EGFR;SPOCK1;GJA1;DMTN;LMO1;IRX2;KNDC1;DMRT2;CNTN2;PRAME;CCK;APOD;MYT1;DAPK1;MBP;COL28A1
557,GO:0001655,0.63190436586067,0.641318464900664,2,294,urogenital system development,BP,CRLF1;IRX2
7476,GO:0030695,0.633082516234074,0.640067363926122,2,292,GTPase regulator activity,MF,RIN1;RGS6
8806,GO:0033036,0.633090846513072,0.470018103016395,17,2693,macromolecule localization,BP,USH1C;SCIN;NOS2;CACNG4;CAV2;ATP10B;PACSIN1;EGFR;GRID2;GJA1;SNX22;DMTN;UGT8;MX2;CNTN2;APOD;MBP
16987,GO:0072657,0.633500819845822,0.592462908991721,3,528,protein localization to membrane,BP,PACSIN1;EGFR;DMTN
13532,GO:0050866,0.63350793015716,0.737407693979616,1,156,negative regulation of cell activation,BP,GPNMB
14811,GO:0060491,0.634060337841445,0.736964490028846,1,143,regulation of cell projection assembly,BP,DMTN
3491,GO:0006906,0.634240932094956,0.736740974299346,1,148,vesicle fusion,BP,CAV2
9652,GO:0035257,0.634638861600537,0.736387393132772,1,143,nuclear hormone receptor binding,MF,PRAME
7027,GO:0022414,0.635078696462045,0.516690488445122,7,1144,reproductive process,BP,CLDN11;DSG2;CHD5;EGFR;GJA1;GJB1;DMRT2
11358,GO:0043604,0.635657930339842,0.561446354895127,4,749,amide biosynthetic process,BP,ST8SIA2;EGFR;UGT8;DAPK1
10401,GO:0038127,0.635928270190951,0.735116201285732,1,141,ERBB signaling pathway,BP,EGFR
5311,GO:0015103,0.635996551156998,0.735047790258553,1,141,inorganic anion transmembrane transporter activity,MF,SLC17A7
715,GO:0001883,0.636396933997132,0.636371937000781,2,341,purine nucleoside binding,MF,MX2;DAPK1
5080,GO:0010959,0.636520258603834,0.636289174657777,2,322,regulation of metal ion transport,BP,CAMK2A;GJA1
14025,GO:0051704,0.636818347140412,0.482143621061722,12,2025,multi-organism process,BP,NOS2;LTF;CLDN11;DSG2;CAV2;EFNB3;CHD5;GJB6;MOG;EGFR;GJA1;MX2
2,GO:0000003,0.636897004300814,0.514718677444345,7,1147,reproduction,BP,CLDN11;DSG2;CHD5;EGFR;GJA1;GJB1;DMRT2
3182,GO:0006475,0.638265852812538,0.732721686769129,1,146,internal protein amino acid acetylation,BP,CHD5
3496,GO:0006913,0.639597379617431,0.632963419277194,2,324,nucleocytoplasmic transport,BP,MX2;APOD
8482,GO:0032549,0.639720292826367,0.632783306733325,2,342,ribonucleoside binding,MF,MX2;DAPK1
7049,GO:0022804,0.639996136538711,0.632593809919039,2,303,active transmembrane transporter activity,MF,SLC17A7;SLC38A1
6352,GO:0018394,0.641027352744337,0.729917759755061,1,147,peptidyl-lysine acetylation,BP,CHD5
12885,GO:0048015,0.643424106733711,0.727529072023873,1,141,phosphatidylinositol-mediated signaling,BP,EGFR
11243,GO:0043408,0.643501158564295,0.552943082315943,4,652,regulation of MAPK cascade,BP,FGFR3;CAV2;GPNMB;EGFR
13728,GO:0051169,0.643635808213056,0.628568310720958,2,327,nuclear transport,BP,MX2;APOD
9602,GO:0035107,0.643947159872684,0.726984370815828,1,142,appendage morphogenesis,BP,GJA1
9603,GO:0035108,0.643947159872684,0.726984370815828,1,142,limb morphogenesis,BP,GJA1
6464,GO:0019216,0.64537970029991,0.626677451230311,2,322,regulation of lipid metabolic process,BP,FGFR3;APOD
3598,GO:0007088,0.64660624287475,0.724171394437445,1,151,regulation of mitotic nuclear division,BP,CAV2
21811,GO:2001233,0.646804616509543,0.62503188465935,2,355,regulation of apoptotic signaling pathway,BP,EYA2;DAPK1
17269,GO:0090174,0.646845531738174,0.723907941126414,1,153,organelle membrane fusion,BP,CAV2
7805,GO:0031331,0.647696923521987,0.62416601149991,2,312,positive regulation of cellular catabolic process,BP,TRIM67;DAPK1
18985,GO:1901653,0.648323365147254,0.623450877754746,2,321,cellular response to peptide,BP,CAMK2A;CAV2
18239,GO:0099531,0.648379901255491,0.722362471673881,1,148,presynaptic process involved in chemical synaptic transmission,BP,CAMK2A
12256,GO:0045934,0.648833599142191,0.492703598122289,8,1282,negative regulation of nucleobase-containing compound metabolic process,BP,ARX;ZIC2;SOX10;AHR;GJA1;LMO1;IRX2;PRAME
16590,GO:0071902,0.650376518077126,0.621170905385252,2,327,positive regulation of protein serine/threonine kinase activity,BP,LTF;EGFR
714,GO:0001882,0.650479095985314,0.62100081883326,2,349,nucleoside binding,MF,MX2;DAPK1
3891,GO:0008104,0.650728821529164,0.456455368890228,15,2415,protein localization,BP,USH1C;SCIN;NOS2;CACNG4;PACSIN1;EGFR;GRID2;GJA1;SNX22;DMTN;UGT8;MX2;CNTN2;APOD;MBP
12887,GO:0048017,0.651152322835764,0.719513195529181,1,144,inositol lipid-mediated signaling,BP,EGFR
7783,GO:0031301,0.65200374803138,0.718445304424763,1,166,integral component of organelle membrane,CC,SLC17A7
5302,GO:0015085,0.653351586462867,0.717320023915114,1,133,calcium ion transmembrane transporter activity,MF,CACNG4
8494,GO:0032561,0.654650254059611,0.616369661570159,2,351,guanyl ribonucleotide binding,MF,MX2;DAPK1
14401,GO:0055037,0.656291976169493,0.714034866952478,1,152,recycling endosome,CC,ST8SIA2
6389,GO:0019001,0.656435597472909,0.614375860436048,2,352,guanyl nucleotide binding,MF,MX2;DAPK1
10797,GO:0042578,0.656769482403758,0.614084243684358,2,321,phosphoric ester hydrolase activity,MF,EYA2;ENPP2
2815,GO:0005875,0.657621487339354,0.712723872359503,1,141,microtubule associated complex,CC,DCX
10589,GO:0042157,0.658776257096384,0.711277468503552,1,167,lipoprotein metabolic process,BP,APOD
4850,GO:0010639,0.659549206390409,0.610951485387309,2,327,negative regulation of organelle organization,BP,SCIN;DMTN
18730,GO:1900542,0.659589185750386,0.710437803753441,1,163,regulation of purine nucleotide metabolic process,BP,NOS2
937,GO:0002221,0.659929916621628,0.710095836540783,1,160,pattern recognition receptor signaling pathway,BP,LTF
1946,GO:0004386,0.662359428168486,0.707633480252891,1,143,helicase activity,MF,CHD5
6962,GO:0021915,0.663154124146295,0.706720562589396,1,149,neural tube development,BP,CTHRC1
15185,GO:0061136,0.663594934106674,0.706115084675032,1,165,regulation of proteasomal protein catabolic process,BP,PRKCG
4508,GO:0009408,0.664357398211455,0.70533516067775,1,159,response to heat,BP,CAMK2A
7025,GO:0022411,0.665174633251719,0.557297376141229,3,526,cellular component disassembly,BP,SCIN;ACAN;DMTN
3815,GO:0007601,0.665744053804012,0.703791471253796,1,164,visual perception,BP,ZIC2
13681,GO:0051099,0.666888569718119,0.70255196717725,1,163,positive regulation of binding,BP,CTHRC1
12415,GO:0046328,0.667047991923594,0.70242490666267,1,157,regulation of JNK cascade,BP,EGFR
19031,GO:1901796,0.667478447001392,0.701878299368405,1,167,regulation of signal transduction by p53 class mediator,BP,CHD5
3517,GO:0006950,0.668215844704637,0.425983565167001,20,3316,response to stress,BP,NOS2;LTF;EYA2;CAMK2A;BVES;PRKCG;GSTM1;GPR17;EGFR;GJA1;DMTN;SCN9A;MX2;CCK;FPR3;APOD;HLA-DRB1;DAPK1;HLA-DRB5;KLRC2
17618,GO:0097164,0.668499146802781,0.700680382403452,1,179,ammonium ion metabolic process,BP,ENPP2
20892,GO:1990138,0.668855825481977,0.700543095590439,1,146,neuron projection extension,BP,MAG
328,GO:0000910,0.669073327838391,0.700207870019227,1,157,cytokinesis,BP,PACSIN1
2979,GO:0006140,0.670031148295923,0.699063855365923,1,169,regulation of nucleotide metabolic process,BP,NOS2
13134,GO:0048639,0.670288766904704,0.698922522343397,1,151,positive regulation of developmental growth,BP,ARX
5676,GO:0016052,0.671391273578544,0.697607838539708,1,163,carbohydrate catabolic process,BP,PHKG1
12115,GO:0045666,0.671775082936958,0.597073107630383,2,319,positive regulation of neuron differentiation,BP,TRIM67;PACSIN1
13882,GO:0051427,0.671808531904771,0.697146558082138,1,163,hormone receptor binding,MF,PRAME
7837,GO:0031396,0.671977041014362,0.696908933898988,1,170,regulation of protein ubiquitination,BP,PRKCG
5499,GO:0015698,0.672998831303474,0.695883685587028,1,156,inorganic anion transport,BP,SLC17A7
13784,GO:0051253,0.674306588770894,0.473338433922415,7,1156,negative regulation of RNA metabolic process,BP,ARX;ZIC2;SOX10;AHR;LMO1;IRX2;PRAME
18508,GO:0140096,0.675418043637755,0.436094521723668,13,2047,catalytic activity, acting on a protein,MF,LTF;EYA2;FGFR3;CAMK2A;EFNB3;MYRF;PRKCG;GALNT13;EGFR;PHKG1;MGAT5B;GALNT9;DAPK1
7309,GO:0030324,0.676264235311489,0.692227241815759,1,158,lung development,BP,EGFR
1139,GO:0002573,0.67641890310026,0.691969636619575,1,169,myeloid leukocyte differentiation,BP,LTF
11357,GO:0043603,0.677443006102941,0.495143947135231,5,963,cellular amide metabolic process,BP,GSTM1;ST8SIA2;EGFR;UGT8;DAPK1
3420,GO:0006793,0.677939226204251,0.419266879970249,18,2937,phosphorus metabolic process,BP,CRLF1;NOS2;LTF;EYA2;FGFR3;CAMK2A;CAV2;PRKCG;GPNMB;ENPP2;EGFR;GFRA1;DMTN;PHKG1;KNDC1;CCK;DAPK1;MBP
7461,GO:0030674,0.681312020839489,0.686495157209237,1,163,protein binding, bridging,MF,CAV2
7782,GO:0031300,0.683108783408993,0.684322757582,1,181,intrinsic component of organelle membrane,CC,SLC17A7
601,GO:0001726,0.683303030157468,0.684276773294691,1,157,ruffle,CC,PACSIN1
3186,GO:0006479,0.683641389495715,0.683841411004661,1,163,protein methylation,BP,CHD5
3963,GO:0008213,0.683641389495715,0.683841411004661,1,163,protein alkylation,BP,CHD5
2897,GO:0006006,0.684103766034114,0.683252740940438,1,171,glucose metabolic process,BP,APOD
3644,GO:0007179,0.684168540474175,0.683246371326202,1,162,transforming growth factor beta receptor signaling pathway,BP,CAV2
11536,GO:0044242,0.684781215664994,0.68238421937622,1,185,cellular lipid catabolic process,BP,ENPP2
4055,GO:0008361,0.685209263720881,0.682094567796571,1,157,regulation of cell size,BP,MAG
7308,GO:0030323,0.685760413063709,0.681420301944281,1,162,respiratory tube development,BP,EGFR
12991,GO:0048284,0.686580660307322,0.680386921617079,1,174,organelle fusion,BP,CAV2
7802,GO:0031328,0.687927338181631,0.435729260123311,10,1652,positive regulation of cellular biosynthetic process,BP,NOS2;ZIC2;SOX10;TOX3;AHR;OTX1;MYRF;EGFR;LMO1;DMRT2
2435,GO:0005126,0.689315306884849,0.677055204660999,1,202,cytokine receptor binding,MF,CRLF1
2176,GO:0004721,0.690145158422393,0.676317079432455,1,166,phosphoprotein phosphatase activity,MF,EYA2
6687,GO:0019887,0.690925193604733,0.675296081488998,1,182,protein kinase regulator activity,MF,LTF
14873,GO:0060589,0.691352753243348,0.574083201029624,2,332,nucleoside-triphosphatase regulator activity,MF,RIN1;RGS6
14065,GO:0051783,0.69234194933516,0.673715149950443,1,171,regulation of nuclear division,BP,CAV2
7752,GO:0031256,0.692738737395274,0.673352626479938,1,158,leading edge membrane,CC,PACSIN1
3180,GO:0006473,0.693749117066329,0.672042575814864,1,174,protein acetylation,BP,CHD5
6170,GO:0017038,0.694275656603462,0.671388811696427,1,179,protein import,BP,APOD
19446,GO:1902905,0.694912190706545,0.670645346435833,1,178,positive regulation of supramolecular fiber organization,BP,SCIN
13978,GO:0051607,0.697678805606442,0.667317373703802,1,186,defense response to virus,BP,MX2
6696,GO:0019902,0.699006948896904,0.665891131919521,1,164,phosphatase binding,MF,EGFR
19101,GO:1901990,0.700069246075884,0.563469847496223,2,376,regulation of mitotic cell cycle phase transition,BP,GPNMB;EGFR
1072,GO:0002449,0.701754406418612,0.66239646690635,1,194,lymphocyte mediated immunity,BP,KLRC2
4621,GO:0009891,0.701761385914328,0.420014928738295,10,1673,positive regulation of biosynthetic process,BP,NOS2;ZIC2;SOX10;TOX3;AHR;OTX1;MYRF;EGFR;LMO1;DMRT2
10702,GO:0042393,0.703433247589399,0.66053137176074,1,170,histone binding,MF,CHD5
13376,GO:0050657,0.703884610137822,0.659921349867522,1,179,nucleic acid transport,BP,MX2
13377,GO:0050658,0.703884610137822,0.659921349867522,1,179,RNA transport,BP,MX2
13657,GO:0051056,0.705524158886214,0.556939457401593,2,324,regulation of small GTPase mediated signal transduction,BP,TRIM67;GPR17
8486,GO:0032553,0.705538269314632,0.410614072490923,11,1728,ribonucleotide binding,MF,NOS2;FGFR3;CAMK2A;BVES;CHD5;ATP10B;PRKCG;EGFR;PHKG1;MX2;DAPK1
3174,GO:0006464,0.706237593358106,0.379602359041885,23,3680,cellular protein modification process,BP,CRLF1;NOS2;LTF;EYA2;FGFR3;CAMK2A;CAV2;CHD5;PRKCG;GPNMB;ENPP2;ST8SIA2;GALNT13;EGFR;GFRA1;DMTN;PHKG1;MGAT5B;KNDC1;GALNT9;CCK;DAPK1;MBP
10182,GO:0036211,0.706237593358106,0.379602359041885,23,3680,protein modification process,BP,CRLF1;NOS2;LTF;EYA2;FGFR3;CAMK2A;CAV2;CHD5;PRKCG;GPNMB;ENPP2;ST8SIA2;GALNT13;EGFR;GFRA1;DMTN;PHKG1;MGAT5B;KNDC1;GALNT9;CCK;DAPK1;MBP
19309,GO:1902531,0.706276706291875,0.414845136216117,10,1666,regulation of intracellular signal transduction,BP,CRLF1;LTF;FGFR3;CAV2;CHD5;TRIM67;GPNMB;GPR17;EGFR;GJA1
6574,GO:0019538,0.706404873351576,0.371646555889743,31,5052,protein metabolic process,BP,CRLF1;NOS2;LTF;EYA2;FGFR3;CAMK2A;CAV2;CHD5;TRIM67;MYRF;PRKCG;GPNMB;ENPP2;ST8SIA2;GALNT13;EGFR;GFRA1;SPOCK1;GJA1;ACAN;DMTN;PHKG1;MGAT5B;KNDC1;GALNT9;CNTN2;CCK;APOD;DAPK1;MBP;COL28A1
3804,GO:0007584,0.708485258564626,0.65423744542587,1,192,response to nutrient,BP,EGFR
565,GO:0001664,0.709544402426227,0.652834159002318,1,211,G-protein coupled receptor binding,MF,CTHRC1
2030,GO:0004518,0.710587972252912,0.6516471652907,1,193,nuclease activity,MF,ENPP2
15186,GO:0061138,0.710886531669211,0.651419010677526,1,172,morphogenesis of a branching epithelium,BP,SOX10
13772,GO:0051236,0.712327054900317,0.649567689032833,1,182,establishment of RNA localization,BP,MX2
18958,GO:1901605,0.712675767699698,0.64902018800502,1,201,alpha-amino acid metabolic process,BP,NOS2
17666,GO:0097237,0.713027104259683,0.648568037101484,1,204,cellular response to toxic substance,BP,GSTM1
6227,GO:0017137,0.71546314215028,0.645752846362695,1,170,Rab GTPase binding,MF,RIN1
12264,GO:0045944,0.717067097782429,0.434742229721128,6,1028,positive regulation of transcription by RNA polymerase II,BP,SOX10;AHR;OTX1;EGFR;LMO1;DMRT2
3710,GO:0007281,0.717739415930789,0.642773193569059,1,188,germ cell development,BP,CHD5
3108,GO:0006366,0.719900659164328,0.385961705354259,13,2184,transcription by RNA polymerase II,BP,ARX;ZIC2;SOX10;TOX3;AHR;OTX1;CHD5;MYRF;EGFR;LMO1;IRX2;DMRT2;MYT1
8492,GO:0032559,0.719958213103447,0.404965920565907,9,1407,adenyl ribonucleotide binding,MF,FGFR3;CAMK2A;BVES;CHD5;ATP10B;PRKCG;EGFR;PHKG1;DAPK1
5742,GO:0016197,0.721948727874824,0.637480229643718,1,183,endosomal transport,BP,BVES
5674,GO:0016050,0.722553753340175,0.535542973617307,2,370,vesicle organization,BP,SLC17A7;CAV2
5884,GO:0016491,0.722660519081844,0.488683165233396,3,642,oxidoreductase activity,MF,NOS2;FA2H;VAT1L
18072,GO:0098858,0.722732155669135,0.636546138291819,1,174,actin-based cell projection,CC,USH1C
13212,GO:0048762,0.722875853565211,0.636285263842617,1,185,mesenchymal cell differentiation,BP,SOX10
19650,GO:1903320,0.722978332622193,0.6360915594687,1,195,regulation of protein modification by small protein conjugation or removal,BP,PRKCG
14530,GO:0060090,0.72361996723383,0.635354917452676,1,182,molecular adaptor activity,MF,CAV2
19102,GO:1901991,0.723795215420213,0.63498525406435,1,206,negative regulation of mitotic cell cycle phase transition,BP,GPNMB
16585,GO:0071897,0.725104803530604,0.633399364971213,1,190,DNA biosynthetic process,BP,GJA1
3691,GO:0007254,0.72565505296968,0.632717944716002,1,186,JNK cascade,BP,EGFR
849,GO:0002064,0.725677331830072,0.632737270580374,1,179,epithelial cell development,BP,GJA1
9071,GO:0033674,0.726674698872397,0.48377001093795,3,541,positive regulation of kinase activity,BP,LTF;FGFR3;EGFR
3142,GO:0006417,0.727048965450904,0.529769488248096,2,386,regulation of translation,BP,EGFR;DAPK1
403,GO:0001076,0.727105387812224,0.63086872815382,1,183,transcription factor activity, RNA polymerase II transcription factor binding,MF,SOX10
7412,GO:0030554,0.727621724916722,0.395968886594289,9,1419,adenyl nucleotide binding,MF,FGFR3;CAMK2A;BVES;CHD5;ATP10B;PRKCG;EGFR;PHKG1;DAPK1
8994,GO:0033500,0.727835697928732,0.629853499468673,1,194,carbohydrate homeostasis,BP,GJB6
10810,GO:0042593,0.727835697928732,0.629853499468673,1,194,glucose homeostasis,BP,GJB6
16179,GO:0071229,0.72867193671516,0.628807547216851,1,188,cellular response to acid chemical,BP,EGFR
4843,GO:0010632,0.72911121674806,0.628263832473237,1,184,regulation of epithelial cell migration,BP,ENPP2
2951,GO:0006091,0.729460662973724,0.5265791725189,2,433,generation of precursor metabolites and energy,BP,NOS2;PHKG1
14840,GO:0060541,0.729785927393762,0.627393382034045,1,183,respiratory system development,BP,EGFR
8688,GO:0032869,0.730331616117482,0.626655704834395,1,187,cellular response to insulin stimulus,BP,CAV2
11666,GO:0044464,0.73095920265467,0.391191286112847,90,13950,cell part,CC,ARX;CRLF1;USH1C;SCIN;NOS2;LTF;CLDN11;ZIC2;DSG2;CA11;EYA2;FGFR3;CAMK2A;CDH19;CACNG4;DCX;SOX10;FA2H;TOX3;SLC17A7;ICAM5;MAG;CAV2;AHR;EFNB3;SLC38A1;BVES;COL9A1;SLC30A3;OTX1;CHD5;ATP10B;PPL;TRIM67;GJB6;PACSIN1;MYRF;PRKCG;GSTM1;PCDH8;GPNMB;ENPP2;MOG;ST8SIA2;GPR17;GALNT13;EGFR;GFRA1;GRID2;SPOCK1;GJA1;NRGN;KCNJ6;SNX22;ACAN;DMTN;PHKG1;CSMD3;CTHRC1;LMO1;MGAT5B;KCNJ4;SCN9A;GJB1;IRX2;SGCD;NPTX1;KNDC1;DMRT2;UGT8;RIN1;CREG2;RGS6;GALNT9;GPC6;MX2;CNTN2;ANKS1B;PRAME;SLITRK2;CCK;FPR3;APOD;HLA-DRB1;MYT1;DAPK1;MBP;HLA-DRB5;KLRC2;COL28A1
6456,GO:0019207,0.731446999900889,0.625107773935529,1,202,kinase regulator activity,MF,LTF
10566,GO:0042113,0.731919341615407,0.624518597721488,1,197,B cell activation,BP,AHR
6693,GO:0019899,0.731974370427885,0.372040657530543,13,2123,enzyme binding,MF,FGFR3;CAMK2A;DCX;MAG;CAV2;GSTM1;EGFR;GFRA1;GJA1;PHKG1;KNDC1;RIN1;MBP
3711,GO:0007283,0.734239035374408,0.520466612878265,2,394,spermatogenesis,BP,CLDN11;CHD5
9435,GO:0034622,0.734465476299661,0.42747618374998,5,968,cellular protein-containing complex assembly,BP,USH1C;SCIN;DMTN;MX2;HLA-DRB1
11230,GO:0043393,0.734497979223256,0.621135083225114,1,196,regulation of protein binding,BP,CTHRC1
19098,GO:1901987,0.734966494393436,0.519507223489309,2,400,regulation of cell cycle phase transition,BP,GPNMB;EGFR
18223,GO:0099513,0.736133095221885,0.471801103157064,3,539,polymeric cytoskeletal fiber,CC,DCX;GJA1;DMTN
13920,GO:0051495,0.736507161492528,0.618458754640109,1,199,positive regulation of cytoskeleton organization,BP,SCIN
16542,GO:0071824,0.73836995498747,0.615872935766076,1,219,protein-DNA complex subunit organization,BP,CHD5
8690,GO:0032872,0.73848021199515,0.615869646113105,1,193,regulation of stress-activated MAPK cascade,BP,EGFR
15554,GO:0070062,0.738630941470482,0.364260673140566,13,2418,extracellular exosome,CC,SCIN;LTF;CLDN11;DSG2;SLC38A1;PPL;GFRA1;GJA1;EDIL3;APOD;HLA-DRB1;CPNE4;HLA-DRB5
622,GO:0001763,0.739059322114499,0.61514867191355,1,185,morphogenesis of a branching structure,BP,SOX10
13989,GO:0051641,0.739688111199141,0.35692345076887,15,2541,cellular localization,BP,SCIN;CAMK2A;CACNG4;SLC17A7;CAV2;BVES;PACSIN1;EGFR;GRID2;DMTN;UGT8;MX2;CNTN2;ANKS1B;APOD
2607,GO:0005515,0.739917649952561,0.332456048700162,64,10177,protein binding,MF,CRLF1;USH1C;SCIN;NOS2;LTF;CLDN11;DSG2;EYA2;FGFR3;CAMK2A;CDH19;DCX;SOX10;TOX3;ICAM5;MAG;CAV2;AHR;EFNB3;SLC38A1;BVES;SLC30A3;OTX1;CHD5;ATP10B;PPL;PACSIN1;GSTM1;GPNMB;ENPP2;MOG;EGFR;GFRA1;GRID2;GJA1;NRGN;KCNJ6;ACAN;DMTN;EDIL3;PHKG1;CTHRC1;LMO1;MGAT5B;KCNJ4;GJB1;SGCD;VAT1L;KNDC1;DMRT2;RIN1;RGS6;GPC6;MX2;CNTN2;ANKS1B;PRAME;CCK;APOD;CPNE4;DAPK1;MBP;SMOC1;KLRC2
15705,GO:0070302,0.740400738766279,0.613293386694579,1,194,regulation of stress-activated protein kinase signaling cascade,BP,EGFR
14680,GO:0060326,0.740612066884742,0.612842984984763,1,225,cell chemotaxis,BP,FPR3
2666,GO:0005623,0.74067044272049,0.380010935988704,90,13967,cell,CC,ARX;CRLF1;USH1C;SCIN;NOS2;LTF;CLDN11;ZIC2;DSG2;CA11;EYA2;FGFR3;CAMK2A;CDH19;CACNG4;DCX;SOX10;FA2H;TOX3;SLC17A7;ICAM5;MAG;CAV2;AHR;EFNB3;SLC38A1;BVES;COL9A1;SLC30A3;OTX1;CHD5;ATP10B;PPL;TRIM67;GJB6;PACSIN1;MYRF;PRKCG;GSTM1;PCDH8;GPNMB;ENPP2;MOG;ST8SIA2;GPR17;GALNT13;EGFR;GFRA1;GRID2;SPOCK1;GJA1;NRGN;KCNJ6;SNX22;ACAN;DMTN;PHKG1;CSMD3;CTHRC1;LMO1;MGAT5B;KCNJ4;SCN9A;GJB1;IRX2;SGCD;NPTX1;KNDC1;DMRT2;UGT8;RIN1;CREG2;RGS6;GALNT9;GPC6;MX2;CNTN2;ANKS1B;PRAME;SLITRK2;CCK;FPR3;APOD;HLA-DRB1;MYT1;DAPK1;MBP;HLA-DRB5;KLRC2;COL28A1
17329,GO:0090257,0.74182558250195,0.611346981197115,1,199,regulation of muscle system process,BP,DSG2
1374,GO:0003012,0.743079363087729,0.508870496426979,2,390,muscle system process,BP,DSG2;GJA1
4796,GO:0010557,0.743296393842071,0.377318123433736,9,1558,positive regulation of macromolecule biosynthetic process,BP,ZIC2;SOX10;TOX3;AHR;OTX1;MYRF;EGFR;LMO1;DMRT2
19099,GO:1901988,0.747171833549077,0.603977927239702,1,219,negative regulation of cell cycle phase transition,BP,GPNMB
3554,GO:0007010,0.748345444695145,0.386374059789738,7,1179,cytoskeleton organization,BP,USH1C;SCIN;PPL;PACSIN1;DMTN;UGT8;CNTN2
19772,GO:1903561,0.748918372538868,0.35220307667116,13,2434,extracellular vesicle,CC,SCIN;LTF;CLDN11;DSG2;SLC38A1;PPL;GFRA1;GJA1;EDIL3;APOD;HLA-DRB1;CPNE4;HLA-DRB5
11132,GO:0043230,0.749589472336084,0.351412536753687,13,2436,extracellular organelle,CC,SCIN;LTF;CLDN11;DSG2;SLC38A1;PPL;GFRA1;GJA1;EDIL3;APOD;HLA-DRB1;CPNE4;HLA-DRB5
3700,GO:0007266,0.749631427248872,0.600785905549518,1,187,Rho protein signal transduction,BP,GPR17
15517,GO:0065003,0.74978871083182,0.369498760513809,9,1652,protein-containing complex assembly,BP,USH1C;SCIN;CAV2;GJA1;DMTN;GJB1;MX2;CCK;HLA-DRB1
12456,GO:0046434,0.749981438583957,0.600174288640624,1,208,organophosphate catabolic process,BP,ENPP2
17221,GO:0090092,0.752362280398094,0.596917809661518,1,201,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,CAV2
6017,GO:0016740,0.75327778794977,0.347088369977594,13,2201,transferase activity,MF,FGFR3;CAMK2A;EFNB3;PRKCG;GSTM1;ST8SIA2;GALNT13;EGFR;PHKG1;MGAT5B;UGT8;GALNT9;DAPK1
13110,GO:0048588,0.754243890293568,0.594365621425942,1,190,developmental cell growth,BP,MAG
11713,GO:0044703,0.754842808014866,0.420391311443892,4,777,multi-organism reproductive process,BP,CLDN11;DSG2;CHD5;GJA1
6497,GO:0019318,0.756147991768644,0.591582697120678,1,209,hexose metabolic process,BP,APOD
7804,GO:0031330,0.756768403804819,0.590721409746256,1,207,negative regulation of cellular catabolic process,BP,PRKCG
12959,GO:0048232,0.759821174115613,0.486259195934301,2,413,male gamete generation,BP,CLDN11;CHD5
5880,GO:0016485,0.761561915705595,0.583842150151398,1,223,protein processing,BP,CNTN2
3698,GO:0007264,0.762346290748576,0.437589347173225,3,550,small GTPase mediated signal transduction,BP,TRIM67;GPR17;KNDC1
2803,GO:0005856,0.762736269443979,0.343508720525238,11,1846,cytoskeleton,CC,USH1C;SCIN;NOS2;DCX;PPL;TRIM67;GJA1;DMTN;SGCD;RIN1;DAPK1
5868,GO:0016458,0.762789781392119,0.582142746801035,1,212,gene silencing,BP,EGFR
16131,GO:0071103,0.763663283279483,0.580842618691512,1,221,DNA conformation change,BP,CHD5
3131,GO:0006403,0.764019336158358,0.580361735747939,1,215,RNA localization,BP,MX2
11640,GO:0044429,0.765413564120775,0.406592432763735,4,909,mitochondrial part,CC,SOX10;GJA1;NRGN;MX2
9429,GO:0034613,0.766576021622238,0.349086660759163,9,1643,cellular protein localization,BP,SCIN;CACNG4;PACSIN1;EGFR;GRID2;DMTN;UGT8;CNTN2;APOD
8118,GO:0031967,0.766677543926515,0.386917420236988,5,1053,organelle envelope,CC,SOX10;EGFR;GJA1;NRGN;MX2
8122,GO:0031975,0.766677543926515,0.386917420236988,5,1053,envelope,CC,SOX10;EGFR;GJA1;NRGN;MX2
18515,GO:0140110,0.767273223786959,0.342718588216833,10,1741,transcription regulator activity,MF,ARX;ZIC2;SOX10;TOX3;AHR;OTX1;MYRF;IRX2;DMRT2;MYT1
11904,GO:0045184,0.767862824786042,0.341981329728802,10,1843,establishment of protein localization,BP,NOS2;CACNG4;EGFR;GJA1;SNX22;DMTN;MX2;CNTN2;APOD;MBP
11322,GO:0043543,0.768672415630276,0.573623892071092,1,215,protein acylation,BP,CHD5
16393,GO:0071560,0.769180096037111,0.572921697311132,1,208,cellular response to transforming growth factor beta stimulus,BP,CAV2
4467,GO:0009266,0.7692463210475,0.572781053122873,1,216,response to temperature stimulus,BP,CAMK2A
6470,GO:0019222,0.769282810273544,0.298441198686748,36,5893,regulation of metabolic process,BP,ARX;CRLF1;NOS2;LTF;ZIC2;EYA2;FGFR3;CAMK2A;SOX10;TOX3;CAV2;AHR;BVES;OTX1;CHD5;TRIM67;MYRF;PRKCG;GPNMB;ENPP2;EGFR;SPOCK1;GJA1;DMTN;LMO1;IRX2;KNDC1;DMRT2;CNTN2;PRAME;CCK;APOD;MYT1;DAPK1;MBP;COL28A1
8199,GO:0032103,0.771250031878714,0.569705961828829,1,246,positive regulation of response to external stimulus,BP,EGFR
12992,GO:0048285,0.771415741952673,0.470172740789498,2,407,organelle fission,BP,CAV2;MX2
15939,GO:0070727,0.77272955661188,0.341508759231785,9,1653,cellular macromolecule localization,BP,SCIN;CACNG4;PACSIN1;EGFR;GRID2;DMTN;UGT8;CNTN2;APOD
19145,GO:1902105,0.773079381407497,0.567114165690748,1,223,regulation of leukocyte differentiation,BP,LTF
1597,GO:0003677,0.775225719238838,0.320878046926405,13,2234,DNA binding,MF,ARX;LTF;ZIC2;SOX10;TOX3;AHR;OTX1;CHD5;MYRF;EGFR;IRX2;DMRT2;MYT1
7320,GO:0030336,0.777327022433263,0.560834166450996,1,216,negative regulation of cell migration,BP,APOD
16392,GO:0071559,0.777515269229447,0.560574200896337,1,212,response to transforming growth factor beta,BP,CAV2
3732,GO:0007346,0.777738159408699,0.416699830363353,3,612,regulation of mitotic cell cycle,BP,CAV2;GPNMB;EGFR
9263,GO:0034248,0.77842140551748,0.460208868654642,2,429,regulation of cellular amide metabolic process,BP,EGFR;DAPK1
11172,GO:0043292,0.778840223259487,0.558586334456973,1,212,contractile fiber,CC,GJA1
4376,GO:0009152,0.778983779054945,0.558254888790159,1,235,purine ribonucleotide biosynthetic process,BP,NOS2
11246,GO:0043412,0.779365046326348,0.29624232216286,23,3845,macromolecule modification,BP,CRLF1;NOS2;LTF;EYA2;FGFR3;CAMK2A;CAV2;CHD5;PRKCG;GPNMB;ENPP2;ST8SIA2;GALNT13;EGFR;GFRA1;DMTN;PHKG1;MGAT5B;KNDC1;GALNT9;CCK;DAPK1;MBP
2668,GO:0005635,0.781195033500576,0.456255364222967,2,420,nuclear envelope,CC,EGFR;MX2
2988,GO:0006164,0.784242940190446,0.550262737765522,1,239,purine nucleotide biosynthetic process,BP,NOS2
18942,GO:1901564,0.785187284033997,0.280575791166551,35,5941,organonitrogen compound metabolic process,BP,CRLF1;NOS2;LTF;EYA2;FGFR3;CAMK2A;FA2H;CAV2;CHD5;TRIM67;MYRF;PRKCG;GSTM1;GPNMB;ENPP2;ST8SIA2;GALNT13;EGFR;GFRA1;SPOCK1;GJA1;ACAN;DMTN;PHKG1;MGAT5B;KNDC1;UGT8;GALNT9;GPC6;CNTN2;CCK;APOD;DAPK1;MBP;COL28A1
12481,GO:0046474,0.785868951560859,0.54784716687663,1,223,glycerophospholipid biosynthetic process,BP,FGFR3
42,GO:0000086,0.785927109862538,0.547690849926754,1,237,G2/M transition of mitotic cell cycle,BP,USH1C
14851,GO:0060560,0.785958313388285,0.547797567322795,1,207,developmental growth involved in morphogenesis,BP,MAG
16969,GO:0072594,0.787212925856122,0.447441153659006,2,493,establishment of protein localization to organelle,BP,CACNG4;APOD
5678,GO:0016054,0.787279362780543,0.545553454129663,1,250,organic acid catabolic process,BP,NOS2
12447,GO:0046395,0.787279362780543,0.545553454129663,1,250,carboxylic acid catabolic process,BP,NOS2
11548,GO:0044267,0.788123149771891,0.282028478310676,27,4601,cellular protein metabolic process,BP,CRLF1;NOS2;LTF;EYA2;FGFR3;CAMK2A;CAV2;CHD5;TRIM67;PRKCG;GPNMB;ENPP2;ST8SIA2;GALNT13;EGFR;GFRA1;SPOCK1;DMTN;PHKG1;MGAT5B;KNDC1;GALNT9;CNTN2;CCK;DAPK1;MBP;COL28A1
135,GO:0000278,0.788153634033873,0.358912540830634,5,971,mitotic cell cycle,BP,USH1C;CAMK2A;CAV2;GPNMB;EGFR
2888,GO:0005996,0.789218228697545,0.542622697214033,1,234,monosaccharide metabolic process,BP,APOD
9401,GO:0034504,0.789756856807741,0.541824541975622,1,226,protein localization to nucleus,BP,APOD
1253,GO:0002758,0.792815525793025,0.536959856568781,1,245,innate immune response-activating signal transduction,BP,LTF
21223,GO:2000146,0.793296039206363,0.536282916733612,1,228,negative regulation of cell motility,BP,APOD
13842,GO:0051347,0.794626886860095,0.393182420397246,3,612,positive regulation of transferase activity,BP,LTF;FGFR3;EGFR
11545,GO:0044262,0.795097806982453,0.53344828772609,1,227,cellular carbohydrate metabolic process,BP,PHKG1
18219,GO:0099503,0.79557998631655,0.36619635960082,4,865,secretory vesicle,CC,LTF;SLC17A7;CAV2;SLC30A3
4461,GO:0009260,0.796662154153242,0.530874272064803,1,248,ribonucleotide biosynthetic process,BP,NOS2
14805,GO:0060485,0.797151440948455,0.530172714896987,1,231,mesenchyme development,BP,SOX10
3795,GO:0007548,0.797615147058511,0.529434613002829,1,231,sex differentiation,BP,DMRT2
11650,GO:0044444,0.798265982769804,0.262875247142248,52,8577,cytoplasmic part,CC,CRLF1;USH1C;SCIN;NOS2;LTF;EYA2;FGFR3;CAMK2A;CACNG4;DCX;SOX10;FA2H;SLC17A7;CAV2;AHR;COL9A1;SLC30A3;CHD5;ATP10B;PPL;GJB6;PACSIN1;MYRF;PRKCG;GSTM1;GPNMB;ST8SIA2;GALNT13;EGFR;GJA1;NRGN;KCNJ6;SNX22;ACAN;DMTN;PHKG1;MGAT5B;KCNJ4;GJB1;NPTX1;RIN1;CREG2;RGS6;GALNT9;GPC6;MX2;ANKS1B;APOD;HLA-DRB1;MYT1;HLA-DRB5;COL28A1
16917,GO:0072522,0.798814233455954,0.527436395762108,1,250,purine-containing compound biosynthetic process,BP,NOS2
8488,GO:0032555,0.799466115663695,0.302810894597115,10,1716,purine ribonucleotide binding,MF,FGFR3;CAMK2A;BVES;CHD5;ATP10B;PRKCG;EGFR;PHKG1;MX2;DAPK1
12444,GO:0046390,0.800530745098322,0.524680185428771,1,251,ribose phosphate biosynthetic process,BP,NOS2
5927,GO:0016570,0.803005365069218,0.424177644406253,2,418,histone modification,BP,EYA2;CHD5
1369,GO:0003007,0.803784600069834,0.519551652861323,1,223,heart morphogenesis,BP,GJA1
284,GO:0000785,0.803829351307697,0.422877844806865,2,450,chromatin,CC,SOX10;CHD5
2615,GO:0005524,0.804753290949257,0.307395297868698,8,1372,ATP binding,MF,FGFR3;CAMK2A;CHD5;ATP10B;PRKCG;EGFR;PHKG1;DAPK1
11427,GO:0043933,0.804837175214919,0.295977422400413,10,1932,protein-containing complex subunit organization,BP,USH1C;SCIN;CAV2;CHD5;GJA1;DMTN;GJB1;MX2;CCK;HLA-DRB1
8687,GO:0032868,0.805075311626035,0.517377897523959,1,238,response to insulin,BP,CAV2
6050,GO:0016791,0.806222882710454,0.515512231487349,1,236,phosphatase activity,MF,EYA2
6192,GO:0017076,0.806504170846071,0.293892737903837,10,1730,purine nucleotide binding,MF,FGFR3;CAMK2A;BVES;CHD5;ATP10B;PRKCG;EGFR;PHKG1;MX2;DAPK1
11768,GO:0044839,0.806555362791932,0.51489793093638,1,252,cell cycle G2/M phase transition,BP,USH1C
13381,GO:0050662,0.807245374031603,0.513742082304638,1,258,coenzyme binding,MF,NOS2
5283,GO:0015031,0.809354269700555,0.295298940709671,9,1750,protein transport,BP,NOS2;CACNG4;EGFR;GJA1;SNX22;DMTN;MX2;APOD;MBP
13871,GO:0051403,0.810821334282924,0.507902704524783,1,242,stress-activated MAPK cascade,BP,EGFR
5926,GO:0016569,0.811628360563139,0.411035482559078,2,426,covalent chromatin modification,BP,EYA2;CHD5
4546,GO:0009615,0.814039918751304,0.50243862404023,1,264,response to virus,BP,MX2
4842,GO:0010631,0.81407868577465,0.502481803422322,1,238,epithelial cell migration,BP,ENPP2
1694,GO:0003924,0.814682417587642,0.501333491285036,1,271,GTPase activity,MF,MX2
17243,GO:0090132,0.814684449106262,0.501459394165238,1,239,epithelium migration,BP,ENPP2
17371,GO:0090305,0.815523452345411,0.499938840979795,1,265,nucleic acid phosphodiester bond hydrolysis,BP,ENPP2
15405,GO:0061695,0.815918933283511,0.499326572250402,1,251,transferase complex, transferring phosphorus-containing groups,CC,PHKG1
11800,GO:0045017,0.816314661215983,0.498679125639255,1,246,glycerolipid biosynthetic process,BP,FGFR3
935,GO:0002218,0.816426693565783,0.498424573141111,1,262,activation of innate immune response,BP,LTF
5668,GO:0016042,0.817280580766765,0.496948550610204,1,270,lipid catabolic process,BP,ENPP2
13742,GO:0051186,0.817312599379524,0.40210596224443,2,512,cofactor metabolic process,BP,GSTM1;EGFR
16842,GO:0072331,0.817794658439567,0.496117119461195,1,259,signal transduction by p53 class mediator,BP,CHD5
9533,GO:0034774,0.818085828206174,0.495501507545102,1,294,secretory granule lumen,CC,LTF
17241,GO:0090130,0.819619322781894,0.493070132322052,1,244,tissue migration,BP,ENPP2
3918,GO:0008144,0.820626849908003,0.280707071789383,9,1585,drug binding,MF,NOS2;FGFR3;CAMK2A;CHD5;ATP10B;PRKCG;EGFR;PHKG1;DAPK1
11241,GO:0043406,0.821330452156044,0.490115670845604,1,249,positive regulation of MAP kinase activity,BP,EGFR
11041,GO:0043086,0.821477062497405,0.354155590117868,3,684,negative regulation of catalytic activity,BP,LTF;SPOCK1;COL28A1
16588,GO:0071900,0.82154072463831,0.395549778428363,2,465,regulation of protein serine/threonine kinase activity,BP,LTF;EGFR
2723,GO:0005739,0.821629787145366,0.292416656519385,7,1555,mitochondrion,CC,EYA2;CAMK2A;SOX10;PPL;GJA1;NRGN;MX2
3699,GO:0007265,0.821954807823795,0.394941653901405,2,438,Ras protein signal transduction,BP,TRIM67;GPR17
5872,GO:0016462,0.822103836476671,0.32899883279857,4,806,pyrophosphatase activity,MF,CHD5;ATP10B;ENPP2;MX2
6067,GO:0016817,0.822739850132133,0.328083700167177,4,808,hydrolase activity, acting on acid anhydrides,MF,CHD5;ATP10B;ENPP2;MX2
6068,GO:0016818,0.822739850132133,0.328083700167177,4,808,hydrolase activity, acting on acid anhydrides, in phosphorus-containing anhydrides,MF,CHD5;ATP10B;ENPP2;MX2
83,GO:0000166,0.825654245855849,0.265129478841822,11,1948,nucleotide binding,MF,NOS2;FGFR3;CAMK2A;BVES;CHD5;ATP10B;PRKCG;EGFR;PHKG1;MX2;DAPK1
18854,GO:1901265,0.825882455595254,0.264835121244841,11,1949,nucleoside phosphate binding,MF,NOS2;FGFR3;CAMK2A;BVES;CHD5;ATP10B;PRKCG;EGFR;PHKG1;MX2;DAPK1
5567,GO:0015833,0.825919911721666,0.273733381978913,9,1784,peptide transport,BP,NOS2;CACNG4;EGFR;GJA1;SNX22;DMTN;MX2;APOD;MBP
16841,GO:0072330,0.826412214585783,0.48123217032819,1,268,monocarboxylic acid biosynthetic process,BP,FA2H
11248,GO:0043414,0.826892393485555,0.480450702086143,1,253,macromolecule methylation,BP,CHD5
13976,GO:0051604,0.828453963368302,0.477598614532687,1,283,protein maturation,BP,CNTN2
18483,GO:0140014,0.828481789972154,0.477664827924528,1,252,mitotic nuclear division,BP,CAV2
7026,GO:0022412,0.828836669315709,0.477003566090556,1,261,cellular process involved in reproduction in multicellular organism,BP,CHD5
14598,GO:0060205,0.832358291927273,0.47060001733788,1,310,cytoplasmic vesicle lumen,CC,LTF
13798,GO:0051271,0.832388802649721,0.470730485127835,1,255,negative regulation of cellular component movement,BP,APOD
4803,GO:0010564,0.832892510872062,0.336967285268684,3,670,regulation of cell cycle process,BP,CAV2;GPNMB;EGFR
4223,GO:0008654,0.832893384167175,0.469798139906882,1,263,phospholipid biosynthetic process,BP,FGFR3
11820,GO:0045055,0.833415050911098,0.33614207798859,3,706,regulated exocytosis,BP,SCIN;LTF;DMTN
404,GO:0001077,0.833978634011123,0.467883505578636,1,256,transcriptional activator activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,OTX1
10944,GO:0042886,0.836071490078938,0.260293929441452,9,1805,amide transport,BP,NOS2;CACNG4;EGFR;GJA1;SNX22;DMTN;MX2;APOD;MBP
10503,GO:0040029,0.838542010129947,0.459598135107609,1,266,regulation of gene expression, epigenetic,BP,EGFR
6698,GO:0019904,0.838569139397971,0.328277049600073,3,653,protein domain specific binding,MF,GRID2;GJA1;KCNJ4
12213,GO:0045860,0.840960585341233,0.364228067802284,2,478,positive regulation of protein kinase activity,BP,LTF;EGFR
4827,GO:0010608,0.841359713607354,0.363528204293087,2,508,posttranscriptional regulation of gene expression,BP,EGFR;DAPK1
12593,GO:0046677,0.842274516590851,0.452673257396846,1,290,response to antibiotic,BP,AHR
7683,GO:0031098,0.843779649726783,0.449964876147953,1,268,stress-activated protein kinase signaling cascade,BP,EGFR
10495,GO:0040013,0.845364986260279,0.447020321181626,1,267,negative regulation of locomotion,BP,APOD
7456,GO:0030667,0.845717677190584,0.44632946121597,1,276,secretory granule membrane,CC,CAV2
4514,GO:0009416,0.847019610931827,0.443896416614811,1,275,response to light stimulus,BP,EGFR
3038,GO:0006260,0.847036156399515,0.443868937253348,1,274,DNA replication,BP,EGFR
3082,GO:0006325,0.847549907962956,0.314272977223509,3,674,chromatin organization,BP,EYA2;TOX3;CHD5
13918,GO:0051493,0.847725273408019,0.352969073607335,2,473,regulation of cytoskeleton organization,BP,SCIN;DMTN
3972,GO:0008233,0.848559760349987,0.351515590113048,2,510,peptidase activity,MF,LTF;MYRF
3037,GO:0006259,0.850206264082796,0.287542872948129,4,896,DNA metabolic process,BP,EYA2;PRKCG;EGFR;GJA1
3212,GO:0006518,0.85095321882395,0.308815090714022,3,803,peptide metabolic process,BP,GSTM1;EGFR;DAPK1
7957,GO:0031625,0.856272295469347,0.426194198075527,1,292,ubiquitin protein ligase binding,MF,EGFR
7034,GO:0022607,0.856449469978577,0.216235648277227,14,2621,cellular component assembly,BP,USH1C;SCIN;CDH19;CAV2;GRID2;GJA1;DMTN;GJB1;UGT8;MX2;SLITRK2;CCK;APOD;HLA-DRB1
8116,GO:0031965,0.85651361036281,0.425772458675308,1,278,nuclear membrane,CC,EGFR
5070,GO:0010948,0.858246786717538,0.422315562106798,1,304,negative regulation of cell cycle process,BP,GPNMB
4388,GO:0009165,0.858640809123821,0.421539704302063,1,306,nucleotide biosynthetic process,BP,NOS2
7017,GO:0022402,0.858818308914769,0.249216712232096,6,1257,cell cycle process,BP,USH1C;CAMK2A;CAV2;PACSIN1;GPNMB;EGFR
3178,GO:0006470,0.860933189595016,0.417115534107795,1,281,protein dephosphorylation,BP,EYA2
18859,GO:1901293,0.861554273816884,0.415799559794929,1,310,nucleoside phosphate biosynthetic process,BP,NOS2
9868,GO:0035639,0.862410672862129,0.224586915756193,9,1677,purine ribonucleoside triphosphate binding,MF,FGFR3;CAMK2A;CHD5;ATP10B;PRKCG;EGFR;PHKG1;MX2;DAPK1
15876,GO:0070588,0.86309048223345,0.41286443103317,1,275,calcium ion transmembrane transport,BP,CACNG4
11851,GO:0045089,0.86321008861633,0.412527444655373,1,306,positive regulation of innate immune response,BP,LTF
5955,GO:0016604,0.86472590808795,0.286720797308119,3,702,nuclear body,CC,ZIC2;CHD5;ANKS1B
4773,GO:0010506,0.866537739743703,0.405909246008039,1,292,regulation of autophagy,BP,DAPK1
3709,GO:0007276,0.866810173524265,0.320015135009183,2,523,gamete generation,BP,CLDN11;CHD5
18950,GO:1901575,0.867148561185589,0.217986297012335,9,1889,organic substance catabolic process,BP,NOS2;TRIM67;PRKCG;ENPP2;EGFR;GJA1;ACAN;PHKG1;GPC6
11618,GO:0044389,0.868394984720635,0.40211623063116,1,305,ubiquitin-like protein ligase binding,MF,EGFR
288,GO:0000790,0.870940124645975,0.396931832345238,1,304,nuclear chromatin,CC,CHD5
3213,GO:0006520,0.872436205314388,0.393765343605175,1,340,cellular amino acid metabolic process,BP,NOS2
3308,GO:0006631,0.873653512794668,0.391285890708491,1,326,fatty acid metabolic process,BP,FA2H
8272,GO:0032259,0.874154724805187,0.390304327955194,1,305,methylation,BP,CHD5
3530,GO:0006974,0.874207772450347,0.271020721304699,3,745,cellular response to DNA damage stimulus,BP,EYA2;PRKCG;EGFR
567,GO:0001666,0.876999966055208,0.38432242250765,1,323,response to hypoxia,BP,NOS2
7841,GO:0031400,0.877427287090871,0.300939968141853,2,536,negative regulation of protein modification process,BP,PRKCG;DMTN
8219,GO:0032147,0.877870787808352,0.382548182621288,1,303,activation of protein kinase activity,BP,EGFR
3643,GO:0007178,0.877917166786792,0.382468487732517,1,297,transmembrane receptor protein serine/threonine kinase signaling pathway,BP,CAV2
1862,GO:0004175,0.878060003335656,0.38208241421269,1,328,endopeptidase activity,MF,LTF
1614,GO:0003713,0.879470317905564,0.379172030442836,1,303,transcription coactivator activity,MF,SOX10
2687,GO:0005667,0.883332688631396,0.370888602061956,1,318,transcription factor complex,CC,AHR
10206,GO:0036293,0.885019112810874,0.367216565255694,1,331,response to decreased oxygen levels,BP,NOS2
11240,GO:0043405,0.886110697399331,0.36488876710461,1,315,regulation of MAP kinase activity,BP,EGFR
7803,GO:0031329,0.88946069234745,0.245024671809543,3,760,regulation of cellular catabolic process,BP,TRIM67;PRKCG;DAPK1
59,GO:0000122,0.890696260340183,0.242882928376408,3,746,negative regulation of transcription by RNA polymerase II,BP,ARX;LMO1;IRX2
3138,GO:0006412,0.891315872885682,0.274988981759853,2,651,translation,BP,EGFR;DAPK1
13680,GO:0051098,0.8913189900901,0.353392581384812,1,333,regulation of binding,BP,CTHRC1
12175,GO:0045786,0.891463964519152,0.274773826621925,2,570,negative regulation of cell cycle,BP,GPNMB;EGFR
4300,GO:0009056,0.8929800029776,0.174458942285468,11,2305,catabolic process,BP,NOS2;TRIM67;PRKCG;GSTM1;ENPP2;EGFR;GJA1;ACAN;PHKG1;GPC6;DAPK1
19911,GO:1903829,0.894316411297168,0.346705707438891,1,326,positive regulation of cellular protein localization,BP,EGFR
3289,GO:0006605,0.895482334163702,0.343934582873871,1,394,protein targeting,BP,DMTN
3477,GO:0006887,0.897746146619608,0.230445388795016,3,808,exocytosis,BP,SCIN;LTF;DMTN
12176,GO:0045787,0.898742346059731,0.336623822025705,1,336,positive regulation of cell cycle,BP,EGFR
4303,GO:0009059,0.898750402105361,0.146729388599953,26,4765,macromolecule biosynthetic process,BP,ARX;LTF;ZIC2;EYA2;CAMK2A;SOX10;TOX3;AHR;OTX1;CHD5;MYRF;ST8SIA2;GALNT13;EGFR;GJA1;ACAN;PHKG1;LMO1;MGAT5B;IRX2;DMRT2;GALNT9;GPC6;PRAME;MYT1;DAPK1
3580,GO:0007049,0.899832610963196,0.175593822764233,8,1708,cell cycle,BP,USH1C;CAMK2A;CAV2;AHR;PACSIN1;GPNMB;EGFR;MX2
6592,GO:0019637,0.900180691329243,0.207804086567178,4,1039,organophosphate metabolic process,BP,NOS2;FGFR3;ENPP2;EGFR
15808,GO:0070482,0.900220977875935,0.333182550036932,1,353,response to oxygen levels,BP,NOS2
18222,GO:0099512,0.901652452580674,0.223503811823424,3,742,supramolecular fiber,CC,DCX;GJA1;DMTN
11022,GO:0043043,0.901913013167404,0.254484429300591,2,671,peptide biosynthetic process,BP,EGFR;DAPK1
668,GO:0001819,0.902139434209678,0.328714977144621,1,362,positive regulation of cytokine production,BP,MBP
11850,GO:0045088,0.905234329983572,0.321458754501849,1,361,regulation of innate immune response,BP,LTF
18178,GO:0099081,0.906029090660414,0.215590231097535,3,749,supramolecular polymer,CC,DCX;GJA1;DMTN
18177,GO:0099080,0.906742894869109,0.214290149635273,3,750,supramolecular complex,CC,DCX;GJA1;DMTN
11556,GO:0044282,0.910295510468405,0.309314244708851,1,389,small molecule catabolic process,BP,NOS2
17425,GO:0090407,0.910640009398609,0.237100386304689,2,610,organophosphate biosynthetic process,BP,NOS2;FGFR3
6211,GO:0017111,0.911065519240867,0.206354206841989,3,764,nucleoside-triphosphatase activity,MF,CHD5;ATP10B;MX2
12446,GO:0046394,0.913101671552745,0.302511973288038,1,374,carboxylic acid biosynthetic process,BP,FA2H
5677,GO:0016053,0.913709384043081,0.301019173305437,1,375,organic acid biosynthetic process,BP,FA2H
11328,GO:0043549,0.914704794457475,0.19958032418633,3,801,regulation of kinase activity,BP,LTF;FGFR3;EGFR
5957,GO:0016607,0.915493742500324,0.296642635609613,1,361,nuclear speck,CC,CHD5
6313,GO:0018205,0.917460128506919,0.291753724084734,1,357,peptidyl-lysine modification,BP,CHD5
11544,GO:0044260,0.919765996362945,0.114771061561822,42,7344,cellular macromolecule metabolic process,BP,ARX;CRLF1;NOS2;LTF;ZIC2;EYA2;FGFR3;CAMK2A;CACNG4;SOX10;TOX3;CAV2;AHR;BVES;OTX1;CHD5;TRIM67;MYRF;PRKCG;GPNMB;ENPP2;ST8SIA2;GALNT13;EGFR;GFRA1;SPOCK1;GJA1;DMTN;PHKG1;LMO1;MGAT5B;IRX2;KNDC1;DMRT2;GALNT9;CNTN2;PRAME;CCK;MYT1;DAPK1;MBP;COL28A1
11478,GO:0044085,0.920806263208297,0.128392750880318,14,2879,cellular component biogenesis,BP,USH1C;SCIN;CDH19;CAV2;GRID2;GJA1;DMTN;GJB1;UGT8;MX2;SLITRK2;CCK;APOD;HLA-DRB1
6229,GO:0017144,0.920888607252885,0.215879542382218,2,685,drug metabolic process,BP,NOS2;EGFR
136,GO:0000280,0.921550166080001,0.281394742661016,1,367,nuclear division,BP,CAV2
6713,GO:0019953,0.924113851596581,0.209078630582563,2,634,sexual reproduction,BP,CLDN11;CHD5
13975,GO:0051603,0.92473428500982,0.20775897322944,2,627,proteolysis involved in cellular protein catabolic process,BP,TRIM67;PRKCG
1066,GO:0002443,0.925314609560918,0.206483582052649,2,680,leukocyte mediated immunity,BP,LTF;KLRC2
3099,GO:0006355,0.926213012402897,0.116780151140768,17,3325,regulation of transcription, DNA-templated,BP,ARX;LTF;ZIC2;EYA2;CAMK2A;SOX10;TOX3;AHR;OTX1;CHD5;MYRF;EGFR;LMO1;IRX2;DMRT2;PRAME;MYT1
10824,GO:0042623,0.92786191765606,0.265044517330284,1,348,ATPase activity, coupled,MF,ATP10B
18951,GO:1901576,0.92787592097938,0.10617931840379,31,5750,organic substance biosynthetic process,BP,ARX;NOS2;LTF;ZIC2;EYA2;FGFR3;CAMK2A;SOX10;FA2H;TOX3;AHR;OTX1;CHD5;MYRF;GSTM1;ST8SIA2;GALNT13;EGFR;GJA1;ACAN;PHKG1;LMO1;MGAT5B;IRX2;DMRT2;UGT8;GALNT9;GPC6;PRAME;MYT1;DAPK1
750,GO:0001933,0.92795114470856,0.264737156257058,1,387,negative regulation of protein phosphorylation,BP,DMTN
13988,GO:0051640,0.928317558339793,0.200054767463093,2,613,organelle localization,BP,CAV2;BVES
461,GO:0001228,0.928508159110246,0.263277459807801,1,379,transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding,MF,OTX1
11649,GO:0044441,0.929195270546018,0.261471702062934,1,369,ciliary part,CC,USH1C
19733,GO:1903506,0.9300357959915,0.111359941535505,17,3344,regulation of nucleic acid-templated transcription,BP,ARX;LTF;ZIC2;EYA2;CAMK2A;SOX10;TOX3;AHR;OTX1;CHD5;MYRF;EGFR;LMO1;IRX2;DMRT2;PRAME;MYT1
6467,GO:0019219,0.930425070692842,0.108139674017764,20,3836,regulation of nucleobase-containing compound metabolic process,BP,ARX;NOS2;LTF;ZIC2;EYA2;CAMK2A;SOX10;TOX3;AHR;OTX1;CHD5;MYRF;PRKCG;EGFR;GJA1;LMO1;IRX2;DMRT2;PRAME;MYT1
21755,GO:2001141,0.930899737833091,0.110129711216411,17,3349,regulation of RNA biosynthetic process,BP,ARX;LTF;ZIC2;EYA2;CAMK2A;SOX10;TOX3;AHR;OTX1;CHD5;MYRF;EGFR;LMO1;IRX2;DMRT2;PRAME;MYT1
367,GO:0000982,0.933930117761075,0.248687083640315,1,387,transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,OTX1
4484,GO:0009314,0.935011712703163,0.245702719483585,1,402,response to radiation,BP,EGFR
7749,GO:0031252,0.935768424938425,0.243679088551279,1,366,cell leading edge,CC,PACSIN1
6048,GO:0016788,0.936526008486971,0.18191462078793,2,660,hydrolase activity, acting on ester bonds,MF,EYA2;ENPP2
15512,GO:0062012,0.937283971260322,0.239391010830727,1,424,regulation of small molecule metabolic process,BP,NOS2
4374,GO:0009150,0.937412028594929,0.239002049129107,1,450,purine ribonucleotide metabolic process,BP,NOS2
2814,GO:0005874,0.93764848121707,0.238442564825425,1,379,microtubule,CC,DCX
4302,GO:0009058,0.937871200089377,0.0927047372099406,31,5810,biosynthetic process,BP,ARX;NOS2;LTF;ZIC2;EYA2;FGFR3;CAMK2A;SOX10;FA2H;TOX3;AHR;OTX1;CHD5;MYRF;GSTM1;ST8SIA2;GALNT13;EGFR;GJA1;ACAN;PHKG1;LMO1;MGAT5B;IRX2;DMRT2;UGT8;GALNT9;GPC6;PRAME;MYT1;DAPK1
14041,GO:0051726,0.940099984548392,0.13660027235091,4,1088,regulation of cell cycle,BP,CAV2;GPNMB;EGFR;MX2
11190,GO:0043312,0.940124090170001,0.231385416292498,1,454,neutrophil degranulation,BP,LTF
970,GO:0002283,0.941112110700457,0.22857802616109,1,457,neutrophil activation involved in immune response,BP,LTF
21206,GO:2000112,0.941830256601076,0.0927421812018864,19,3735,regulation of cellular macromolecule biosynthetic process,BP,ARX;LTF;ZIC2;EYA2;CAMK2A;SOX10;TOX3;AHR;OTX1;CHD5;MYRF;EGFR;GJA1;LMO1;IRX2;DMRT2;PRAME;MYT1;DAPK1
11540,GO:0044249,0.941863734475811,0.0875286320794653,30,5674,cellular biosynthetic process,BP,ARX;NOS2;LTF;ZIC2;EYA2;FGFR3;CAMK2A;SOX10;FA2H;TOX3;AHR;OTX1;CHD5;MYRF;GSTM1;ST8SIA2;GALNT13;EGFR;GJA1;ACAN;PHKG1;LMO1;MGAT5B;IRX2;DMRT2;UGT8;GALNT9;PRAME;MYT1;DAPK1
2722,GO:0005737,0.942068208232304,0.0859147334632882,59,10141,cytoplasm,CC,CRLF1;USH1C;SCIN;NOS2;LTF;ZIC2;EYA2;FGFR3;CAMK2A;CACNG4;DCX;SOX10;FA2H;SLC17A7;MAG;CAV2;AHR;COL9A1;SLC30A3;CHD5;ATP10B;PPL;TRIM67;GJB6;PACSIN1;MYRF;PRKCG;GSTM1;GPNMB;ST8SIA2;GALNT13;EGFR;SPOCK1;GJA1;NRGN;KCNJ6;SNX22;ACAN;DMTN;PHKG1;CTHRC1;MGAT5B;KCNJ4;GJB1;SGCD;NPTX1;RIN1;CREG2;RGS6;GALNT9;GPC6;MX2;ANKS1B;APOD;HLA-DRB1;MYT1;DAPK1;HLA-DRB5;COL28A1
10669,GO:0042326,0.94213310980521,0.225707636005815,1,420,negative regulation of phosphorylation,BP,DMTN
9451,GO:0034645,0.942566794438622,0.0887467054324931,24,4656,cellular macromolecule biosynthetic process,BP,ARX;LTF;ZIC2;EYA2;CAMK2A;SOX10;TOX3;AHR;OTX1;CHD5;MYRF;ST8SIA2;GALNT13;EGFR;GJA1;PHKG1;LMO1;MGAT5B;IRX2;DMRT2;GALNT9;PRAME;MYT1;DAPK1
1111,GO:0002521,0.942669339644988,0.224166360784191,1,422,leukocyte differentiation,BP,LTF
11542,GO:0044257,0.942993046540502,0.167168078645711,2,676,cellular protein catabolic process,BP,TRIM67;PRKCG
2987,GO:0006163,0.943047981019601,0.223023767572398,1,467,purine nucleotide metabolic process,BP,NOS2
4460,GO:0009259,0.943157503001114,0.222710304159775,1,465,ribonucleotide metabolic process,BP,NOS2
10570,GO:0042119,0.944018447471496,0.220221825886788,1,465,neutrophil activation,BP,LTF
4770,GO:0010498,0.944230615340732,0.21963951700215,1,436,proteasomal protein catabolic process,BP,PRKCG
1069,GO:0002446,0.944789261421543,0.217980255095857,1,467,neutrophil mediated immunity,BP,LTF
13833,GO:0051338,0.945012232225555,0.139952907169768,3,896,regulation of transferase activity,BP,LTF;FGFR3;EGFR
10190,GO:0036230,0.945688375888917,0.21535100770853,1,470,granulocyte activation,BP,LTF
7175,GO:0030141,0.945727537262461,0.160771335651873,2,736,secretory granule,CC,LTF;CAV2
5806,GO:0016311,0.946087057392358,0.214250113923503,1,412,dephosphorylation,BP,EYA2
4760,GO:0010468,0.946769401640604,0.0843443803282855,21,4126,regulation of gene expression,BP,ARX;NOS2;LTF;ZIC2;EYA2;CAMK2A;SOX10;TOX3;AHR;OTX1;CHD5;MYRF;EGFR;GJA1;LMO1;IRX2;DMRT2;CNTN2;PRAME;MYT1;DAPK1
6601,GO:0019693,0.947719453155288,0.209353188777603,1,479,ribose phosphate metabolic process,BP,NOS2
7800,GO:0031326,0.948162100322676,0.0829359514115631,20,3955,regulation of cellular biosynthetic process,BP,ARX;NOS2;LTF;ZIC2;EYA2;CAMK2A;SOX10;TOX3;AHR;OTX1;CHD5;MYRF;EGFR;GJA1;LMO1;IRX2;DMRT2;PRAME;MYT1;DAPK1
13996,GO:0051649,0.950997198946198,0.0947188694118967,8,1938,establishment of localization in cell,BP,CAMK2A;CACNG4;SLC17A7;BVES;PACSIN1;DMTN;MX2;APOD
3095,GO:0006351,0.951351086276551,0.0803728368437632,17,3476,transcription, DNA-templated,BP,ARX;LTF;ZIC2;EYA2;CAMK2A;SOX10;TOX3;AHR;OTX1;CHD5;MYRF;EGFR;LMO1;IRX2;DMRT2;PRAME;MYT1
16916,GO:0072521,0.95256405646651,0.194722449323653,1,494,purine-containing compound metabolic process,BP,NOS2
17859,GO:0097659,0.953312988196867,0.0774461498088662,17,3490,nucleic acid-templated transcription,BP,ARX;LTF;ZIC2;EYA2;CAMK2A;SOX10;TOX3;AHR;OTX1;CHD5;MYRF;EGFR;LMO1;IRX2;DMRT2;PRAME;MYT1
4795,GO:0010556,0.953583912969354,0.0756441950443925,19,3815,regulation of macromolecule biosynthetic process,BP,ARX;LTF;ZIC2;EYA2;CAMK2A;SOX10;TOX3;AHR;OTX1;CHD5;MYRF;EGFR;GJA1;LMO1;IRX2;DMRT2;PRAME;MYT1;DAPK1
953,GO:0002252,0.953637171775249,0.121641930516697,3,994,immune effector process,BP,LTF;MX2;KLRC2
11484,GO:0044092,0.953723967823206,0.121461884499562,3,962,negative regulation of molecular function,BP,LTF;SPOCK1;COL28A1
3497,GO:0006914,0.95403141510916,0.190234103536533,1,456,autophagy,BP,DAPK1
15495,GO:0061919,0.95403141510916,0.190234103536533,1,456,process utilizing autophagic mechanism,BP,DAPK1
11177,GO:0043299,0.954959190978802,0.187309285427441,1,497,leukocyte degranulation,BP,LTF
8628,GO:0032774,0.95502108165908,0.0748863130776604,17,3503,RNA biosynthetic process,BP,ARX;LTF;ZIC2;EYA2;CAMK2A;SOX10;TOX3;AHR;OTX1;CHD5;MYRF;EGFR;LMO1;IRX2;DMRT2;PRAME;MYT1
3476,GO:0006886,0.955047574492613,0.118581044234344,3,1001,intracellular protein transport,BP,CACNG4;DMTN;APOD
6111,GO:0016887,0.955407535410973,0.186003175863285,1,407,ATPase activity,MF,ATP10B
9008,GO:0033554,0.95581779283921,0.0895856523657892,7,1782,cellular response to stress,BP,EYA2;CAMK2A;PRKCG;GSTM1;EGFR;APOD;DAPK1
4619,GO:0009889,0.956471952450604,0.0707980270684704,20,4015,regulation of biosynthetic process,BP,ARX;NOS2;LTF;ZIC2;EYA2;CAMK2A;SOX10;TOX3;AHR;OTX1;CHD5;MYRF;EGFR;GJA1;LMO1;IRX2;DMRT2;PRAME;MYT1;DAPK1
2786,GO:0005829,0.956616778017306,0.0691591491032533,23,4599,cytosol,CC,CRLF1;USH1C;NOS2;EYA2;CAMK2A;DCX;AHR;CHD5;PPL;GJB6;PACSIN1;MYRF;PRKCG;GSTM1;GJA1;DMTN;PHKG1;RIN1;RGS6;MX2;ANKS1B;APOD;MYT1
19310,GO:1902532,0.957137252095293,0.180493346268163,1,458,negative regulation of intracellular signal transduction,BP,TRIM67
963,GO:0002275,0.957290735152096,0.179963363691071,1,505,myeloid cell activation involved in immune response,BP,LTF
12212,GO:0045859,0.957492130787875,0.132333670815978,2,719,regulation of protein kinase activity,BP,LTF;EGFR
11260,GO:0043436,0.957525213486277,0.113152452866636,3,1015,oxoacid metabolic process,BP,NOS2;FA2H;ACAN
1067,GO:0002444,0.957879862371124,0.178086104125335,1,508,myeloid leukocyte mediated immunity,BP,LTF
2944,GO:0006082,0.959735243490155,0.108252947203814,3,1026,organic acid metabolic process,BP,NOS2;FA2H;ACAN
15530,GO:0070011,0.959778031897847,0.172005758273782,1,486,peptidase activity, acting on L-amino acid peptides,MF,LTF
8966,GO:0033365,0.960010630049465,0.125974158550517,2,778,protein localization to organelle,BP,CACNG4;APOD
11539,GO:0044248,0.960453865971185,0.0785044515493066,8,2055,cellular catabolic process,BP,NOS2;TRIM67;PRKCG;GSTM1;ENPP2;ACAN;PHKG1;DAPK1
11660,GO:0044454,0.961169682125306,0.167482124328678,1,479,nuclear chromosome part,CC,CHD5
13783,GO:0051252,0.963890771343573,0.0614023551281314,17,3546,regulation of RNA metabolic process,BP,ARX;LTF;ZIC2;EYA2;CAMK2A;SOX10;TOX3;AHR;OTX1;CHD5;MYRF;EGFR;LMO1;IRX2;DMRT2;PRAME;MYT1
2851,GO:0005929,0.966571603269352,0.149394112746277,1,480,cilium,CC,USH1C
9458,GO:0034654,0.967604788945064,0.0545805056898423,19,3968,nucleobase-containing compound biosynthetic process,BP,ARX;NOS2;LTF;ZIC2;EYA2;CAMK2A;SOX10;TOX3;AHR;OTX1;CHD5;MYRF;EGFR;GJA1;LMO1;IRX2;DMRT2;PRAME;MYT1
11089,GO:0043170,0.967754775940188,0.0496825558266851,45,8159,macromolecule metabolic process,BP,ARX;CRLF1;NOS2;LTF;ZIC2;EYA2;FGFR3;CAMK2A;CACNG4;SOX10;TOX3;CAV2;AHR;BVES;OTX1;CHD5;TRIM67;MYRF;PRKCG;GPNMB;ENPP2;ST8SIA2;GALNT13;EGFR;GFRA1;SPOCK1;GJA1;ACAN;DMTN;PHKG1;LMO1;MGAT5B;IRX2;KNDC1;DMRT2;GALNT9;GPC6;CNTN2;PRAME;CCK;APOD;MYT1;DAPK1;MBP;COL28A1
8639,GO:0032787,0.968041459051165,0.14428579155643,1,530,monocarboxylic acid metabolic process,BP,FA2H
11550,GO:0044271,0.969527878933194,0.0504245183157989,22,4581,cellular nitrogen compound biosynthetic process,BP,ARX;NOS2;LTF;ZIC2;EYA2;CAMK2A;SOX10;TOX3;AHR;OTX1;CHD5;MYRF;ST8SIA2;EGFR;GJA1;LMO1;IRX2;DMRT2;UGT8;PRAME;MYT1;DAPK1
11638,GO:0044427,0.9697476786057,0.100477899179537,2,784,chromosomal part,CC,SOX10;CHD5
112,GO:0000228,0.969849830080739,0.13796438378968,1,511,nuclear chromosome,CC,CHD5
111,GO:0000226,0.971436156339945,0.132333054679941,1,487,microtubule cytoskeleton organization,BP,CNTN2
6293,GO:0018130,0.972568745698852,0.0469046748503371,19,4024,heterocycle biosynthetic process,BP,ARX;NOS2;LTF;ZIC2;EYA2;CAMK2A;SOX10;TOX3;AHR;OTX1;CHD5;MYRF;EGFR;GJA1;LMO1;IRX2;DMRT2;PRAME;MYT1
4344,GO:0009117,0.972849359011045,0.127162775865526,1,587,nucleotide metabolic process,BP,NOS2
6547,GO:0019438,0.973313539741492,0.0457412306435361,19,4031,aromatic compound biosynthetic process,BP,ARX;NOS2;LTF;ZIC2;EYA2;CAMK2A;SOX10;TOX3;AHR;OTX1;CHD5;MYRF;EGFR;GJA1;LMO1;IRX2;DMRT2;PRAME;MYT1
18446,GO:0120031,0.973731143084859,0.123984803828339,1,506,plasma membrane bounded cell projection assembly,BP,DMTN
3397,GO:0006753,0.973956386912127,0.123105556101156,1,594,nucleoside phosphate metabolic process,BP,NOS2
1613,GO:0003712,0.973994306784084,0.123002660417341,1,527,transcription cofactor activity,MF,SOX10
962,GO:0002274,0.974052276810606,0.122758641869003,1,581,myeloid leukocyte activation,BP,LTF
11657,GO:0044451,0.974683143454668,0.0734330351309079,3,1030,nucleoplasm part,CC,ZIC2;CHD5;ANKS1B
3207,GO:0006511,0.974814218232498,0.119960197637498,1,539,ubiquitin-dependent protein catabolic process,BP,TRIM67
12258,GO:0045936,0.975328126894272,0.118044368983372,1,538,negative regulation of phosphate metabolic process,BP,DMTN
4802,GO:0010563,0.975476476520609,0.117488536226439,1,539,negative regulation of phosphorus metabolic process,BP,DMTN
7115,GO:0030031,0.976135518635101,0.115021757474566,1,520,cell projection assembly,BP,DMTN
6711,GO:0019941,0.976326589708349,0.114283058553866,1,549,modification-dependent protein catabolic process,BP,TRIM67
11128,GO:0043226,0.976972181736966,0.0382133677294738,69,11807,organelle,CC,ARX;USH1C;SCIN;NOS2;LTF;CLDN11;ZIC2;DSG2;EYA2;FGFR3;CAMK2A;CACNG4;DCX;SOX10;FA2H;TOX3;SLC17A7;CAV2;AHR;SLC38A1;COL9A1;SLC30A3;OTX1;CHD5;ATP10B;PPL;TRIM67;PACSIN1;MYRF;PRKCG;GPNMB;ST8SIA2;GALNT13;EGFR;GFRA1;GRID2;SPOCK1;GJA1;NRGN;KCNJ6;SNX22;ACAN;DMTN;EDIL3;LMO1;MGAT5B;KCNJ4;GJB1;IRX2;SGCD;NPTX1;DMRT2;UGT8;RIN1;CREG2;RGS6;GALNT9;GPC6;MX2;ANKS1B;PRAME;APOD;HLA-DRB1;MYT1;CPNE4;DAPK1;MBP;HLA-DRB5;COL28A1
11378,GO:0043632,0.977597573053519,0.109435184549293,1,558,modification-dependent macromolecule catabolic process,BP,TRIM67
13819,GO:0051301,0.978989654418159,0.104043498734761,1,561,cell division,BP,PACSIN1
1023,GO:0002366,0.9810357525427,0.0959199234334412,1,622,leukocyte activation involved in immune response,BP,LTF
6618,GO:0019752,0.981455543405163,0.0671077491629623,2,928,carboxylic acid metabolic process,BP,NOS2;FA2H
13800,GO:0051276,0.981515456444915,0.056241827030389,3,1085,chromosome organization,BP,EYA2;TOX3;CHD5
958,GO:0002263,0.981614020492737,0.0935902125140397,1,625,cell activation involved in immune response,BP,LTF
18890,GO:1901362,0.98179529723944,0.0322344636050571,19,4153,organic cyclic compound biosynthetic process,BP,ARX;NOS2;LTF;ZIC2;EYA2;CAMK2A;SOX10;TOX3;AHR;OTX1;CHD5;MYRF;EGFR;GJA1;LMO1;IRX2;DMRT2;PRAME;MYT1
4849,GO:0010638,0.982443514482183,0.0902317200778601,1,587,positive regulation of organelle organization,BP,SCIN
12689,GO:0046907,0.983871114762607,0.0412105025723564,5,1614,intracellular transport,BP,CACNG4;BVES;DMTN;MX2;APOD
14425,GO:0055086,0.984102244245623,0.0833331443899353,1,670,nucleobase-containing small molecule metabolic process,BP,NOS2
371,GO:0000989,0.984761350621869,0.0805784945013943,1,599,transcription factor activity, transcription factor binding,MF,SOX10
21111,GO:1990904,0.984996461439931,0.0795441707232221,1,717,ribonucleoprotein complex,CC,APOD
370,GO:0000988,0.985188330651535,0.0787613167688149,1,603,transcription factor activity, protein binding,MF,SOX10
3543,GO:0006996,0.985626318569941,0.0272145030110151,15,3463,organelle organization,BP,USH1C;SCIN;EYA2;CAMK2A;TOX3;SLC17A7;CAV2;CHD5;PPL;PACSIN1;DMTN;UGT8;MX2;CNTN2;CCK
2708,GO:0005694,0.985772492538417,0.05378237024273,2,898,chromosome,CC,SOX10;CHD5
11557,GO:0044283,0.987225275645611,0.0698956778534903,1,673,small molecule biosynthetic process,BP,FA2H
8811,GO:0033043,0.988321843668538,0.0379371072472291,3,1156,regulation of organelle organization,BP,SCIN;CAV2;DMTN
11641,GO:0044430,0.989623950202038,0.0304204705597116,4,1378,cytoskeletal part,CC,SCIN;DCX;GJA1;DMTN
11131,GO:0043229,0.990556865930988,0.0163201512386561,62,11050,intracellular organelle,CC,ARX;USH1C;SCIN;NOS2;LTF;ZIC2;DSG2;EYA2;FGFR3;CAMK2A;CACNG4;DCX;SOX10;FA2H;TOX3;SLC17A7;CAV2;AHR;COL9A1;SLC30A3;OTX1;CHD5;ATP10B;PPL;TRIM67;PACSIN1;MYRF;PRKCG;GPNMB;ST8SIA2;GALNT13;EGFR;GJA1;NRGN;KCNJ6;SNX22;ACAN;DMTN;LMO1;MGAT5B;KCNJ4;GJB1;IRX2;SGCD;NPTX1;DMRT2;UGT8;RIN1;CREG2;RGS6;GALNT9;GPC6;MX2;ANKS1B;PRAME;APOD;HLA-DRB1;MYT1;DAPK1;MBP;HLA-DRB5;COL28A1
11547,GO:0044265,0.991019341271635,0.0364432706626299,2,1024,cellular macromolecule catabolic process,BP,TRIM67;PRKCG
3426,GO:0006807,0.991878096970844,0.0138115647642569,46,8813,nitrogen compound metabolic process,BP,ARX;CRLF1;NOS2;LTF;ZIC2;EYA2;FGFR3;CAMK2A;SOX10;FA2H;TOX3;CAV2;AHR;OTX1;CHD5;TRIM67;MYRF;PRKCG;GSTM1;GPNMB;ENPP2;ST8SIA2;GALNT13;EGFR;GFRA1;SPOCK1;GJA1;ACAN;DMTN;PHKG1;LMO1;MGAT5B;IRX2;KNDC1;DMRT2;UGT8;GALNT9;GPC6;CNTN2;PRAME;CCK;APOD;MYT1;DAPK1;MBP;COL28A1
11129,GO:0043227,0.992300523202603,0.013457644399707,61,11041,membrane-bounded organelle,CC,ARX;SCIN;NOS2;LTF;CLDN11;ZIC2;DSG2;EYA2;FGFR3;CAMK2A;CACNG4;SOX10;FA2H;TOX3;SLC17A7;CAV2;AHR;SLC38A1;COL9A1;SLC30A3;OTX1;CHD5;ATP10B;PPL;PACSIN1;MYRF;PRKCG;GPNMB;ST8SIA2;GALNT13;EGFR;GFRA1;GJA1;NRGN;KCNJ6;SNX22;ACAN;DMTN;EDIL3;LMO1;MGAT5B;KCNJ4;GJB1;IRX2;NPTX1;DMRT2;UGT8;CREG2;RGS6;GALNT9;GPC6;MX2;ANKS1B;PRAME;APOD;HLA-DRB1;MYT1;CPNE4;MBP;HLA-DRB5;COL28A1
19293,GO:1902494,0.992558792524932,0.0256618137940489,3,1316,catalytic complex,CC,CHD5;PHKG1;RGS6
17615,GO:0097159,0.993795609220049,0.0113612153447731,25,5402,organic cyclic compound binding,MF,ARX;NOS2;LTF;ZIC2;FGFR3;CAMK2A;SOX10;FA2H;TOX3;AHR;BVES;OTX1;CHD5;ATP10B;MYRF;PRKCG;ENPP2;EGFR;PHKG1;IRX2;DMRT2;MX2;APOD;MYT1;DAPK1
20917,GO:1990234,0.993900270416495,0.0381233392139662,1,744,transferase complex,CC,PHKG1
6047,GO:0016787,0.994356635239738,0.0143818076295746,7,2218,hydrolase activity,MF,LTF;EYA2;CHD5;ATP10B;MYRF;ENPP2;MX2
3558,GO:0007017,0.994358986036664,0.035730006354857,1,701,microtubule-based process,BP,CNTN2
1638,GO:0003824,0.994509568629937,0.0102806047165854,23,5189,catalytic activity,MF,NOS2;LTF;EYA2;FGFR3;CAMK2A;FA2H;EFNB3;CHD5;ATP10B;MYRF;PRKCG;GSTM1;ENPP2;ST8SIA2;GALNT13;EGFR;PHKG1;MGAT5B;VAT1L;UGT8;GALNT9;MX2;DAPK1
5925,GO:0016567,0.994772288048079,0.0335261449082001,1,762,protein ubiquitination,BP,PRKCG
1596,GO:0003676,0.995289562978646,0.00992038394586802,14,3624,nucleic acid binding,MF,ARX;LTF;ZIC2;SOX10;TOX3;AHR;OTX1;CHD5;MYRF;ENPP2;EGFR;IRX2;DMRT2;MYT1
4759,GO:0010467,0.995344492522331,0.00896527755831115,21,4917,gene expression,BP,ARX;NOS2;LTF;ZIC2;EYA2;CAMK2A;SOX10;TOX3;AHR;OTX1;CHD5;MYRF;EGFR;GJA1;LMO1;IRX2;DMRT2;CNTN2;PRAME;MYT1;DAPK1
18891,GO:1901363,0.995915914965447,0.00774391621512413,24,5338,heterocyclic compound binding,MF,ARX;NOS2;LTF;ZIC2;FGFR3;CAMK2A;SOX10;FA2H;TOX3;AHR;BVES;OTX1;CHD5;ATP10B;MYRF;PRKCG;ENPP2;EGFR;PHKG1;IRX2;DMRT2;MX2;MYT1;DAPK1
17370,GO:0090304,0.995918200924111,0.00800873541098658,20,4746,nucleic acid metabolic process,BP,ARX;LTF;ZIC2;EYA2;CAMK2A;SOX10;TOX3;AHR;OTX1;CHD5;MYRF;PRKCG;ENPP2;EGFR;GJA1;LMO1;IRX2;DMRT2;PRAME;MYT1
11130,GO:0043228,0.99611294250262,0.00830657690305401,14,3648,non-membrane-bounded organelle,CC,USH1C;SCIN;NOS2;DCX;SOX10;CHD5;PPL;TRIM67;GJA1;DMTN;SGCD;RIN1;APOD;DAPK1
11134,GO:0043232,0.99611294250262,0.00830657690305401,14,3648,intracellular non-membrane-bounded organelle,CC,USH1C;SCIN;NOS2;DCX;SOX10;CHD5;PPL;TRIM67;GJA1;DMTN;SGCD;RIN1;APOD;DAPK1
3124,GO:0006396,0.996246789327685,0.0253810902633906,1,891,RNA processing,BP,EGFR
11533,GO:0044237,0.99694480682516,0.00553197746626208,48,9385,cellular metabolic process,BP,ARX;CRLF1;NOS2;LTF;ZIC2;EYA2;FGFR3;CAMK2A;CACNG4;SOX10;FA2H;TOX3;CAV2;AHR;BVES;OTX1;CHD5;TRIM67;MYRF;PRKCG;GSTM1;GPNMB;ENPP2;ST8SIA2;GALNT13;EGFR;GFRA1;SPOCK1;GJA1;ACAN;DMTN;PHKG1;LMO1;MGAT5B;IRX2;KNDC1;DMRT2;UGT8;GALNT9;GPC6;CNTN2;PRAME;CCK;APOD;MYT1;DAPK1;MBP;COL28A1
11635,GO:0044422,0.997043330641482,0.00537372287984437,41,8301,organelle part,CC,USH1C;SCIN;NOS2;LTF;ZIC2;EYA2;CAMK2A;CACNG4;DCX;SOX10;FA2H;SLC17A7;CAV2;AHR;COL9A1;SLC30A3;CHD5;ATP10B;PACSIN1;MYRF;ST8SIA2;GALNT13;EGFR;GRID2;GJA1;NRGN;SNX22;ACAN;DMTN;LMO1;MGAT5B;KCNJ4;GJB1;GALNT9;GPC6;MX2;ANKS1B;HLA-DRB1;MYT1;HLA-DRB5;COL28A1
8409,GO:0032446,0.997099455884199,0.020414522512133,1,844,protein modification by small protein conjugation,BP,PRKCG
5684,GO:0016070,0.997162916325493,0.00591362620572914,17,4304,RNA metabolic process,BP,ARX;LTF;ZIC2;EYA2;CAMK2A;SOX10;TOX3;AHR;OTX1;CHD5;MYRF;EGFR;LMO1;IRX2;DMRT2;PRAME;MYT1
11555,GO:0044281,0.997959058890686,0.00716864694282853,4,1868,small molecule metabolic process,BP,NOS2;FA2H;ACAN;APOD
2667,GO:0005634,0.997993573761438,0.00386056898391215,29,6455,nucleus,CC,ARX;NOS2;LTF;ZIC2;EYA2;FGFR3;CAMK2A;SOX10;TOX3;CAV2;AHR;OTX1;CHD5;PPL;MYRF;PRKCG;EGFR;GJA1;NRGN;LMO1;IRX2;DMRT2;RGS6;GPC6;MX2;ANKS1B;PRAME;MYT1;MBP
2677,GO:0005654,0.998054226338881,0.00468636034711313,11,3238,nucleoplasm,CC,ZIC2;EYA2;CAMK2A;SOX10;AHR;CHD5;MYRF;GJA1;LMO1;ANKS1B;MYT1
9448,GO:0034641,0.998223734202324,0.00352523935932443,25,5915,cellular nitrogen compound metabolic process,BP,ARX;NOS2;LTF;ZIC2;EYA2;CAMK2A;SOX10;TOX3;AHR;OTX1;CHD5;MYRF;PRKCG;GSTM1;ENPP2;ST8SIA2;EGFR;GJA1;LMO1;IRX2;DMRT2;UGT8;PRAME;MYT1;DAPK1
16492,GO:0071704,0.998254020380877,0.00326902611601366,48,9506,organic substance metabolic process,BP,ARX;CRLF1;NOS2;LTF;ZIC2;EYA2;FGFR3;CAMK2A;CACNG4;SOX10;FA2H;TOX3;CAV2;AHR;BVES;OTX1;CHD5;TRIM67;MYRF;PRKCG;GSTM1;GPNMB;ENPP2;ST8SIA2;GALNT13;EGFR;GFRA1;SPOCK1;GJA1;ACAN;DMTN;PHKG1;LMO1;MGAT5B;IRX2;KNDC1;DMRT2;UGT8;GALNT9;GPC6;CNTN2;PRAME;CCK;APOD;MYT1;DAPK1;MBP;COL28A1
3378,GO:0006725,0.998872880397399,0.00235566354003878,22,5463,cellular aromatic compound metabolic process,BP,ARX;NOS2;LTF;ZIC2;EYA2;CAMK2A;SOX10;TOX3;AHR;OTX1;CHD5;MYRF;PRKCG;GSTM1;ENPP2;EGFR;GJA1;LMO1;IRX2;DMRT2;PRAME;MYT1
2978,GO:0006139,0.998918907397676,0.00228726230345663,21,5285,nucleobase-containing compound metabolic process,BP,ARX;NOS2;LTF;ZIC2;EYA2;CAMK2A;SOX10;TOX3;AHR;OTX1;CHD5;MYRF;PRKCG;ENPP2;EGFR;GJA1;LMO1;IRX2;DMRT2;PRAME;MYT1
11636,GO:0044424,0.998926162157608,0.00226398906492746,70,12539,intracellular part,CC,ARX;CRLF1;USH1C;SCIN;NOS2;LTF;ZIC2;DSG2;EYA2;FGFR3;CAMK2A;CACNG4;DCX;SOX10;FA2H;TOX3;SLC17A7;MAG;CAV2;AHR;COL9A1;SLC30A3;OTX1;CHD5;ATP10B;PPL;TRIM67;GJB6;PACSIN1;MYRF;PRKCG;GSTM1;GPNMB;ST8SIA2;GALNT13;EGFR;SPOCK1;GJA1;NRGN;KCNJ6;SNX22;ACAN;DMTN;PHKG1;CTHRC1;LMO1;MGAT5B;KCNJ4;GJB1;IRX2;SGCD;NPTX1;KNDC1;DMRT2;UGT8;RIN1;CREG2;RGS6;GALNT9;GPC6;MX2;ANKS1B;PRAME;APOD;HLA-DRB1;MYT1;DAPK1;MBP;HLA-DRB5;COL28A1
11133,GO:0043231,0.998932875882268,0.00205538539845301,48,9620,intracellular membrane-bounded organelle,CC,ARX;NOS2;LTF;ZIC2;DSG2;EYA2;FGFR3;CAMK2A;SOX10;FA2H;TOX3;CAV2;AHR;COL9A1;SLC30A3;OTX1;CHD5;ATP10B;PPL;MYRF;PRKCG;ST8SIA2;GALNT13;EGFR;GJA1;NRGN;KCNJ6;ACAN;DMTN;LMO1;MGAT5B;GJB1;IRX2;DMRT2;UGT8;CREG2;RGS6;GALNT9;GPC6;MX2;ANKS1B;PRAME;APOD;HLA-DRB1;MYT1;MBP;HLA-DRB5;COL28A1
11652,GO:0044446,0.998989736968319,0.00196233871500457,38,8105,intracellular organelle part,CC,SCIN;LTF;ZIC2;EYA2;CAMK2A;CACNG4;DCX;SOX10;FA2H;SLC17A7;CAV2;AHR;COL9A1;SLC30A3;CHD5;ATP10B;PACSIN1;MYRF;ST8SIA2;GALNT13;EGFR;GJA1;NRGN;SNX22;ACAN;DMTN;LMO1;MGAT5B;KCNJ4;GJB1;GALNT9;GPC6;MX2;ANKS1B;HLA-DRB1;MYT1;HLA-DRB5;COL28A1
11534,GO:0044238,0.999172978502982,0.00161382270081062,45,9218,primary metabolic process,BP,ARX;CRLF1;NOS2;LTF;ZIC2;EYA2;FGFR3;CAMK2A;SOX10;FA2H;TOX3;CAV2;AHR;OTX1;CHD5;TRIM67;MYRF;PRKCG;GPNMB;ENPP2;ST8SIA2;GALNT13;EGFR;GFRA1;SPOCK1;GJA1;ACAN;DMTN;PHKG1;LMO1;MGAT5B;IRX2;KNDC1;DMRT2;UGT8;GALNT9;GPC6;CNTN2;PRAME;CCK;APOD;MYT1;DAPK1;MBP;COL28A1
15901,GO:0070647,0.999183673246742,0.00685405008972882,1,1010,protein modification by small protein conjugation or removal,BP,PRKCG
2665,GO:0005622,0.999334216774234,0.00146345576034125,71,12743,intracellular,CC,ARX;CRLF1;USH1C;SCIN;NOS2;LTF;ZIC2;DSG2;EYA2;FGFR3;CAMK2A;CACNG4;DCX;SOX10;FA2H;TOX3;SLC17A7;MAG;CAV2;AHR;COL9A1;SLC30A3;OTX1;CHD5;ATP10B;PPL;TRIM67;GJB6;PACSIN1;MYRF;PRKCG;GSTM1;GPNMB;ST8SIA2;GALNT13;EGFR;GFRA1;SPOCK1;GJA1;NRGN;KCNJ6;SNX22;ACAN;DMTN;PHKG1;CTHRC1;LMO1;MGAT5B;KCNJ4;GJB1;IRX2;SGCD;NPTX1;KNDC1;DMRT2;UGT8;RIN1;CREG2;RGS6;GALNT9;GPC6;MX2;ANKS1B;PRAME;APOD;HLA-DRB1;MYT1;DAPK1;MBP;HLA-DRB5;COL28A1
12487,GO:0046483,0.99939485767943,0.00132495349549206,21,5424,heterocycle metabolic process,BP,ARX;NOS2;LTF;ZIC2;EYA2;CAMK2A;SOX10;TOX3;AHR;OTX1;CHD5;MYRF;PRKCG;ENPP2;EGFR;GJA1;LMO1;IRX2;DMRT2;PRAME;MYT1
18888,GO:1901360,0.99946603394113,0.00116570304215307,22,5637,organic cyclic compound metabolic process,BP,ARX;NOS2;LTF;ZIC2;EYA2;CAMK2A;SOX10;TOX3;AHR;OTX1;CHD5;MYRF;PRKCG;GSTM1;ENPP2;EGFR;GJA1;LMO1;IRX2;DMRT2;PRAME;MYT1
8121,GO:0031974,0.999477279250466,0.00121455362545236,17,4759,membrane-enclosed lumen,CC,LTF;ZIC2;EYA2;CAMK2A;SOX10;AHR;COL9A1;CHD5;MYRF;EGFR;GJA1;ACAN;LMO1;GPC6;ANKS1B;MYT1;COL28A1
11135,GO:0043233,0.999477279250466,0.00121455362545236,17,4759,organelle lumen,CC,LTF;ZIC2;EYA2;CAMK2A;SOX10;AHR;COL9A1;CHD5;MYRF;EGFR;GJA1;ACAN;LMO1;GPC6;ANKS1B;MYT1;COL28A1
15532,GO:0070013,0.999477279250466,0.00121455362545236,17,4759,intracellular organelle lumen,CC,LTF;ZIC2;EYA2;CAMK2A;SOX10;AHR;COL9A1;CHD5;MYRF;EGFR;GJA1;ACAN;LMO1;GPC6;ANKS1B;MYT1;COL28A1
3922,GO:0008152,0.999517854880901,0.000971201723046442,49,9943,metabolic process,BP,ARX;CRLF1;NOS2;LTF;ZIC2;EYA2;FGFR3;CAMK2A;CACNG4;SOX10;FA2H;TOX3;CAV2;AHR;BVES;OTX1;CHD5;TRIM67;MYRF;PRKCG;GSTM1;GPNMB;ENPP2;ST8SIA2;GALNT13;EGFR;GFRA1;SPOCK1;GJA1;ACAN;DMTN;PHKG1;LMO1;MGAT5B;IRX2;VAT1L;KNDC1;DMRT2;UGT8;GALNT9;GPC6;CNTN2;PRAME;CCK;APOD;MYT1;DAPK1;MBP;COL28A1
5470,GO:0015630,0.999595242599701,0.00370593882634327,1,1069,microtubule cytoskeleton,CC,DCX
11639,GO:0044428,0.999776414210621,0.000590692506776998,13,4087,nuclear part,CC,ZIC2;EYA2;CAMK2A;SOX10;AHR;CHD5;MYRF;EGFR;GJA1;LMO1;MX2;ANKS1B;MYT1
8123,GO:0031981,0.999851625223956,0.000424924968201565,11,3766,nuclear lumen,CC,ZIC2;EYA2;CAMK2A;SOX10;AHR;CHD5;MYRF;GJA1;LMO1;ANKS1B;MYT1
5397,GO:0015278,0.999999999999989,0.832572593143341,0,21,calcium-release channel activity,MF,
4809,GO:0010573,0.99999999999999,0.809889102474809,0,31,vascular endothelial growth factor production,BP,
21272,GO:2000243,0.999999999999991,0.736135988910604,0,47,positive regulation of reproductive process,BP,
9621,GO:0035176,0.999999999999991,0.693639678308218,0,49,social behavior,BP,
14024,GO:0051703,0.999999999999991,0.693639678308218,0,49,intraspecies interaction between organisms,BP,
7549,GO:0030866,0.999999999999992,0.752294221698221,0,39,cortical actin cytoskeleton organization,BP,
6153,GO:0017000,0.999999999999993,0.904196679763134,0,15,antibiotic biosynthetic process,BP,
19490,GO:1902991,0.999999999999999,0.847741667614709,0,23,regulation of amyloid precursor protein catabolic process,BP,
18750,GO:1900745,0.999999999999999,0.875084045956577,0,21,positive regulation of p38MAPK cascade,BP,
141,GO:0000289,0.999999999999999,0.766842639953619,0,36,nuclear-transcribed mRNA poly(A) tail shortening,BP,
7674,GO:0031087,1,0.963012810014559,0,6,deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
1,GO:0000002,1,0.8380364099698,0,26,mitochondrial genome maintenance,BP,
3,GO:0000009,1,0.993786209041868,0,1,alpha-1,6-mannosyltransferase activity,MF,
4,GO:0000010,1,0.988084581517514,0,2,trans-hexaprenyltranstransferase activity,MF,
5,GO:0000011,1,0.993058458973322,0,1,vacuole inheritance,BP,
6,GO:0000012,1,0.945628740823672,0,8,single strand break repair,BP,
7,GO:0000014,1,0.950128100747016,0,7,single-stranded DNA endodeoxyribonuclease activity,MF,
8,GO:0000015,1,0.977765483234445,0,4,phosphopyruvate hydratase complex,CC,
9,GO:0000018,1,0.631090011809483,0,66,regulation of DNA recombination,BP,
10,GO:0000019,1,0.972478480406138,0,4,regulation of mitotic recombination,BP,
11,GO:0000022,1,0.934371388804127,0,10,mitotic spindle elongation,BP,
12,GO:0000023,1,0.97621337927841,0,3,maltose metabolic process,BP,
13,GO:0000026,1,0.978153203184617,0,3,alpha-1,2-mannosyltransferase activity,MF,
14,GO:0000027,1,0.878840807418488,0,26,ribosomal large subunit assembly,BP,
15,GO:0000028,1,0.945739074382948,0,17,ribosomal small subunit assembly,BP,
16,GO:0000030,1,0.875278961448213,0,23,mannosyltransferase activity,MF,
17,GO:0000032,1,0.99517012130739,0,1,cell wall mannoprotein biosynthetic process,BP,
18,GO:0000033,1,0.984056683885861,0,3,alpha-1,3-mannosyltransferase activity,MF,
19,GO:0000035,1,0.988039992485381,0,3,acyl binding,MF,
20,GO:0000036,1,0.995228475299946,0,2,acyl carrier activity,MF,
21,GO:0000038,1,0.828788291523934,0,29,very long-chain fatty acid metabolic process,BP,
23,GO:0000045,1,0.550761170829186,0,87,autophagosome assembly,BP,
24,GO:0000048,1,0.987384276956332,0,2,peptidyltransferase activity,MF,
25,GO:0000049,1,0.702231222943454,0,55,tRNA binding,MF,
26,GO:0000050,1,0.932784128828341,0,12,urea cycle,BP,
27,GO:0000052,1,0.945339610398127,0,8,citrulline metabolic process,BP,
28,GO:0000053,1,0.99504639207388,0,1,argininosuccinate metabolic process,BP,
29,GO:0000054,1,0.934535180294117,0,13,ribosomal subunit export from nucleus,BP,
30,GO:0000055,1,0.958465137010975,0,8,ribosomal large subunit export from nucleus,BP,
31,GO:0000056,1,0.965012390156102,0,7,ribosomal small subunit export from nucleus,BP,
32,GO:0000060,1,0.75519008702093,0,43,protein import into nucleus, translocation,BP,
33,GO:0000062,1,0.899807429677661,0,18,fatty-acyl-CoA binding,MF,
34,GO:0000064,1,0.959432293666035,0,6,L-ornithine transmembrane transporter activity,MF,
35,GO:0000070,1,0.371648864390988,0,143,mitotic sister chromatid segregation,BP,
36,GO:0000075,1,0.239780965754855,0,211,cell cycle checkpoint,BP,
37,GO:0000076,1,0.903828498085604,0,16,DNA replication checkpoint,BP,
38,GO:0000077,1,0.367733457059166,0,147,DNA damage checkpoint,BP,
41,GO:0000083,1,0.832570557215169,0,28,regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
43,GO:0000095,1,0.994107897982335,0,1,S-adenosyl-L-methionine transmembrane transporter activity,MF,
44,GO:0000096,1,0.788349622767827,0,37,sulfur amino acid metabolic process,BP,
45,GO:0000097,1,0.90369747369196,0,16,sulfur amino acid biosynthetic process,BP,
46,GO:0000098,1,0.938181777448997,0,10,sulfur amino acid catabolic process,BP,
47,GO:0000099,1,0.955838040973397,0,6,sulfur amino acid transmembrane transporter activity,MF,
48,GO:0000101,1,0.966124953652887,0,5,sulfur amino acid transport,BP,
49,GO:0000103,1,0.982438868815716,0,3,sulfate assimilation,BP,
50,GO:0000104,1,0.979732084600258,0,4,succinate dehydrogenase activity,MF,
51,GO:0000105,1,0.986414991216695,0,2,histidine biosynthetic process,BP,
52,GO:0000109,1,0.937261709709864,0,10,nucleotide-excision repair complex,CC,
53,GO:0000110,1,0.979395817015928,0,3,nucleotide-excision repair factor 1 complex,CC,
54,GO:0000111,1,0.992519601752913,0,1,nucleotide-excision repair factor 2 complex,CC,
55,GO:0000117,1,0.984598258908897,0,2,regulation of transcription involved in G2/M transition of mitotic cell cycle,BP,
57,GO:0000120,1,0.970804151859945,0,5,RNA polymerase I transcription factor complex,CC,
58,GO:0000121,1,0.992702730269534,0,1,glycerol-1-phosphatase activity,MF,
60,GO:0000123,1,0.602350263488627,0,75,histone acetyltransferase complex,CC,
61,GO:0000124,1,0.937646228289994,0,11,SAGA complex,CC,
62,GO:0000125,1,0.977476849995725,0,3,PCAF complex,CC,
63,GO:0000126,1,0.981157173941136,0,2,transcription factor TFIIIB complex,CC,
64,GO:0000127,1,0.959991980582872,0,6,transcription factor TFIIIC complex,CC,
65,GO:0000132,1,0.869907022118028,0,20,establishment of mitotic spindle orientation,BP,
66,GO:0000137,1,0.896887194097655,0,16,Golgi cis cisterna,CC,
67,GO:0000138,1,0.961334113565961,0,7,Golgi trans cisterna,CC,
69,GO:0000145,1,0.876717282128401,0,18,exocyst,CC,
70,GO:0000146,1,0.854587790833719,0,17,microfilament motor activity,MF,
71,GO:0000147,1,0.964654753478658,0,5,actin cortical patch assembly,BP,
73,GO:0000150,1,0.952152682844596,0,8,recombinase activity,MF,
74,GO:0000151,1,0.137434797828461,0,289,ubiquitin ligase complex,CC,
75,GO:0000152,1,0.788990165985734,0,38,nuclear ubiquitin ligase complex,CC,
76,GO:0000153,1,0.93133242807459,0,11,cytoplasmic ubiquitin ligase complex,CC,
77,GO:0000154,1,0.841900128282439,0,31,rRNA modification,BP,
78,GO:0000155,1,0.953618347460544,0,6,phosphorelay sensor kinase activity,MF,
79,GO:0000159,1,0.877463227674255,0,19,protein phosphatase type 2A complex,CC,
80,GO:0000160,1,0.946469215902196,0,7,phosphorelay signal transduction system,BP,
81,GO:0000164,1,0.929284794411059,0,11,protein phosphatase type 1 complex,CC,
84,GO:0000170,1,0.996017221888988,0,1,sphingosine hydroxylase activity,MF,
85,GO:0000171,1,0.985886052320955,0,2,ribonuclease MRP activity,MF,
86,GO:0000172,1,0.967275883131943,0,6,ribonuclease MRP complex,CC,
87,GO:0000173,1,0.995457389854497,0,1,inactivation of MAPK activity involved in osmosensory signaling pathway,BP,
88,GO:0000175,1,0.823982387460653,0,30,3'-5'-exoribonuclease activity,MF,
89,GO:0000176,1,0.943047374995878,0,13,nuclear exosome (RNase complex),CC,
90,GO:0000177,1,0.917986776988504,0,15,cytoplasmic exosome (RNase complex),CC,
91,GO:0000178,1,0.881154168086256,0,22,exosome (RNase complex),CC,
92,GO:0000179,1,0.97772164434771,0,4,rRNA (adenine-N6,N6-)-dimethyltransferase activity,MF,
93,GO:0000182,1,0.925244424647211,0,10,rDNA binding,MF,
94,GO:0000183,1,0.909121761860395,0,18,chromatin silencing at rDNA,BP,
95,GO:0000184,1,0.607521433051999,0,117,nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
96,GO:0000185,1,0.884660042916309,0,18,activation of MAPKKK activity,BP,
98,GO:0000187,1,0.409859089996072,0,133,activation of MAPK activity,BP,
99,GO:0000188,1,0.856184997588795,0,24,inactivation of MAPK activity,BP,
100,GO:0000209,1,0.143718803389008,0,290,protein polyubiquitination,BP,
101,GO:0000210,1,0.992545470420504,0,1,NAD+ diphosphatase activity,MF,
102,GO:0000212,1,0.925773012673182,0,10,meiotic spindle organization,BP,
103,GO:0000213,1,0.978033122412515,0,4,tRNA-intron endonuclease activity,MF,
104,GO:0000214,1,0.978516516848733,0,4,tRNA-intron endonuclease complex,CC,
105,GO:0000215,1,0.989956906404693,0,2,tRNA 2'-phosphotransferase activity,MF,
106,GO:0000217,1,0.849034504241883,0,24,DNA secondary structure binding,MF,
107,GO:0000220,1,0.963859992360933,0,6,vacuolar proton-transporting V-type ATPase, V0 domain,CC,
108,GO:0000221,1,0.978912347627033,0,3,vacuolar proton-transporting V-type ATPase, V1 domain,CC,
109,GO:0000224,1,0.993464227140591,0,1,peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity,MF,
110,GO:0000225,1,0.996563983594608,0,1,N-acetylglucosaminylphosphatidylinositol deacetylase activity,MF,
113,GO:0000229,1,0.992270623858078,0,2,cytoplasmic chromosome,CC,
114,GO:0000235,1,0.94031511259877,0,8,astral microtubule,CC,
115,GO:0000242,1,0.855030275908682,0,20,pericentriolar material,CC,
116,GO:0000243,1,0.959172333924329,0,8,commitment complex,CC,
117,GO:0000244,1,0.917423212157518,0,12,spliceosomal tri-snRNP complex assembly,BP,
118,GO:0000245,1,0.695797572993955,0,57,spliceosomal complex assembly,BP,
119,GO:0000246,1,0.992414853997043,0,1,delta24(24-1) sterol reductase activity,MF,
120,GO:0000247,1,0.996559675344949,0,1,C-8 sterol isomerase activity,MF,
121,GO:0000248,1,0.985485708380348,0,2,C-5 sterol desaturase activity,MF,
122,GO:0000250,1,0.992423310468726,0,1,lanosterol synthase activity,MF,
123,GO:0000252,1,0.99557327560826,0,1,C-3 sterol dehydrogenase (C-4 sterol decarboxylase) activity,MF,
124,GO:0000253,1,0.988743640829637,0,3,3-keto sterol reductase activity,MF,
125,GO:0000254,1,0.982304213371489,0,3,C-4 methylsterol oxidase activity,MF,
126,GO:0000255,1,0.973047694973885,0,4,allantoin metabolic process,BP,
127,GO:0000256,1,0.995914666298543,0,1,allantoin catabolic process,BP,
128,GO:0000257,1,0.996103670957157,0,1,nitrilase activity,MF,
129,GO:0000262,1,0.99558470130424,0,1,mitochondrial chromosome,CC,
131,GO:0000268,1,0.973802809868151,0,4,peroxisome targeting sequence binding,MF,
132,GO:0000270,1,0.993915432324873,0,2,peptidoglycan metabolic process,BP,
137,GO:0000281,1,0.634320322406284,0,64,mitotic cytokinesis,BP,
138,GO:0000285,1,0.973590720843354,0,4,1-phosphatidylinositol-3-phosphate 5-kinase activity,MF,
140,GO:0000288,1,0.618321579613314,0,74,nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
142,GO:0000290,1,0.951013244490206,0,8,deadenylation-dependent decapping of nuclear-transcribed mRNA,BP,
143,GO:0000291,1,0.83042478182526,0,34,nuclear-transcribed mRNA catabolic process, exonucleolytic,BP,
144,GO:0000293,1,0.978599601291031,0,3,ferric-chelate reductase activity,MF,
145,GO:0000294,1,0.985130447952044,0,2,nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay,BP,
146,GO:0000295,1,0.933220645248138,0,11,adenine nucleotide transmembrane transporter activity,MF,
147,GO:0000296,1,0.993970497119947,0,1,spermine transport,BP,
148,GO:0000298,1,0.976974422612972,0,4,endopolyphosphatase activity,MF,
149,GO:0000301,1,0.974231357738608,0,4,retrograde transport, vesicle recycling within Golgi,BP,
151,GO:0000303,1,0.863228546985815,0,27,response to superoxide,BP,
152,GO:0000305,1,0.846159745314992,0,30,response to oxygen radical,BP,
153,GO:0000306,1,0.971394443515484,0,4,extrinsic component of vacuolar membrane,CC,
154,GO:0000307,1,0.784866763728738,0,39,cyclin-dependent protein kinase holoenzyme complex,CC,
155,GO:0000308,1,0.984679205545485,0,2,cytoplasmic cyclin-dependent protein kinase holoenzyme complex,CC,
156,GO:0000309,1,0.979414860515984,0,3,nicotinamide-nucleotide adenylyltransferase activity,MF,
157,GO:0000313,1,0.723898818028457,0,82,organellar ribosome,CC,
158,GO:0000314,1,0.900074087583783,0,27,organellar small ribosomal subunit,CC,
159,GO:0000315,1,0.821122096623723,0,50,organellar large ribosomal subunit,CC,
160,GO:0000320,1,0.984884735998896,0,2,re-entry into mitotic cell cycle,BP,
161,GO:0000322,1,0.982287894627436,0,3,storage vacuole,CC,
163,GO:0000333,1,0.983956787115616,0,2,telomerase catalytic core complex,CC,
164,GO:0000334,1,0.996270867477429,0,1,3-hydroxyanthranilate 3,4-dioxygenase activity,MF,
165,GO:0000338,1,0.948464646214192,0,10,protein deneddylation,BP,
166,GO:0000339,1,0.908566839697607,0,15,RNA cap binding,MF,
167,GO:0000340,1,0.951493703378348,0,7,RNA 7-methylguanosine cap binding,MF,
168,GO:0000346,1,0.92346104528315,0,13,transcription export complex,CC,
169,GO:0000347,1,0.967926105662356,0,6,THO complex,CC,
170,GO:0000349,1,0.987118019539581,0,2,generation of catalytic spliceosome for first transesterification step,BP,
171,GO:0000350,1,0.984917600426778,0,3,generation of catalytic spliceosome for second transesterification step,BP,
172,GO:0000354,1,0.983444330409183,0,2,cis assembly of pre-catalytic spliceosome,BP,
173,GO:0000375,1,0.138573475509729,0,314,RNA splicing, via transesterification reactions,BP,
174,GO:0000377,1,0.140968213365477,0,311,RNA splicing, via transesterification reactions with bulged adenosine as nucleophile,BP,
175,GO:0000379,1,0.983203843108884,0,3,tRNA-type intron splice site recognition and cleavage,BP,
176,GO:0000380,1,0.68842285054447,0,54,alternative mRNA splicing, via spliceosome,BP,
177,GO:0000381,1,0.74736641040786,0,42,regulation of alternative mRNA splicing, via spliceosome,BP,
178,GO:0000384,1,0.990950867062792,0,2,first spliceosomal transesterification activity,MF,
179,GO:0000386,1,0.978702955234336,0,3,second spliceosomal transesterification activity,MF,
180,GO:0000387,1,0.805441464731918,0,38,spliceosomal snRNP assembly,BP,
181,GO:0000389,1,0.961693687643632,0,6,mRNA 3'-splice site recognition,BP,
182,GO:0000390,1,0.989404027319676,0,2,spliceosomal complex disassembly,BP,
183,GO:0000393,1,0.972227993341977,0,5,spliceosomal conformational changes to generate catalytic conformation,BP,
184,GO:0000394,1,0.911762864939098,0,17,RNA splicing, via endonucleolytic cleavage and ligation,BP,
185,GO:0000395,1,0.961778489754629,0,6,mRNA 5'-splice site recognition,BP,
186,GO:0000398,1,0.140968213365477,0,311,mRNA splicing, via spliceosome,BP,
187,GO:0000400,1,0.898872999547444,0,16,four-way junction DNA binding,MF,
188,GO:0000403,1,0.954601187461692,0,6,Y-form DNA binding,MF,
189,GO:0000404,1,0.977666487383823,0,3,heteroduplex DNA loop binding,MF,
190,GO:0000405,1,0.948890807750159,0,7,bubble DNA binding,MF,
191,GO:0000406,1,0.985036055322724,0,2,double-strand/single-strand DNA junction binding,MF,
192,GO:0000407,1,0.788225124553915,0,33,phagophore assembly site,CC,
193,GO:0000408,1,0.974902240692381,0,5,EKC/KEOPS complex,CC,
194,GO:0000409,1,0.990962876533541,0,1,regulation of transcription by galactose,BP,
195,GO:0000411,1,0.990962876533541,0,1,positive regulation of transcription by galactose,BP,
196,GO:0000412,1,0.992926083293958,0,1,histone peptidyl-prolyl isomerization,BP,
197,GO:0000413,1,0.844660359971255,0,31,protein peptidyl-prolyl isomerization,BP,
198,GO:0000414,1,0.96481857424829,0,4,regulation of histone H3-K36 methylation,BP,
199,GO:0000415,1,0.991290383283294,0,1,negative regulation of histone H3-K36 methylation,BP,
200,GO:0000416,1,0.992504643462907,0,1,positive regulation of histone H3-K36 methylation,BP,
201,GO:0000417,1,0.992469524748395,0,1,HIR complex,CC,
202,GO:0000421,1,0.829914540097384,0,30,autophagosome membrane,CC,
203,GO:0000422,1,0.591608901310941,0,80,autophagy of mitochondrion,BP,
204,GO:0000423,1,0.87760712841001,0,18,mitophagy,BP,
205,GO:0000428,1,0.43002002662871,0,132,DNA-directed RNA polymerase complex,CC,
206,GO:0000429,1,0.975574927630182,0,4,carbon catabolite regulation of transcription from RNA polymerase II promoter,BP,
207,GO:0000430,1,0.984473118711716,0,3,regulation of transcription from RNA polymerase II promoter by glucose,BP,
208,GO:0000431,1,0.990962876533541,0,1,regulation of transcription from RNA polymerase II promoter by galactose,BP,
209,GO:0000432,1,0.984473118711716,0,3,positive regulation of transcription from RNA polymerase II promoter by glucose,BP,
210,GO:0000435,1,0.990962876533541,0,1,positive regulation of transcription from RNA polymerase II promoter by galactose,BP,
211,GO:0000436,1,0.975574927630182,0,4,carbon catabolite activation of transcription from RNA polymerase II promoter,BP,
212,GO:0000438,1,0.98585425674364,0,3,core TFIIH complex portion of holo TFIIH complex,CC,
213,GO:0000439,1,0.951721820933529,0,8,core TFIIH complex,CC,
214,GO:0000444,1,0.972053140114017,0,4,MIS12/MIND type complex,CC,
215,GO:0000445,1,0.967926105662356,0,6,THO complex part of transcription export complex,CC,
216,GO:0000447,1,0.948667162169838,0,9,endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
217,GO:0000448,1,0.991079148369449,0,1,cleavage in ITS2 between 5.8S rRNA and LSU-rRNA of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
218,GO:0000451,1,0.992036210342068,0,1,rRNA 2'-O-methylation,BP,
219,GO:0000453,1,0.992036210342068,0,1,enzyme-directed rRNA 2'-O-methylation,BP,
220,GO:0000454,1,0.989668265089665,0,3,snoRNA guided rRNA pseudouridine synthesis,BP,
221,GO:0000455,1,0.989566195265378,0,2,enzyme-directed rRNA pseudouridine synthesis,BP,
222,GO:0000459,1,0.965214184172052,0,7,exonucleolytic trimming involved in rRNA processing,BP,
223,GO:0000460,1,0.830726185401195,0,32,maturation of 5.8S rRNA,BP,
224,GO:0000461,1,0.994780361317987,0,2,endonucleolytic cleavage to generate mature 3'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
225,GO:0000462,1,0.811632905413704,0,37,maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
226,GO:0000463,1,0.954522008894382,0,9,maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
227,GO:0000466,1,0.882083339726925,0,21,maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
228,GO:0000467,1,0.965214184172052,0,7,exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
229,GO:0000469,1,0.863345834337329,0,25,cleavage involved in rRNA processing,BP,
230,GO:0000470,1,0.889929234663796,0,22,maturation of LSU-rRNA,BP,
231,GO:0000472,1,0.976801590819537,0,3,endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
232,GO:0000478,1,0.911006765169246,0,14,endonucleolytic cleavage involved in rRNA processing,BP,
233,GO:0000479,1,0.91683866152027,0,13,endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
234,GO:0000480,1,0.957838274541346,0,6,endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA),BP,
235,GO:0000481,1,0.992520086327099,0,1,maturation of 5S rRNA,BP,
236,GO:0000491,1,0.956641291672478,0,8,small nucleolar ribonucleoprotein complex assembly,BP,
237,GO:0000492,1,0.968090006038132,0,6,box C/D snoRNP assembly,BP,
238,GO:0000493,1,0.988177731162871,0,2,box H/ACA snoRNP assembly,BP,
239,GO:0000494,1,0.996531647484467,0,1,box C/D snoRNA 3'-end processing,BP,
240,GO:0000495,1,0.993389871031089,0,1,box H/ACA snoRNA 3'-end processing,BP,
241,GO:0000502,1,0.737017716806429,0,62,proteasome complex,CC,
242,GO:0000506,1,0.956635842154165,0,9,glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex,CC,
243,GO:0000578,1,0.813557054233022,0,31,embryonic axis specification,BP,
244,GO:0000700,1,0.977577000375927,0,4,mismatch base pair DNA N-glycosylase activity,MF,
245,GO:0000701,1,0.99118731533013,0,2,purine-specific mismatch base pair DNA N-glycosylase activity,MF,
246,GO:0000702,1,0.979625553452631,0,5,oxidized base lesion DNA N-glycosylase activity,MF,
247,GO:0000703,1,0.992404200892606,0,2,oxidized pyrimidine nucleobase lesion DNA N-glycosylase activity,MF,
248,GO:0000706,1,0.978600404527236,0,3,meiotic DNA double-strand break processing,BP,
249,GO:0000707,1,0.951419838020247,0,8,meiotic DNA recombinase assembly,BP,
250,GO:0000710,1,0.970321168692479,0,4,meiotic mismatch repair,BP,
251,GO:0000711,1,0.995982737377546,0,1,meiotic DNA repair synthesis,BP,
252,GO:0000712,1,0.914441013961959,0,13,resolution of meiotic recombination intermediates,BP,
253,GO:0000715,1,0.880545446636576,0,23,nucleotide-excision repair, DNA damage recognition,BP,
254,GO:0000717,1,0.877208206144894,0,22,nucleotide-excision repair, DNA duplex unwinding,BP,
255,GO:0000718,1,0.995280108756433,0,1,nucleotide-excision repair, DNA damage removal,BP,
256,GO:0000720,1,0.981452220884158,0,3,pyrimidine dimer repair by nucleotide-excision repair,BP,
257,GO:0000722,1,0.904068032142247,0,14,telomere maintenance via recombination,BP,
258,GO:0000723,1,0.380191329066183,0,144,telomere maintenance,BP,
259,GO:0000724,1,0.478108147114042,0,104,double-strand break repair via homologous recombination,BP,
260,GO:0000725,1,0.474764855604303,0,105,recombinational repair,BP,
261,GO:0000726,1,0.642016544546409,0,64,non-recombinational repair,BP,
262,GO:0000727,1,0.970526458795141,0,5,double-strand break repair via break-induced replication,BP,
263,GO:0000729,1,0.852288314264551,0,22,DNA double-strand break processing,BP,
264,GO:0000730,1,0.938399163519219,0,10,DNA recombinase assembly,BP,
265,GO:0000731,1,0.631417476428775,0,68,DNA synthesis involved in DNA repair,BP,
266,GO:0000732,1,0.828987151233631,0,25,strand displacement,BP,
267,GO:0000733,1,0.939004063233821,0,9,DNA strand renaturation,BP,
268,GO:0000737,1,0.849886822299053,0,26,DNA catabolic process, endonucleolytic,BP,
269,GO:0000738,1,0.975602726914452,0,4,DNA catabolic process, exonucleolytic,BP,
270,GO:0000741,1,0.995233406655209,0,1,karyogamy,BP,
271,GO:0000768,1,0.769176053293773,0,37,syncytium formation by plasma membrane fusion,BP,
272,GO:0000773,1,0.99690558516184,0,1,phosphatidyl-N-methylethanolamine N-methyltransferase activity,MF,
273,GO:0000774,1,0.936514844109811,0,11,adenyl-nucleotide exchange factor activity,MF,
274,GO:0000775,1,0.287208016730956,0,181,chromosome, centromeric region,CC,
275,GO:0000776,1,0.429191418397521,0,125,kinetochore,CC,
276,GO:0000777,1,0.530309160919235,0,96,condensed chromosome kinetochore,CC,
277,GO:0000778,1,0.928838972040453,0,12,condensed nuclear chromosome kinetochore,CC,
278,GO:0000779,1,0.492912270379496,0,107,condensed chromosome, centromeric region,CC,
279,GO:0000780,1,0.880413880984577,0,20,condensed nuclear chromosome, centromeric region,CC,
280,GO:0000781,1,0.399653971437655,0,135,chromosome, telomeric region,CC,
281,GO:0000782,1,0.929496935416527,0,11,telomere cap complex,CC,
282,GO:0000783,1,0.929496935416527,0,11,nuclear telomere cap complex,CC,
283,GO:0000784,1,0.490065172438128,0,105,nuclear chromosome, telomeric region,CC,
285,GO:0000786,1,0.826211012502548,0,47,nucleosome,CC,
286,GO:0000788,1,0.948609297592405,0,14,nuclear nucleosome,CC,
287,GO:0000789,1,0.996671372751133,0,1,cytoplasmic chromatin,CC,
289,GO:0000791,1,0.83611123737154,0,29,euchromatin,CC,
291,GO:0000793,1,0.267440716256115,0,194,condensed chromosome,CC,
292,GO:0000794,1,0.569798674975191,0,82,condensed nuclear chromosome,CC,
293,GO:0000795,1,0.819169720107828,0,31,synaptonemal complex,CC,
294,GO:0000796,1,0.945861672119703,0,7,condensin complex,CC,
295,GO:0000797,1,0.99220476521144,0,1,condensin core heterodimer,CC,
296,GO:0000798,1,0.966845280467865,0,5,nuclear cohesin complex,CC,
297,GO:0000799,1,0.976482522119128,0,3,nuclear condensin complex,CC,
298,GO:0000800,1,0.912859935720796,0,13,lateral element,CC,
299,GO:0000801,1,0.964901311595473,0,6,central element,CC,
300,GO:0000803,1,0.842404477356165,0,25,sex chromosome,CC,
301,GO:0000805,1,0.948738476435869,0,7,X chromosome,CC,
302,GO:0000806,1,0.986163963998907,0,2,Y chromosome,CC,
303,GO:0000808,1,0.939493420086757,0,9,origin recognition complex,CC,
304,GO:0000811,1,0.981719675199971,0,3,GINS complex,CC,
305,GO:0000812,1,0.935717476569575,0,10,Swr1 complex,CC,
306,GO:0000813,1,0.940629021738615,0,10,ESCRT I complex,CC,
307,GO:0000814,1,0.985543309645821,0,3,ESCRT II complex,CC,
308,GO:0000815,1,0.932695369676094,0,12,ESCRT III complex,CC,
309,GO:0000818,1,0.987630080175448,0,2,nuclear MIS12/MIND complex,CC,
310,GO:0000819,1,0.217850302843641,0,223,sister chromatid segregation,BP,
311,GO:0000820,1,0.967178360087786,0,5,regulation of glutamine family amino acid metabolic process,BP,
312,GO:0000821,1,0.983901391670659,0,2,regulation of arginine metabolic process,BP,
313,GO:0000822,1,0.973022429272811,0,3,inositol hexakisphosphate binding,MF,
314,GO:0000823,1,0.995123078791941,0,1,inositol-1,4,5-trisphosphate 6-kinase activity,MF,
315,GO:0000824,1,0.995123078791941,0,1,inositol tetrakisphosphate 3-kinase activity,MF,
316,GO:0000825,1,0.995123078791941,0,1,inositol tetrakisphosphate 6-kinase activity,MF,
317,GO:0000827,1,0.965837820280973,0,5,inositol-1,3,4,5,6-pentakisphosphate kinase activity,MF,
318,GO:0000828,1,0.965837820280973,0,5,inositol hexakisphosphate kinase activity,MF,
319,GO:0000829,1,0.965837820280973,0,5,inositol heptakisphosphate kinase activity,MF,
320,GO:0000831,1,0.993093358879877,0,1,inositol hexakisphosphate 6-kinase activity,MF,
321,GO:0000832,1,0.965837820280973,0,5,inositol hexakisphosphate 5-kinase activity,MF,
322,GO:0000835,1,0.957404435863507,0,6,ER ubiquitin ligase complex,CC,
323,GO:0000836,1,0.964840816712224,0,5,Hrd1p ubiquitin ligase complex,CC,
324,GO:0000839,1,0.979599590541483,0,3,Hrd1p ubiquitin ligase ERAD-L complex,CC,
325,GO:0000900,1,0.90712097285362,0,13,translation repressor activity, mRNA regulatory element binding,MF,
329,GO:0000912,1,0.955270565918858,0,6,assembly of actomyosin apparatus involved in cytokinesis,BP,
330,GO:0000915,1,0.955270565918858,0,6,actomyosin contractile ring assembly,BP,
331,GO:0000916,1,0.994214168842005,0,1,actomyosin contractile ring contraction,BP,
332,GO:0000917,1,0.994993164821226,0,1,division septum assembly,BP,
333,GO:0000920,1,0.906000532699842,0,17,cell separation after cytokinesis,BP,
334,GO:0000921,1,0.91253154608232,0,13,septin ring assembly,BP,
335,GO:0000922,1,0.37199213036086,0,141,spindle pole,CC,
336,GO:0000923,1,0.962990077345259,0,5,equatorial microtubule organizing center,CC,
337,GO:0000928,1,0.993058458973322,0,1,gamma-tubulin small complex, spindle pole body,CC,
338,GO:0000930,1,0.871228071142894,0,19,gamma-tubulin complex,CC,
339,GO:0000931,1,0.946908496211867,0,7,gamma-tubulin large complex,CC,
340,GO:0000932,1,0.587208817351539,0,79,P-body,CC,
341,GO:0000938,1,0.969926931929903,0,4,GARP complex,CC,
342,GO:0000939,1,0.983252179180492,0,3,condensed chromosome inner kinetochore,CC,
343,GO:0000940,1,0.909974546653968,0,13,condensed chromosome outer kinetochore,CC,
344,GO:0000941,1,0.994049863380193,0,1,condensed nuclear chromosome inner kinetochore,CC,
345,GO:0000942,1,0.975622304175693,0,4,condensed nuclear chromosome outer kinetochore,CC,
346,GO:0000956,1,0.34908936053823,0,200,nuclear-transcribed mRNA catabolic process,BP,
347,GO:0000957,1,0.963078319009071,0,5,mitochondrial RNA catabolic process,BP,
348,GO:0000958,1,0.978504485721402,0,3,mitochondrial mRNA catabolic process,BP,
349,GO:0000959,1,0.763112200340546,0,41,mitochondrial RNA metabolic process,BP,
350,GO:0000960,1,0.970382159012628,0,4,regulation of mitochondrial RNA catabolic process,BP,
351,GO:0000961,1,0.984238350997708,0,2,negative regulation of mitochondrial RNA catabolic process,BP,
352,GO:0000962,1,0.985924133097944,0,2,positive regulation of mitochondrial RNA catabolic process,BP,
353,GO:0000963,1,0.906643302787915,0,16,mitochondrial RNA processing,BP,
354,GO:0000964,1,0.975905818495242,0,4,mitochondrial RNA 5'-end processing,BP,
355,GO:0000965,1,0.970279897633209,0,5,mitochondrial RNA 3'-end processing,BP,
356,GO:0000966,1,0.885683045389689,0,21,RNA 5'-end processing,BP,
357,GO:0000967,1,0.976801590819537,0,3,rRNA 5'-end processing,BP,
358,GO:0000972,1,0.954923725334144,0,7,transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
359,GO:0000973,1,0.980122331724368,0,3,posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery,BP,
360,GO:0000974,1,0.924009648513353,0,13,Prp19 complex,CC,
364,GO:0000979,1,0.78558671747883,0,36,RNA polymerase II core promoter sequence-specific DNA binding,MF,
368,GO:0000983,1,0.856164492282129,0,21,transcription factor activity, RNA polymerase II core promoter sequence-specific DNA binding,MF,
372,GO:0000990,1,0.939731842436848,0,8,transcription factor activity, core RNA polymerase binding,MF,
373,GO:0000991,1,0.987515944176653,0,2,transcription factor activity, core RNA polymerase II binding,MF,
374,GO:0000992,1,0.984545979979501,0,2,polymerase III regulatory region sequence-specific DNA binding,MF,
375,GO:0000993,1,0.828472502565111,0,28,RNA polymerase II core binding,MF,
376,GO:0000994,1,0.995160723227285,0,1,RNA polymerase III core binding,MF,
377,GO:0000995,1,0.965211284780935,0,4,transcription factor activity, core RNA polymerase III binding,MF,
378,GO:0001002,1,0.984545979979501,0,2,RNA polymerase III type 1 promoter sequence-specific DNA binding,MF,
379,GO:0001003,1,0.984545979979501,0,2,RNA polymerase III type 2 promoter sequence-specific DNA binding,MF,
380,GO:0001007,1,0.96699280452123,0,4,transcription factor activity, RNA polymerase III transcription factor binding,MF,
381,GO:0001010,1,0.875902374505723,0,18,transcription factor activity, sequence-specific DNA binding transcription factor recruiting,MF,
382,GO:0001011,1,0.990109517311091,0,1,transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting,MF,
384,GO:0001013,1,0.94592939781237,0,8,RNA polymerase I regulatory region DNA binding,MF,
385,GO:0001016,1,0.953650709823957,0,7,RNA polymerase III regulatory region DNA binding,MF,
386,GO:0001018,1,0.987531825400366,0,2,mitochondrial promoter sequence-specific DNA binding,MF,
387,GO:0001025,1,0.969836679932304,0,3,RNA polymerase III transcription factor binding,MF,
388,GO:0001026,1,0.981157173941136,0,2,TFIIIB-type transcription factor activity,MF,
389,GO:0001030,1,0.96122792634049,0,5,RNA polymerase III type 1 promoter DNA binding,MF,
390,GO:0001031,1,0.96122792634049,0,5,RNA polymerase III type 2 promoter DNA binding,MF,
391,GO:0001032,1,0.971138442580132,0,4,RNA polymerase III type 3 promoter DNA binding,MF,
392,GO:0001034,1,0.99509833293069,0,1,RNA polymerase III transcription factor activity, sequence-specific DNA binding,MF,
393,GO:0001042,1,0.961661039059067,0,5,RNA polymerase I core binding,MF,
394,GO:0001046,1,0.543341183849359,0,85,core promoter sequence-specific DNA binding,MF,
395,GO:0001047,1,0.369906762741657,0,138,core promoter binding,MF,
396,GO:0001054,1,0.944394739124868,0,11,RNA polymerase I activity,MF,
397,GO:0001055,1,0.946407654507389,0,11,RNA polymerase II activity,MF,
398,GO:0001056,1,0.922506833623548,0,15,RNA polymerase III activity,MF,
400,GO:0001069,1,0.98433522084044,0,2,regulatory region RNA binding,MF,
401,GO:0001074,1,0.993371042688108,0,1,transcription factor activity, RNA polymerase II proximal promoter sequence-specific DNA binding involved in preinitiation complex assembly,MF,
402,GO:0001075,1,0.946645819573642,0,7,transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly,MF,
405,GO:0001078,1,0.397090553449105,0,134,transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding,MF,
406,GO:0001079,1,0.994287414484928,0,1,nitrogen catabolite regulation of transcription from RNA polymerase II promoter,BP,
407,GO:0001080,1,0.994287414484928,0,1,nitrogen catabolite activation of transcription from RNA polymerase II promoter,BP,
408,GO:0001083,1,0.953469339077632,0,6,transcription factor activity, RNA polymerase II basal transcription factor binding,MF,
409,GO:0001084,1,0.993371042688108,0,1,transcription factor activity, TFIID-class binding,MF,
411,GO:0001087,1,0.990109517311091,0,1,transcription factor activity, TFIIB-class binding,MF,
413,GO:0001093,1,0.976690686928025,0,3,TFIIB-class transcription factor binding,MF,
415,GO:0001096,1,0.992511070973275,0,1,TFIIF-class transcription factor binding,MF,
416,GO:0001097,1,0.979640349841325,0,3,TFIIH-class transcription factor binding,MF,
419,GO:0001100,1,0.993058458973322,0,1,negative regulation of exit from mitosis,BP,
421,GO:0001102,1,0.724782900226055,0,47,RNA polymerase II activating transcription factor binding,MF,
422,GO:0001103,1,0.809419399008733,0,32,RNA polymerase II repressing transcription factor binding,MF,
423,GO:0001104,1,0.489842851777547,0,101,RNA polymerase II transcription cofactor activity,MF,
424,GO:0001105,1,0.729403879059867,0,43,RNA polymerase II transcription coactivator activity,MF,
425,GO:0001106,1,0.826167955546815,0,28,RNA polymerase II transcription corepressor activity,MF,
426,GO:0001112,1,0.992780842406763,0,1,DNA-templated transcriptional open complex formation,BP,
427,GO:0001113,1,0.992780842406763,0,1,transcriptional open complex formation at RNA polymerase II promoter,BP,
428,GO:0001120,1,0.992780842406763,0,1,protein-DNA complex remodeling,BP,
429,GO:0001128,1,0.996143419498043,0,1,RNA polymerase II transcription coactivator activity involved in preinitiation complex assembly,MF,
430,GO:0001129,1,0.969425686598444,0,4,RNA polymerase II transcription factor activity, TBP-class protein binding, involved in preinitiation complex assembly,MF,
431,GO:0001132,1,0.969425686598444,0,4,RNA polymerase II transcription factor activity, TBP-class protein binding,MF,
432,GO:0001133,1,0.882193023488677,0,17,RNA polymerase II transcription factor activity, sequence-specific transcription regulatory region DNA binding,MF,
433,GO:0001134,1,0.817844568006606,0,27,transcription factor activity, transcription factor recruiting,MF,
434,GO:0001135,1,0.949198720825819,0,7,transcription factor activity, RNA polymerase II transcription factor recruiting,MF,
435,GO:0001147,1,0.98123054739247,0,2,transcription termination site sequence-specific DNA binding,MF,
436,GO:0001156,1,0.969836679932304,0,3,TFIIIC-class transcription factor binding,MF,
438,GO:0001160,1,0.98123054739247,0,2,transcription termination site DNA binding,MF,
439,GO:0001161,1,0.92241625283096,0,12,intronic transcription regulatory region sequence-specific DNA binding,MF,
440,GO:0001162,1,0.934925502289313,0,10,RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding,MF,
441,GO:0001163,1,0.94592939781237,0,8,RNA polymerase I regulatory region sequence-specific DNA binding,MF,
442,GO:0001164,1,0.94592939781237,0,8,RNA polymerase I CORE element sequence-specific DNA binding,MF,
443,GO:0001165,1,0.992314167798148,0,1,RNA polymerase I upstream control element sequence-specific DNA binding,MF,
444,GO:0001172,1,0.983687538071183,0,2,transcription, RNA-templated,BP,
445,GO:0001179,1,0.994964743115465,0,1,RNA polymerase I transcription factor binding,MF,
446,GO:0001181,1,0.992501200387369,0,1,transcription factor activity, core RNA polymerase I binding,MF,
447,GO:0001188,1,0.94592939781237,0,8,RNA polymerase I transcriptional preinitiation complex assembly,BP,
449,GO:0001191,1,0.735289509838673,0,46,transcriptional repressor activity, RNA polymerase II transcription factor binding,MF,
450,GO:0001192,1,0.997160256169353,0,1,maintenance of transcriptional fidelity during DNA-templated transcription elongation,BP,
451,GO:0001193,1,0.997160256169353,0,1,maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter,BP,
452,GO:0001205,1,0.817496740665767,0,30,transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific DNA binding,MF,
455,GO:0001222,1,0.908390544338604,0,14,transcription corepressor binding,MF,
457,GO:0001224,1,0.974536247902677,0,3,RNA polymerase II transcription cofactor binding,MF,
458,GO:0001225,1,0.981789220521309,0,2,RNA polymerase II transcription coactivator binding,MF,
459,GO:0001226,1,0.992613845995336,0,1,RNA polymerase II transcription corepressor binding,MF,
462,GO:0001300,1,0.985436735682695,0,2,chronological cell aging,BP,
463,GO:0001302,1,0.962600804975702,0,6,replicative cell aging,BP,
464,GO:0001306,1,0.996841976500444,0,1,age-dependent response to oxidative stress,BP,
465,GO:0001315,1,0.996841976500444,0,1,age-dependent response to reactive oxygen species,BP,
466,GO:0001325,1,0.901474764790415,0,14,formation of extrachromosomal circular DNA,BP,
467,GO:0001401,1,0.987834030333244,0,2,mitochondrial sorting and assembly machinery complex,CC,
468,GO:0001405,1,0.970708014868124,0,5,presequence translocase-associated import motor,CC,
470,GO:0001502,1,0.897937368801783,0,16,cartilage condensation,BP,
474,GO:0001507,1,0.986230156662761,0,2,acetylcholine catabolic process in synaptic cleft,BP,
476,GO:0001510,1,0.694688071214013,0,57,RNA methylation,BP,
477,GO:0001512,1,0.996589812374165,0,1,dihydronicotinamide riboside quinone reductase activity,MF,
478,GO:0001514,1,0.947316804681385,0,8,selenocysteine incorporation,BP,
479,GO:0001515,1,0.98104746672639,0,4,opioid peptide activity,MF,
480,GO:0001516,1,0.889110799598378,0,22,prostaglandin biosynthetic process,BP,
481,GO:0001517,1,0.955251573879809,0,6,N-acetylglucosamine 6-O-sulfotransferase activity,MF,
483,GO:0001519,1,0.992504348414736,0,1,peptide amidation,BP,
484,GO:0001520,1,0.980392818847851,0,3,outer dense fiber,CC,
485,GO:0001522,1,0.912604314569765,0,18,pseudouridine synthesis,BP,
488,GO:0001527,1,0.92569771069362,0,10,microfibril,CC,
490,GO:0001532,1,0.992624673964917,0,1,interleukin-21 receptor activity,MF,
492,GO:0001534,1,0.971988208327064,0,4,radial spoke,CC,
493,GO:0001536,1,0.97876724056888,0,3,radial spoke stalk,CC,
494,GO:0001537,1,0.969677498271253,0,5,N-acetylgalactosamine 4-O-sulfotransferase activity,MF,
495,GO:0001539,1,0.796707939321322,0,31,cilium or flagellum-dependent cell motility,BP,
496,GO:0001540,1,0.691715214255657,0,55,amyloid-beta binding,MF,
497,GO:0001541,1,0.723785968525235,0,49,ovarian follicle development,BP,
498,GO:0001542,1,0.929225685795961,0,9,ovulation from ovarian follicle,BP,
499,GO:0001543,1,0.990573453252987,0,1,ovarian follicle rupture,BP,
500,GO:0001544,1,0.990710504699364,0,1,initiation of primordial ovarian follicle growth,BP,
501,GO:0001545,1,0.992466083493268,0,1,primary ovarian follicle growth,BP,
502,GO:0001546,1,0.984036523791336,0,3,preantral ovarian follicle growth,BP,
503,GO:0001547,1,0.956837895235845,0,6,antral ovarian follicle growth,BP,
504,GO:0001550,1,0.984155390627073,0,2,ovarian cumulus expansion,BP,
505,GO:0001552,1,0.994775022209268,0,1,ovarian follicle atresia,BP,
506,GO:0001553,1,0.939062668369425,0,9,luteinization,BP,
507,GO:0001554,1,0.961304254290721,0,5,luteolysis,BP,
508,GO:0001555,1,0.980676252997358,0,3,oocyte growth,BP,
509,GO:0001556,1,0.878086192454969,0,20,oocyte maturation,BP,
511,GO:0001560,1,0.974748656784263,0,3,regulation of cell growth by extracellular stimulus,BP,
512,GO:0001561,1,0.953851958082783,0,8,fatty acid alpha-oxidation,BP,
513,GO:0001562,1,0.902478375651016,0,18,response to protozoan,BP,
514,GO:0001567,1,0.996085974552639,0,1,cholesterol 25-hydroxylase activity,MF,
516,GO:0001569,1,0.810006001881661,0,31,branching involved in blood vessel morphogenesis,BP,
517,GO:0001570,1,0.590716137482927,0,73,vasculogenesis,BP,
518,GO:0001572,1,0.992212450977572,0,1,lactosylceramide biosynthetic process,BP,
521,GO:0001575,1,0.989316321480739,0,2,globoside metabolic process,BP,
522,GO:0001576,1,0.994426369933777,0,1,globoside biosynthetic process,BP,
523,GO:0001578,1,0.56971951523947,0,77,microtubule bundle formation,BP,
524,GO:0001579,1,0.98543709287506,0,2,medium-chain fatty acid transport,BP,
525,GO:0001580,1,0.914579668999874,0,21,detection of chemical stimulus involved in sensory perception of bitter taste,BP,
526,GO:0001581,1,0.992755740382503,0,1,detection of chemical stimulus involved in sensory perception of sour taste,BP,
527,GO:0001582,1,0.993425333841069,0,1,detection of chemical stimulus involved in sensory perception of sweet taste,BP,
528,GO:0001587,1,0.992242866294708,0,1,Gq/11-coupled serotonin receptor activity,MF,
529,GO:0001588,1,0.979202709861217,0,4,dopamine neurotransmitter receptor activity, coupled via Gs,MF,
530,GO:0001591,1,0.982709388221645,0,3,dopamine neurotransmitter receptor activity, coupled via Gi/Go,MF,
531,GO:0001595,1,0.987064807774574,0,3,angiotensin receptor activity,MF,
532,GO:0001596,1,0.993892387500742,0,1,angiotensin type I receptor activity,MF,
533,GO:0001601,1,0.980753178319523,0,3,peptide YY receptor activity,MF,
534,GO:0001602,1,0.977918059393811,0,4,pancreatic polypeptide receptor activity,MF,
535,GO:0001604,1,0.992370655215379,0,2,urotensin II receptor activity,MF,
536,GO:0001605,1,0.985679003702621,0,3,adrenomedullin receptor activity,MF,
537,GO:0001607,1,0.98715013462986,0,2,neuromedin U receptor activity,MF,
538,GO:0001608,1,0.933739317848986,0,12,G-protein coupled nucleotide receptor activity,MF,
539,GO:0001609,1,0.965088842578427,0,6,G-protein coupled adenosine receptor activity,MF,
540,GO:0001614,1,0.896270379404634,0,19,purinergic nucleotide receptor activity,MF,
542,GO:0001621,1,0.995832823131165,0,1,ADP receptor activity,MF,
543,GO:0001626,1,0.992619408894178,0,1,nociceptin receptor activity,MF,
544,GO:0001631,1,0.967567226589228,0,6,cysteinyl leukotriene receptor activity,MF,
545,GO:0001632,1,0.988370360429473,0,2,leukotriene B4 receptor activity,MF,
546,GO:0001635,1,0.982488819840167,0,3,calcitonin gene-related peptide receptor activity,MF,
548,GO:0001640,1,0.952635644478356,0,6,adenylate cyclase inhibiting G-protein coupled glutamate receptor activity,MF,
549,GO:0001641,1,0.985753991396588,0,2,group II metabotropic glutamate receptor activity,MF,
550,GO:0001642,1,0.976569660787278,0,3,group III metabotropic glutamate receptor activity,MF,
552,GO:0001650,1,0.432048967476626,0,126,fibrillar center,CC,
553,GO:0001651,1,0.996531647484467,0,1,dense fibrillar component,CC,
554,GO:0001652,1,0.973784543552553,0,5,granular component,CC,
560,GO:0001658,1,0.684460267320846,0,54,branching involved in ureteric bud morphogenesis,BP,
561,GO:0001659,1,0.793572886441851,0,35,temperature homeostasis,BP,
562,GO:0001660,1,0.937267859126435,0,10,fever generation,BP,
563,GO:0001661,1,0.96415721795036,0,5,conditioned taste aversion,BP,
566,GO:0001665,1,0.966243029371799,0,6,alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity,MF,
570,GO:0001671,1,0.861007179115342,0,25,ATPase activator activity,MF,
571,GO:0001672,1,0.93209154143826,0,9,regulation of chromatin assembly or disassembly,BP,
572,GO:0001673,1,0.93141760592448,0,11,male germ cell nucleus,CC,
573,GO:0001674,1,0.994089980651462,0,1,female germ cell nucleus,CC,
574,GO:0001675,1,0.941063777587481,0,8,acrosome assembly,BP,
575,GO:0001676,1,0.58300872570623,0,86,long-chain fatty acid metabolic process,BP,
577,GO:0001680,1,0.994001218984072,0,1,tRNA 3'-terminal CCA addition,BP,
578,GO:0001681,1,0.992980600067089,0,1,sialate O-acetylesterase activity,MF,
579,GO:0001682,1,0.94054572959415,0,12,tRNA 5'-leader removal,BP,
580,GO:0001692,1,0.985497301852033,0,3,histamine metabolic process,BP,
581,GO:0001694,1,0.993713632905731,0,1,histamine biosynthetic process,BP,
582,GO:0001695,1,0.997093186593732,0,1,histamine catabolic process,BP,
583,GO:0001696,1,0.909996308700118,0,16,gastric acid secretion,BP,
584,GO:0001697,1,0.993009612248036,0,1,histamine-induced gastric acid secretion,BP,
585,GO:0001698,1,0.990925390993961,0,2,gastrin-induced gastric acid secretion,BP,
587,GO:0001702,1,0.824437395009743,0,25,gastrulation with mouth forming second,BP,
589,GO:0001705,1,0.985058664444263,0,2,ectoderm formation,BP,
590,GO:0001706,1,0.684018442075597,0,53,endoderm formation,BP,
593,GO:0001709,1,0.77971600992198,0,37,cell fate determination,BP,
595,GO:0001711,1,0.909712430848897,0,15,endodermal cell fate commitment,BP,
596,GO:0001712,1,0.985058664444263,0,2,ectodermal cell fate commitment,BP,
597,GO:0001714,1,0.956795780456525,0,8,endodermal cell fate specification,BP,
598,GO:0001715,1,0.99249165342284,0,1,ectodermal cell fate specification,BP,
599,GO:0001716,1,0.994504705636358,0,1,L-amino-acid oxidase activity,MF,
600,GO:0001725,1,0.678985379175786,0,52,stress fiber,CC,
602,GO:0001727,1,0.964080158830646,0,5,lipid kinase activity,MF,
603,GO:0001729,1,0.985291055976104,0,2,ceramide kinase activity,MF,
604,GO:0001730,1,0.97488921839846,0,4,2'-5'-oligoadenylate synthetase activity,MF,
605,GO:0001731,1,0.944706617519574,0,8,formation of translation preinitiation complex,BP,
606,GO:0001732,1,0.986716567718596,0,2,formation of cytoplasmic translation initiation complex,BP,
607,GO:0001733,1,0.97730596001707,0,4,galactosylceramide sulfotransferase activity,MF,
608,GO:0001735,1,0.985397316686362,0,2,prenylcysteine oxidase activity,MF,
611,GO:0001739,1,0.969488951956234,0,5,sex chromatin,CC,
612,GO:0001740,1,0.979063954691734,0,3,Barr body,CC,
613,GO:0001741,1,0.927378440907516,0,12,XY body,CC,
614,GO:0001743,1,0.97649434780513,0,3,optic placode formation,BP,
619,GO:0001757,1,0.969635766372687,0,5,somite specification,BP,
620,GO:0001758,1,0.962230719162393,0,7,retinal dehydrogenase activity,MF,
621,GO:0001759,1,0.898940109358885,0,18,organ induction,BP,
625,GO:0001766,1,0.949297261623811,0,9,membrane raft polarization,BP,
626,GO:0001767,1,0.933226742185571,0,10,establishment of lymphocyte polarity,BP,
627,GO:0001768,1,0.941848441628306,0,9,establishment of T cell polarity,BP,
628,GO:0001770,1,0.990851432293721,0,1,establishment of natural killer cell polarity,BP,
629,GO:0001771,1,0.920817359876348,0,13,immunological synapse formation,BP,
630,GO:0001772,1,0.816621656581504,0,32,immunological synapse,CC,
631,GO:0001773,1,0.877925788949078,0,24,myeloid dendritic cell activation,BP,
632,GO:0001774,1,0.84290098959967,0,25,microglial cell activation,BP,
636,GO:0001778,1,0.961178734024875,0,5,plasma membrane repair,BP,
637,GO:0001779,1,0.896787433532625,0,17,natural killer cell differentiation,BP,
638,GO:0001780,1,0.907144656194374,0,14,neutrophil homeostasis,BP,
639,GO:0001781,1,0.955449920366261,0,7,neutrophil apoptotic process,BP,
640,GO:0001782,1,0.831177524797968,0,28,B cell homeostasis,BP,
641,GO:0001783,1,0.86909503970232,0,22,B cell apoptotic process,BP,
642,GO:0001784,1,0.770791207963207,0,35,phosphotyrosine residue binding,MF,
643,GO:0001785,1,0.985978237583199,0,2,prostaglandin J receptor activity,MF,
645,GO:0001787,1,0.959294103855874,0,7,natural killer cell proliferation,BP,
646,GO:0001788,1,0.995560697417249,0,1,antibody-dependent cellular cytotoxicity,BP,
647,GO:0001791,1,0.995273112943448,0,1,IgM binding,MF,
648,GO:0001792,1,0.992417859991166,0,1,polymeric immunoglobulin receptor activity,MF,
649,GO:0001794,1,0.985411375403177,0,3,type IIa hypersensitivity,BP,
650,GO:0001796,1,0.985411375403177,0,3,regulation of type IIa hypersensitivity,BP,
651,GO:0001797,1,0.995560697417249,0,1,negative regulation of type IIa hypersensitivity,BP,
652,GO:0001798,1,0.989805873511615,0,2,positive regulation of type IIa hypersensitivity,BP,
653,GO:0001802,1,0.991064710719699,0,2,type III hypersensitivity,BP,
654,GO:0001803,1,0.991064710719699,0,2,regulation of type III hypersensitivity,BP,
655,GO:0001805,1,0.991064710719699,0,2,positive regulation of type III hypersensitivity,BP,
656,GO:0001806,1,0.983420432953212,0,3,type IV hypersensitivity,BP,
657,GO:0001807,1,0.99060166612169,0,2,regulation of type IV hypersensitivity,BP,
658,GO:0001808,1,0.994536397298184,0,1,negative regulation of type IV hypersensitivity,BP,
659,GO:0001809,1,0.996043869819361,0,1,positive regulation of type IV hypersensitivity,BP,
660,GO:0001810,1,0.986664679384695,0,3,regulation of type I hypersensitivity,BP,
661,GO:0001811,1,0.995560697417249,0,1,negative regulation of type I hypersensitivity,BP,
662,GO:0001812,1,0.991064710719699,0,2,positive regulation of type I hypersensitivity,BP,
663,GO:0001813,1,0.995560697417249,0,1,regulation of antibody-dependent cellular cytotoxicity,BP,
664,GO:0001814,1,0.995560697417249,0,1,negative regulation of antibody-dependent cellular cytotoxicity,BP,
669,GO:0001820,1,0.945163175245805,0,10,serotonin secretion,BP,
670,GO:0001821,1,0.952110286508784,0,9,histamine secretion,BP,
673,GO:0001824,1,0.703125407528921,0,54,blastocyst development,BP,
674,GO:0001825,1,0.849091920870935,0,25,blastocyst formation,BP,
675,GO:0001826,1,0.95385651907577,0,6,inner cell mass cell differentiation,BP,
676,GO:0001827,1,0.984108706122368,0,2,inner cell mass cell fate commitment,BP,
677,GO:0001828,1,0.978055057909607,0,3,inner cell mass cellular morphogenesis,BP,
678,GO:0001829,1,0.924429925707671,0,12,trophectodermal cell differentiation,BP,
679,GO:0001831,1,0.985519011659846,0,2,trophectodermal cellular morphogenesis,BP,
680,GO:0001832,1,0.888792061032114,0,16,blastocyst growth,BP,
681,GO:0001833,1,0.922451968240472,0,11,inner cell mass cell proliferation,BP,
682,GO:0001834,1,0.983871297925416,0,2,trophectodermal cell proliferation,BP,
683,GO:0001835,1,0.992632621830319,0,1,blastocyst hatching,BP,
685,GO:0001837,1,0.427741180388635,0,123,epithelial to mesenchymal transition,BP,
687,GO:0001839,1,0.961087815365174,0,6,neural plate morphogenesis,BP,
688,GO:0001840,1,0.936586570280958,0,9,neural plate development,BP,
690,GO:0001842,1,0.956498577743944,0,7,neural fold formation,BP,
692,GO:0001844,1,0.828186462758279,0,32,protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
694,GO:0001846,1,0.918943559812632,0,12,opsonin binding,MF,
695,GO:0001847,1,0.97234340691117,0,4,opsonin receptor activity,MF,
696,GO:0001848,1,0.899373124461574,0,15,complement binding,MF,
697,GO:0001849,1,0.96025058329058,0,6,complement component C1q binding,MF,
698,GO:0001850,1,0.995042846607536,0,1,complement component C3a binding,MF,
699,GO:0001851,1,0.97001402228783,0,4,complement component C3b binding,MF,
700,GO:0001855,1,0.985195128479268,0,2,complement component C4b binding,MF,
701,GO:0001856,1,0.993866650729673,0,1,complement component C5a binding,MF,
702,GO:0001861,1,0.989540988123595,0,1,complement component C4b receptor activity,MF,
703,GO:0001865,1,0.945592057914447,0,8,NK T cell differentiation,BP,
704,GO:0001866,1,0.974028251510131,0,5,NK T cell proliferation,BP,
705,GO:0001867,1,0.95224088049759,0,9,complement activation, lectin pathway,BP,
706,GO:0001868,1,0.987202381193991,0,2,regulation of complement activation, lectin pathway,BP,
707,GO:0001869,1,0.987202381193991,0,2,negative regulation of complement activation, lectin pathway,BP,
709,GO:0001872,1,0.994789249680222,0,1,(1->3)-beta-D-glucan binding,MF,
710,GO:0001875,1,0.968115861005991,0,5,lipopolysaccharide receptor activity,MF,
711,GO:0001878,1,0.978591005038483,0,4,response to yeast,BP,
712,GO:0001880,1,0.978166128832192,0,3,Mullerian duct regression,BP,
716,GO:0001884,1,0.985260804195121,0,2,pyrimidine nucleoside binding,MF,
717,GO:0001885,1,0.68653555562256,0,53,endothelial cell development,BP,
718,GO:0001886,1,0.929225858247418,0,10,endothelial cell morphogenesis,BP,
719,GO:0001887,1,0.966502266373131,0,5,selenium compound metabolic process,BP,
720,GO:0001888,1,0.984421477824019,0,2,glucuronyl-galactosyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
723,GO:0001891,1,0.876432395387258,0,20,phagocytic cup,CC,
728,GO:0001897,1,0.987276757373615,0,2,cytolysis by symbiont of host cells,BP,
729,GO:0001905,1,0.975270876940401,0,3,activation of membrane attack complex,BP,
731,GO:0001907,1,0.97259703259559,0,5,killing by symbiont of host cells,BP,
734,GO:0001911,1,0.92032026235133,0,14,negative regulation of leukocyte mediated cytotoxicity,BP,
736,GO:0001913,1,0.860180271898929,0,27,T cell mediated cytotoxicity,BP,
737,GO:0001914,1,0.896186853529229,0,20,regulation of T cell mediated cytotoxicity,BP,
738,GO:0001915,1,0.961566273207329,0,6,negative regulation of T cell mediated cytotoxicity,BP,
739,GO:0001916,1,0.94051502080752,0,12,positive regulation of T cell mediated cytotoxicity,BP,
742,GO:0001920,1,0.97361473427664,0,4,negative regulation of receptor recycling,BP,
744,GO:0001922,1,0.976772020967833,0,3,B-1 B cell homeostasis,BP,
745,GO:0001923,1,0.980932482304825,0,3,B-1 B cell differentiation,BP,
746,GO:0001927,1,0.978623229809118,0,3,exocyst assembly,BP,
747,GO:0001928,1,0.994040986541587,0,1,regulation of exocyst assembly,BP,
748,GO:0001931,1,0.917405941024206,0,13,uropod,CC,
756,GO:0001939,1,0.957885581017277,0,6,female pronucleus,CC,
757,GO:0001940,1,0.961309224181472,0,5,male pronucleus,CC,
758,GO:0001941,1,0.784141496550732,0,33,postsynaptic membrane organization,BP,
761,GO:0001945,1,0.834101760998332,0,24,lymph vessel development,BP,
762,GO:0001946,1,0.893322537980216,0,15,lymphangiogenesis,BP,
765,GO:0001951,1,0.970791497165426,0,4,intestinal D-glucose absorption,BP,
768,GO:0001954,1,0.726996780794627,0,45,positive regulation of cell-matrix adhesion,BP,
769,GO:0001955,1,0.946475484280581,0,8,blood vessel maturation,BP,
770,GO:0001956,1,0.909124240639826,0,13,positive regulation of neurotransmitter secretion,BP,
771,GO:0001957,1,0.958900636071047,0,6,intramembranous ossification,BP,
773,GO:0001959,1,0.398795902430799,0,142,regulation of cytokine-mediated signaling pathway,BP,
774,GO:0001960,1,0.764326476629242,0,44,negative regulation of cytokine-mediated signaling pathway,BP,
775,GO:0001961,1,0.75484564066082,0,43,positive regulation of cytokine-mediated signaling pathway,BP,
776,GO:0001963,1,0.855927619866438,0,26,synaptic transmission, dopaminergic,BP,
778,GO:0001965,1,0.876916295378699,0,21,G-protein alpha-subunit binding,MF,
779,GO:0001966,1,0.996112512123046,0,1,thigmotaxis,BP,
780,GO:0001967,1,0.92528149624253,0,11,suckling behavior,BP,
781,GO:0001968,1,0.832477308288423,0,25,fibronectin binding,MF,
782,GO:0001969,1,0.975270876940401,0,3,regulation of activation of membrane attack complex,BP,
783,GO:0001970,1,0.984620458892062,0,2,positive regulation of activation of membrane attack complex,BP,
784,GO:0001971,1,0.990505842206051,0,1,negative regulation of activation of membrane attack complex,BP,
785,GO:0001972,1,0.925932020064846,0,12,retinoic acid binding,MF,
787,GO:0001974,1,0.757557391111461,0,39,blood vessel remodeling,BP,
788,GO:0001975,1,0.846522996136646,0,24,response to amphetamine,BP,
789,GO:0001976,1,0.930935919599426,0,11,neurological system process involved in regulation of systemic arterial blood pressure,BP,
791,GO:0001978,1,0.994210752193191,0,1,regulation of systemic arterial blood pressure by carotid sinus baroreceptor feedback,BP,
792,GO:0001979,1,0.995344082193764,0,1,regulation of systemic arterial blood pressure by chemoreceptor signaling,BP,
793,GO:0001980,1,0.997222960228024,0,1,regulation of systemic arterial blood pressure by ischemic conditions,BP,
794,GO:0001983,1,0.994210752193191,0,1,baroreceptor response to increased systemic arterial blood pressure,BP,
795,GO:0001985,1,0.994210752193191,0,1,negative regulation of heart rate involved in baroreceptor response to increased systemic arterial blood pressure,BP,
796,GO:0001990,1,0.831351037147901,0,29,regulation of systemic arterial blood pressure by hormone,BP,
797,GO:0001991,1,0.915576996335655,0,13,regulation of systemic arterial blood pressure by circulatory renin-angiotensin,BP,
798,GO:0001992,1,0.974407121169074,0,4,regulation of systemic arterial blood pressure by vasopressin,BP,
799,GO:0001993,1,0.942944608545498,0,9,regulation of systemic arterial blood pressure by norepinephrine-epinephrine,BP,
800,GO:0001994,1,0.975533092287613,0,4,norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
801,GO:0001996,1,0.972812753844847,0,4,positive regulation of heart rate by epinephrine-norepinephrine,BP,
802,GO:0001997,1,0.987215454026727,0,2,positive regulation of the force of heart contraction by epinephrine-norepinephrine,BP,
803,GO:0001998,1,0.994827199554952,0,1,angiotensin-mediated vasoconstriction involved in regulation of systemic arterial blood pressure,BP,
804,GO:0001999,1,0.97138624683506,0,4,renal response to blood flow involved in circulatory renin-angiotensin regulation of systemic arterial blood pressure,BP,
805,GO:0002001,1,0.97138624683506,0,4,renin secretion into blood stream,BP,
806,GO:0002002,1,0.942562985411504,0,9,regulation of angiotensin levels in blood,BP,
807,GO:0002003,1,0.942562985411504,0,9,angiotensin maturation,BP,
808,GO:0002007,1,0.995344082193764,0,1,detection of hypoxic conditions in blood by chemoreceptor signaling,BP,
810,GO:0002011,1,0.686060250603567,0,50,morphogenesis of an epithelial sheet,BP,
811,GO:0002016,1,0.963140598362336,0,6,regulation of blood volume by renin-angiotensin,BP,
812,GO:0002017,1,0.994919707354621,0,1,regulation of blood volume by renal aldosterone,BP,
813,GO:0002018,1,0.987321333976237,0,2,renin-angiotensin regulation of aldosterone production,BP,
814,GO:0002019,1,0.983597595054013,0,3,regulation of renal output by angiotensin,BP,
816,GO:0002021,1,0.883039286360706,0,19,response to dietary excess,BP,
817,GO:0002023,1,0.994487128084414,0,1,reduction of food intake in response to dietary excess,BP,
818,GO:0002024,1,0.949607179504554,0,8,diet induced thermogenesis,BP,
819,GO:0002025,1,0.980913991423373,0,3,norepinephrine-epinephrine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
820,GO:0002026,1,0.844814746207013,0,24,regulation of the force of heart contraction,BP,
822,GO:0002028,1,0.57725701402907,0,80,regulation of sodium ion transport,BP,
823,GO:0002029,1,0.909609322400971,0,16,desensitization of G-protein coupled receptor protein signaling pathway,BP,
824,GO:0002030,1,0.992907795971071,0,1,inhibitory G-protein coupled receptor phosphorylation,BP,
825,GO:0002031,1,0.926182834856317,0,13,G-protein coupled receptor internalization,BP,
826,GO:0002032,1,0.989436303172249,0,2,desensitization of G-protein coupled receptor protein signaling pathway by arrestin,BP,
827,GO:0002034,1,0.976339825981373,0,4,regulation of blood vessel diameter by renin-angiotensin,BP,
828,GO:0002035,1,0.978709217154621,0,3,brain renin-angiotensin system,BP,
829,GO:0002036,1,0.964577380175118,0,5,regulation of L-glutamate import across plasma membrane,BP,
830,GO:0002037,1,0.994345076992214,0,1,negative regulation of L-glutamate import across plasma membrane,BP,
831,GO:0002038,1,0.994025486367947,0,1,positive regulation of L-glutamate import across plasma membrane,BP,
832,GO:0002039,1,0.613900955791122,0,68,p53 binding,MF,
833,GO:0002040,1,0.51053416780272,0,94,sprouting angiogenesis,BP,
834,GO:0002041,1,0.993968309890624,0,1,intussusceptive angiogenesis,BP,
835,GO:0002042,1,0.728497306714285,0,45,cell migration involved in sprouting angiogenesis,BP,
836,GO:0002043,1,0.900945505731185,0,15,blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
837,GO:0002046,1,0.996943658062354,0,1,opsin binding,MF,
838,GO:0002051,1,0.966402962246846,0,4,osteoblast fate commitment,BP,
840,GO:0002053,1,0.823204452988837,0,27,positive regulation of mesenchymal cell proliferation,BP,
841,GO:0002054,1,0.978675578012787,0,4,nucleobase binding,MF,
842,GO:0002055,1,0.997439116607315,0,1,adenine binding,MF,
843,GO:0002058,1,0.994338138655642,0,1,uracil binding,MF,
844,GO:0002059,1,0.994338138655642,0,1,thymine binding,MF,
845,GO:0002060,1,0.984249143596071,0,3,purine nucleobase binding,MF,
846,GO:0002061,1,0.994338138655642,0,1,pyrimidine nucleobase binding,MF,
848,GO:0002063,1,0.839672271890111,0,23,chondrocyte development,BP,
851,GO:0002066,1,0.701677921491312,0,51,columnar/cuboidal epithelial cell development,BP,
852,GO:0002067,1,0.750964752498421,0,42,glandular epithelial cell differentiation,BP,
853,GO:0002068,1,0.849460939680161,0,23,glandular epithelial cell development,BP,
854,GO:0002069,1,0.968199363289271,0,6,columnar/cuboidal epithelial cell maturation,BP,
856,GO:0002071,1,0.989378879486233,0,2,glandular epithelial cell maturation,BP,
857,GO:0002072,1,0.935359933943586,0,8,optic cup morphogenesis involved in camera-type eye development,BP,
858,GO:0002074,1,0.962191763097566,0,5,extraocular skeletal muscle development,BP,
859,GO:0002076,1,0.889227084049901,0,17,osteoblast development,BP,
860,GO:0002077,1,0.996092612908046,0,1,acrosome matrix dispersal,BP,
861,GO:0002079,1,0.976131777303532,0,3,inner acrosomal membrane,CC,
863,GO:0002081,1,0.983373835572436,0,2,outer acrosomal membrane,CC,
864,GO:0002082,1,0.909930778287575,0,15,regulation of oxidative phosphorylation,BP,
865,GO:0002083,1,0.995479258357632,0,1,4-hydroxybenzoate decaprenyltransferase activity,MF,
866,GO:0002084,1,0.945273811211873,0,9,protein depalmitoylation,BP,
867,GO:0002085,1,0.972761718276936,0,4,inhibition of neuroepithelial cell differentiation,BP,
868,GO:0002086,1,0.990065966530674,0,2,diaphragm contraction,BP,
869,GO:0002087,1,0.921330729941038,0,12,regulation of respiratory gaseous exchange by neurological system process,BP,
871,GO:0002089,1,0.881022634746377,0,16,lens morphogenesis in camera-type eye,BP,
872,GO:0002090,1,0.7895758236564,0,35,regulation of receptor internalization,BP,
873,GO:0002091,1,0.942398194878001,0,9,negative regulation of receptor internalization,BP,
874,GO:0002092,1,0.856689529625289,0,22,positive regulation of receptor internalization,BP,
875,GO:0002093,1,0.919689856674934,0,12,auditory receptor cell morphogenesis,BP,
876,GO:0002094,1,0.988121909350683,0,2,polyprenyltransferase activity,MF,
877,GO:0002097,1,0.905284488696118,0,16,tRNA wobble base modification,BP,
878,GO:0002098,1,0.930017729652146,0,12,tRNA wobble uridine modification,BP,
879,GO:0002100,1,0.991364114518273,0,1,tRNA wobble adenosine to inosine editing,BP,
880,GO:0002101,1,0.981905826136589,0,3,tRNA wobble cytosine modification,BP,
882,GO:0002113,1,0.99397925570808,0,1,interleukin-33 binding,MF,
883,GO:0002114,1,0.98651954132075,0,2,interleukin-33 receptor activity,MF,
884,GO:0002115,1,0.89756565766212,0,16,store-operated calcium entry,BP,
885,GO:0002116,1,0.907509279555533,0,11,semaphorin receptor complex,CC,
886,GO:0002118,1,0.955152897517255,0,7,aggressive behavior,BP,
887,GO:0002121,1,0.985296429459401,0,2,inter-male aggressive behavior,BP,
888,GO:0002125,1,0.98750265175882,0,2,maternal aggressive behavior,BP,
889,GO:0002127,1,0.995943715245789,0,1,tRNA wobble base cytosine methylation,BP,
890,GO:0002133,1,0.979154910871085,0,2,polycystin complex,CC,
891,GO:0002134,1,0.985260804195121,0,2,UTP binding,MF,
892,GO:0002135,1,0.993451183141474,0,1,CTP binding,MF,
893,GO:0002138,1,0.954120118477364,0,8,retinoic acid biosynthetic process,BP,
895,GO:0002140,1,0.990676311599433,0,1,stereocilia tip link,CC,
898,GO:0002143,1,0.978244559896472,0,4,tRNA wobble position uridine thiolation,BP,
899,GO:0002144,1,0.994391455058646,0,1,cytosolic tRNA wobble base thiouridylase complex,CC,
900,GO:0002148,1,0.992647930596004,0,1,hypochlorous acid metabolic process,BP,
901,GO:0002149,1,0.992647930596004,0,1,hypochlorous acid biosynthetic process,BP,
902,GO:0002151,1,0.950335071888401,0,6,G-quadruplex RNA binding,MF,
903,GO:0002152,1,0.992562890664473,0,1,bile acid conjugation,BP,
904,GO:0002153,1,0.993694199101831,0,1,steroid receptor RNA activator RNA binding,MF,
905,GO:0002154,1,0.960350336182305,0,5,thyroid hormone mediated signaling pathway,BP,
906,GO:0002155,1,0.979021970164033,0,3,regulation of thyroid hormone mediated signaling pathway,BP,
907,GO:0002158,1,0.968964677731985,0,5,osteoclast proliferation,BP,
908,GO:0002159,1,0.968218146262826,0,4,desmosome assembly,BP,
909,GO:0002161,1,0.927298315891607,0,11,aminoacyl-tRNA editing activity,MF,
910,GO:0002162,1,0.936957470263601,0,8,dystroglycan binding,MF,
911,GO:0002169,1,0.986006198283534,0,2,3-methylcrotonyl-CoA carboxylase complex, mitochondrial,CC,
912,GO:0002174,1,0.99287289100993,0,1,mammary stem cell proliferation,BP,
914,GO:0002176,1,0.970435291747608,0,6,male germ cell proliferation,BP,
915,GO:0002177,1,0.961428595649948,0,7,manchette,CC,
916,GO:0002178,1,0.932016042686986,0,11,palmitoyltransferase complex,CC,
917,GO:0002181,1,0.664427245144224,0,84,cytoplasmic translation,BP,
918,GO:0002182,1,0.933114570020659,0,10,cytoplasmic translational elongation,BP,
919,GO:0002183,1,0.889589929424131,0,18,cytoplasmic translational initiation,BP,
920,GO:0002184,1,0.983858019625973,0,2,cytoplasmic translational termination,BP,
921,GO:0002188,1,0.974248248850554,0,3,translation reinitiation,BP,
922,GO:0002189,1,0.993465161865292,0,1,ribose phosphate diphosphokinase complex,CC,
923,GO:0002190,1,0.975481650578395,0,5,cap-independent translational initiation,BP,
924,GO:0002191,1,0.981678475968294,0,3,cap-dependent translational initiation,BP,
925,GO:0002192,1,0.992680948106692,0,2,IRES-dependent translational initiation of linear mRNA,BP,
926,GO:0002193,1,0.975262207032815,0,3,MAML1-RBP-Jkappa- ICN1 complex,CC,
927,GO:0002194,1,0.992750120792518,0,1,hepatocyte cell migration,BP,
928,GO:0002196,1,0.994875830458898,0,1,Ser-tRNA(Ala) hydrolase activity,MF,
929,GO:0002199,1,0.953560321839738,0,8,zona pellucida receptor complex,CC,
930,GO:0002200,1,0.66738748260831,0,57,somatic diversification of immune receptors,BP,
931,GO:0002204,1,0.768076723320508,0,39,somatic recombination of immunoglobulin genes involved in immune response,BP,
932,GO:0002208,1,0.768076723320508,0,39,somatic diversification of immunoglobulins involved in immune response,BP,
934,GO:0002215,1,0.989757579539919,0,2,defense response to nematode,BP,
936,GO:0002220,1,0.528435039768622,0,108,innate immune response activating cell surface receptor signaling pathway,BP,
938,GO:0002223,1,0.535906330962186,0,105,stimulatory C-type lectin receptor signaling pathway,BP,
940,GO:0002225,1,0.990790546133231,0,2,positive regulation of antimicrobial peptide production,BP,
943,GO:0002230,1,0.874291909591696,0,21,positive regulation of defense response to virus by host,BP,
944,GO:0002232,1,0.989582612951209,0,2,leukocyte chemotaxis involved in inflammatory response,BP,
946,GO:0002238,1,0.985462169209114,0,2,response to molecule of fungal origin,BP,
948,GO:0002246,1,0.964388202833061,0,6,wound healing involved in inflammatory response,BP,
949,GO:0002248,1,0.968566819685989,0,5,connective tissue replacement involved in inflammatory response wound healing,BP,
950,GO:0002249,1,0.970185938498835,0,5,lymphocyte anergy,BP,
951,GO:0002250,1,0.139141922020397,0,310,adaptive immune response,BP,
955,GO:0002254,1,0.982863065231372,0,3,kinin cascade,BP,
959,GO:0002265,1,0.970868700748728,0,3,astrocyte activation involved in immune response,BP,
960,GO:0002266,1,0.983353861452273,0,3,follicular dendritic cell activation,BP,
961,GO:0002268,1,0.987739275665311,0,2,follicular dendritic cell differentiation,BP,
964,GO:0002276,1,0.986858737985371,0,2,basophil activation involved in immune response,BP,
965,GO:0002277,1,0.983262847782755,0,3,myeloid dendritic cell activation involved in immune response,BP,
966,GO:0002278,1,0.976987079416518,0,4,eosinophil activation involved in immune response,BP,
967,GO:0002279,1,0.767127975027198,0,42,mast cell activation involved in immune response,BP,
968,GO:0002281,1,0.943468312319361,0,9,macrophage activation involved in immune response,BP,
969,GO:0002282,1,0.98599331176981,0,2,microglial cell activation involved in immune response,BP,
971,GO:0002285,1,0.414963594458453,0,132,lymphocyte activation involved in immune response,BP,
972,GO:0002286,1,0.619494861109017,0,73,T cell activation involved in immune response,BP,
973,GO:0002287,1,0.715711252693824,0,50,alpha-beta T cell activation involved in immune response,BP,
974,GO:0002290,1,0.99295458484256,0,1,gamma-delta T cell activation involved in immune response,BP,
975,GO:0002291,1,0.953324463518268,0,8,T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
976,GO:0002292,1,0.693975856963389,0,55,T cell differentiation involved in immune response,BP,
977,GO:0002293,1,0.715711252693824,0,50,alpha-beta T cell differentiation involved in immune response,BP,
978,GO:0002294,1,0.720678273430919,0,49,CD4-positive, alpha-beta T cell differentiation involved in immune response,BP,
979,GO:0002295,1,0.922104359816058,0,13,T-helper cell lineage commitment,BP,
980,GO:0002296,1,0.983520501196792,0,2,T-helper 1 cell lineage commitment,BP,
981,GO:0002298,1,0.995407779536441,0,1,CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response,BP,
982,GO:0002299,1,0.995661033833454,0,1,alpha-beta intraepithelial T cell differentiation,BP,
983,GO:0002300,1,0.995661033833454,0,1,CD8-positive, alpha-beta intraepithelial T cell differentiation,BP,
984,GO:0002302,1,0.993130309648399,0,1,CD8-positive, alpha-beta T cell differentiation involved in immune response,BP,
985,GO:0002304,1,0.995661033833454,0,1,gamma-delta intraepithelial T cell differentiation,BP,
986,GO:0002305,1,0.995661033833454,0,1,CD8-positive, gamma-delta intraepithelial T cell differentiation,BP,
987,GO:0002309,1,0.98025116079747,0,4,T cell proliferation involved in immune response,BP,
988,GO:0002312,1,0.663893189686853,0,61,B cell activation involved in immune response,BP,
989,GO:0002313,1,0.897215623362525,0,17,mature B cell differentiation involved in immune response,BP,
990,GO:0002314,1,0.982127743377156,0,3,germinal center B cell differentiation,BP,
991,GO:0002315,1,0.933261912421917,0,9,marginal zone B cell differentiation,BP,
992,GO:0002316,1,0.988014818218423,0,2,follicular B cell differentiation,BP,
993,GO:0002317,1,0.988141167470959,0,3,plasma cell differentiation,BP,
994,GO:0002318,1,0.964439776365248,0,5,myeloid progenitor cell differentiation,BP,
995,GO:0002320,1,0.881208046632041,0,18,lymphoid progenitor cell differentiation,BP,
996,GO:0002322,1,0.96378704351709,0,5,B cell proliferation involved in immune response,BP,
997,GO:0002323,1,0.952333092058459,0,8,natural killer cell activation involved in immune response,BP,
998,GO:0002325,1,0.992462728111527,0,2,natural killer cell differentiation involved in immune response,BP,
999,GO:0002326,1,0.972441539129189,0,3,B cell lineage commitment,BP,
1000,GO:0002327,1,0.940087535370982,0,7,immature B cell differentiation,BP,
1001,GO:0002328,1,0.923270380454132,0,10,pro-B cell differentiation,BP,
1002,GO:0002329,1,0.964069400210578,0,4,pre-B cell differentiation,BP,
1003,GO:0002331,1,0.979821143069178,0,2,pre-B cell allelic exclusion,BP,
1004,GO:0002332,1,0.991747163125289,0,1,transitional stage B cell differentiation,BP,
1005,GO:0002333,1,0.991747163125289,0,1,transitional one stage B cell differentiation,BP,
1006,GO:0002335,1,0.873346115062128,0,21,mature B cell differentiation,BP,
1007,GO:0002337,1,0.988736966215475,0,2,B-1a B cell differentiation,BP,
1008,GO:0002339,1,0.984856466990691,0,3,B cell selection,BP,
1009,GO:0002343,1,0.993307954138853,0,1,peripheral B cell selection,BP,
1010,GO:0002344,1,0.993307954138853,0,1,B cell affinity maturation,BP,
1011,GO:0002347,1,0.903547017883665,0,17,response to tumor cell,BP,
1012,GO:0002349,1,0.968685619073896,0,6,histamine production involved in inflammatory response,BP,
1013,GO:0002351,1,0.982883047798071,0,3,serotonin production involved in inflammatory response,BP,
1014,GO:0002352,1,0.991492143860198,0,2,B cell negative selection,BP,
1015,GO:0002353,1,0.982863065231372,0,3,plasma kallikrein-kinin cascade,BP,
1016,GO:0002355,1,0.993685034479677,0,1,detection of tumor cell,BP,
1017,GO:0002357,1,0.979782866645495,0,3,defense response to tumor cell,BP,
1018,GO:0002358,1,0.997289666042589,0,1,B cell homeostatic proliferation,BP,
1019,GO:0002360,1,0.869328701783939,0,21,T cell lineage commitment,BP,
1020,GO:0002361,1,0.97651736582964,0,4,CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation,BP,
1021,GO:0002362,1,0.993873070355695,0,1,CD4-positive, CD25-positive, alpha-beta regulatory T cell lineage commitment,BP,
1022,GO:0002363,1,0.904853716989732,0,16,alpha-beta T cell lineage commitment,BP,
1024,GO:0002367,1,0.623954731590405,0,76,cytokine production involved in immune response,BP,
1025,GO:0002368,1,0.987262229226481,0,2,B cell cytokine production,BP,
1026,GO:0002369,1,0.833251558892218,0,30,T cell cytokine production,BP,
1027,GO:0002370,1,0.985697781496821,0,2,natural killer cell cytokine production,BP,
1028,GO:0002371,1,0.958488187797069,0,6,dendritic cell cytokine production,BP,
1029,GO:0002373,1,0.997021707873429,0,1,plasmacytoid dendritic cell cytokine production,BP,
1030,GO:0002374,1,0.899702342610904,0,16,cytokine secretion involved in immune response,BP,
1032,GO:0002377,1,0.579472564895512,0,86,immunoglobulin production,BP,
1033,GO:0002378,1,0.977680232060325,0,3,immunoglobulin biosynthetic process,BP,
1034,GO:0002380,1,0.992347516262239,0,1,immunoglobulin secretion involved in immune response,BP,
1035,GO:0002381,1,0.747217572842426,0,44,immunoglobulin production involved in immunoglobulin mediated immune response,BP,
1036,GO:0002384,1,0.988979688177438,0,2,hepatic immune response,BP,
1038,GO:0002386,1,0.987273296223457,0,2,immune response in mucosal-associated lymphoid tissue,BP,
1040,GO:0002397,1,0.994836688400663,0,1,MHC class I protein complex assembly,BP,
1042,GO:0002407,1,0.874686962189017,0,22,dendritic cell chemotaxis,BP,
1043,GO:0002408,1,0.980912264732339,0,4,myeloid dendritic cell chemotaxis,BP,
1044,GO:0002414,1,0.982530923889204,0,3,immunoglobulin transcytosis in epithelial cells,BP,
1045,GO:0002415,1,0.987273296223457,0,2,immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor,BP,
1046,GO:0002416,1,0.995197109366169,0,1,IgG immunoglobulin transcytosis in epithelial cells mediated by FcRn immunoglobulin receptor,BP,
1047,GO:0002418,1,0.919249695439567,0,14,immune response to tumor cell,BP,
1048,GO:0002420,1,0.948335726836238,0,9,natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1049,GO:0002423,1,0.948335726836238,0,9,natural killer cell mediated immune response to tumor cell,BP,
1050,GO:0002424,1,0.986522108989559,0,2,T cell mediated immune response to tumor cell,BP,
1051,GO:0002426,1,0.99641910777211,0,1,immunoglobulin production in mucosal tissue,BP,
1052,GO:0002428,1,0.984855596936637,0,3,antigen processing and presentation of peptide antigen via MHC class Ib,BP,
1055,GO:0002431,1,0.602730959213704,0,75,Fc receptor mediated stimulatory signaling pathway,BP,
1056,GO:0002432,1,0.992376509458001,0,1,granuloma formation,BP,
1057,GO:0002433,1,0.620816935965827,0,70,immune response-regulating cell surface receptor signaling pathway involved in phagocytosis,BP,
1058,GO:0002434,1,0.989125488593042,0,2,immune complex clearance,BP,
1059,GO:0002436,1,0.989125488593042,0,2,immune complex clearance by monocytes and macrophages,BP,
1061,GO:0002438,1,0.899452478747131,0,19,acute inflammatory response to antigenic stimulus,BP,
1062,GO:0002439,1,0.981004974786914,0,4,chronic inflammatory response to antigenic stimulus,BP,
1063,GO:0002440,1,0.381525614115107,0,153,production of molecular mediator of immune response,BP,
1064,GO:0002441,1,0.968685619073896,0,6,histamine secretion involved in inflammatory response,BP,
1065,GO:0002442,1,0.982883047798071,0,3,serotonin secretion involved in inflammatory response,BP,
1068,GO:0002445,1,0.985411375403177,0,3,type II hypersensitivity,BP,
1070,GO:0002447,1,0.976987079416518,0,4,eosinophil mediated immunity,BP,
1071,GO:0002448,1,0.757554457052275,0,44,mast cell mediated immunity,BP,
1073,GO:0002450,1,0.995560697417249,0,1,B cell antigen processing and presentation,BP,
1074,GO:0002455,1,0.803654813489977,0,37,humoral immune response mediated by circulating immunoglobulin,BP,
1075,GO:0002456,1,0.635004458776099,0,74,T cell mediated immunity,BP,
1076,GO:0002457,1,0.967477945981204,0,5,T cell antigen processing and presentation,BP,
1077,GO:0002458,1,0.988274320043935,0,2,peripheral T cell tolerance induction,BP,
1078,GO:0002460,1,0.28162616655483,0,200,adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
1079,GO:0002461,1,0.982246126333189,0,3,tolerance induction dependent upon immune response,BP,
1080,GO:0002465,1,0.988274320043935,0,2,peripheral tolerance induction,BP,
1081,GO:0002467,1,0.904984948507248,0,15,germinal center formation,BP,
1082,GO:0002468,1,0.950642535778383,0,9,dendritic cell antigen processing and presentation,BP,
1083,GO:0002474,1,0.632636263539708,0,88,antigen processing and presentation of peptide antigen via MHC class I,BP,
1084,GO:0002475,1,0.956157643874787,0,7,antigen processing and presentation via MHC class Ib,BP,
1085,GO:0002476,1,0.987896203900538,0,2,antigen processing and presentation of endogenous peptide antigen via MHC class Ib,BP,
1086,GO:0002477,1,0.996922514887318,0,1,antigen processing and presentation of exogenous peptide antigen via MHC class Ib,BP,
1088,GO:0002479,1,0.715603677386855,0,69,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent,BP,
1089,GO:0002480,1,0.964240834596775,0,8,antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent,BP,
1090,GO:0002481,1,0.996922514887318,0,1,antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent,BP,
1091,GO:0002483,1,0.949824056450418,0,8,antigen processing and presentation of endogenous peptide antigen,BP,
1092,GO:0002488,1,0.992470257377452,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway,BP,
1093,GO:0002489,1,0.992470257377452,0,1,antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent,BP,
1095,GO:0002501,1,0.984026354318507,0,4,peptide antigen assembly with MHC protein complex,BP,
1096,GO:0002502,1,0.994836688400663,0,1,peptide antigen assembly with MHC class I protein complex,BP,
1097,GO:0002503,1,0.989134120465915,0,3,peptide antigen assembly with MHC class II protein complex,BP,
1102,GO:0002508,1,0.987693648760981,0,2,central tolerance induction,BP,
1103,GO:0002509,1,0.994367080541708,0,1,central tolerance induction to self antigen,BP,
1104,GO:0002510,1,0.993289142355086,0,1,central B cell tolerance induction,BP,
1105,GO:0002513,1,0.967859064715911,0,5,tolerance induction to self antigen,BP,
1106,GO:0002514,1,0.985621432421476,0,2,B cell tolerance induction,BP,
1107,GO:0002517,1,0.928932419968844,0,12,T cell tolerance induction,BP,
1108,GO:0002518,1,0.996460308534979,0,1,lymphocyte chemotaxis across high endothelial venule,BP,
1109,GO:0002519,1,0.989336509055319,0,2,natural killer cell tolerance induction,BP,
1112,GO:0002522,1,0.988013784170059,0,2,leukocyte migration involved in immune response,BP,
1113,GO:0002523,1,0.9399389044255,0,11,leukocyte migration involved in inflammatory response,BP,
1114,GO:0002524,1,0.957039098065551,0,8,hypersensitivity,BP,
1115,GO:0002525,1,0.982719675021261,0,3,acute inflammatory response to non-antigenic stimulus,BP,
1116,GO:0002526,1,0.474576640437399,0,125,acute inflammatory response,BP,
1117,GO:0002528,1,0.983205881869382,0,2,regulation of vascular permeability involved in acute inflammatory response,BP,
1120,GO:0002536,1,0.986377176682267,0,3,respiratory burst involved in inflammatory response,BP,
1121,GO:0002537,1,0.982382917104337,0,2,nitric oxide production involved in inflammatory response,BP,
1122,GO:0002538,1,0.986156478304075,0,2,arachidonic acid metabolite production involved in inflammatory response,BP,
1123,GO:0002540,1,0.986156478304075,0,2,leukotriene production involved in inflammatory response,BP,
1124,GO:0002541,1,0.982483227314155,0,3,activation of plasma proteins involved in acute inflammatory response,BP,
1125,GO:0002542,1,0.988576698320593,0,2,Factor XII activation,BP,
1126,GO:0002543,1,0.986111374619199,0,2,activation of blood coagulation via clotting cascade,BP,
1128,GO:0002545,1,0.994914964861877,0,1,chronic inflammatory response to non-antigenic stimulus,BP,
1129,GO:0002548,1,0.815642780001645,0,40,monocyte chemotaxis,BP,
1130,GO:0002551,1,0.940795304236488,0,10,mast cell chemotaxis,BP,
1131,GO:0002553,1,0.968685619073896,0,6,histamine secretion by mast cell,BP,
1132,GO:0002554,1,0.982883047798071,0,3,serotonin secretion by platelet,BP,
1133,GO:0002560,1,0.992440287823366,0,1,basophil mediated immunity,BP,
1134,GO:0002561,1,0.992440287823366,0,1,basophil degranulation,BP,
1135,GO:0002562,1,0.697960644364763,0,51,somatic diversification of immune receptors via germline recombination within a single locus,BP,
1136,GO:0002566,1,0.919021118060091,0,12,somatic diversification of immune receptors via somatic mutation,BP,
1137,GO:0002568,1,0.95651800456501,0,5,somatic diversification of T cell receptor genes,BP,
1138,GO:0002572,1,0.98528270765706,0,2,pro-T cell differentiation,BP,
1141,GO:0002577,1,0.913483772985291,0,17,regulation of antigen processing and presentation,BP,
1142,GO:0002578,1,0.959257074971859,0,7,negative regulation of antigen processing and presentation,BP,
1143,GO:0002579,1,0.957064188400167,0,9,positive regulation of antigen processing and presentation,BP,
1144,GO:0002580,1,0.974421972528496,0,5,regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1145,GO:0002581,1,0.980397907479207,0,3,negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1146,GO:0002582,1,0.993905789389836,0,2,positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II,BP,
1147,GO:0002583,1,0.972665899741948,0,6,regulation of antigen processing and presentation of peptide antigen,BP,
1148,GO:0002584,1,0.978631174282418,0,4,negative regulation of antigen processing and presentation of peptide antigen,BP,
1149,GO:0002585,1,0.993905789389836,0,2,positive regulation of antigen processing and presentation of peptide antigen,BP,
1150,GO:0002586,1,0.982636269845361,0,4,regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1151,GO:0002587,1,0.988662072550498,0,2,negative regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1152,GO:0002588,1,0.993905789389836,0,2,positive regulation of antigen processing and presentation of peptide antigen via MHC class II,BP,
1153,GO:0002589,1,0.989855220478657,0,2,regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,
1154,GO:0002590,1,0.989855220478657,0,2,negative regulation of antigen processing and presentation of peptide antigen via MHC class I,BP,
1155,GO:0002604,1,0.950642535778383,0,9,regulation of dendritic cell antigen processing and presentation,BP,
1156,GO:0002605,1,0.987239442878019,0,2,negative regulation of dendritic cell antigen processing and presentation,BP,
1157,GO:0002606,1,0.962934735225046,0,7,positive regulation of dendritic cell antigen processing and presentation,BP,
1158,GO:0002622,1,0.995560697417249,0,1,regulation of B cell antigen processing and presentation,BP,
1159,GO:0002625,1,0.989815250062716,0,2,regulation of T cell antigen processing and presentation,BP,
1160,GO:0002626,1,0.994763168170186,0,1,negative regulation of T cell antigen processing and presentation,BP,
1161,GO:0002634,1,0.941710366678886,0,9,regulation of germinal center formation,BP,
1162,GO:0002635,1,0.981973460573696,0,2,negative regulation of germinal center formation,BP,
1163,GO:0002636,1,0.989302777931077,0,3,positive regulation of germinal center formation,BP,
1164,GO:0002637,1,0.723699033359952,0,52,regulation of immunoglobulin production,BP,
1165,GO:0002638,1,0.933036815040614,0,10,negative regulation of immunoglobulin production,BP,
1166,GO:0002639,1,0.816077532808044,0,34,positive regulation of immunoglobulin production,BP,
1167,GO:0002640,1,0.993058458973322,0,1,regulation of immunoglobulin biosynthetic process,BP,
1168,GO:0002642,1,0.993058458973322,0,1,positive regulation of immunoglobulin biosynthetic process,BP,
1169,GO:0002643,1,0.900617570215076,0,16,regulation of tolerance induction,BP,
1170,GO:0002644,1,0.994375199122102,0,1,negative regulation of tolerance induction,BP,
1171,GO:0002645,1,0.942281278760275,0,9,positive regulation of tolerance induction,BP,
1172,GO:0002646,1,0.993289142355086,0,1,regulation of central tolerance induction,BP,
1173,GO:0002648,1,0.993289142355086,0,1,positive regulation of central tolerance induction,BP,
1174,GO:0002649,1,0.992281002971285,0,1,regulation of tolerance induction to self antigen,BP,
1175,GO:0002651,1,0.992281002971285,0,1,positive regulation of tolerance induction to self antigen,BP,
1176,GO:0002652,1,0.987811067523978,0,2,regulation of tolerance induction dependent upon immune response,BP,
1177,GO:0002654,1,0.993873070355695,0,1,positive regulation of tolerance induction dependent upon immune response,BP,
1178,GO:0002658,1,0.993873070355695,0,1,regulation of peripheral tolerance induction,BP,
1179,GO:0002660,1,0.993873070355695,0,1,positive regulation of peripheral tolerance induction,BP,
1180,GO:0002661,1,0.985621432421476,0,2,regulation of B cell tolerance induction,BP,
1181,GO:0002663,1,0.985621432421476,0,2,positive regulation of B cell tolerance induction,BP,
1182,GO:0002664,1,0.940521803693236,0,10,regulation of T cell tolerance induction,BP,
1183,GO:0002666,1,0.958079231756866,0,7,positive regulation of T cell tolerance induction,BP,
1184,GO:0002667,1,0.970185938498835,0,5,regulation of T cell anergy,BP,
1185,GO:0002669,1,0.981026245209606,0,3,positive regulation of T cell anergy,BP,
1186,GO:0002673,1,0.645365336303562,0,72,regulation of acute inflammatory response,BP,
1187,GO:0002674,1,0.944695175810963,0,9,negative regulation of acute inflammatory response,BP,
1188,GO:0002675,1,0.866877015597626,0,25,positive regulation of acute inflammatory response,BP,
1189,GO:0002676,1,0.956881053542712,0,8,regulation of chronic inflammatory response,BP,
1190,GO:0002677,1,0.974355637023182,0,4,negative regulation of chronic inflammatory response,BP,
1191,GO:0002678,1,0.982070121277245,0,4,positive regulation of chronic inflammatory response,BP,
1192,GO:0002679,1,0.957777303280436,0,7,respiratory burst involved in defense response,BP,
1193,GO:0002681,1,0.95651800456501,0,5,somatic recombination of T cell receptor gene segments,BP,
1199,GO:0002687,1,0.529557557450814,0,113,positive regulation of leukocyte migration,BP,
1200,GO:0002688,1,0.57802346382728,0,100,regulation of leukocyte chemotaxis,BP,
1201,GO:0002689,1,0.924747671103124,0,14,negative regulation of leukocyte chemotaxis,BP,
1202,GO:0002690,1,0.654262461171502,0,79,positive regulation of leukocyte chemotaxis,BP,
1203,GO:0002691,1,0.872053891074425,0,22,regulation of cellular extravasation,BP,
1204,GO:0002692,1,0.95383834438692,0,8,negative regulation of cellular extravasation,BP,
1205,GO:0002693,1,0.922911372680039,0,12,positive regulation of cellular extravasation,BP,
1209,GO:0002697,1,0.14872459352406,0,300,regulation of immune effector process,BP,
1210,GO:0002698,1,0.551855945948459,0,93,negative regulation of immune effector process,BP,
1211,GO:0002699,1,0.375046230318703,0,158,positive regulation of immune effector process,BP,
1212,GO:0002700,1,0.521583373662153,0,104,regulation of production of molecular mediator of immune response,BP,
1213,GO:0002701,1,0.828359484306467,0,30,negative regulation of production of molecular mediator of immune response,BP,
1214,GO:0002702,1,0.658729195855714,0,68,positive regulation of production of molecular mediator of immune response,BP,
1215,GO:0002703,1,0.388401095369067,0,152,regulation of leukocyte mediated immunity,BP,
1216,GO:0002704,1,0.779196033094402,0,41,negative regulation of leukocyte mediated immunity,BP,
1217,GO:0002705,1,0.574627927784137,0,90,positive regulation of leukocyte mediated immunity,BP,
1218,GO:0002706,1,0.509401497916601,0,110,regulation of lymphocyte mediated immunity,BP,
1219,GO:0002707,1,0.829250691903445,0,31,negative regulation of lymphocyte mediated immunity,BP,
1220,GO:0002708,1,0.645961687599369,0,71,positive regulation of lymphocyte mediated immunity,BP,
1221,GO:0002709,1,0.756262790681599,0,48,regulation of T cell mediated immunity,BP,
1222,GO:0002710,1,0.917815841724317,0,15,negative regulation of T cell mediated immunity,BP,
1223,GO:0002711,1,0.842206966137214,0,29,positive regulation of T cell mediated immunity,BP,
1224,GO:0002712,1,0.769783887594853,0,41,regulation of B cell mediated immunity,BP,
1225,GO:0002713,1,0.941327389455092,0,9,negative regulation of B cell mediated immunity,BP,
1226,GO:0002714,1,0.841046681088638,0,28,positive regulation of B cell mediated immunity,BP,
1227,GO:0002715,1,0.817080066840959,0,33,regulation of natural killer cell mediated immunity,BP,
1228,GO:0002716,1,0.936079884892998,0,11,negative regulation of natural killer cell mediated immunity,BP,
1229,GO:0002717,1,0.878371204994811,0,21,positive regulation of natural killer cell mediated immunity,BP,
1230,GO:0002718,1,0.689005073351496,0,60,regulation of cytokine production involved in immune response,BP,
1231,GO:0002719,1,0.882457221211189,0,21,negative regulation of cytokine production involved in immune response,BP,
1232,GO:0002720,1,0.802987611372919,0,35,positive regulation of cytokine production involved in immune response,BP,
1233,GO:0002721,1,0.993307954138853,0,1,regulation of B cell cytokine production,BP,
1234,GO:0002724,1,0.87954022914755,0,21,regulation of T cell cytokine production,BP,
1235,GO:0002725,1,0.967543313986439,0,6,negative regulation of T cell cytokine production,BP,
1236,GO:0002726,1,0.914837349979313,0,14,positive regulation of T cell cytokine production,BP,
1237,GO:0002727,1,0.985697781496821,0,2,regulation of natural killer cell cytokine production,BP,
1238,GO:0002728,1,0.992359560301871,0,1,negative regulation of natural killer cell cytokine production,BP,
1239,GO:0002729,1,0.993287443236099,0,1,positive regulation of natural killer cell cytokine production,BP,
1240,GO:0002730,1,0.966201833309184,0,5,regulation of dendritic cell cytokine production,BP,
1241,GO:0002731,1,0.988907602562571,0,2,negative regulation of dendritic cell cytokine production,BP,
1242,GO:0002732,1,0.992350070453485,0,1,positive regulation of dendritic cell cytokine production,BP,
1243,GO:0002736,1,0.997021707873429,0,1,regulation of plasmacytoid dendritic cell cytokine production,BP,
1244,GO:0002737,1,0.997021707873429,0,1,negative regulation of plasmacytoid dendritic cell cytokine production,BP,
1245,GO:0002739,1,0.920422917217538,0,13,regulation of cytokine secretion involved in immune response,BP,
1246,GO:0002740,1,0.973664649482906,0,5,negative regulation of cytokine secretion involved in immune response,BP,
1247,GO:0002741,1,0.952349202675508,0,7,positive regulation of cytokine secretion involved in immune response,BP,
1248,GO:0002752,1,0.99082879332458,0,2,cell surface pattern recognition receptor signaling pathway,BP,
1249,GO:0002753,1,0.697485064617306,0,51,cytoplasmic pattern recognition receptor signaling pathway,BP,
1251,GO:0002756,1,0.827625957884944,0,30,MyD88-independent toll-like receptor signaling pathway,BP,
1254,GO:0002759,1,0.978465340459202,0,4,regulation of antimicrobial humoral response,BP,
1255,GO:0002760,1,0.990790546133231,0,2,positive regulation of antimicrobial humoral response,BP,
1258,GO:0002763,1,0.75927440252694,0,42,positive regulation of myeloid leukocyte differentiation,BP,
1260,GO:0002765,1,0.963571464627577,0,6,immune response-inhibiting signal transduction,BP,
1261,GO:0002767,1,0.968866638180027,0,5,immune response-inhibiting cell surface receptor signaling pathway,BP,
1263,GO:0002769,1,0.994275926511383,0,1,natural killer cell inhibitory signaling pathway,BP,
1264,GO:0002774,1,0.978736948757614,0,3,Fc receptor mediated inhibitory signaling pathway,BP,
1265,GO:0002775,1,0.980474970635718,0,4,antimicrobial peptide production,BP,
1266,GO:0002777,1,0.997055373326101,0,1,antimicrobial peptide biosynthetic process,BP,
1267,GO:0002778,1,0.980474970635718,0,4,antibacterial peptide production,BP,
1268,GO:0002780,1,0.997055373326101,0,1,antibacterial peptide biosynthetic process,BP,
1269,GO:0002784,1,0.983371118515655,0,3,regulation of antimicrobial peptide production,BP,
1270,GO:0002785,1,0.992512299234245,0,1,negative regulation of antimicrobial peptide production,BP,
1271,GO:0002786,1,0.983371118515655,0,3,regulation of antibacterial peptide production,BP,
1272,GO:0002787,1,0.992512299234245,0,1,negative regulation of antibacterial peptide production,BP,
1275,GO:0002792,1,0.505607714536327,0,107,negative regulation of peptide secretion,BP,
1277,GO:0002803,1,0.990790546133231,0,2,positive regulation of antibacterial peptide production,BP,
1278,GO:0002812,1,0.997055373326101,0,1,biosynthetic process of antibacterial peptides active against Gram-negative bacteria,BP,
1279,GO:0002818,1,0.997173856098771,0,1,intracellular defense response,BP,
1280,GO:0002819,1,0.476385422521874,0,120,regulation of adaptive immune response,BP,
1281,GO:0002820,1,0.800875999052764,0,34,negative regulation of adaptive immune response,BP,
1282,GO:0002821,1,0.643354523872642,0,73,positive regulation of adaptive immune response,BP,
1283,GO:0002822,1,0.50972360023914,0,109,regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
1284,GO:0002823,1,0.816372635345185,0,31,negative regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
1285,GO:0002824,1,0.660388230099107,0,69,positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains,BP,
1286,GO:0002825,1,0.894623474980453,0,19,regulation of T-helper 1 type immune response,BP,
1287,GO:0002826,1,0.956554603436838,0,7,negative regulation of T-helper 1 type immune response,BP,
1288,GO:0002827,1,0.934926764436907,0,12,positive regulation of T-helper 1 type immune response,BP,
1289,GO:0002828,1,0.848084196869936,0,27,regulation of type 2 immune response,BP,
1290,GO:0002829,1,0.932211945446104,0,11,negative regulation of type 2 immune response,BP,
1291,GO:0002830,1,0.914639587125128,0,15,positive regulation of type 2 immune response,BP,
1294,GO:0002833,1,0.806398266768602,0,34,positive regulation of response to biotic stimulus,BP,
1295,GO:0002834,1,0.935547423247109,0,11,regulation of response to tumor cell,BP,
1296,GO:0002835,1,0.986495515250278,0,2,negative regulation of response to tumor cell,BP,
1297,GO:0002836,1,0.955470026740364,0,8,positive regulation of response to tumor cell,BP,
1298,GO:0002837,1,0.935547423247109,0,11,regulation of immune response to tumor cell,BP,
1299,GO:0002838,1,0.986495515250278,0,2,negative regulation of immune response to tumor cell,BP,
1300,GO:0002839,1,0.955470026740364,0,8,positive regulation of immune response to tumor cell,BP,
1301,GO:0002840,1,0.986522108989559,0,2,regulation of T cell mediated immune response to tumor cell,BP,
1302,GO:0002842,1,0.993913951729972,0,1,positive regulation of T cell mediated immune response to tumor cell,BP,
1303,GO:0002849,1,0.993873070355695,0,1,regulation of peripheral T cell tolerance induction,BP,
1304,GO:0002851,1,0.993873070355695,0,1,positive regulation of peripheral T cell tolerance induction,BP,
1305,GO:0002855,1,0.948335726836238,0,9,regulation of natural killer cell mediated immune response to tumor cell,BP,
1306,GO:0002856,1,0.986495515250278,0,2,negative regulation of natural killer cell mediated immune response to tumor cell,BP,
1307,GO:0002857,1,0.961322987798926,0,7,positive regulation of natural killer cell mediated immune response to tumor cell,BP,
1308,GO:0002858,1,0.948335726836238,0,9,regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1309,GO:0002859,1,0.986495515250278,0,2,negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1310,GO:0002860,1,0.961322987798926,0,7,positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target,BP,
1313,GO:0002863,1,0.947208713427666,0,10,positive regulation of inflammatory response to antigenic stimulus,BP,
1314,GO:0002864,1,0.941425079045066,0,11,regulation of acute inflammatory response to antigenic stimulus,BP,
1315,GO:0002865,1,0.977969882775807,0,4,negative regulation of acute inflammatory response to antigenic stimulus,BP,
1316,GO:0002866,1,0.962640151498168,0,7,positive regulation of acute inflammatory response to antigenic stimulus,BP,
1317,GO:0002870,1,0.970185938498835,0,5,T cell anergy,BP,
1318,GO:0002874,1,0.986960955924543,0,3,regulation of chronic inflammatory response to antigenic stimulus,BP,
1319,GO:0002875,1,0.995506836278652,0,1,negative regulation of chronic inflammatory response to antigenic stimulus,BP,
1320,GO:0002876,1,0.991415934420102,0,2,positive regulation of chronic inflammatory response to antigenic stimulus,BP,
1321,GO:0002877,1,0.982719675021261,0,3,regulation of acute inflammatory response to non-antigenic stimulus,BP,
1322,GO:0002878,1,0.992678142299321,0,1,negative regulation of acute inflammatory response to non-antigenic stimulus,BP,
1323,GO:0002879,1,0.989968814390702,0,2,positive regulation of acute inflammatory response to non-antigenic stimulus,BP,
1324,GO:0002880,1,0.994914964861877,0,1,regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1325,GO:0002882,1,0.994914964861877,0,1,positive regulation of chronic inflammatory response to non-antigenic stimulus,BP,
1326,GO:0002883,1,0.964029594836916,0,7,regulation of hypersensitivity,BP,
1327,GO:0002884,1,0.99012110743309,0,2,negative regulation of hypersensitivity,BP,
1328,GO:0002885,1,0.973650746533497,0,5,positive regulation of hypersensitivity,BP,
1329,GO:0002886,1,0.767135548377964,0,43,regulation of myeloid leukocyte mediated immunity,BP,
1330,GO:0002887,1,0.941726820630717,0,10,negative regulation of myeloid leukocyte mediated immunity,BP,
1331,GO:0002888,1,0.881791961248323,0,21,positive regulation of myeloid leukocyte mediated immunity,BP,
1332,GO:0002889,1,0.769783887594853,0,41,regulation of immunoglobulin mediated immune response,BP,
1333,GO:0002890,1,0.941327389455092,0,9,negative regulation of immunoglobulin mediated immune response,BP,
1334,GO:0002891,1,0.841046681088638,0,28,positive regulation of immunoglobulin mediated immune response,BP,
1335,GO:0002892,1,0.985411375403177,0,3,regulation of type II hypersensitivity,BP,
1336,GO:0002893,1,0.995560697417249,0,1,negative regulation of type II hypersensitivity,BP,
1337,GO:0002894,1,0.989805873511615,0,2,positive regulation of type II hypersensitivity,BP,
1338,GO:0002895,1,0.993289142355086,0,1,regulation of central B cell tolerance induction,BP,
1339,GO:0002897,1,0.993289142355086,0,1,positive regulation of central B cell tolerance induction,BP,
1340,GO:0002901,1,0.982570454216304,0,4,mature B cell apoptotic process,BP,
1341,GO:0002902,1,0.900303048440806,0,17,regulation of B cell apoptotic process,BP,
1342,GO:0002903,1,0.935498080712666,0,11,negative regulation of B cell apoptotic process,BP,
1343,GO:0002904,1,0.984031658482155,0,3,positive regulation of B cell apoptotic process,BP,
1344,GO:0002905,1,0.982570454216304,0,4,regulation of mature B cell apoptotic process,BP,
1345,GO:0002906,1,0.982570454216304,0,4,negative regulation of mature B cell apoptotic process,BP,
1346,GO:0002911,1,0.970185938498835,0,5,regulation of lymphocyte anergy,BP,
1347,GO:0002913,1,0.981026245209606,0,3,positive regulation of lymphocyte anergy,BP,
1348,GO:0002920,1,0.737542183300536,0,51,regulation of humoral immune response,BP,
1349,GO:0002921,1,0.931805458343541,0,10,negative regulation of humoral immune response,BP,
1350,GO:0002922,1,0.940322738400098,0,12,positive regulation of humoral immune response,BP,
1351,GO:0002923,1,0.950061624917867,0,9,regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1352,GO:0002924,1,0.966944123849759,0,5,negative regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1353,GO:0002925,1,0.982546182777725,0,4,positive regulation of humoral immune response mediated by circulating immunoglobulin,BP,
1354,GO:0002930,1,0.986771841922739,0,2,trabecular meshwork development,BP,
1356,GO:0002933,1,0.9835434621117,0,3,lipid hydroxylation,BP,
1358,GO:0002940,1,0.98729656982232,0,2,tRNA N2-guanine methylation,BP,
1359,GO:0002943,1,0.977461537989223,0,4,tRNA dihydrouridine synthesis,BP,
1360,GO:0002944,1,0.984207751177167,0,2,cyclin K-CDK12 complex,CC,
1361,GO:0002945,1,0.98503288513548,0,2,cyclin K-CDK13 complex,CC,
1362,GO:0002946,1,0.995943715245789,0,1,tRNA C5-cytosine methylation,BP,
1363,GO:0002947,1,0.992453608187127,0,1,tumor necrosis factor receptor superfamily complex,CC,
1364,GO:0002949,1,0.984689073382154,0,3,tRNA threonylcarbamoyladenosine modification,BP,
1365,GO:0002950,1,0.979855141218144,0,3,ceramide phosphoethanolamine synthase activity,MF,
1366,GO:0002951,1,0.987384276956332,0,2,leukotriene-C(4) hydrolase,MF,
1371,GO:0003009,1,0.814359975975272,0,36,skeletal muscle contraction,BP,
1372,GO:0003010,1,0.968812518810572,0,5,voluntary skeletal muscle contraction,BP,
1373,GO:0003011,1,0.982244205288442,0,3,involuntary skeletal muscle contraction,BP,
1378,GO:0003016,1,0.826468024953694,0,29,respiratory system process,BP,
1379,GO:0003017,1,0.989632667997305,0,1,lymph circulation,BP,
1381,GO:0003025,1,0.976137979175216,0,3,regulation of systemic arterial blood pressure by baroreceptor feedback,BP,
1382,GO:0003026,1,0.993058458973322,0,1,regulation of systemic arterial blood pressure by aortic arch baroreceptor feedback,BP,
1383,GO:0003027,1,0.995344082193764,0,1,regulation of systemic arterial blood pressure by carotid body chemoreceptor signaling,BP,
1384,GO:0003029,1,0.995344082193764,0,1,detection of hypoxic conditions in blood by carotid body chemoreceptor signaling,BP,
1385,GO:0003032,1,0.986757871973249,0,2,detection of oxygen,BP,
1386,GO:0003044,1,0.781435301123143,0,39,regulation of systemic arterial blood pressure mediated by a chemical signal,BP,
1387,GO:0003050,1,0.992142719689514,0,1,regulation of systemic arterial blood pressure by atrial natriuretic peptide,BP,
1388,GO:0003051,1,0.978709217154621,0,3,angiotensin-mediated drinking behavior,BP,
1389,GO:0003056,1,0.948741435206043,0,7,regulation of vascular smooth muscle contraction,BP,
1390,GO:0003057,1,0.970727177702563,0,5,regulation of the force of heart contraction by chemical signal,BP,
1391,GO:0003058,1,0.996375636404581,0,1,hormonal regulation of the force of heart contraction,BP,
1392,GO:0003062,1,0.958261218545866,0,6,regulation of heart rate by chemical signal,BP,
1393,GO:0003064,1,0.987708079158413,0,2,regulation of heart rate by hormone,BP,
1394,GO:0003065,1,0.995132497390853,0,1,positive regulation of heart rate by epinephrine,BP,
1395,GO:0003068,1,0.996841976500444,0,1,regulation of systemic arterial blood pressure by acetylcholine,BP,
1396,GO:0003069,1,0.996841976500444,0,1,acetylcholine-mediated vasodilation involved in regulation of systemic arterial blood pressure,BP,
1397,GO:0003070,1,0.996841976500444,0,1,regulation of systemic arterial blood pressure by neurotransmitter,BP,
1399,GO:0003072,1,0.976339825981373,0,4,renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure,BP,
1401,GO:0003081,1,0.891015079408409,0,18,regulation of systemic arterial blood pressure by renin-angiotensin,BP,
1402,GO:0003083,1,0.997542416310035,0,1,negative regulation of renal output by angiotensin,BP,
1403,GO:0003084,1,0.945328717882896,0,9,positive regulation of systemic arterial blood pressure,BP,
1404,GO:0003085,1,0.922758942676036,0,13,negative regulation of systemic arterial blood pressure,BP,
1405,GO:0003091,1,0.806073399780125,0,29,renal water homeostasis,BP,
1408,GO:0003095,1,0.995266113785771,0,1,pressure natriuresis,BP,
1409,GO:0003096,1,0.96645819606863,0,5,renal sodium ion transport,BP,
1410,GO:0003097,1,0.967996370939822,0,5,renal water transport,BP,
1411,GO:0003099,1,0.983636965486006,0,3,positive regulation of the force of heart contraction by chemical signal,BP,
1412,GO:0003100,1,0.965128670934384,0,6,regulation of systemic arterial blood pressure by endothelin,BP,
1414,GO:0003105,1,0.979198373170483,0,4,negative regulation of glomerular filtration,BP,
1415,GO:0003106,1,0.997542416310035,0,1,negative regulation of glomerular filtration by angiotensin,BP,
1416,GO:0003127,1,0.981863983785871,0,2,detection of nodal flow,BP,
1417,GO:0003128,1,0.935234238931689,0,10,heart field specification,BP,
1418,GO:0003129,1,0.979650565163223,0,4,heart induction,BP,
1419,GO:0003130,1,0.987876687310783,0,2,BMP signaling pathway involved in heart induction,BP,
1420,GO:0003131,1,0.992999161121732,0,1,mesodermal-endodermal cell signaling,BP,
1421,GO:0003133,1,0.987876687310783,0,2,endodermal-mesodermal cell signaling,BP,
1422,GO:0003134,1,0.987876687310783,0,2,endodermal-mesodermal cell signaling involved in heart induction,BP,
1423,GO:0003137,1,0.996555366104087,0,1,Notch signaling pathway involved in heart induction,BP,
1424,GO:0003138,1,0.991334778806719,0,1,primary heart field specification,BP,
1425,GO:0003139,1,0.939840552897983,0,9,secondary heart field specification,BP,
1426,GO:0003140,1,0.953523197043755,0,8,determination of left/right asymmetry in lateral mesoderm,BP,
1427,GO:0003142,1,0.993849579949817,0,1,cardiogenic plate morphogenesis,BP,
1429,GO:0003147,1,0.996793076521281,0,1,neural crest cell migration involved in heart formation,BP,
1430,GO:0003148,1,0.832486178472704,0,25,outflow tract septum morphogenesis,BP,
1431,GO:0003149,1,0.943373933296837,0,9,membranous septum morphogenesis,BP,
1432,GO:0003150,1,0.964015433091609,0,5,muscular septum morphogenesis,BP,
1433,GO:0003151,1,0.606080154914856,0,71,outflow tract morphogenesis,BP,
1434,GO:0003156,1,0.818968277747694,0,32,regulation of animal organ formation,BP,
1435,GO:0003157,1,0.924456595309724,0,11,endocardium development,BP,
1437,GO:0003159,1,0.908804783185094,0,15,morphogenesis of an endothelium,BP,
1438,GO:0003160,1,0.961598242871709,0,6,endocardium morphogenesis,BP,
1440,GO:0003162,1,0.9762431315956,0,3,atrioventricular node development,BP,
1444,GO:0003166,1,0.975904371898371,0,4,bundle of His development,BP,
1445,GO:0003167,1,0.992241262445998,0,1,atrioventricular bundle cell differentiation,BP,
1446,GO:0003168,1,0.994822455267186,0,1,Purkinje myocyte differentiation,BP,
1447,GO:0003169,1,0.982159169925876,0,2,coronary vein morphogenesis,BP,
1448,GO:0003170,1,0.74750570701318,0,38,heart valve development,BP,
1449,GO:0003171,1,0.841705437071415,0,23,atrioventricular valve development,BP,
1450,GO:0003172,1,0.991334778806719,0,1,sinoatrial valve development,BP,
1451,GO:0003174,1,0.923338073435442,0,10,mitral valve development,BP,
1452,GO:0003175,1,0.955118290336693,0,6,tricuspid valve development,BP,
1453,GO:0003176,1,0.964693489325875,0,6,aortic valve development,BP,
1454,GO:0003177,1,0.920679094914964,0,11,pulmonary valve development,BP,
1455,GO:0003179,1,0.768863782414529,0,34,heart valve morphogenesis,BP,
1456,GO:0003180,1,0.964693489325875,0,6,aortic valve morphogenesis,BP,
1457,GO:0003181,1,0.850485943646181,0,21,atrioventricular valve morphogenesis,BP,
1458,GO:0003183,1,0.923338073435442,0,10,mitral valve morphogenesis,BP,
1459,GO:0003184,1,0.920679094914964,0,11,pulmonary valve morphogenesis,BP,
1460,GO:0003185,1,0.991334778806719,0,1,sinoatrial valve morphogenesis,BP,
1461,GO:0003186,1,0.959365801033046,0,5,tricuspid valve morphogenesis,BP,
1462,GO:0003188,1,0.91714009649851,0,12,heart valve formation,BP,
1463,GO:0003190,1,0.943901395916926,0,7,atrioventricular valve formation,BP,
1464,GO:0003192,1,0.971193814279172,0,3,mitral valve formation,BP,
1465,GO:0003193,1,0.995574418564069,0,1,pulmonary valve formation,BP,
1466,GO:0003195,1,0.985915839701298,0,2,tricuspid valve formation,BP,
1467,GO:0003197,1,0.756057857388211,0,39,endocardial cushion development,BP,
1468,GO:0003198,1,0.897123546598955,0,16,epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
1469,GO:0003199,1,0.976719741958167,0,4,endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
1470,GO:0003203,1,0.817023725451329,0,29,endocardial cushion morphogenesis,BP,
1471,GO:0003205,1,0.345490106201412,0,145,cardiac chamber development,BP,
1472,GO:0003206,1,0.451531584108447,0,112,cardiac chamber morphogenesis,BP,
1473,GO:0003207,1,0.926687598874547,0,11,cardiac chamber formation,BP,
1474,GO:0003208,1,0.615686178002045,0,67,cardiac ventricle morphogenesis,BP,
1475,GO:0003209,1,0.809033858214481,0,28,cardiac atrium morphogenesis,BP,
1476,GO:0003210,1,0.996555366104087,0,1,cardiac atrium formation,BP,
1477,GO:0003211,1,0.937774793391672,0,9,cardiac ventricle formation,BP,
1478,GO:0003213,1,0.981253192418147,0,2,cardiac right atrium morphogenesis,BP,
1479,GO:0003214,1,0.90498297681238,0,13,cardiac left ventricle morphogenesis,BP,
1480,GO:0003215,1,0.876933732692764,0,18,cardiac right ventricle morphogenesis,BP,
1481,GO:0003218,1,0.99251470947205,0,1,cardiac left ventricle formation,BP,
1482,GO:0003219,1,0.978859442581919,0,3,cardiac right ventricle formation,BP,
1483,GO:0003220,1,0.975873844970858,0,2,left ventricular cardiac muscle tissue morphogenesis,BP,
1484,GO:0003221,1,0.976255862291248,0,3,right ventricular cardiac muscle tissue morphogenesis,BP,
1485,GO:0003222,1,0.881100700641291,0,16,ventricular trabecula myocardium morphogenesis,BP,
1486,GO:0003223,1,0.929586421557375,0,8,ventricular compact myocardium morphogenesis,BP,
1487,GO:0003226,1,0.988899659285102,0,1,right ventricular compact myocardium morphogenesis,BP,
1488,GO:0003228,1,0.95961136557191,0,6,atrial cardiac muscle tissue development,BP,
1490,GO:0003230,1,0.783466823532843,0,32,cardiac atrium development,BP,
1491,GO:0003231,1,0.44451772951049,0,110,cardiac ventricle development,BP,
1492,GO:0003235,1,0.996555366104087,0,1,sinus venosus development,BP,
1493,GO:0003236,1,0.996555366104087,0,1,sinus venosus morphogenesis,BP,
1494,GO:0003241,1,0.974582219002777,0,4,growth involved in heart morphogenesis,BP,
1495,GO:0003245,1,0.98828655951858,0,2,cardiac muscle tissue growth involved in heart morphogenesis,BP,
1496,GO:0003247,1,0.995486157582346,0,1,post-embryonic cardiac muscle cell growth involved in heart morphogenesis,BP,
1497,GO:0003249,1,0.978015276752155,0,2,cell proliferation involved in heart valve morphogenesis,BP,
1498,GO:0003250,1,0.978015276752155,0,2,regulation of cell proliferation involved in heart valve morphogenesis,BP,
1499,GO:0003251,1,0.989857033990238,0,1,positive regulation of cell proliferation involved in heart valve morphogenesis,BP,
1500,GO:0003252,1,0.988038110561059,0,1,negative regulation of cell proliferation involved in heart valve morphogenesis,BP,
1501,GO:0003253,1,0.960436712898848,0,7,cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
1503,GO:0003256,1,0.952766123208534,0,6,regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,
1504,GO:0003257,1,0.976070168226415,0,3,positive regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation,BP,
1505,GO:0003259,1,0.996555366104087,0,1,cardioblast anterior-lateral migration,BP,
1506,GO:0003260,1,0.996555366104087,0,1,cardioblast migration,BP,
1507,GO:0003263,1,0.94547162316375,0,9,cardioblast proliferation,BP,
1508,GO:0003264,1,0.935580100268136,0,10,regulation of cardioblast proliferation,BP,
1509,GO:0003266,1,0.942016309446277,0,9,regulation of secondary heart field cardioblast proliferation,BP,
1510,GO:0003270,1,0.989543829144195,0,1,Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation,BP,
1511,GO:0003272,1,0.864839443788326,0,21,endocardial cushion formation,BP,
1512,GO:0003273,1,0.96582623395761,0,4,cell migration involved in endocardial cushion formation,BP,
1513,GO:0003274,1,0.977312065444049,0,3,endocardial cushion fusion,BP,
1514,GO:0003275,1,0.980099005389561,0,3,apoptotic process involved in outflow tract morphogenesis,BP,
1515,GO:0003278,1,0.963139444499046,0,6,apoptotic process involved in heart morphogenesis,BP,
1516,GO:0003279,1,0.493985985069187,0,93,cardiac septum development,BP,
1517,GO:0003281,1,0.625163143108538,0,61,ventricular septum development,BP,
1518,GO:0003283,1,0.870991451017457,0,18,atrial septum development,BP,
1519,GO:0003284,1,0.969953567034083,0,4,septum primum development,BP,
1520,GO:0003285,1,0.987428265218175,0,2,septum secundum development,BP,
1521,GO:0003289,1,0.969953567034083,0,4,atrial septum primum morphogenesis,BP,
1522,GO:0003290,1,0.992567711513595,0,1,atrial septum secundum morphogenesis,BP,
1523,GO:0003292,1,0.986560159980816,0,2,cardiac septum cell differentiation,BP,
1525,GO:0003298,1,0.890610492235063,0,17,physiological muscle hypertrophy,BP,
1526,GO:0003299,1,0.846970501784774,0,22,muscle hypertrophy in response to stress,BP,
1527,GO:0003300,1,0.593499834000304,0,68,cardiac muscle hypertrophy,BP,
1528,GO:0003301,1,0.890610492235063,0,17,physiological cardiac muscle hypertrophy,BP,
1529,GO:0003306,1,0.94927294744502,0,8,Wnt signaling pathway involved in heart development,BP,
1530,GO:0003307,1,0.972326544632085,0,5,regulation of Wnt signaling pathway involved in heart development,BP,
1531,GO:0003308,1,0.978371213453833,0,4,negative regulation of Wnt signaling pathway involved in heart development,BP,
1532,GO:0003309,1,0.849918044930299,0,23,type B pancreatic cell differentiation,BP,
1533,GO:0003310,1,0.960840470887208,0,6,pancreatic A cell differentiation,BP,
1534,GO:0003312,1,0.987806650619778,0,2,pancreatic PP cell differentiation,BP,
1535,GO:0003318,1,0.996555366104087,0,1,cell migration to the midline involved in heart development,BP,
1536,GO:0003321,1,0.954533147015812,0,7,positive regulation of blood pressure by epinephrine-norepinephrine,BP,
1537,GO:0003322,1,0.990970163923478,0,1,pancreatic A cell development,BP,
1538,GO:0003323,1,0.875945827589465,0,19,type B pancreatic cell development,BP,
1539,GO:0003326,1,0.987806650619778,0,2,pancreatic A cell fate commitment,BP,
1540,GO:0003327,1,0.994463725794407,0,1,type B pancreatic cell fate commitment,BP,
1541,GO:0003329,1,0.987806650619778,0,2,pancreatic PP cell fate commitment,BP,
1542,GO:0003330,1,0.986492864160882,0,2,regulation of extracellular matrix constituent secretion,BP,
1543,GO:0003331,1,0.986492864160882,0,2,positive regulation of extracellular matrix constituent secretion,BP,
1545,GO:0003334,1,0.936163701021768,0,9,keratinocyte development,BP,
1546,GO:0003335,1,0.996185274727766,0,1,corneocyte development,BP,
1547,GO:0003337,1,0.922316676023927,0,13,mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1548,GO:0003338,1,0.804761441988764,0,31,metanephros morphogenesis,BP,
1549,GO:0003339,1,0.953962293376149,0,8,regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1550,GO:0003340,1,0.982257483368022,0,3,negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
1551,GO:0003341,1,0.653729674099702,0,60,cilium movement,BP,
1552,GO:0003342,1,0.987651646223789,0,2,proepicardium development,BP,
1553,GO:0003343,1,0.987651646223789,0,2,septum transversum development,BP,
1554,GO:0003344,1,0.929973676581206,0,9,pericardium morphogenesis,BP,
1555,GO:0003345,1,0.992488994915289,0,1,proepicardium cell migration involved in pericardium morphogenesis,BP,
1556,GO:0003348,1,0.956022914270496,0,6,cardiac endothelial cell differentiation,BP,
1557,GO:0003350,1,0.981050444979751,0,3,pulmonary myocardium development,BP,
1558,GO:0003351,1,0.892258452732015,0,19,epithelial cilium movement,BP,
1559,GO:0003352,1,0.908399437901002,0,13,regulation of cilium movement,BP,
1560,GO:0003353,1,0.99280534268686,0,1,positive regulation of cilium movement,BP,
1561,GO:0003356,1,0.925958934065054,0,10,regulation of cilium beat frequency,BP,
1562,GO:0003357,1,0.963031014464098,0,5,noradrenergic neuron differentiation,BP,
1563,GO:0003358,1,0.986639050157939,0,2,noradrenergic neuron development,BP,
1564,GO:0003359,1,0.993587012283989,0,1,noradrenergic neuron fate commitment,BP,
1565,GO:0003360,1,0.954111902251785,0,6,brainstem development,BP,
1566,GO:0003365,1,0.97315887059428,0,3,establishment of cell polarity involved in ameboidal cell migration,BP,
1567,GO:0003366,1,0.984582732749363,0,2,cell-matrix adhesion involved in ameboidal cell migration,BP,
1570,GO:0003376,1,0.927424519197032,0,12,sphingosine-1-phosphate signaling pathway,BP,
1571,GO:0003382,1,0.824767967784119,0,26,epithelial cell morphogenesis,BP,
1572,GO:0003383,1,0.974648224971931,0,3,apical constriction,BP,
1573,GO:0003400,1,0.994243844117059,0,1,regulation of COPII vesicle coating,BP,
1574,GO:0003401,1,0.813524830805701,0,29,axis elongation,BP,
1575,GO:0003402,1,0.957122880894613,0,6,planar cell polarity pathway involved in axis elongation,BP,
1576,GO:0003404,1,0.986156499035177,0,2,optic vesicle morphogenesis,BP,
1577,GO:0003406,1,0.962196839508274,0,5,retinal pigment epithelium development,BP,
1579,GO:0003408,1,0.974797838068595,0,3,optic cup formation involved in camera-type eye development,BP,
1580,GO:0003409,1,0.992608909065779,0,1,optic cup structural organization,BP,
1581,GO:0003413,1,0.933238691855196,0,10,chondrocyte differentiation involved in endochondral bone morphogenesis,BP,
1582,GO:0003414,1,0.992493312849118,0,1,chondrocyte morphogenesis involved in endochondral bone morphogenesis,BP,
1583,GO:0003415,1,0.970535722326637,0,4,chondrocyte hypertrophy,BP,
1585,GO:0003417,1,0.912227578952757,0,14,growth plate cartilage development,BP,
1586,GO:0003418,1,0.962439408158211,0,6,growth plate cartilage chondrocyte differentiation,BP,
1587,GO:0003419,1,0.981112176716459,0,4,growth plate cartilage chondrocyte proliferation,BP,
1588,GO:0003420,1,0.986395444031059,0,2,regulation of growth plate cartilage chondrocyte proliferation,BP,
1589,GO:0003421,1,0.992488626920326,0,1,growth plate cartilage axis specification,BP,
1590,GO:0003422,1,0.985037766121156,0,2,growth plate cartilage morphogenesis,BP,
1591,GO:0003429,1,0.992493312849118,0,1,growth plate cartilage chondrocyte morphogenesis,BP,
1592,GO:0003430,1,0.985326623304084,0,2,growth plate cartilage chondrocyte growth,BP,
1593,GO:0003431,1,0.971493806593294,0,4,growth plate cartilage chondrocyte development,BP,
1594,GO:0003433,1,0.95857228859615,0,6,chondrocyte development involved in endochondral bone morphogenesis,BP,
1598,GO:0003678,1,0.714590893526452,0,45,DNA helicase activity,MF,
1599,GO:0003680,1,0.941077863346173,0,10,AT DNA binding,MF,
1601,GO:0003684,1,0.639353444767922,0,66,damaged DNA binding,MF,
1602,GO:0003688,1,0.907942863663068,0,14,DNA replication origin binding,MF,
1603,GO:0003689,1,0.953192259978248,0,8,DNA clamp loader activity,MF,
1605,GO:0003691,1,0.94149161017982,0,9,double-stranded telomeric DNA binding,MF,
1606,GO:0003692,1,0.994206199098946,0,1,left-handed Z-DNA binding,MF,
1607,GO:0003696,1,0.952302896731113,0,7,satellite DNA binding,MF,
1608,GO:0003697,1,0.52733420231936,0,96,single-stranded DNA binding,MF,
1611,GO:0003707,1,0.674863362549531,0,54,steroid hormone receptor activity,MF,
1612,GO:0003708,1,0.952553561668396,0,7,retinoic acid receptor activity,MF,
1615,GO:0003714,1,0.235243144330906,0,209,transcription corepressor activity,MF,
1616,GO:0003720,1,0.944758328645427,0,8,telomerase activity,MF,
1617,GO:0003721,1,0.992473353745584,0,1,telomerase RNA reverse transcriptase activity,MF,
1618,GO:0003723,1,3.69177760969443e-05,0,1531,RNA binding,MF,
1619,GO:0003724,1,0.628316989267723,0,65,RNA helicase activity,MF,
1620,GO:0003725,1,0.629838270335698,0,65,double-stranded RNA binding,MF,
1621,GO:0003726,1,0.977703821884947,0,3,double-stranded RNA adenosine deaminase activity,MF,
1622,GO:0003727,1,0.592684808923602,0,77,single-stranded RNA binding,MF,
1623,GO:0003729,1,0.285254369405672,0,189,mRNA binding,MF,
1624,GO:0003730,1,0.643266775690172,0,62,mRNA 3'-UTR binding,MF,
1625,GO:0003735,1,0.594774921350402,0,153,structural constituent of ribosome,MF,
1626,GO:0003743,1,0.740154106883972,0,50,translation initiation factor activity,MF,
1627,GO:0003746,1,0.894250432986239,0,18,translation elongation factor activity,MF,
1628,GO:0003747,1,0.959245653418575,0,6,translation release factor activity,MF,
1629,GO:0003755,1,0.844660359971255,0,31,peptidyl-prolyl cis-trans isomerase activity,MF,
1630,GO:0003756,1,0.892214941840943,0,17,protein disulfide isomerase activity,MF,
1631,GO:0003774,1,0.357696972893244,0,125,motor activity,MF,
1632,GO:0003777,1,0.394288391049768,0,109,microtubule motor activity,MF,
1634,GO:0003785,1,0.866343648904495,0,25,actin monomer binding,MF,
1635,GO:0003796,1,0.990171434611389,0,3,lysozyme activity,MF,
1636,GO:0003810,1,0.959166323685392,0,6,protein-glutamine gamma-glutamyltransferase activity,MF,
1639,GO:0003826,1,0.988487007737387,0,2,alpha-ketoacid dehydrogenase activity,MF,
1640,GO:0003827,1,0.985907187574827,0,2,alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
1642,GO:0003829,1,0.984396581954798,0,2,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity,MF,
1643,GO:0003830,1,0.992108036757953,0,1,beta-1,4-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,MF,
1644,GO:0003831,1,0.948734660489677,0,8,beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity,MF,
1645,GO:0003834,1,0.993058458973322,0,1,beta-carotene 15,15'-monooxygenase activity,MF,
1646,GO:0003835,1,0.983521682724681,0,2,beta-galactoside alpha-2,6-sialyltransferase activity,MF,
1647,GO:0003836,1,0.961644742893567,0,6,beta-galactoside (CMP) alpha-2,3-sialyltransferase activity,MF,
1648,GO:0003837,1,0.994468402997698,0,1,beta-ureidopropionase activity,MF,
1649,GO:0003839,1,0.981846946746783,0,4,gamma-glutamylcyclotransferase activity,MF,
1650,GO:0003841,1,0.884202437556811,0,17,1-acylglycerol-3-phosphate O-acyltransferase activity,MF,
1651,GO:0003842,1,0.992632621830319,0,1,1-pyrroline-5-carboxylate dehydrogenase activity,MF,
1652,GO:0003844,1,0.992718951160495,0,1,1,4-alpha-glucan branching enzyme activity,MF,
1653,GO:0003845,1,0.990940367817136,0,2,11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity,MF,
1654,GO:0003846,1,0.98617777173441,0,2,2-acylglycerol O-acyltransferase activity,MF,
1655,GO:0003847,1,0.976048106608346,0,5,1-alkyl-2-acetylglycerophosphocholine esterase activity,MF,
1656,GO:0003854,1,0.982927769771054,0,3,3-beta-hydroxy-delta5-steroid dehydrogenase activity,MF,
1657,GO:0003857,1,0.9516666633517,0,9,3-hydroxyacyl-CoA dehydrogenase activity,MF,
1658,GO:0003858,1,0.985510645223213,0,2,3-hydroxybutyrate dehydrogenase activity,MF,
1659,GO:0003860,1,0.994802293599388,0,1,3-hydroxyisobutyryl-CoA hydrolase activity,MF,
1660,GO:0003863,1,0.988487007737387,0,2,3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity,MF,
1661,GO:0003865,1,0.987320892996893,0,2,3-oxo-5-alpha-steroid 4-dehydrogenase activity,MF,
1662,GO:0003867,1,0.992162690456213,0,1,4-aminobutyrate transaminase activity,MF,
1663,GO:0003868,1,0.990555239899229,0,2,4-hydroxyphenylpyruvate dioxygenase activity,MF,
1664,GO:0003870,1,0.988466828997408,0,2,5-aminolevulinate synthase activity,MF,
1665,GO:0003872,1,0.978774844420272,0,3,6-phosphofructokinase activity,MF,
1666,GO:0003873,1,0.972404329322113,0,4,6-phosphofructo-2-kinase activity,MF,
1667,GO:0003874,1,0.997032233810024,0,1,6-pyruvoyltetrahydropterin synthase activity,MF,
1668,GO:0003875,1,0.987728696111131,0,2,ADP-ribosylarginine hydrolase activity,MF,
1669,GO:0003876,1,0.984958262978687,0,2,AMP deaminase activity,MF,
1670,GO:0003877,1,0.994376359435733,0,1,ATP adenylyltransferase activity,MF,
1671,GO:0003878,1,0.992394577272763,0,1,ATP citrate synthase activity,MF,
1672,GO:0003880,1,0.981483881106176,0,3,protein C-terminal carboxyl O-methyltransferase activity,MF,
1673,GO:0003881,1,0.994933932942601,0,1,CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity,MF,
1674,GO:0003882,1,0.993632611133699,0,1,CDP-diacylglycerol-serine O-phosphatidyltransferase activity,MF,
1675,GO:0003883,1,0.985590813617924,0,2,CTP synthase activity,MF,
1676,GO:0003884,1,0.991120369761304,0,2,D-amino-acid oxidase activity,MF,
1677,GO:0003886,1,0.976960289494875,0,3,DNA (cytosine-5-)-methyltransferase activity,MF,
1678,GO:0003887,1,0.834304128176703,0,26,DNA-directed DNA polymerase activity,MF,
1679,GO:0003896,1,0.983002040748389,0,3,DNA primase activity,MF,
1680,GO:0003899,1,0.793416936582098,0,41,DNA-directed 5'-3' RNA polymerase activity,MF,
1681,GO:0003905,1,0.99670774898663,0,1,alkylbase DNA N-glycosylase activity,MF,
1682,GO:0003906,1,0.934181518158856,0,13,DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
1683,GO:0003908,1,0.996321147282986,0,1,methylated-DNA-[protein]-cysteine S-methyltransferase activity,MF,
1684,GO:0003909,1,0.954256030946102,0,7,DNA ligase activity,MF,
1685,GO:0003910,1,0.959662842048797,0,6,DNA ligase (ATP) activity,MF,
1686,GO:0003916,1,0.956976763510032,0,6,DNA topoisomerase activity,MF,
1687,GO:0003917,1,0.972781843284091,0,4,DNA topoisomerase type I activity,MF,
1688,GO:0003918,1,0.983757141597064,0,2,DNA topoisomerase type II (ATP-hydrolyzing) activity,MF,
1689,GO:0003919,1,0.994700388265012,0,1,FMN adenylyltransferase activity,MF,
1690,GO:0003920,1,0.990698150942483,0,2,GMP reductase activity,MF,
1691,GO:0003921,1,0.993604766458822,0,1,GMP synthase activity,MF,
1692,GO:0003922,1,0.993604766458822,0,1,GMP synthase (glutamine-hydrolyzing) activity,MF,
1693,GO:0003923,1,0.969187752266996,0,5,GPI-anchor transamidase activity,MF,
1695,GO:0003933,1,0.994745391576593,0,1,GTP cyclohydrolase activity,MF,
1696,GO:0003934,1,0.994745391576593,0,1,GTP cyclohydrolase I activity,MF,
1697,GO:0003937,1,0.994405408097248,0,1,IMP cyclohydrolase activity,MF,
1698,GO:0003938,1,0.988895813223728,0,2,IMP dehydrogenase activity,MF,
1699,GO:0003939,1,0.993481113080797,0,1,L-iditol 2-dehydrogenase activity,MF,
1700,GO:0003940,1,0.994184610546592,0,1,L-iduronidase activity,MF,
1701,GO:0003941,1,0.985229586797714,0,3,L-serine ammonia-lyase activity,MF,
1702,GO:0003943,1,0.986297234621851,0,2,N-acetylgalactosamine-4-sulfatase activity,MF,
1703,GO:0003944,1,0.99415517482521,0,1,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity,MF,
1704,GO:0003945,1,0.975751210722302,0,4,N-acetyllactosamine synthase activity,MF,
1705,GO:0003947,1,0.992794920419147,0,1,(N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity,MF,
1706,GO:0003948,1,0.994426369933777,0,1,N4-(beta-N-acetylglucosaminyl)-L-asparaginase activity,MF,
1707,GO:0003950,1,0.875792367116648,0,19,NAD+ ADP-ribosyltransferase activity,MF,
1708,GO:0003951,1,0.886062119194838,0,16,NAD+ kinase activity,MF,
1709,GO:0003952,1,0.993646635265403,0,1,NAD+ synthase (glutamine-hydrolyzing) activity,MF,
1710,GO:0003953,1,0.991669392789779,0,2,NAD+ nucleosidase activity,MF,
1711,GO:0003954,1,0.875600829810665,0,40,NADH dehydrogenase activity,MF,
1712,GO:0003955,1,0.982798536667749,0,3,NAD(P)H dehydrogenase (quinone) activity,MF,
1713,GO:0003956,1,0.98733275997088,0,3,NAD(P)+-protein-arginine ADP-ribosyltransferase activity,MF,
1714,GO:0003957,1,0.992276264725365,0,1,NAD(P)+ transhydrogenase (B-specific) activity,MF,
1716,GO:0003960,1,0.98020972018916,0,4,NADPH:quinone reductase activity,MF,
1717,GO:0003962,1,0.995239252591955,0,1,cystathionine gamma-synthase activity,MF,
1718,GO:0003963,1,0.987330514027424,0,2,RNA-3'-phosphate cyclase activity,MF,
1719,GO:0003964,1,0.944758328645427,0,8,RNA-directed DNA polymerase activity,MF,
1720,GO:0003968,1,0.983687538071183,0,2,RNA-directed 5'-3' RNA polymerase activity,MF,
1721,GO:0003972,1,0.993058458973322,0,1,RNA ligase (ATP) activity,MF,
1722,GO:0003973,1,0.986729171261856,0,2,(S)-2-hydroxy-acid oxidase activity,MF,
1723,GO:0003974,1,0.99554352851851,0,1,UDP-N-acetylglucosamine 4-epimerase activity,MF,
1724,GO:0003975,1,0.994296615871421,0,1,UDP-N-acetylglucosamine-dolichyl-phosphate N-acetylglucosaminephosphotransferase activity,MF,
1725,GO:0003976,1,0.982499070791149,0,3,UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase activity,MF,
1726,GO:0003977,1,0.986508590021897,0,2,UDP-N-acetylglucosamine diphosphorylase activity,MF,
1727,GO:0003978,1,0.99554352851851,0,1,UDP-glucose 4-epimerase activity,MF,
1728,GO:0003979,1,0.992662685052359,0,1,UDP-glucose 6-dehydrogenase activity,MF,
1729,GO:0003980,1,0.980901744294669,0,2,UDP-glucose:glycoprotein glucosyltransferase activity,MF,
1730,GO:0003983,1,0.994298917725665,0,1,UTP:glucose-1-phosphate uridylyltransferase activity,MF,
1731,GO:0003985,1,0.982851387158814,0,3,acetyl-CoA C-acetyltransferase activity,MF,
1732,GO:0003986,1,0.983451182933116,0,4,acetyl-CoA hydrolase activity,MF,
1733,GO:0003987,1,0.9781017419924,0,3,acetate-CoA ligase activity,MF,
1734,GO:0003988,1,0.967213177539561,0,6,acetyl-CoA C-acyltransferase activity,MF,
1735,GO:0003989,1,0.98956031487143,0,1,acetyl-CoA carboxylase activity,MF,
1736,GO:0003990,1,0.987076295598033,0,2,acetylcholinesterase activity,MF,
1737,GO:0003991,1,0.994463725794407,0,1,acetylglutamate kinase activity,MF,
1738,GO:0003993,1,0.969107674401469,0,6,acid phosphatase activity,MF,
1739,GO:0003994,1,0.985684060761233,0,2,aconitate hydratase activity,MF,
1740,GO:0003995,1,0.90576175669276,0,15,acyl-CoA dehydrogenase activity,MF,
1741,GO:0003996,1,0.970400246947326,0,5,acyl-CoA ligase activity,MF,
1742,GO:0003997,1,0.966518239984058,0,5,acyl-CoA oxidase activity,MF,
1743,GO:0003998,1,0.994064728567425,0,2,acylphosphatase activity,MF,
1744,GO:0003999,1,0.997439116607315,0,1,adenine phosphoribosyltransferase activity,MF,
1745,GO:0004000,1,0.939536090628663,0,9,adenosine deaminase activity,MF,
1746,GO:0004001,1,0.994505878229905,0,1,adenosine kinase activity,MF,
1747,GO:0004003,1,0.79030811508984,0,32,ATP-dependent DNA helicase activity,MF,
1748,GO:0004004,1,0.632916677148777,0,64,ATP-dependent RNA helicase activity,MF,
1749,GO:0004008,1,0.981407554015502,0,2,copper-exporting ATPase activity,MF,
1751,GO:0004013,1,0.978673336828831,0,3,adenosylhomocysteinase activity,MF,
1752,GO:0004014,1,0.992625893017814,0,1,adenosylmethionine decarboxylase activity,MF,
1753,GO:0004016,1,0.897181002763206,0,13,adenylate cyclase activity,MF,
1754,GO:0004017,1,0.945875743273141,0,8,adenylate kinase activity,MF,
1755,GO:0004018,1,0.995845182606778,0,1,N6-(1,2-dicarboxyethyl)AMP AMP-lyase (fumarate-forming) activity,MF,
1756,GO:0004019,1,0.988254549015441,0,2,adenylosuccinate synthase activity,MF,
1757,GO:0004020,1,0.985985065752903,0,2,adenylylsulfate kinase activity,MF,
1758,GO:0004021,1,0.987415274528258,0,2,L-alanine:2-oxoglutarate aminotransferase activity,MF,
1759,GO:0004022,1,0.971390226431047,0,5,alcohol dehydrogenase (NAD) activity,MF,
1760,GO:0004024,1,0.987924154311414,0,2,alcohol dehydrogenase activity, zinc-dependent,MF,
1761,GO:0004027,1,0.996403904795327,0,1,alcohol sulfotransferase activity,MF,
1762,GO:0004028,1,0.954641278414963,0,7,3-chloroallyl aldehyde dehydrogenase activity,MF,
1763,GO:0004029,1,0.89971748703018,0,15,aldehyde dehydrogenase (NAD) activity,MF,
1764,GO:0004030,1,0.962210879758751,0,6,aldehyde dehydrogenase [NAD(P)+] activity,MF,
1765,GO:0004031,1,0.992140648859012,0,1,aldehyde oxidase activity,MF,
1766,GO:0004032,1,0.954979373106335,0,11,alditol:NADP+ 1-oxidoreductase activity,MF,
1767,GO:0004033,1,0.886859637466384,0,25,aldo-keto reductase (NADP) activity,MF,
1768,GO:0004034,1,0.993567422063829,0,1,aldose 1-epimerase activity,MF,
1769,GO:0004035,1,0.986374136717437,0,2,alkaline phosphatase activity,MF,
1770,GO:0004037,1,0.995914666298543,0,1,allantoicase activity,MF,
1771,GO:0004040,1,0.983028781098299,0,3,amidase activity,MF,
1772,GO:0004042,1,0.994463725794407,0,1,acetyl-CoA:L-glutamate N-acetyltransferase activity,MF,
1773,GO:0004043,1,0.992529096241671,0,1,L-aminoadipate-semialdehyde dehydrogenase activity,MF,
1774,GO:0004044,1,0.992502099076703,0,1,amidophosphoribosyltransferase activity,MF,
1775,GO:0004045,1,0.983291169615126,0,4,aminoacyl-tRNA hydrolase activity,MF,
1776,GO:0004046,1,0.976301391211365,0,5,aminoacylase activity,MF,
1777,GO:0004047,1,0.99027693968545,0,2,aminomethyltransferase activity,MF,
1778,GO:0004051,1,0.993425333841069,0,1,arachidonate 5-lipoxygenase activity,MF,
1779,GO:0004052,1,0.980651865570527,0,3,arachidonate 12-lipoxygenase activity,MF,
1780,GO:0004053,1,0.990614230294571,0,2,arginase activity,MF,
1781,GO:0004055,1,0.99504639207388,0,1,argininosuccinate synthase activity,MF,
1782,GO:0004056,1,0.994651897658644,0,1,argininosuccinate lyase activity,MF,
1783,GO:0004057,1,0.994137123883384,0,1,arginyltransferase activity,MF,
1784,GO:0004058,1,0.994586993820206,0,1,aromatic-L-amino-acid decarboxylase activity,MF,
1785,GO:0004059,1,0.995869872745912,0,1,aralkylamine N-acetyltransferase activity,MF,
1786,GO:0004060,1,0.986736726787111,0,3,arylamine N-acetyltransferase activity,MF,
1787,GO:0004061,1,0.995349884203026,0,1,arylformamidase activity,MF,
1788,GO:0004062,1,0.962641418692283,0,8,aryl sulfotransferase activity,MF,
1789,GO:0004063,1,0.991711332825543,0,2,aryldialkylphosphatase activity,MF,
1790,GO:0004064,1,0.972289239403578,0,6,arylesterase activity,MF,
1791,GO:0004065,1,0.925905271230028,0,11,arylsulfatase activity,MF,
1792,GO:0004066,1,0.987519775066523,0,2,asparagine synthase (glutamine-hydrolyzing) activity,MF,
1793,GO:0004067,1,0.98878668636561,0,2,asparaginase activity,MF,
1794,GO:0004069,1,0.987997566129003,0,2,L-aspartate:2-oxoglutarate aminotransferase activity,MF,
1795,GO:0004070,1,0.982569029954425,0,2,aspartate carbamoyltransferase activity,MF,
1796,GO:0004074,1,0.993925531301531,0,2,biliverdin reductase activity,MF,
1797,GO:0004075,1,0.983075514560083,0,2,biotin carboxylase activity,MF,
1798,GO:0004077,1,0.991511043527596,0,1,biotin-[acetyl-CoA-carboxylase] ligase activity,MF,
1799,GO:0004078,1,0.991511043527596,0,1,biotin-[methylcrotonoyl-CoA-carboxylase] ligase activity,MF,
1800,GO:0004079,1,0.991511043527596,0,1,biotin-[methylmalonyl-CoA-carboxytransferase] ligase activity,MF,
1801,GO:0004080,1,0.991511043527596,0,1,biotin-[propionyl-CoA-carboxylase (ATP-hydrolyzing)] ligase activity,MF,
1802,GO:0004081,1,0.990032060870289,0,2,bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity,MF,
1803,GO:0004082,1,0.982786604600001,0,4,bisphosphoglycerate mutase activity,MF,
1804,GO:0004084,1,0.985720978868277,0,2,branched-chain-amino-acid transaminase activity,MF,
1805,GO:0004085,1,0.994822455267186,0,1,butyryl-CoA dehydrogenase activity,MF,
1806,GO:0004087,1,0.982569029954425,0,2,carbamoyl-phosphate synthase (ammonia) activity,MF,
1807,GO:0004088,1,0.982569029954425,0,2,carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity,MF,
1808,GO:0004089,1,0.935252471797814,0,13,carbonate dehydratase activity,MF,
1809,GO:0004090,1,0.982075112067968,0,5,carbonyl reductase (NADPH) activity,MF,
1810,GO:0004092,1,0.99300633027747,0,1,carnitine O-acetyltransferase activity,MF,
1811,GO:0004095,1,0.971773150129865,0,4,carnitine O-palmitoyltransferase activity,MF,
1812,GO:0004096,1,0.978096713469349,0,4,catalase activity,MF,
1813,GO:0004098,1,0.994862783390386,0,1,cerebroside-sulfatase activity,MF,
1814,GO:0004102,1,0.993598835577614,0,1,choline O-acetyltransferase activity,MF,
1815,GO:0004103,1,0.988716365613389,0,2,choline kinase activity,MF,
1816,GO:0004104,1,0.980356335422919,0,3,cholinesterase activity,MF,
1817,GO:0004105,1,0.987483253982037,0,2,choline-phosphate cytidylyltransferase activity,MF,
1818,GO:0004108,1,0.992826483645098,0,1,citrate (Si)-synthase activity,MF,
1819,GO:0004109,1,0.986744482443529,0,2,coproporphyrinogen oxidase activity,MF,
1820,GO:0004111,1,0.973168822101772,0,5,creatine kinase activity,MF,
1821,GO:0004112,1,0.842552744373411,0,23,cyclic-nucleotide phosphodiesterase activity,MF,
1822,GO:0004113,1,0.991998120435714,0,1,2',3'-cyclic-nucleotide 3'-phosphodiesterase activity,MF,
1823,GO:0004114,1,0.849360273608471,0,22,3',5'-cyclic-nucleotide phosphodiesterase activity,MF,
1824,GO:0004115,1,0.886638515558818,0,15,3',5'-cyclic-AMP phosphodiesterase activity,MF,
1825,GO:0004117,1,0.98003718581935,0,3,calmodulin-dependent cyclic-nucleotide phosphodiesterase activity,MF,
1826,GO:0004118,1,0.973105161202764,0,3,cGMP-stimulated cyclic-nucleotide phosphodiesterase activity,MF,
1827,GO:0004119,1,0.983975136663482,0,2,cGMP-inhibited cyclic-nucleotide phosphodiesterase activity,MF,
1828,GO:0004122,1,0.993347995930623,0,1,cystathionine beta-synthase activity,MF,
1829,GO:0004123,1,0.995239252591955,0,1,cystathionine gamma-lyase activity,MF,
1830,GO:0004126,1,0.950510799532871,0,10,cytidine deaminase activity,MF,
1831,GO:0004127,1,0.972379573384088,0,4,cytidylate kinase activity,MF,
1832,GO:0004128,1,0.958812139090248,0,7,cytochrome-b5 reductase activity, acting on NAD(P)H,MF,
1833,GO:0004129,1,0.934933672479148,0,22,cytochrome-c oxidase activity,MF,
1834,GO:0004132,1,0.994563442731594,0,1,dCMP deaminase activity,MF,
1835,GO:0004133,1,0.990780254397619,0,1,glycogen debranching enzyme activity,MF,
1836,GO:0004134,1,0.990780254397619,0,1,4-alpha-glucanotransferase activity,MF,
1837,GO:0004135,1,0.990780254397619,0,1,amylo-alpha-1,6-glucosidase activity,MF,
1838,GO:0004137,1,0.985487035531569,0,2,deoxycytidine kinase activity,MF,
1839,GO:0004138,1,0.996867443319391,0,1,deoxyguanosine kinase activity,MF,
1840,GO:0004139,1,0.995280108756433,0,1,deoxyribose-phosphate aldolase activity,MF,
1841,GO:0004140,1,0.988519797773494,0,2,dephospho-CoA kinase activity,MF,
1842,GO:0004142,1,0.982165212682864,0,3,diacylglycerol cholinephosphotransferase activity,MF,
1843,GO:0004143,1,0.923730403981008,0,10,diacylglycerol kinase activity,MF,
1844,GO:0004144,1,0.98617777173441,0,2,diacylglycerol O-acyltransferase activity,MF,
1845,GO:0004145,1,0.987934089275937,0,3,diamine N-acetyltransferase activity,MF,
1846,GO:0004146,1,0.989246029948632,0,2,dihydrofolate reductase activity,MF,
1847,GO:0004148,1,0.99252484461045,0,1,dihydrolipoyl dehydrogenase activity,MF,
1848,GO:0004149,1,0.992969326151488,0,1,dihydrolipoyllysine-residue succinyltransferase activity,MF,
1849,GO:0004151,1,0.982569029954425,0,2,dihydroorotase activity,MF,
1850,GO:0004152,1,0.994473081848742,0,1,dihydroorotate dehydrogenase activity,MF,
1851,GO:0004155,1,0.995456237995866,0,1,6,7-dihydropteridine reductase activity,MF,
1852,GO:0004157,1,0.986709848760387,0,2,dihydropyrimidinase activity,MF,
1853,GO:0004161,1,0.988880477514521,0,2,dimethylallyltranstransferase activity,MF,
1854,GO:0004163,1,0.995108942093202,0,1,diphosphomevalonate decarboxylase activity,MF,
1855,GO:0004164,1,0.995127788691714,0,1,diphthine synthase activity,MF,
1856,GO:0004165,1,0.978752389200175,0,3,dodecenoyl-CoA delta-isomerase activity,MF,
1857,GO:0004167,1,0.989317393283741,0,3,dopachrome isomerase activity,MF,
1858,GO:0004168,1,0.994173274303947,0,1,dolichol kinase activity,MF,
1859,GO:0004169,1,0.975813132909177,0,5,dolichyl-phosphate-mannose-protein mannosyltransferase activity,MF,
1860,GO:0004170,1,0.994936303571462,0,1,dUTP diphosphatase activity,MF,
1861,GO:0004174,1,0.986513753988356,0,2,electron-transferring-flavoprotein dehydrogenase activity,MF,
1863,GO:0004176,1,0.971709961298198,0,4,ATP-dependent peptidase activity,MF,
1864,GO:0004177,1,0.747565135890701,0,43,aminopeptidase activity,MF,
1865,GO:0004180,1,0.795354885168385,0,36,carboxypeptidase activity,MF,
1866,GO:0004181,1,0.863168602588834,0,23,metallocarboxypeptidase activity,MF,
1867,GO:0004185,1,0.941467505017438,0,9,serine-type carboxypeptidase activity,MF,
1868,GO:0004190,1,0.895519222907993,0,18,aspartic-type endopeptidase activity,MF,
1869,GO:0004197,1,0.5821091958498,0,81,cysteine-type endopeptidase activity,MF,
1870,GO:0004198,1,0.885076864594051,0,19,calcium-dependent cysteine-type endopeptidase activity,MF,
1871,GO:0004222,1,0.506444511344744,0,94,metalloendopeptidase activity,MF,
1873,GO:0004298,1,0.939962367517636,0,18,threonine-type endopeptidase activity,MF,
1874,GO:0004300,1,0.955979846464333,0,8,enoyl-CoA hydratase activity,MF,
1875,GO:0004301,1,0.962383722014517,0,7,epoxide hydrolase activity,MF,
1876,GO:0004303,1,0.959498813026235,0,9,estradiol 17-beta-dehydrogenase activity,MF,
1877,GO:0004304,1,0.995151319772094,0,1,estrone sulfotransferase activity,MF,
1878,GO:0004305,1,0.974728137965658,0,4,ethanolamine kinase activity,MF,
1879,GO:0004306,1,0.994971850386629,0,1,ethanolamine-phosphate cytidylyltransferase activity,MF,
1880,GO:0004307,1,0.99082761605285,0,2,ethanolaminephosphotransferase activity,MF,
1881,GO:0004308,1,0.969384511333402,0,5,exo-alpha-sialidase activity,MF,
1882,GO:0004309,1,0.967713134351569,0,4,exopolyphosphatase activity,MF,
1883,GO:0004310,1,0.994382162919748,0,1,farnesyl-diphosphate farnesyltransferase activity,MF,
1884,GO:0004311,1,0.980342075793242,0,3,farnesyltranstransferase activity,MF,
1885,GO:0004312,1,0.937104796152676,0,10,fatty acid synthase activity,MF,
1886,GO:0004313,1,0.990019785722482,0,1,[acyl-carrier-protein] S-acetyltransferase activity,MF,
1887,GO:0004314,1,0.984828832464379,0,2,[acyl-carrier-protein] S-malonyltransferase activity,MF,
1888,GO:0004315,1,0.986353492243022,0,2,3-oxoacyl-[acyl-carrier-protein] synthase activity,MF,
1889,GO:0004316,1,0.990019785722482,0,1,3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity,MF,
1890,GO:0004317,1,0.990019785722482,0,1,3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity,MF,
1891,GO:0004319,1,0.990019785722482,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity,MF,
1892,GO:0004320,1,0.985274796161948,0,2,oleoyl-[acyl-carrier-protein] hydrolase activity,MF,
1893,GO:0004321,1,0.976201493727113,0,4,fatty-acyl-CoA synthase activity,MF,
1894,GO:0004322,1,0.963913657090689,0,5,ferroxidase activity,MF,
1895,GO:0004324,1,0.994877016520247,0,1,ferredoxin-NADP+ reductase activity,MF,
1896,GO:0004325,1,0.990741744636815,0,1,ferrochelatase activity,MF,
1897,GO:0004326,1,0.993553795800342,0,1,tetrahydrofolylpolyglutamate synthase activity,MF,
1898,GO:0004329,1,0.985124307003538,0,2,formate-tetrahydrofolate ligase activity,MF,
1899,GO:0004331,1,0.972404329322113,0,4,fructose-2,6-bisphosphate 2-phosphatase activity,MF,
1900,GO:0004332,1,0.984915325798229,0,3,fructose-bisphosphate aldolase activity,MF,
1901,GO:0004333,1,0.995127788691714,0,1,fumarate hydratase activity,MF,
1902,GO:0004334,1,0.995899002803291,0,1,fumarylacetoacetase activity,MF,
1903,GO:0004335,1,0.988812876317515,0,2,galactokinase activity,MF,
1904,GO:0004336,1,0.992901083054532,0,1,galactosylceramidase activity,MF,
1905,GO:0004337,1,0.988880477514521,0,2,geranyltranstransferase activity,MF,
1906,GO:0004339,1,0.991196020711257,0,1,glucan 1,4-alpha-glucosidase activity,MF,
1907,GO:0004340,1,0.962571044827959,0,5,glucokinase activity,MF,
1908,GO:0004341,1,0.994807037247671,0,1,gluconolactonase activity,MF,
1909,GO:0004342,1,0.988817705151071,0,2,glucosamine-6-phosphate deaminase activity,MF,
1910,GO:0004343,1,0.992482980351092,0,1,glucosamine 6-phosphate N-acetyltransferase activity,MF,
1911,GO:0004344,1,0.98966350985906,0,1,glucose dehydrogenase activity,MF,
1912,GO:0004345,1,0.983587642215593,0,2,glucose-6-phosphate dehydrogenase activity,MF,
1913,GO:0004346,1,0.981124099262899,0,3,glucose-6-phosphatase activity,MF,
1914,GO:0004347,1,0.99442870134977,0,1,glucose-6-phosphate isomerase activity,MF,
1915,GO:0004348,1,0.981735016002202,0,3,glucosylceramidase activity,MF,
1916,GO:0004349,1,0.992549786087151,0,1,glutamate 5-kinase activity,MF,
1917,GO:0004350,1,0.992549786087151,0,1,glutamate-5-semialdehyde dehydrogenase activity,MF,
1918,GO:0004351,1,0.979624004095663,0,3,glutamate decarboxylase activity,MF,
1919,GO:0004352,1,0.98647777079577,0,2,glutamate dehydrogenase (NAD+) activity,MF,
1920,GO:0004353,1,0.98647777079577,0,2,glutamate dehydrogenase [NAD(P)+] activity,MF,
1921,GO:0004356,1,0.98433350185627,0,2,glutamate-ammonia ligase activity,MF,
1922,GO:0004357,1,0.985303075321928,0,2,glutamate-cysteine ligase activity,MF,
1923,GO:0004359,1,0.979474866972002,0,3,glutaminase activity,MF,
1924,GO:0004360,1,0.982785840502929,0,2,glutamine-fructose-6-phosphate transaminase (isomerizing) activity,MF,
1925,GO:0004361,1,0.995315037853685,0,1,glutaryl-CoA dehydrogenase activity,MF,
1926,GO:0004362,1,0.994014441945039,0,1,glutathione-disulfide reductase activity,MF,
1927,GO:0004363,1,0.994855666600963,0,1,glutathione synthase activity,MF,
1929,GO:0004365,1,0.996213853163821,0,1,glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity,MF,
1930,GO:0004366,1,0.9776314330914,0,3,glycerol-3-phosphate O-acyltransferase activity,MF,
1931,GO:0004367,1,0.985476177424617,0,2,glycerol-3-phosphate dehydrogenase [NAD+] activity,MF,
1932,GO:0004368,1,0.984564405021272,0,2,glycerol-3-phosphate dehydrogenase activity,MF,
1933,GO:0004370,1,0.981542822220199,0,2,glycerol kinase activity,MF,
1934,GO:0004372,1,0.98773289675845,0,2,glycine hydroxymethyltransferase activity,MF,
1935,GO:0004373,1,0.985308262440519,0,2,glycogen (starch) synthase activity,MF,
1936,GO:0004375,1,0.992493728080011,0,1,glycine dehydrogenase (decarboxylating) activity,MF,
1937,GO:0004376,1,0.974595918086376,0,4,glycolipid mannosyltransferase activity,MF,
1938,GO:0004377,1,0.993469841478012,0,1,GDP-Man:Man3GlcNAc2-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
1939,GO:0004378,1,0.992905549610952,0,1,GDP-Man:Man1GlcNAc2-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
1940,GO:0004379,1,0.984352772510227,0,2,glycylpeptide N-tetradecanoyltransferase activity,MF,
1941,GO:0004380,1,0.995616647769459,0,1,glycoprotein-fucosylgalactoside alpha-N-acetylgalactosaminyltransferase activity,MF,
1942,GO:0004381,1,0.995616647769459,0,1,fucosylgalactoside 3-alpha-galactosyltransferase activity,MF,
1943,GO:0004382,1,0.98708973814324,0,2,guanosine-diphosphatase activity,MF,
1944,GO:0004383,1,0.904424816347309,0,12,guanylate cyclase activity,MF,
1945,GO:0004385,1,0.906310601654488,0,13,guanylate kinase activity,MF,
1947,GO:0004392,1,0.990952548981599,0,2,heme oxygenase (decyclizing) activity,MF,
1948,GO:0004394,1,0.992444950694951,0,1,heparan sulfate 2-O-sulfotransferase activity,MF,
1949,GO:0004395,1,0.996318964210472,0,1,hexaprenyldihydroxybenzoate methyltransferase activity,MF,
1950,GO:0004396,1,0.962571044827959,0,5,hexokinase activity,MF,
1951,GO:0004397,1,0.992688031878015,0,1,histidine ammonia-lyase activity,MF,
1952,GO:0004398,1,0.993713632905731,0,1,histidine decarboxylase activity,MF,
1953,GO:0004402,1,0.694101382460972,0,50,histone acetyltransferase activity,MF,
1954,GO:0004407,1,0.73787493578881,0,43,histone deacetylase activity,MF,
1955,GO:0004408,1,0.993974874484915,0,1,holocytochrome-c synthase activity,MF,
1956,GO:0004411,1,0.994805851317589,0,1,homogentisate 1,2-dioxygenase activity,MF,
1957,GO:0004415,1,0.969083458939213,0,5,hyalurononglucosaminidase activity,MF,
1958,GO:0004416,1,0.988503962609357,0,2,hydroxyacylglutathione hydrolase activity,MF,
1959,GO:0004418,1,0.995869872745912,0,1,hydroxymethylbilane synthase activity,MF,
1960,GO:0004419,1,0.989320354366729,0,2,hydroxymethylglutaryl-CoA lyase activity,MF,
1961,GO:0004420,1,0.992341604605686,0,1,hydroxymethylglutaryl-CoA reductase (NADPH) activity,MF,
1962,GO:0004421,1,0.986315665145128,0,2,hydroxymethylglutaryl-CoA synthase activity,MF,
1963,GO:0004422,1,0.99080784512918,0,2,hypoxanthine phosphoribosyltransferase activity,MF,
1964,GO:0004423,1,0.991638259887335,0,1,iduronate-2-sulfatase activity,MF,
1965,GO:0004427,1,0.987356534852255,0,3,inorganic diphosphatase activity,MF,
1966,GO:0004430,1,0.970015499634379,0,4,1-phosphatidylinositol 4-kinase activity,MF,
1967,GO:0004435,1,0.838709270304609,0,23,phosphatidylinositol phospholipase C activity,MF,
1968,GO:0004438,1,0.886356033897539,0,15,phosphatidylinositol-3-phosphatase activity,MF,
1969,GO:0004439,1,0.940559039135993,0,8,phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity,MF,
1970,GO:0004441,1,0.994420543402286,0,1,inositol-1,4-bisphosphate 1-phosphatase activity,MF,
1971,GO:0004445,1,0.964859077357703,0,5,inositol-polyphosphate 5-phosphatase activity,MF,
1972,GO:0004446,1,0.992975566243211,0,1,inositol-hexakisphosphate phosphatase activity,MF,
1973,GO:0004447,1,0.992849143077403,0,1,iodide peroxidase activity,MF,
1974,GO:0004448,1,0.973953078742924,0,5,isocitrate dehydrogenase activity,MF,
1975,GO:0004449,1,0.984620603719261,0,3,isocitrate dehydrogenase (NAD+) activity,MF,
1976,GO:0004450,1,0.989167524863412,0,2,isocitrate dehydrogenase (NADP+) activity,MF,
1977,GO:0004452,1,0.994321968735094,0,1,isopentenyl-diphosphate delta-isomerase activity,MF,
1978,GO:0004454,1,0.993699301961572,0,1,ketohexokinase activity,MF,
1979,GO:0004457,1,0.974880702851677,0,5,lactate dehydrogenase activity,MF,
1980,GO:0004458,1,0.987950260650132,0,2,D-lactate dehydrogenase (cytochrome) activity,MF,
1981,GO:0004459,1,0.986772632542203,0,3,L-lactate dehydrogenase activity,MF,
1982,GO:0004461,1,0.984370412523999,0,3,lactose synthase activity,MF,
1983,GO:0004462,1,0.994529349162214,0,1,lactoylglutathione lyase activity,MF,
1984,GO:0004463,1,0.994461387817034,0,1,leukotriene-A4 hydrolase activity,MF,
1985,GO:0004464,1,0.989700198900106,0,4,leukotriene-C4 synthase activity,MF,
1986,GO:0004465,1,0.963216148443687,0,6,lipoprotein lipase activity,MF,
1987,GO:0004466,1,0.970345804036774,0,5,long-chain-acyl-CoA dehydrogenase activity,MF,
1988,GO:0004467,1,0.91836656355047,0,12,long-chain fatty acid-CoA ligase activity,MF,
1989,GO:0004468,1,0.968080129140358,0,4,lysine N-acetyltransferase activity, acting on acetyl phosphate as donor,MF,
1990,GO:0004470,1,0.975505638459847,0,4,malic enzyme activity,MF,
1991,GO:0004471,1,0.979123420877371,0,3,malate dehydrogenase (decarboxylating) (NAD+) activity,MF,
1992,GO:0004473,1,0.979123420877371,0,3,malate dehydrogenase (decarboxylating) (NADP+) activity,MF,
1993,GO:0004474,1,0.991662641627008,0,1,malate synthase activity,MF,
1994,GO:0004475,1,0.995561841319725,0,1,mannose-1-phosphate guanylyltransferase activity,MF,
1995,GO:0004476,1,0.99517012130739,0,1,mannose-6-phosphate isomerase activity,MF,
1996,GO:0004477,1,0.973244585622097,0,4,methenyltetrahydrofolate cyclohydrolase activity,MF,
1997,GO:0004478,1,0.985629064080638,0,2,methionine adenosyltransferase activity,MF,
1998,GO:0004479,1,0.993109452947755,0,1,methionyl-tRNA formyltransferase activity,MF,
1999,GO:0004482,1,0.991390703303505,0,1,mRNA (guanine-N7-)-methyltransferase activity,MF,
2000,GO:0004483,1,0.986164624597214,0,2,mRNA (nucleoside-2'-O-)-methyltransferase activity,MF,
2001,GO:0004484,1,0.992356547537272,0,1,mRNA guanylyltransferase activity,MF,
2002,GO:0004485,1,0.986006198283534,0,2,methylcrotonoyl-CoA carboxylase activity,MF,
2003,GO:0004486,1,0.992549525476374,0,1,methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity,MF,
2004,GO:0004487,1,0.980581155778437,0,3,methylenetetrahydrofolate dehydrogenase (NAD+) activity,MF,
2005,GO:0004488,1,0.973244585622097,0,4,methylenetetrahydrofolate dehydrogenase (NADP+) activity,MF,
2006,GO:0004489,1,0.990812195958232,0,1,methylenetetrahydrofolate reductase (NAD(P)H) activity,MF,
2007,GO:0004490,1,0.995593835692456,0,1,methylglutaconyl-CoA hydratase activity,MF,
2008,GO:0004491,1,0.994205061262777,0,1,methylmalonate-semialdehyde dehydrogenase (acylating) activity,MF,
2009,GO:0004492,1,0.994363603104224,0,1,methylmalonyl-CoA decarboxylase activity,MF,
2010,GO:0004493,1,0.997168626285884,0,1,methylmalonyl-CoA epimerase activity,MF,
2011,GO:0004494,1,0.992845124917025,0,1,methylmalonyl-CoA mutase activity,MF,
2012,GO:0004496,1,0.99446255675343,0,1,mevalonate kinase activity,MF,
2014,GO:0004498,1,0.993553795800342,0,1,calcidiol 1-monooxygenase activity,MF,
2015,GO:0004499,1,0.969020982685409,0,5,N,N-dimethylaniline monooxygenase activity,MF,
2016,GO:0004500,1,0.985901102134398,0,2,dopamine beta-monooxygenase activity,MF,
2017,GO:0004502,1,0.992107503057158,0,1,kynurenine 3-monooxygenase activity,MF,
2018,GO:0004504,1,0.992504348414736,0,1,peptidylglycine monooxygenase activity,MF,
2019,GO:0004505,1,0.983949959763066,0,3,phenylalanine 4-monooxygenase activity,MF,
2020,GO:0004506,1,0.992816022981962,0,1,squalene monooxygenase activity,MF,
2021,GO:0004509,1,0.994569327709452,0,1,steroid 21-monooxygenase activity,MF,
2022,GO:0004510,1,0.995061750138532,0,1,tryptophan 5-monooxygenase activity,MF,
2023,GO:0004511,1,0.994858038873917,0,1,tyrosine 3-monooxygenase activity,MF,
2024,GO:0004512,1,0.994029910497057,0,1,inositol-3-phosphate synthase activity,MF,
2025,GO:0004513,1,0.993926940147604,0,1,neolactotetraosylceramide alpha-2,3-sialyltransferase activity,MF,
2026,GO:0004514,1,0.981179701052658,0,3,nicotinate-nucleotide diphosphorylase (carboxylating) activity,MF,
2027,GO:0004515,1,0.971330236368377,0,4,nicotinate-nucleotide adenylyltransferase activity,MF,
2028,GO:0004516,1,0.993058458973322,0,1,nicotinate phosphoribosyltransferase activity,MF,
2031,GO:0004519,1,0.485082513517921,0,118,endonuclease activity,MF,
2032,GO:0004520,1,0.744492658059419,0,47,endodeoxyribonuclease activity,MF,
2033,GO:0004521,1,0.743877258504673,0,51,endoribonuclease activity,MF,
2034,GO:0004522,1,0.99026606730748,0,3,ribonuclease A activity,MF,
2035,GO:0004523,1,0.970614504419843,0,6,RNA-DNA hybrid ribonuclease activity,MF,
2036,GO:0004525,1,0.970004171794289,0,4,ribonuclease III activity,MF,
2037,GO:0004526,1,0.944825993968752,0,11,ribonuclease P activity,MF,
2040,GO:0004529,1,0.88626813302053,0,19,exodeoxyribonuclease activity,MF,
2041,GO:0004530,1,0.98181662294307,0,2,deoxyribonuclease I activity,MF,
2042,GO:0004531,1,0.991237078386156,0,2,deoxyribonuclease II activity,MF,
2043,GO:0004532,1,0.797757964208389,0,34,exoribonuclease activity,MF,
2044,GO:0004534,1,0.971677495529078,0,3,5'-3' exoribonuclease activity,MF,
2045,GO:0004535,1,0.913497194702515,0,12,poly(A)-specific ribonuclease activity,MF,
2046,GO:0004536,1,0.666299495892516,0,65,deoxyribonuclease activity,MF,
2047,GO:0004540,1,0.568308453419416,0,94,ribonuclease activity,MF,
2048,GO:0004549,1,0.917118513079433,0,16,tRNA-specific ribonuclease activity,MF,
2049,GO:0004550,1,0.911459113492241,0,17,nucleoside diphosphate kinase activity,MF,
2051,GO:0004553,1,0.60811477797717,0,75,hydrolase activity, hydrolyzing O-glycosyl compounds,MF,
2052,GO:0004556,1,0.989737658285596,0,2,alpha-amylase activity,MF,
2053,GO:0004557,1,0.988513640279578,0,2,alpha-galactosidase activity,MF,
2054,GO:0004558,1,0.97621337927841,0,3,alpha-1,4-glucosidase activity,MF,
2055,GO:0004559,1,0.905251780025373,0,13,alpha-mannosidase activity,MF,
2056,GO:0004560,1,0.988800250463333,0,2,alpha-L-fucosidase activity,MF,
2057,GO:0004561,1,0.993063363737694,0,1,alpha-N-acetylglucosaminidase activity,MF,
2058,GO:0004563,1,0.967601189921973,0,5,beta-N-acetylhexosaminidase activity,MF,
2059,GO:0004565,1,0.961561335391187,0,6,beta-galactosidase activity,MF,
2060,GO:0004566,1,0.981364410380726,0,3,beta-glucuronidase activity,MF,
2061,GO:0004567,1,0.992599903835715,0,1,beta-mannosidase activity,MF,
2062,GO:0004568,1,0.964669204964465,0,6,chitinase activity,MF,
2063,GO:0004569,1,0.992318940245336,0,1,glycoprotein endo-alpha-1,2-mannosidase activity,MF,
2064,GO:0004571,1,0.948651678306132,0,7,mannosyl-oligosaccharide 1,2-alpha-mannosidase activity,MF,
2065,GO:0004572,1,0.983453814599099,0,2,mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity,MF,
2066,GO:0004573,1,0.993137101350596,0,1,mannosyl-oligosaccharide glucosidase activity,MF,
2067,GO:0004574,1,0.992521735947444,0,1,oligo-1,6-glucosidase activity,MF,
2068,GO:0004576,1,0.948425402136401,0,10,oligosaccharyl transferase activity,MF,
2069,GO:0004577,1,0.989562142151599,0,2,N-acetylglucosaminyldiphosphodolichol N-acetylglucosaminyltransferase activity,MF,
2070,GO:0004578,1,0.992481609420521,0,1,chitobiosyldiphosphodolichol beta-mannosyltransferase activity,MF,
2071,GO:0004579,1,0.951733121246958,0,9,dolichyl-diphosphooligosaccharide-protein glycotransferase activity,MF,
2072,GO:0004581,1,0.996526252670423,0,1,dolichyl-phosphate beta-glucosyltransferase activity,MF,
2073,GO:0004582,1,0.990547906362222,0,3,dolichyl-phosphate beta-D-mannosyltransferase activity,MF,
2074,GO:0004583,1,0.970050275137987,0,4,dolichyl-phosphate-glucose-glycolipid alpha-glucosyltransferase activity,MF,
2075,GO:0004584,1,0.993813542481185,0,1,dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase activity,MF,
2076,GO:0004585,1,0.995456237995866,0,1,ornithine carbamoyltransferase activity,MF,
2077,GO:0004586,1,0.980080031604302,0,3,ornithine decarboxylase activity,MF,
2078,GO:0004587,1,0.994676724509826,0,1,ornithine-oxo-acid transaminase activity,MF,
2079,GO:0004588,1,0.993253853055623,0,1,orotate phosphoribosyltransferase activity,MF,
2080,GO:0004590,1,0.993253853055623,0,1,orotidine-5'-phosphate decarboxylase activity,MF,
2081,GO:0004591,1,0.973386538462484,0,4,oxoglutarate dehydrogenase (succinyl-transferring) activity,MF,
2082,GO:0004594,1,0.974455619417016,0,4,pantothenate kinase activity,MF,
2083,GO:0004595,1,0.993953026648861,0,1,pantetheine-phosphate adenylyltransferase activity,MF,
2084,GO:0004596,1,0.933900271075115,0,11,peptide alpha-N-acetyltransferase activity,MF,
2085,GO:0004597,1,0.992517324020557,0,1,peptide-aspartate beta-dioxygenase activity,MF,
2086,GO:0004598,1,0.992504348414736,0,1,peptidylamidoglycolate lyase activity,MF,
2087,GO:0004601,1,0.828361298377761,0,38,peroxidase activity,MF,
2088,GO:0004602,1,0.941043853185391,0,16,glutathione peroxidase activity,MF,
2089,GO:0004603,1,0.996559675344949,0,1,phenylethanolamine N-methyltransferase activity,MF,
2090,GO:0004605,1,0.978708464595726,0,3,phosphatidate cytidylyltransferase activity,MF,
2091,GO:0004607,1,0.99612355701128,0,1,phosphatidylcholine-sterol O-acyltransferase activity,MF,
2092,GO:0004608,1,0.99690558516184,0,1,phosphatidylethanolamine N-methyltransferase activity,MF,
2093,GO:0004609,1,0.98758063276134,0,2,phosphatidylserine decarboxylase activity,MF,
2094,GO:0004610,1,0.994635359291124,0,1,phosphoacetylglucosamine mutase activity,MF,
2095,GO:0004611,1,0.987957491779351,0,2,phosphoenolpyruvate carboxykinase activity,MF,
2096,GO:0004613,1,0.987957491779351,0,2,phosphoenolpyruvate carboxykinase (GTP) activity,MF,
2097,GO:0004614,1,0.963975019174695,0,5,phosphoglucomutase activity,MF,
2098,GO:0004615,1,0.990192299036787,0,2,phosphomannomutase activity,MF,
2099,GO:0004616,1,0.982061426585077,0,3,phosphogluconate dehydrogenase (decarboxylating) activity,MF,
2100,GO:0004617,1,0.994585815572028,0,1,phosphoglycerate dehydrogenase activity,MF,
2101,GO:0004618,1,0.99368096983463,0,1,phosphoglycerate kinase activity,MF,
2102,GO:0004619,1,0.982786604600001,0,4,phosphoglycerate mutase activity,MF,
2104,GO:0004621,1,0.993971591098376,0,1,glycosylphosphatidylinositol phospholipase D activity,MF,
2106,GO:0004623,1,0.859593335997056,0,26,phospholipase A2 activity,MF,
2107,GO:0004629,1,0.821901946248252,0,26,phospholipase C activity,MF,
2108,GO:0004630,1,0.963292467579072,0,6,phospholipase D activity,MF,
2109,GO:0004631,1,0.996248961222927,0,1,phosphomevalonate kinase activity,MF,
2110,GO:0004632,1,0.996324421382679,0,1,phosphopantothenate--cysteine ligase activity,MF,
2111,GO:0004633,1,0.994128117021164,0,1,phosphopantothenoylcysteine decarboxylase activity,MF,
2112,GO:0004634,1,0.977765483234445,0,4,phosphopyruvate hydratase activity,MF,
2113,GO:0004637,1,0.992556727847268,0,1,phosphoribosylamine-glycine ligase activity,MF,
2114,GO:0004638,1,0.992591040871549,0,1,phosphoribosylaminoimidazole carboxylase activity,MF,
2115,GO:0004639,1,0.992591040871549,0,1,phosphoribosylaminoimidazolesuccinocarboxamide synthase activity,MF,
2116,GO:0004641,1,0.992556727847268,0,1,phosphoribosylformylglycinamidine cyclo-ligase activity,MF,
2117,GO:0004642,1,0.991888506608268,0,1,phosphoribosylformylglycinamidine synthase activity,MF,
2118,GO:0004643,1,0.994405408097248,0,1,phosphoribosylaminoimidazolecarboxamide formyltransferase activity,MF,
2119,GO:0004644,1,0.992556727847268,0,1,phosphoribosylglycinamide formyltransferase activity,MF,
2120,GO:0004645,1,0.959366112929424,0,6,phosphorylase activity,MF,
2121,GO:0004647,1,0.984541150834257,0,3,phosphoserine phosphatase activity,MF,
2122,GO:0004648,1,0.994353177935505,0,1,O-phospho-L-serine:2-oxoglutarate aminotransferase activity,MF,
2123,GO:0004649,1,0.987820451593381,0,2,poly(ADP-ribose) glycohydrolase activity,MF,
2124,GO:0004651,1,0.987867733151982,0,2,polynucleotide 5'-phosphatase activity,MF,
2125,GO:0004652,1,0.933360591300387,0,9,polynucleotide adenylyltransferase activity,MF,
2127,GO:0004654,1,0.992307720971646,0,1,polyribonucleotide nucleotidyltransferase activity,MF,
2128,GO:0004655,1,0.992666829269963,0,1,porphobilinogen synthase activity,MF,
2129,GO:0004656,1,0.974661680527718,0,4,procollagen-proline 4-dioxygenase activity,MF,
2130,GO:0004657,1,0.994128117021164,0,1,proline dehydrogenase activity,MF,
2131,GO:0004658,1,0.988677583009079,0,2,propionyl-CoA carboxylase activity,MF,
2132,GO:0004659,1,0.906656457717782,0,15,prenyltransferase activity,MF,
2133,GO:0004660,1,0.98860084101475,0,2,protein farnesyltransferase activity,MF,
2134,GO:0004661,1,0.971710884393175,0,5,protein geranylgeranyltransferase activity,MF,
2135,GO:0004662,1,0.98873439560513,0,2,CAAX-protein geranylgeranyltransferase activity,MF,
2136,GO:0004663,1,0.978426445185217,0,4,Rab geranylgeranyltransferase activity,MF,
2137,GO:0004666,1,0.98450516878103,0,2,prostaglandin-endoperoxide synthase activity,MF,
2138,GO:0004667,1,0.992832079011726,0,2,prostaglandin-D synthase activity,MF,
2139,GO:0004668,1,0.979197440942314,0,3,protein-arginine deiminase activity,MF,
2140,GO:0004671,1,0.992214360392067,0,1,protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity,MF,
2142,GO:0004673,1,0.951190871737014,0,7,protein histidine kinase activity,MF,
2144,GO:0004675,1,0.883704079851061,0,15,transmembrane receptor protein serine/threonine kinase activity,MF,
2145,GO:0004676,1,0.990875612104228,0,1,3-phosphoinositide-dependent protein kinase activity,MF,
2146,GO:0004677,1,0.969149665966874,0,3,DNA-dependent protein kinase activity,MF,
2147,GO:0004679,1,0.949901872589661,0,7,AMP-activated protein kinase activity,MF,
2149,GO:0004686,1,0.990651749312105,0,1,elongation factor-2 kinase activity,MF,
2150,GO:0004687,1,0.966004469324333,0,4,myosin light chain kinase activity,MF,
2152,GO:0004690,1,0.93871896702667,0,8,cyclic nucleotide-dependent protein kinase activity,MF,
2153,GO:0004691,1,0.952884061067906,0,6,cAMP-dependent protein kinase activity,MF,
2154,GO:0004692,1,0.985141616532682,0,2,cGMP-dependent protein kinase activity,MF,
2155,GO:0004693,1,0.804743680226879,0,34,cyclin-dependent protein serine/threonine kinase activity,MF,
2156,GO:0004694,1,0.969957899833526,0,4,eukaryotic translation initiation factor 2alpha kinase activity,MF,
2159,GO:0004699,1,0.977572070615175,0,3,calcium-independent protein kinase C activity,MF,
2161,GO:0004703,1,0.975003671826491,0,4,G-protein coupled receptor kinase activity,MF,
2162,GO:0004704,1,0.96768069245351,0,5,NF-kappaB-inducing kinase activity,MF,
2163,GO:0004705,1,0.980976239036748,0,3,JUN kinase activity,MF,
2164,GO:0004706,1,0.977028155091894,0,3,JUN kinase kinase kinase activity,MF,
2165,GO:0004707,1,0.913204150883001,0,14,MAP kinase activity,MF,
2166,GO:0004708,1,0.902928655993356,0,15,MAP kinase kinase activity,MF,
2168,GO:0004711,1,0.946042096112248,0,7,ribosomal protein S6 kinase activity,MF,
2172,GO:0004715,1,0.707606965846526,0,49,non-membrane spanning protein tyrosine kinase activity,MF,
2174,GO:0004719,1,0.980315863733346,0,3,protein-L-isoaspartate (D-aspartate) O-methyltransferase activity,MF,
2175,GO:0004720,1,0.957821668626511,0,6,protein-lysine 6-oxidase activity,MF,
2177,GO:0004722,1,0.638870835099058,0,66,protein serine/threonine phosphatase activity,MF,
2178,GO:0004723,1,0.947950798260782,0,7,calcium-dependent protein serine/threonine phosphatase activity,MF,
2180,GO:0004726,1,0.948342344355858,0,8,non-membrane spanning protein tyrosine phosphatase activity,MF,
2181,GO:0004727,1,0.990783960515206,0,2,prenylated protein tyrosine phosphatase activity,MF,
2182,GO:0004728,1,0.993367477867485,0,1,signal transducer, downstream of receptor, with protein tyrosine phosphatase activity,MF,
2183,GO:0004729,1,0.995236914498508,0,1,oxygen-dependent protoporphyrinogen oxidase activity,MF,
2184,GO:0004730,1,0.995419331557463,0,1,pseudouridylate synthase activity,MF,
2185,GO:0004731,1,0.985916983714275,0,2,purine-nucleoside phosphorylase activity,MF,
2186,GO:0004733,1,0.992551367841632,0,1,pyridoxamine-phosphate oxidase activity,MF,
2187,GO:0004735,1,0.99027629824037,0,2,pyrroline-5-carboxylate reductase activity,MF,
2188,GO:0004736,1,0.992471264579728,0,1,pyruvate carboxylase activity,MF,
2189,GO:0004738,1,0.966907903702193,0,5,pyruvate dehydrogenase activity,MF,
2190,GO:0004739,1,0.988337071395742,0,2,pyruvate dehydrogenase (acetyl-transferring) activity,MF,
2191,GO:0004740,1,0.96985283481513,0,4,pyruvate dehydrogenase (acetyl-transferring) kinase activity,MF,
2192,GO:0004741,1,0.975426667642945,0,3,[pyruvate dehydrogenase (lipoamide)] phosphatase activity,MF,
2193,GO:0004742,1,0.992396566095798,0,1,dihydrolipoyllysine-residue acetyltransferase activity,MF,
2194,GO:0004743,1,0.985883797318786,0,2,pyruvate kinase activity,MF,
2195,GO:0004744,1,0.993321774029604,0,1,retinal isomerase activity,MF,
2196,GO:0004745,1,0.936668185212303,0,12,retinol dehydrogenase activity,MF,
2197,GO:0004747,1,0.996464640019307,0,1,ribokinase activity,MF,
2198,GO:0004748,1,0.977575275840088,0,3,ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor,MF,
2199,GO:0004749,1,0.976630025983522,0,4,ribose phosphate diphosphokinase activity,MF,
2200,GO:0004750,1,0.993950847268195,0,1,ribulose-phosphate 3-epimerase activity,MF,
2201,GO:0004751,1,0.995021564275156,0,1,ribose-5-phosphate isomerase activity,MF,
2202,GO:0004753,1,0.991590785875459,0,1,saccharopine dehydrogenase activity,MF,
2203,GO:0004756,1,0.987421175502056,0,2,selenide, water dikinase activity,MF,
2204,GO:0004757,1,0.995896763911969,0,1,sepiapterin reductase activity,MF,
2205,GO:0004758,1,0.964788895421762,0,5,serine C-palmitoyltransferase activity,MF,
2206,GO:0004760,1,0.995566416067967,0,1,serine-pyruvate transaminase activity,MF,
2207,GO:0004766,1,0.996297118502833,0,1,spermidine synthase activity,MF,
2208,GO:0004767,1,0.969127100952117,0,5,sphingomyelin phosphodiesterase activity,MF,
2209,GO:0004768,1,0.97806743995319,0,3,stearoyl-CoA 9-desaturase activity,MF,
2210,GO:0004769,1,0.996559675344949,0,1,steroid delta-isomerase activity,MF,
2211,GO:0004771,1,0.946418517000474,0,8,sterol esterase activity,MF,
2212,GO:0004772,1,0.992569967091373,0,1,sterol O-acyltransferase activity,MF,
2213,GO:0004773,1,0.991285763683374,0,1,steryl-sulfatase activity,MF,
2214,GO:0004774,1,0.984041317842059,0,3,succinate-CoA ligase activity,MF,
2215,GO:0004775,1,0.99015280624814,0,2,succinate-CoA ligase (ADP-forming) activity,MF,
2216,GO:0004776,1,0.989741272974392,0,2,succinate-CoA ligase (GDP-forming) activity,MF,
2217,GO:0004777,1,0.992035648124119,0,1,succinate-semialdehyde dehydrogenase (NAD+) activity,MF,
2218,GO:0004778,1,0.995509132159025,0,1,succinyl-CoA hydrolase activity,MF,
2219,GO:0004779,1,0.985985065752903,0,2,sulfate adenylyltransferase activity,MF,
2220,GO:0004781,1,0.985985065752903,0,2,sulfate adenylyltransferase (ATP) activity,MF,
2221,GO:0004782,1,0.993174814481327,0,1,sulfinoalanine decarboxylase activity,MF,
2222,GO:0004784,1,0.980087738215867,0,5,superoxide dismutase activity,MF,
2223,GO:0004788,1,0.993819878128903,0,1,thiamine diphosphokinase activity,MF,
2224,GO:0004790,1,0.993429006919672,0,1,thioether S-methyltransferase activity,MF,
2225,GO:0004791,1,0.959091658280024,0,8,thioredoxin-disulfide reductase activity,MF,
2226,GO:0004792,1,0.98616954644334,0,3,thiosulfate sulfurtransferase activity,MF,
2227,GO:0004793,1,0.98773289675845,0,2,threonine aldolase activity,MF,
2228,GO:0004794,1,0.991600920619404,0,2,L-threonine ammonia-lyase activity,MF,
2229,GO:0004795,1,0.994365921264761,0,1,threonine synthase activity,MF,
2230,GO:0004796,1,0.994371718953324,0,1,thromboxane-A synthase activity,MF,
2231,GO:0004797,1,0.987706929611242,0,2,thymidine kinase activity,MF,
2232,GO:0004798,1,0.989444287114099,0,2,thymidylate kinase activity,MF,
2233,GO:0004799,1,0.995607527026098,0,1,thymidylate synthase activity,MF,
2234,GO:0004800,1,0.985736990689119,0,2,thyroxine 5'-deiodinase activity,MF,
2235,GO:0004801,1,0.996364751995709,0,1,sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity,MF,
2236,GO:0004802,1,0.987695588868914,0,2,transketolase activity,MF,
2237,GO:0004803,1,0.992468780789337,0,1,transposase activity,MF,
2238,GO:0004806,1,0.889088097850721,0,18,triglyceride lipase activity,MF,
2239,GO:0004807,1,0.995890045359564,0,1,triose-phosphate isomerase activity,MF,
2240,GO:0004809,1,0.98209986149728,0,3,tRNA (guanine-N2-)-methyltransferase activity,MF,
2241,GO:0004810,1,0.994001218984072,0,1,tRNA adenylyltransferase activity,MF,
2242,GO:0004812,1,0.75237228848752,0,44,aminoacyl-tRNA ligase activity,MF,
2243,GO:0004813,1,0.979815689400248,0,3,alanine-tRNA ligase activity,MF,
2244,GO:0004814,1,0.983453331077939,0,3,arginine-tRNA ligase activity,MF,
2245,GO:0004815,1,0.986507252535323,0,2,aspartate-tRNA ligase activity,MF,
2246,GO:0004816,1,0.986982408428826,0,2,asparagine-tRNA ligase activity,MF,
2247,GO:0004817,1,0.988236279867585,0,2,cysteine-tRNA ligase activity,MF,
2248,GO:0004818,1,0.984640648564896,0,2,glutamate-tRNA ligase activity,MF,
2249,GO:0004819,1,0.985871578586392,0,2,glutamine-tRNA ligase activity,MF,
2250,GO:0004820,1,0.988709697401966,0,2,glycine-tRNA ligase activity,MF,
2251,GO:0004821,1,0.988279973897723,0,2,histidine-tRNA ligase activity,MF,
2252,GO:0004822,1,0.984938318256935,0,2,isoleucine-tRNA ligase activity,MF,
2253,GO:0004823,1,0.984675301063122,0,2,leucine-tRNA ligase activity,MF,
2254,GO:0004824,1,0.994376359435733,0,1,lysine-tRNA ligase activity,MF,
2255,GO:0004825,1,0.985862065419091,0,2,methionine-tRNA ligase activity,MF,
2256,GO:0004826,1,0.970435315861068,0,5,phenylalanine-tRNA ligase activity,MF,
2257,GO:0004827,1,0.982664399545941,0,3,proline-tRNA ligase activity,MF,
2258,GO:0004828,1,0.989360581464103,0,2,serine-tRNA ligase activity,MF,
2259,GO:0004829,1,0.979473084264907,0,3,threonine-tRNA ligase activity,MF,
2260,GO:0004830,1,0.986255708736886,0,2,tryptophan-tRNA ligase activity,MF,
2261,GO:0004831,1,0.987014132462881,0,2,tyrosine-tRNA ligase activity,MF,
2262,GO:0004832,1,0.977281730039618,0,3,valine-tRNA ligase activity,MF,
2263,GO:0004833,1,0.991000186396194,0,2,tryptophan 2,3-dioxygenase activity,MF,
2264,GO:0004835,1,0.992032270684876,0,1,tubulin-tyrosine ligase activity,MF,
2265,GO:0004838,1,0.993087571229264,0,1,L-tyrosine:2-oxoglutarate aminotransferase activity,MF,
2266,GO:0004839,1,0.962652849791923,0,5,ubiquitin activating enzyme activity,MF,
2267,GO:0004842,1,0.0490534991154348,0,422,ubiquitin-protein transferase activity,MF,
2268,GO:0004843,1,0.591830153127966,0,70,thiol-dependent ubiquitin-specific protease activity,MF,
2269,GO:0004844,1,0.974825163249299,0,5,uracil DNA N-glycosylase activity,MF,
2270,GO:0004849,1,0.972432848252897,0,5,uridine kinase activity,MF,
2271,GO:0004850,1,0.98882417305564,0,2,uridine phosphorylase activity,MF,
2272,GO:0004852,1,0.996116930952928,0,1,uroporphyrinogen-III synthase activity,MF,
2273,GO:0004853,1,0.996050525066347,0,1,uroporphyrinogen decarboxylase activity,MF,
2274,GO:0004854,1,0.983883671546724,0,2,xanthine dehydrogenase activity,MF,
2275,GO:0004855,1,0.991678267239222,0,1,xanthine oxidase activity,MF,
2276,GO:0004856,1,0.992508322050937,0,1,xylulokinase activity,MF,
2278,GO:0004859,1,0.964568084407583,0,8,phospholipase inhibitor activity,MF,
2279,GO:0004860,1,0.564805211027465,0,89,protein kinase inhibitor activity,MF,
2280,GO:0004861,1,0.935930735956427,0,12,cyclin-dependent protein serine/threonine kinase inhibitor activity,MF,
2281,GO:0004862,1,0.947151568927725,0,9,cAMP-dependent protein kinase inhibitor activity,MF,
2282,GO:0004864,1,0.817498140411671,0,31,protein phosphatase inhibitor activity,MF,
2283,GO:0004865,1,0.951354380240258,0,10,protein serine/threonine phosphatase inhibitor activity,MF,
2288,GO:0004873,1,0.991778400499217,0,2,asialoglycoprotein receptor activity,MF,
2291,GO:0004876,1,0.994748946424566,0,1,complement component C3a receptor activity,MF,
2292,GO:0004877,1,0.989540988123595,0,1,complement component C3b receptor activity,MF,
2293,GO:0004878,1,0.98696726161048,0,2,complement component C5a receptor activity,MF,
2295,GO:0004882,1,0.98544456299769,0,2,androgen receptor activity,MF,
2296,GO:0004883,1,0.991140263073938,0,1,glucocorticoid receptor activity,MF,
2297,GO:0004886,1,0.981254474314226,0,3,9-cis retinoic acid receptor activity,MF,
2298,GO:0004887,1,0.959000037217186,0,6,thyroid hormone receptor activity,MF,
2300,GO:0004890,1,0.88937501210774,0,16,GABA-A receptor activity,MF,
2302,GO:0004897,1,0.969188744108996,0,4,ciliary neurotrophic factor receptor activity,MF,
2303,GO:0004900,1,0.994988429296323,0,1,erythropoietin receptor activity,MF,
2304,GO:0004904,1,0.969334745038272,0,5,interferon receptor activity,MF,
2305,GO:0004905,1,0.987486739262881,0,2,type I interferon receptor activity,MF,
2306,GO:0004906,1,0.988503960891545,0,2,interferon-gamma receptor activity,MF,
2307,GO:0004908,1,0.955512313339562,0,7,interleukin-1 receptor activity,MF,
2308,GO:0004909,1,0.986913093756027,0,2,interleukin-1, Type I, activating receptor activity,MF,
2309,GO:0004910,1,0.988799328851125,0,2,interleukin-1, Type II, blocking receptor activity,MF,
2310,GO:0004911,1,0.980951165682635,0,3,interleukin-2 receptor activity,MF,
2311,GO:0004912,1,0.99219505124702,0,1,interleukin-3 receptor activity,MF,
2312,GO:0004913,1,0.989502162611453,0,2,interleukin-4 receptor activity,MF,
2313,GO:0004914,1,0.986820366323442,0,2,interleukin-5 receptor activity,MF,
2314,GO:0004915,1,0.985169063558035,0,2,interleukin-6 receptor activity,MF,
2315,GO:0004917,1,0.990834565264013,0,2,interleukin-7 receptor activity,MF,
2316,GO:0004918,1,0.986705555057927,0,2,interleukin-8 receptor activity,MF,
2317,GO:0004920,1,0.967821665738112,0,5,interleukin-10 receptor activity,MF,
2318,GO:0004921,1,0.99266209905125,0,1,interleukin-11 receptor activity,MF,
2319,GO:0004923,1,0.981799240865409,0,2,leukemia inhibitory factor receptor activity,MF,
2320,GO:0004924,1,0.974449419808021,0,3,oncostatin-M receptor activity,MF,
2321,GO:0004925,1,0.988187975164272,0,1,prolactin receptor activity,MF,
2323,GO:0004931,1,0.959899134226701,0,7,extracellularly ATP-gated cation channel activity,MF,
2324,GO:0004935,1,0.940198947475495,0,10,adrenergic receptor activity,MF,
2325,GO:0004936,1,0.969132579912784,0,5,alpha-adrenergic receptor activity,MF,
2326,GO:0004937,1,0.981623525449149,0,3,alpha1-adrenergic receptor activity,MF,
2327,GO:0004938,1,0.987277563366913,0,2,alpha2-adrenergic receptor activity,MF,
2328,GO:0004939,1,0.980913991423373,0,3,beta-adrenergic receptor activity,MF,
2329,GO:0004940,1,0.992964375645639,0,1,beta1-adrenergic receptor activity,MF,
2330,GO:0004941,1,0.994548150917564,0,1,beta2-adrenergic receptor activity,MF,
2331,GO:0004945,1,0.987064807774574,0,3,angiotensin type II receptor activity,MF,
2332,GO:0004947,1,0.988744215384922,0,2,bradykinin receptor activity,MF,
2333,GO:0004948,1,0.984696108214799,0,2,calcitonin receptor activity,MF,
2334,GO:0004949,1,0.979446462009283,0,3,cannabinoid receptor activity,MF,
2336,GO:0004951,1,0.989767086749539,0,2,cholecystokinin receptor activity,MF,
2337,GO:0004952,1,0.962268163753188,0,7,dopamine neurotransmitter receptor activity,MF,
2338,GO:0004953,1,0.902931409288732,0,17,icosanoid receptor activity,MF,
2339,GO:0004954,1,0.933218887469952,0,11,prostanoid receptor activity,MF,
2340,GO:0004955,1,0.938840875838011,0,10,prostaglandin receptor activity,MF,
2341,GO:0004956,1,0.985978237583199,0,2,prostaglandin D receptor activity,MF,
2342,GO:0004957,1,0.963309442866795,0,6,prostaglandin E receptor activity,MF,
2343,GO:0004958,1,0.985011074526586,0,2,prostaglandin F receptor activity,MF,
2344,GO:0004960,1,0.994015545358986,0,1,thromboxane receptor activity,MF,
2345,GO:0004961,1,0.994015545358986,0,1,thromboxane A2 receptor activity,MF,
2346,GO:0004962,1,0.984966626169303,0,2,endothelin receptor activity,MF,
2347,GO:0004965,1,0.976659793133731,0,3,G-protein coupled GABA receptor activity,MF,
2348,GO:0004966,1,0.952637037552857,0,10,galanin receptor activity,MF,
2349,GO:0004967,1,0.988150331774359,0,2,glucagon receptor activity,MF,
2350,GO:0004968,1,0.992426536151336,0,1,gonadotropin-releasing hormone receptor activity,MF,
2351,GO:0004969,1,0.966613839690904,0,5,histamine receptor activity,MF,
2353,GO:0004971,1,0.968123881587203,0,4,AMPA glutamate receptor activity,MF,
2354,GO:0004972,1,0.939718573573021,0,7,NMDA glutamate receptor activity,MF,
2355,GO:0004974,1,0.967567226589228,0,6,leukotriene receptor activity,MF,
2356,GO:0004977,1,0.980718926783383,0,4,melanocortin receptor activity,MF,
2357,GO:0004979,1,0.994955265031546,0,1,beta-endorphin receptor activity,MF,
2358,GO:0004980,1,0.988708105168199,0,2,melanocyte-stimulating hormone receptor activity,MF,
2360,GO:0004983,1,0.952222390245429,0,8,neuropeptide Y receptor activity,MF,
2361,GO:0004984,1,0.933492928025503,0,17,olfactory receptor activity,MF,
2362,GO:0004985,1,0.958714616830661,0,8,opioid receptor activity,MF,
2363,GO:0004990,1,0.992395344427474,0,1,oxytocin receptor activity,MF,
2364,GO:0004991,1,0.987518187876082,0,2,parathyroid hormone receptor activity,MF,
2365,GO:0004992,1,0.980060760430083,0,3,platelet activating factor receptor activity,MF,
2366,GO:0004993,1,0.928264986600908,0,13,G-protein coupled serotonin receptor activity,MF,
2367,GO:0004994,1,0.976724426667632,0,4,somatostatin receptor activity,MF,
2368,GO:0004995,1,0.981664264682186,0,3,tachykinin receptor activity,MF,
2369,GO:0004996,1,0.98887877452445,0,2,thyroid-stimulating hormone receptor activity,MF,
2370,GO:0004998,1,0.984996293869419,0,2,transferrin receptor activity,MF,
2371,GO:0004999,1,0.981086270494777,0,3,vasoactive intestinal polypeptide receptor activity,MF,
2372,GO:0005000,1,0.966675688889905,0,5,vasopressin receptor activity,MF,
2373,GO:0005001,1,0.874136714608219,0,16,transmembrane receptor protein tyrosine phosphatase activity,MF,
2375,GO:0005004,1,0.945331867816498,0,7,GPI-linked ephrin receptor activity,MF,
2379,GO:0005008,1,0.991111518645563,0,1,hepatocyte growth factor-activated receptor activity,MF,
2380,GO:0005009,1,0.989695256709258,0,1,insulin-activated receptor activity,MF,
2381,GO:0005010,1,0.962864611845425,0,4,insulin-like growth factor-activated receptor activity,MF,
2382,GO:0005011,1,0.984759462811995,0,2,macrophage colony-stimulating factor receptor activity,MF,
2383,GO:0005017,1,0.978782420958047,0,3,platelet-derived growth factor-activated receptor activity,MF,
2384,GO:0005018,1,0.991156179889696,0,1,platelet-derived growth factor alpha-receptor activity,MF,
2385,GO:0005019,1,0.987516934597322,0,2,platelet-derived growth factor beta-receptor activity,MF,
2386,GO:0005020,1,0.992019259254054,0,1,stem cell factor receptor activity,MF,
2387,GO:0005021,1,0.946116593703633,0,7,vascular endothelial growth factor-activated receptor activity,MF,
2388,GO:0005024,1,0.93776605346449,0,8,transforming growth factor beta-activated receptor activity,MF,
2389,GO:0005025,1,0.968748339807039,0,4,transforming growth factor beta receptor activity, type I,MF,
2390,GO:0005026,1,0.992281002971285,0,1,transforming growth factor beta receptor activity, type II,MF,
2391,GO:0005030,1,0.968310955325501,0,4,neurotrophin receptor activity,MF,
2392,GO:0005031,1,0.869386664165206,0,24,tumor necrosis factor-activated receptor activity,MF,
2393,GO:0005034,1,0.992686411033338,0,1,osmosensor activity,MF,
2394,GO:0005035,1,0.869386664165206,0,24,death receptor activity,MF,
2395,GO:0005041,1,0.893658260887742,0,13,low-density lipoprotein particle receptor activity,MF,
2396,GO:0005042,1,0.950735624370616,0,6,netrin receptor activity,MF,
2398,GO:0005046,1,0.988835512915024,0,2,KDEL sequence binding,MF,
2400,GO:0005048,1,0.764381385206188,0,39,signal sequence binding,MF,
2401,GO:0005049,1,0.93832909862265,0,8,nuclear export signal receptor activity,MF,
2402,GO:0005052,1,0.985250738470379,0,2,peroxisome matrix targeting signal-1 binding,MF,
2403,GO:0005053,1,0.995831699064408,0,1,peroxisome matrix targeting signal-2 binding,MF,
2404,GO:0005055,1,0.990308740236939,0,2,laminin receptor activity,MF,
2406,GO:0005068,1,0.926392850896351,0,11,transmembrane receptor protein tyrosine kinase adaptor activity,MF,
2407,GO:0005070,1,0.680220943362838,0,57,SH3/SH2 adaptor activity,MF,
2408,GO:0005072,1,0.920916899308492,0,10,transforming growth factor beta receptor, cytoplasmic mediator activity,MF,
2409,GO:0005078,1,0.940526057882998,0,7,MAP-kinase scaffold activity,MF,
2410,GO:0005080,1,0.742158876795447,0,43,protein kinase C binding,MF,
2412,GO:0005086,1,0.855371355240355,0,20,ARF guanyl-nucleotide exchange factor activity,MF,
2413,GO:0005087,1,0.979428390284131,0,4,Ran guanyl-nucleotide exchange factor activity,MF,
2415,GO:0005089,1,0.531235738382632,0,76,Rho guanyl-nucleotide exchange factor activity,MF,
2416,GO:0005090,1,0.994243844117059,0,1,Sar guanyl-nucleotide exchange factor activity,MF,
2417,GO:0005092,1,0.91944621476494,0,14,GDP-dissociation inhibitor activity,MF,
2418,GO:0005093,1,0.987447890085594,0,2,Rab GDP-dissociation inhibitor activity,MF,
2419,GO:0005094,1,0.988442426245526,0,3,Rho GDP-dissociation inhibitor activity,MF,
2420,GO:0005095,1,0.912182056452396,0,14,GTPase inhibitor activity,MF,
2423,GO:0005104,1,0.890675900106781,0,19,fibroblast growth factor receptor binding,MF,
2424,GO:0005105,1,0.986249166981311,0,3,type 1 fibroblast growth factor receptor binding,MF,
2426,GO:0005111,1,0.989892756072471,0,3,type 2 fibroblast growth factor receptor binding,MF,
2427,GO:0005112,1,0.845512219315058,0,21,Notch binding,MF,
2428,GO:0005113,1,0.954468860390902,0,7,patched binding,MF,
2429,GO:0005114,1,0.950463418510435,0,7,type II transforming growth factor beta receptor binding,MF,
2430,GO:0005115,1,0.991622634195076,0,1,receptor tyrosine kinase-like orphan receptor binding,MF,
2431,GO:0005119,1,0.975648037943411,0,3,smoothened binding,MF,
2432,GO:0005123,1,0.903773713315232,0,16,death receptor binding,MF,
2433,GO:0005124,1,0.979214748156874,0,4,scavenger receptor binding,MF,
2437,GO:0005128,1,0.988834172601996,0,2,erythropoietin receptor binding,MF,
2438,GO:0005130,1,0.99576185001983,0,1,granulocyte colony-stimulating factor receptor binding,MF,
2439,GO:0005131,1,0.970922651902056,0,4,growth hormone receptor binding,MF,
2440,GO:0005134,1,0.980991572732912,0,3,interleukin-2 receptor binding,MF,
2441,GO:0005135,1,0.992623222126441,0,1,interleukin-3 receptor binding,MF,
2442,GO:0005136,1,0.987946569280504,0,2,interleukin-4 receptor binding,MF,
2443,GO:0005137,1,0.994246131515409,0,1,interleukin-5 receptor binding,MF,
2444,GO:0005138,1,0.958808650950237,0,7,interleukin-6 receptor binding,MF,
2445,GO:0005139,1,0.988002925715805,0,2,interleukin-7 receptor binding,MF,
2446,GO:0005141,1,0.995506836278652,0,1,interleukin-10 receptor binding,MF,
2447,GO:0005142,1,0.993832580343169,0,1,interleukin-11 receptor binding,MF,
2448,GO:0005143,1,0.982652494446713,0,3,interleukin-12 receptor binding,MF,
2449,GO:0005144,1,0.996286185390552,0,1,interleukin-13 receptor binding,MF,
2450,GO:0005146,1,0.987954809440715,0,2,leukemia inhibitory factor receptor binding,MF,
2451,GO:0005147,1,0.994967112333128,0,1,oncostatin-M receptor binding,MF,
2452,GO:0005149,1,0.930259553002025,0,11,interleukin-1 receptor binding,MF,
2453,GO:0005150,1,0.987709121925979,0,2,interleukin-1, Type I receptor binding,MF,
2454,GO:0005151,1,0.987114203291181,0,2,interleukin-1, Type II receptor binding,MF,
2455,GO:0005152,1,0.986199918042145,0,2,interleukin-1 receptor antagonist activity,MF,
2456,GO:0005153,1,0.985816844346409,0,2,interleukin-8 receptor binding,MF,
2457,GO:0005154,1,0.81178599004022,0,29,epidermal growth factor receptor binding,MF,
2458,GO:0005157,1,0.98467872151376,0,3,macrophage colony-stimulating factor receptor binding,MF,
2459,GO:0005158,1,0.84130475046337,0,21,insulin receptor binding,MF,
2460,GO:0005159,1,0.91158133989804,0,13,insulin-like growth factor receptor binding,MF,
2461,GO:0005160,1,0.743430481941745,0,45,transforming growth factor beta receptor binding,MF,
2462,GO:0005161,1,0.897450010688977,0,14,platelet-derived growth factor receptor binding,MF,
2463,GO:0005163,1,0.996790947763308,0,1,nerve growth factor receptor binding,MF,
2464,GO:0005164,1,0.854657899874182,0,29,tumor necrosis factor receptor binding,MF,
2465,GO:0005165,1,0.929877973499588,0,11,neurotrophin receptor binding,MF,
2466,GO:0005166,1,0.986590869693061,0,3,neurotrophin p75 receptor binding,MF,
2467,GO:0005167,1,0.942630293709142,0,8,neurotrophin TRK receptor binding,MF,
2468,GO:0005168,1,0.952735704548139,0,6,neurotrophin TRKA receptor binding,MF,
2469,GO:0005169,1,0.981415191534677,0,3,neurotrophin TRKB receptor binding,MF,
2470,GO:0005170,1,0.991932129188522,0,1,neurotrophin TRKC receptor binding,MF,
2471,GO:0005171,1,0.989171448936877,0,2,hepatocyte growth factor receptor binding,MF,
2472,GO:0005172,1,0.938627518401085,0,10,vascular endothelial growth factor receptor binding,MF,
2473,GO:0005173,1,0.975273908450827,0,3,stem cell factor receptor binding,MF,
2474,GO:0005174,1,0.989050981181739,0,2,CD40 receptor binding,MF,
2475,GO:0005175,1,0.997577453293387,0,1,CD27 receptor binding,MF,
2476,GO:0005176,1,0.982817275098323,0,3,ErbB-2 class receptor binding,MF,
2479,GO:0005183,1,0.993452805242173,0,2,gonadotropin hormone-releasing hormone activity,MF,
2482,GO:0005199,1,0.992581647518425,0,1,structural constituent of cell wall,MF,
2485,GO:0005212,1,0.952019522740043,0,13,structural constituent of eye lens,MF,
2488,GO:0005217,1,0.778031126373636,0,30,intracellular ligand-gated ion channel activity,MF,
2489,GO:0005219,1,0.956105461962598,0,4,ryanodine-sensitive calcium-release channel activity,MF,
2490,GO:0005220,1,0.966887057572697,0,3,inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,MF,
2491,GO:0005221,1,0.942692475150004,0,8,intracellular cyclic nucleotide activated cation channel activity,MF,
2492,GO:0005222,1,0.949242254786675,0,7,intracellular cAMP activated cation channel activity,MF,
2493,GO:0005223,1,0.966428996996725,0,5,intracellular cGMP activated cation channel activity,MF,
2494,GO:0005225,1,0.927993557729352,0,10,volume-sensitive anion channel activity,MF,
2495,GO:0005227,1,0.846927417186304,0,25,calcium activated cation channel activity,MF,
2496,GO:0005228,1,0.983852132874315,0,2,intracellular sodium activated potassium channel activity,MF,
2497,GO:0005229,1,0.876803325861852,0,18,intracellular calcium activated chloride channel activity,MF,
2501,GO:0005237,1,0.895462839675449,0,15,inhibitory extracellular ligand-gated ion channel activity,MF,
2506,GO:0005246,1,0.827229219698398,0,30,calcium channel regulator activity,MF,
2507,GO:0005247,1,0.934848033062465,0,9,voltage-gated chloride channel activity,MF,
2510,GO:0005250,1,0.971434758429655,0,4,A-type (transient outward) potassium channel activity,MF,
2511,GO:0005251,1,0.833263969724574,0,26,delayed rectifier potassium channel activity,MF,
2512,GO:0005252,1,0.992477402077949,0,1,open rectifier potassium channel activity,MF,
2515,GO:0005260,1,0.991427235493867,0,1,intracellularly ATP-gated chloride channel activity,MF,
2520,GO:0005275,1,0.987526629570867,0,2,amine transmembrane transporter activity,MF,
2521,GO:0005277,1,0.98725352991757,0,2,acetylcholine transmembrane transporter activity,MF,
2522,GO:0005280,1,0.97285056053021,0,4,amino acid:proton symporter activity,MF,
2524,GO:0005287,1,0.98442748934105,0,2,high-affinity basic amino acid transmembrane transporter activity,MF,
2525,GO:0005289,1,0.98442748934105,0,2,high-affinity arginine transmembrane transporter activity,MF,
2526,GO:0005290,1,0.979856849301814,0,3,L-histidine transmembrane transporter activity,MF,
2527,GO:0005292,1,0.98442748934105,0,2,high-affinity lysine transmembrane transporter activity,MF,
2528,GO:0005294,1,0.989356043494652,0,1,neutral L-amino acid secondary active transmembrane transporter activity,MF,
2529,GO:0005295,1,0.985645317344822,0,2,neutral amino acid:sodium symporter activity,MF,
2530,GO:0005298,1,0.9849541220631,0,2,proline:sodium symporter activity,MF,
2531,GO:0005302,1,0.992688031878015,0,1,L-tyrosine transmembrane transporter activity,MF,
2532,GO:0005308,1,0.984888499349361,0,2,creatine transmembrane transporter activity,MF,
2533,GO:0005309,1,0.992533274296706,0,1,creatine:sodium symporter activity,MF,
2536,GO:0005314,1,0.950177888078835,0,7,high-affinity glutamate transmembrane transporter activity,MF,
2538,GO:0005316,1,0.992614760206317,0,1,high-affinity inorganic phosphate:sodium symporter activity,MF,
2540,GO:0005324,1,0.973294330036229,0,5,long-chain fatty acid transporter activity,MF,
2542,GO:0005328,1,0.843483045991611,0,23,neurotransmitter:sodium symporter activity,MF,
2543,GO:0005329,1,0.963205387947208,0,5,dopamine transmembrane transporter activity,MF,
2544,GO:0005330,1,0.977566041806552,0,3,dopamine:sodium symporter activity,MF,
2545,GO:0005332,1,0.974045281996695,0,4,gamma-aminobutyric acid:sodium symporter activity,MF,
2546,GO:0005333,1,0.986140244818927,0,2,norepinephrine transmembrane transporter activity,MF,
2547,GO:0005334,1,0.992584948142418,0,1,norepinephrine:sodium symporter activity,MF,
2548,GO:0005335,1,0.992331782807655,0,1,serotonin:sodium symporter activity,MF,
2549,GO:0005337,1,0.963626194959055,0,6,nucleoside transmembrane transporter activity,MF,
2550,GO:0005338,1,0.927065185877054,0,12,nucleotide-sugar transmembrane transporter activity,MF,
2553,GO:0005344,1,0.957442011949103,0,13,oxygen carrier activity,MF,
2554,GO:0005345,1,0.970309717714708,0,5,purine nucleobase transmembrane transporter activity,MF,
2555,GO:0005346,1,0.933220645248138,0,11,purine ribonucleotide transmembrane transporter activity,MF,
2556,GO:0005347,1,0.949784728879802,0,8,ATP transmembrane transporter activity,MF,
2557,GO:0005350,1,0.981556516002149,0,3,pyrimidine nucleobase transmembrane transporter activity,MF,
2558,GO:0005351,1,0.932024894308644,0,10,carbohydrate:proton symporter activity,MF,
2559,GO:0005353,1,0.993903156509167,0,1,fructose transmembrane transporter activity,MF,
2560,GO:0005355,1,0.887418220703491,0,18,glucose transmembrane transporter activity,MF,
2561,GO:0005362,1,0.986664865278937,0,2,low-affinity glucose:sodium symporter activity,MF,
2562,GO:0005365,1,0.979314226886978,0,2,myo-inositol transmembrane transporter activity,MF,
2563,GO:0005366,1,0.990903451286658,0,1,myo-inositol:proton symporter activity,MF,
2564,GO:0005367,1,0.988305445878141,0,1,myo-inositol:sodium symporter activity,MF,
2565,GO:0005368,1,0.991204610937364,0,1,taurine transmembrane transporter activity,MF,
2566,GO:0005369,1,0.991204610937364,0,1,taurine:sodium symporter activity,MF,
2567,GO:0005372,1,0.937609729804634,0,11,water transmembrane transporter activity,MF,
2568,GO:0005375,1,0.959788884659165,0,6,copper ion transmembrane transporter activity,MF,
2569,GO:0005381,1,0.936755869425909,0,10,iron ion transmembrane transporter activity,MF,
2570,GO:0005384,1,0.956311914269986,0,6,manganese ion transmembrane transporter activity,MF,
2572,GO:0005388,1,0.888550633623328,0,14,calcium-transporting ATPase activity,MF,
2573,GO:0005391,1,0.930477319389517,0,11,sodium:potassium-exchanging ATPase activity,MF,
2574,GO:0005395,1,0.99068530464727,0,1,eye pigment precursor transporter activity,MF,
2575,GO:0005402,1,0.893610353200683,0,16,carbohydrate:cation symporter activity,MF,
2576,GO:0005412,1,0.967592767525548,0,5,glucose:sodium symporter activity,MF,
2577,GO:0005415,1,0.988686162986857,0,2,nucleoside:sodium symporter activity,MF,
2579,GO:0005427,1,0.992506510678346,0,1,proton-dependent oligopeptide secondary active transmembrane transporter activity,MF,
2580,GO:0005432,1,0.957667251103132,0,6,calcium:sodium antiporter activity,MF,
2582,GO:0005451,1,0.908344064982009,0,13,monovalent cation:proton antiporter activity,MF,
2583,GO:0005452,1,0.842415563836645,0,24,inorganic anion exchanger activity,MF,
2584,GO:0005456,1,0.995075918256662,0,1,CMP-N-acetylneuraminate transmembrane transporter activity,MF,
2585,GO:0005457,1,0.983736367541626,0,2,GDP-fucose transmembrane transporter activity,MF,
2586,GO:0005459,1,0.991787624528082,0,2,UDP-galactose transmembrane transporter activity,MF,
2587,GO:0005461,1,0.991232244299252,0,1,UDP-glucuronic acid transmembrane transporter activity,MF,
2588,GO:0005462,1,0.985348369185324,0,2,UDP-N-acetylglucosamine transmembrane transporter activity,MF,
2589,GO:0005464,1,0.99101698094818,0,1,UDP-xylose transmembrane transporter activity,MF,
2590,GO:0005471,1,0.988543995876443,0,2,ATP:ADP antiporter activity,MF,
2591,GO:0005476,1,0.983496819842399,0,3,carnitine:acyl carnitine antiporter activity,MF,
2592,GO:0005477,1,0.992533895554766,0,1,pyruvate secondary active transmembrane transporter activity,MF,
2593,GO:0005483,1,0.980119688026806,0,3,soluble NSF attachment protein activity,MF,
2594,GO:0005484,1,0.807472584027306,0,36,SNAP receptor activity,MF,
2597,GO:0005497,1,0.981149500119385,0,4,androgen binding,MF,
2598,GO:0005499,1,0.972621921928707,0,4,vitamin D binding,MF,
2599,GO:0005501,1,0.879191045728541,0,23,retinoid binding,MF,
2600,GO:0005502,1,0.974563760957691,0,4,11-cis retinal binding,MF,
2601,GO:0005503,1,0.986992462677702,0,2,all-trans retinal binding,MF,
2602,GO:0005504,1,0.88876885375165,0,24,fatty acid binding,MF,
2604,GO:0005507,1,0.754858727668384,0,49,copper ion binding,MF,
2606,GO:0005513,1,0.923126712260585,0,12,detection of calcium ion,BP,
2610,GO:0005519,1,0.992477024759575,0,1,cytoskeletal regulatory protein binding,MF,
2611,GO:0005520,1,0.828035152603058,0,29,insulin-like growth factor binding,MF,
2612,GO:0005521,1,0.895520101316883,0,15,lamin binding,MF,
2613,GO:0005522,1,0.921348006568557,0,10,profilin binding,MF,
2614,GO:0005523,1,0.928086194798822,0,13,tropomyosin binding,MF,
2617,GO:0005527,1,0.93169989914515,0,13,macrolide binding,MF,
2618,GO:0005528,1,0.93169989914515,0,13,FK506 binding,MF,
2619,GO:0005534,1,0.969950498906256,0,5,galactose binding,MF,
2620,GO:0005536,1,0.925227850802068,0,11,glucose binding,MF,
2621,GO:0005537,1,0.918163011377393,0,14,mannose binding,MF,
2624,GO:0005542,1,0.952705095890976,0,10,folic acid binding,MF,
2626,GO:0005544,1,0.724473313565834,0,47,calcium-dependent phospholipid binding,MF,
2631,GO:0005549,1,0.994075285165274,0,2,odorant binding,MF,
2634,GO:0005577,1,0.95388449933493,0,7,fibrinogen complex,CC,
2636,GO:0005579,1,0.970340310677067,0,4,membrane attack complex,CC,
2638,GO:0005582,1,0.991946311622715,0,1,collagen type XV trimer,CC,
2639,GO:0005583,1,0.904953960705545,0,12,fibrillar collagen trimer,CC,
2640,GO:0005584,1,0.98346490289956,0,2,collagen type I trimer,CC,
2641,GO:0005585,1,0.992103760510146,0,1,collagen type II trimer,CC,
2642,GO:0005586,1,0.991809941438191,0,1,collagen type III trimer,CC,
2643,GO:0005587,1,0.945464044401363,0,6,collagen type IV trimer,CC,
2644,GO:0005588,1,0.972565413380832,0,3,collagen type V trimer,CC,
2645,GO:0005589,1,0.978231657509789,0,3,collagen type VI trimer,CC,
2646,GO:0005590,1,0.989567140448524,0,1,collagen type VII trimer,CC,
2647,GO:0005591,1,0.993305375845177,0,1,collagen type VIII trimer,CC,
2648,GO:0005592,1,0.982229487984525,0,2,collagen type XI trimer,CC,
2651,GO:0005595,1,0.989226690185669,0,1,collagen type XII trimer,CC,
2652,GO:0005596,1,0.991215046276751,0,1,collagen type XIV trimer,CC,
2653,GO:0005597,1,0.991739391090166,0,1,collagen type XVI trimer,CC,
2654,GO:0005598,1,0.993305375845177,0,1,short-chain collagen trimer,CC,
2655,GO:0005600,1,0.99275736229216,0,1,collagen type XIII trimer,CC,
2656,GO:0005602,1,0.993502694690183,0,2,complement component C1 complex,CC,
2658,GO:0005605,1,0.841579142868746,0,20,basal lamina,CC,
2659,GO:0005606,1,0.971633531259353,0,3,laminin-1 complex,CC,
2660,GO:0005607,1,0.983738789244134,0,2,laminin-2 complex,CC,
2661,GO:0005608,1,0.981116334000544,0,2,laminin-3 complex,CC,
2662,GO:0005610,1,0.971371815714706,0,3,laminin-5 complex,CC,
2669,GO:0005637,1,0.714103606903478,0,50,nuclear inner membrane,CC,
2670,GO:0005638,1,0.973531975524877,0,4,lamin filament,CC,
2671,GO:0005639,1,0.911147852004119,0,14,integral component of nuclear inner membrane,CC,
2672,GO:0005640,1,0.863899095876451,0,20,nuclear outer membrane,CC,
2673,GO:0005641,1,0.941013821763959,0,8,nuclear envelope lumen,CC,
2674,GO:0005642,1,0.961636445813848,0,5,annulate lamellae,CC,
2676,GO:0005652,1,0.939581197416183,0,9,nuclear lamina,CC,
2678,GO:0005655,1,0.964184959296201,0,8,nucleolar ribonuclease P complex,CC,
2679,GO:0005656,1,0.983637094796707,0,3,nuclear pre-replicative complex,CC,
2680,GO:0005657,1,0.647068863277886,0,67,replication fork,CC,
2681,GO:0005658,1,0.961179316816398,0,6,alpha DNA polymerase:primase complex,CC,
2682,GO:0005662,1,0.914235870109564,0,14,DNA replication factor A complex,CC,
2683,GO:0005663,1,0.96913117430275,0,6,DNA replication factor C complex,CC,
2684,GO:0005664,1,0.939493420086757,0,9,nuclear origin of replication recognition complex,CC,
2685,GO:0005665,1,0.905053676470202,0,18,DNA-directed RNA polymerase II, core complex,CC,
2686,GO:0005666,1,0.912510532680037,0,17,DNA-directed RNA polymerase III complex,CC,
2688,GO:0005668,1,0.990263666879887,0,2,RNA polymerase transcription factor SL1 complex,CC,
2689,GO:0005669,1,0.804603782535232,0,36,transcription factor TFIID complex,CC,
2690,GO:0005671,1,0.91357658063101,0,13,Ada2/Gcn5/Ada3 transcription activator complex,CC,
2691,GO:0005672,1,0.978225785808837,0,5,transcription factor TFIIA complex,CC,
2692,GO:0005673,1,0.988525828514096,0,2,transcription factor TFIIE complex,CC,
2693,GO:0005674,1,0.989355478334094,0,2,transcription factor TFIIF complex,CC,
2694,GO:0005675,1,0.934924411503065,0,12,holo TFIIH complex,CC,
2695,GO:0005677,1,0.940773802481901,0,8,chromatin silencing complex,CC,
2696,GO:0005680,1,0.885492167556208,0,21,anaphase-promoting complex,CC,
2697,GO:0005681,1,0.327579197067474,0,180,spliceosomal complex,CC,
2698,GO:0005682,1,0.866655397956871,0,22,U5 snRNP,CC,
2699,GO:0005683,1,0.974492117618404,0,7,U7 snRNP,CC,
2700,GO:0005684,1,0.719306821677981,0,57,U2-type spliceosomal complex,CC,
2701,GO:0005685,1,0.898537383969731,0,20,U1 snRNP,CC,
2702,GO:0005686,1,0.902861634701424,0,20,U2 snRNP,CC,
2703,GO:0005687,1,0.948235304799628,0,11,U4 snRNP,CC,
2704,GO:0005688,1,0.966987562504952,0,8,U6 snRNP,CC,
2705,GO:0005689,1,0.882809635827126,0,26,U12-type spliceosomal complex,CC,
2706,GO:0005690,1,0.994189150138512,0,1,U4atac snRNP,CC,
2707,GO:0005691,1,0.992386913179088,0,1,U6atac snRNP,CC,
2709,GO:0005697,1,0.870299153769633,0,22,telomerase holoenzyme complex,CC,
2710,GO:0005712,1,0.984045603661567,0,2,chiasma,CC,
2711,GO:0005713,1,0.993596861458281,0,1,recombination nodule,CC,
2712,GO:0005715,1,0.993596861458281,0,1,late recombination nodule,CC,
2713,GO:0005719,1,0.869889759862886,0,23,nuclear euchromatin,CC,
2714,GO:0005720,1,0.81187904628029,0,31,nuclear heterochromatin,CC,
2715,GO:0005721,1,0.869867549625465,0,19,pericentric heterochromatin,CC,
2716,GO:0005724,1,0.995486157582346,0,1,nuclear telomeric heterochromatin,CC,
2717,GO:0005726,1,0.968826489341133,0,4,perichromatin fibrils,CC,
2718,GO:0005730,1,0.00310886264001847,0,876,nucleolus,CC,
2719,GO:0005731,1,0.995301076185118,0,1,nucleolus organizer region,CC,
2720,GO:0005732,1,0.9122971656293,0,20,small nucleolar ribonucleoprotein complex,CC,
2721,GO:0005736,1,0.937193234848747,0,12,DNA-directed RNA polymerase I complex,CC,
2726,GO:0005742,1,0.962935679310608,0,8,mitochondrial outer membrane translocase complex,CC,
2727,GO:0005743,1,0.103395210690174,0,435,mitochondrial inner membrane,CC,
2728,GO:0005744,1,0.94131865327316,0,11,mitochondrial inner membrane presequence translocase complex,CC,
2729,GO:0005745,1,0.986066648498724,0,2,m-AAA complex,CC,
2730,GO:0005746,1,0.757424030235047,0,76,mitochondrial respiratory chain,CC,
2731,GO:0005747,1,0.86478980049352,0,43,mitochondrial respiratory chain complex I,CC,
2732,GO:0005749,1,0.979732084600258,0,4,mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone),CC,
2733,GO:0005750,1,0.949036463383635,0,11,mitochondrial respiratory chain complex III,CC,
2734,GO:0005751,1,0.965472630030754,0,13,mitochondrial respiratory chain complex IV,CC,
2735,GO:0005753,1,0.994180073855839,0,1,mitochondrial proton-transporting ATP synthase complex,CC,
2736,GO:0005757,1,0.979887503624192,0,4,mitochondrial permeability transition pore complex,CC,
2737,GO:0005758,1,0.698728856673865,0,68,mitochondrial intermembrane space,CC,
2738,GO:0005759,1,0.094313232857337,0,420,mitochondrial matrix,CC,
2739,GO:0005760,1,0.984791016143054,0,2,gamma DNA polymerase complex,CC,
2740,GO:0005761,1,0.723898818028457,0,82,mitochondrial ribosome,CC,
2741,GO:0005762,1,0.821122096623723,0,50,mitochondrial large ribosomal subunit,CC,
2742,GO:0005763,1,0.900074087583783,0,27,mitochondrial small ribosomal subunit,CC,
2745,GO:0005766,1,0.425032799300614,0,140,primary lysosome,CC,
2746,GO:0005767,1,0.927544564251545,0,13,secondary lysosome,CC,
2754,GO:0005776,1,0.556115481862734,0,86,autophagosome,CC,
2756,GO:0005778,1,0.690924356897003,0,57,peroxisomal membrane,CC,
2757,GO:0005779,1,0.908145516021793,0,17,integral component of peroxisomal membrane,CC,
2758,GO:0005782,1,0.790834983499225,0,41,peroxisomal matrix,CC,
2760,GO:0005784,1,0.985284670280573,0,4,Sec61 translocon complex,CC,
2762,GO:0005786,1,0.969854923497145,0,6,signal recognition particle, endoplasmic reticulum targeting,CC,
2763,GO:0005787,1,0.975837106520592,0,5,signal peptidase complex,CC,
2766,GO:0005790,1,0.797970197801912,0,31,smooth endoplasmic reticulum,CC,
2768,GO:0005793,1,0.473284386911389,0,113,endoplasmic reticulum-Golgi intermediate compartment,CC,
2770,GO:0005795,1,0.408353034079695,0,129,Golgi stack,CC,
2772,GO:0005797,1,0.953792657862982,0,8,Golgi medial cisterna,CC,
2774,GO:0005801,1,0.69051525007668,0,53,cis-Golgi network,CC,
2776,GO:0005811,1,0.626474904854698,0,71,lipid droplet,CC,
2777,GO:0005813,1,0.0374296270831983,0,464,centrosome,CC,
2778,GO:0005814,1,0.426942886398986,0,117,centriole,CC,
2779,GO:0005815,1,0.00922998862272494,0,655,microtubule organizing center,CC,
2780,GO:0005816,1,0.956302931110505,0,6,spindle pole body,CC,
2781,GO:0005818,1,0.94031511259877,0,8,aster,CC,
2782,GO:0005819,1,0.117643322043848,0,304,spindle,CC,
2783,GO:0005826,1,0.962983468642449,0,5,actomyosin contractile ring,CC,
2784,GO:0005827,1,0.964522109854488,0,5,polar microtubule,CC,
2785,GO:0005828,1,0.942559817003233,0,7,kinetochore microtubule,CC,
2787,GO:0005832,1,0.932313183045713,0,11,chaperonin-containing T-complex,CC,
2788,GO:0005833,1,0.970479337338021,0,11,hemoglobin complex,CC,
2790,GO:0005838,1,0.902307945111359,0,21,proteasome regulatory particle,CC,
2791,GO:0005839,1,0.926854572601127,0,19,proteasome core complex,CC,
2793,GO:0005844,1,0.6927560592385,0,69,polysome,CC,
2794,GO:0005845,1,0.932814425693972,0,11,mRNA cap binding complex,CC,
2795,GO:0005846,1,0.986365062201739,0,2,nuclear cap binding complex,CC,
2796,GO:0005847,1,0.895502753810524,0,16,mRNA cleavage and polyadenylation specificity factor complex,CC,
2797,GO:0005849,1,0.883708050575974,0,18,mRNA cleavage factor complex,CC,
2798,GO:0005850,1,0.971158896197516,0,4,eukaryotic translation initiation factor 2 complex,CC,
2799,GO:0005851,1,0.966780998209903,0,6,eukaryotic translation initiation factor 2B complex,CC,
2800,GO:0005852,1,0.911490240970539,0,17,eukaryotic translation initiation factor 3 complex,CC,
2801,GO:0005853,1,0.980776474537056,0,4,eukaryotic translation elongation factor 1 complex,CC,
2802,GO:0005854,1,0.988945388635345,0,2,nascent polypeptide-associated complex,CC,
2804,GO:0005858,1,0.851927651313049,0,17,axonemal dynein complex,CC,
2805,GO:0005859,1,0.858086566908459,0,21,muscle myosin complex,CC,
2806,GO:0005861,1,0.979870807834441,0,7,troponin complex,CC,
2807,GO:0005862,1,0.97742388854338,0,4,muscle thin filament tropomyosin,CC,
2808,GO:0005863,1,0.97679938431406,0,3,striated muscle myosin thick filament,CC,
2809,GO:0005865,1,0.83010200455495,0,29,striated muscle thin filament,CC,
2810,GO:0005868,1,0.868493504312813,0,22,cytoplasmic dynein complex,CC,
2811,GO:0005869,1,0.955618352955032,0,8,dynactin complex,CC,
2812,GO:0005871,1,0.675702980704468,0,50,kinesin complex,CC,
2813,GO:0005873,1,0.983712848736176,0,2,plus-end kinesin complex,CC,
2816,GO:0005876,1,0.665775232491458,0,57,spindle microtubule,CC,
2817,GO:0005879,1,0.970634295993363,0,4,axonemal microtubule,CC,
2818,GO:0005880,1,0.995893404988176,0,1,nuclear microtubule,CC,
2819,GO:0005881,1,0.684052432523254,0,54,cytoplasmic microtubule,CC,
2821,GO:0005883,1,0.944324791430362,0,7,neurofilament,CC,
2823,GO:0005885,1,0.949223269850276,0,11,Arp2/3 protein complex,CC,
2826,GO:0005889,1,0.985107153518313,0,2,potassium:proton exchanging ATPase complex,CC,
2827,GO:0005890,1,0.942531499894803,0,10,sodium:potassium-exchanging ATPase complex,CC,
2829,GO:0005892,1,0.901106981005522,0,16,acetylcholine-gated channel complex,CC,
2830,GO:0005895,1,0.994246131515409,0,1,interleukin-5 receptor complex,CC,
2831,GO:0005896,1,0.981721851717779,0,3,interleukin-6 receptor complex,CC,
2832,GO:0005898,1,0.992472667499475,0,1,interleukin-13 receptor complex,CC,
2833,GO:0005899,1,0.971383484562171,0,3,insulin receptor complex,CC,
2834,GO:0005900,1,0.985231771029273,0,2,oncostatin-M receptor complex,CC,
2842,GO:0005914,1,0.99259143139985,0,1,spot adherens junction,CC,
2843,GO:0005915,1,0.947273722204114,0,7,zonula adherens,CC,
2850,GO:0005927,1,0.984732367027189,0,3,muscle tendon junction,CC,
2852,GO:0005930,1,0.472554166702242,0,99,axoneme,CC,
2854,GO:0005940,1,0.919686549592876,0,12,septin ring,CC,
2855,GO:0005942,1,0.868577144550755,0,18,phosphatidylinositol 3-kinase complex,CC,
2856,GO:0005943,1,0.984206669027068,0,2,phosphatidylinositol 3-kinase complex, class IA,CC,
2857,GO:0005944,1,0.984323366504425,0,2,phosphatidylinositol 3-kinase complex, class IB,CC,
2858,GO:0005945,1,0.985381855655301,0,2,6-phosphofructokinase complex,CC,
2859,GO:0005947,1,0.968074431180735,0,5,mitochondrial alpha-ketoglutarate dehydrogenase complex,CC,
2860,GO:0005952,1,0.958773480499087,0,6,cAMP-dependent protein kinase complex,CC,
2861,GO:0005953,1,0.98873439560513,0,2,CAAX-protein geranylgeranyltransferase complex,CC,
2862,GO:0005954,1,0.99358112000882,0,1,calcium- and calmodulin-dependent protein kinase complex,CC,
2863,GO:0005955,1,0.967253138184353,0,4,calcineurin complex,CC,
2864,GO:0005956,1,0.989778862626953,0,2,protein kinase CK2 complex,CC,
2865,GO:0005958,1,0.975376983967751,0,3,DNA-dependent protein kinase-DNA ligase 4 complex,CC,
2866,GO:0005960,1,0.988312829208835,0,2,glycine cleavage complex,CC,
2868,GO:0005965,1,0.98860084101475,0,2,protein farnesyltransferase complex,CC,
2869,GO:0005967,1,0.978821618803897,0,3,mitochondrial pyruvate dehydrogenase complex,CC,
2870,GO:0005968,1,0.97381084738676,0,4,Rab-protein geranylgeranyltransferase complex,CC,
2871,GO:0005969,1,0.990294247195984,0,1,serine-pyruvate aminotransferase complex,CC,
2872,GO:0005971,1,0.977575275840088,0,3,ribonucleoside-diphosphate reductase complex,CC,
2877,GO:0005979,1,0.830693227207232,0,23,regulation of glycogen biosynthetic process,BP,
2879,GO:0005981,1,0.97297170123469,0,4,regulation of glycogen catabolic process,BP,
2880,GO:0005982,1,0.991196020711257,0,1,starch metabolic process,BP,
2881,GO:0005983,1,0.991196020711257,0,1,starch catabolic process,BP,
2882,GO:0005984,1,0.942668106458549,0,9,disaccharide metabolic process,BP,
2883,GO:0005985,1,0.988263324194662,0,2,sucrose metabolic process,BP,
2884,GO:0005986,1,0.995709824540287,0,1,sucrose biosynthetic process,BP,
2885,GO:0005988,1,0.982506626983712,0,3,lactose metabolic process,BP,
2886,GO:0005989,1,0.982506626983712,0,3,lactose biosynthetic process,BP,
2887,GO:0005991,1,0.992851164494148,0,1,trehalose metabolic process,BP,
2889,GO:0005997,1,0.980630685422215,0,4,xylulose metabolic process,BP,
2890,GO:0005998,1,0.992508322050937,0,1,xylulose catabolic process,BP,
2891,GO:0005999,1,0.9907625069066,0,2,xylulose biosynthetic process,BP,
2892,GO:0006000,1,0.925549267083863,0,13,fructose metabolic process,BP,
2893,GO:0006001,1,0.974648699192126,0,4,fructose catabolic process,BP,
2894,GO:0006002,1,0.94969938126758,0,8,fructose 6-phosphate metabolic process,BP,
2895,GO:0006003,1,0.972404329322113,0,4,fructose 2,6-bisphosphate metabolic process,BP,
2896,GO:0006004,1,0.90225459104752,0,14,fucose metabolic process,BP,
2898,GO:0006007,1,0.841549554840389,0,28,glucose catabolic process,BP,
2899,GO:0006011,1,0.958841815565985,0,6,UDP-glucose metabolic process,BP,
2900,GO:0006012,1,0.912319279879362,0,14,galactose metabolic process,BP,
2901,GO:0006013,1,0.947627189594957,0,8,mannose metabolic process,BP,
2902,GO:0006014,1,0.987978671013313,0,3,D-ribose metabolic process,BP,
2903,GO:0006015,1,0.980881291812425,0,3,5-phosphoribose 1-diphosphate biosynthetic process,BP,
2904,GO:0006020,1,0.919910314612613,0,11,inositol metabolic process,BP,
2905,GO:0006021,1,0.97342560764262,0,4,inositol biosynthetic process,BP,
2911,GO:0006029,1,0.540273654706237,0,83,proteoglycan metabolic process,BP,
2912,GO:0006030,1,0.964669204964465,0,6,chitin metabolic process,BP,
2913,GO:0006032,1,0.964669204964465,0,6,chitin catabolic process,BP,
2914,GO:0006040,1,0.793199350462533,0,36,amino sugar metabolic process,BP,
2915,GO:0006041,1,0.976118150499206,0,4,glucosamine metabolic process,BP,
2916,GO:0006043,1,0.988817705151071,0,2,glucosamine catabolic process,BP,
2917,GO:0006044,1,0.904160257739108,0,15,N-acetylglucosamine metabolic process,BP,
2918,GO:0006045,1,0.984508579767,0,2,N-acetylglucosamine biosynthetic process,BP,
2919,GO:0006046,1,0.983897895548284,0,3,N-acetylglucosamine catabolic process,BP,
2920,GO:0006047,1,0.909048887623364,0,15,UDP-N-acetylglucosamine metabolic process,BP,
2921,GO:0006048,1,0.933641786645833,0,11,UDP-N-acetylglucosamine biosynthetic process,BP,
2922,GO:0006049,1,0.992888978804726,0,1,UDP-N-acetylglucosamine catabolic process,BP,
2923,GO:0006050,1,0.991497882016803,0,2,mannosamine metabolic process,BP,
2924,GO:0006051,1,0.991497882016803,0,2,N-acetylmannosamine metabolic process,BP,
2925,GO:0006054,1,0.935959925701495,0,11,N-acetylneuraminate metabolic process,BP,
2926,GO:0006055,1,0.996375636404581,0,1,CMP-N-acetylneuraminate biosynthetic process,BP,
2927,GO:0006056,1,0.99517012130739,0,1,mannoprotein metabolic process,BP,
2928,GO:0006057,1,0.99517012130739,0,1,mannoprotein biosynthetic process,BP,
2929,GO:0006059,1,0.985670309527932,0,3,hexitol metabolic process,BP,
2930,GO:0006060,1,0.9895240394409,0,2,sorbitol metabolic process,BP,
2931,GO:0006061,1,0.996017221888988,0,1,sorbitol biosynthetic process,BP,
2932,GO:0006062,1,0.993481113080797,0,1,sorbitol catabolic process,BP,
2933,GO:0006063,1,0.955322624314069,0,8,uronic acid metabolic process,BP,
2934,GO:0006064,1,0.975131983747371,0,5,glucuronate catabolic process,BP,
2935,GO:0006065,1,0.978348090136128,0,3,UDP-glucuronate biosynthetic process,BP,
2936,GO:0006066,1,0.155647198992441,0,281,alcohol metabolic process,BP,
2937,GO:0006067,1,0.918860751313894,0,15,ethanol metabolic process,BP,
2938,GO:0006068,1,0.955813638102864,0,9,ethanol catabolic process,BP,
2939,GO:0006069,1,0.948431181839304,0,8,ethanol oxidation,BP,
2940,GO:0006071,1,0.924550100743006,0,12,glycerol metabolic process,BP,
2941,GO:0006072,1,0.937661027444973,0,8,glycerol-3-phosphate metabolic process,BP,
2943,GO:0006081,1,0.658306475807907,0,69,cellular aldehyde metabolic process,BP,
2945,GO:0006083,1,0.977377540803851,0,3,acetate metabolic process,BP,
2946,GO:0006084,1,0.793764018187243,0,34,acetyl-CoA metabolic process,BP,
2947,GO:0006085,1,0.871788558048076,0,19,acetyl-CoA biosynthetic process,BP,
2948,GO:0006086,1,0.902024192073917,0,14,acetyl-CoA biosynthetic process from pyruvate,BP,
2949,GO:0006089,1,0.935810450593897,0,11,lactate metabolic process,BP,
2950,GO:0006090,1,0.42378233825043,0,126,pyruvate metabolic process,BP,
2952,GO:0006094,1,0.662386551764894,0,67,gluconeogenesis,BP,
2953,GO:0006096,1,0.528883470041404,0,92,glycolytic process,BP,
2954,GO:0006097,1,0.989167524863412,0,2,glyoxylate cycle,BP,
2955,GO:0006098,1,0.913899883707707,0,17,pentose-phosphate shunt,BP,
2956,GO:0006099,1,0.842310954393319,0,29,tricarboxylic acid cycle,BP,
2957,GO:0006101,1,0.816667840682913,0,33,citrate metabolic process,BP,
2958,GO:0006102,1,0.97382669947313,0,5,isocitrate metabolic process,BP,
2959,GO:0006103,1,0.889051199014348,0,18,2-oxoglutarate metabolic process,BP,
2960,GO:0006104,1,0.965347615487382,0,6,succinyl-CoA metabolic process,BP,
2961,GO:0006105,1,0.9324092169308,0,11,succinate metabolic process,BP,
2962,GO:0006106,1,0.98318325254458,0,3,fumarate metabolic process,BP,
2963,GO:0006107,1,0.930150926805724,0,12,oxaloacetate metabolic process,BP,
2964,GO:0006108,1,0.961160672543878,0,7,malate metabolic process,BP,
2965,GO:0006109,1,0.331123200170459,0,155,regulation of carbohydrate metabolic process,BP,
2966,GO:0006110,1,0.642199614346612,0,61,regulation of glycolytic process,BP,
2967,GO:0006111,1,0.832852661923939,0,26,regulation of gluconeogenesis,BP,
2969,GO:0006114,1,0.967932260309418,0,5,glycerol biosynthetic process,BP,
2970,GO:0006116,1,0.973161604608355,0,4,NADH oxidation,BP,
2971,GO:0006117,1,0.993389871031089,0,1,acetaldehyde metabolic process,BP,
2972,GO:0006119,1,0.653975284415081,0,98,oxidative phosphorylation,BP,
2973,GO:0006120,1,0.85860964481943,0,44,mitochondrial electron transport, NADH to ubiquinone,BP,
2974,GO:0006121,1,0.979604674076419,0,4,mitochondrial electron transport, succinate to ubiquinone,BP,
2975,GO:0006122,1,0.933790981482412,0,13,mitochondrial electron transport, ubiquinol to cytochrome c,BP,
2976,GO:0006123,1,0.946761611549163,0,16,mitochondrial electron transport, cytochrome c to oxygen,BP,
2977,GO:0006127,1,0.984564405021272,0,2,glycerophosphate shuttle,BP,
2980,GO:0006144,1,0.872281030646481,0,22,purine nucleobase metabolic process,BP,
2981,GO:0006145,1,0.968764904501759,0,4,purine nucleobase catabolic process,BP,
2982,GO:0006147,1,0.991869782709611,0,1,guanine catabolic process,BP,
2983,GO:0006148,1,0.99370748335756,0,1,inosine catabolic process,BP,
2984,GO:0006152,1,0.965550162090553,0,6,purine nucleoside catabolic process,BP,
2985,GO:0006154,1,0.989147587267463,0,2,adenosine catabolic process,BP,
2986,GO:0006157,1,0.99571435540411,0,1,deoxyadenosine catabolic process,BP,
2989,GO:0006165,1,0.481769895896039,0,109,nucleoside diphosphate phosphorylation,BP,
2990,GO:0006166,1,0.975133802678068,0,5,purine ribonucleoside salvage,BP,
2991,GO:0006167,1,0.969852116895822,0,6,AMP biosynthetic process,BP,
2992,GO:0006168,1,0.988270266267504,0,3,adenine salvage,BP,
2993,GO:0006169,1,0.994505878229905,0,1,adenosine salvage,BP,
2994,GO:0006171,1,0.698250754989745,0,54,cAMP biosynthetic process,BP,
2995,GO:0006172,1,0.9865490104089,0,2,ADP biosynthetic process,BP,
2996,GO:0006173,1,0.992523008914138,0,1,dADP biosynthetic process,BP,
2997,GO:0006174,1,0.993058458973322,0,1,dADP phosphorylation,BP,
2998,GO:0006175,1,0.994505878229905,0,1,dATP biosynthetic process,BP,
2999,GO:0006177,1,0.973537361723135,0,5,GMP biosynthetic process,BP,
3000,GO:0006178,1,0.99080784512918,0,2,guanine salvage,BP,
3002,GO:0006183,1,0.959407947369732,0,10,GTP biosynthetic process,BP,
3003,GO:0006185,1,0.996911935398822,0,1,dGDP biosynthetic process,BP,
3004,GO:0006186,1,0.993058458973322,0,1,dGDP phosphorylation,BP,
3005,GO:0006188,1,0.937291636263525,0,10,IMP biosynthetic process,BP,
3006,GO:0006189,1,0.960444696843415,0,6,'de novo' IMP biosynthetic process,BP,
3007,GO:0006193,1,0.996676726459821,0,1,ITP catabolic process,BP,
3008,GO:0006195,1,0.749646952996468,0,44,purine nucleotide catabolic process,BP,
3009,GO:0006196,1,0.984921514096571,0,2,AMP catabolic process,BP,
3010,GO:0006198,1,0.873379871181793,0,17,cAMP catabolic process,BP,
3011,GO:0006203,1,0.984810241234134,0,3,dGTP catabolic process,BP,
3012,GO:0006206,1,0.892434698371768,0,18,pyrimidine nucleobase metabolic process,BP,
3013,GO:0006207,1,0.953934589569301,0,6,'de novo' pyrimidine nucleobase biosynthetic process,BP,
3014,GO:0006208,1,0.98136574240707,0,3,pyrimidine nucleobase catabolic process,BP,
3015,GO:0006210,1,0.98136574240707,0,3,thymine catabolic process,BP,
3016,GO:0006211,1,0.96783466424811,0,3,5-methylcytosine catabolic process,BP,
3017,GO:0006212,1,0.987086590412537,0,2,uracil catabolic process,BP,
3018,GO:0006213,1,0.794743953583472,0,43,pyrimidine nucleoside metabolic process,BP,
3019,GO:0006214,1,0.992707573339815,0,1,thymidine catabolic process,BP,
3020,GO:0006216,1,0.960826257666516,0,8,cytidine catabolic process,BP,
3021,GO:0006218,1,0.99508299905701,0,1,uridine catabolic process,BP,
3022,GO:0006220,1,0.789612546907698,0,45,pyrimidine nucleotide metabolic process,BP,
3023,GO:0006221,1,0.850612698423695,0,31,pyrimidine nucleotide biosynthetic process,BP,
3024,GO:0006222,1,0.941067007782844,0,10,UMP biosynthetic process,BP,
3025,GO:0006226,1,0.985109936173045,0,3,dUMP biosynthetic process,BP,
3026,GO:0006227,1,0.989444287114099,0,2,dUDP biosynthetic process,BP,
3027,GO:0006228,1,0.961274193848696,0,9,UTP biosynthetic process,BP,
3028,GO:0006231,1,0.983873247367248,0,3,dTMP biosynthetic process,BP,
3029,GO:0006233,1,0.989444287114099,0,2,dTDP biosynthetic process,BP,
3030,GO:0006235,1,0.981356609166164,0,4,dTTP biosynthetic process,BP,
3031,GO:0006238,1,0.99636257431311,0,1,CMP salvage,BP,
3032,GO:0006241,1,0.942592132087875,0,13,CTP biosynthetic process,BP,
3033,GO:0006244,1,0.93618537437668,0,13,pyrimidine nucleotide catabolic process,BP,
3034,GO:0006253,1,0.996643509555738,0,1,dCTP catabolic process,BP,
3035,GO:0006256,1,0.992877134307693,0,1,UDP catabolic process,BP,
3036,GO:0006258,1,0.99038814110796,0,2,UDP-glucose catabolic process,BP,
3039,GO:0006261,1,0.390279852881311,0,141,DNA-dependent DNA replication,BP,
3040,GO:0006264,1,0.932541236094476,0,10,mitochondrial DNA replication,BP,
3041,GO:0006265,1,0.93939929765531,0,9,DNA topological change,BP,
3042,GO:0006266,1,0.871997528215742,0,23,DNA ligation,BP,
3043,GO:0006267,1,0.983637094796707,0,3,pre-replicative complex assembly involved in nuclear cell cycle DNA replication,BP,
3044,GO:0006268,1,0.953598102480451,0,7,DNA unwinding involved in DNA replication,BP,
3045,GO:0006269,1,0.967753747610137,0,5,DNA replication, synthesis of RNA primer,BP,
3046,GO:0006270,1,0.759540650088741,0,42,DNA replication initiation,BP,
3047,GO:0006271,1,0.88440875053707,0,20,DNA strand elongation involved in DNA replication,BP,
3048,GO:0006272,1,0.978536021646637,0,3,leading strand elongation,BP,
3049,GO:0006273,1,0.931539640180208,0,11,lagging strand elongation,BP,
3051,GO:0006278,1,0.630790687850949,0,67,RNA-dependent DNA biosynthetic process,BP,
3054,GO:0006283,1,0.658364102937099,0,73,transcription-coupled nucleotide-excision repair,BP,
3055,GO:0006284,1,0.773279664715189,0,41,base-excision repair,BP,
3056,GO:0006285,1,0.950032470535268,0,10,base-excision repair, AP site formation,BP,
3057,GO:0006286,1,0.992150300475389,0,2,base-excision repair, base-free sugar-phosphate removal,BP,
3058,GO:0006287,1,0.965435996953233,0,5,base-excision repair, gap-filling,BP,
3059,GO:0006288,1,0.983344687042798,0,3,base-excision repair, DNA ligation,BP,
3060,GO:0006289,1,0.511373097061681,0,112,nucleotide-excision repair,BP,
3061,GO:0006290,1,0.95448542633445,0,7,pyrimidine dimer repair,BP,
3062,GO:0006293,1,0.874371489379686,0,21,nucleotide-excision repair, preincision complex stabilization,BP,
3063,GO:0006294,1,0.845738363623037,0,29,nucleotide-excision repair, preincision complex assembly,BP,
3064,GO:0006295,1,0.874371489379686,0,21,nucleotide-excision repair, DNA incision, 3'-to lesion,BP,
3065,GO:0006296,1,0.803746013197481,0,37,nucleotide-excision repair, DNA incision, 5'-to lesion,BP,
3066,GO:0006297,1,0.873432019784488,0,23,nucleotide-excision repair, DNA gap filling,BP,
3068,GO:0006301,1,0.737899362981273,0,48,postreplication repair,BP,
3069,GO:0006302,1,0.269851284189282,0,189,double-strand break repair,BP,
3070,GO:0006303,1,0.668797427117042,0,58,double-strand break repair via nonhomologous end joining,BP,
3071,GO:0006304,1,0.53987333191068,0,92,DNA modification,BP,
3072,GO:0006305,1,0.676981377571185,0,54,DNA alkylation,BP,
3073,GO:0006306,1,0.676981377571185,0,54,DNA methylation,BP,
3074,GO:0006307,1,0.94471248880082,0,10,DNA dealkylation involved in DNA repair,BP,
3075,GO:0006308,1,0.800994802184292,0,35,DNA catabolic process,BP,
3076,GO:0006309,1,0.882443621070411,0,20,apoptotic DNA fragmentation,BP,
3077,GO:0006310,1,0.202782368983744,0,232,DNA recombination,BP,
3078,GO:0006311,1,0.971583766050639,0,4,meiotic gene conversion,BP,
3079,GO:0006312,1,0.849334698041432,0,23,mitotic recombination,BP,
3080,GO:0006313,1,0.992468780789337,0,1,transposition, DNA-mediated,BP,
3083,GO:0006333,1,0.445957447445888,0,133,chromatin assembly or disassembly,BP,
3084,GO:0006334,1,0.602445230575841,0,91,nucleosome assembly,BP,
3085,GO:0006335,1,0.936135825410846,0,14,DNA replication-dependent nucleosome assembly,BP,
3086,GO:0006336,1,0.793901595450062,0,40,DNA replication-independent nucleosome assembly,BP,
3087,GO:0006337,1,0.88933452268621,0,17,nucleosome disassembly,BP,
3089,GO:0006342,1,0.629005781117574,0,75,chromatin silencing,BP,
3090,GO:0006343,1,0.992492016498709,0,1,establishment of chromatin silencing,BP,
3091,GO:0006344,1,0.967454216709719,0,4,maintenance of chromatin silencing,BP,
3092,GO:0006346,1,0.902056884732437,0,14,methylation-dependent chromatin silencing,BP,
3093,GO:0006348,1,0.954475328766671,0,8,chromatin silencing at telomere,BP,
3094,GO:0006349,1,0.887649010401151,0,16,regulation of gene expression by genetic imprinting,BP,
3096,GO:0006352,1,0.232735116518817,0,223,DNA-templated transcription, initiation,BP,
3097,GO:0006353,1,0.524205653747482,0,107,DNA-templated transcription, termination,BP,
3100,GO:0006356,1,0.81019237560768,0,30,regulation of transcription by RNA polymerase I,BP,
3102,GO:0006359,1,0.825175455408912,0,27,regulation of transcription by RNA polymerase III,BP,
3103,GO:0006360,1,0.680670240865163,0,59,transcription by RNA polymerase I,BP,
3104,GO:0006361,1,0.816698462769023,0,35,transcription initiation from RNA polymerase I promoter,BP,
3105,GO:0006362,1,0.841788741943828,0,30,transcription elongation from RNA polymerase I promoter,BP,
3106,GO:0006363,1,0.843307550976449,0,30,termination of RNA polymerase I transcription,BP,
3107,GO:0006364,1,0.281454465706841,0,249,rRNA processing,BP,
3109,GO:0006367,1,0.31517797898681,0,175,transcription initiation from RNA polymerase II promoter,BP,
3111,GO:0006369,1,0.657970998688578,0,68,termination of RNA polymerase II transcription,BP,
3112,GO:0006370,1,0.83881687524466,0,31,7-methylguanosine mRNA capping,BP,
3113,GO:0006376,1,0.829601498600857,0,27,mRNA splice site selection,BP,
3114,GO:0006378,1,0.758676494873447,0,40,mRNA polyadenylation,BP,
3115,GO:0006379,1,0.844801837975665,0,27,mRNA cleavage,BP,
3116,GO:0006382,1,0.961527586486743,0,5,adenosine to inosine editing,BP,
3117,GO:0006383,1,0.714051698043851,0,53,transcription by RNA polymerase III,BP,
3118,GO:0006384,1,0.948444178426007,0,7,transcription initiation from RNA polymerase III promoter,BP,
3119,GO:0006386,1,0.99732295201018,0,1,termination of RNA polymerase III transcription,BP,
3120,GO:0006388,1,0.931284717583092,0,14,tRNA splicing, via endonucleolytic cleavage and ligation,BP,
3121,GO:0006390,1,0.915545308296015,0,13,mitochondrial transcription,BP,
3122,GO:0006391,1,0.982525688649276,0,3,transcription initiation from mitochondrial promoter,BP,
3123,GO:0006393,1,0.986164624597214,0,2,termination of mitochondrial transcription,BP,
3125,GO:0006397,1,0.0520279991168748,0,455,mRNA processing,BP,
3126,GO:0006398,1,0.96771589642984,0,5,mRNA 3'-end processing by stem-loop binding and cleavage,BP,
3127,GO:0006399,1,0.336895721160215,0,181,tRNA metabolic process,BP,
3128,GO:0006400,1,0.641190115039064,0,73,tRNA modification,BP,
3129,GO:0006401,1,0.125828522882766,0,361,RNA catabolic process,BP,
3130,GO:0006402,1,0.150700879798001,0,332,mRNA catabolic process,BP,
3132,GO:0006404,1,0.981484067154132,0,3,RNA import into nucleus,BP,
3133,GO:0006405,1,0.408561624261308,0,135,RNA export from nucleus,BP,
3134,GO:0006406,1,0.494285970981031,0,104,mRNA export from nucleus,BP,
3135,GO:0006407,1,0.982760262940952,0,3,rRNA export from nucleus,BP,
3136,GO:0006408,1,0.989675612290908,0,2,snRNA export from nucleus,BP,
3137,GO:0006409,1,0.801203394259312,0,31,tRNA export from nucleus,BP,
3139,GO:0006413,1,0.388175876637087,0,191,translational initiation,BP,
3140,GO:0006414,1,0.543865865915942,0,126,translational elongation,BP,
3141,GO:0006415,1,0.644574019090001,0,99,translational termination,BP,
3143,GO:0006418,1,0.736538796861623,0,49,tRNA aminoacylation for protein translation,BP,
3144,GO:0006419,1,0.979815689400248,0,3,alanyl-tRNA aminoacylation,BP,
3145,GO:0006420,1,0.983453331077939,0,3,arginyl-tRNA aminoacylation,BP,
3146,GO:0006421,1,0.979662927595342,0,3,asparaginyl-tRNA aminoacylation,BP,
3147,GO:0006422,1,0.993877355531146,0,1,aspartyl-tRNA aminoacylation,BP,
3148,GO:0006423,1,0.988236279867585,0,2,cysteinyl-tRNA aminoacylation,BP,
3149,GO:0006424,1,0.984640648564896,0,2,glutamyl-tRNA aminoacylation,BP,
3150,GO:0006425,1,0.985871578586392,0,2,glutaminyl-tRNA aminoacylation,BP,
3151,GO:0006426,1,0.988709697401966,0,2,glycyl-tRNA aminoacylation,BP,
3152,GO:0006427,1,0.988279973897723,0,2,histidyl-tRNA aminoacylation,BP,
3153,GO:0006428,1,0.984938318256935,0,2,isoleucyl-tRNA aminoacylation,BP,
3154,GO:0006429,1,0.984675301063122,0,2,leucyl-tRNA aminoacylation,BP,
3155,GO:0006430,1,0.994376359435733,0,1,lysyl-tRNA aminoacylation,BP,
3156,GO:0006431,1,0.985862065419091,0,2,methionyl-tRNA aminoacylation,BP,
3157,GO:0006432,1,0.970435315861068,0,5,phenylalanyl-tRNA aminoacylation,BP,
3158,GO:0006433,1,0.982664399545941,0,3,prolyl-tRNA aminoacylation,BP,
3159,GO:0006434,1,0.989360581464103,0,2,seryl-tRNA aminoacylation,BP,
3160,GO:0006435,1,0.979473084264907,0,3,threonyl-tRNA aminoacylation,BP,
3161,GO:0006436,1,0.986255708736886,0,2,tryptophanyl-tRNA aminoacylation,BP,
3162,GO:0006437,1,0.987014132462881,0,2,tyrosyl-tRNA aminoacylation,BP,
3163,GO:0006438,1,0.977281730039618,0,3,valyl-tRNA aminoacylation,BP,
3164,GO:0006446,1,0.620646440677062,0,74,regulation of translational initiation,BP,
3165,GO:0006447,1,0.97972794524252,0,3,regulation of translational initiation by iron,BP,
3166,GO:0006448,1,0.885649743427067,0,18,regulation of translational elongation,BP,
3167,GO:0006449,1,0.94626685689129,0,8,regulation of translational termination,BP,
3168,GO:0006450,1,0.903525701077553,0,18,regulation of translational fidelity,BP,
3169,GO:0006451,1,0.947316804681385,0,8,translational readthrough,BP,
3170,GO:0006452,1,0.980643179484519,0,3,translational frameshifting,BP,
3171,GO:0006457,1,0.256885941227857,0,225,protein folding,BP,
3172,GO:0006458,1,0.7356130662512,0,48,'de novo' protein folding,BP,
3173,GO:0006463,1,0.992502667515722,0,1,steroid hormone receptor complex assembly,BP,
3175,GO:0006465,1,0.894657511192742,0,20,signal peptide processing,BP,
3177,GO:0006469,1,0.209035399279661,0,236,negative regulation of protein kinase activity,BP,
3179,GO:0006471,1,0.844026700628702,0,26,protein ADP-ribosylation,BP,
3181,GO:0006474,1,0.896354738381918,0,16,N-terminal protein amino acid acetylation,BP,
3183,GO:0006476,1,0.508603223110339,0,95,protein deacetylation,BP,
3184,GO:0006477,1,0.9584272083051,0,6,protein sulfation,BP,
3185,GO:0006478,1,0.989302151778572,0,2,peptidyl-tyrosine sulfation,BP,
3187,GO:0006480,1,0.990102725431807,0,2,N-terminal protein amino acid methylation,BP,
3188,GO:0006481,1,0.981483881106176,0,3,C-terminal protein methylation,BP,
3189,GO:0006482,1,0.791773917916549,0,29,protein demethylation,BP,
3192,GO:0006488,1,0.879604748154756,0,20,dolichol-linked oligosaccharide biosynthetic process,BP,
3193,GO:0006489,1,0.9568349684083,0,7,dolichyl diphosphate biosynthetic process,BP,
3194,GO:0006490,1,0.87385344007095,0,21,oligosaccharide-lipid intermediate biosynthetic process,BP,
3197,GO:0006497,1,0.427745304139991,0,134,protein lipidation,BP,
3198,GO:0006498,1,0.958006741629797,0,6,N-terminal protein lipidation,BP,
3199,GO:0006499,1,0.968253204474494,0,4,N-terminal protein myristoylation,BP,
3200,GO:0006500,1,0.98942097517546,0,2,N-terminal protein palmitoylation,BP,
3201,GO:0006501,1,0.710305703047619,0,55,C-terminal protein lipidation,BP,
3202,GO:0006505,1,0.825761855253597,0,33,GPI anchor metabolic process,BP,
3203,GO:0006506,1,0.834070266650646,0,31,GPI anchor biosynthetic process,BP,
3204,GO:0006507,1,0.993971591098376,0,1,GPI anchor release,BP,
3206,GO:0006509,1,0.764963400345997,0,40,membrane protein ectodomain proteolysis,BP,
3208,GO:0006513,1,0.642694328384271,0,63,protein monoubiquitination,BP,
3209,GO:0006515,1,0.843317698903269,0,25,protein quality control for misfolded or incompletely synthesized proteins,BP,
3210,GO:0006516,1,0.893997943366735,0,17,glycoprotein catabolic process,BP,
3211,GO:0006517,1,0.788456947883642,0,34,protein deglycosylation,BP,
3214,GO:0006521,1,0.770302418450309,0,55,regulation of cellular amino acid metabolic process,BP,
3215,GO:0006522,1,0.978682306157254,0,4,alanine metabolic process,BP,
3216,GO:0006524,1,0.978682306157254,0,4,alanine catabolic process,BP,
3218,GO:0006526,1,0.962689852088301,0,6,arginine biosynthetic process,BP,
3220,GO:0006528,1,0.972830634082492,0,5,asparagine metabolic process,BP,
3221,GO:0006529,1,0.987519775066523,0,2,asparagine biosynthetic process,BP,
3222,GO:0006530,1,0.98878668636561,0,2,asparagine catabolic process,BP,
3223,GO:0006531,1,0.94355581734592,0,10,aspartate metabolic process,BP,
3224,GO:0006532,1,0.987997566129003,0,2,aspartate biosynthetic process,BP,
3225,GO:0006533,1,0.984101596623745,0,3,aspartate catabolic process,BP,
3226,GO:0006534,1,0.921270613338541,0,13,cysteine metabolic process,BP,
3227,GO:0006535,1,0.993347995930623,0,1,cysteine biosynthetic process from serine,BP,
3228,GO:0006536,1,0.816707301458311,0,31,glutamate metabolic process,BP,
3229,GO:0006537,1,0.965125756004882,0,5,glutamate biosynthetic process,BP,
3230,GO:0006538,1,0.942300232581731,0,9,glutamate catabolic process,BP,
3231,GO:0006539,1,0.994867527850545,0,1,glutamate catabolic process via 2-oxoglutarate,BP,
3232,GO:0006540,1,0.97927132333645,0,3,glutamate decarboxylation to succinate,BP,
3233,GO:0006541,1,0.850704428409558,0,23,glutamine metabolic process,BP,
3234,GO:0006542,1,0.98433350185627,0,2,glutamine biosynthetic process,BP,
3235,GO:0006543,1,0.978346493178376,0,3,glutamine catabolic process,BP,
3236,GO:0006544,1,0.941121925064,0,10,glycine metabolic process,BP,
3237,GO:0006545,1,0.983353159776178,0,3,glycine biosynthetic process,BP,
3238,GO:0006546,1,0.982842927620261,0,3,glycine catabolic process,BP,
3239,GO:0006547,1,0.945456427578857,0,9,histidine metabolic process,BP,
3240,GO:0006548,1,0.958482912128252,0,7,histidine catabolic process,BP,
3241,GO:0006549,1,0.967132609319018,0,5,isoleucine metabolic process,BP,
3242,GO:0006550,1,0.989861975479602,0,2,isoleucine catabolic process,BP,
3243,GO:0006551,1,0.949927217056683,0,8,leucine metabolic process,BP,
3244,GO:0006552,1,0.963692861040793,0,6,leucine catabolic process,BP,
3245,GO:0006553,1,0.916619318523881,0,13,lysine metabolic process,BP,
3246,GO:0006554,1,0.923126060819014,0,12,lysine catabolic process,BP,
3247,GO:0006555,1,0.879664074496993,0,20,methionine metabolic process,BP,
3248,GO:0006556,1,0.980142784861333,0,3,S-adenosylmethionine biosynthetic process,BP,
3249,GO:0006557,1,0.992625893017814,0,1,S-adenosylmethioninamine biosynthetic process,BP,
3250,GO:0006558,1,0.950315937288447,0,10,L-phenylalanine metabolic process,BP,
3251,GO:0006559,1,0.950315937288447,0,10,L-phenylalanine catabolic process,BP,
3252,GO:0006560,1,0.960485626146584,0,7,proline metabolic process,BP,
3253,GO:0006561,1,0.977664672114957,0,4,proline biosynthetic process,BP,
3254,GO:0006562,1,0.982432425843181,0,3,proline catabolic process,BP,
3255,GO:0006563,1,0.940192362979239,0,11,L-serine metabolic process,BP,
3256,GO:0006564,1,0.966861163701205,0,6,L-serine biosynthetic process,BP,
3257,GO:0006565,1,0.978715673079497,0,4,L-serine catabolic process,BP,
3258,GO:0006566,1,0.98168429213809,0,4,threonine metabolic process,BP,
3259,GO:0006567,1,0.987247234298895,0,3,threonine catabolic process,BP,
3260,GO:0006568,1,0.951054207710266,0,9,tryptophan metabolic process,BP,
3261,GO:0006569,1,0.965174537778612,0,7,tryptophan catabolic process,BP,
3262,GO:0006570,1,0.959897538225433,0,8,tyrosine metabolic process,BP,
3263,GO:0006572,1,0.970840660550038,0,6,tyrosine catabolic process,BP,
3264,GO:0006573,1,0.941922130233409,0,9,valine metabolic process,BP,
3265,GO:0006574,1,0.978033356620258,0,4,valine catabolic process,BP,
3267,GO:0006576,1,0.768349954078934,0,46,cellular biogenic amine metabolic process,BP,
3268,GO:0006577,1,0.890678308359812,0,17,amino-acid betaine metabolic process,BP,
3269,GO:0006578,1,0.954281618540559,0,7,amino-acid betaine biosynthetic process,BP,
3270,GO:0006579,1,0.979946018477735,0,3,amino-acid betaine catabolic process,BP,
3271,GO:0006580,1,0.993192938376038,0,1,ethanolamine metabolic process,BP,
3272,GO:0006581,1,0.986230156662761,0,2,acetylcholine catabolic process,BP,
3273,GO:0006582,1,0.894580613272421,0,16,melanin metabolic process,BP,
3274,GO:0006583,1,0.9938421337875,0,1,melanin biosynthetic process from tyrosine,BP,
3275,GO:0006584,1,0.737816089988481,0,47,catecholamine metabolic process,BP,
3276,GO:0006585,1,0.994858038873917,0,1,dopamine biosynthetic process from tyrosine,BP,
3277,GO:0006586,1,0.937340105365865,0,12,indolalkylamine metabolic process,BP,
3278,GO:0006589,1,0.985901102134398,0,2,octopamine biosynthetic process,BP,
3279,GO:0006590,1,0.90859092874033,0,13,thyroid hormone generation,BP,
3280,GO:0006591,1,0.950148163570934,0,9,ornithine metabolic process,BP,
3281,GO:0006592,1,0.992549786087151,0,1,ornithine biosynthetic process,BP,
3282,GO:0006593,1,0.995456237995866,0,1,ornithine catabolic process,BP,
3283,GO:0006595,1,0.923983063425225,0,16,polyamine metabolic process,BP,
3284,GO:0006596,1,0.935414107839262,0,13,polyamine biosynthetic process,BP,
3285,GO:0006597,1,0.988018937233579,0,2,spermine biosynthetic process,BP,
3286,GO:0006598,1,0.974460840638268,0,6,polyamine catabolic process,BP,
3287,GO:0006600,1,0.943202268998422,0,10,creatine metabolic process,BP,
3288,GO:0006601,1,0.990271356082909,0,2,creatine biosynthetic process,BP,
3292,GO:0006610,1,0.942694924791438,0,8,ribosomal protein import into nucleus,BP,
3293,GO:0006611,1,0.315323692278501,0,173,protein export from nucleus,BP,
3295,GO:0006613,1,0.723424599944486,0,95,cotranslational protein targeting to membrane,BP,
3296,GO:0006614,1,0.75028289831793,0,90,SRP-dependent cotranslational protein targeting to membrane,BP,
3297,GO:0006616,1,0.973721966462766,0,6,SRP-dependent cotranslational protein targeting to membrane, translocation,BP,
3298,GO:0006617,1,0.991223086027916,0,2,SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition,BP,
3299,GO:0006620,1,0.957074550507155,0,7,posttranslational protein targeting to endoplasmic reticulum membrane,BP,
3300,GO:0006621,1,0.939279380030754,0,10,protein retention in ER lumen,BP,
3301,GO:0006622,1,0.870195594205031,0,19,protein targeting to lysosome,BP,
3302,GO:0006623,1,0.787962370440073,0,31,protein targeting to vacuole,BP,
3303,GO:0006624,1,0.991770166127947,0,2,vacuolar protein processing,BP,
3304,GO:0006625,1,0.892862885078239,0,17,protein targeting to peroxisome,BP,
3305,GO:0006626,1,0.449404268705083,0,135,protein targeting to mitochondrion,BP,
3306,GO:0006627,1,0.956024748828338,0,8,protein processing involved in protein targeting to mitochondrion,BP,
3310,GO:0006635,1,0.641984449279666,0,70,fatty acid beta-oxidation,BP,
3311,GO:0006636,1,0.795269403261729,0,40,unsaturated fatty acid biosynthetic process,BP,
3312,GO:0006637,1,0.56163390942179,0,91,acyl-CoA metabolic process,BP,
3313,GO:0006638,1,0.560271448226199,0,89,neutral lipid metabolic process,BP,
3314,GO:0006639,1,0.564426999662773,0,88,acylglycerol metabolic process,BP,
3315,GO:0006641,1,0.624674440131146,0,74,triglyceride metabolic process,BP,
3316,GO:0006642,1,0.965620497404083,0,4,triglyceride mobilization,BP,
3319,GO:0006646,1,0.909594233394057,0,14,phosphatidylethanolamine biosynthetic process,BP,
3320,GO:0006649,1,0.98344861744874,0,2,phospholipid transfer to membrane,BP,
3322,GO:0006651,1,0.987724518135724,0,2,diacylglycerol biosynthetic process,BP,
3323,GO:0006654,1,0.789766695822042,0,33,phosphatidic acid biosynthetic process,BP,
3324,GO:0006655,1,0.935359289699176,0,10,phosphatidylglycerol biosynthetic process,BP,
3325,GO:0006656,1,0.817586854905994,0,33,phosphatidylcholine biosynthetic process,BP,
3326,GO:0006657,1,0.958922515571555,0,7,CDP-choline pathway,BP,
3327,GO:0006658,1,0.859962764919126,0,24,phosphatidylserine metabolic process,BP,
3328,GO:0006659,1,0.974071391554533,0,4,phosphatidylserine biosynthetic process,BP,
3329,GO:0006660,1,0.995151319772094,0,1,phosphatidylserine catabolic process,BP,
3331,GO:0006662,1,0.935604813295042,0,12,glycerol ether metabolic process,BP,
3332,GO:0006663,1,0.975522907122034,0,4,platelet activating factor biosynthetic process,BP,
3335,GO:0006666,1,0.992009006729881,0,1,3-keto-sphinganine metabolic process,BP,
3336,GO:0006667,1,0.981803631633757,0,3,sphinganine metabolic process,BP,
3337,GO:0006668,1,0.985504089010676,0,2,sphinganine-1-phosphate metabolic process,BP,
3338,GO:0006669,1,0.992844125503495,0,1,sphinganine-1-phosphate biosynthetic process,BP,
3339,GO:0006670,1,0.935038948145908,0,11,sphingosine metabolic process,BP,
3340,GO:0006671,1,0.992384031824099,0,1,phytosphingosine metabolic process,BP,
3343,GO:0006678,1,0.954644646314138,0,7,glucosylceramide metabolic process,BP,
3344,GO:0006679,1,0.987593236183921,0,2,glucosylceramide biosynthetic process,BP,
3345,GO:0006680,1,0.979437875139255,0,3,glucosylceramide catabolic process,BP,
3348,GO:0006683,1,0.992901083054532,0,1,galactosylceramide catabolic process,BP,
3349,GO:0006684,1,0.921887263772394,0,13,sphingomyelin metabolic process,BP,
3350,GO:0006685,1,0.966858044221182,0,5,sphingomyelin catabolic process,BP,
3351,GO:0006686,1,0.962880079176713,0,6,sphingomyelin biosynthetic process,BP,
3354,GO:0006689,1,0.969189045692786,0,5,ganglioside catabolic process,BP,
3355,GO:0006690,1,0.60910728861891,0,86,icosanoid metabolic process,BP,
3356,GO:0006691,1,0.894020358893078,0,20,leukotriene metabolic process,BP,
3357,GO:0006692,1,0.824969412793737,0,34,prostanoid metabolic process,BP,
3358,GO:0006693,1,0.824969412793737,0,34,prostaglandin metabolic process,BP,
3359,GO:0006694,1,0.356469431143448,0,161,steroid biosynthetic process,BP,
3360,GO:0006695,1,0.658217019639995,0,62,cholesterol biosynthetic process,BP,
3361,GO:0006696,1,0.988724243729354,0,2,ergosterol biosynthetic process,BP,
3362,GO:0006699,1,0.813175909014325,0,32,bile acid biosynthetic process,BP,
3363,GO:0006700,1,0.881915224802041,0,20,C21-steroid hormone biosynthetic process,BP,
3364,GO:0006701,1,0.965675612155788,0,5,progesterone biosynthetic process,BP,
3365,GO:0006702,1,0.956374755397379,0,7,androgen biosynthetic process,BP,
3366,GO:0006703,1,0.949733992745418,0,10,estrogen biosynthetic process,BP,
3367,GO:0006704,1,0.91965918829022,0,13,glucocorticoid biosynthetic process,BP,
3368,GO:0006705,1,0.943983166331999,0,8,mineralocorticoid biosynthetic process,BP,
3369,GO:0006706,1,0.892019583002584,0,20,steroid catabolic process,BP,
3370,GO:0006707,1,0.948488623699545,0,9,cholesterol catabolic process,BP,
3371,GO:0006710,1,0.978841412578141,0,4,androgen catabolic process,BP,
3372,GO:0006711,1,0.995151319772094,0,1,estrogen catabolic process,BP,
3373,GO:0006713,1,0.995134851283793,0,1,glucocorticoid catabolic process,BP,
3374,GO:0006714,1,0.991995103233853,0,2,sesquiterpenoid metabolic process,BP,
3377,GO:0006722,1,0.9937228787619,0,1,triterpenoid metabolic process,BP,
3379,GO:0006726,1,0.980366693513217,0,3,eye pigment biosynthetic process,BP,
3380,GO:0006729,1,0.966751845549,0,7,tetrahydrobiopterin biosynthetic process,BP,
3381,GO:0006730,1,0.819462721583793,0,33,one-carbon metabolic process,BP,
3382,GO:0006732,1,0.109190337793031,0,348,coenzyme metabolic process,BP,
3383,GO:0006733,1,0.327419717595019,0,172,oxidoreduction coenzyme metabolic process,BP,
3384,GO:0006734,1,0.806994908678737,0,35,NADH metabolic process,BP,
3385,GO:0006735,1,0.863866970890729,0,24,NADH regeneration,BP,
3386,GO:0006738,1,0.99370748335756,0,1,nicotinamide riboside catabolic process,BP,
3387,GO:0006739,1,0.829799122308972,0,33,NADP metabolic process,BP,
3388,GO:0006740,1,0.980145621482354,0,3,NADPH regeneration,BP,
3389,GO:0006741,1,0.973800317173409,0,4,NADP biosynthetic process,BP,
3390,GO:0006742,1,0.986299352032046,0,3,NADP catabolic process,BP,
3391,GO:0006743,1,0.924993600004098,0,15,ubiquinone metabolic process,BP,
3392,GO:0006744,1,0.932137277638303,0,14,ubiquinone biosynthetic process,BP,
3393,GO:0006747,1,0.994700388265012,0,1,FAD biosynthetic process,BP,
3395,GO:0006750,1,0.922915262992426,0,14,glutathione biosynthetic process,BP,
3396,GO:0006751,1,0.973024929747262,0,5,glutathione catabolic process,BP,
3398,GO:0006754,1,0.463922330990465,0,115,ATP biosynthetic process,BP,
3399,GO:0006756,1,0.993058458973322,0,1,AMP phosphorylation,BP,
3400,GO:0006757,1,0.525188833876503,0,93,ATP generation from ADP,BP,
3401,GO:0006760,1,0.838866857709749,0,28,folic acid-containing compound metabolic process,BP,
3402,GO:0006766,1,0.463519409463912,0,122,vitamin metabolic process,BP,
3403,GO:0006767,1,0.582617300524247,0,83,water-soluble vitamin metabolic process,BP,
3404,GO:0006768,1,0.933631468318587,0,10,biotin metabolic process,BP,
3405,GO:0006771,1,0.954203697059059,0,7,riboflavin metabolic process,BP,
3406,GO:0006772,1,0.975922473591659,0,4,thiamine metabolic process,BP,
3407,GO:0006775,1,0.799101679938284,0,37,fat-soluble vitamin metabolic process,BP,
3408,GO:0006776,1,0.956843803240115,0,7,vitamin A metabolic process,BP,
3409,GO:0006777,1,0.961978693434699,0,6,Mo-molybdopterin cofactor biosynthetic process,BP,
3410,GO:0006778,1,0.829675764828791,0,31,porphyrin-containing compound metabolic process,BP,
3411,GO:0006779,1,0.864613730253679,0,23,porphyrin-containing compound biosynthetic process,BP,
3412,GO:0006780,1,0.990380625645618,0,2,uroporphyrinogen III biosynthetic process,BP,
3413,GO:0006781,1,0.994241557377807,0,1,succinyl-CoA pathway,BP,
3414,GO:0006782,1,0.958311596810781,0,8,protoporphyrinogen IX biosynthetic process,BP,
3415,GO:0006783,1,0.89030534931265,0,19,heme biosynthetic process,BP,
3416,GO:0006784,1,0.983738355140799,0,2,heme a biosynthetic process,BP,
3417,GO:0006787,1,0.984932490499356,0,4,porphyrin-containing compound catabolic process,BP,
3418,GO:0006788,1,0.990952548981599,0,2,heme oxidation,BP,
3422,GO:0006797,1,0.960913276001346,0,5,polyphosphate metabolic process,BP,
3423,GO:0006798,1,0.967713134351569,0,4,polyphosphate catabolic process,BP,
3427,GO:0006808,1,0.984146613447104,0,3,regulation of nitrogen utilization,BP,
3438,GO:0006824,1,0.977278024883802,0,4,cobalt ion transport,BP,
3439,GO:0006825,1,0.883030715341819,0,20,copper ion transport,BP,
3440,GO:0006826,1,0.714959780144342,0,54,iron ion transport,BP,
3441,GO:0006828,1,0.927596885432238,0,10,manganese ion transport,BP,
3443,GO:0006833,1,0.911693064973224,0,15,water transport,BP,
3446,GO:0006837,1,0.914003292124733,0,15,serotonin transport,BP,
3448,GO:0006842,1,0.973394197925728,0,4,tricarboxylic acid transport,BP,
3449,GO:0006843,1,0.995566416067967,0,1,mitochondrial citrate transmembrane transport,BP,
3450,GO:0006844,1,0.988777183362907,0,2,acyl carnitine transport,BP,
3451,GO:0006848,1,0.974007783962165,0,4,pyruvate transport,BP,
3452,GO:0006850,1,0.986164624597214,0,2,mitochondrial pyruvate transmembrane transport,BP,
3453,GO:0006851,1,0.869326448426882,0,22,mitochondrial calcium ion transmembrane transport,BP,
3454,GO:0006853,1,0.933638172397958,0,9,carnitine shuttle,BP,
3456,GO:0006857,1,0.945803031953852,0,8,oligopeptide transport,BP,
3457,GO:0006858,1,0.98388431496564,0,3,extracellular transport,BP,
3459,GO:0006863,1,0.966375928511449,0,6,purine nucleobase transport,BP,
3460,GO:0006864,1,0.98819992926779,0,2,pyrimidine nucleotide transport,BP,
3462,GO:0006867,1,0.986717382233571,0,2,asparagine transport,BP,
3463,GO:0006868,1,0.959327729845515,0,6,glutamine transport,BP,
3468,GO:0006876,1,0.992490197829783,0,1,cellular cadmium ion homeostasis,BP,
3469,GO:0006878,1,0.925216188270519,0,13,cellular copper ion homeostasis,BP,
3471,GO:0006880,1,0.988242749287663,0,3,intracellular sequestering of iron ion,BP,
3473,GO:0006883,1,0.890483319823495,0,16,cellular sodium ion homeostasis,BP,
3474,GO:0006884,1,0.851751795823315,0,22,cell volume homeostasis,BP,
3475,GO:0006885,1,0.527780790721814,0,96,regulation of pH,BP,
3478,GO:0006888,1,0.284467805942649,0,186,ER to Golgi vesicle-mediated transport,BP,
3479,GO:0006890,1,0.582848708701448,0,79,retrograde vesicle-mediated transport, Golgi to ER,BP,
3480,GO:0006891,1,0.802073290948702,0,33,intra-Golgi vesicle-mediated transport,BP,
3481,GO:0006892,1,0.51057262240039,0,92,post-Golgi vesicle-mediated transport,BP,
3482,GO:0006893,1,0.71579740541875,0,47,Golgi to plasma membrane transport,BP,
3483,GO:0006895,1,0.853935582174462,0,19,Golgi to endosome transport,BP,
3484,GO:0006896,1,0.907632520406596,0,14,Golgi to vacuole transport,BP,
3487,GO:0006900,1,0.533223494022839,0,93,vesicle budding from membrane,BP,
3488,GO:0006901,1,0.645374209839367,0,66,vesicle coating,BP,
3489,GO:0006903,1,0.562705976079602,0,85,vesicle targeting,BP,
3490,GO:0006904,1,0.728962245144002,0,48,vesicle docking involved in exocytosis,BP,
3492,GO:0006907,1,0.887975773397316,0,18,pinocytosis,BP,
3494,GO:0006910,1,0.916609464511147,0,14,phagocytosis, recognition,BP,
3495,GO:0006911,1,0.754341659822406,0,44,phagocytosis, engulfment,BP,
3500,GO:0006921,1,0.826478908722391,0,30,cellular component disassembly involved in execution phase of apoptosis,BP,
3501,GO:0006924,1,0.947006035681093,0,9,activation-induced cell death of T cells,BP,
3502,GO:0006925,1,0.89709222454725,0,17,inflammatory cell apoptotic process,BP,
3504,GO:0006929,1,0.833872658355809,0,25,substrate-dependent cell migration,BP,
3505,GO:0006930,1,0.94641883487664,0,8,substrate-dependent cell migration, cell extension,BP,
3506,GO:0006931,1,0.972351225245909,0,4,substrate-dependent cell migration, cell attachment to substrate,BP,
3507,GO:0006933,1,0.981617057016068,0,3,negative regulation of cell adhesion involved in substrate-bound cell migration,BP,
3511,GO:0006939,1,0.52885443539025,0,94,smooth muscle contraction,BP,
3512,GO:0006940,1,0.700330539065301,0,55,regulation of smooth muscle contraction,BP,
3515,GO:0006948,1,0.99272040386425,0,1,induction by virus of host cell-cell fusion,BP,
3516,GO:0006949,1,0.76347178009159,0,38,syncytium formation,BP,
3519,GO:0006953,1,0.817319634900416,0,36,acute-phase response,BP,
3522,GO:0006956,1,0.749504818828327,0,48,complement activation,BP,
3523,GO:0006957,1,0.93446982571724,0,10,complement activation, alternative pathway,BP,
3524,GO:0006958,1,0.848972600225117,0,26,complement activation, classical pathway,BP,
3528,GO:0006971,1,0.932612518639703,0,9,hypotonic response,BP,
3529,GO:0006972,1,0.8744185275891,0,20,hyperosmotic response,BP,
3531,GO:0006975,1,0.947376745898733,0,8,DNA damage induced protein phosphorylation,BP,
3532,GO:0006977,1,0.681274138082454,0,60,DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest,BP,
3533,GO:0006978,1,0.880051336999338,0,19,DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
3535,GO:0006982,1,0.992286970076734,0,2,response to lipid hydroperoxide,BP,
3536,GO:0006983,1,0.931479055444499,0,10,ER overload response,BP,
3537,GO:0006984,1,0.756261271098769,0,42,ER-nucleus signaling pathway,BP,
3538,GO:0006986,1,0.331619414393613,0,170,response to unfolded protein,BP,
3539,GO:0006987,1,0.948537863092929,0,8,activation of signaling protein activity involved in unfolded protein response,BP,
3540,GO:0006990,1,0.980050069018754,0,3,positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response,BP,
3541,GO:0006991,1,0.931220980372518,0,10,response to sterol depletion,BP,
3542,GO:0006995,1,0.947083040650369,0,11,cellular response to nitrogen starvation,BP,
3545,GO:0006998,1,0.574912582297985,0,81,nuclear envelope organization,BP,
3546,GO:0006999,1,0.894456624431135,0,15,nuclear pore organization,BP,
3547,GO:0007000,1,0.954462166747248,0,7,nucleolus organization,BP,
3548,GO:0007004,1,0.641864539183785,0,65,telomere maintenance via telomerase,BP,
3551,GO:0007007,1,0.889278561985296,0,22,inner mitochondrial membrane organization,BP,
3552,GO:0007008,1,0.992576689408957,0,1,outer mitochondrial membrane organization,BP,
3555,GO:0007014,1,0.992506143966437,0,1,actin ubiquitination,BP,
3557,GO:0007016,1,0.912734813918107,0,10,cytoskeletal anchoring at plasma membrane,BP,
3559,GO:0007018,1,0.115419821913893,0,288,microtubule-based movement,BP,
3560,GO:0007019,1,0.755443147598619,0,38,microtubule depolymerization,BP,
3561,GO:0007020,1,0.829954237802901,0,25,microtubule nucleation,BP,
3562,GO:0007021,1,0.969477656484867,0,7,tubulin complex assembly,BP,
3563,GO:0007023,1,0.980293023820756,0,4,post-chaperonin tubulin folding pathway,BP,
3564,GO:0007026,1,0.852630747241356,0,22,negative regulation of microtubule depolymerization,BP,
3565,GO:0007028,1,0.929483316678727,0,9,cytoplasm organization,BP,
3567,GO:0007030,1,0.391578395184312,0,127,Golgi organization,BP,
3568,GO:0007031,1,0.823027759631838,0,31,peroxisome organization,BP,
3569,GO:0007032,1,0.629302888449757,0,69,endosome organization,BP,
3570,GO:0007033,1,0.355052639807698,0,152,vacuole organization,BP,
3572,GO:0007035,1,0.87192063948208,0,22,vacuolar acidification,BP,
3573,GO:0007039,1,0.904345428217677,0,14,protein catabolic process in the vacuole,BP,
3574,GO:0007040,1,0.678119807426199,0,58,lysosome organization,BP,
3576,GO:0007042,1,0.961375050698206,0,8,lysosomal lumen acidification,BP,
3581,GO:0007050,1,0.208784870057413,0,234,cell cycle arrest,BP,
3582,GO:0007051,1,0.310863518606261,0,162,spindle organization,BP,
3583,GO:0007052,1,0.46998828735813,0,106,mitotic spindle organization,BP,
3584,GO:0007056,1,0.988360687186123,0,2,spindle assembly involved in female meiosis,BP,
3585,GO:0007057,1,0.988360687186123,0,2,spindle assembly involved in female meiosis I,BP,
3586,GO:0007059,1,0.105314301660015,0,328,chromosome segregation,BP,
3587,GO:0007060,1,0.972718074207561,0,4,male meiosis chromosome segregation,BP,
3588,GO:0007062,1,0.433209743696728,0,123,sister chromatid cohesion,BP,
3589,GO:0007063,1,0.869117516460364,0,19,regulation of sister chromatid cohesion,BP,
3590,GO:0007064,1,0.866733695438771,0,19,mitotic sister chromatid cohesion,BP,
3591,GO:0007066,1,0.997025918849197,0,1,female meiosis sister chromatid cohesion,BP,
3592,GO:0007072,1,0.995301076185118,0,1,positive regulation of transcription involved in exit from mitosis,BP,
3593,GO:0007076,1,0.872401432793322,0,16,mitotic chromosome condensation,BP,
3594,GO:0007077,1,0.745431623313981,0,42,mitotic nuclear envelope disassembly,BP,
3595,GO:0007079,1,0.975325921322692,0,3,mitotic chromosome movement towards spindle pole,BP,
3596,GO:0007080,1,0.755448683678145,0,44,mitotic metaphase plate congression,BP,
3597,GO:0007084,1,0.944747483383829,0,10,mitotic nuclear envelope reassembly,BP,
3599,GO:0007089,1,0.971732825461387,0,4,traversing start control point of mitotic cell cycle,BP,
3600,GO:0007091,1,0.705236525414471,0,51,metaphase/anaphase transition of mitotic cell cycle,BP,
3601,GO:0007093,1,0.355244025542326,0,157,mitotic cell cycle checkpoint,BP,
3602,GO:0007094,1,0.809514598974333,0,31,mitotic spindle assembly checkpoint,BP,
3603,GO:0007095,1,0.87018787318699,0,19,mitotic G2 DNA damage checkpoint,BP,
3604,GO:0007096,1,0.905898439618405,0,16,regulation of exit from mitosis,BP,
3605,GO:0007097,1,0.853218330987237,0,19,nuclear migration,BP,
3606,GO:0007098,1,0.4453364527413,0,114,centrosome cycle,BP,
3607,GO:0007099,1,0.812186064411372,0,29,centriole replication,BP,
3608,GO:0007100,1,0.899957156904112,0,15,mitotic centrosome separation,BP,
3609,GO:0007113,1,0.985191310025681,0,3,endomitotic cell cycle,BP,
3610,GO:0007127,1,0.530761588811084,0,96,meiosis I,BP,
3611,GO:0007129,1,0.802036323680247,0,34,synapsis,BP,
3612,GO:0007130,1,0.900647401991053,0,16,synaptonemal complex assembly,BP,
3613,GO:0007131,1,0.742637506810919,0,44,reciprocal meiotic recombination,BP,
3614,GO:0007135,1,0.951405279937707,0,8,meiosis II,BP,
3615,GO:0007140,1,0.766703273518791,0,39,male meiotic nuclear division,BP,
3616,GO:0007141,1,0.893856946083078,0,18,male meiosis I,BP,
3617,GO:0007143,1,0.852382668405213,0,23,female meiotic nuclear division,BP,
3618,GO:0007144,1,0.956822732536693,0,7,female meiosis I,BP,
3619,GO:0007146,1,0.993058458973322,0,1,meiotic recombination nodule assembly,BP,
3620,GO:0007147,1,0.992517709297307,0,1,female meiosis II,BP,
3625,GO:0007158,1,0.884526244868494,0,16,neuron cell-cell adhesion,BP,
3628,GO:0007161,1,0.962910678406005,0,4,calcium-independent cell-matrix adhesion,BP,
3630,GO:0007163,1,0.239695521605494,0,196,establishment or maintenance of cell polarity,BP,
3635,GO:0007168,1,0.974639742772968,0,5,receptor guanylyl cyclase signaling pathway,BP,
3637,GO:0007171,1,0.908045496829116,0,13,activation of transmembrane receptor protein tyrosine kinase activity,BP,
3638,GO:0007172,1,0.948096800122386,0,8,signal complex assembly,BP,
3640,GO:0007174,1,0.994096693478931,0,1,epidermal growth factor catabolic process,BP,
3641,GO:0007175,1,0.909455235006043,0,14,negative regulation of epidermal growth factor-activated receptor activity,BP,
3642,GO:0007176,1,0.831075710451079,0,27,regulation of epidermal growth factor-activated receptor activity,BP,
3645,GO:0007181,1,0.980260746575949,0,3,transforming growth factor beta receptor complex assembly,BP,
3646,GO:0007182,1,0.953633761562875,0,6,common-partner SMAD protein phosphorylation,BP,
3647,GO:0007183,1,0.903195838687159,0,14,SMAD protein complex assembly,BP,
3648,GO:0007185,1,0.949161533443602,0,6,transmembrane receptor protein tyrosine phosphatase signaling pathway,BP,
3650,GO:0007187,1,0.288476249722415,0,196,G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger,BP,
3651,GO:0007188,1,0.329939974263053,0,170,adenylate cyclase-modulating G-protein coupled receptor signaling pathway,BP,
3652,GO:0007189,1,0.587209942836234,0,82,adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
3653,GO:0007190,1,0.806032220866618,0,31,activation of adenylate cyclase activity,BP,
3654,GO:0007191,1,0.942530140173736,0,9,adenylate cyclase-activating dopamine receptor signaling pathway,BP,
3655,GO:0007193,1,0.588145646556533,0,76,adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway,BP,
3656,GO:0007194,1,0.873847767424691,0,20,negative regulation of adenylate cyclase activity,BP,
3657,GO:0007195,1,0.959438267093127,0,6,adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
3658,GO:0007196,1,0.927904272930815,0,9,adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway,BP,
3659,GO:0007197,1,0.961342676125923,0,6,adenylate cyclase-inhibiting G-protein coupled acetylcholine receptor signaling pathway,BP,
3660,GO:0007198,1,0.979383124294308,0,4,adenylate cyclase-inhibiting serotonin receptor signaling pathway,BP,
3661,GO:0007199,1,0.993388970162643,0,1,G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger,BP,
3666,GO:0007206,1,0.982877990163632,0,2,phospholipase C-activating G-protein coupled glutamate receptor signaling pathway,BP,
3667,GO:0007207,1,0.963211699546584,0,6,phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway,BP,
3668,GO:0007208,1,0.984963950482958,0,2,phospholipase C-activating serotonin receptor signaling pathway,BP,
3669,GO:0007210,1,0.928264986600908,0,13,serotonin receptor signaling pathway,BP,
3671,GO:0007213,1,0.904830623243315,0,16,G-protein coupled acetylcholine receptor signaling pathway,BP,
3672,GO:0007214,1,0.85125061421788,0,22,gamma-aminobutyric acid signaling pathway,BP,
3674,GO:0007216,1,0.891040385782115,0,15,G-protein coupled glutamate receptor signaling pathway,BP,
3675,GO:0007217,1,0.966973689123439,0,7,tachykinin receptor signaling pathway,BP,
3676,GO:0007218,1,0.629915695495571,0,86,neuropeptide signaling pathway,BP,
3678,GO:0007220,1,0.885971919237864,0,17,Notch receptor processing,BP,
3679,GO:0007221,1,0.85824879266752,0,18,positive regulation of transcription of Notch receptor target,BP,
3681,GO:0007224,1,0.419852133988374,0,123,smoothened signaling pathway,BP,
3682,GO:0007225,1,0.992245606563932,0,1,patched ligand maturation,BP,
3683,GO:0007227,1,0.973036105672155,0,4,signal transduction downstream of smoothened,BP,
3684,GO:0007228,1,0.980409807458838,0,3,positive regulation of hh target transcription factor activity,BP,
3686,GO:0007231,1,0.98313008841367,0,3,osmosensory signaling pathway,BP,
3688,GO:0007250,1,0.889141760573615,0,18,activation of NF-kappaB-inducing kinase activity,BP,
3689,GO:0007252,1,0.906195176473456,0,14,I-kappaB phosphorylation,BP,
3690,GO:0007253,1,0.964067776775725,0,7,cytoplasmic sequestering of NF-kappaB,BP,
3692,GO:0007256,1,0.950765903772478,0,6,activation of JNKK activity,BP,
3693,GO:0007257,1,0.792324069665864,0,32,activation of JUN kinase activity,BP,
3694,GO:0007258,1,0.973873228218293,0,4,JUN phosphorylation,BP,
3704,GO:0007270,1,0.936522303201826,0,8,neuron-neuron synaptic transmission,BP,
3705,GO:0007271,1,0.816655170301622,0,31,synaptic transmission, cholinergic,BP,
3707,GO:0007274,1,0.844708119046048,0,25,neuromuscular synaptic transmission,BP,
3712,GO:0007284,1,0.984840350776996,0,2,spermatogonial cell division,BP,
3714,GO:0007288,1,0.932305672096276,0,10,sperm axoneme assembly,BP,
3716,GO:0007290,1,0.99223202257038,0,1,spermatid nucleus elongation,BP,
3717,GO:0007291,1,0.996935203311138,0,1,sperm individualization,BP,
3718,GO:0007292,1,0.48838705861994,0,105,female gamete generation,BP,
3719,GO:0007296,1,0.968007032190607,0,4,vitellogenesis,BP,
3720,GO:0007308,1,0.985986823594548,0,2,oocyte construction,BP,
3721,GO:0007309,1,0.985986823594548,0,2,oocyte axis specification,BP,
3722,GO:0007314,1,0.985986823594548,0,2,oocyte anterior/posterior axis specification,BP,
3723,GO:0007315,1,0.985986823594548,0,2,pole plasm assembly,BP,
3724,GO:0007320,1,0.939200685774931,0,10,insemination,BP,
3725,GO:0007338,1,0.547853341699915,0,101,single fertilization,BP,
3726,GO:0007339,1,0.867886143211652,0,25,binding of sperm to zona pellucida,BP,
3727,GO:0007340,1,0.858220311261097,0,26,acrosome reaction,BP,
3728,GO:0007341,1,0.972688487207,0,6,penetration of zona pellucida,BP,
3729,GO:0007342,1,0.959736072108016,0,9,fusion of sperm to egg plasma membrane involved in single fertilization,BP,
3730,GO:0007343,1,0.985005058432815,0,2,egg activation,BP,
3731,GO:0007344,1,0.995233406655209,0,1,pronuclear fusion,BP,
3733,GO:0007349,1,0.996935203311138,0,1,cellularization,BP,
3734,GO:0007350,1,0.901125262849107,0,15,blastoderm segmentation,BP,
3735,GO:0007351,1,0.921419616694064,0,12,tripartite regional subdivision,BP,
3736,GO:0007352,1,0.979408111380843,0,3,zygotic specification of dorsal/ventral axis,BP,
3737,GO:0007354,1,0.977063849778806,0,4,zygotic determination of anterior/posterior axis, embryo,BP,
3738,GO:0007356,1,0.984341217318026,0,3,thorax and anterior abdomen determination,BP,
3741,GO:0007371,1,0.992502896428707,0,1,ventral midline determination,BP,
3743,GO:0007386,1,0.964203404498274,0,5,compartment pattern specification,BP,
3744,GO:0007387,1,0.993166241044429,0,1,anterior compartment pattern formation,BP,
3745,GO:0007388,1,0.993166241044429,0,1,posterior compartment specification,BP,
3747,GO:0007398,1,0.878016442948354,0,18,ectoderm development,BP,
3749,GO:0007400,1,0.993587012283989,0,1,neuroblast fate determination,BP,
3750,GO:0007402,1,0.990923076766741,0,2,ganglion mother cell fate determination,BP,
3751,GO:0007403,1,0.992562739064772,0,1,glial cell fate determination,BP,
3753,GO:0007406,1,0.960560492115345,0,5,negative regulation of neuroblast proliferation,BP,
3756,GO:0007412,1,0.989129097017928,0,2,axon target recognition,BP,
3760,GO:0007418,1,0.972015612550063,0,4,ventral midline development,BP,
3766,GO:0007439,1,0.986316871539866,0,2,ectodermal digestive tract development,BP,
3767,GO:0007440,1,0.920595860513187,0,10,foregut morphogenesis,BP,
3768,GO:0007442,1,0.948983855628714,0,7,hindgut morphogenesis,BP,
3769,GO:0007468,1,0.988060729782096,0,2,regulation of rhodopsin gene expression,BP,
3770,GO:0007492,1,0.57866861756101,0,76,endoderm development,BP,
3771,GO:0007493,1,0.986438746276037,0,2,endodermal cell fate determination,BP,
3773,GO:0007495,1,0.992669230765027,0,1,visceral mesoderm-endoderm interaction involved in midgut development,BP,
3774,GO:0007497,1,0.984646527211565,0,2,posterior midgut development,BP,
3776,GO:0007499,1,0.992292663099456,0,1,ectoderm and mesoderm interaction,BP,
3777,GO:0007500,1,0.988061372879349,0,2,mesodermal cell fate determination,BP,
3779,GO:0007506,1,0.98698786213271,0,2,gonadal mesoderm development,BP,
3781,GO:0007509,1,0.991175785121106,0,1,mesoderm migration involved in gastrulation,BP,
3784,GO:0007518,1,0.98893178768568,0,2,myoblast fate determination,BP,
3786,GO:0007520,1,0.819757556528408,0,29,myoblast fusion,BP,
3787,GO:0007521,1,0.983976191183676,0,2,muscle cell fate determination,BP,
3788,GO:0007522,1,0.991536556313429,0,1,visceral muscle development,BP,
3789,GO:0007525,1,0.975448581527456,0,2,somatic muscle development,BP,
3790,GO:0007528,1,0.704231622884073,0,44,neuromuscular junction development,BP,
3791,GO:0007529,1,0.984973039034915,0,2,establishment of synaptic specificity at neuromuscular junction,BP,
3792,GO:0007530,1,0.87067671026561,0,21,sex determination,BP,
3793,GO:0007538,1,0.984418825367022,0,2,primary sex determination,BP,
3794,GO:0007542,1,0.984418825367022,0,2,primary sex determination, germ-line,BP,
3796,GO:0007549,1,0.909794000641926,0,12,dosage compensation,BP,
3798,GO:0007566,1,0.763531178298225,0,42,embryo implantation,BP,
3799,GO:0007567,1,0.898008664517001,0,16,parturition,BP,
3801,GO:0007569,1,0.522593943255071,0,96,cell aging,BP,
3802,GO:0007571,1,0.996841976500444,0,1,age-dependent general metabolic decline,BP,
3803,GO:0007576,1,0.993449326164178,0,1,nucleolar fragmentation,BP,
3805,GO:0007585,1,0.680806581443829,0,59,respiratory gaseous exchange,BP,
3807,GO:0007588,1,0.72363998399657,0,50,excretion,BP,
3811,GO:0007597,1,0.917884561699264,0,15,blood coagulation, intrinsic pathway,BP,
3812,GO:0007598,1,0.97597146749681,0,4,blood coagulation, extrinsic pathway,BP,
3816,GO:0007602,1,0.774438543385237,0,41,phototransduction,BP,
3817,GO:0007603,1,0.84094691059731,0,26,phototransduction, visible light,BP,
3819,GO:0007606,1,0.638107146917544,0,81,sensory perception of chemical stimulus,BP,
3820,GO:0007608,1,0.819721192698676,0,35,sensory perception of smell,BP,
3825,GO:0007614,1,0.944882447270918,0,9,short-term memory,BP,
3827,GO:0007617,1,0.887877373322172,0,18,mating behavior,BP,
3828,GO:0007618,1,0.813949228745201,0,32,mating,BP,
3829,GO:0007619,1,0.979310455728777,0,3,courtship behavior,BP,
3830,GO:0007620,1,0.90446719786669,0,16,copulation,BP,
3831,GO:0007621,1,0.978631311138167,0,3,negative regulation of female receptivity,BP,
3832,GO:0007622,1,0.785769003098993,0,39,rhythmic behavior,BP,
3834,GO:0007624,1,0.992449597670918,0,1,ultradian rhythm,BP,
3835,GO:0007625,1,0.912811725998328,0,15,grooming behavior,BP,
3839,GO:0007632,1,0.691530051815564,0,49,visual behavior,BP,
3840,GO:0007634,1,0.993652666076921,0,1,optokinetic behavior,BP,
3842,GO:0007638,1,0.895991617760349,0,13,mechanosensory behavior,BP,
3843,GO:0008009,1,0.881433694934977,0,32,chemokine activity,MF,
3844,GO:0008013,1,0.540558391681772,0,79,beta-catenin binding,MF,
3848,GO:0008020,1,0.958009104497374,0,8,G-protein coupled photoreceptor activity,MF,
3850,GO:0008022,1,0.279702573660508,0,183,protein C-terminus binding,MF,
3851,GO:0008023,1,0.707662209888446,0,48,transcription elongation factor complex,CC,
3852,GO:0008024,1,0.942436567146642,0,8,cyclin/CDK positive transcription elongation factor complex,CC,
3853,GO:0008026,1,0.519089026198673,0,91,ATP-dependent helicase activity,MF,
3854,GO:0008028,1,0.723840595940358,0,49,monocarboxylic acid transmembrane transporter activity,MF,
3855,GO:0008033,1,0.496366866074693,0,118,tRNA processing,BP,
3856,GO:0008035,1,0.961053854905215,0,7,high-density lipoprotein particle binding,MF,
3859,GO:0008043,1,0.993582692531095,0,2,intracellular ferritin complex,CC,
3860,GO:0008045,1,0.854830831690683,0,21,motor neuron axon guidance,BP,
3861,GO:0008046,1,0.946288214023853,0,7,axon guidance receptor activity,MF,
3863,GO:0008048,1,0.985473459492992,0,3,calcium sensitive guanylate cyclase activator activity,MF,
3864,GO:0008049,1,0.994853294321578,0,1,male courtship behavior,BP,
3865,GO:0008050,1,0.984377553265688,0,2,female courtship behavior,BP,
3866,GO:0008052,1,0.996903467990892,0,1,sensory organ boundary specification,BP,
3867,GO:0008053,1,0.886173893643381,0,21,mitochondrial fusion,BP,
3868,GO:0008057,1,0.990636187417284,0,1,eye pigment granule organization,BP,
3869,GO:0008061,1,0.957592297414485,0,7,chitin binding,MF,
3870,GO:0008063,1,0.958326975045527,0,6,Toll signaling pathway,BP,
3872,GO:0008065,1,0.980324339849087,0,3,establishment of blood-nerve barrier,BP,
3875,GO:0008073,1,0.988624609579043,0,3,ornithine decarboxylase inhibitor activity,MF,
3876,GO:0008074,1,0.904424816347309,0,12,guanylate cyclase complex, soluble,CC,
3878,GO:0008078,1,0.984596333141302,0,3,mesodermal cell migration,BP,
3879,GO:0008079,1,0.959245653418575,0,6,translation termination factor activity,MF,
3880,GO:0008080,1,0.592924910061354,0,77,N-acetyltransferase activity,MF,
3882,GO:0008083,1,0.472557758885896,0,131,growth factor activity,MF,
3883,GO:0008088,1,0.681380175614039,0,54,axo-dendritic transport,BP,
3884,GO:0008089,1,0.779273775744224,0,37,anterograde axonal transport,BP,
3885,GO:0008090,1,0.944019964088363,0,8,retrograde axonal transport,BP,
3886,GO:0008091,1,0.925457502445082,0,8,spectrin,CC,
3888,GO:0008093,1,0.91711899131426,0,12,cytoskeletal adaptor activity,MF,
3889,GO:0008094,1,0.567690229858868,0,78,DNA-dependent ATPase activity,MF,
3890,GO:0008097,1,0.956940362120458,0,10,5S rRNA binding,MF,
3892,GO:0008106,1,0.915036408206762,0,19,alcohol dehydrogenase (NADP+) activity,MF,
3893,GO:0008107,1,0.992427299206355,0,1,galactoside 2-alpha-L-fucosyltransferase activity,MF,
3894,GO:0008108,1,0.996161055383937,0,1,UDP-glucose:hexose-1-phosphate uridylyltransferase activity,MF,
3895,GO:0008109,1,0.98495739051069,0,2,N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity,MF,
3896,GO:0008111,1,0.994695654146371,0,1,alpha-methylacyl-CoA racemase activity,MF,
3897,GO:0008112,1,0.995628041058922,0,1,nicotinamide N-methyltransferase activity,MF,
3898,GO:0008113,1,0.992021895350214,0,2,peptide-methionine (S)-S-oxide reductase activity,MF,
3899,GO:0008115,1,0.99370543607473,0,1,sarcosine oxidase activity,MF,
3900,GO:0008116,1,0.991766714052875,0,1,prostaglandin-I synthase activity,MF,
3901,GO:0008117,1,0.991660141051055,0,1,sphinganine-1-phosphate aldolase activity,MF,
3902,GO:0008118,1,0.994115753229916,0,1,N-acetyllactosaminide alpha-2,3-sialyltransferase activity,MF,
3903,GO:0008119,1,0.99263313015297,0,1,thiopurine S-methyltransferase activity,MF,
3904,GO:0008120,1,0.995497649255634,0,1,ceramide glucosyltransferase activity,MF,
3905,GO:0008121,1,0.971333938200679,0,7,ubiquinol-cytochrome-c reductase activity,MF,
3906,GO:0008124,1,0.990685566379621,0,2,4-alpha-hydroxytetrahydrobiopterin dehydratase activity,MF,
3907,GO:0008126,1,0.992980600067089,0,1,acetylesterase activity,MF,
3908,GO:0008127,1,0.996246769068373,0,1,quercetin 2,3-dioxygenase activity,MF,
3909,GO:0008131,1,0.964931030536664,0,5,primary amine oxidase activity,MF,
3911,GO:0008135,1,0.587270660398109,0,84,translation factor activity, RNA binding,MF,
3912,GO:0008137,1,0.884640743099864,0,38,NADH dehydrogenase (ubiquinone) activity,MF,
3913,GO:0008138,1,0.778446170127705,0,40,protein tyrosine/serine/threonine phosphatase activity,MF,
3914,GO:0008139,1,0.847644300537249,0,22,nuclear localization sequence binding,MF,
3915,GO:0008140,1,0.950166679524069,0,8,cAMP response element binding protein binding,MF,
3916,GO:0008142,1,0.961740463286541,0,5,oxysterol binding,MF,
3917,GO:0008143,1,0.892763037984149,0,16,poly(A) binding,MF,
3919,GO:0008146,1,0.739582869759317,0,46,sulfotransferase activity,MF,
3920,GO:0008147,1,0.995465620097414,0,2,structural constituent of bone,MF,
3924,GO:0008156,1,0.796204963833008,0,32,negative regulation of DNA replication,BP,
3925,GO:0008157,1,0.878315991721997,0,18,protein phosphatase 1 binding,MF,
3926,GO:0008158,1,0.98003627620074,0,3,hedgehog receptor activity,MF,
3927,GO:0008160,1,0.993323509645954,0,1,protein tyrosine phosphatase activator activity,MF,
3928,GO:0008168,1,0.300067423146075,0,181,methyltransferase activity,MF,
3929,GO:0008169,1,0.981967281850481,0,3,C-methyltransferase activity,MF,
3930,GO:0008170,1,0.574521616229583,0,81,N-methyltransferase activity,MF,
3931,GO:0008171,1,0.891702282464919,0,18,O-methyltransferase activity,MF,
3932,GO:0008172,1,0.960063326697914,0,6,S-methyltransferase activity,MF,
3933,GO:0008173,1,0.718445349744739,0,51,RNA methyltransferase activity,MF,
3934,GO:0008174,1,0.941912345398401,0,9,mRNA methyltransferase activity,MF,
3935,GO:0008175,1,0.835219084880973,0,27,tRNA methyltransferase activity,MF,
3936,GO:0008176,1,0.99149484035628,0,2,tRNA (guanine-N7-)-methyltransferase activity,MF,
3937,GO:0008177,1,0.979732084600258,0,4,succinate dehydrogenase (ubiquinone) activity,MF,
3938,GO:0008179,1,0.909096401824537,0,13,adenylate cyclase binding,MF,
3939,GO:0008180,1,0.807597494302427,0,33,COP9 signalosome,CC,
3940,GO:0008184,1,0.978177874817495,0,3,glycogen phosphorylase activity,MF,
3941,GO:0008186,1,0.628136148358424,0,65,RNA-dependent ATPase activity,MF,
3942,GO:0008187,1,0.851419920966609,0,23,poly-pyrimidine tract binding,MF,
3943,GO:0008188,1,0.788726746322422,0,42,neuropeptide receptor activity,MF,
3944,GO:0008190,1,0.937214188346801,0,10,eukaryotic initiation factor 4E binding,MF,
3946,GO:0008192,1,0.981159586065378,0,3,RNA guanylyltransferase activity,MF,
3947,GO:0008193,1,0.988717656748298,0,2,tRNA guanylyltransferase activity,MF,
3949,GO:0008195,1,0.975865303229135,0,3,phosphatidate phosphatase activity,MF,
3950,GO:0008198,1,0.880390254830641,0,21,ferrous iron binding,MF,
3951,GO:0008199,1,0.968293947577464,0,6,ferric iron binding,MF,
3952,GO:0008200,1,0.820457322012914,0,31,ion channel inhibitor activity,MF,
3954,GO:0008202,1,0.190004085613353,0,259,steroid metabolic process,BP,
3955,GO:0008203,1,0.450577181785363,0,118,cholesterol metabolic process,BP,
3956,GO:0008204,1,0.988724243729354,0,2,ergosterol metabolic process,BP,
3957,GO:0008206,1,0.761947567470341,0,42,bile acid metabolic process,BP,
3958,GO:0008207,1,0.843629676189099,0,29,C21-steroid hormone metabolic process,BP,
3959,GO:0008209,1,0.878434081565328,0,21,androgen metabolic process,BP,
3960,GO:0008210,1,0.900870336334051,0,18,estrogen metabolic process,BP,
3961,GO:0008211,1,0.892322234260192,0,19,glucocorticoid metabolic process,BP,
3962,GO:0008212,1,0.943983166331999,0,8,mineralocorticoid metabolic process,BP,
3964,GO:0008214,1,0.791773917916549,0,29,protein dealkylation,BP,
3965,GO:0008215,1,0.966174610951453,0,7,spermine metabolic process,BP,
3966,GO:0008216,1,0.963412092512719,0,8,spermidine metabolic process,BP,
3968,GO:0008218,1,0.992546464183433,0,1,bioluminescence,BP,
3970,GO:0008227,1,0.821481371260596,0,32,G-protein coupled amine receptor activity,MF,
3971,GO:0008228,1,0.954215925595949,0,7,opsonization,BP,
3973,GO:0008234,1,0.334213436363755,0,157,cysteine-type peptidase activity,MF,
3974,GO:0008235,1,0.695937928430368,0,54,metalloexopeptidase activity,MF,
3976,GO:0008237,1,0.327730221437082,0,160,metallopeptidase activity,MF,
3977,GO:0008238,1,0.534134152481308,0,94,exopeptidase activity,MF,
3978,GO:0008239,1,0.934433875618373,0,11,dipeptidyl-peptidase activity,MF,
3979,GO:0008240,1,0.977537872057761,0,3,tripeptidyl-peptidase activity,MF,
3980,GO:0008241,1,0.992583653886802,0,1,peptidyl-dipeptidase activity,MF,
3981,GO:0008242,1,0.94386860569635,0,9,omega peptidase activity,MF,
3982,GO:0008250,1,0.941156055450933,0,12,oligosaccharyltransferase complex,CC,
3983,GO:0008251,1,0.984556149426631,0,2,tRNA-specific adenosine deaminase activity,MF,
3984,GO:0008252,1,0.912637397364602,0,14,nucleotidase activity,MF,
3985,GO:0008253,1,0.92707449100946,0,12,5'-nucleotidase activity,MF,
3986,GO:0008254,1,0.990771824670014,0,1,3'-nucleotidase activity,MF,
3987,GO:0008260,1,0.987626425138668,0,2,3-oxoacid CoA-transferase activity,MF,
3988,GO:0008263,1,0.986269883947366,0,2,pyrimidine-specific mismatch base pair DNA N-glycosylase activity,MF,
3989,GO:0008265,1,0.993128806149118,0,1,Mo-molybdopterin cofactor sulfurase activity,MF,
3990,GO:0008266,1,0.878139774489305,0,19,poly(U) RNA binding,MF,
3991,GO:0008267,1,0.990294836187093,0,1,poly-glutamine tract binding,MF,
3992,GO:0008269,1,0.989066663532011,0,2,JAK pathway signal transduction adaptor activity,MF,
3994,GO:0008271,1,0.927607999538749,0,10,secondary active sulfate transmembrane transporter activity,MF,
3995,GO:0008272,1,0.916032481340588,0,12,sulfate transport,BP,
3996,GO:0008273,1,0.97095128852992,0,4,calcium, potassium:sodium antiporter activity,MF,
3997,GO:0008274,1,0.946908496211867,0,7,gamma-tubulin ring complex,CC,
3998,GO:0008275,1,0.970545099300237,0,4,gamma-tubulin small complex,CC,
3999,GO:0008276,1,0.584907402302923,0,77,protein methyltransferase activity,MF,
4001,GO:0008278,1,0.927423036624473,0,10,cohesin complex,CC,
4002,GO:0008281,1,0.984439713555387,0,2,sulfonylurea receptor activity,MF,
4003,GO:0008282,1,0.971216356360802,0,4,inward rectifying potassium channel,CC,
4008,GO:0008287,1,0.737365095507474,0,44,protein serine/threonine phosphatase complex,CC,
4010,GO:0008290,1,0.956445964243764,0,7,F-actin capping protein complex,CC,
4011,GO:0008291,1,0.979592457432877,0,3,acetylcholine metabolic process,BP,
4012,GO:0008292,1,0.993270554299511,0,1,acetylcholine biosynthetic process,BP,
4013,GO:0008294,1,0.980358600841388,0,2,calcium- and calmodulin-responsive adenylate cyclase activity,MF,
4014,GO:0008295,1,0.97861658724438,0,4,spermidine biosynthetic process,BP,
4015,GO:0008296,1,0.942833614250339,0,10,3'-5'-exodeoxyribonuclease activity,MF,
4016,GO:0008297,1,0.953140630828196,0,7,single-stranded DNA exodeoxyribonuclease activity,MF,
4017,GO:0008298,1,0.92957399187252,0,12,intracellular mRNA localization,BP,
4018,GO:0008299,1,0.847352360256208,0,27,isoprenoid biosynthetic process,BP,
4019,GO:0008300,1,0.962698083195613,0,7,isoprenoid catabolic process,BP,
4020,GO:0008301,1,0.89062692444001,0,18,DNA binding, bending,MF,
4021,GO:0008305,1,0.782086678624878,0,32,integrin complex,CC,
4023,GO:0008307,1,0.737745924957502,0,41,structural constituent of muscle,MF,
4024,GO:0008308,1,0.912467418429858,0,14,voltage-gated anion channel activity,MF,
4025,GO:0008309,1,0.977433296949703,0,4,double-stranded DNA exodeoxyribonuclease activity,MF,
4026,GO:0008310,1,0.966905574626595,0,5,single-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
4027,GO:0008311,1,0.990532164464127,0,2,double-stranded DNA 3'-5' exodeoxyribonuclease activity,MF,
4028,GO:0008312,1,0.964204315848657,0,7,7S RNA binding,MF,
4029,GO:0008318,1,0.954421375625601,0,7,protein prenyltransferase activity,MF,
4030,GO:0008320,1,0.941638562126217,0,13,protein transmembrane transporter activity,MF,
4031,GO:0008321,1,0.976945191255693,0,3,Ral guanyl-nucleotide exchange factor activity,MF,
4033,GO:0008327,1,0.903447899848023,0,15,methyl-CpG binding,MF,
4035,GO:0008329,1,0.918680481368627,0,14,signaling pattern recognition receptor activity,MF,
4036,GO:0008330,1,0.977119409081931,0,4,protein tyrosine/threonine phosphatase activity,MF,
4037,GO:0008331,1,0.898304516042122,0,12,high voltage-gated calcium channel activity,MF,
4038,GO:0008332,1,0.965219616054647,0,4,low voltage-gated calcium channel activity,MF,
4040,GO:0008334,1,0.861090521752245,0,24,histone mRNA metabolic process,BP,
4041,GO:0008336,1,0.994895992285313,0,1,gamma-butyrobetaine dioxygenase activity,MF,
4042,GO:0008340,1,0.913922297803363,0,11,determination of adult lifespan,BP,
4043,GO:0008343,1,0.96640552461901,0,7,adult feeding behavior,BP,
4045,GO:0008347,1,0.770979095477461,0,38,glial cell migration,BP,
4046,GO:0008348,1,0.992512299234245,0,1,negative regulation of antimicrobial humoral response,BP,
4047,GO:0008349,1,0.918505560503578,0,11,MAP kinase kinase kinase kinase activity,MF,
4048,GO:0008352,1,0.993247225680846,0,1,katanin complex,CC,
4049,GO:0008353,1,0.909247423623557,0,16,RNA polymerase II carboxy-terminal domain kinase activity,MF,
4050,GO:0008354,1,0.951295149784937,0,7,germ cell migration,BP,
4051,GO:0008355,1,0.984853836458958,0,2,olfactory learning,BP,
4052,GO:0008356,1,0.881013334528741,0,18,asymmetric cell division,BP,
4053,GO:0008358,1,0.985986823594548,0,2,maternal determination of anterior/posterior axis, embryo,BP,
4058,GO:0008374,1,0.768741633049516,0,37,O-acyltransferase activity,MF,
4062,GO:0008379,1,0.983858497354837,0,5,thioredoxin peroxidase activity,MF,
4063,GO:0008380,1,0.0749930252265991,0,405,RNA splicing,BP,
4064,GO:0008381,1,0.940666705531708,0,9,mechanosensitive ion channel activity,MF,
4065,GO:0008384,1,0.985072085943014,0,2,IkappaB kinase activity,MF,
4066,GO:0008385,1,0.94452996153716,0,9,IkappaB kinase complex,CC,
4067,GO:0008386,1,0.994702755566728,0,1,cholesterol monooxygenase (side-chain-cleaving) activity,MF,
4068,GO:0008387,1,0.993994620078383,0,1,steroid 7-alpha-hydroxylase activity,MF,
4069,GO:0008389,1,0.990435691263476,0,2,coumarin 7-hydroxylase activity,MF,
4070,GO:0008391,1,0.959072105174587,0,8,arachidonic acid monooxygenase activity,MF,
4071,GO:0008392,1,0.959072105174587,0,8,arachidonic acid epoxygenase activity,MF,
4072,GO:0008395,1,0.881646889812172,0,22,steroid hydroxylase activity,MF,
4073,GO:0008396,1,0.987776364608213,0,2,oxysterol 7-alpha-hydroxylase activity,MF,
4074,GO:0008397,1,0.992481028403495,0,1,sterol 12-alpha-hydroxylase activity,MF,
4075,GO:0008398,1,0.992745374232163,0,1,sterol 14-demethylase activity,MF,
4076,GO:0008401,1,0.979986158069861,0,3,retinoic acid 4-hydroxylase activity,MF,
4077,GO:0008403,1,0.992676271816402,0,1,25-hydroxycholecalciferol-24-hydroxylase activity,MF,
4078,GO:0008404,1,0.994967112333128,0,1,arachidonic acid 14,15-epoxygenase activity,MF,
4079,GO:0008405,1,0.994967112333128,0,1,arachidonic acid 11,12-epoxygenase activity,MF,
4080,GO:0008406,1,0.283803931465423,0,183,gonad development,BP,
4081,GO:0008408,1,0.730836205024638,0,48,3'-5' exonuclease activity,MF,
4082,GO:0008409,1,0.885522121292164,0,16,5'-3' exonuclease activity,MF,
4083,GO:0008410,1,0.975914110835653,0,4,CoA-transferase activity,MF,
4084,GO:0008413,1,0.992092429380124,0,2,8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity,MF,
4085,GO:0008417,1,0.915277779131046,0,12,fucosyltransferase activity,MF,
4086,GO:0008418,1,0.996647798822422,0,1,protein-N-terminal asparagine amidohydrolase activity,MF,
4087,GO:0008419,1,0.993262180057268,0,1,RNA lariat debranching enzyme activity,MF,
4088,GO:0008420,1,0.950230449708863,0,8,CTD phosphatase activity,MF,
4089,GO:0008422,1,0.974579697178406,0,4,beta-glucosidase activity,MF,
4090,GO:0008424,1,0.992613845995336,0,1,glycoprotein 6-alpha-L-fucosyltransferase activity,MF,
4091,GO:0008425,1,0.996318964210472,0,1,2-polyprenyl-6-methoxy-1,4-benzoquinone methyltransferase activity,MF,
4092,GO:0008426,1,0.985897468447691,0,3,protein kinase C inhibitor activity,MF,
4093,GO:0008427,1,0.986957898126558,0,3,calcium-dependent protein kinase inhibitor activity,MF,
4094,GO:0008428,1,0.980191419596662,0,3,ribonuclease inhibitor activity,MF,
4095,GO:0008429,1,0.948875641565272,0,9,phosphatidylethanolamine binding,MF,
4096,GO:0008430,1,0.974353610168168,0,4,selenium binding,MF,
4097,GO:0008431,1,0.986108320862115,0,2,vitamin E binding,MF,
4098,GO:0008432,1,0.947453867714053,0,8,JUN kinase binding,MF,
4099,GO:0008434,1,0.992258462460885,0,1,calcitriol receptor activity,MF,
4100,GO:0008437,1,0.994623553047403,0,1,thyrotropin-releasing hormone activity,MF,
4101,GO:0008440,1,0.96714819962807,0,5,inositol-1,4,5-trisphosphate 3-kinase activity,MF,
4102,GO:0008441,1,0.984438947202258,0,2,3'(2'),5'-bisphosphate nucleotidase activity,MF,
4103,GO:0008442,1,0.994685004836045,0,1,3-hydroxyisobutyrate dehydrogenase activity,MF,
4104,GO:0008443,1,0.951759183681293,0,7,phosphofructokinase activity,MF,
4105,GO:0008444,1,0.994184610546592,0,1,CDP-diacylglycerol-glycerol-3-phosphate 3-phosphatidyltransferase activity,MF,
4106,GO:0008445,1,0.995529779370763,0,1,D-aspartate oxidase activity,MF,
4107,GO:0008446,1,0.995396218536013,0,1,GDP-mannose 4,6-dehydratase activity,MF,
4108,GO:0008448,1,0.995025112422485,0,1,N-acetylglucosamine-6-phosphate deacetylase activity,MF,
4109,GO:0008449,1,0.97639973043458,0,3,N-acetylglucosamine-6-sulfatase activity,MF,
4110,GO:0008452,1,0.993058458973322,0,1,RNA ligase activity,MF,
4111,GO:0008453,1,0.981791772326035,0,3,alanine-glyoxylate transaminase activity,MF,
4112,GO:0008454,1,0.979614337593482,0,3,alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity,MF,
4113,GO:0008455,1,0.993174814481327,0,1,alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity,MF,
4114,GO:0008456,1,0.992504407295285,0,1,alpha-N-acetylgalactosaminidase activity,MF,
4115,GO:0008457,1,0.992454963238182,0,1,beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity,MF,
4116,GO:0008458,1,0.992632114881839,0,1,carnitine O-octanoyltransferase activity,MF,
4117,GO:0008459,1,0.984913217176343,0,2,chondroitin 6-sulfotransferase activity,MF,
4118,GO:0008460,1,0.994853294321578,0,1,dTDP-glucose 4,6-dehydratase activity,MF,
4119,GO:0008465,1,0.99637781248704,0,1,glycerate dehydrogenase activity,MF,
4120,GO:0008466,1,0.987715276302503,0,2,glycogenin glucosyltransferase activity,MF,
4121,GO:0008467,1,0.96387798255969,0,6,[heparan sulfate]-glucosamine 3-sulfotransferase 1 activity,MF,
4122,GO:0008469,1,0.945274382472814,0,9,histone-arginine N-methyltransferase activity,MF,
4123,GO:0008470,1,0.992297666877675,0,1,isovaleryl-CoA dehydrogenase activity,MF,
4124,GO:0008474,1,0.940741187013966,0,10,palmitoyl-(protein) hydrolase activity,MF,
4125,GO:0008475,1,0.97823919732578,0,3,procollagen-lysine 5-dioxygenase activity,MF,
4126,GO:0008476,1,0.989302151778572,0,2,protein-tyrosine sulfotransferase activity,MF,
4127,GO:0008478,1,0.990674513429981,0,1,pyridoxal kinase activity,MF,
4128,GO:0008479,1,0.981866556316447,0,4,queuine tRNA-ribosyltransferase activity,MF,
4129,GO:0008480,1,0.992604338498186,0,1,sarcosine dehydrogenase activity,MF,
4130,GO:0008481,1,0.987835130982211,0,2,sphinganine kinase activity,MF,
4131,GO:0008482,1,0.993875212402642,0,1,sulfite oxidase activity,MF,
4132,GO:0008483,1,0.893889180537021,0,17,transaminase activity,MF,
4133,GO:0008484,1,0.891081641047775,0,16,sulfuric ester hydrolase activity,MF,
4134,GO:0008486,1,0.976974422612972,0,4,diphosphoinositol-polyphosphate diphosphatase activity,MF,
4135,GO:0008488,1,0.992677829577327,0,1,gamma-glutamyl carboxylase activity,MF,
4137,GO:0008493,1,0.994958819534913,0,1,tetracycline transmembrane transporter activity,MF,
4138,GO:0008494,1,0.932037149405735,0,11,translation activator activity,MF,
4139,GO:0008495,1,0.992809491006854,0,1,protoheme IX farnesyltransferase activity,MF,
4140,GO:0008496,1,0.992423961560943,0,1,mannan endo-1,6-alpha-mannosidase activity,MF,
4141,GO:0008499,1,0.924951456730744,0,12,UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity,MF,
4142,GO:0008502,1,0.979383119530188,0,4,melatonin receptor activity,MF,
4143,GO:0008503,1,0.930804288508575,0,10,benzodiazepine receptor activity,MF,
4144,GO:0008504,1,0.944772727440988,0,8,monoamine transmembrane transporter activity,MF,
4145,GO:0008506,1,0.979385092178553,0,3,sucrose:proton symporter activity,MF,
4146,GO:0008507,1,0.992525201544002,0,1,sodium:iodide symporter activity,MF,
4147,GO:0008508,1,0.981402221531041,0,4,bile acid:sodium symporter activity,MF,
4149,GO:0008510,1,0.929123130033314,0,9,sodium:bicarbonate symporter activity,MF,
4150,GO:0008511,1,0.983301772356678,0,2,sodium:potassium:chloride symporter activity,MF,
4151,GO:0008513,1,0.987727370010835,0,2,secondary active organic cation transmembrane transporter activity,MF,
4153,GO:0008515,1,0.979385092178553,0,3,sucrose transmembrane transporter activity,MF,
4154,GO:0008517,1,0.963483919785177,0,6,folic acid transmembrane transporter activity,MF,
4155,GO:0008518,1,0.992985671165203,0,1,reduced folate carrier activity,MF,
4156,GO:0008519,1,0.839605346446329,0,27,ammonium transmembrane transporter activity,MF,
4157,GO:0008520,1,0.990928293703605,0,1,L-ascorbate:sodium symporter activity,MF,
4158,GO:0008521,1,0.993248879662176,0,1,acetyl-CoA transmembrane transporter activity,MF,
4159,GO:0008523,1,0.992607370275599,0,1,sodium-dependent multivitamin transmembrane transporter activity,MF,
4160,GO:0008525,1,0.941153476590518,0,8,phosphatidylcholine transporter activity,MF,
4161,GO:0008526,1,0.942356990942531,0,8,phosphatidylinositol transporter activity,MF,
4162,GO:0008527,1,0.940536734719026,0,14,taste receptor activity,MF,
4164,GO:0008531,1,0.993174814481327,0,1,riboflavin kinase activity,MF,
4165,GO:0008532,1,0.951500228431829,0,8,N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity,MF,
4166,GO:0008534,1,0.983912193297725,0,4,oxidized purine nucleobase lesion DNA N-glycosylase activity,MF,
4167,GO:0008535,1,0.869983581620487,0,24,respiratory chain complex IV assembly,BP,
4168,GO:0008536,1,0.782759951823586,0,33,Ran GTPase binding,MF,
4169,GO:0008537,1,0.986660578019675,0,3,proteasome activator complex,CC,
4170,GO:0008540,1,0.940285865004462,0,12,proteasome regulatory particle, base subcomplex,CC,
4171,GO:0008541,1,0.96769977252775,0,7,proteasome regulatory particle, lid subcomplex,CC,
4172,GO:0008542,1,0.716640996391801,0,44,visual learning,BP,
4175,GO:0008545,1,0.985136091512516,0,2,JUN kinase kinase activity,MF,
4176,GO:0008553,1,0.918930498285493,0,13,proton-exporting ATPase activity, phosphorylative mechanism,MF,
4177,GO:0008554,1,0.992221477335208,0,1,sodium-exporting ATPase activity, phosphorylative mechanism,MF,
4178,GO:0008555,1,0.991906517475161,0,1,chloride-transporting ATPase activity,MF,
4179,GO:0008556,1,0.930477319389517,0,11,potassium-transporting ATPase activity,MF,
4180,GO:0008559,1,0.953416209213581,0,6,xenobiotic transmembrane transporting ATPase activity,MF,
4181,GO:0008565,1,0.614152447665951,0,77,protein transporter activity,MF,
4182,GO:0008568,1,0.931231431570457,0,10,microtubule-severing ATPase activity,MF,
4183,GO:0008569,1,0.821967924094602,0,18,ATP-dependent microtubule motor activity, minus-end-directed,MF,
4184,GO:0008574,1,0.799568998699793,0,30,ATP-dependent microtubule motor activity, plus-end-directed,MF,
4185,GO:0008579,1,0.991960993493475,0,1,JUN kinase phosphatase activity,MF,
4186,GO:0008582,1,0.96846522702635,0,4,regulation of synaptic growth at neuromuscular junction,BP,
4187,GO:0008584,1,0.450620008432554,0,116,male gonad development,BP,
4188,GO:0008585,1,0.552979181335233,0,85,female gonad development,BP,
4189,GO:0008589,1,0.590709266033228,0,72,regulation of smoothened signaling pathway,BP,
4190,GO:0008591,1,0.995101869933184,0,1,regulation of Wnt signaling pathway, calcium modulating pathway,BP,
4191,GO:0008592,1,0.992638813066294,0,1,regulation of Toll signaling pathway,BP,
4193,GO:0008594,1,0.984991782573283,0,2,photoreceptor cell morphogenesis,BP,
4194,GO:0008595,1,0.921419616694064,0,12,anterior/posterior axis specification, embryo,BP,
4195,GO:0008597,1,0.98179061037742,0,3,calcium-dependent protein serine/threonine phosphatase regulator activity,MF,
4196,GO:0008603,1,0.957592878398306,0,7,cAMP-dependent protein kinase regulator activity,MF,
4197,GO:0008607,1,0.981096436121816,0,3,phosphorylase kinase regulator activity,MF,
4198,GO:0008608,1,0.818579086951493,0,30,attachment of spindle microtubules to kinetochore,BP,
4199,GO:0008609,1,0.990499003419732,0,1,alkylglycerone-phosphate synthase activity,MF,
4201,GO:0008611,1,0.967974230464353,0,5,ether lipid biosynthetic process,BP,
4202,GO:0008612,1,0.979575142047115,0,4,peptidyl-lysine modification to peptidyl-hypusine,BP,
4203,GO:0008614,1,0.986946188961265,0,2,pyridoxine metabolic process,BP,
4204,GO:0008615,1,0.986946188961265,0,2,pyridoxine biosynthetic process,BP,
4205,GO:0008616,1,0.985650963504797,0,3,queuosine biosynthetic process,BP,
4206,GO:0008617,1,0.996867443319391,0,1,guanosine metabolic process,BP,
4207,GO:0008622,1,0.971125612719706,0,5,epsilon DNA polymerase complex,CC,
4208,GO:0008623,1,0.985262743794014,0,2,CHRAC,CC,
4210,GO:0008626,1,0.971685848762507,0,6,granzyme-mediated apoptotic signaling pathway,BP,
4211,GO:0008627,1,0.947575028242511,0,8,intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
4212,GO:0008628,1,0.987073489199772,0,3,hormone-mediated apoptotic signaling pathway,BP,
4213,GO:0008630,1,0.539741125949787,0,99,intrinsic apoptotic signaling pathway in response to DNA damage,BP,
4214,GO:0008631,1,0.768369523019709,0,42,intrinsic apoptotic signaling pathway in response to oxidative stress,BP,
4215,GO:0008635,1,0.945006469946954,0,9,activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c,BP,
4217,GO:0008641,1,0.93328770673377,0,10,ubiquitin-like modifier activating enzyme activity,MF,
4218,GO:0008643,1,0.411150415694658,0,127,carbohydrate transport,BP,
4219,GO:0008645,1,0.505854123568679,0,96,hexose transmembrane transport,BP,
4220,GO:0008649,1,0.916052829598735,0,15,rRNA methyltransferase activity,MF,
4221,GO:0008650,1,0.992527393650525,0,1,rRNA (uridine-2'-O-)-methyltransferase activity,MF,
4222,GO:0008652,1,0.615132456857895,0,75,cellular amino acid biosynthetic process,BP,
4224,GO:0008655,1,0.938692612500033,0,12,pyrimidine-containing compound salvage,BP,
4225,GO:0008656,1,0.915841389591513,0,14,cysteine-type endopeptidase activator activity involved in apoptotic process,MF,
4226,GO:0008670,1,0.991961949267808,0,2,2,4-dienoyl-CoA reductase (NADPH) activity,MF,
4227,GO:0008689,1,0.996318964210472,0,1,3-demethylubiquinone-9 3-O-methyltransferase activity,MF,
4228,GO:0008700,1,0.993058458973322,0,1,4-hydroxy-2-oxoglutarate aldolase activity,MF,
4229,GO:0008705,1,0.988839235855494,0,1,methionine synthase activity,MF,
4230,GO:0008709,1,0.996995371001083,0,1,cholate 7-alpha-dehydrogenase activity,MF,
4231,GO:0008721,1,0.993575240739539,0,1,D-serine ammonia-lyase activity,MF,
4232,GO:0008725,1,0.99670774898663,0,1,DNA-3-methyladenine glycosylase activity,MF,
4233,GO:0008732,1,0.98773289675845,0,2,L-allo-threonine aldolase activity,MF,
4234,GO:0008745,1,0.996996425083931,0,1,N-acetylmuramoyl-L-alanine amidase activity,MF,
4235,GO:0008746,1,0.989015551903477,0,2,NAD(P)+ transhydrogenase activity,MF,
4236,GO:0008747,1,0.995666715096851,0,1,N-acetylneuraminate lyase activity,MF,
4237,GO:0008750,1,0.992276264725365,0,1,NAD(P)+ transhydrogenase (AB-specific) activity,MF,
4238,GO:0008753,1,0.99255490328608,0,1,NADPH dehydrogenase (quinone) activity,MF,
4239,GO:0008757,1,0.413771691384005,0,132,S-adenosylmethionine-dependent methyltransferase activity,MF,
4240,GO:0008761,1,0.991951608096997,0,1,UDP-N-acetylglucosamine 2-epimerase activity,MF,
4241,GO:0008768,1,0.997176993430727,0,1,UDP-sugar diphosphatase activity,MF,
4242,GO:0008775,1,0.995049937063203,0,1,acetate CoA-transferase activity,MF,
4243,GO:0008781,1,0.991635465056056,0,2,N-acylneuraminate cytidylyltransferase activity,MF,
4244,GO:0008783,1,0.994175540086614,0,1,agmatinase activity,MF,
4245,GO:0008785,1,0.995653076542004,0,1,alkyl hydroperoxide reductase activity,MF,
4246,GO:0008792,1,0.993058458973322,0,1,arginine decarboxylase activity,MF,
4247,GO:0008794,1,0.997080589200415,0,1,arsenate reductase (glutaredoxin) activity,MF,
4248,GO:0008796,1,0.990032060870289,0,2,bis(5'-nucleosyl)-tetraphosphatase activity,MF,
4249,GO:0008798,1,0.985515959395818,0,2,beta-aspartyl-peptidase activity,MF,
4250,GO:0008802,1,0.992529096241671,0,1,betaine-aldehyde dehydrogenase activity,MF,
4251,GO:0008803,1,0.996916167829107,0,1,bis(5'-nucleosyl)-tetraphosphatase (symmetrical) activity,MF,
4252,GO:0008808,1,0.992496392024204,0,1,cardiolipin synthase activity,MF,
4253,GO:0008812,1,0.99251544213873,0,1,choline dehydrogenase activity,MF,
4254,GO:0008817,1,0.992450822347901,0,1,cob(I)yrinic acid a,c-diamide adenosyltransferase activity,MF,
4255,GO:0008821,1,0.952555279240835,0,8,crossover junction endodeoxyribonuclease activity,MF,
4256,GO:0008823,1,0.965685209486323,0,5,cupric reductase activity,MF,
4257,GO:0008829,1,0.995059387970464,0,1,dCTP deaminase activity,MF,
4258,GO:0008832,1,0.992660350041409,0,1,dGTPase activity,MF,
4259,GO:0008841,1,0.993553795800342,0,1,dihydrofolate synthase activity,MF,
4260,GO:0008843,1,0.993920441312131,0,1,endochitinase activity,MF,
4261,GO:0008852,1,0.992993348029592,0,1,exodeoxyribonuclease I activity,MF,
4262,GO:0008853,1,0.9786197258173,0,4,exodeoxyribonuclease III activity,MF,
4263,GO:0008859,1,0.996985881961834,0,1,exoribonuclease II activity,MF,
4264,GO:0008865,1,0.962571044827959,0,5,fructokinase activity,MF,
4265,GO:0008887,1,0.992639338061425,0,1,glycerate kinase activity,MF,
4266,GO:0008889,1,0.96446643796354,0,5,glycerophosphodiester phosphodiesterase activity,MF,
4267,GO:0008890,1,0.995609807722115,0,1,glycine C-acetyltransferase activity,MF,
4268,GO:0008891,1,0.995228728217183,0,1,glycolate oxidase activity,MF,
4269,GO:0008892,1,0.991869782709611,0,1,guanine deaminase activity,MF,
4270,GO:0008893,1,0.99680158931286,0,1,guanosine-3',5'-bis(diphosphate) 3'-diphosphatase activity,MF,
4271,GO:0008894,1,0.993127304752758,0,1,guanosine-5'-triphosphate,3'-diphosphate diphosphatase activity,MF,
4272,GO:0008897,1,0.99295701881417,0,1,holo-[acyl-carrier-protein] synthase activity,MF,
4273,GO:0008900,1,0.985107881179954,0,2,potassium:proton exchanging ATPase activity,MF,
4274,GO:0008903,1,0.996658517811425,0,1,hydroxypyruvate isomerase activity,MF,
4275,GO:0008905,1,0.995561841319725,0,1,mannose-phosphate guanylyltransferase activity,MF,
4276,GO:0008934,1,0.972117065986413,0,4,inositol monophosphate 1-phosphatase activity,MF,
4277,GO:0008940,1,0.97868925804653,0,3,nitrate reductase activity,MF,
4278,GO:0008941,1,0.988306441259368,0,2,nitric oxide dioxygenase activity,MF,
4279,GO:0008948,1,0.97460800319579,0,4,oxaloacetate decarboxylase activity,MF,
4280,GO:0008955,1,0.992479847505615,0,1,peptidoglycan glycosyltransferase activity,MF,
4281,GO:0008962,1,0.988041360028882,0,2,phosphatidylglycerophosphatase activity,MF,
4282,GO:0008963,1,0.994296615871421,0,1,phospho-N-acetylmuramoyl-pentapeptide-transferase activity,MF,
4283,GO:0008967,1,0.987327661888244,0,2,phosphoglycolate phosphatase activity,MF,
4284,GO:0008970,1,0.947639385668265,0,9,phosphatidylcholine 1-acylhydrolase activity,MF,
4285,GO:0008973,1,0.992634663389341,0,1,phosphopentomutase activity,MF,
4286,GO:0008988,1,0.986164624597214,0,2,rRNA (adenine-N6-)-methyltransferase activity,MF,
4287,GO:0008995,1,0.993367477867485,0,1,ribonuclease E activity,MF,
4288,GO:0009000,1,0.993602788080427,0,1,selenocysteine lyase activity,MF,
4289,GO:0009007,1,0.99251093643518,0,1,site-specific DNA-methyltransferase (adenine-specific) activity,MF,
4290,GO:0009008,1,0.96607380367808,0,5,DNA-methyltransferase activity,MF,
4291,GO:0009013,1,0.992035648124119,0,1,succinate-semialdehyde dehydrogenase [NAD(P)+] activity,MF,
4292,GO:0009019,1,0.971447226932725,0,4,tRNA (guanine-N1-)-methyltransferase activity,MF,
4293,GO:0009020,1,0.994732359360662,0,1,tRNA (guanosine-2'-O-)-methyltransferase activity,MF,
4294,GO:0009032,1,0.99543318216766,0,1,thymidine phosphorylase activity,MF,
4295,GO:0009041,1,0.982482192238232,0,3,uridylate kinase activity,MF,
4296,GO:0009048,1,0.919864151292738,0,10,dosage compensation by inactivation of X chromosome,BP,
4297,GO:0009051,1,0.985519538804391,0,3,pentose-phosphate shunt, oxidative branch,BP,
4298,GO:0009052,1,0.972507369499308,0,5,pentose-phosphate shunt, non-oxidative branch,BP,
4299,GO:0009055,1,0.616815714675488,0,101,electron transfer activity,MF,
4304,GO:0009060,1,0.679997584426833,0,74,aerobic respiration,BP,
4305,GO:0009061,1,0.993742481693133,0,1,anaerobic respiration,BP,
4306,GO:0009062,1,0.518095604123531,0,104,fatty acid catabolic process,BP,
4310,GO:0009066,1,0.710455630223445,0,55,aspartate family amino acid metabolic process,BP,
4311,GO:0009067,1,0.864410498131816,0,22,aspartate family amino acid biosynthetic process,BP,
4312,GO:0009068,1,0.880176714988305,0,21,aspartate family amino acid catabolic process,BP,
4313,GO:0009069,1,0.804733363048464,0,36,serine family amino acid metabolic process,BP,
4314,GO:0009070,1,0.915011139762347,0,15,serine family amino acid biosynthetic process,BP,
4315,GO:0009071,1,0.943811358543298,0,11,serine family amino acid catabolic process,BP,
4316,GO:0009072,1,0.884820945588131,0,23,aromatic amino acid family metabolic process,BP,
4317,GO:0009074,1,0.912722816625213,0,18,aromatic amino acid family catabolic process,BP,
4318,GO:0009078,1,0.978682306157254,0,4,pyruvate family amino acid metabolic process,BP,
4319,GO:0009080,1,0.978682306157254,0,4,pyruvate family amino acid catabolic process,BP,
4320,GO:0009081,1,0.854056617579619,0,24,branched-chain amino acid metabolic process,BP,
4321,GO:0009082,1,0.985720978868277,0,2,branched-chain amino acid biosynthetic process,BP,
4322,GO:0009083,1,0.874153741492627,0,21,branched-chain amino acid catabolic process,BP,
4323,GO:0009084,1,0.894093240700204,0,17,glutamine family amino acid biosynthetic process,BP,
4324,GO:0009085,1,0.984606443476849,0,2,lysine biosynthetic process,BP,
4325,GO:0009086,1,0.92511348419196,0,12,methionine biosynthetic process,BP,
4326,GO:0009087,1,0.992568672128432,0,1,methionine catabolic process,BP,
4327,GO:0009088,1,0.994365921264761,0,1,threonine biosynthetic process,BP,
4328,GO:0009092,1,0.977186509799577,0,4,homoserine metabolic process,BP,
4329,GO:0009093,1,0.984538186797667,0,3,cysteine catabolic process,BP,
4330,GO:0009098,1,0.985720978868277,0,2,leucine biosynthetic process,BP,
4331,GO:0009099,1,0.985720978868277,0,2,valine biosynthetic process,BP,
4334,GO:0009106,1,0.987958578302535,0,2,lipoate metabolic process,BP,
4335,GO:0009107,1,0.995399687780569,0,1,lipoate biosynthetic process,BP,
4336,GO:0009108,1,0.233836383686137,0,221,coenzyme biosynthetic process,BP,
4337,GO:0009109,1,0.924970208755576,0,14,coenzyme catabolic process,BP,
4338,GO:0009110,1,0.875317565455478,0,21,vitamin biosynthetic process,BP,
4339,GO:0009111,1,0.944886442476972,0,10,vitamin catabolic process,BP,
4340,GO:0009112,1,0.784064235073944,0,39,nucleobase metabolic process,BP,
4341,GO:0009113,1,0.924292939263904,0,13,purine nucleobase biosynthetic process,BP,
4342,GO:0009115,1,0.983883671546724,0,2,xanthine catabolic process,BP,
4343,GO:0009116,1,0.505885564406705,0,113,nucleoside metabolic process,BP,
4345,GO:0009119,1,0.562798839470927,0,94,ribonucleoside metabolic process,BP,
4346,GO:0009120,1,0.968646456102423,0,6,deoxyribonucleoside metabolic process,BP,
4347,GO:0009123,1,0.16430055605812,0,304,nucleoside monophosphate metabolic process,BP,
4348,GO:0009124,1,0.357512753445708,0,159,nucleoside monophosphate biosynthetic process,BP,
4349,GO:0009125,1,0.940327893748286,0,11,nucleoside monophosphate catabolic process,BP,
4350,GO:0009126,1,0.191163096311148,0,278,purine nucleoside monophosphate metabolic process,BP,
4351,GO:0009127,1,0.406461926258519,0,137,purine nucleoside monophosphate biosynthetic process,BP,
4352,GO:0009128,1,0.951086333005418,0,9,purine nucleoside monophosphate catabolic process,BP,
4353,GO:0009129,1,0.913040739432358,0,16,pyrimidine nucleoside monophosphate metabolic process,BP,
4354,GO:0009130,1,0.9170745461618,0,15,pyrimidine nucleoside monophosphate biosynthetic process,BP,
4355,GO:0009131,1,0.995605245989603,0,1,pyrimidine nucleoside monophosphate catabolic process,BP,
4356,GO:0009132,1,0.408481459590048,0,134,nucleoside diphosphate metabolic process,BP,
4357,GO:0009133,1,0.967511385794802,0,6,nucleoside diphosphate biosynthetic process,BP,
4358,GO:0009134,1,0.964580349982558,0,6,nucleoside diphosphate catabolic process,BP,
4359,GO:0009135,1,0.455580087408391,0,113,purine nucleoside diphosphate metabolic process,BP,
4360,GO:0009136,1,0.983502069941515,0,3,purine nucleoside diphosphate biosynthetic process,BP,
4361,GO:0009137,1,0.981803785929217,0,3,purine nucleoside diphosphate catabolic process,BP,
4362,GO:0009138,1,0.982395862721371,0,3,pyrimidine nucleoside diphosphate metabolic process,BP,
4363,GO:0009139,1,0.989444287114099,0,2,pyrimidine nucleoside diphosphate biosynthetic process,BP,
4364,GO:0009140,1,0.992877134307693,0,1,pyrimidine nucleoside diphosphate catabolic process,BP,
4365,GO:0009141,1,0.185712632606728,0,289,nucleoside triphosphate metabolic process,BP,
4366,GO:0009142,1,0.399113766051043,0,143,nucleoside triphosphate biosynthetic process,BP,
4367,GO:0009143,1,0.932848416685547,0,12,nucleoside triphosphate catabolic process,BP,
4368,GO:0009144,1,0.209436682415316,0,269,purine nucleoside triphosphate metabolic process,BP,
4369,GO:0009145,1,0.442483869861911,0,126,purine nucleoside triphosphate biosynthetic process,BP,
4370,GO:0009146,1,0.969024247008427,0,6,purine nucleoside triphosphate catabolic process,BP,
4371,GO:0009147,1,0.902687066456051,0,21,pyrimidine nucleoside triphosphate metabolic process,BP,
4372,GO:0009148,1,0.916509438802207,0,18,pyrimidine nucleoside triphosphate biosynthetic process,BP,
4373,GO:0009149,1,0.991596639453222,0,2,pyrimidine nucleoside triphosphate catabolic process,BP,
4375,GO:0009151,1,0.947094533887652,0,10,purine deoxyribonucleotide metabolic process,BP,
4377,GO:0009153,1,0.984021026308109,0,3,purine deoxyribonucleotide biosynthetic process,BP,
4378,GO:0009154,1,0.807352182779701,0,31,purine ribonucleotide catabolic process,BP,
4379,GO:0009155,1,0.972256231415911,0,5,purine deoxyribonucleotide catabolic process,BP,
4380,GO:0009156,1,0.377466409888512,0,149,ribonucleoside monophosphate biosynthetic process,BP,
4381,GO:0009157,1,0.953130629769296,0,9,deoxyribonucleoside monophosphate biosynthetic process,BP,
4382,GO:0009158,1,0.954274473548877,0,8,ribonucleoside monophosphate catabolic process,BP,
4383,GO:0009159,1,0.988693907568664,0,2,deoxyribonucleoside monophosphate catabolic process,BP,
4384,GO:0009161,1,0.178031495223801,0,289,ribonucleoside monophosphate metabolic process,BP,
4385,GO:0009162,1,0.939437526851851,0,12,deoxyribonucleoside monophosphate metabolic process,BP,
4386,GO:0009163,1,0.803672709645373,0,41,nucleoside biosynthetic process,BP,
4387,GO:0009164,1,0.863626863604387,0,27,nucleoside catabolic process,BP,
4389,GO:0009166,1,0.354757205579738,0,156,nucleotide catabolic process,BP,
4390,GO:0009167,1,0.191814312829757,0,277,purine ribonucleoside monophosphate metabolic process,BP,
4391,GO:0009168,1,0.406461926258519,0,137,purine ribonucleoside monophosphate biosynthetic process,BP,
4392,GO:0009169,1,0.954274473548877,0,8,purine ribonucleoside monophosphate catabolic process,BP,
4393,GO:0009170,1,0.996911935398822,0,1,purine deoxyribonucleoside monophosphate metabolic process,BP,
4394,GO:0009173,1,0.941067007782844,0,10,pyrimidine ribonucleoside monophosphate metabolic process,BP,
4395,GO:0009174,1,0.941067007782844,0,10,pyrimidine ribonucleoside monophosphate biosynthetic process,BP,
4396,GO:0009176,1,0.970236462312398,0,6,pyrimidine deoxyribonucleoside monophosphate metabolic process,BP,
4397,GO:0009177,1,0.974520345273728,0,5,pyrimidine deoxyribonucleoside monophosphate biosynthetic process,BP,
4398,GO:0009178,1,0.995605245989603,0,1,pyrimidine deoxyribonucleoside monophosphate catabolic process,BP,
4399,GO:0009179,1,0.455580087408391,0,113,purine ribonucleoside diphosphate metabolic process,BP,
4400,GO:0009180,1,0.983502069941515,0,3,purine ribonucleoside diphosphate biosynthetic process,BP,
4401,GO:0009181,1,0.981803785929217,0,3,purine ribonucleoside diphosphate catabolic process,BP,
4402,GO:0009182,1,0.982588715553708,0,3,purine deoxyribonucleoside diphosphate metabolic process,BP,
4403,GO:0009183,1,0.989457803333985,0,2,purine deoxyribonucleoside diphosphate biosynthetic process,BP,
4404,GO:0009185,1,0.450688828533171,0,115,ribonucleoside diphosphate metabolic process,BP,
4405,GO:0009186,1,0.972214976779137,0,5,deoxyribonucleoside diphosphate metabolic process,BP,
4407,GO:0009188,1,0.983502069941515,0,3,ribonucleoside diphosphate biosynthetic process,BP,
4408,GO:0009189,1,0.979012268040985,0,4,deoxyribonucleoside diphosphate biosynthetic process,BP,
4410,GO:0009191,1,0.971343054393207,0,5,ribonucleoside diphosphate catabolic process,BP,
4411,GO:0009193,1,0.992877134307693,0,1,pyrimidine ribonucleoside diphosphate metabolic process,BP,
4412,GO:0009195,1,0.992877134307693,0,1,pyrimidine ribonucleoside diphosphate catabolic process,BP,
4413,GO:0009196,1,0.989444287114099,0,2,pyrimidine deoxyribonucleoside diphosphate metabolic process,BP,
4414,GO:0009197,1,0.989444287114099,0,2,pyrimidine deoxyribonucleoside diphosphate biosynthetic process,BP,
4415,GO:0009199,1,0.209163756216313,0,268,ribonucleoside triphosphate metabolic process,BP,
4416,GO:0009200,1,0.921277572058451,0,16,deoxyribonucleoside triphosphate metabolic process,BP,
4417,GO:0009201,1,0.428194955092218,0,131,ribonucleoside triphosphate biosynthetic process,BP,
4418,GO:0009202,1,0.969187564853429,0,6,deoxyribonucleoside triphosphate biosynthetic process,BP,
4419,GO:0009203,1,0.996676726459821,0,1,ribonucleoside triphosphate catabolic process,BP,
4420,GO:0009204,1,0.964083717051031,0,7,deoxyribonucleoside triphosphate catabolic process,BP,
4421,GO:0009205,1,0.21740743061377,0,262,purine ribonucleoside triphosphate metabolic process,BP,
4422,GO:0009206,1,0.444948304716518,0,125,purine ribonucleoside triphosphate biosynthetic process,BP,
4423,GO:0009207,1,0.996676726459821,0,1,purine ribonucleoside triphosphate catabolic process,BP,
4424,GO:0009208,1,0.927651669660239,0,15,pyrimidine ribonucleoside triphosphate metabolic process,BP,
4425,GO:0009209,1,0.93393293755904,0,14,pyrimidine ribonucleoside triphosphate biosynthetic process,BP,
4426,GO:0009211,1,0.97310836545599,0,6,pyrimidine deoxyribonucleoside triphosphate metabolic process,BP,
4427,GO:0009212,1,0.981356609166164,0,4,pyrimidine deoxyribonucleoside triphosphate biosynthetic process,BP,
4428,GO:0009213,1,0.991596639453222,0,2,pyrimidine deoxyribonucleoside triphosphate catabolic process,BP,
4429,GO:0009214,1,0.85434079200032,0,20,cyclic nucleotide catabolic process,BP,
4430,GO:0009215,1,0.954232655129805,0,9,purine deoxyribonucleoside triphosphate metabolic process,BP,
4431,GO:0009216,1,0.987602095699313,0,2,purine deoxyribonucleoside triphosphate biosynthetic process,BP,
4432,GO:0009217,1,0.972256231415911,0,5,purine deoxyribonucleoside triphosphate catabolic process,BP,
4433,GO:0009218,1,0.880753829905459,0,23,pyrimidine ribonucleotide metabolic process,BP,
4434,GO:0009219,1,0.910317557251574,0,19,pyrimidine deoxyribonucleotide metabolic process,BP,
4435,GO:0009220,1,0.893089178796484,0,21,pyrimidine ribonucleotide biosynthetic process,BP,
4436,GO:0009221,1,0.960568294166793,0,8,pyrimidine deoxyribonucleotide biosynthetic process,BP,
4437,GO:0009222,1,0.992877134307693,0,1,pyrimidine ribonucleotide catabolic process,BP,
4438,GO:0009223,1,0.942905502331727,0,12,pyrimidine deoxyribonucleotide catabolic process,BP,
4439,GO:0009224,1,0.99636257431311,0,1,CMP biosynthetic process,BP,
4440,GO:0009225,1,0.799665566125359,0,36,nucleotide-sugar metabolic process,BP,
4441,GO:0009226,1,0.87366807654318,0,23,nucleotide-sugar biosynthetic process,BP,
4442,GO:0009227,1,0.983344791626397,0,3,nucleotide-sugar catabolic process,BP,
4443,GO:0009229,1,0.993819878128903,0,1,thiamine diphosphate biosynthetic process,BP,
4444,GO:0009231,1,0.993174814481327,0,1,riboflavin biosynthetic process,BP,
4445,GO:0009233,1,0.985234407656951,0,2,menaquinone metabolic process,BP,
4446,GO:0009234,1,0.99251470947205,0,1,menaquinone biosynthetic process,BP,
4447,GO:0009235,1,0.887836407183521,0,18,cobalamin metabolic process,BP,
4448,GO:0009236,1,0.977156163534353,0,3,cobalamin biosynthetic process,BP,
4449,GO:0009237,1,0.992885722858015,0,1,siderophore metabolic process,BP,
4450,GO:0009240,1,0.980287216760656,0,4,isopentenyl diphosphate biosynthetic process,BP,
4451,GO:0009245,1,0.995228475299946,0,2,lipid A biosynthetic process,BP,
4453,GO:0009249,1,0.972432278784778,0,8,protein lipoylation,BP,
4456,GO:0009253,1,0.993915432324873,0,2,peptidoglycan catabolic process,BP,
4457,GO:0009256,1,0.962732608323283,0,5,10-formyltetrahydrofolate metabolic process,BP,
4458,GO:0009257,1,0.985124307003538,0,2,10-formyltetrahydrofolate biosynthetic process,BP,
4459,GO:0009258,1,0.983351794821266,0,2,10-formyltetrahydrofolate catabolic process,BP,
4462,GO:0009261,1,0.801589251520857,0,32,ribonucleotide catabolic process,BP,
4463,GO:0009262,1,0.838767104248087,0,33,deoxyribonucleotide metabolic process,BP,
4464,GO:0009263,1,0.924005297047586,0,14,deoxyribonucleotide biosynthetic process,BP,
4465,GO:0009264,1,0.912399924800634,0,18,deoxyribonucleotide catabolic process,BP,
4466,GO:0009265,1,0.945213261524734,0,11,2'-deoxyribonucleotide biosynthetic process,BP,
4468,GO:0009267,1,0.417314303119416,0,130,cellular response to starvation,BP,
4470,GO:0009295,1,0.765043753718959,0,41,nucleoid,CC,
4471,GO:0009298,1,0.981035273049875,0,4,GDP-mannose biosynthetic process,BP,
4472,GO:0009299,1,0.844857014867301,0,25,mRNA transcription,BP,
4473,GO:0009301,1,0.662464230640958,0,66,snRNA transcription,BP,
4474,GO:0009303,1,0.841585720171055,0,27,rRNA transcription,BP,
4475,GO:0009304,1,0.952806794044669,0,7,tRNA transcription,BP,
4476,GO:0009305,1,0.991511043527596,0,1,protein biotinylation,BP,
4478,GO:0009308,1,0.517957759872395,0,120,amine metabolic process,BP,
4479,GO:0009309,1,0.900019647139528,0,20,amine biosynthetic process,BP,
4480,GO:0009310,1,0.888310884864443,0,21,amine catabolic process,BP,
4483,GO:0009313,1,0.929528247755526,0,11,oligosaccharide catabolic process,BP,
4485,GO:0009328,1,0.97530587560598,0,4,phenylalanine-tRNA ligase complex,CC,
4486,GO:0009330,1,0.984256629730717,0,2,DNA topoisomerase complex (ATP-hydrolyzing),CC,
4487,GO:0009331,1,0.97716391552857,0,3,glycerol-3-phosphate dehydrogenase complex,CC,
4488,GO:0009346,1,0.992394577272763,0,1,citrate lyase complex,CC,
4489,GO:0009353,1,0.99618747477248,0,1,mitochondrial oxoglutarate dehydrogenase complex,CC,
4490,GO:0009360,1,0.993184237229553,0,1,DNA polymerase III complex,CC,
4491,GO:0009368,1,0.99040913230768,0,2,endopeptidase Clp complex,CC,
4492,GO:0009372,1,0.992618000628388,0,1,quorum sensing,BP,
4493,GO:0009374,1,0.961189236585071,0,5,biotin binding,MF,
4494,GO:0009378,1,0.962085190934653,0,5,four-way junction helicase activity,MF,
4495,GO:0009383,1,0.98559582194137,0,2,rRNA (cytosine-C5-)-methyltransferase activity,MF,
4496,GO:0009384,1,0.991951608096997,0,1,N-acylmannosamine kinase activity,MF,
4497,GO:0009386,1,0.989560660876467,0,2,translational attenuation,BP,
4498,GO:0009394,1,0.86211264288361,0,29,2'-deoxyribonucleotide metabolic process,BP,
4500,GO:0009396,1,0.947912419791831,0,9,folic acid-containing compound biosynthetic process,BP,
4501,GO:0009397,1,0.97294961463182,0,4,folic acid-containing compound catabolic process,BP,
4502,GO:0009398,1,0.993174814481327,0,1,FMN biosynthetic process,BP,
4503,GO:0009400,1,0.992976821212928,0,1,signal transducer, downstream of receptor, with serine/threonine phosphatase activity,MF,
4504,GO:0009403,1,0.975199930835579,0,4,toxin biosynthetic process,BP,
4505,GO:0009404,1,0.88912543920735,0,20,toxin metabolic process,BP,
4506,GO:0009405,1,0.983498304925807,0,2,pathogenesis,BP,
4507,GO:0009407,1,0.978000305794476,0,5,toxin catabolic process,BP,
4509,GO:0009409,1,0.754489389091452,0,43,response to cold,BP,
4512,GO:0009414,1,0.959811672672161,0,7,response to water deprivation,BP,
4513,GO:0009415,1,0.923726563835357,0,12,response to water,BP,
4515,GO:0009435,1,0.745406607626423,0,47,NAD biosynthetic process,BP,
4516,GO:0009436,1,0.988655344521388,0,2,glyoxylate catabolic process,BP,
4517,GO:0009437,1,0.91672416438509,0,13,carnitine metabolic process,BP,
4518,GO:0009438,1,0.974715528040139,0,5,methylglyoxal metabolic process,BP,
4519,GO:0009439,1,0.992495572611331,0,2,cyanate metabolic process,BP,
4520,GO:0009440,1,0.992495572611331,0,2,cyanate catabolic process,BP,
4521,GO:0009441,1,0.983094993749074,0,3,glycolate metabolic process,BP,
4522,GO:0009443,1,0.990674513429981,0,1,pyridoxal 5'-phosphate salvage,BP,
4523,GO:0009444,1,0.991946017017525,0,1,pyruvate oxidation,BP,
4524,GO:0009445,1,0.963644151595134,0,7,putrescine metabolic process,BP,
4525,GO:0009446,1,0.969838338232996,0,5,putrescine biosynthetic process,BP,
4526,GO:0009447,1,0.988994410525837,0,3,putrescine catabolic process,BP,
4527,GO:0009448,1,0.97083148518559,0,4,gamma-aminobutyric acid metabolic process,BP,
4528,GO:0009449,1,0.978627293201162,0,3,gamma-aminobutyric acid biosynthetic process,BP,
4529,GO:0009450,1,0.984260139074388,0,2,gamma-aminobutyric acid catabolic process,BP,
4530,GO:0009451,1,0.452099021784866,0,130,RNA modification,BP,
4531,GO:0009452,1,0.832521608136304,0,32,7-methylguanosine RNA capping,BP,
4532,GO:0009566,1,0.448652847323201,0,129,fertilization,BP,
4533,GO:0009581,1,0.486113737352895,0,103,detection of external stimulus,BP,
4534,GO:0009582,1,0.477517525178617,0,106,detection of abiotic stimulus,BP,
4535,GO:0009583,1,0.709916223828549,0,53,detection of light stimulus,BP,
4536,GO:0009584,1,0.753802180770479,0,43,detection of visible light,BP,
4537,GO:0009593,1,0.670449979973673,0,75,detection of chemical stimulus,BP,
4538,GO:0009595,1,0.878958087862776,0,19,detection of biotic stimulus,BP,
4539,GO:0009597,1,0.96703265086285,0,5,detection of virus,BP,
4542,GO:0009608,1,0.989284458300125,0,2,response to symbiont,BP,
4543,GO:0009609,1,0.989284458300125,0,2,response to symbiotic bacterium,BP,
4549,GO:0009624,1,0.993335709167869,0,1,response to nematode,BP,
4551,GO:0009629,1,0.949557887919499,0,9,response to gravity,BP,
4552,GO:0009631,1,0.992060194717323,0,1,cold acclimation,BP,
4553,GO:0009635,1,0.936310857399776,0,11,response to herbicide,BP,
4555,GO:0009637,1,0.985131488431315,0,2,response to blue light,BP,
4556,GO:0009642,1,0.926705124863635,0,11,response to light intensity,BP,
4557,GO:0009644,1,0.986446799005134,0,2,response to high light intensity,BP,
4558,GO:0009645,1,0.992546464183433,0,1,response to low light intensity stimulus,BP,
4559,GO:0009646,1,0.992612484295299,0,1,response to absence of light,BP,
4560,GO:0009648,1,0.854830849824273,0,24,photoperiodism,BP,
4561,GO:0009649,1,0.843708002358462,0,26,entrainment of circadian clock,BP,
4562,GO:0009650,1,0.922261517316603,0,13,UV protection,BP,
4563,GO:0009651,1,0.879992444024459,0,20,response to salt stress,BP,
4565,GO:0009669,1,0.979385092178553,0,3,sucrose:cation symporter activity,MF,
4566,GO:0009673,1,0.992512576541679,0,1,low-affinity phosphate transmembrane transporter activity,MF,
4567,GO:0009674,1,0.983301772356678,0,2,potassium:sodium symporter activity,MF,
4568,GO:0009692,1,0.993335709167869,0,1,ethylene metabolic process,BP,
4569,GO:0009698,1,0.970355125041201,0,6,phenylpropanoid metabolic process,BP,
4570,GO:0009712,1,0.737816089988481,0,47,catechol-containing compound metabolic process,BP,
4571,GO:0009713,1,0.887276533692936,0,19,catechol-containing compound biosynthetic process,BP,
4573,GO:0009720,1,0.992823129101474,0,1,detection of hormone stimulus,BP,
4575,GO:0009726,1,0.974815989065714,0,3,detection of endogenous stimulus,BP,
4576,GO:0009730,1,0.977367762130338,0,4,detection of carbohydrate stimulus,BP,
4577,GO:0009732,1,0.977367762130338,0,4,detection of hexose stimulus,BP,
4578,GO:0009737,1,0.99239595615167,0,1,response to abscisic acid,BP,
4579,GO:0009738,1,0.99239595615167,0,1,abscisic acid-activated signaling pathway,BP,
4581,GO:0009744,1,0.971081450517986,0,4,response to sucrose,BP,
4584,GO:0009750,1,0.948197641942061,0,8,response to fructose,BP,
4585,GO:0009753,1,0.984840674027201,0,4,response to jasmonic acid,BP,
4586,GO:0009755,1,0.250654456652066,0,198,hormone-mediated signaling pathway,BP,
4587,GO:0009756,1,0.959510623024049,0,7,carbohydrate mediated signaling,BP,
4588,GO:0009757,1,0.972711988435309,0,5,hexose mediated signaling,BP,
4589,GO:0009758,1,0.989856457056912,0,1,carbohydrate utilization,BP,
4590,GO:0009785,1,0.985131488431315,0,2,blue light signaling pathway,BP,
4591,GO:0009786,1,0.971818830644536,0,4,regulation of asymmetric cell division,BP,
4592,GO:0009787,1,0.99239595615167,0,1,regulation of abscisic acid-activated signaling pathway,BP,
4593,GO:0009789,1,0.99239595615167,0,1,positive regulation of abscisic acid-activated signaling pathway,BP,
4597,GO:0009794,1,0.974580384262854,0,4,regulation of mitotic cell cycle, embryonic,BP,
4598,GO:0009798,1,0.586736982018704,0,80,axis specification,BP,
4600,GO:0009804,1,0.970355125041201,0,6,coumarin metabolic process,BP,
4601,GO:0009810,1,0.99415291577638,0,1,stilbene metabolic process,BP,
4602,GO:0009812,1,0.966972486685719,0,6,flavonoid metabolic process,BP,
4603,GO:0009814,1,0.994168744955213,0,1,defense response, incompatible interaction,BP,
4604,GO:0009817,1,0.994168744955213,0,1,defense response to fungus, incompatible interaction,BP,
4605,GO:0009820,1,0.974274612017719,0,5,alkaloid metabolic process,BP,
4606,GO:0009822,1,0.990938305829931,0,2,alkaloid catabolic process,BP,
4607,GO:0009826,1,0.98621269249454,0,2,unidimensional cell growth,BP,
4608,GO:0009838,1,0.972944005495373,0,5,abscission,BP,
4609,GO:0009841,1,0.993821992310233,0,1,mitochondrial endopeptidase Clp complex,CC,
4610,GO:0009850,1,0.9915448270492,0,2,auxin metabolic process,BP,
4611,GO:0009852,1,0.9915448270492,0,2,auxin catabolic process,BP,
4613,GO:0009880,1,0.6791856247867,0,56,embryonic pattern specification,BP,
4614,GO:0009881,1,0.943758866770146,0,10,photoreceptor activity,MF,
4615,GO:0009882,1,0.985131488431315,0,2,blue light photoreceptor activity,MF,
4616,GO:0009886,1,0.925423617358716,0,11,post-embryonic animal morphogenesis,BP,
4629,GO:0009912,1,0.968009757292688,0,5,auditory receptor cell fate commitment,BP,
4632,GO:0009918,1,0.99325634617697,0,1,sterol delta7 reductase activity,MF,
4633,GO:0009922,1,0.959687244086777,0,6,fatty acid elongase activity,MF,
4636,GO:0009946,1,0.98567362122315,0,3,proximal/distal axis specification,BP,
4637,GO:0009948,1,0.758724074621818,0,43,anterior/posterior axis specification,BP,
4638,GO:0009949,1,0.995632596003417,0,1,polarity specification of anterior/posterior axis,BP,
4639,GO:0009950,1,0.889184578563786,0,16,dorsal/ventral axis specification,BP,
4641,GO:0009953,1,0.568346349177152,0,86,dorsal/ventral pattern formation,BP,
4643,GO:0009955,1,0.994161956511822,0,1,adaxial/abaxial pattern specification,BP,
4644,GO:0009956,1,0.992484817319773,0,1,radial pattern formation,BP,
4645,GO:0009957,1,0.976873009707927,0,3,epidermal cell fate specification,BP,
4649,GO:0009972,1,0.960826257666516,0,8,cytidine deamination,BP,
4650,GO:0009975,1,0.882111141918239,0,16,cyclase activity,MF,
4651,GO:0009982,1,0.928244517692184,0,13,pseudouridine synthase activity,MF,
4654,GO:0009988,1,0.744954179324771,0,51,cell-cell recognition,BP,
4656,GO:0009992,1,0.994217587048252,0,1,cellular water homeostasis,BP,
4657,GO:0009994,1,0.753928861065271,0,43,oocyte differentiation,BP,
4658,GO:0009996,1,0.972952155147421,0,5,negative regulation of cell fate specification,BP,
4660,GO:0010002,1,0.88760662587064,0,16,cardioblast differentiation,BP,
4662,GO:0010009,1,0.966796517072837,0,5,cytoplasmic side of endosome membrane,CC,
4663,GO:0010015,1,0.997356194534619,0,1,root morphogenesis,BP,
4664,GO:0010021,1,0.992688683011616,0,1,amylopectin biosynthetic process,BP,
4665,GO:0010025,1,0.986406915242731,0,2,wax biosynthetic process,BP,
4666,GO:0010032,1,0.9604533168405,0,5,meiotic chromosome condensation,BP,
4668,GO:0010034,1,0.992534104034888,0,1,response to acetate,BP,
4670,GO:0010037,1,0.992730389328597,0,1,response to carbon dioxide,BP,
4672,GO:0010039,1,0.810803923989606,0,32,response to iron ion,BP,
4673,GO:0010040,1,0.976695751842017,0,4,response to iron(II) ion,BP,
4674,GO:0010041,1,0.968932402977968,0,5,response to iron(III) ion,BP,
4675,GO:0010042,1,0.895096903175657,0,16,response to manganese ion,BP,
4677,GO:0010044,1,0.968851080996233,0,5,response to aluminum ion,BP,
4678,GO:0010045,1,0.990560331674592,0,1,response to nickel cation,BP,
4679,GO:0010046,1,0.96108579982162,0,6,response to mycotoxin,BP,
4680,GO:0010053,1,0.997356194534619,0,1,root epidermal cell differentiation,BP,
4681,GO:0010054,1,0.997356194534619,0,1,trichoblast differentiation,BP,
4682,GO:0010070,1,0.99370543607473,0,1,zygote asymmetric cell division,BP,
4683,GO:0010085,1,0.994438031540948,0,1,polarity specification of proximal/distal axis,BP,
4684,GO:0010092,1,0.824519289295897,0,29,specification of animal organ identity,BP,
4685,GO:0010106,1,0.994763168170186,0,1,cellular response to iron ion starvation,BP,
4687,GO:0010121,1,0.994676724509826,0,1,arginine catabolic process to proline via ornithine,BP,
4688,GO:0010124,1,0.9915448270492,0,2,phenylacetate catabolic process,BP,
4689,GO:0010133,1,0.986803569480417,0,2,proline catabolic process to glutamate,BP,
4690,GO:0010138,1,0.974756183749436,0,5,pyrimidine ribonucleotide salvage,BP,
4691,GO:0010139,1,0.995536655506774,0,1,pyrimidine deoxyribonucleotide salvage,BP,
4692,GO:0010142,1,0.986315665145128,0,2,farnesyl diphosphate biosynthetic process, mevalonate pathway,BP,
4693,GO:0010155,1,0.926322548698769,0,15,regulation of proton transport,BP,
4694,GO:0010157,1,0.990407629814867,0,1,response to chlorate,BP,
4695,GO:0010159,1,0.980150327702786,0,3,specification of animal organ position,BP,
4696,GO:0010160,1,0.996903467990892,0,1,formation of animal organ boundary,BP,
4697,GO:0010164,1,0.995536655506774,0,1,response to cesium ion,BP,
4698,GO:0010165,1,0.778265779309939,0,35,response to X-ray,BP,
4699,GO:0010166,1,0.986406915242731,0,2,wax metabolic process,BP,
4700,GO:0010171,1,0.710627589533059,0,47,body morphogenesis,BP,
4701,GO:0010172,1,0.915771548605993,0,11,embryonic body morphogenesis,BP,
4703,GO:0010182,1,0.972711988435309,0,5,sugar mediated signaling pathway,BP,
4704,GO:0010189,1,0.995395061941067,0,1,vitamin E biosynthetic process,BP,
4705,GO:0010193,1,0.976585573912231,0,4,response to ozone,BP,
4706,GO:0010212,1,0.381052890417684,0,142,response to ionizing radiation,BP,
4707,GO:0010216,1,0.962069247035496,0,5,maintenance of DNA methylation,BP,
4708,GO:0010224,1,0.901800919845034,0,17,response to UV-B,BP,
4709,GO:0010225,1,0.910647210777331,0,13,response to UV-C,BP,
4710,GO:0010226,1,0.874170359193537,0,21,response to lithium ion,BP,
4713,GO:0010248,1,0.929780637934035,0,12,establishment or maintenance of transmembrane electrochemical gradient,BP,
4714,GO:0010255,1,0.972711988435309,0,5,glucose mediated signaling pathway,BP,
4716,GO:0010257,1,0.806193743478719,0,55,NADH dehydrogenase complex assembly,BP,
4717,GO:0010259,1,0.830186487676968,0,25,multicellular organism aging,BP,
4718,GO:0010265,1,0.96125730852309,0,6,SCF complex assembly,BP,
4719,GO:0010266,1,0.980859575659024,0,3,response to vitamin B1,BP,
4720,GO:0010269,1,0.966151256109241,0,5,response to selenium ion,BP,
4721,GO:0010273,1,0.96989457747883,0,11,detoxification of copper ion,BP,
4722,GO:0010286,1,0.974347906959903,0,5,heat acclimation,BP,
4723,GO:0010288,1,0.870256811465369,0,21,response to lead ion,BP,
4724,GO:0010309,1,0.995403156215303,0,1,acireductone dioxygenase [iron(II)-requiring] activity,MF,
4725,GO:0010310,1,0.924895074683551,0,14,regulation of hydrogen peroxide metabolic process,BP,
4726,GO:0010314,1,0.931597623270637,0,10,phosphatidylinositol-5-phosphate binding,MF,
4727,GO:0010324,1,0.676634156163619,0,61,membrane invagination,BP,
4728,GO:0010332,1,0.698458376384628,0,52,response to gamma radiation,BP,
4729,GO:0010335,1,0.992348248037886,0,1,response to non-ionic osmotic stress,BP,
4730,GO:0010340,1,0.962160642581689,0,6,carboxyl-O-methyltransferase activity,MF,
4731,GO:0010348,1,0.993058458973322,0,1,lithium:proton antiporter activity,MF,
4732,GO:0010359,1,0.932969717385592,0,9,regulation of anion channel activity,BP,
4733,GO:0010360,1,0.97844534853534,0,3,negative regulation of anion channel activity,BP,
4734,GO:0010369,1,0.906297911795715,0,14,chromocenter,CC,
4735,GO:0010370,1,0.987135385110931,0,2,perinucleolar chromocenter,CC,
4736,GO:0010385,1,0.965086591627108,0,5,double-stranded methylated DNA binding,MF,
4737,GO:0010387,1,0.987066050835063,0,2,COP9 signalosome assembly,BP,
4738,GO:0010389,1,0.304919475556819,0,186,regulation of G2/M transition of mitotic cell cycle,BP,
4739,GO:0010390,1,0.826904375751707,0,27,histone monoubiquitination,BP,
4740,GO:0010412,1,0.992599903835715,0,1,mannan metabolic process,BP,
4741,GO:0010420,1,0.996318964210472,0,1,polyprenyldihydroxybenzoate methyltransferase activity,MF,
4742,GO:0010421,1,0.929826316645885,0,12,hydrogen peroxide-mediated programmed cell death,BP,
4743,GO:0010428,1,0.991582050769352,0,1,methyl-CpNpG binding,MF,
4744,GO:0010430,1,0.992262244678278,0,1,fatty acid omega-oxidation,BP,
4745,GO:0010446,1,0.987565800908386,0,2,response to alkaline pH,BP,
4746,GO:0010447,1,0.884468607598803,0,19,response to acidic pH,BP,
4747,GO:0010452,1,0.92878666254726,0,9,histone H3-K36 methylation,BP,
4748,GO:0010453,1,0.870759571087958,0,23,regulation of cell fate commitment,BP,
4749,GO:0010454,1,0.946760457507915,0,10,negative regulation of cell fate commitment,BP,
4750,GO:0010455,1,0.968486719816954,0,6,positive regulation of cell fate commitment,BP,
4751,GO:0010457,1,0.914555675384512,0,11,centriole-centriole cohesion,BP,
4752,GO:0010458,1,0.844350310060581,0,27,exit from mitosis,BP,
4753,GO:0010459,1,0.955145109257622,0,9,negative regulation of heart rate,BP,
4754,GO:0010460,1,0.866660392891959,0,22,positive regulation of heart rate,BP,
4755,GO:0010463,1,0.716193542378613,0,46,mesenchymal cell proliferation,BP,
4756,GO:0010464,1,0.779227482844557,0,35,regulation of mesenchymal cell proliferation,BP,
4757,GO:0010465,1,0.984216714443585,0,2,nerve growth factor receptor activity,MF,
4763,GO:0010477,1,0.992634150930149,0,1,response to sulfur dioxide,BP,
4764,GO:0010481,1,0.988541944656152,0,2,epidermal cell division,BP,
4765,GO:0010482,1,0.988541944656152,0,2,regulation of epidermal cell division,BP,
4766,GO:0010484,1,0.966421700345067,0,4,H3 histone acetyltransferase activity,MF,
4767,GO:0010485,1,0.873944103562845,0,18,H4 histone acetyltransferase activity,MF,
4768,GO:0010494,1,0.744179083199673,0,40,cytoplasmic stress granule,CC,
4769,GO:0010496,1,0.994630636083079,0,1,intercellular transport,BP,
4771,GO:0010499,1,0.913611655090724,0,21,proteasomal ubiquitin-independent protein catabolic process,BP,
4772,GO:0010501,1,0.739061377296237,0,44,RNA secondary structure unwinding,BP,
4774,GO:0010507,1,0.627592863140728,0,67,negative regulation of autophagy,BP,
4776,GO:0010509,1,0.991809941438191,0,1,polyamine homeostasis,BP,
4777,GO:0010510,1,0.914690483368278,0,12,regulation of acetyl-CoA biosynthetic process from pyruvate,BP,
4778,GO:0010511,1,0.956622497513215,0,7,regulation of phosphatidylinositol biosynthetic process,BP,
4779,GO:0010512,1,0.986061727246329,0,2,negative regulation of phosphatidylinositol biosynthetic process,BP,
4780,GO:0010513,1,0.970148765926866,0,5,positive regulation of phosphatidylinositol biosynthetic process,BP,
4783,GO:0010519,1,0.968929254859807,0,5,negative regulation of phospholipase activity,BP,
4784,GO:0010520,1,0.9786457442396,0,3,regulation of reciprocal meiotic recombination,BP,
4785,GO:0010521,1,0.982584159609824,0,3,telomerase inhibitor activity,MF,
4786,GO:0010522,1,0.551218125220604,0,87,regulation of calcium ion transport into cytosol,BP,
4787,GO:0010523,1,0.902186225280452,0,17,negative regulation of calcium ion transport into cytosol,BP,
4788,GO:0010524,1,0.736883854098274,0,48,positive regulation of calcium ion transport into cytosol,BP,
4789,GO:0010528,1,0.897214699007518,0,17,regulation of transposition,BP,
4790,GO:0010529,1,0.897214699007518,0,17,negative regulation of transposition,BP,
4791,GO:0010533,1,0.981650178137855,0,4,regulation of activation of Janus kinase activity,BP,
4792,GO:0010536,1,0.99021572035437,0,2,positive regulation of activation of Janus kinase activity,BP,
4794,GO:0010544,1,0.891157153333939,0,17,negative regulation of platelet activation,BP,
4798,GO:0010559,1,0.793848557615281,0,36,regulation of glycoprotein biosynthetic process,BP,
4799,GO:0010560,1,0.879266537674431,0,19,positive regulation of glycoprotein biosynthetic process,BP,
4800,GO:0010561,1,0.940925159035409,0,10,negative regulation of glycoprotein biosynthetic process,BP,
4804,GO:0010565,1,0.405989225929731,0,147,regulation of cellular ketone metabolic process,BP,
4805,GO:0010566,1,0.919427916470368,0,13,regulation of ketone biosynthetic process,BP,
4806,GO:0010569,1,0.823724420042836,0,27,regulation of double-strand break repair via homologous recombination,BP,
4807,GO:0010571,1,0.950773531964101,0,6,positive regulation of nuclear cell cycle DNA replication,BP,
4810,GO:0010574,1,0.816745585683367,0,30,regulation of vascular endothelial growth factor production,BP,
4811,GO:0010575,1,0.836236025691159,0,25,positive regulation of vascular endothelial growth factor production,BP,
4812,GO:0010578,1,0.993418007545344,0,1,regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway,BP,
4813,GO:0010585,1,0.99480822318924,0,1,glutamine secretion,BP,
4814,GO:0010586,1,0.857953321776673,0,22,miRNA metabolic process,BP,
4815,GO:0010587,1,0.962033628393111,0,5,miRNA catabolic process,BP,
4817,GO:0010592,1,0.89768689321174,0,15,positive regulation of lamellipodium assembly,BP,
4818,GO:0010593,1,0.983516706424052,0,2,negative regulation of lamellipodium assembly,BP,
4819,GO:0010594,1,0.401132710374344,0,130,regulation of endothelial cell migration,BP,
4820,GO:0010595,1,0.560236783767248,0,83,positive regulation of endothelial cell migration,BP,
4821,GO:0010596,1,0.747496153666396,0,42,negative regulation of endothelial cell migration,BP,
4822,GO:0010603,1,0.937879592140952,0,8,regulation of cytoplasmic mRNA processing body assembly,BP,
4825,GO:0010606,1,0.957402277855383,0,5,positive regulation of cytoplasmic mRNA processing body assembly,BP,
4826,GO:0010607,1,0.994727621297974,0,1,negative regulation of cytoplasmic mRNA processing body assembly,BP,
4828,GO:0010609,1,0.987009976064171,0,2,mRNA localization resulting in posttranscriptional regulation of gene expression,BP,
4829,GO:0010611,1,0.728141909265205,0,44,regulation of cardiac muscle hypertrophy,BP,
4830,GO:0010612,1,0.93811704464393,0,8,regulation of cardiac muscle adaptation,BP,
4831,GO:0010613,1,0.829010241897896,0,26,positive regulation of cardiac muscle hypertrophy,BP,
4832,GO:0010614,1,0.894007345503102,0,16,negative regulation of cardiac muscle hypertrophy,BP,
4833,GO:0010615,1,0.984899980783645,0,2,positive regulation of cardiac muscle adaptation,BP,
4834,GO:0010616,1,0.952506856417658,0,6,negative regulation of cardiac muscle adaptation,BP,
4835,GO:0010621,1,0.985193039221701,0,3,negative regulation of transcription by transcription factor localization,BP,
4836,GO:0010623,1,0.923877970289003,0,12,programmed cell death involved in cell development,BP,
4838,GO:0010625,1,0.993629614724202,0,1,positive regulation of Schwann cell proliferation,BP,
4844,GO:0010633,1,0.675082998646016,0,57,negative regulation of epithelial cell migration,BP,
4846,GO:0010635,1,0.948637198599988,0,8,regulation of mitochondrial fusion,BP,
4847,GO:0010636,1,0.984744314323509,0,2,positive regulation of mitochondrial fusion,BP,
4848,GO:0010637,1,0.969973382935951,0,5,negative regulation of mitochondrial fusion,BP,
4852,GO:0010641,1,0.962689061904988,0,5,positive regulation of platelet-derived growth factor receptor signaling pathway,BP,
4860,GO:0010649,1,0.916544932882391,0,12,regulation of cell communication by electrical coupling,BP,
4861,GO:0010650,1,0.981616791175755,0,2,positive regulation of cell communication by electrical coupling,BP,
4863,GO:0010656,1,0.809697632208544,0,32,negative regulation of muscle cell apoptotic process,BP,
4871,GO:0010664,1,0.865850997776367,0,22,negative regulation of striated muscle cell apoptotic process,BP,
4874,GO:0010667,1,0.885008494285921,0,19,negative regulation of cardiac muscle cell apoptotic process,BP,
4875,GO:0010668,1,0.955182790702385,0,6,ectodermal cell differentiation,BP,
4876,GO:0010669,1,0.88307561073737,0,19,epithelial structure maintenance,BP,
4877,GO:0010675,1,0.481410756203643,0,104,regulation of cellular carbohydrate metabolic process,BP,
4878,GO:0010676,1,0.724613564211861,0,44,positive regulation of cellular carbohydrate metabolic process,BP,
4879,GO:0010677,1,0.818974204033366,0,29,negative regulation of cellular carbohydrate metabolic process,BP,
4880,GO:0010692,1,0.930414100821729,0,9,regulation of alkaline phosphatase activity,BP,
4881,GO:0010693,1,0.979901041624319,0,3,negative regulation of alkaline phosphatase activity,BP,
4882,GO:0010694,1,0.949508005021797,0,6,positive regulation of alkaline phosphatase activity,BP,
4883,GO:0010698,1,0.990345270918035,0,2,acetyltransferase activator activity,MF,
4884,GO:0010700,1,0.972394038422621,0,5,negative regulation of norepinephrine secretion,BP,
4885,GO:0010701,1,0.979421592481186,0,3,positive regulation of norepinephrine secretion,BP,
4886,GO:0010705,1,0.985441889053926,0,2,meiotic DNA double-strand break processing involved in reciprocal meiotic recombination,BP,
4887,GO:0010710,1,0.982993228984639,0,3,regulation of collagen catabolic process,BP,
4888,GO:0010711,1,0.997366574054577,0,1,negative regulation of collagen catabolic process,BP,
4889,GO:0010712,1,0.824425701437647,0,31,regulation of collagen metabolic process,BP,
4890,GO:0010713,1,0.956898973362893,0,8,negative regulation of collagen metabolic process,BP,
4891,GO:0010714,1,0.878559284630798,0,20,positive regulation of collagen metabolic process,BP,
4892,GO:0010715,1,0.905234011761813,0,13,regulation of extracellular matrix disassembly,BP,
4893,GO:0010716,1,0.977244086398711,0,4,negative regulation of extracellular matrix disassembly,BP,
4894,GO:0010717,1,0.583813597451206,0,77,regulation of epithelial to mesenchymal transition,BP,
4895,GO:0010718,1,0.725290892830718,0,44,positive regulation of epithelial to mesenchymal transition,BP,
4896,GO:0010719,1,0.858958228525561,0,25,negative regulation of epithelial to mesenchymal transition,BP,
4899,GO:0010722,1,0.990805562801006,0,1,regulation of ferrochelatase activity,BP,
4900,GO:0010724,1,0.974043057106299,0,4,regulation of definitive erythrocyte differentiation,BP,
4901,GO:0010725,1,0.988459662060358,0,2,regulation of primitive erythrocyte differentiation,BP,
4902,GO:0010726,1,0.987292760654129,0,2,positive regulation of hydrogen peroxide metabolic process,BP,
4903,GO:0010727,1,0.96063125484031,0,7,negative regulation of hydrogen peroxide metabolic process,BP,
4904,GO:0010728,1,0.973413341472154,0,4,regulation of hydrogen peroxide biosynthetic process,BP,
4905,GO:0010729,1,0.99457403705405,0,1,positive regulation of hydrogen peroxide biosynthetic process,BP,
4906,GO:0010730,1,0.978725006549054,0,3,negative regulation of hydrogen peroxide biosynthetic process,BP,
4907,GO:0010731,1,0.991736775640299,0,2,protein glutathionylation,BP,
4908,GO:0010732,1,0.991736775640299,0,2,regulation of protein glutathionylation,BP,
4909,GO:0010734,1,0.991736775640299,0,2,negative regulation of protein glutathionylation,BP,
4910,GO:0010735,1,0.972345867150438,0,4,positive regulation of transcription via serum response element binding,BP,
4911,GO:0010736,1,0.987268039712525,0,2,serum response element binding,MF,
4912,GO:0010737,1,0.815788373807105,0,26,protein kinase A signaling,BP,
4913,GO:0010738,1,0.872287816091441,0,18,regulation of protein kinase A signaling,BP,
4914,GO:0010739,1,0.964390212161497,0,6,positive regulation of protein kinase A signaling,BP,
4915,GO:0010742,1,0.816884381154812,0,29,macrophage derived foam cell differentiation,BP,
4916,GO:0010743,1,0.842658173730677,0,25,regulation of macrophage derived foam cell differentiation,BP,
4917,GO:0010744,1,0.913319073278179,0,14,positive regulation of macrophage derived foam cell differentiation,BP,
4918,GO:0010745,1,0.922700183371667,0,11,negative regulation of macrophage derived foam cell differentiation,BP,
4919,GO:0010746,1,0.967865500031301,0,4,regulation of plasma membrane long-chain fatty acid transport,BP,
4920,GO:0010748,1,0.967865500031301,0,4,negative regulation of plasma membrane long-chain fatty acid transport,BP,
4923,GO:0010751,1,0.979636189242122,0,3,negative regulation of nitric oxide mediated signal transduction,BP,
4924,GO:0010752,1,0.984102400612806,0,2,regulation of cGMP-mediated signaling,BP,
4925,GO:0010754,1,0.991642010791449,0,1,negative regulation of cGMP-mediated signaling,BP,
4926,GO:0010755,1,0.943894186564721,0,10,regulation of plasminogen activation,BP,
4927,GO:0010756,1,0.974529970569853,0,5,positive regulation of plasminogen activation,BP,
4928,GO:0010757,1,0.968571517553466,0,5,negative regulation of plasminogen activation,BP,
4929,GO:0010758,1,0.89708082192947,0,18,regulation of macrophage chemotaxis,BP,
4930,GO:0010759,1,0.939372023651226,0,10,positive regulation of macrophage chemotaxis,BP,
4931,GO:0010760,1,0.975622523325102,0,5,negative regulation of macrophage chemotaxis,BP,
4935,GO:0010764,1,0.948797995988234,0,8,negative regulation of fibroblast migration,BP,
4936,GO:0010765,1,0.810958796578938,0,30,positive regulation of sodium ion transport,BP,
4937,GO:0010766,1,0.902628966180138,0,14,negative regulation of sodium ion transport,BP,
4938,GO:0010767,1,0.975177967724588,0,3,regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,
4939,GO:0010768,1,0.981847786487954,0,2,negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,BP,
4943,GO:0010789,1,0.993058458973322,0,1,meiotic sister chromatid cohesion involved in meiosis I,BP,
4944,GO:0010792,1,0.965097877625205,0,5,DNA double-strand break processing involved in repair via single-strand annealing,BP,
4945,GO:0010793,1,0.961972238259148,0,5,regulation of mRNA export from nucleus,BP,
4946,GO:0010795,1,0.996318964210472,0,1,regulation of ubiquinone biosynthetic process,BP,
4947,GO:0010796,1,0.985382066867426,0,3,regulation of multivesicular body size,BP,
4948,GO:0010797,1,0.99643212868072,0,1,regulation of multivesicular body size involved in endosome transport,BP,
4950,GO:0010800,1,0.826842858871401,0,27,positive regulation of peptidyl-threonine phosphorylation,BP,
4952,GO:0010803,1,0.723016790125683,0,54,regulation of tumor necrosis factor-mediated signaling pathway,BP,
4953,GO:0010804,1,0.917567245440314,0,17,negative regulation of tumor necrosis factor-mediated signaling pathway,BP,
4954,GO:0010807,1,0.958670940089375,0,6,regulation of synaptic vesicle priming,BP,
4955,GO:0010808,1,0.991271602712062,0,1,positive regulation of synaptic vesicle priming,BP,
4959,GO:0010813,1,0.987939782372502,0,2,neuropeptide catabolic process,BP,
4960,GO:0010814,1,0.992049643591319,0,1,substance P catabolic process,BP,
4961,GO:0010815,1,0.973741999189561,0,4,bradykinin catabolic process,BP,
4962,GO:0010816,1,0.992049643591319,0,1,calcitonin catabolic process,BP,
4964,GO:0010818,1,0.905647408715097,0,18,T cell chemotaxis,BP,
4965,GO:0010819,1,0.946370486774217,0,10,regulation of T cell chemotaxis,BP,
4966,GO:0010820,1,0.949674197771168,0,9,positive regulation of T cell chemotaxis,BP,
4967,GO:0010821,1,0.261125281154709,0,209,regulation of mitochondrion organization,BP,
4968,GO:0010822,1,0.367939211830033,0,156,positive regulation of mitochondrion organization,BP,
4969,GO:0010823,1,0.750821802775009,0,45,negative regulation of mitochondrion organization,BP,
4970,GO:0010824,1,0.758325401420798,0,39,regulation of centrosome duplication,BP,
4971,GO:0010825,1,0.956181353420301,0,6,positive regulation of centrosome duplication,BP,
4972,GO:0010826,1,0.921971731007576,0,12,negative regulation of centrosome duplication,BP,
4973,GO:0010827,1,0.621769567895179,0,66,regulation of glucose transmembrane transport,BP,
4974,GO:0010828,1,0.744735302643379,0,39,positive regulation of glucose transmembrane transport,BP,
4975,GO:0010829,1,0.904329619282399,0,16,negative regulation of glucose transmembrane transport,BP,
4976,GO:0010830,1,0.739574336668453,0,46,regulation of myotube differentiation,BP,
4977,GO:0010831,1,0.85015170550187,0,25,positive regulation of myotube differentiation,BP,
4978,GO:0010832,1,0.913148031430541,0,14,negative regulation of myotube differentiation,BP,
4979,GO:0010833,1,0.597507591222521,0,75,telomere maintenance via telomere lengthening,BP,
4980,GO:0010835,1,0.962538818038331,0,6,regulation of protein ADP-ribosylation,BP,
4981,GO:0010836,1,0.984332161537298,0,3,negative regulation of protein ADP-ribosylation,BP,
4982,GO:0010837,1,0.832910216475594,0,25,regulation of keratinocyte proliferation,BP,
4983,GO:0010838,1,0.952979734583221,0,7,positive regulation of keratinocyte proliferation,BP,
4984,GO:0010839,1,0.917506166315029,0,11,negative regulation of keratinocyte proliferation,BP,
4985,GO:0010840,1,0.985065107046273,0,3,regulation of circadian sleep/wake cycle, wakefulness,BP,
4986,GO:0010841,1,0.985065107046273,0,3,positive regulation of circadian sleep/wake cycle, wakefulness,BP,
4987,GO:0010842,1,0.858056766203738,0,19,retina layer formation,BP,
4988,GO:0010845,1,0.985855954553839,0,2,positive regulation of reciprocal meiotic recombination,BP,
4989,GO:0010847,1,0.96935849975016,0,4,regulation of chromatin assembly,BP,
4990,GO:0010848,1,0.985065402197943,0,2,regulation of chromatin disassembly,BP,
4991,GO:0010849,1,0.994180073855839,0,1,regulation of proton-transporting ATPase activity, rotational mechanism,BP,
4992,GO:0010851,1,0.973090014075977,0,5,cyclase regulator activity,MF,
4993,GO:0010853,1,0.980505951004925,0,4,cyclase activator activity,MF,
4994,GO:0010854,1,0.99243810633655,0,1,adenylate cyclase regulator activity,MF,
4995,GO:0010855,1,0.99243810633655,0,1,adenylate cyclase inhibitor activity,MF,
4996,GO:0010856,1,0.992616141185987,0,1,adenylate cyclase activator activity,MF,
4998,GO:0010858,1,0.986957898126558,0,3,calcium-dependent protein kinase regulator activity,MF,
4999,GO:0010859,1,0.992388814474749,0,1,calcium-dependent cysteine-type endopeptidase inhibitor activity,MF,
5000,GO:0010862,1,0.745466555229249,0,44,positive regulation of pathway-restricted SMAD protein phosphorylation,BP,
5002,GO:0010866,1,0.907594575159646,0,15,regulation of triglyceride biosynthetic process,BP,
5003,GO:0010867,1,0.931799210727013,0,11,positive regulation of triglyceride biosynthetic process,BP,
5004,GO:0010868,1,0.984821482478009,0,2,negative regulation of triglyceride biosynthetic process,BP,
5005,GO:0010869,1,0.881278441941558,0,18,regulation of receptor biosynthetic process,BP,
5006,GO:0010870,1,0.940061673733804,0,10,positive regulation of receptor biosynthetic process,BP,
5007,GO:0010871,1,0.960929811870641,0,5,negative regulation of receptor biosynthetic process,BP,
5008,GO:0010872,1,0.959531053475866,0,8,regulation of cholesterol esterification,BP,
5009,GO:0010873,1,0.973227166601774,0,6,positive regulation of cholesterol esterification,BP,
5010,GO:0010874,1,0.880743499709731,0,18,regulation of cholesterol efflux,BP,
5011,GO:0010875,1,0.909009130416173,0,13,positive regulation of cholesterol efflux,BP,
5013,GO:0010877,1,0.990556187697412,0,2,lipid transport involved in lipid storage,BP,
5014,GO:0010878,1,0.892895859797188,0,15,cholesterol storage,BP,
5015,GO:0010879,1,0.994025486367947,0,1,cholesterol transport involved in cholesterol storage,BP,
5016,GO:0010880,1,0.830065392670917,0,25,regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,
5017,GO:0010881,1,0.879204001522874,0,18,regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion,BP,
5018,GO:0010882,1,0.848249207154311,0,23,regulation of cardiac muscle contraction by calcium ion signaling,BP,
5019,GO:0010883,1,0.766002453610531,0,40,regulation of lipid storage,BP,
5020,GO:0010884,1,0.877372291386632,0,20,positive regulation of lipid storage,BP,
5021,GO:0010885,1,0.904999177225092,0,13,regulation of cholesterol storage,BP,
5022,GO:0010886,1,0.94591663104948,0,7,positive regulation of cholesterol storage,BP,
5023,GO:0010887,1,0.956766565556643,0,6,negative regulation of cholesterol storage,BP,
5024,GO:0010888,1,0.896953363937374,0,16,negative regulation of lipid storage,BP,
5025,GO:0010889,1,0.93011963793767,0,12,regulation of sequestering of triglyceride,BP,
5026,GO:0010890,1,0.967024719218114,0,7,positive regulation of sequestering of triglyceride,BP,
5027,GO:0010891,1,0.961849023363468,0,5,negative regulation of sequestering of triglyceride,BP,
5028,GO:0010893,1,0.914633886280678,0,13,positive regulation of steroid biosynthetic process,BP,
5029,GO:0010894,1,0.872119434718868,0,22,negative regulation of steroid biosynthetic process,BP,
5030,GO:0010896,1,0.96113528311281,0,7,regulation of triglyceride catabolic process,BP,
5031,GO:0010897,1,0.979664951982474,0,3,negative regulation of triglyceride catabolic process,BP,
5032,GO:0010898,1,0.981089560940109,0,4,positive regulation of triglyceride catabolic process,BP,
5033,GO:0010899,1,0.983268892735808,0,3,regulation of phosphatidylcholine catabolic process,BP,
5034,GO:0010900,1,0.998009221150867,0,1,negative regulation of phosphatidylcholine catabolic process,BP,
5035,GO:0010901,1,0.994595601821586,0,2,regulation of very-low-density lipoprotein particle remodeling,BP,
5036,GO:0010902,1,0.997478415427759,0,1,positive regulation of very-low-density lipoprotein particle remodeling,BP,
5037,GO:0010903,1,0.997109972288868,0,1,negative regulation of very-low-density lipoprotein particle remodeling,BP,
5038,GO:0010904,1,0.994205061262777,0,1,regulation of UDP-glucose catabolic process,BP,
5039,GO:0010905,1,0.994205061262777,0,1,negative regulation of UDP-glucose catabolic process,BP,
5040,GO:0010906,1,0.556893915692248,0,81,regulation of glucose metabolic process,BP,
5041,GO:0010907,1,0.804618615197677,0,28,positive regulation of glucose metabolic process,BP,
5042,GO:0010908,1,0.978255305391338,0,3,regulation of heparan sulfate proteoglycan biosynthetic process,BP,
5043,GO:0010909,1,0.978255305391338,0,3,positive regulation of heparan sulfate proteoglycan biosynthetic process,BP,
5044,GO:0010911,1,0.949758578988256,0,7,regulation of isomerase activity,BP,
5045,GO:0010912,1,0.949758578988256,0,7,positive regulation of isomerase activity,BP,
5046,GO:0010915,1,0.991146956710384,0,3,regulation of very-low-density lipoprotein particle clearance,BP,
5047,GO:0010916,1,0.991146956710384,0,3,negative regulation of very-low-density lipoprotein particle clearance,BP,
5048,GO:0010917,1,0.955554821140377,0,8,negative regulation of mitochondrial membrane potential,BP,
5049,GO:0010918,1,0.953969053040661,0,8,positive regulation of mitochondrial membrane potential,BP,
5050,GO:0010919,1,0.923779396239225,0,12,regulation of inositol phosphate biosynthetic process,BP,
5051,GO:0010920,1,0.992965609817527,0,1,negative regulation of inositol phosphate biosynthetic process,BP,
5052,GO:0010921,1,0.327028287412067,0,155,regulation of phosphatase activity,BP,
5053,GO:0010922,1,0.808784576964187,0,28,positive regulation of phosphatase activity,BP,
5054,GO:0010923,1,0.532467472026604,0,88,negative regulation of phosphatase activity,BP,
5055,GO:0010924,1,0.992965609817527,0,1,regulation of inositol-polyphosphate 5-phosphatase activity,BP,
5056,GO:0010925,1,0.992965609817527,0,1,positive regulation of inositol-polyphosphate 5-phosphatase activity,BP,
5058,GO:0010931,1,0.990163304986992,0,1,macrophage tolerance induction,BP,
5059,GO:0010932,1,0.990163304986992,0,1,regulation of macrophage tolerance induction,BP,
5060,GO:0010933,1,0.990163304986992,0,1,positive regulation of macrophage tolerance induction,BP,
5061,GO:0010934,1,0.910099535160747,0,14,macrophage cytokine production,BP,
5062,GO:0010935,1,0.922973171716153,0,12,regulation of macrophage cytokine production,BP,
5063,GO:0010936,1,0.965933314149997,0,5,negative regulation of macrophage cytokine production,BP,
5064,GO:0010938,1,0.992513702219898,0,1,cytoplasmic microtubule depolymerization,BP,
5065,GO:0010939,1,0.862338636160557,0,27,regulation of necrotic cell death,BP,
5066,GO:0010940,1,0.974732175507915,0,6,positive regulation of necrotic cell death,BP,
5069,GO:0010944,1,0.951916863616714,0,8,negative regulation of transcription by competitive promoter binding,BP,
5071,GO:0010949,1,0.993229158668432,0,1,negative regulation of intestinal phytosterol absorption,BP,
5076,GO:0010955,1,0.788196670495924,0,35,negative regulation of protein processing,BP,
5077,GO:0010956,1,0.979335370818497,0,3,negative regulation of calcidiol 1-monooxygenase activity,BP,
5078,GO:0010957,1,0.969350376287868,0,5,negative regulation of vitamin D biosynthetic process,BP,
5079,GO:0010958,1,0.958198238466095,0,6,regulation of amino acid import across plasma membrane,BP,
5082,GO:0010961,1,0.968797594131847,0,4,cellular magnesium ion homeostasis,BP,
5083,GO:0010962,1,0.830693227207232,0,23,regulation of glucan biosynthetic process,BP,
5084,GO:0010963,1,0.989328153506102,0,2,regulation of L-arginine import,BP,
5085,GO:0010965,1,0.703462203986584,0,52,regulation of mitotic sister chromatid separation,BP,
5086,GO:0010966,1,0.968076996025833,0,4,regulation of phosphate transport,BP,
5087,GO:0010967,1,0.995349884203026,0,1,regulation of polyamine biosynthetic process,BP,
5088,GO:0010968,1,0.963001042242436,0,6,regulation of microtubule nucleation,BP,
5089,GO:0010970,1,0.37776687511785,0,137,transport along microtubule,BP,
5090,GO:0010971,1,0.86921286978024,0,21,positive regulation of G2/M transition of mitotic cell cycle,BP,
5091,GO:0010972,1,0.622826189073935,0,86,negative regulation of G2/M transition of mitotic cell cycle,BP,
5095,GO:0010979,1,0.985861666506761,0,2,regulation of vitamin D 24-hydroxylase activity,BP,
5096,GO:0010980,1,0.985861666506761,0,2,positive regulation of vitamin D 24-hydroxylase activity,BP,
5097,GO:0010982,1,0.986466661480763,0,2,regulation of high-density lipoprotein particle clearance,BP,
5098,GO:0010983,1,0.986466661480763,0,2,positive regulation of high-density lipoprotein particle clearance,BP,
5099,GO:0010984,1,0.922403705309013,0,14,regulation of lipoprotein particle clearance,BP,
5100,GO:0010985,1,0.962646956748662,0,7,negative regulation of lipoprotein particle clearance,BP,
5101,GO:0010986,1,0.974124328730665,0,4,positive regulation of lipoprotein particle clearance,BP,
5102,GO:0010988,1,0.951067655802445,0,8,regulation of low-density lipoprotein particle clearance,BP,
5103,GO:0010989,1,0.971247963660775,0,4,negative regulation of low-density lipoprotein particle clearance,BP,
5104,GO:0010990,1,0.957408960570032,0,6,regulation of SMAD protein complex assembly,BP,
5105,GO:0010991,1,0.964671781102928,0,5,negative regulation of SMAD protein complex assembly,BP,
5106,GO:0010992,1,0.956690688441608,0,7,ubiquitin recycling,BP,
5107,GO:0010994,1,0.972042827682769,0,5,free ubiquitin chain polymerization,BP,
5108,GO:0010996,1,0.858491285576047,0,21,response to auditory stimulus,BP,
5109,GO:0010997,1,0.966803564016252,0,5,anaphase-promoting complex binding,MF,
5110,GO:0010998,1,0.932844865844581,0,10,regulation of translational initiation by eIF2 alpha phosphorylation,BP,
5111,GO:0010999,1,0.992357436714209,0,1,regulation of eIF2 alpha phosphorylation by heme,BP,
5119,GO:0014004,1,0.977935927667175,0,3,microglia differentiation,BP,
5120,GO:0014005,1,0.977935927667175,0,3,microglia development,BP,
5123,GO:0014011,1,0.993058458973322,0,1,Schwann cell proliferation involved in axon regeneration,BP,
5128,GO:0014016,1,0.980855911090984,0,3,neuroblast differentiation,BP,
5129,GO:0014017,1,0.993587012283989,0,1,neuroblast fate commitment,BP,
5131,GO:0014022,1,0.97775107884649,0,3,neural plate elongation,BP,
5132,GO:0014028,1,0.987506255869887,0,2,notochord formation,BP,
5133,GO:0014029,1,0.929813339667783,0,11,neural crest formation,BP,
5137,GO:0014034,1,0.981445229032413,0,3,neural crest cell fate commitment,BP,
5138,GO:0014036,1,0.98900229968028,0,2,neural crest cell fate specification,BP,
5140,GO:0014038,1,0.977789844635261,0,3,regulation of Schwann cell differentiation,BP,
5141,GO:0014040,1,0.982473723782816,0,2,positive regulation of Schwann cell differentiation,BP,
5142,GO:0014041,1,0.934111264244318,0,9,regulation of neuron maturation,BP,
5143,GO:0014042,1,0.966235127846901,0,4,positive regulation of neuron maturation,BP,
5144,GO:0014043,1,0.9801248253989,0,3,negative regulation of neuron maturation,BP,
5146,GO:0014045,1,0.973326183901924,0,4,establishment of endothelial blood-brain barrier,BP,
5147,GO:0014046,1,0.87047751678947,0,22,dopamine secretion,BP,
5151,GO:0014050,1,0.968673540697137,0,5,negative regulation of glutamate secretion,BP,
5152,GO:0014051,1,0.93060167943944,0,9,gamma-aminobutyric acid secretion,BP,
5153,GO:0014052,1,0.957422229691937,0,6,regulation of gamma-aminobutyric acid secretion,BP,
5154,GO:0014053,1,0.992162690456213,0,1,negative regulation of gamma-aminobutyric acid secretion,BP,
5155,GO:0014054,1,0.972403643288793,0,4,positive regulation of gamma-aminobutyric acid secretion,BP,
5156,GO:0014055,1,0.980475234693016,0,3,acetylcholine secretion, neurotransmission,BP,
5157,GO:0014056,1,0.980475234693016,0,3,regulation of acetylcholine secretion, neurotransmission,BP,
5158,GO:0014057,1,0.987162430037007,0,2,positive regulation of acetylcholine secretion, neurotransmission,BP,
5159,GO:0014059,1,0.87047751678947,0,22,regulation of dopamine secretion,BP,
5160,GO:0014060,1,0.980743053526734,0,4,regulation of epinephrine secretion,BP,
5161,GO:0014061,1,0.929192839065538,0,12,regulation of norepinephrine secretion,BP,
5162,GO:0014062,1,0.961629738237636,0,7,regulation of serotonin secretion,BP,
5163,GO:0014063,1,0.976255951338507,0,4,negative regulation of serotonin secretion,BP,
5164,GO:0014064,1,0.992331782807655,0,1,positive regulation of serotonin secretion,BP,
5167,GO:0014067,1,0.934246591465692,0,10,negative regulation of phosphatidylinositol 3-kinase signaling,BP,
5168,GO:0014068,1,0.648493845650561,0,60,positive regulation of phosphatidylinositol 3-kinase signaling,BP,
5173,GO:0014075,1,0.780152391092096,0,36,response to amine,BP,
5174,GO:0014701,1,0.919438842472058,0,9,junctional sarcoplasmic reticulum membrane,CC,
5176,GO:0014705,1,0.992426790982205,0,1,C zone,CC,
5178,GO:0014707,1,0.988317562317599,0,2,branchiomeric skeletal muscle development,BP,
5179,GO:0014717,1,0.988708406237794,0,2,regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
5180,GO:0014718,1,0.988708406237794,0,2,positive regulation of satellite cell activation involved in skeletal muscle regeneration,BP,
5181,GO:0014719,1,0.967175035472613,0,5,skeletal muscle satellite cell activation,BP,
5182,GO:0014721,1,0.968812518810572,0,5,twitch skeletal muscle contraction,BP,
5183,GO:0014722,1,0.965513674711978,0,6,regulation of skeletal muscle contraction by calcium ion signaling,BP,
5184,GO:0014724,1,0.984079645367073,0,2,regulation of twitch skeletal muscle contraction,BP,
5185,GO:0014728,1,0.991481210421921,0,1,regulation of the force of skeletal muscle contraction,BP,
5187,GO:0014732,1,0.957535136232761,0,7,skeletal muscle atrophy,BP,
5188,GO:0014733,1,0.92944072565075,0,10,regulation of skeletal muscle adaptation,BP,
5189,GO:0014734,1,0.975956866218483,0,3,skeletal muscle hypertrophy,BP,
5190,GO:0014735,1,0.981277800061726,0,3,regulation of muscle atrophy,BP,
5191,GO:0014736,1,0.985962008231691,0,2,negative regulation of muscle atrophy,BP,
5192,GO:0014737,1,0.995249769378109,0,1,positive regulation of muscle atrophy,BP,
5193,GO:0014738,1,0.984204814602567,0,3,regulation of muscle hyperplasia,BP,
5194,GO:0014739,1,0.997645349213748,0,1,positive regulation of muscle hyperplasia,BP,
5195,GO:0014740,1,0.986528060154726,0,2,negative regulation of muscle hyperplasia,BP,
5196,GO:0014741,1,0.880089373334882,0,18,negative regulation of muscle hypertrophy,BP,
5197,GO:0014742,1,0.829010241897896,0,26,positive regulation of muscle hypertrophy,BP,
5198,GO:0014743,1,0.716783056838369,0,46,regulation of muscle hypertrophy,BP,
5199,GO:0014744,1,0.967990529245566,0,5,positive regulation of muscle adaptation,BP,
5200,GO:0014745,1,0.918471543286519,0,11,negative regulation of muscle adaptation,BP,
5201,GO:0014802,1,0.972121523799823,0,4,terminal cisterna,CC,
5202,GO:0014804,1,0.994725252462468,0,1,terminal cisterna lumen,CC,
5203,GO:0014805,1,0.98274234088094,0,4,smooth muscle adaptation,BP,
5204,GO:0014806,1,0.989319223658879,0,2,smooth muscle hyperplasia,BP,
5206,GO:0014808,1,0.809374290492544,0,28,release of sequestered calcium ion into cytosol by sarcoplasmic reticulum,BP,
5207,GO:0014809,1,0.972370463457682,0,5,regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
5208,GO:0014810,1,0.997347887927764,0,1,positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion,BP,
5209,GO:0014812,1,0.577032135118578,0,74,muscle cell migration,BP,
5210,GO:0014813,1,0.994032123914288,0,1,skeletal muscle satellite cell commitment,BP,
5211,GO:0014816,1,0.945788777610296,0,7,skeletal muscle satellite cell differentiation,BP,
5212,GO:0014819,1,0.932861118193988,0,11,regulation of skeletal muscle contraction,BP,
5213,GO:0014820,1,0.94489422824191,0,9,tonic smooth muscle contraction,BP,
5214,GO:0014821,1,0.902380874667173,0,18,phasic smooth muscle contraction,BP,
5215,GO:0014822,1,0.993427169554927,0,1,detection of wounding,BP,
5216,GO:0014823,1,0.686810757822445,0,54,response to activity,BP,
5217,GO:0014824,1,0.956505133089761,0,7,artery smooth muscle contraction,BP,
5218,GO:0014825,1,0.997281337658679,0,1,stomach fundus smooth muscle contraction,BP,
5219,GO:0014826,1,0.976755188240688,0,4,vein smooth muscle contraction,BP,
5220,GO:0014827,1,0.96545072505503,0,6,intestine smooth muscle contraction,BP,
5221,GO:0014828,1,0.992019259254054,0,1,distal stomach smooth muscle contraction,BP,
5222,GO:0014829,1,0.871608018790609,0,19,vascular smooth muscle contraction,BP,
5223,GO:0014831,1,0.933944003884571,0,11,gastro-intestinal system smooth muscle contraction,BP,
5224,GO:0014832,1,0.954163825919867,0,7,urinary bladder smooth muscle contraction,BP,
5225,GO:0014834,1,0.972134695607426,0,4,skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration,BP,
5226,GO:0014835,1,0.986466101350105,0,2,myoblast differentiation involved in skeletal muscle regeneration,BP,
5227,GO:0014839,1,0.991021280516134,0,2,myoblast migration involved in skeletal muscle regeneration,BP,
5228,GO:0014841,1,0.908726999455624,0,13,skeletal muscle satellite cell proliferation,BP,
5229,GO:0014842,1,0.917464391317925,0,12,regulation of skeletal muscle satellite cell proliferation,BP,
5230,GO:0014843,1,0.991045605461512,0,1,growth factor dependent regulation of skeletal muscle satellite cell proliferation,BP,
5231,GO:0014846,1,0.984228682371328,0,2,esophagus smooth muscle contraction,BP,
5232,GO:0014847,1,0.997281337658679,0,1,proximal stomach smooth muscle contraction,BP,
5233,GO:0014848,1,0.954163825919867,0,7,urinary tract smooth muscle contraction,BP,
5234,GO:0014850,1,0.861232749477465,0,21,response to muscle activity,BP,
5235,GO:0014852,1,0.992950347329576,0,1,regulation of skeletal muscle contraction by neural stimulation via neuromuscular junction,BP,
5236,GO:0014853,1,0.992950347329576,0,1,regulation of excitatory postsynaptic membrane potential involved in skeletal muscle contraction,BP,
5237,GO:0014854,1,0.912736788620121,0,13,response to inactivity,BP,
5239,GO:0014856,1,0.904754424788989,0,14,skeletal muscle cell proliferation,BP,
5240,GO:0014857,1,0.913454003581714,0,13,regulation of skeletal muscle cell proliferation,BP,
5241,GO:0014858,1,0.979851178916799,0,3,positive regulation of skeletal muscle cell proliferation,BP,
5242,GO:0014859,1,0.978047078465504,0,3,negative regulation of skeletal muscle cell proliferation,BP,
5243,GO:0014861,1,0.991904122528462,0,1,regulation of skeletal muscle contraction via regulation of action potential,BP,
5244,GO:0014862,1,0.991481210421921,0,1,regulation of skeletal muscle contraction by chemo-mechanical energy conversion,BP,
5245,GO:0014866,1,0.904047964585341,0,12,skeletal myofibril assembly,BP,
5246,GO:0014870,1,0.928730592889455,0,10,response to muscle inactivity,BP,
5247,GO:0014873,1,0.988669830828738,0,2,response to muscle activity involved in regulation of muscle adaptation,BP,
5248,GO:0014874,1,0.905554345408259,0,14,response to stimulus involved in regulation of muscle adaptation,BP,
5249,GO:0014876,1,0.996066043553681,0,1,response to injury involved in regulation of muscle adaptation,BP,
5250,GO:0014877,1,0.935226839619538,0,9,response to muscle inactivity involved in regulation of muscle adaptation,BP,
5251,GO:0014878,1,0.973940007833435,0,4,response to electrical stimulus involved in regulation of muscle adaptation,BP,
5252,GO:0014883,1,0.968705960515049,0,5,transition between fast and slow fiber,BP,
5253,GO:0014886,1,0.992626137834174,0,1,transition between slow and fast fiber,BP,
5254,GO:0014887,1,0.846970501784774,0,22,cardiac muscle adaptation,BP,
5255,GO:0014888,1,0.757178288306149,0,40,striated muscle adaptation,BP,
5256,GO:0014889,1,0.926498900890507,0,12,muscle atrophy,BP,
5257,GO:0014891,1,0.950953600710314,0,8,striated muscle atrophy,BP,
5258,GO:0014894,1,0.935226839619538,0,9,response to denervation involved in regulation of muscle adaptation,BP,
5259,GO:0014895,1,0.997542416310035,0,1,smooth muscle hypertrophy,BP,
5260,GO:0014896,1,0.579579158016639,0,72,muscle hypertrophy,BP,
5261,GO:0014897,1,0.585123484580912,0,70,striated muscle hypertrophy,BP,
5262,GO:0014898,1,0.846970501784774,0,22,cardiac muscle hypertrophy in response to stress,BP,
5263,GO:0014900,1,0.979959411171552,0,4,muscle hyperplasia,BP,
5264,GO:0014901,1,0.988708406237794,0,2,satellite cell activation involved in skeletal muscle regeneration,BP,
5267,GO:0014908,1,0.9864918796965,0,2,myotube differentiation involved in skeletal muscle regeneration,BP,
5268,GO:0014909,1,0.622079400128295,0,63,smooth muscle cell migration,BP,
5269,GO:0014910,1,0.657763189426219,0,55,regulation of smooth muscle cell migration,BP,
5270,GO:0014911,1,0.793704697225971,0,30,positive regulation of smooth muscle cell migration,BP,
5271,GO:0014912,1,0.862376464682263,0,21,negative regulation of smooth muscle cell migration,BP,
5272,GO:0014916,1,0.974566779796944,0,3,regulation of lung blood pressure,BP,
5273,GO:0015002,1,0.934933672479148,0,22,heme-copper terminal oxidase activity,MF,
5274,GO:0015012,1,0.826081143279965,0,25,heparan sulfate proteoglycan biosynthetic process,BP,
5275,GO:0015014,1,0.952793350060797,0,6,heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
5276,GO:0015015,1,0.956198853054957,0,6,heparan sulfate proteoglycan biosynthetic process, enzymatic modification,BP,
5277,GO:0015016,1,0.967302630477427,0,4,[heparan sulfate]-glucosamine N-sulfotransferase activity,MF,
5278,GO:0015018,1,0.983363836447036,0,3,galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity,MF,
5279,GO:0015019,1,0.991995244925213,0,1,heparan-alpha-glucosaminide N-acetyltransferase activity,MF,
5284,GO:0015035,1,0.908123899417337,0,20,protein disulfide oxidoreductase activity,MF,
5285,GO:0015036,1,0.830230947767011,0,36,disulfide oxidoreductase activity,MF,
5286,GO:0015037,1,0.938867104121646,0,13,peptide disulfide oxidoreductase activity,MF,
5287,GO:0015038,1,0.980515536880678,0,5,glutathione disulfide oxidoreductase activity,MF,
5288,GO:0015039,1,0.994877016520247,0,1,NADPH-adrenodoxin reductase activity,MF,
5289,GO:0015052,1,0.993280665300864,0,1,beta3-adrenergic receptor activity,MF,
5290,GO:0015054,1,0.99435665179252,0,1,gastrin receptor activity,MF,
5291,GO:0015056,1,0.98879127671761,0,2,corticotrophin-releasing factor receptor activity,MF,
5292,GO:0015057,1,0.965177711602391,0,5,thrombin-activated receptor activity,MF,
5293,GO:0015065,1,0.984167066118025,0,3,uridine nucleotide receptor activity,MF,
5294,GO:0015067,1,0.993372827694134,0,1,amidinotransferase activity,MF,
5295,GO:0015068,1,0.993372827694134,0,1,glycine amidinotransferase activity,MF,
5296,GO:0015074,1,0.931308695208856,0,10,DNA integration,BP,
5299,GO:0015078,1,0.570273594168766,0,97,proton transmembrane transporter activity,MF,
5303,GO:0015086,1,0.992443860497474,0,1,cadmium ion transmembrane transporter activity,MF,
5304,GO:0015087,1,0.992443860497474,0,1,cobalt ion transmembrane transporter activity,MF,
5305,GO:0015091,1,0.978134117813301,0,3,ferric iron transmembrane transporter activity,MF,
5306,GO:0015093,1,0.97746879184746,0,3,ferrous iron transmembrane transporter activity,MF,
5307,GO:0015094,1,0.992443860497474,0,1,lead ion transmembrane transporter activity,MF,
5308,GO:0015095,1,0.892218473113866,0,16,magnesium ion transmembrane transporter activity,MF,
5309,GO:0015098,1,0.994875830458898,0,1,molybdate ion transmembrane transporter activity,MF,
5310,GO:0015101,1,0.859123021069137,0,24,organic cation transmembrane transporter activity,MF,
5312,GO:0015105,1,0.996281810222167,0,1,arsenite transmembrane transporter activity,MF,
5313,GO:0015106,1,0.848331727794919,0,21,bicarbonate transmembrane transporter activity,MF,
5315,GO:0015111,1,0.97728136445383,0,3,iodide transmembrane transporter activity,MF,
5316,GO:0015112,1,0.993260510867532,0,1,nitrate transmembrane transporter activity,MF,
5318,GO:0015116,1,0.922869929381856,0,11,sulfate transmembrane transporter activity,MF,
5319,GO:0015117,1,0.994895992285313,0,1,thiosulfate transmembrane transporter activity,MF,
5320,GO:0015119,1,0.979683146978749,0,3,hexose phosphate transmembrane transporter activity,MF,
5321,GO:0015125,1,0.92003474646575,0,13,bile acid transmembrane transporter activity,MF,
5322,GO:0015126,1,0.992221477335208,0,1,canalicular bile acid transmembrane transporter activity,MF,
5323,GO:0015127,1,0.99207833818527,0,1,bilirubin transmembrane transporter activity,MF,
5324,GO:0015129,1,0.966237900160648,0,5,lactate transmembrane transporter activity,MF,
5325,GO:0015130,1,0.992450517902719,0,1,mevalonate transmembrane transporter activity,MF,
5326,GO:0015131,1,0.994895992285313,0,1,oxaloacetate transmembrane transporter activity,MF,
5327,GO:0015132,1,0.992430555781127,0,1,prostaglandin transmembrane transporter activity,MF,
5328,GO:0015136,1,0.992601157172089,0,1,sialic acid transmembrane transporter activity,MF,
5329,GO:0015137,1,0.973394197925728,0,4,citrate transmembrane transporter activity,MF,
5330,GO:0015139,1,0.99295458484256,0,1,alpha-ketoglutarate transmembrane transporter activity,MF,
5331,GO:0015140,1,0.990076491637114,0,2,malate transmembrane transporter activity,MF,
5332,GO:0015141,1,0.980140898643121,0,3,succinate transmembrane transporter activity,MF,
5333,GO:0015142,1,0.973394197925728,0,4,tricarboxylic acid transmembrane transporter activity,MF,
5334,GO:0015143,1,0.983332280391838,0,3,urate transmembrane transporter activity,MF,
5335,GO:0015144,1,0.809316532663949,0,32,carbohydrate transmembrane transporter activity,MF,
5336,GO:0015145,1,0.873744829540415,0,20,monosaccharide transmembrane transporter activity,MF,
5337,GO:0015149,1,0.881753858977138,0,19,hexose transmembrane transporter activity,MF,
5338,GO:0015152,1,0.994384485201502,0,1,glucose-6-phosphate transmembrane transporter activity,MF,
5339,GO:0015154,1,0.979385092178553,0,3,disaccharide transmembrane transporter activity,MF,
5340,GO:0015157,1,0.979385092178553,0,3,oligosaccharide transmembrane transporter activity,MF,
5341,GO:0015165,1,0.940462719140285,0,10,pyrimidine nucleotide-sugar transmembrane transporter activity,MF,
5342,GO:0015166,1,0.946697559426733,0,8,polyol transmembrane transporter activity,MF,
5343,GO:0015168,1,0.972714373013329,0,5,glycerol transmembrane transporter activity,MF,
5346,GO:0015173,1,0.97935078085438,0,3,aromatic amino acid transmembrane transporter activity,MF,
5347,GO:0015174,1,0.927947322161343,0,11,basic amino acid transmembrane transporter activity,MF,
5350,GO:0015180,1,0.964839408150436,0,5,L-alanine transmembrane transporter activity,MF,
5351,GO:0015181,1,0.958565194600312,0,6,arginine transmembrane transporter activity,MF,
5352,GO:0015182,1,0.986717382233571,0,2,L-asparagine transmembrane transporter activity,MF,
5353,GO:0015183,1,0.973743855378391,0,4,L-aspartate transmembrane transporter activity,MF,
5354,GO:0015184,1,0.980222718456899,0,3,L-cystine transmembrane transporter activity,MF,
5355,GO:0015185,1,0.967616477271984,0,5,gamma-aminobutyric acid transmembrane transporter activity,MF,
5356,GO:0015186,1,0.96651812196934,0,5,L-glutamine transmembrane transporter activity,MF,
5357,GO:0015187,1,0.960294371359359,0,6,glycine transmembrane transporter activity,MF,
5358,GO:0015189,1,0.958565194600312,0,6,L-lysine transmembrane transporter activity,MF,
5359,GO:0015190,1,0.993064770092322,0,1,L-leucine transmembrane transporter activity,MF,
5360,GO:0015191,1,0.993064770092322,0,1,L-methionine transmembrane transporter activity,MF,
5361,GO:0015193,1,0.962637988238221,0,5,L-proline transmembrane transporter activity,MF,
5362,GO:0015194,1,0.948407495747731,0,9,L-serine transmembrane transporter activity,MF,
5363,GO:0015195,1,0.992410805622225,0,1,L-threonine transmembrane transporter activity,MF,
5364,GO:0015196,1,0.993596861458281,0,1,L-tryptophan transmembrane transporter activity,MF,
5365,GO:0015203,1,0.990245504074095,0,2,polyamine transmembrane transporter activity,MF,
5366,GO:0015204,1,0.964736490265417,0,6,urea transmembrane transporter activity,MF,
5367,GO:0015205,1,0.961504713180466,0,6,nucleobase transmembrane transporter activity,MF,
5368,GO:0015207,1,0.988543995876443,0,2,adenine transmembrane transporter activity,MF,
5369,GO:0015215,1,0.904378017619995,0,16,nucleotide transmembrane transporter activity,MF,
5370,GO:0015216,1,0.926037488231615,0,12,purine nucleotide transmembrane transporter activity,MF,
5371,GO:0015217,1,0.943559803010725,0,9,ADP transmembrane transporter activity,MF,
5372,GO:0015218,1,0.98819992926779,0,2,pyrimidine nucleotide transmembrane transporter activity,MF,
5373,GO:0015220,1,0.958831140986419,0,6,choline transmembrane transporter activity,MF,
5374,GO:0015222,1,0.980289424244824,0,3,serotonin transmembrane transporter activity,MF,
5375,GO:0015226,1,0.965408428612782,0,6,carnitine transmembrane transporter activity,MF,
5376,GO:0015227,1,0.988777183362907,0,2,acyl carnitine transmembrane transporter activity,MF,
5377,GO:0015228,1,0.980305153810067,0,3,coenzyme A transmembrane transporter activity,MF,
5378,GO:0015229,1,0.990928293703605,0,1,L-ascorbic acid transmembrane transporter activity,MF,
5379,GO:0015230,1,0.986855094309458,0,2,FAD transmembrane transporter activity,MF,
5380,GO:0015232,1,0.944876345036424,0,8,heme transporter activity,MF,
5381,GO:0015234,1,0.980611873451649,0,3,thiamine transmembrane transporter activity,MF,
5383,GO:0015245,1,0.947994057605899,0,8,fatty acid transmembrane transporter activity,MF,
5384,GO:0015247,1,0.97652672467514,0,3,aminophospholipid transmembrane transporter activity,MF,
5385,GO:0015248,1,0.848955838408761,0,25,sterol transporter activity,MF,
5386,GO:0015250,1,0.944738240024178,0,10,water channel activity,MF,
5387,GO:0015252,1,0.98147075566201,0,3,proton channel activity,MF,
5388,GO:0015254,1,0.979470620532667,0,4,glycerol channel activity,MF,
5389,GO:0015265,1,0.980503215090371,0,3,urea channel activity,MF,
5391,GO:0015269,1,0.904519399269185,0,16,calcium-activated potassium channel activity,MF,
5392,GO:0015271,1,0.900860440650865,0,14,outward rectifier potassium channel activity,MF,
5393,GO:0015272,1,0.964898929484941,0,5,ATP-activated inward rectifier potassium channel activity,MF,
5394,GO:0015275,1,0.977813692933746,0,3,stretch-activated, cation-selective, calcium channel activity,MF,
5396,GO:0015277,1,0.960541207619472,0,5,kainate selective glutamate receptor activity,MF,
5398,GO:0015279,1,0.931877890583989,0,9,store-operated calcium channel activity,MF,
5399,GO:0015280,1,0.94308989551509,0,8,ligand-gated sodium channel activity,MF,
5400,GO:0015288,1,0.968567822868686,0,6,porin activity,MF,
5402,GO:0015292,1,0.993058458973322,0,1,uniporter activity,MF,
5405,GO:0015295,1,0.867883176260181,0,21,solute:proton symporter activity,MF,
5406,GO:0015296,1,0.922896582991504,0,10,anion:cation symporter activity,MF,
5407,GO:0015297,1,0.583196999787294,0,76,antiporter activity,MF,
5408,GO:0015298,1,0.799667336053127,0,31,solute:cation antiporter activity,MF,
5409,GO:0015299,1,0.878454373625226,0,18,solute:proton antiporter activity,MF,
5410,GO:0015301,1,0.817404455903484,0,28,anion:anion antiporter activity,MF,
5411,GO:0015307,1,0.982334967049237,0,3,drug:proton antiporter activity,MF,
5412,GO:0015315,1,0.979683146978749,0,3,organophosphate:inorganic phosphate antiporter activity,MF,
5413,GO:0015317,1,0.99538233344484,0,1,phosphate:proton symporter activity,MF,
5417,GO:0015322,1,0.992506510678346,0,1,secondary active oligopeptide transmembrane transporter activity,MF,
5418,GO:0015327,1,0.989356043494652,0,1,cystine:glutamate antiporter activity,MF,
5419,GO:0015328,1,0.989356043494652,0,1,cystine secondary active transmembrane transporter activity,MF,
5420,GO:0015333,1,0.979576931822732,0,3,peptide:proton symporter activity,MF,
5421,GO:0015343,1,0.993058458973322,0,1,siderophore transmembrane transporter activity,MF,
5422,GO:0015347,1,0.858229391607995,0,22,sodium-independent organic anion transmembrane transporter activity,MF,
5423,GO:0015349,1,0.971298104358296,0,4,thyroid hormone transmembrane transporter activity,MF,
5424,GO:0015350,1,0.984265995709688,0,2,methotrexate transmembrane transporter activity,MF,
5425,GO:0015355,1,0.934371372958736,0,11,secondary active monocarboxylate transmembrane transporter activity,MF,
5426,GO:0015362,1,0.992464718266025,0,1,high-affinity sodium:dicarboxylate symporter activity,MF,
5427,GO:0015367,1,0.995156022161353,0,1,oxoglutarate:malate antiporter activity,MF,
5428,GO:0015368,1,0.922253631996835,0,11,calcium:cation antiporter activity,MF,
5429,GO:0015369,1,0.991850953412117,0,1,calcium:proton antiporter activity,MF,
5431,GO:0015373,1,0.969032759361215,0,4,anion:sodium symporter activity,MF,
5432,GO:0015375,1,0.985645317344822,0,2,glycine:sodium symporter activity,MF,
5433,GO:0015377,1,0.93649291290785,0,8,cation:chloride symporter activity,MF,
5434,GO:0015378,1,0.983301772356678,0,2,sodium:chloride symporter activity,MF,
5435,GO:0015379,1,0.93649291290785,0,8,potassium:chloride symporter activity,MF,
5436,GO:0015382,1,0.992913450177408,0,1,sodium:sulfate symporter activity,MF,
5437,GO:0015385,1,0.915109594500256,0,12,sodium:proton antiporter activity,MF,
5438,GO:0015386,1,0.92795776954305,0,10,potassium:proton antiporter activity,MF,
5439,GO:0015389,1,0.988686162986857,0,2,pyrimidine- and adenine-specific:sodium symporter activity,MF,
5440,GO:0015390,1,0.994119122781983,0,1,purine-specific nucleoside:sodium symporter activity,MF,
5441,GO:0015391,1,0.988686162986857,0,2,nucleobase:cation symporter activity,MF,
5442,GO:0015399,1,0.476204821993019,0,102,primary active transmembrane transporter activity,MF,
5443,GO:0015405,1,0.476204821993019,0,102,P-P-bond-hydrolysis-driven transmembrane transporter activity,MF,
5444,GO:0015410,1,0.97776488011331,0,3,manganese-transporting ATPase activity,MF,
5445,GO:0015420,1,0.99126790998446,0,1,cobalamin-transporting ATPase activity,MF,
5446,GO:0015421,1,0.992534733690355,0,1,oligopeptide-transporting ATPase activity,MF,
5447,GO:0015431,1,0.99126790998446,0,1,glutathione S-conjugate-exporting ATPase activity,MF,
5448,GO:0015432,1,0.984812769154141,0,2,bile acid-exporting ATPase activity,MF,
5449,GO:0015433,1,0.985067717449935,0,2,peptide antigen-transporting ATPase activity,MF,
5450,GO:0015439,1,0.992822651878865,0,1,heme-transporting ATPase activity,MF,
5451,GO:0015440,1,0.970721746188394,0,4,peptide-transporting ATPase activity,MF,
5452,GO:0015450,1,0.973989935368048,0,6,P-P-bond-hydrolysis-driven protein transmembrane transporter activity,MF,
5453,GO:0015459,1,0.738308092836685,0,46,potassium channel regulator activity,MF,
5454,GO:0015464,1,0.882992496864116,0,19,acetylcholine receptor activity,MF,
5457,GO:0015489,1,0.990245504074095,0,2,putrescine transmembrane transporter activity,MF,
5458,GO:0015491,1,0.813979708440776,0,28,cation:cation antiporter activity,MF,
5459,GO:0015495,1,0.993401620947692,0,1,gamma-aminobutyric acid:proton symporter activity,MF,
5460,GO:0015499,1,0.99325634617697,0,1,formate transmembrane transporter activity,MF,
5461,GO:0015501,1,0.950177888078835,0,7,glutamate:sodium symporter activity,MF,
5462,GO:0015526,1,0.979683146978749,0,3,hexose-phosphate:inorganic phosphate antiporter activity,MF,
5463,GO:0015538,1,0.992601157172089,0,1,sialic acid:proton symporter activity,MF,
5464,GO:0015556,1,0.949775830333725,0,8,C4-dicarboxylate transmembrane transporter activity,MF,
5465,GO:0015562,1,0.97633489450359,0,3,efflux transmembrane transporter activity,MF,
5466,GO:0015578,1,0.993624627626803,0,1,mannose transmembrane transporter activity,MF,
5467,GO:0015605,1,0.859333264016296,0,23,organophosphate ester transmembrane transporter activity,MF,
5468,GO:0015616,1,0.964770534414935,0,4,DNA translocase activity,MF,
5473,GO:0015636,1,0.993924772845207,0,1,short-chain fatty acid transmembrane transporter activity,MF,
5474,GO:0015643,1,0.948395018796954,0,9,toxic substance binding,MF,
5475,GO:0015645,1,0.891083080051306,0,17,fatty acid ligase activity,MF,
5476,GO:0015651,1,0.94532893822109,0,9,quaternary ammonium group transmembrane transporter activity,MF,
5477,GO:0015658,1,0.993064770092322,0,1,branched-chain amino acid transmembrane transporter activity,MF,
5478,GO:0015660,1,0.99325634617697,0,1,formate efflux transmembrane transporter activity,MF,
5479,GO:0015662,1,0.764056355448201,0,37,ATPase activity, coupled to transmembrane movement of ions, phosphorylative mechanism,MF,
5480,GO:0015665,1,0.990035548376043,0,2,alcohol transmembrane transporter activity,MF,
5481,GO:0015669,1,0.935971927445318,0,17,gas transport,BP,
5482,GO:0015670,1,0.983669606138166,0,3,carbon dioxide transport,BP,
5483,GO:0015671,1,0.951518282436566,0,14,oxygen transport,BP,
5485,GO:0015677,1,0.94035805512819,0,8,copper ion import,BP,
5486,GO:0015679,1,0.982322107150171,0,2,plasma membrane copper ion transport,BP,
5487,GO:0015680,1,0.986131868186631,0,3,intracellular copper ion transport,BP,
5488,GO:0015682,1,0.792105222879329,0,38,ferric iron transport,BP,
5489,GO:0015684,1,0.97746879184746,0,3,ferrous iron transport,BP,
5490,GO:0015688,1,0.984615208784106,0,3,iron chelate transport,BP,
5491,GO:0015689,1,0.994875830458898,0,1,molybdate ion transport,BP,
5492,GO:0015691,1,0.972459763997186,0,4,cadmium ion transport,BP,
5493,GO:0015692,1,0.992443860497474,0,1,lead ion transport,BP,
5494,GO:0015693,1,0.884986979843925,0,17,magnesium ion transport,BP,
5495,GO:0015694,1,0.99207833818527,0,1,mercury ion transport,BP,
5496,GO:0015695,1,0.781577533453735,0,38,organic cation transport,BP,
5497,GO:0015696,1,0.586386712320005,0,85,ammonium transport,BP,
5498,GO:0015697,1,0.925090347170544,0,12,quaternary ammonium group transport,BP,
5500,GO:0015700,1,0.996281810222167,0,1,arsenite transport,BP,
5501,GO:0015701,1,0.770112878508003,0,41,bicarbonate transport,BP,
5502,GO:0015705,1,0.957708866361224,0,5,iodide transport,BP,
5503,GO:0015706,1,0.993260510867532,0,1,nitrate transport,BP,
5504,GO:0015707,1,0.992490197829783,0,1,nitrite transport,BP,
5505,GO:0015709,1,0.994895992285313,0,1,thiosulfate transport,BP,
5507,GO:0015712,1,0.968169713024033,0,5,hexose phosphate transport,BP,
5509,GO:0015721,1,0.851276274755323,0,25,bile acid and bile salt transport,BP,
5510,GO:0015722,1,0.969963945753872,0,4,canalicular bile acid transport,BP,
5511,GO:0015723,1,0.99207833818527,0,1,bilirubin transport,BP,
5512,GO:0015724,1,0.99325634617697,0,1,formate transport,BP,
5513,GO:0015727,1,0.958900640464984,0,6,lactate transport,BP,
5514,GO:0015728,1,0.992450517902719,0,1,mevalonate transport,BP,
5515,GO:0015729,1,0.994895992285313,0,1,oxaloacetate transport,BP,
5517,GO:0015734,1,0.991204610937364,0,1,taurine transport,BP,
5518,GO:0015739,1,0.992601157172089,0,1,sialic acid transport,BP,
5519,GO:0015740,1,0.914681755866985,0,12,C4-dicarboxylate transport,BP,
5520,GO:0015742,1,0.982577594927753,0,3,alpha-ketoglutarate transport,BP,
5521,GO:0015743,1,0.994895992285313,0,1,malate transport,BP,
5522,GO:0015744,1,0.980140898643121,0,3,succinate transport,BP,
5523,GO:0015746,1,0.973394197925728,0,4,citrate transport,BP,
5524,GO:0015747,1,0.976855316910818,0,4,urate transport,BP,
5526,GO:0015749,1,0.501233961640955,0,97,monosaccharide transmembrane transport,BP,
5527,GO:0015755,1,0.993903156509167,0,1,fructose transmembrane transport,BP,
5528,GO:0015760,1,0.968169713024033,0,5,glucose-6-phosphate transport,BP,
5529,GO:0015761,1,0.993624627626803,0,1,mannose transmembrane transport,BP,
5530,GO:0015766,1,0.979385092178553,0,3,disaccharide transport,BP,
5531,GO:0015770,1,0.979385092178553,0,3,sucrose transport,BP,
5532,GO:0015772,1,0.979385092178553,0,3,oligosaccharide transport,BP,
5533,GO:0015780,1,0.921511990309315,0,13,nucleotide-sugar transmembrane transport,BP,
5534,GO:0015782,1,0.995075918256662,0,1,CMP-N-acetylneuraminate transmembrane transport,BP,
5535,GO:0015783,1,0.983736367541626,0,2,GDP-fucose transmembrane transport,BP,
5536,GO:0015786,1,0.994014441945039,0,1,UDP-glucose transmembrane transport,BP,
5537,GO:0015787,1,0.991232244299252,0,1,UDP-glucuronic acid transmembrane transport,BP,
5538,GO:0015790,1,0.99101698094818,0,1,UDP-xylose transmembrane transport,BP,
5539,GO:0015791,1,0.929527780302203,0,10,polyol transport,BP,
5540,GO:0015793,1,0.972714373013329,0,5,glycerol transport,BP,
5541,GO:0015797,1,0.99325634617697,0,1,mannitol transport,BP,
5542,GO:0015798,1,0.962104578388467,0,4,myo-inositol transport,BP,
5544,GO:0015801,1,0.966234360167691,0,5,aromatic amino acid transport,BP,
5545,GO:0015802,1,0.92543976540588,0,12,basic amino acid transport,BP,
5546,GO:0015803,1,0.971070972157978,0,4,branched-chain amino acid transport,BP,
5548,GO:0015805,1,0.994107897982335,0,1,S-adenosyl-L-methionine transport,BP,
5550,GO:0015808,1,0.964839408150436,0,5,L-alanine transport,BP,
5551,GO:0015809,1,0.949342857315578,0,8,arginine transport,BP,
5552,GO:0015810,1,0.980545495075794,0,3,aspartate transmembrane transport,BP,
5553,GO:0015811,1,0.980222718456899,0,3,L-cystine transport,BP,
5554,GO:0015812,1,0.907396424487094,0,13,gamma-aminobutyric acid transport,BP,
5556,GO:0015816,1,0.94419649519636,0,8,glycine transport,BP,
5557,GO:0015817,1,0.986700758736321,0,2,histidine transport,BP,
5558,GO:0015819,1,0.99490073577944,0,1,lysine transport,BP,
5559,GO:0015820,1,0.977854128109881,0,3,leucine transport,BP,
5560,GO:0015821,1,0.993064770092322,0,1,methionine transport,BP,
5561,GO:0015822,1,0.958336504408226,0,6,ornithine transport,BP,
5562,GO:0015824,1,0.946970172651302,0,7,proline transport,BP,
5563,GO:0015825,1,0.948407495747731,0,9,L-serine transport,BP,
5564,GO:0015826,1,0.992410805622225,0,1,threonine transport,BP,
5565,GO:0015827,1,0.980291551429142,0,3,tryptophan transport,BP,
5566,GO:0015828,1,0.992688031878015,0,1,tyrosine transport,BP,
5569,GO:0015838,1,0.944744249909399,0,9,amino-acid betaine transport,BP,
5570,GO:0015840,1,0.965551677287737,0,6,urea transport,BP,
5571,GO:0015842,1,0.977464581941073,0,4,aminergic neurotransmitter loading into synaptic vesicle,BP,
5572,GO:0015844,1,0.678099035771895,0,62,monoamine transport,BP,
5573,GO:0015846,1,0.961147903147194,0,7,polyamine transport,BP,
5574,GO:0015847,1,0.990245504074095,0,2,putrescine transport,BP,
5576,GO:0015850,1,0.288726280384993,0,189,organic hydroxy compound transport,BP,
5577,GO:0015851,1,0.957606265844294,0,7,nucleobase transport,BP,
5578,GO:0015853,1,0.98453702818411,0,3,adenine transport,BP,
5579,GO:0015855,1,0.981556516002149,0,3,pyrimidine nucleobase transport,BP,
5580,GO:0015858,1,0.956863282452135,0,7,nucleoside transport,BP,
5581,GO:0015860,1,0.994119122781983,0,1,purine nucleoside transmembrane transport,BP,
5582,GO:0015862,1,0.993881645022665,0,1,uridine transport,BP,
5583,GO:0015864,1,0.988036391229059,0,2,pyrimidine nucleoside transport,BP,
5585,GO:0015866,1,0.943559803010725,0,9,ADP transport,BP,
5588,GO:0015870,1,0.973875883230378,0,4,acetylcholine transport,BP,
5589,GO:0015871,1,0.949039554349227,0,7,choline transport,BP,
5590,GO:0015872,1,0.808172326594482,0,34,dopamine transport,BP,
5591,GO:0015874,1,0.902288648186949,0,16,norepinephrine transport,BP,
5592,GO:0015876,1,0.993248879662176,0,1,acetyl-CoA transport,BP,
5593,GO:0015878,1,0.992607370275599,0,1,biotin transport,BP,
5594,GO:0015879,1,0.959974049358257,0,7,carnitine transport,BP,
5595,GO:0015880,1,0.980305153810067,0,3,coenzyme A transport,BP,
5596,GO:0015881,1,0.984888499349361,0,2,creatine transmembrane transport,BP,
5597,GO:0015882,1,0.990928293703605,0,1,L-ascorbic acid transmembrane transport,BP,
5598,GO:0015884,1,0.947518671355678,0,8,folic acid transport,BP,
5599,GO:0015886,1,0.944876345036424,0,8,heme transport,BP,
5600,GO:0015887,1,0.992607370275599,0,1,pantothenate transmembrane transport,BP,
5601,GO:0015888,1,0.978096414681637,0,3,thiamine transport,BP,
5602,GO:0015889,1,0.962377846317581,0,6,cobalamin transport,BP,
5603,GO:0015891,1,0.984615208784106,0,3,siderophore transport,BP,
5605,GO:0015904,1,0.994958819534913,0,1,tetracycline transport,BP,
5607,GO:0015909,1,0.72415945790077,0,50,long-chain fatty acid transport,BP,
5608,GO:0015910,1,0.98650231313514,0,2,peroxisomal long-chain fatty acid import,BP,
5609,GO:0015911,1,0.961861618666547,0,5,plasma membrane long-chain fatty acid transport,BP,
5610,GO:0015912,1,0.993924772845207,0,1,short-chain fatty acid transport,BP,
5611,GO:0015913,1,0.993924772845207,0,1,short-chain fatty acid import,BP,
5613,GO:0015916,1,0.993248879662176,0,1,fatty-acyl-CoA transport,BP,
5614,GO:0015917,1,0.967443176171263,0,4,aminophospholipid transport,BP,
5615,GO:0015918,1,0.607428999306631,0,74,sterol transport,BP,
5616,GO:0015919,1,0.89710739988738,0,16,peroxisomal membrane transport,BP,
5617,GO:0015920,1,0.988274147159861,0,2,lipopolysaccharide transport,BP,
5618,GO:0015922,1,0.995529779370763,0,1,aspartate oxidase activity,MF,
5619,GO:0015923,1,0.898546188494093,0,14,mannosidase activity,MF,
5620,GO:0015924,1,0.93294691285071,0,9,mannosyl-oligosaccharide mannosidase activity,MF,
5621,GO:0015925,1,0.950512188853209,0,8,galactosidase activity,MF,
5622,GO:0015926,1,0.929103674839015,0,10,glucosidase activity,MF,
5623,GO:0015928,1,0.988800250463333,0,2,fucosidase activity,MF,
5624,GO:0015929,1,0.92614793828103,0,12,hexosaminidase activity,MF,
5626,GO:0015932,1,0.79537998083435,0,36,nucleobase-containing compound transmembrane transporter activity,MF,
5627,GO:0015934,1,0.657270642165654,0,113,large ribosomal subunit,CC,
5628,GO:0015935,1,0.778612425891469,0,69,small ribosomal subunit,CC,
5629,GO:0015936,1,0.913578227529305,0,15,coenzyme A metabolic process,BP,
5630,GO:0015937,1,0.944603699084365,0,10,coenzyme A biosynthetic process,BP,
5631,GO:0015938,1,0.996867443319391,0,1,coenzyme A catabolic process,BP,
5632,GO:0015939,1,0.950644865949539,0,8,pantothenate metabolic process,BP,
5633,GO:0015942,1,0.964632239690826,0,6,formate metabolic process,BP,
5634,GO:0015949,1,0.840127829164255,0,32,nucleobase-containing small molecule interconversion,BP,
5635,GO:0015950,1,0.990698150942483,0,2,purine nucleotide interconversion,BP,
5636,GO:0015951,1,0.990698150942483,0,2,purine ribonucleotide interconversion,BP,
5637,GO:0015959,1,0.957537158999672,0,7,diadenosine polyphosphate metabolic process,BP,
5638,GO:0015960,1,0.980109223615621,0,3,diadenosine polyphosphate biosynthetic process,BP,
5639,GO:0015961,1,0.976974422612972,0,4,diadenosine polyphosphate catabolic process,BP,
5640,GO:0015965,1,0.980109223615621,0,3,diadenosine tetraphosphate metabolic process,BP,
5641,GO:0015966,1,0.980109223615621,0,3,diadenosine tetraphosphate biosynthetic process,BP,
5643,GO:0015985,1,0.950568069135604,0,9,energy coupled proton transport, down electrochemical gradient,BP,
5644,GO:0015986,1,0.950568069135604,0,9,ATP synthesis coupled proton transport,BP,
5645,GO:0015988,1,0.847148822371633,0,28,energy coupled proton transmembrane transport, against electrochemical gradient,BP,
5646,GO:0015990,1,0.997335423000157,0,1,electron transport coupled proton transport,BP,
5647,GO:0015991,1,0.849415866579509,0,27,ATP hydrolysis coupled proton transport,BP,
5648,GO:0016004,1,0.947258572146885,0,9,phospholipase activator activity,MF,
5649,GO:0016005,1,0.985560989568782,0,2,phospholipase A2 activator activity,MF,
5653,GO:0016013,1,0.974512717746118,0,4,syntrophin complex,CC,
5654,GO:0016015,1,0.96920451654545,0,6,morphogen activity,MF,
5655,GO:0016018,1,0.943571513764343,0,10,cyclosporin A binding,MF,
5656,GO:0016019,1,0.992607914031495,0,2,peptidoglycan receptor activity,MF,
5659,GO:0016024,1,0.9214568109878,0,11,CDP-diacylglycerol biosynthetic process,BP,
5660,GO:0016028,1,0.992516186137117,0,1,rhabdomere,CC,
5661,GO:0016031,1,0.992576689408957,0,1,tRNA import into mitochondrion,BP,
5663,GO:0016034,1,0.996161055383937,0,1,maleylacetoacetate isomerase activity,MF,
5664,GO:0016035,1,0.98539458599231,0,2,zeta DNA polymerase complex,CC,
5665,GO:0016036,1,0.994015545358986,0,1,cellular response to phosphate starvation,BP,
5666,GO:0016037,1,0.993083253309447,0,1,light absorption,BP,
5667,GO:0016038,1,0.993083253309447,0,1,absorption of visible light,BP,
5670,GO:0016045,1,0.928910449203547,0,10,detection of bacterium,BP,
5671,GO:0016046,1,0.991741257029872,0,1,detection of fungus,BP,
5672,GO:0016048,1,0.887458394933896,0,18,detection of temperature stimulus,BP,
5680,GO:0016056,1,0.857577353813896,0,23,rhodopsin mediated signaling pathway,BP,
5681,GO:0016062,1,0.993412530282365,0,1,adaptation of rhodopsin mediated signaling,BP,
5682,GO:0016064,1,0.570212209917647,0,90,immunoglobulin mediated immune response,BP,
5683,GO:0016068,1,0.986664679384695,0,3,type I hypersensitivity,BP,
5685,GO:0016071,1,0.00834116418626857,0,771,mRNA metabolic process,BP,
5686,GO:0016072,1,0.228634306508511,0,279,rRNA metabolic process,BP,
5687,GO:0016073,1,0.606044164047419,0,84,snRNA metabolic process,BP,
5688,GO:0016074,1,0.948680046089091,0,12,snoRNA metabolic process,BP,
5689,GO:0016075,1,0.911073360943485,0,16,rRNA catabolic process,BP,
5690,GO:0016077,1,0.991503892523375,0,1,snoRNA catabolic process,BP,
5691,GO:0016078,1,0.971454389129501,0,6,tRNA catabolic process,BP,
5692,GO:0016079,1,0.541206269952184,0,85,synaptic vesicle exocytosis,BP,
5693,GO:0016080,1,0.968539639319507,0,4,synaptic vesicle targeting,BP,
5694,GO:0016081,1,0.932087648441413,0,9,synaptic vesicle docking,BP,
5695,GO:0016082,1,0.892208092956535,0,15,synaptic vesicle priming,BP,
5696,GO:0016093,1,0.957621702691095,0,8,polyprenol metabolic process,BP,
5697,GO:0016094,1,0.978234594940086,0,3,polyprenol biosynthetic process,BP,
5698,GO:0016095,1,0.985297487432195,0,3,polyprenol catabolic process,BP,
5699,GO:0016098,1,0.991037577440571,0,2,monoterpenoid metabolic process,BP,
5701,GO:0016102,1,0.947493953467425,0,9,diterpenoid biosynthetic process,BP,
5702,GO:0016103,1,0.983993275973364,0,3,diterpenoid catabolic process,BP,
5703,GO:0016107,1,0.991995103233853,0,2,sesquiterpenoid catabolic process,BP,
5704,GO:0016108,1,0.979482632922,0,3,tetraterpenoid metabolic process,BP,
5705,GO:0016109,1,0.993321774029604,0,1,tetraterpenoid biosynthetic process,BP,
5706,GO:0016114,1,0.917946388708785,0,14,terpenoid biosynthetic process,BP,
5707,GO:0016115,1,0.976115241900879,0,5,terpenoid catabolic process,BP,
5708,GO:0016116,1,0.979482632922,0,3,carotenoid metabolic process,BP,
5709,GO:0016117,1,0.993321774029604,0,1,carotenoid biosynthetic process,BP,
5710,GO:0016119,1,0.986068743381,0,2,carotene metabolic process,BP,
5711,GO:0016121,1,0.992961914196941,0,1,carotene catabolic process,BP,
5712,GO:0016122,1,0.986330223481997,0,2,xanthophyll metabolic process,BP,
5713,GO:0016123,1,0.993321774029604,0,1,xanthophyll biosynthetic process,BP,
5714,GO:0016125,1,0.411377678317415,0,133,sterol metabolic process,BP,
5715,GO:0016126,1,0.637177284209305,0,68,sterol biosynthetic process,BP,
5716,GO:0016127,1,0.948488623699545,0,9,sterol catabolic process,BP,
5717,GO:0016128,1,0.982055875815883,0,3,phytosteroid metabolic process,BP,
5718,GO:0016129,1,0.982055875815883,0,3,phytosteroid biosynthetic process,BP,
5719,GO:0016131,1,0.99325634617697,0,1,brassinosteroid metabolic process,BP,
5720,GO:0016132,1,0.99325634617697,0,1,brassinosteroid biosynthetic process,BP,
5721,GO:0016137,1,0.915520912034093,0,17,glycoside metabolic process,BP,
5722,GO:0016139,1,0.953132230863953,0,8,glycoside catabolic process,BP,
5723,GO:0016149,1,0.992509091581307,0,1,translation release factor activity, codon specific,MF,
5724,GO:0016150,1,0.995529779370763,0,1,translation release factor activity, codon nonspecific,MF,
5725,GO:0016151,1,0.989364272596967,0,2,nickel cation binding,MF,
5726,GO:0016153,1,0.992581106109342,0,1,urocanate hydratase activity,MF,
5727,GO:0016154,1,0.99543318216766,0,1,pyrimidine-nucleoside phosphorylase activity,MF,
5728,GO:0016155,1,0.983351794821266,0,2,formyltetrahydrofolate dehydrogenase activity,MF,
5729,GO:0016160,1,0.981023133472566,0,3,amylase activity,MF,
5730,GO:0016165,1,0.987152786208368,0,2,linoleate 13S-lipoxygenase activity,MF,
5732,GO:0016174,1,0.956535398151308,0,6,NAD(P)H oxidase activity,MF,
5733,GO:0016175,1,0.958769653221512,0,7,superoxide-generating NADPH oxidase activity,MF,
5734,GO:0016176,1,0.95059692415199,0,8,superoxide-generating NADPH oxidase activator activity,MF,
5735,GO:0016180,1,0.867991948825765,0,23,snRNA processing,BP,
5736,GO:0016182,1,0.992207656350658,0,1,synaptic vesicle budding from endosome,BP,
5737,GO:0016185,1,0.975857846284119,0,3,synaptic vesicle budding from presynaptic endocytic zone membrane,BP,
5739,GO:0016189,1,0.990294247195984,0,1,synaptic vesicle to endosome fusion,BP,
5740,GO:0016191,1,0.96220058068448,0,5,synaptic vesicle uncoating,BP,
5744,GO:0016199,1,0.967490706186072,0,4,axon midline choice point recognition,BP,
5746,GO:0016206,1,0.986819882785499,0,2,catechol O-methyltransferase activity,MF,
5747,GO:0016208,1,0.944379371500885,0,10,AMP binding,MF,
5748,GO:0016209,1,0.700717511703482,0,71,antioxidant activity,MF,
5749,GO:0016211,1,0.98433350185627,0,2,ammonia ligase activity,MF,
5750,GO:0016212,1,0.987783472787719,0,2,kynurenine-oxoglutarate transaminase activity,MF,
5751,GO:0016213,1,0.992687382343135,0,1,linoleoyl-CoA desaturase activity,MF,
5752,GO:0016215,1,0.97806743995319,0,3,acyl-CoA desaturase activity,MF,
5753,GO:0016222,1,0.9863929285296,0,2,procollagen-proline 4-dioxygenase complex,CC,
5754,GO:0016226,1,0.903207143203265,0,20,iron-sulfur cluster assembly,BP,
5755,GO:0016229,1,0.886787970157331,0,25,steroid dehydrogenase activity,MF,
5756,GO:0016230,1,0.988602419159245,0,2,sphingomyelin phosphodiesterase activator activity,MF,
5757,GO:0016231,1,0.992047970804738,0,1,beta-N-acetylglucosaminidase activity,MF,
5758,GO:0016232,1,0.993015556268365,0,1,HNK-1 sulfotransferase activity,MF,
5759,GO:0016233,1,0.754314469007996,0,42,telomere capping,BP,
5760,GO:0016234,1,0.571708271826305,0,77,inclusion body,CC,
5761,GO:0016235,1,0.745007906463611,0,41,aggresome,CC,
5762,GO:0016236,1,0.158024414461142,0,278,macroautophagy,BP,
5763,GO:0016237,1,0.992132846738313,0,1,lysosomal microautophagy,BP,
5764,GO:0016239,1,0.657848791367074,0,57,positive regulation of macroautophagy,BP,
5765,GO:0016240,1,0.974121196758052,0,4,autophagosome membrane docking,BP,
5766,GO:0016241,1,0.347550092726,0,155,regulation of macroautophagy,BP,
5767,GO:0016242,1,0.824079619719243,0,27,negative regulation of macroautophagy,BP,
5768,GO:0016243,1,0.992473489815072,0,1,regulation of autophagosome size,BP,
5769,GO:0016246,1,0.900443790752841,0,15,RNA interference,BP,
5771,GO:0016248,1,0.814284933802249,0,32,channel inhibitor activity,MF,
5772,GO:0016250,1,0.993080385600111,0,1,N-sulfoglucosamine sulfohydrolase activity,MF,
5773,GO:0016254,1,0.914252077671892,0,16,preassembly of GPI anchor in ER membrane,BP,
5774,GO:0016255,1,0.954183544152953,0,7,attachment of GPI anchor to protein,BP,
5775,GO:0016256,1,0.988135458173986,0,2,N-glycan processing to lysosome,BP,
5776,GO:0016259,1,0.97423867741332,0,4,selenocysteine metabolic process,BP,
5777,GO:0016260,1,0.987421175502056,0,2,selenocysteine biosynthetic process,BP,
5778,GO:0016262,1,0.979972731137751,0,3,protein N-acetylglucosaminyltransferase activity,MF,
5779,GO:0016263,1,0.989903483109772,0,2,glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase activity,MF,
5782,GO:0016267,1,0.989903483109772,0,2,O-glycan processing, core 1,BP,
5783,GO:0016272,1,0.97722424082089,0,7,prefoldin complex,CC,
5784,GO:0016273,1,0.926632942471947,0,12,arginine N-methyltransferase activity,MF,
5785,GO:0016274,1,0.926632942471947,0,12,protein-arginine N-methyltransferase activity,MF,
5786,GO:0016277,1,0.993728026440238,0,1,[myelin basic protein]-arginine N-methyltransferase activity,MF,
5787,GO:0016278,1,0.685358426330558,0,51,lysine N-methyltransferase activity,MF,
5788,GO:0016279,1,0.690166975112546,0,50,protein-lysine N-methyltransferase activity,MF,
5789,GO:0016281,1,0.942970011727226,0,9,eukaryotic translation initiation factor 4F complex,CC,
5790,GO:0016282,1,0.992349342692823,0,1,eukaryotic 43S preinitiation complex,CC,
5791,GO:0016286,1,0.975729516356861,0,4,small conductance calcium-activated potassium channel activity,MF,
5792,GO:0016287,1,0.993200102459617,0,1,glycerone-phosphate O-acyltransferase activity,MF,
5793,GO:0016289,1,0.913285351288484,0,17,CoA hydrolase activity,MF,
5794,GO:0016290,1,0.953297387753046,0,9,palmitoyl-CoA hydrolase activity,MF,
5795,GO:0016295,1,0.985274796161948,0,2,myristoyl-[acyl-carrier-protein] hydrolase activity,MF,
5796,GO:0016296,1,0.985274796161948,0,2,palmitoyl-[acyl-carrier-protein] hydrolase activity,MF,
5797,GO:0016297,1,0.985274796161948,0,2,acyl-[acyl-carrier-protein] hydrolase activity,MF,
5799,GO:0016300,1,0.978361199688088,0,3,tRNA (uracil) methyltransferase activity,MF,
5802,GO:0016307,1,0.894119476254034,0,15,phosphatidylinositol phosphate kinase activity,MF,
5803,GO:0016308,1,0.958752176528404,0,6,1-phosphatidylinositol-4-phosphate 5-kinase activity,MF,
5804,GO:0016309,1,0.9852562037473,0,2,1-phosphatidylinositol-5-phosphate 4-kinase activity,MF,
5807,GO:0016312,1,0.970931820338425,0,4,inositol bisphosphate phosphatase activity,MF,
5808,GO:0016314,1,0.979167574308111,0,3,phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity,MF,
5809,GO:0016316,1,0.983612487903002,0,2,phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity,MF,
5810,GO:0016320,1,0.986553344524973,0,2,endoplasmic reticulum membrane fusion,BP,
5811,GO:0016321,1,0.973922481436914,0,4,female meiosis chromosome segregation,BP,
5812,GO:0016322,1,0.933990881631784,0,10,neuron remodeling,BP,
5815,GO:0016327,1,0.905578729463068,0,16,apicolateral plasma membrane,CC,
5818,GO:0016332,1,0.992484872212748,0,1,establishment or maintenance of polarity of embryonic epithelium,BP,
5819,GO:0016333,1,0.992868157675994,0,1,morphogenesis of follicular epithelium,BP,
5820,GO:0016334,1,0.992868157675994,0,1,establishment or maintenance of polarity of follicular epithelium,BP,
5823,GO:0016340,1,0.98252241495963,0,2,calcium-dependent cell-matrix adhesion,BP,
5825,GO:0016344,1,0.97706373472422,0,3,meiotic chromosome movement towards spindle pole,BP,
5827,GO:0016361,1,0.970648961921087,0,4,activin receptor activity, type I,MF,
5828,GO:0016362,1,0.976585103059602,0,2,activin receptor activity, type II,MF,
5829,GO:0016363,1,0.486648708325195,0,102,nuclear matrix,CC,
5830,GO:0016401,1,0.973362872622098,0,4,palmitoyl-CoA oxidase activity,MF,
5831,GO:0016402,1,0.986921968327999,0,2,pristanoyl-CoA oxidase activity,MF,
5832,GO:0016403,1,0.988676604788671,0,2,dimethylargininase activity,MF,
5833,GO:0016404,1,0.98550379141032,0,2,15-hydroxyprostaglandin dehydrogenase (NAD+) activity,MF,
5834,GO:0016405,1,0.859937538098563,0,22,CoA-ligase activity,MF,
5835,GO:0016406,1,0.957862602188478,0,6,carnitine O-acyltransferase activity,MF,
5836,GO:0016407,1,0.530437554802726,0,94,acetyltransferase activity,MF,
5837,GO:0016408,1,0.903267904683341,0,17,C-acyltransferase activity,MF,
5838,GO:0016409,1,0.773387500535957,0,38,palmitoyltransferase activity,MF,
5839,GO:0016410,1,0.536961561723304,0,92,N-acyltransferase activity,MF,
5840,GO:0016411,1,0.86106879592915,0,21,acylglycerol O-acyltransferase activity,MF,
5841,GO:0016413,1,0.952486116047576,0,7,O-acetyltransferase activity,MF,
5842,GO:0016414,1,0.992632114881839,0,1,O-octanoyltransferase activity,MF,
5843,GO:0016415,1,0.989637888990961,0,2,octanoyltransferase activity,MF,
5844,GO:0016416,1,0.964170522624068,0,5,O-palmitoyltransferase activity,MF,
5845,GO:0016417,1,0.813005289455789,0,31,S-acyltransferase activity,MF,
5846,GO:0016418,1,0.982491484689057,0,2,S-acetyltransferase activity,MF,
5847,GO:0016419,1,0.984828832464379,0,2,S-malonyltransferase activity,MF,
5848,GO:0016420,1,0.984828832464379,0,2,malonyltransferase activity,MF,
5849,GO:0016421,1,0.964661053322523,0,5,CoA carboxylase activity,MF,
5850,GO:0016422,1,0.98226767108134,0,3,mRNA (2'-O-methyladenosine-N6-)-methyltransferase activity,MF,
5851,GO:0016423,1,0.920844380673064,0,13,tRNA (guanine) methyltransferase activity,MF,
5852,GO:0016426,1,0.980826199804542,0,3,tRNA (adenine) methyltransferase activity,MF,
5853,GO:0016427,1,0.947046668212428,0,8,tRNA (cytosine) methyltransferase activity,MF,
5854,GO:0016428,1,0.973404572367948,0,4,tRNA (cytosine-5-)-methyltransferase activity,MF,
5855,GO:0016429,1,0.980826199804542,0,3,tRNA (adenine-N1-)-methyltransferase activity,MF,
5856,GO:0016433,1,0.966084283837176,0,6,rRNA (adenine) methyltransferase activity,MF,
5857,GO:0016434,1,0.978753279341515,0,3,rRNA (cytosine) methyltransferase activity,MF,
5858,GO:0016435,1,0.982426937118249,0,3,rRNA (guanine) methyltransferase activity,MF,
5859,GO:0016436,1,0.985358228660122,0,2,rRNA (uridine) methyltransferase activity,MF,
5861,GO:0016442,1,0.917621597030145,0,11,RISC complex,CC,
5862,GO:0016444,1,0.697960644364763,0,51,somatic cell DNA recombination,BP,
5863,GO:0016445,1,0.717725160120952,0,48,somatic diversification of immunoglobulins,BP,
5864,GO:0016446,1,0.92720055554334,0,11,somatic hypermutation of immunoglobulin genes,BP,
5865,GO:0016447,1,0.743944608971267,0,43,somatic recombination of immunoglobulin gene segments,BP,
5866,GO:0016453,1,0.978535734308002,0,4,C-acetyltransferase activity,MF,
5867,GO:0016454,1,0.964788895421762,0,5,C-palmitoyltransferase activity,MF,
5869,GO:0016459,1,0.622308151392262,0,61,myosin complex,CC,
5870,GO:0016460,1,0.817614960069374,0,27,myosin II complex,CC,
5871,GO:0016461,1,0.926003986525295,0,10,unconventional myosin complex,CC,
5873,GO:0016469,1,0.860295261259558,0,28,proton-transporting two-sector ATPase complex,CC,
5874,GO:0016471,1,0.916123485980584,0,15,vacuolar proton-transporting V-type ATPase complex,CC,
5875,GO:0016476,1,0.978411116864722,0,3,regulation of embryonic cell shape,BP,
5877,GO:0016479,1,0.971813807877469,0,4,negative regulation of transcription by RNA polymerase I,BP,
5878,GO:0016480,1,0.985800952357754,0,3,negative regulation of transcription by RNA polymerase III,BP,
5879,GO:0016482,1,0.371675712194554,0,136,cytosolic transport,BP,
5881,GO:0016486,1,0.842921458475617,0,26,peptide hormone processing,BP,
5882,GO:0016487,1,0.991995103233853,0,2,farnesol metabolic process,BP,
5883,GO:0016488,1,0.991995103233853,0,2,farnesol catabolic process,BP,
5885,GO:0016492,1,0.988045555291813,0,2,G-protein coupled neurotensin receptor activity,MF,
5886,GO:0016493,1,0.942093059260426,0,10,C-C chemokine receptor activity,MF,
5887,GO:0016494,1,0.953744665262579,0,8,C-X-C chemokine receptor activity,MF,
5888,GO:0016495,1,0.992672267043728,0,1,C-X3-C chemokine receptor activity,MF,
5889,GO:0016496,1,0.992631105098037,0,1,substance P receptor activity,MF,
5890,GO:0016497,1,0.993703390079436,0,1,substance K receptor activity,MF,
5891,GO:0016499,1,0.994623553047403,0,1,orexin receptor activity,MF,
5892,GO:0016500,1,0.931155954222246,0,10,protein-hormone receptor activity,MF,
5893,GO:0016501,1,0.987350389123853,0,2,prostacyclin receptor activity,MF,
5894,GO:0016502,1,0.896270379404634,0,19,nucleotide receptor activity,MF,
5895,GO:0016503,1,0.996224832148941,0,1,pheromone receptor activity,MF,
5896,GO:0016504,1,0.808041056945946,0,35,peptidase activator activity,MF,
5897,GO:0016505,1,0.901440534222727,0,17,peptidase activator activity involved in apoptotic process,MF,
5898,GO:0016507,1,0.99276475129987,0,1,mitochondrial fatty acid beta-oxidation multienzyme complex,CC,
5899,GO:0016508,1,0.97860088082057,0,3,long-chain-enoyl-CoA hydratase activity,MF,
5900,GO:0016509,1,0.980523114111189,0,3,long-chain-3-hydroxyacyl-CoA dehydrogenase activity,MF,
5901,GO:0016514,1,0.901909678724808,0,15,SWI/SNF complex,CC,
5902,GO:0016517,1,0.994667264080108,0,1,interleukin-12 receptor activity,MF,
5903,GO:0016519,1,0.994557559682999,0,1,gastric inhibitory peptide receptor activity,MF,
5904,GO:0016520,1,0.98842771667139,0,2,growth hormone-releasing hormone receptor activity,MF,
5905,GO:0016521,1,0.992678142299321,0,1,pituitary adenylate cyclase activating polypeptide activity,MF,
5906,GO:0016525,1,0.548726867214167,0,85,negative regulation of angiogenesis,BP,
5908,GO:0016529,1,0.647482172302782,0,59,sarcoplasmic reticulum,CC,
5909,GO:0016530,1,0.964265736073043,0,7,metallochaperone activity,MF,
5910,GO:0016531,1,0.980044355674371,0,5,copper chaperone activity,MF,
5911,GO:0016532,1,0.983934859612418,0,3,superoxide dismutase copper chaperone activity,MF,
5912,GO:0016533,1,0.982742699356083,0,3,cyclin-dependent protein kinase 5 holoenzyme complex,CC,
5913,GO:0016534,1,0.986124078308622,0,2,cyclin-dependent protein kinase 5 activator activity,MF,
5914,GO:0016538,1,0.850185138987399,0,29,cyclin-dependent protein serine/threonine kinase regulator activity,MF,
5915,GO:0016539,1,0.995632596003417,0,1,intein-mediated protein splicing,BP,
5916,GO:0016540,1,0.917421681871025,0,13,protein autoprocessing,BP,
5917,GO:0016553,1,0.916362680475158,0,14,base conversion or substitution editing,BP,
5918,GO:0016554,1,0.953045958875752,0,9,cytidine to uridine editing,BP,
5919,GO:0016556,1,0.912515809140937,0,15,mRNA modification,BP,
5920,GO:0016557,1,0.984702815513805,0,3,peroxisome membrane biogenesis,BP,
5921,GO:0016558,1,0.924292823839353,0,12,protein import into peroxisome matrix,BP,
5922,GO:0016559,1,0.955653416843868,0,9,peroxisome fission,BP,
5923,GO:0016560,1,0.972625429013425,0,4,protein import into peroxisome matrix, docking,BP,
5924,GO:0016561,1,0.987385135876579,0,2,protein import into peroxisome matrix, translocation,BP,
5929,GO:0016572,1,0.795839840464361,0,34,histone phosphorylation,BP,
5931,GO:0016574,1,0.732448784279716,0,43,histone ubiquitination,BP,
5932,GO:0016575,1,0.555065315180147,0,83,histone deacetylation,BP,
5934,GO:0016577,1,0.801289331826122,0,27,histone demethylation,BP,
5935,GO:0016578,1,0.855750466827646,0,22,histone deubiquitination,BP,
5936,GO:0016579,1,0.185330337558996,0,249,protein deubiquitination,BP,
5937,GO:0016580,1,0.915421029015375,0,12,Sin3 complex,CC,
5939,GO:0016584,1,0.964062645544211,0,7,nucleosome positioning,BP,
5940,GO:0016586,1,0.982996359312354,0,2,RSC-type complex,CC,
5941,GO:0016589,1,0.949761346747331,0,7,NURF complex,CC,
5942,GO:0016590,1,0.991528775061749,0,1,ACF complex,CC,
5943,GO:0016591,1,0.503867406296797,0,107,DNA-directed RNA polymerase II, holoenzyme,CC,
5944,GO:0016592,1,0.789784563692609,0,36,mediator complex,CC,
5945,GO:0016593,1,0.945826532688698,0,8,Cdc73/Paf1 complex,CC,
5946,GO:0016594,1,0.904948261610958,0,15,glycine binding,MF,
5947,GO:0016595,1,0.928122465191729,0,10,glutamate binding,MF,
5948,GO:0016596,1,0.993058458973322,0,1,thienylcyclohexylpiperidine binding,MF,
5950,GO:0016598,1,0.989194640086563,0,2,protein arginylation,BP,
5951,GO:0016600,1,0.931490141484634,0,9,flotillin complex,CC,
5952,GO:0016601,1,0.772214444469153,0,37,Rac protein signal transduction,BP,
5953,GO:0016602,1,0.975248588482973,0,4,CCAAT-binding factor complex,CC,
5954,GO:0016603,1,0.989614320474747,0,2,glutaminyl-peptide cyclotransferase activity,MF,
5956,GO:0016605,1,0.514360131486082,0,94,PML body,CC,
5958,GO:0016608,1,0.995525268820051,0,2,growth hormone-releasing hormone activity,MF,
5959,GO:0016614,1,0.514736279255833,0,117,oxidoreductase activity, acting on CH-OH group of donors,MF,
5960,GO:0016615,1,0.960637017549761,0,7,malate dehydrogenase activity,MF,
5961,GO:0016616,1,0.566944817846921,0,103,oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,
5962,GO:0016618,1,0.982786602229003,0,3,hydroxypyruvate reductase activity,MF,
5963,GO:0016620,1,0.811248838760072,0,32,oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor,MF,
5964,GO:0016623,1,0.987406503302198,0,2,oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor,MF,
5965,GO:0016624,1,0.950950834632083,0,8,oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor,MF,
5966,GO:0016627,1,0.728993810822785,0,53,oxidoreductase activity, acting on the CH-CH group of donors,MF,
5967,GO:0016628,1,0.876574204706725,0,24,oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor,MF,
5968,GO:0016634,1,0.949157490156541,0,8,oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor,MF,
5969,GO:0016635,1,0.974316078111265,0,5,oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor,MF,
5970,GO:0016638,1,0.873792081507342,0,21,oxidoreductase activity, acting on the CH-NH2 group of donors,MF,
5971,GO:0016639,1,0.98261287024201,0,3,oxidoreductase activity, acting on the CH-NH2 group of donors, NAD or NADP as acceptor,MF,
5972,GO:0016641,1,0.898699607443992,0,16,oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor,MF,
5973,GO:0016642,1,0.992493728080011,0,1,oxidoreductase activity, acting on the CH-NH2 group of donors, disulfide as acceptor,MF,
5974,GO:0016645,1,0.859271913679498,0,24,oxidoreductase activity, acting on the CH-NH group of donors,MF,
5975,GO:0016646,1,0.904028635194924,0,16,oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor,MF,
5976,GO:0016647,1,0.983606700806262,0,3,oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor,MF,
5977,GO:0016649,1,0.986513753988356,0,2,oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor,MF,
5979,GO:0016652,1,0.989015551903477,0,2,oxidoreductase activity, acting on NAD(P)H, NAD(P) as acceptor,MF,
5981,GO:0016655,1,0.830777830393556,0,52,oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor,MF,
5982,GO:0016657,1,0.990698150942483,0,2,oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor,MF,
5983,GO:0016661,1,0.96886137111846,0,5,oxidoreductase activity, acting on other nitrogenous compounds as donors,MF,
5984,GO:0016662,1,0.993347995930623,0,1,oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor,MF,
5985,GO:0016667,1,0.746363705310591,0,53,oxidoreductase activity, acting on a sulfur group of donors,MF,
5986,GO:0016668,1,0.930960425978593,0,13,oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor,MF,
5987,GO:0016670,1,0.946949355927116,0,8,oxidoreductase activity, acting on a sulfur group of donors, oxygen as acceptor,MF,
5988,GO:0016671,1,0.94554214311254,0,11,oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor,MF,
5989,GO:0016672,1,0.99317033719142,0,2,oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor,MF,
5990,GO:0016675,1,0.928870373626541,0,23,oxidoreductase activity, acting on a heme group of donors,MF,
5991,GO:0016676,1,0.934933672479148,0,22,oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor,MF,
5992,GO:0016679,1,0.964858806244564,0,8,oxidoreductase activity, acting on diphenols and related substances as donors,MF,
5993,GO:0016681,1,0.971333938200679,0,7,oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor,MF,
5994,GO:0016684,1,0.809693958456282,0,42,oxidoreductase activity, acting on peroxide as acceptor,MF,
5995,GO:0016701,1,0.864381447489447,0,25,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen,MF,
5996,GO:0016702,1,0.864381447489447,0,25,oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen,MF,
5998,GO:0016706,1,0.74485042819142,0,41,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, 2-oxoglutarate as one donor, and incorporation of one atom each of oxygen into both donors,MF,
5999,GO:0016708,1,0.988306441259368,0,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor,MF,
6001,GO:0016711,1,0.993335709167869,0,1,flavonoid 3'-monooxygenase activity,MF,
6002,GO:0016712,1,0.895596951548541,0,19,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen,MF,
6003,GO:0016713,1,0.989993695899616,0,2,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen,MF,
6004,GO:0016714,1,0.9672914636481,0,6,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen,MF,
6005,GO:0016715,1,0.971138676015756,0,4,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen,MF,
6006,GO:0016717,1,0.963868360370061,0,5,oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water,MF,
6007,GO:0016721,1,0.980087738215867,0,5,oxidoreductase activity, acting on superoxide radicals as acceptor,MF,
6008,GO:0016722,1,0.892254977649979,0,16,oxidoreductase activity, oxidizing metal ions,MF,
6009,GO:0016723,1,0.931433493510019,0,10,oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor,MF,
6010,GO:0016724,1,0.963913657090689,0,5,oxidoreductase activity, oxidizing metal ions, oxygen as acceptor,MF,
6011,GO:0016725,1,0.95099137227168,0,7,oxidoreductase activity, acting on CH or CH2 groups,MF,
6012,GO:0016726,1,0.983883671546724,0,2,oxidoreductase activity, acting on CH or CH2 groups, NAD or NADP as acceptor,MF,
6013,GO:0016727,1,0.991678267239222,0,1,oxidoreductase activity, acting on CH or CH2 groups, oxygen as acceptor,MF,
6014,GO:0016728,1,0.977575275840088,0,3,oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor,MF,
6015,GO:0016730,1,0.994877016520247,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors,MF,
6016,GO:0016731,1,0.994877016520247,0,1,oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor,MF,
6018,GO:0016741,1,0.27586662885778,0,193,transferase activity, transferring one-carbon groups,MF,
6019,GO:0016742,1,0.947169325249388,0,8,hydroxymethyl-, formyl- and related transferase activity,MF,
6020,GO:0016743,1,0.978103686309463,0,3,carboxyl- or carbamoyltransferase activity,MF,
6021,GO:0016744,1,0.984104625481614,0,3,transferase activity, transferring aldehyde or ketonic groups,MF,
6022,GO:0016746,1,0.231578459225187,0,220,transferase activity, transferring acyl groups,MF,
6023,GO:0016747,1,0.275268694091811,0,193,transferase activity, transferring acyl groups other than amino-acyl groups,MF,
6024,GO:0016748,1,0.981516437583884,0,3,succinyltransferase activity,MF,
6025,GO:0016749,1,0.988466828997408,0,2,N-succinyltransferase activity,MF,
6026,GO:0016751,1,0.992969326151488,0,1,S-succinyltransferase activity,MF,
6027,GO:0016755,1,0.925443663572831,0,12,transferase activity, transferring amino-acyl groups,MF,
6030,GO:0016763,1,0.753619026923628,0,44,transferase activity, transferring pentosyl groups,MF,
6032,GO:0016768,1,0.99535916268014,0,1,spermine synthase activity,MF,
6033,GO:0016769,1,0.884592655963098,0,19,transferase activity, transferring nitrogenous groups,MF,
6036,GO:0016774,1,0.980816311924585,0,3,phosphotransferase activity, carboxyl group as acceptor,MF,
6037,GO:0016775,1,0.925656692637274,0,12,phosphotransferase activity, nitrogenous group as acceptor,MF,
6038,GO:0016776,1,0.769959889817794,0,41,phosphotransferase activity, phosphate group as acceptor,MF,
6039,GO:0016778,1,0.970592909607293,0,5,diphosphotransferase activity,MF,
6040,GO:0016779,1,0.43315956745728,0,131,nucleotidyltransferase activity,MF,
6041,GO:0016780,1,0.892369373779619,0,18,phosphotransferase activity, for other substituted phosphate groups,MF,
6042,GO:0016781,1,0.987421175502056,0,2,phosphotransferase activity, paired acceptors,MF,
6043,GO:0016782,1,0.67071467683285,0,65,transferase activity, transferring sulfur-containing groups,MF,
6044,GO:0016783,1,0.944770235844634,0,12,sulfurtransferase activity,MF,
6045,GO:0016784,1,0.995857532466422,0,1,3-mercaptopyruvate sulfurtransferase activity,MF,
6046,GO:0016785,1,0.991739391090166,0,1,transferase activity, transferring selenium-containing groups,MF,
6049,GO:0016790,1,0.833704731466043,0,32,thiolester hydrolase activity,MF,
6051,GO:0016793,1,0.992660350041409,0,1,triphosphoric monoester hydrolase activity,MF,
6052,GO:0016794,1,0.99680158931286,0,1,diphosphoric monoester hydrolase activity,MF,
6053,GO:0016796,1,0.716864104930088,0,50,exonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,
6054,GO:0016798,1,0.534123109314951,0,100,hydrolase activity, acting on glycosyl bonds,MF,
6055,GO:0016799,1,0.889737401235576,0,22,hydrolase activity, hydrolyzing N-glycosyl compounds,MF,
6056,GO:0016801,1,0.918295319684848,0,14,hydrolase activity, acting on ether bonds,MF,
6057,GO:0016802,1,0.978673336828831,0,3,trialkylsulfonium hydrolase activity,MF,
6058,GO:0016803,1,0.938319146149043,0,11,ether hydrolase activity,MF,
6059,GO:0016805,1,0.904294421637541,0,16,dipeptidase activity,MF,
6060,GO:0016807,1,0.993058458973322,0,1,cysteine-type carboxypeptidase activity,MF,
6061,GO:0016810,1,0.423874293491939,0,135,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds,MF,
6062,GO:0016811,1,0.586399451950734,0,84,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides,MF,
6063,GO:0016812,1,0.949580187027323,0,7,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides,MF,
6064,GO:0016813,1,0.949532883754974,0,9,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines,MF,
6065,GO:0016814,1,0.835254912845071,0,29,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines,MF,
6066,GO:0016815,1,0.996103670957157,0,1,hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in nitriles,MF,
6069,GO:0016822,1,0.987173458465907,0,3,hydrolase activity, acting on acid carbon-carbon bonds,MF,
6070,GO:0016823,1,0.987173458465907,0,3,hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances,MF,
6071,GO:0016826,1,0.993080385600111,0,1,hydrolase activity, acting on acid sulfur-nitrogen bonds,MF,
6072,GO:0016829,1,0.383565510775135,0,160,lyase activity,MF,
6073,GO:0016830,1,0.748579381156724,0,47,carbon-carbon lyase activity,MF,
6074,GO:0016831,1,0.81833962682507,0,32,carboxy-lyase activity,MF,
6075,GO:0016832,1,0.953493251022689,0,8,aldehyde-lyase activity,MF,
6076,GO:0016833,1,0.962849630247777,0,6,oxo-acid-lyase activity,MF,
6077,GO:0016835,1,0.684522100231708,0,66,carbon-oxygen lyase activity,MF,
6078,GO:0016836,1,0.760330527538285,0,48,hydro-lyase activity,MF,
6079,GO:0016838,1,0.984532170385217,0,3,carbon-oxygen lyase activity, acting on phosphates,MF,
6080,GO:0016840,1,0.932660777130408,0,13,carbon-nitrogen lyase activity,MF,
6081,GO:0016841,1,0.973010714226029,0,5,ammonia-lyase activity,MF,
6082,GO:0016842,1,0.965244612714519,0,7,amidine-lyase activity,MF,
6083,GO:0016843,1,0.993058458973322,0,1,amine-lyase activity,MF,
6084,GO:0016844,1,0.993058458973322,0,1,strictosidine synthase activity,MF,
6085,GO:0016846,1,0.964118454651872,0,9,carbon-sulfur lyase activity,MF,
6086,GO:0016849,1,0.882970078146112,0,16,phosphorus-oxygen lyase activity,MF,
6087,GO:0016853,1,0.463772923791946,0,132,isomerase activity,MF,
6088,GO:0016854,1,0.912000064464701,0,16,racemase and epimerase activity,MF,
6089,GO:0016855,1,0.993575240739539,0,1,racemase and epimerase activity, acting on amino acids and derivatives,MF,
6090,GO:0016857,1,0.932918143843143,0,11,racemase and epimerase activity, acting on carbohydrates and derivatives,MF,
6091,GO:0016859,1,0.835783445467339,0,33,cis-trans isomerase activity,MF,
6092,GO:0016860,1,0.784813209392586,0,43,intramolecular oxidoreductase activity,MF,
6093,GO:0016861,1,0.959404600772556,0,8,intramolecular oxidoreductase activity, interconverting aldoses and ketoses,MF,
6094,GO:0016862,1,0.995447506421938,0,2,intramolecular oxidoreductase activity, interconverting keto- and enol-groups,MF,
6095,GO:0016863,1,0.953022769867256,0,10,intramolecular oxidoreductase activity, transposing C=C bonds,MF,
6096,GO:0016864,1,0.892214941840943,0,17,intramolecular oxidoreductase activity, transposing S-S bonds,MF,
6097,GO:0016866,1,0.853140208562837,0,27,intramolecular transferase activity,MF,
6098,GO:0016868,1,0.938079107439189,0,11,intramolecular transferase activity, phosphotransferases,MF,
6099,GO:0016872,1,0.994029910497057,0,1,intramolecular lyase activity,MF,
6100,GO:0016874,1,0.365644390055369,0,149,ligase activity,MF,
6101,GO:0016875,1,0.75237228848752,0,44,ligase activity, forming carbon-oxygen bonds,MF,
6102,GO:0016877,1,0.783736799922236,0,36,ligase activity, forming carbon-sulfur bonds,MF,
6103,GO:0016878,1,0.839860338578021,0,26,acid-thiol ligase activity,MF,
6104,GO:0016879,1,0.722015922643544,0,47,ligase activity, forming carbon-nitrogen bonds,MF,
6105,GO:0016880,1,0.977499635988748,0,3,acid-ammonia (or amide) ligase activity,MF,
6106,GO:0016881,1,0.884983492497292,0,18,acid-amino acid ligase activity,MF,
6107,GO:0016882,1,0.9897171258424,0,2,cyclo-ligase activity,MF,
6108,GO:0016884,1,0.934703905593697,0,10,carbon-nitrogen ligase activity, with glutamine as amido-N-donor,MF,
6109,GO:0016885,1,0.951946243341258,0,7,ligase activity, forming carbon-carbon bonds,MF,
6110,GO:0016886,1,0.935616542153289,0,10,ligase activity, forming phosphoric ester bonds,MF,
6112,GO:0016888,1,0.931549772019524,0,10,endodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,
6113,GO:0016889,1,0.896302489735051,0,20,endodeoxyribonuclease activity, producing 3'-phosphomonoesters,MF,
6114,GO:0016890,1,0.98822350224135,0,2,site-specific endodeoxyribonuclease activity, specific for altered base,MF,
6115,GO:0016891,1,0.853154572681982,0,27,endoribonuclease activity, producing 5'-phosphomonoesters,MF,
6116,GO:0016892,1,0.964978443370649,0,8,endoribonuclease activity, producing 3'-phosphomonoesters,MF,
6117,GO:0016893,1,0.813976445389988,0,34,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 5'-phosphomonoesters,MF,
6118,GO:0016894,1,0.864878729828821,0,28,endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters,MF,
6119,GO:0016895,1,0.88626813302053,0,19,exodeoxyribonuclease activity, producing 5'-phosphomonoesters,MF,
6120,GO:0016896,1,0.80662038804774,0,32,exoribonuclease activity, producing 5'-phosphomonoesters,MF,
6121,GO:0016898,1,0.987950260650132,0,2,oxidoreductase activity, acting on the CH-OH group of donors, cytochrome as acceptor,MF,
6122,GO:0016899,1,0.979327756670609,0,3,oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor,MF,
6123,GO:0016900,1,0.993614137120308,0,2,oxidoreductase activity, acting on the CH-OH group of donors, disulfide as acceptor,MF,
6124,GO:0016901,1,0.984564405021272,0,2,oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor,MF,
6125,GO:0016903,1,0.767003597163341,0,41,oxidoreductase activity, acting on the aldehyde or oxo group of donors,MF,
6126,GO:0016907,1,0.961342676125923,0,6,G-protein coupled acetylcholine receptor activity,MF,
6127,GO:0016909,1,0.980976239036748,0,3,SAP kinase activity,MF,
6128,GO:0016917,1,0.868592770588461,0,19,GABA receptor activity,MF,
6129,GO:0016918,1,0.939444217547833,0,13,retinal binding,MF,
6130,GO:0016920,1,0.990856266159935,0,1,pyroglutamyl-peptidase activity,MF,
6131,GO:0016922,1,0.850860298045261,0,21,ligand-dependent nuclear receptor binding,MF,
6132,GO:0016925,1,0.544542632507494,0,88,protein sumoylation,BP,
6133,GO:0016926,1,0.949891473729586,0,7,protein desumoylation,BP,
6134,GO:0016929,1,0.954284636665684,0,6,SUMO-specific protease activity,MF,
6135,GO:0016933,1,0.968572127508053,0,5,extracellularly glycine-gated ion channel activity,MF,
6136,GO:0016934,1,0.968572127508053,0,5,extracellularly glycine-gated chloride channel activity,MF,
6137,GO:0016935,1,0.985341917866295,0,2,glycine-gated chloride channel complex,CC,
6138,GO:0016936,1,0.983745380436875,0,4,galactoside binding,MF,
6139,GO:0016938,1,0.992855742872144,0,1,kinesin I complex,CC,
6140,GO:0016939,1,0.975808521929741,0,3,kinesin II complex,CC,
6141,GO:0016941,1,0.978423601964798,0,3,natriuretic peptide receptor activity,MF,
6142,GO:0016942,1,0.967276706800498,0,5,insulin-like growth factor binding protein complex,CC,
6143,GO:0016964,1,0.986580336156989,0,1,alpha-2 macroglobulin receptor activity,MF,
6144,GO:0016971,1,0.979059531359429,0,3,flavin-linked sulfhydryl oxidase activity,MF,
6145,GO:0016972,1,0.971462338651085,0,4,thiol oxidase activity,MF,
6146,GO:0016973,1,0.926388886966391,0,12,poly(A)+ mRNA export from nucleus,BP,
6147,GO:0016979,1,0.995994982153187,0,1,lipoate-protein ligase activity,MF,
6148,GO:0016990,1,0.994001218984072,0,1,arginine deiminase activity,MF,
6149,GO:0016992,1,0.995399687780569,0,1,lipoate synthase activity,MF,
6150,GO:0016997,1,0.969384511333402,0,5,alpha-sialidase activity,MF,
6151,GO:0016998,1,0.982843347660955,0,4,cell wall macromolecule catabolic process,BP,
6154,GO:0017001,1,0.808329539668875,0,42,antibiotic catabolic process,BP,
6155,GO:0017002,1,0.940310176077159,0,7,activin-activated receptor activity,MF,
6156,GO:0017003,1,0.993974874484915,0,1,protein-heme linkage,BP,
6157,GO:0017004,1,0.819411804614137,0,34,cytochrome complex assembly,BP,
6158,GO:0017005,1,0.99251544213873,0,1,3'-tyrosyl-DNA phosphodiesterase activity,MF,
6159,GO:0017006,1,0.993974874484915,0,1,protein-tetrapyrrole linkage,BP,
6163,GO:0017017,1,0.93095550266463,0,11,MAP kinase tyrosine/serine/threonine phosphatase activity,MF,
6164,GO:0017018,1,0.975406215190191,0,3,myosin phosphatase activity,MF,
6165,GO:0017020,1,0.992950347329576,0,1,myosin phosphatase regulator activity,MF,
6166,GO:0017022,1,0.68225228535998,0,57,myosin binding,MF,
6167,GO:0017024,1,0.9971141667904,0,1,myosin I binding,MF,
6169,GO:0017034,1,0.96066509536928,0,5,Rap guanyl-nucleotide exchange factor activity,MF,
6171,GO:0017040,1,0.970558129609572,0,5,N-acylsphingosine amidohydrolase activity,MF,
6172,GO:0017042,1,0.995378860140206,0,1,glycosylceramidase activity,MF,
6173,GO:0017045,1,0.996297118502833,0,1,corticotropin-releasing hormone activity,MF,
6174,GO:0017046,1,0.793820997846479,0,35,peptide hormone binding,MF,
6175,GO:0017048,1,0.27769296620673,0,163,Rho GTPase binding,MF,
6176,GO:0017049,1,0.871185582387752,0,20,GTP-Rho binding,MF,
6177,GO:0017050,1,0.987835130982211,0,2,D-erythro-sphingosine kinase activity,MF,
6179,GO:0017055,1,0.986303974462813,0,2,negative regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
6180,GO:0017056,1,0.844664187256703,0,23,structural constituent of nuclear pore,MF,
6181,GO:0017057,1,0.986518879147467,0,2,6-phosphogluconolactonase activity,MF,
6182,GO:0017059,1,0.950282883413309,0,8,serine C-palmitoyltransferase complex,CC,
6183,GO:0017060,1,0.981674711424678,0,3,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity,MF,
6184,GO:0017061,1,0.992160660806244,0,1,S-methyl-5-thioadenosine phosphorylase activity,MF,
6185,GO:0017062,1,0.94587471830719,0,9,respiratory chain complex III assembly,BP,
6186,GO:0017064,1,0.989016742803312,0,2,fatty acid amide hydrolase activity,MF,
6187,GO:0017065,1,0.995643977451473,0,1,single-strand selective uracil DNA N-glycosylase activity,MF,
6188,GO:0017069,1,0.803745718924984,0,38,snRNA binding,MF,
6189,GO:0017070,1,0.938839391538594,0,11,U6 snRNA binding,MF,
6190,GO:0017071,1,0.992513773465994,0,1,intracellular cyclic nucleotide activated cation channel complex,CC,
6193,GO:0017077,1,0.989368917429784,0,2,oxidative phosphorylation uncoupler activity,MF,
6194,GO:0017080,1,0.820308315227115,0,32,sodium channel regulator activity,MF,
6195,GO:0017081,1,0.906828611859648,0,15,chloride channel regulator activity,MF,
6196,GO:0017082,1,0.993058458973322,0,1,mineralocorticoid receptor activity,MF,
6197,GO:0017084,1,0.992549786087151,0,1,delta1-pyrroline-5-carboxylate synthetase activity,MF,
6198,GO:0017085,1,0.901004168512527,0,16,response to insecticide,BP,
6199,GO:0017087,1,0.992483205819765,0,1,mitochondrial processing peptidase complex,CC,
6200,GO:0017089,1,0.988540875828015,0,2,glycolipid transporter activity,MF,
6201,GO:0017090,1,0.992870782039758,0,1,meprin A complex,CC,
6202,GO:0017091,1,0.855437719998066,0,24,AU-rich element binding,MF,
6203,GO:0017095,1,0.975455631589631,0,3,heparan sulfate 6-O-sulfotransferase activity,MF,
6204,GO:0017098,1,0.987273520446137,0,2,sulfonylurea receptor binding,MF,
6205,GO:0017099,1,0.97664864731949,0,4,very-long-chain-acyl-CoA dehydrogenase activity,MF,
6206,GO:0017101,1,0.928023211471975,0,12,aminoacyl-tRNA synthetase multienzyme complex,CC,
6207,GO:0017102,1,0.986136048975927,0,2,methionyl glutamyl tRNA synthetase complex,CC,
6208,GO:0017108,1,0.966085409564356,0,5,5'-flap endonuclease activity,MF,
6209,GO:0017109,1,0.985303075321928,0,2,glutamate-cysteine ligase complex,CC,
6210,GO:0017110,1,0.916844967499045,0,13,nucleoside-diphosphatase activity,MF,
6213,GO:0017113,1,0.992707573339815,0,1,dihydropyrimidine dehydrogenase (NADP+) activity,MF,
6214,GO:0017116,1,0.978277389327877,0,3,single-stranded DNA-dependent ATP-dependent DNA helicase activity,MF,
6215,GO:0017119,1,0.914913141893679,0,13,Golgi transport complex,CC,
6216,GO:0017121,1,0.933614792834185,0,10,phospholipid scrambling,BP,
6218,GO:0017125,1,0.992244009486343,0,1,deoxycytidyl transferase activity,MF,
6219,GO:0017126,1,0.99193183283743,0,1,nucleologenesis,BP,
6220,GO:0017127,1,0.910544617797572,0,15,cholesterol transporter activity,MF,
6221,GO:0017128,1,0.945910172137247,0,8,phospholipid scramblase activity,MF,
6222,GO:0017129,1,0.987814705991681,0,2,triglyceride binding,MF,
6223,GO:0017130,1,0.991012416566479,0,1,poly(C) RNA binding,MF,
6224,GO:0017133,1,0.993832580343169,0,1,mitochondrial electron transfer flavoprotein complex,CC,
6226,GO:0017136,1,0.896619524691118,0,16,NAD-dependent histone deacetylase activity,MF,
6228,GO:0017143,1,0.986611976325884,0,2,insecticide metabolic process,BP,
6230,GO:0017145,1,0.764931655486604,0,37,stem cell division,BP,
6231,GO:0017146,1,0.910317685446181,0,11,NMDA selective glutamate receptor complex,CC,
6234,GO:0017150,1,0.977461537989223,0,4,tRNA dihydrouridine synthase activity,MF,
6235,GO:0017151,1,0.944711896610739,0,8,DEAD/H-box RNA helicase binding,MF,
6236,GO:0017153,1,0.936079570603515,0,9,sodium:dicarboxylate symporter activity,MF,
6237,GO:0017154,1,0.907509279555533,0,11,semaphorin receptor activity,MF,
6239,GO:0017157,1,0.304901837153736,0,174,regulation of exocytosis,BP,
6240,GO:0017158,1,0.596402663994021,0,72,regulation of calcium ion-dependent exocytosis,BP,
6241,GO:0017159,1,0.982534417403682,0,3,pantetheine hydrolase activity,MF,
6242,GO:0017160,1,0.891802357044985,0,16,Ral GTPase binding,MF,
6243,GO:0017161,1,0.983612487903002,0,2,inositol-1,3,4-trisphosphate 4-phosphatase activity,MF,
6244,GO:0017162,1,0.937737705220612,0,9,aryl hydrocarbon receptor binding,MF,
6245,GO:0017166,1,0.918256238119323,0,10,vinculin binding,MF,
6246,GO:0017168,1,0.992469524748395,0,1,5-oxoprolinase (ATP-hydrolyzing) activity,MF,
6247,GO:0017169,1,0.962147960962278,0,7,CDP-alcohol phosphatidyltransferase activity,MF,
6249,GO:0017172,1,0.995545818829149,0,1,cysteine dioxygenase activity,MF,
6250,GO:0017174,1,0.996746191662414,0,1,glycine N-methyltransferase activity,MF,
6251,GO:0017176,1,0.967488333264023,0,7,phosphatidylinositol N-acetylglucosaminyltransferase activity,MF,
6252,GO:0017177,1,0.99248541887796,0,1,glucosidase II complex,CC,
6253,GO:0017178,1,0.993058458973322,0,1,diphthine-ammonia ligase activity,MF,
6254,GO:0017182,1,0.948812262392753,0,8,peptidyl-diphthamide metabolic process,BP,
6255,GO:0017183,1,0.948812262392753,0,8,peptidyl-diphthamide biosynthetic process from peptidyl-histidine,BP,
6256,GO:0017185,1,0.944415268075639,0,8,peptidyl-lysine hydroxylation,BP,
6257,GO:0017186,1,0.989614320474747,0,2,peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase,BP,
6258,GO:0017187,1,0.960924749627341,0,8,peptidyl-glutamic acid carboxylation,BP,
6259,GO:0017188,1,0.991603270263567,0,1,aspartate N-acetyltransferase activity,MF,
6260,GO:0017196,1,0.961239267014943,0,6,N-terminal peptidyl-methionine acetylation,BP,
6261,GO:0017198,1,0.992918166422528,0,2,N-terminal peptidyl-serine acetylation,BP,
6262,GO:0018002,1,0.992918166422528,0,2,N-terminal peptidyl-glutamic acid acetylation,BP,
6263,GO:0018008,1,0.984352772510227,0,2,N-terminal peptidyl-glycine N-myristoylation,BP,
6264,GO:0018009,1,0.994317353871872,0,1,N-terminal peptidyl-L-cysteine N-palmitoylation,BP,
6265,GO:0018011,1,0.993058458973322,0,1,N-terminal peptidyl-alanine methylation,BP,
6266,GO:0018012,1,0.993058458973322,0,1,N-terminal peptidyl-alanine trimethylation,BP,
6267,GO:0018013,1,0.993058458973322,0,1,N-terminal peptidyl-glycine methylation,BP,
6268,GO:0018016,1,0.993058458973322,0,1,N-terminal peptidyl-proline dimethylation,BP,
6270,GO:0018023,1,0.781402322111548,0,35,peptidyl-lysine trimethylation,BP,
6271,GO:0018024,1,0.734870920018692,0,41,histone-lysine N-methyltransferase activity,MF,
6272,GO:0018025,1,0.993058458973322,0,1,calmodulin-lysine N-methyltransferase activity,MF,
6273,GO:0018026,1,0.94483052234721,0,8,peptidyl-lysine monomethylation,BP,
6274,GO:0018027,1,0.899404226893913,0,15,peptidyl-lysine dimethylation,BP,
6275,GO:0018032,1,0.992504348414736,0,1,protein amidation,BP,
6276,GO:0018057,1,0.971085718124362,0,4,peptidyl-lysine oxidation,BP,
6277,GO:0018063,1,0.993974874484915,0,1,cytochrome c-heme linkage,BP,
6278,GO:0018065,1,0.954421836414155,0,12,protein-cofactor linkage,BP,
6279,GO:0018076,1,0.963806088121014,0,4,N-terminal peptidyl-lysine acetylation,BP,
6280,GO:0018094,1,0.992568030712992,0,1,protein polyglycylation,BP,
6281,GO:0018095,1,0.938877603837361,0,9,protein polyglutamylation,BP,
6282,GO:0018101,1,0.979197440942314,0,3,protein citrullination,BP,
6283,GO:0018103,1,0.966006071647555,0,5,protein C-linked glycosylation,BP,
6285,GO:0018106,1,0.997455670325962,0,1,peptidyl-histidine phosphorylation,BP,
6288,GO:0018114,1,0.993575240739539,0,1,threonine racemase activity,MF,
6289,GO:0018117,1,0.995460844898659,0,1,protein adenylylation,BP,
6291,GO:0018125,1,0.983278542461191,0,3,peptidyl-cysteine methylation,BP,
6292,GO:0018126,1,0.855472736038091,0,22,protein hydroxylation,BP,
6295,GO:0018149,1,0.841985015084504,0,27,peptide cross-linking,BP,
6296,GO:0018153,1,0.987275952922261,0,2,isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine,BP,
6297,GO:0018158,1,0.933567163682682,0,12,protein oxidation,BP,
6298,GO:0018160,1,0.995869872745912,0,1,peptidyl-pyrromethane cofactor linkage,BP,
6299,GO:0018166,1,0.992032270684876,0,1,C-terminal protein-tyrosinylation,BP,
6300,GO:0018171,1,0.980822036833149,0,4,peptidyl-cysteine oxidation,BP,
6301,GO:0018175,1,0.995460844898659,0,1,protein nucleotidylation,BP,
6302,GO:0018192,1,0.993626621426091,0,1,enzyme active site formation via cysteine modification to L-cysteine persulfide,BP,
6304,GO:0018194,1,0.993058458973322,0,1,peptidyl-alanine modification,BP,
6305,GO:0018195,1,0.878392271335334,0,21,peptidyl-arginine modification,BP,
6306,GO:0018196,1,0.7703569866201,0,43,peptidyl-asparagine modification,BP,
6307,GO:0018197,1,0.976139663880135,0,3,peptidyl-aspartic acid modification,BP,
6309,GO:0018199,1,0.977021113794143,0,4,peptidyl-glutamine modification,BP,
6310,GO:0018200,1,0.84663631835202,0,27,peptidyl-glutamic acid modification,BP,
6311,GO:0018201,1,0.977518774182355,0,3,peptidyl-glycine modification,BP,
6312,GO:0018202,1,0.937836053764048,0,10,peptidyl-histidine modification,BP,
6314,GO:0018206,1,0.934922713501466,0,11,peptidyl-methionine modification,BP,
6315,GO:0018208,1,0.767071718757266,0,45,peptidyl-proline modification,BP,
6318,GO:0018211,1,0.966006071647555,0,5,peptidyl-tryptophan modification,BP,
6320,GO:0018214,1,0.960924749627341,0,8,protein carboxylation,BP,
6321,GO:0018216,1,0.908011129579432,0,15,peptidyl-arginine methylation,BP,
6322,GO:0018217,1,0.992473489815072,0,1,peptidyl-aspartic acid phosphorylation,BP,
6323,GO:0018230,1,0.86637385823248,0,22,peptidyl-L-cysteine S-palmitoylation,BP,
6324,GO:0018231,1,0.86637385823248,0,22,peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine,BP,
6327,GO:0018262,1,0.987275952922261,0,2,isopeptide cross-linking,BP,
6328,GO:0018271,1,0.991511043527596,0,1,biotin-protein ligase activity,MF,
6329,GO:0018272,1,0.995239252591955,0,1,protein-pyridoxal-5-phosphate linkage via peptidyl-N6-pyridoxal phosphate-L-lysine,BP,
6330,GO:0018277,1,0.993813542481185,0,1,protein deamination,BP,
6332,GO:0018282,1,0.984642115410386,0,2,metal incorporation into metallo-sulfur cluster,BP,
6333,GO:0018283,1,0.984642115410386,0,2,iron incorporation into metallo-sulfur cluster,BP,
6334,GO:0018293,1,0.996449475310065,0,1,protein-FAD linkage,BP,
6335,GO:0018298,1,0.954369442657945,0,8,protein-chromophore linkage,BP,
6336,GO:0018307,1,0.990677580923991,0,2,enzyme active site formation,BP,
6337,GO:0018312,1,0.987437341253057,0,2,peptidyl-serine ADP-ribosylation,BP,
6338,GO:0018315,1,0.992420809289738,0,1,molybdenum incorporation into molybdenum-molybdopterin complex,BP,
6339,GO:0018317,1,0.966006071647555,0,5,protein C-linked glycosylation via tryptophan,BP,
6340,GO:0018322,1,0.992032270684876,0,1,protein tyrosinylation,BP,
6341,GO:0018323,1,0.997032233810024,0,1,enzyme active site formation via L-cysteine sulfinic acid,BP,
6342,GO:0018335,1,0.970931562647634,0,4,protein succinylation,BP,
6343,GO:0018342,1,0.945704204082036,0,8,protein prenylation,BP,
6344,GO:0018343,1,0.98860084101475,0,2,protein farnesylation,BP,
6345,GO:0018344,1,0.962837382886239,0,6,protein geranylgeranylation,BP,
6346,GO:0018345,1,0.810296320638688,0,32,protein palmitoylation,BP,
6347,GO:0018350,1,0.993756997792406,0,1,protein esterification,BP,
6348,GO:0018352,1,0.989067280782644,0,2,protein-pyridoxal-5-phosphate linkage,BP,
6349,GO:0018364,1,0.994309772526849,0,2,peptidyl-glutamine methylation,BP,
6350,GO:0018377,1,0.968253204474494,0,4,protein myristoylation,BP,
6353,GO:0018395,1,0.992518804425241,0,1,peptidyl-lysine hydroxylation to 5-hydroxy-L-lysine,BP,
6354,GO:0018400,1,0.991118854188098,0,1,peptidyl-proline hydroxylation to 3-hydroxy-L-proline,BP,
6355,GO:0018401,1,0.965196242072124,0,5,peptidyl-proline hydroxylation to 4-hydroxy-L-proline,BP,
6356,GO:0018406,1,0.966006071647555,0,5,protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan,BP,
6357,GO:0018410,1,0.673123043647336,0,63,C-terminal protein amino acid modification,BP,
6358,GO:0018423,1,0.98918616233281,0,2,protein C-terminal leucine carboxyl O-methyltransferase activity,MF,
6359,GO:0018444,1,0.976486835569515,0,3,translation release factor complex,CC,
6360,GO:0018455,1,0.996290559458947,0,1,alcohol dehydrogenase [NAD(P)+] activity,MF,
6361,GO:0018467,1,0.993273917152675,0,1,formaldehyde dehydrogenase activity,MF,
6362,GO:0018478,1,0.994205061262777,0,1,malonate-semialdehyde dehydrogenase (acetylating) activity,MF,
6363,GO:0018479,1,0.989572011024418,0,2,benzaldehyde dehydrogenase (NAD+) activity,MF,
6364,GO:0018549,1,0.995317363509999,0,1,methanethiol oxidase activity,MF,
6365,GO:0018585,1,0.994256432895777,0,1,fluorene oxygenase activity,MF,
6366,GO:0018636,1,0.988328763246817,0,3,phenanthrene 9,10-monooxygenase activity,MF,
6367,GO:0018685,1,0.995266113785771,0,1,alkane 1-monooxygenase activity,MF,
6368,GO:0018733,1,0.996477628303973,0,1,3,4-dihydrocoumarin hydrolase activity,MF,
6369,GO:0018738,1,0.996471135316586,0,1,S-formylglutathione hydrolase activity,MF,
6370,GO:0018773,1,0.995389277614451,0,1,acetylpyruvate hydrolase activity,MF,
6371,GO:0018812,1,0.972518779653678,0,4,3-hydroxyacyl-CoA dehydratase activity,MF,
6372,GO:0018872,1,0.993594888763717,0,1,arsonoacetate metabolic process,BP,
6373,GO:0018874,1,0.994496500106381,0,1,benzoate metabolic process,BP,
6374,GO:0018879,1,0.987526529753378,0,2,biphenyl metabolic process,BP,
6375,GO:0018885,1,0.995410090658141,0,1,carbon tetrachloride metabolic process,BP,
6376,GO:0018894,1,0.986611976325884,0,2,dibenzo-p-dioxin metabolic process,BP,
6377,GO:0018904,1,0.915466538107692,0,16,ether metabolic process,BP,
6378,GO:0018910,1,0.995410090658141,0,1,benzene metabolic process,BP,
6380,GO:0018917,1,0.994256432895777,0,1,fluorene metabolic process,BP,
6381,GO:0018931,1,0.996017221888988,0,1,naphthalene metabolic process,BP,
6382,GO:0018958,1,0.572291336516803,0,83,phenol-containing compound metabolic process,BP,
6383,GO:0018963,1,0.988124104053755,0,2,phthalate metabolic process,BP,
6384,GO:0018964,1,0.992418130458195,0,1,propylene metabolic process,BP,
6385,GO:0018969,1,0.992915727231584,0,1,thiocyanate metabolic process,BP,
6386,GO:0018992,1,0.984418825367022,0,2,germ-line sex determination,BP,
6387,GO:0018993,1,0.985721548242236,0,2,somatic sex determination,BP,
6388,GO:0018995,1,0.645539488673644,0,65,host,CC,
6390,GO:0019002,1,0.987464319023414,0,2,GMP binding,MF,
6391,GO:0019003,1,0.695180163162154,0,58,GDP binding,MF,
6392,GO:0019005,1,0.705029369587604,0,55,SCF ubiquitin ligase complex,CC,
6393,GO:0019008,1,0.988446433792124,0,2,molybdopterin synthase complex,CC,
6394,GO:0019034,1,0.984614515683887,0,2,viral replication complex,CC,
6395,GO:0019035,1,0.991692635295332,0,1,viral integration complex,CC,
6396,GO:0019042,1,0.930882995502053,0,11,viral latency,BP,
6397,GO:0019043,1,0.948559333428451,0,9,establishment of viral latency,BP,
6398,GO:0019045,1,0.981374810109299,0,2,latent virus replication,BP,
6399,GO:0019046,1,0.981374810109299,0,2,release from viral latency,BP,
6400,GO:0019048,1,0.79288065521722,0,32,modulation by virus of host morphology or physiology,BP,
6401,GO:0019049,1,0.971232151525118,0,4,evasion or tolerance of host defenses by virus,BP,
6402,GO:0019050,1,0.983482272949939,0,3,suppression by virus of host apoptotic process,BP,
6403,GO:0019054,1,0.86400799013143,0,21,modulation by virus of host process,BP,
6404,GO:0019056,1,0.992942551431755,0,1,modulation by virus of host transcription,BP,
6406,GO:0019060,1,0.992519221230875,0,2,intracellular transport of viral protein in host cell,BP,
6407,GO:0019061,1,0.994003420490721,0,1,uncoating of virus,BP,
6408,GO:0019062,1,0.952919929865294,0,7,virion attachment to host cell,BP,
6409,GO:0019064,1,0.962675316483484,0,6,fusion of virus membrane with host plasma membrane,BP,
6411,GO:0019068,1,0.802361220236861,0,37,virion assembly,BP,
6412,GO:0019072,1,0.983910795742565,0,2,viral genome packaging,BP,
6413,GO:0019074,1,0.983910795742565,0,2,viral RNA genome packaging,BP,
6414,GO:0019075,1,0.986164624597214,0,2,virus maturation,BP,
6417,GO:0019080,1,0.394728896609715,0,184,viral gene expression,BP,
6418,GO:0019081,1,0.911001313740407,0,14,viral translation,BP,
6419,GO:0019082,1,0.992439832277321,0,1,viral protein processing,BP,
6420,GO:0019083,1,0.433568225893886,0,170,viral transcription,BP,
6421,GO:0019085,1,0.984990960180381,0,2,early viral transcription,BP,
6422,GO:0019086,1,0.975834781581365,0,4,late viral transcription,BP,
6423,GO:0019087,1,0.979584226277533,0,3,transformation of host cell by virus,BP,
6424,GO:0019088,1,0.995607527026098,0,1,immortalization of host cell by virus,BP,
6425,GO:0019089,1,0.991274064861212,0,1,transmission of virus,BP,
6426,GO:0019098,1,0.828196300448672,0,28,reproductive behavior,BP,
6427,GO:0019100,1,0.984418825367022,0,2,male germ-line sex determination,BP,
6428,GO:0019101,1,0.992898862820728,0,1,female somatic sex determination,BP,
6429,GO:0019102,1,0.992771866788736,0,1,male somatic sex determination,BP,
6430,GO:0019103,1,0.968510864040971,0,6,pyrimidine nucleotide binding,MF,
6431,GO:0019104,1,0.930134057200693,0,15,DNA N-glycosylase activity,MF,
6432,GO:0019107,1,0.984352772510227,0,2,myristoyltransferase activity,MF,
6433,GO:0019115,1,0.99468027294805,0,1,benzaldehyde dehydrogenase activity,MF,
6434,GO:0019118,1,0.996103670957157,0,1,phenanthrene-epoxide hydrolase activity,MF,
6435,GO:0019119,1,0.996103670957157,0,1,phenanthrene-9,10-epoxide hydrolase activity,MF,
6436,GO:0019135,1,0.994904293256982,0,1,deoxyhypusine monooxygenase activity,MF,
6437,GO:0019136,1,0.97805664262663,0,4,deoxynucleoside kinase activity,MF,
6438,GO:0019144,1,0.992182475998992,0,2,ADP-sugar diphosphatase activity,MF,
6439,GO:0019145,1,0.993524842093636,0,1,aminobutyraldehyde dehydrogenase activity,MF,
6440,GO:0019150,1,0.99449532826661,0,1,D-ribulokinase activity,MF,
6441,GO:0019153,1,0.995577846916248,0,1,protein-disulfide reductase (glutathione) activity,MF,
6442,GO:0019158,1,0.962571044827959,0,5,mannokinase activity,MF,
6443,GO:0019166,1,0.984399497703521,0,3,trans-2-enoyl-CoA reductase (NADPH) activity,MF,
6444,GO:0019171,1,0.990019785722482,0,1,3-hydroxyacyl-[acyl-carrier-protein] dehydratase activity,MF,
6445,GO:0019184,1,0.909491383419655,0,16,nonribosomal peptide biosynthetic process,BP,
6446,GO:0019185,1,0.985581051307817,0,2,snRNA-activating protein complex,CC,
6447,GO:0019187,1,0.992481609420521,0,1,beta-1,4-mannosyltransferase activity,MF,
6448,GO:0019198,1,0.874136714608219,0,16,transmembrane receptor protein phosphatase activity,MF,
6450,GO:0019200,1,0.863493740003104,0,22,carbohydrate kinase activity,MF,
6451,GO:0019201,1,0.838189108388819,0,25,nucleotide kinase activity,MF,
6452,GO:0019202,1,0.985659447868716,0,2,amino acid kinase activity,MF,
6453,GO:0019203,1,0.949949291480954,0,8,carbohydrate phosphatase activity,MF,
6454,GO:0019205,1,0.735495513084845,0,49,nucleobase-containing compound kinase activity,MF,
6455,GO:0019206,1,0.919531342581093,0,14,nucleoside kinase activity,MF,
6457,GO:0019208,1,0.568509750952574,0,83,phosphatase regulator activity,MF,
6459,GO:0019210,1,0.549383192804397,0,93,kinase inhibitor activity,MF,
6460,GO:0019211,1,0.936117692954201,0,10,phosphatase activator activity,MF,
6461,GO:0019212,1,0.80887101063269,0,33,phosphatase inhibitor activity,MF,
6462,GO:0019213,1,0.684107573577137,0,55,deacetylase activity,MF,
6463,GO:0019215,1,0.918107646653209,0,12,intermediate filament binding,MF,
6465,GO:0019217,1,0.602485870926007,0,73,regulation of fatty acid metabolic process,BP,
6466,GO:0019218,1,0.527696120152544,0,97,regulation of steroid metabolic process,BP,
6472,GO:0019227,1,0.959958989728232,0,6,neuronal action potential propagation,BP,
6475,GO:0019230,1,0.970070983641363,0,4,proprioception,BP,
6477,GO:0019236,1,0.982466428091941,0,4,response to pheromone,BP,
6478,GO:0019237,1,0.955791089725341,0,6,centromeric DNA binding,MF,
6479,GO:0019238,1,0.962711143659884,0,6,cyclohydrolase activity,MF,
6480,GO:0019239,1,0.836852541752518,0,30,deaminase activity,MF,
6481,GO:0019240,1,0.960933526611022,0,5,citrulline biosynthetic process,BP,
6482,GO:0019242,1,0.99442870134977,0,1,methylglyoxal biosynthetic process,BP,
6483,GO:0019243,1,0.988503962609357,0,2,methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione,BP,
6484,GO:0019244,1,0.996334240023178,0,1,lactate biosynthetic process from pyruvate,BP,
6485,GO:0019249,1,0.984732998118054,0,3,lactate biosynthetic process,BP,
6486,GO:0019254,1,0.980014509833488,0,3,carnitine metabolic process, CoA-linked,BP,
6487,GO:0019255,1,0.988964556761018,0,2,glucose 1-phosphate metabolic process,BP,
6488,GO:0019262,1,0.971303021020274,0,6,N-acetylneuraminate catabolic process,BP,
6489,GO:0019264,1,0.98773289675845,0,2,glycine biosynthetic process from serine,BP,
6490,GO:0019265,1,0.995566416067967,0,1,glycine biosynthetic process, by transamination of glyoxylate,BP,
6491,GO:0019276,1,0.985480889250133,0,2,UDP-N-acetylgalactosamine metabolic process,BP,
6492,GO:0019285,1,0.985099900237671,0,2,glycine betaine biosynthetic process from choline,BP,
6493,GO:0019287,1,0.985885902613475,0,3,isopentenyl diphosphate biosynthetic process, mevalonate pathway,BP,
6494,GO:0019290,1,0.992885722858015,0,1,siderophore biosynthetic process,BP,
6495,GO:0019303,1,0.992922222026352,0,2,D-ribose catabolic process,BP,
6496,GO:0019317,1,0.939501938829513,0,8,fucose catabolic process,BP,
6498,GO:0019319,1,0.650334415414484,0,70,hexose biosynthetic process,BP,
6499,GO:0019320,1,0.740101046297877,0,47,hexose catabolic process,BP,
6500,GO:0019321,1,0.930634069863653,0,14,pentose metabolic process,BP,
6501,GO:0019322,1,0.979527228660804,0,4,pentose biosynthetic process,BP,
6502,GO:0019323,1,0.976301618029941,0,5,pentose catabolic process,BP,
6503,GO:0019336,1,0.942605843254766,0,9,phenol-containing compound catabolic process,BP,
6504,GO:0019341,1,0.993335709167869,0,1,dibenzo-p-dioxin catabolic process,BP,
6505,GO:0019343,1,0.98861860178861,0,2,cysteine biosynthetic process via cystathionine,BP,
6506,GO:0019344,1,0.982496644042884,0,3,cysteine biosynthetic process,BP,
6507,GO:0019346,1,0.977186509799577,0,4,transsulfuration,BP,
6508,GO:0019348,1,0.972541457375809,0,5,dolichol metabolic process,BP,
6509,GO:0019353,1,0.993170130433943,0,1,protoporphyrinogen IX biosynthetic process from glutamate,BP,
6510,GO:0019355,1,0.979414860515984,0,3,nicotinamide nucleotide biosynthetic process from aspartate,BP,
6511,GO:0019357,1,0.993058458973322,0,1,nicotinate nucleotide biosynthetic process,BP,
6512,GO:0019358,1,0.993058458973322,0,1,nicotinate nucleotide salvage,BP,
6513,GO:0019359,1,0.443986921160381,0,119,nicotinamide nucleotide biosynthetic process,BP,
6514,GO:0019362,1,0.354258063829292,0,157,pyridine nucleotide metabolic process,BP,
6515,GO:0019363,1,0.443986921160381,0,119,pyridine nucleotide biosynthetic process,BP,
6516,GO:0019364,1,0.986299352032046,0,3,pyridine nucleotide catabolic process,BP,
6517,GO:0019365,1,0.993058458973322,0,1,pyridine nucleotide salvage,BP,
6518,GO:0019367,1,0.959687244086777,0,6,fatty acid elongation, saturated fatty acid,BP,
6519,GO:0019368,1,0.959687244086777,0,6,fatty acid elongation, unsaturated fatty acid,BP,
6520,GO:0019369,1,0.782964290672639,0,41,arachidonic acid metabolic process,BP,
6521,GO:0019370,1,0.946464695060201,0,11,leukotriene biosynthetic process,BP,
6522,GO:0019371,1,0.943244625290357,0,11,cyclooxygenase pathway,BP,
6523,GO:0019372,1,0.917737093543277,0,16,lipoxygenase pathway,BP,
6524,GO:0019373,1,0.939559790536146,0,11,epoxygenase P450 pathway,BP,
6527,GO:0019376,1,0.992901083054532,0,1,galactolipid catabolic process,BP,
6528,GO:0019377,1,0.922135965940723,0,13,glycolipid catabolic process,BP,
6529,GO:0019388,1,0.945072897276004,0,9,galactose catabolic process,BP,
6530,GO:0019389,1,0.99327897546493,0,1,glucuronoside metabolic process,BP,
6531,GO:0019391,1,0.99327897546493,0,1,glucuronoside catabolic process,BP,
6532,GO:0019395,1,0.54519149790448,0,95,fatty acid oxidation,BP,
6533,GO:0019400,1,0.911291249043585,0,15,alditol metabolic process,BP,
6534,GO:0019401,1,0.964075944108225,0,6,alditol biosynthetic process,BP,
6535,GO:0019402,1,0.99610588168743,0,1,galactitol metabolic process,BP,
6536,GO:0019405,1,0.962941780764488,0,5,alditol catabolic process,BP,
6537,GO:0019406,1,0.996017221888988,0,1,hexitol biosynthetic process,BP,
6538,GO:0019407,1,0.993481113080797,0,1,hexitol catabolic process,BP,
6539,GO:0019408,1,0.98551905917869,0,2,dolichol biosynthetic process,BP,
6540,GO:0019413,1,0.985225384728166,0,2,acetate biosynthetic process,BP,
6541,GO:0019417,1,0.985074234999136,0,2,sulfur oxidation,BP,
6542,GO:0019418,1,0.983592365413252,0,4,sulfide oxidation,BP,
6543,GO:0019427,1,0.985225384728166,0,2,acetyl-CoA biosynthetic process from acetate,BP,
6544,GO:0019430,1,0.887244823822758,0,22,removal of superoxide radicals,BP,
6545,GO:0019432,1,0.824659091930767,0,28,triglyceride biosynthetic process,BP,
6546,GO:0019433,1,0.867410027809229,0,25,triglyceride catabolic process,BP,
6548,GO:0019439,1,0.021343175174485,0,632,aromatic compound catabolic process,BP,
6549,GO:0019441,1,0.968788425451051,0,6,tryptophan catabolic process to kynurenine,BP,
6550,GO:0019442,1,0.991192719853252,0,2,tryptophan catabolic process to acetyl-CoA,BP,
6551,GO:0019448,1,0.984538186797667,0,3,L-cysteine catabolic process,BP,
6552,GO:0019464,1,0.982842927620261,0,3,glycine decarboxylation via glycine cleavage system,BP,
6553,GO:0019470,1,0.973709767305697,0,4,4-hydroxyproline catabolic process,BP,
6554,GO:0019471,1,0.937043020526265,0,10,4-hydroxyproline metabolic process,BP,
6555,GO:0019474,1,0.972661429009886,0,4,L-lysine catabolic process to acetyl-CoA,BP,
6556,GO:0019477,1,0.972661429009886,0,4,L-lysine catabolic process,BP,
6557,GO:0019478,1,0.991120369761304,0,2,D-amino acid catabolic process,BP,
6558,GO:0019482,1,0.974289796063989,0,4,beta-alanine metabolic process,BP,
6559,GO:0019483,1,0.987215914190058,0,2,beta-alanine biosynthetic process,BP,
6560,GO:0019493,1,0.994676724509826,0,1,arginine catabolic process to proline,BP,
6561,GO:0019509,1,0.971539791893025,0,5,L-methionine salvage from methylthioadenosine,BP,
6562,GO:0019510,1,0.993966123633487,0,1,S-adenosylhomocysteine catabolic process,BP,
6563,GO:0019511,1,0.914644643780851,0,13,peptidyl-proline hydroxylation,BP,
6564,GO:0019516,1,0.989725788642366,0,2,lactate oxidation,BP,
6565,GO:0019518,1,0.995609807722115,0,1,L-threonine catabolic process to glycine,BP,
6566,GO:0019519,1,0.993481113080797,0,1,pentitol metabolic process,BP,
6567,GO:0019520,1,0.987862326060423,0,2,aldonic acid metabolic process,BP,
6568,GO:0019521,1,0.987862326060423,0,2,D-gluconate metabolic process,BP,
6569,GO:0019527,1,0.993481113080797,0,1,pentitol catabolic process,BP,
6570,GO:0019530,1,0.958859564434927,0,6,taurine metabolic process,BP,
6571,GO:0019531,1,0.934232974446335,0,9,oxalate transmembrane transporter activity,MF,
6572,GO:0019532,1,0.930088158593565,0,10,oxalate transport,BP,
6573,GO:0019534,1,0.966612406515497,0,4,toxin transmembrane transporter activity,MF,
6575,GO:0019541,1,0.973359044610042,0,4,propionate metabolic process,BP,
6576,GO:0019542,1,0.985225384728166,0,2,propionate biosynthetic process,BP,
6577,GO:0019543,1,0.987957491779351,0,2,propionate catabolic process,BP,
6578,GO:0019544,1,0.994676724509826,0,1,arginine catabolic process to glutamate,BP,
6579,GO:0019546,1,0.994001218984072,0,1,arginine deiminase pathway,BP,
6580,GO:0019547,1,0.990614230294571,0,2,arginine catabolic process to ornithine,BP,
6581,GO:0019550,1,0.987997566129003,0,2,glutamate catabolic process to aspartate,BP,
6582,GO:0019551,1,0.987997566129003,0,2,glutamate catabolic process to 2-oxoglutarate,BP,
6583,GO:0019556,1,0.974693542470938,0,4,histidine catabolic process to glutamate and formamide,BP,
6584,GO:0019557,1,0.974693542470938,0,4,histidine catabolic process to glutamate and formate,BP,
6585,GO:0019563,1,0.969262257329219,0,4,glycerol catabolic process,BP,
6586,GO:0019566,1,0.986164624597214,0,2,arabinose metabolic process,BP,
6587,GO:0019585,1,0.955322624314069,0,8,glucuronate metabolic process,BP,
6588,GO:0019605,1,0.989347166150168,0,2,butyrate metabolic process,BP,
6589,GO:0019614,1,0.947911854260439,0,8,catechol-containing compound catabolic process,BP,
6590,GO:0019626,1,0.953897985993647,0,8,short-chain fatty acid catabolic process,BP,
6591,GO:0019627,1,0.92745181806746,0,13,urea metabolic process,BP,
6593,GO:0019640,1,0.975131983747371,0,5,glucuronate catabolic process to xylulose 5-phosphate,BP,
6594,GO:0019646,1,0.946761611549163,0,16,aerobic electron transport chain,BP,
6595,GO:0019673,1,0.96970756322053,0,7,GDP-mannose metabolic process,BP,
6596,GO:0019674,1,0.673956295986737,0,64,NAD metabolic process,BP,
6597,GO:0019676,1,0.98672331890227,0,2,ammonia assimilation cycle,BP,
6598,GO:0019677,1,0.989262657059072,0,2,NAD catabolic process,BP,
6599,GO:0019682,1,0.890710711628,0,21,glyceraldehyde-3-phosphate metabolic process,BP,
6600,GO:0019692,1,0.851708136407767,0,31,deoxyribose phosphate metabolic process,BP,
6602,GO:0019694,1,0.958859564434927,0,6,alkanesulfonate metabolic process,BP,
6603,GO:0019695,1,0.937359613028637,0,9,choline metabolic process,BP,
6604,GO:0019706,1,0.837791202005588,0,27,protein-cysteine S-palmitoyltransferase activity,MF,
6605,GO:0019707,1,0.837791202005588,0,27,protein-cysteine S-acyltransferase activity,MF,
6606,GO:0019720,1,0.961978693434699,0,6,Mo-molybdopterin cofactor metabolic process,BP,
6608,GO:0019724,1,0.566538294199084,0,91,B cell mediated immunity,BP,
6613,GO:0019740,1,0.96872603708658,0,5,nitrogen utilization,BP,
6614,GO:0019742,1,0.9937228787619,0,1,pentacyclic triterpenoid metabolic process,BP,
6615,GO:0019747,1,0.993526332040473,0,2,regulation of isoprenoid metabolic process,BP,
6616,GO:0019748,1,0.718944803032164,0,56,secondary metabolic process,BP,
6617,GO:0019751,1,0.506811061462229,0,101,polyol metabolic process,BP,
6619,GO:0019755,1,0.949778349157695,0,9,one-carbon compound transport,BP,
6620,GO:0019763,1,0.978031699375325,0,5,immunoglobulin receptor activity,MF,
6621,GO:0019767,1,0.997741795926482,0,1,IgE receptor activity,MF,
6622,GO:0019770,1,0.990778915466943,0,2,IgG receptor activity,MF,
6623,GO:0019772,1,0.995560697417249,0,1,low-affinity IgG receptor activity,MF,
6624,GO:0019773,1,0.976813116791959,0,7,proteasome core complex, alpha-subunit complex,CC,
6625,GO:0019774,1,0.972021174515196,0,9,proteasome core complex, beta-subunit complex,CC,
6626,GO:0019776,1,0.981470486272149,0,3,Atg8 ligase activity,MF,
6627,GO:0019777,1,0.990206701446511,0,2,Atg12 transferase activity,MF,
6628,GO:0019778,1,0.992132846738313,0,1,Atg12 activating enzyme activity,MF,
6629,GO:0019779,1,0.992132846738313,0,1,Atg8 activating enzyme activity,MF,
6630,GO:0019780,1,0.991227943579524,0,1,FAT10 activating enzyme activity,MF,
6631,GO:0019781,1,0.98945146572116,0,2,NEDD8 activating enzyme activity,MF,
6632,GO:0019782,1,0.992596208814189,0,1,ISG15 activating enzyme activity,MF,
6633,GO:0019783,1,0.481915570835713,0,98,ubiquitin-like protein-specific protease activity,MF,
6634,GO:0019784,1,0.964399156522717,0,7,NEDD8-specific protease activity,MF,
6635,GO:0019785,1,0.987046893460678,0,2,ISG15-specific protease activity,MF,
6636,GO:0019787,1,0.0419623055576384,0,446,ubiquitin-like protein transferase activity,MF,
6637,GO:0019788,1,0.970765476859953,0,6,NEDD8 transferase activity,MF,
6638,GO:0019789,1,0.899219424236332,0,16,SUMO transferase activity,MF,
6639,GO:0019797,1,0.979318172289429,0,3,procollagen-proline 3-dioxygenase activity,MF,
6640,GO:0019798,1,0.954498775562701,0,7,procollagen-proline dioxygenase activity,MF,
6641,GO:0019799,1,0.993058458973322,0,1,tubulin N-acetyltransferase activity,MF,
6642,GO:0019800,1,0.961089498398916,0,6,peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan,BP,
6643,GO:0019805,1,0.984285937860342,0,3,quinolinate biosynthetic process,BP,
6644,GO:0019807,1,0.996057177630722,0,1,aspartoacylase activity,MF,
6645,GO:0019808,1,0.980648075025694,0,4,polyamine binding,MF,
6646,GO:0019809,1,0.987934089275937,0,3,spermidine binding,MF,
6647,GO:0019810,1,0.992625893017814,0,1,putrescine binding,MF,
6648,GO:0019811,1,0.992331782807655,0,1,cocaine binding,MF,
6649,GO:0019814,1,0.975415308796181,0,5,immunoglobulin complex,CC,
6650,GO:0019815,1,0.984961192110094,0,3,B cell receptor complex,CC,
6651,GO:0019825,1,0.84779284213528,0,33,oxygen binding,MF,
6652,GO:0019826,1,0.977867233524542,0,3,oxygen sensor activity,MF,
6653,GO:0019827,1,0.350653596365378,0,147,stem cell population maintenance,BP,
6654,GO:0019828,1,0.985808106900885,0,3,aspartic-type endopeptidase inhibitor activity,MF,
6655,GO:0019829,1,0.705193909960057,0,51,cation-transporting ATPase activity,MF,
6656,GO:0019834,1,0.987071711882134,0,3,phospholipase A2 inhibitor activity,MF,
6657,GO:0019835,1,0.857354023991005,0,30,cytolysis,BP,
6658,GO:0019836,1,0.987276757373615,0,2,hemolysis by symbiont of host erythrocytes,BP,
6661,GO:0019841,1,0.951516752292876,0,11,retinol binding,MF,
6662,GO:0019842,1,0.473756018293082,0,119,vitamin binding,MF,
6663,GO:0019843,1,0.776019702388195,0,55,rRNA binding,MF,
6664,GO:0019852,1,0.943778172137333,0,10,L-ascorbic acid metabolic process,BP,
6665,GO:0019853,1,0.990685866701913,0,2,L-ascorbic acid biosynthetic process,BP,
6666,GO:0019855,1,0.953300568183311,0,9,calcium channel inhibitor activity,MF,
6667,GO:0019856,1,0.953934589569301,0,6,pyrimidine nucleobase biosynthetic process,BP,
6668,GO:0019857,1,0.96783466424811,0,3,5-methylcytosine metabolic process,BP,
6669,GO:0019858,1,0.989513089817296,0,2,cytosine metabolic process,BP,
6670,GO:0019859,1,0.98136574240707,0,3,thymine metabolic process,BP,
6671,GO:0019860,1,0.98275027601057,0,3,uracil metabolic process,BP,
6672,GO:0019862,1,0.995646252729125,0,1,IgA binding,MF,
6673,GO:0019863,1,0.985888842260013,0,4,IgE binding,MF,
6674,GO:0019864,1,0.958100538290333,0,9,IgG binding,MF,
6675,GO:0019865,1,0.92178951951105,0,16,immunoglobulin binding,MF,
6676,GO:0019866,1,0.0732577991358241,0,485,organelle inner membrane,CC,
6678,GO:0019869,1,0.942209020587634,0,9,chloride channel inhibitor activity,MF,
6679,GO:0019870,1,0.954884350425302,0,6,potassium channel inhibitor activity,MF,
6680,GO:0019871,1,0.958313367931006,0,6,sodium channel inhibitor activity,MF,
6681,GO:0019878,1,0.984606443476849,0,2,lysine biosynthetic process via aminoadipic acid,BP,
6683,GO:0019883,1,0.932205604022141,0,11,antigen processing and presentation of endogenous antigen,BP,
6685,GO:0019885,1,0.954223567206744,0,7,antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
6688,GO:0019888,1,0.631575098882359,0,70,protein phosphatase regulator activity,MF,
6689,GO:0019894,1,0.755107716935257,0,37,kinesin binding,MF,
6690,GO:0019896,1,0.924096533687784,0,11,axonal transport of mitochondrion,BP,
6700,GO:0019907,1,0.959107810730286,0,7,cyclin-dependent protein kinase activating kinase holoenzyme complex,CC,
6701,GO:0019908,1,0.900185590943049,0,16,nuclear cyclin-dependent protein kinase holoenzyme complex,CC,
6703,GO:0019912,1,0.98808447225968,0,2,cyclin-dependent protein kinase activating kinase activity,MF,
6704,GO:0019915,1,0.675506363144535,0,59,lipid storage,BP,
6705,GO:0019918,1,0.973760021868971,0,4,peptidyl-arginine methylation, to symmetrical-dimethyl arginine,BP,
6706,GO:0019919,1,0.951312814002257,0,8,peptidyl-arginine methylation, to asymmetrical-dimethyl arginine,BP,
6709,GO:0019934,1,0.934461450715897,0,10,cGMP-mediated signaling,BP,
6712,GO:0019948,1,0.986872292035663,0,2,SUMO activating enzyme activity,MF,
6715,GO:0019956,1,0.847396239525655,0,25,chemokine binding,MF,
6716,GO:0019957,1,0.939499819029964,0,10,C-C chemokine binding,MF,
6717,GO:0019958,1,0.9599854245304,0,6,C-X-C chemokine binding,MF,
6718,GO:0019959,1,0.979080489980821,0,3,interleukin-8 binding,MF,
6719,GO:0019960,1,0.960379120766125,0,5,C-X3-C chemokine binding,MF,
6720,GO:0019961,1,0.984073661839859,0,2,interferon binding,MF,
6721,GO:0019962,1,0.991460101807059,0,1,type I interferon binding,MF,
6722,GO:0019964,1,0.992550573073969,0,1,interferon-gamma binding,MF,
6723,GO:0019966,1,0.956922339362988,0,7,interleukin-1 binding,MF,
6724,GO:0019969,1,0.99250529837727,0,1,interleukin-10 binding,MF,
6725,GO:0019970,1,0.99266209905125,0,1,interleukin-11 binding,MF,
6726,GO:0019972,1,0.995939249581314,0,1,interleukin-12 binding,MF,
6727,GO:0019975,1,0.995939249581314,0,1,interleukin-17 binding,MF,
6728,GO:0019976,1,0.980951165682635,0,3,interleukin-2 binding,MF,
6729,GO:0019981,1,0.985169063558035,0,2,interleukin-6 binding,MF,
6730,GO:0019985,1,0.786978518284386,0,38,translesion synthesis,BP,
6731,GO:0019988,1,0.993109452947755,0,1,charged-tRNA amino acid modification,BP,
6732,GO:0019992,1,0.913729495313976,0,12,diacylglycerol binding,MF,
6733,GO:0020003,1,0.984217724312754,0,3,symbiont-containing vacuole,CC,
6734,GO:0020005,1,0.991098086202614,0,2,symbiont-containing vacuole membrane,CC,
6735,GO:0020012,1,0.985229037370364,0,2,evasion or tolerance of host immune response,BP,
6736,GO:0020016,1,0.977629617989253,0,3,ciliary pocket,CC,
6737,GO:0020018,1,0.977629617989253,0,3,ciliary pocket membrane,CC,
6738,GO:0020021,1,0.995607527026098,0,1,immortalization of host cell,BP,
6739,GO:0020027,1,0.924884079986428,0,14,hemoglobin metabolic process,BP,
6741,GO:0021501,1,0.994433365545022,0,1,prechordal plate formation,BP,
6742,GO:0021502,1,0.979323962701869,0,3,neural fold elevation formation,BP,
6743,GO:0021503,1,0.990043929173924,0,1,neural fold bending,BP,
6744,GO:0021508,1,0.991043167918589,0,1,floor plate formation,BP,
6745,GO:0021509,1,0.994656624862147,0,1,roof plate formation,BP,
6746,GO:0021510,1,0.53896850895569,0,89,spinal cord development,BP,
6747,GO:0021511,1,0.846613252745483,0,24,spinal cord patterning,BP,
6748,GO:0021512,1,0.992423701480541,0,1,spinal cord anterior/posterior patterning,BP,
6749,GO:0021513,1,0.863221103869165,0,22,spinal cord dorsal/ventral patterning,BP,
6750,GO:0021514,1,0.896290493786215,0,16,ventral spinal cord interneuron differentiation,BP,
6751,GO:0021515,1,0.749967457328918,0,44,cell differentiation in spinal cord,BP,
6752,GO:0021516,1,0.895005048074343,0,18,dorsal spinal cord development,BP,
6753,GO:0021517,1,0.769788042482147,0,39,ventral spinal cord development,BP,
6754,GO:0021519,1,0.996286185390552,0,1,spinal cord association neuron specification,BP,
6755,GO:0021520,1,0.927145478205621,0,12,spinal cord motor neuron cell fate specification,BP,
6756,GO:0021521,1,0.935208760014759,0,10,ventral spinal cord interneuron specification,BP,
6757,GO:0021522,1,0.834136062792601,0,28,spinal cord motor neuron differentiation,BP,
6758,GO:0021523,1,0.9745607971985,0,4,somatic motor neuron differentiation,BP,
6759,GO:0021524,1,0.983935483257833,0,3,visceral motor neuron differentiation,BP,
6760,GO:0021526,1,0.988742776183723,0,2,medial motor column neuron differentiation,BP,
6761,GO:0021527,1,0.93610906707138,0,11,spinal cord association neuron differentiation,BP,
6762,GO:0021528,1,0.993058458973322,0,1,commissural neuron differentiation in spinal cord,BP,
6763,GO:0021529,1,0.981727261831217,0,3,spinal cord oligodendrocyte cell differentiation,BP,
6764,GO:0021530,1,0.981727261831217,0,3,spinal cord oligodendrocyte cell fate specification,BP,
6765,GO:0021532,1,0.788196457757656,0,35,neural tube patterning,BP,
6767,GO:0021534,1,0.93117234081952,0,11,cell proliferation in hindbrain,BP,
6768,GO:0021535,1,0.902091266133603,0,13,cell migration in hindbrain,BP,
6771,GO:0021538,1,0.976190148037438,0,3,epithalamus development,BP,
6772,GO:0021539,1,0.989729969946448,0,2,subthalamus development,BP,
6773,GO:0021540,1,0.965917651406647,0,5,corpus callosum morphogenesis,BP,
6774,GO:0021541,1,0.992431664044525,0,1,ammon gyrus development,BP,
6775,GO:0021542,1,0.897455636504786,0,15,dentate gyrus development,BP,
6777,GO:0021544,1,0.848318870417754,0,23,subpallium development,BP,
6778,GO:0021545,1,0.749906250165499,0,41,cranial nerve development,BP,
6779,GO:0021546,1,0.970174075091748,0,5,rhombomere development,BP,
6780,GO:0021547,1,0.994433365545022,0,1,midbrain-hindbrain boundary initiation,BP,
6781,GO:0021548,1,0.94580459061549,0,8,pons development,BP,
6783,GO:0021550,1,0.993587012283989,0,1,medulla oblongata development,BP,
6784,GO:0021551,1,0.988120014668766,0,1,central nervous system morphogenesis,BP,
6785,GO:0021553,1,0.974395385093121,0,3,olfactory nerve development,BP,
6786,GO:0021554,1,0.924794181021999,0,11,optic nerve development,BP,
6787,GO:0021555,1,0.984123934521505,0,3,midbrain-hindbrain boundary morphogenesis,BP,
6788,GO:0021557,1,0.988546807801632,0,2,oculomotor nerve development,BP,
6789,GO:0021558,1,0.995907955243566,0,1,trochlear nerve development,BP,
6790,GO:0021559,1,0.935255982301882,0,10,trigeminal nerve development,BP,
6791,GO:0021560,1,0.986286449263289,0,2,abducens nerve development,BP,
6792,GO:0021561,1,0.937149119356035,0,9,facial nerve development,BP,
6793,GO:0021562,1,0.958809615927504,0,6,vestibulocochlear nerve development,BP,
6794,GO:0021563,1,0.960971529995274,0,5,glossopharyngeal nerve development,BP,
6795,GO:0021564,1,0.977134497873161,0,3,vagus nerve development,BP,
6796,GO:0021566,1,0.99214890728012,0,1,hypoglossal nerve development,BP,
6797,GO:0021568,1,0.996174270226139,0,1,rhombomere 2 development,BP,
6798,GO:0021569,1,0.988571011947613,0,2,rhombomere 3 development,BP,
6799,GO:0021570,1,0.995580132055237,0,1,rhombomere 4 development,BP,
6800,GO:0021571,1,0.985598940740636,0,2,rhombomere 5 development,BP,
6801,GO:0021572,1,0.992587198822204,0,1,rhombomere 6 development,BP,
6803,GO:0021577,1,0.985893375686139,0,2,hindbrain structural organization,BP,
6804,GO:0021578,1,0.957509095016173,0,6,hindbrain maturation,BP,
6805,GO:0021586,1,0.978646374032611,0,3,pons maturation,BP,
6807,GO:0021589,1,0.985893375686139,0,2,cerebellum structural organization,BP,
6808,GO:0021590,1,0.978406123413649,0,3,cerebellum maturation,BP,
6809,GO:0021591,1,0.844192962494367,0,24,ventricular system development,BP,
6810,GO:0021592,1,0.991963333611379,0,1,fourth ventricle development,BP,
6811,GO:0021593,1,0.992960074134372,0,1,rhombomere morphogenesis,BP,
6812,GO:0021594,1,0.992960074134372,0,1,rhombomere formation,BP,
6813,GO:0021598,1,0.986286449263289,0,2,abducens nerve morphogenesis,BP,
6814,GO:0021599,1,0.986286449263289,0,2,abducens nerve formation,BP,
6815,GO:0021602,1,0.843097966274369,0,24,cranial nerve morphogenesis,BP,
6816,GO:0021603,1,0.959914954343112,0,6,cranial nerve formation,BP,
6817,GO:0021604,1,0.938516891206709,0,9,cranial nerve structural organization,BP,
6818,GO:0021610,1,0.937149119356035,0,9,facial nerve morphogenesis,BP,
6819,GO:0021612,1,0.951028683723913,0,7,facial nerve structural organization,BP,
6820,GO:0021615,1,0.971970711201334,0,4,glossopharyngeal nerve morphogenesis,BP,
6821,GO:0021618,1,0.99214890728012,0,1,hypoglossal nerve morphogenesis,BP,
6822,GO:0021622,1,0.992608909065779,0,1,oculomotor nerve morphogenesis,BP,
6823,GO:0021623,1,0.992608909065779,0,1,oculomotor nerve formation,BP,
6824,GO:0021626,1,0.957509095016173,0,6,central nervous system maturation,BP,
6825,GO:0021631,1,0.954033574078734,0,6,optic nerve morphogenesis,BP,
6826,GO:0021633,1,0.986850496556942,0,2,optic nerve structural organization,BP,
6827,GO:0021634,1,0.992456292901894,0,1,optic nerve formation,BP,
6828,GO:0021636,1,0.962027922055488,0,5,trigeminal nerve morphogenesis,BP,
6829,GO:0021637,1,0.962027922055488,0,5,trigeminal nerve structural organization,BP,
6830,GO:0021644,1,0.988316806799974,0,2,vagus nerve morphogenesis,BP,
6831,GO:0021648,1,0.974203576414963,0,4,vestibulocochlear nerve morphogenesis,BP,
6832,GO:0021649,1,0.99356547104577,0,1,vestibulocochlear nerve structural organization,BP,
6833,GO:0021650,1,0.980513959597095,0,3,vestibulocochlear nerve formation,BP,
6834,GO:0021658,1,0.992960074134372,0,1,rhombomere 3 morphogenesis,BP,
6835,GO:0021660,1,0.992960074134372,0,1,rhombomere 3 formation,BP,
6836,GO:0021664,1,0.992960074134372,0,1,rhombomere 5 morphogenesis,BP,
6837,GO:0021666,1,0.992960074134372,0,1,rhombomere 5 formation,BP,
6838,GO:0021670,1,0.930411640894344,0,10,lateral ventricle development,BP,
6840,GO:0021678,1,0.987166229917043,0,3,third ventricle development,BP,
6841,GO:0021679,1,0.985416101685407,0,2,cerebellar molecular layer development,BP,
6842,GO:0021680,1,0.847941780354023,0,21,cerebellar Purkinje cell layer development,BP,
6844,GO:0021682,1,0.991708240074137,0,1,nerve maturation,BP,
6847,GO:0021685,1,0.990724917648536,0,1,cerebellar granular layer structural organization,BP,
6848,GO:0021686,1,0.995474657112284,0,1,cerebellar granular layer maturation,BP,
6849,GO:0021687,1,0.985416101685407,0,2,cerebellar molecular layer morphogenesis,BP,
6850,GO:0021688,1,0.992603270400501,0,1,cerebellar molecular layer formation,BP,
6851,GO:0021691,1,0.982854645709016,0,2,cerebellar Purkinje cell layer maturation,BP,
6852,GO:0021692,1,0.911239893963386,0,11,cerebellar Purkinje cell layer morphogenesis,BP,
6853,GO:0021693,1,0.983396113861985,0,2,cerebellar Purkinje cell layer structural organization,BP,
6854,GO:0021694,1,0.935653805203116,0,8,cerebellar Purkinje cell layer formation,BP,
6858,GO:0021698,1,0.983396113861985,0,2,cerebellar cortex structural organization,BP,
6859,GO:0021699,1,0.978406123413649,0,3,cerebellar cortex maturation,BP,
6861,GO:0021702,1,0.935653805203116,0,8,cerebellar Purkinje cell differentiation,BP,
6863,GO:0021718,1,0.986124078308622,0,2,superior olivary nucleus development,BP,
6864,GO:0021722,1,0.986124078308622,0,2,superior olivary nucleus maturation,BP,
6865,GO:0021730,1,0.982966495405206,0,2,trigeminal sensory nucleus development,BP,
6866,GO:0021740,1,0.982966495405206,0,2,principal sensory nucleus of trigeminal nerve development,BP,
6867,GO:0021747,1,0.976976184480805,0,3,cochlear nucleus development,BP,
6868,GO:0021750,1,0.993587012283989,0,1,vestibular nucleus development,BP,
6869,GO:0021756,1,0.878727195026236,0,17,striatum development,BP,
6870,GO:0021757,1,0.99251544213873,0,1,caudate nucleus development,BP,
6871,GO:0021758,1,0.99251544213873,0,1,putamen development,BP,
6873,GO:0021761,1,0.505580787604629,0,96,limbic system development,BP,
6875,GO:0021763,1,0.994092217431797,0,1,subthalamic nucleus development,BP,
6876,GO:0021764,1,0.964846720047914,0,4,amygdala development,BP,
6877,GO:0021766,1,0.594871232910989,0,72,hippocampus development,BP,
6878,GO:0021767,1,0.989628102769887,0,1,mammillary body development,BP,
6879,GO:0021768,1,0.992542567041937,0,1,nucleus accumbens development,BP,
6880,GO:0021769,1,0.97242428412269,0,4,orbitofrontal cortex development,BP,
6881,GO:0021771,1,0.991697630478123,0,1,lateral geniculate nucleus development,BP,
6883,GO:0021773,1,0.975722558554655,0,3,striatal medium spiny neuron differentiation,BP,
6884,GO:0021775,1,0.97362355467927,0,3,smoothened signaling pathway involved in ventral spinal cord interneuron specification,BP,
6885,GO:0021776,1,0.97362355467927,0,3,smoothened signaling pathway involved in spinal cord motor neuron cell fate specification,BP,
6886,GO:0021778,1,0.962894348961846,0,5,oligodendrocyte cell fate specification,BP,
6887,GO:0021779,1,0.962894348961846,0,5,oligodendrocyte cell fate commitment,BP,
6888,GO:0021780,1,0.962894348961846,0,5,glial cell fate specification,BP,
6889,GO:0021781,1,0.918965230318645,0,12,glial cell fate commitment,BP,
6891,GO:0021783,1,0.911993576512378,0,13,preganglionic parasympathetic fiber development,BP,
6892,GO:0021784,1,0.990149632295247,0,2,postganglionic parasympathetic fiber development,BP,
6893,GO:0021785,1,0.941004852714885,0,7,branchiomotor neuron axon guidance,BP,
6894,GO:0021793,1,0.992568672128432,0,1,chemorepulsion of branchiomotor axon,BP,
6895,GO:0021794,1,0.918411431843576,0,13,thalamus development,BP,
6897,GO:0021796,1,0.957254828798496,0,6,cerebral cortex regionalization,BP,
6898,GO:0021797,1,0.980761750027367,0,3,forebrain anterior/posterior pattern specification,BP,
6899,GO:0021798,1,0.954966308529368,0,7,forebrain dorsal/ventral pattern formation,BP,
6900,GO:0021799,1,0.834945039052888,0,24,cerebral cortex radially oriented cell migration,BP,
6902,GO:0021801,1,0.877467849684521,0,17,cerebral cortex radial glia guided migration,BP,
6903,GO:0021812,1,0.985019780697916,0,2,neuronal-glial interaction involved in cerebral cortex radial glia guided migration,BP,
6904,GO:0021813,1,0.993365698057973,0,1,cell-cell adhesion involved in neuronal-glial interactions involved in cerebral cortex radial glia guided migration,BP,
6905,GO:0021814,1,0.960197200325683,0,5,cell motility involved in cerebral cortex radial glia guided migration,BP,
6906,GO:0021815,1,0.973141031551604,0,3,modulation of microtubule cytoskeleton involved in cerebral cortex radial glia guided migration,BP,
6907,GO:0021817,1,0.973141031551604,0,3,nucleokinesis involved in cell motility in cerebral cortex radial glia guided migration,BP,
6908,GO:0021819,1,0.921293307959982,0,11,layer formation in cerebral cortex,BP,
6909,GO:0021822,1,0.99430697890766,0,1,negative regulation of cell motility involved in cerebral cortex radial glia guided migration,BP,
6910,GO:0021823,1,0.982847473485503,0,2,cerebral cortex tangential migration using cell-cell interactions,BP,
6911,GO:0021824,1,0.98534821193752,0,2,cerebral cortex tangential migration using cell-axon interactions,BP,
6912,GO:0021825,1,0.968444529963868,0,4,substrate-dependent cerebral cortex tangential migration,BP,
6914,GO:0021827,1,0.982847473485503,0,2,postnatal olfactory bulb interneuron migration,BP,
6915,GO:0021828,1,0.98534821193752,0,2,gonadotrophin-releasing hormone neuronal migration to the hypothalamus,BP,
6918,GO:0021836,1,0.982847473485503,0,2,chemorepulsion involved in postnatal olfactory bulb interneuron migration,BP,
6919,GO:0021840,1,0.986330746990552,0,2,directional guidance of interneurons involved in migration from the subpallium to the cortex,BP,
6920,GO:0021842,1,0.986330746990552,0,2,chemorepulsion involved in interneuron migration from the subpallium to the cortex,BP,
6923,GO:0021847,1,0.978202951924774,0,3,ventricular zone neuroblast division,BP,
6924,GO:0021849,1,0.985114122491093,0,2,neuroblast division in subventricular zone,BP,
6926,GO:0021854,1,0.899477772840049,0,18,hypothalamus development,BP,
6927,GO:0021855,1,0.979526132219307,0,3,hypothalamus cell migration,BP,
6928,GO:0021856,1,0.98534821193752,0,2,hypothalamic tangential migration using cell-axon interactions,BP,
6929,GO:0021859,1,0.938265788522177,0,8,pyramidal neuron differentiation,BP,
6930,GO:0021860,1,0.947053973520265,0,7,pyramidal neuron development,BP,
6931,GO:0021861,1,0.959500095505392,0,7,forebrain radial glial cell differentiation,BP,
6932,GO:0021869,1,0.958750723966373,0,6,forebrain ventricular zone progenitor cell division,BP,
6933,GO:0021870,1,0.99146506681211,0,1,Cajal-Retzius cell differentiation,BP,
6934,GO:0021871,1,0.867988029043798,0,21,forebrain regionalization,BP,
6936,GO:0021873,1,0.945599789653168,0,7,forebrain neuroblast division,BP,
6937,GO:0021877,1,0.929123798146357,0,10,forebrain neuron fate commitment,BP,
6939,GO:0021881,1,0.992571113550535,0,1,Wnt-activated signaling pathway involved in forebrain neuron fate commitment,BP,
6940,GO:0021882,1,0.987980382263189,0,2,regulation of transcription from RNA polymerase II promoter involved in forebrain neuron fate commitment,BP,
6943,GO:0021886,1,0.982352859872838,0,3,hypothalamus gonadotrophin-releasing hormone neuron differentiation,BP,
6944,GO:0021888,1,0.982352859872838,0,3,hypothalamus gonadotrophin-releasing hormone neuron development,BP,
6948,GO:0021893,1,0.987980382263189,0,2,cerebral cortex GABAergic interneuron fate commitment,BP,
6951,GO:0021896,1,0.979876497453793,0,2,forebrain astrocyte differentiation,BP,
6952,GO:0021897,1,0.979876497453793,0,2,forebrain astrocyte development,BP,
6953,GO:0021898,1,0.980639904002364,0,3,commitment of multipotent stem cells to neuronal lineage in forebrain,BP,
6954,GO:0021902,1,0.953150931055654,0,6,commitment of neuronal cell to specific neuron type in forebrain,BP,
6955,GO:0021903,1,0.9383345635833,0,10,rostrocaudal neural tube patterning,BP,
6956,GO:0021904,1,0.864758699744668,0,21,dorsal/ventral neural tube patterning,BP,
6957,GO:0021905,1,0.990970163923478,0,1,forebrain-midbrain boundary formation,BP,
6958,GO:0021910,1,0.941184893958007,0,8,smoothened signaling pathway involved in ventral spinal cord patterning,BP,
6959,GO:0021912,1,0.984541108800823,0,3,regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification,BP,
6960,GO:0021913,1,0.979594583056647,0,4,regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification,BP,
6961,GO:0021914,1,0.966721289304373,0,5,negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning,BP,
6963,GO:0021917,1,0.990970163923478,0,1,somatic motor neuron fate commitment,BP,
6964,GO:0021918,1,0.990970163923478,0,1,regulation of transcription from RNA polymerase II promoter involved in somatic motor neuron fate commitment,BP,
6965,GO:0021919,1,0.992533687773242,0,1,BMP signaling pathway involved in spinal cord dorsal/ventral patterning,BP,
6966,GO:0021920,1,0.996286185390552,0,1,regulation of transcription from RNA polymerase II promoter involved in spinal cord association neuron specification,BP,
6967,GO:0021924,1,0.936922548714385,0,10,cell proliferation in external granule layer,BP,
6968,GO:0021930,1,0.936922548714385,0,10,cerebellar granule cell precursor proliferation,BP,
6969,GO:0021932,1,0.934272249007626,0,9,hindbrain radial glia guided cell migration,BP,
6970,GO:0021933,1,0.995474657112284,0,1,radial glia guided migration of cerebellar granule cell,BP,
6971,GO:0021934,1,0.980204789238342,0,2,hindbrain tangential cell migration,BP,
6972,GO:0021935,1,0.980204789238342,0,2,cerebellar granule cell precursor tangential migration,BP,
6973,GO:0021936,1,0.941331654639955,0,9,regulation of cerebellar granule cell precursor proliferation,BP,
6974,GO:0021937,1,0.966607761448135,0,5,cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation,BP,
6975,GO:0021938,1,0.972015612550063,0,4,smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation,BP,
6976,GO:0021940,1,0.952924007018457,0,7,positive regulation of cerebellar granule cell precursor proliferation,BP,
6977,GO:0021941,1,0.987840795996875,0,2,negative regulation of cerebellar granule cell precursor proliferation,BP,
6978,GO:0021942,1,0.969549228313617,0,4,radial glia guided migration of Purkinje cell,BP,
6979,GO:0021943,1,0.968008097639773,0,4,formation of radial glial scaffolds,BP,
6980,GO:0021952,1,0.834675176533389,0,23,central nervous system projection neuron axonogenesis,BP,
6983,GO:0021955,1,0.806314649047543,0,28,central nervous system neuron axonogenesis,BP,
6984,GO:0021956,1,0.994640083422756,0,1,central nervous system interneuron axonogenesis,BP,
6985,GO:0021957,1,0.954420677220479,0,6,corticospinal tract morphogenesis,BP,
6986,GO:0021960,1,0.960893046145391,0,5,anterior commissure morphogenesis,BP,
6987,GO:0021965,1,0.972476167057248,0,3,spinal cord ventral commissure morphogenesis,BP,
6988,GO:0021966,1,0.988449172932221,0,2,corticospinal neuron axon guidance,BP,
6989,GO:0021972,1,0.992129709912967,0,1,corticospinal neuron axon guidance through spinal cord,BP,
6990,GO:0021978,1,0.926186523534957,0,12,telencephalon regionalization,BP,
6991,GO:0021979,1,0.961061521470753,0,6,hypothalamus cell differentiation,BP,
6992,GO:0021983,1,0.77007149908217,0,41,pituitary gland development,BP,
6993,GO:0021984,1,0.935803158844929,0,12,adenohypophysis development,BP,
6994,GO:0021985,1,0.98573654389717,0,2,neurohypophysis development,BP,
6995,GO:0021986,1,0.976190148037438,0,3,habenula development,BP,
6998,GO:0021993,1,0.991963333611379,0,1,initiation of neural tube closure,BP,
6999,GO:0021997,1,0.981820121896074,0,2,neural plate axis specification,BP,
7000,GO:0021998,1,0.992518804425241,0,1,neural plate mediolateral regionalization,BP,
7001,GO:0021999,1,0.959330671003977,0,6,neural plate anterior/posterior regionalization,BP,
7002,GO:0022007,1,0.97775107884649,0,3,convergent extension involved in neural plate elongation,BP,
7004,GO:0022009,1,0.973326183901924,0,4,central nervous system vasculogenesis,BP,
7007,GO:0022012,1,0.990179116344062,0,1,subpallium cell proliferation in forebrain,BP,
7008,GO:0022018,1,0.990179116344062,0,1,lateral ganglionic eminence cell proliferation,BP,
7009,GO:0022027,1,0.946032791158222,0,6,interkinetic nuclear migration,BP,
7012,GO:0022030,1,0.877467849684521,0,17,telencephalon glial cell migration,BP,
7014,GO:0022038,1,0.903248869033838,0,15,corpus callosum development,BP,
7015,GO:0022400,1,0.875101989160439,0,20,regulation of rhodopsin mediated signaling pathway,BP,
7016,GO:0022401,1,0.909609322400971,0,16,negative adaptation of signaling pathway,BP,
7024,GO:0022410,1,0.891566711430202,0,21,circadian sleep/wake cycle process,BP,
7028,GO:0022417,1,0.970216633534801,0,7,protein maturation by protein folding,BP,
7029,GO:0022600,1,0.626594076640006,0,74,digestive system process,BP,
7030,GO:0022602,1,0.759977061637495,0,39,ovulation cycle process,BP,
7033,GO:0022605,1,0.965776345212794,0,6,mammalian oogenesis stage,BP,
7037,GO:0022613,1,0.0778706031600145,0,442,ribonucleoprotein complex biogenesis,BP,
7038,GO:0022614,1,0.962331537020439,0,5,membrane to membrane docking,BP,
7039,GO:0022615,1,0.978780526457065,0,4,protein to membrane docking,BP,
7040,GO:0022616,1,0.843246568603679,0,26,DNA strand elongation,BP,
7042,GO:0022618,1,0.298846813757558,0,195,ribonucleoprotein complex assembly,BP,
7043,GO:0022622,1,0.997356194534619,0,1,root system development,BP,
7044,GO:0022624,1,0.890259349863997,0,24,proteasome accessory complex,CC,
7045,GO:0022625,1,0.80435721808668,0,62,cytosolic large ribosomal subunit,CC,
7047,GO:0022627,1,0.855098174806503,0,45,cytosolic small ribosomal subunit,CC,
7050,GO:0022821,1,0.900981938270364,0,14,potassium ion antiporter activity,MF,
7059,GO:0022840,1,0.907699214940368,0,16,leak channel activity,MF,
7060,GO:0022841,1,0.922398427825561,0,14,potassium ion leak channel activity,MF,
7061,GO:0022842,1,0.907699214940368,0,16,narrow pore channel activity,MF,
7063,GO:0022848,1,0.915464961810705,0,14,acetylcholine-gated cation-selective channel activity,MF,
7064,GO:0022849,1,0.95606246418158,0,5,glutamate-gated calcium ion channel activity,MF,
7065,GO:0022850,1,0.978397168092274,0,4,serotonin-gated cation-selective channel activity,MF,
7066,GO:0022851,1,0.920024413640608,0,11,GABA-gated chloride ion channel activity,MF,
7067,GO:0022852,1,0.985176023059403,0,2,glycine-gated chloride ion channel activity,MF,
7068,GO:0022853,1,0.699785143829455,0,52,active ion transmembrane transporter activity,MF,
7070,GO:0022858,1,0.964839408150436,0,5,alanine transmembrane transporter activity,MF,
7071,GO:0022884,1,0.927175258372147,0,15,macromolecule transmembrane transporter activity,MF,
7072,GO:0022889,1,0.948407495747731,0,9,serine transmembrane transporter activity,MF,
7074,GO:0022894,1,0.994076577534993,0,1,Intermediate conductance calcium-activated potassium channel activity,MF,
7076,GO:0022900,1,0.477524703292605,0,158,electron transport chain,BP,
7077,GO:0022904,1,0.658578297440338,0,97,respiratory electron transport chain,BP,
7079,GO:0023016,1,0.976657750299684,0,3,signal transduction by trans-phosphorylation,BP,
7080,GO:0023019,1,0.897711690763004,0,18,signal transduction involved in regulation of gene expression,BP,
7081,GO:0023021,1,0.980793377823807,0,3,termination of signal transduction,BP,
7084,GO:0023025,1,0.986867051567224,0,2,MHC class Ib protein complex binding,MF,
7086,GO:0023029,1,0.965504035213141,0,5,MHC class Ib protein binding,MF,
7087,GO:0023030,1,0.986867051567224,0,2,MHC class Ib protein binding, via antigen binding groove,MF,
7088,GO:0023035,1,0.951972508920851,0,8,CD40 signaling pathway,BP,
7089,GO:0023041,1,0.960238386390251,0,6,neuronal signal transduction,BP,
7094,GO:0023058,1,0.903611635934246,0,17,adaptation of signaling pathway,BP,
7097,GO:0030002,1,0.930653341223378,0,10,cellular anion homeostasis,BP,
7099,GO:0030004,1,0.486329109774501,0,106,cellular monovalent inorganic cation homeostasis,BP,
7100,GO:0030007,1,0.910038864543954,0,13,cellular potassium ion homeostasis,BP,
7101,GO:0030008,1,0.926262127240174,0,14,TRAPP complex,CC,
7102,GO:0030010,1,0.413350886259754,0,119,establishment of cell polarity,BP,
7103,GO:0030011,1,0.885226891059653,0,17,maintenance of cell polarity,BP,
7104,GO:0030014,1,0.895691593813609,0,15,CCR4-NOT complex,CC,
7105,GO:0030015,1,0.964652432652597,0,5,CCR4-NOT core complex,CC,
7106,GO:0030016,1,0.234256849566676,0,201,myofibril,CC,
7107,GO:0030017,1,0.272489994799466,0,181,sarcomere,CC,
7108,GO:0030018,1,0.399282210072284,0,119,Z disc,CC,
7110,GO:0030021,1,0.99274146790083,0,1,extracellular matrix structural constituent conferring compression resistance,MF,
7111,GO:0030023,1,0.953915138739253,0,5,extracellular matrix constituent conferring elasticity,MF,
7112,GO:0030027,1,0.273961689631001,0,176,lamellipodium,CC,
7117,GO:0030033,1,0.887292954449492,0,16,microvillus assembly,BP,
7118,GO:0030035,1,0.96960860787055,0,4,microspike assembly,BP,
7120,GO:0030037,1,0.992133368659972,0,1,actin filament reorganization involved in cell cycle,BP,
7121,GO:0030038,1,0.539587001112534,0,86,contractile actin filament bundle assembly,BP,
7124,GO:0030043,1,0.97750119051129,0,4,actin filament fragmentation,BP,
7126,GO:0030047,1,0.977685690987013,0,3,actin modification,BP,
7128,GO:0030049,1,0.815894588041416,0,32,muscle filament sliding,BP,
7129,GO:0030050,1,0.936904312439871,0,8,vesicle transport along actin filament,BP,
7132,GO:0030056,1,0.948147105903628,0,5,hemidesmosome,CC,
7134,GO:0030060,1,0.981123384316609,0,4,L-malate dehydrogenase activity,MF,
7135,GO:0030061,1,0.970653673223565,0,4,mitochondrial crista,CC,
7136,GO:0030062,1,0.962097873303335,0,6,mitochondrial tricarboxylic acid cycle enzyme complex,CC,
7137,GO:0030070,1,0.970620805789808,0,4,insulin processing,BP,
7138,GO:0030071,1,0.722409411500379,0,48,regulation of mitotic metaphase/anaphase transition,BP,
7141,GO:0030091,1,0.967060091203983,0,7,protein repair,BP,
7143,GO:0030098,1,0.143975878025449,0,286,lymphocyte differentiation,BP,
7146,GO:0030101,1,0.743094162248201,0,49,natural killer cell activation,BP,
7147,GO:0030103,1,0.990446591348293,0,2,vasopressin secretion,BP,
7148,GO:0030104,1,0.669527505088033,0,56,water homeostasis,BP,
7149,GO:0030107,1,0.99295458484256,0,1,HLA-A specific inhibitory MHC class I receptor activity,MF,
7150,GO:0030108,1,0.995857532466422,0,1,HLA-A specific activating MHC class I receptor activity,MF,
7151,GO:0030109,1,0.987853202082495,0,2,HLA-B specific inhibitory MHC class I receptor activity,MF,
7157,GO:0030121,1,0.959888582833968,0,6,AP-1 adaptor complex,CC,
7159,GO:0030123,1,0.93066825545135,0,10,AP-3 adaptor complex,CC,
7160,GO:0030124,1,0.975599284811441,0,4,AP-4 adaptor complex,CC,
7162,GO:0030126,1,0.91094064822954,0,15,COPI vesicle coat,CC,
7163,GO:0030127,1,0.908155672427729,0,14,COPII vesicle coat,CC,
7165,GO:0030130,1,0.922072893537294,0,12,clathrin coat of trans-Golgi network vesicle,CC,
7177,GO:0030145,1,0.720397335821103,0,48,manganese ion binding,MF,
7179,GO:0030149,1,0.873704800132988,0,22,sphingolipid catabolic process,BP,
7180,GO:0030150,1,0.912656504739387,0,17,protein import into mitochondrial matrix,BP,
7181,GO:0030151,1,0.973387769289414,0,4,molybdenum ion binding,MF,
7184,GO:0030156,1,0.997441186371337,0,1,benzodiazepine receptor binding,MF,
7185,GO:0030157,1,0.920209160841823,0,13,pancreatic juice secretion,BP,
7186,GO:0030158,1,0.975319840301105,0,3,protein xylosyltransferase activity,MF,
7187,GO:0030159,1,0.839246080130009,0,24,receptor signaling complex scaffold activity,MF,
7188,GO:0030160,1,0.966596528008001,0,4,GKAP/Homer scaffold activity,MF,
7192,GO:0030166,1,0.637302427839152,0,60,proteoglycan biosynthetic process,BP,
7193,GO:0030167,1,0.973183822999951,0,4,proteoglycan catabolic process,BP,
7195,GO:0030169,1,0.908597332081995,0,13,low-density lipoprotein particle binding,MF,
7196,GO:0030170,1,0.749481024645463,0,45,pyridoxal phosphate binding,MF,
7197,GO:0030171,1,0.995281274400491,0,1,voltage-gated proton channel activity,MF,
7198,GO:0030172,1,0.990320186123347,0,3,troponin C binding,MF,
7199,GO:0030173,1,0.761950999032487,0,41,integral component of Golgi membrane,CC,
7200,GO:0030174,1,0.962243563502518,0,6,regulation of DNA-dependent DNA replication initiation,BP,
7201,GO:0030175,1,0.50420408392492,0,90,filopodium,CC,
7203,GO:0030177,1,0.3498764414716,0,160,positive regulation of Wnt signaling pathway,BP,
7206,GO:0030183,1,0.517010891247652,0,96,B cell differentiation,BP,
7207,GO:0030184,1,0.993103570478837,0,1,nitric oxide transmembrane transporter activity,MF,
7208,GO:0030185,1,0.985251113730595,0,3,nitric oxide transport,BP,
7209,GO:0030186,1,0.995869872745912,0,1,melatonin metabolic process,BP,
7210,GO:0030187,1,0.995869872745912,0,1,melatonin biosynthetic process,BP,
7213,GO:0030195,1,0.764620204023867,0,43,negative regulation of blood coagulation,BP,
7214,GO:0030197,1,0.985487032273689,0,2,extracellular matrix constituent, lubricant activity,MF,
7216,GO:0030199,1,0.72187908919032,0,43,collagen fibril organization,BP,
7217,GO:0030200,1,0.980900665164732,0,3,heparan sulfate proteoglycan catabolic process,BP,
7218,GO:0030201,1,0.791602038000826,0,31,heparan sulfate proteoglycan metabolic process,BP,
7219,GO:0030202,1,0.938127403016343,0,8,heparin metabolic process,BP,
7221,GO:0030204,1,0.747574002034816,0,40,chondroitin sulfate metabolic process,BP,
7222,GO:0030205,1,0.909192142632773,0,13,dermatan sulfate metabolic process,BP,
7223,GO:0030206,1,0.829980162412493,0,25,chondroitin sulfate biosynthetic process,BP,
7224,GO:0030207,1,0.913014732041313,0,13,chondroitin sulfate catabolic process,BP,
7225,GO:0030208,1,0.914515145153525,0,12,dermatan sulfate biosynthetic process,BP,
7226,GO:0030209,1,0.994184610546592,0,1,dermatan sulfate catabolic process,BP,
7227,GO:0030210,1,0.938127403016343,0,8,heparin biosynthetic process,BP,
7228,GO:0030212,1,0.792786104859114,0,34,hyaluronan metabolic process,BP,
7229,GO:0030213,1,0.914070082514707,0,13,hyaluronan biosynthetic process,BP,
7230,GO:0030214,1,0.911831458014811,0,14,hyaluronan catabolic process,BP,
7231,GO:0030215,1,0.855303262707044,0,20,semaphorin receptor binding,MF,
7233,GO:0030217,1,0.251042733262466,0,204,T cell differentiation,BP,
7236,GO:0030220,1,0.882096159166192,0,18,platelet formation,BP,
7237,GO:0030221,1,0.988001772174655,0,2,basophil differentiation,BP,
7238,GO:0030222,1,0.981063171068311,0,3,eosinophil differentiation,BP,
7239,GO:0030223,1,0.963673807826263,0,6,neutrophil differentiation,BP,
7240,GO:0030224,1,0.814309054269328,0,30,monocyte differentiation,BP,
7241,GO:0030225,1,0.794937843589381,0,36,macrophage differentiation,BP,
7242,GO:0030226,1,0.96684887400488,0,3,apolipoprotein receptor activity,MF,
7243,GO:0030228,1,0.87545673478933,0,16,lipoprotein particle receptor activity,MF,
7244,GO:0030229,1,0.970310986177905,0,4,very-low-density lipoprotein particle receptor activity,MF,
7245,GO:0030233,1,0.995472355960302,0,1,deoxynucleotide transmembrane transporter activity,MF,
7248,GO:0030237,1,0.98543743819663,0,2,female sex determination,BP,
7249,GO:0030238,1,0.909630385962664,0,14,male sex determination,BP,
7250,GO:0030239,1,0.630842866945638,0,62,myofibril assembly,BP,
7251,GO:0030240,1,0.917159474748108,0,10,skeletal muscle thin filament assembly,BP,
7252,GO:0030241,1,0.933320195723262,0,7,skeletal muscle myosin thick filament assembly,BP,
7253,GO:0030242,1,0.962061132929935,0,5,autophagy of peroxisome,BP,
7256,GO:0030249,1,0.980505951004925,0,4,guanylate cyclase regulator activity,MF,
7257,GO:0030250,1,0.980505951004925,0,4,guanylate cyclase activator activity,MF,
7258,GO:0030252,1,0.913156988081582,0,14,growth hormone secretion,BP,
7260,GO:0030259,1,0.958417759083274,0,7,lipid glycosylation,BP,
7262,GO:0030261,1,0.810499136477637,0,27,chromosome condensation,BP,
7263,GO:0030262,1,0.835986733051922,0,28,apoptotic nuclear changes,BP,
7264,GO:0030263,1,0.970079426259365,0,4,apoptotic chromosome condensation,BP,
7265,GO:0030264,1,0.993058458973322,0,1,nuclear fragmentation involved in apoptotic nuclear change,BP,
7266,GO:0030267,1,0.982786602229003,0,3,glyoxylate reductase (NADP) activity,MF,
7267,GO:0030272,1,0.997139317785995,0,1,5-formyltetrahydrofolate cyclo-ligase activity,MF,
7268,GO:0030273,1,0.993697259844088,0,1,melanin-concentrating hormone receptor activity,MF,
7269,GO:0030274,1,0.957353993037017,0,6,LIM domain binding,MF,
7270,GO:0030275,1,0.907147654824216,0,15,LRR domain binding,MF,
7271,GO:0030276,1,0.613526988320904,0,68,clathrin binding,MF,
7272,GO:0030277,1,0.920843976190226,0,13,maintenance of gastrointestinal epithelium,BP,
7274,GO:0030279,1,0.674536361193597,0,59,negative regulation of ossification,BP,
7275,GO:0030280,1,0.974298294137393,0,5,structural constituent of epidermis,MF,
7277,GO:0030283,1,0.996995371001083,0,1,testosterone dehydrogenase [NAD(P)] activity,MF,
7278,GO:0030284,1,0.963679617816929,0,5,estrogen receptor activity,MF,
7280,GO:0030286,1,0.680305264191375,0,48,dynein complex,CC,
7281,GO:0030289,1,0.984614046643869,0,3,protein phosphatase 4 complex,CC,
7282,GO:0030290,1,0.992526104304396,0,1,sphingolipid activator protein activity,MF,
7283,GO:0030291,1,0.819065109441796,0,33,protein serine/threonine kinase inhibitor activity,MF,
7284,GO:0030292,1,0.980880677353969,0,3,protein tyrosine kinase inhibitor activity,MF,
7285,GO:0030294,1,0.994151786537162,0,1,receptor signaling protein tyrosine kinase inhibitor activity,MF,
7287,GO:0030296,1,0.896552555289189,0,15,protein tyrosine kinase activator activity,MF,
7288,GO:0030297,1,0.950995390745635,0,7,transmembrane receptor protein tyrosine kinase activator activity,MF,
7289,GO:0030299,1,0.95227040394571,0,8,intestinal cholesterol absorption,BP,
7290,GO:0030300,1,0.982992537803676,0,3,regulation of intestinal cholesterol absorption,BP,
7291,GO:0030301,1,0.641308598363996,0,67,cholesterol transport,BP,
7292,GO:0030302,1,0.995472355960302,0,1,deoxynucleotide transport,BP,
7293,GO:0030305,1,0.987648271836138,0,2,heparanase activity,MF,
7294,GO:0030306,1,0.939637533962261,0,8,ADP-ribosylation factor binding,MF,
7297,GO:0030309,1,0.951062684131707,0,8,poly-N-acetyllactosamine metabolic process,BP,
7298,GO:0030311,1,0.958154128591331,0,7,poly-N-acetyllactosamine biosynthetic process,BP,
7299,GO:0030312,1,0.994065431553779,0,1,external encapsulating structure,CC,
7300,GO:0030314,1,0.94305400309362,0,7,junctional membrane complex,CC,
7301,GO:0030315,1,0.698806606198865,0,44,T-tubule,CC,
7303,GO:0030317,1,0.69056818225211,0,58,flagellated sperm motility,BP,
7305,GO:0030320,1,0.930653341223378,0,10,cellular monovalent inorganic anion homeostasis,BP,
7306,GO:0030321,1,0.968420751219548,0,5,transepithelial chloride transport,BP,
7307,GO:0030322,1,0.921388435315459,0,14,stabilization of membrane potential,BP,
7310,GO:0030325,1,0.883108240600951,0,19,adrenal gland development,BP,
7312,GO:0030327,1,0.978189151828654,0,3,prenylated protein catabolic process,BP,
7313,GO:0030328,1,0.985397316686362,0,2,prenylcysteine catabolic process,BP,
7314,GO:0030329,1,0.985397316686362,0,2,prenylcysteine metabolic process,BP,
7315,GO:0030330,1,0.491862589627091,0,107,DNA damage response, signal transduction by p53 class mediator,BP,
7316,GO:0030331,1,0.766241759575752,0,37,estrogen receptor binding,MF,
7317,GO:0030332,1,0.82378239699684,0,30,cyclin binding,MF,
7321,GO:0030337,1,0.989246991008932,0,2,DNA polymerase processivity factor activity,MF,
7322,GO:0030342,1,0.992676271816402,0,1,1-alpha,25-dihydroxyvitamin D3 24-hydroxylase activity,MF,
7323,GO:0030343,1,0.995536655506774,0,1,vitamin D3 25-hydroxylase activity,MF,
7324,GO:0030345,1,0.99274146790083,0,1,structural constituent of tooth enamel,MF,
7325,GO:0030346,1,0.953985336228205,0,7,protein phosphatase 2B binding,MF,
7326,GO:0030348,1,0.979684605090985,0,3,syntaxin-3 binding,MF,
7327,GO:0030350,1,0.983877254985868,0,2,iron-responsive element binding,MF,
7328,GO:0030351,1,0.992975566243211,0,1,inositol-1,3,4,5,6-pentakisphosphate 3-phosphatase activity,MF,
7329,GO:0030366,1,0.991445994879477,0,2,molybdopterin synthase activity,MF,
7330,GO:0030368,1,0.943037605696207,0,8,interleukin-17 receptor activity,MF,
7331,GO:0030369,1,0.984980416451996,0,2,ICAM-3 receptor activity,MF,
7332,GO:0030371,1,0.842310969187606,0,24,translation repressor activity,MF,
7333,GO:0030372,1,0.992220059453521,0,1,high molecular weight B cell growth factor receptor binding,MF,
7334,GO:0030374,1,0.610744192051918,0,67,ligand-dependent nuclear receptor transcription coactivator activity,MF,
7335,GO:0030375,1,0.967237824343227,0,4,thyroid hormone receptor coactivator activity,MF,
7336,GO:0030377,1,0.99593701628593,0,1,urokinase plasminogen activator receptor activity,MF,
7337,GO:0030378,1,0.993575240739539,0,1,serine racemase activity,MF,
7338,GO:0030379,1,0.990887106694191,0,1,neurotensin receptor activity, non-G-protein coupled,MF,
7339,GO:0030382,1,0.995242759029559,0,1,sperm mitochondrion organization,BP,
7340,GO:0030387,1,0.995948179676618,0,1,fructosamine-3-kinase activity,MF,
7341,GO:0030388,1,0.973504917224583,0,5,fructose 1,6-bisphosphate metabolic process,BP,
7342,GO:0030389,1,0.993512774850779,0,2,fructosamine metabolic process,BP,
7343,GO:0030393,1,0.995948179676618,0,1,fructoselysine metabolic process,BP,
7344,GO:0030395,1,0.993075523209015,0,2,lactose binding,MF,
7345,GO:0030397,1,0.724917581815814,0,46,membrane disassembly,BP,
7346,GO:0030407,1,0.994874644390529,0,1,formimidoyltransferase activity,MF,
7347,GO:0030409,1,0.994874644390529,0,1,glutamate formimidoyltransferase activity,MF,
7348,GO:0030412,1,0.994874644390529,0,1,formimidoyltetrahydrofolate cyclodeaminase activity,MF,
7350,GO:0030421,1,0.997109972288868,0,1,defecation,BP,
7351,GO:0030422,1,0.941198952204322,0,9,production of siRNA involved in RNA interference,BP,
7352,GO:0030423,1,0.972723681367598,0,4,targeting of mRNA for destruction involved in RNA interference,BP,
7355,GO:0030426,1,0.341549400068545,0,145,growth cone,CC,
7356,GO:0030427,1,0.325519135410064,0,150,site of polarized growth,CC,
7357,GO:0030429,1,0.99583057491786,0,1,kynureninase activity,MF,
7358,GO:0030430,1,0.964637085674657,0,6,host cell cytoplasm,CC,
7359,GO:0030431,1,0.838431200499511,0,29,sleep,BP,
7360,GO:0030432,1,0.956949169474217,0,8,peristalsis,BP,
7361,GO:0030433,1,0.63421582163765,0,70,ubiquitin-dependent ERAD pathway,BP,
7362,GO:0030449,1,0.797098548897524,0,36,regulation of complement activation,BP,
7363,GO:0030450,1,0.983681113496367,0,2,regulation of complement activation, classical pathway,BP,
7364,GO:0030451,1,0.989540988123595,0,1,regulation of complement activation, alternative pathway,BP,
7365,GO:0030473,1,0.958133897098482,0,5,nuclear migration along microtubule,BP,
7366,GO:0030474,1,0.993058458973322,0,1,spindle pole body duplication,BP,
7367,GO:0030478,1,0.970667246882396,0,4,actin cap,CC,
7368,GO:0030479,1,0.948408436511747,0,7,actin cortical patch,CC,
7369,GO:0030485,1,0.987982919977341,0,2,smooth muscle contractile fiber,CC,
7370,GO:0030488,1,0.821357165510068,0,31,tRNA methylation,BP,
7371,GO:0030490,1,0.744271286404491,0,51,maturation of SSU-rRNA,BP,
7372,GO:0030492,1,0.988164892565493,0,4,hemoglobin binding,MF,
7373,GO:0030496,1,0.324143604029977,0,160,midbody,CC,
7374,GO:0030497,1,0.930059873874178,0,11,fatty acid elongation,BP,
7377,GO:0030502,1,0.931546481039111,0,11,negative regulation of bone mineralization,BP,
7378,GO:0030504,1,0.990184389404135,0,1,inorganic diphosphate transmembrane transporter activity,MF,
7379,GO:0030505,1,0.980905655602299,0,2,inorganic diphosphate transport,BP,
7380,GO:0030506,1,0.857074578094861,0,17,ankyrin binding,MF,
7382,GO:0030509,1,0.365931469446148,0,139,BMP signaling pathway,BP,
7383,GO:0030510,1,0.562403274772371,0,79,regulation of BMP signaling pathway,BP,
7384,GO:0030511,1,0.840339696514726,0,25,positive regulation of transforming growth factor beta receptor signaling pathway,BP,
7386,GO:0030513,1,0.796017167648607,0,31,positive regulation of BMP signaling pathway,BP,
7387,GO:0030514,1,0.733060383744727,0,43,negative regulation of BMP signaling pathway,BP,
7388,GO:0030515,1,0.850776781553146,0,29,snoRNA binding,MF,
7391,GO:0030518,1,0.414631308359296,0,125,intracellular steroid hormone receptor signaling pathway,BP,
7392,GO:0030520,1,0.694794875380544,0,51,intracellular estrogen receptor signaling pathway,BP,
7393,GO:0030521,1,0.650003415971499,0,61,androgen receptor signaling pathway,BP,
7395,GO:0030523,1,0.992396566095798,0,1,dihydrolipoamide S-acyltransferase activity,MF,
7396,GO:0030526,1,0.99219505124702,0,1,granulocyte macrophage colony-stimulating factor receptor complex,CC,
7397,GO:0030532,1,0.664776316238854,0,68,small nuclear ribonucleoprotein complex,CC,
7399,GO:0030538,1,0.983200418394797,0,3,embryonic genitalia morphogenesis,BP,
7400,GO:0030539,1,0.883479965846872,0,19,male genitalia development,BP,
7401,GO:0030540,1,0.891193119926972,0,16,female genitalia development,BP,
7402,GO:0030544,1,0.794563552934305,0,36,Hsp70 protein binding,MF,
7404,GO:0030546,1,0.923857100078843,0,11,receptor activator activity,MF,
7405,GO:0030547,1,0.893041224998356,0,19,receptor inhibitor activity,MF,
7406,GO:0030548,1,0.963608113537256,0,7,acetylcholine receptor regulator activity,MF,
7407,GO:0030549,1,0.996571520651634,0,1,acetylcholine receptor activator activity,MF,
7408,GO:0030550,1,0.975495264933053,0,4,acetylcholine receptor inhibitor activity,MF,
7411,GO:0030553,1,0.916355652925307,0,12,cGMP binding,MF,
7413,GO:0030572,1,0.992496392024204,0,1,phosphatidyltransferase activity,MF,
7414,GO:0030573,1,0.993994620078383,0,1,bile acid catabolic process,BP,
7415,GO:0030574,1,0.637818435818561,0,60,collagen catabolic process,BP,
7416,GO:0030575,1,0.915128636320735,0,11,nuclear body organization,BP,
7417,GO:0030576,1,0.980089683674198,0,3,Cajal body organization,BP,
7418,GO:0030578,1,0.967674057227887,0,4,PML body organization,BP,
7419,GO:0030579,1,0.967079378908416,0,5,ubiquitin-dependent SMAD protein catabolic process,BP,
7420,GO:0030580,1,0.996318964210472,0,1,quinone cofactor methyltransferase activity,MF,
7421,GO:0030581,1,0.992519221230875,0,2,symbiont intracellular protein transport in host,BP,
7422,GO:0030586,1,0.992612484295299,0,1,[methionine synthase] reductase activity,MF,
7423,GO:0030593,1,0.695852726818399,0,69,neutrophil chemotaxis,BP,
7425,GO:0030595,1,0.37830458042365,0,169,leukocyte chemotaxis,BP,
7426,GO:0030611,1,0.997080589200415,0,1,arsenate reductase activity,MF,
7427,GO:0030613,1,0.99027066519396,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors,MF,
7428,GO:0030614,1,0.99027066519396,0,3,oxidoreductase activity, acting on phosphorus or arsenic in donors, disulfide as acceptor,MF,
7429,GO:0030616,1,0.989857033990238,0,1,transforming growth factor beta receptor, common-partner cytoplasmic mediator activity,MF,
7430,GO:0030617,1,0.98572972040144,0,2,transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity,MF,
7431,GO:0030618,1,0.956798114597452,0,5,transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity,MF,
7432,GO:0030619,1,0.95982888062658,0,7,U1 snRNA binding,MF,
7433,GO:0030620,1,0.971354394827993,0,6,U2 snRNA binding,MF,
7434,GO:0030621,1,0.965121319045863,0,5,U4 snRNA binding,MF,
7435,GO:0030622,1,0.986112325477096,0,2,U4atac snRNA binding,MF,
7436,GO:0030623,1,0.990706902930445,0,1,U5 snRNA binding,MF,
7437,GO:0030624,1,0.992386913179088,0,1,U6atac snRNA binding,MF,
7438,GO:0030626,1,0.987420278929245,0,2,U12 snRNA binding,MF,
7439,GO:0030627,1,0.989439305904338,0,2,pre-mRNA 5'-splice site binding,MF,
7440,GO:0030628,1,0.968700484734695,0,6,pre-mRNA 3'-splice site binding,MF,
7441,GO:0030629,1,0.993058458973322,0,1,U6 snRNA 3'-end binding,MF,
7442,GO:0030638,1,0.96552426900612,0,8,polyketide metabolic process,BP,
7443,GO:0030641,1,0.552321174710276,0,89,regulation of cellular pH,BP,
7444,GO:0030643,1,0.954807818517028,0,6,cellular phosphate ion homeostasis,BP,
7445,GO:0030644,1,0.974713806403481,0,4,cellular chloride ion homeostasis,BP,
7446,GO:0030647,1,0.96552426900612,0,8,aminoglycoside antibiotic metabolic process,BP,
7447,GO:0030653,1,0.99207833818527,0,1,beta-lactam antibiotic metabolic process,BP,
7448,GO:0030656,1,0.938753967174481,0,11,regulation of vitamin metabolic process,BP,
7453,GO:0030663,1,0.898184118740775,0,18,COPI-coated vesicle membrane,CC,
7458,GO:0030670,1,0.661540039821928,0,67,phagocytic vesicle membrane,CC,
7460,GO:0030673,1,0.874208277568708,0,16,axolemma,CC,
7462,GO:0030676,1,0.881339782945504,0,16,Rac guanyl-nucleotide exchange factor activity,MF,
7463,GO:0030677,1,0.935442795778826,0,13,ribonuclease P complex,CC,
7464,GO:0030678,1,0.983472217376503,0,3,mitochondrial ribonuclease P complex,CC,
7465,GO:0030681,1,0.951171368594095,0,10,multimeric ribonuclease P complex,CC,
7466,GO:0030682,1,0.985229037370364,0,2,evasion or tolerance of host defense response,BP,
7467,GO:0030683,1,0.985229037370364,0,2,evasion or tolerance by virus of host immune response,BP,
7468,GO:0030684,1,0.637561185263473,0,72,preribosome,CC,
7469,GO:0030686,1,0.821447241793285,0,30,90S preribosome,CC,
7470,GO:0030687,1,0.863837536482932,0,24,preribosome, large subunit precursor,CC,
7471,GO:0030688,1,0.924594063880028,0,12,preribosome, small subunit precursor,CC,
7472,GO:0030689,1,0.981486855200815,0,3,Noc complex,CC,
7473,GO:0030690,1,0.993019544905697,0,1,Noc1p-Noc2p complex,CC,
7474,GO:0030691,1,0.993019544905697,0,1,Noc2p-Noc3p complex,CC,
7475,GO:0030692,1,0.988387049911574,0,2,Noc4p-Nop14p complex,CC,
7477,GO:0030696,1,0.992683199174057,0,1,tRNA (m5U54) methyltransferase activity,MF,
7478,GO:0030697,1,0.992683199174057,0,1,S-adenosylmethionine-dependent tRNA (m5U54) methyltransferase activity,MF,
7479,GO:0030702,1,0.992469524748395,0,1,chromatin silencing at centromere,BP,
7480,GO:0030705,1,0.314063077320563,0,159,cytoskeleton-dependent intracellular transport,BP,
7481,GO:0030718,1,0.988194126311392,0,2,germ-line stem cell population maintenance,BP,
7482,GO:0030719,1,0.985986823594548,0,2,P granule organization,BP,
7483,GO:0030728,1,0.872329152802819,0,19,ovulation,BP,
7484,GO:0030729,1,0.99259459754851,0,1,acetoacetate-CoA ligase activity,MF,
7485,GO:0030730,1,0.9133210861802,0,15,sequestering of triglyceride,BP,
7486,GO:0030731,1,0.996878045263738,0,1,guanidinoacetate N-methyltransferase activity,MF,
7487,GO:0030742,1,0.867061443988739,0,23,GTP-dependent protein binding,MF,
7488,GO:0030748,1,0.993429006919672,0,1,amine N-methyltransferase activity,MF,
7489,GO:0030760,1,0.995628041058922,0,1,pyridine N-methyltransferase activity,MF,
7490,GO:0030791,1,0.993594888763717,0,1,arsenite methyltransferase activity,MF,
7491,GO:0030792,1,0.993594888763717,0,1,methylarsonite methyltransferase activity,MF,
7493,GO:0030800,1,0.84253870298641,0,26,negative regulation of cyclic nucleotide metabolic process,BP,
7496,GO:0030803,1,0.864275699382671,0,22,negative regulation of cyclic nucleotide biosynthetic process,BP,
7498,GO:0030805,1,0.975484377807458,0,3,regulation of cyclic nucleotide catabolic process,BP,
7499,GO:0030806,1,0.983829460386201,0,2,negative regulation of cyclic nucleotide catabolic process,BP,
7500,GO:0030807,1,0.991519129919948,0,1,positive regulation of cyclic nucleotide catabolic process,BP,
7502,GO:0030809,1,0.789883828526995,0,35,negative regulation of nucleotide biosynthetic process,BP,
7504,GO:0030811,1,0.626386741972117,0,64,regulation of nucleotide catabolic process,BP,
7505,GO:0030812,1,0.91861381444381,0,12,negative regulation of nucleotide catabolic process,BP,
7506,GO:0030813,1,0.876323799797989,0,17,positive regulation of nucleotide catabolic process,BP,
7507,GO:0030814,1,0.690670184971793,0,60,regulation of cAMP metabolic process,BP,
7508,GO:0030815,1,0.845915321651729,0,25,negative regulation of cAMP metabolic process,BP,
7509,GO:0030816,1,0.86986018270795,0,26,positive regulation of cAMP metabolic process,BP,
7510,GO:0030817,1,0.76952807979243,0,42,regulation of cAMP biosynthetic process,BP,
7511,GO:0030818,1,0.867738546988852,0,21,negative regulation of cAMP biosynthetic process,BP,
7512,GO:0030819,1,0.910635718892367,0,17,positive regulation of cAMP biosynthetic process,BP,
7513,GO:0030820,1,0.975484377807458,0,3,regulation of cAMP catabolic process,BP,
7514,GO:0030821,1,0.983829460386201,0,2,negative regulation of cAMP catabolic process,BP,
7515,GO:0030822,1,0.991519129919948,0,1,positive regulation of cAMP catabolic process,BP,
7517,GO:0030824,1,0.996014999274804,0,1,negative regulation of cGMP metabolic process,BP,
7520,GO:0030827,1,0.996014999274804,0,1,negative regulation of cGMP biosynthetic process,BP,
7526,GO:0030836,1,0.933492078470916,0,10,positive regulation of actin filament depolymerization,BP,
7529,GO:0030842,1,0.991798242295597,0,1,regulation of intermediate filament depolymerization,BP,
7530,GO:0030844,1,0.991798242295597,0,1,positive regulation of intermediate filament depolymerization,BP,
7531,GO:0030845,1,0.992965609817527,0,1,phospholipase C-inhibiting G-protein coupled receptor signaling pathway,BP,
7532,GO:0030846,1,0.988593461709096,0,1,termination of RNA polymerase II transcription, poly(A)-coupled,BP,
7533,GO:0030849,1,0.987333653172422,0,2,autosome,CC,
7534,GO:0030850,1,0.71827062393346,0,46,prostate gland development,BP,
7535,GO:0030851,1,0.854717491827678,0,25,granulocyte differentiation,BP,
7536,GO:0030852,1,0.921040639866826,0,13,regulation of granulocyte differentiation,BP,
7537,GO:0030853,1,0.952256347236498,0,7,negative regulation of granulocyte differentiation,BP,
7538,GO:0030854,1,0.959995757940633,0,7,positive regulation of granulocyte differentiation,BP,
7540,GO:0030856,1,0.436211325541402,0,120,regulation of epithelial cell differentiation,BP,
7541,GO:0030857,1,0.800041283367777,0,33,negative regulation of epithelial cell differentiation,BP,
7542,GO:0030858,1,0.715099313562952,0,50,positive regulation of epithelial cell differentiation,BP,
7543,GO:0030859,1,0.878292780004257,0,18,polarized epithelial cell differentiation,BP,
7544,GO:0030860,1,0.985394387280377,0,2,regulation of polarized epithelial cell differentiation,BP,
7545,GO:0030862,1,0.991799783217798,0,1,positive regulation of polarized epithelial cell differentiation,BP,
7547,GO:0030864,1,0.573714760881849,0,72,cortical actin cytoskeleton,CC,
7548,GO:0030865,1,0.703318318357467,0,49,cortical cytoskeleton organization,BP,
7551,GO:0030868,1,0.971654774943952,0,5,smooth endoplasmic reticulum membrane,CC,
7552,GO:0030870,1,0.96402839977873,0,5,Mre11 complex,CC,
7553,GO:0030874,1,0.995301076185118,0,1,nucleolar chromatin,CC,
7554,GO:0030877,1,0.909395779297552,0,12,beta-catenin destruction complex,CC,
7555,GO:0030878,1,0.850982524490277,0,25,thyroid gland development,BP,
7557,GO:0030880,1,0.423576580895987,0,134,RNA polymerase complex,CC,
7558,GO:0030881,1,0.967345599499896,0,6,beta-2-microglobulin binding,MF,
7559,GO:0030882,1,0.985913330396099,0,2,lipid antigen binding,MF,
7560,GO:0030883,1,0.985913330396099,0,2,endogenous lipid antigen binding,MF,
7561,GO:0030884,1,0.985913330396099,0,2,exogenous lipid antigen binding,MF,
7562,GO:0030885,1,0.978202668256828,0,5,regulation of myeloid dendritic cell activation,BP,
7563,GO:0030886,1,0.985542159747061,0,3,negative regulation of myeloid dendritic cell activation,BP,
7564,GO:0030887,1,0.995732465661948,0,1,positive regulation of myeloid dendritic cell activation,BP,
7566,GO:0030889,1,0.898413823172399,0,16,negative regulation of B cell proliferation,BP,
7567,GO:0030890,1,0.803506583253686,0,36,positive regulation of B cell proliferation,BP,
7568,GO:0030891,1,0.976336180239337,0,4,VCB complex,CC,
7569,GO:0030893,1,0.956433958117789,0,6,meiotic cohesin complex,CC,
7570,GO:0030894,1,0.851208824497096,0,26,replisome,CC,
7571,GO:0030895,1,0.988206958309045,0,2,apolipoprotein B mRNA editing enzyme complex,CC,
7572,GO:0030896,1,0.969693073596975,0,5,checkpoint clamp complex,CC,
7573,GO:0030897,1,0.896743858073217,0,14,HOPS complex,CC,
7574,GO:0030898,1,0.904056512597533,0,12,actin-dependent ATPase activity,MF,
7575,GO:0030899,1,0.989973423808128,0,3,calcium-dependent ATPase activity,MF,
7579,GO:0030903,1,0.896846606272677,0,16,notochord development,BP,
7580,GO:0030904,1,0.864672381711741,0,21,retromer complex,CC,
7581,GO:0030905,1,0.972155094395276,0,4,retromer, tubulation complex,CC,
7582,GO:0030906,1,0.975336429097482,0,4,retromer, cargo-selective complex,CC,
7583,GO:0030908,1,0.995632596003417,0,1,protein splicing,BP,
7584,GO:0030910,1,0.970254785222843,0,4,olfactory placode formation,BP,
7585,GO:0030911,1,0.943447503608105,0,8,TPR domain binding,MF,
7587,GO:0030914,1,0.931255737509225,0,11,STAGA complex,CC,
7588,GO:0030915,1,0.969067842853532,0,6,Smc5-Smc6 complex,CC,
7589,GO:0030916,1,0.956779888148597,0,8,otic vesicle formation,BP,
7590,GO:0030917,1,0.957979369653047,0,7,midbrain-hindbrain boundary development,BP,
7591,GO:0030920,1,0.992918166422528,0,2,peptidyl-serine acetylation,BP,
7592,GO:0030934,1,0.970303659659337,0,3,anchoring collagen complex,CC,
7593,GO:0030935,1,0.993305375845177,0,1,sheet-forming collagen trimer,CC,
7594,GO:0030936,1,0.99275736229216,0,1,transmembrane collagen trimer,CC,
7595,GO:0030942,1,0.984261744830683,0,3,endoplasmic reticulum signal peptide binding,MF,
7596,GO:0030943,1,0.981317823578346,0,3,mitochondrion targeting sequence binding,MF,
7597,GO:0030947,1,0.831955941594902,0,28,regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7598,GO:0030948,1,0.939785126654894,0,9,negative regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7599,GO:0030949,1,0.909565891438423,0,15,positive regulation of vascular endothelial growth factor receptor signaling pathway,BP,
7600,GO:0030950,1,0.912526077902445,0,14,establishment or maintenance of actin cytoskeleton polarity,BP,
7601,GO:0030951,1,0.970132971369248,0,4,establishment or maintenance of microtubule cytoskeleton polarity,BP,
7602,GO:0030952,1,0.885247059930943,0,18,establishment or maintenance of cytoskeleton polarity,BP,
7603,GO:0030953,1,0.945682656709753,0,7,astral microtubule organization,BP,
7604,GO:0030955,1,0.898975006007429,0,14,potassium ion binding,MF,
7605,GO:0030956,1,0.983704527496903,0,3,glutamyl-tRNA(Gln) amidotransferase complex,CC,
7606,GO:0030957,1,0.94033443621073,0,10,Tat protein binding,MF,
7607,GO:0030961,1,0.993058458973322,0,1,peptidyl-arginine hydroxylation,BP,
7608,GO:0030964,1,0.86478980049352,0,43,NADH dehydrogenase complex,CC,
7609,GO:0030968,1,0.443980349662253,0,123,endoplasmic reticulum unfolded protein response,BP,
7610,GO:0030969,1,0.97905249016939,0,3,mRNA splicing via endonucleolytic cleavage and ligation involved in unfolded protein response,BP,
7611,GO:0030970,1,0.843404720802432,0,26,retrograde protein transport, ER to cytosol,BP,
7612,GO:0030971,1,0.679097996616744,0,55,receptor tyrosine kinase binding,MF,
7613,GO:0030974,1,0.988773075413266,0,2,thiamine pyrophosphate transmembrane transport,BP,
7614,GO:0030975,1,0.993819878128903,0,1,thiamine binding,MF,
7615,GO:0030976,1,0.96588273563024,0,5,thiamine pyrophosphate binding,MF,
7616,GO:0030977,1,0.99508063903843,0,1,taurine binding,MF,
7617,GO:0030981,1,0.974646963323306,0,3,cortical microtubule cytoskeleton,CC,
7618,GO:0030983,1,0.914650141247368,0,13,mismatched DNA binding,MF,
7619,GO:0030984,1,0.98962251116857,0,2,kininogen binding,MF,
7620,GO:0030990,1,0.810206368770547,0,31,intraciliary transport particle,CC,
7621,GO:0030991,1,0.940380959541839,0,8,intraciliary transport particle A,CC,
7622,GO:0030992,1,0.878897838821874,0,20,intraciliary transport particle B,CC,
7623,GO:0030997,1,0.977159414504512,0,3,regulation of centriole-centriole cohesion,BP,
7624,GO:0031000,1,0.864685006724273,0,18,response to caffeine,BP,
7625,GO:0031001,1,0.993058458973322,0,1,response to brefeldin A,BP,
7626,GO:0031005,1,0.921071674177172,0,11,filamin binding,MF,
7627,GO:0031010,1,0.920631998714886,0,11,ISWI-type complex,CC,
7628,GO:0031011,1,0.921552138964229,0,15,Ino80 complex,CC,
7630,GO:0031013,1,0.978802766977949,0,5,troponin I binding,MF,
7631,GO:0031014,1,0.989116268557245,0,4,troponin T binding,MF,
7632,GO:0031016,1,0.630476421493776,0,67,pancreas development,BP,
7633,GO:0031017,1,0.969603707014366,0,5,exocrine pancreas development,BP,
7634,GO:0031018,1,0.761520992721035,0,40,endocrine pancreas development,BP,
7635,GO:0031021,1,0.983215435512435,0,3,interphase microtubule organizing center,CC,
7636,GO:0031022,1,0.980491839494345,0,2,nuclear migration along microfilament,BP,
7637,GO:0031023,1,0.418779630971996,0,122,microtubule organizing center organization,BP,
7638,GO:0031032,1,0.267508248692487,0,178,actomyosin structure organization,BP,
7639,GO:0031033,1,0.885047523717532,0,15,myosin filament organization,BP,
7640,GO:0031034,1,0.89005350927863,0,14,myosin filament assembly,BP,
7641,GO:0031038,1,0.994382162919748,0,1,myosin II filament organization,BP,
7642,GO:0031045,1,0.912635740122606,0,13,dense core granule,CC,
7644,GO:0031048,1,0.98545269724372,0,2,chromatin silencing by small RNA,BP,
7645,GO:0031049,1,0.992999161121732,0,1,programmed DNA elimination,BP,
7647,GO:0031052,1,0.992999161121732,0,1,chromosome breakage,BP,
7648,GO:0031053,1,0.928308643853679,0,10,primary miRNA processing,BP,
7649,GO:0031054,1,0.911535083034043,0,13,pre-miRNA processing,BP,
7650,GO:0031055,1,0.842744384242574,0,32,chromatin remodeling at centromere,BP,
7651,GO:0031056,1,0.386186688839539,0,132,regulation of histone modification,BP,
7652,GO:0031057,1,0.767795551272452,0,37,negative regulation of histone modification,BP,
7653,GO:0031058,1,0.564399380477032,0,81,positive regulation of histone modification,BP,
7654,GO:0031060,1,0.652607603044015,0,57,regulation of histone methylation,BP,
7655,GO:0031061,1,0.88306330051003,0,17,negative regulation of histone methylation,BP,
7656,GO:0031062,1,0.785513846567564,0,33,positive regulation of histone methylation,BP,
7657,GO:0031063,1,0.839610704509621,0,25,regulation of histone deacetylation,BP,
7658,GO:0031064,1,0.972208375137953,0,4,negative regulation of histone deacetylation,BP,
7659,GO:0031065,1,0.882352400401251,0,17,positive regulation of histone deacetylation,BP,
7660,GO:0031069,1,0.849771970853729,0,24,hair follicle morphogenesis,BP,
7661,GO:0031071,1,0.993779929642573,0,1,cysteine desulfurase activity,MF,
7663,GO:0031074,1,0.981145356589652,0,3,nucleocytoplasmic transport complex,CC,
7664,GO:0031076,1,0.750014295415576,0,37,embryonic camera-type eye development,BP,
7665,GO:0031077,1,0.955639060577659,0,7,post-embryonic camera-type eye development,BP,
7666,GO:0031078,1,0.923073608688978,0,11,histone deacetylase activity (H3-K14 specific),MF,
7667,GO:0031080,1,0.932912394599653,0,10,nuclear pore outer ring,CC,
7668,GO:0031081,1,0.985550476238211,0,2,nuclear pore distribution,BP,
7669,GO:0031082,1,0.89022286822745,0,19,BLOC complex,CC,
7670,GO:0031083,1,0.923453507844408,0,14,BLOC-1 complex,CC,
7671,GO:0031084,1,0.978048415727956,0,3,BLOC-2 complex,CC,
7672,GO:0031085,1,0.985683349038675,0,2,BLOC-3 complex,CC,
7673,GO:0031086,1,0.956069041572499,0,7,nuclear-transcribed mRNA catabolic process, deadenylation-independent decay,BP,
7675,GO:0031088,1,0.960249081345132,0,6,platelet dense granule membrane,CC,
7676,GO:0031089,1,0.943638059033032,0,11,platelet dense granule lumen,CC,
7678,GO:0031091,1,0.580528912792137,0,84,platelet alpha granule,CC,
7679,GO:0031092,1,0.891425903761646,0,16,platelet alpha granule membrane,CC,
7680,GO:0031093,1,0.674169484487976,0,63,platelet alpha granule lumen,CC,
7688,GO:0031104,1,0.99246003987146,0,1,dendrite regeneration,BP,
7689,GO:0031105,1,0.919686549592876,0,12,septin complex,CC,
7690,GO:0031106,1,0.899146587663787,0,15,septin ring organization,BP,
7691,GO:0031109,1,0.503484794812927,0,97,microtubule polymerization or depolymerization,BP,
7692,GO:0031110,1,0.624365060220337,0,66,regulation of microtubule polymerization or depolymerization,BP,
7693,GO:0031111,1,0.796400516651339,0,32,negative regulation of microtubule polymerization or depolymerization,BP,
7694,GO:0031112,1,0.825856276796051,0,27,positive regulation of microtubule polymerization or depolymerization,BP,
7695,GO:0031113,1,0.749342495221102,0,41,regulation of microtubule polymerization,BP,
7696,GO:0031114,1,0.820964183931421,0,26,regulation of microtubule depolymerization,BP,
7697,GO:0031115,1,0.931820358688317,0,11,negative regulation of microtubule polymerization,BP,
7698,GO:0031116,1,0.839716770559704,0,24,positive regulation of microtubule polymerization,BP,
7699,GO:0031117,1,0.98352242683931,0,3,positive regulation of microtubule depolymerization,BP,
7700,GO:0031118,1,0.966470596733513,0,8,rRNA pseudouridine synthesis,BP,
7701,GO:0031119,1,0.96440260765689,0,7,tRNA pseudouridine synthesis,BP,
7702,GO:0031120,1,0.984750924004234,0,4,snRNA pseudouridine synthesis,BP,
7703,GO:0031122,1,0.673260779637537,0,52,cytoplasmic microtubule organization,BP,
7704,GO:0031123,1,0.461885765327264,0,120,RNA 3'-end processing,BP,
7705,GO:0031124,1,0.558592039423639,0,88,mRNA 3'-end processing,BP,
7706,GO:0031125,1,0.950006307491785,0,12,rRNA 3'-end processing,BP,
7707,GO:0031126,1,0.970431285113504,0,7,snoRNA 3'-end processing,BP,
7708,GO:0031127,1,0.992427299206355,0,1,alpha-(1,2)-fucosyltransferase activity,MF,
7709,GO:0031128,1,0.830885432373518,0,28,developmental induction,BP,
7710,GO:0031129,1,0.992012430904543,0,1,inductive cell-cell signaling,BP,
7712,GO:0031134,1,0.980437040160925,0,3,sister chromatid biorientation,BP,
7713,GO:0031143,1,0.907061104849082,0,14,pseudopodium,CC,
7714,GO:0031145,1,0.684716579443941,0,77,anaphase-promoting complex-dependent catabolic process,BP,
7715,GO:0031146,1,0.693216081481483,0,70,SCF-dependent proteasomal ubiquitin-dependent protein catabolic process,BP,
7716,GO:0031151,1,0.990631401356782,0,1,histone methyltransferase activity (H3-K79 specific),MF,
7717,GO:0031161,1,0.992693949915812,0,1,phosphatidylinositol catabolic process,BP,
7718,GO:0031163,1,0.903207143203265,0,20,metallo-sulfur cluster assembly,BP,
7719,GO:0031166,1,0.977975190835555,0,3,integral component of vacuolar membrane,CC,
7720,GO:0031167,1,0.900355044859045,0,18,rRNA methylation,BP,
7722,GO:0031177,1,0.985295407033256,0,3,phosphopantetheine binding,MF,
7723,GO:0031179,1,0.992504348414736,0,1,peptide modification,BP,
7724,GO:0031201,1,0.742698612341704,0,49,SNARE complex,CC,
7725,GO:0031204,1,0.981435190185409,0,3,posttranslational protein targeting to membrane, translocation,BP,
7726,GO:0031205,1,0.981117095048433,0,3,endoplasmic reticulum Sec complex,CC,
7727,GO:0031208,1,0.984500810648581,0,2,POZ domain binding,MF,
7728,GO:0031209,1,0.939494501871881,0,8,SCAR complex,CC,
7729,GO:0031210,1,0.899591333145456,0,17,phosphatidylcholine binding,MF,
7730,GO:0031211,1,0.950282883413309,0,8,endoplasmic reticulum palmitoyltransferase complex,CC,
7731,GO:0031213,1,0.984590362031313,0,2,RSF complex,CC,
7733,GO:0031223,1,0.9117957970373,0,11,auditory behavior,BP,
7738,GO:0031228,1,0.741644428667811,0,45,intrinsic component of Golgi membrane,CC,
7739,GO:0031229,1,0.911147852004119,0,14,intrinsic component of nuclear inner membrane,CC,
7740,GO:0031231,1,0.908145516021793,0,17,intrinsic component of peroxisomal membrane,CC,
7741,GO:0031232,1,0.954626295342831,0,7,extrinsic component of external side of plasma membrane,CC,
7742,GO:0031233,1,0.901806078708808,0,18,intrinsic component of external side of plasma membrane,CC,
7744,GO:0031235,1,0.888605077479716,0,14,intrinsic component of the cytoplasmic side of the plasma membrane,CC,
7745,GO:0031247,1,0.98771426098977,0,2,actin rod assembly,BP,
7746,GO:0031248,1,0.563547337919934,0,85,protein acetyltransferase complex,CC,
7747,GO:0031249,1,0.993689104376492,0,1,denatured protein binding,MF,
7748,GO:0031251,1,0.983748774872602,0,2,PAN complex,CC,
7751,GO:0031254,1,0.917405941024206,0,13,cell trailing edge,CC,
7753,GO:0031257,1,0.993058458973322,0,1,cell trailing edge membrane,CC,
7754,GO:0031258,1,0.847425542459147,0,22,lamellipodium membrane,CC,
7755,GO:0031259,1,0.993058458973322,0,1,uropod membrane,CC,
7756,GO:0031261,1,0.969850259610329,0,5,DNA replication preinitiation complex,CC,
7757,GO:0031262,1,0.982882702993611,0,4,Ndc80 complex,CC,
7758,GO:0031264,1,0.94431793755648,0,9,death-inducing signaling complex,CC,
7759,GO:0031265,1,0.961823279146158,0,6,CD95 death-inducing signaling complex,CC,
7761,GO:0031268,1,0.920271286608829,0,13,pseudopodium organization,BP,
7762,GO:0031269,1,0.920271286608829,0,13,pseudopodium assembly,BP,
7763,GO:0031271,1,0.993058458973322,0,1,lateral pseudopodium assembly,BP,
7764,GO:0031272,1,0.920271286608829,0,13,regulation of pseudopodium assembly,BP,
7765,GO:0031274,1,0.926708955650589,0,12,positive regulation of pseudopodium assembly,BP,
7766,GO:0031275,1,0.993058458973322,0,1,regulation of lateral pseudopodium assembly,BP,
7768,GO:0031280,1,0.870360784617505,0,21,negative regulation of cyclase activity,BP,
7771,GO:0031283,1,0.996014999274804,0,1,negative regulation of guanylate cyclase activity,BP,
7773,GO:0031289,1,0.99276808309798,0,1,actin phosphorylation,BP,
7774,GO:0031290,1,0.862770648924768,0,19,retinal ganglion cell axon guidance,BP,
7775,GO:0031291,1,0.982552191358896,0,3,Ran protein signal transduction,BP,
7776,GO:0031293,1,0.845284929397943,0,24,membrane protein intracellular domain proteolysis,BP,
7779,GO:0031296,1,0.990073006979996,0,3,B cell costimulation,BP,
7780,GO:0031297,1,0.825360347052332,0,27,replication fork processing,BP,
7781,GO:0031298,1,0.945412587075217,0,9,replication fork protection complex,CC,
7784,GO:0031302,1,0.992049643591319,0,1,intrinsic component of endosome membrane,CC,
7785,GO:0031304,1,0.817269551963812,0,35,intrinsic component of mitochondrial inner membrane,CC,
7786,GO:0031305,1,0.817269551963812,0,35,integral component of mitochondrial inner membrane,CC,
7787,GO:0031306,1,0.865246289833101,0,23,intrinsic component of mitochondrial outer membrane,CC,
7788,GO:0031307,1,0.871968222088524,0,22,integral component of mitochondrial outer membrane,CC,
7789,GO:0031308,1,0.993058458973322,0,1,intrinsic component of nuclear outer membrane,CC,
7790,GO:0031309,1,0.993058458973322,0,1,integral component of nuclear outer membrane,CC,
7791,GO:0031310,1,0.977975190835555,0,3,intrinsic component of vacuolar membrane,CC,
7793,GO:0031313,1,0.946682272862077,0,8,extrinsic component of endosome membrane,CC,
7794,GO:0031314,1,0.964041671919515,0,5,extrinsic component of mitochondrial inner membrane,CC,
7796,GO:0031320,1,0.993481113080797,0,1,hexitol dehydrogenase activity,MF,
7806,GO:0031332,1,0.917621597030145,0,11,RNAi effector complex,CC,
7809,GO:0031335,1,0.987586394891776,0,2,regulation of sulfur amino acid metabolic process,BP,
7810,GO:0031337,1,0.994015545358986,0,1,positive regulation of sulfur amino acid metabolic process,BP,
7811,GO:0031338,1,0.669602726772214,0,57,regulation of vesicle fusion,BP,
7812,GO:0031339,1,0.958062918114542,0,6,negative regulation of vesicle fusion,BP,
7813,GO:0031340,1,0.95781007926175,0,7,positive regulation of vesicle fusion,BP,
7815,GO:0031342,1,0.910889717911141,0,16,negative regulation of cell killing,BP,
7823,GO:0031362,1,0.921168769438742,0,14,anchored component of external side of plasma membrane,CC,
7824,GO:0031365,1,0.829259479916864,0,28,N-terminal protein amino acid modification,BP,
7825,GO:0031369,1,0.835260316204171,0,29,translation initiation factor binding,MF,
7826,GO:0031370,1,0.992243323813171,0,1,eukaryotic initiation factor 4G binding,MF,
7827,GO:0031371,1,0.952978274011513,0,8,ubiquitin conjugating enzyme complex,CC,
7828,GO:0031372,1,0.989224147642848,0,2,UBC13-MMS2 complex,CC,
7829,GO:0031379,1,0.985140889789979,0,2,RNA-directed RNA polymerase complex,CC,
7830,GO:0031380,1,0.992612484295299,0,1,nuclear RNA-directed RNA polymerase complex,CC,
7831,GO:0031386,1,0.93016788001128,0,16,protein tag,MF,
7832,GO:0031389,1,0.992914587604173,0,1,Rad17 RFC-like complex,CC,
7833,GO:0031390,1,0.953503208175477,0,8,Ctf18 RFC-like complex,CC,
7834,GO:0031392,1,0.966455927631216,0,5,regulation of prostaglandin biosynthetic process,BP,
7835,GO:0031393,1,0.985255186483262,0,2,negative regulation of prostaglandin biosynthetic process,BP,
7836,GO:0031394,1,0.980922207524749,0,3,positive regulation of prostaglandin biosynthetic process,BP,
7839,GO:0031398,1,0.532018274778944,0,97,positive regulation of protein ubiquitination,BP,
7844,GO:0031403,1,0.983314055852498,0,2,lithium ion binding,MF,
7845,GO:0031404,1,0.949282938684954,0,8,chloride ion binding,MF,
7846,GO:0031405,1,0.98871077880571,0,1,lipoic acid binding,MF,
7848,GO:0031407,1,0.993807217231287,0,1,oxylipin metabolic process,BP,
7850,GO:0031414,1,0.935895904530658,0,10,N-terminal protein acetyltransferase complex,CC,
7851,GO:0031415,1,0.972551713916608,0,5,NatA complex,CC,
7852,GO:0031416,1,0.988402159289799,0,2,NatB complex,CC,
7853,GO:0031417,1,0.973614776369818,0,3,NatC complex,CC,
7854,GO:0031418,1,0.875675338088511,0,20,L-ascorbic acid binding,MF,
7855,GO:0031419,1,0.937650289114998,0,9,cobalamin binding,MF,
7858,GO:0031427,1,0.973088957940853,0,4,response to methotrexate,BP,
7859,GO:0031428,1,0.981594607020368,0,4,box C/D snoRNP complex,CC,
7860,GO:0031429,1,0.981399633808129,0,5,box H/ACA snoRNP complex,CC,
7861,GO:0031430,1,0.801712232190953,0,29,M band,CC,
7862,GO:0031431,1,0.985558015112648,0,2,Dbf4-dependent protein kinase complex,CC,
7863,GO:0031432,1,0.908698456399653,0,14,titin binding,MF,
7864,GO:0031433,1,0.950847886814982,0,5,telethonin binding,MF,
7866,GO:0031435,1,0.896730346519966,0,15,mitogen-activated protein kinase kinase kinase binding,MF,
7867,GO:0031436,1,0.984240680091728,0,2,BRCA1-BARD1 complex,CC,
7868,GO:0031437,1,0.978961751042512,0,3,regulation of mRNA cleavage,BP,
7869,GO:0031438,1,0.99274616084698,0,1,negative regulation of mRNA cleavage,BP,
7870,GO:0031439,1,0.986115873001762,0,2,positive regulation of mRNA cleavage,BP,
7871,GO:0031440,1,0.858430874245551,0,22,regulation of mRNA 3'-end processing,BP,
7872,GO:0031441,1,0.937482058236049,0,9,negative regulation of mRNA 3'-end processing,BP,
7873,GO:0031442,1,0.940744841040951,0,9,positive regulation of mRNA 3'-end processing,BP,
7874,GO:0031443,1,0.983579310384164,0,2,fast-twitch skeletal muscle fiber contraction,BP,
7875,GO:0031444,1,0.984989146991862,0,3,slow-twitch skeletal muscle fiber contraction,BP,
7876,GO:0031445,1,0.984836594135712,0,2,regulation of heterochromatin assembly,BP,
7877,GO:0031446,1,0.992535476345904,0,1,regulation of fast-twitch skeletal muscle fiber contraction,BP,
7878,GO:0031448,1,0.992535476345904,0,1,positive regulation of fast-twitch skeletal muscle fiber contraction,BP,
7879,GO:0031449,1,0.991481210421921,0,1,regulation of slow-twitch skeletal muscle fiber contraction,BP,
7880,GO:0031453,1,0.984836594135712,0,2,positive regulation of heterochromatin assembly,BP,
7881,GO:0031455,1,0.985099900237671,0,2,glycine betaine metabolic process,BP,
7882,GO:0031456,1,0.985099900237671,0,2,glycine betaine biosynthetic process,BP,
7883,GO:0031460,1,0.992174776728773,0,1,glycine betaine transport,BP,
7884,GO:0031461,1,0.294145864543262,0,180,cullin-RING ubiquitin ligase complex,CC,
7885,GO:0031462,1,0.913996775638222,0,14,Cul2-RING ubiquitin ligase complex,CC,
7886,GO:0031463,1,0.625423395108512,0,66,Cul3-RING ubiquitin ligase complex,CC,
7887,GO:0031464,1,0.926806977079033,0,12,Cul4A-RING E3 ubiquitin ligase complex,CC,
7888,GO:0031465,1,0.969957806330517,0,5,Cul4B-RING E3 ubiquitin ligase complex,CC,
7889,GO:0031466,1,0.966857521465979,0,6,Cul5-RING ubiquitin ligase complex,CC,
7890,GO:0031467,1,0.97167745923009,0,5,Cul7-RING ubiquitin ligase complex,CC,
7891,GO:0031468,1,0.8992679895805,0,18,nuclear envelope reassembly,BP,
7892,GO:0031475,1,0.995755073919098,0,1,myosin V complex,CC,
7893,GO:0031477,1,0.990676311599433,0,1,myosin VII complex,CC,
7894,GO:0031489,1,0.906272512000362,0,16,myosin V binding,MF,
7896,GO:0031491,1,0.703063076080655,0,55,nucleosome binding,MF,
7897,GO:0031492,1,0.828221890729183,0,32,nucleosomal DNA binding,MF,
7898,GO:0031493,1,0.98841031298774,0,2,nucleosomal histone binding,MF,
7899,GO:0031497,1,0.53532790774307,0,108,chromatin assembly,BP,
7900,GO:0031498,1,0.87603720819003,0,19,chromatin disassembly,BP,
7901,GO:0031501,1,0.984419341518751,0,4,mannosyltransferase complex,CC,
7903,GO:0031506,1,0.99517012130739,0,1,cell wall glycoprotein biosynthetic process,BP,
7904,GO:0031507,1,0.941023947047902,0,9,heterochromatin assembly,BP,
7905,GO:0031508,1,0.989282717612277,0,2,pericentric heterochromatin assembly,BP,
7906,GO:0031509,1,0.995486157582346,0,1,telomeric heterochromatin assembly,BP,
7907,GO:0031510,1,0.982835641099692,0,3,SUMO activating enzyme complex,CC,
7908,GO:0031514,1,0.452964102055505,0,120,motile cilium,CC,
7909,GO:0031515,1,0.981669124491346,0,3,tRNA (m1A) methyltransferase complex,CC,
7910,GO:0031519,1,0.721538643309605,0,46,PcG protein complex,CC,
7911,GO:0031523,1,0.983211258547113,0,2,Myb complex,CC,
7912,GO:0031526,1,0.74390065991412,0,41,brush border membrane,CC,
7913,GO:0031527,1,0.874607651746769,0,17,filopodium membrane,CC,
7914,GO:0031528,1,0.86500909449986,0,21,microvillus membrane,CC,
7915,GO:0031529,1,0.754285110461512,0,44,ruffle organization,BP,
7916,GO:0031530,1,0.993452805242173,0,2,gonadotropin-releasing hormone receptor binding,MF,
7917,GO:0031531,1,0.99618747477248,0,1,thyrotropin-releasing hormone receptor binding,MF,
7919,GO:0031533,1,0.991390703303505,0,1,mRNA cap methyltransferase complex,CC,
7920,GO:0031536,1,0.980991646717234,0,4,positive regulation of exit from mitosis,BP,
7921,GO:0031543,1,0.922847131774144,0,12,peptidyl-proline dioxygenase activity,MF,
7922,GO:0031544,1,0.972251106495987,0,4,peptidyl-proline 3-dioxygenase activity,MF,
7923,GO:0031545,1,0.949199921417907,0,8,peptidyl-proline 4-dioxygenase activity,MF,
7924,GO:0031547,1,0.959157491354143,0,5,brain-derived neurotrophic factor receptor signaling pathway,BP,
7925,GO:0031548,1,0.984429152943644,0,2,regulation of brain-derived neurotrophic factor receptor signaling pathway,BP,
7926,GO:0031549,1,0.991896925545636,0,1,negative regulation of brain-derived neurotrophic factor receptor signaling pathway,BP,
7927,GO:0031550,1,0.992471830718823,0,1,positive regulation of brain-derived neurotrophic factor receptor signaling pathway,BP,
7928,GO:0031554,1,0.988593461709096,0,1,regulation of DNA-templated transcription, termination,BP,
7929,GO:0031559,1,0.992423310468726,0,1,oxidosqualene cyclase activity,MF,
7930,GO:0031570,1,0.342977598049209,0,157,DNA integrity checkpoint,BP,
7931,GO:0031571,1,0.636196412221811,0,69,mitotic G1 DNA damage checkpoint,BP,
7932,GO:0031572,1,0.789836638116133,0,32,G2 DNA damage checkpoint,BP,
7933,GO:0031573,1,0.918495002831797,0,14,intra-S DNA damage checkpoint,BP,
7934,GO:0031577,1,0.795035967978437,0,34,spindle checkpoint,BP,
7936,GO:0031580,1,0.949297261623811,0,9,membrane raft distribution,BP,
7937,GO:0031581,1,0.915505351467152,0,11,hemidesmosome assembly,BP,
7938,GO:0031583,1,0.994406571639271,0,1,phospholipase D-activating G-protein coupled receptor signaling pathway,BP,
7939,GO:0031584,1,0.969968995977947,0,5,activation of phospholipase D activity,BP,
7940,GO:0031585,1,0.960408003706099,0,4,regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,
7941,GO:0031587,1,0.972112492552807,0,3,positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity,BP,
7942,GO:0031588,1,0.935878869539228,0,9,nucleotide-activated protein kinase complex,CC,
7944,GO:0031590,1,0.986006125362422,0,2,wybutosine metabolic process,BP,
7945,GO:0031591,1,0.986006125362422,0,2,wybutosine biosynthetic process,BP,
7946,GO:0031592,1,0.990340827257099,0,1,centrosomal corona,CC,
7947,GO:0031593,1,0.781329568217313,0,35,polyubiquitin modification-dependent protein binding,MF,
7949,GO:0031595,1,0.963040692498245,0,8,nuclear proteasome complex,CC,
7950,GO:0031597,1,0.937241871605462,0,12,cytosolic proteasome complex,CC,
7951,GO:0031616,1,0.945771697320717,0,10,spindle pole centrosome,CC,
7952,GO:0031618,1,0.931835192964899,0,9,nuclear pericentric heterochromatin,CC,
7953,GO:0031620,1,0.955812849253359,0,7,regulation of fever generation,BP,
7954,GO:0031622,1,0.963119663798557,0,6,positive regulation of fever generation,BP,
7956,GO:0031624,1,0.776310178387826,0,33,ubiquitin conjugating enzyme binding,MF,
7958,GO:0031626,1,0.992008435392823,0,1,beta-endorphin binding,MF,
7959,GO:0031627,1,0.978457879104305,0,3,telomeric loop formation,BP,
7960,GO:0031628,1,0.952534812531103,0,8,opioid receptor binding,MF,
7961,GO:0031629,1,0.906749728885585,0,16,synaptic vesicle fusion to presynaptic active zone membrane,BP,
7962,GO:0031630,1,0.980933127922783,0,3,regulation of synaptic vesicle fusion to presynaptic active zone membrane,BP,
7963,GO:0031635,1,0.987136713886733,0,2,adenylate cyclase-inhibiting opioid receptor signaling pathway,BP,
7964,GO:0031638,1,0.780446826628586,0,40,zymogen activation,BP,
7965,GO:0031639,1,0.892385862474191,0,19,plasminogen activation,BP,
7968,GO:0031642,1,0.955198793824384,0,6,negative regulation of myelination,BP,
7971,GO:0031645,1,0.921155887900103,0,12,negative regulation of neurological system process,BP,
7973,GO:0031647,1,0.213656192553158,0,234,regulation of protein stability,BP,
7974,GO:0031648,1,0.749471818986151,0,41,protein destabilization,BP,
7975,GO:0031649,1,0.88945198749489,0,18,heat generation,BP,
7976,GO:0031650,1,0.924723150754557,0,12,regulation of heat generation,BP,
7977,GO:0031651,1,0.99244581380195,0,1,negative regulation of heat generation,BP,
7978,GO:0031652,1,0.938891660161622,0,10,positive regulation of heat generation,BP,
7980,GO:0031658,1,0.957493274487722,0,7,negative regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle,BP,
7985,GO:0031666,1,0.953324967840913,0,8,positive regulation of lipopolysaccharide-mediated signaling pathway,BP,
7987,GO:0031668,1,0.226610694251012,0,223,cellular response to extracellular stimulus,BP,
7988,GO:0031669,1,0.269583974439011,0,195,cellular response to nutrient levels,BP,
7989,GO:0031670,1,0.683290747566182,0,58,cellular response to nutrient,BP,
7990,GO:0031672,1,0.745664409419406,0,39,A band,CC,
7991,GO:0031673,1,0.985304173771485,0,1,H zone,CC,
7992,GO:0031674,1,0.372262575999451,0,130,I band,CC,
7993,GO:0031681,1,0.944042848039812,0,9,G-protein beta-subunit binding,MF,
7994,GO:0031682,1,0.992775261717837,0,1,G-protein gamma-subunit binding,MF,
7995,GO:0031683,1,0.88981287322957,0,18,G-protein beta/gamma-subunit complex binding,MF,
7996,GO:0031685,1,0.980854369225883,0,3,adenosine receptor binding,MF,
7997,GO:0031686,1,0.992724803059811,0,1,A1 adenosine receptor binding,MF,
7998,GO:0031687,1,0.995545818829149,0,1,A2A adenosine receptor binding,MF,
7999,GO:0031690,1,0.887244022525116,0,18,adrenergic receptor binding,MF,
8000,GO:0031691,1,0.989055450120032,0,2,alpha-1A adrenergic receptor binding,MF,
8001,GO:0031692,1,0.981626405075849,0,3,alpha-1B adrenergic receptor binding,MF,
8002,GO:0031694,1,0.978125009023542,0,4,alpha-2A adrenergic receptor binding,MF,
8003,GO:0031695,1,0.993615672757953,0,1,alpha-2B adrenergic receptor binding,MF,
8004,GO:0031696,1,0.986152717074825,0,2,alpha-2C adrenergic receptor binding,MF,
8005,GO:0031697,1,0.968476508169578,0,4,beta-1 adrenergic receptor binding,MF,
8006,GO:0031698,1,0.97132528918358,0,4,beta-2 adrenergic receptor binding,MF,
8007,GO:0031699,1,0.9857767344849,0,2,beta-3 adrenergic receptor binding,MF,
8008,GO:0031700,1,0.995916902694163,0,1,adrenomedullin receptor binding,MF,
8009,GO:0031701,1,0.927382673509637,0,11,angiotensin receptor binding,MF,
8010,GO:0031702,1,0.932829180901154,0,10,type 1 angiotensin receptor binding,MF,
8011,GO:0031703,1,0.993388970162643,0,1,type 2 angiotensin receptor binding,MF,
8012,GO:0031704,1,0.992649030422308,0,1,apelin receptor binding,MF,
8013,GO:0031705,1,0.984220475708275,0,3,bombesin receptor binding,MF,
8014,GO:0031707,1,0.994406571639271,0,1,endothelin A receptor binding,MF,
8015,GO:0031708,1,0.984220475708275,0,3,endothelin B receptor binding,MF,
8016,GO:0031711,1,0.986520887713065,0,2,bradykinin receptor binding,MF,
8017,GO:0031714,1,0.992046296181567,0,1,C5a anaphylatoxin chemotactic receptor binding,MF,
8018,GO:0031715,1,0.992046296181567,0,1,C5L2 anaphylatoxin chemotactic receptor binding,MF,
8019,GO:0031717,1,0.995474657112284,0,1,cannabinoid receptor binding,MF,
8020,GO:0031718,1,0.995474657112284,0,1,type 1 cannabinoid receptor binding,MF,
8021,GO:0031720,1,0.993185347468225,0,3,haptoglobin binding,MF,
8022,GO:0031724,1,0.996460308534979,0,1,CXCR5 chemokine receptor binding,MF,
8023,GO:0031726,1,0.99730631451224,0,1,CCR1 chemokine receptor binding,MF,
8024,GO:0031727,1,0.988311965947976,0,3,CCR2 chemokine receptor binding,MF,
8025,GO:0031728,1,0.995849229049182,0,2,CCR3 chemokine receptor binding,MF,
8026,GO:0031730,1,0.974661409445541,0,4,CCR5 chemokine receptor binding,MF,
8027,GO:0031731,1,0.997228178169082,0,1,CCR6 chemokine receptor binding,MF,
8028,GO:0031732,1,0.994717708256146,0,2,CCR7 chemokine receptor binding,MF,
8029,GO:0031735,1,0.991165289669968,0,3,CCR10 chemokine receptor binding,MF,
8030,GO:0031737,1,0.992623704739742,0,1,CX3C chemokine receptor binding,MF,
8031,GO:0031739,1,0.99435665179252,0,1,cholecystokinin receptor binding,MF,
8032,GO:0031741,1,0.99435665179252,0,1,type B gastrin/cholecystokinin receptor binding,MF,
8033,GO:0031748,1,0.955003837349066,0,7,D1 dopamine receptor binding,MF,
8034,GO:0031749,1,0.980682001394254,0,3,D2 dopamine receptor binding,MF,
8035,GO:0031750,1,0.988464496724827,0,2,D3 dopamine receptor binding,MF,
8036,GO:0031751,1,0.995411246084362,0,1,D4 dopamine receptor binding,MF,
8037,GO:0031752,1,0.979268281612942,0,3,D5 dopamine receptor binding,MF,
8038,GO:0031753,1,0.993048040728252,0,1,endothelial differentiation G-protein coupled receptor binding,MF,
8039,GO:0031755,1,0.993048040728252,0,1,Edg-2 lysophosphatidic acid receptor binding,MF,
8040,GO:0031762,1,0.989055450120032,0,2,follicle-stimulating hormone receptor binding,MF,
8041,GO:0031763,1,0.997356194534619,0,1,galanin receptor binding,MF,
8042,GO:0031764,1,0.997356194534619,0,1,type 1 galanin receptor binding,MF,
8043,GO:0031765,1,0.997356194534619,0,1,type 2 galanin receptor binding,MF,
8044,GO:0031766,1,0.997356194534619,0,1,type 3 galanin receptor binding,MF,
8045,GO:0031768,1,0.997490814002907,0,1,ghrelin receptor binding,MF,
8046,GO:0031770,1,0.998029560571487,0,1,growth hormone-releasing hormone receptor binding,MF,
8047,GO:0031773,1,0.997494945641853,0,1,kisspeptin receptor binding,MF,
8048,GO:0031775,1,0.990165646669906,0,1,lutropin-choriogonadotropic hormone receptor binding,MF,
8049,GO:0031779,1,0.985585750810683,0,4,melanocortin receptor binding,MF,
8050,GO:0031780,1,0.991453767099969,0,2,corticotropin hormone receptor binding,MF,
8051,GO:0031781,1,0.985585750810683,0,4,type 3 melanocortin receptor binding,MF,
8052,GO:0031782,1,0.985585750810683,0,4,type 4 melanocortin receptor binding,MF,
8053,GO:0031783,1,0.991453767099969,0,2,type 5 melanocortin receptor binding,MF,
8054,GO:0031798,1,0.990515360610157,0,1,type 1 metabotropic glutamate receptor binding,MF,
8055,GO:0031802,1,0.967489740027148,0,5,type 5 metabotropic glutamate receptor binding,MF,
8056,GO:0031811,1,0.992486339385229,0,1,G-protein coupled nucleotide receptor binding,MF,
8057,GO:0031812,1,0.992486339385229,0,1,P2Y1 nucleotide receptor binding,MF,
8058,GO:0031821,1,0.955300720636768,0,7,G-protein coupled serotonin receptor binding,MF,
8059,GO:0031826,1,0.984770310580935,0,3,type 2A serotonin receptor binding,MF,
8060,GO:0031834,1,0.996597339112052,0,1,neurokinin receptor binding,MF,
8061,GO:0031835,1,0.996597339112052,0,1,substance P receptor binding,MF,
8062,GO:0031838,1,0.98935587999196,0,4,haptoglobin-hemoglobin complex,CC,
8063,GO:0031839,1,0.997281337658679,0,1,type 1 neuromedin U receptor binding,MF,
8064,GO:0031840,1,0.997281337658679,0,1,type 2 neuromedin U receptor binding,MF,
8065,GO:0031841,1,0.997807301551196,0,1,neuropeptide Y receptor binding,MF,
8066,GO:0031848,1,0.932211664170638,0,10,protection from non-homologous end joining at telomere,BP,
8067,GO:0031849,1,0.976778766155322,0,4,olfactory receptor binding,MF,
8068,GO:0031852,1,0.971114675566641,0,4,mu-type opioid receptor binding,MF,
8069,GO:0031858,1,0.992678142299321,0,1,pituitary adenylate cyclase-activating polypeptide receptor binding,MF,
8070,GO:0031859,1,0.994860411137915,0,1,platelet activating factor receptor binding,MF,
8071,GO:0031860,1,0.976607323533897,0,3,telomeric 3' overhang formation,BP,
8072,GO:0031862,1,0.984028488135673,0,2,prostanoid receptor binding,MF,
8073,GO:0031867,1,0.992492586825175,0,1,EP4 subtype prostaglandin E2 receptor binding,MF,
8074,GO:0031870,1,0.99147251631323,0,1,thromboxane A2 receptor binding,MF,
8075,GO:0031871,1,0.979496420653873,0,3,proteinase activated receptor binding,MF,
8076,GO:0031877,1,0.991113352308787,0,1,somatostatin receptor binding,MF,
8077,GO:0031883,1,0.994398429380171,0,1,taste receptor binding,MF,
8078,GO:0031893,1,0.986657535326872,0,2,vasopressin receptor binding,MF,
8079,GO:0031894,1,0.992448563085848,0,1,V1A vasopressin receptor binding,MF,
8080,GO:0031896,1,0.994165349893219,0,1,V2 vasopressin receptor binding,MF,
8083,GO:0031903,1,0.690924356897003,0,57,microbody membrane,CC,
8084,GO:0031904,1,0.847498895628915,0,26,endosome lumen,CC,
8085,GO:0031905,1,0.983487700497962,0,3,early endosome lumen,CC,
8086,GO:0031906,1,0.977117915768077,0,6,late endosome lumen,CC,
8087,GO:0031907,1,0.790834983499225,0,41,microbody lumen,CC,
8088,GO:0031914,1,0.972044094192885,0,4,negative regulation of synaptic plasticity,BP,
8089,GO:0031915,1,0.93731458827173,0,9,positive regulation of synaptic plasticity,BP,
8090,GO:0031929,1,0.493332163230366,0,99,TOR signaling,BP,
8091,GO:0031930,1,0.995885564757089,0,1,mitochondria-nucleus signaling pathway,BP,
8092,GO:0031931,1,0.948978439367451,0,7,TORC1 complex,CC,
8093,GO:0031932,1,0.914499272021113,0,13,TORC2 complex,CC,
8094,GO:0031933,1,0.978316965283171,0,3,telomeric heterochromatin,CC,
8095,GO:0031935,1,0.865938800560337,0,19,regulation of chromatin silencing,BP,
8096,GO:0031936,1,0.937825386154303,0,8,negative regulation of chromatin silencing,BP,
8097,GO:0031937,1,0.942311067307991,0,8,positive regulation of chromatin silencing,BP,
8098,GO:0031938,1,0.990327027393498,0,2,regulation of chromatin silencing at telomere,BP,
8099,GO:0031940,1,0.995486157582346,0,1,positive regulation of chromatin silencing at telomere,BP,
8100,GO:0031941,1,0.786380923988049,0,36,filamentous actin,CC,
8101,GO:0031943,1,0.94416307296426,0,9,regulation of glucocorticoid metabolic process,BP,
8102,GO:0031944,1,0.965537818240073,0,5,negative regulation of glucocorticoid metabolic process,BP,
8103,GO:0031945,1,0.992485744980242,0,1,positive regulation of glucocorticoid metabolic process,BP,
8104,GO:0031946,1,0.950885204559731,0,7,regulation of glucocorticoid biosynthetic process,BP,
8105,GO:0031947,1,0.965537818240073,0,5,negative regulation of glucocorticoid biosynthetic process,BP,
8106,GO:0031948,1,0.992485744980242,0,1,positive regulation of glucocorticoid biosynthetic process,BP,
8108,GO:0031953,1,0.9289242620583,0,10,negative regulation of protein autophosphorylation,BP,
8110,GO:0031956,1,0.950240659286933,0,7,medium-chain fatty acid-CoA ligase activity,MF,
8111,GO:0031957,1,0.94052760900184,0,9,very long-chain fatty acid-CoA ligase activity,MF,
8112,GO:0031958,1,0.881416438713252,0,17,corticosteroid receptor signaling pathway,BP,
8113,GO:0031959,1,0.985063629227393,0,2,mineralocorticoid receptor signaling pathway,BP,
8115,GO:0031962,1,0.991577996294273,0,1,mineralocorticoid receptor binding,MF,
8120,GO:0031970,1,0.657369872387366,0,76,organelle envelope lumen,CC,
8127,GO:0031985,1,0.510276085590919,0,98,Golgi cisterna,CC,
8128,GO:0031987,1,0.938274463282779,0,8,locomotion involved in locomotory behavior,BP,
8129,GO:0031990,1,0.983266095108348,0,2,mRNA export from nucleus in response to heat stress,BP,
8130,GO:0031994,1,0.908307083079543,0,13,insulin-like growth factor I binding,MF,
8131,GO:0031995,1,0.947729390892061,0,8,insulin-like growth factor II binding,MF,
8132,GO:0031996,1,0.92905546589515,0,11,thioesterase binding,MF,
8133,GO:0031997,1,0.982799002996145,0,3,N-terminal myristoylation domain binding,MF,
8134,GO:0031998,1,0.883271164737326,0,16,regulation of fatty acid beta-oxidation,BP,
8135,GO:0031999,1,0.968180138123642,0,4,negative regulation of fatty acid beta-oxidation,BP,
8136,GO:0032000,1,0.935253412359419,0,9,positive regulation of fatty acid beta-oxidation,BP,
8137,GO:0032002,1,0.987878809365452,0,2,interleukin-28 receptor complex,CC,
8138,GO:0032006,1,0.555505076507007,0,82,regulation of TOR signaling,BP,
8139,GO:0032007,1,0.761965834584183,0,38,negative regulation of TOR signaling,BP,
8140,GO:0032008,1,0.795277460701734,0,33,positive regulation of TOR signaling,BP,
8141,GO:0032009,1,0.943622901629102,0,8,early phagosome,CC,
8142,GO:0032010,1,0.972090151084934,0,5,phagolysosome,CC,
8143,GO:0032011,1,0.708509720363463,0,44,ARF protein signal transduction,BP,
8144,GO:0032012,1,0.708509720363463,0,44,regulation of ARF protein signal transduction,BP,
8145,GO:0032020,1,0.970558391171854,0,6,ISG15-protein conjugation,BP,
8146,GO:0032021,1,0.972518779653678,0,4,NELF complex,CC,
8147,GO:0032023,1,0.993994620078383,0,1,trypsinogen activation,BP,
8149,GO:0032025,1,0.944187492483948,0,9,response to cobalt ion,BP,
8150,GO:0032026,1,0.881437566250458,0,16,response to magnesium ion,BP,
8151,GO:0032027,1,0.976598345545407,0,4,myosin light chain binding,MF,
8152,GO:0032028,1,0.994384485201502,0,1,myosin head/neck binding,MF,
8153,GO:0032029,1,0.988192214489326,0,1,myosin tail binding,MF,
8154,GO:0032036,1,0.950082455246449,0,9,myosin heavy chain binding,MF,
8155,GO:0032038,1,0.994182064431212,0,2,myosin II heavy chain binding,MF,
8156,GO:0032039,1,0.888909164813567,0,15,integrator complex,CC,
8157,GO:0032040,1,0.819410259602703,0,32,small-subunit processome,CC,
8158,GO:0032041,1,0.923073608688978,0,11,NAD-dependent histone deacetylase activity (H3-K14 specific),MF,
8159,GO:0032042,1,0.893432551025923,0,16,mitochondrial DNA metabolic process,BP,
8160,GO:0032044,1,0.988360401872371,0,2,DSIF complex,CC,
8162,GO:0032048,1,0.911522753129132,0,14,cardiolipin metabolic process,BP,
8163,GO:0032049,1,0.949079948351475,0,8,cardiolipin biosynthetic process,BP,
8164,GO:0032050,1,0.949208448374102,0,7,clathrin heavy chain binding,MF,
8165,GO:0032051,1,0.9623949458818,0,5,clathrin light chain binding,MF,
8166,GO:0032052,1,0.956927121618757,0,10,bile acid binding,MF,
8167,GO:0032053,1,0.984216502693603,0,2,ciliary basal body organization,BP,
8168,GO:0032055,1,0.960508363570089,0,6,negative regulation of translation in response to stress,BP,
8169,GO:0032056,1,0.959346190256568,0,6,positive regulation of translation in response to stress,BP,
8170,GO:0032057,1,0.972125094863561,0,4,negative regulation of translational initiation in response to stress,BP,
8171,GO:0032058,1,0.970195072074945,0,4,positive regulation of translational initiation in response to stress,BP,
8172,GO:0032059,1,0.945007096810852,0,8,bleb,CC,
8173,GO:0032060,1,0.926752144798129,0,11,bleb assembly,BP,
8174,GO:0032069,1,0.82949362658839,0,30,regulation of nuclease activity,BP,
8175,GO:0032070,1,0.944696395134554,0,10,regulation of deoxyribonuclease activity,BP,
8176,GO:0032071,1,0.954869958706178,0,8,regulation of endodeoxyribonuclease activity,BP,
8177,GO:0032072,1,0.992563346914044,0,1,regulation of restriction endodeoxyribonuclease activity,BP,
8178,GO:0032074,1,0.956929485246323,0,7,negative regulation of nuclease activity,BP,
8179,GO:0032075,1,0.906230968107032,0,16,positive regulation of nuclease activity,BP,
8180,GO:0032076,1,0.990293983380881,0,2,negative regulation of deoxyribonuclease activity,BP,
8181,GO:0032077,1,0.972176386340497,0,5,positive regulation of deoxyribonuclease activity,BP,
8182,GO:0032078,1,0.997112069635422,0,1,negative regulation of endodeoxyribonuclease activity,BP,
8183,GO:0032079,1,0.975922738037597,0,4,positive regulation of endodeoxyribonuclease activity,BP,
8184,GO:0032088,1,0.595029727856233,0,79,negative regulation of NF-kappaB transcription factor activity,BP,
8185,GO:0032089,1,0.984952952316352,0,2,NACHT domain binding,MF,
8186,GO:0032090,1,0.989671075920318,0,2,Pyrin domain binding,MF,
8187,GO:0032091,1,0.553189780093153,0,91,negative regulation of protein binding,BP,
8189,GO:0032093,1,0.993058458973322,0,1,SAM domain binding,MF,
8193,GO:0032097,1,0.990282281889364,0,3,positive regulation of response to food,BP,
8196,GO:0032100,1,0.990282281889364,0,3,positive regulation of appetite,BP,
8202,GO:0032106,1,0.978315129445466,0,5,positive regulation of response to extracellular stimulus,BP,
8205,GO:0032109,1,0.978315129445466,0,5,positive regulation of response to nutrient levels,BP,
8206,GO:0032116,1,0.982209767071976,0,2,SMC loading complex,CC,
8208,GO:0032127,1,0.985205639383206,0,2,dense core granule membrane,CC,
8209,GO:0032129,1,0.988011726720632,0,2,histone deacetylase activity (H3-K9 specific),MF,
8210,GO:0032133,1,0.974602694753391,0,5,chromosome passenger complex,CC,
8211,GO:0032135,1,0.959728564528665,0,6,DNA insertion or deletion binding,MF,
8212,GO:0032137,1,0.978838313209387,0,3,guanine/thymine mispair binding,MF,
8213,GO:0032138,1,0.970690729273573,0,4,single base insertion or deletion binding,MF,
8214,GO:0032139,1,0.981255071643608,0,3,dinucleotide insertion or deletion binding,MF,
8215,GO:0032142,1,0.977553501941349,0,3,single guanine insertion binding,MF,
8216,GO:0032143,1,0.985147288454605,0,2,single thymine insertion binding,MF,
8217,GO:0032144,1,0.992162690456213,0,1,4-aminobutyrate transaminase complex,CC,
8218,GO:0032145,1,0.992162690456213,0,1,succinate-semialdehyde dehydrogenase binding,MF,
8220,GO:0032148,1,0.825260472070119,0,29,activation of protein kinase B activity,BP,
8221,GO:0032153,1,0.581728378609041,0,76,cell division site,CC,
8222,GO:0032154,1,0.692020830720038,0,51,cleavage furrow,CC,
8223,GO:0032155,1,0.647679411682456,0,60,cell division site part,CC,
8224,GO:0032156,1,0.912720361431325,0,13,septin cytoskeleton,CC,
8225,GO:0032160,1,0.919686549592876,0,12,septin filament array,CC,
8226,GO:0032173,1,0.992809028124714,0,1,septin collar,CC,
8227,GO:0032181,1,0.985036055322724,0,2,dinucleotide repeat insertion binding,MF,
8228,GO:0032182,1,0.569043963827735,0,83,ubiquitin-like protein binding,MF,
8229,GO:0032183,1,0.893641033148155,0,14,SUMO binding,MF,
8230,GO:0032184,1,0.960797943751166,0,5,SUMO polymer binding,MF,
8231,GO:0032185,1,0.892898511883429,0,16,septin cytoskeleton organization,BP,
8232,GO:0032190,1,0.985969834058673,0,3,acrosin binding,MF,
8233,GO:0032194,1,0.99251470947205,0,1,ubiquinone biosynthetic process via 3,4-dihydroxy-5-polyprenylbenzoate,BP,
8234,GO:0032196,1,0.883814622336644,0,19,transposition,BP,
8235,GO:0032200,1,0.370972829766468,0,149,telomere organization,BP,
8236,GO:0032201,1,0.850151041576001,0,27,telomere maintenance via semi-conservative replication,BP,
8237,GO:0032202,1,0.97672387753376,0,4,telomere assembly,BP,
8238,GO:0032203,1,0.994973034818595,0,1,telomere formation via telomerase,BP,
8239,GO:0032204,1,0.580507833678972,0,76,regulation of telomere maintenance,BP,
8240,GO:0032205,1,0.770557877942133,0,34,negative regulation of telomere maintenance,BP,
8241,GO:0032206,1,0.715351666192652,0,49,positive regulation of telomere maintenance,BP,
8242,GO:0032207,1,0.992913450177408,0,1,regulation of telomere maintenance via recombination,BP,
8243,GO:0032208,1,0.992913450177408,0,1,negative regulation of telomere maintenance via recombination,BP,
8244,GO:0032210,1,0.694756450565409,0,52,regulation of telomere maintenance via telomerase,BP,
8245,GO:0032211,1,0.869045407897006,0,19,negative regulation of telomere maintenance via telomerase,BP,
8246,GO:0032212,1,0.798265161578545,0,34,positive regulation of telomere maintenance via telomerase,BP,
8247,GO:0032213,1,0.985837922697338,0,2,regulation of telomere maintenance via semi-conservative replication,BP,
8248,GO:0032214,1,0.985837922697338,0,2,negative regulation of telomere maintenance via semi-conservative replication,BP,
8249,GO:0032217,1,0.975881700442304,0,4,riboflavin transmembrane transporter activity,MF,
8250,GO:0032218,1,0.979318172289429,0,3,riboflavin transport,BP,
8251,GO:0032222,1,0.95321372840551,0,7,regulation of synaptic transmission, cholinergic,BP,
8252,GO:0032223,1,0.993388069720249,0,1,negative regulation of synaptic transmission, cholinergic,BP,
8253,GO:0032224,1,0.966106855834046,0,5,positive regulation of synaptic transmission, cholinergic,BP,
8254,GO:0032225,1,0.910787272111461,0,15,regulation of synaptic transmission, dopaminergic,BP,
8255,GO:0032226,1,0.960559105377618,0,7,positive regulation of synaptic transmission, dopaminergic,BP,
8256,GO:0032227,1,0.977528143826224,0,3,negative regulation of synaptic transmission, dopaminergic,BP,
8257,GO:0032228,1,0.805777818723673,0,30,regulation of synaptic transmission, GABAergic,BP,
8258,GO:0032229,1,0.965042934476329,0,6,negative regulation of synaptic transmission, GABAergic,BP,
8259,GO:0032230,1,0.923306887167075,0,12,positive regulation of synaptic transmission, GABAergic,BP,
8260,GO:0032231,1,0.539375263540699,0,86,regulation of actin filament bundle assembly,BP,
8261,GO:0032232,1,0.849953984082579,0,22,negative regulation of actin filament bundle assembly,BP,
8262,GO:0032233,1,0.68405826468491,0,56,positive regulation of actin filament bundle assembly,BP,
8263,GO:0032237,1,0.970298132547079,0,4,activation of store-operated calcium channel activity,BP,
8264,GO:0032239,1,0.875432228954269,0,17,regulation of nucleobase-containing compound transport,BP,
8265,GO:0032240,1,0.981096223527621,0,2,negative regulation of nucleobase-containing compound transport,BP,
8266,GO:0032241,1,0.941981814340744,0,8,positive regulation of nucleobase-containing compound transport,BP,
8267,GO:0032242,1,0.992984399887997,0,1,regulation of nucleoside transport,BP,
8268,GO:0032244,1,0.992984399887997,0,1,positive regulation of nucleoside transport,BP,
8269,GO:0032252,1,0.965500010410099,0,4,secretory granule localization,BP,
8270,GO:0032253,1,0.993058458973322,0,1,dense core granule localization,BP,
8271,GO:0032258,1,0.98738285042631,0,2,protein localization by the Cvt pathway,BP,
8273,GO:0032261,1,0.963903703409464,0,7,purine nucleotide salvage,BP,
8274,GO:0032262,1,0.970404398418275,0,6,pyrimidine nucleotide salvage,BP,
8275,GO:0032263,1,0.99080784512918,0,2,GMP salvage,BP,
8276,GO:0032264,1,0.97590300682833,0,4,IMP salvage,BP,
8277,GO:0032266,1,0.787015033449354,0,33,phosphatidylinositol-3-phosphate binding,MF,
8284,GO:0032274,1,0.911372399187919,0,14,gonadotropin secretion,BP,
8285,GO:0032275,1,0.934193966202844,0,10,luteinizing hormone secretion,BP,
8286,GO:0032276,1,0.939505432689971,0,10,regulation of gonadotropin secretion,BP,
8287,GO:0032277,1,0.965513420402816,0,6,negative regulation of gonadotropin secretion,BP,
8288,GO:0032278,1,0.95649705125657,0,7,positive regulation of gonadotropin secretion,BP,
8290,GO:0032280,1,0.941993173505905,0,8,symmetric synapse,CC,
8295,GO:0032289,1,0.980017851529099,0,3,central nervous system myelin formation,BP,
8296,GO:0032290,1,0.959731942827708,0,4,peripheral nervous system myelin formation,BP,
8299,GO:0032296,1,0.970004171794289,0,4,double-stranded RNA-specific ribonuclease activity,MF,
8300,GO:0032298,1,0.994075461978203,0,1,positive regulation of DNA-dependent DNA replication initiation,BP,
8301,GO:0032299,1,0.985341672247814,0,3,ribonuclease H2 complex,CC,
8302,GO:0032300,1,0.933896854926477,0,9,mismatch repair complex,CC,
8303,GO:0032301,1,0.985147288454605,0,2,MutSalpha complex,CC,
8304,GO:0032302,1,0.985036055322724,0,2,MutSbeta complex,CC,
8305,GO:0032303,1,0.934275522257182,0,11,regulation of icosanoid secretion,BP,
8306,GO:0032304,1,0.992098394010898,0,1,negative regulation of icosanoid secretion,BP,
8307,GO:0032305,1,0.941717766462262,0,10,positive regulation of icosanoid secretion,BP,
8308,GO:0032306,1,0.963490373761632,0,7,regulation of prostaglandin secretion,BP,
8309,GO:0032308,1,0.963490373761632,0,7,positive regulation of prostaglandin secretion,BP,
8312,GO:0032311,1,0.991834334920804,0,2,angiogenin-PRI complex,CC,
8313,GO:0032324,1,0.957607106433363,0,7,molybdopterin cofactor biosynthetic process,BP,
8314,GO:0032328,1,0.943939606696052,0,8,alanine transport,BP,
8315,GO:0032329,1,0.942129112738511,0,10,serine transport,BP,
8317,GO:0032331,1,0.891574259819726,0,17,negative regulation of chondrocyte differentiation,BP,
8318,GO:0032332,1,0.868960421001529,0,19,positive regulation of chondrocyte differentiation,BP,
8319,GO:0032341,1,0.949140321021985,0,7,aldosterone metabolic process,BP,
8320,GO:0032342,1,0.949140321021985,0,7,aldosterone biosynthetic process,BP,
8321,GO:0032344,1,0.958493116253877,0,6,regulation of aldosterone metabolic process,BP,
8322,GO:0032345,1,0.972834913042933,0,4,negative regulation of aldosterone metabolic process,BP,
8323,GO:0032346,1,0.985261755690043,0,2,positive regulation of aldosterone metabolic process,BP,
8324,GO:0032347,1,0.958493116253877,0,6,regulation of aldosterone biosynthetic process,BP,
8325,GO:0032348,1,0.972834913042933,0,4,negative regulation of aldosterone biosynthetic process,BP,
8326,GO:0032349,1,0.985261755690043,0,2,positive regulation of aldosterone biosynthetic process,BP,
8327,GO:0032350,1,0.816845706253045,0,31,regulation of hormone metabolic process,BP,
8328,GO:0032351,1,0.932127246134981,0,11,negative regulation of hormone metabolic process,BP,
8329,GO:0032352,1,0.921301231261474,0,12,positive regulation of hormone metabolic process,BP,
8330,GO:0032353,1,0.935491574818617,0,10,negative regulation of hormone biosynthetic process,BP,
8331,GO:0032354,1,0.897131450811674,0,14,response to follicle-stimulating hormone,BP,
8333,GO:0032356,1,0.937287706837777,0,10,oxidized DNA binding,MF,
8334,GO:0032357,1,0.942599331819631,0,9,oxidized purine DNA binding,MF,
8335,GO:0032358,1,0.997227134670758,0,1,oxidized pyrimidine DNA binding,MF,
8336,GO:0032361,1,0.994630636083079,0,1,pyridoxal phosphate catabolic process,BP,
8337,GO:0032364,1,0.96222203858091,0,6,oxygen homeostasis,BP,
8338,GO:0032365,1,0.813178657498408,0,29,intracellular lipid transport,BP,
8339,GO:0032366,1,0.882898356269599,0,18,intracellular sterol transport,BP,
8340,GO:0032367,1,0.882898356269599,0,18,intracellular cholesterol transport,BP,
8341,GO:0032368,1,0.585619652229829,0,82,regulation of lipid transport,BP,
8342,GO:0032369,1,0.878205895493479,0,19,negative regulation of lipid transport,BP,
8343,GO:0032370,1,0.742494085256591,0,47,positive regulation of lipid transport,BP,
8344,GO:0032371,1,0.799211068836448,0,35,regulation of sterol transport,BP,
8345,GO:0032372,1,0.95479481790357,0,8,negative regulation of sterol transport,BP,
8346,GO:0032373,1,0.881374666045529,0,18,positive regulation of sterol transport,BP,
8347,GO:0032374,1,0.799211068836448,0,35,regulation of cholesterol transport,BP,
8348,GO:0032375,1,0.95479481790357,0,8,negative regulation of cholesterol transport,BP,
8349,GO:0032376,1,0.881374666045529,0,18,positive regulation of cholesterol transport,BP,
8350,GO:0032377,1,0.956030963406286,0,7,regulation of intracellular lipid transport,BP,
8351,GO:0032378,1,0.992515738361928,0,1,negative regulation of intracellular lipid transport,BP,
8352,GO:0032379,1,0.984414394777065,0,3,positive regulation of intracellular lipid transport,BP,
8353,GO:0032380,1,0.956030963406286,0,7,regulation of intracellular sterol transport,BP,
8354,GO:0032381,1,0.992515738361928,0,1,negative regulation of intracellular sterol transport,BP,
8355,GO:0032382,1,0.984414394777065,0,3,positive regulation of intracellular sterol transport,BP,
8356,GO:0032383,1,0.956030963406286,0,7,regulation of intracellular cholesterol transport,BP,
8357,GO:0032384,1,0.992515738361928,0,1,negative regulation of intracellular cholesterol transport,BP,
8358,GO:0032385,1,0.984414394777065,0,3,positive regulation of intracellular cholesterol transport,BP,
8361,GO:0032388,1,0.21665844663902,0,224,positive regulation of intracellular transport,BP,
8362,GO:0032389,1,0.971121135827289,0,4,MutLalpha complex,CC,
8364,GO:0032392,1,0.572476632054113,0,80,DNA geometric change,BP,
8365,GO:0032393,1,0.965427451231104,0,7,MHC class I receptor activity,MF,
8366,GO:0032394,1,0.995623484760264,0,1,MHC class Ib receptor activity,MF,
8367,GO:0032395,1,0.961891594749345,0,9,MHC class II receptor activity,MF,
8368,GO:0032396,1,0.980816525904117,0,3,inhibitory MHC class I receptor activity,MF,
8369,GO:0032397,1,0.995857532466422,0,1,activating MHC class I receptor activity,MF,
8370,GO:0032398,1,0.995391591615577,0,1,MHC class Ib protein complex,CC,
8371,GO:0032400,1,0.844010177320546,0,26,melanosome localization,BP,
8372,GO:0032401,1,0.855461962228977,0,24,establishment of melanosome localization,BP,
8373,GO:0032402,1,0.863559980511877,0,23,melanosome transport,BP,
8374,GO:0032404,1,0.949556718727729,0,8,mismatch repair complex binding,MF,
8375,GO:0032405,1,0.967268490831918,0,5,MutLalpha complex binding,MF,
8376,GO:0032407,1,0.967592844162156,0,5,MutSalpha complex binding,MF,
8378,GO:0032410,1,0.643107368769788,0,67,negative regulation of transporter activity,BP,
8379,GO:0032411,1,0.52399175098607,0,93,positive regulation of transporter activity,BP,
8381,GO:0032413,1,0.675518454776627,0,60,negative regulation of ion transmembrane transporter activity,BP,
8382,GO:0032414,1,0.553410223403055,0,84,positive regulation of ion transmembrane transporter activity,BP,
8383,GO:0032415,1,0.973409982795473,0,5,regulation of sodium:proton antiporter activity,BP,
8384,GO:0032416,1,0.994625913819046,0,1,negative regulation of sodium:proton antiporter activity,BP,
8385,GO:0032417,1,0.978670575396465,0,4,positive regulation of sodium:proton antiporter activity,BP,
8386,GO:0032418,1,0.672844936797535,0,62,lysosome localization,BP,
8387,GO:0032419,1,0.994096693478931,0,1,extrinsic component of lysosome membrane,CC,
8390,GO:0032422,1,0.971512422864713,0,4,purine-rich negative regulatory element binding,MF,
8394,GO:0032427,1,0.986619708408073,0,2,GBD domain binding,MF,
8395,GO:0032428,1,0.992526104304396,0,1,beta-N-acetylgalactosaminidase activity,MF,
8399,GO:0032432,1,0.662596703842374,0,56,actin filament bundle,CC,
8400,GO:0032433,1,0.882144605730788,0,16,filopodium tip,CC,
8401,GO:0032434,1,0.47091255682105,0,113,regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
8402,GO:0032435,1,0.841959702333127,0,27,negative regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
8403,GO:0032436,1,0.590263881702472,0,78,positive regulation of proteasomal ubiquitin-dependent protein catabolic process,BP,
8404,GO:0032437,1,0.961885761569105,0,5,cuticular plate,CC,
8405,GO:0032438,1,0.846339021761171,0,26,melanosome organization,BP,
8406,GO:0032440,1,0.996349502593585,0,1,2-alkenal reductase [NAD(P)] activity,MF,
8407,GO:0032444,1,0.973222490230969,0,3,activin responsive factor complex,CC,
8408,GO:0032445,1,0.993903156509167,0,1,fructose import,BP,
8410,GO:0032447,1,0.993626621426091,0,1,protein urmylation,BP,
8411,GO:0032448,1,0.995616647769459,0,1,DNA hairpin binding,MF,
8412,GO:0032449,1,0.966642097990906,0,5,CBM complex,CC,
8413,GO:0032450,1,0.97621337927841,0,3,maltose alpha-glucosidase activity,MF,
8414,GO:0032451,1,0.768034198975053,0,34,demethylase activity,MF,
8415,GO:0032452,1,0.812072787574891,0,25,histone demethylase activity,MF,
8416,GO:0032453,1,0.949288421286904,0,6,histone demethylase activity (H3-K4 specific),MF,
8417,GO:0032454,1,0.907728181188205,0,12,histone demethylase activity (H3-K9 specific),MF,
8418,GO:0032455,1,0.974656828066821,0,4,nerve growth factor processing,BP,
8420,GO:0032458,1,0.992488732165395,0,1,slow endocytic recycling,BP,
8422,GO:0032460,1,0.908435989736041,0,14,negative regulation of protein oligomerization,BP,
8424,GO:0032462,1,0.904798508024638,0,17,regulation of protein homooligomerization,BP,
8425,GO:0032463,1,0.939999095067884,0,10,negative regulation of protein homooligomerization,BP,
8426,GO:0032464,1,0.959161183451944,0,7,positive regulation of protein homooligomerization,BP,
8427,GO:0032465,1,0.592016347545663,0,73,regulation of cytokinesis,BP,
8428,GO:0032466,1,0.956758776780833,0,7,negative regulation of cytokinesis,BP,
8429,GO:0032467,1,0.817326855936967,0,29,positive regulation of cytokinesis,BP,
8430,GO:0032468,1,0.992542804590808,0,1,Golgi calcium ion homeostasis,BP,
8431,GO:0032469,1,0.866292186487166,0,21,endoplasmic reticulum calcium ion homeostasis,BP,
8432,GO:0032470,1,0.982773805082949,0,2,positive regulation of endoplasmic reticulum calcium ion concentration,BP,
8433,GO:0032471,1,0.954853797428894,0,8,negative regulation of endoplasmic reticulum calcium ion concentration,BP,
8434,GO:0032472,1,0.987297596850708,0,2,Golgi calcium ion transport,BP,
8435,GO:0032473,1,0.989575106505612,0,1,cytoplasmic side of mitochondrial outer membrane,CC,
8436,GO:0032474,1,0.97815278714408,0,3,otolith morphogenesis,BP,
8437,GO:0032475,1,0.993270554299511,0,1,otolith formation,BP,
8438,GO:0032479,1,0.463613946695598,0,115,regulation of type I interferon production,BP,
8439,GO:0032480,1,0.742518457271686,0,45,negative regulation of type I interferon production,BP,
8440,GO:0032481,1,0.626163567730845,0,69,positive regulation of type I interferon production,BP,
8441,GO:0032482,1,0.666632078579182,0,67,Rab protein signal transduction,BP,
8442,GO:0032483,1,0.969008611138122,0,4,regulation of Rab protein signal transduction,BP,
8443,GO:0032484,1,0.975742537470508,0,3,Ral protein signal transduction,BP,
8444,GO:0032485,1,0.975742537470508,0,3,regulation of Ral protein signal transduction,BP,
8445,GO:0032486,1,0.905346872065662,0,13,Rap protein signal transduction,BP,
8446,GO:0032487,1,0.975782931512066,0,3,regulation of Rap protein signal transduction,BP,
8447,GO:0032488,1,0.915518996021624,0,14,Cdc42 protein signal transduction,BP,
8448,GO:0032489,1,0.965026707313497,0,6,regulation of Cdc42 protein signal transduction,BP,
8449,GO:0032490,1,0.921429133432227,0,12,detection of molecule of bacterial origin,BP,
8450,GO:0032493,1,0.946285215474564,0,8,response to bacterial lipoprotein,BP,
8451,GO:0032494,1,0.938268545985889,0,10,response to peptidoglycan,BP,
8452,GO:0032495,1,0.902363851971567,0,14,response to muramyl dipeptide,BP,
8454,GO:0032497,1,0.979621106801388,0,4,detection of lipopolysaccharide,BP,
8455,GO:0032498,1,0.992350070453485,0,1,detection of muramyl dipeptide,BP,
8456,GO:0032499,1,0.989156869611943,0,2,detection of peptidoglycan,BP,
8457,GO:0032500,1,0.992350070453485,0,1,muramyl dipeptide binding,MF,
8461,GO:0032506,1,0.849910833973192,0,23,cytokinetic process,BP,
8463,GO:0032508,1,0.614052612415875,0,70,DNA duplex unwinding,BP,
8464,GO:0032509,1,0.873815483322153,0,21,endosome transport via multivesicular body sorting pathway,BP,
8465,GO:0032510,1,0.954527171630819,0,6,endosome to lysosome transport via multivesicular body sorting pathway,BP,
8466,GO:0032511,1,0.958462241359695,0,8,late endosome to vacuole transport via multivesicular body sorting pathway,BP,
8467,GO:0032515,1,0.745949356122223,0,45,negative regulation of phosphoprotein phosphatase activity,BP,
8468,GO:0032516,1,0.887032365477331,0,16,positive regulation of phosphoprotein phosphatase activity,BP,
8469,GO:0032525,1,0.947365875295585,0,9,somite rostral/caudal axis specification,BP,
8471,GO:0032527,1,0.766108830684845,0,39,protein exit from endoplasmic reticulum,BP,
8475,GO:0032534,1,0.954121545930372,0,6,regulation of microvillus assembly,BP,
8478,GO:0032541,1,0.970028107832373,0,5,cortical endoplasmic reticulum,CC,
8479,GO:0032542,1,0.986017508294849,0,2,sulfiredoxin activity,MF,
8480,GO:0032543,1,0.54847484896403,0,127,mitochondrial translation,BP,
8481,GO:0032545,1,0.988922995855053,0,2,CURI complex,CC,
8484,GO:0032551,1,0.985260804195121,0,2,pyrimidine ribonucleoside binding,MF,
8485,GO:0032552,1,0.968121535820778,0,6,deoxyribonucleotide binding,MF,
8487,GO:0032554,1,0.976327933018256,0,4,purine deoxyribonucleotide binding,MF,
8489,GO:0032556,1,0.991596639453222,0,2,pyrimidine deoxyribonucleotide binding,MF,
8490,GO:0032557,1,0.979642919461211,0,3,pyrimidine ribonucleotide binding,MF,
8491,GO:0032558,1,0.983548024756897,0,3,adenyl deoxyribonucleotide binding,MF,
8493,GO:0032560,1,0.992660350041409,0,1,guanyl deoxyribonucleotide binding,MF,
8495,GO:0032564,1,0.983548024756897,0,3,dATP binding,MF,
8496,GO:0032567,1,0.992660350041409,0,1,dGTP binding,MF,
8498,GO:0032571,1,0.976949726215873,0,4,response to vitamin K,BP,
8499,GO:0032574,1,0.992478761594796,0,1,5'-3' RNA helicase activity,MF,
8500,GO:0032575,1,0.992478761594796,0,1,ATP-dependent 5'-3' RNA helicase activity,MF,
8501,GO:0032580,1,0.586789443341911,0,77,Golgi cisterna membrane,CC,
8502,GO:0032581,1,0.995001450490178,0,1,ER-dependent peroxisome organization,BP,
8503,GO:0032584,1,0.959733233051601,0,6,growth cone membrane,CC,
8504,GO:0032585,1,0.948209717191206,0,9,multivesicular body membrane,CC,
8507,GO:0032589,1,0.666743539119164,0,53,neuron projection membrane,CC,
8508,GO:0032590,1,0.767601083747957,0,37,dendrite membrane,CC,
8509,GO:0032591,1,0.903058256973046,0,13,dendritic spine membrane,CC,
8510,GO:0032592,1,0.677093025922981,0,65,integral component of mitochondrial membrane,CC,
8511,GO:0032593,1,0.953106669151771,0,7,insulin-responsive compartment,CC,
8513,GO:0032596,1,0.966893523568269,0,5,protein transport into membrane raft,BP,
8514,GO:0032601,1,0.996286185390552,0,1,connective tissue growth factor production,BP,
8516,GO:0032603,1,0.997076388513025,0,1,fractalkine production,BP,
8517,GO:0032604,1,0.929611002695936,0,12,granulocyte macrophage colony-stimulating factor production,BP,
8518,GO:0032605,1,0.992660350041409,0,1,hepatocyte growth factor production,BP,
8519,GO:0032606,1,0.4617074055831,0,116,type I interferon production,BP,
8520,GO:0032607,1,0.831791714036536,0,26,interferon-alpha production,BP,
8521,GO:0032608,1,0.725636636532948,0,47,interferon-beta production,BP,
8522,GO:0032609,1,0.576466947943605,0,91,interferon-gamma production,BP,
8523,GO:0032610,1,0.967034389325677,0,7,interleukin-1 alpha production,BP,
8524,GO:0032611,1,0.699557712526247,0,59,interleukin-1 beta production,BP,
8525,GO:0032612,1,0.653517768363087,0,72,interleukin-1 production,BP,
8526,GO:0032613,1,0.776205706106948,0,42,interleukin-10 production,BP,
8527,GO:0032615,1,0.732468808176766,0,49,interleukin-12 production,BP,
8528,GO:0032616,1,0.89553979684582,0,17,interleukin-13 production,BP,
8529,GO:0032618,1,0.990558048032372,0,2,interleukin-15 production,BP,
8530,GO:0032620,1,0.888433921207343,0,20,interleukin-17 production,BP,
8531,GO:0032621,1,0.944402820844923,0,8,interleukin-18 production,BP,
8532,GO:0032623,1,0.689764047560639,0,56,interleukin-2 production,BP,
8533,GO:0032625,1,0.992529000303621,0,1,interleukin-21 production,BP,
8534,GO:0032627,1,0.96590867767983,0,5,interleukin-23 production,BP,
8535,GO:0032632,1,0.978644497391486,0,3,interleukin-3 production,BP,
8536,GO:0032633,1,0.821366276184598,0,31,interleukin-4 production,BP,
8537,GO:0032634,1,0.901047592020451,0,15,interleukin-5 production,BP,
8540,GO:0032639,1,0.988210134300538,0,2,TRAIL production,BP,
8542,GO:0032641,1,0.98593484996541,0,2,lymphotoxin A production,BP,
8544,GO:0032643,1,0.996286185390552,0,1,regulation of connective tissue growth factor production,BP,
8545,GO:0032644,1,0.997076388513025,0,1,regulation of fractalkine production,BP,
8546,GO:0032645,1,0.934029063882404,0,11,regulation of granulocyte macrophage colony-stimulating factor production,BP,
8547,GO:0032646,1,0.992660350041409,0,1,regulation of hepatocyte growth factor production,BP,
8548,GO:0032647,1,0.835206215371121,0,25,regulation of interferon-alpha production,BP,
8549,GO:0032648,1,0.734523758338591,0,45,regulation of interferon-beta production,BP,
8550,GO:0032649,1,0.621577474107654,0,80,regulation of interferon-gamma production,BP,
8551,GO:0032650,1,0.969253662934723,0,6,regulation of interleukin-1 alpha production,BP,
8552,GO:0032651,1,0.739331448290024,0,51,regulation of interleukin-1 beta production,BP,
8553,GO:0032652,1,0.692290387329977,0,63,regulation of interleukin-1 production,BP,
8554,GO:0032653,1,0.787225191663653,0,40,regulation of interleukin-10 production,BP,
8555,GO:0032655,1,0.743153856342338,0,47,regulation of interleukin-12 production,BP,
8556,GO:0032656,1,0.89861720886066,0,16,regulation of interleukin-13 production,BP,
8557,GO:0032658,1,0.995146616079973,0,1,regulation of interleukin-15 production,BP,
8558,GO:0032660,1,0.903352241841342,0,17,regulation of interleukin-17 production,BP,
8559,GO:0032661,1,0.958843113395381,0,6,regulation of interleukin-18 production,BP,
8560,GO:0032663,1,0.719849037074757,0,49,regulation of interleukin-2 production,BP,
8561,GO:0032667,1,0.96590867767983,0,5,regulation of interleukin-23 production,BP,
8562,GO:0032672,1,0.986050577903994,0,2,regulation of interleukin-3 production,BP,
8563,GO:0032673,1,0.855719528910516,0,25,regulation of interleukin-4 production,BP,
8564,GO:0032674,1,0.901047592020451,0,15,regulation of interleukin-5 production,BP,
8566,GO:0032677,1,0.714298313949738,0,55,regulation of interleukin-8 production,BP,
8567,GO:0032679,1,0.988210134300538,0,2,regulation of TRAIL production,BP,
8569,GO:0032681,1,0.993160044566882,0,1,regulation of lymphotoxin A production,BP,
8571,GO:0032685,1,0.992625160581459,0,1,negative regulation of granulocyte macrophage colony-stimulating factor production,BP,
8572,GO:0032686,1,0.992660350041409,0,1,negative regulation of hepatocyte growth factor production,BP,
8573,GO:0032687,1,0.963504238299121,0,6,negative regulation of interferon-alpha production,BP,
8574,GO:0032688,1,0.91409521564534,0,14,negative regulation of interferon-beta production,BP,
8575,GO:0032689,1,0.854972056762497,0,26,negative regulation of interferon-gamma production,BP,
8576,GO:0032690,1,0.995952642875535,0,1,negative regulation of interleukin-1 alpha production,BP,
8577,GO:0032691,1,0.921596303678874,0,15,negative regulation of interleukin-1 beta production,BP,
8578,GO:0032692,1,0.889287093060701,0,21,negative regulation of interleukin-1 production,BP,
8579,GO:0032693,1,0.924709704599189,0,14,negative regulation of interleukin-10 production,BP,
8580,GO:0032695,1,0.898667067399725,0,16,negative regulation of interleukin-12 production,BP,
8581,GO:0032696,1,0.979873117830726,0,3,negative regulation of interleukin-13 production,BP,
8582,GO:0032700,1,0.945312469728116,0,9,negative regulation of interleukin-17 production,BP,
8583,GO:0032701,1,0.98816480345468,0,2,negative regulation of interleukin-18 production,BP,
8584,GO:0032703,1,0.884834318559725,0,19,negative regulation of interleukin-2 production,BP,
8585,GO:0032707,1,0.985590762802316,0,2,negative regulation of interleukin-23 production,BP,
8586,GO:0032712,1,0.993901000600317,0,1,negative regulation of interleukin-3 production,BP,
8587,GO:0032713,1,0.965638354857698,0,5,negative regulation of interleukin-4 production,BP,
8588,GO:0032714,1,0.979077812744889,0,3,negative regulation of interleukin-5 production,BP,
8589,GO:0032715,1,0.80736766345051,0,33,negative regulation of interleukin-6 production,BP,
8590,GO:0032717,1,0.908293628866996,0,16,negative regulation of interleukin-8 production,BP,
8593,GO:0032723,1,0.996286185390552,0,1,positive regulation of connective tissue growth factor production,BP,
8594,GO:0032724,1,0.997076388513025,0,1,positive regulation of fractalkine production,BP,
8595,GO:0032725,1,0.940972794416493,0,10,positive regulation of granulocyte macrophage colony-stimulating factor production,BP,
8596,GO:0032727,1,0.866888351685999,0,19,positive regulation of interferon-alpha production,BP,
8597,GO:0032728,1,0.816046028301623,0,29,positive regulation of interferon-beta production,BP,
8598,GO:0032729,1,0.717867761511449,0,55,positive regulation of interferon-gamma production,BP,
8599,GO:0032730,1,0.973193596033142,0,5,positive regulation of interleukin-1 alpha production,BP,
8600,GO:0032731,1,0.821190397672082,0,32,positive regulation of interleukin-1 beta production,BP,
8601,GO:0032732,1,0.794272059447994,0,38,positive regulation of interleukin-1 production,BP,
8602,GO:0032733,1,0.845057774157703,0,28,positive regulation of interleukin-10 production,BP,
8603,GO:0032735,1,0.840369908400979,0,29,positive regulation of interleukin-12 production,BP,
8604,GO:0032736,1,0.917091214493565,0,13,positive regulation of interleukin-13 production,BP,
8605,GO:0032738,1,0.995146616079973,0,1,positive regulation of interleukin-15 production,BP,
8606,GO:0032740,1,0.950061649295033,0,9,positive regulation of interleukin-17 production,BP,
8607,GO:0032741,1,0.977528000083342,0,3,positive regulation of interleukin-18 production,BP,
8608,GO:0032743,1,0.818098606686102,0,29,positive regulation of interleukin-2 production,BP,
8609,GO:0032747,1,0.985782201302213,0,2,positive regulation of interleukin-23 production,BP,
8610,GO:0032752,1,0.992101884900028,0,1,positive regulation of interleukin-3 production,BP,
8611,GO:0032753,1,0.880770968443486,0,21,positive regulation of interleukin-4 production,BP,
8612,GO:0032754,1,0.925334483254429,0,11,positive regulation of interleukin-5 production,BP,
8614,GO:0032757,1,0.783827823942328,0,40,positive regulation of interleukin-8 production,BP,
8615,GO:0032759,1,0.988210134300538,0,2,positive regulation of TRAIL production,BP,
8616,GO:0032760,1,0.672670463889429,0,64,positive regulation of tumor necrosis factor production,BP,
8617,GO:0032761,1,0.993160044566882,0,1,positive regulation of lymphotoxin A production,BP,
8618,GO:0032762,1,0.957942761911691,0,7,mast cell cytokine production,BP,
8619,GO:0032763,1,0.970963145045952,0,5,regulation of mast cell cytokine production,BP,
8620,GO:0032764,1,0.988254181619595,0,2,negative regulation of mast cell cytokine production,BP,
8621,GO:0032765,1,0.982505502713,0,3,positive regulation of mast cell cytokine production,BP,
8622,GO:0032767,1,0.980580282676648,0,3,copper-dependent protein binding,MF,
8624,GO:0032769,1,0.936263936865256,0,10,negative regulation of monooxygenase activity,BP,
8625,GO:0032770,1,0.870092693318902,0,23,positive regulation of monooxygenase activity,BP,
8626,GO:0032771,1,0.99241567941278,0,1,regulation of monophenol monooxygenase activity,BP,
8627,GO:0032773,1,0.99241567941278,0,1,positive regulation of monophenol monooxygenase activity,BP,
8629,GO:0032775,1,0.99251093643518,0,1,DNA methylation on adenine,BP,
8630,GO:0032776,1,0.976960289494875,0,3,DNA methylation on cytosine,BP,
8631,GO:0032777,1,0.975067589551586,0,4,Piccolo NuA4 histone acetyltransferase complex,CC,
8633,GO:0032781,1,0.756315190538998,0,50,positive regulation of ATPase activity,BP,
8634,GO:0032782,1,0.975053815470426,0,4,bile acid secretion,BP,
8635,GO:0032783,1,0.946753268670046,0,6,ELL-EAF complex,CC,
8636,GO:0032784,1,0.76344677259968,0,41,regulation of DNA-templated transcription, elongation,BP,
8637,GO:0032785,1,0.917124076357432,0,13,negative regulation of DNA-templated transcription, elongation,BP,
8638,GO:0032786,1,0.862182827650359,0,23,positive regulation of DNA-templated transcription, elongation,BP,
8640,GO:0032788,1,0.995509132159025,0,1,saturated monocarboxylic acid metabolic process,BP,
8641,GO:0032789,1,0.995509132159025,0,1,unsaturated monocarboxylic acid metabolic process,BP,
8642,GO:0032790,1,0.947024011893494,0,8,ribosome disassembly,BP,
8643,GO:0032792,1,0.969549923710566,0,5,negative regulation of CREB transcription factor activity,BP,
8644,GO:0032793,1,0.901457822702348,0,14,positive regulation of CREB transcription factor activity,BP,
8645,GO:0032794,1,0.897116948927078,0,14,GTPase activating protein binding,MF,
8646,GO:0032795,1,0.982297915400474,0,3,heterotrimeric G-protein binding,MF,
8647,GO:0032796,1,0.986140230765116,0,2,uropod organization,BP,
8648,GO:0032797,1,0.929801997433399,0,12,SMN complex,CC,
8649,GO:0032798,1,0.986164624597214,0,2,Swi5-Sfr1 complex,CC,
8650,GO:0032799,1,0.876140709702239,0,20,low-density lipoprotein receptor particle metabolic process,BP,
8651,GO:0032800,1,0.861027307908986,0,22,receptor biosynthetic process,BP,
8652,GO:0032801,1,0.797967963599232,0,32,receptor catabolic process,BP,
8653,GO:0032802,1,0.920293959833117,0,13,low-density lipoprotein particle receptor catabolic process,BP,
8654,GO:0032803,1,0.970055721820055,0,5,regulation of low-density lipoprotein particle receptor catabolic process,BP,
8655,GO:0032804,1,0.987960916679927,0,2,negative regulation of low-density lipoprotein particle receptor catabolic process,BP,
8656,GO:0032805,1,0.989051656400222,0,2,positive regulation of low-density lipoprotein particle receptor catabolic process,BP,
8657,GO:0032806,1,0.856899282619487,0,24,carboxy-terminal domain protein kinase complex,CC,
8658,GO:0032807,1,0.975107914552194,0,4,DNA ligase IV complex,CC,
8660,GO:0032809,1,0.850445002932731,0,23,neuronal cell body membrane,CC,
8661,GO:0032810,1,0.987834950147913,0,2,sterol response element binding,MF,
8662,GO:0032811,1,0.983621323114894,0,3,negative regulation of epinephrine secretion,BP,
8663,GO:0032812,1,0.997074287876559,0,1,positive regulation of epinephrine secretion,BP,
8664,GO:0032813,1,0.783531062991592,0,43,tumor necrosis factor receptor superfamily binding,MF,
8665,GO:0032814,1,0.877169547959717,0,22,regulation of natural killer cell activation,BP,
8666,GO:0032815,1,0.975188212347411,0,5,negative regulation of natural killer cell activation,BP,
8667,GO:0032816,1,0.92425688142507,0,13,positive regulation of natural killer cell activation,BP,
8668,GO:0032817,1,0.966593560910716,0,6,regulation of natural killer cell proliferation,BP,
8669,GO:0032819,1,0.980899147875299,0,4,positive regulation of natural killer cell proliferation,BP,
8670,GO:0032823,1,0.940787779660361,0,10,regulation of natural killer cell differentiation,BP,
8671,GO:0032824,1,0.996996425083931,0,1,negative regulation of natural killer cell differentiation,BP,
8672,GO:0032825,1,0.955428077663931,0,7,positive regulation of natural killer cell differentiation,BP,
8673,GO:0032826,1,0.992462728111527,0,2,regulation of natural killer cell differentiation involved in immune response,BP,
8674,GO:0032827,1,0.996996425083931,0,1,negative regulation of natural killer cell differentiation involved in immune response,BP,
8675,GO:0032829,1,0.989308705803038,0,2,regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation,BP,
8676,GO:0032831,1,0.989308705803038,0,2,positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation,BP,
8677,GO:0032832,1,0.995407779536441,0,1,regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response,BP,
8678,GO:0032834,1,0.995407779536441,0,1,positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation involved in immune response,BP,
8679,GO:0032835,1,0.668371790166787,0,54,glomerulus development,BP,
8680,GO:0032836,1,0.923498474502356,0,10,glomerular basement membrane development,BP,
8681,GO:0032838,1,0.294027595127453,0,167,plasma membrane bounded cell projection cytoplasm,CC,
8682,GO:0032839,1,0.826367977273891,0,27,dendrite cytoplasm,CC,
8683,GO:0032841,1,0.992519601752913,0,1,calcitonin binding,MF,
8684,GO:0032847,1,0.976081927809207,0,4,regulation of cellular pH reduction,BP,
8685,GO:0032848,1,0.99249170530249,0,1,negative regulation of cellular pH reduction,BP,
8686,GO:0032849,1,0.98346731692756,0,3,positive regulation of cellular pH reduction,BP,
8691,GO:0032873,1,0.763753809256027,0,39,negative regulation of stress-activated MAPK cascade,BP,
8692,GO:0032874,1,0.38983347709438,0,136,positive regulation of stress-activated MAPK cascade,BP,
8693,GO:0032875,1,0.943909938341251,0,7,regulation of DNA endoreduplication,BP,
8694,GO:0032876,1,0.966120942066854,0,4,negative regulation of DNA endoreduplication,BP,
8695,GO:0032877,1,0.984245375869562,0,2,positive regulation of DNA endoreduplication,BP,
8696,GO:0032878,1,0.847161670491816,0,21,regulation of establishment or maintenance of cell polarity,BP,
8699,GO:0032881,1,0.776342708297572,0,33,regulation of polysaccharide metabolic process,BP,
8700,GO:0032885,1,0.787455176083847,0,30,regulation of polysaccharide biosynthetic process,BP,
8701,GO:0032886,1,0.252941831489921,0,189,regulation of microtubule-based process,BP,
8702,GO:0032887,1,0.990783868118484,0,1,regulation of spindle elongation,BP,
8703,GO:0032888,1,0.990783868118484,0,1,regulation of mitotic spindle elongation,BP,
8704,GO:0032889,1,0.993486770208981,0,1,regulation of vacuole fusion, non-autophagic,BP,
8706,GO:0032891,1,0.899422737481339,0,15,negative regulation of organic acid transport,BP,
8708,GO:0032897,1,0.872467401961996,0,20,negative regulation of viral transcription,BP,
8709,GO:0032898,1,0.970840653370148,0,4,neurotrophin production,BP,
8710,GO:0032899,1,0.985523939246622,0,2,regulation of neurotrophin production,BP,
8711,GO:0032900,1,0.992984399887997,0,1,negative regulation of neurotrophin production,BP,
8712,GO:0032901,1,0.992487356569933,0,1,positive regulation of neurotrophin production,BP,
8713,GO:0032902,1,0.985103190463839,0,2,nerve growth factor production,BP,
8714,GO:0032905,1,0.934384113471332,0,10,transforming growth factor beta1 production,BP,
8715,GO:0032906,1,0.941575275696107,0,8,transforming growth factor beta2 production,BP,
8716,GO:0032907,1,0.980964539487081,0,2,transforming growth factor beta3 production,BP,
8717,GO:0032908,1,0.934384113471332,0,10,regulation of transforming growth factor beta1 production,BP,
8718,GO:0032909,1,0.941575275696107,0,8,regulation of transforming growth factor beta2 production,BP,
8719,GO:0032910,1,0.980964539487081,0,2,regulation of transforming growth factor beta3 production,BP,
8720,GO:0032911,1,0.971258127539789,0,4,negative regulation of transforming growth factor beta1 production,BP,
8721,GO:0032912,1,0.985015431835927,0,2,negative regulation of transforming growth factor beta2 production,BP,
8722,GO:0032914,1,0.962045651084123,0,6,positive regulation of transforming growth factor beta1 production,BP,
8723,GO:0032915,1,0.989198545519956,0,2,positive regulation of transforming growth factor beta2 production,BP,
8724,GO:0032916,1,0.980964539487081,0,2,positive regulation of transforming growth factor beta3 production,BP,
8725,GO:0032917,1,0.987934089275937,0,3,polyamine acetylation,BP,
8726,GO:0032918,1,0.987934089275937,0,3,spermidine acetylation,BP,
8727,GO:0032919,1,0.996966891436453,0,1,spermine acetylation,BP,
8728,GO:0032920,1,0.996966891436453,0,1,putrescine acetylation,BP,
8730,GO:0032924,1,0.782715455862232,0,36,activin receptor signaling pathway,BP,
8731,GO:0032925,1,0.862111819828674,0,23,regulation of activin receptor signaling pathway,BP,
8732,GO:0032926,1,0.943682799155006,0,9,negative regulation of activin receptor signaling pathway,BP,
8733,GO:0032927,1,0.941941620801379,0,8,positive regulation of activin receptor signaling pathway,BP,
8735,GO:0032929,1,0.992107289688392,0,2,negative regulation of superoxide anion generation,BP,
8737,GO:0032933,1,0.945486881590345,0,8,SREBP signaling pathway,BP,
8739,GO:0032937,1,0.979096719597925,0,3,SREBP-SCAP-Insig complex,CC,
8745,GO:0032946,1,0.501142046742878,0,118,positive regulation of mononuclear cell proliferation,BP,
8747,GO:0032954,1,0.98397665757088,0,2,regulation of cytokinetic process,BP,
8749,GO:0032957,1,0.941056275922,0,8,inositol trisphosphate metabolic process,BP,
8750,GO:0032958,1,0.848582943142176,0,24,inositol phosphate biosynthetic process,BP,
8751,GO:0032959,1,0.956256110267935,0,6,inositol trisphosphate biosynthetic process,BP,
8752,GO:0032960,1,0.970893728239276,0,4,regulation of inositol trisphosphate biosynthetic process,BP,
8753,GO:0032962,1,0.978333149824036,0,3,positive regulation of inositol trisphosphate biosynthetic process,BP,
8754,GO:0032963,1,0.483123739431533,0,103,collagen metabolic process,BP,
8755,GO:0032964,1,0.793695908523362,0,35,collagen biosynthetic process,BP,
8756,GO:0032965,1,0.842867893660873,0,27,regulation of collagen biosynthetic process,BP,
8757,GO:0032966,1,0.959426602935432,0,7,negative regulation of collagen biosynthetic process,BP,
8758,GO:0032967,1,0.878559284630798,0,20,positive regulation of collagen biosynthetic process,BP,
8759,GO:0032968,1,0.912370788484236,0,14,positive regulation of transcription elongation from RNA polymerase II promoter,BP,
8761,GO:0032971,1,0.979731520201634,0,4,regulation of muscle filament sliding,BP,
8762,GO:0032972,1,0.994132659041199,0,2,regulation of muscle filament sliding speed,BP,
8763,GO:0032976,1,0.997289666042589,0,1,release of matrix enzymes from mitochondria,BP,
8764,GO:0032977,1,0.99233823472857,0,1,membrane insertase activity,MF,
8765,GO:0032978,1,0.99233823472857,0,1,protein insertion into membrane from inner side,BP,
8766,GO:0032979,1,0.99233823472857,0,1,protein insertion into mitochondrial membrane from inner side,BP,
8767,GO:0032981,1,0.806193743478719,0,55,mitochondrial respiratory chain complex I assembly,BP,
8768,GO:0032982,1,0.872741452536089,0,17,myosin filament,CC,
8769,GO:0032983,1,0.960541207619472,0,5,kainate selective glutamate receptor complex,CC,
8771,GO:0032986,1,0.881855166949605,0,19,protein-DNA complex disassembly,BP,
8772,GO:0032988,1,0.917628615509531,0,13,ribonucleoprotein complex disassembly,BP,
8776,GO:0032993,1,0.458291293342951,0,137,protein-DNA complex,CC,
8777,GO:0032994,1,0.82409100118504,0,34,protein-lipid complex,CC,
8778,GO:0032996,1,0.994950525297417,0,1,Bcl3-Bcl10 complex,CC,
8779,GO:0032997,1,0.993071947722192,0,2,Fc receptor complex,CC,
8780,GO:0032998,1,0.993071947722192,0,2,Fc-epsilon receptor I complex,CC,
8782,GO:0033003,1,0.807899026028275,0,35,regulation of mast cell activation,BP,
8783,GO:0033004,1,0.937839220829588,0,11,negative regulation of mast cell activation,BP,
8784,GO:0033005,1,0.91531268619765,0,15,positive regulation of mast cell activation,BP,
8785,GO:0033006,1,0.851281379852151,0,27,regulation of mast cell activation involved in immune response,BP,
8786,GO:0033007,1,0.961598473585047,0,7,negative regulation of mast cell activation involved in immune response,BP,
8787,GO:0033008,1,0.935058608656976,0,12,positive regulation of mast cell activation involved in immune response,BP,
8788,GO:0033010,1,0.948957789168711,0,7,paranodal junction,CC,
8789,GO:0033011,1,0.988732035408682,0,2,perinuclear theca,CC,
8790,GO:0033013,1,0.73645244988664,0,49,tetrapyrrole metabolic process,BP,
8791,GO:0033014,1,0.844834221480205,0,26,tetrapyrrole biosynthetic process,BP,
8792,GO:0033015,1,0.984932490499356,0,4,tetrapyrrole catabolic process,BP,
8793,GO:0033017,1,0.759803954698717,0,36,sarcoplasmic reticulum membrane,CC,
8794,GO:0033018,1,0.954747192490346,0,7,sarcoplasmic reticulum lumen,CC,
8795,GO:0033023,1,0.982261357660831,0,3,mast cell homeostasis,BP,
8796,GO:0033024,1,0.982261357660831,0,3,mast cell apoptotic process,BP,
8797,GO:0033025,1,0.982261357660831,0,3,regulation of mast cell apoptotic process,BP,
8798,GO:0033026,1,0.989655937962083,0,2,negative regulation of mast cell apoptotic process,BP,
8799,GO:0033028,1,0.840354610075621,0,28,myeloid cell apoptotic process,BP,
8800,GO:0033029,1,0.958805795297125,0,6,regulation of neutrophil apoptotic process,BP,
8801,GO:0033030,1,0.984566194005685,0,2,negative regulation of neutrophil apoptotic process,BP,
8802,GO:0033031,1,0.973839801774497,0,4,positive regulation of neutrophil apoptotic process,BP,
8803,GO:0033032,1,0.859499222941857,0,24,regulation of myeloid cell apoptotic process,BP,
8804,GO:0033033,1,0.926117382639081,0,13,negative regulation of myeloid cell apoptotic process,BP,
8805,GO:0033034,1,0.954846414446135,0,7,positive regulation of myeloid cell apoptotic process,BP,
8807,GO:0033037,1,0.991677329897686,0,1,polysaccharide localization,BP,
8808,GO:0033038,1,0.965866347833672,0,10,bitter taste receptor activity,MF,
8809,GO:0033040,1,0.992755740382503,0,1,sour taste receptor activity,MF,
8810,GO:0033041,1,0.993425333841069,0,1,sweet taste receptor activity,MF,
8812,GO:0033044,1,0.120372305424832,0,295,regulation of chromosome organization,BP,
8813,GO:0033045,1,0.613756581635695,0,70,regulation of sister chromatid segregation,BP,
8814,GO:0033046,1,0.774555269521571,0,37,negative regulation of sister chromatid segregation,BP,
8815,GO:0033047,1,0.653237309958779,0,61,regulation of mitotic sister chromatid segregation,BP,
8816,GO:0033048,1,0.781511589585378,0,36,negative regulation of mitotic sister chromatid segregation,BP,
8817,GO:0033058,1,0.972550741461279,0,3,directional locomotion,BP,
8818,GO:0033059,1,0.709849269850542,0,52,cellular pigmentation,BP,
8819,GO:0033061,1,0.944812239913544,0,9,DNA recombinase mediator complex,CC,
8820,GO:0033063,1,0.958073181626211,0,7,Rad51B-Rad51C-Rad51D-XRCC2 complex,CC,
8821,GO:0033065,1,0.990386489811781,0,2,Rad51C-XRCC3 complex,CC,
8822,GO:0033076,1,0.985125897206932,0,3,isoquinoline alkaloid metabolic process,BP,
8823,GO:0033077,1,0.666411138395931,0,60,T cell differentiation in thymus,BP,
8824,GO:0033078,1,0.983029714330368,0,3,extrathymic T cell differentiation,BP,
8825,GO:0033079,1,0.958805017833306,0,7,immature T cell proliferation,BP,
8826,GO:0033080,1,0.969751962839535,0,5,immature T cell proliferation in thymus,BP,
8827,GO:0033081,1,0.881954730849703,0,20,regulation of T cell differentiation in thymus,BP,
8828,GO:0033082,1,0.987650503480393,0,2,regulation of extrathymic T cell differentiation,BP,
8829,GO:0033083,1,0.966066787184106,0,6,regulation of immature T cell proliferation,BP,
8830,GO:0033084,1,0.977095804919265,0,4,regulation of immature T cell proliferation in thymus,BP,
8831,GO:0033085,1,0.967038893270683,0,6,negative regulation of T cell differentiation in thymus,BP,
8832,GO:0033087,1,0.982806730272496,0,3,negative regulation of immature T cell proliferation,BP,
8833,GO:0033088,1,0.987433402883452,0,2,negative regulation of immature T cell proliferation in thymus,BP,
8834,GO:0033089,1,0.943192878524679,0,9,positive regulation of T cell differentiation in thymus,BP,
8835,GO:0033091,1,0.982970138713787,0,3,positive regulation of immature T cell proliferation,BP,
8836,GO:0033092,1,0.989532158465132,0,2,positive regulation of immature T cell proliferation in thymus,BP,
8837,GO:0033093,1,0.962235727084785,0,5,Weibel-Palade body,CC,
8838,GO:0033106,1,0.982838665704016,0,3,cis-Golgi network membrane,CC,
8839,GO:0033108,1,0.674902360899735,0,87,mitochondrial respiratory chain complex assembly,BP,
8840,GO:0033116,1,0.671827622726838,0,62,endoplasmic reticulum-Golgi intermediate compartment membrane,CC,
8841,GO:0033119,1,0.858343075267632,0,24,negative regulation of RNA splicing,BP,
8842,GO:0033120,1,0.818444539636077,0,29,positive regulation of RNA splicing,BP,
8843,GO:0033121,1,0.975484377807458,0,3,regulation of purine nucleotide catabolic process,BP,
8844,GO:0033122,1,0.983829460386201,0,2,negative regulation of purine nucleotide catabolic process,BP,
8845,GO:0033123,1,0.991519129919948,0,1,positive regulation of purine nucleotide catabolic process,BP,
8846,GO:0033127,1,0.918703325335996,0,13,regulation of histone phosphorylation,BP,
8847,GO:0033128,1,0.983638872655776,0,3,negative regulation of histone phosphorylation,BP,
8848,GO:0033129,1,0.946376176865268,0,8,positive regulation of histone phosphorylation,BP,
8849,GO:0033130,1,0.938013063338331,0,9,acetylcholine receptor binding,MF,
8850,GO:0033131,1,0.946742651430078,0,9,regulation of glucokinase activity,BP,
8851,GO:0033132,1,0.977216398808857,0,4,negative regulation of glucokinase activity,BP,
8852,GO:0033133,1,0.968822841290344,0,5,positive regulation of glucokinase activity,BP,
8856,GO:0033139,1,0.972687898533586,0,4,regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8857,GO:0033140,1,0.994960004311046,0,1,negative regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8858,GO:0033141,1,0.977616193252477,0,3,positive regulation of peptidyl-serine phosphorylation of STAT protein,BP,
8859,GO:0033142,1,0.994191421016044,0,1,progesterone receptor binding,MF,
8860,GO:0033143,1,0.622861405419811,0,69,regulation of intracellular steroid hormone receptor signaling pathway,BP,
8861,GO:0033144,1,0.81297506333768,0,30,negative regulation of intracellular steroid hormone receptor signaling pathway,BP,
8862,GO:0033145,1,0.914861838851363,0,14,positive regulation of intracellular steroid hormone receptor signaling pathway,BP,
8863,GO:0033146,1,0.785410218844826,0,34,regulation of intracellular estrogen receptor signaling pathway,BP,
8864,GO:0033147,1,0.917601114308839,0,12,negative regulation of intracellular estrogen receptor signaling pathway,BP,
8865,GO:0033148,1,0.944892260816555,0,8,positive regulation of intracellular estrogen receptor signaling pathway,BP,
8866,GO:0033149,1,0.983529775324954,0,2,FFAT motif binding,MF,
8867,GO:0033150,1,0.99478450690246,0,1,cytoskeletal calyx,CC,
8868,GO:0033151,1,0.909100223975788,0,12,V(D)J recombination,BP,
8869,GO:0033152,1,0.968831758701013,0,4,immunoglobulin V(D)J recombination,BP,
8870,GO:0033153,1,0.95651800456501,0,5,T cell receptor V(D)J recombination,BP,
8872,GO:0033158,1,0.874116647870361,0,18,regulation of protein import into nucleus, translocation,BP,
8873,GO:0033159,1,0.978648933441982,0,3,negative regulation of protein import into nucleus, translocation,BP,
8874,GO:0033160,1,0.911868118155509,0,11,positive regulation of protein import into nucleus, translocation,BP,
8875,GO:0033162,1,0.940915255032247,0,11,melanosome membrane,CC,
8876,GO:0033165,1,0.988876906745861,0,2,interphotoreceptor matrix,CC,
8877,GO:0033167,1,0.989011939256005,0,1,ARC complex,CC,
8878,GO:0033168,1,0.989011939256005,0,1,conversion of ds siRNA to ss siRNA involved in RNA interference,BP,
8879,GO:0033169,1,0.901737817354374,0,13,histone H3-K9 demethylation,BP,
8880,GO:0033170,1,0.953192259978248,0,8,protein-DNA loading ATPase activity,MF,
8881,GO:0033173,1,0.837165451557902,0,24,calcineurin-NFAT signaling cascade,BP,
8882,GO:0033176,1,0.876802758142342,0,24,proton-transporting V-type ATPase complex,CC,
8883,GO:0033177,1,0.940604064308956,0,11,proton-transporting two-sector ATPase complex, proton-transporting domain,CC,
8884,GO:0033178,1,0.940441252354611,0,11,proton-transporting two-sector ATPase complex, catalytic domain,CC,
8885,GO:0033179,1,0.944348461791945,0,10,proton-transporting V-type ATPase, V0 domain,CC,
8886,GO:0033180,1,0.949111842633371,0,9,proton-transporting V-type ATPase, V1 domain,CC,
8887,GO:0033181,1,0.98922620364832,0,2,plasma membrane proton-transporting V-type ATPase complex,CC,
8888,GO:0033182,1,0.928241162491276,0,10,regulation of histone ubiquitination,BP,
8889,GO:0033183,1,0.974654757001541,0,3,negative regulation of histone ubiquitination,BP,
8890,GO:0033184,1,0.964153602326333,0,5,positive regulation of histone ubiquitination,BP,
8891,GO:0033185,1,0.990547906362222,0,3,dolichol-phosphate-mannose synthase complex,CC,
8892,GO:0033186,1,0.977079280382331,0,3,CAF-1 complex,CC,
8893,GO:0033188,1,0.979855141218144,0,3,sphingomyelin synthase activity,MF,
8894,GO:0033189,1,0.91346699849274,0,15,response to vitamin A,BP,
8895,GO:0033192,1,0.962042163702338,0,5,calmodulin-dependent protein phosphatase activity,MF,
8896,GO:0033193,1,0.992119717382285,0,1,Lsd1/2 complex,CC,
8898,GO:0033197,1,0.928945160328963,0,12,response to vitamin E,BP,
8899,GO:0033198,1,0.826997228570708,0,29,response to ATP,BP,
8900,GO:0033202,1,0.921552138964229,0,15,DNA helicase complex,CC,
8901,GO:0033204,1,0.993568398121605,0,1,ribonuclease P RNA binding,MF,
8902,GO:0033206,1,0.961989842787926,0,5,meiotic cytokinesis,BP,
8903,GO:0033209,1,0.416845554487839,0,161,tumor necrosis factor-mediated signaling pathway,BP,
8904,GO:0033210,1,0.943062340947808,0,9,leptin-mediated signaling pathway,BP,
8905,GO:0033211,1,0.968828236504486,0,5,adiponectin-activated signaling pathway,BP,
8908,GO:0033216,1,0.959061337136922,0,6,ferric iron import,BP,
8910,GO:0033220,1,0.970721746188394,0,4,amide-transporting ATPase activity,MF,
8911,GO:0033227,1,0.965608859327451,0,5,dsRNA transport,BP,
8912,GO:0033229,1,0.992504407295285,0,1,cysteine transmembrane transporter activity,MF,
8913,GO:0033231,1,0.992475485630838,0,1,carbohydrate export,BP,
8914,GO:0033233,1,0.874447873686733,0,21,regulation of protein sumoylation,BP,
8915,GO:0033234,1,0.937805076074817,0,10,negative regulation of protein sumoylation,BP,
8916,GO:0033235,1,0.932668251080533,0,11,positive regulation of protein sumoylation,BP,
8917,GO:0033238,1,0.689284229096997,0,72,regulation of cellular amine metabolic process,BP,
8918,GO:0033239,1,0.961451282065237,0,5,negative regulation of cellular amine metabolic process,BP,
8919,GO:0033240,1,0.948824988839047,0,9,positive regulation of cellular amine metabolic process,BP,
8920,GO:0033241,1,0.989824462282673,0,1,regulation of cellular amine catabolic process,BP,
8921,GO:0033242,1,0.989824462282673,0,1,negative regulation of cellular amine catabolic process,BP,
8922,GO:0033256,1,0.957353353526804,0,7,I-kappaB/NF-kappaB complex,CC,
8923,GO:0033257,1,0.987739275665311,0,2,Bcl3/NF-kappaB2 complex,CC,
8924,GO:0033260,1,0.73549624064609,0,49,nuclear DNA replication,BP,
8925,GO:0033262,1,0.915893912125303,0,12,regulation of nuclear cell cycle DNA replication,BP,
8926,GO:0033263,1,0.969922291158724,0,4,CORVET complex,CC,
8927,GO:0033265,1,0.986882391757352,0,2,choline binding,MF,
8933,GO:0033274,1,0.990812195958232,0,1,response to vitamin B2,BP,
8934,GO:0033275,1,0.815894588041416,0,32,actin-myosin filament sliding,BP,
8935,GO:0033276,1,0.916494833552852,0,13,transcription factor TFTC complex,CC,
8936,GO:0033277,1,0.985433690178583,0,2,abortive mitotic cell cycle,BP,
8937,GO:0033278,1,0.962969965196193,0,5,cell proliferation in midbrain,BP,
8938,GO:0033280,1,0.808941860680985,0,32,response to vitamin D,BP,
8939,GO:0033283,1,0.984812769154141,0,2,organic acid-transporting ATPase activity,MF,
8940,GO:0033284,1,0.984812769154141,0,2,carboxylic acid-transporting ATPase activity,MF,
8941,GO:0033285,1,0.984812769154141,0,2,monocarboxylic acid-transporting ATPase activity,MF,
8942,GO:0033290,1,0.992445167226871,0,1,eukaryotic 48S preinitiation complex,CC,
8943,GO:0033291,1,0.998186885389187,0,1,eukaryotic 80S initiation complex,CC,
8944,GO:0033292,1,0.980498482324556,0,2,T-tubule organization,BP,
8945,GO:0033293,1,0.752950713877495,0,51,monocarboxylic acid binding,MF,
8946,GO:0033299,1,0.970022765643339,0,5,secretion of lysosomal enzymes,BP,
8947,GO:0033300,1,0.97771566845516,0,3,dehydroascorbic acid transmembrane transporter activity,MF,
8948,GO:0033301,1,0.992505358320892,0,1,cell cycle comprising mitosis without cytokinesis,BP,
8949,GO:0033306,1,0.987464530146545,0,2,phytol metabolic process,BP,
8950,GO:0033313,1,0.966087169521145,0,5,meiotic cell cycle checkpoint,BP,
8951,GO:0033314,1,0.949678976541872,0,8,mitotic DNA replication checkpoint,BP,
8952,GO:0033316,1,0.992781274983959,0,1,meiotic spindle assembly checkpoint,BP,
8953,GO:0033319,1,0.994417048873401,0,1,UDP-D-xylose metabolic process,BP,
8954,GO:0033320,1,0.994417048873401,0,1,UDP-D-xylose biosynthetic process,BP,
8955,GO:0033326,1,0.985318010649958,0,2,cerebrospinal fluid secretion,BP,
8956,GO:0033327,1,0.936542736742751,0,10,Leydig cell differentiation,BP,
8957,GO:0033328,1,0.992519843455163,0,1,peroxisome membrane targeting sequence binding,MF,
8958,GO:0033341,1,0.983923449166447,0,2,regulation of collagen binding,BP,
8959,GO:0033342,1,0.993488659060961,0,1,negative regulation of collagen binding,BP,
8960,GO:0033343,1,0.99037272483199,0,1,positive regulation of collagen binding,BP,
8961,GO:0033344,1,0.806787651758714,0,32,cholesterol efflux,BP,
8962,GO:0033345,1,0.993776793975128,0,1,asparagine catabolic process via L-aspartate,BP,
8963,GO:0033353,1,0.971441820202077,0,4,S-adenosylmethionine cycle,BP,
8964,GO:0033363,1,0.836509608182592,0,25,secretory granule organization,BP,
8965,GO:0033364,1,0.983693172057905,0,2,mast cell secretory granule organization,BP,
8967,GO:0033366,1,0.996353860906085,0,1,protein localization to secretory granule,BP,
8968,GO:0033367,1,0.996353860906085,0,1,protein localization to mast cell secretory granule,BP,
8969,GO:0033368,1,0.996353860906085,0,1,protease localization to mast cell secretory granule,BP,
8970,GO:0033370,1,0.996353860906085,0,1,maintenance of protein location in mast cell secretory granule,BP,
8971,GO:0033371,1,0.996353860906085,0,1,T cell secretory granule organization,BP,
8972,GO:0033373,1,0.996353860906085,0,1,maintenance of protease location in mast cell secretory granule,BP,
8973,GO:0033374,1,0.996353860906085,0,1,protein localization to T cell secretory granule,BP,
8974,GO:0033375,1,0.996353860906085,0,1,protease localization to T cell secretory granule,BP,
8975,GO:0033377,1,0.996353860906085,0,1,maintenance of protein location in T cell secretory granule,BP,
8976,GO:0033379,1,0.996353860906085,0,1,maintenance of protease location in T cell secretory granule,BP,
8977,GO:0033380,1,0.996353860906085,0,1,granzyme B localization to T cell secretory granule,BP,
8978,GO:0033382,1,0.996353860906085,0,1,maintenance of granzyme B location in T cell secretory granule,BP,
8979,GO:0033383,1,0.988880477514521,0,2,geranyl diphosphate metabolic process,BP,
8980,GO:0033384,1,0.988880477514521,0,2,geranyl diphosphate biosynthetic process,BP,
8981,GO:0033385,1,0.993022215493547,0,1,geranylgeranyl diphosphate metabolic process,BP,
8982,GO:0033386,1,0.993022215493547,0,1,geranylgeranyl diphosphate biosynthetic process,BP,
8983,GO:0033387,1,0.980080031604302,0,3,putrescine biosynthetic process from ornithine,BP,
8984,GO:0033388,1,0.994175540086614,0,1,putrescine biosynthetic process from arginine,BP,
8985,GO:0033391,1,0.9224265002744,0,11,chromatoid body,CC,
8986,GO:0033396,1,0.994468402997698,0,1,beta-alanine biosynthetic process via 3-ureidopropionate,BP,
8987,GO:0033477,1,0.994649534375166,0,1,S-methylmethionine metabolic process,BP,
8988,GO:0033483,1,0.945473444173593,0,9,gas homeostasis,BP,
8989,GO:0033484,1,0.982600482806427,0,3,nitric oxide homeostasis,BP,
8990,GO:0033488,1,0.992745374232163,0,1,cholesterol biosynthetic process via 24,25-dihydrolanosterol,BP,
8991,GO:0033489,1,0.975510056091815,0,4,cholesterol biosynthetic process via desmosterol,BP,
8992,GO:0033490,1,0.975510056091815,0,4,cholesterol biosynthetic process via lathosterol,BP,
8993,GO:0033499,1,0.98975292551117,0,2,galactose catabolic process via UDP-galactose,BP,
8995,GO:0033503,1,0.973585860401974,0,4,HULC complex,CC,
8996,GO:0033504,1,0.962624378336373,0,5,floor plate development,BP,
8997,GO:0033505,1,0.98553052265169,0,2,floor plate morphogenesis,BP,
8998,GO:0033512,1,0.978824013860623,0,3,L-lysine catabolic process to acetyl-CoA via saccharopine,BP,
8999,GO:0033514,1,0.99370543607473,0,1,L-lysine catabolic process to acetyl-CoA via L-pipecolate,BP,
9000,GO:0033522,1,0.841123665835581,0,24,histone H2A ubiquitination,BP,
9001,GO:0033523,1,0.920374946775166,0,12,histone H2B ubiquitination,BP,
9002,GO:0033526,1,0.993170130433943,0,1,tetrapyrrole biosynthetic process from glutamate,BP,
9003,GO:0033539,1,0.915971937121132,0,14,fatty acid beta-oxidation using acyl-CoA dehydrogenase,BP,
9004,GO:0033540,1,0.915684296441571,0,14,fatty acid beta-oxidation using acyl-CoA oxidase,BP,
9005,GO:0033549,1,0.923926403087508,0,12,MAP kinase phosphatase activity,MF,
9006,GO:0033552,1,0.993371042688108,0,1,response to vitamin B3,BP,
9007,GO:0033553,1,0.971095748831305,0,4,rDNA heterochromatin,CC,
9010,GO:0033557,1,0.986164624597214,0,2,Slx1-Slx4 complex,CC,
9011,GO:0033558,1,0.732465196470523,0,44,protein deacetylase activity,MF,
9012,GO:0033559,1,0.607022505215473,0,86,unsaturated fatty acid metabolic process,BP,
9013,GO:0033560,1,0.992484099751837,0,1,folate reductase activity,MF,
9014,GO:0033561,1,0.886369967878234,0,18,regulation of water loss via skin,BP,
9015,GO:0033563,1,0.976330470279451,0,3,dorsal/ventral axon guidance,BP,
9016,GO:0033564,1,0.952615756207514,0,6,anterior/posterior axon guidance,BP,
9017,GO:0033565,1,0.977587938755379,0,3,ESCRT-0 complex,CC,
9018,GO:0033566,1,0.986799034953354,0,2,gamma-tubulin complex localization,BP,
9019,GO:0033567,1,0.971559121661087,0,5,DNA replication, Okazaki fragment processing,BP,
9020,GO:0033570,1,0.984996293869419,0,2,transferrin transmembrane transporter activity,MF,
9021,GO:0033572,1,0.807894359840633,0,35,transferrin transport,BP,
9022,GO:0033574,1,0.777441981060877,0,41,response to testosterone,BP,
9023,GO:0033577,1,0.986421258952124,0,2,protein glycosylation in endoplasmic reticulum,BP,
9024,GO:0033578,1,0.965498574051485,0,5,protein glycosylation in Golgi,BP,
9025,GO:0033588,1,0.968321367482921,0,5,Elongator holoenzyme complex,CC,
9027,GO:0033591,1,0.966976946739327,0,5,response to L-ascorbic acid,BP,
9028,GO:0033592,1,0.963860374651255,0,5,RNA strand annealing activity,MF,
9029,GO:0033593,1,0.988393101666378,0,1,BRCA2-MAGE-D1 complex,CC,
9031,GO:0033595,1,0.986761689521347,0,2,response to genistein,BP,
9032,GO:0033596,1,0.981794480298116,0,2,TSC1-TSC2 complex,CC,
9033,GO:0033597,1,0.994277074612634,0,1,mitotic checkpoint complex,CC,
9034,GO:0033598,1,0.834842534595902,0,26,mammary gland epithelial cell proliferation,BP,
9035,GO:0033599,1,0.887278445139851,0,17,regulation of mammary gland epithelial cell proliferation,BP,
9036,GO:0033600,1,0.968110057248075,0,4,negative regulation of mammary gland epithelial cell proliferation,BP,
9037,GO:0033601,1,0.938776413080815,0,8,positive regulation of mammary gland epithelial cell proliferation,BP,
9038,GO:0033602,1,0.977226839737337,0,3,negative regulation of dopamine secretion,BP,
9039,GO:0033603,1,0.962548767684314,0,6,positive regulation of dopamine secretion,BP,
9040,GO:0033604,1,0.937914695281434,0,10,negative regulation of catecholamine secretion,BP,
9041,GO:0033605,1,0.939973765038218,0,10,positive regulation of catecholamine secretion,BP,
9042,GO:0033608,1,0.993058458973322,0,1,formyl-CoA transferase activity,MF,
9043,GO:0033609,1,0.993058458973322,0,1,oxalate metabolic process,BP,
9044,GO:0033612,1,0.887799790371489,0,18,receptor serine/threonine kinase binding,MF,
9045,GO:0033613,1,0.609252458719121,0,70,activating transcription factor binding,MF,
9046,GO:0033615,1,0.982283924905531,0,3,mitochondrial proton-transporting ATP synthase complex assembly,BP,
9047,GO:0033617,1,0.89357052734716,0,20,mitochondrial respiratory chain complex IV assembly,BP,
9048,GO:0033619,1,0.663080473571061,0,61,membrane protein proteolysis,BP,
9049,GO:0033622,1,0.870828646053948,0,19,integrin activation,BP,
9050,GO:0033623,1,0.931157186948168,0,10,regulation of integrin activation,BP,
9051,GO:0033624,1,0.983360251983177,0,2,negative regulation of integrin activation,BP,
9052,GO:0033625,1,0.967868236214068,0,5,positive regulation of integrin activation,BP,
9053,GO:0033626,1,0.992506510678346,0,1,positive regulation of integrin activation by cell surface receptor linked signal transduction,BP,
9054,GO:0033627,1,0.702892140431968,0,52,cell adhesion mediated by integrin,BP,
9055,GO:0033628,1,0.79152796640255,0,37,regulation of cell adhesion mediated by integrin,BP,
9056,GO:0033629,1,0.945336127481834,0,8,negative regulation of cell adhesion mediated by integrin,BP,
9057,GO:0033630,1,0.907767634636671,0,16,positive regulation of cell adhesion mediated by integrin,BP,
9058,GO:0033631,1,0.927107391646523,0,11,cell-cell adhesion mediated by integrin,BP,
9059,GO:0033632,1,0.955747568290995,0,7,regulation of cell-cell adhesion mediated by integrin,BP,
9060,GO:0033633,1,0.992195539728116,0,1,negative regulation of cell-cell adhesion mediated by integrin,BP,
9061,GO:0033634,1,0.981190391880815,0,3,positive regulation of cell-cell adhesion mediated by integrin,BP,
9062,GO:0033643,1,0.923668946553049,0,12,host cell part,CC,
9063,GO:0033644,1,0.992440287823366,0,1,host cell membrane,CC,
9064,GO:0033646,1,0.94404924788908,0,9,host intracellular part,CC,
9065,GO:0033647,1,0.966735514129568,0,5,host intracellular organelle,CC,
9066,GO:0033648,1,0.966735514129568,0,5,host intracellular membrane-bounded organelle,CC,
9067,GO:0033650,1,0.995219366830879,0,1,host cell mitochondrion,CC,
9068,GO:0033655,1,0.964637085674657,0,6,host cell cytoplasm part,CC,
9069,GO:0033668,1,0.976055555726026,0,4,negative regulation by symbiont of host apoptotic process,BP,
9070,GO:0033673,1,0.189796538584101,0,250,negative regulation of kinase activity,BP,
9072,GO:0033676,1,0.996008329622322,0,1,double-stranded DNA-dependent ATPase activity,MF,
9073,GO:0033677,1,0.978833424641995,0,3,DNA/RNA helicase activity,MF,
9074,GO:0033678,1,0.993242275221885,0,1,5'-3' DNA/RNA helicase activity,MF,
9075,GO:0033679,1,0.992297874244277,0,1,3'-5' DNA/RNA helicase activity,MF,
9076,GO:0033680,1,0.985591681874631,0,2,ATP-dependent DNA/RNA helicase activity,MF,
9077,GO:0033681,1,0.992297874244277,0,1,ATP-dependent 3'-5' DNA/RNA helicase activity,MF,
9078,GO:0033682,1,0.993242275221885,0,1,ATP-dependent 5'-3' DNA/RNA helicase activity,MF,
9079,GO:0033683,1,0.794025154503102,0,39,nucleotide-excision repair, DNA incision,BP,
9080,GO:0033684,1,0.955789251851154,0,7,regulation of luteinizing hormone secretion,BP,
9081,GO:0033685,1,0.982243409234946,0,3,negative regulation of luteinizing hormone secretion,BP,
9082,GO:0033686,1,0.973072375940447,0,4,positive regulation of luteinizing hormone secretion,BP,
9085,GO:0033689,1,0.932716124635963,0,9,negative regulation of osteoblast proliferation,BP,
9089,GO:0033693,1,0.985482805584092,0,2,neurofilament bundle assembly,BP,
9090,GO:0033695,1,0.99480822318924,0,1,oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor,MF,
9091,GO:0033699,1,0.994585815572028,0,1,DNA 5'-adenosine monophosphate hydrolase activity,MF,
9092,GO:0033700,1,0.952722260534074,0,8,phospholipid efflux,BP,
9093,GO:0033735,1,0.997004855917649,0,1,aspartate dehydrogenase activity,MF,
9094,GO:0033737,1,0.993524842093636,0,1,1-pyrroline dehydrogenase activity,MF,
9095,GO:0033743,1,0.976924090603169,0,4,peptide-methionine (R)-S-oxide reductase activity,MF,
9096,GO:0033745,1,0.980683131206192,0,3,L-methionine-(R)-S-oxide reductase activity,MF,
9097,GO:0033746,1,0.992518804425241,0,1,histone demethylase activity (H3-R2 specific),MF,
9098,GO:0033749,1,0.992518804425241,0,1,histone demethylase activity (H4-R3 specific),MF,
9099,GO:0033750,1,0.934535180294117,0,13,ribosome localization,BP,
9100,GO:0033754,1,0.995637149595466,0,1,indoleamine 2,3-dioxygenase activity,MF,
9101,GO:0033762,1,0.736807335114618,0,46,response to glucagon,BP,
9102,GO:0033764,1,0.903745657408252,0,22,steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor,MF,
9103,GO:0033765,1,0.987320892996893,0,2,steroid dehydrogenase activity, acting on the CH-CH group of donors,MF,
9104,GO:0033768,1,0.992861395693353,0,1,SUMO-targeted ubiquitin ligase complex,CC,
9105,GO:0033778,1,0.992481028403495,0,1,7alpha-hydroxycholest-4-en-3-one 12alpha-hydroxylase activity,MF,
9106,GO:0033781,1,0.994433365545022,0,1,cholesterol 24-hydroxylase activity,MF,
9107,GO:0033787,1,0.992975566243211,0,1,cyanocobalamin reductase (cyanide-eliminating) activity,MF,
9108,GO:0033791,1,0.993909630516511,0,1,3alpha,7alpha,12alpha-trihydroxy-5beta-cholestanoyl-CoA 24-hydroxylase activity,MF,
9109,GO:0033798,1,0.994405408097248,0,1,thyroxine 5-deiodinase activity,MF,
9110,GO:0033814,1,0.995977168526206,0,1,propanoyl-CoA C-acyltransferase activity,MF,
9111,GO:0033819,1,0.996983772724596,0,1,lipoyl(octanoyl) transferase activity,MF,
9112,GO:0033823,1,0.992818852022948,0,1,procollagen glucosyltransferase activity,MF,
9113,GO:0033829,1,0.983816283011033,0,3,O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity,MF,
9114,GO:0033842,1,0.985160650098334,0,2,N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity,MF,
9115,GO:0033857,1,0.983759943843758,0,2,diphosphoinositol-pentakisphosphate kinase activity,MF,
9116,GO:0033858,1,0.992678768915447,0,1,N-acetylgalactosamine kinase activity,MF,
9117,GO:0033860,1,0.965615851952885,0,7,regulation of NAD(P)H oxidase activity,BP,
9118,GO:0033861,1,0.990105691903049,0,2,negative regulation of NAD(P)H oxidase activity,BP,
9119,GO:0033862,1,0.992821698929158,0,1,UMP kinase activity,MF,
9120,GO:0033864,1,0.975267862416991,0,5,positive regulation of NAD(P)H oxidase activity,BP,
9121,GO:0033865,1,0.800758171494734,0,37,nucleoside bisphosphate metabolic process,BP,
9122,GO:0033866,1,0.905396928924145,0,16,nucleoside bisphosphate biosynthetic process,BP,
9123,GO:0033867,1,0.995470054455147,0,1,Fas-activated serine/threonine kinase activity,MF,
9124,GO:0033869,1,0.996867443319391,0,1,nucleoside bisphosphate catabolic process,BP,
9125,GO:0033871,1,0.99476079763154,0,1,[heparan sulfate]-glucosamine 3-sulfotransferase 2 activity,MF,
9126,GO:0033872,1,0.98809253719523,0,2,[heparan sulfate]-glucosamine 3-sulfotransferase 3 activity,MF,
9127,GO:0033875,1,0.800758171494734,0,37,ribonucleoside bisphosphate metabolic process,BP,
9128,GO:0033878,1,0.992495499625045,0,1,hormone-sensitive lipase activity,MF,
9129,GO:0033882,1,0.996553211111413,0,1,choloyl-CoA hydrolase activity,MF,
9130,GO:0033883,1,0.991279182632911,0,2,pyridoxal phosphatase activity,MF,
9131,GO:0033885,1,0.99415291577638,0,1,10-hydroxy-9-(phosphonooxy)octadecanoate phosphatase activity,MF,
9132,GO:0033897,1,0.996353860906085,0,1,ribonuclease T2 activity,MF,
9133,GO:0033906,1,0.988957061289103,0,2,hyaluronoglucuronidase activity,MF,
9134,GO:0033919,1,0.99248541887796,0,1,glucan 1,3-alpha-glucosidase activity,MF,
9135,GO:0033925,1,0.992348248037886,0,1,mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase activity,MF,
9136,GO:0033961,1,0.995229897967512,0,1,cis-stilbene-oxide hydrolase activity,MF,
9137,GO:0033962,1,0.868610387679836,0,18,cytoplasmic mRNA processing body assembly,BP,
9138,GO:0033967,1,0.996531647484467,0,1,box C/D snoRNA metabolic process,BP,
9139,GO:0033979,1,0.993389871031089,0,1,box H/ACA snoRNA metabolic process,BP,
9140,GO:0033981,1,0.997635071656587,0,1,D-dopachrome decarboxylase activity,MF,
9141,GO:0033989,1,0.993198506957189,0,1,3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity,MF,
9143,GO:0034014,1,0.993971591098376,0,1,response to triglyceride,BP,
9144,GO:0034030,1,0.905396928924145,0,16,ribonucleoside bisphosphate biosynthetic process,BP,
9145,GO:0034031,1,0.996867443319391,0,1,ribonucleoside bisphosphate catabolic process,BP,
9146,GO:0034032,1,0.800758171494734,0,37,purine nucleoside bisphosphate metabolic process,BP,
9147,GO:0034033,1,0.905396928924145,0,16,purine nucleoside bisphosphate biosynthetic process,BP,
9148,GO:0034034,1,0.996867443319391,0,1,purine nucleoside bisphosphate catabolic process,BP,
9149,GO:0034035,1,0.876612015586938,0,22,purine ribonucleoside bisphosphate metabolic process,BP,
9150,GO:0034036,1,0.958517108260964,0,6,purine ribonucleoside bisphosphate biosynthetic process,BP,
9151,GO:0034038,1,0.996490607372436,0,1,deoxyhypusine synthase activity,MF,
9152,GO:0034039,1,0.989869580538138,0,2,8-oxo-7,8-dihydroguanine DNA N-glycosylase activity,MF,
9153,GO:0034040,1,0.954139225507978,0,6,lipid-transporting ATPase activity,MF,
9154,GO:0034041,1,0.978707729855018,0,3,sterol-transporting ATPase activity,MF,
9155,GO:0034045,1,0.888775587580193,0,16,phagophore assembly site membrane,CC,
9156,GO:0034046,1,0.947268787068215,0,7,poly(G) binding,MF,
9158,GO:0034057,1,0.986020250334919,0,2,RNA strand-exchange activity,MF,
9159,GO:0034058,1,0.925762158698262,0,10,endosomal vesicle fusion,BP,
9160,GO:0034059,1,0.977080351464235,0,3,response to anoxia,BP,
9161,GO:0034061,1,0.788134576424132,0,34,DNA polymerase activity,MF,
9162,GO:0034062,1,0.782696478561579,0,43,5'-3' RNA polymerase activity,MF,
9163,GO:0034063,1,0.90203173503181,0,13,stress granule assembly,BP,
9164,GO:0034066,1,0.98932884416997,0,2,RIC1-RGP1 guanyl-nucleotide exchange factor complex,CC,
9165,GO:0034067,1,0.841594572722551,0,21,protein localization to Golgi apparatus,BP,
9166,GO:0034080,1,0.851888907468094,0,30,CENP-A containing nucleosome assembly,BP,
9167,GO:0034085,1,0.956005679608391,0,6,establishment of sister chromatid cohesion,BP,
9168,GO:0034086,1,0.928530508514089,0,10,maintenance of sister chromatid cohesion,BP,
9169,GO:0034087,1,0.981683895718303,0,2,establishment of mitotic sister chromatid cohesion,BP,
9170,GO:0034088,1,0.928530508514089,0,10,maintenance of mitotic sister chromatid cohesion,BP,
9171,GO:0034091,1,0.958513919806527,0,6,regulation of maintenance of sister chromatid cohesion,BP,
9172,GO:0034092,1,0.975221768914503,0,3,negative regulation of maintenance of sister chromatid cohesion,BP,
9173,GO:0034093,1,0.982871901541802,0,3,positive regulation of maintenance of sister chromatid cohesion,BP,
9175,GO:0034098,1,0.938340328744941,0,9,VCP-NPL4-UFD1 AAA ATPase complex,CC,
9178,GO:0034104,1,0.9042036312244,0,16,negative regulation of tissue remodeling,BP,
9182,GO:0034111,1,0.909143872818462,0,14,negative regulation of homotypic cell-cell adhesion,BP,
9187,GO:0034116,1,0.942470778852918,0,10,positive regulation of heterotypic cell-cell adhesion,BP,
9188,GO:0034117,1,0.997815481060114,0,1,erythrocyte aggregation,BP,
9189,GO:0034118,1,0.997815481060114,0,1,regulation of erythrocyte aggregation,BP,
9190,GO:0034120,1,0.997815481060114,0,1,positive regulation of erythrocyte aggregation,BP,
9192,GO:0034122,1,0.795462161808435,0,33,negative regulation of toll-like receptor signaling pathway,BP,
9194,GO:0034124,1,0.977509201745035,0,4,regulation of MyD88-dependent toll-like receptor signaling pathway,BP,
9195,GO:0034125,1,0.990125562634333,0,2,negative regulation of MyD88-dependent toll-like receptor signaling pathway,BP,
9196,GO:0034127,1,0.950537529645902,0,8,regulation of MyD88-independent toll-like receptor signaling pathway,BP,
9197,GO:0034128,1,0.955614393047596,0,7,negative regulation of MyD88-independent toll-like receptor signaling pathway,BP,
9198,GO:0034130,1,0.992974313593734,0,1,toll-like receptor 1 signaling pathway,BP,
9199,GO:0034134,1,0.923807162427227,0,12,toll-like receptor 2 signaling pathway,BP,
9200,GO:0034135,1,0.956149297748199,0,7,regulation of toll-like receptor 2 signaling pathway,BP,
9201,GO:0034136,1,0.976901162254965,0,3,negative regulation of toll-like receptor 2 signaling pathway,BP,
9202,GO:0034137,1,0.978762369498547,0,4,positive regulation of toll-like receptor 2 signaling pathway,BP,
9203,GO:0034138,1,0.880851139830948,0,19,toll-like receptor 3 signaling pathway,BP,
9204,GO:0034139,1,0.940386743413308,0,9,regulation of toll-like receptor 3 signaling pathway,BP,
9205,GO:0034140,1,0.977923229470544,0,3,negative regulation of toll-like receptor 3 signaling pathway,BP,
9206,GO:0034141,1,0.954829553229456,0,7,positive regulation of toll-like receptor 3 signaling pathway,BP,
9209,GO:0034144,1,0.959577400825346,0,6,negative regulation of toll-like receptor 4 signaling pathway,BP,
9211,GO:0034146,1,0.984849199868138,0,2,toll-like receptor 5 signaling pathway,BP,
9212,GO:0034147,1,0.992371143331572,0,1,regulation of toll-like receptor 5 signaling pathway,BP,
9213,GO:0034148,1,0.992371143331572,0,1,negative regulation of toll-like receptor 5 signaling pathway,BP,
9214,GO:0034150,1,0.991598275708435,0,1,toll-like receptor 6 signaling pathway,BP,
9215,GO:0034154,1,0.955336874730097,0,7,toll-like receptor 7 signaling pathway,BP,
9216,GO:0034155,1,0.982431050165764,0,3,regulation of toll-like receptor 7 signaling pathway,BP,
9217,GO:0034156,1,0.995319688798766,0,1,negative regulation of toll-like receptor 7 signaling pathway,BP,
9218,GO:0034157,1,0.987051359195771,0,2,positive regulation of toll-like receptor 7 signaling pathway,BP,
9219,GO:0034158,1,0.992435168146907,0,1,toll-like receptor 8 signaling pathway,BP,
9220,GO:0034162,1,0.868594449594446,0,20,toll-like receptor 9 signaling pathway,BP,
9221,GO:0034163,1,0.957573962327898,0,6,regulation of toll-like receptor 9 signaling pathway,BP,
9222,GO:0034164,1,0.986480305047218,0,2,negative regulation of toll-like receptor 9 signaling pathway,BP,
9223,GO:0034165,1,0.985158053144093,0,2,positive regulation of toll-like receptor 9 signaling pathway,BP,
9224,GO:0034166,1,0.992604983052565,0,1,toll-like receptor 10 signaling pathway,BP,
9225,GO:0034182,1,0.958513919806527,0,6,regulation of maintenance of mitotic sister chromatid cohesion,BP,
9226,GO:0034183,1,0.975221768914503,0,3,negative regulation of maintenance of mitotic sister chromatid cohesion,BP,
9227,GO:0034184,1,0.982871901541802,0,3,positive regulation of maintenance of mitotic sister chromatid cohesion,BP,
9228,GO:0034185,1,0.879726286792225,0,16,apolipoprotein binding,MF,
9229,GO:0034186,1,0.972431024214803,0,4,apolipoprotein A-I binding,MF,
9230,GO:0034188,1,0.980002814002865,0,2,apolipoprotein A-I receptor activity,MF,
9231,GO:0034189,1,0.985092474173048,0,2,very-low-density lipoprotein particle binding,MF,
9232,GO:0034190,1,0.968658663943948,0,5,apolipoprotein receptor binding,MF,
9233,GO:0034191,1,0.97596481027649,0,4,apolipoprotein A-I receptor binding,MF,
9234,GO:0034196,1,0.978822138888374,0,4,acylglycerol transport,BP,
9235,GO:0034197,1,0.978822138888374,0,4,triglyceride transport,BP,
9236,GO:0034198,1,0.761995843897448,0,42,cellular response to amino acid starvation,BP,
9237,GO:0034199,1,0.884581677944038,0,16,activation of protein kinase A activity,BP,
9238,GO:0034201,1,0.96749672171034,0,5,response to oleic acid,BP,
9239,GO:0034203,1,0.992064062897157,0,1,glycolipid translocation,BP,
9241,GO:0034205,1,0.849227424219766,0,23,amyloid-beta formation,BP,
9242,GO:0034211,1,0.989575106505612,0,1,GTP-dependent protein kinase activity,MF,
9243,GO:0034212,1,0.652795340968555,0,60,peptide N-acetyltransferase activity,MF,
9244,GO:0034213,1,0.995691687835932,0,1,quinolinate catabolic process,BP,
9245,GO:0034214,1,0.943822605103574,0,8,protein hexamerization,BP,
9246,GO:0034219,1,0.4907261045386,0,100,carbohydrate transmembrane transport,BP,
9248,GO:0034224,1,0.994062091938459,0,1,cellular response to zinc ion starvation,BP,
9249,GO:0034227,1,0.974030159468705,0,5,tRNA thio-modification,BP,
9250,GO:0034230,1,0.992244237882716,0,1,enkephalin processing,BP,
9251,GO:0034231,1,0.992244237882716,0,1,islet amyloid polypeptide processing,BP,
9252,GO:0034235,1,0.964432247778524,0,6,GPI anchor binding,MF,
9253,GO:0034236,1,0.902411558297158,0,14,protein kinase A catalytic subunit binding,MF,
9254,GO:0034237,1,0.865778321550501,0,17,protein kinase A regulatory subunit binding,MF,
9255,GO:0034238,1,0.992475745570782,0,1,macrophage fusion,BP,
9256,GO:0034239,1,0.992475745570782,0,1,regulation of macrophage fusion,BP,
9257,GO:0034241,1,0.992475745570782,0,1,positive regulation of macrophage fusion,BP,
9258,GO:0034242,1,0.98286356956617,0,3,negative regulation of syncytium formation by plasma membrane fusion,BP,
9259,GO:0034243,1,0.846222261602241,0,25,regulation of transcription elongation from RNA polymerase II promoter,BP,
9260,GO:0034244,1,0.931047741374795,0,11,negative regulation of transcription elongation from RNA polymerase II promoter,BP,
9261,GO:0034245,1,0.992494872728685,0,1,mitochondrial DNA-directed RNA polymerase complex,CC,
9262,GO:0034247,1,0.996264298514217,0,1,snoRNA splicing,BP,
9265,GO:0034250,1,0.427981038093464,0,131,positive regulation of cellular amide metabolic process,BP,
9266,GO:0034255,1,0.994287414484928,0,1,regulation of urea metabolic process,BP,
9267,GO:0034260,1,0.736443120329799,0,44,negative regulation of GTPase activity,BP,
9268,GO:0034271,1,0.979257024951479,0,3,phosphatidylinositol 3-kinase complex, class III, type I,CC,
9269,GO:0034272,1,0.979257024951479,0,3,phosphatidylinositol 3-kinase complex, class III, type II,CC,
9270,GO:0034274,1,0.977457380677906,0,3,Atg12-Atg5-Atg16 complex,CC,
9271,GO:0034275,1,0.995637149595466,0,1,kynurenic acid metabolic process,BP,
9272,GO:0034276,1,0.995637149595466,0,1,kynurenic acid biosynthetic process,BP,
9274,GO:0034285,1,0.971081450517986,0,4,response to disaccharide,BP,
9275,GO:0034287,1,0.977367762130338,0,4,detection of monosaccharide stimulus,BP,
9276,GO:0034308,1,0.74239936355023,0,50,primary alcohol metabolic process,BP,
9277,GO:0034309,1,0.997032233810024,0,1,primary alcohol biosynthetic process,BP,
9278,GO:0034310,1,0.943632660611176,0,12,primary alcohol catabolic process,BP,
9279,GO:0034311,1,0.900326267580645,0,19,diol metabolic process,BP,
9280,GO:0034312,1,0.913902264220895,0,16,diol biosynthetic process,BP,
9281,GO:0034314,1,0.825581700744087,0,31,Arp2/3 complex-mediated actin nucleation,BP,
9282,GO:0034315,1,0.90643527519369,0,15,regulation of Arp2/3 complex-mediated actin nucleation,BP,
9283,GO:0034316,1,0.97191827036044,0,5,negative regulation of Arp2/3 complex-mediated actin nucleation,BP,
9286,GO:0034331,1,0.929206673986269,0,11,cell junction maintenance,BP,
9289,GO:0034334,1,0.96997388070846,0,4,adherens junction maintenance,BP,
9290,GO:0034338,1,0.973391010140522,0,4,short-chain carboxylesterase activity,MF,
9293,GO:0034342,1,0.987437805332328,0,2,response to type III interferon,BP,
9294,GO:0034343,1,0.977737111534353,0,3,type III interferon production,BP,
9295,GO:0034344,1,0.977737111534353,0,3,regulation of type III interferon production,BP,
9296,GO:0034346,1,0.992774835717277,0,1,positive regulation of type III interferon production,BP,
9297,GO:0034349,1,0.906912895892139,0,14,glial cell apoptotic process,BP,
9298,GO:0034350,1,0.946430255016532,0,8,regulation of glial cell apoptotic process,BP,
9299,GO:0034351,1,0.946430255016532,0,8,negative regulation of glial cell apoptotic process,BP,
9300,GO:0034353,1,0.993058458973322,0,1,RNA pyrophosphohydrolase activity,MF,
9301,GO:0034354,1,0.996270867477429,0,1,'de novo' NAD biosynthetic process from tryptophan,BP,
9302,GO:0034355,1,0.993058458973322,0,1,NAD salvage,BP,
9303,GO:0034356,1,0.920404465633417,0,12,NAD biosynthesis via nicotinamide riboside salvage pathway,BP,
9304,GO:0034358,1,0.834953165026056,0,32,plasma lipoprotein particle,CC,
9305,GO:0034359,1,0.986983923931638,0,1,mature chylomicron,CC,
9306,GO:0034360,1,0.986983923931638,0,1,chylomicron remnant,CC,
9307,GO:0034361,1,0.924183170494245,0,15,very-low-density lipoprotein particle,CC,
9308,GO:0034362,1,0.9299301463836,0,12,low-density lipoprotein particle,CC,
9309,GO:0034363,1,0.978222637504474,0,4,intermediate-density lipoprotein particle,CC,
9310,GO:0034364,1,0.913572234815458,0,21,high-density lipoprotein particle,CC,
9311,GO:0034365,1,0.991037933520334,0,3,discoidal high-density lipoprotein particle,CC,
9312,GO:0034366,1,0.976765480662852,0,6,spherical high-density lipoprotein particle,CC,
9313,GO:0034367,1,0.874777216138896,0,23,protein-containing complex remodeling,BP,
9314,GO:0034368,1,0.881146376672683,0,22,protein-lipid complex remodeling,BP,
9315,GO:0034369,1,0.881146376672683,0,22,plasma lipoprotein particle remodeling,BP,
9316,GO:0034370,1,0.958275003511944,0,8,triglyceride-rich lipoprotein particle remodeling,BP,
9317,GO:0034371,1,0.970886190696998,0,5,chylomicron remodeling,BP,
9318,GO:0034372,1,0.970916229940091,0,7,very-low-density lipoprotein particle remodeling,BP,
9319,GO:0034373,1,0.995557265192383,0,1,intermediate-density lipoprotein particle remodeling,BP,
9320,GO:0034374,1,0.932498001970304,0,11,low-density lipoprotein particle remodeling,BP,
9321,GO:0034375,1,0.93335503851864,0,14,high-density lipoprotein particle remodeling,BP,
9322,GO:0034377,1,0.870965083352934,0,22,plasma lipoprotein particle assembly,BP,
9323,GO:0034378,1,0.956442411644026,0,7,chylomicron assembly,BP,
9324,GO:0034379,1,0.942185512783714,0,9,very-low-density lipoprotein particle assembly,BP,
9325,GO:0034380,1,0.934518613079088,0,11,high-density lipoprotein particle assembly,BP,
9326,GO:0034381,1,0.750717180221676,0,46,plasma lipoprotein particle clearance,BP,
9327,GO:0034382,1,0.96047245576867,0,7,chylomicron remnant clearance,BP,
9328,GO:0034383,1,0.823310797674931,0,29,low-density lipoprotein particle clearance,BP,
9329,GO:0034384,1,0.944473152969726,0,10,high-density lipoprotein particle clearance,BP,
9330,GO:0034385,1,0.924183170494245,0,15,triglyceride-rich plasma lipoprotein particle,CC,
9331,GO:0034386,1,0.992162690456213,0,1,4-aminobutyrate:2-oxoglutarate transaminase activity,MF,
9332,GO:0034388,1,0.959613911454796,0,6,Pwp2p-containing subcomplex of 90S preribosome,CC,
9333,GO:0034389,1,0.900629834858927,0,17,lipid particle organization,BP,
9334,GO:0034390,1,0.893309208032194,0,17,smooth muscle cell apoptotic process,BP,
9335,GO:0034391,1,0.893309208032194,0,17,regulation of smooth muscle cell apoptotic process,BP,
9336,GO:0034392,1,0.96602766534325,0,5,negative regulation of smooth muscle cell apoptotic process,BP,
9337,GO:0034393,1,0.937255711024831,0,10,positive regulation of smooth muscle cell apoptotic process,BP,
9338,GO:0034394,1,0.7017793873694,0,51,protein localization to cell surface,BP,
9339,GO:0034395,1,0.988305249704075,0,2,regulation of transcription from RNA polymerase II promoter in response to iron,BP,
9340,GO:0034397,1,0.921398475415678,0,11,telomere localization,BP,
9341,GO:0034398,1,0.95841879652721,0,6,telomere tethering at nuclear periphery,BP,
9342,GO:0034399,1,0.403389704902213,0,127,nuclear periphery,CC,
9343,GO:0034402,1,0.985502621972177,0,2,recruitment of 3'-end processing factors to RNA polymerase II holoenzyme complex,BP,
9344,GO:0034404,1,0.281143873506639,0,198,nucleobase-containing small molecule biosynthetic process,BP,
9346,GO:0034414,1,0.986639566405845,0,2,tRNA 3'-trailer cleavage, endonucleolytic,BP,
9347,GO:0034416,1,0.992975566243211,0,1,bisphosphoglycerate phosphatase activity,MF,
9348,GO:0034417,1,0.992975566243211,0,1,bisphosphoglycerate 3-phosphatase activity,MF,
9349,GO:0034418,1,0.988012228029918,0,2,urate biosynthetic process,BP,
9350,GO:0034421,1,0.979084432722445,0,3,post-translational protein acetylation,BP,
9351,GO:0034423,1,0.993292546137503,0,1,autophagosome lumen,CC,
9352,GO:0034427,1,0.954158311198488,0,10,nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5',BP,
9353,GO:0034431,1,0.976974422612972,0,4,bis(5'-adenosyl)-hexaphosphatase activity,MF,
9354,GO:0034432,1,0.976974422612972,0,4,bis(5'-adenosyl)-pentaphosphatase activity,MF,
9355,GO:0034433,1,0.948705047696894,0,10,steroid esterification,BP,
9356,GO:0034434,1,0.948705047696894,0,10,sterol esterification,BP,
9357,GO:0034435,1,0.948705047696894,0,10,cholesterol esterification,BP,
9358,GO:0034436,1,0.982354168869116,0,3,glycoprotein transport,BP,
9359,GO:0034437,1,0.985397588688418,0,2,glycoprotein transporter activity,MF,
9362,GO:0034441,1,0.992514216229341,0,2,plasma lipoprotein particle oxidation,BP,
9365,GO:0034444,1,0.99739146810888,0,1,regulation of plasma lipoprotein oxidation,BP,
9366,GO:0034445,1,0.99739146810888,0,1,negative regulation of plasma lipoprotein oxidation,BP,
9368,GO:0034447,1,0.958609475597979,0,8,very-low-density lipoprotein particle clearance,BP,
9369,GO:0034448,1,0.973171314376684,0,5,EGO complex,CC,
9370,GO:0034450,1,0.914714072288435,0,13,ubiquitin-ubiquitin ligase activity,MF,
9371,GO:0034451,1,0.817221703195618,0,27,centriolar satellite,CC,
9372,GO:0034452,1,0.917951424146989,0,10,dynactin binding,MF,
9373,GO:0034453,1,0.836996234496379,0,22,microtubule anchoring,BP,
9374,GO:0034454,1,0.925622360966827,0,9,microtubule anchoring at centrosome,BP,
9375,GO:0034455,1,0.984667449825649,0,2,t-UTP complex,CC,
9376,GO:0034456,1,0.988922995855053,0,2,UTP-C complex,CC,
9377,GO:0034457,1,0.986777414650813,0,3,Mpp10 complex,CC,
9378,GO:0034458,1,0.985914349085869,0,2,3'-5' RNA helicase activity,MF,
9379,GO:0034459,1,0.992297874244277,0,1,ATP-dependent 3'-5' RNA helicase activity,MF,
9380,GO:0034462,1,0.994058754267211,0,1,small-subunit processome assembly,BP,
9381,GO:0034463,1,0.998186885389187,0,1,90S preribosome assembly,BP,
9382,GO:0034464,1,0.94184690221735,0,9,BBSome,CC,
9383,GO:0034465,1,0.976540160680378,0,4,response to carbon monoxide,BP,
9384,GO:0034466,1,0.993081818362706,0,1,chromaffin granule lumen,CC,
9385,GO:0034470,1,0.114142840283157,0,389,ncRNA processing,BP,
9386,GO:0034471,1,0.899314963397437,0,19,ncRNA 5'-end processing,BP,
9387,GO:0034472,1,0.91698090680319,0,15,snRNA 3'-end processing,BP,
9388,GO:0034473,1,0.988137441340789,0,3,U1 snRNA 3'-end processing,BP,
9389,GO:0034474,1,0.990896790936479,0,1,U2 snRNA 3'-end processing,BP,
9390,GO:0034475,1,0.968659768056773,0,8,U4 snRNA 3'-end processing,BP,
9391,GO:0034476,1,0.988137441340789,0,3,U5 snRNA 3'-end processing,BP,
9392,GO:0034477,1,0.993058458973322,0,1,U6 snRNA 3'-end processing,BP,
9393,GO:0034481,1,0.960985825341529,0,6,chondroitin sulfotransferase activity,MF,
9394,GO:0034483,1,0.9025730940902,0,14,heparan sulfate sulfotransferase activity,MF,
9395,GO:0034485,1,0.971477520168098,0,4,phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,MF,
9396,GO:0034497,1,0.91013921918982,0,13,protein localization to phagophore assembly site,BP,
9397,GO:0034498,1,0.945960565651082,0,8,early endosome to Golgi transport,BP,
9398,GO:0034499,1,0.983219588640767,0,2,late endosome to Golgi transport,BP,
9399,GO:0034501,1,0.903622909080243,0,16,protein localization to kinetochore,BP,
9400,GO:0034502,1,0.62360948197771,0,70,protein localization to chromosome,BP,
9402,GO:0034505,1,0.894909761161196,0,15,tooth mineralization,BP,
9403,GO:0034506,1,0.992470257377452,0,1,chromosome, centromeric core domain,CC,
9404,GO:0034508,1,0.787758342673772,0,40,centromere complex assembly,BP,
9405,GO:0034511,1,0.968562675470051,0,5,U3 snoRNA binding,MF,
9406,GO:0034513,1,0.981399633808129,0,5,box H/ACA snoRNA binding,MF,
9407,GO:0034515,1,0.985557433543352,0,2,proteasome storage granule,CC,
9408,GO:0034516,1,0.99583057491786,0,1,response to vitamin B6,BP,
9409,GO:0034518,1,0.932814425693972,0,11,RNA cap binding complex,CC,
9410,GO:0034545,1,0.995389277614451,0,1,fumarylpyruvate hydrolase activity,MF,
9411,GO:0034551,1,0.94587471830719,0,9,mitochondrial respiratory chain complex III assembly,BP,
9412,GO:0034552,1,0.993079117492023,0,2,respiratory chain complex II assembly,BP,
9413,GO:0034553,1,0.993079117492023,0,2,mitochondrial respiratory chain complex II assembly,BP,
9414,GO:0034584,1,0.98520048308686,0,2,piRNA binding,MF,
9415,GO:0034587,1,0.907868466930247,0,14,piRNA metabolic process,BP,
9416,GO:0034589,1,0.992410805622225,0,1,hydroxyproline transport,BP,
9417,GO:0034590,1,0.992410805622225,0,1,L-hydroxyproline transmembrane transporter activity,MF,
9418,GO:0034593,1,0.823782880044066,0,25,phosphatidylinositol bisphosphate phosphatase activity,MF,
9419,GO:0034594,1,0.958718681775641,0,6,phosphatidylinositol trisphosphate phosphatase activity,MF,
9420,GO:0034595,1,0.904762031218447,0,13,phosphatidylinositol phosphate 5-phosphatase activity,MF,
9421,GO:0034596,1,0.937169310950642,0,8,phosphatidylinositol phosphate 4-phosphatase activity,MF,
9422,GO:0034597,1,0.983612487903002,0,2,phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity,MF,
9424,GO:0034602,1,0.992410097811214,0,1,oxoglutarate dehydrogenase (NAD+) activity,MF,
9425,GO:0034603,1,0.966907903702193,0,5,pyruvate dehydrogenase [NAD(P)+] activity,MF,
9426,GO:0034604,1,0.966907903702193,0,5,pyruvate dehydrogenase (NAD+) activity,MF,
9428,GO:0034612,1,0.211150659695182,0,268,response to tumor necrosis factor,BP,
9431,GO:0034616,1,0.905912870111129,0,14,response to laminar fluid shear stress,BP,
9434,GO:0034620,1,0.395796895642179,0,140,cellular response to unfolded protein,BP,
9436,GO:0034625,1,0.959687244086777,0,6,fatty acid elongation, monounsaturated fatty acid,BP,
9437,GO:0034626,1,0.959687244086777,0,6,fatty acid elongation, polyunsaturated fatty acid,BP,
9438,GO:0034627,1,0.9757617326596,0,4,'de novo' NAD biosynthetic process,BP,
9439,GO:0034628,1,0.979414860515984,0,3,'de novo' NAD biosynthetic process from aspartate,BP,
9440,GO:0034629,1,0.856583583955493,0,23,cellular protein-containing complex localization,BP,
9441,GO:0034632,1,0.990035548376043,0,2,retinol transmembrane transporter activity,MF,
9442,GO:0034633,1,0.990035548376043,0,2,retinol transport,BP,
9443,GO:0034634,1,0.99126790998446,0,1,glutathione transmembrane transporter activity,MF,
9444,GO:0034635,1,0.985940284885172,0,2,glutathione transport,BP,
9447,GO:0034640,1,0.992645206224271,0,1,establishment of mitochondrion localization by microtubule attachment,BP,
9449,GO:0034643,1,0.871966188649914,0,19,establishment of mitochondrion localization, microtubule-mediated,BP,
9450,GO:0034644,1,0.609146811722465,0,74,cellular response to UV,BP,
9452,GO:0034647,1,0.980032405981928,0,2,histone demethylase activity (H3-trimethyl-K4 specific),MF,
9453,GO:0034648,1,0.965601699600376,0,4,histone demethylase activity (H3-dimethyl-K4 specific),MF,
9454,GO:0034649,1,0.992487356569933,0,1,histone demethylase activity (H3-monomethyl-K4 specific),MF,
9455,GO:0034650,1,0.943695668051096,0,8,cortisol metabolic process,BP,
9456,GO:0034651,1,0.948723930531411,0,7,cortisol biosynthetic process,BP,
9457,GO:0034653,1,0.983993275973364,0,3,retinoic acid catabolic process,BP,
9459,GO:0034655,1,0.029787291649646,0,577,nucleobase-containing compound catabolic process,BP,
9460,GO:0034656,1,0.780374185126779,0,43,nucleobase-containing small molecule catabolic process,BP,
9461,GO:0034657,1,0.973717597519773,0,4,GID complex,CC,
9462,GO:0034660,1,0.041327102112103,0,546,ncRNA metabolic process,BP,
9463,GO:0034661,1,0.853875063597759,0,24,ncRNA catabolic process,BP,
9464,GO:0034663,1,0.945912314950394,0,9,endoplasmic reticulum chaperone complex,CC,
9465,GO:0034665,1,0.984769640631914,0,2,integrin alpha1-beta1 complex,CC,
9466,GO:0034666,1,0.975820617771153,0,3,integrin alpha2-beta1 complex,CC,
9467,GO:0034667,1,0.984691835990945,0,2,integrin alpha3-beta1 complex,CC,
9468,GO:0034668,1,0.992482413000109,0,1,integrin alpha4-beta1 complex,CC,
9469,GO:0034669,1,0.984582732749363,0,2,integrin alpha4-beta7 complex,CC,
9470,GO:0034670,1,0.989297296030475,0,1,chemotaxis to arachidonic acid,BP,
9471,GO:0034673,1,0.97935344047257,0,3,inhibin-betaglycan-ActRII complex,CC,
9472,GO:0034676,1,0.991667329929283,0,1,integrin alpha6-beta4 complex,CC,
9473,GO:0034677,1,0.992500313959768,0,1,integrin alpha7-beta1 complex,CC,
9474,GO:0034678,1,0.977596261437334,0,3,integrin alpha8-beta1 complex,CC,
9475,GO:0034679,1,0.992476389370143,0,1,integrin alpha9-beta1 complex,CC,
9476,GO:0034680,1,0.984573186743775,0,2,integrin alpha10-beta1 complex,CC,
9477,GO:0034681,1,0.984665361270116,0,2,integrin alpha11-beta1 complex,CC,
9478,GO:0034683,1,0.983180314744529,0,2,integrin alphav-beta3 complex,CC,
9479,GO:0034684,1,0.983583784293533,0,2,integrin alphav-beta5 complex,CC,
9480,GO:0034685,1,0.984717982721451,0,2,integrin alphav-beta6 complex,CC,
9481,GO:0034686,1,0.980884407876433,0,2,integrin alphav-beta8 complex,CC,
9482,GO:0034687,1,0.984980416451996,0,2,integrin alphaL-beta2 complex,CC,
9483,GO:0034688,1,0.985152978012082,0,2,integrin alphaM-beta2 complex,CC,
9484,GO:0034693,1,0.993608727456903,0,1,U11/U12 snRNP,CC,
9485,GO:0034694,1,0.822791499224868,0,29,response to prostaglandin,BP,
9486,GO:0034695,1,0.865750247846814,0,22,response to prostaglandin E,BP,
9487,GO:0034696,1,0.987809009181694,0,2,response to prostaglandin F,BP,
9488,GO:0034698,1,0.831825136200882,0,25,response to gonadotropin,BP,
9489,GO:0034699,1,0.977690029589991,0,3,response to luteinizing hormone,BP,
9495,GO:0034707,1,0.747128147536724,0,42,chloride channel complex,CC,
9496,GO:0034708,1,0.55650246856315,0,88,methyltransferase complex,CC,
9497,GO:0034709,1,0.954150664675181,0,12,methylosome,CC,
9498,GO:0034711,1,0.970020295195146,0,5,inhibin binding,MF,
9499,GO:0034713,1,0.937181584585206,0,9,type I transforming growth factor beta receptor binding,MF,
9500,GO:0034714,1,0.978995643409312,0,3,type III transforming growth factor beta receptor binding,MF,
9501,GO:0034715,1,0.978236582545587,0,6,pICln-Sm protein complex,CC,
9502,GO:0034718,1,0.991876439214468,0,1,SMN-Gemin2 complex,CC,
9503,GO:0034719,1,0.921478169589831,0,17,SMN-Sm protein complex,CC,
9504,GO:0034720,1,0.949288421286904,0,6,histone H3-K4 demethylation,BP,
9505,GO:0034721,1,0.980032405981928,0,2,histone H3-K4 demethylation, trimethyl-H3-K4-specific,BP,
9506,GO:0034722,1,0.995818204031736,0,1,gamma-glutamyl-peptidase activity,MF,
9507,GO:0034723,1,0.936135825410846,0,14,DNA replication-dependent nucleosome organization,BP,
9508,GO:0034724,1,0.7877458504631,0,41,DNA replication-independent nucleosome organization,BP,
9509,GO:0034727,1,0.992132846738313,0,1,piecemeal microautophagy of the nucleus,BP,
9511,GO:0034729,1,0.9796397369541,0,3,histone H3-K79 methylation,BP,
9512,GO:0034736,1,0.992569967091373,0,1,cholesterol O-acyltransferase activity,MF,
9513,GO:0034739,1,0.99008624695944,0,2,histone deacetylase activity (H4-K16 specific),MF,
9514,GO:0034750,1,0.984624908314348,0,2,Scrib-APC-beta-catenin complex,CC,
9518,GO:0034754,1,0.585203645104966,0,91,cellular hormone metabolic process,BP,
9519,GO:0034755,1,0.898434772390491,0,16,iron ion transmembrane transport,BP,
9520,GO:0034756,1,0.973091446052377,0,5,regulation of iron ion transport,BP,
9521,GO:0034757,1,0.988119350664754,0,2,negative regulation of iron ion transport,BP,
9522,GO:0034759,1,0.988119350664754,0,2,regulation of iron ion transmembrane transport,BP,
9523,GO:0034760,1,0.988119350664754,0,2,negative regulation of iron ion transmembrane transport,BP,
9525,GO:0034763,1,0.521649527592462,0,100,negative regulation of transmembrane transport,BP,
9526,GO:0034764,1,0.306437228238279,0,169,positive regulation of transmembrane transport,BP,
9528,GO:0034766,1,0.588814713991768,0,80,negative regulation of ion transmembrane transport,BP,
9529,GO:0034767,1,0.42066485410295,0,127,positive regulation of ion transmembrane transport,BP,
9530,GO:0034769,1,0.986943864659672,0,2,basement membrane disassembly,BP,
9531,GO:0034770,1,0.949058658699419,0,6,histone H4-K20 methylation,BP,
9532,GO:0034773,1,0.969718865907679,0,4,histone H4-K20 trimethylation,BP,
9534,GO:0034775,1,0.99126790998446,0,1,glutathione transmembrane transport,BP,
9535,GO:0034776,1,0.936646554604296,0,9,response to histamine,BP,
9536,GO:0034777,1,0.994091098937761,0,1,recycling endosome lumen,CC,
9537,GO:0034875,1,0.99480822318924,0,1,caffeine oxidase activity,MF,
9538,GO:0034899,1,0.99444620130536,0,1,trimethylamine monooxygenase activity,MF,
9539,GO:0034959,1,0.992049643591319,0,1,endothelin maturation,BP,
9540,GO:0034963,1,0.996531647484467,0,1,box C/D snoRNA processing,BP,
9541,GO:0034964,1,0.993389871031089,0,1,box H/ACA snoRNA processing,BP,
9543,GO:0034969,1,0.926281692005567,0,12,histone arginine methylation,BP,
9544,GO:0034970,1,0.986165439641154,0,2,histone H3-R2 methylation,BP,
9545,GO:0034971,1,0.987158312190511,0,2,histone H3-R17 methylation,BP,
9546,GO:0034975,1,0.914830041012516,0,13,protein folding in endoplasmic reticulum,BP,
9547,GO:0034976,1,0.177625900902762,0,260,response to endoplasmic reticulum stress,BP,
9548,GO:0034979,1,0.890058689165949,0,17,NAD-dependent protein deacetylase activity,MF,
9549,GO:0034982,1,0.933691842087314,0,12,mitochondrial protein processing,BP,
9550,GO:0034983,1,0.952368776960936,0,7,peptidyl-lysine deacetylation,BP,
9551,GO:0034986,1,0.983903319843988,0,2,iron chaperone activity,MF,
9552,GO:0034987,1,0.962813333840338,0,6,immunoglobulin receptor binding,MF,
9553,GO:0034988,1,0.983694985636963,0,2,Fc-gamma receptor I complex binding,MF,
9554,GO:0034991,1,0.974152266999115,0,4,nuclear meiotic cohesin complex,CC,
9555,GO:0034992,1,0.941054733056983,0,7,microtubule organizing center attachment site,CC,
9556,GO:0034993,1,0.941054733056983,0,7,meiotic nuclear membrane microtubule tethering complex,CC,
9557,GO:0034998,1,0.993058458973322,0,1,oligosaccharyltransferase I complex,CC,
9559,GO:0035005,1,0.943186560399448,0,7,1-phosphatidylinositol-4-phosphate 3-kinase activity,MF,
9560,GO:0035014,1,0.941922871888514,0,8,phosphatidylinositol 3-kinase regulator activity,MF,
9561,GO:0035019,1,0.638721998930503,0,67,somatic stem cell population maintenance,BP,
9562,GO:0035020,1,0.8861818695009,0,16,regulation of Rac protein signal transduction,BP,
9563,GO:0035021,1,0.967320267973661,0,4,negative regulation of Rac protein signal transduction,BP,
9564,GO:0035022,1,0.973416375347392,0,4,positive regulation of Rac protein signal transduction,BP,
9566,GO:0035024,1,0.874703756756205,0,18,negative regulation of Rho protein signal transduction,BP,
9568,GO:0035026,1,0.984963625591752,0,2,leading edge cell differentiation,BP,
9569,GO:0035032,1,0.960438794567262,0,6,phosphatidylinositol 3-kinase complex, class III,CC,
9570,GO:0035033,1,0.985443498103897,0,3,histone deacetylase regulator activity,MF,
9571,GO:0035034,1,0.987145532705787,0,2,histone acetyltransferase regulator activity,MF,
9572,GO:0035035,1,0.810580786557478,0,29,histone acetyltransferase binding,MF,
9573,GO:0035036,1,0.825332649937614,0,35,sperm-egg recognition,BP,
9574,GO:0035037,1,0.992339361566123,0,1,sperm entry,BP,
9575,GO:0035038,1,0.986710696586776,0,2,female pronucleus assembly,BP,
9576,GO:0035039,1,0.99391611389164,0,1,male pronucleus assembly,BP,
9579,GO:0035054,1,0.979616896354569,0,3,embryonic heart tube anterior/posterior pattern specification,BP,
9580,GO:0035061,1,0.968100049973763,0,4,interchromatin granule,CC,
9581,GO:0035063,1,0.97983120200074,0,2,nuclear speck organization,BP,
9583,GO:0035065,1,0.701416890214195,0,52,regulation of histone acetylation,BP,
9584,GO:0035066,1,0.830859890507435,0,28,positive regulation of histone acetylation,BP,
9585,GO:0035067,1,0.892139086643834,0,17,negative regulation of histone acetylation,BP,
9586,GO:0035068,1,0.933428695540439,0,9,micro-ribonucleoprotein complex,CC,
9587,GO:0035082,1,0.692952186007501,0,51,axoneme assembly,BP,
9588,GO:0035087,1,0.973469410834494,0,4,siRNA loading onto RISC involved in RNA interference,BP,
9589,GO:0035088,1,0.73148416052231,0,45,establishment or maintenance of apical/basal cell polarity,BP,
9590,GO:0035089,1,0.886994598735718,0,17,establishment of apical/basal cell polarity,BP,
9591,GO:0035090,1,0.925857041700544,0,12,maintenance of apical/basal cell polarity,BP,
9595,GO:0035094,1,0.755382434743687,0,42,response to nicotine,BP,
9596,GO:0035095,1,0.948063042508525,0,7,behavioral response to nicotine,BP,
9597,GO:0035097,1,0.610371351113098,0,68,histone methyltransferase complex,CC,
9598,GO:0035098,1,0.891287467941042,0,16,ESC/E(Z) complex,CC,
9599,GO:0035101,1,0.978534612915251,0,3,FACT complex,CC,
9600,GO:0035102,1,0.924463098150575,0,11,PRC1 complex,CC,
9601,GO:0035106,1,0.979062116518105,0,3,operant conditioning,BP,
9604,GO:0035112,1,0.926604340619486,0,11,genitalia morphogenesis,BP,
9606,GO:0035115,1,0.809526221501135,0,32,embryonic forelimb morphogenesis,BP,
9607,GO:0035116,1,0.832404097002286,0,28,embryonic hindlimb morphogenesis,BP,
9608,GO:0035120,1,0.988529945830477,0,1,post-embryonic appendage morphogenesis,BP,
9609,GO:0035127,1,0.988529945830477,0,1,post-embryonic limb morphogenesis,BP,
9610,GO:0035128,1,0.988529945830477,0,1,post-embryonic forelimb morphogenesis,BP,
9611,GO:0035136,1,0.758285429479339,0,40,forelimb morphogenesis,BP,
9612,GO:0035137,1,0.782462112234426,0,36,hindlimb morphogenesis,BP,
9613,GO:0035145,1,0.882381466468045,0,19,exon-exon junction complex,CC,
9616,GO:0035162,1,0.862067405340404,0,20,embryonic hemopoiesis,BP,
9617,GO:0035166,1,0.977894332217191,0,3,post-embryonic hemopoiesis,BP,
9618,GO:0035173,1,0.897695624582559,0,16,histone kinase activity,MF,
9619,GO:0035174,1,0.958386651006268,0,7,histone serine kinase activity,MF,
9620,GO:0035175,1,0.995319688798766,0,1,histone kinase activity (H3-S10 specific),MF,
9622,GO:0035184,1,0.96360204783011,0,5,histone threonine kinase activity,MF,
9623,GO:0035188,1,0.992632621830319,0,1,hatching,BP,
9624,GO:0035189,1,0.979734494989472,0,3,Rb-E2F complex,CC,
9628,GO:0035197,1,0.928264683548331,0,10,siRNA binding,MF,
9629,GO:0035198,1,0.857904961875424,0,22,miRNA binding,MF,
9630,GO:0035226,1,0.992744589403332,0,1,glutamate-cysteine ligase catalytic subunit binding,MF,
9631,GO:0035227,1,0.992744589403332,0,1,regulation of glutamate-cysteine ligase activity,BP,
9632,GO:0035229,1,0.992744589403332,0,1,positive regulation of glutamate-cysteine ligase activity,BP,
9633,GO:0035234,1,0.950675709461961,0,7,ectopic germ cell programmed cell death,BP,
9635,GO:0035238,1,0.993058458973322,0,1,vitamin A biosynthetic process,BP,
9637,GO:0035240,1,0.952668940923811,0,8,dopamine binding,MF,
9638,GO:0035241,1,0.974176781689585,0,4,protein-arginine omega-N monomethyltransferase activity,MF,
9639,GO:0035242,1,0.951312814002257,0,8,protein-arginine omega-N asymmetric methyltransferase activity,MF,
9640,GO:0035243,1,0.973760021868971,0,4,protein-arginine omega-N symmetric methyltransferase activity,MF,
9641,GO:0035246,1,0.926632942471947,0,12,peptidyl-arginine N-methylation,BP,
9642,GO:0035247,1,0.938709040581942,0,10,peptidyl-arginine omega-N-methylation,BP,
9643,GO:0035248,1,0.992948539779071,0,1,alpha-1,4-N-acetylgalactosaminyltransferase activity,MF,
9646,GO:0035251,1,0.940430709541732,0,9,UDP-glucosyltransferase activity,MF,
9647,GO:0035252,1,0.955353646625017,0,6,UDP-xylosyltransferase activity,MF,
9648,GO:0035253,1,0.921192032975027,0,11,ciliary rootlet,CC,
9650,GO:0035255,1,0.820106792211494,0,26,ionotropic glutamate receptor binding,MF,
9651,GO:0035256,1,0.951084340207769,0,8,G-protein coupled glutamate receptor binding,MF,
9653,GO:0035258,1,0.55238288995328,0,84,steroid hormone receptor binding,MF,
9654,GO:0035259,1,0.904327405031913,0,14,glucocorticoid receptor binding,MF,
9655,GO:0035261,1,0.978301663941287,0,2,external genitalia morphogenesis,BP,
9656,GO:0035262,1,0.983872945492693,0,2,gonad morphogenesis,BP,
9657,GO:0035264,1,0.388174663973987,0,131,multicellular organism growth,BP,
9659,GO:0035267,1,0.892448669994945,0,18,NuA4 histone acetyltransferase complex,CC,
9660,GO:0035268,1,0.895651108566311,0,17,protein mannosylation,BP,
9661,GO:0035269,1,0.932636270470517,0,12,protein O-linked mannosylation,BP,
9662,GO:0035270,1,0.458882839030218,0,117,endocrine system development,BP,
9664,GO:0035276,1,0.986537630901906,0,2,ethanol binding,MF,
9665,GO:0035278,1,0.90535869817833,0,13,miRNA mediated inhibition of translation,BP,
9666,GO:0035279,1,0.985633541813997,0,2,mRNA cleavage involved in gene silencing by miRNA,BP,
9667,GO:0035280,1,0.949451293853502,0,7,miRNA loading onto RISC involved in gene silencing by miRNA,BP,
9668,GO:0035281,1,0.988664664763273,0,2,pre-miRNA export from nucleus,BP,
9670,GO:0035283,1,0.985598940740636,0,2,central nervous system segmentation,BP,
9671,GO:0035284,1,0.985598940740636,0,2,brain segmentation,BP,
9672,GO:0035290,1,0.977992716590448,0,3,trunk segmentation,BP,
9675,GO:0035299,1,0.992378822910163,0,1,inositol pentakisphosphate 2-kinase activity,MF,
9676,GO:0035303,1,0.266827987054599,0,183,regulation of dephosphorylation,BP,
9677,GO:0035304,1,0.44607531979551,0,118,regulation of protein dephosphorylation,BP,
9678,GO:0035305,1,0.508682151990445,0,94,negative regulation of dephosphorylation,BP,
9680,GO:0035307,1,0.776158017065522,0,36,positive regulation of protein dephosphorylation,BP,
9681,GO:0035308,1,0.724750902316921,0,49,negative regulation of protein dephosphorylation,BP,
9682,GO:0035312,1,0.958408720478419,0,6,5'-3' exodeoxyribonuclease activity,MF,
9683,GO:0035313,1,0.893582349697956,0,14,wound healing, spreading of epidermal cells,BP,
9685,GO:0035325,1,0.942676973161512,0,10,Toll-like receptor binding,MF,
9687,GO:0035327,1,0.874808222510821,0,21,transcriptionally active chromatin,CC,
9688,GO:0035329,1,0.734355124378373,0,38,hippo signaling,BP,
9689,GO:0035330,1,0.911917049753151,0,11,regulation of hippo signaling,BP,
9690,GO:0035331,1,0.935691019123512,0,8,negative regulation of hippo signaling,BP,
9691,GO:0035332,1,0.980590766207978,0,2,positive regulation of hippo signaling,BP,
9692,GO:0035333,1,0.913699104457207,0,13,Notch receptor processing, ligand-dependent,BP,
9694,GO:0035336,1,0.863578994478845,0,22,long-chain fatty-acyl-CoA metabolic process,BP,
9695,GO:0035337,1,0.794739061817,0,35,fatty-acyl-CoA metabolic process,BP,
9696,GO:0035338,1,0.896838858401984,0,16,long-chain fatty-acyl-CoA biosynthetic process,BP,
9697,GO:0035339,1,0.979966400978078,0,4,SPOTS complex,CC,
9698,GO:0035349,1,0.980305153810067,0,3,coenzyme A transmembrane transport,BP,
9699,GO:0035350,1,0.986855094309458,0,2,FAD transmembrane transport,BP,
9700,GO:0035352,1,0.994025486367947,0,1,NAD transmembrane transport,BP,
9701,GO:0035354,1,0.985597594050916,0,2,Toll-like receptor 1-Toll-like receptor 2 protein complex,CC,
9702,GO:0035355,1,0.991598275708435,0,1,Toll-like receptor 2-Toll-like receptor 6 protein complex,CC,
9703,GO:0035356,1,0.9585825514107,0,7,cellular triglyceride homeostasis,BP,
9704,GO:0035357,1,0.868841961616595,0,20,peroxisome proliferator activated receptor signaling pathway,BP,
9705,GO:0035358,1,0.920975728416297,0,12,regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9706,GO:0035359,1,0.981659761449177,0,3,negative regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9707,GO:0035360,1,0.951763516295742,0,7,positive regulation of peroxisome proliferator activated receptor signaling pathway,BP,
9708,GO:0035363,1,0.974386006493998,0,4,histone locus body,CC,
9709,GO:0035368,1,0.973229601541622,0,4,selenocysteine insertion sequence binding,MF,
9710,GO:0035370,1,0.987392928500538,0,2,UBC13-UEV1A complex,CC,
9711,GO:0035371,1,0.859253047397319,0,18,microtubule plus-end,CC,
9712,GO:0035372,1,0.905463004860294,0,13,protein localization to microtubule,BP,
9713,GO:0035373,1,0.974530482213363,0,3,chondroitin sulfate proteoglycan binding,MF,
9714,GO:0035374,1,0.957868689381755,0,6,chondroitin sulfate binding,MF,
9715,GO:0035375,1,0.990485332285452,0,1,zymogen binding,MF,
9716,GO:0035376,1,0.960720226260293,0,7,sterol import,BP,
9717,GO:0035377,1,0.984589341320801,0,2,transepithelial water transport,BP,
9718,GO:0035378,1,0.993103570478837,0,1,carbon dioxide transmembrane transport,BP,
9719,GO:0035379,1,0.993103570478837,0,1,carbon dioxide transmembrane transporter activity,MF,
9720,GO:0035381,1,0.951666792129574,0,8,ATP-gated ion channel activity,MF,
9721,GO:0035383,1,0.56163390942179,0,91,thioester metabolic process,BP,
9722,GO:0035384,1,0.726259500658481,0,46,thioester biosynthetic process,BP,
9723,GO:0035385,1,0.945215059319212,0,7,Roundabout signaling pathway,BP,
9724,GO:0035397,1,0.99272040386425,0,1,helper T cell enhancement of adaptive immune response,BP,
9725,GO:0035400,1,0.991949843963027,0,1,histone tyrosine kinase activity,MF,
9726,GO:0035401,1,0.991949843963027,0,1,histone kinase activity (H3-Y41 specific),MF,
9727,GO:0035402,1,0.986039650185678,0,2,histone kinase activity (H3-T11 specific),MF,
9728,GO:0035403,1,0.981844062532429,0,2,histone kinase activity (H3-T6 specific),MF,
9729,GO:0035404,1,0.927350303717405,0,12,histone-serine phosphorylation,BP,
9730,GO:0035405,1,0.96360204783011,0,5,histone-threonine phosphorylation,BP,
9731,GO:0035406,1,0.991949843963027,0,1,histone-tyrosine phosphorylation,BP,
9732,GO:0035407,1,0.986039650185678,0,2,histone H3-T11 phosphorylation,BP,
9733,GO:0035408,1,0.981844062532429,0,2,histone H3-T6 phosphorylation,BP,
9734,GO:0035409,1,0.991949843963027,0,1,histone H3-Y41 phosphorylation,BP,
9735,GO:0035410,1,0.996406077437465,0,1,dihydrotestosterone 17-beta-dehydrogenase activity,MF,
9736,GO:0035418,1,0.759260774970674,0,35,protein localization to synapse,BP,
9737,GO:0035425,1,0.985509686256614,0,2,autocrine signaling,BP,
9738,GO:0035426,1,0.96326202303643,0,5,extracellular matrix-cell signaling,BP,
9739,GO:0035434,1,0.959788884659165,0,6,copper ion transmembrane transport,BP,
9740,GO:0035435,1,0.934309610574139,0,9,phosphate ion transmembrane transport,BP,
9741,GO:0035437,1,0.918706049558502,0,13,maintenance of protein localization in endoplasmic reticulum,BP,
9742,GO:0035438,1,0.9953661177185,0,1,cyclic-di-GMP binding,MF,
9743,GO:0035441,1,0.974467959121964,0,3,cell migration involved in vasculogenesis,BP,
9744,GO:0035442,1,0.988703966357826,0,2,dipeptide transmembrane transport,BP,
9745,GO:0035443,1,0.99126790998446,0,1,tripeptide transmembrane transport,BP,
9746,GO:0035445,1,0.992714633871337,0,1,borate transmembrane transport,BP,
9748,GO:0035456,1,0.898111287732033,0,20,response to interferon-beta,BP,
9749,GO:0035457,1,0.928107839084536,0,10,cellular response to interferon-alpha,BP,
9750,GO:0035458,1,0.923492266951567,0,13,cellular response to interferon-beta,BP,
9751,GO:0035459,1,0.870534845217286,0,20,cargo loading into vesicle,BP,
9752,GO:0035461,1,0.916657323196377,0,11,vitamin transmembrane transport,BP,
9753,GO:0035469,1,0.962895025454323,0,5,determination of pancreatic left/right asymmetry,BP,
9754,GO:0035470,1,0.990516800103608,0,2,positive regulation of vascular wound healing,BP,
9755,GO:0035473,1,0.968953098863715,0,4,lipase binding,MF,
9756,GO:0035480,1,0.996555366104087,0,1,regulation of Notch signaling pathway involved in heart induction,BP,
9757,GO:0035481,1,0.996555366104087,0,1,positive regulation of Notch signaling pathway involved in heart induction,BP,
9758,GO:0035482,1,0.987956675004699,0,4,gastric motility,BP,
9759,GO:0035483,1,0.99248953708091,0,3,gastric emptying,BP,
9760,GO:0035485,1,0.995006184266117,0,1,adenine/guanine mispair binding,MF,
9761,GO:0035490,1,0.992683518576315,0,1,regulation of leukotriene production involved in inflammatory response,BP,
9762,GO:0035491,1,0.992683518576315,0,1,positive regulation of leukotriene production involved in inflammatory response,BP,
9763,GO:0035493,1,0.904633917509302,0,15,SNARE complex assembly,BP,
9764,GO:0035494,1,0.980656673207324,0,3,SNARE complex disassembly,BP,
9765,GO:0035497,1,0.912839581227951,0,13,cAMP response element binding,MF,
9766,GO:0035498,1,0.992479488058318,0,1,carnosine metabolic process,BP,
9767,GO:0035499,1,0.992479488058318,0,1,carnosine biosynthetic process,BP,
9768,GO:0035500,1,0.985551239941556,0,2,MH2 domain binding,MF,
9769,GO:0035501,1,0.992999161121732,0,1,MH1 domain binding,MF,
9770,GO:0035502,1,0.967220322251849,0,5,metanephric part of ureteric bud development,BP,
9771,GO:0035504,1,0.995800192700666,0,1,regulation of myosin light chain kinase activity,BP,
9772,GO:0035505,1,0.995800192700666,0,1,positive regulation of myosin light chain kinase activity,BP,
9773,GO:0035507,1,0.946769086801839,0,7,regulation of myosin-light-chain-phosphatase activity,BP,
9774,GO:0035508,1,0.991769192814075,0,1,positive regulation of myosin-light-chain-phosphatase activity,BP,
9775,GO:0035509,1,0.96328889986903,0,5,negative regulation of myosin-light-chain-phosphatase activity,BP,
9776,GO:0035510,1,0.830617440934202,0,28,DNA dealkylation,BP,
9777,GO:0035511,1,0.971389502991073,0,5,oxidative DNA demethylation,BP,
9778,GO:0035513,1,0.97423099192183,0,4,oxidative RNA demethylation,BP,
9779,GO:0035514,1,0.985125320668629,0,3,DNA demethylase activity,MF,
9780,GO:0035515,1,0.97423099192183,0,4,oxidative RNA demethylase activity,MF,
9781,GO:0035516,1,0.992413469005246,0,1,oxidative DNA demethylase activity,MF,
9782,GO:0035517,1,0.96672235535537,0,4,PR-DUB complex,CC,
9783,GO:0035518,1,0.894963137227406,0,16,histone H2A monoubiquitination,BP,
9784,GO:0035519,1,0.98098982153561,0,4,protein K29-linked ubiquitination,BP,
9785,GO:0035520,1,0.931528300050508,0,9,monoubiquitinated protein deubiquitination,BP,
9786,GO:0035521,1,0.971465807857414,0,4,monoubiquitinated histone deubiquitination,BP,
9787,GO:0035522,1,0.971465807857414,0,4,monoubiquitinated histone H2A deubiquitination,BP,
9788,GO:0035523,1,0.974072552790619,0,3,protein K29-linked deubiquitination,BP,
9789,GO:0035524,1,0.962637988238221,0,5,proline transmembrane transport,BP,
9790,GO:0035525,1,0.993389871031089,0,1,NF-kappaB p50/p65 complex,CC,
9791,GO:0035526,1,0.98471906981217,0,2,retrograde transport, plasma membrane to Golgi,BP,
9792,GO:0035529,1,0.961099422883831,0,7,NADH pyrophosphatase activity,MF,
9793,GO:0035538,1,0.992628853050634,0,1,carbohydrate response element binding,MF,
9794,GO:0035539,1,0.992092429380124,0,2,8-oxo-7,8-dihydrodeoxyguanosine triphosphate pyrophosphatase activity,MF,
9795,GO:0035542,1,0.937849881890832,0,9,regulation of SNARE complex assembly,BP,
9796,GO:0035544,1,0.978219517211566,0,3,negative regulation of SNARE complex assembly,BP,
9797,GO:0035545,1,0.992482184538932,0,1,determination of left/right asymmetry in nervous system,BP,
9798,GO:0035546,1,0.958931359794157,0,5,interferon-beta secretion,BP,
9799,GO:0035547,1,0.958931359794157,0,5,regulation of interferon-beta secretion,BP,
9800,GO:0035548,1,0.99295458484256,0,1,negative regulation of interferon-beta secretion,BP,
9801,GO:0035549,1,0.965737744837638,0,4,positive regulation of interferon-beta secretion,BP,
9802,GO:0035552,1,0.98153344984231,0,3,oxidative single-stranded DNA demethylation,BP,
9803,GO:0035553,1,0.980728200425875,0,3,oxidative single-stranded RNA demethylation,BP,
9805,GO:0035561,1,0.860864411491053,0,21,regulation of chromatin binding,BP,
9806,GO:0035562,1,0.947112453425026,0,7,negative regulation of chromatin binding,BP,
9807,GO:0035563,1,0.915799944574541,0,13,positive regulation of chromatin binding,BP,
9808,GO:0035564,1,0.982109263624376,0,2,regulation of kidney size,BP,
9809,GO:0035566,1,0.992456292901894,0,1,regulation of metanephros size,BP,
9811,GO:0035568,1,0.993058458973322,0,1,N-terminal peptidyl-proline methylation,BP,
9812,GO:0035570,1,0.993058458973322,0,1,N-terminal peptidyl-serine methylation,BP,
9813,GO:0035572,1,0.993058458973322,0,1,N-terminal peptidyl-serine dimethylation,BP,
9814,GO:0035573,1,0.993058458973322,0,1,N-terminal peptidyl-serine trimethylation,BP,
9815,GO:0035574,1,0.984592048960114,0,2,histone H4-K20 demethylation,BP,
9816,GO:0035575,1,0.984592048960114,0,2,histone demethylase activity (H4-K20 specific),MF,
9817,GO:0035577,1,0.707376540525744,0,53,azurophil granule membrane,CC,
9818,GO:0035578,1,0.625347061849822,0,81,azurophil granule lumen,CC,
9819,GO:0035579,1,0.556148693356585,0,86,specific granule membrane,CC,
9821,GO:0035581,1,0.941814425777889,0,8,sequestering of extracellular ligand from receptor,BP,
9822,GO:0035582,1,0.974715799361943,0,4,sequestering of BMP in extracellular matrix,BP,
9823,GO:0035583,1,0.969268873985349,0,3,sequestering of TGFbeta in extracellular matrix,BP,
9826,GO:0035586,1,0.879609743279246,0,22,purinergic receptor activity,MF,
9829,GO:0035589,1,0.933739317848986,0,12,G-protein coupled purinergic nucleotide receptor signaling pathway,BP,
9830,GO:0035590,1,0.889296174980898,0,20,purinergic nucleotide receptor signaling pathway,BP,
9831,GO:0035591,1,0.566285333534109,0,80,signaling adaptor activity,MF,
9833,GO:0035596,1,0.987234497538111,0,2,methylthiotransferase activity,MF,
9834,GO:0035597,1,0.994576392173427,0,1,N6-isopentenyladenosine methylthiotransferase activity,MF,
9835,GO:0035598,1,0.992618468743188,0,1,N6-threonylcarbomyladenosine methylthiotransferase activity,MF,
9836,GO:0035600,1,0.987234497538111,0,2,tRNA methylthiolation,BP,
9837,GO:0035601,1,0.477739851922602,0,105,protein deacylation,BP,
9838,GO:0035602,1,0.992458875642522,0,1,fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow,BP,
9839,GO:0035603,1,0.992458875642522,0,1,fibroblast growth factor receptor signaling pathway involved in hemopoiesis,BP,
9840,GO:0035604,1,0.992458875642522,0,1,fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow,BP,
9841,GO:0035605,1,0.996213853163821,0,1,peptidyl-cysteine S-nitrosylase activity,MF,
9842,GO:0035606,1,0.993998797952901,0,2,peptidyl-cysteine S-trans-nitrosylation,BP,
9843,GO:0035607,1,0.984264881432378,0,2,fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development,BP,
9844,GO:0035608,1,0.952286144666357,0,7,protein deglutamylation,BP,
9845,GO:0035609,1,0.97347256512697,0,4,C-terminal protein deglutamylation,BP,
9846,GO:0035610,1,0.970611217206605,0,4,protein side chain deglutamylation,BP,
9847,GO:0035611,1,0.992979968803749,0,1,protein branching point deglutamylation,BP,
9848,GO:0035612,1,0.932534265874641,0,8,AP-2 adaptor complex binding,MF,
9849,GO:0035613,1,0.900811933601843,0,15,RNA stem-loop binding,MF,
9850,GO:0035614,1,0.984839384207657,0,3,snRNA stem-loop binding,MF,
9851,GO:0035615,1,0.926032510369323,0,11,clathrin adaptor activity,MF,
9852,GO:0035616,1,0.977017140596442,0,3,histone H2B conserved C-terminal lysine deubiquitination,BP,
9853,GO:0035617,1,0.979356256706375,0,3,stress granule disassembly,BP,
9854,GO:0035620,1,0.972791297193767,0,4,ceramide transporter activity,MF,
9855,GO:0035621,1,0.986609155143352,0,2,ER to Golgi ceramide transport,BP,
9856,GO:0035622,1,0.992483430475493,0,1,intrahepatic bile duct development,BP,
9857,GO:0035623,1,0.992637767280423,0,1,renal glucose absorption,BP,
9858,GO:0035624,1,0.970399822485724,0,4,receptor transactivation,BP,
9859,GO:0035625,1,0.979900577775698,0,3,epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway,BP,
9860,GO:0035627,1,0.951155473598883,0,7,ceramide transport,BP,
9862,GO:0035631,1,0.929447426178906,0,11,CD40 receptor complex,CC,
9864,GO:0035634,1,0.982429528636395,0,3,response to stilbenoid,BP,
9865,GO:0035635,1,0.878084755896104,0,18,entry of bacterium into host cell,BP,
9867,GO:0035638,1,0.992245606563932,0,1,signal maturation,BP,
9869,GO:0035640,1,0.853401220067236,0,23,exploration behavior,BP,
9870,GO:0035641,1,0.914712957829789,0,13,locomotory exploration behavior,BP,
9871,GO:0035642,1,0.992830347471568,0,1,histone methyltransferase activity (H3-R17 specific),MF,
9872,GO:0035643,1,0.99534524277805,0,1,L-DOPA receptor activity,MF,
9873,GO:0035644,1,0.992802599102766,0,1,phosphoanandamide dephosphorylation,BP,
9874,GO:0035645,1,0.992416227360051,0,1,enteric smooth muscle cell differentiation,BP,
9875,GO:0035646,1,0.939796500291573,0,10,endosome to melanosome transport,BP,
9876,GO:0035650,1,0.97808505521439,0,4,AP-1 adaptor complex binding,MF,
9877,GO:0035651,1,0.984981377034938,0,3,AP-3 adaptor complex binding,MF,
9878,GO:0035655,1,0.951507632097521,0,8,interleukin-18-mediated signaling pathway,BP,
9879,GO:0035658,1,0.980456532071877,0,3,Mon1-Ccz1 complex,CC,
9880,GO:0035659,1,0.995312711829602,0,1,Wnt signaling pathway involved in wound healing, spreading of epidermal cells,BP,
9881,GO:0035662,1,0.991068027334938,0,3,Toll-like receptor 4 binding,MF,
9882,GO:0035663,1,0.979851500698814,0,3,Toll-like receptor 2 binding,MF,
9883,GO:0035664,1,0.995146616079973,0,1,TIRAP-dependent toll-like receptor signaling pathway,BP,
9884,GO:0035665,1,0.995146616079973,0,1,TIRAP-dependent toll-like receptor 4 signaling pathway,BP,
9885,GO:0035666,1,0.84748855113069,0,27,TRIF-dependent toll-like receptor signaling pathway,BP,
9886,GO:0035668,1,0.984695065950263,0,2,TRAM-dependent toll-like receptor signaling pathway,BP,
9887,GO:0035669,1,0.984695065950263,0,2,TRAM-dependent toll-like receptor 4 signaling pathway,BP,
9888,GO:0035671,1,0.983772084947862,0,3,enone reductase activity,MF,
9889,GO:0035672,1,0.957575805749534,0,6,oligopeptide transmembrane transport,BP,
9890,GO:0035673,1,0.968519717023632,0,4,oligopeptide transmembrane transporter activity,MF,
9891,GO:0035674,1,0.988249090105508,0,2,tricarboxylic acid transmembrane transport,BP,
9892,GO:0035675,1,0.993270554299511,0,1,neuromast hair cell development,BP,
9893,GO:0035684,1,0.99742876541944,0,1,helper T cell extravasation,BP,
9894,GO:0035686,1,0.978622521766011,0,4,sperm fibrous sheath,CC,
9896,GO:0035691,1,0.988644708593303,0,2,macrophage migration inhibitory factor signaling pathway,BP,
9897,GO:0035692,1,0.988371586331431,0,2,macrophage migration inhibitory factor receptor complex,CC,
9898,GO:0035693,1,0.996216049524213,0,1,NOS2-CD74 complex,CC,
9899,GO:0035694,1,0.973416340084132,0,4,mitochondrial protein catabolic process,BP,
9900,GO:0035695,1,0.992410097811214,0,1,mitophagy by induced vacuole formation,BP,
9901,GO:0035696,1,0.977219340561924,0,3,monocyte extravasation,BP,
9902,GO:0035697,1,0.983430956903397,0,3,CD8-positive, alpha-beta T cell extravasation,BP,
9903,GO:0035698,1,0.989829488120235,0,2,CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
9904,GO:0035700,1,0.988721067149383,0,2,astrocyte chemotaxis,BP,
9905,GO:0035701,1,0.956431994435287,0,6,hematopoietic stem cell migration,BP,
9906,GO:0035704,1,0.993536383049275,0,1,helper T cell chemotaxis,BP,
9907,GO:0035705,1,0.993536383049275,0,1,T-helper 17 cell chemotaxis,BP,
9908,GO:0035708,1,0.992545224030108,0,1,interleukin-4-dependent isotype switching to IgE isotypes,BP,
9909,GO:0035709,1,0.986750269519722,0,2,memory T cell activation,BP,
9910,GO:0035710,1,0.645660120098468,0,66,CD4-positive, alpha-beta T cell activation,BP,
9911,GO:0035711,1,0.989008819102822,0,2,T-helper 1 cell activation,BP,
9912,GO:0035712,1,0.985221463692283,0,2,T-helper 2 cell activation,BP,
9913,GO:0035713,1,0.992545224030108,0,1,response to nitrogen dioxide,BP,
9914,GO:0035715,1,0.993536383049275,0,1,chemokine (C-C motif) ligand 2 binding,MF,
9915,GO:0035716,1,0.993536383049275,0,1,chemokine (C-C motif) ligand 12 binding,MF,
9916,GO:0035717,1,0.986807250690011,0,2,chemokine (C-C motif) ligand 7 binding,MF,
9917,GO:0035718,1,0.992056642673886,0,2,macrophage migration inhibitory factor binding,MF,
9918,GO:0035720,1,0.979402027425034,0,3,intraciliary anterograde transport,BP,
9919,GO:0035721,1,0.918137581440755,0,12,intraciliary retrograde transport,BP,
9920,GO:0035722,1,0.778174507710981,0,44,interleukin-12-mediated signaling pathway,BP,
9921,GO:0035723,1,0.9120581125685,0,13,interleukin-15-mediated signaling pathway,BP,
9922,GO:0035724,1,0.99103494315388,0,1,CD24 biosynthetic process,BP,
9924,GO:0035726,1,0.961535162681439,0,6,common myeloid progenitor cell proliferation,BP,
9925,GO:0035727,1,0.967457010971033,0,5,lysophosphatidic acid binding,MF,
9926,GO:0035728,1,0.898562959090287,0,15,response to hepatocyte growth factor,BP,
9927,GO:0035729,1,0.912838356322819,0,13,cellular response to hepatocyte growth factor stimulus,BP,
9928,GO:0035730,1,0.996977443783338,0,1,S-nitrosoglutathione binding,MF,
9929,GO:0035731,1,0.996977443783338,0,1,dinitrosyl-iron complex binding,MF,
9930,GO:0035732,1,0.996977443783338,0,1,nitric oxide storage,BP,
9931,GO:0035733,1,0.95059816170146,0,7,hepatic stellate cell activation,BP,
9932,GO:0035735,1,0.761095097733103,0,40,intraciliary transport involved in cilium assembly,BP,
9933,GO:0035739,1,0.964766962741978,0,6,CD4-positive, alpha-beta T cell proliferation,BP,
9934,GO:0035740,1,0.984417545927332,0,3,CD8-positive, alpha-beta T cell proliferation,BP,
9935,GO:0035743,1,0.92305591565833,0,14,CD4-positive, alpha-beta T cell cytokine production,BP,
9936,GO:0035744,1,0.982280687045202,0,4,T-helper 1 cell cytokine production,BP,
9937,GO:0035745,1,0.942991539800193,0,10,T-helper 2 cell cytokine production,BP,
9938,GO:0035746,1,0.99641910777211,0,1,granzyme A production,BP,
9939,GO:0035747,1,0.965756952450311,0,7,natural killer cell chemotaxis,BP,
9940,GO:0035748,1,0.956660493470411,0,6,myelin sheath abaxonal region,CC,
9942,GO:0035750,1,0.991913092913726,0,1,protein localization to myelin sheath abaxonal region,BP,
9943,GO:0035751,1,0.935461872970629,0,12,regulation of lysosomal lumen pH,BP,
9944,GO:0035752,1,0.99486159726575,0,1,lysosomal lumen pH elevation,BP,
9945,GO:0035754,1,0.955574013746372,0,8,B cell chemotaxis,BP,
9946,GO:0035755,1,0.993401620947692,0,1,cardiolipin hydrolase activity,MF,
9947,GO:0035757,1,0.994241557377807,0,1,chemokine (C-C motif) ligand 19 binding,MF,
9948,GO:0035758,1,0.994241557377807,0,1,chemokine (C-C motif) ligand 21 binding,MF,
9949,GO:0035759,1,0.990331753708512,0,2,mesangial cell-matrix adhesion,BP,
9950,GO:0035766,1,0.967917256512691,0,5,cell chemotaxis to fibroblast growth factor,BP,
9951,GO:0035767,1,0.853912955439852,0,23,endothelial cell chemotaxis,BP,
9952,GO:0035768,1,0.967917256512691,0,5,endothelial cell chemotaxis to fibroblast growth factor,BP,
9953,GO:0035770,1,0.283067610404096,0,187,ribonucleoprotein granule,CC,
9954,GO:0035771,1,0.955670535377291,0,7,interleukin-4-mediated signaling pathway,BP,
9955,GO:0035772,1,0.995202969898598,0,1,interleukin-13-mediated signaling pathway,BP,
9956,GO:0035773,1,0.700939661019582,0,55,insulin secretion involved in cellular response to glucose stimulus,BP,
9957,GO:0035774,1,0.862020721832394,0,25,positive regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
9958,GO:0035782,1,0.99641910777211,0,1,mature natural killer cell chemotaxis,BP,
9959,GO:0035783,1,0.992545224030108,0,1,CD4-positive, alpha-beta T cell costimulation,BP,
9960,GO:0035787,1,0.969966136086373,0,4,cell migration involved in kidney development,BP,
9961,GO:0035788,1,0.97786531322969,0,3,cell migration involved in metanephros development,BP,
9962,GO:0035789,1,0.97786531322969,0,3,metanephric mesenchymal cell migration,BP,
9963,GO:0035790,1,0.983713783658583,0,2,platelet-derived growth factor receptor-alpha signaling pathway,BP,
9964,GO:0035791,1,0.902358405189962,0,13,platelet-derived growth factor receptor-beta signaling pathway,BP,
9965,GO:0035793,1,0.97786531322969,0,3,positive regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
9967,GO:0035795,1,0.975179522513358,0,5,negative regulation of mitochondrial membrane permeability,BP,
9968,GO:0035799,1,0.970332386137244,0,4,ureter maturation,BP,
9969,GO:0035800,1,0.988584448938048,0,2,deubiquitinase activator activity,MF,
9970,GO:0035801,1,0.987975762840623,0,2,adrenal cortex development,BP,
9971,GO:0035802,1,0.987975762840623,0,2,adrenal cortex formation,BP,
9972,GO:0035803,1,0.992001247842847,0,2,egg coat formation,BP,
9973,GO:0035805,1,0.994065431553779,0,1,egg coat,CC,
9974,GO:0035809,1,0.893672904182605,0,18,regulation of urine volume,BP,
9975,GO:0035810,1,0.922001273848931,0,12,positive regulation of urine volume,BP,
9976,GO:0035811,1,0.983518038381341,0,3,negative regulation of urine volume,BP,
9977,GO:0035812,1,0.903725545128465,0,16,renal sodium excretion,BP,
9978,GO:0035813,1,0.903725545128465,0,16,regulation of renal sodium excretion,BP,
9979,GO:0035814,1,0.972420820120383,0,5,negative regulation of renal sodium excretion,BP,
9980,GO:0035815,1,0.942500338423359,0,9,positive regulation of renal sodium excretion,BP,
9982,GO:0035822,1,0.963069881377797,0,5,gene conversion,BP,
9983,GO:0035825,1,0.742637506810919,0,44,homologous recombination,BP,
9984,GO:0035838,1,0.975937475949457,0,3,growing cell tip,CC,
9985,GO:0035841,1,0.983372731203578,0,2,new growing cell tip,CC,
9986,GO:0035844,1,0.974296636456665,0,4,cloaca development,BP,
9987,GO:0035845,1,0.936485323924558,0,9,photoreceptor cell outer segment organization,BP,
9988,GO:0035850,1,0.743417149192521,0,41,epithelial cell differentiation involved in kidney development,BP,
9989,GO:0035851,1,0.992837186763866,0,1,Krueppel-associated box domain binding,MF,
9990,GO:0035853,1,0.99235260491819,0,1,chromosome passenger complex localization to spindle midzone,BP,
9991,GO:0035854,1,0.988459662060358,0,2,eosinophil fate commitment,BP,
9992,GO:0035855,1,0.890310083619067,0,15,megakaryocyte development,BP,
9993,GO:0035859,1,0.917221461100925,0,13,Seh1-associated complex,CC,
9995,GO:0035861,1,0.806950090655255,0,30,site of double-strand break,CC,
9996,GO:0035862,1,0.991503892523375,0,1,dITP metabolic process,BP,
9997,GO:0035863,1,0.991503892523375,0,1,dITP catabolic process,BP,
9998,GO:0035864,1,0.935547628083512,0,10,response to potassium ion,BP,
9999,GO:0035865,1,0.961486155701804,0,6,cellular response to potassium ion,BP,
10000,GO:0035866,1,0.973202866518951,0,3,alphav-beta3 integrin-PKCalpha complex,CC,
10001,GO:0035867,1,0.962853593328082,0,4,alphav-beta3 integrin-IGF-1-IGF1R complex,CC,
10002,GO:0035868,1,0.97586750947299,0,3,alphav-beta3 integrin-HMGB1 complex,CC,
10004,GO:0035870,1,0.988208572521537,0,2,dITP diphosphatase activity,MF,
10005,GO:0035871,1,0.935081020888122,0,8,protein K11-linked deubiquitination,BP,
10006,GO:0035872,1,0.789441920207984,0,34,nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway,BP,
10007,GO:0035873,1,0.958900640464984,0,6,lactate transmembrane transport,BP,
10008,GO:0035877,1,0.976017812350569,0,4,death effector domain binding,MF,
10009,GO:0035878,1,0.946880087237862,0,8,nail development,BP,
10010,GO:0035879,1,0.979552739426867,0,3,plasma membrane lactate transport,BP,
10011,GO:0035880,1,0.98157015064794,0,3,embryonic nail plate morphogenesis,BP,
10012,GO:0035881,1,0.952522713787266,0,7,amacrine cell differentiation,BP,
10013,GO:0035883,1,0.840759230527917,0,25,enteroendocrine cell differentiation,BP,
10014,GO:0035886,1,0.881930747174781,0,19,vascular smooth muscle cell differentiation,BP,
10015,GO:0035887,1,0.995239252591955,0,1,aortic smooth muscle cell differentiation,BP,
10018,GO:0035897,1,0.963415592996779,0,6,proteolysis in other organism,BP,
10019,GO:0035898,1,0.979523137308461,0,3,parathyroid hormone secretion,BP,
10020,GO:0035900,1,0.96671649672611,0,6,response to isolation stress,BP,
10021,GO:0035902,1,0.884883412268491,0,19,response to immobilization stress,BP,
10022,GO:0035904,1,0.694060713353423,0,47,aorta development,BP,
10023,GO:0035905,1,0.973594117779678,0,4,ascending aorta development,BP,
10024,GO:0035907,1,0.93802284740164,0,9,dorsal aorta development,BP,
10025,GO:0035909,1,0.795372672946407,0,30,aorta morphogenesis,BP,
10026,GO:0035910,1,0.973594117779678,0,4,ascending aorta morphogenesis,BP,
10027,GO:0035912,1,0.945000996708893,0,8,dorsal aorta morphogenesis,BP,
10028,GO:0035914,1,0.649955051256515,0,61,skeletal muscle cell differentiation,BP,
10029,GO:0035915,1,0.994532872845646,0,1,pore formation in membrane of other organism,BP,
10030,GO:0035921,1,0.994410062983299,0,1,desmosome disassembly,BP,
10031,GO:0035922,1,0.995574418564069,0,1,foramen ovale closure,BP,
10032,GO:0035924,1,0.750818985678493,0,41,cellular response to vascular endothelial growth factor stimulus,BP,
10033,GO:0035925,1,0.916906399571243,0,12,mRNA 3'-UTR AU-rich region binding,MF,
10035,GO:0035927,1,0.978614763152264,0,4,RNA import into mitochondrion,BP,
10036,GO:0035928,1,0.985934696472161,0,3,rRNA import into mitochondrion,BP,
10037,GO:0035929,1,0.902479528398529,0,18,steroid hormone secretion,BP,
10038,GO:0035930,1,0.929986707809371,0,13,corticosteroid hormone secretion,BP,
10039,GO:0035931,1,0.973431418089994,0,4,mineralocorticoid secretion,BP,
10040,GO:0035932,1,0.973431418089994,0,4,aldosterone secretion,BP,
10041,GO:0035933,1,0.955381277854589,0,9,glucocorticoid secretion,BP,
10042,GO:0035934,1,0.982734408134721,0,4,corticosterone secretion,BP,
10043,GO:0035935,1,0.992619880935046,0,1,androgen secretion,BP,
10044,GO:0035936,1,0.983641068126021,0,2,testosterone secretion,BP,
10045,GO:0035938,1,0.979380019476984,0,3,estradiol secretion,BP,
10046,GO:0035939,1,0.979775873585641,0,3,microsatellite binding,MF,
10047,GO:0035945,1,0.993567422063829,0,1,mitochondrial ncRNA surveillance,BP,
10048,GO:0035946,1,0.993567422063829,0,1,mitochondrial mRNA surveillance,BP,
10049,GO:0035947,1,0.962946734654474,0,5,regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter,BP,
10050,GO:0035948,1,0.977788615772936,0,3,positive regulation of gluconeogenesis by positive regulation of transcription from RNA polymerase II promoter,BP,
10051,GO:0035962,1,0.98102003343212,0,3,response to interleukin-13,BP,
10052,GO:0035963,1,0.98102003343212,0,3,cellular response to interleukin-13,BP,
10053,GO:0035964,1,0.960904511955813,0,6,COPI-coated vesicle budding,BP,
10054,GO:0035965,1,0.967344549819332,0,5,cardiolipin acyl-chain remodeling,BP,
10055,GO:0035966,1,0.294436605218457,0,188,response to topologically incorrect protein,BP,
10056,GO:0035967,1,0.355982833663103,0,156,cellular response to topologically incorrect protein,BP,
10057,GO:0035970,1,0.898368573221817,0,16,peptidyl-threonine dephosphorylation,BP,
10058,GO:0035971,1,0.99641910777211,0,1,peptidyl-histidine dephosphorylation,BP,
10059,GO:0035973,1,0.947753768757185,0,7,aggrephagy,BP,
10060,GO:0035976,1,0.974257234616145,0,5,transcription factor AP-1 complex,CC,
10061,GO:0035977,1,0.970814248191043,0,4,protein deglycosylation involved in glycoprotein catabolic process,BP,
10062,GO:0035978,1,0.992999161121732,0,1,histone H2A-S139 phosphorylation,BP,
10063,GO:0035981,1,0.988085468776987,0,2,tongue muscle cell differentiation,BP,
10064,GO:0035983,1,0.972313067851344,0,4,response to trichostatin A,BP,
10065,GO:0035984,1,0.972313067851344,0,4,cellular response to trichostatin A,BP,
10066,GO:0035985,1,0.979439231302095,0,4,senescence-associated heterochromatin focus,CC,
10067,GO:0035986,1,0.984324101983062,0,3,senescence-associated heterochromatin focus assembly,BP,
10068,GO:0035987,1,0.720518662532479,0,45,endodermal cell differentiation,BP,
10070,GO:0035989,1,0.967115111043621,0,5,tendon development,BP,
10071,GO:0035990,1,0.986009133458381,0,3,tendon cell differentiation,BP,
10072,GO:0035992,1,0.986009133458381,0,3,tendon formation,BP,
10073,GO:0035993,1,0.989269558892742,0,2,deltoid tuberosity development,BP,
10074,GO:0035994,1,0.874958857164002,0,17,response to muscle stretch,BP,
10075,GO:0035995,1,0.972812439674097,0,2,detection of muscle stretch,BP,
10076,GO:0035998,1,0.994745391576593,0,1,7,8-dihydroneopterin 3'-triphosphate biosynthetic process,BP,
10077,GO:0035999,1,0.946316782657034,0,9,tetrahydrofolate interconversion,BP,
10078,GO:0036002,1,0.795347459811686,0,35,pre-mRNA binding,MF,
10079,GO:0036003,1,0.852003389390495,0,25,positive regulation of transcription from RNA polymerase II promoter in response to stress,BP,
10080,GO:0036004,1,0.99639086340471,0,1,GAF domain binding,MF,
10081,GO:0036005,1,0.948535273884851,0,8,response to macrophage colony-stimulating factor,BP,
10082,GO:0036006,1,0.948535273884851,0,8,cellular response to macrophage colony-stimulating factor stimulus,BP,
10083,GO:0036009,1,0.996531647484467,0,1,protein-glutamine N-methyltransferase activity,MF,
10084,GO:0036010,1,0.870340881868789,0,18,protein localization to endosome,BP,
10085,GO:0036015,1,0.975553718359547,0,4,response to interleukin-3,BP,
10086,GO:0036016,1,0.975553718359547,0,4,cellular response to interleukin-3,BP,
10087,GO:0036017,1,0.97339482006882,0,7,response to erythropoietin,BP,
10088,GO:0036018,1,0.975261492460054,0,6,cellular response to erythropoietin,BP,
10089,GO:0036019,1,0.875912845489507,0,19,endolysosome,CC,
10090,GO:0036020,1,0.904732300030105,0,14,endolysosome membrane,CC,
10091,GO:0036021,1,0.968177236049531,0,5,endolysosome lumen,CC,
10092,GO:0036022,1,0.982600519536445,0,3,limb joint morphogenesis,BP,
10093,GO:0036023,1,0.982600519536445,0,3,embryonic skeletal limb joint morphogenesis,BP,
10094,GO:0036024,1,0.993920441312131,0,1,protein C inhibitor-TMPRSS7 complex,CC,
10095,GO:0036025,1,0.993920441312131,0,1,protein C inhibitor-TMPRSS11E complex,CC,
10096,GO:0036026,1,0.993920441312131,0,1,protein C inhibitor-PLAT complex,CC,
10097,GO:0036027,1,0.993920441312131,0,1,protein C inhibitor-PLAU complex,CC,
10098,GO:0036028,1,0.993920441312131,0,1,protein C inhibitor-thrombin complex,CC,
10099,GO:0036029,1,0.993920441312131,0,1,protein C inhibitor-KLK3 complex,CC,
10100,GO:0036030,1,0.993920441312131,0,1,protein C inhibitor-plasma kallikrein complex,CC,
10101,GO:0036033,1,0.961607681960795,0,4,mediator complex binding,MF,
10102,GO:0036034,1,0.987108662456525,0,2,mediator complex assembly,BP,
10104,GO:0036037,1,0.921269506476783,0,13,CD8-positive, alpha-beta T cell activation,BP,
10105,GO:0036038,1,0.926606264568121,0,13,MKS complex,CC,
10106,GO:0036041,1,0.961941802426289,0,9,long-chain fatty acid binding,MF,
10107,GO:0036042,1,0.982287213859097,0,4,long-chain fatty acyl-CoA binding,MF,
10108,GO:0036046,1,0.992690646028277,0,1,protein demalonylation,BP,
10109,GO:0036047,1,0.992690646028277,0,1,peptidyl-lysine demalonylation,BP,
10110,GO:0036048,1,0.992690646028277,0,1,protein desuccinylation,BP,
10111,GO:0036049,1,0.992690646028277,0,1,peptidyl-lysine desuccinylation,BP,
10112,GO:0036053,1,0.993158500568297,0,1,glomerular endothelium fenestra,CC,
10113,GO:0036054,1,0.992690646028277,0,1,protein-malonyllysine demalonylase activity,MF,
10114,GO:0036055,1,0.992690646028277,0,1,protein-succinyllysine desuccinylase activity,MF,
10115,GO:0036056,1,0.944379418511191,0,7,filtration diaphragm,CC,
10116,GO:0036057,1,0.944379418511191,0,7,slit diaphragm,CC,
10117,GO:0036058,1,0.992469892460923,0,1,filtration diaphragm assembly,BP,
10118,GO:0036060,1,0.992469892460923,0,1,slit diaphragm assembly,BP,
10119,GO:0036064,1,0.487970299244613,0,101,ciliary basal body,CC,
10120,GO:0036065,1,0.835019840927499,0,25,fucosylation,BP,
10121,GO:0036066,1,0.905325880248198,0,14,protein O-linked fucosylation,BP,
10122,GO:0036071,1,0.992613845995336,0,1,N-glycan fucosylation,BP,
10123,GO:0036072,1,0.958900636071047,0,6,direct ossification,BP,
10125,GO:0036080,1,0.983736367541626,0,2,purine nucleotide-sugar transmembrane transporter activity,MF,
10126,GO:0036085,1,0.992654051521244,0,1,GDP-fucose import into Golgi lumen,BP,
10127,GO:0036088,1,0.995570989438816,0,1,D-serine catabolic process,BP,
10128,GO:0036089,1,0.953729215345212,0,7,cleavage furrow formation,BP,
10129,GO:0036090,1,0.989219814045758,0,2,cleavage furrow ingression,BP,
10130,GO:0036091,1,0.968058088053783,0,5,positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,
10132,GO:0036093,1,0.970435291747608,0,6,germ cell proliferation,BP,
10134,GO:0036100,1,0.988113939178789,0,2,leukotriene catabolic process,BP,
10135,GO:0036101,1,0.988113939178789,0,2,leukotriene B4 catabolic process,BP,
10136,GO:0036102,1,0.988113939178789,0,2,leukotriene B4 metabolic process,BP,
10137,GO:0036105,1,0.992519843455163,0,1,peroxisome membrane class-1 targeting sequence binding,MF,
10138,GO:0036109,1,0.925223958835272,0,12,alpha-linolenic acid metabolic process,BP,
10139,GO:0036111,1,0.993198506957189,0,1,very long-chain fatty-acyl-CoA metabolic process,BP,
10140,GO:0036112,1,0.981873103494916,0,3,medium-chain fatty-acyl-CoA metabolic process,BP,
10141,GO:0036114,1,0.995731334388177,0,1,medium-chain fatty-acyl-CoA catabolic process,BP,
10142,GO:0036115,1,0.995731334388177,0,1,fatty-acyl-CoA catabolic process,BP,
10143,GO:0036116,1,0.995731334388177,0,1,long-chain fatty-acyl-CoA catabolic process,BP,
10144,GO:0036117,1,0.987908838265767,0,2,hyaluranon cable,CC,
10145,GO:0036118,1,0.980468513726914,0,3,hyaluranon cable assembly,BP,
10146,GO:0036119,1,0.853898172150621,0,21,response to platelet-derived growth factor,BP,
10147,GO:0036120,1,0.86006277768179,0,20,cellular response to platelet-derived growth factor stimulus,BP,
10148,GO:0036122,1,0.943772425410306,0,9,BMP binding,MF,
10149,GO:0036123,1,0.963926747833983,0,6,histone H3-K9 dimethylation,BP,
10150,GO:0036124,1,0.899760612425084,0,14,histone H3-K9 trimethylation,BP,
10151,GO:0036125,1,0.99276475129987,0,1,fatty acid beta-oxidation multienzyme complex,CC,
10152,GO:0036126,1,0.681826092018386,0,61,sperm flagellum,CC,
10153,GO:0036128,1,0.962937693975993,0,6,CatSper complex,CC,
10154,GO:0036130,1,0.996406077437465,0,1,prostaglandin H2 endoperoxidase reductase activity,MF,
10155,GO:0036131,1,0.996406077437465,0,1,prostaglandin D2 11-ketoreductase activity,MF,
10156,GO:0036132,1,0.98172583993303,0,3,13-prostaglandin reductase activity,MF,
10157,GO:0036134,1,0.994371718953324,0,1,12-hydroxyheptadecatrienoic acid synthase activity,MF,
10158,GO:0036135,1,0.983894902466278,0,2,Schwann cell migration,BP,
10159,GO:0036137,1,0.987783472787719,0,2,kynurenine aminotransferase activity,MF,
10160,GO:0036138,1,0.990959233724992,0,1,peptidyl-histidine hydroxylation,BP,
10161,GO:0036139,1,0.990959233724992,0,1,peptidyl-histidine dioxygenase activity,MF,
10162,GO:0036140,1,0.990959233724992,0,1,peptidyl-asparagine 3-dioxygenase activity,MF,
10163,GO:0036143,1,0.997208343993995,0,1,kringle domain binding,MF,
10164,GO:0036145,1,0.995153671130864,0,1,dendritic cell homeostasis,BP,
10165,GO:0036146,1,0.96670728338904,0,5,cellular response to mycotoxin,BP,
10166,GO:0036148,1,0.915282900923785,0,13,phosphatidylglycerol acyl-chain remodeling,BP,
10167,GO:0036149,1,0.942413786803491,0,10,phosphatidylinositol acyl-chain remodeling,BP,
10168,GO:0036150,1,0.908500077526689,0,15,phosphatidylserine acyl-chain remodeling,BP,
10169,GO:0036151,1,0.87701688056019,0,21,phosphatidylcholine acyl-chain remodeling,BP,
10170,GO:0036152,1,0.887575111037299,0,20,phosphatidylethanolamine acyl-chain remodeling,BP,
10171,GO:0036153,1,0.99302489525474,0,1,triglyceride acyl-chain remodeling,BP,
10172,GO:0036155,1,0.966446554487006,0,5,acylglycerol acyl-chain remodeling,BP,
10173,GO:0036156,1,0.953684860292483,0,4,inner dynein arm,CC,
10174,GO:0036157,1,0.934677817810413,0,9,outer dynein arm,CC,
10175,GO:0036158,1,0.893157644773593,0,16,outer dynein arm assembly,BP,
10176,GO:0036159,1,0.898131051725434,0,14,inner dynein arm assembly,BP,
10177,GO:0036164,1,0.996679937976751,0,1,cell-abiotic substrate adhesion,BP,
10178,GO:0036166,1,0.969792734933932,0,4,phenotypic switching,BP,
10179,GO:0036179,1,0.993099181152047,0,1,osteoclast maturation,BP,
10180,GO:0036194,1,0.987139330965621,0,3,muscle cell projection,CC,
10181,GO:0036195,1,0.987139330965621,0,3,muscle cell projection membrane,CC,
10183,GO:0036213,1,0.994214168842005,0,1,contractile ring contraction,BP,
10184,GO:0036215,1,0.984918938146985,0,2,response to stem cell factor,BP,
10185,GO:0036216,1,0.984918938146985,0,2,cellular response to stem cell factor stimulus,BP,
10186,GO:0036219,1,0.997490814002907,0,1,GTP diphosphatase activity,MF,
10187,GO:0036220,1,0.996676726459821,0,1,ITP diphosphatase activity,MF,
10188,GO:0036222,1,0.996676726459821,0,1,XTP diphosphatase activity,MF,
10189,GO:0036228,1,0.986276275692619,0,2,protein localization to nuclear inner membrane,BP,
10191,GO:0036245,1,0.988077240008706,0,2,cellular response to menadione,BP,
10192,GO:0036250,1,0.994805851317589,0,1,peroxisome transport along microtubule,BP,
10193,GO:0036255,1,0.992493728080011,0,1,response to methylamine,BP,
10194,GO:0036257,1,0.829522186018445,0,31,multivesicular body organization,BP,
10195,GO:0036258,1,0.835351968529491,0,30,multivesicular body assembly,BP,
10196,GO:0036260,1,0.832521608136304,0,32,RNA capping,BP,
10197,GO:0036261,1,0.992508194970706,0,1,7-methylguanosine cap hypermethylation,BP,
10198,GO:0036265,1,0.980766127209567,0,4,RNA (guanine-N7)-methylation,BP,
10199,GO:0036266,1,0.993440989855558,0,1,Cdc48p-Npl4p-Vms1p AAA ATPase complex,CC,
10200,GO:0036269,1,0.987044720555028,0,2,swimming behavior,BP,
10201,GO:0036270,1,0.864685006724273,0,18,response to diuretic,BP,
10202,GO:0036284,1,0.986348294953749,0,2,tubulobulbar complex,CC,
10203,GO:0036289,1,0.947809448402911,0,7,peptidyl-serine autophosphorylation,BP,
10204,GO:0036290,1,0.992471121987881,0,1,protein trans-autophosphorylation,BP,
10205,GO:0036292,1,0.988544760371099,0,2,DNA rewinding,BP,
10207,GO:0036294,1,0.299729266486483,0,189,cellular response to decreased oxygen levels,BP,
10208,GO:0036295,1,0.92105074747834,0,13,cellular response to increased oxygen levels,BP,
10209,GO:0036296,1,0.843984901996962,0,27,response to increased oxygen levels,BP,
10210,GO:0036297,1,0.74226175110946,0,44,interstrand cross-link repair,BP,
10211,GO:0036301,1,0.966716349678225,0,5,macrophage colony-stimulating factor production,BP,
10212,GO:0036302,1,0.943118500282355,0,7,atrioventricular canal development,BP,
10213,GO:0036303,1,0.868890745298514,0,18,lymph vessel morphogenesis,BP,
10214,GO:0036304,1,0.987224344563637,0,2,umbilical cord morphogenesis,BP,
10215,GO:0036306,1,0.995574418564069,0,1,embryonic heart tube elongation,BP,
10216,GO:0036309,1,0.973814355840417,0,2,protein localization to M-band,BP,
10217,GO:0036310,1,0.945273757621135,0,8,annealing helicase activity,MF,
10218,GO:0036312,1,0.933349945664802,0,8,phosphatidylinositol 3-kinase regulatory subunit binding,MF,
10219,GO:0036313,1,0.993668807613453,0,1,phosphatidylinositol 3-kinase catalytic subunit binding,MF,
10220,GO:0036314,1,0.83147448398632,0,23,response to sterol,BP,
10221,GO:0036315,1,0.884639405510881,0,15,cellular response to sterol,BP,
10222,GO:0036316,1,0.993162364409317,0,1,SREBP-SCAP complex retention in endoplasmic reticulum,BP,
10223,GO:0036317,1,0.993058458973322,0,1,tyrosyl-RNA phosphodiesterase activity,MF,
10224,GO:0036323,1,0.992247199673688,0,1,vascular endothelial growth factor receptor-1 signaling pathway,BP,
10225,GO:0036324,1,0.988978726736588,0,2,vascular endothelial growth factor receptor-2 signaling pathway,BP,
10226,GO:0036326,1,0.992247199673688,0,1,VEGF-A-activated receptor activity,MF,
10227,GO:0036327,1,0.992247199673688,0,1,VEGF-B-activated receptor activity,MF,
10228,GO:0036328,1,0.992007578045337,0,1,VEGF-C-activated receptor activity,MF,
10229,GO:0036332,1,0.992247199673688,0,1,placental growth factor-activated receptor activity,MF,
10230,GO:0036333,1,0.993293398236355,0,1,hepatocyte homeostasis,BP,
10231,GO:0036335,1,0.991976739542134,0,1,intestinal stem cell homeostasis,BP,
10232,GO:0036336,1,0.848658152025174,0,26,dendritic cell migration,BP,
10233,GO:0036337,1,0.970917090281917,0,4,Fas signaling pathway,BP,
10234,GO:0036342,1,0.902436109370792,0,15,post-anal tail morphogenesis,BP,
10235,GO:0036343,1,0.980935266819686,0,4,psychomotor behavior,BP,
10236,GO:0036344,1,0.877758665456543,0,19,platelet morphogenesis,BP,
10237,GO:0036345,1,0.988276298544337,0,2,platelet maturation,BP,
10238,GO:0036351,1,0.993913951729972,0,1,histone H2A-K13 ubiquitination,BP,
10239,GO:0036352,1,0.993913951729972,0,1,histone H2A-K15 ubiquitination,BP,
10240,GO:0036353,1,0.952500881511115,0,7,histone H2A-K119 monoubiquitination,BP,
10241,GO:0036361,1,0.993575240739539,0,1,racemase activity, acting on amino acids and derivatives,MF,
10242,GO:0036363,1,0.985816770988168,0,2,transforming growth factor beta activation,BP,
10243,GO:0036367,1,0.993412530282365,0,1,light adaption,BP,
10244,GO:0036369,1,0.981263975470977,0,2,transcription factor catabolic process,BP,
10245,GO:0036371,1,0.990237779188274,0,1,protein localization to T-tubule,BP,
10246,GO:0036372,1,0.996943658062354,0,1,opsin transport,BP,
10247,GO:0036374,1,0.98073557383568,0,3,glutathione hydrolase activity,MF,
10248,GO:0036376,1,0.913508461531723,0,14,sodium ion export across plasma membrane,BP,
10249,GO:0036378,1,0.989118936344189,0,2,calcitriol biosynthetic process from calciol,BP,
10250,GO:0036379,1,0.823869793055307,0,30,myofilament,CC,
10251,GO:0036387,1,0.983637094796707,0,3,pre-replicative complex,CC,
10252,GO:0036388,1,0.983637094796707,0,3,pre-replicative complex assembly,BP,
10253,GO:0036392,1,0.992506143966437,0,1,chemokine (C-C motif) ligand 20 production,BP,
10254,GO:0036393,1,0.992915727231584,0,1,thiocyanate peroxidase activity,MF,
10255,GO:0036396,1,0.984467725801226,0,3,RNA N6-methyladenosine methyltransferase complex,CC,
10256,GO:0036398,1,0.986323056313302,0,2,TCR signalosome,CC,
10257,GO:0036399,1,0.992618000628388,0,1,TCR signalosome assembly,BP,
10258,GO:0036402,1,0.974985693918577,0,6,proteasome-activating ATPase activity,MF,
10259,GO:0036403,1,0.993304517325951,0,1,arachidonate 8(S)-lipoxygenase activity,MF,
10260,GO:0036404,1,0.989011939256005,0,1,conversion of ds siRNA to ss siRNA,BP,
10261,GO:0036413,1,0.98643680091823,0,2,histone H3-R26 citrullination,BP,
10262,GO:0036414,1,0.979197440942314,0,3,histone citrullination,BP,
10263,GO:0036435,1,0.988781229560109,0,2,K48-linked polyubiquitin modification-dependent protein binding,MF,
10264,GO:0036438,1,0.973245257903998,0,4,maintenance of lens transparency,BP,
10265,GO:0036440,1,0.992826483645098,0,1,citrate synthase activity,MF,
10266,GO:0036442,1,0.850158150140734,0,27,proton-exporting ATPase activity,MF,
10267,GO:0036444,1,0.943400136986165,0,8,calcium import into the mitochondrion,BP,
10268,GO:0036445,1,0.90390743880536,0,13,neuronal stem cell division,BP,
10269,GO:0036446,1,0.976922004390027,0,3,myofibroblast differentiation,BP,
10270,GO:0036449,1,0.939386440243129,0,7,microtubule minus-end,CC,
10271,GO:0036451,1,0.986164624597214,0,2,cap mRNA methylation,BP,
10272,GO:0036452,1,0.845178743029911,0,28,ESCRT complex,CC,
10273,GO:0036454,1,0.967276706800498,0,5,growth factor complex,CC,
10274,GO:0036455,1,0.996627416263835,0,1,iron-sulfur transferase activity,MF,
10275,GO:0036458,1,0.994184610546592,0,1,hepatocyte growth factor binding,MF,
10276,GO:0036459,1,0.514775752240742,0,88,thiol-dependent ubiquitinyl hydrolase activity,MF,
10277,GO:0036461,1,0.992484841732286,0,2,BLOC-2 complex binding,MF,
10278,GO:0036462,1,0.959216750291923,0,7,TRAIL-activated apoptotic signaling pathway,BP,
10279,GO:0036464,1,0.301426347907664,0,178,cytoplasmic ribonucleoprotein granule,CC,
10281,GO:0036466,1,0.984595931640153,0,2,synaptic vesicle recycling via endosome,BP,
10282,GO:0036468,1,0.994586993820206,0,1,L-dopa decarboxylase activity,MF,
10283,GO:0036470,1,0.997032233810024,0,1,tyrosine 3-monooxygenase activator activity,MF,
10284,GO:0036471,1,0.997032233810024,0,1,cellular response to glyoxal,BP,
10285,GO:0036473,1,0.619831754371377,0,73,cell death in response to oxidative stress,BP,
10286,GO:0036474,1,0.846827649750197,0,26,cell death in response to hydrogen peroxide,BP,
10287,GO:0036475,1,0.864190543775565,0,21,neuron death in response to oxidative stress,BP,
10288,GO:0036476,1,0.977906521159045,0,4,neuron death in response to hydrogen peroxide,BP,
10290,GO:0036478,1,0.997032233810024,0,1,L-dopa decarboxylase activator activity,MF,
10291,GO:0036479,1,0.989575106505612,0,1,peroxidase inhibitor activity,MF,
10292,GO:0036480,1,0.953879624218704,0,7,neuron intrinsic apoptotic signaling pathway in response to oxidative stress,BP,
10293,GO:0036481,1,0.967711600377839,0,6,intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
10294,GO:0036482,1,0.990297652745539,0,2,neuron intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
10295,GO:0036483,1,0.992324049087638,0,1,neuron intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,
10296,GO:0036484,1,0.977992716590448,0,3,trunk neural crest cell migration,BP,
10297,GO:0036486,1,0.977992716590448,0,3,ventral trunk neural crest cell migration,BP,
10298,GO:0036487,1,0.989824462282673,0,1,nitric-oxide synthase inhibitor activity,MF,
10299,GO:0036488,1,0.992130154761414,0,2,CHOP-C/EBP complex,CC,
10300,GO:0036490,1,0.944335822747755,0,8,regulation of translation in response to endoplasmic reticulum stress,BP,
10301,GO:0036491,1,0.951431815931313,0,7,regulation of translation initiation in response to endoplasmic reticulum stress,BP,
10302,GO:0036492,1,0.957391445708159,0,6,eiF2alpha phosphorylation in response to endoplasmic reticulum stress,BP,
10303,GO:0036493,1,0.980690675270155,0,3,positive regulation of translation in response to endoplasmic reticulum stress,BP,
10304,GO:0036494,1,0.991778479606835,0,1,positive regulation of translation initiation in response to endoplasmic reticulum stress,BP,
10305,GO:0036496,1,0.989666465366881,0,2,regulation of translational initiation by eIF2 alpha dephosphorylation,BP,
10306,GO:0036497,1,0.993777838898081,0,1,eIF2alpha dephosphorylation in response to endoplasmic reticulum stress,BP,
10307,GO:0036498,1,0.638682251560178,0,67,IRE1-mediated unfolded protein response,BP,
10308,GO:0036499,1,0.884386270322648,0,20,PERK-mediated unfolded protein response,BP,
10309,GO:0036500,1,0.938387615259189,0,10,ATF6-mediated unfolded protein response,BP,
10310,GO:0036501,1,0.992384675165888,0,1,UFD1-NPL4 complex,CC,
10311,GO:0036502,1,0.992702045021941,0,1,Derlin-1-VIMP complex,CC,
10312,GO:0036503,1,0.557251051529964,0,89,ERAD pathway,BP,
10313,GO:0036505,1,0.986524957923887,0,2,prosaposin receptor activity,MF,
10314,GO:0036506,1,0.977976409464025,0,3,maintenance of unfolded protein,BP,
10315,GO:0036507,1,0.845632301583687,0,24,protein demannosylation,BP,
10316,GO:0036508,1,0.845632301583687,0,24,protein alpha-1,2-demannosylation,BP,
10317,GO:0036509,1,0.987986720639451,0,2,trimming of terminal mannose on B branch,BP,
10318,GO:0036510,1,0.979511026379262,0,3,trimming of terminal mannose on C branch,BP,
10319,GO:0036511,1,0.987986720639451,0,2,trimming of first mannose on A branch,BP,
10320,GO:0036512,1,0.987986720639451,0,2,trimming of second mannose on A branch,BP,
10321,GO:0036513,1,0.928934438880142,0,11,Derlin-1 retrotranslocation complex,CC,
10322,GO:0036514,1,0.957699786182336,0,5,dopaminergic neuron axon guidance,BP,
10323,GO:0036515,1,0.964586561258357,0,4,serotonergic neuron axon guidance,BP,
10324,GO:0036517,1,0.991622634195076,0,1,chemoattraction of serotonergic neuron axon,BP,
10325,GO:0036518,1,0.984544779491218,0,2,chemorepulsion of dopaminergic neuron axon,BP,
10326,GO:0036524,1,0.997032233810024,0,1,protein deglycase activity,MF,
10327,GO:0036525,1,0.997032233810024,0,1,protein deglycation,BP,
10328,GO:0036526,1,0.997032233810024,0,1,peptidyl-cysteine deglycation,BP,
10329,GO:0036527,1,0.997032233810024,0,1,peptidyl-arginine deglycation,BP,
10330,GO:0036528,1,0.997032233810024,0,1,peptidyl-lysine deglycation,BP,
10331,GO:0036529,1,0.997032233810024,0,1,protein deglycation, glyoxal removal,BP,
10332,GO:0036530,1,0.997032233810024,0,1,protein deglycation, methylglyoxal removal,BP,
10333,GO:0036531,1,0.997032233810024,0,1,glutathione deglycation,BP,
10334,GO:0038001,1,0.973853542391455,0,3,paracrine signaling,BP,
10335,GO:0038002,1,0.991916970921735,0,1,endocrine signaling,BP,
10336,GO:0038003,1,0.945458334824174,0,10,opioid receptor signaling pathway,BP,
10337,GO:0038007,1,0.943465237416364,0,7,netrin-activated signaling pathway,BP,
10338,GO:0038016,1,0.986504081503886,0,2,insulin receptor internalization,BP,
10339,GO:0038018,1,0.983575801836722,0,2,Wnt receptor catabolic process,BP,
10340,GO:0038021,1,0.992422131026183,0,1,leptin receptor activity,MF,
10343,GO:0038025,1,0.985009022426027,0,2,reelin receptor activity,MF,
10344,GO:0038026,1,0.966013370581788,0,4,reelin-mediated signaling pathway,BP,
10345,GO:0038027,1,0.958530254632235,0,5,apolipoprotein A-I-mediated signaling pathway,BP,
10346,GO:0038028,1,0.970774198805949,0,4,insulin receptor signaling pathway via phosphatidylinositol 3-kinase,BP,
10347,GO:0038030,1,0.950300644766274,0,7,non-canonical Wnt signaling pathway via MAPK cascade,BP,
10348,GO:0038031,1,0.957498645253905,0,6,non-canonical Wnt signaling pathway via JNK cascade,BP,
10349,GO:0038033,1,0.966696748465228,0,5,positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway,BP,
10351,GO:0038036,1,0.951512763087565,0,8,sphingosine-1-phosphate receptor activity,MF,
10352,GO:0038037,1,0.951270962781246,0,8,G-protein coupled receptor dimeric complex,CC,
10353,GO:0038038,1,0.990967127223715,0,1,G-protein coupled receptor homodimeric complex,CC,
10354,GO:0038039,1,0.984100948118939,0,2,G-protein coupled receptor heterodimeric complex,CC,
10355,GO:0038042,1,0.962696627780268,0,7,dimeric G-protein coupled receptor signaling pathway,BP,
10356,GO:0038043,1,0.986820366323442,0,2,interleukin-5-mediated signaling pathway,BP,
10357,GO:0038044,1,0.960359050649898,0,5,transforming growth factor-beta secretion,BP,
10358,GO:0038046,1,0.99517481828068,0,1,enkephalin receptor activity,MF,
10359,GO:0038047,1,0.994955265031546,0,1,morphine receptor activity,MF,
10360,GO:0038048,1,0.992142202368947,0,1,dynorphin receptor activity,MF,
10361,GO:0038049,1,0.979611832024891,0,2,transcription factor activity, ligand-activated RNA polymerase II transcription factor binding,MF,
10362,GO:0038051,1,0.991140263073938,0,1,glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity,MF,
10363,GO:0038052,1,0.984981517708715,0,2,RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding,MF,
10364,GO:0038060,1,0.992591040871549,0,1,nitric oxide-cGMP-mediated signaling pathway,BP,
10366,GO:0038062,1,0.985203416213352,0,2,protein tyrosine kinase collagen receptor activity,MF,
10367,GO:0038063,1,0.926386544734584,0,9,collagen-activated tyrosine kinase receptor signaling pathway,BP,
10368,GO:0038064,1,0.968013415703277,0,4,collagen receptor activity,MF,
10369,GO:0038065,1,0.91021294126594,0,11,collagen-activated signaling pathway,BP,
10370,GO:0038066,1,0.783229789384451,0,37,p38MAPK cascade,BP,
10372,GO:0038084,1,0.832799778751213,0,25,vascular endothelial growth factor signaling pathway,BP,
10373,GO:0038085,1,0.964095373600422,0,5,vascular endothelial growth factor binding,MF,
10374,GO:0038086,1,0.975582139963799,0,3,VEGF-activated platelet-derived growth factor receptor signaling pathway,BP,
10375,GO:0038089,1,0.949966537350048,0,7,positive regulation of cell migration by vascular endothelial growth factor signaling pathway,BP,
10376,GO:0038091,1,0.975582139963799,0,3,positive regulation of cell proliferation by VEGF-activated platelet derived growth factor receptor signaling pathway,BP,
10377,GO:0038092,1,0.914503075052694,0,14,nodal signaling pathway,BP,
10378,GO:0038093,1,0.328296110127529,0,178,Fc receptor signaling pathway,BP,
10379,GO:0038094,1,0.609660236430378,0,74,Fc-gamma receptor signaling pathway,BP,
10380,GO:0038095,1,0.487705759774489,0,118,Fc-epsilon receptor signaling pathway,BP,
10381,GO:0038096,1,0.620816935965827,0,70,Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
10382,GO:0038097,1,0.991946017017525,0,1,positive regulation of mast cell activation by Fc-epsilon receptor signaling pathway,BP,
10383,GO:0038098,1,0.98703286721796,0,2,sequestering of BMP from receptor via BMP binding,BP,
10384,GO:0038100,1,0.984666622921967,0,2,nodal binding,MF,
10385,GO:0038101,1,0.995275445252455,0,1,sequestering of nodal from receptor via nodal binding,BP,
10386,GO:0038107,1,0.960728755555021,0,7,nodal signaling pathway involved in determination of left/right asymmetry,BP,
10387,GO:0038108,1,0.972731512104546,0,4,negative regulation of appetite by leptin-mediated signaling pathway,BP,
10388,GO:0038109,1,0.984918938146985,0,2,Kit signaling pathway,BP,
10389,GO:0038110,1,0.924372319261334,0,11,interleukin-2-mediated signaling pathway,BP,
10390,GO:0038111,1,0.888171737137644,0,18,interleukin-7-mediated signaling pathway,BP,
10391,GO:0038112,1,0.986705555057927,0,2,interleukin-8-mediated signaling pathway,BP,
10392,GO:0038113,1,0.979791218395524,0,3,interleukin-9-mediated signaling pathway,BP,
10393,GO:0038114,1,0.951057052217041,0,7,interleukin-21-mediated signaling pathway,BP,
10394,GO:0038115,1,0.994241557377807,0,1,chemokine (C-C motif) ligand 19 signaling pathway,BP,
10395,GO:0038116,1,0.994241557377807,0,1,chemokine (C-C motif) ligand 21 signaling pathway,BP,
10396,GO:0038117,1,0.994241557377807,0,1,C-C motif chemokine 19 receptor activity,MF,
10397,GO:0038118,1,0.996782430484662,0,1,C-C chemokine receptor CCR7 signaling pathway,BP,
10398,GO:0038121,1,0.994241557377807,0,1,C-C motif chemokine 21 receptor activity,MF,
10399,GO:0038123,1,0.981258759716165,0,3,toll-like receptor TLR1:TLR2 signaling pathway,BP,
10400,GO:0038124,1,0.974475000364072,0,4,toll-like receptor TLR6:TLR2 signaling pathway,BP,
10403,GO:0038129,1,0.982070066148065,0,3,ERBB3 signaling pathway,BP,
10404,GO:0038131,1,0.987490647143503,0,2,neuregulin receptor activity,MF,
10405,GO:0038132,1,0.959730572944424,0,5,neuregulin binding,MF,
10406,GO:0038133,1,0.994538747356248,0,1,ERBB2-ERBB3 signaling pathway,BP,
10407,GO:0038145,1,0.969837912354032,0,5,macrophage colony-stimulating factor signaling pathway,BP,
10408,GO:0038154,1,0.99266209905125,0,1,interleukin-11-mediated signaling pathway,BP,
10409,GO:0038155,1,0.955289707237404,0,7,interleukin-23-mediated signaling pathway,BP,
10410,GO:0038156,1,0.99219505124702,0,1,interleukin-3-mediated signaling pathway,BP,
10411,GO:0038158,1,0.98803470547721,0,2,granulocyte colony-stimulating factor signaling pathway,BP,
10412,GO:0038161,1,0.981327616823339,0,2,prolactin signaling pathway,BP,
10413,GO:0038162,1,0.98327930960564,0,3,erythropoietin-mediated signaling pathway,BP,
10414,GO:0038163,1,0.984620489713639,0,3,thrombopoietin-mediated signaling pathway,BP,
10415,GO:0038164,1,0.992514564272821,0,1,thrombopoietin receptor activity,MF,
10416,GO:0038165,1,0.969543858781456,0,4,oncostatin-M-mediated signaling pathway,BP,
10418,GO:0038167,1,0.991916374671401,0,1,epidermal growth factor receptor signaling pathway via positive regulation of NF-kappaB transcription factor activity,BP,
10419,GO:0038168,1,0.991916374671401,0,1,epidermal growth factor receptor signaling pathway via I-kappaB kinase/NF-kappaB cascade,BP,
10420,GO:0038169,1,0.976724426667632,0,4,somatostatin receptor signaling pathway,BP,
10421,GO:0038170,1,0.976724426667632,0,4,somatostatin signaling pathway,BP,
10422,GO:0038171,1,0.951283232977878,0,7,cannabinoid signaling pathway,BP,
10423,GO:0038172,1,0.979881571831617,0,3,interleukin-33-mediated signaling pathway,BP,
10424,GO:0038178,1,0.98696726161048,0,2,complement component C5a signaling pathway,BP,
10425,GO:0038179,1,0.784592298709186,0,35,neurotrophin signaling pathway,BP,
10426,GO:0038180,1,0.923967269627911,0,12,nerve growth factor signaling pathway,BP,
10427,GO:0038181,1,0.982463388369391,0,3,bile acid receptor activity,MF,
10428,GO:0038182,1,0.995818204031736,0,1,G-protein coupled bile acid receptor activity,MF,
10429,GO:0038183,1,0.982463388369391,0,3,bile acid signaling pathway,BP,
10430,GO:0038184,1,0.995818204031736,0,1,cell surface bile acid receptor signaling pathway,BP,
10431,GO:0038185,1,0.994287414484928,0,1,intracellular bile acid receptor signaling pathway,BP,
10432,GO:0038186,1,0.992258462460885,0,1,lithocholic acid receptor activity,MF,
10433,GO:0038187,1,0.918680481368627,0,14,pattern recognition receptor activity,MF,
10434,GO:0038188,1,0.989767086749539,0,2,cholecystokinin signaling pathway,BP,
10435,GO:0038189,1,0.972380590037311,0,4,neuropilin signaling pathway,BP,
10436,GO:0038190,1,0.986151098080956,0,2,VEGF-activated neuropilin signaling pathway,BP,
10437,GO:0038191,1,0.85860769567626,0,19,neuropilin binding,MF,
10438,GO:0038192,1,0.994557559682999,0,1,gastric inhibitory peptide signaling pathway,BP,
10439,GO:0038193,1,0.994015545358986,0,1,thromboxane A2 signaling pathway,BP,
10440,GO:0038194,1,0.98887877452445,0,2,thyroid-stimulating hormone signaling pathway,BP,
10441,GO:0038195,1,0.99593701628593,0,1,urokinase plasminogen activator signaling pathway,BP,
10442,GO:0038201,1,0.893484891547311,0,16,TOR complex,CC,
10443,GO:0038202,1,0.802408939525797,0,32,TORC1 signaling,BP,
10444,GO:0038203,1,0.954061213427015,0,7,TORC2 signaling,BP,
10445,GO:0039003,1,0.985001542988399,0,2,pronephric field specification,BP,
10446,GO:0039007,1,0.991799783217798,0,1,pronephric nephron morphogenesis,BP,
10447,GO:0039008,1,0.991799783217798,0,1,pronephric nephron tubule morphogenesis,BP,
10448,GO:0039017,1,0.985001542988399,0,2,pattern specification involved in pronephros development,BP,
10449,GO:0039019,1,0.984376433444935,0,2,pronephric nephron development,BP,
10450,GO:0039020,1,0.991799783217798,0,1,pronephric nephron tubule development,BP,
10451,GO:0039022,1,0.991799783217798,0,1,pronephric duct development,BP,
10452,GO:0039023,1,0.991799783217798,0,1,pronephric duct morphogenesis,BP,
10453,GO:0039502,1,0.992003285188543,0,1,suppression by virus of host type I interferon-mediated signaling pathway,BP,
10454,GO:0039503,1,0.992003285188543,0,1,suppression by virus of host innate immune response,BP,
10455,GO:0039506,1,0.985149888032672,0,2,modulation by virus of host molecular function,BP,
10456,GO:0039507,1,0.985149888032672,0,2,suppression by virus of host molecular function,BP,
10457,GO:0039513,1,0.993091908715104,0,1,suppression by virus of host catalytic activity,BP,
10458,GO:0039514,1,0.992003285188543,0,1,suppression by virus of host JAK-STAT cascade,BP,
10459,GO:0039516,1,0.993091908715104,0,1,modulation by virus of host catalytic activity,BP,
10460,GO:0039519,1,0.984000476138221,0,2,modulation by virus of host autophagy,BP,
10461,GO:0039520,1,0.991803787431416,0,1,induction by virus of host autophagy,BP,
10462,GO:0039521,1,0.992132846738313,0,1,suppression by virus of host autophagy,BP,
10463,GO:0039526,1,0.983482272949939,0,3,modulation by virus of host apoptotic process,BP,
10464,GO:0039528,1,0.865770868848694,0,20,cytoplasmic pattern recognition receptor signaling pathway in response to virus,BP,
10465,GO:0039529,1,0.892504897567698,0,15,RIG-I signaling pathway,BP,
10466,GO:0039530,1,0.947489276339261,0,8,MDA-5 signaling pathway,BP,
10467,GO:0039531,1,0.894483086703129,0,15,regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,
10468,GO:0039532,1,0.941068200714537,0,9,negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway,BP,
10469,GO:0039533,1,0.963996090676922,0,5,regulation of MDA-5 signaling pathway,BP,
10470,GO:0039534,1,0.982413609244391,0,3,negative regulation of MDA-5 signaling pathway,BP,
10471,GO:0039535,1,0.906298291368755,0,13,regulation of RIG-I signaling pathway,BP,
10472,GO:0039536,1,0.953492401361654,0,7,negative regulation of RIG-I signaling pathway,BP,
10473,GO:0039552,1,0.991831415935237,0,1,RIG-I binding,MF,
10474,GO:0039562,1,0.992003285188543,0,1,suppression by virus of host STAT activity,BP,
10475,GO:0039563,1,0.992003285188543,0,1,suppression by virus of host STAT1 activity,BP,
10476,GO:0039564,1,0.992003285188543,0,1,suppression by virus of host STAT2 activity,BP,
10477,GO:0039650,1,0.993091908715104,0,1,suppression by virus of host cysteine-type endopeptidase activity involved in apoptotic process,BP,
10478,GO:0039656,1,0.98093945427902,0,3,modulation by virus of host gene expression,BP,
10479,GO:0039663,1,0.962675316483484,0,6,membrane fusion involved in viral entry into host cell,BP,
10480,GO:0039689,1,0.9796197129787,0,3,negative stranded viral RNA replication,BP,
10481,GO:0039692,1,0.92917254396705,0,12,single stranded viral RNA replication via double stranded DNA intermediate,BP,
10482,GO:0039694,1,0.83982138135977,0,26,viral RNA genome replication,BP,
10483,GO:0039695,1,0.992297874244277,0,1,DNA-templated viral transcription,BP,
10484,GO:0039702,1,0.88578125000337,0,21,viral budding via host ESCRT complex,BP,
10485,GO:0039706,1,0.931573860077901,0,11,co-receptor binding,MF,
10486,GO:0039713,1,0.992558446435096,0,1,viral factory,CC,
10487,GO:0039714,1,0.992558446435096,0,1,cytoplasmic viral factory,CC,
10488,GO:0040001,1,0.842006564991042,0,24,establishment of mitotic spindle localization,BP,
10491,GO:0040009,1,0.961604958143428,0,5,regulation of growth rate,BP,
10492,GO:0040010,1,0.997490814002907,0,1,positive regulation of growth rate,BP,
10496,GO:0040014,1,0.660245536072422,0,60,regulation of multicellular organism growth,BP,
10497,GO:0040015,1,0.924739548550769,0,11,negative regulation of multicellular organism growth,BP,
10498,GO:0040016,1,0.957893033334304,0,6,embryonic cleavage,BP,
10500,GO:0040018,1,0.820024380580301,0,29,positive regulation of multicellular organism growth,BP,
10502,GO:0040020,1,0.841894907866125,0,26,regulation of meiotic nuclear division,BP,
10504,GO:0040030,1,0.990274158975749,0,2,regulation of molecular function, epigenetic,BP,
10505,GO:0040031,1,0.971180107706031,0,6,snRNA modification,BP,
10506,GO:0040032,1,0.994890062639806,0,1,post-embryonic body morphogenesis,BP,
10507,GO:0040033,1,0.90535869817833,0,13,negative regulation of translation, ncRNA-mediated,BP,
10508,GO:0040034,1,0.921696374406533,0,12,regulation of development, heterochronic,BP,
10509,GO:0040036,1,0.829929190026312,0,26,regulation of fibroblast growth factor receptor signaling pathway,BP,
10510,GO:0040037,1,0.910315506838158,0,13,negative regulation of fibroblast growth factor receptor signaling pathway,BP,
10511,GO:0040038,1,0.975960711731305,0,3,polar body extrusion after meiotic divisions,BP,
10512,GO:0040040,1,0.991476862960455,0,1,thermosensory behavior,BP,
10513,GO:0042000,1,0.993704412915987,0,1,translocation of peptides or proteins into host,BP,
10514,GO:0042007,1,0.995981623759712,0,1,interleukin-18 binding,MF,
10515,GO:0042008,1,0.992537316659797,0,1,interleukin-18 receptor activity,MF,
10516,GO:0042011,1,0.99272040386425,0,1,interleukin-16 binding,MF,
10517,GO:0042012,1,0.99272040386425,0,1,interleukin-16 receptor activity,MF,
10518,GO:0042015,1,0.980213138419755,0,3,interleukin-20 binding,MF,
10519,GO:0042019,1,0.994667264080108,0,1,interleukin-23 binding,MF,
10520,GO:0042020,1,0.994667264080108,0,1,interleukin-23 receptor activity,MF,
10521,GO:0042022,1,0.994667264080108,0,1,interleukin-12 receptor complex,CC,
10522,GO:0042023,1,0.937353981810303,0,8,DNA endoreduplication,BP,
10523,GO:0042025,1,0.978665027435129,0,3,host cell nucleus,CC,
10524,GO:0042026,1,0.845598096663989,0,26,protein refolding,BP,
10525,GO:0042030,1,0.978281153158628,0,3,ATPase inhibitor activity,MF,
10526,GO:0042033,1,0.941406754656093,0,12,chemokine biosynthetic process,BP,
10527,GO:0042035,1,0.578148638174779,0,87,regulation of cytokine biosynthetic process,BP,
10528,GO:0042036,1,0.847925036623263,0,28,negative regulation of cytokine biosynthetic process,BP,
10529,GO:0042040,1,0.992420809289738,0,1,metal incorporation into metallo-molybdopterin complex,BP,
10530,GO:0042043,1,0.907884822371465,0,13,neurexin family protein binding,MF,
10531,GO:0042044,1,0.870799900629152,0,21,fluid transport,BP,
10532,GO:0042045,1,0.947365287921509,0,7,epithelial fluid transport,BP,
10533,GO:0042048,1,0.941870298333077,0,7,olfactory behavior,BP,
10534,GO:0042053,1,0.891225546646812,0,18,regulation of dopamine metabolic process,BP,
10535,GO:0042054,1,0.68222978673877,0,53,histone methyltransferase activity,MF,
10541,GO:0042069,1,0.891225546646812,0,18,regulation of catecholamine metabolic process,BP,
10542,GO:0042073,1,0.71289320761139,0,50,intraciliary transport,BP,
10543,GO:0042074,1,0.916641839485784,0,13,cell migration involved in gastrulation,BP,
10544,GO:0042078,1,0.983086917173549,0,3,germ-line stem cell division,BP,
10545,GO:0042083,1,0.995607527026098,0,1,5,10-methylenetetrahydrofolate-dependent methyltransferase activity,MF,
10546,GO:0042084,1,0.988839235855494,0,1,5-methyltetrahydrofolate-dependent methyltransferase activity,MF,
10547,GO:0042088,1,0.804561956233207,0,36,T-helper 1 type immune response,BP,
10548,GO:0042089,1,0.557213612277114,0,93,cytokine biosynthetic process,BP,
10549,GO:0042090,1,0.953375338921784,0,7,interleukin-12 biosynthetic process,BP,
10550,GO:0042091,1,0.979549294276238,0,3,interleukin-10 biosynthetic process,BP,
10551,GO:0042092,1,0.8206250143301,0,33,type 2 immune response,BP,
10552,GO:0042093,1,0.724013848292763,0,48,T-helper cell differentiation,BP,
10553,GO:0042094,1,0.884760499780344,0,20,interleukin-2 biosynthetic process,BP,
10554,GO:0042095,1,0.915263250579063,0,15,interferon-gamma biosynthetic process,BP,
10555,GO:0042097,1,0.977900718951339,0,3,interleukin-4 biosynthetic process,BP,
10558,GO:0042101,1,0.896596673377587,0,19,T cell receptor complex,CC,
10559,GO:0042102,1,0.613603224976282,0,84,positive regulation of T cell proliferation,BP,
10560,GO:0042104,1,0.899695463336247,0,19,positive regulation of activated T cell proliferation,BP,
10561,GO:0042105,1,0.979150461433905,0,5,alpha-beta T cell receptor complex,CC,
10562,GO:0042107,1,0.554220104652939,0,94,cytokine metabolic process,BP,
10563,GO:0042108,1,0.717033442549677,0,52,positive regulation of cytokine biosynthetic process,BP,
10564,GO:0042109,1,0.98593484996541,0,2,lymphotoxin A biosynthetic process,BP,
10567,GO:0042116,1,0.669462955385296,0,60,macrophage activation,BP,
10568,GO:0042117,1,0.961174070011285,0,7,monocyte activation,BP,
10569,GO:0042118,1,0.939434231064879,0,9,endothelial cell activation,BP,
10571,GO:0042126,1,0.973770373842142,0,4,nitrate metabolic process,BP,
10573,GO:0042128,1,0.993875212402642,0,1,nitrate assimilation,BP,
10576,GO:0042131,1,0.993483939874803,0,1,thiamine phosphate phosphatase activity,MF,
10577,GO:0042132,1,0.995709824540287,0,1,fructose 1,6-bisphosphate 1-phosphatase activity,MF,
10579,GO:0042134,1,0.991482486800823,0,2,rRNA primary transcript binding,MF,
10580,GO:0042135,1,0.866878618365772,0,21,neurotransmitter catabolic process,BP,
10583,GO:0042138,1,0.980037329781476,0,3,meiotic DNA double-strand break formation,BP,
10584,GO:0042140,1,0.993058458973322,0,1,late meiotic recombination nodule assembly,BP,
10585,GO:0042144,1,0.985719433303622,0,2,vacuole fusion, non-autophagic,BP,
10586,GO:0042147,1,0.60031581801186,0,72,retrograde transport, endosome to Golgi,BP,
10587,GO:0042148,1,0.950080777663858,0,8,strand invasion,BP,
10588,GO:0042149,1,0.778140035712509,0,37,cellular response to glucose starvation,BP,
10590,GO:0042158,1,0.4177783297115,0,138,lipoprotein biosynthetic process,BP,
10591,GO:0042159,1,0.906303374632711,0,14,lipoprotein catabolic process,BP,
10594,GO:0042162,1,0.772557577775763,0,36,telomeric DNA binding,MF,
10595,GO:0042163,1,0.995939249581314,0,1,interleukin-12 beta subunit binding,MF,
10596,GO:0042165,1,0.728634576526789,0,49,neurotransmitter binding,MF,
10597,GO:0042166,1,0.900457161566885,0,16,acetylcholine binding,MF,
10598,GO:0042167,1,0.984932490499356,0,4,heme catabolic process,BP,
10599,GO:0042168,1,0.866713343033098,0,25,heme metabolic process,BP,
10600,GO:0042169,1,0.790045459994223,0,32,SH2 domain binding,MF,
10601,GO:0042171,1,0.878027468460026,0,18,lysophosphatidic acid acyltransferase activity,MF,
10606,GO:0042180,1,0.302371996224109,0,199,cellular ketone metabolic process,BP,
10607,GO:0042181,1,0.822736174979623,0,33,ketone biosynthetic process,BP,
10608,GO:0042182,1,0.966618190733585,0,6,ketone catabolic process,BP,
10609,GO:0042197,1,0.995410090658141,0,1,halogenated hydrocarbon metabolic process,BP,
10610,GO:0042214,1,0.980997706224115,0,3,terpene metabolic process,BP,
10611,GO:0042219,1,0.880645276548206,0,20,cellular modified amino acid catabolic process,BP,
10612,GO:0042220,1,0.752864133975951,0,41,response to cocaine,BP,
10614,GO:0042222,1,0.987056407850184,0,3,interleukin-1 biosynthetic process,BP,
10615,GO:0042223,1,0.992101884900028,0,1,interleukin-3 biosynthetic process,BP,
10616,GO:0042226,1,0.915279805745125,0,14,interleukin-6 biosynthetic process,BP,
10617,GO:0042228,1,0.937300319463428,0,10,interleukin-8 biosynthetic process,BP,
10618,GO:0042231,1,0.9885485290944,0,2,interleukin-13 biosynthetic process,BP,
10619,GO:0042241,1,0.992638813066294,0,1,interleukin-18 biosynthetic process,BP,
10620,GO:0042245,1,0.985839623310233,0,2,RNA repair,BP,
10622,GO:0042247,1,0.992868157675994,0,1,establishment of planar polarity of follicular epithelium,BP,
10624,GO:0042253,1,0.981882581688188,0,3,granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
10625,GO:0042254,1,0.195573299358432,0,309,ribosome biogenesis,BP,
10626,GO:0042255,1,0.782381342773351,0,53,ribosome assembly,BP,
10627,GO:0042256,1,0.973343683799244,0,5,mature ribosome assembly,BP,
10628,GO:0042262,1,0.979316305675296,0,5,DNA protection,BP,
10629,GO:0042264,1,0.983543536809325,0,2,peptidyl-aspartic acid hydroxylation,BP,
10630,GO:0042265,1,0.990959233724992,0,1,peptidyl-asparagine hydroxylation,BP,
10631,GO:0042267,1,0.749088146114053,0,48,natural killer cell mediated cytotoxicity,BP,
10632,GO:0042268,1,0.951565068509157,0,10,regulation of cytolysis,BP,
10633,GO:0042269,1,0.828804072013506,0,31,regulation of natural killer cell mediated cytotoxicity,BP,
10634,GO:0042270,1,0.987875842913223,0,2,protection from natural killer cell mediated cytotoxicity,BP,
10635,GO:0042271,1,0.980984829438531,0,3,susceptibility to natural killer cell mediated cytotoxicity,BP,
10636,GO:0042272,1,0.975762789380602,0,3,nuclear RNA export factor complex,CC,
10637,GO:0042273,1,0.716896794123533,0,66,ribosomal large subunit biogenesis,BP,
10638,GO:0042274,1,0.702690769396727,0,67,ribosomal small subunit biogenesis,BP,
10639,GO:0042275,1,0.995752814566154,0,1,error-free postreplication DNA repair,BP,
10640,GO:0042276,1,0.895135019326111,0,19,error-prone translesion synthesis,BP,
10642,GO:0042278,1,0.633928804766388,0,73,purine nucleoside metabolic process,BP,
10643,GO:0042281,1,0.987922580783247,0,2,dolichyl pyrophosphate Man9GlcNAc2 alpha-1,3-glucosyltransferase activity,MF,
10644,GO:0042282,1,0.992341604605686,0,1,hydroxymethylglutaryl-CoA reductase activity,MF,
10645,GO:0042284,1,0.991020694403876,0,2,sphingolipid delta-4 desaturase activity,MF,
10646,GO:0042285,1,0.955353646625017,0,6,xylosyltransferase activity,MF,
10647,GO:0042287,1,0.84595013264423,0,27,MHC protein binding,MF,
10648,GO:0042288,1,0.906738075060511,0,16,MHC class I protein binding,MF,
10649,GO:0042289,1,0.966543518524057,0,6,MHC class II protein binding,MF,
10650,GO:0042292,1,0.993626621426091,0,1,URM1 activating enzyme activity,MF,
10651,GO:0042296,1,0.98015015193388,0,4,ISG15 transferase activity,MF,
10652,GO:0042297,1,0.935421142762793,0,7,vocal learning,BP,
10653,GO:0042301,1,0.931144460405721,0,11,phosphate ion binding,MF,
10655,GO:0042304,1,0.801987979537588,0,34,regulation of fatty acid biosynthetic process,BP,
10657,GO:0042307,1,0.797830263655081,0,30,positive regulation of protein import into nucleus,BP,
10659,GO:0042309,1,0.993081818362706,0,1,homoiothermy,BP,
10661,GO:0042311,1,0.844451755083942,0,27,vasodilation,BP,
10662,GO:0042313,1,0.994406571639271,0,1,protein kinase C deactivation,BP,
10663,GO:0042316,1,0.99207833818527,0,1,penicillin metabolic process,BP,
10664,GO:0042320,1,0.980197820786098,0,5,regulation of circadian sleep/wake cycle, REM sleep,BP,
10665,GO:0042321,1,0.975964981077879,0,5,negative regulation of circadian sleep/wake cycle, sleep,BP,
10666,GO:0042322,1,0.993797130394294,0,2,negative regulation of circadian sleep/wake cycle, REM sleep,BP,
10667,GO:0042323,1,0.988728522250398,0,2,negative regulation of circadian sleep/wake cycle, non-REM sleep,BP,
10671,GO:0042328,1,0.967326361872675,0,4,heparan sulfate N-acetylglucosaminyltransferase activity,MF,
10673,GO:0042335,1,0.977362823803536,0,3,cuticle development,BP,
10676,GO:0042350,1,0.984064092132839,0,3,GDP-L-fucose biosynthetic process,BP,
10677,GO:0042351,1,0.991517648092179,0,2,'de novo' GDP-L-fucose biosynthetic process,BP,
10678,GO:0042352,1,0.992483318248079,0,1,GDP-L-fucose salvage,BP,
10679,GO:0042354,1,0.939501938829513,0,8,L-fucose metabolic process,BP,
10680,GO:0042355,1,0.939501938829513,0,8,L-fucose catabolic process,BP,
10681,GO:0042356,1,0.996103670957157,0,1,GDP-4-dehydro-D-rhamnose reductase activity,MF,
10682,GO:0042357,1,0.988970455783912,0,2,thiamine diphosphate metabolic process,BP,
10683,GO:0042359,1,0.884400046081426,0,19,vitamin D metabolic process,BP,
10684,GO:0042360,1,0.984040557529691,0,3,vitamin E metabolic process,BP,
10685,GO:0042361,1,0.992665340688475,0,1,menaquinone catabolic process,BP,
10686,GO:0042362,1,0.931195743114685,0,12,fat-soluble vitamin biosynthetic process,BP,
10687,GO:0042363,1,0.96336726253013,0,6,fat-soluble vitamin catabolic process,BP,
10688,GO:0042364,1,0.940034563551119,0,9,water-soluble vitamin biosynthetic process,BP,
10689,GO:0042365,1,0.984110337823584,0,3,water-soluble vitamin catabolic process,BP,
10690,GO:0042368,1,0.949158151402754,0,9,vitamin D biosynthetic process,BP,
10691,GO:0042369,1,0.986276809137909,0,2,vitamin D catabolic process,BP,
10692,GO:0042371,1,0.99251470947205,0,1,vitamin K biosynthetic process,BP,
10693,GO:0042373,1,0.975386708639828,0,5,vitamin K metabolic process,BP,
10694,GO:0042374,1,0.989350250206725,0,2,phylloquinone metabolic process,BP,
10695,GO:0042376,1,0.989350250206725,0,2,phylloquinone catabolic process,BP,
10696,GO:0042377,1,0.992665340688475,0,1,vitamin K catabolic process,BP,
10697,GO:0042379,1,0.833363516135135,0,41,chemokine receptor binding,MF,
10698,GO:0042382,1,0.958249860335123,0,6,paraspeckles,CC,
10701,GO:0042392,1,0.989098103478281,0,2,sphingosine-1-phosphate phosphatase activity,MF,
10703,GO:0042398,1,0.804548129895475,0,36,cellular modified amino acid biosynthetic process,BP,
10704,GO:0042401,1,0.903195481991015,0,19,cellular biogenic amine biosynthetic process,BP,
10705,GO:0042402,1,0.897452780300385,0,20,cellular biogenic amine catabolic process,BP,
10706,GO:0042403,1,0.885951901674296,0,17,thyroid hormone metabolic process,BP,
10707,GO:0042404,1,0.994405408097248,0,1,thyroid hormone catabolic process,BP,
10708,GO:0042405,1,0.909886495050511,0,11,nuclear inclusion body,CC,
10709,GO:0042406,1,0.976114243449012,0,4,extrinsic component of endoplasmic reticulum membrane,CC,
10710,GO:0042407,1,0.919734142568304,0,15,cristae formation,BP,
10711,GO:0042412,1,0.988750731211835,0,2,taurine biosynthetic process,BP,
10712,GO:0042413,1,0.993547978132438,0,1,carnitine catabolic process,BP,
10713,GO:0042414,1,0.981533879761235,0,3,epinephrine metabolic process,BP,
10714,GO:0042415,1,0.933066422240987,0,10,norepinephrine metabolic process,BP,
10715,GO:0042416,1,0.934001291030975,0,11,dopamine biosynthetic process,BP,
10716,GO:0042417,1,0.797732628786735,0,34,dopamine metabolic process,BP,
10717,GO:0042418,1,0.991435227428095,0,2,epinephrine biosynthetic process,BP,
10718,GO:0042420,1,0.954826598305734,0,7,dopamine catabolic process,BP,
10719,GO:0042421,1,0.960921579947738,0,6,norepinephrine biosynthetic process,BP,
10720,GO:0042423,1,0.887276533692936,0,19,catecholamine biosynthetic process,BP,
10721,GO:0042424,1,0.947911854260439,0,8,catecholamine catabolic process,BP,
10722,GO:0042426,1,0.957023625390807,0,6,choline catabolic process,BP,
10723,GO:0042427,1,0.989675208352352,0,2,serotonin biosynthetic process,BP,
10724,GO:0042428,1,0.933983196958023,0,9,serotonin metabolic process,BP,
10725,GO:0042430,1,0.893497785381662,0,18,indole-containing compound metabolic process,BP,
10726,GO:0042435,1,0.985587299291851,0,3,indole-containing compound biosynthetic process,BP,
10727,GO:0042436,1,0.965174537778612,0,7,indole-containing compound catabolic process,BP,
10728,GO:0042438,1,0.901355255843945,0,15,melanin biosynthetic process,BP,
10729,GO:0042439,1,0.959749149576199,0,6,ethanolamine-containing compound metabolic process,BP,
10730,GO:0042440,1,0.696604539404423,0,58,pigment metabolic process,BP,
10731,GO:0042441,1,0.980366693513217,0,3,eye pigment metabolic process,BP,
10732,GO:0042445,1,0.338638244961971,0,177,hormone metabolic process,BP,
10733,GO:0042446,1,0.663569823938361,0,67,hormone biosynthetic process,BP,
10734,GO:0042447,1,0.920747865791986,0,14,hormone catabolic process,BP,
10735,GO:0042448,1,0.928080953340028,0,13,progesterone metabolic process,BP,
10736,GO:0042450,1,0.990132193837785,0,2,arginine biosynthetic process via ornithine,BP,
10737,GO:0042451,1,0.902990519605326,0,21,purine nucleoside biosynthetic process,BP,
10738,GO:0042454,1,0.916567239672054,0,16,ribonucleoside catabolic process,BP,
10739,GO:0042455,1,0.825420243455889,0,36,ribonucleoside biosynthetic process,BP,
10745,GO:0042473,1,0.944888451332436,0,9,outer ear morphogenesis,BP,
10746,GO:0042474,1,0.895031095420127,0,19,middle ear morphogenesis,BP,
10747,GO:0042475,1,0.610403721417376,0,70,odontogenesis of dentin-containing tooth,BP,
10748,GO:0042476,1,0.48383885100175,0,104,odontogenesis,BP,
10749,GO:0042481,1,0.881963947112558,0,20,regulation of odontogenesis,BP,
10750,GO:0042482,1,0.956865632575166,0,7,positive regulation of odontogenesis,BP,
10751,GO:0042483,1,0.971726720324608,0,4,negative regulation of odontogenesis,BP,
10752,GO:0042487,1,0.945981151648728,0,9,regulation of odontogenesis of dentin-containing tooth,BP,
10753,GO:0042488,1,0.993676910461691,0,1,positive regulation of odontogenesis of dentin-containing tooth,BP,
10754,GO:0042489,1,0.986588158358117,0,2,negative regulation of odontogenesis of dentin-containing tooth,BP,
10757,GO:0042492,1,0.957626100371698,0,6,gamma-delta T cell differentiation,BP,
10759,GO:0042494,1,0.96042563990484,0,5,detection of bacterial lipoprotein,BP,
10760,GO:0042495,1,0.985597594050916,0,2,detection of triacyl bacterial lipopeptide,BP,
10761,GO:0042496,1,0.984231677222147,0,2,detection of diacyl bacterial lipopeptide,BP,
10762,GO:0042497,1,0.992571608735484,0,1,triacyl lipopeptide binding,MF,
10763,GO:0042500,1,0.960883794960849,0,6,aspartic endopeptidase activity, intramembrane cleaving,MF,
10764,GO:0042501,1,0.954885252089362,0,7,serine phosphorylation of STAT protein,BP,
10767,GO:0042532,1,0.93460208303854,0,10,negative regulation of tyrosine phosphorylation of STAT protein,BP,
10768,GO:0042533,1,0.894171993353821,0,18,tumor necrosis factor biosynthetic process,BP,
10769,GO:0042534,1,0.894171993353821,0,18,regulation of tumor necrosis factor biosynthetic process,BP,
10770,GO:0042535,1,0.930157890324262,0,11,positive regulation of tumor necrosis factor biosynthetic process,BP,
10771,GO:0042536,1,0.973876458588233,0,5,negative regulation of tumor necrosis factor biosynthetic process,BP,
10773,GO:0042538,1,0.956640092558912,0,7,hyperosmotic salinity response,BP,
10774,GO:0042539,1,0.983361910374799,0,2,hypotonic salinity response,BP,
10775,GO:0042541,1,0.949935479856129,0,9,hemoglobin biosynthetic process,BP,
10776,GO:0042542,1,0.46848009658375,0,123,response to hydrogen peroxide,BP,
10777,GO:0042543,1,0.997833878081693,0,1,protein N-linked glycosylation via arginine,BP,
10778,GO:0042546,1,0.99517012130739,0,1,cell wall biogenesis,BP,
10782,GO:0042555,1,0.924659423557272,0,11,MCM complex,CC,
10783,GO:0042558,1,0.812220464491171,0,34,pteridine-containing compound metabolic process,BP,
10784,GO:0042559,1,0.92820559734273,0,14,pteridine-containing compound biosynthetic process,BP,
10785,GO:0042560,1,0.97294961463182,0,4,pteridine-containing compound catabolic process,BP,
10787,GO:0042564,1,0.992395344427474,0,1,NLS-dependent protein nuclear import complex,CC,
10788,GO:0042565,1,0.988664664763273,0,2,RNA nuclear export complex,CC,
10789,GO:0042567,1,0.970222436919288,0,4,insulin-like growth factor ternary complex,CC,
10790,GO:0042568,1,0.996964780348417,0,1,insulin-like growth factor binary complex,CC,
10791,GO:0042571,1,0.990309830442311,0,2,immunoglobulin complex, circulating,CC,
10792,GO:0042572,1,0.849631191884334,0,27,retinol metabolic process,BP,
10793,GO:0042573,1,0.903790850103087,0,17,retinoic acid metabolic process,BP,
10794,GO:0042574,1,0.916939209426361,0,13,retinal metabolic process,BP,
10795,GO:0042575,1,0.90032145723365,0,16,DNA polymerase complex,CC,
10796,GO:0042577,1,0.986844500933494,0,2,lipid phosphatase activity,MF,
10800,GO:0042582,1,0.425032799300614,0,140,azurophil granule,CC,
10801,GO:0042583,1,0.943745089564163,0,8,chromaffin granule,CC,
10802,GO:0042584,1,0.955651621173368,0,6,chromaffin granule membrane,CC,
10803,GO:0042585,1,0.994089980651462,0,1,germinal vesicle,CC,
10804,GO:0042586,1,0.996559675344949,0,1,peptide deformylase activity,MF,
10805,GO:0042587,1,0.966297129150929,0,5,glycogen granule,CC,
10806,GO:0042588,1,0.923503517133309,0,12,zymogen granule,CC,
10807,GO:0042589,1,0.935471979362445,0,10,zymogen granule membrane,CC,
10808,GO:0042590,1,0.706267573325695,0,72,antigen processing and presentation of exogenous peptide antigen via MHC class I,BP,
10811,GO:0042594,1,0.337408385131004,0,162,response to starvation,BP,
10812,GO:0042595,1,0.989585966062568,0,2,behavioral response to starvation,BP,
10814,GO:0042599,1,0.914013500465936,0,15,lamellar body,CC,
10815,GO:0042602,1,0.997193718860838,0,1,riboflavin reductase (NADPH) activity,MF,
10817,GO:0042608,1,0.961970421449159,0,7,T cell receptor binding,MF,
10818,GO:0042609,1,0.958082127645657,0,7,CD4 receptor binding,MF,
10819,GO:0042610,1,0.988850078332394,0,2,CD8 receptor binding,MF,
10821,GO:0042612,1,0.968065161123679,0,8,MHC class I protein complex,CC,
10823,GO:0042622,1,0.912447197410414,0,13,photoreceptor outer segment membrane,CC,
10825,GO:0042624,1,0.997542416310035,0,1,ATPase activity, uncoupled,MF,
10826,GO:0042625,1,0.699785143829455,0,52,ATPase coupled ion transmembrane transporter activity,MF,
10827,GO:0042626,1,0.489014343742607,0,96,ATPase activity, coupled to transmembrane movement of substances,MF,
10828,GO:0042627,1,0.953172161723811,0,9,chylomicron,CC,
10829,GO:0042628,1,0.994033230959954,0,1,mating plug formation,BP,
10830,GO:0042629,1,0.875811942405083,0,21,mast cell granule,CC,
10831,GO:0042631,1,0.985031182466956,0,2,cellular response to water deprivation,BP,
10832,GO:0042632,1,0.718367361873573,0,52,cholesterol homeostasis,BP,
10835,GO:0042635,1,0.932996488434639,0,12,positive regulation of hair cycle,BP,
10836,GO:0042636,1,0.969855365491463,0,4,negative regulation of hair cycle,BP,
10837,GO:0042637,1,0.976150712840454,0,4,catagen,BP,
10838,GO:0042640,1,0.96328903361945,0,5,anagen,BP,
10839,GO:0042641,1,0.612483591697102,0,64,actomyosin,CC,
10840,GO:0042643,1,0.985429632501946,0,2,actomyosin, actin portion,CC,
10841,GO:0042645,1,0.765043753718959,0,41,mitochondrial nucleoid,CC,
10842,GO:0042658,1,0.996216049524213,0,1,MHC class II protein binding, via antigen binding groove,MF,
10843,GO:0042659,1,0.928396232245298,0,11,regulation of cell fate specification,BP,
10844,GO:0042660,1,0.991045605461512,0,1,positive regulation of cell fate specification,BP,
10845,GO:0042661,1,0.964944028766493,0,6,regulation of mesodermal cell fate specification,BP,
10846,GO:0042662,1,0.980314152526523,0,4,negative regulation of mesodermal cell fate specification,BP,
10847,GO:0042663,1,0.985086404274225,0,3,regulation of endodermal cell fate specification,BP,
10848,GO:0042664,1,0.996555366104087,0,1,negative regulation of endodermal cell fate specification,BP,
10849,GO:0042665,1,0.99249165342284,0,1,regulation of ectodermal cell fate specification,BP,
10850,GO:0042666,1,0.99249165342284,0,1,negative regulation of ectodermal cell fate specification,BP,
10851,GO:0042668,1,0.992161193186937,0,2,auditory receptor cell fate determination,BP,
10854,GO:0042693,1,0.931503943978936,0,12,muscle cell fate commitment,BP,
10855,GO:0042695,1,0.968724227552157,0,5,thelarche,BP,
10857,GO:0042699,1,0.989055450120032,0,2,follicle-stimulating hormone signaling pathway,BP,
10858,GO:0042700,1,0.992297044236658,0,1,luteinizing hormone signaling pathway,BP,
10859,GO:0042701,1,0.97765999849929,0,4,progesterone secretion,BP,
10860,GO:0042704,1,0.984738786935179,0,2,uterine wall breakdown,BP,
10861,GO:0042709,1,0.993828341714919,0,1,succinate-CoA ligase complex,CC,
10863,GO:0042711,1,0.918640290388962,0,12,maternal behavior,BP,
10864,GO:0042713,1,0.962362581234316,0,5,sperm ejaculation,BP,
10865,GO:0042719,1,0.979225341703553,0,5,mitochondrial intermembrane space protein transporter complex,CC,
10866,GO:0042720,1,0.99308306426529,0,2,mitochondrial inner membrane peptidase complex,CC,
10867,GO:0042721,1,0.975869011577826,0,5,mitochondrial inner membrane protein insertion complex,CC,
10868,GO:0042723,1,0.956996596605627,0,7,thiamine-containing compound metabolic process,BP,
10869,GO:0042726,1,0.947033472216203,0,8,flavin-containing compound metabolic process,BP,
10870,GO:0042727,1,0.987911013834079,0,2,flavin-containing compound biosynthetic process,BP,
10871,GO:0042728,1,0.992489152328139,0,1,flavin-containing compound catabolic process,BP,
10872,GO:0042730,1,0.886401087616162,0,20,fibrinolysis,BP,
10873,GO:0042731,1,0.973542510415062,0,4,PH domain binding,MF,
10874,GO:0042732,1,0.986522084538851,0,3,D-xylose metabolic process,BP,
10877,GO:0042737,1,0.529113923726727,0,113,drug catabolic process,BP,
10878,GO:0042738,1,0.922094990767044,0,14,exogenous drug catabolic process,BP,
10881,GO:0042744,1,0.897728876658824,0,21,hydrogen peroxide catabolic process,BP,
10882,GO:0042745,1,0.881618731873698,0,23,circadian sleep/wake cycle,BP,
10883,GO:0042746,1,0.985065107046273,0,3,circadian sleep/wake cycle, wakefulness,BP,
10884,GO:0042747,1,0.965201141168404,0,8,circadian sleep/wake cycle, REM sleep,BP,
10885,GO:0042748,1,0.951769819823769,0,8,circadian sleep/wake cycle, non-REM sleep,BP,
10886,GO:0042749,1,0.914670629320222,0,17,regulation of circadian sleep/wake cycle,BP,
10888,GO:0042753,1,0.906284824864001,0,16,positive regulation of circadian rhythm,BP,
10889,GO:0042754,1,0.918110563767567,0,13,negative regulation of circadian rhythm,BP,
10891,GO:0042756,1,0.952968312638354,0,8,drinking behavior,BP,
10892,GO:0042758,1,0.952813687699891,0,8,long-chain fatty acid catabolic process,BP,
10893,GO:0042759,1,0.916903218658343,0,12,long-chain fatty acid biosynthetic process,BP,
10894,GO:0042760,1,0.953487273237229,0,7,very long-chain fatty acid catabolic process,BP,
10895,GO:0042761,1,0.930059873874178,0,11,very long-chain fatty acid biosynthetic process,BP,
10896,GO:0042762,1,0.882092777011943,0,17,regulation of sulfur metabolic process,BP,
10897,GO:0042765,1,0.969187752266996,0,5,GPI-anchor transamidase complex,CC,
10898,GO:0042766,1,0.990148382810319,0,1,nucleosome mobilization,BP,
10899,GO:0042769,1,0.808182560884152,0,37,DNA damage response, detection of DNA damage,BP,
10900,GO:0042770,1,0.426923664860912,0,127,signal transduction in response to DNA damage,BP,
10901,GO:0042771,1,0.770104558661036,0,42,intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
10902,GO:0042772,1,0.877051092910191,0,20,DNA damage response, signal transduction resulting in transcription,BP,
10903,GO:0042773,1,0.725748142882219,0,81,ATP synthesis coupled electron transport,BP,
10904,GO:0042774,1,0.993058458973322,0,1,plasma membrane ATP synthesis coupled electron transport,BP,
10905,GO:0042775,1,0.730837187858889,0,80,mitochondrial ATP synthesis coupled electron transport,BP,
10906,GO:0042776,1,0.986754800634318,0,4,mitochondrial ATP synthesis coupled proton transport,BP,
10907,GO:0042779,1,0.986639566405845,0,2,tRNA 3'-trailer cleavage,BP,
10908,GO:0042780,1,0.959571169102174,0,7,tRNA 3'-end processing,BP,
10909,GO:0042781,1,0.986639566405845,0,2,3'-tRNA processing endoribonuclease activity,MF,
10910,GO:0042788,1,0.888247174874098,0,30,polysomal ribosome,CC,
10911,GO:0042789,1,0.881968250366798,0,19,mRNA transcription by RNA polymerase II,BP,
10912,GO:0042790,1,0.923839866712361,0,12,nucleolar large rRNA transcription by RNA polymerase I,BP,
10913,GO:0042791,1,0.959991980582872,0,6,5S class rRNA transcription by RNA polymerase III,BP,
10914,GO:0042795,1,0.662464230640958,0,66,snRNA transcription by RNA polymerase II,BP,
10915,GO:0042796,1,0.960332765898579,0,6,snRNA transcription by RNA polymerase III,BP,
10916,GO:0042797,1,0.959991980582872,0,6,tRNA transcription by RNA polymerase III,BP,
10917,GO:0042799,1,0.987761187201191,0,1,histone methyltransferase activity (H4-K20 specific),MF,
10918,GO:0042800,1,0.892237106526828,0,16,histone methyltransferase activity (H3-K4 specific),MF,
10921,GO:0042805,1,0.721522994090673,0,40,actinin binding,MF,
10922,GO:0042806,1,0.976652495043522,0,4,fucose binding,MF,
10923,GO:0042809,1,0.89632400841077,0,15,vitamin D receptor binding,MF,
10924,GO:0042813,1,0.8488665479943,0,22,Wnt-activated receptor activity,MF,
10925,GO:0042816,1,0.964844940928285,0,5,vitamin B6 metabolic process,BP,
10926,GO:0042819,1,0.977741232905789,0,3,vitamin B6 biosynthetic process,BP,
10927,GO:0042820,1,0.994630636083079,0,1,vitamin B6 catabolic process,BP,
10928,GO:0042822,1,0.978014101551404,0,3,pyridoxal phosphate metabolic process,BP,
10929,GO:0042823,1,0.983294655498711,0,2,pyridoxal phosphate biosynthetic process,BP,
10930,GO:0042824,1,0.972973609844444,0,4,MHC class I peptide loading complex,CC,
10931,GO:0042825,1,0.978024575340017,0,3,TAP complex,CC,
10932,GO:0042826,1,0.482130524644992,0,104,histone deacetylase binding,MF,
10933,GO:0042827,1,0.899221184093848,0,18,platelet dense granule,CC,
10934,GO:0042832,1,0.908532519386779,0,17,defense response to protozoan,BP,
10935,GO:0042834,1,0.952751544365716,0,8,peptidoglycan binding,MF,
10936,GO:0042835,1,0.984785730328436,0,2,BRE binding,MF,
10937,GO:0042839,1,0.995857532466422,0,1,D-glucuronate metabolic process,BP,
10938,GO:0042840,1,0.995857532466422,0,1,D-glucuronate catabolic process,BP,
10939,GO:0042843,1,0.996714161305283,0,1,D-xylose catabolic process,BP,
10940,GO:0042851,1,0.983036931898023,0,3,L-alanine metabolic process,BP,
10941,GO:0042853,1,0.983036931898023,0,3,L-alanine catabolic process,BP,
10942,GO:0042866,1,0.517142600315058,0,96,pyruvate biosynthetic process,BP,
10943,GO:0042883,1,0.992504407295285,0,1,cysteine transport,BP,
10945,GO:0042887,1,0.807804354221362,0,36,amide transmembrane transporter activity,MF,
10946,GO:0042891,1,0.94744768368431,0,8,antibiotic transport,BP,
10947,GO:0042895,1,0.961952603201065,0,6,antibiotic transmembrane transporter activity,MF,
10948,GO:0042903,1,0.987254130704087,0,2,tubulin deacetylase activity,MF,
10949,GO:0042904,1,0.97483747698072,0,4,9-cis-retinoic acid biosynthetic process,BP,
10950,GO:0042905,1,0.97483747698072,0,4,9-cis-retinoic acid metabolic process,BP,
10951,GO:0042908,1,0.937945471618438,0,8,xenobiotic transport,BP,
10952,GO:0042910,1,0.937945471618438,0,8,xenobiotic transmembrane transporter activity,MF,
10953,GO:0042921,1,0.894796188485136,0,15,glucocorticoid receptor signaling pathway,BP,
10954,GO:0042922,1,0.997281337658679,0,1,neuromedin U receptor binding,MF,
10955,GO:0042923,1,0.899050704190041,0,19,neuropeptide binding,MF,
10956,GO:0042924,1,0.98715013462986,0,2,neuromedin U binding,MF,
10957,GO:0042930,1,0.993058458973322,0,1,enterobactin transport,BP,
10958,GO:0042931,1,0.993058458973322,0,1,enterobactin transmembrane transporter activity,MF,
10959,GO:0042937,1,0.99126790998446,0,1,tripeptide transmembrane transporter activity,MF,
10960,GO:0042938,1,0.988703966357826,0,2,dipeptide transport,BP,
10961,GO:0042939,1,0.985940284885172,0,2,tripeptide transport,BP,
10962,GO:0042940,1,0.954540836995281,0,6,D-amino acid transport,BP,
10963,GO:0042941,1,0.994748946424566,0,1,D-alanine transport,BP,
10964,GO:0042942,1,0.988166917905362,0,2,D-serine transport,BP,
10965,GO:0042946,1,0.993058458973322,0,1,glucoside transport,BP,
10966,GO:0042947,1,0.993058458973322,0,1,glucoside transmembrane transporter activity,MF,
10967,GO:0042953,1,0.894939556363924,0,13,lipoprotein transport,BP,
10968,GO:0042954,1,0.951479525363798,0,6,lipoprotein transporter activity,MF,
10970,GO:0042975,1,0.924428797963686,0,10,peroxisome proliferator activated receptor binding,MF,
10971,GO:0042976,1,0.940742719603931,0,9,activation of Janus kinase activity,BP,
10972,GO:0042978,1,0.973884992470748,0,3,ornithine decarboxylase activator activity,MF,
10973,GO:0042979,1,0.962803750855653,0,6,ornithine decarboxylase regulator activity,MF,
10975,GO:0042982,1,0.733809808575743,0,46,amyloid precursor protein metabolic process,BP,
10976,GO:0042983,1,0.939979235109809,0,10,amyloid precursor protein biosynthetic process,BP,
10977,GO:0042984,1,0.939979235109809,0,10,regulation of amyloid precursor protein biosynthetic process,BP,
10978,GO:0042985,1,0.969143981867692,0,5,negative regulation of amyloid precursor protein biosynthetic process,BP,
10979,GO:0042986,1,0.987359893768944,0,2,positive regulation of amyloid precursor protein biosynthetic process,BP,
10980,GO:0042987,1,0.800158916342229,0,32,amyloid precursor protein catabolic process,BP,
10981,GO:0042988,1,0.992016132927063,0,1,X11-like protein binding,MF,
10983,GO:0042994,1,0.892741345940597,0,18,cytoplasmic sequestering of transcription factor,BP,
10985,GO:0042996,1,0.958420882555834,0,6,regulation of Golgi to plasma membrane protein transport,BP,
10986,GO:0042997,1,0.973069294245151,0,4,negative regulation of Golgi to plasma membrane protein transport,BP,
10987,GO:0042998,1,0.984950254220105,0,2,positive regulation of Golgi to plasma membrane protein transport,BP,
10988,GO:0042999,1,0.99231156023388,0,1,regulation of Golgi to plasma membrane CFTR protein transport,BP,
10989,GO:0043000,1,0.988265090115434,0,2,Golgi to plasma membrane CFTR protein transport,BP,
10990,GO:0043001,1,0.803677992126152,0,31,Golgi to plasma membrane protein transport,BP,
10991,GO:0043002,1,0.99231156023388,0,1,negative regulation of Golgi to plasma membrane CFTR protein transport,BP,
10992,GO:0043004,1,0.99231156023388,0,1,cytoplasmic sequestering of CFTR protein,BP,
10995,GO:0043008,1,0.947257423635911,0,8,ATP-dependent protein binding,MF,
10998,GO:0043011,1,0.919646436528901,0,15,myeloid dendritic cell differentiation,BP,
10999,GO:0043012,1,0.993362143653244,0,1,regulation of fusion of sperm to egg plasma membrane,BP,
11000,GO:0043014,1,0.829848538613246,0,27,alpha-tubulin binding,MF,
11001,GO:0043015,1,0.832940165938183,0,26,gamma-tubulin binding,MF,
11002,GO:0043016,1,0.993160044566882,0,1,regulation of lymphotoxin A biosynthetic process,BP,
11003,GO:0043017,1,0.993160044566882,0,1,positive regulation of lymphotoxin A biosynthetic process,BP,
11004,GO:0043020,1,0.960692345733546,0,8,NADPH oxidase complex,CC,
11006,GO:0043022,1,0.731554835708278,0,47,ribosome binding,MF,
11007,GO:0043023,1,0.935084570317724,0,11,ribosomal large subunit binding,MF,
11008,GO:0043024,1,0.914760820864422,0,14,ribosomal small subunit binding,MF,
11010,GO:0043027,1,0.864193796728923,0,23,cysteine-type endopeptidase inhibitor activity involved in apoptotic process,MF,
11011,GO:0043028,1,0.785730064131398,0,38,cysteine-type endopeptidase regulator activity involved in apoptotic process,MF,
11013,GO:0043030,1,0.78736422318631,0,36,regulation of macrophage activation,BP,
11014,GO:0043031,1,0.956631548764779,0,8,negative regulation of macrophage activation,BP,
11015,GO:0043032,1,0.873620375991625,0,21,positive regulation of macrophage activation,BP,
11016,GO:0043033,1,0.990780254397619,0,1,isoamylase complex,CC,
11017,GO:0043034,1,0.851808478454768,0,19,costamere,CC,
11018,GO:0043035,1,0.992497290754169,0,1,chromatin insulator sequence binding,MF,
11019,GO:0043038,1,0.719069296962748,0,53,amino acid activation,BP,
11020,GO:0043039,1,0.724500061788118,0,52,tRNA aminoacylation,BP,
11021,GO:0043041,1,0.992528144041421,0,1,amino acid activation for nonribosomal peptide biosynthetic process,BP,
11024,GO:0043045,1,0.955948860658215,0,6,DNA methylation involved in embryo development,BP,
11025,GO:0043046,1,0.889514799640301,0,17,DNA methylation involved in gamete generation,BP,
11026,GO:0043047,1,0.927968706509861,0,11,single-stranded telomeric DNA binding,MF,
11027,GO:0043048,1,0.994173274303947,0,1,dolichyl monophosphate biosynthetic process,BP,
11028,GO:0043049,1,0.992750120792518,0,1,otic placode formation,BP,
11029,GO:0043060,1,0.993596861458281,0,1,meiotic metaphase I plate congression,BP,
11031,GO:0043063,1,0.992174526550225,0,1,intercellular bridge organization,BP,
11037,GO:0043073,1,0.92590900758565,0,12,germ cell nucleus,CC,
11038,GO:0043083,1,0.932434977522282,0,9,synaptic cleft,CC,
11039,GO:0043084,1,0.950390766786823,0,7,penile erection,BP,
11044,GO:0043094,1,0.826796152510532,0,34,cellular metabolic compound salvage,BP,
11045,GO:0043095,1,0.997494945641853,0,1,regulation of GTP cyclohydrolase I activity,BP,
11046,GO:0043096,1,0.977543887261647,0,5,purine nucleobase salvage,BP,
11047,GO:0043097,1,0.942903590946193,0,11,pyrimidine nucleoside salvage,BP,
11048,GO:0043101,1,0.926124349662419,0,14,purine-containing compound salvage,BP,
11049,GO:0043102,1,0.960088192837519,0,7,amino acid salvage,BP,
11050,GO:0043103,1,0.985176792244987,0,3,hypoxanthine salvage,BP,
11051,GO:0043105,1,0.997494945641853,0,1,negative regulation of GTP cyclohydrolase I activity,BP,
11052,GO:0043111,1,0.988342849840828,0,2,replication fork arrest,BP,
11054,GO:0043113,1,0.707198767317575,0,47,receptor clustering,BP,
11055,GO:0043114,1,0.815564295782816,0,30,regulation of vascular permeability,BP,
11056,GO:0043116,1,0.928403490491345,0,11,negative regulation of vascular permeability,BP,
11057,GO:0043117,1,0.940188816088554,0,10,positive regulation of vascular permeability,BP,
11058,GO:0043120,1,0.972657457302346,0,5,tumor necrosis factor binding,MF,
11059,GO:0043121,1,0.925325953711183,0,10,neurotrophin binding,MF,
11062,GO:0043124,1,0.753709196481902,0,39,negative regulation of I-kappaB kinase/NF-kappaB signaling,BP,
11063,GO:0043125,1,0.974472333387183,0,4,ErbB-3 class receptor binding,MF,
11064,GO:0043126,1,0.995800192700666,0,1,regulation of 1-phosphatidylinositol 4-kinase activity,BP,
11065,GO:0043128,1,0.995800192700666,0,1,positive regulation of 1-phosphatidylinositol 4-kinase activity,BP,
11066,GO:0043129,1,0.950401813993263,0,8,surfactant homeostasis,BP,
11067,GO:0043130,1,0.659300692824808,0,65,ubiquitin binding,MF,
11068,GO:0043131,1,0.992035648124119,0,1,erythrocyte enucleation,BP,
11069,GO:0043132,1,0.986764642689654,0,2,NAD transport,BP,
11070,GO:0043136,1,0.992702730269534,0,1,glycerol-3-phosphatase activity,MF,
11071,GO:0043137,1,0.978683644829704,0,4,DNA replication, removal of RNA primer,BP,
11072,GO:0043138,1,0.918312631087689,0,12,3'-5' DNA helicase activity,MF,
11073,GO:0043139,1,0.956715836538147,0,7,5'-3' DNA helicase activity,MF,
11074,GO:0043140,1,0.946842754377156,0,7,ATP-dependent 3'-5' DNA helicase activity,MF,
11075,GO:0043141,1,0.969645010270999,0,5,ATP-dependent 5'-3' DNA helicase activity,MF,
11076,GO:0043142,1,0.916572693441315,0,13,single-stranded DNA-dependent ATPase activity,MF,
11077,GO:0043144,1,0.966804952834073,0,8,snoRNA processing,BP,
11078,GO:0043149,1,0.539587001112534,0,86,stress fiber assembly,BP,
11079,GO:0043152,1,0.979468681230539,0,4,induction of bacterial agglutination,BP,
11080,GO:0043153,1,0.867997034864258,0,21,entrainment of circadian clock by photoperiod,BP,
11081,GO:0043154,1,0.58563458821044,0,86,negative regulation of cysteine-type endopeptidase activity involved in apoptotic process,BP,
11082,GO:0043159,1,0.988646374905974,0,2,acrosomal matrix,CC,
11083,GO:0043161,1,0.0784805879042573,0,387,proteasome-mediated ubiquitin-dependent protein catabolic process,BP,
11084,GO:0043162,1,0.892341173817025,0,18,ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,
11085,GO:0043163,1,0.986314149348236,0,2,cell envelope organization,BP,
11090,GO:0043171,1,0.841963951689079,0,25,peptide catabolic process,BP,
11091,GO:0043173,1,0.921881683708024,0,15,nucleotide salvage,BP,
11092,GO:0043174,1,0.919443524236324,0,16,nucleoside salvage,BP,
11093,GO:0043175,1,0.787271206342712,0,35,RNA polymerase core enzyme binding,MF,
11094,GO:0043176,1,0.934545064385932,0,11,amine binding,MF,
11097,GO:0043179,1,0.994406571639271,0,1,rhythmic excitation,BP,
11098,GO:0043181,1,0.992521735947444,0,1,vacuolar sequestering,BP,
11099,GO:0043183,1,0.989200007280254,0,2,vascular endothelial growth factor receptor 1 binding,MF,
11100,GO:0043184,1,0.956125455666771,0,7,vascular endothelial growth factor receptor 2 binding,MF,
11101,GO:0043185,1,0.994445033866488,0,1,vascular endothelial growth factor receptor 3 binding,MF,
11102,GO:0043186,1,0.908482680651149,0,14,P granule,CC,
11103,GO:0043189,1,0.892448669994945,0,18,H4/H2A histone acetyltransferase complex,CC,
11104,GO:0043190,1,0.946389752510909,0,7,ATP-binding cassette (ABC) transporter complex,CC,
11107,GO:0043196,1,0.962034190237327,0,7,varicosity,CC,
11109,GO:0043198,1,0.775060792476391,0,35,dendritic shaft,CC,
11110,GO:0043199,1,0.972619093554102,0,4,sulfate binding,MF,
11112,GO:0043201,1,0.908059064533659,0,12,response to leucine,BP,
11119,GO:0043210,1,0.99508063903843,0,1,alkanesulfonate binding,MF,
11120,GO:0043215,1,0.992475485630838,0,1,daunorubicin transport,BP,
11123,GO:0043219,1,0.975055135132842,0,4,lateral loop,CC,
11125,GO:0043221,1,0.992489675867271,0,1,SMC family protein binding,MF,
11126,GO:0043224,1,0.99348863942024,0,2,nuclear SCF ubiquitin ligase complex,CC,
11127,GO:0043225,1,0.909621319236281,0,12,ATPase-coupled anion transmembrane transporter activity,MF,
11137,GO:0043236,1,0.831694662738414,0,26,laminin binding,MF,
11138,GO:0043237,1,0.964097519449408,0,5,laminin-1 binding,MF,
11139,GO:0043240,1,0.941672501492893,0,9,Fanconi anaemia nuclear complex,CC,
11141,GO:0043243,1,0.806975765638252,0,30,positive regulation of protein complex disassembly,BP,
11143,GO:0043247,1,0.912018316669897,0,13,telomere maintenance in response to DNA damage,BP,
11144,GO:0043248,1,0.948972673830698,0,12,proteasome assembly,BP,
11145,GO:0043249,1,0.923458052387431,0,13,erythrocyte maturation,BP,
11146,GO:0043250,1,0.995793433141323,0,1,sodium-dependent organic anion transmembrane transporter activity,MF,
11147,GO:0043251,1,0.995793433141323,0,1,sodium-dependent organic anion transport,BP,
11148,GO:0043252,1,0.842335954785878,0,25,sodium-independent organic anion transport,BP,
11150,GO:0043255,1,0.609409971239631,0,67,regulation of carbohydrate biosynthetic process,BP,
11151,GO:0043256,1,0.928477269349348,0,8,laminin complex,CC,
11152,GO:0043257,1,0.991598899969506,0,1,laminin-8 complex,CC,
11153,GO:0043259,1,0.970592830816445,0,3,laminin-10 complex,CC,
11154,GO:0043260,1,0.970617902610753,0,3,laminin-11 complex,CC,
11155,GO:0043262,1,0.981087717678004,0,3,adenosine-diphosphatase activity,MF,
11156,GO:0043265,1,0.992697294298227,0,1,ectoplasm,CC,
11157,GO:0043266,1,0.555665763922728,0,83,regulation of potassium ion transport,BP,
11158,GO:0043267,1,0.837558503554911,0,25,negative regulation of potassium ion transport,BP,
11159,GO:0043268,1,0.753936657188518,0,39,positive regulation of potassium ion transport,BP,
11162,GO:0043271,1,0.45103702219278,0,119,negative regulation of ion transport,BP,
11163,GO:0043273,1,0.991889108746233,0,1,CTPase activity,MF,
11164,GO:0043274,1,0.912534650317401,0,13,phospholipase binding,MF,
11165,GO:0043276,1,0.811231212952633,0,29,anoikis,BP,
11166,GO:0043277,1,0.758801749418357,0,41,apoptotic cell clearance,BP,
11171,GO:0043291,1,0.977438722355698,0,2,RAVE complex,CC,
11173,GO:0043293,1,0.98609818196099,0,2,apoptosome,CC,
11178,GO:0043300,1,0.77264524624688,0,41,regulation of leukocyte degranulation,BP,
11179,GO:0043301,1,0.934706311219373,0,11,negative regulation of leukocyte degranulation,BP,
11180,GO:0043302,1,0.884602902275162,0,20,positive regulation of leukocyte degranulation,BP,
11181,GO:0043303,1,0.767127975027198,0,42,mast cell degranulation,BP,
11182,GO:0043304,1,0.851281379852151,0,27,regulation of mast cell degranulation,BP,
11183,GO:0043305,1,0.968532345192026,0,6,negative regulation of mast cell degranulation,BP,
11184,GO:0043306,1,0.935058608656976,0,12,positive regulation of mast cell degranulation,BP,
11185,GO:0043307,1,0.972001687916211,0,5,eosinophil activation,BP,
11186,GO:0043308,1,0.976987079416518,0,4,eosinophil degranulation,BP,
11187,GO:0043309,1,0.982614879939233,0,3,regulation of eosinophil degranulation,BP,
11188,GO:0043310,1,0.993536383049275,0,1,negative regulation of eosinophil degranulation,BP,
11189,GO:0043311,1,0.989008154560891,0,2,positive regulation of eosinophil degranulation,BP,
11191,GO:0043313,1,0.942154036524937,0,8,regulation of neutrophil degranulation,BP,
11192,GO:0043314,1,0.98302401880193,0,2,negative regulation of neutrophil degranulation,BP,
11193,GO:0043315,1,0.971656282586284,0,4,positive regulation of neutrophil degranulation,BP,
11194,GO:0043316,1,0.981258417885646,0,3,cytotoxic T cell degranulation,BP,
11195,GO:0043317,1,0.988142968644057,0,2,regulation of cytotoxic T cell degranulation,BP,
11196,GO:0043318,1,0.988142968644057,0,2,negative regulation of cytotoxic T cell degranulation,BP,
11197,GO:0043320,1,0.965837662745453,0,5,natural killer cell degranulation,BP,
11198,GO:0043321,1,0.98450347208861,0,2,regulation of natural killer cell degranulation,BP,
11199,GO:0043323,1,0.98450347208861,0,2,positive regulation of natural killer cell degranulation,BP,
11200,GO:0043324,1,0.980366693513217,0,3,pigment metabolic process involved in developmental pigmentation,BP,
11201,GO:0043325,1,0.868660556856234,0,20,phosphatidylinositol-3,4-bisphosphate binding,MF,
11202,GO:0043328,1,0.982462904088152,0,4,protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,BP,
11203,GO:0043330,1,0.83078951219264,0,28,response to exogenous dsRNA,BP,
11205,GO:0043335,1,0.988571205702997,0,2,protein unfolding,BP,
11206,GO:0043337,1,0.992496392024204,0,1,CDP-diacylglycerol-phosphatidylglycerol phosphatidyltransferase activity,MF,
11207,GO:0043353,1,0.946557992523956,0,8,enucleate erythrocyte differentiation,BP,
11208,GO:0043354,1,0.992035648124119,0,1,enucleate erythrocyte maturation,BP,
11209,GO:0043363,1,0.993058458973322,0,1,nucleate erythrocyte differentiation,BP,
11210,GO:0043366,1,0.981807284026707,0,3,beta selection,BP,
11211,GO:0043367,1,0.676340778112683,0,58,CD4-positive, alpha-beta T cell differentiation,BP,
11212,GO:0043368,1,0.833557716825825,0,28,positive T cell selection,BP,
11213,GO:0043369,1,0.890066947540608,0,18,CD4-positive or CD8-positive, alpha-beta T cell lineage commitment,BP,
11214,GO:0043370,1,0.81214014798588,0,32,regulation of CD4-positive, alpha-beta T cell differentiation,BP,
11215,GO:0043371,1,0.903982670376584,0,14,negative regulation of CD4-positive, alpha-beta T cell differentiation,BP,
11216,GO:0043372,1,0.881569641858486,0,21,positive regulation of CD4-positive, alpha-beta T cell differentiation,BP,
11217,GO:0043373,1,0.916450120063197,0,14,CD4-positive, alpha-beta T cell lineage commitment,BP,
11218,GO:0043374,1,0.940389472873864,0,9,CD8-positive, alpha-beta T cell differentiation,BP,
11219,GO:0043375,1,0.99249170530249,0,1,CD8-positive, alpha-beta T cell lineage commitment,BP,
11220,GO:0043376,1,0.985060008194125,0,2,regulation of CD8-positive, alpha-beta T cell differentiation,BP,
11221,GO:0043378,1,0.992484099751837,0,1,positive regulation of CD8-positive, alpha-beta T cell differentiation,BP,
11222,GO:0043379,1,0.9598010192903,0,6,memory T cell differentiation,BP,
11223,GO:0043380,1,0.969556927389121,0,5,regulation of memory T cell differentiation,BP,
11224,GO:0043382,1,0.976850665942199,0,4,positive regulation of memory T cell differentiation,BP,
11225,GO:0043383,1,0.93235793583501,0,11,negative T cell selection,BP,
11226,GO:0043385,1,0.99312430827893,0,1,mycotoxin metabolic process,BP,
11227,GO:0043387,1,0.99312430827893,0,1,mycotoxin catabolic process,BP,
11228,GO:0043388,1,0.720178192802097,0,51,positive regulation of DNA binding,BP,
11229,GO:0043392,1,0.721328366601255,0,51,negative regulation of DNA binding,BP,
11233,GO:0043396,1,0.984948353720478,0,2,corticotropin-releasing hormone secretion,BP,
11234,GO:0043397,1,0.984948353720478,0,2,regulation of corticotropin-releasing hormone secretion,BP,
11235,GO:0043398,1,0.981150421553687,0,3,HLH domain binding,MF,
11236,GO:0043400,1,0.975767656505025,0,5,cortisol secretion,BP,
11237,GO:0043401,1,0.289099570268903,0,174,steroid hormone mediated signaling pathway,BP,
11238,GO:0043402,1,0.971851573993358,0,3,glucocorticoid mediated signaling pathway,BP,
11242,GO:0043407,1,0.642511156370283,0,67,negative regulation of MAP kinase activity,BP,
11244,GO:0043409,1,0.374229402174786,0,143,negative regulation of MAPK cascade,BP,
11249,GO:0043415,1,0.9689837586875,0,5,positive regulation of skeletal muscle tissue regeneration,BP,
11250,GO:0043416,1,0.9689837586875,0,5,regulation of skeletal muscle tissue regeneration,BP,
11251,GO:0043418,1,0.979783652161772,0,3,homocysteine catabolic process,BP,
11252,GO:0043420,1,0.99583057491786,0,1,anthranilate metabolic process,BP,
11253,GO:0043422,1,0.920911209637813,0,12,protein kinase B binding,MF,
11254,GO:0043423,1,0.992397477668934,0,1,3-phosphoinositide-dependent protein kinase binding,MF,
11255,GO:0043425,1,0.842398371938466,0,24,bHLH transcription factor binding,MF,
11256,GO:0043426,1,0.96242511228192,0,5,MRF binding,MF,
11257,GO:0043433,1,0.367133613967964,0,149,negative regulation of DNA binding transcription factor activity,BP,
11259,GO:0043435,1,0.967037663322132,0,5,response to corticotropin-releasing hormone,BP,
11261,GO:0043438,1,0.992937801392563,0,1,acetoacetic acid metabolic process,BP,
11262,GO:0043449,1,0.985803865967285,0,2,cellular alkene metabolic process,BP,
11263,GO:0043455,1,0.930796730861312,0,11,regulation of secondary metabolic process,BP,
11264,GO:0043456,1,0.982786604600001,0,4,regulation of pentose-phosphate shunt,BP,
11266,GO:0043461,1,0.978035574350374,0,4,proton-transporting ATP synthase complex assembly,BP,
11269,GO:0043470,1,0.613282063520987,0,69,regulation of carbohydrate catabolic process,BP,
11270,GO:0043471,1,0.950675290662705,0,9,regulation of cellular carbohydrate catabolic process,BP,
11272,GO:0043474,1,0.980366693513217,0,3,pigment metabolic process involved in pigmentation,BP,
11273,GO:0043476,1,0.920370618195525,0,12,pigment accumulation,BP,
11274,GO:0043482,1,0.920370618195525,0,12,cellular pigment accumulation,BP,
11275,GO:0043484,1,0.461746502318061,0,111,regulation of RNA splicing,BP,
11276,GO:0043485,1,0.939796500291573,0,10,endosome to pigment granule transport,BP,
11278,GO:0043487,1,0.372693449937838,0,156,regulation of RNA stability,BP,
11279,GO:0043488,1,0.395257943746941,0,148,regulation of mRNA stability,BP,
11280,GO:0043489,1,0.782000084829055,0,35,RNA stabilization,BP,
11281,GO:0043490,1,0.98518697759083,0,2,malate-aspartate shuttle,BP,
11284,GO:0043495,1,0.939434936167596,0,9,protein membrane anchor,MF,
11285,GO:0043496,1,0.873152784897451,0,21,regulation of protein homodimerization activity,BP,
11286,GO:0043497,1,0.939936850702139,0,10,regulation of protein heterodimerization activity,BP,
11287,GO:0043500,1,0.571230978801079,0,83,muscle adaptation,BP,
11288,GO:0043501,1,0.877049758939904,0,20,skeletal muscle adaptation,BP,
11289,GO:0043502,1,0.620818369919753,0,67,regulation of muscle adaptation,BP,
11290,GO:0043503,1,0.990940352454368,0,2,skeletal muscle fiber adaptation,BP,
11291,GO:0043504,1,0.978064446263842,0,3,mitochondrial DNA repair,BP,
11292,GO:0043506,1,0.575045879031361,0,77,regulation of JUN kinase activity,BP,
11293,GO:0043507,1,0.623313857204012,0,64,positive regulation of JUN kinase activity,BP,
11294,GO:0043508,1,0.919232036985403,0,13,negative regulation of JUN kinase activity,BP,
11295,GO:0043509,1,0.994236985886711,0,1,activin A complex,CC,
11296,GO:0043511,1,0.99023932183642,0,2,inhibin complex,CC,
11297,GO:0043512,1,0.99023932183642,0,2,inhibin A complex,CC,
11298,GO:0043513,1,0.995979396295435,0,1,inhibin B complex,CC,
11299,GO:0043514,1,0.995939249581314,0,1,interleukin-12 complex,CC,
11300,GO:0043515,1,0.963068259567767,0,5,kinetochore binding,MF,
11301,GO:0043516,1,0.832328064164072,0,29,regulation of DNA damage response, signal transduction by p53 class mediator,BP,
11302,GO:0043517,1,0.910769324332993,0,14,positive regulation of DNA damage response, signal transduction by p53 class mediator,BP,
11303,GO:0043518,1,0.918213354116099,0,14,negative regulation of DNA damage response, signal transduction by p53 class mediator,BP,
11304,GO:0043519,1,0.994382162919748,0,1,regulation of myosin II filament organization,BP,
11305,GO:0043522,1,0.94881383354573,0,9,leucine zipper domain binding,MF,
11308,GO:0043525,1,0.740370044210923,0,45,positive regulation of neuron apoptotic process,BP,
11309,GO:0043527,1,0.973318330652042,0,5,tRNA methyltransferase complex,CC,
11310,GO:0043531,1,0.78728352779322,0,33,ADP binding,MF,
11311,GO:0043532,1,0.991068165211003,0,1,angiostatin binding,MF,
11312,GO:0043533,1,0.960132671610506,0,5,inositol 1,3,4,5 tetrakisphosphate binding,MF,
11313,GO:0043534,1,0.507352541524083,0,98,blood vessel endothelial cell migration,BP,
11314,GO:0043535,1,0.581682596481452,0,78,regulation of blood vessel endothelial cell migration,BP,
11315,GO:0043536,1,0.71829385367369,0,48,positive regulation of blood vessel endothelial cell migration,BP,
11316,GO:0043537,1,0.816887774969238,0,29,negative regulation of blood vessel endothelial cell migration,BP,
11317,GO:0043538,1,0.99276808309798,0,1,regulation of actin phosphorylation,BP,
11319,GO:0043540,1,0.995245096186547,0,1,6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex,CC,
11320,GO:0043541,1,0.985326453832948,0,2,UDP-N-acetylglucosamine transferase complex,CC,
11321,GO:0043542,1,0.310599500524736,0,169,endothelial cell migration,BP,
11323,GO:0043544,1,0.99252484461045,0,1,lipoamide binding,MF,
11324,GO:0043545,1,0.957607106433363,0,7,molybdopterin cofactor metabolic process,BP,
11325,GO:0043546,1,0.957013153248002,0,6,molybdopterin cofactor binding,MF,
11327,GO:0043548,1,0.811771981657094,0,27,phosphatidylinositol 3-kinase binding,MF,
11332,GO:0043553,1,0.986069169786505,0,2,negative regulation of phosphatidylinositol 3-kinase activity,BP,
11333,GO:0043555,1,0.885870044786067,0,18,regulation of translation in response to stress,BP,
11334,GO:0043558,1,0.911910507345689,0,14,regulation of translational initiation in response to stress,BP,
11335,GO:0043559,1,0.955215567392037,0,5,insulin binding,MF,
11336,GO:0043560,1,0.914221412492547,0,11,insulin receptor substrate binding,MF,
11337,GO:0043562,1,0.947083040650369,0,11,cellular response to nitrogen levels,BP,
11338,GO:0043564,1,0.98690522491948,0,2,Ku70:Ku80 complex,CC,
11340,GO:0043567,1,0.888470474619826,0,18,regulation of insulin-like growth factor receptor signaling pathway,BP,
11341,GO:0043568,1,0.938615743457823,0,9,positive regulation of insulin-like growth factor receptor signaling pathway,BP,
11342,GO:0043569,1,0.949421423365688,0,7,negative regulation of insulin-like growth factor receptor signaling pathway,BP,
11343,GO:0043570,1,0.962849469853301,0,5,maintenance of DNA repeat elements,BP,
11344,GO:0043574,1,0.886169600003961,0,18,peroxisomal transport,BP,
11345,GO:0043576,1,0.860197095326144,0,21,regulation of respiratory gaseous exchange,BP,
11346,GO:0043578,1,0.96992315794296,0,3,nuclear matrix organization,BP,
11348,GO:0043584,1,0.890660646998141,0,16,nose development,BP,
11349,GO:0043585,1,0.975062825587905,0,3,nose morphogenesis,BP,
11351,GO:0043587,1,0.945796614777831,0,8,tongue morphogenesis,BP,
11353,GO:0043589,1,0.938092232822154,0,8,skin morphogenesis,BP,
11354,GO:0043596,1,0.766737067743318,0,41,nuclear replication fork,CC,
11355,GO:0043601,1,0.85945986625464,0,24,nuclear replisome,CC,
11356,GO:0043602,1,0.993519092085155,0,1,nitrate catabolic process,BP,
11359,GO:0043605,1,0.985524906679656,0,3,cellular amide catabolic process,BP,
11360,GO:0043606,1,0.974693542470938,0,4,formamide metabolic process,BP,
11361,GO:0043610,1,0.989856457056912,0,1,regulation of carbohydrate utilization,BP,
11362,GO:0043614,1,0.984445278707859,0,2,multi-eIF complex,CC,
11363,GO:0043615,1,0.95962961510196,0,7,astrocyte cell migration,BP,
11364,GO:0043616,1,0.783801952984551,0,33,keratinocyte proliferation,BP,
11365,GO:0043618,1,0.534889458315374,0,108,regulation of transcription from RNA polymerase II promoter in response to stress,BP,
11366,GO:0043619,1,0.92949427850022,0,11,regulation of transcription from RNA polymerase II promoter in response to oxidative stress,BP,
11367,GO:0043620,1,0.514261827894551,0,113,regulation of DNA-templated transcription in response to stress,BP,
11369,GO:0043622,1,0.969601415646889,0,4,cortical microtubule organization,BP,
11371,GO:0043625,1,0.977645503125881,0,4,delta DNA polymerase complex,CC,
11372,GO:0043626,1,0.996162157015169,0,1,PCNA complex,CC,
11373,GO:0043627,1,0.648881062676024,0,68,response to estrogen,BP,
11374,GO:0043628,1,0.854226935064775,0,28,ncRNA 3'-end processing,BP,
11375,GO:0043629,1,0.990281587792087,0,1,ncRNA polyadenylation,BP,
11376,GO:0043630,1,0.990281587792087,0,1,ncRNA polyadenylation involved in polyadenylation-dependent ncRNA catabolic process,BP,
11377,GO:0043631,1,0.745717154306526,0,42,RNA polyadenylation,BP,
11379,GO:0043633,1,0.955364753285805,0,8,polyadenylation-dependent RNA catabolic process,BP,
11380,GO:0043634,1,0.962773475338378,0,7,polyadenylation-dependent ncRNA catabolic process,BP,
11381,GO:0043647,1,0.644023326760191,0,62,inositol phosphate metabolic process,BP,
11382,GO:0043648,1,0.543396296757469,0,98,dicarboxylic acid metabolic process,BP,
11383,GO:0043649,1,0.896587411686407,0,18,dicarboxylic acid catabolic process,BP,
11384,GO:0043650,1,0.924576455390348,0,12,dicarboxylic acid biosynthetic process,BP,
11385,GO:0043651,1,0.909100078703644,0,15,linoleic acid metabolic process,BP,
11386,GO:0043652,1,0.93418194524457,0,11,engulfment of apoptotic cell,BP,
11387,GO:0043653,1,0.948690746312739,0,9,mitochondrial fragmentation involved in apoptotic process,BP,
11388,GO:0043654,1,0.962124277236383,0,6,recognition of apoptotic cell,BP,
11389,GO:0043656,1,0.94404924788908,0,9,intracellular region of host,CC,
11390,GO:0043657,1,0.645539488673644,0,65,host cell,CC,
11391,GO:0043666,1,0.50285700792468,0,100,regulation of phosphoprotein phosphatase activity,BP,
11393,GO:0043682,1,0.981407554015502,0,2,copper-transporting ATPase activity,MF,
11394,GO:0043686,1,0.983221120086005,0,3,co-translational protein modification,BP,
11395,GO:0043687,1,0.0805292732656009,0,392,post-translational protein modification,BP,
11396,GO:0043691,1,0.928120392811752,0,13,reverse cholesterol transport,BP,
11397,GO:0043696,1,0.949204072489065,0,7,dedifferentiation,BP,
11398,GO:0043697,1,0.949204072489065,0,7,cell dedifferentiation,BP,
11399,GO:0043733,1,0.99670774898663,0,1,DNA-3-methylbase glycosylase activity,MF,
11400,GO:0043734,1,0.978599271797264,0,4,DNA-N1-methyladenine dioxygenase activity,MF,
11401,GO:0043739,1,0.992634150930149,0,1,G/U mismatch-specific uracil-DNA glycosylase activity,MF,
11402,GO:0043754,1,0.98871077880571,0,1,dihydrolipoyllysine-residue (2-methylpropanoyl)transferase activity,MF,
11403,GO:0043783,1,0.993832580343169,0,1,oxidoreductase activity, oxidizing metal ions with flavin as acceptor,MF,
11404,GO:0043795,1,0.996017221888988,0,1,glyceraldehyde oxidoreductase activity,MF,
11405,GO:0043812,1,0.976252688802051,0,3,phosphatidylinositol-4-phosphate phosphatase activity,MF,
11406,GO:0043813,1,0.958860705206777,0,5,phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity,MF,
11407,GO:0043843,1,0.993425333841069,0,1,ADP-specific glucokinase activity,MF,
11408,GO:0043849,1,0.99289170684964,0,1,Ras palmitoyltransferase activity,MF,
11409,GO:0043855,1,0.942692475150004,0,8,cyclic nucleotide-gated ion channel activity,MF,
11410,GO:0043865,1,0.993064770092322,0,1,methionine transmembrane transporter activity,MF,
11411,GO:0043874,1,0.994602317372997,0,1,acireductone synthase activity,MF,
11412,GO:0043890,1,0.993796698440874,0,1,N-acetylgalactosamine-6-sulfatase activity,MF,
11413,GO:0043891,1,0.996213853163821,0,1,glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity,MF,
11418,GO:0043914,1,0.992483205819765,0,1,NADPH:sulfur oxidoreductase activity,MF,
11419,GO:0043916,1,0.99670774898663,0,1,DNA-7-methylguanine glycosylase activity,MF,
11420,GO:0043921,1,0.846207876598775,0,24,modulation by host of viral transcription,BP,
11421,GO:0043922,1,0.939222126159579,0,9,negative regulation by host of viral transcription,BP,
11422,GO:0043923,1,0.886744148162363,0,17,positive regulation by host of viral transcription,BP,
11423,GO:0043924,1,0.985874952456476,0,1,suramin binding,MF,
11424,GO:0043928,1,0.839005493136101,0,32,exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay,BP,
11428,GO:0043946,1,0.995234576030083,0,1,positive regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
11429,GO:0043947,1,0.995234576030083,0,1,positive regulation by host of symbiont catalytic activity,BP,
11430,GO:0043949,1,0.774699583177904,0,40,regulation of cAMP-mediated signaling,BP,
11431,GO:0043950,1,0.900761031205427,0,19,positive regulation of cAMP-mediated signaling,BP,
11432,GO:0043951,1,0.89217391813408,0,17,negative regulation of cAMP-mediated signaling,BP,
11433,GO:0043954,1,0.781366066470358,0,35,cellular component maintenance,BP,
11434,GO:0043966,1,0.687599663863149,0,56,histone H3 acetylation,BP,
11436,GO:0043968,1,0.908554714649782,0,15,histone H2A acetylation,BP,
11437,GO:0043969,1,0.989851265375405,0,1,histone H2B acetylation,BP,
11438,GO:0043970,1,0.913506767596686,0,13,histone H3-K9 acetylation,BP,
11439,GO:0043972,1,0.992254656203569,0,1,histone H3-K23 acetylation,BP,
11440,GO:0043973,1,0.994160825759648,0,1,histone H3-K4 acetylation,BP,
11441,GO:0043974,1,0.976813953195906,0,3,histone H3-K27 acetylation,BP,
11442,GO:0043981,1,0.900710210558311,0,15,histone H4-K5 acetylation,BP,
11443,GO:0043982,1,0.900710210558311,0,15,histone H4-K8 acetylation,BP,
11444,GO:0043983,1,0.956003485799051,0,7,histone H4-K12 acetylation,BP,
11445,GO:0043984,1,0.876827751489632,0,18,histone H4-K16 acetylation,BP,
11446,GO:0043985,1,0.962719172657233,0,6,histone H4-R3 methylation,BP,
11447,GO:0043987,1,0.96371385680513,0,6,histone H3-S10 phosphorylation,BP,
11448,GO:0043988,1,0.981911091420818,0,3,histone H3-S28 phosphorylation,BP,
11449,GO:0043990,1,0.992730013876044,0,1,histone H2A-S1 phosphorylation,BP,
11450,GO:0043994,1,0.992254656203569,0,1,histone acetyltransferase activity (H3-K23 specific),MF,
11451,GO:0043995,1,0.928816218194738,0,10,histone acetyltransferase activity (H4-K5 specific),MF,
11452,GO:0043996,1,0.928816218194738,0,10,histone acetyltransferase activity (H4-K8 specific),MF,
11453,GO:0043997,1,0.992708271854673,0,1,histone acetyltransferase activity (H4-K12 specific),MF,
11454,GO:0043998,1,0.99259379899157,0,1,H2A histone acetyltransferase activity,MF,
11455,GO:0044003,1,0.761191376356177,0,38,modification by symbiont of host morphology or physiology,BP,
11456,GO:0044004,1,0.97259703259559,0,5,disruption by symbiont of host cell,BP,
11457,GO:0044007,1,0.991274064861212,0,1,dissemination or transmission of symbiont from host,BP,
11459,GO:0044020,1,0.97683796573401,0,4,histone methyltransferase activity (H4-R3 specific),MF,
11460,GO:0044026,1,0.988536904098786,0,2,DNA hypermethylation,BP,
11461,GO:0044027,1,0.996009441419768,0,1,hypermethylation of CpG island,BP,
11462,GO:0044028,1,0.985050888394715,0,2,DNA hypomethylation,BP,
11463,GO:0044029,1,0.985050888394715,0,2,hypomethylation of CpG island,BP,
11464,GO:0044030,1,0.897687408396129,0,15,regulation of DNA methylation,BP,
11465,GO:0044033,1,0.959066374719548,0,7,multi-organism metabolic process,BP,
11466,GO:0044035,1,0.995487307145082,0,1,multi-organism catabolic process,BP,
11467,GO:0044036,1,0.978095511656257,0,5,cell wall macromolecule metabolic process,BP,
11468,GO:0044038,1,0.99517012130739,0,1,cell wall macromolecule biosynthetic process,BP,
11470,GO:0044053,1,0.993704412915987,0,1,translocation of peptides or proteins into host cell cytoplasm,BP,
11472,GO:0044058,1,0.830624511763308,0,32,regulation of digestive system process,BP,
11473,GO:0044060,1,0.781276832518341,0,40,regulation of endocrine process,BP,
11474,GO:0044062,1,0.885044613221221,0,19,regulation of excretion,BP,
11475,GO:0044065,1,0.903919960688801,0,15,regulation of respiratory system process,BP,
11476,GO:0044068,1,0.840213736410256,0,25,modulation by symbiont of host cellular process,BP,
11480,GO:0044088,1,0.766163883832476,0,39,regulation of vacuole organization,BP,
11482,GO:0044090,1,0.921606238056153,0,11,positive regulation of vacuole organization,BP,
11486,GO:0044094,1,0.978665027435129,0,3,host cell nuclear part,CC,
11487,GO:0044105,1,0.997245910794596,0,1,L-xylulose reductase (NAD+) activity,MF,
11488,GO:0044106,1,0.544094183541944,0,112,cellular amine metabolic process,BP,
11489,GO:0044107,1,0.977964657498944,0,4,cellular alcohol metabolic process,BP,
11490,GO:0044108,1,0.977964657498944,0,4,cellular alcohol biosynthetic process,BP,
11491,GO:0044110,1,0.935901449514538,0,13,growth involved in symbiotic interaction,BP,
11492,GO:0044111,1,0.986800358043868,0,2,development involved in symbiotic interaction,BP,
11493,GO:0044115,1,0.995487307145082,0,1,development of symbiont involved in interaction with host,BP,
11494,GO:0044116,1,0.935901449514538,0,13,growth of symbiont involved in interaction with host,BP,
11495,GO:0044117,1,0.938257219231949,0,12,growth of symbiont in host,BP,
11496,GO:0044126,1,0.94108556201767,0,11,regulation of growth of symbiont in host,BP,
11497,GO:0044128,1,0.992070669716768,0,1,positive regulation of growth of symbiont in host,BP,
11498,GO:0044130,1,0.948611369251983,0,10,negative regulation of growth of symbiont in host,BP,
11499,GO:0044133,1,0.997490814002907,0,1,growth of symbiont on or near host,BP,
11500,GO:0044139,1,0.997490814002907,0,1,modulation of growth of symbiont on or near host,BP,
11501,GO:0044140,1,0.997490814002907,0,1,negative regulation of growth of symbiont on or near host surface,BP,
11502,GO:0044144,1,0.938722762582512,0,12,modulation of growth of symbiont involved in interaction with host,BP,
11503,GO:0044145,1,0.995487307145082,0,1,modulation of development of symbiont involved in interaction with host,BP,
11504,GO:0044146,1,0.94622986497287,0,11,negative regulation of growth of symbiont involved in interaction with host,BP,
11505,GO:0044147,1,0.995487307145082,0,1,negative regulation of development of symbiont involved in interaction with host,BP,
11506,GO:0044148,1,0.992070669716768,0,1,positive regulation of growth of symbiont involved in interaction with host,BP,
11507,GO:0044154,1,0.947280382312654,0,8,histone H3-K14 acetylation,BP,
11508,GO:0044179,1,0.987276757373615,0,2,hemolysis in other organism,BP,
11509,GO:0044183,1,0.791006980179855,0,38,protein binding involved in protein folding,MF,
11510,GO:0044190,1,0.995219366830879,0,1,host cell mitochondrial envelope,CC,
11511,GO:0044194,1,0.972684234702064,0,5,cytolytic granule,CC,
11512,GO:0044205,1,0.978693912143697,0,3,'de novo' UMP biosynthetic process,BP,
11513,GO:0044206,1,0.974756183749436,0,5,UMP salvage,BP,
11514,GO:0044207,1,0.992445167226871,0,1,translation initiation ternary complex,CC,
11515,GO:0044208,1,0.984148046623552,0,3,'de novo' AMP biosynthetic process,BP,
11516,GO:0044209,1,0.991958923724685,0,2,AMP salvage,BP,
11517,GO:0044210,1,0.985590813617924,0,2,'de novo' CTP biosynthetic process,BP,
11518,GO:0044211,1,0.985774602574266,0,3,CTP salvage,BP,
11520,GO:0044213,1,0.92241625283096,0,12,intronic transcription regulatory region DNA binding,MF,
11521,GO:0044214,1,0.959247108041957,0,5,spanning component of plasma membrane,CC,
11526,GO:0044220,1,0.992201378708722,0,1,host cell perinuclear region of cytoplasm,CC,
11527,GO:0044221,1,0.992440287823366,0,1,host cell synapse,CC,
11529,GO:0044228,1,0.992249695083283,0,1,host cell surface,CC,
11530,GO:0044231,1,0.992440287823366,0,1,host cell presynaptic membrane,CC,
11531,GO:0044232,1,0.87958122175297,0,19,organelle membrane contact site,CC,
11532,GO:0044233,1,0.918476443401094,0,13,ER-mitochondrion membrane contact site,CC,
11537,GO:0044245,1,0.980740004540796,0,3,polysaccharide digestion,BP,
11543,GO:0044258,1,0.993756997792406,0,1,intestinal lipid catabolic process,BP,
11549,GO:0044270,1,0.0233569727003948,0,617,cellular nitrogen compound catabolic process,BP,
11558,GO:0044284,1,0.997103679097596,0,1,mitochondrial crista junction,CC,
11560,GO:0044292,1,0.933944084936613,0,10,dendrite terminus,CC,
11561,GO:0044294,1,0.954425296346452,0,6,dendritic growth cone,CC,
11562,GO:0044295,1,0.855774501699279,0,21,axonal growth cone,CC,
11564,GO:0044298,1,0.850445002932731,0,23,cell body membrane,CC,
11565,GO:0044299,1,0.991199088277706,0,1,C-fiber,CC,
11567,GO:0044301,1,0.988193355900952,0,2,climbing fiber,CC,
11568,GO:0044302,1,0.965926314007896,0,4,dentate gyrus mossy fiber,CC,
11570,GO:0044305,1,0.963782952508943,0,4,calyx of Held,CC,
11572,GO:0044307,1,0.98781976133013,0,1,dendritic branch,CC,
11573,GO:0044308,1,0.974466221624289,0,3,axonal spine,CC,
11575,GO:0044313,1,0.974269623462023,0,3,protein K6-linked deubiquitination,BP,
11576,GO:0044314,1,0.982272090939765,0,4,protein K27-linked ubiquitination,BP,
11577,GO:0044316,1,0.98595606022496,0,2,cone cell pedicle,CC,
11578,GO:0044317,1,0.996085974552639,0,1,rod spherule,CC,
11579,GO:0044319,1,0.824435213780714,0,27,wound healing, spreading of cells,BP,
11580,GO:0044320,1,0.902310437741088,0,15,cellular response to leptin stimulus,BP,
11581,GO:0044321,1,0.878284422975438,0,19,response to leptin,BP,
11582,GO:0044322,1,0.827416231650155,0,28,endoplasmic reticulum quality control compartment,CC,
11583,GO:0044323,1,0.969587819054019,0,4,retinoic acid-responsive element binding,MF,
11584,GO:0044324,1,0.9970847891085,0,1,regulation of transcription involved in anterior/posterior axis specification,BP,
11585,GO:0044325,1,0.441484586710769,0,115,ion channel binding,MF,
11586,GO:0044326,1,0.969006669316333,0,4,dendritic spine neck,CC,
11589,GO:0044332,1,0.948297491633178,0,6,Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
11590,GO:0044333,1,0.994922078489237,0,1,Wnt signaling pathway involved in digestive tract morphogenesis,BP,
11591,GO:0044334,1,0.98509440142086,0,2,canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition,BP,
11592,GO:0044335,1,0.989107621297466,0,1,canonical Wnt signaling pathway involved in neural crest cell differentiation,BP,
11593,GO:0044336,1,0.978018538537177,0,3,canonical Wnt signaling pathway involved in negative regulation of apoptotic process,BP,
11594,GO:0044338,1,0.988239726173071,0,2,canonical Wnt signaling pathway involved in mesenchymal stem cell differentiation,BP,
11595,GO:0044339,1,0.972839311599758,0,4,canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
11596,GO:0044340,1,0.963163603327348,0,5,canonical Wnt signaling pathway involved in regulation of cell proliferation,BP,
11598,GO:0044342,1,0.899818806151814,0,16,type B pancreatic cell proliferation,BP,
11599,GO:0044343,1,0.992359736600904,0,1,canonical Wnt signaling pathway involved in regulation of type B pancreatic cell proliferation,BP,
11601,GO:0044345,1,0.992359736600904,0,1,stromal-epithelial cell signaling involved in prostate gland development,BP,
11602,GO:0044346,1,0.879749009791209,0,18,fibroblast apoptotic process,BP,
11603,GO:0044349,1,0.995280108756433,0,1,DNA excision,BP,
11604,GO:0044351,1,0.953110069514216,0,7,macropinocytosis,BP,
11605,GO:0044352,1,0.972075863404844,0,4,pinosome,CC,
11606,GO:0044354,1,0.972075863404844,0,4,macropinosome,CC,
11607,GO:0044355,1,0.99592584516889,0,1,clearance of foreign intracellular DNA,BP,
11608,GO:0044356,1,0.99592584516889,0,1,clearance of foreign intracellular DNA by conversion of DNA cytidine to uridine,BP,
11609,GO:0044359,1,0.955712119045257,0,8,modulation of molecular function in other organism,BP,
11610,GO:0044362,1,0.964161611979361,0,7,negative regulation of molecular function in other organism,BP,
11612,GO:0044375,1,0.988909621088408,0,3,regulation of peroxisome size,BP,
11613,GO:0044378,1,0.987330438916345,0,2,non-sequence-specific DNA binding, bending,MF,
11614,GO:0044380,1,0.682689817081344,0,49,protein localization to cytoskeleton,BP,
11615,GO:0044381,1,0.855711169114535,0,21,glucose import in response to insulin stimulus,BP,
11616,GO:0044387,1,0.949534066292634,0,8,negative regulation of protein kinase activity by regulation of protein phosphorylation,BP,
11617,GO:0044388,1,0.97644899475038,0,5,small protein activating enzyme binding,MF,
11619,GO:0044390,1,0.753142240724686,0,39,ubiquitin-like protein conjugating enzyme binding,MF,
11620,GO:0044391,1,0.514020186481155,0,181,ribosomal subunit,CC,
11621,GO:0044393,1,0.978416612646915,0,3,microspike,CC,
11622,GO:0044396,1,0.964654753478658,0,5,actin cortical patch organization,BP,
11627,GO:0044413,1,0.971232151525118,0,4,avoidance of host defenses,BP,
11628,GO:0044414,1,0.992003285188543,0,1,suppression of host defenses,BP,
11629,GO:0044415,1,0.971232151525118,0,4,evasion or tolerance of host defenses,BP,
11630,GO:0044416,1,0.994168744955213,0,1,induction by symbiont of host defense response,BP,
11631,GO:0044417,1,0.948518028963618,0,9,translocation of molecules into host,BP,
11646,GO:0044438,1,0.581599335552127,0,89,microbody part,CC,
11647,GO:0044439,1,0.581599335552127,0,89,peroxisomal part,CC,
11653,GO:0044447,1,0.778574101174528,0,29,axoneme part,CC,
11655,GO:0044449,1,0.244961587228303,0,196,contractile fiber part,CC,
11656,GO:0044450,1,0.314521566640324,0,159,microtubule organizing center part,CC,
11658,GO:0044452,1,0.342148593222954,0,169,nucleolar part,CC,
11659,GO:0044453,1,0.90481721569737,0,15,nuclear membrane part,CC,
11663,GO:0044458,1,0.890647285893044,0,19,motile cilium assembly,BP,
11667,GO:0044467,1,0.986458049079474,0,2,glial cell-derived neurotrophic factor secretion,BP,
11668,GO:0044495,1,0.997281337658679,0,1,modulation of blood pressure in other organism,BP,
11669,GO:0044497,1,0.997281337658679,0,1,positive regulation of blood pressure in other organism,BP,
11670,GO:0044501,1,0.984680662431921,0,2,modulation of signal transduction in other organism,BP,
11671,GO:0044508,1,0.992704795922991,0,1,glucagon-like peptide 1 receptor activity,MF,
11672,GO:0044524,1,0.995239252591955,0,1,protein sulfhydration,BP,
11673,GO:0044528,1,0.974080494250578,0,4,regulation of mitochondrial mRNA stability,BP,
11674,GO:0044530,1,0.97773560694977,0,3,supraspliceosomal complex,CC,
11675,GO:0044531,1,0.964735868765068,0,6,modulation of programmed cell death in other organism,BP,
11676,GO:0044532,1,0.964735868765068,0,6,modulation of apoptotic process in other organism,BP,
11677,GO:0044533,1,0.98513298625883,0,3,positive regulation of apoptotic process in other organism,BP,
11678,GO:0044537,1,0.995148968087614,0,1,regulation of circulating fibrinogen levels,BP,
11679,GO:0044539,1,0.956692321705353,0,7,long-chain fatty acid import,BP,
11680,GO:0044540,1,0.995239252591955,0,1,L-cystine L-cysteine-lyase (deaminating),MF,
11681,GO:0044545,1,0.967637817906621,0,5,NSL complex,CC,
11682,GO:0044546,1,0.916364965089199,0,12,NLRP3 inflammasome complex assembly,BP,
11683,GO:0044547,1,0.965745921033167,0,5,DNA topoisomerase binding,MF,
11684,GO:0044548,1,0.918528729636886,0,14,S100 protein binding,MF,
11685,GO:0044549,1,0.997494945641853,0,1,GTP cyclohydrolase binding,MF,
11686,GO:0044550,1,0.861226988250619,0,22,secondary metabolite biosynthetic process,BP,
11687,GO:0044557,1,0.957871269531664,0,7,relaxation of smooth muscle,BP,
11688,GO:0044558,1,0.992114422505465,0,1,uterine smooth muscle relaxation,BP,
11689,GO:0044565,1,0.988759529923147,0,2,dendritic cell proliferation,BP,
11690,GO:0044571,1,0.983970181699137,0,4,[2Fe-2S] cluster assembly,BP,
11691,GO:0044594,1,0.993198506957189,0,1,17-beta-hydroxysteroid dehydrogenase (NAD+) activity,MF,
11692,GO:0044595,1,0.996318964210472,0,1,decaprenyldihydroxybenzoate methyltransferase activity,MF,
11693,GO:0044596,1,0.996318964210472,0,1,3-demethylubiquinone-10 3-O-methyltransferase activity,MF,
11694,GO:0044597,1,0.96552426900612,0,8,daunorubicin metabolic process,BP,
11695,GO:0044598,1,0.96552426900612,0,8,doxorubicin metabolic process,BP,
11696,GO:0044599,1,0.993058458973322,0,1,AP-5 adaptor complex,CC,
11697,GO:0044601,1,0.995460844898659,0,1,protein denucleotidylation,BP,
11698,GO:0044602,1,0.995460844898659,0,1,protein deadenylylation,BP,
11699,GO:0044603,1,0.995460844898659,0,1,protein adenylylhydrolase activity,MF,
11700,GO:0044609,1,0.987414867066515,0,2,DBIRD complex,CC,
11701,GO:0044610,1,0.994025486367947,0,1,FMN transmembrane transporter activity,MF,
11702,GO:0044611,1,0.975638371824497,0,3,nuclear pore inner ring,CC,
11703,GO:0044613,1,0.933547783683596,0,11,nuclear pore central transport channel,CC,
11704,GO:0044614,1,0.966433269308314,0,4,nuclear pore cytoplasmic filaments,CC,
11705,GO:0044615,1,0.934342825684143,0,8,nuclear pore nuclear basket,CC,
11706,GO:0044620,1,0.995228475299946,0,2,ACP phosphopantetheine attachment site binding,MF,
11707,GO:0044648,1,0.993058458973322,0,1,histone H3-K4 dimethylation,BP,
11708,GO:0044650,1,0.942401324869059,0,9,adhesion of symbiont to host cell,BP,
11709,GO:0044651,1,0.996279622224939,0,1,adhesion of symbiont to host epithelial cell,BP,
11710,GO:0044665,1,0.824088047144114,0,28,MLL1/2 complex,CC,
11711,GO:0044666,1,0.931510414179279,0,10,MLL3/4 complex,CC,
11712,GO:0044691,1,0.973595427924426,0,3,tooth eruption,BP,
11715,GO:0044713,1,0.997490814002907,0,1,2-hydroxy-adenosine triphosphate pyrophosphatase activity,MF,
11716,GO:0044714,1,0.997490814002907,0,1,2-hydroxy-(deoxy)adenosine-triphosphate pyrophosphatase activity,MF,
11717,GO:0044715,1,0.996445140209914,0,1,8-oxo-dGDP phosphatase activity,MF,
11718,GO:0044721,1,0.994805851317589,0,1,protein import into peroxisome matrix, substrate release,BP,
11719,GO:0044722,1,0.992488626920326,0,1,renal phosphate excretion,BP,
11720,GO:0044725,1,0.988621638835636,0,1,chromatin reprogramming in the zygote,BP,
11721,GO:0044727,1,0.988621638835636,0,1,DNA demethylation of male pronucleus,BP,
11722,GO:0044728,1,0.593173895231996,0,74,DNA methylation or demethylation,BP,
11723,GO:0044729,1,0.985560965202864,0,2,hemi-methylated DNA-binding,MF,
11724,GO:0044730,1,0.995487307145082,0,1,bone sialoprotein binding,MF,
11725,GO:0044732,1,0.993058458973322,0,1,mitotic spindle pole body,CC,
11726,GO:0044736,1,0.979318172289429,0,3,acid-sensing ion channel activity,MF,
11727,GO:0044743,1,0.814240845930225,0,37,protein transmembrane import into intracellular organelle,BP,
11728,GO:0044752,1,0.979282218396865,0,3,response to human chorionic gonadotropin,BP,
11729,GO:0044753,1,0.982557220930232,0,2,amphisome,CC,
11730,GO:0044754,1,0.952687888962144,0,8,autolysosome,CC,
11733,GO:0044769,1,0.892755603388069,0,20,ATPase activity, coupled to transmembrane movement of ions, rotational mechanism,MF,
11735,GO:0044771,1,0.985651451371516,0,2,meiotic cell cycle phase transition,BP,
11737,GO:0044773,1,0.515850235211151,0,100,mitotic DNA damage checkpoint,BP,
11738,GO:0044774,1,0.494909711348176,0,106,mitotic DNA integrity checkpoint,BP,
11739,GO:0044778,1,0.98781975590721,0,2,meiotic DNA integrity checkpoint,BP,
11740,GO:0044779,1,0.992781274983959,0,1,meiotic spindle checkpoint,BP,
11741,GO:0044782,1,0.0834041451918415,0,349,cilium organization,BP,
11742,GO:0044783,1,0.63144388348584,0,70,G1 DNA damage checkpoint,BP,
11743,GO:0044784,1,0.705236525414471,0,51,metaphase/anaphase transition of cell cycle,BP,
11744,GO:0044785,1,0.992781274983959,0,1,metaphase/anaphase transition of meiotic cell cycle,BP,
11745,GO:0044786,1,0.689283134709666,0,57,cell cycle DNA replication,BP,
11751,GO:0044795,1,0.996557520848522,0,1,trans-Golgi network to recycling endosome transport,BP,
11752,GO:0044796,1,0.996162157015169,0,1,DNA polymerase processivity factor complex,CC,
11753,GO:0044798,1,0.306612134150497,0,175,nuclear transcription factor complex,CC,
11754,GO:0044800,1,0.962675316483484,0,6,multi-organism membrane fusion,BP,
11755,GO:0044803,1,0.955130598116968,0,7,multi-organism membrane organization,BP,
11756,GO:0044804,1,0.878555654203214,0,19,autophagy of nucleus,BP,
11757,GO:0044805,1,0.977125806834854,0,3,late nucleophagy,BP,
11758,GO:0044806,1,0.948075805146569,0,7,G-quadruplex DNA unwinding,BP,
11759,GO:0044815,1,0.781398079363062,0,54,DNA packaging complex,CC,
11760,GO:0044818,1,0.831783343848603,0,26,mitotic G2/M transition checkpoint,BP,
11761,GO:0044819,1,0.636196412221811,0,69,mitotic G1/S transition checkpoint,BP,
11762,GO:0044821,1,0.966163431541637,0,5,meiotic telomere tethering at nuclear periphery,BP,
11763,GO:0044827,1,0.917754752643221,0,12,modulation by host of viral genome replication,BP,
11764,GO:0044828,1,0.970254177232297,0,4,negative regulation by host of viral genome replication,BP,
11765,GO:0044829,1,0.951286388335579,0,7,positive regulation by host of viral genome replication,BP,
11766,GO:0044830,1,0.985349877358738,0,2,modulation by host of viral RNA genome replication,BP,
11767,GO:0044837,1,0.949741009352204,0,7,actomyosin contractile ring organization,BP,
11770,GO:0044848,1,0.940306786225912,0,9,biological phase,BP,
11771,GO:0044849,1,0.919174360445342,0,14,estrous cycle,BP,
11772,GO:0044851,1,0.940306786225912,0,9,hair cycle phase,BP,
11775,GO:0044855,1,0.993129557636053,0,1,plasma membrane raft distribution,BP,
11776,GO:0044856,1,0.993129557636053,0,1,plasma membrane raft localization,BP,
11778,GO:0044858,1,0.993129557636053,0,1,plasma membrane raft polarization,BP,
11779,GO:0044860,1,0.973320409151633,0,4,protein localization to plasma membrane raft,BP,
11780,GO:0044861,1,0.986579437200835,0,2,protein transport into plasma membrane raft,BP,
11781,GO:0044866,1,0.994789249680222,0,1,modulation by host of viral exo-alpha-sialidase activity,BP,
11782,GO:0044867,1,0.994789249680222,0,1,modulation by host of viral catalytic activity,BP,
11783,GO:0044868,1,0.986074063376303,0,2,modulation by host of viral molecular function,BP,
11784,GO:0044869,1,0.994789249680222,0,1,negative regulation by host of viral exo-alpha-sialidase activity,BP,
11785,GO:0044870,1,0.994789249680222,0,1,modulation by host of viral glycoprotein metabolic process,BP,
11786,GO:0044871,1,0.994789249680222,0,1,negative regulation by host of viral glycoprotein metabolic process,BP,
11787,GO:0044872,1,0.894939556363924,0,13,lipoprotein localization,BP,
11789,GO:0044878,1,0.979746342809157,0,4,mitotic cytokinesis checkpoint,BP,
11790,GO:0045002,1,0.960114154606204,0,6,double-strand break repair via single-strand annealing,BP,
11791,GO:0045003,1,0.938399163519219,0,10,double-strand break repair via synthesis-dependent strand annealing,BP,
11792,GO:0045004,1,0.982999848657048,0,2,DNA replication proofreading,BP,
11793,GO:0045005,1,0.793558166179475,0,33,DNA-dependent DNA replication maintenance of fidelity,BP,
11794,GO:0045006,1,0.94411781301573,0,12,DNA deamination,BP,
11795,GO:0045007,1,0.986610348763177,0,3,depurination,BP,
11796,GO:0045008,1,0.957957980126768,0,8,depyrimidination,BP,
11797,GO:0045009,1,0.940915255032247,0,11,chitosome,CC,
11799,GO:0045016,1,0.992589876217607,0,1,mitochondrial magnesium ion transmembrane transport,BP,
11801,GO:0045019,1,0.926552086966698,0,12,negative regulation of nitric oxide biosynthetic process,BP,
11802,GO:0045022,1,0.770950672993277,0,37,early endosome to late endosome transport,BP,
11803,GO:0045023,1,0.738199997197651,0,42,G0 to G1 transition,BP,
11804,GO:0045025,1,0.985924133097944,0,2,mitochondrial degradosome,CC,
11805,GO:0045026,1,0.851134183333976,0,28,plasma membrane fusion,BP,
11806,GO:0045027,1,0.994398429380171,0,1,DNA end binding,MF,
11807,GO:0045028,1,0.933739317848986,0,12,G-protein coupled purinergic nucleotide receptor activity,MF,
11808,GO:0045029,1,0.988623247731298,0,2,UDP-activated nucleotide receptor activity,MF,
11809,GO:0045030,1,0.995493053640204,0,1,UTP-activated nucleotide receptor activity,MF,
11810,GO:0045031,1,0.987466889170978,0,2,ATP-activated adenosine receptor activity,MF,
11811,GO:0045032,1,0.992724803059811,0,1,ADP-activated adenosine receptor activity,MF,
11812,GO:0045039,1,0.975415935423202,0,6,protein import into mitochondrial inner membrane,BP,
11813,GO:0045040,1,0.971952256048735,0,6,protein import into mitochondrial outer membrane,BP,
11814,GO:0045041,1,0.989702460478962,0,2,protein import into mitochondrial intermembrane space,BP,
11815,GO:0045046,1,0.959460968889511,0,6,protein import into peroxisome membrane,BP,
11816,GO:0045047,1,0.709987026692608,0,100,protein targeting to ER,BP,
11817,GO:0045048,1,0.96844938753604,0,5,protein insertion into ER membrane,BP,
11818,GO:0045053,1,0.945670617565937,0,5,protein retention in Golgi apparatus,BP,
11819,GO:0045054,1,0.977030009821799,0,4,constitutive secretory pathway,BP,
11821,GO:0045056,1,0.898397676504867,0,15,transcytosis,BP,
11822,GO:0045058,1,0.757126558114253,0,42,T cell selection,BP,
11823,GO:0045059,1,0.948581687716464,0,9,positive thymic T cell selection,BP,
11824,GO:0045060,1,0.939417659846178,0,10,negative thymic T cell selection,BP,
11825,GO:0045061,1,0.890339290022099,0,18,thymic T cell selection,BP,
11826,GO:0045062,1,0.995322013720195,0,1,extrathymic T cell selection,BP,
11827,GO:0045063,1,0.894634714700315,0,17,T-helper 1 cell differentiation,BP,
11828,GO:0045064,1,0.918278912726019,0,14,T-helper 2 cell differentiation,BP,
11829,GO:0045065,1,0.981030595444187,0,3,cytotoxic T cell differentiation,BP,
11830,GO:0045066,1,0.8408610108689,0,26,regulatory T cell differentiation,BP,
11832,GO:0045070,1,0.799506870006842,0,32,positive regulation of viral genome replication,BP,
11834,GO:0045072,1,0.918407752424586,0,14,regulation of interferon-gamma biosynthetic process,BP,
11835,GO:0045073,1,0.944640161710297,0,11,regulation of chemokine biosynthetic process,BP,
11836,GO:0045074,1,0.979549294276238,0,3,regulation of interleukin-10 biosynthetic process,BP,
11837,GO:0045075,1,0.953375338921784,0,7,regulation of interleukin-12 biosynthetic process,BP,
11838,GO:0045076,1,0.899246455104564,0,17,regulation of interleukin-2 biosynthetic process,BP,
11839,GO:0045077,1,0.977236600535875,0,4,negative regulation of interferon-gamma biosynthetic process,BP,
11840,GO:0045078,1,0.939814260398704,0,10,positive regulation of interferon-gamma biosynthetic process,BP,
11841,GO:0045079,1,0.988997123055946,0,3,negative regulation of chemokine biosynthetic process,BP,
11842,GO:0045080,1,0.955154418983084,0,8,positive regulation of chemokine biosynthetic process,BP,
11843,GO:0045081,1,0.992519521444065,0,1,negative regulation of interleukin-10 biosynthetic process,BP,
11844,GO:0045082,1,0.986932992448273,0,2,positive regulation of interleukin-10 biosynthetic process,BP,
11845,GO:0045083,1,0.992458239563912,0,1,negative regulation of interleukin-12 biosynthetic process,BP,
11846,GO:0045084,1,0.968695890696976,0,5,positive regulation of interleukin-12 biosynthetic process,BP,
11847,GO:0045085,1,0.980195459478029,0,4,negative regulation of interleukin-2 biosynthetic process,BP,
11848,GO:0045086,1,0.922331970776476,0,12,positive regulation of interleukin-2 biosynthetic process,BP,
11852,GO:0045091,1,0.933506692960938,0,11,regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
11853,GO:0045092,1,0.992521903877945,0,1,interleukin-18 receptor complex,CC,
11854,GO:0045095,1,0.88847588589587,0,20,keratin filament,CC,
11855,GO:0045098,1,0.984240320196451,0,3,type III intermediate filament,CC,
11856,GO:0045103,1,0.794777310471704,0,32,intermediate filament-based process,BP,
11857,GO:0045104,1,0.800752079098851,0,31,intermediate filament cytoskeleton organization,BP,
11858,GO:0045105,1,0.991798242295597,0,1,intermediate filament polymerization or depolymerization,BP,
11859,GO:0045106,1,0.991798242295597,0,1,intermediate filament depolymerization,BP,
11860,GO:0045108,1,0.991798242295597,0,1,regulation of intermediate filament polymerization or depolymerization,BP,
11861,GO:0045109,1,0.900852765436585,0,15,intermediate filament organization,BP,
11862,GO:0045110,1,0.965661134618963,0,5,intermediate filament bundle assembly,BP,
11864,GO:0045112,1,0.9680536082196,0,5,integrin biosynthetic process,BP,
11865,GO:0045113,1,0.977815733439569,0,4,regulation of integrin biosynthetic process,BP,
11866,GO:0045116,1,0.927992661985087,0,14,protein neddylation,BP,
11867,GO:0045117,1,0.889222555604909,0,19,azole transport,BP,
11868,GO:0045120,1,0.914083473997382,0,12,pronucleus,CC,
11870,GO:0045123,1,0.733720267825152,0,48,cellular extravasation,BP,
11872,GO:0045125,1,0.917177136944452,0,15,bioactive lipid receptor activity,MF,
11873,GO:0045127,1,0.995625763078975,0,1,N-acetylglucosamine kinase activity,MF,
11874,GO:0045128,1,0.992687382343135,0,1,negative regulation of reciprocal meiotic recombination,BP,
11875,GO:0045130,1,0.993157729338872,0,1,keratan sulfotransferase activity,MF,
11876,GO:0045131,1,0.992825522703749,0,1,pre-mRNA branch point binding,MF,
11877,GO:0045132,1,0.623963044959602,0,70,meiotic chromosome segregation,BP,
11878,GO:0045134,1,0.973320928943946,0,4,uridine-diphosphatase activity,MF,
11879,GO:0045136,1,0.944569856998081,0,9,development of secondary sexual characteristics,BP,
11880,GO:0045137,1,0.275174751259965,0,188,development of primary sexual characteristics,BP,
11881,GO:0045141,1,0.928846904435596,0,10,meiotic telomere clustering,BP,
11882,GO:0045142,1,0.984836356297945,0,2,triplex DNA binding,MF,
11883,GO:0045143,1,0.734226985082037,0,46,homologous chromosome segregation,BP,
11884,GO:0045144,1,0.958580682160497,0,7,meiotic sister chromatid segregation,BP,
11885,GO:0045145,1,0.985768675878022,0,2,single-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
11886,GO:0045153,1,0.99643863561483,0,1,electron transporter, transferring electrons within CoQH2-cytochrome c reductase complex activity,MF,
11887,GO:0045155,1,0.988297022995788,0,2,electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity,MF,
11888,GO:0045159,1,0.967661651578775,0,6,myosin II binding,MF,
11890,GO:0045162,1,0.943691201431343,0,7,clustering of voltage-gated sodium channels,BP,
11893,GO:0045167,1,0.995312711829602,0,1,asymmetric protein localization involved in cell fate determination,BP,
11894,GO:0045168,1,0.988541191981748,0,2,cell-cell signaling involved in cell fate commitment,BP,
11896,GO:0045174,1,0.99317033719142,0,2,glutathione dehydrogenase (ascorbate) activity,MF,
11897,GO:0045176,1,0.917270992813675,0,11,apical protein localization,BP,
11900,GO:0045179,1,0.958797891795873,0,7,apical cortex,CC,
11901,GO:0045180,1,0.957271224725222,0,5,basal cortex,CC,
11902,GO:0045182,1,0.716925503821458,0,49,translation regulator activity,MF,
11903,GO:0045183,1,0.993058458973322,0,1,translation factor activity, non-nucleic acid binding,MF,
11906,GO:0045186,1,0.990603901727341,0,1,zonula adherens assembly,BP,
11907,GO:0045187,1,0.921902658555785,0,16,regulation of circadian sleep/wake cycle, sleep,BP,
11908,GO:0045188,1,0.961478088502818,0,7,regulation of circadian sleep/wake cycle, non-REM sleep,BP,
11909,GO:0045190,1,0.768076723320508,0,39,isotype switching,BP,
11910,GO:0045191,1,0.832790693179196,0,27,regulation of isotype switching,BP,
11911,GO:0045196,1,0.977621479983896,0,3,establishment or maintenance of neuroblast polarity,BP,
11912,GO:0045197,1,0.747314147917799,0,42,establishment or maintenance of epithelial cell apical/basal polarity,BP,
11913,GO:0045198,1,0.913645309377871,0,13,establishment of epithelial cell apical/basal polarity,BP,
11914,GO:0045199,1,0.925857041700544,0,12,maintenance of epithelial cell apical/basal polarity,BP,
11915,GO:0045200,1,0.977621479983896,0,3,establishment of neuroblast polarity,BP,
11917,GO:0045204,1,0.97714373449145,0,3,MAPK export from nucleus,BP,
11918,GO:0045208,1,0.992528333210422,0,1,MAPK phosphatase export from nucleus,BP,
11919,GO:0045209,1,0.992528333210422,0,1,MAPK phosphatase export from nucleus, leptomycin B sensitive,BP,
11920,GO:0045210,1,0.983507446099205,0,2,FasL biosynthetic process,BP,
11922,GO:0045212,1,0.993388069720249,0,1,neurotransmitter receptor biosynthetic process,BP,
11923,GO:0045213,1,0.98282714680258,0,3,neurotransmitter receptor metabolic process,BP,
11924,GO:0045214,1,0.725069543482443,0,43,sarcomere organization,BP,
11926,GO:0045217,1,0.93690722845057,0,10,cell-cell junction maintenance,BP,
11927,GO:0045218,1,0.978008819332625,0,3,zonula adherens maintenance,BP,
11928,GO:0045219,1,0.991861898853826,0,1,regulation of FasL biosynthetic process,BP,
11929,GO:0045221,1,0.991861898853826,0,1,negative regulation of FasL biosynthetic process,BP,
11930,GO:0045222,1,0.996553211111413,0,1,CD4 biosynthetic process,BP,
11931,GO:0045223,1,0.996553211111413,0,1,regulation of CD4 biosynthetic process,BP,
11932,GO:0045225,1,0.996553211111413,0,1,negative regulation of CD4 biosynthetic process,BP,
11933,GO:0045226,1,0.980385549458221,0,3,extracellular polysaccharide biosynthetic process,BP,
11934,GO:0045229,1,0.986314149348236,0,2,external encapsulating structure organization,BP,
11935,GO:0045234,1,0.995141911105427,0,1,protein palmitoleylation,BP,
11936,GO:0045236,1,0.928324255357761,0,16,CXCR chemokine receptor binding,MF,
11937,GO:0045239,1,0.915228185488057,0,13,tricarboxylic acid cycle enzyme complex,CC,
11938,GO:0045240,1,0.925428812046196,0,11,dihydrolipoyl dehydrogenase complex,CC,
11939,GO:0045244,1,0.993828341714919,0,1,succinate-CoA ligase complex (GDP-forming),CC,
11940,GO:0045251,1,0.993832580343169,0,1,electron transfer flavoprotein complex,CC,
11941,GO:0045252,1,0.952315693753103,0,7,oxoglutarate dehydrogenase complex,CC,
11942,GO:0045254,1,0.953678196752564,0,7,pyruvate dehydrogenase complex,CC,
11943,GO:0045257,1,0.979732084600258,0,4,succinate dehydrogenase complex (ubiquinone),CC,
11944,GO:0045259,1,0.990240118796901,0,2,proton-transporting ATP synthase complex,CC,
11945,GO:0045263,1,0.996037211883949,0,1,proton-transporting ATP synthase complex, coupling factor F(o),CC,
11946,GO:0045271,1,0.86478980049352,0,43,respiratory chain complex I,CC,
11947,GO:0045272,1,0.986980524121825,0,3,plasma membrane respiratory chain complex I,CC,
11948,GO:0045273,1,0.979732084600258,0,4,respiratory chain complex II,CC,
11949,GO:0045274,1,0.993742481693133,0,1,plasma membrane respiratory chain complex II,CC,
11950,GO:0045275,1,0.949036463383635,0,11,respiratory chain complex III,CC,
11951,GO:0045277,1,0.963561692239001,0,14,respiratory chain complex IV,CC,
11952,GO:0045281,1,0.979732084600258,0,4,succinate dehydrogenase complex,CC,
11953,GO:0045282,1,0.993742481693133,0,1,plasma membrane succinate dehydrogenase complex,CC,
11954,GO:0045283,1,0.979732084600258,0,4,fumarate reductase complex,CC,
11955,GO:0045292,1,0.897298855950271,0,17,mRNA cis splicing, via spliceosome,BP,
11956,GO:0045293,1,0.984467725801226,0,3,mRNA editing complex,CC,
11957,GO:0045294,1,0.918030052890534,0,11,alpha-catenin binding,MF,
11958,GO:0045295,1,0.90684673884823,0,11,gamma-catenin binding,MF,
11960,GO:0045297,1,0.994033230959954,0,1,post-mating behavior,BP,
11961,GO:0045298,1,0.965263088349205,0,5,tubulin complex,CC,
11962,GO:0045309,1,0.725964026476671,0,44,protein phosphorylated amino acid binding,MF,
11964,GO:0045322,1,0.978542086400764,0,3,unmethylated CpG binding,MF,
11965,GO:0045323,1,0.980419027428615,0,3,interleukin-1 receptor complex,CC,
11966,GO:0045324,1,0.93841002284105,0,11,late endosome to vacuole transport,BP,
11967,GO:0045329,1,0.968720198378188,0,5,carnitine biosynthetic process,BP,
11972,GO:0045337,1,0.975346802448174,0,4,farnesyl diphosphate biosynthetic process,BP,
11973,GO:0045338,1,0.969866097997465,0,5,farnesyl diphosphate metabolic process,BP,
11974,GO:0045340,1,0.997032233810024,0,1,mercury ion binding,MF,
11975,GO:0045341,1,0.961885085458426,0,5,MHC class I biosynthetic process,BP,
11976,GO:0045342,1,0.936201177984147,0,11,MHC class II biosynthetic process,BP,
11977,GO:0045343,1,0.961885085458426,0,5,regulation of MHC class I biosynthetic process,BP,
11978,GO:0045345,1,0.961885085458426,0,5,positive regulation of MHC class I biosynthetic process,BP,
11979,GO:0045346,1,0.943289214694701,0,10,regulation of MHC class II biosynthetic process,BP,
11980,GO:0045347,1,0.973415250706002,0,5,negative regulation of MHC class II biosynthetic process,BP,
11981,GO:0045348,1,0.964703902879374,0,6,positive regulation of MHC class II biosynthetic process,BP,
11982,GO:0045349,1,0.961783218148151,0,6,interferon-alpha biosynthetic process,BP,
11983,GO:0045350,1,0.940548793218586,0,9,interferon-beta biosynthetic process,BP,
11984,GO:0045351,1,0.931344792673022,0,11,type I interferon biosynthetic process,BP,
11985,GO:0045352,1,0.995151319772094,0,1,interleukin-1 Type I receptor antagonist activity,MF,
11986,GO:0045353,1,0.995151319772094,0,1,interleukin-1 Type II receptor antagonist activity,MF,
11987,GO:0045354,1,0.961783218148151,0,6,regulation of interferon-alpha biosynthetic process,BP,
11988,GO:0045355,1,0.991366027416377,0,2,negative regulation of interferon-alpha biosynthetic process,BP,
11989,GO:0045356,1,0.970162100994358,0,4,positive regulation of interferon-alpha biosynthetic process,BP,
11990,GO:0045357,1,0.940548793218586,0,9,regulation of interferon-beta biosynthetic process,BP,
11991,GO:0045358,1,0.991395723847533,0,2,negative regulation of interferon-beta biosynthetic process,BP,
11992,GO:0045359,1,0.948716093933301,0,7,positive regulation of interferon-beta biosynthetic process,BP,
11993,GO:0045360,1,0.987056407850184,0,3,regulation of interleukin-1 biosynthetic process,BP,
11994,GO:0045362,1,0.987056407850184,0,3,positive regulation of interleukin-1 biosynthetic process,BP,
11995,GO:0045366,1,0.991942183771409,0,1,regulation of interleukin-13 biosynthetic process,BP,
11996,GO:0045368,1,0.991942183771409,0,1,positive regulation of interleukin-13 biosynthetic process,BP,
11997,GO:0045381,1,0.992638813066294,0,1,regulation of interleukin-18 biosynthetic process,BP,
11998,GO:0045399,1,0.992101884900028,0,1,regulation of interleukin-3 biosynthetic process,BP,
11999,GO:0045401,1,0.992101884900028,0,1,positive regulation of interleukin-3 biosynthetic process,BP,
12000,GO:0045402,1,0.977900718951339,0,3,regulation of interleukin-4 biosynthetic process,BP,
12001,GO:0045403,1,0.992635692460644,0,1,negative regulation of interleukin-4 biosynthetic process,BP,
12002,GO:0045404,1,0.985156796786678,0,2,positive regulation of interleukin-4 biosynthetic process,BP,
12003,GO:0045408,1,0.921992227998067,0,13,regulation of interleukin-6 biosynthetic process,BP,
12004,GO:0045409,1,0.975825776724198,0,4,negative regulation of interleukin-6 biosynthetic process,BP,
12005,GO:0045410,1,0.954637361510276,0,7,positive regulation of interleukin-6 biosynthetic process,BP,
12006,GO:0045414,1,0.944534196052406,0,9,regulation of interleukin-8 biosynthetic process,BP,
12007,GO:0045415,1,0.978857660068638,0,4,negative regulation of interleukin-8 biosynthetic process,BP,
12008,GO:0045416,1,0.962100135632974,0,6,positive regulation of interleukin-8 biosynthetic process,BP,
12009,GO:0045423,1,0.985253581487384,0,2,regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
12010,GO:0045425,1,0.985253581487384,0,2,positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process,BP,
12011,GO:0045428,1,0.734803578827783,0,47,regulation of nitric oxide biosynthetic process,BP,
12012,GO:0045429,1,0.793191963372288,0,35,positive regulation of nitric oxide biosynthetic process,BP,
12013,GO:0045444,1,0.268796328542184,0,193,fat cell differentiation,BP,
12014,GO:0045445,1,0.606091271246959,0,76,myoblast differentiation,BP,
12015,GO:0045446,1,0.524304216646016,0,90,endothelial cell differentiation,BP,
12016,GO:0045448,1,0.974580384262854,0,4,mitotic cell cycle, embryonic,BP,
12019,GO:0045471,1,0.483891652451671,0,116,response to ethanol,BP,
12020,GO:0045472,1,0.934088800227988,0,10,response to ether,BP,
12021,GO:0045475,1,0.925009950260643,0,10,locomotor rhythm,BP,
12022,GO:0045485,1,0.99237484420226,0,1,omega-6 fatty acid desaturase activity,MF,
12024,GO:0045495,1,0.908482680651149,0,14,pole plasm,CC,
12025,GO:0045499,1,0.852466306405363,0,21,chemorepellent activity,MF,
12026,GO:0045503,1,0.785469401887602,0,24,dynein light chain binding,MF,
12027,GO:0045504,1,0.909339491957408,0,14,dynein heavy chain binding,MF,
12028,GO:0045505,1,0.773167239604063,0,28,dynein intermediate chain binding,MF,
12029,GO:0045509,1,0.985340838662023,0,2,interleukin-27 receptor activity,MF,
12030,GO:0045513,1,0.995939249581314,0,1,interleukin-27 binding,MF,
12031,GO:0045519,1,0.996805844367504,0,1,interleukin-23 receptor binding,MF,
12032,GO:0045523,1,0.993423649275404,0,2,interleukin-27 receptor binding,MF,
12033,GO:0045540,1,0.751062325858518,0,41,regulation of cholesterol biosynthetic process,BP,
12034,GO:0045541,1,0.973983119168808,0,5,negative regulation of cholesterol biosynthetic process,BP,
12035,GO:0045542,1,0.963570471952552,0,5,positive regulation of cholesterol biosynthetic process,BP,
12037,GO:0045550,1,0.991995103233853,0,2,geranylgeranyl reductase activity,MF,
12038,GO:0045553,1,0.992785626761858,0,1,TRAIL biosynthetic process,BP,
12039,GO:0045554,1,0.992785626761858,0,1,regulation of TRAIL biosynthetic process,BP,
12040,GO:0045556,1,0.992785626761858,0,1,positive regulation of TRAIL biosynthetic process,BP,
12041,GO:0045569,1,0.97647588868707,0,4,TRAIL binding,MF,
12042,GO:0045575,1,0.986858737985371,0,2,basophil activation,BP,
12043,GO:0045576,1,0.723556139140081,0,52,mast cell activation,BP,
12044,GO:0045577,1,0.835052826627291,0,27,regulation of B cell differentiation,BP,
12045,GO:0045578,1,0.97153953993176,0,5,negative regulation of B cell differentiation,BP,
12046,GO:0045579,1,0.919708905773033,0,13,positive regulation of B cell differentiation,BP,
12047,GO:0045580,1,0.480869543288507,0,112,regulation of T cell differentiation,BP,
12048,GO:0045581,1,0.827358517838901,0,28,negative regulation of T cell differentiation,BP,
12049,GO:0045582,1,0.667133434067667,0,64,positive regulation of T cell differentiation,BP,
12050,GO:0045583,1,0.987982506761412,0,2,regulation of cytotoxic T cell differentiation,BP,
12051,GO:0045585,1,0.987982506761412,0,2,positive regulation of cytotoxic T cell differentiation,BP,
12052,GO:0045586,1,0.969462841605919,0,4,regulation of gamma-delta T cell differentiation,BP,
12053,GO:0045588,1,0.976827844213696,0,3,positive regulation of gamma-delta T cell differentiation,BP,
12054,GO:0045589,1,0.851891987480209,0,24,regulation of regulatory T cell differentiation,BP,
12055,GO:0045590,1,0.98003027217042,0,3,negative regulation of regulatory T cell differentiation,BP,
12056,GO:0045591,1,0.943520335492483,0,10,positive regulation of regulatory T cell differentiation,BP,
12060,GO:0045598,1,0.467902634041753,0,111,regulation of fat cell differentiation,BP,
12061,GO:0045599,1,0.740621532965481,0,43,negative regulation of fat cell differentiation,BP,
12062,GO:0045600,1,0.697869852339906,0,54,positive regulation of fat cell differentiation,BP,
12063,GO:0045601,1,0.808180356233639,0,30,regulation of endothelial cell differentiation,BP,
12064,GO:0045602,1,0.94073258374279,0,8,negative regulation of endothelial cell differentiation,BP,
12065,GO:0045603,1,0.901089015683383,0,15,positive regulation of endothelial cell differentiation,BP,
12066,GO:0045604,1,0.722708372029232,0,48,regulation of epidermal cell differentiation,BP,
12067,GO:0045605,1,0.943340249640126,0,9,negative regulation of epidermal cell differentiation,BP,
12068,GO:0045606,1,0.871984172641783,0,20,positive regulation of epidermal cell differentiation,BP,
12069,GO:0045607,1,0.954806871484361,0,7,regulation of inner ear auditory receptor cell differentiation,BP,
12070,GO:0045608,1,0.978203652182093,0,3,negative regulation of inner ear auditory receptor cell differentiation,BP,
12071,GO:0045616,1,0.801766227918791,0,31,regulation of keratinocyte differentiation,BP,
12072,GO:0045617,1,0.974370735148141,0,4,negative regulation of keratinocyte differentiation,BP,
12073,GO:0045618,1,0.90456749569308,0,14,positive regulation of keratinocyte differentiation,BP,
12074,GO:0045619,1,0.409366981683861,0,137,regulation of lymphocyte differentiation,BP,
12075,GO:0045620,1,0.797118398623542,0,35,negative regulation of lymphocyte differentiation,BP,
12076,GO:0045621,1,0.621624034381403,0,75,positive regulation of lymphocyte differentiation,BP,
12077,GO:0045622,1,0.845472695643902,0,26,regulation of T-helper cell differentiation,BP,
12078,GO:0045623,1,0.910761997511714,0,13,negative regulation of T-helper cell differentiation,BP,
12079,GO:0045624,1,0.909861921089941,0,16,positive regulation of T-helper cell differentiation,BP,
12080,GO:0045625,1,0.942854163577804,0,10,regulation of T-helper 1 cell differentiation,BP,
12081,GO:0045626,1,0.978322246238396,0,3,negative regulation of T-helper 1 cell differentiation,BP,
12082,GO:0045627,1,0.966849300123622,0,6,positive regulation of T-helper 1 cell differentiation,BP,
12083,GO:0045628,1,0.932452239386598,0,11,regulation of T-helper 2 cell differentiation,BP,
12084,GO:0045629,1,0.975136317880014,0,4,negative regulation of T-helper 2 cell differentiation,BP,
12085,GO:0045630,1,0.956238357253047,0,7,positive regulation of T-helper 2 cell differentiation,BP,
12086,GO:0045631,1,0.954806871484361,0,7,regulation of mechanoreceptor differentiation,BP,
12087,GO:0045632,1,0.974522836582114,0,4,negative regulation of mechanoreceptor differentiation,BP,
12088,GO:0045634,1,0.94741544372499,0,7,regulation of melanocyte differentiation,BP,
12089,GO:0045636,1,0.957126573928838,0,5,positive regulation of melanocyte differentiation,BP,
12093,GO:0045643,1,0.992518019714365,0,1,regulation of eosinophil differentiation,BP,
12094,GO:0045645,1,0.992518019714365,0,1,positive regulation of eosinophil differentiation,BP,
12095,GO:0045646,1,0.751079179461878,0,42,regulation of erythrocyte differentiation,BP,
12096,GO:0045647,1,0.9482084434442,0,8,negative regulation of erythrocyte differentiation,BP,
12097,GO:0045648,1,0.829710153380643,0,27,positive regulation of erythrocyte differentiation,BP,
12098,GO:0045649,1,0.890620633103264,0,19,regulation of macrophage differentiation,BP,
12099,GO:0045650,1,0.967470063564813,0,6,negative regulation of macrophage differentiation,BP,
12100,GO:0045651,1,0.920591827094338,0,13,positive regulation of macrophage differentiation,BP,
12102,GO:0045653,1,0.975845743234706,0,8,negative regulation of megakaryocyte differentiation,BP,
12104,GO:0045655,1,0.895165267517883,0,16,regulation of monocyte differentiation,BP,
12105,GO:0045656,1,0.955133409318639,0,6,negative regulation of monocyte differentiation,BP,
12106,GO:0045657,1,0.949345588452376,0,8,positive regulation of monocyte differentiation,BP,
12107,GO:0045658,1,0.979506477819509,0,3,regulation of neutrophil differentiation,BP,
12108,GO:0045659,1,0.984771615634005,0,2,negative regulation of neutrophil differentiation,BP,
12109,GO:0045660,1,0.994654261155144,0,1,positive regulation of neutrophil differentiation,BP,
12110,GO:0045661,1,0.741001413717284,0,46,regulation of myoblast differentiation,BP,
12111,GO:0045662,1,0.872282872962568,0,23,negative regulation of myoblast differentiation,BP,
12112,GO:0045663,1,0.886900257108774,0,17,positive regulation of myoblast differentiation,BP,
12117,GO:0045668,1,0.77612198572211,0,38,negative regulation of osteoblast differentiation,BP,
12121,GO:0045672,1,0.891832097370259,0,17,positive regulation of osteoclast differentiation,BP,
12122,GO:0045682,1,0.634574302238256,0,68,regulation of epidermis development,BP,
12123,GO:0045683,1,0.921750063660776,0,12,negative regulation of epidermis development,BP,
12124,GO:0045684,1,0.816296348328213,0,32,positive regulation of epidermis development,BP,
12126,GO:0045686,1,0.872423371267908,0,21,negative regulation of glial cell differentiation,BP,
12128,GO:0045703,1,0.996406077437465,0,1,ketoreductase activity,MF,
12129,GO:0045713,1,0.944860268075667,0,8,low-density lipoprotein particle receptor biosynthetic process,BP,
12130,GO:0045714,1,0.94963652060483,0,7,regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
12131,GO:0045715,1,0.983180314744529,0,2,negative regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
12132,GO:0045716,1,0.981819827657544,0,3,positive regulation of low-density lipoprotein particle receptor biosynthetic process,BP,
12133,GO:0045717,1,0.917627694416593,0,13,negative regulation of fatty acid biosynthetic process,BP,
12134,GO:0045719,1,0.961264189921692,0,5,negative regulation of glycogen biosynthetic process,BP,
12135,GO:0045720,1,0.98788770993153,0,2,negative regulation of integrin biosynthetic process,BP,
12136,GO:0045721,1,0.940476589710072,0,9,negative regulation of gluconeogenesis,BP,
12137,GO:0045722,1,0.932839737043588,0,9,positive regulation of gluconeogenesis,BP,
12138,GO:0045723,1,0.926040433173179,0,13,positive regulation of fatty acid biosynthetic process,BP,
12139,GO:0045724,1,0.877676296017033,0,18,positive regulation of cilium assembly,BP,
12140,GO:0045725,1,0.897015985805867,0,13,positive regulation of glycogen biosynthetic process,BP,
12141,GO:0045726,1,0.98484061113501,0,2,positive regulation of integrin biosynthetic process,BP,
12142,GO:0045727,1,0.487987061782287,0,112,positive regulation of translation,BP,
12143,GO:0045728,1,0.994264454123425,0,1,respiratory burst after phagocytosis,BP,
12144,GO:0045730,1,0.876190969297013,0,23,respiratory burst,BP,
12146,GO:0045736,1,0.816782203405465,0,30,negative regulation of cyclin-dependent protein serine/threonine kinase activity,BP,
12148,GO:0045738,1,0.854415709858457,0,22,negative regulation of DNA repair,BP,
12151,GO:0045741,1,0.933288004609195,0,10,positive regulation of epidermal growth factor-activated receptor activity,BP,
12152,GO:0045742,1,0.807299519616758,0,32,positive regulation of epidermal growth factor receptor signaling pathway,BP,
12153,GO:0045743,1,0.963544696582486,0,5,positive regulation of fibroblast growth factor receptor signaling pathway,BP,
12154,GO:0045744,1,0.775105007391439,0,40,negative regulation of G-protein coupled receptor protein signaling pathway,BP,
12157,GO:0045747,1,0.7345889329261,0,44,positive regulation of Notch signaling pathway,BP,
12158,GO:0045751,1,0.992638813066294,0,1,negative regulation of Toll signaling pathway,BP,
12159,GO:0045759,1,0.962694795593939,0,6,negative regulation of action potential,BP,
12160,GO:0045760,1,0.92836947394102,0,10,positive regulation of action potential,BP,
12161,GO:0045761,1,0.822971465621212,0,29,regulation of adenylate cyclase activity,BP,
12162,GO:0045762,1,0.96696847739811,0,5,positive regulation of adenylate cyclase activity,BP,
12163,GO:0045763,1,0.982001931425436,0,2,negative regulation of cellular amino acid metabolic process,BP,
12164,GO:0045764,1,0.985403308787573,0,3,positive regulation of cellular amino acid metabolic process,BP,
12166,GO:0045766,1,0.374481967160447,0,144,positive regulation of angiogenesis,BP,
12167,GO:0045769,1,0.988661809048349,0,1,negative regulation of asymmetric cell division,BP,
12168,GO:0045773,1,0.745778848601446,0,37,positive regulation of axon extension,BP,
12170,GO:0045777,1,0.827681137078094,0,31,positive regulation of blood pressure,BP,
12172,GO:0045779,1,0.946317241021796,0,9,negative regulation of bone resorption,BP,
12177,GO:0045792,1,0.938773493888594,0,9,negative regulation of cell size,BP,
12178,GO:0045793,1,0.932878133878029,0,10,positive regulation of cell size,BP,
12179,GO:0045794,1,0.960195936818537,0,5,negative regulation of cell volume,BP,
12180,GO:0045795,1,0.990979276485501,0,1,positive regulation of cell volume,BP,
12181,GO:0045796,1,0.993229158668432,0,1,negative regulation of intestinal cholesterol absorption,BP,
12182,GO:0045799,1,0.977074623399265,0,3,positive regulation of chromatin assembly or disassembly,BP,
12184,GO:0045807,1,0.441090222143225,0,123,positive regulation of endocytosis,BP,
12185,GO:0045813,1,0.995101869933184,0,1,positive regulation of Wnt signaling pathway, calcium modulating pathway,BP,
12186,GO:0045814,1,0.563993705048962,0,90,negative regulation of gene expression, epigenetic,BP,
12187,GO:0045815,1,0.70255995990756,0,57,positive regulation of gene expression, epigenetic,BP,
12188,GO:0045819,1,0.992482298880486,0,1,positive regulation of glycogen catabolic process,BP,
12189,GO:0045820,1,0.933722883332218,0,10,negative regulation of glycolytic process,BP,
12190,GO:0045821,1,0.883828647370465,0,16,positive regulation of glycolytic process,BP,
12191,GO:0045822,1,0.880039041023572,0,19,negative regulation of heart contraction,BP,
12192,GO:0045823,1,0.804368878549356,0,34,positive regulation of heart contraction,BP,
12193,GO:0045824,1,0.773161953347329,0,39,negative regulation of innate immune response,BP,
12194,GO:0045827,1,0.996406077437465,0,1,negative regulation of isoprenoid metabolic process,BP,
12195,GO:0045829,1,0.973516318371504,0,4,negative regulation of isotype switching,BP,
12196,GO:0045830,1,0.879720042299502,0,19,positive regulation of isotype switching,BP,
12199,GO:0045835,1,0.941033225111967,0,9,negative regulation of meiotic nuclear division,BP,
12200,GO:0045836,1,0.930237575069947,0,11,positive regulation of meiotic nuclear division,BP,
12201,GO:0045837,1,0.951442624934959,0,9,negative regulation of membrane potential,BP,
12202,GO:0045838,1,0.933304904616444,0,11,positive regulation of membrane potential,BP,
12203,GO:0045839,1,0.737005965837674,0,46,negative regulation of mitotic nuclear division,BP,
12204,GO:0045840,1,0.730390284169791,0,45,positive regulation of mitotic nuclear division,BP,
12205,GO:0045841,1,0.803431334388319,0,32,negative regulation of mitotic metaphase/anaphase transition,BP,
12206,GO:0045842,1,0.948645602448063,0,8,positive regulation of mitotic metaphase/anaphase transition,BP,
12209,GO:0045848,1,0.994287414484928,0,1,positive regulation of nitrogen utilization,BP,
12210,GO:0045851,1,0.753124438785645,0,48,pH reduction,BP,
12211,GO:0045852,1,0.972322818614544,0,4,pH elevation,BP,
12216,GO:0045869,1,0.947914882781667,0,9,negative regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
12217,GO:0045870,1,0.991692635295332,0,1,positive regulation of single stranded viral RNA replication via double stranded DNA intermediate,BP,
12218,GO:0045872,1,0.99470393927708,0,1,positive regulation of rhodopsin gene expression,BP,
12219,GO:0045875,1,0.966560311055701,0,4,negative regulation of sister chromatid cohesion,BP,
12220,GO:0045876,1,0.944997674918406,0,8,positive regulation of sister chromatid cohesion,BP,
12221,GO:0045879,1,0.807010874520657,0,29,negative regulation of smoothened signaling pathway,BP,
12222,GO:0045880,1,0.810832894512633,0,29,positive regulation of smoothened signaling pathway,BP,
12223,GO:0045887,1,0.990696101146959,0,1,positive regulation of synaptic growth at neuromuscular junction,BP,
12226,GO:0045898,1,0.916205497977806,0,14,regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
12227,GO:0045899,1,0.936170222071938,0,11,positive regulation of RNA polymerase II transcriptional preinitiation complex assembly,BP,
12228,GO:0045900,1,0.974561520792147,0,4,negative regulation of translational elongation,BP,
12229,GO:0045901,1,0.97360526664592,0,4,positive regulation of translational elongation,BP,
12230,GO:0045903,1,0.98849961809118,0,3,positive regulation of translational fidelity,BP,
12231,GO:0045905,1,0.980643179484519,0,3,positive regulation of translational termination,BP,
12232,GO:0045906,1,0.944206088728871,0,7,negative regulation of vasoconstriction,BP,
12234,GO:0045910,1,0.844194263245297,0,23,negative regulation of DNA recombination,BP,
12235,GO:0045911,1,0.853565324633605,0,23,positive regulation of DNA recombination,BP,
12236,GO:0045912,1,0.799976028967172,0,32,negative regulation of carbohydrate metabolic process,BP,
12237,GO:0045913,1,0.646522249935097,0,59,positive regulation of carbohydrate metabolic process,BP,
12238,GO:0045914,1,0.979076456171008,0,3,negative regulation of catecholamine metabolic process,BP,
12239,GO:0045915,1,0.964513227257127,0,6,positive regulation of catecholamine metabolic process,BP,
12240,GO:0045916,1,0.955094986754316,0,6,negative regulation of complement activation,BP,
12241,GO:0045917,1,0.979738789173436,0,3,positive regulation of complement activation,BP,
12242,GO:0045918,1,0.987172964233736,0,3,negative regulation of cytolysis,BP,
12243,GO:0045919,1,0.963934009194835,0,7,positive regulation of cytolysis,BP,
12244,GO:0045920,1,0.835907102398362,0,27,negative regulation of exocytosis,BP,
12245,GO:0045921,1,0.603854812663395,0,76,positive regulation of exocytosis,BP,
12246,GO:0045922,1,0.87966625869464,0,19,negative regulation of fatty acid metabolic process,BP,
12247,GO:0045923,1,0.827766455266995,0,28,positive regulation of fatty acid metabolic process,BP,
12248,GO:0045924,1,0.966424792609554,0,5,regulation of female receptivity,BP,
12249,GO:0045925,1,0.993694199101831,0,1,positive regulation of female receptivity,BP,
12253,GO:0045931,1,0.408286537588575,0,129,positive regulation of mitotic cell cycle,BP,
12254,GO:0045932,1,0.88037220363637,0,19,negative regulation of muscle contraction,BP,
12255,GO:0045933,1,0.760538252684128,0,44,positive regulation of muscle contraction,BP,
12260,GO:0045938,1,0.974347228726451,0,6,positive regulation of circadian sleep/wake cycle, sleep,BP,
12261,GO:0045939,1,0.872119434718868,0,22,negative regulation of steroid metabolic process,BP,
12262,GO:0045940,1,0.889090748109115,0,19,positive regulation of steroid metabolic process,BP,
12263,GO:0045943,1,0.85984191861262,0,21,positive regulation of transcription by RNA polymerase I,BP,
12265,GO:0045945,1,0.919478093308352,0,11,positive regulation of transcription by RNA polymerase III,BP,
12266,GO:0045947,1,0.884328776077342,0,19,negative regulation of translational initiation,BP,
12267,GO:0045948,1,0.836498891872832,0,26,positive regulation of translational initiation,BP,
12268,GO:0045950,1,0.980704063718993,0,3,negative regulation of mitotic recombination,BP,
12269,GO:0045953,1,0.943291237100457,0,10,negative regulation of natural killer cell mediated cytotoxicity,BP,
12270,GO:0045954,1,0.888248540391173,0,19,positive regulation of natural killer cell mediated cytotoxicity,BP,
12271,GO:0045955,1,0.934956595551907,0,9,negative regulation of calcium ion-dependent exocytosis,BP,
12272,GO:0045956,1,0.857519734211863,0,22,positive regulation of calcium ion-dependent exocytosis,BP,
12273,GO:0045957,1,0.989540988123595,0,1,negative regulation of complement activation, alternative pathway,BP,
12274,GO:0045959,1,0.983681113496367,0,2,negative regulation of complement activation, classical pathway,BP,
12275,GO:0045963,1,0.979076456171008,0,3,negative regulation of dopamine metabolic process,BP,
12276,GO:0045964,1,0.964513227257127,0,6,positive regulation of dopamine metabolic process,BP,
12277,GO:0045967,1,0.978033783378364,0,2,negative regulation of growth rate,BP,
12278,GO:0045974,1,0.90535869817833,0,13,regulation of translation, ncRNA-mediated,BP,
12279,GO:0045976,1,0.985102730722224,0,2,negative regulation of mitotic cell cycle, embryonic,BP,
12280,GO:0045977,1,0.995907955243566,0,1,positive regulation of mitotic cell cycle, embryonic,BP,
12281,GO:0045980,1,0.740506006319232,0,46,negative regulation of nucleotide metabolic process,BP,
12283,GO:0045986,1,0.923705772816183,0,12,negative regulation of smooth muscle contraction,BP,
12284,GO:0045987,1,0.824730109533099,0,30,positive regulation of smooth muscle contraction,BP,
12285,GO:0045988,1,0.949403221458324,0,7,negative regulation of striated muscle contraction,BP,
12286,GO:0045989,1,0.921518650039928,0,14,positive regulation of striated muscle contraction,BP,
12287,GO:0045990,1,0.968165231250603,0,5,carbon catabolite regulation of transcription,BP,
12288,GO:0045991,1,0.968165231250603,0,5,carbon catabolite activation of transcription,BP,
12289,GO:0045992,1,0.840596241834085,0,25,negative regulation of embryonic development,BP,
12290,GO:0045993,1,0.992357436714209,0,1,negative regulation of translational initiation by iron,BP,
12291,GO:0045994,1,0.987274213250081,0,2,positive regulation of translational initiation by iron,BP,
12293,GO:0046005,1,0.99457443246176,0,2,positive regulation of circadian sleep/wake cycle, REM sleep,BP,
12294,GO:0046006,1,0.829952715255563,0,32,regulation of activated T cell proliferation,BP,
12295,GO:0046007,1,0.929545748770418,0,11,negative regulation of activated T cell proliferation,BP,
12296,GO:0046010,1,0.986155324686783,0,3,positive regulation of circadian sleep/wake cycle, non-REM sleep,BP,
12298,GO:0046015,1,0.972504369017122,0,5,regulation of transcription by glucose,BP,
12299,GO:0046016,1,0.9769965140956,0,4,positive regulation of transcription by glucose,BP,
12300,GO:0046030,1,0.920554182857577,0,11,inositol trisphosphate phosphatase activity,MF,
12301,GO:0046031,1,0.510195639397255,0,98,ADP metabolic process,BP,
12302,GO:0046032,1,0.995722281237045,0,1,ADP catabolic process,BP,
12303,GO:0046033,1,0.935666885227876,0,11,AMP metabolic process,BP,
12304,GO:0046034,1,0.255412690801608,0,234,ATP metabolic process,BP,
12305,GO:0046035,1,0.99636257431311,0,1,CMP metabolic process,BP,
12306,GO:0046036,1,0.942592132087875,0,13,CTP metabolic process,BP,
12307,GO:0046037,1,0.86406598806837,0,21,GMP metabolic process,BP,
12308,GO:0046038,1,0.995986077774223,0,1,GMP catabolic process,BP,
12309,GO:0046039,1,0.839121636140454,0,30,GTP metabolic process,BP,
12310,GO:0046040,1,0.91880152428266,0,13,IMP metabolic process,BP,
12311,GO:0046041,1,0.989977814816518,0,2,ITP metabolic process,BP,
12312,GO:0046048,1,0.992877134307693,0,1,UDP metabolic process,BP,
12313,GO:0046049,1,0.941067007782844,0,10,UMP metabolic process,BP,
12314,GO:0046051,1,0.954810898974524,0,10,UTP metabolic process,BP,
12315,GO:0046054,1,0.996911935398822,0,1,dGMP metabolic process,BP,
12316,GO:0046056,1,0.98563285473828,0,2,dADP metabolic process,BP,
12317,GO:0046058,1,0.564363160687033,0,85,cAMP metabolic process,BP,
12318,GO:0046060,1,0.97747943145765,0,5,dATP metabolic process,BP,
12319,GO:0046061,1,0.98592546283543,0,3,dATP catabolic process,BP,
12320,GO:0046065,1,0.996643509555738,0,1,dCTP metabolic process,BP,
12321,GO:0046066,1,0.989991616285717,0,2,dGDP metabolic process,BP,
12323,GO:0046069,1,0.956200401327189,0,6,cGMP catabolic process,BP,
12324,GO:0046070,1,0.981724793769976,0,4,dGTP metabolic process,BP,
12325,GO:0046072,1,0.989444287114099,0,2,dTDP metabolic process,BP,
12326,GO:0046073,1,0.983873247367248,0,3,dTMP metabolic process,BP,
12327,GO:0046075,1,0.981356609166164,0,4,dTTP metabolic process,BP,
12328,GO:0046077,1,0.989444287114099,0,2,dUDP metabolic process,BP,
12329,GO:0046078,1,0.976471084499811,0,5,dUMP metabolic process,BP,
12330,GO:0046079,1,0.995605245989603,0,1,dUMP catabolic process,BP,
12331,GO:0046080,1,0.994936303571462,0,1,dUTP metabolic process,BP,
12332,GO:0046081,1,0.994936303571462,0,1,dUTP catabolic process,BP,
12333,GO:0046083,1,0.988270266267504,0,3,adenine metabolic process,BP,
12334,GO:0046084,1,0.988270266267504,0,3,adenine biosynthetic process,BP,
12335,GO:0046085,1,0.945448431086934,0,9,adenosine metabolic process,BP,
12336,GO:0046086,1,0.987012388052254,0,2,adenosine biosynthetic process,BP,
12337,GO:0046087,1,0.960826257666516,0,8,cytidine metabolic process,BP,
12338,GO:0046090,1,0.99571435540411,0,1,deoxyadenosine metabolic process,BP,
12339,GO:0046092,1,0.992092193807047,0,1,deoxycytidine metabolic process,BP,
12340,GO:0046098,1,0.975612499584087,0,4,guanine metabolic process,BP,
12341,GO:0046099,1,0.99080784512918,0,2,guanine biosynthetic process,BP,
12342,GO:0046100,1,0.974436419525872,0,5,hypoxanthine metabolic process,BP,
12343,GO:0046101,1,0.979529942566417,0,4,hypoxanthine biosynthetic process,BP,
12344,GO:0046102,1,0.982922682023732,0,3,inosine metabolic process,BP,
12345,GO:0046103,1,0.989147587267463,0,2,inosine biosynthetic process,BP,
12346,GO:0046104,1,0.980503261657339,0,3,thymidine metabolic process,BP,
12347,GO:0046108,1,0.98882417305564,0,2,uridine metabolic process,BP,
12348,GO:0046110,1,0.979666411403492,0,3,xanthine metabolic process,BP,
12349,GO:0046111,1,0.99571435540411,0,1,xanthine biosynthetic process,BP,
12350,GO:0046112,1,0.881682259548601,0,19,nucleobase biosynthetic process,BP,
12351,GO:0046113,1,0.957693935431966,0,6,nucleobase catabolic process,BP,
12352,GO:0046116,1,0.985650963504797,0,3,queuosine metabolic process,BP,
12353,GO:0046121,1,0.983786938806249,0,3,deoxyribonucleoside catabolic process,BP,
12354,GO:0046122,1,0.992595089301611,0,2,purine deoxyribonucleoside metabolic process,BP,
12355,GO:0046124,1,0.99571435540411,0,1,purine deoxyribonucleoside catabolic process,BP,
12356,GO:0046125,1,0.980503261657339,0,3,pyrimidine deoxyribonucleoside metabolic process,BP,
12357,GO:0046127,1,0.992707573339815,0,1,pyrimidine deoxyribonucleoside catabolic process,BP,
12358,GO:0046128,1,0.645745777300794,0,70,purine ribonucleoside metabolic process,BP,
12359,GO:0046129,1,0.902990519605326,0,21,purine ribonucleoside biosynthetic process,BP,
12360,GO:0046130,1,0.965550162090553,0,6,purine ribonucleoside catabolic process,BP,
12361,GO:0046131,1,0.852593335335082,0,30,pyrimidine ribonucleoside metabolic process,BP,
12362,GO:0046132,1,0.899824238168256,0,20,pyrimidine ribonucleoside biosynthetic process,BP,
12363,GO:0046133,1,0.949286765390513,0,10,pyrimidine ribonucleoside catabolic process,BP,
12364,GO:0046134,1,0.876136577721201,0,25,pyrimidine nucleoside biosynthetic process,BP,
12365,GO:0046135,1,0.898721615111123,0,20,pyrimidine nucleoside catabolic process,BP,
12366,GO:0046136,1,0.991240869766744,0,2,positive regulation of vitamin metabolic process,BP,
12367,GO:0046137,1,0.965865520391256,0,6,negative regulation of vitamin metabolic process,BP,
12368,GO:0046144,1,0.995570989438816,0,1,D-alanine family amino acid metabolic process,BP,
12369,GO:0046146,1,0.966751845549,0,7,tetrahydrobiopterin metabolic process,BP,
12370,GO:0046148,1,0.727373578654372,0,50,pigment biosynthetic process,BP,
12371,GO:0046149,1,0.984932490499356,0,4,pigment catabolic process,BP,
12372,GO:0046160,1,0.983738355140799,0,2,heme a metabolic process,BP,
12373,GO:0046164,1,0.782688570921913,0,40,alcohol catabolic process,BP,
12374,GO:0046165,1,0.438193425731432,0,126,alcohol biosynthetic process,BP,
12375,GO:0046166,1,0.990290442858034,0,2,glyceraldehyde-3-phosphate biosynthetic process,BP,
12376,GO:0046167,1,0.981542822220199,0,2,glycerol-3-phosphate biosynthetic process,BP,
12377,GO:0046168,1,0.985476177424617,0,2,glycerol-3-phosphate catabolic process,BP,
12378,GO:0046173,1,0.719618870816262,0,52,polyol biosynthetic process,BP,
12379,GO:0046174,1,0.885313066548636,0,17,polyol catabolic process,BP,
12380,GO:0046176,1,0.993058458973322,0,1,aldonic acid catabolic process,BP,
12381,GO:0046177,1,0.993058458973322,0,1,D-gluconate catabolic process,BP,
12382,GO:0046184,1,0.91191017728437,0,13,aldehyde biosynthetic process,BP,
12383,GO:0046185,1,0.946104220399492,0,10,aldehyde catabolic process,BP,
12384,GO:0046189,1,0.795694224370375,0,35,phenol-containing compound biosynthetic process,BP,
12385,GO:0046203,1,0.991856647468126,0,2,spermidine catabolic process,BP,
12386,GO:0046204,1,0.996966891436453,0,1,nor-spermidine metabolic process,BP,
12387,GO:0046208,1,0.980869080820968,0,4,spermine catabolic process,BP,
12389,GO:0046210,1,0.993519092085155,0,1,nitric oxide catabolic process,BP,
12390,GO:0046218,1,0.965174537778612,0,7,indolalkylamine catabolic process,BP,
12391,GO:0046219,1,0.985587299291851,0,3,indolalkylamine biosynthetic process,BP,
12392,GO:0046222,1,0.99312430827893,0,1,aflatoxin metabolic process,BP,
12393,GO:0046223,1,0.99312430827893,0,1,aflatoxin catabolic process,BP,
12394,GO:0046226,1,0.991680968068411,0,2,coumarin catabolic process,BP,
12395,GO:0046247,1,0.992961914196941,0,1,terpene catabolic process,BP,
12396,GO:0046271,1,0.991680968068411,0,2,phenylpropanoid catabolic process,BP,
12397,GO:0046272,1,0.99415291577638,0,1,stilbene catabolic process,BP,
12398,GO:0046292,1,0.9820792634154,0,3,formaldehyde metabolic process,BP,
12399,GO:0046293,1,0.99223202257038,0,1,formaldehyde biosynthetic process,BP,
12400,GO:0046294,1,0.989768551138334,0,2,formaldehyde catabolic process,BP,
12401,GO:0046295,1,0.997032233810024,0,1,glycolate biosynthetic process,BP,
12402,GO:0046296,1,0.995228728217183,0,1,glycolate catabolic process,BP,
12403,GO:0046305,1,0.988750731211835,0,2,alkanesulfonate biosynthetic process,BP,
12404,GO:0046316,1,0.993058458973322,0,1,gluconokinase activity,MF,
12405,GO:0046317,1,0.992060194717323,0,1,regulation of glucosylceramide biosynthetic process,BP,
12406,GO:0046318,1,0.992060194717323,0,1,negative regulation of glucosylceramide biosynthetic process,BP,
12407,GO:0046320,1,0.815410366893843,0,28,regulation of fatty acid oxidation,BP,
12408,GO:0046321,1,0.893954292734392,0,15,positive regulation of fatty acid oxidation,BP,
12409,GO:0046322,1,0.946777036673447,0,8,negative regulation of fatty acid oxidation,BP,
12410,GO:0046323,1,0.613633106049864,0,67,glucose import,BP,
12411,GO:0046324,1,0.671279444946722,0,55,regulation of glucose import,BP,
12412,GO:0046325,1,0.926991880344341,0,12,negative regulation of glucose import,BP,
12413,GO:0046326,1,0.768009401873703,0,35,positive regulation of glucose import,BP,
12414,GO:0046327,1,0.987957491779351,0,2,glycerol biosynthetic process from pyruvate,BP,
12416,GO:0046329,1,0.8117457528376,0,30,negative regulation of JNK cascade,BP,
12417,GO:0046330,1,0.447976024269269,0,116,positive regulation of JNK cascade,BP,
12418,GO:0046331,1,0.988541191981748,0,2,lateral inhibition,BP,
12419,GO:0046332,1,0.566875935458058,0,74,SMAD binding,MF,
12420,GO:0046333,1,0.985901102134398,0,2,octopamine metabolic process,BP,
12421,GO:0046337,1,0.882962389703584,0,18,phosphatidylethanolamine metabolic process,BP,
12422,GO:0046338,1,0.985735199166226,0,2,phosphatidylethanolamine catabolic process,BP,
12423,GO:0046339,1,0.917799409538817,0,12,diacylglycerol metabolic process,BP,
12424,GO:0046340,1,0.977477708803565,0,3,diacylglycerol catabolic process,BP,
12425,GO:0046341,1,0.916784836511459,0,12,CDP-diacylglycerol metabolic process,BP,
12426,GO:0046348,1,0.930309099564261,0,13,amino sugar catabolic process,BP,
12427,GO:0046349,1,0.91916849542029,0,13,amino sugar biosynthetic process,BP,
12428,GO:0046351,1,0.978290757286558,0,4,disaccharide biosynthetic process,BP,
12429,GO:0046355,1,0.992599903835715,0,1,mannan catabolic process,BP,
12430,GO:0046356,1,0.991195523966848,0,2,acetyl-CoA catabolic process,BP,
12431,GO:0046359,1,0.994822455267186,0,1,butyrate catabolic process,BP,
12432,GO:0046360,1,0.994365921264761,0,1,2-oxobutyrate biosynthetic process,BP,
12433,GO:0046361,1,0.994365921264761,0,1,2-oxobutyrate metabolic process,BP,
12434,GO:0046364,1,0.631003888474936,0,76,monosaccharide biosynthetic process,BP,
12435,GO:0046365,1,0.709820267287774,0,56,monosaccharide catabolic process,BP,
12436,GO:0046368,1,0.976794479392451,0,4,GDP-L-fucose metabolic process,BP,
12437,GO:0046370,1,0.9895240394409,0,2,fructose biosynthetic process,BP,
12438,GO:0046373,1,0.986164624597214,0,2,L-arabinose metabolic process,BP,
12439,GO:0046379,1,0.980385549458221,0,3,extracellular polysaccharide metabolic process,BP,
12440,GO:0046380,1,0.99249718464592,0,1,N-acetylneuraminate biosynthetic process,BP,
12441,GO:0046381,1,0.996375636404581,0,1,CMP-N-acetylneuraminate metabolic process,BP,
12442,GO:0046385,1,0.945213261524734,0,11,deoxyribose phosphate biosynthetic process,BP,
12443,GO:0046386,1,0.905673647885949,0,19,deoxyribose phosphate catabolic process,BP,
12445,GO:0046391,1,0.980881291812425,0,3,5-phosphoribose 1-diphosphate metabolic process,BP,
12448,GO:0046398,1,0.970989159889276,0,4,UDP-glucuronate metabolic process,BP,
12449,GO:0046403,1,0.995280108756433,0,1,polynucleotide 3'-phosphatase activity,MF,
12450,GO:0046404,1,0.98163392972448,0,3,ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity,MF,
12451,GO:0046415,1,0.955528614407132,0,7,urate metabolic process,BP,
12452,GO:0046416,1,0.98475209295017,0,3,D-amino acid metabolic process,BP,
12454,GO:0046426,1,0.734961951341324,0,45,negative regulation of JAK-STAT cascade,BP,
12457,GO:0046436,1,0.995570989438816,0,1,D-alanine metabolic process,BP,
12458,GO:0046437,1,0.993575240739539,0,1,D-amino acid biosynthetic process,BP,
12459,GO:0046439,1,0.956417246966215,0,7,L-cysteine metabolic process,BP,
12460,GO:0046440,1,0.972661429009886,0,4,L-lysine metabolic process,BP,
12461,GO:0046443,1,0.994700388265012,0,1,FAD metabolic process,BP,
12462,GO:0046444,1,0.993174814481327,0,1,FMN metabolic process,BP,
12463,GO:0046448,1,0.993646635265403,0,1,tropane alkaloid metabolic process,BP,
12464,GO:0046449,1,0.968953961337427,0,4,creatinine metabolic process,BP,
12465,GO:0046452,1,0.983711004641833,0,3,dihydrofolate metabolic process,BP,
12466,GO:0046456,1,0.812656752411156,0,38,icosanoid biosynthetic process,BP,
12467,GO:0046457,1,0.889110799598378,0,22,prostanoid biosynthetic process,BP,
12468,GO:0046459,1,0.907937556448092,0,16,short-chain fatty acid metabolic process,BP,
12469,GO:0046460,1,0.814516588668612,0,30,neutral lipid biosynthetic process,BP,
12470,GO:0046461,1,0.830315716618707,0,31,neutral lipid catabolic process,BP,
12471,GO:0046462,1,0.988243101149474,0,2,monoacylglycerol metabolic process,BP,
12472,GO:0046463,1,0.814516588668612,0,30,acylglycerol biosynthetic process,BP,
12473,GO:0046464,1,0.830315716618707,0,31,acylglycerol catabolic process,BP,
12474,GO:0046465,1,0.9568349684083,0,7,dolichyl diphosphate metabolic process,BP,
12475,GO:0046466,1,0.85952481175959,0,25,membrane lipid catabolic process,BP,
12477,GO:0046469,1,0.962748870756535,0,6,platelet activating factor metabolic process,BP,
12479,GO:0046471,1,0.834338985129127,0,27,phosphatidylglycerol metabolic process,BP,
12480,GO:0046473,1,0.783778940508747,0,34,phosphatidic acid metabolic process,BP,
12484,GO:0046477,1,0.956865992971216,0,7,glycosylceramide catabolic process,BP,
12485,GO:0046478,1,0.992212450977572,0,1,lactosylceramide metabolic process,BP,
12486,GO:0046479,1,0.927371233780435,0,12,glycosphingolipid catabolic process,BP,
12488,GO:0046485,1,0.946065338218801,0,9,ether lipid metabolic process,BP,
12490,GO:0046487,1,0.961058161931823,0,7,glyoxylate metabolic process,BP,
12492,GO:0046490,1,0.980287216760656,0,4,isopentenyl diphosphate metabolic process,BP,
12493,GO:0046491,1,0.997168626285884,0,1,L-methylmalonyl-CoA metabolic process,BP,
12494,GO:0046493,1,0.995228475299946,0,2,lipid A metabolic process,BP,
12495,GO:0046495,1,0.99370748335756,0,1,nicotinamide riboside metabolic process,BP,
12496,GO:0046496,1,0.354258063829292,0,157,nicotinamide nucleotide metabolic process,BP,
12497,GO:0046497,1,0.993058458973322,0,1,nicotinate nucleotide metabolic process,BP,
12498,GO:0046498,1,0.965410521874336,0,6,S-adenosylhomocysteine metabolic process,BP,
12499,GO:0046499,1,0.992625893017814,0,1,S-adenosylmethioninamine metabolic process,BP,
12500,GO:0046500,1,0.929479055261892,0,12,S-adenosylmethionine metabolic process,BP,
12501,GO:0046501,1,0.942175670029839,0,10,protoporphyrinogen IX metabolic process,BP,
12502,GO:0046502,1,0.990380625645618,0,2,uroporphyrinogen III metabolic process,BP,
12504,GO:0046504,1,0.967974230464353,0,5,glycerol ether biosynthetic process,BP,
12505,GO:0046511,1,0.985730140234317,0,2,sphinganine biosynthetic process,BP,
12506,GO:0046512,1,0.945350831653976,0,9,sphingosine biosynthetic process,BP,
12508,GO:0046514,1,0.919441960105346,0,14,ceramide catabolic process,BP,
12509,GO:0046519,1,0.916922353968253,0,14,sphingoid metabolic process,BP,
12510,GO:0046520,1,0.938248344833366,0,10,sphingoid biosynthetic process,BP,
12511,GO:0046521,1,0.994955265031546,0,1,sphingoid catabolic process,BP,
12512,GO:0046523,1,0.992721497876454,0,1,S-methyl-5-thioribose-1-phosphate isomerase activity,MF,
12513,GO:0046525,1,0.995282439951821,0,1,xylosylprotein 4-beta-galactosyltransferase activity,MF,
12514,GO:0046526,1,0.993481113080797,0,1,D-xylulose reductase activity,MF,
12515,GO:0046527,1,0.893747351461323,0,16,glucosyltransferase activity,MF,
12517,GO:0046532,1,0.9583661661237,0,6,regulation of photoreceptor cell differentiation,BP,
12518,GO:0046533,1,0.9583661661237,0,6,negative regulation of photoreceptor cell differentiation,BP,
12519,GO:0046538,1,0.982786604600001,0,4,2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity,MF,
12520,GO:0046539,1,0.997093186593732,0,1,histamine N-methyltransferase activity,MF,
12521,GO:0046540,1,0.877720535952568,0,23,U4/U6 x U5 tri-snRNP complex,CC,
12522,GO:0046541,1,0.945103563880416,0,10,saliva secretion,BP,
12523,GO:0046543,1,0.954358766956221,0,7,development of secondary female sexual characteristics,BP,
12524,GO:0046544,1,0.992062406377873,0,1,development of secondary male sexual characteristics,BP,
12525,GO:0046545,1,0.539952837024721,0,89,development of primary female sexual characteristics,BP,
12526,GO:0046546,1,0.447030535026252,0,117,development of primary male sexual characteristics,BP,
12527,GO:0046548,1,0.950065557185076,0,7,retinal rod cell development,BP,
12529,GO:0046554,1,0.996229221774225,0,1,malate dehydrogenase (NADP+) activity,MF,
12530,GO:0046556,1,0.986164624597214,0,2,alpha-L-arabinofuranosidase activity,MF,
12531,GO:0046570,1,0.996332058576695,0,1,methylthioribulose 1-phosphate dehydratase activity,MF,
12532,GO:0046573,1,0.98723225065118,0,3,lactonohydrolase activity,MF,
12533,GO:0046577,1,0.992500039276656,0,1,long-chain-alcohol oxidase activity,MF,
12537,GO:0046581,1,0.955268008270863,0,6,intercellular canaliculus,CC,
12538,GO:0046586,1,0.989910063424377,0,2,regulation of calcium-dependent cell-cell adhesion,BP,
12539,GO:0046587,1,0.992800326150592,0,1,positive regulation of calcium-dependent cell-cell adhesion,BP,
12540,GO:0046588,1,0.997088988239028,0,1,negative regulation of calcium-dependent cell-cell adhesion,BP,
12541,GO:0046592,1,0.989837934035546,0,2,polyamine oxidase activity,MF,
12542,GO:0046596,1,0.859984957075113,0,26,regulation of viral entry into host cell,BP,
12543,GO:0046597,1,0.91228659980202,0,16,negative regulation of viral entry into host cell,BP,
12544,GO:0046598,1,0.949929615322404,0,9,positive regulation of viral entry into host cell,BP,
12545,GO:0046599,1,0.885451593614479,0,17,regulation of centriole replication,BP,
12546,GO:0046600,1,0.94334907488669,0,8,negative regulation of centriole replication,BP,
12547,GO:0046601,1,0.977836667869966,0,3,positive regulation of centriole replication,BP,
12548,GO:0046602,1,0.932685481122645,0,10,regulation of mitotic centrosome separation,BP,
12549,GO:0046603,1,0.995944831469082,0,1,negative regulation of mitotic centrosome separation,BP,
12550,GO:0046604,1,0.97158082447601,0,4,positive regulation of mitotic centrosome separation,BP,
12551,GO:0046605,1,0.681483801221042,0,54,regulation of centrosome cycle,BP,
12552,GO:0046606,1,0.913013886111861,0,14,negative regulation of centrosome cycle,BP,
12553,GO:0046607,1,0.928995470599448,0,10,positive regulation of centrosome cycle,BP,
12554,GO:0046618,1,0.974942061039174,0,4,drug export,BP,
12555,GO:0046619,1,0.983804104613739,0,2,optic placode formation involved in camera-type eye formation,BP,
12559,GO:0046623,1,0.99126790998446,0,1,sphingolipid-translocating ATPase activity,MF,
12560,GO:0046624,1,0.942794424623097,0,9,sphingolipid transporter activity,MF,
12562,GO:0046626,1,0.71707241675186,0,48,regulation of insulin receptor signaling pathway,BP,
12563,GO:0046627,1,0.811702417509251,0,31,negative regulation of insulin receptor signaling pathway,BP,
12564,GO:0046628,1,0.918319911027829,0,11,positive regulation of insulin receptor signaling pathway,BP,
12565,GO:0046629,1,0.927875615920968,0,11,gamma-delta T cell activation,BP,
12566,GO:0046631,1,0.497182401732055,0,106,alpha-beta T cell activation,BP,
12567,GO:0046632,1,0.570925415339796,0,83,alpha-beta T cell differentiation,BP,
12568,GO:0046633,1,0.868734368463395,0,23,alpha-beta T cell proliferation,BP,
12569,GO:0046634,1,0.65245086120563,0,67,regulation of alpha-beta T cell activation,BP,
12570,GO:0046635,1,0.759455146190314,0,45,positive regulation of alpha-beta T cell activation,BP,
12571,GO:0046636,1,0.844394314296723,0,25,negative regulation of alpha-beta T cell activation,BP,
12572,GO:0046637,1,0.736216954406936,0,47,regulation of alpha-beta T cell differentiation,BP,
12573,GO:0046638,1,0.809234827161511,0,34,positive regulation of alpha-beta T cell differentiation,BP,
12574,GO:0046639,1,0.891182275835181,0,16,negative regulation of alpha-beta T cell differentiation,BP,
12575,GO:0046640,1,0.887079599639704,0,20,regulation of alpha-beta T cell proliferation,BP,
12576,GO:0046641,1,0.913320864354864,0,16,positive regulation of alpha-beta T cell proliferation,BP,
12577,GO:0046642,1,0.970621615217363,0,5,negative regulation of alpha-beta T cell proliferation,BP,
12578,GO:0046643,1,0.955263616697228,0,6,regulation of gamma-delta T cell activation,BP,
12579,GO:0046645,1,0.962521821885417,0,5,positive regulation of gamma-delta T cell activation,BP,
12582,GO:0046653,1,0.892775743747597,0,18,tetrahydrofolate metabolic process,BP,
12583,GO:0046654,1,0.956803728406012,0,7,tetrahydrofolate biosynthetic process,BP,
12584,GO:0046655,1,0.877597294927968,0,20,folic acid metabolic process,BP,
12585,GO:0046657,1,0.989423476740052,0,2,folic acid catabolic process,BP,
12587,GO:0046660,1,0.490206471673313,0,102,female sex differentiation,BP,
12588,GO:0046661,1,0.385526845098691,0,139,male sex differentiation,BP,
12589,GO:0046666,1,0.979806158128734,0,4,retinal cell programmed cell death,BP,
12590,GO:0046668,1,0.987430347209491,0,2,regulation of retinal cell programmed cell death,BP,
12591,GO:0046671,1,0.99249170530249,0,1,negative regulation of retinal cell programmed cell death,BP,
12592,GO:0046676,1,0.794117184155887,0,35,negative regulation of insulin secretion,BP,
12594,GO:0046680,1,0.994421708477763,0,1,response to DDT,BP,
12596,GO:0046684,1,0.978073174465366,0,4,response to pyrethroid,BP,
12597,GO:0046685,1,0.838547463358045,0,29,response to arsenic-containing substance,BP,
12599,GO:0046687,1,0.996689569348466,0,1,response to chromate,BP,
12600,GO:0046688,1,0.866753267670519,0,30,response to copper ion,BP,
12601,GO:0046689,1,0.954309760735563,0,8,response to mercury ion,BP,
12602,GO:0046690,1,0.992546464183433,0,1,response to tellurium ion,BP,
12603,GO:0046691,1,0.992959461926035,0,1,intracellular canaliculus,CC,
12604,GO:0046695,1,0.984355185683601,0,3,SLIK (SAGA-like) complex,CC,
12605,GO:0046696,1,0.972026849228477,0,5,lipopolysaccharide receptor complex,CC,
12607,GO:0046700,1,0.0235898892580477,0,615,heterocycle catabolic process,BP,
12608,GO:0046703,1,0.968896761583555,0,7,natural killer cell lectin-like receptor binding,MF,
12609,GO:0046707,1,0.98726215624569,0,2,IDP metabolic process,BP,
12610,GO:0046709,1,0.98726215624569,0,2,IDP catabolic process,BP,
12611,GO:0046710,1,0.906310601654488,0,13,GDP metabolic process,BP,
12612,GO:0046711,1,0.996911935398822,0,1,GDP biosynthetic process,BP,
12613,GO:0046713,1,0.992714633871337,0,1,borate transport,BP,
12614,GO:0046715,1,0.992714633871337,0,1,active borate transmembrane transporter activity,MF,
12615,GO:0046716,1,0.902745035921832,0,15,muscle cell cellular homeostasis,BP,
12618,GO:0046719,1,0.956212152908271,0,7,regulation by virus of viral protein levels in host cell,BP,
12619,GO:0046724,1,0.988852363055137,0,2,oxalic acid secretion,BP,
12620,GO:0046725,1,0.992527580310158,0,1,negative regulation by virus of viral protein levels in host cell,BP,
12621,GO:0046726,1,0.970677439515864,0,4,positive regulation by virus of viral protein levels in host cell,BP,
12622,GO:0046730,1,0.994168744955213,0,1,induction of host immune response by virus,BP,
12623,GO:0046732,1,0.994168744955213,0,1,active induction of host immune response by virus,BP,
12624,GO:0046745,1,0.993058458973322,0,1,viral capsid secondary envelopment,BP,
12625,GO:0046755,1,0.869112725414409,0,24,viral budding,BP,
12627,GO:0046778,1,0.98791244048094,0,2,modification by virus of host mRNA processing,BP,
12628,GO:0046782,1,0.681607538713558,0,60,regulation of viral transcription,BP,
12629,GO:0046784,1,0.954530146435588,0,8,viral mRNA export from host cell nucleus,BP,
12630,GO:0046785,1,0.62911964948179,0,66,microtubule polymerization,BP,
12631,GO:0046786,1,0.992165726805901,0,1,viral replication complex formation and maintenance,BP,
12632,GO:0046789,1,0.992660350041409,0,1,host cell surface receptor binding,MF,
12633,GO:0046790,1,0.963914125306,0,5,virion binding,MF,
12635,GO:0046811,1,0.989420888708494,0,2,histone deacetylase inhibitor activity,MF,
12636,GO:0046812,1,0.992660350041409,0,1,host cell surface binding,MF,
12637,GO:0046813,1,0.966521392564515,0,5,receptor-mediated virion attachment to host cell,BP,
12640,GO:0046824,1,0.667940881193731,0,55,positive regulation of nucleocytoplasmic transport,BP,
12641,GO:0046825,1,0.766014709095638,0,39,regulation of protein export from nucleus,BP,
12642,GO:0046826,1,0.962734582662934,0,7,negative regulation of protein export from nucleus,BP,
12643,GO:0046827,1,0.869362987725458,0,20,positive regulation of protein export from nucleus,BP,
12644,GO:0046831,1,0.888304539507189,0,15,regulation of RNA export from nucleus,BP,
12645,GO:0046832,1,0.981096223527621,0,2,negative regulation of RNA export from nucleus,BP,
12646,GO:0046833,1,0.948640592774719,0,7,positive regulation of RNA export from nucleus,BP,
12648,GO:0046835,1,0.840105925939007,0,26,carbohydrate phosphorylation,BP,
12649,GO:0046836,1,0.971003367568697,0,5,glycolipid transport,BP,
12650,GO:0046838,1,0.923238758414653,0,11,phosphorylated carbohydrate dephosphorylation,BP,
12651,GO:0046839,1,0.829526649980316,0,24,phospholipid dephosphorylation,BP,
12653,GO:0046848,1,0.997860435024562,0,1,hydroxyapatite binding,MF,
12656,GO:0046851,1,0.93199110296052,0,11,negative regulation of bone remodeling,BP,
12659,GO:0046855,1,0.930005469917235,0,10,inositol phosphate dephosphorylation,BP,
12660,GO:0046856,1,0.83441435367359,0,23,phosphatidylinositol dephosphorylation,BP,
12661,GO:0046864,1,0.990035548376043,0,2,isoprenoid transport,BP,
12662,GO:0046865,1,0.990035548376043,0,2,terpenoid transport,BP,
12663,GO:0046870,1,0.969115426379613,0,5,cadmium ion binding,MF,
12666,GO:0046874,1,0.980044654884731,0,4,quinolinate metabolic process,BP,
12668,GO:0046877,1,0.968854629616803,0,6,regulation of saliva secretion,BP,
12669,GO:0046878,1,0.982430217560242,0,3,positive regulation of saliva secretion,BP,
12671,GO:0046880,1,0.958900160344274,0,6,regulation of follicle-stimulating hormone secretion,BP,
12672,GO:0046881,1,0.958900160344274,0,6,positive regulation of follicle-stimulating hormone secretion,BP,
12673,GO:0046882,1,0.982970601013657,0,3,negative regulation of follicle-stimulating hormone secretion,BP,
12675,GO:0046884,1,0.95145719695323,0,7,follicle-stimulating hormone secretion,BP,
12676,GO:0046885,1,0.850352873336354,0,24,regulation of hormone biosynthetic process,BP,
12677,GO:0046886,1,0.94028863272431,0,9,positive regulation of hormone biosynthetic process,BP,
12679,GO:0046888,1,0.699455359892612,0,56,negative regulation of hormone secretion,BP,
12680,GO:0046889,1,0.685176239952922,0,58,positive regulation of lipid biosynthetic process,BP,
12681,GO:0046890,1,0.367384147821501,0,151,regulation of lipid biosynthetic process,BP,
12682,GO:0046898,1,0.971364012072351,0,4,response to cycloheximide,BP,
12683,GO:0046899,1,0.986383625463302,0,2,nucleoside triphosphate adenylate kinase activity,MF,
12684,GO:0046900,1,0.989398687905511,0,2,tetrahydrofolylpolyglutamate metabolic process,BP,
12685,GO:0046901,1,0.993553795800342,0,1,tetrahydrofolylpolyglutamate biosynthetic process,BP,
12690,GO:0046911,1,0.996510058796768,0,1,metal chelating activity,MF,
12691,GO:0046912,1,0.963685787234196,0,5,transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer,MF,
12695,GO:0046920,1,0.942929480040065,0,8,alpha-(1->3)-fucosyltransferase activity,MF,
12696,GO:0046921,1,0.992613845995336,0,1,alpha-(1->6)-fucosyltransferase activity,MF,
12697,GO:0046922,1,0.985379374294274,0,2,peptide-O-fucosyltransferase activity,MF,
12698,GO:0046923,1,0.972088044127712,0,5,ER retention sequence binding,MF,
12700,GO:0046929,1,0.924723089628223,0,10,negative regulation of neurotransmitter secretion,BP,
12701,GO:0046930,1,0.91351083145626,0,15,pore complex,CC,
12702,GO:0046931,1,0.895529376297042,0,16,pore complex assembly,BP,
12703,GO:0046933,1,0.988533681657132,0,3,proton-transporting ATP synthase activity, rotational mechanism,MF,
12705,GO:0046935,1,0.963252078034312,0,5,1-phosphatidylinositol-3-kinase regulator activity,MF,
12706,GO:0046939,1,0.466178111235238,0,115,nucleotide phosphorylation,BP,
12707,GO:0046940,1,0.96911790443277,0,5,nucleoside monophosphate phosphorylation,BP,
12710,GO:0046946,1,0.97823919732578,0,3,hydroxylysine metabolic process,BP,
12711,GO:0046947,1,0.97823919732578,0,3,hydroxylysine biosynthetic process,BP,
12712,GO:0046949,1,0.83704331111795,0,27,fatty-acyl-CoA biosynthetic process,BP,
12713,GO:0046950,1,0.931725973110862,0,11,cellular ketone body metabolic process,BP,
12714,GO:0046951,1,0.943406040417452,0,9,ketone body biosynthetic process,BP,
12715,GO:0046952,1,0.974711494197855,0,4,ketone body catabolic process,BP,
12716,GO:0046958,1,0.954628030589778,0,6,nonassociative learning,BP,
12717,GO:0046959,1,0.967729835206846,0,4,habituation,BP,
12718,GO:0046960,1,0.986423907269631,0,2,sensitization,BP,
12719,GO:0046961,1,0.892755603388069,0,20,proton-transporting ATPase activity, rotational mechanism,MF,
12720,GO:0046963,1,0.989048726133533,0,2,3'-phosphoadenosine 5'-phosphosulfate transport,BP,
12721,GO:0046964,1,0.989048726133533,0,2,3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity,MF,
12722,GO:0046965,1,0.902954822743374,0,14,retinoid X receptor binding,MF,
12723,GO:0046966,1,0.827527331050405,0,26,thyroid hormone receptor binding,MF,
12724,GO:0046967,1,0.985374716779356,0,2,cytosol to ER transport,BP,
12725,GO:0046968,1,0.984958587057547,0,2,peptide antigen transport,BP,
12726,GO:0046969,1,0.988011726720632,0,2,NAD-dependent histone deacetylase activity (H3-K9 specific),MF,
12727,GO:0046970,1,0.99476079763154,0,1,NAD-dependent histone deacetylase activity (H4-K16 specific),MF,
12728,GO:0046972,1,0.928816218194738,0,10,histone acetyltransferase activity (H4-K16 specific),MF,
12729,GO:0046974,1,0.962977723185906,0,5,histone methyltransferase activity (H3-K9 specific),MF,
12730,GO:0046975,1,0.950880962911311,0,6,histone methyltransferase activity (H3-K36 specific),MF,
12731,GO:0046976,1,0.965264823393554,0,5,histone methyltransferase activity (H3-K27 specific),MF,
12732,GO:0046977,1,0.974383005028738,0,4,TAP binding,MF,
12733,GO:0046978,1,0.974383005028738,0,4,TAP1 binding,MF,
12734,GO:0046979,1,0.98177688659982,0,3,TAP2 binding,MF,
12735,GO:0046980,1,0.992470257377452,0,1,tapasin binding,MF,
12738,GO:0046984,1,0.975584252560375,0,4,regulation of hemoglobin biosynthetic process,BP,
12739,GO:0046985,1,0.983098924249471,0,3,positive regulation of hemoglobin biosynthetic process,BP,
12740,GO:0046986,1,0.992357436714209,0,1,negative regulation of hemoglobin biosynthetic process,BP,
12741,GO:0046996,1,0.993058458973322,0,1,oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, with NAD(P)H as one donor, and the other dehydrogenated,MF,
12742,GO:0046997,1,0.985389078768448,0,2,oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor,MF,
12743,GO:0047006,1,0.992030019412791,0,2,17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity,MF,
12744,GO:0047012,1,0.99557327560826,0,1,sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity,MF,
12745,GO:0047015,1,0.996995371001083,0,1,3-hydroxy-2-methylbutyryl-CoA dehydrogenase activity,MF,
12746,GO:0047016,1,0.99420051167721,0,1,cholest-5-ene-3-beta,7-alpha-diol 3-beta-dehydrogenase activity,MF,
12747,GO:0047017,1,0.989489235000956,0,2,prostaglandin-F synthase activity,MF,
12748,GO:0047020,1,0.996406077437465,0,1,15-hydroxyprostaglandin-D dehydrogenase (NADP+) activity,MF,
12749,GO:0047021,1,0.996369106559447,0,1,15-hydroxyprostaglandin dehydrogenase (NADP+) activity,MF,
12750,GO:0047023,1,0.984840674027201,0,4,androsterone dehydrogenase activity,MF,
12751,GO:0047025,1,0.989483296763761,0,2,3-oxoacyl-[acyl-carrier-protein] reductase (NADH) activity,MF,
12752,GO:0047035,1,0.976881866398943,0,6,testosterone dehydrogenase (NAD+) activity,MF,
12753,GO:0047042,1,0.996063827518315,0,1,androsterone dehydrogenase (B-specific) activity,MF,
12754,GO:0047045,1,0.989408721563788,0,3,testosterone 17-beta-dehydrogenase (NADP+) activity,MF,
12755,GO:0047057,1,0.993614137120308,0,2,vitamin-K-epoxide reductase (warfarin-sensitive) activity,MF,
12756,GO:0047066,1,0.99701749609411,0,1,phospholipid-hydroperoxide glutathione peroxidase activity,MF,
12757,GO:0047086,1,0.984840674027201,0,4,ketosteroid monooxygenase activity,MF,
12758,GO:0047105,1,0.993524842093636,0,1,4-trimethylammoniobutyraldehyde dehydrogenase activity,MF,
12759,GO:0047115,1,0.985080891675656,0,4,trans-1,2-dihydrobenzene-1,2-diol dehydrogenase activity,MF,
12760,GO:0047117,1,0.990019785722482,0,1,enoyl-[acyl-carrier-protein] reductase (NADPH, A-specific) activity,MF,
12761,GO:0047127,1,0.996082654380957,0,1,thiomorpholine-carboxylate dehydrogenase activity,MF,
12762,GO:0047130,1,0.991590785875459,0,1,saccharopine dehydrogenase (NADP+, L-lysine-forming) activity,MF,
12763,GO:0047131,1,0.991590785875459,0,1,saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity,MF,
12764,GO:0047134,1,0.970131383909353,0,6,protein-disulfide reductase activity,MF,
12765,GO:0047144,1,0.936694568584115,0,9,2-acylglycerol-3-phosphate O-acyltransferase activity,MF,
12766,GO:0047150,1,0.988216324113403,0,2,betaine-homocysteine S-methyltransferase activity,MF,
12767,GO:0047159,1,0.992480085778328,0,1,1-alkenylglycerophosphocholine O-acyltransferase activity,MF,
12768,GO:0047166,1,0.994834316161852,0,1,1-alkenylglycerophosphoethanolamine O-acyltransferase activity,MF,
12769,GO:0047173,1,0.992178770105001,0,1,phosphatidylcholine-retinol O-acyltransferase activity,MF,
12770,GO:0047179,1,0.993220306142637,0,2,platelet-activating factor acetyltransferase activity,MF,
12771,GO:0047184,1,0.968503721428361,0,5,1-acylglycerophosphocholine O-acyltransferase activity,MF,
12772,GO:0047186,1,0.992487143351421,0,1,N-acetylneuraminate 7-O(or 9-O)-acetyltransferase activity,MF,
12773,GO:0047191,1,0.992480085778328,0,1,1-alkylglycerophosphocholine O-acyltransferase activity,MF,
12774,GO:0047192,1,0.979349474339473,0,3,1-alkylglycerophosphocholine O-acetyltransferase activity,MF,
12775,GO:0047220,1,0.993056365272789,0,1,galactosylxylosylprotein 3-beta-galactosyltransferase activity,MF,
12776,GO:0047223,1,0.992968705321383,0,1,beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,3-N-acetylglucosaminyltransferase activity,MF,
12777,GO:0047237,1,0.978093634177499,0,3,glucuronylgalactosylproteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
12778,GO:0047238,1,0.963227112452524,0,5,glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity,MF,
12779,GO:0047256,1,0.992454963238182,0,1,lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity,MF,
12781,GO:0047273,1,0.99260242144494,0,1,galactosylgalactosylglucosylceramide beta-D-acetylgalactosaminyltransferase activity,MF,
12782,GO:0047275,1,0.98682627995467,0,2,glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity,MF,
12783,GO:0047277,1,0.994756056843853,0,1,globoside alpha-N-acetylgalactosaminyltransferase activity,MF,
12784,GO:0047280,1,0.992314567563515,0,1,nicotinamide phosphoribosyltransferase activity,MF,
12785,GO:0047288,1,0.98763372522888,0,2,monosialoganglioside sialyltransferase activity,MF,
12786,GO:0047290,1,0.995465450384512,0,1,(alpha-N-acetylneuraminyl-2,3-beta-galactosyl-1,3)-N-acetyl-galactosaminide 6-alpha-sialyltransferase activity,MF,
12787,GO:0047291,1,0.993926940147604,0,1,lactosylceramide alpha-2,3-sialyltransferase activity,MF,
12788,GO:0047293,1,0.995479258357632,0,1,4-hydroxybenzoate nonaprenyltransferase activity,MF,
12789,GO:0047298,1,0.992162690456213,0,1,(S)-3-amino-2-methylpropionate transaminase activity,MF,
12790,GO:0047322,1,0.981668189878568,0,2,[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity,MF,
12791,GO:0047323,1,0.994326585888226,0,1,[3-methyl-2-oxobutanoate dehydrogenase (acetyl-transferring)] kinase activity,MF,
12792,GO:0047325,1,0.99263010078286,0,1,inositol tetrakisphosphate 1-kinase activity,MF,
12793,GO:0047326,1,0.995123078791941,0,1,inositol tetrakisphosphate 5-kinase activity,MF,
12794,GO:0047341,1,0.992563042505725,0,1,fucose-1-phosphate guanylyltransferase activity,MF,
12795,GO:0047349,1,0.991860380659693,0,1,D-ribitol-5-phosphate cytidylyltransferase activity,MF,
12796,GO:0047369,1,0.993058458973322,0,1,succinate-hydroxymethylglutarate CoA-transferase activity,MF,
12797,GO:0047372,1,0.929760216702967,0,11,acylglycerol lipase activity,MF,
12798,GO:0047374,1,0.983637919615938,0,3,methylumbelliferyl-acetate deacetylase activity,MF,
12799,GO:0047389,1,0.98457691165351,0,2,glycerophosphocholine phosphodiesterase activity,MF,
12800,GO:0047390,1,0.992481840159367,0,1,glycerophosphocholine cholinephosphodiesterase activity,MF,
12802,GO:0047394,1,0.994084392347108,0,1,glycerophosphoinositol inositolphosphodiesterase activity,MF,
12803,GO:0047395,1,0.99287289100993,0,1,glycerophosphoinositol glycerophosphodiesterase activity,MF,
12804,GO:0047408,1,0.987792459900028,0,2,alkenylglycerophosphocholine hydrolase activity,MF,
12805,GO:0047409,1,0.987792459900028,0,2,alkenylglycerophosphoethanolamine hydrolase activity,MF,
12806,GO:0047429,1,0.948613369946437,0,9,nucleoside-triphosphate diphosphatase activity,MF,
12807,GO:0047444,1,0.996375636404581,0,1,N-acylneuraminate-9-phosphate synthase activity,MF,
12808,GO:0047451,1,0.990019785722482,0,1,3-hydroxyoctanoyl-[acyl-carrier-protein] dehydratase activity,MF,
12809,GO:0047464,1,0.992097317910561,0,1,heparosan-N-sulfate-glucuronate 5-epimerase activity,MF,
12810,GO:0047484,1,0.942037282905356,0,9,regulation of response to osmotic stress,BP,
12811,GO:0047485,1,0.500455812447848,0,106,protein N-terminus binding,MF,
12812,GO:0047493,1,0.979855141218144,0,3,ceramide cholinephosphotransferase activity,MF,
12813,GO:0047496,1,0.759372599013361,0,38,vesicle transport along microtubule,BP,
12814,GO:0047497,1,0.871966188649914,0,19,mitochondrion transport along microtubule,BP,
12815,GO:0047498,1,0.956601178898605,0,7,calcium-dependent phospholipase A2 activity,MF,
12816,GO:0047499,1,0.962941748397974,0,6,calcium-independent phospholipase A2 activity,MF,
12817,GO:0047522,1,0.98172583993303,0,3,15-oxoprostaglandin 13-oxidase activity,MF,
12818,GO:0047536,1,0.994115753229916,0,1,2-aminoadipate transaminase activity,MF,
12819,GO:0047545,1,0.991460101807059,0,1,2-hydroxyglutarate dehydrogenase activity,MF,
12820,GO:0047555,1,0.914438157722908,0,12,3',5'-cyclic-GMP phosphodiesterase activity,MF,
12821,GO:0047560,1,0.992009006729881,0,1,3-dehydrosphinganine reductase activity,MF,
12822,GO:0047578,1,0.993630613182083,0,1,4-hydroxyglutamate transaminase activity,MF,
12823,GO:0047598,1,0.99325634617697,0,1,7-dehydrocholesterol reductase activity,MF,
12824,GO:0047617,1,0.920948547291173,0,15,acyl-CoA hydrolase activity,MF,
12825,GO:0047620,1,0.99287289100993,0,1,acylglycerol kinase activity,MF,
12826,GO:0047621,1,0.995389277614451,0,1,acylpyruvate hydrolase activity,MF,
12827,GO:0047623,1,0.984958262978687,0,2,adenosine-phosphate deaminase activity,MF,
12828,GO:0047631,1,0.979227017896013,0,5,ADP-ribose diphosphatase activity,MF,
12829,GO:0047635,1,0.987415274528258,0,2,alanine-oxo-acid transaminase activity,MF,
12830,GO:0047658,1,0.995349884203026,0,1,alpha-amino-acid esterase activity,MF,
12831,GO:0047661,1,0.993575240739539,0,1,amino-acid racemase activity,MF,
12832,GO:0047676,1,0.992015563896095,0,1,arachidonate-CoA ligase activity,MF,
12833,GO:0047685,1,0.995785543316105,0,1,amine sulfotransferase activity,MF,
12834,GO:0047693,1,0.997490814002907,0,1,ATP diphosphatase activity,MF,
12835,GO:0047696,1,0.986304694352186,0,2,beta-adrenergic receptor kinase activity,MF,
12836,GO:0047708,1,0.99103555918727,0,2,biotinidase activity,MF,
12837,GO:0047710,1,0.989005574786301,0,2,bis(5'-adenosyl)-triphosphatase activity,MF,
12838,GO:0047718,1,0.988090124893521,0,3,indanol dehydrogenase activity,MF,
12839,GO:0047726,1,0.993519092085155,0,1,iron-cytochrome-c reductase activity,MF,
12840,GO:0047730,1,0.992479488058318,0,1,carnosine synthase activity,MF,
12841,GO:0047734,1,0.993058458973322,0,1,CDP-glycerol diphosphatase activity,MF,
12842,GO:0047743,1,0.996471135316586,0,1,chlordecone reductase activity,MF,
12843,GO:0047747,1,0.993798799857816,0,1,cholate-CoA ligase activity,MF,
12844,GO:0047750,1,0.993511636546258,0,2,cholestenol delta-isomerase activity,MF,
12845,GO:0047751,1,0.987320892996893,0,2,cholestenone 5-alpha-reductase activity,MF,
12846,GO:0047756,1,0.975709738347676,0,4,chondroitin 4-sulfotransferase activity,MF,
12847,GO:0047757,1,0.982118432820912,0,2,chondroitin-glucuronate 5-epimerase activity,MF,
12848,GO:0047760,1,0.968970593962754,0,5,butyrate-CoA ligase activity,MF,
12849,GO:0047777,1,0.991662641627008,0,1,(3S)-citramalyl-CoA lyase activity,MF,
12850,GO:0047787,1,0.996406077437465,0,1,delta4-3-oxosteroid 5beta-reductase activity,MF,
12851,GO:0047800,1,0.992505598787548,0,1,cysteamine dioxygenase activity,MF,
12852,GO:0047801,1,0.994331205310875,0,1,L-cysteine:2-oxoglutarate aminotransferase activity,MF,
12853,GO:0047837,1,0.996714161305283,0,1,D-xylose 1-dehydrogenase (NADP+) activity,MF,
12854,GO:0047840,1,0.996643509555738,0,1,dCTP diphosphatase activity,MF,
12855,GO:0047844,1,0.963618113808099,0,7,deoxycytidine deaminase activity,MF,
12856,GO:0047856,1,0.996477628303973,0,1,dihydrocoumarin hydrolase activity,MF,
12857,GO:0047860,1,0.996305860060835,0,1,diiodophenylpyruvate reductase activity,MF,
12858,GO:0047865,1,0.992731518297933,0,1,dimethylglycine dehydrogenase activity,MF,
12859,GO:0047874,1,0.994370559155478,0,1,dolichyldiphosphatase activity,MF,
12860,GO:0047888,1,0.994753686599896,0,1,fatty acid peroxidase activity,MF,
12861,GO:0047894,1,0.988026556707618,0,3,flavonol 3-sulfotransferase activity,MF,
12862,GO:0047915,1,0.995384648529303,0,1,ganglioside galactosyltransferase activity,MF,
12863,GO:0047933,1,0.990011065968688,0,1,glucose-1,6-bisphosphate synthase activity,MF,
12864,GO:0047936,1,0.98966350985906,0,1,glucose 1-dehydrogenase [NAD(P)] activity,MF,
12865,GO:0047939,1,0.995857532466422,0,1,L-glucuronate reductase activity,MF,
12866,GO:0047946,1,0.994470742218531,0,1,glutamine N-acyltransferase activity,MF,
12867,GO:0047961,1,0.990567133219252,0,2,glycine N-acyltransferase activity,MF,
12868,GO:0047963,1,0.992562890664473,0,1,glycine N-choloyltransferase activity,MF,
12869,GO:0047969,1,0.995228728217183,0,1,glyoxylate oxidase activity,MF,
12870,GO:0047977,1,0.987055374168798,0,2,hepoxilin-epoxide hydrolase activity,MF,
12871,GO:0047982,1,0.995239252591955,0,1,homocysteine desulfhydrase activity,MF,
12872,GO:0047988,1,0.994867527850545,0,1,hydroxyacid-oxoacid transhydrogenase activity,MF,
12873,GO:0047992,1,0.993058458973322,0,1,hydroxylysine kinase activity,MF,
12875,GO:0048003,1,0.970865134357159,0,4,antigen processing and presentation of lipid antigen via MHC class Ib,BP,
12876,GO:0048006,1,0.992498358133675,0,1,antigen processing and presentation, endogenous lipid antigen via MHC class Ib,BP,
12877,GO:0048007,1,0.970865134357159,0,4,antigen processing and presentation, exogenous lipid antigen via MHC class Ib,BP,
12879,GO:0048009,1,0.792001280877638,0,31,insulin-like growth factor receptor signaling pathway,BP,
12880,GO:0048010,1,0.539315630741061,0,91,vascular endothelial growth factor receptor signaling pathway,BP,
12881,GO:0048011,1,0.846859108983044,0,24,neurotrophin TRK receptor signaling pathway,BP,
12882,GO:0048012,1,0.900036027884987,0,16,hepatocyte growth factor receptor signaling pathway,BP,
12884,GO:0048014,1,0.976784206612023,0,3,Tie signaling pathway,BP,
12886,GO:0048016,1,0.763116243883944,0,36,inositol phosphate-mediated signaling,BP,
12889,GO:0048019,1,0.932443047295888,0,12,receptor antagonist activity,MF,
12890,GO:0048020,1,0.918865672135998,0,20,CCR chemokine receptor binding,MF,
12891,GO:0048021,1,0.956165461039674,0,6,regulation of melanin biosynthetic process,BP,
12892,GO:0048022,1,0.982703262209146,0,2,negative regulation of melanin biosynthetic process,BP,
12893,GO:0048023,1,0.972999745597393,0,4,positive regulation of melanin biosynthetic process,BP,
12894,GO:0048024,1,0.606102875293143,0,74,regulation of mRNA splicing, via spliceosome,BP,
12895,GO:0048025,1,0.881252295840746,0,19,negative regulation of mRNA splicing, via spliceosome,BP,
12896,GO:0048026,1,0.912063116019648,0,15,positive regulation of mRNA splicing, via spliceosome,BP,
12897,GO:0048027,1,0.883925210174053,0,22,mRNA 5'-UTR binding,MF,
12898,GO:0048029,1,0.664661738033277,0,64,monosaccharide binding,MF,
12899,GO:0048030,1,0.988514783975508,0,3,disaccharide binding,MF,
12900,GO:0048033,1,0.992809491006854,0,1,heme o metabolic process,BP,
12901,GO:0048034,1,0.992809491006854,0,1,heme O biosynthetic process,BP,
12903,GO:0048038,1,0.933252106415153,0,14,quinone binding,MF,
12904,GO:0048039,1,0.971752014556959,0,6,ubiquinone binding,MF,
12905,GO:0048040,1,0.994417048873401,0,1,UDP-glucuronate decarboxylase activity,MF,
12907,GO:0048048,1,0.763337640321971,0,34,embryonic eye morphogenesis,BP,
12908,GO:0048050,1,0.966215919216488,0,6,post-embryonic eye morphogenesis,BP,
12910,GO:0048069,1,0.953090075584888,0,7,eye pigmentation,BP,
12911,GO:0048070,1,0.897154527278051,0,15,regulation of developmental pigmentation,BP,
12912,GO:0048073,1,0.984861458620593,0,2,regulation of eye pigmentation,BP,
12913,GO:0048075,1,0.99240895933708,0,1,positive regulation of eye pigmentation,BP,
12914,GO:0048087,1,0.934169010078097,0,9,positive regulation of developmental pigmentation,BP,
12915,GO:0048096,1,0.937144313339887,0,9,chromatin-mediated maintenance of transcription,BP,
12916,GO:0048101,1,0.986772988128282,0,2,calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity,MF,
12917,GO:0048102,1,0.956127926739841,0,7,autophagic cell death,BP,
12918,GO:0048103,1,0.845249344751404,0,22,somatic stem cell division,BP,
12919,GO:0048104,1,0.965530933983864,0,4,establishment of body hair or bristle planar orientation,BP,
12920,GO:0048105,1,0.965530933983864,0,4,establishment of body hair planar orientation,BP,
12921,GO:0048133,1,0.983086917173549,0,3,male germ-line stem cell asymmetric division,BP,
12926,GO:0048147,1,0.847363750927683,0,27,negative regulation of fibroblast proliferation,BP,
12927,GO:0048148,1,0.905954476072272,0,15,behavioral response to cocaine,BP,
12928,GO:0048149,1,0.934583766445384,0,10,behavioral response to ethanol,BP,
12929,GO:0048156,1,0.933257820402539,0,11,tau protein binding,MF,
12930,GO:0048160,1,0.992297044236658,0,1,primary follicle stage,BP,
12931,GO:0048162,1,0.984036523791336,0,3,multi-layer follicle stage,BP,
12932,GO:0048165,1,0.984155390627073,0,2,fused antrum stage,BP,
12935,GO:0048169,1,0.82735610431788,0,26,regulation of long-term neuronal synaptic plasticity,BP,
12936,GO:0048170,1,0.962632204886876,0,5,positive regulation of long-term neuronal synaptic plasticity,BP,
12937,GO:0048172,1,0.893137816876312,0,15,regulation of short-term neuronal synaptic plasticity,BP,
12938,GO:0048174,1,0.99245977317499,0,1,negative regulation of short-term neuronal synaptic plasticity,BP,
12939,GO:0048175,1,0.992660350041409,0,1,hepatocyte growth factor biosynthetic process,BP,
12940,GO:0048176,1,0.992660350041409,0,1,regulation of hepatocyte growth factor biosynthetic process,BP,
12941,GO:0048178,1,0.992660350041409,0,1,negative regulation of hepatocyte growth factor biosynthetic process,BP,
12942,GO:0048179,1,0.978046365536505,0,3,activin receptor complex,CC,
12943,GO:0048180,1,0.994236985886711,0,1,activin complex,CC,
12944,GO:0048185,1,0.918591925538995,0,12,activin binding,MF,
12945,GO:0048188,1,0.914826121573203,0,12,Set1C/COMPASS complex,CC,
12946,GO:0048193,1,0.0947857278460967,0,335,Golgi vesicle transport,BP,
12947,GO:0048194,1,0.58536488668455,0,78,Golgi vesicle budding,BP,
12948,GO:0048199,1,0.627929709862823,0,70,vesicle targeting, to, from or within Golgi,BP,
12949,GO:0048200,1,0.960904511955813,0,6,Golgi transport vesicle coating,BP,
12950,GO:0048203,1,0.987793237034853,0,2,vesicle targeting, trans-Golgi to endosome,BP,
12951,GO:0048205,1,0.960904511955813,0,6,COPI coating of Golgi vesicle,BP,
12952,GO:0048207,1,0.662871217616788,0,62,vesicle targeting, rough ER to cis-Golgi,BP,
12953,GO:0048208,1,0.662871217616788,0,62,COPII vesicle coating,BP,
12954,GO:0048209,1,0.986289280607991,0,2,regulation of vesicle targeting, to, from or within Golgi,BP,
12955,GO:0048210,1,0.97823722475679,0,4,Golgi vesicle fusion to target membrane,BP,
12956,GO:0048211,1,0.985592848558658,0,2,Golgi vesicle docking,BP,
12957,GO:0048213,1,0.988235182316642,0,2,Golgi vesicle prefusion complex stabilization,BP,
12958,GO:0048227,1,0.949231924803719,0,8,plasma membrane to endosome transport,BP,
12960,GO:0048237,1,0.985504825784085,0,3,rough endoplasmic reticulum lumen,CC,
12961,GO:0048239,1,0.987321203198508,0,2,negative regulation of DNA recombination at telomere,BP,
12962,GO:0048240,1,0.904689327216982,0,17,sperm capacitation,BP,
12963,GO:0048241,1,0.980743053526734,0,4,epinephrine transport,BP,
12964,GO:0048242,1,0.980743053526734,0,4,epinephrine secretion,BP,
12965,GO:0048243,1,0.921734389649081,0,13,norepinephrine secretion,BP,
12966,GO:0048244,1,0.995423949857651,0,1,phytanoyl-CoA dioxygenase activity,MF,
12967,GO:0048245,1,0.952079145328279,0,11,eosinophil chemotaxis,BP,
12968,GO:0048246,1,0.853339212904853,0,29,macrophage chemotaxis,BP,
12969,GO:0048247,1,0.818751576239524,0,39,lymphocyte chemotaxis,BP,
12970,GO:0048248,1,0.980408402912753,0,5,CXCR3 chemokine receptor binding,MF,
12971,GO:0048250,1,0.990662000111742,0,2,iron import into the mitochondrion,BP,
12972,GO:0048251,1,0.934528345810997,0,9,elastic fiber assembly,BP,
12973,GO:0048254,1,0.97917159220629,0,4,snoRNA localization,BP,
12974,GO:0048255,1,0.802838732822308,0,31,mRNA stabilization,BP,
12975,GO:0048256,1,0.952964532427551,0,7,flap endonuclease activity,MF,
12976,GO:0048257,1,0.986819373350891,0,2,3'-flap endonuclease activity,MF,
12977,GO:0048259,1,0.611531814121495,0,72,regulation of receptor-mediated endocytosis,BP,
12978,GO:0048260,1,0.740392882640274,0,44,positive regulation of receptor-mediated endocytosis,BP,
12979,GO:0048261,1,0.900334671375023,0,17,negative regulation of receptor-mediated endocytosis,BP,
12980,GO:0048262,1,0.947406825441224,0,9,determination of dorsal/ventral asymmetry,BP,
12981,GO:0048263,1,0.954279665915197,0,8,determination of dorsal identity,BP,
12982,GO:0048264,1,0.992801233875787,0,1,determination of ventral identity,BP,
12985,GO:0048268,1,0.893942302519632,0,16,clathrin coat assembly,BP,
12986,GO:0048269,1,0.987482008221533,0,2,methionine adenosyltransferase complex,CC,
12987,GO:0048270,1,0.994434531875985,0,1,methionine adenosyltransferase regulator activity,MF,
12988,GO:0048273,1,0.959037196340294,0,6,mitogen-activated protein kinase p38 binding,MF,
12990,GO:0048280,1,0.952548164305853,0,8,vesicle fusion with Golgi apparatus,BP,
12993,GO:0048286,1,0.77014000712833,0,35,lung alveolus development,BP,
12994,GO:0048289,1,0.959748641800058,0,6,isotype switching to IgE isotypes,BP,
12995,GO:0048290,1,0.962079843550951,0,6,isotype switching to IgA isotypes,BP,
12996,GO:0048291,1,0.927082423151703,0,11,isotype switching to IgG isotypes,BP,
12997,GO:0048293,1,0.959748641800058,0,6,regulation of isotype switching to IgE isotypes,BP,
12998,GO:0048294,1,0.979076719191898,0,3,negative regulation of isotype switching to IgE isotypes,BP,
12999,GO:0048295,1,0.980263005069132,0,3,positive regulation of isotype switching to IgE isotypes,BP,
13000,GO:0048296,1,0.969263118667892,0,5,regulation of isotype switching to IgA isotypes,BP,
13001,GO:0048297,1,0.994321968735094,0,1,negative regulation of isotype switching to IgA isotypes,BP,
13002,GO:0048298,1,0.974799470214195,0,4,positive regulation of isotype switching to IgA isotypes,BP,
13003,GO:0048302,1,0.932763205869439,0,10,regulation of isotype switching to IgG isotypes,BP,
13004,GO:0048304,1,0.952620087287268,0,7,positive regulation of isotype switching to IgG isotypes,BP,
13005,GO:0048305,1,0.909482416788495,0,18,immunoglobulin secretion,BP,
13006,GO:0048306,1,0.736808373560182,0,54,calcium-dependent protein binding,MF,
13007,GO:0048308,1,0.909818964852312,0,15,organelle inheritance,BP,
13008,GO:0048311,1,0.88391883866429,0,16,mitochondrion distribution,BP,
13009,GO:0048312,1,0.940578052697312,0,8,intracellular distribution of mitochondria,BP,
13010,GO:0048313,1,0.91618424544138,0,14,Golgi inheritance,BP,
13011,GO:0048318,1,0.95925759988483,0,7,axial mesoderm development,BP,
13012,GO:0048319,1,0.978338982518163,0,3,axial mesoderm morphogenesis,BP,
13013,GO:0048320,1,0.987050053730636,0,2,axial mesoderm formation,BP,
13014,GO:0048321,1,0.994438031540948,0,1,axial mesodermal cell differentiation,BP,
13015,GO:0048322,1,0.994438031540948,0,1,axial mesodermal cell fate commitment,BP,
13016,GO:0048327,1,0.994438031540948,0,1,axial mesodermal cell fate specification,BP,
13019,GO:0048338,1,0.992518804425241,0,1,mesoderm structural organization,BP,
13020,GO:0048339,1,0.884690316500768,0,17,paraxial mesoderm development,BP,
13021,GO:0048340,1,0.934788587362791,0,9,paraxial mesoderm morphogenesis,BP,
13022,GO:0048341,1,0.960494350034744,0,6,paraxial mesoderm formation,BP,
13023,GO:0048342,1,0.995400844015433,0,1,paraxial mesodermal cell differentiation,BP,
13024,GO:0048343,1,0.995400844015433,0,1,paraxial mesodermal cell fate commitment,BP,
13025,GO:0048352,1,0.992518804425241,0,1,paraxial mesoderm structural organization,BP,
13026,GO:0048364,1,0.997356194534619,0,1,root development,BP,
13027,GO:0048365,1,0.636037755248015,0,60,Rac GTPase binding,MF,
13028,GO:0048368,1,0.912336210790354,0,15,lateral mesoderm development,BP,
13029,GO:0048369,1,0.973524966563091,0,4,lateral mesoderm morphogenesis,BP,
13030,GO:0048370,1,0.973524966563091,0,4,lateral mesoderm formation,BP,
13031,GO:0048371,1,0.977853505117439,0,3,lateral mesodermal cell differentiation,BP,
13032,GO:0048372,1,0.984324320336221,0,2,lateral mesodermal cell fate commitment,BP,
13033,GO:0048377,1,0.984324320336221,0,2,lateral mesodermal cell fate specification,BP,
13034,GO:0048378,1,0.984324320336221,0,2,regulation of lateral mesodermal cell fate specification,BP,
13035,GO:0048382,1,0.976743143209819,0,4,mesendoderm development,BP,
13038,GO:0048386,1,0.972567778098239,0,4,positive regulation of retinoic acid receptor signaling pathway,BP,
13040,GO:0048388,1,0.983468312725747,0,3,endosomal lumen acidification,BP,
13041,GO:0048389,1,0.990067112779632,0,2,intermediate mesoderm development,BP,
13042,GO:0048390,1,0.995148968087614,0,1,intermediate mesoderm morphogenesis,BP,
13043,GO:0048391,1,0.995148968087614,0,1,intermediate mesoderm formation,BP,
13044,GO:0048392,1,0.995148968087614,0,1,intermediate mesodermal cell differentiation,BP,
13045,GO:0048403,1,0.975420837580332,0,3,brain-derived neurotrophic factor binding,MF,
13046,GO:0048406,1,0.955400991374661,0,6,nerve growth factor binding,MF,
13047,GO:0048407,1,0.913348884432263,0,11,platelet-derived growth factor binding,MF,
13053,GO:0048476,1,0.974094977442731,0,5,Holliday junction resolvase complex,CC,
13054,GO:0048477,1,0.64052952326591,0,67,oogenesis,BP,
13055,GO:0048478,1,0.952208925974707,0,7,replication fork protection,BP,
13058,GO:0048485,1,0.868827746247189,0,19,sympathetic nervous system development,BP,
13059,GO:0048486,1,0.909769020358084,0,14,parasympathetic nervous system development,BP,
13062,GO:0048489,1,0.441010876646444,0,115,synaptic vesicle transport,BP,
13063,GO:0048490,1,0.900959799871975,0,17,anterograde synaptic vesicle transport,BP,
13064,GO:0048495,1,0.960574960603483,0,5,Roundabout binding,MF,
13065,GO:0048496,1,0.966183682809904,0,4,maintenance of animal organ identity,BP,
13066,GO:0048499,1,0.977583595690805,0,4,synaptic vesicle membrane organization,BP,
13067,GO:0048500,1,0.95253920091155,0,9,signal recognition particle,CC,
13068,GO:0048505,1,0.925171458977264,0,11,regulation of timing of cell differentiation,BP,
13070,GO:0048512,1,0.791353075915306,0,38,circadian behavior,BP,
13077,GO:0048521,1,0.938032278308883,0,13,negative regulation of behavior,BP,
13082,GO:0048531,1,0.91560541011093,0,14,beta-1,3-galactosyltransferase activity,MF,
13083,GO:0048532,1,0.896399322846584,0,15,anatomical structure arrangement,BP,
13085,GO:0048535,1,0.913274184399293,0,15,lymph node development,BP,
13086,GO:0048536,1,0.802011406862938,0,33,spleen development,BP,
13087,GO:0048537,1,0.964381690323509,0,6,mucosal-associated lymphoid tissue development,BP,
13088,GO:0048538,1,0.736197029737501,0,43,thymus development,BP,
13089,GO:0048539,1,0.954760508215974,0,7,bone marrow development,BP,
13090,GO:0048541,1,0.964381690323509,0,6,Peyer's patch development,BP,
13093,GO:0048548,1,0.940516066820107,0,9,regulation of pinocytosis,BP,
13094,GO:0048549,1,0.97103639230904,0,4,positive regulation of pinocytosis,BP,
13095,GO:0048550,1,0.968578417578574,0,5,negative regulation of pinocytosis,BP,
13096,GO:0048557,1,0.899011810423413,0,16,embryonic digestive tract morphogenesis,BP,
13097,GO:0048560,1,0.988371448621688,0,2,establishment of anatomical structure orientation,BP,
13098,GO:0048561,1,0.994123618313512,0,1,establishment of animal organ orientation,BP,
13100,GO:0048563,1,0.949698483870721,0,8,post-embryonic animal organ morphogenesis,BP,
13102,GO:0048566,1,0.811903943675484,0,32,embryonic digestive tract development,BP,
13103,GO:0048567,1,0.993427169554927,0,1,ectodermal digestive tract morphogenesis,BP,
13105,GO:0048569,1,0.899868340382487,0,15,post-embryonic animal organ development,BP,
13106,GO:0048570,1,0.945372669928287,0,8,notochord morphogenesis,BP,
13114,GO:0048596,1,0.815178588725782,0,25,embryonic camera-type eye morphogenesis,BP,
13115,GO:0048597,1,0.987770526206222,0,3,post-embryonic camera-type eye morphogenesis,BP,
13117,GO:0048599,1,0.77532287454841,0,38,oocyte development,BP,
13120,GO:0048611,1,0.986316871539866,0,2,embryonic ectodermal digestive tract development,BP,
13121,GO:0048613,1,0.993427169554927,0,1,embryonic ectodermal digestive tract morphogenesis,BP,
13122,GO:0048617,1,0.930330533665631,0,9,embryonic foregut morphogenesis,BP,
13123,GO:0048619,1,0.979515671289874,0,3,embryonic hindgut morphogenesis,BP,
13124,GO:0048625,1,0.967600036392724,0,5,myoblast fate commitment,BP,
13125,GO:0048627,1,0.988707125799274,0,2,myoblast development,BP,
13126,GO:0048630,1,0.951977199856353,0,7,skeletal muscle tissue growth,BP,
13127,GO:0048631,1,0.961752317942803,0,5,regulation of skeletal muscle tissue growth,BP,
13128,GO:0048632,1,0.984124899091388,0,2,negative regulation of skeletal muscle tissue growth,BP,
13129,GO:0048633,1,0.977270115122475,0,3,positive regulation of skeletal muscle tissue growth,BP,
13136,GO:0048641,1,0.722689680372811,0,46,regulation of skeletal muscle tissue development,BP,
13137,GO:0048642,1,0.916264428520493,0,13,negative regulation of skeletal muscle tissue development,BP,
13138,GO:0048643,1,0.86382740596114,0,21,positive regulation of skeletal muscle tissue development,BP,
13139,GO:0048644,1,0.559783620083429,0,78,muscle organ morphogenesis,BP,
13140,GO:0048645,1,0.685328656192324,0,58,animal organ formation,BP,
13146,GO:0048663,1,0.68404505983263,0,58,neuron fate commitment,BP,
13147,GO:0048664,1,0.969982184040639,0,6,neuron fate determination,BP,
13148,GO:0048665,1,0.832583625295433,0,29,neuron fate specification,BP,
13151,GO:0048668,1,0.840246583173046,0,25,collateral sprouting,BP,
13152,GO:0048669,1,0.980423683408878,0,3,collateral sprouting in absence of injury,BP,
13153,GO:0048670,1,0.882512744926561,0,19,regulation of collateral sprouting,BP,
13154,GO:0048671,1,0.939508054846657,0,8,negative regulation of collateral sprouting,BP,
13155,GO:0048672,1,0.939371623849592,0,11,positive regulation of collateral sprouting,BP,
13156,GO:0048673,1,0.995612088077875,0,1,collateral sprouting of intact axon in response to injury,BP,
13157,GO:0048674,1,0.993648644178067,0,1,collateral sprouting of injured axon,BP,
13159,GO:0048677,1,0.976752856022131,0,3,axon extension involved in regeneration,BP,
13161,GO:0048679,1,0.857500990183441,0,22,regulation of axon regeneration,BP,
13162,GO:0048680,1,0.958374129965843,0,7,positive regulation of axon regeneration,BP,
13163,GO:0048681,1,0.917216074077882,0,12,negative regulation of axon regeneration,BP,
13164,GO:0048682,1,0.970547696972725,0,4,sprouting of injured axon,BP,
13165,GO:0048683,1,0.995612088077875,0,1,regulation of collateral sprouting of intact axon in response to injury,BP,
13166,GO:0048685,1,0.995612088077875,0,1,negative regulation of collateral sprouting of intact axon in response to injury,BP,
13167,GO:0048686,1,0.978746935291081,0,3,regulation of sprouting of injured axon,BP,
13168,GO:0048687,1,0.986635574788663,0,2,positive regulation of sprouting of injured axon,BP,
13169,GO:0048688,1,0.985704491706204,0,2,negative regulation of sprouting of injured axon,BP,
13170,GO:0048689,1,0.993648644178067,0,1,formation of growth cone in injured axon,BP,
13171,GO:0048690,1,0.985003988130011,0,2,regulation of axon extension involved in regeneration,BP,
13172,GO:0048691,1,0.992942551431755,0,1,positive regulation of axon extension involved in regeneration,BP,
13173,GO:0048692,1,0.992005575977753,0,1,negative regulation of axon extension involved in regeneration,BP,
13174,GO:0048693,1,0.993648644178067,0,1,regulation of collateral sprouting of injured axon,BP,
13175,GO:0048694,1,0.993648644178067,0,1,positive regulation of collateral sprouting of injured axon,BP,
13176,GO:0048696,1,0.995809200936825,0,1,regulation of collateral sprouting in absence of injury,BP,
13177,GO:0048697,1,0.995809200936825,0,1,positive regulation of collateral sprouting in absence of injury,BP,
13179,GO:0048701,1,0.734283261264443,0,43,embryonic cranial skeleton morphogenesis,BP,
13180,GO:0048702,1,0.947220598836759,0,7,embryonic neurocranium morphogenesis,BP,
13181,GO:0048703,1,0.933133007557765,0,9,embryonic viscerocranium morphogenesis,BP,
13182,GO:0048704,1,0.55339543153059,0,88,embryonic skeletal system morphogenesis,BP,
13189,GO:0048712,1,0.925663334446974,0,11,negative regulation of astrocyte differentiation,BP,
13190,GO:0048713,1,0.806224293670193,0,33,regulation of oligodendrocyte differentiation,BP,
13191,GO:0048714,1,0.898091479364565,0,17,positive regulation of oligodendrocyte differentiation,BP,
13192,GO:0048715,1,0.927900139350728,0,11,negative regulation of oligodendrocyte differentiation,BP,
13194,GO:0048730,1,0.834790413096831,0,27,epidermis morphogenesis,BP,
13200,GO:0048739,1,0.893942872780476,0,13,cardiac muscle fiber development,BP,
13202,GO:0048742,1,0.938277770512128,0,9,regulation of skeletal muscle fiber development,BP,
13203,GO:0048743,1,0.961117893566376,0,6,positive regulation of skeletal muscle fiber development,BP,
13204,GO:0048745,1,0.867257367785413,0,19,smooth muscle tissue development,BP,
13206,GO:0048749,1,0.992470475000482,0,1,compound eye development,BP,
13207,GO:0048752,1,0.952843414459241,0,7,semicircular canal morphogenesis,BP,
13208,GO:0048753,1,0.839973892048669,0,27,pigment granule organization,BP,
13209,GO:0048754,1,0.359157824598377,0,142,branching morphogenesis of an epithelial tube,BP,
13210,GO:0048755,1,0.931609304339028,0,9,branching morphogenesis of a nerve,BP,
13211,GO:0048757,1,0.939796500291573,0,10,pigment granule maturation,BP,
13213,GO:0048763,1,0.951435221257518,0,4,calcium-induced calcium release activity,MF,
13214,GO:0048764,1,0.997356194534619,0,1,trichoblast maturation,BP,
13215,GO:0048765,1,0.997356194534619,0,1,root hair cell differentiation,BP,
13216,GO:0048767,1,0.997356194534619,0,1,root hair elongation,BP,
13217,GO:0048769,1,0.956668835472077,0,4,sarcomerogenesis,BP,
13221,GO:0048787,1,0.964088725745355,0,5,presynaptic active zone membrane,CC,
13222,GO:0048788,1,0.939195891152994,0,6,cytoskeleton of presynaptic active zone,CC,
13223,GO:0048789,1,0.992161676171263,0,1,cytoskeletal matrix organization at active zone,BP,
13224,GO:0048790,1,0.995797939836702,0,1,maintenance of presynaptic active zone structure,BP,
13225,GO:0048791,1,0.770893063117916,0,36,calcium ion-regulated exocytosis of neurotransmitter,BP,
13226,GO:0048792,1,0.992560346082195,0,1,spontaneous exocytosis of neurotransmitter,BP,
13227,GO:0048793,1,0.955304281567068,0,6,pronephros development,BP,
13229,GO:0048806,1,0.750092782459848,0,40,genitalia development,BP,
13230,GO:0048807,1,0.987052481241944,0,3,female genitalia morphogenesis,BP,
13231,GO:0048808,1,0.982358827734912,0,3,male genitalia morphogenesis,BP,
13235,GO:0048817,1,0.984508340066961,0,2,negative regulation of hair follicle maturation,BP,
13236,GO:0048818,1,0.969530947169342,0,5,positive regulation of hair follicle maturation,BP,
13237,GO:0048819,1,0.940306786225912,0,9,regulation of hair follicle maturation,BP,
13238,GO:0048820,1,0.88597576215309,0,16,hair follicle maturation,BP,
13240,GO:0048822,1,0.976759823584779,0,3,enucleate erythrocyte development,BP,
13241,GO:0048823,1,0.993058458973322,0,1,nucleate erythrocyte development,BP,
13243,GO:0048840,1,0.970947784829269,0,4,otolith development,BP,
13244,GO:0048841,1,0.799157531455073,0,27,regulation of axon extension involved in axon guidance,BP,
13245,GO:0048842,1,0.938211502344707,0,7,positive regulation of axon extension involved in axon guidance,BP,
13246,GO:0048843,1,0.861474999057704,0,19,negative regulation of axon extension involved in axon guidance,BP,
13247,GO:0048844,1,0.639875041193059,0,58,artery morphogenesis,BP,
13248,GO:0048845,1,0.928024427097065,0,10,venous blood vessel morphogenesis,BP,
13249,GO:0048846,1,0.766457842847705,0,32,axon extension involved in axon guidance,BP,
13250,GO:0048850,1,0.982984342449348,0,2,hypophysis morphogenesis,BP,
13254,GO:0048855,1,0.991289459288861,0,1,adenohypophysis morphogenesis,BP,
13258,GO:0048859,1,0.973516409886505,0,5,formation of anatomical boundary,BP,
13259,GO:0048861,1,0.96997112396395,0,4,leukemia inhibitory factor signaling pathway,BP,
13262,GO:0048865,1,0.955877072010492,0,8,stem cell fate commitment,BP,
13263,GO:0048866,1,0.978340530464275,0,4,stem cell fate specification,BP,
13264,GO:0048867,1,0.984567720783611,0,3,stem cell fate determination,BP,
13269,GO:0048873,1,0.836835406378245,0,27,homeostasis of number of cells within a tissue,BP,
13270,GO:0048874,1,0.992618000628388,0,1,homeostasis of number of cells in a free-living population,BP,
13271,GO:0048875,1,0.938401417530805,0,10,chemical homeostasis within a tissue,BP,
13273,GO:0048880,1,0.97097898271871,0,4,sensory system development,BP,
13274,GO:0048882,1,0.993270554299511,0,1,lateral line development,BP,
13275,GO:0048884,1,0.993270554299511,0,1,neuromast development,BP,
13276,GO:0048886,1,0.993270554299511,0,1,neuromast hair cell differentiation,BP,
13277,GO:0048925,1,0.993270554299511,0,1,lateral line system development,BP,
13278,GO:0048934,1,0.908104399431866,0,13,peripheral nervous system neuron differentiation,BP,
13279,GO:0048935,1,0.908104399431866,0,13,peripheral nervous system neuron development,BP,
13280,GO:0048936,1,0.980559334424506,0,3,peripheral nervous system neuron axonogenesis,BP,
13281,GO:0050000,1,0.614430527297409,0,71,chromosome localization,BP,
13282,GO:0050011,1,0.995593835692456,0,1,itaconyl-CoA hydratase activity,MF,
13283,GO:0050023,1,0.994962373773909,0,1,L-fuconate dehydratase activity,MF,
13284,GO:0050031,1,0.99370543607473,0,1,L-pipecolate oxidase activity,MF,
13285,GO:0050038,1,0.997245910794596,0,1,L-xylulose reductase (NADP+) activity,MF,
13286,GO:0050046,1,0.993058458973322,0,1,lathosterol oxidase activity,MF,
13287,GO:0050051,1,0.988113939178789,0,2,leukotriene-B4 20-monooxygenase activity,MF,
13288,GO:0050072,1,0.954762613816057,0,7,m7G(5')pppN diphosphatase activity,MF,
13289,GO:0050080,1,0.994186879981186,0,1,malonyl-CoA decarboxylase activity,MF,
13290,GO:0050104,1,0.995797939836702,0,1,L-gulonate 3-dehydrogenase activity,MF,
13291,GO:0050115,1,0.992178770105001,0,1,myosin-light-chain-phosphatase activity,MF,
13292,GO:0050119,1,0.982832331157854,0,2,N-acetylglucosamine deacetylase activity,MF,
13293,GO:0050121,1,0.995854165274491,0,1,N-acylglucosamine 2-epimerase activity,MF,
13294,GO:0050124,1,0.99249718464592,0,1,N-acylneuraminate-9-phosphatase activity,MF,
13295,GO:0050129,1,0.992659770028156,0,1,N-formylglutamate deformylase activity,MF,
13296,GO:0050135,1,0.991669392789779,0,2,NAD(P)+ nucleosidase activity,MF,
13297,GO:0050136,1,0.884640743099864,0,38,NADH dehydrogenase (quinone) activity,MF,
13298,GO:0050144,1,0.993058458973322,0,1,nucleoside deoxyribosyltransferase activity,MF,
13299,GO:0050145,1,0.96911790443277,0,5,nucleoside phosphate kinase activity,MF,
13300,GO:0050146,1,0.991937161699481,0,1,nucleoside phosphotransferase activity,MF,
13301,GO:0050152,1,0.996299304302672,0,1,omega-amidase activity,MF,
13302,GO:0050178,1,0.995447506421938,0,2,phenylpyruvate tautomerase activity,MF,
13303,GO:0050185,1,0.984646767108879,0,2,phosphatidylinositol deacylase activity,MF,
13304,GO:0050197,1,0.99391611389164,0,1,phytanate-CoA ligase activity,MF,
13305,GO:0050201,1,0.992483318248079,0,1,fucokinase activity,MF,
13306,GO:0050211,1,0.979081847812498,0,3,procollagen galactosyltransferase activity,MF,
13307,GO:0050220,1,0.982759334158305,0,4,prostaglandin-E synthase activity,MF,
13308,GO:0050221,1,0.996369106559447,0,1,prostaglandin-E2 9-reductase activity,MF,
13309,GO:0050252,1,0.98617777173441,0,2,retinol O-fatty-acyltransferase activity,MF,
13310,GO:0050253,1,0.985177560008178,0,2,retinyl-palmitate esterase activity,MF,
13311,GO:0050254,1,0.988543628790337,0,2,rhodopsin kinase activity,MF,
13312,GO:0050262,1,0.986164624597214,0,2,ribosylnicotinamide kinase activity,MF,
13313,GO:0050265,1,0.976522380824015,0,3,RNA uridylyltransferase activity,MF,
13314,GO:0050277,1,0.992492379445952,0,1,sedoheptulokinase activity,MF,
13315,GO:0050290,1,0.992244694433173,0,1,sphingomyelin phosphodiesterase D activity,MF,
13316,GO:0050291,1,0.954099075006836,0,7,sphingosine N-acyltransferase activity,MF,
13317,GO:0050294,1,0.98794379960763,0,3,steroid sulfotransferase activity,MF,
13318,GO:0050308,1,0.949949291480954,0,8,sugar-phosphatase activity,MF,
13319,GO:0050309,1,0.981124099262899,0,3,sugar-terminal-phosphatase activity,MF,
13320,GO:0050313,1,0.996966891436453,0,1,sulfur dioxygenase activity,MF,
13322,GO:0050333,1,0.995120723398191,0,1,thiamin-triphosphatase activity,MF,
13323,GO:0050337,1,0.997758184119408,0,1,thiosulfate-thiol sulfurtransferase activity,MF,
13324,GO:0050346,1,0.993058458973322,0,1,trans-L-3-hydroxyproline dehydratase activity,MF,
13325,GO:0050347,1,0.988084581517514,0,2,trans-octaprenyltranstransferase activity,MF,
13326,GO:0050353,1,0.992961914196941,0,1,trimethyllysine dioxygenase activity,MF,
13327,GO:0050355,1,0.992356547537272,0,1,triphosphatase activity,MF,
13328,GO:0050379,1,0.992097317910561,0,1,UDP-glucuronate 5'-epimerase activity,MF,
13329,GO:0050405,1,0.981668189878568,0,2,[acetyl-CoA carboxylase] kinase activity,MF,
13330,GO:0050421,1,0.993347995930623,0,1,nitrite reductase (NO-forming) activity,MF,
13331,GO:0050427,1,0.876612015586938,0,22,3'-phosphoadenosine 5'-phosphosulfate metabolic process,BP,
13332,GO:0050428,1,0.958517108260964,0,6,3'-phosphoadenosine 5'-phosphosulfate biosynthetic process,BP,
13333,GO:0050429,1,0.991234702216843,0,1,calcium-dependent phospholipase C activity,MF,
13334,GO:0050431,1,0.864788467756335,0,19,transforming growth factor beta binding,MF,
13335,GO:0050432,1,0.782374231065346,0,39,catecholamine secretion,BP,
13336,GO:0050433,1,0.80196867867237,0,36,regulation of catecholamine secretion,BP,
13337,GO:0050434,1,0.772263176782639,0,41,positive regulation of viral transcription,BP,
13338,GO:0050435,1,0.792693674891748,0,32,amyloid-beta metabolic process,BP,
13339,GO:0050436,1,0.984561365786991,0,2,microfibril binding,MF,
13340,GO:0050444,1,0.992612484295299,0,1,aquacobalamin reductase (NADPH) activity,MF,
13341,GO:0050459,1,0.993058458973322,0,1,ethanolamine-phosphate phospho-lyase activity,MF,
13342,GO:0050462,1,0.996375636404581,0,1,N-acetylneuraminate synthase activity,MF,
13343,GO:0050473,1,0.979006156086859,0,3,arachidonate 15-lipoxygenase activity,MF,
13344,GO:0050479,1,0.993058458973322,0,1,glyceryl-ether monooxygenase activity,MF,
13345,GO:0050480,1,0.994310435915199,0,1,imidazolonepropionase activity,MF,
13346,GO:0050482,1,0.890437541940278,0,19,arachidonic acid secretion,BP,
13347,GO:0050497,1,0.987234497538111,0,2,transferase activity, transferring alkylthio groups,MF,
13348,GO:0050501,1,0.975156378504815,0,4,hyaluronan synthase activity,MF,
13349,GO:0050508,1,0.97772466976572,0,3,glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity,MF,
13350,GO:0050509,1,0.985142231238766,0,2,N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity,MF,
13351,GO:0050510,1,0.970501540465522,0,4,N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity,MF,
13352,GO:0050512,1,0.994426369933777,0,1,lactosylceramide 4-alpha-galactosyltransferase activity,MF,
13353,GO:0050528,1,0.993752844177504,0,1,acyloxyacyl hydrolase activity,MF,
13354,GO:0050542,1,0.976326605868051,0,6,icosanoid binding,MF,
13355,GO:0050543,1,0.977775230419071,0,6,icosatetraenoic acid binding,MF,
13356,GO:0050544,1,0.981026625144298,0,5,arachidonic acid binding,MF,
13357,GO:0050560,1,0.992584948142418,0,1,aspartate-tRNA(Asn) ligase activity,MF,
13358,GO:0050561,1,0.992483988680781,0,1,glutamate-tRNA(Gln) ligase activity,MF,
13359,GO:0050567,1,0.983704527496903,0,3,glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity,MF,
13360,GO:0050571,1,0.995550398411786,0,1,1,5-anhydro-D-fructose reductase activity,MF,
13361,GO:0050577,1,0.996103670957157,0,1,GDP-L-fucose synthase activity,MF,
13362,GO:0050610,1,0.99317033719142,0,2,methylarsonate reductase activity,MF,
13363,GO:0050613,1,0.988126280074827,0,2,delta14-sterol reductase activity,MF,
13364,GO:0050614,1,0.992414853997043,0,1,delta24-sterol reductase activity,MF,
13365,GO:0050632,1,0.995977168526206,0,1,propionyl-CoA C2-trimethyltridecanoyltransferase activity,MF,
13366,GO:0050646,1,0.995209999419439,0,1,5-oxo-6E,8Z,11Z,14Z-icosatetraenoic acid binding,MF,
13367,GO:0050647,1,0.995209999419439,0,1,5-hydroxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding,MF,
13368,GO:0050648,1,0.995209999419439,0,1,5(S)-hydroxyperoxy-6E,8Z,11Z,14Z-icosatetraenoic acid binding,MF,
13369,GO:0050650,1,0.807950044183429,0,30,chondroitin sulfate proteoglycan biosynthetic process,BP,
13370,GO:0050651,1,0.897154586682933,0,15,dermatan sulfate proteoglycan biosynthetic process,BP,
13371,GO:0050652,1,0.992504999682798,0,1,dermatan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
13372,GO:0050653,1,0.985040651774243,0,2,chondroitin sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process,BP,
13373,GO:0050654,1,0.740059256368634,0,42,chondroitin sulfate proteoglycan metabolic process,BP,
13374,GO:0050655,1,0.891931634075839,0,16,dermatan sulfate proteoglycan metabolic process,BP,
13375,GO:0050656,1,0.957345418882574,0,6,3'-phosphoadenosine 5'-phosphosulfate binding,MF,
13378,GO:0050659,1,0.984015950980876,0,2,N-acetylgalactosamine 4-sulfate 6-O-sulfotransferase activity,MF,
13383,GO:0050664,1,0.924121781767772,0,12,oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor,MF,
13384,GO:0050665,1,0.931955737725014,0,11,hydrogen peroxide biosynthetic process,BP,
13385,GO:0050666,1,0.987586394891776,0,2,regulation of homocysteine metabolic process,BP,
13386,GO:0050667,1,0.911665961462252,0,14,homocysteine metabolic process,BP,
13387,GO:0050668,1,0.994015545358986,0,1,positive regulation of homocysteine metabolic process,BP,
13389,GO:0050671,1,0.504352960420285,0,117,positive regulation of lymphocyte proliferation,BP,
13392,GO:0050674,1,0.9976720550329,0,1,urothelial cell proliferation,BP,
13393,GO:0050675,1,0.9976720550329,0,1,regulation of urothelial cell proliferation,BP,
13394,GO:0050677,1,0.9976720550329,0,1,positive regulation of urothelial cell proliferation,BP,
13398,GO:0050681,1,0.749152368221724,0,41,androgen receptor binding,MF,
13399,GO:0050682,1,0.975079311291314,0,3,AF-2 domain binding,MF,
13400,GO:0050683,1,0.992456104508289,0,1,AF-1 domain binding,MF,
13401,GO:0050684,1,0.468293552218229,0,111,regulation of mRNA processing,BP,
13402,GO:0050685,1,0.859524396291902,0,24,positive regulation of mRNA processing,BP,
13403,GO:0050686,1,0.820087014810526,0,29,negative regulation of mRNA processing,BP,
13404,GO:0050687,1,0.871402655706624,0,21,negative regulation of defense response to virus,BP,
13405,GO:0050688,1,0.680785798147808,0,58,regulation of defense response to virus,BP,
13406,GO:0050689,1,0.973901826691687,0,5,negative regulation of defense response to virus by host,BP,
13407,GO:0050690,1,0.833384270770805,0,29,regulation of defense response to virus by virus,BP,
13408,GO:0050691,1,0.818344245135234,0,32,regulation of defense response to virus by host,BP,
13409,GO:0050692,1,0.979673904917414,0,3,DBD domain binding,MF,
13410,GO:0050693,1,0.962535942830695,0,6,LBD domain binding,MF,
13411,GO:0050694,1,0.97730596001707,0,4,galactose 3-O-sulfotransferase activity,MF,
13412,GO:0050698,1,0.986114097613532,0,2,proteoglycan sulfotransferase activity,MF,
13413,GO:0050699,1,0.829204072370739,0,30,WW domain binding,MF,
13414,GO:0050700,1,0.930979491130807,0,11,CARD domain binding,MF,
13415,GO:0050701,1,0.76878406452659,0,44,interleukin-1 secretion,BP,
13416,GO:0050702,1,0.786459387540791,0,39,interleukin-1 beta secretion,BP,
13417,GO:0050703,1,0.976397935211114,0,5,interleukin-1 alpha secretion,BP,
13418,GO:0050704,1,0.807904470702966,0,37,regulation of interleukin-1 secretion,BP,
13419,GO:0050705,1,0.978638479783898,0,4,regulation of interleukin-1 alpha secretion,BP,
13420,GO:0050706,1,0.824574510801101,0,33,regulation of interleukin-1 beta secretion,BP,
13423,GO:0050709,1,0.521899140927178,0,101,negative regulation of protein secretion,BP,
13424,GO:0050710,1,0.735404707145478,0,49,negative regulation of cytokine secretion,BP,
13425,GO:0050711,1,0.939859429914769,0,11,negative regulation of interleukin-1 secretion,BP,
13426,GO:0050712,1,0.995952642875535,0,1,negative regulation of interleukin-1 alpha secretion,BP,
13427,GO:0050713,1,0.956883271609966,0,8,negative regulation of interleukin-1 beta secretion,BP,
13430,GO:0050716,1,0.855870693975276,0,26,positive regulation of interleukin-1 secretion,BP,
13431,GO:0050717,1,0.982616176088116,0,3,positive regulation of interleukin-1 alpha secretion,BP,
13432,GO:0050718,1,0.864337160698783,0,24,positive regulation of interleukin-1 beta secretion,BP,
13433,GO:0050719,1,0.997228178169082,0,1,interleukin-1 alpha biosynthetic process,BP,
13434,GO:0050720,1,0.9898002401349,0,2,interleukin-1 beta biosynthetic process,BP,
13435,GO:0050721,1,0.997228178169082,0,1,regulation of interleukin-1 alpha biosynthetic process,BP,
13436,GO:0050722,1,0.9898002401349,0,2,regulation of interleukin-1 beta biosynthetic process,BP,
13437,GO:0050725,1,0.9898002401349,0,2,positive regulation of interleukin-1 beta biosynthetic process,BP,
13438,GO:0050726,1,0.997228178169082,0,1,positive regulation of interleukin-1 alpha biosynthetic process,BP,
13445,GO:0050733,1,0.965172726530999,0,5,RS domain binding,MF,
13447,GO:0050747,1,0.96988054892469,0,5,positive regulation of lipoprotein metabolic process,BP,
13449,GO:0050750,1,0.878945069135601,0,18,low-density lipoprotein particle receptor binding,MF,
13450,GO:0050751,1,0.997076388513025,0,1,fractalkine biosynthetic process,BP,
13451,GO:0050752,1,0.997076388513025,0,1,regulation of fractalkine biosynthetic process,BP,
13452,GO:0050754,1,0.997076388513025,0,1,positive regulation of fractalkine biosynthetic process,BP,
13453,GO:0050755,1,0.941406754656093,0,12,chemokine metabolic process,BP,
13454,GO:0050756,1,0.997076388513025,0,1,fractalkine metabolic process,BP,
13455,GO:0050757,1,0.989938376963283,0,2,thymidylate synthase biosynthetic process,BP,
13456,GO:0050758,1,0.989938376963283,0,2,regulation of thymidylate synthase biosynthetic process,BP,
13457,GO:0050760,1,0.993283203544632,0,1,negative regulation of thymidylate synthase biosynthetic process,BP,
13459,GO:0050765,1,0.926738677025028,0,13,negative regulation of phagocytosis,BP,
13460,GO:0050766,1,0.737740982001202,0,49,positive regulation of phagocytosis,BP,
13466,GO:0050772,1,0.557306254991115,0,77,positive regulation of axonogenesis,BP,
13468,GO:0050774,1,0.899428906795998,0,15,negative regulation of dendrite morphogenesis,BP,
13469,GO:0050775,1,0.780203593335944,0,32,positive regulation of dendrite morphogenesis,BP,
13473,GO:0050779,1,0.830768654339914,0,24,RNA destabilization,BP,
13474,GO:0050780,1,0.914191875254254,0,13,dopamine receptor binding,MF,
13475,GO:0050783,1,0.993646635265403,0,1,cocaine metabolic process,BP,
13476,GO:0050785,1,0.996154444087333,0,1,advanced glycation end-product receptor activity,MF,
13477,GO:0050786,1,0.969062043373239,0,10,RAGE receptor binding,MF,
13478,GO:0050787,1,0.989133847042102,0,2,detoxification of mercury ion,BP,
13486,GO:0050798,1,0.806101052065778,0,36,activated T cell proliferation,BP,
13488,GO:0050802,1,0.898617874734741,0,20,circadian sleep/wake cycle, sleep,BP,
13495,GO:0050810,1,0.596514082040647,0,77,regulation of steroid biosynthetic process,BP,
13496,GO:0050811,1,0.90928812239638,0,14,GABA receptor binding,MF,
13497,GO:0050812,1,0.907988450231184,0,13,regulation of acyl-CoA biosynthetic process,BP,
13498,GO:0050815,1,0.962893263252252,0,6,phosphoserine residue binding,MF,
13499,GO:0050816,1,0.980790797893828,0,3,phosphothreonine residue binding,MF,
13502,GO:0050819,1,0.752871219660281,0,46,negative regulation of coagulation,BP,
13504,GO:0050821,1,0.388912677914741,0,145,protein stabilization,BP,
13505,GO:0050822,1,0.992541859124483,0,1,peptide stabilization,BP,
13506,GO:0050823,1,0.992541859124483,0,1,peptide antigen stabilization,BP,
13508,GO:0050830,1,0.786926228378434,0,49,defense response to Gram-positive bacterium,BP,
13510,GO:0050833,1,0.974007783962165,0,4,pyruvate transmembrane transporter activity,MF,
13513,GO:0050847,1,0.936640723076912,0,8,progesterone receptor signaling pathway,BP,
13514,GO:0050848,1,0.623111433202289,0,71,regulation of calcium-mediated signaling,BP,
13515,GO:0050849,1,0.895656175313492,0,17,negative regulation of calcium-mediated signaling,BP,
13516,GO:0050850,1,0.814756109385954,0,33,positive regulation of calcium-mediated signaling,BP,
13519,GO:0050853,1,0.707497717215292,0,52,B cell receptor signaling pathway,BP,
13520,GO:0050854,1,0.707687105308453,0,52,regulation of antigen receptor-mediated signaling pathway,BP,
13521,GO:0050855,1,0.870118756260165,0,20,regulation of B cell receptor signaling pathway,BP,
13522,GO:0050856,1,0.799100966648656,0,35,regulation of T cell receptor signaling pathway,BP,
13523,GO:0050857,1,0.877316295701329,0,20,positive regulation of antigen receptor-mediated signaling pathway,BP,
13524,GO:0050858,1,0.873836317990357,0,22,negative regulation of antigen receptor-mediated signaling pathway,BP,
13525,GO:0050859,1,0.969471240079516,0,5,negative regulation of B cell receptor signaling pathway,BP,
13526,GO:0050860,1,0.89600765403941,0,18,negative regulation of T cell receptor signaling pathway,BP,
13527,GO:0050861,1,0.95219078714116,0,7,positive regulation of B cell receptor signaling pathway,BP,
13528,GO:0050862,1,0.928747805195222,0,12,positive regulation of T cell receptor signaling pathway,BP,
13535,GO:0050869,1,0.817927148009497,0,31,negative regulation of B cell activation,BP,
13537,GO:0050871,1,0.654733043392239,0,68,positive regulation of B cell activation,BP,
13538,GO:0050872,1,0.924153017445386,0,12,white fat cell differentiation,BP,
13539,GO:0050873,1,0.812188159073815,0,33,brown fat cell differentiation,BP,
13542,GO:0050879,1,0.752229156149734,0,45,multicellular organismal movement,BP,
13544,GO:0050881,1,0.752229156149734,0,45,musculoskeletal movement,BP,
13545,GO:0050882,1,0.945996380944605,0,6,voluntary musculoskeletal movement,BP,
13546,GO:0050883,1,0.993587012283989,0,1,musculoskeletal movement, spinal reflex action,BP,
13547,GO:0050884,1,0.90542859556605,0,14,neuromuscular process controlling posture,BP,
13549,GO:0050886,1,0.635800678569918,0,71,endocrine process,BP,
13551,GO:0050891,1,0.687879565527531,0,52,multicellular organismal water homeostasis,BP,
13552,GO:0050892,1,0.842125436086498,0,26,intestinal absorption,BP,
13553,GO:0050893,1,0.973386027714272,0,4,sensory processing,BP,
13554,GO:0050894,1,0.991113352308787,0,1,determination of affect,BP,
13556,GO:0050897,1,0.991503892523375,0,1,cobalt ion binding,MF,
13558,GO:0050901,1,0.859831841044445,0,24,leukocyte tethering or rolling,BP,
13559,GO:0050902,1,0.986150556889709,0,2,leukocyte adhesive activation,BP,
13560,GO:0050904,1,0.984364359279495,0,2,diapedesis,BP,
13562,GO:0050906,1,0.611331096952878,0,86,detection of stimulus involved in sensory perception,BP,
13563,GO:0050907,1,0.829748653785998,0,42,detection of chemical stimulus involved in sensory perception,BP,
13564,GO:0050908,1,0.906477428890023,0,14,detection of light stimulus involved in visual perception,BP,
13565,GO:0050909,1,0.79670474368645,0,42,sensory perception of taste,BP,
13566,GO:0050910,1,0.928595765414515,0,11,detection of mechanical stimulus involved in sensory perception of sound,BP,
13567,GO:0050911,1,0.933492928025503,0,17,detection of chemical stimulus involved in sensory perception of smell,BP,
13568,GO:0050912,1,0.901973096520601,0,23,detection of chemical stimulus involved in sensory perception of taste,BP,
13569,GO:0050913,1,0.88662143683558,0,25,sensory perception of bitter taste,BP,
13570,GO:0050915,1,0.972222260523276,0,4,sensory perception of sour taste,BP,
13571,GO:0050916,1,0.970591435339773,0,4,sensory perception of sweet taste,BP,
13572,GO:0050917,1,0.963470434425853,0,5,sensory perception of umami taste,BP,
13574,GO:0050919,1,0.752532404047252,0,36,negative chemotaxis,BP,
13575,GO:0050920,1,0.324916906465662,0,180,regulation of chemotaxis,BP,
13576,GO:0050921,1,0.493528678715055,0,120,positive regulation of chemotaxis,BP,
13577,GO:0050922,1,0.739515307916945,0,45,negative regulation of chemotaxis,BP,
13578,GO:0050923,1,0.967326743976186,0,4,regulation of negative chemotaxis,BP,
13579,GO:0050924,1,0.992129709912967,0,1,positive regulation of negative chemotaxis,BP,
13580,GO:0050925,1,0.982303342346985,0,2,negative regulation of negative chemotaxis,BP,
13581,GO:0050926,1,0.861513298398928,0,24,regulation of positive chemotaxis,BP,
13582,GO:0050927,1,0.868495297710418,0,23,positive regulation of positive chemotaxis,BP,
13583,GO:0050928,1,0.991972086340282,0,1,negative regulation of positive chemotaxis,BP,
13584,GO:0050929,1,0.992129709912967,0,1,induction of negative chemotaxis,BP,
13585,GO:0050930,1,0.934990334735302,0,13,induction of positive chemotaxis,BP,
13587,GO:0050932,1,0.934300566635751,0,9,regulation of pigment cell differentiation,BP,
13588,GO:0050942,1,0.943878610388351,0,7,positive regulation of pigment cell differentiation,BP,
13589,GO:0050951,1,0.877064764618551,0,19,sensory perception of temperature stimulus,BP,
13592,GO:0050955,1,0.984258011705443,0,2,thermoception,BP,
13594,GO:0050960,1,0.99245132719801,0,1,detection of temperature stimulus involved in thermoception,BP,
13595,GO:0050961,1,0.912654222382616,0,14,detection of temperature stimulus involved in sensory perception,BP,
13596,GO:0050962,1,0.906477428890023,0,14,detection of light stimulus involved in sensory perception,BP,
13597,GO:0050965,1,0.912654222382616,0,14,detection of temperature stimulus involved in sensory perception of pain,BP,
13598,GO:0050966,1,0.940748810545447,0,8,detection of mechanical stimulus involved in sensory perception of pain,BP,
13599,GO:0050968,1,0.985561665699053,0,2,detection of chemical stimulus involved in sensory perception of pain,BP,
13600,GO:0050974,1,0.852069388795873,0,23,detection of mechanical stimulus involved in sensory perception,BP,
13601,GO:0050975,1,0.981311109972065,0,3,sensory perception of touch,BP,
13602,GO:0050976,1,0.985452647745825,0,2,detection of mechanical stimulus involved in sensory perception of touch,BP,
13603,GO:0050982,1,0.746055874073914,0,37,detection of mechanical stimulus,BP,
13604,GO:0050992,1,0.994321968735094,0,1,dimethylallyl diphosphate biosynthetic process,BP,
13605,GO:0050993,1,0.994321968735094,0,1,dimethylallyl diphosphate metabolic process,BP,
13606,GO:0050994,1,0.757734791516756,0,42,regulation of lipid catabolic process,BP,
13607,GO:0050995,1,0.893736727228737,0,17,negative regulation of lipid catabolic process,BP,
13608,GO:0050996,1,0.899908453052951,0,16,positive regulation of lipid catabolic process,BP,
13609,GO:0050997,1,0.899591333145456,0,17,quaternary ammonium group binding,MF,
13610,GO:0050998,1,0.912886098964046,0,12,nitric-oxide synthase binding,MF,
13612,GO:0051000,1,0.895121373496691,0,17,positive regulation of nitric-oxide synthase activity,BP,
13613,GO:0051001,1,0.963081689450787,0,6,negative regulation of nitric-oxide synthase activity,BP,
13614,GO:0051004,1,0.919162581555718,0,15,regulation of lipoprotein lipase activity,BP,
13615,GO:0051005,1,0.983965917988646,0,3,negative regulation of lipoprotein lipase activity,BP,
13616,GO:0051006,1,0.966891819801561,0,7,positive regulation of lipoprotein lipase activity,BP,
13617,GO:0051010,1,0.889399953181669,0,13,microtubule plus-end binding,MF,
13618,GO:0051011,1,0.92433251388671,0,9,microtubule minus-end binding,MF,
13619,GO:0051012,1,0.987375593749203,0,2,microtubule sliding,BP,
13620,GO:0051013,1,0.951710895329622,0,7,microtubule severing,BP,
13623,GO:0051016,1,0.911039347568538,0,14,barbed-end actin filament capping,BP,
13625,GO:0051018,1,0.692310651257227,0,46,protein kinase A binding,MF,
13626,GO:0051019,1,0.829912764329857,0,26,mitogen-activated protein kinase binding,MF,
13628,GO:0051021,1,0.97033631810768,0,5,GDP-dissociation inhibitor binding,MF,
13629,GO:0051022,1,0.97443200035693,0,4,Rho GDP-dissociation inhibitor binding,MF,
13630,GO:0051023,1,0.925973815385043,0,15,regulation of immunoglobulin secretion,BP,
13631,GO:0051024,1,0.957854451482926,0,9,positive regulation of immunoglobulin secretion,BP,
13632,GO:0051025,1,0.986066713335325,0,2,negative regulation of immunoglobulin secretion,BP,
13633,GO:0051026,1,0.961309126739086,0,6,chiasma assembly,BP,
13635,GO:0051029,1,0.968935050451952,0,6,rRNA transport,BP,
13636,GO:0051030,1,0.98185412981184,0,4,snRNA transport,BP,
13637,GO:0051031,1,0.795242673425706,0,32,tRNA transport,BP,
13638,GO:0051032,1,0.984649451559425,0,2,nucleic acid transmembrane transporter activity,MF,
13639,GO:0051033,1,0.984649451559425,0,2,RNA transmembrane transporter activity,MF,
13640,GO:0051036,1,0.971287444245153,0,5,regulation of endosome size,BP,
13641,GO:0051040,1,0.985369694925834,0,2,regulation of calcium-independent cell-cell adhesion,BP,
13642,GO:0051041,1,0.992623704739742,0,1,positive regulation of calcium-independent cell-cell adhesion,BP,
13643,GO:0051042,1,0.992692623517792,0,1,negative regulation of calcium-independent cell-cell adhesion,BP,
13644,GO:0051043,1,0.87238217506468,0,21,regulation of membrane protein ectodomain proteolysis,BP,
13645,GO:0051044,1,0.919517180878147,0,13,positive regulation of membrane protein ectodomain proteolysis,BP,
13646,GO:0051045,1,0.948781280536717,0,8,negative regulation of membrane protein ectodomain proteolysis,BP,
13649,GO:0051048,1,0.31877933466627,0,178,negative regulation of secretion,BP,
13656,GO:0051055,1,0.753665721755988,0,44,negative regulation of lipid biosynthetic process,BP,
13660,GO:0051059,1,0.842918859653414,0,28,NF-kappaB binding,MF,
13661,GO:0051066,1,0.990225267150092,0,2,dihydrobiopterin metabolic process,BP,
13662,GO:0051068,1,0.99252484461045,0,1,dihydrolipoamide metabolic process,BP,
13663,GO:0051081,1,0.724917581815814,0,46,nuclear envelope disassembly,BP,
13664,GO:0051082,1,0.520543390867092,0,108,unfolded protein binding,MF,
13665,GO:0051083,1,0.989408413172504,0,2,'de novo' cotranslational protein folding,BP,
13666,GO:0051084,1,0.811960542733903,0,32,'de novo' posttranslational protein folding,BP,
13667,GO:0051085,1,0.84037987582952,0,27,chaperone cofactor-dependent protein refolding,BP,
13668,GO:0051086,1,0.994718146769879,0,1,chaperone mediated protein folding independent of cofactor,BP,
13669,GO:0051087,1,0.565652045558328,0,89,chaperone binding,MF,
13670,GO:0051088,1,0.977653356467794,0,3,PMA-inducible membrane protein ectodomain proteolysis,BP,
13671,GO:0051089,1,0.992481840159367,0,1,constitutive protein ectodomain proteolysis,BP,
13677,GO:0051095,1,0.942883385720126,0,9,regulation of helicase activity,BP,
13678,GO:0051096,1,0.961190352469012,0,6,positive regulation of helicase activity,BP,
13679,GO:0051097,1,0.980961325437788,0,3,negative regulation of helicase activity,BP,
13682,GO:0051100,1,0.387253501488222,0,147,negative regulation of binding,BP,
13683,GO:0051101,1,0.494197301400065,0,110,regulation of DNA binding,BP,
13684,GO:0051102,1,0.992466162648775,0,1,DNA ligation involved in DNA recombination,BP,
13685,GO:0051103,1,0.935480317037355,0,11,DNA ligation involved in DNA repair,BP,
13686,GO:0051105,1,0.960878960230701,0,6,regulation of DNA ligation,BP,
13687,GO:0051106,1,0.967738023664945,0,5,positive regulation of DNA ligation,BP,
13688,GO:0051107,1,0.992914587604173,0,1,negative regulation of DNA ligation,BP,
13689,GO:0051117,1,0.625949201841412,0,73,ATPase binding,MF,
13690,GO:0051119,1,0.855927994698063,0,23,sugar transmembrane transporter activity,MF,
13691,GO:0051120,1,0.979748895054563,0,3,hepoxilin A3 synthase activity,MF,
13692,GO:0051121,1,0.966873233534832,0,5,hepoxilin metabolic process,BP,
13693,GO:0051122,1,0.966873233534832,0,5,hepoxilin biosynthetic process,BP,
13694,GO:0051123,1,0.825054112760752,0,31,RNA polymerase II transcriptional preinitiation complex assembly,BP,
13695,GO:0051124,1,0.924821429834719,0,9,synaptic growth at neuromuscular junction,BP,
13697,GO:0051126,1,0.960840406061107,0,7,negative regulation of actin nucleation,BP,
13702,GO:0051131,1,0.895243150800462,0,18,chaperone-mediated protein complex assembly,BP,
13703,GO:0051132,1,0.957890923772399,0,8,NK T cell activation,BP,
13704,GO:0051133,1,0.969717532209524,0,6,regulation of NK T cell activation,BP,
13705,GO:0051134,1,0.994898364058571,0,1,negative regulation of NK T cell activation,BP,
13706,GO:0051135,1,0.974691326377243,0,5,positive regulation of NK T cell activation,BP,
13707,GO:0051136,1,0.959167207970501,0,6,regulation of NK T cell differentiation,BP,
13708,GO:0051138,1,0.971164082993047,0,4,positive regulation of NK T cell differentiation,BP,
13709,GO:0051139,1,0.984401742398958,0,2,metal ion:proton antiporter activity,MF,
13710,GO:0051140,1,0.986052076920313,0,3,regulation of NK T cell proliferation,BP,
13711,GO:0051142,1,0.986052076920313,0,3,positive regulation of NK T cell proliferation,BP,
13712,GO:0051145,1,0.709835462702288,0,51,smooth muscle cell differentiation,BP,
13714,GO:0051147,1,0.418419087633754,0,127,regulation of muscle cell differentiation,BP,
13715,GO:0051148,1,0.759874093738942,0,40,negative regulation of muscle cell differentiation,BP,
13716,GO:0051149,1,0.616182114945733,0,73,positive regulation of muscle cell differentiation,BP,
13717,GO:0051150,1,0.838128638195295,0,26,regulation of smooth muscle cell differentiation,BP,
13718,GO:0051151,1,0.926737019142074,0,11,negative regulation of smooth muscle cell differentiation,BP,
13719,GO:0051152,1,0.932752974342073,0,11,positive regulation of smooth muscle cell differentiation,BP,
13720,GO:0051153,1,0.576732801618497,0,82,regulation of striated muscle cell differentiation,BP,
13721,GO:0051154,1,0.8261636425043,0,28,negative regulation of striated muscle cell differentiation,BP,
13722,GO:0051155,1,0.735879096631096,0,47,positive regulation of striated muscle cell differentiation,BP,
13723,GO:0051156,1,0.858222458987438,0,26,glucose 6-phosphate metabolic process,BP,
13724,GO:0051160,1,0.993481113080797,0,1,L-xylitol catabolic process,BP,
13725,GO:0051164,1,0.993481113080797,0,1,L-xylitol metabolic process,BP,
13726,GO:0051167,1,0.975131983747371,0,5,xylulose 5-phosphate metabolic process,BP,
13727,GO:0051168,1,0.275139190927118,0,191,nuclear export,BP,
13734,GO:0051176,1,0.977832794464615,0,3,positive regulation of sulfur metabolic process,BP,
13735,GO:0051177,1,0.964320601496104,0,6,meiotic sister chromatid cohesion,BP,
13737,GO:0051180,1,0.817369833215492,0,30,vitamin transport,BP,
13738,GO:0051181,1,0.767890148092596,0,41,cofactor transport,BP,
13739,GO:0051182,1,0.945112276469347,0,8,coenzyme transport,BP,
13740,GO:0051184,1,0.866109571310292,0,20,cofactor transmembrane transporter activity,MF,
13741,GO:0051185,1,0.959163324958981,0,6,coenzyme transmembrane transporter activity,MF,
13743,GO:0051187,1,0.790853492468804,0,45,cofactor catabolic process,BP,
13744,GO:0051188,1,0.167450711509478,0,274,cofactor biosynthetic process,BP,
13745,GO:0051189,1,0.957607106433363,0,7,prosthetic group metabolic process,BP,
13746,GO:0051192,1,0.995228475299946,0,2,prosthetic group binding,MF,
13747,GO:0051193,1,0.52203531362616,0,94,regulation of cofactor metabolic process,BP,
13748,GO:0051194,1,0.866576073621803,0,19,positive regulation of cofactor metabolic process,BP,
13749,GO:0051195,1,0.904053893960024,0,16,negative regulation of cofactor metabolic process,BP,
13750,GO:0051196,1,0.56469673733418,0,80,regulation of coenzyme metabolic process,BP,
13751,GO:0051197,1,0.883828647370465,0,16,positive regulation of coenzyme metabolic process,BP,
13752,GO:0051198,1,0.933722883332218,0,10,negative regulation of coenzyme metabolic process,BP,
13753,GO:0051204,1,0.818600716405714,0,34,protein insertion into mitochondrial membrane,BP,
13755,GO:0051208,1,0.476038900595173,0,103,sequestering of calcium ion,BP,
13756,GO:0051209,1,0.489833993486516,0,99,release of sequestered calcium ion into cytosol,BP,
13757,GO:0051213,1,0.557232589593374,0,85,dioxygenase activity,MF,
13760,GO:0051220,1,0.850973098905763,0,24,cytoplasmic sequestering of protein,BP,
13764,GO:0051225,1,0.469387810789855,0,105,spindle assembly,BP,
13765,GO:0051228,1,0.992024079629287,0,1,mitotic spindle disassembly,BP,
13766,GO:0051230,1,0.992024079629287,0,1,spindle disassembly,BP,
13767,GO:0051231,1,0.928563429158085,0,11,spindle elongation,BP,
13768,GO:0051232,1,0.993788304555107,0,1,meiotic spindle elongation,BP,
13769,GO:0051233,1,0.802859243441183,0,31,spindle midzone,CC,
13786,GO:0051255,1,0.936859678834864,0,10,spindle midzone assembly,BP,
13787,GO:0051256,1,0.94996229306778,0,8,mitotic spindle midzone assembly,BP,
13788,GO:0051257,1,0.993596861458281,0,1,meiotic spindle midzone assembly,BP,
13791,GO:0051260,1,0.145797086235666,0,294,protein homooligomerization,BP,
13793,GO:0051262,1,0.456462396361076,0,125,protein tetramerization,BP,
13794,GO:0051264,1,0.99302489525474,0,1,mono-olein transacylation activity,MF,
13795,GO:0051265,1,0.99302489525474,0,1,diolein transacylation activity,MF,
13796,GO:0051267,1,0.992635692460644,0,1,CP2 mannose-ethanolamine phosphotransferase activity,MF,
13801,GO:0051279,1,0.619510297037366,0,68,regulation of release of sequestered calcium ion into cytosol,BP,
13802,GO:0051280,1,0.927703206796992,0,13,negative regulation of release of sequestered calcium ion into cytosol,BP,
13803,GO:0051281,1,0.796778418480126,0,35,positive regulation of release of sequestered calcium ion into cytosol,BP,
13804,GO:0051282,1,0.48615951487936,0,100,regulation of sequestering of calcium ion,BP,
13805,GO:0051283,1,0.489833993486516,0,99,negative regulation of sequestering of calcium ion,BP,
13806,GO:0051284,1,0.914589599726223,0,14,positive regulation of sequestering of calcium ion,BP,
13807,GO:0051286,1,0.947579862864735,0,7,cell tip,CC,
13808,GO:0051287,1,0.715163090118463,0,56,NAD binding,MF,
13809,GO:0051289,1,0.624607680921105,0,75,protein homotetramerization,BP,
13810,GO:0051290,1,0.853206865425663,0,28,protein heterotetramerization,BP,
13811,GO:0051291,1,0.528876909587382,0,100,protein heterooligomerization,BP,
13812,GO:0051292,1,0.92717629671173,0,10,nuclear pore complex assembly,BP,
13813,GO:0051293,1,0.775804136966151,0,34,establishment of spindle localization,BP,
13814,GO:0051294,1,0.832074429695199,0,26,establishment of spindle orientation,BP,
13815,GO:0051295,1,0.966767285655601,0,4,establishment of meiotic spindle localization,BP,
13816,GO:0051298,1,0.635408981171124,0,62,centrosome duplication,BP,
13817,GO:0051299,1,0.893202078512804,0,16,centrosome separation,BP,
13818,GO:0051300,1,0.993058458973322,0,1,spindle pole body organization,BP,
13820,GO:0051302,1,0.389204551330827,0,138,regulation of cell division,BP,
13821,GO:0051303,1,0.61941771260426,0,70,establishment of chromosome localization,BP,
13822,GO:0051304,1,0.597589192954924,0,75,chromosome separation,BP,
13823,GO:0051305,1,0.952950068265332,0,6,chromosome movement towards spindle pole,BP,
13824,GO:0051306,1,0.693842629892596,0,54,mitotic sister chromatid separation,BP,
13825,GO:0051307,1,0.893513003373598,0,16,meiotic chromosome separation,BP,
13826,GO:0051308,1,0.993058458973322,0,1,male meiosis chromosome separation,BP,
13827,GO:0051310,1,0.692863383095188,0,55,metaphase plate congression,BP,
13828,GO:0051311,1,0.993596861458281,0,1,meiotic metaphase plate congression,BP,
13829,GO:0051315,1,0.914910480161896,0,13,attachment of mitotic spindle microtubules to kinetochore,BP,
13830,GO:0051316,1,0.987149215037361,0,2,attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation,BP,
13831,GO:0051321,1,0.253911516160924,0,202,meiotic cell cycle,BP,
13835,GO:0051340,1,0.951595621452945,0,9,regulation of ligase activity,BP,
13837,GO:0051342,1,0.95148305356941,0,8,regulation of cyclic-nucleotide phosphodiesterase activity,BP,
13838,GO:0051343,1,0.975699410266127,0,4,positive regulation of cyclic-nucleotide phosphodiesterase activity,BP,
13839,GO:0051344,1,0.968141399667261,0,5,negative regulation of cyclic-nucleotide phosphodiesterase activity,BP,
13843,GO:0051348,1,0.1649367067133,0,275,negative regulation of transferase activity,BP,
13845,GO:0051350,1,0.860823939501967,0,23,negative regulation of lyase activity,BP,
13846,GO:0051351,1,0.963393813562188,0,7,positive regulation of ligase activity,BP,
13847,GO:0051352,1,0.987758053227987,0,2,negative regulation of ligase activity,BP,
13848,GO:0051353,1,0.774950264646185,0,41,positive regulation of oxidoreductase activity,BP,
13849,GO:0051354,1,0.888354439633149,0,20,negative regulation of oxidoreductase activity,BP,
13850,GO:0051355,1,0.992495604331318,0,1,proprioception involved in equilibrioception,BP,
13851,GO:0051365,1,0.979559232451385,0,3,cellular response to potassium ion starvation,BP,
13852,GO:0051371,1,0.857646923751938,0,18,muscle alpha-actinin binding,MF,
13853,GO:0051373,1,0.971229688901339,0,5,FATZ binding,MF,
13854,GO:0051377,1,0.977622932649752,0,3,mannose-ethanolamine phosphotransferase activity,MF,
13855,GO:0051378,1,0.934545064385932,0,11,serotonin binding,MF,
13856,GO:0051379,1,0.958830630634995,0,7,epinephrine binding,MF,
13857,GO:0051380,1,0.969761983237616,0,5,norepinephrine binding,MF,
13858,GO:0051382,1,0.906324788516441,0,14,kinetochore assembly,BP,
13859,GO:0051383,1,0.875678760221123,0,19,kinetochore organization,BP,
13861,GO:0051385,1,0.842375459219028,0,28,response to mineralocorticoid,BP,
13862,GO:0051386,1,0.93993679229271,0,9,regulation of neurotrophin TRK receptor signaling pathway,BP,
13863,GO:0051387,1,0.981601261243011,0,3,negative regulation of neurotrophin TRK receptor signaling pathway,BP,
13864,GO:0051388,1,0.96984835481103,0,4,positive regulation of neurotrophin TRK receptor signaling pathway,BP,
13865,GO:0051389,1,0.980746374203713,0,2,inactivation of MAPKK activity,BP,
13866,GO:0051391,1,0.992479787768794,0,1,tRNA acetylation,BP,
13867,GO:0051392,1,0.992479787768794,0,1,tRNA N-acetyltransferase activity,MF,
13868,GO:0051393,1,0.761312812509023,0,33,alpha-actinin binding,MF,
13869,GO:0051400,1,0.949418020843614,0,8,BH domain binding,MF,
13872,GO:0051409,1,0.937402056942949,0,10,response to nitrosative stress,BP,
13874,GO:0051412,1,0.90149000547367,0,16,response to corticosterone,BP,
13875,GO:0051413,1,0.993515266373982,0,1,response to cortisone,BP,
13876,GO:0051414,1,0.964018059069019,0,5,response to cortisol,BP,
13877,GO:0051415,1,0.962990077345259,0,5,microtubule nucleation by interphase microtubule organizing center,BP,
13878,GO:0051417,1,0.993058458973322,0,1,microtubule nucleation by spindle pole body,BP,
13879,GO:0051418,1,0.945161411579031,0,7,microtubule nucleation by microtubule organizing center,BP,
13880,GO:0051424,1,0.995016832765426,0,1,corticotropin-releasing hormone binding,MF,
13881,GO:0051425,1,0.967439492379379,0,4,PTB domain binding,MF,
13883,GO:0051428,1,0.918722699534034,0,17,peptide hormone receptor binding,MF,
13884,GO:0051429,1,0.977160511554317,0,5,corticotropin-releasing hormone receptor binding,MF,
13885,GO:0051430,1,0.981242577885785,0,4,corticotropin-releasing hormone receptor 1 binding,MF,
13886,GO:0051431,1,0.989869670361285,0,3,corticotropin-releasing hormone receptor 2 binding,MF,
13887,GO:0051433,1,0.992329093505677,0,1,BH2 domain binding,MF,
13888,GO:0051434,1,0.97609174806339,0,4,BH3 domain binding,MF,
13889,GO:0051438,1,0.726017478396874,0,51,regulation of ubiquitin-protein transferase activity,BP,
13890,GO:0051443,1,0.814840567326346,0,32,positive regulation of ubiquitin-protein transferase activity,BP,
13891,GO:0051444,1,0.926845120938944,0,14,negative regulation of ubiquitin-protein transferase activity,BP,
13892,GO:0051445,1,0.776683286279562,0,38,regulation of meiotic cell cycle,BP,
13893,GO:0051446,1,0.908766270183961,0,14,positive regulation of meiotic cell cycle,BP,
13894,GO:0051447,1,0.913558167266106,0,14,negative regulation of meiotic cell cycle,BP,
13895,GO:0051450,1,0.889228323417604,0,18,myoblast proliferation,BP,
13896,GO:0051451,1,0.927916184826811,0,11,myoblast migration,BP,
13897,GO:0051452,1,0.75738405893994,0,47,intracellular pH reduction,BP,
13898,GO:0051453,1,0.567394031774597,0,85,regulation of intracellular pH,BP,
13899,GO:0051454,1,0.972322818614544,0,4,intracellular pH elevation,BP,
13900,GO:0051455,1,0.993058458973322,0,1,attachment of spindle microtubules to kinetochore involved in homologous chromosome segregation,BP,
13901,GO:0051456,1,0.994049863380193,0,1,attachment of spindle microtubules to kinetochore involved in meiotic sister chromatid segregation,BP,
13902,GO:0051457,1,0.861916745795854,0,22,maintenance of protein location in nucleus,BP,
13903,GO:0051458,1,0.965262027634056,0,7,corticotropin secretion,BP,
13904,GO:0051459,1,0.971659316948816,0,6,regulation of corticotropin secretion,BP,
13905,GO:0051460,1,0.995016832765426,0,1,negative regulation of corticotropin secretion,BP,
13906,GO:0051461,1,0.976526668332492,0,5,positive regulation of corticotropin secretion,BP,
13907,GO:0051462,1,0.975767656505025,0,5,regulation of cortisol secretion,BP,
13908,GO:0051463,1,0.991339408276264,0,1,negative regulation of cortisol secretion,BP,
13909,GO:0051464,1,0.984293566785975,0,4,positive regulation of cortisol secretion,BP,
13910,GO:0051466,1,0.992649030422308,0,1,positive regulation of corticotropin-releasing hormone secretion,BP,
13912,GO:0051481,1,0.9291728229384,0,9,negative regulation of cytosolic calcium ion concentration,BP,
13915,GO:0051490,1,0.988392767649386,0,2,negative regulation of filopodium assembly,BP,
13916,GO:0051491,1,0.814127352731762,0,28,positive regulation of filopodium assembly,BP,
13917,GO:0051492,1,0.583444409445183,0,75,regulation of stress fiber assembly,BP,
13921,GO:0051496,1,0.722835108425852,0,47,positive regulation of stress fiber assembly,BP,
13922,GO:0051497,1,0.865553805387192,0,20,negative regulation of stress fiber assembly,BP,
13923,GO:0051499,1,0.989184514972558,0,2,D-aminoacyl-tRNA deacylase activity,MF,
13924,GO:0051500,1,0.989184514972558,0,2,D-tyrosyl-tRNA(Tyr) deacylase activity,MF,
13926,GO:0051525,1,0.964510946799243,0,5,NFAT protein binding,MF,
13927,GO:0051536,1,0.692593622623448,0,61,iron-sulfur cluster binding,MF,
13928,GO:0051537,1,0.895751723375275,0,20,2 iron, 2 sulfur cluster binding,MF,
13929,GO:0051538,1,0.982311602799299,0,3,3 iron, 4 sulfur cluster binding,MF,
13930,GO:0051539,1,0.780759646060007,0,40,4 iron, 4 sulfur cluster binding,MF,
13931,GO:0051540,1,0.692593622623448,0,61,metal cluster binding,MF,
13932,GO:0051541,1,0.973920483423403,0,4,elastin metabolic process,BP,
13933,GO:0051542,1,0.983899141219864,0,2,elastin biosynthetic process,BP,
13934,GO:0051543,1,0.993824107636707,0,1,regulation of elastin biosynthetic process,BP,
13935,GO:0051545,1,0.993824107636707,0,1,negative regulation of elastin biosynthetic process,BP,
13936,GO:0051546,1,0.915919163468068,0,13,keratinocyte migration,BP,
13937,GO:0051547,1,0.938567367250764,0,9,regulation of keratinocyte migration,BP,
13938,GO:0051548,1,0.991801323675887,0,1,negative regulation of keratinocyte migration,BP,
13939,GO:0051549,1,0.946330283054824,0,8,positive regulation of keratinocyte migration,BP,
13940,GO:0051552,1,0.991319662364429,0,1,flavone metabolic process,BP,
13941,GO:0051560,1,0.870567960708218,0,21,mitochondrial calcium ion homeostasis,BP,
13942,GO:0051561,1,0.940692729404006,0,10,positive regulation of mitochondrial calcium ion concentration,BP,
13943,GO:0051562,1,0.982748289633531,0,3,negative regulation of mitochondrial calcium ion concentration,BP,
13944,GO:0051563,1,0.984076781331432,0,2,smooth endoplasmic reticulum calcium ion homeostasis,BP,
13945,GO:0051567,1,0.802385967132789,0,29,histone H3-K9 methylation,BP,
13946,GO:0051568,1,0.707627574950908,0,48,histone H3-K4 methylation,BP,
13947,GO:0051569,1,0.841089503854962,0,24,regulation of histone H3-K4 methylation,BP,
13948,GO:0051570,1,0.860568887645556,0,20,regulation of histone H3-K9 methylation,BP,
13949,GO:0051571,1,0.894228386573278,0,15,positive regulation of histone H3-K4 methylation,BP,
13950,GO:0051572,1,0.977109641395395,0,3,negative regulation of histone H3-K4 methylation,BP,
13951,GO:0051573,1,0.931054503747515,0,10,negative regulation of histone H3-K9 methylation,BP,
13952,GO:0051574,1,0.934424796206089,0,9,positive regulation of histone H3-K9 methylation,BP,
13953,GO:0051575,1,0.963591190730821,0,5,5'-deoxyribose-5-phosphate lyase activity,MF,
13954,GO:0051580,1,0.910033757951766,0,15,regulation of neurotransmitter uptake,BP,
13955,GO:0051581,1,0.973394951017489,0,4,negative regulation of neurotransmitter uptake,BP,
13956,GO:0051582,1,0.979247118677159,0,4,positive regulation of neurotransmitter uptake,BP,
13957,GO:0051583,1,0.938459686383487,0,11,dopamine uptake involved in synaptic transmission,BP,
13958,GO:0051584,1,0.962863737895457,0,7,regulation of dopamine uptake involved in synaptic transmission,BP,
13959,GO:0051585,1,0.992679397096388,0,1,negative regulation of dopamine uptake involved in synaptic transmission,BP,
13960,GO:0051586,1,0.985133693487826,0,3,positive regulation of dopamine uptake involved in synaptic transmission,BP,
13962,GO:0051589,1,0.871811926407505,0,19,negative regulation of neurotransmitter transport,BP,
13963,GO:0051590,1,0.842561112356825,0,26,positive regulation of neurotransmitter transport,BP,
13966,GO:0051593,1,0.939209731278944,0,11,response to folic acid,BP,
13967,GO:0051594,1,0.977367762130338,0,4,detection of glucose,BP,
13968,GO:0051595,1,0.984214929416438,0,3,response to methylglyoxal,BP,
13969,GO:0051596,1,0.988503962609357,0,2,methylglyoxal catabolic process,BP,
13970,GO:0051597,1,0.952748758556089,0,7,response to methylmercury,BP,
13971,GO:0051598,1,0.992307517981614,0,1,meiotic recombination checkpoint,BP,
13972,GO:0051599,1,0.962419095440619,0,5,response to hydrostatic pressure,BP,
13973,GO:0051601,1,0.946338424092698,0,8,exocyst localization,BP,
13977,GO:0051606,1,0.252672747540998,0,220,detection of stimulus,BP,
13979,GO:0051608,1,0.944253864895021,0,10,histamine transport,BP,
13980,GO:0051610,1,0.971423657624935,0,4,serotonin uptake,BP,
13981,GO:0051611,1,0.978931911435365,0,3,regulation of serotonin uptake,BP,
13982,GO:0051612,1,0.978931911435365,0,3,negative regulation of serotonin uptake,BP,
13983,GO:0051615,1,0.991752443864588,0,1,histamine uptake,BP,
13984,GO:0051620,1,0.992679397096388,0,1,norepinephrine uptake,BP,
13985,GO:0051621,1,0.992679397096388,0,1,regulation of norepinephrine uptake,BP,
13986,GO:0051622,1,0.992679397096388,0,1,negative regulation of norepinephrine uptake,BP,
13987,GO:0051639,1,0.942504213678041,0,8,actin filament network formation,BP,
13990,GO:0051642,1,0.835585671387586,0,22,centrosome localization,BP,
13991,GO:0051643,1,0.958063455933062,0,5,endoplasmic reticulum localization,BP,
13992,GO:0051645,1,0.910210386126688,0,13,Golgi localization,BP,
13993,GO:0051646,1,0.753558976404215,0,39,mitochondrion localization,BP,
13994,GO:0051647,1,0.839750371886266,0,22,nucleus localization,BP,
13995,GO:0051648,1,0.167939130177841,0,250,vesicle localization,BP,
13997,GO:0051650,1,0.184605645545657,0,238,establishment of vesicle localization,BP,
13999,GO:0051653,1,0.750198757631146,0,38,spindle localization,BP,
14000,GO:0051654,1,0.871966188649914,0,19,establishment of mitochondrion localization,BP,
14001,GO:0051656,1,0.0521065941534927,0,422,establishment of organelle localization,BP,
14002,GO:0051657,1,0.919426730143161,0,10,maintenance of organelle location,BP,
14003,GO:0051659,1,0.986627109393031,0,2,maintenance of mitochondrion location,BP,
14004,GO:0051660,1,0.969408903838819,0,4,establishment of centrosome localization,BP,
14005,GO:0051661,1,0.954758658413166,0,5,maintenance of centrosome location,BP,
14006,GO:0051664,1,0.985550476238211,0,2,nuclear pore localization,BP,
14007,GO:0051665,1,0.942694362050562,0,10,membrane raft localization,BP,
14008,GO:0051666,1,0.964654753478658,0,5,actin cortical patch localization,BP,
14012,GO:0051683,1,0.956882078520853,0,7,establishment of Golgi localization,BP,
14013,GO:0051684,1,0.975934781494651,0,3,maintenance of Golgi location,BP,
14014,GO:0051685,1,0.993058458973322,0,1,maintenance of ER location,BP,
14015,GO:0051686,1,0.987963114460795,0,1,establishment of ER localization,BP,
14016,GO:0051691,1,0.995378860140206,0,1,cellular oligosaccharide metabolic process,BP,
14017,GO:0051692,1,0.995378860140206,0,1,cellular oligosaccharide catabolic process,BP,
14019,GO:0051694,1,0.958458721556934,0,6,pointed-end actin filament capping,BP,
14020,GO:0051695,1,0.99233063256789,0,1,actin filament uncapping,BP,
14021,GO:0051697,1,0.97732688185777,0,4,protein delipidation,BP,
14026,GO:0051705,1,0.631621154522029,0,63,multi-organism behavior,BP,
14028,GO:0051708,1,0.992519221230875,0,2,intracellular protein transport in other organism involved in symbiotic interaction,BP,
14030,GO:0051710,1,0.996996425083931,0,1,regulation of cytolysis in other organism,BP,
14032,GO:0051714,1,0.996996425083931,0,1,positive regulation of cytolysis in other organism,BP,
14033,GO:0051715,1,0.98235516485009,0,4,cytolysis in other organism,BP,
14035,GO:0051717,1,0.984833909929323,0,2,inositol-1,3,4,5-tetrakisphosphate 3-phosphatase activity,MF,
14036,GO:0051721,1,0.822991299854021,0,27,protein phosphatase 2A binding,MF,
14037,GO:0051722,1,0.99361269409307,0,1,protein C-terminal methylesterase activity,MF,
14038,GO:0051723,1,0.99361269409307,0,1,protein methylesterase activity,MF,
14039,GO:0051724,1,0.994025486367947,0,1,NAD transmembrane transporter activity,MF,
14040,GO:0051725,1,0.976509604848188,0,4,protein de-ADP-ribosylation,BP,
14042,GO:0051728,1,0.992818852022948,0,1,cell cycle switching, mitotic to meiotic cell cycle,BP,
14043,GO:0051729,1,0.992818852022948,0,1,germline cell cycle switching, mitotic to meiotic cell cycle,BP,
14044,GO:0051731,1,0.972875303975957,0,4,polynucleotide 5'-hydroxyl-kinase activity,MF,
14045,GO:0051732,1,0.995233406655209,0,1,polyribonucleotide kinase activity,MF,
14046,GO:0051733,1,0.98163392972448,0,3,polydeoxyribonucleotide kinase activity,MF,
14047,GO:0051734,1,0.98163392972448,0,3,ATP-dependent polynucleotide kinase activity,MF,
14048,GO:0051736,1,0.995233406655209,0,1,ATP-dependent polyribonucleotide 5'-hydroxyl-kinase activity,MF,
14049,GO:0051747,1,0.992656695557166,0,2,cytosine C-5 DNA demethylase activity,MF,
14050,GO:0051748,1,0.994298917725665,0,1,UTP-monosaccharide-1-phosphate uridylyltransferase activity,MF,
14051,GO:0051750,1,0.996318964210472,0,1,delta3,5-delta2,4-dienoyl-CoA isomerase activity,MF,
14052,GO:0051754,1,0.972177634881435,0,4,meiotic sister chromatid cohesion, centromeric,BP,
14053,GO:0051758,1,0.991251300075914,0,1,homologous chromosome movement towards spindle pole involved in homologous chromosome segregation,BP,
14054,GO:0051764,1,0.923419685537519,0,11,actin crosslink formation,BP,
14055,GO:0051765,1,0.987788764499261,0,2,inositol tetrakisphosphate kinase activity,MF,
14056,GO:0051766,1,0.960018043329842,0,6,inositol trisphosphate kinase activity,MF,
14057,GO:0051767,1,0.894656553231958,0,17,nitric-oxide synthase biosynthetic process,BP,
14058,GO:0051769,1,0.894656553231958,0,17,regulation of nitric-oxide synthase biosynthetic process,BP,
14059,GO:0051770,1,0.908666022846452,0,14,positive regulation of nitric-oxide synthase biosynthetic process,BP,
14060,GO:0051771,1,0.984597034226673,0,3,negative regulation of nitric-oxide synthase biosynthetic process,BP,
14061,GO:0051775,1,0.932232845925783,0,11,response to redox state,BP,
14062,GO:0051780,1,0.992450517902719,0,1,behavioral response to nutrient,BP,
14063,GO:0051781,1,0.628943114780971,0,71,positive regulation of cell division,BP,
14064,GO:0051782,1,0.904015866757743,0,14,negative regulation of cell division,BP,
14066,GO:0051784,1,0.698478446008817,0,54,negative regulation of nuclear division,BP,
14067,GO:0051785,1,0.683311006455992,0,55,positive regulation of nuclear division,BP,
14068,GO:0051786,1,0.99260242144494,0,1,all-trans-retinol 13,14-reductase activity,MF,
14069,GO:0051787,1,0.842218261649284,0,26,misfolded protein binding,MF,
14070,GO:0051788,1,0.855337894100946,0,23,response to misfolded protein,BP,
14071,GO:0051790,1,0.976045362192983,0,4,short-chain fatty acid biosynthetic process,BP,
14072,GO:0051791,1,0.943637678008029,0,10,medium-chain fatty acid metabolic process,BP,
14073,GO:0051792,1,0.972472800222627,0,5,medium-chain fatty acid biosynthetic process,BP,
14074,GO:0051793,1,0.969907627092764,0,5,medium-chain fatty acid catabolic process,BP,
14075,GO:0051794,1,0.976150712840454,0,4,regulation of timing of catagen,BP,
14076,GO:0051795,1,0.983611969658536,0,3,positive regulation of timing of catagen,BP,
14077,GO:0051796,1,0.99241567941278,0,1,negative regulation of timing of catagen,BP,
14078,GO:0051797,1,0.889734580817402,0,18,regulation of hair follicle development,BP,
14079,GO:0051798,1,0.940076469148988,0,11,positive regulation of hair follicle development,BP,
14080,GO:0051799,1,0.977126231989836,0,3,negative regulation of hair follicle development,BP,
14081,GO:0051800,1,0.986870337169149,0,2,phosphatidylinositol-3,4-bisphosphate 3-phosphatase activity,MF,
14082,GO:0051801,1,0.987276757373615,0,2,cytolysis in other organism involved in symbiotic interaction,BP,
14083,GO:0051805,1,0.985229037370364,0,2,evasion or tolerance of immune response of other organism involved in symbiotic interaction,BP,
14085,GO:0051807,1,0.985229037370364,0,2,evasion or tolerance of defense response of other organism involved in symbiotic interaction,BP,
14086,GO:0051808,1,0.993704412915987,0,1,translocation of peptides or proteins into other organism involved in symbiotic interaction,BP,
14088,GO:0051818,1,0.947420828747383,0,12,disruption of cells of other organism involved in symbiotic interaction,BP,
14089,GO:0051821,1,0.991274064861212,0,1,dissemination or transmission of organism from other organism involved in symbiotic interaction,BP,
14090,GO:0051823,1,0.933192369917832,0,9,regulation of synapse structural plasticity,BP,
14092,GO:0051832,1,0.971232151525118,0,4,avoidance of defenses of other organism involved in symbiotic interaction,BP,
14093,GO:0051833,1,0.992003285188543,0,1,suppression of defenses of other organism involved in symbiotic interaction,BP,
14094,GO:0051834,1,0.971232151525118,0,4,evasion or tolerance of defenses of other organism involved in symbiotic interaction,BP,
14095,GO:0051835,1,0.97121484724163,0,4,positive regulation of synapse structural plasticity,BP,
14096,GO:0051836,1,0.948518028963618,0,9,translocation of molecules into other organism involved in symbiotic interaction,BP,
14098,GO:0051852,1,0.970432437691041,0,8,disruption by host of symbiont cells,BP,
14100,GO:0051864,1,0.938589258004993,0,8,histone demethylase activity (H3-K36 specific),MF,
14101,GO:0051865,1,0.678343666269119,0,54,protein autoubiquitination,BP,
14102,GO:0051866,1,0.988878499421557,0,2,general adaptation syndrome,BP,
14103,GO:0051867,1,0.996315689092069,0,1,general adaptation syndrome, behavioral process,BP,
14104,GO:0051870,1,0.985969487609691,0,3,methotrexate binding,MF,
14105,GO:0051873,1,0.970432437691041,0,8,killing by host of symbiont cells,BP,
14106,GO:0051875,1,0.836127607433845,0,27,pigment granule localization,BP,
14107,GO:0051877,1,0.986082741696439,0,2,pigment granule aggregation in cell center,BP,
14109,GO:0051880,1,0.943805190440271,0,7,G-quadruplex DNA binding,MF,
14112,GO:0051883,1,0.947420828747383,0,12,killing of cells in other organism involved in symbiotic interaction,BP,
14113,GO:0051884,1,0.96328903361945,0,5,regulation of timing of anagen,BP,
14114,GO:0051885,1,0.985686721705911,0,2,positive regulation of timing of anagen,BP,
14115,GO:0051886,1,0.99203283408172,0,1,negative regulation of timing of anagen,BP,
14116,GO:0051890,1,0.957641594944827,0,6,regulation of cardioblast differentiation,BP,
14117,GO:0051891,1,0.964954599453152,0,5,positive regulation of cardioblast differentiation,BP,
14118,GO:0051892,1,0.992424091422782,0,1,negative regulation of cardioblast differentiation,BP,
14120,GO:0051894,1,0.840738469406886,0,23,positive regulation of focal adhesion assembly,BP,
14124,GO:0051898,1,0.759183107296394,0,39,negative regulation of protein kinase B signaling,BP,
14128,GO:0051902,1,0.963748496715203,0,6,negative regulation of mitochondrial depolarization,BP,
14129,GO:0051903,1,0.993273917152675,0,1,S-(hydroxymethyl)glutathione dehydrogenase activity,MF,
14130,GO:0051904,1,0.855496662099117,0,24,pigment granule transport,BP,
14131,GO:0051905,1,0.847473509789258,0,25,establishment of pigment granule localization,BP,
14132,GO:0051908,1,0.992659770028156,0,1,double-stranded DNA 5'-3' exodeoxyribonuclease activity,MF,
14133,GO:0051916,1,0.992840643652522,0,1,granulocyte colony-stimulating factor binding,MF,
14134,GO:0051917,1,0.939475822378624,0,10,regulation of fibrinolysis,BP,
14135,GO:0051918,1,0.95700378679131,0,7,negative regulation of fibrinolysis,BP,
14136,GO:0051919,1,0.982439404290529,0,3,positive regulation of fibrinolysis,BP,
14137,GO:0051920,1,0.96968880013001,0,8,peroxiredoxin activity,MF,
14138,GO:0051923,1,0.921425425020255,0,14,sulfation,BP,
14140,GO:0051926,1,0.729739335244054,0,50,negative regulation of calcium ion transport,BP,
14144,GO:0051932,1,0.731380908680881,0,43,synaptic transmission, GABAergic,BP,
14145,GO:0051933,1,0.975713684620602,0,3,amino acid neurotransmitter reuptake,BP,
14146,GO:0051934,1,0.938459686383487,0,11,catecholamine uptake involved in synaptic transmission,BP,
14147,GO:0051935,1,0.975713684620602,0,3,glutamate reuptake,BP,
14148,GO:0051937,1,0.726317478096804,0,51,catecholamine transport,BP,
14150,GO:0051939,1,0.992345679821318,0,1,gamma-aminobutyric acid import,BP,
14151,GO:0051940,1,0.962863737895457,0,7,regulation of catecholamine uptake involved in synaptic transmission,BP,
14152,GO:0051941,1,0.983217443698642,0,2,regulation of amino acid uptake involved in synaptic transmission,BP,
14153,GO:0051944,1,0.985133693487826,0,3,positive regulation of catecholamine uptake involved in synaptic transmission,BP,
14154,GO:0051945,1,0.992679397096388,0,1,negative regulation of catecholamine uptake involved in synaptic transmission,BP,
14155,GO:0051946,1,0.983217443698642,0,2,regulation of glutamate uptake involved in transmission of nerve impulse,BP,
14157,GO:0051953,1,0.878978547532887,0,20,negative regulation of amine transport,BP,
14160,GO:0051956,1,0.936713449911389,0,10,negative regulation of amino acid transport,BP,
14162,GO:0051958,1,0.984265995709688,0,2,methotrexate transport,BP,
14163,GO:0051959,1,0.756050383556179,0,29,dynein light intermediate chain binding,MF,
14168,GO:0051964,1,0.95061732496419,0,6,negative regulation of synapse assembly,BP,
14171,GO:0051967,1,0.930749036382306,0,10,negative regulation of synaptic transmission, glutamatergic,BP,
14173,GO:0051969,1,0.923399186647593,0,13,regulation of transmission of nerve impulse,BP,
14174,GO:0051970,1,0.982569304419365,0,3,negative regulation of transmission of nerve impulse,BP,
14175,GO:0051971,1,0.967238449103012,0,5,positive regulation of transmission of nerve impulse,BP,
14176,GO:0051972,1,0.743312328911106,0,45,regulation of telomerase activity,BP,
14177,GO:0051973,1,0.795064520484635,0,35,positive regulation of telomerase activity,BP,
14178,GO:0051974,1,0.943742030233514,0,9,negative regulation of telomerase activity,BP,
14179,GO:0051977,1,0.994194828677141,0,1,lysophospholipid transport,BP,
14180,GO:0051978,1,0.994194828677141,0,1,lysophospholipid transporter activity,MF,
14181,GO:0051983,1,0.528173138446146,0,90,regulation of chromosome segregation,BP,
14182,GO:0051984,1,0.842044729374602,0,24,positive regulation of chromosome segregation,BP,
14183,GO:0051985,1,0.774555269521571,0,37,negative regulation of chromosome segregation,BP,
14184,GO:0051987,1,0.967375099841072,0,5,positive regulation of attachment of spindle microtubules to kinetochore,BP,
14185,GO:0051988,1,0.918045639945818,0,12,regulation of attachment of spindle microtubules to kinetochore,BP,
14186,GO:0051990,1,0.987285038397411,0,2,(R)-2-hydroxyglutarate dehydrogenase activity,MF,
14187,GO:0051996,1,0.994382162919748,0,1,squalene synthase activity,MF,
14188,GO:0051998,1,0.962160642581689,0,6,protein carboxyl O-methyltransferase activity,MF,
14189,GO:0052026,1,0.992942551431755,0,1,modulation by symbiont of host transcription,BP,
14190,GO:0052027,1,0.984680662431921,0,2,modulation by symbiont of host signal transduction pathway,BP,
14191,GO:0052029,1,0.992003285188543,0,1,negative regulation by symbiont of host signal transduction pathway,BP,
14192,GO:0052031,1,0.986218198019591,0,2,modulation by symbiont of host defense response,BP,
14193,GO:0052037,1,0.992003285188543,0,1,negative regulation by symbiont of host defense response,BP,
14194,GO:0052040,1,0.964735868765068,0,6,modulation by symbiont of host programmed cell death,BP,
14195,GO:0052041,1,0.976055555726026,0,4,negative regulation by symbiont of host programmed cell death,BP,
14196,GO:0052042,1,0.98513298625883,0,3,positive regulation by symbiont of host programmed cell death,BP,
14197,GO:0052047,1,0.983930330260967,0,2,interaction with other organism via secreted substance involved in symbiotic interaction,BP,
14198,GO:0052053,1,0.993091908715104,0,1,negative regulation by symbiont of host catalytic activity,BP,
14199,GO:0052055,1,0.985149888032672,0,2,modulation by symbiont of host molecular function,BP,
14200,GO:0052056,1,0.985149888032672,0,2,negative regulation by symbiont of host molecular function,BP,
14201,GO:0052066,1,0.990939815390663,0,1,entry of symbiont into host cell by promotion of host phagocytosis,BP,
14202,GO:0052097,1,0.992618000628388,0,1,interspecies quorum sensing,BP,
14203,GO:0052106,1,0.992618000628388,0,1,quorum sensing involved in interaction with host,BP,
14205,GO:0052148,1,0.993091908715104,0,1,modulation by symbiont of host catalytic activity,BP,
14206,GO:0052150,1,0.968403564813367,0,5,modulation by symbiont of host apoptotic process,BP,
14207,GO:0052151,1,0.988877440650483,0,2,positive regulation by symbiont of host apoptotic process,BP,
14208,GO:0052167,1,0.992003285188543,0,1,modulation by symbiont of host innate immune response,BP,
14209,GO:0052170,1,0.992003285188543,0,1,negative regulation by symbiont of host innate immune response,BP,
14210,GO:0052173,1,0.966752764072485,0,5,response to defenses of other organism involved in symbiotic interaction,BP,
14211,GO:0052182,1,0.993792499136506,0,1,modification by host of symbiont morphology or physiology via secreted substance,BP,
14212,GO:0052190,1,0.990939815390663,0,1,modulation by symbiont of host phagocytosis,BP,
14213,GO:0052191,1,0.990939815390663,0,1,positive regulation by symbiont of host phagocytosis,BP,
14215,GO:0052199,1,0.987916796712114,0,2,negative regulation of catalytic activity in other organism involved in symbiotic interaction,BP,
14216,GO:0052200,1,0.966752764072485,0,5,response to host defenses,BP,
14217,GO:0052203,1,0.983208382514533,0,3,modulation of catalytic activity in other organism involved in symbiotic interaction,BP,
14218,GO:0052204,1,0.964161611979361,0,7,negative regulation of molecular function in other organism involved in symbiotic interaction,BP,
14219,GO:0052205,1,0.955712119045257,0,8,modulation of molecular function in other organism involved in symbiotic interaction,BP,
14220,GO:0052212,1,0.993792499136506,0,1,modification of morphology or physiology of other organism via secreted substance involved in symbiotic interaction,BP,
14221,GO:0052213,1,0.993792499136506,0,1,interaction with symbiont via secreted substance involved in symbiotic interaction,BP,
14222,GO:0052214,1,0.995487307145082,0,1,metabolism of substance in other organism involved in symbiotic interaction,BP,
14223,GO:0052227,1,0.995487307145082,0,1,catabolism of substance in other organism involved in symbiotic interaction,BP,
14224,GO:0052229,1,0.995487307145082,0,1,metabolism of macromolecule in other organism involved in symbiotic interaction,BP,
14225,GO:0052231,1,0.990939815390663,0,1,modulation of phagocytosis in other organism involved in symbiotic interaction,BP,
14226,GO:0052248,1,0.964735868765068,0,6,modulation of programmed cell death in other organism involved in symbiotic interaction,BP,
14227,GO:0052250,1,0.984680662431921,0,2,modulation of signal transduction in other organism involved in symbiotic interaction,BP,
14228,GO:0052251,1,0.994168744955213,0,1,induction by organism of defense response of other organism involved in symbiotic interaction,BP,
14229,GO:0052255,1,0.986218198019591,0,2,modulation by organism of defense response of other organism involved in symbiotic interaction,BP,
14230,GO:0052261,1,0.992003285188543,0,1,suppression of defense response of other organism involved in symbiotic interaction,BP,
14231,GO:0052306,1,0.992003285188543,0,1,modulation by organism of innate immune response in other organism involved in symbiotic interaction,BP,
14232,GO:0052309,1,0.992003285188543,0,1,negative regulation by organism of innate immune response in other organism involved in symbiotic interaction,BP,
14233,GO:0052312,1,0.84022586644217,0,25,modulation of transcription in other organism involved in symbiotic interaction,BP,
14234,GO:0052314,1,0.989472588864158,0,2,phytoalexin metabolic process,BP,
14235,GO:0052330,1,0.98513298625883,0,3,positive regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,
14236,GO:0052331,1,0.987276757373615,0,2,hemolysis in other organism involved in symbiotic interaction,BP,
14237,GO:0052360,1,0.995487307145082,0,1,catabolism by host of symbiont macromolecule,BP,
14238,GO:0052361,1,0.995487307145082,0,1,catabolism by organism of macromolecule in other organism involved in symbiotic interaction,BP,
14239,GO:0052362,1,0.995487307145082,0,1,catabolism by host of symbiont protein,BP,
14240,GO:0052363,1,0.995487307145082,0,1,catabolism by organism of protein in other organism involved in symbiotic interaction,BP,
14241,GO:0052364,1,0.995487307145082,0,1,catabolism by host of substance in symbiont,BP,
14242,GO:0052370,1,0.990939815390663,0,1,entry of organism into cell of other organism by promotion of phagocytosis in other organism involved in symbiotic interaction,BP,
14243,GO:0052381,1,0.994326585888226,0,1,tRNA dimethylallyltransferase activity,MF,
14244,GO:0052403,1,0.994789249680222,0,1,negative regulation by host of symbiont catalytic activity,BP,
14245,GO:0052405,1,0.978698504814455,0,5,negative regulation by host of symbiont molecular function,BP,
14246,GO:0052416,1,0.995487307145082,0,1,metabolism by host of symbiont macromolecule,BP,
14247,GO:0052417,1,0.995487307145082,0,1,metabolism by host of symbiont protein,BP,
14248,GO:0052418,1,0.995487307145082,0,1,metabolism by organism of protein in other organism involved in symbiotic interaction,BP,
14249,GO:0052419,1,0.995487307145082,0,1,metabolism by host of substance in symbiont,BP,
14250,GO:0052422,1,0.990048409567452,0,2,modulation by host of symbiont catalytic activity,BP,
14251,GO:0052428,1,0.970122893112145,0,6,modulation by host of symbiont molecular function,BP,
14252,GO:0052433,1,0.964735868765068,0,6,modulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
14253,GO:0052472,1,0.846207876598775,0,24,modulation by host of symbiont transcription,BP,
14254,GO:0052490,1,0.976055555726026,0,4,negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction,BP,
14255,GO:0052493,1,0.992003285188543,0,1,negative regulation by organism of signal transduction in other organism involved in symbiotic interaction,BP,
14256,GO:0052501,1,0.98513298625883,0,3,positive regulation by organism of apoptotic process in other organism involved in symbiotic interaction,BP,
14257,GO:0052509,1,0.994168744955213,0,1,positive regulation by symbiont of host defense response,BP,
14258,GO:0052510,1,0.994168744955213,0,1,positive regulation by organism of defense response of other organism involved in symbiotic interaction,BP,
14259,GO:0052522,1,0.990939815390663,0,1,positive regulation by organism of phagocytosis in other organism involved in symbiotic interaction,BP,
14262,GO:0052550,1,0.995389277614451,0,1,response to defense-related reactive oxygen species production by other organism involved in symbiotic interaction,BP,
14263,GO:0052552,1,0.986218198019591,0,2,modulation by organism of immune response of other organism involved in symbiotic interaction,BP,
14264,GO:0052553,1,0.986218198019591,0,2,modulation by symbiont of host immune response,BP,
14265,GO:0052561,1,0.992003285188543,0,1,negative regulation by organism of immune response of other organism involved in symbiotic interaction,BP,
14266,GO:0052562,1,0.992003285188543,0,1,negative regulation by symbiont of host immune response,BP,
14267,GO:0052564,1,0.974966003343944,0,4,response to immune response of other organism involved in symbiotic interaction,BP,
14268,GO:0052567,1,0.995389277614451,0,1,response to defense-related host reactive oxygen species production,BP,
14269,GO:0052572,1,0.974966003343944,0,4,response to host immune response,BP,
14270,GO:0052590,1,0.991566460486065,0,1,sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity,MF,
14271,GO:0052591,1,0.991566460486065,0,1,sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity,MF,
14272,GO:0052593,1,0.98583494667468,0,2,tryptamine:oxygen oxidoreductase (deaminating) activity,MF,
14273,GO:0052594,1,0.98583494667468,0,2,aminoacetone:oxygen oxidoreductase(deaminating) activity,MF,
14274,GO:0052595,1,0.98583494667468,0,2,aliphatic-amine oxidase activity,MF,
14275,GO:0052596,1,0.98583494667468,0,2,phenethylamine:oxygen oxidoreductase (deaminating) activity,MF,
14276,GO:0052629,1,0.90706623016524,0,12,phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity,MF,
14277,GO:0052642,1,0.988593969661982,0,2,lysophosphatidic acid phosphatase activity,MF,
14278,GO:0052646,1,0.933043155817082,0,9,alditol phosphate metabolic process,BP,
14279,GO:0052650,1,0.959401522872521,0,8,NADP-retinol dehydrogenase activity,MF,
14280,GO:0052651,1,0.988243101149474,0,2,monoacylglycerol catabolic process,BP,
14282,GO:0052654,1,0.985720978868277,0,2,L-leucine transaminase activity,MF,
14283,GO:0052655,1,0.985720978868277,0,2,L-valine transaminase activity,MF,
14284,GO:0052656,1,0.985720978868277,0,2,L-isoleucine transaminase activity,MF,
14285,GO:0052657,1,0.995986077774223,0,1,guanine phosphoribosyltransferase activity,MF,
14286,GO:0052658,1,0.955657679311702,0,6,inositol-1,4,5-trisphosphate 5-phosphatase activity,MF,
14287,GO:0052659,1,0.933905746979054,0,9,inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity,MF,
14288,GO:0052666,1,0.994732359360662,0,1,tRNA (cytosine-2'-O-)-methyltransferase activity,MF,
14290,GO:0052692,1,0.995979396295435,0,1,raffinose alpha-galactosidase activity,MF,
14291,GO:0052695,1,0.979690525566472,0,3,cellular glucuronidation,BP,
14292,GO:0052717,1,0.991364114518273,0,1,tRNA-specific adenosine-34 deaminase activity,MF,
14293,GO:0052718,1,0.991364114518273,0,1,tRNA-specific adenosine-34 deaminase complex,CC,
14294,GO:0052723,1,0.965837820280973,0,5,inositol hexakisphosphate 1-kinase activity,MF,
14295,GO:0052724,1,0.965837820280973,0,5,inositol hexakisphosphate 3-kinase activity,MF,
14296,GO:0052725,1,0.99263010078286,0,1,inositol-1,3,4-trisphosphate 6-kinase activity,MF,
14297,GO:0052726,1,0.99263010078286,0,1,inositol-1,3,4-trisphosphate 5-kinase activity,MF,
14298,GO:0052731,1,0.994383323997504,0,1,phosphocholine phosphatase activity,MF,
14299,GO:0052732,1,0.994383323997504,0,1,phosphoethanolamine phosphatase activity,MF,
14300,GO:0052735,1,0.978082467142254,0,3,tRNA (cytosine-3-)-methyltransferase activity,MF,
14301,GO:0052739,1,0.986118788017723,0,3,phosphatidylserine 1-acylhydrolase activity,MF,
14302,GO:0052740,1,0.990865469812629,0,2,1-acyl-2-lysophosphatidylserine acylhydrolase activity,MF,
14304,GO:0052743,1,0.919732441946346,0,11,inositol tetrakisphosphate phosphatase activity,MF,
14305,GO:0052744,1,0.886356033897539,0,15,phosphatidylinositol monophosphate phosphatase activity,MF,
14306,GO:0052745,1,0.867987387661441,0,19,inositol phosphate phosphatase activity,MF,
14307,GO:0052746,1,0.985064533974123,0,2,inositol phosphorylation,BP,
14308,GO:0052794,1,0.981541597751567,0,3,exo-alpha-(2->3)-sialidase activity,MF,
14309,GO:0052795,1,0.981541597751567,0,3,exo-alpha-(2->6)-sialidase activity,MF,
14310,GO:0052796,1,0.981541597751567,0,3,exo-alpha-(2->8)-sialidase activity,MF,
14311,GO:0052798,1,0.994405408097248,0,1,beta-galactoside alpha-2,3-sialyltransferase activity,MF,
14312,GO:0052803,1,0.940370384657666,0,10,imidazole-containing compound metabolic process,BP,
14313,GO:0052805,1,0.958482912128252,0,7,imidazole-containing compound catabolic process,BP,
14314,GO:0052810,1,0.985796019854571,0,2,1-phosphatidylinositol-5-kinase activity,MF,
14315,GO:0052811,1,0.970651682456059,0,4,1-phosphatidylinositol-3-phosphate 4-kinase activity,MF,
14316,GO:0052812,1,0.977995423171406,0,3,phosphatidylinositol-3,4-bisphosphate 5-kinase activity,MF,
14318,GO:0052815,1,0.989141480334801,0,2,medium-chain acyl-CoA hydrolase activity,MF,
14319,GO:0052816,1,0.992562890664473,0,1,long-chain acyl-CoA hydrolase activity,MF,
14320,GO:0052817,1,0.992562890664473,0,1,very long chain acyl-CoA hydrolase activity,MF,
14321,GO:0052821,1,0.99670774898663,0,1,DNA-7-methyladenine glycosylase activity,MF,
14322,GO:0052822,1,0.99670774898663,0,1,DNA-3-methylguanine glycosylase activity,MF,
14323,GO:0052825,1,0.99263010078286,0,1,inositol-1,3,4,5,6-pentakisphosphate 1-phosphatase activity,MF,
14324,GO:0052826,1,0.992975566243211,0,1,inositol hexakisphosphate 2-phosphatase activity,MF,
14325,GO:0052827,1,0.985656922710953,0,2,inositol pentakisphosphate phosphatase activity,MF,
14326,GO:0052828,1,0.983612487903002,0,2,inositol-3,4-bisphosphate 4-phosphatase activity,MF,
14327,GO:0052829,1,0.994420543402286,0,1,inositol-1,3,4-trisphosphate 1-phosphatase activity,MF,
14328,GO:0052830,1,0.99263010078286,0,1,inositol-1,3,4,6-tetrakisphosphate 6-phosphatase activity,MF,
14329,GO:0052831,1,0.99263010078286,0,1,inositol-1,3,4,6-tetrakisphosphate 1-phosphatase activity,MF,
14330,GO:0052832,1,0.972117065986413,0,4,inositol monophosphate 3-phosphatase activity,MF,
14331,GO:0052833,1,0.972117065986413,0,4,inositol monophosphate 4-phosphatase activity,MF,
14332,GO:0052834,1,0.972117065986413,0,4,inositol monophosphate phosphatase activity,MF,
14333,GO:0052835,1,0.99263010078286,0,1,inositol-3,4,6-trisphosphate 1-kinase activity,MF,
14334,GO:0052836,1,0.981784969622937,0,3,inositol 5-diphosphate pentakisphosphate 5-kinase activity,MF,
14335,GO:0052839,1,0.981784969622937,0,3,inositol diphosphate tetrakisphosphate kinase activity,MF,
14336,GO:0052840,1,0.976974422612972,0,4,inositol diphosphate tetrakisphosphate diphosphatase activity,MF,
14337,GO:0052841,1,0.976974422612972,0,4,inositol bisdiphosphate tetrakisphosphate diphosphatase activity,MF,
14338,GO:0052842,1,0.976974422612972,0,4,inositol diphosphate pentakisphosphate diphosphatase activity,MF,
14339,GO:0052843,1,0.976974422612972,0,4,inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity,MF,
14340,GO:0052844,1,0.976974422612972,0,4,inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity,MF,
14341,GO:0052845,1,0.976974422612972,0,4,inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity,MF,
14342,GO:0052846,1,0.976974422612972,0,4,inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity,MF,
14343,GO:0052847,1,0.976974422612972,0,4,inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity,MF,
14344,GO:0052848,1,0.976974422612972,0,4,inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity,MF,
14345,GO:0052851,1,0.965685209486323,0,5,ferric-chelate reductase (NADPH) activity,MF,
14346,GO:0052852,1,0.995228728217183,0,1,very-long-chain-(S)-2-hydroxy-acid oxidase activity,MF,
14347,GO:0052853,1,0.995228728217183,0,1,long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity,MF,
14348,GO:0052854,1,0.995228728217183,0,1,medium-chain-(S)-2-hydroxy-acid oxidase activity,MF,
14349,GO:0052856,1,0.996924630150993,0,1,NADHX epimerase activity,MF,
14350,GO:0052857,1,0.996924630150993,0,1,NADPHX epimerase activity,MF,
14351,GO:0052858,1,0.992526837391331,0,1,peptidyl-lysine acetyltransferase activity,MF,
14352,GO:0052866,1,0.805056948611298,0,28,phosphatidylinositol phosphate phosphatase activity,MF,
14353,GO:0052870,1,0.992814146848517,0,1,tocopherol omega-hydroxylase activity,MF,
14354,GO:0052871,1,0.992814146848517,0,1,alpha-tocopherol omega-hydroxylase activity,MF,
14355,GO:0052884,1,0.993321774029604,0,1,all-trans-retinyl-palmitate hydrolase, 11-cis retinol forming activity,MF,
14356,GO:0052885,1,0.993321774029604,0,1,all-trans-retinyl-ester hydrolase, 11-cis retinol forming activity,MF,
14357,GO:0052890,1,0.994822455267186,0,1,oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor,MF,
14358,GO:0052894,1,0.99446255675343,0,1,norspermine:oxygen oxidoreductase activity,MF,
14359,GO:0052895,1,0.99446255675343,0,1,N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity,MF,
14360,GO:0052899,1,0.995349884203026,0,1,N(1),N(12)-diacetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
14361,GO:0052901,1,0.989837934035546,0,2,spermine:oxygen oxidoreductase (spermidine-forming) activity,MF,
14362,GO:0052902,1,0.995349884203026,0,1,spermidine:oxygen oxidoreductase (3-aminopropanal-forming) activity,MF,
14363,GO:0052903,1,0.995349884203026,0,1,N1-acetylspermine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
14364,GO:0052904,1,0.995349884203026,0,1,N1-acetylspermidine:oxygen oxidoreductase (3-acetamidopropanal-forming) activity,MF,
14365,GO:0052905,1,0.979318172289429,0,3,tRNA (guanine(9)-N(1))-methyltransferase activity,MF,
14366,GO:0052906,1,0.991964502722022,0,1,tRNA (guanine(37)-N(1))-methyltransferase activity,MF,
14367,GO:0052907,1,0.993058458973322,0,1,23S rRNA (adenine(1618)-N(6))-methyltransferase activity,MF,
14368,GO:0052909,1,0.993058458973322,0,1,18S rRNA (adenine(1779)-N(6)/adenine(1780)-N(6))-dimethyltransferase activity,MF,
14369,GO:0052917,1,0.993786209041868,0,1,dol-P-Man:Man(7)GlcNAc(2)-PP-Dol alpha-1,6-mannosyltransferase activity,MF,
14370,GO:0052918,1,0.991337865016234,0,1,dol-P-Man:Man(8)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
14371,GO:0052925,1,0.995758462336402,0,1,dol-P-Man:Man(5)GlcNAc(2)-PP-Dol alpha-1,3-mannosyltransferase activity,MF,
14372,GO:0052926,1,0.991337865016234,0,1,dol-P-Man:Man(6)GlcNAc(2)-PP-Dol alpha-1,2-mannosyltransferase activity,MF,
14373,GO:0052927,1,0.994001218984072,0,1,CTP:tRNA cytidylyltransferase activity,MF,
14374,GO:0052928,1,0.994001218984072,0,1,CTP:3'-cytidine-tRNA cytidylyltransferase activity,MF,
14375,GO:0052929,1,0.994001218984072,0,1,ATP:3'-cytidine-cytidine-tRNA adenylyltransferase activity,MF,
14378,GO:0055003,1,0.847608008587516,0,19,cardiac myofibril assembly,BP,
14379,GO:0055005,1,0.979560662708565,0,3,ventricular cardiac myofibril assembly,BP,
14382,GO:0055008,1,0.619497989059375,0,63,cardiac muscle tissue morphogenesis,BP,
14383,GO:0055009,1,0.95961136557191,0,6,atrial cardiac muscle tissue morphogenesis,BP,
14384,GO:0055010,1,0.720880915051971,0,44,ventricular cardiac muscle tissue morphogenesis,BP,
14385,GO:0055011,1,0.990191557923563,0,2,atrial cardiac muscle cell differentiation,BP,
14386,GO:0055012,1,0.901520733082888,0,15,ventricular cardiac muscle cell differentiation,BP,
14388,GO:0055014,1,0.990191557923563,0,2,atrial cardiac muscle cell development,BP,
14389,GO:0055015,1,0.938808561807593,0,10,ventricular cardiac muscle cell development,BP,
14391,GO:0055018,1,0.995148968087614,0,1,regulation of cardiac muscle fiber development,BP,
14392,GO:0055020,1,0.995148968087614,0,1,positive regulation of cardiac muscle fiber development,BP,
14395,GO:0055023,1,0.806232312756373,0,29,positive regulation of cardiac muscle tissue growth,BP,
14397,GO:0055025,1,0.755752990800185,0,38,positive regulation of cardiac muscle tissue development,BP,
14399,GO:0055028,1,0.990783868118484,0,1,cortical microtubule,CC,
14400,GO:0055029,1,0.43329919124528,0,131,nuclear DNA-directed RNA polymerase complex,CC,
14402,GO:0055038,1,0.641510119918759,0,67,recycling endosome membrane,CC,
14403,GO:0055048,1,0.990783868118484,0,1,anastral spindle assembly,BP,
14404,GO:0055056,1,0.93832904821205,0,9,D-glucose transmembrane transporter activity,MF,
14405,GO:0055057,1,0.90390743880536,0,13,neuroblast division,BP,
14406,GO:0055059,1,0.955933179929701,0,6,asymmetric neuroblast division,BP,
14407,GO:0055062,1,0.933263315267557,0,9,phosphate ion homeostasis,BP,
14408,GO:0055064,1,0.913720499522005,0,12,chloride ion homeostasis,BP,
14410,GO:0055067,1,0.379868130475599,0,142,monovalent inorganic cation homeostasis,BP,
14412,GO:0055070,1,0.910146500343119,0,16,copper ion homeostasis,BP,
14414,GO:0055073,1,0.990273179253892,0,2,cadmium ion homeostasis,BP,
14416,GO:0055075,1,0.824246550993913,0,26,potassium ion homeostasis,BP,
14418,GO:0055077,1,0.985928053610579,0,2,gap junction hemi-channel activity,MF,
14419,GO:0055078,1,0.760655444047012,0,40,sodium ion homeostasis,BP,
14421,GO:0055081,1,0.733574293867607,0,44,anion homeostasis,BP,
14423,GO:0055083,1,0.852688687062154,0,21,monovalent inorganic anion homeostasis,BP,
14426,GO:0055087,1,0.981043926982177,0,3,Ski complex,CC,
14427,GO:0055088,1,0.537806550496655,0,95,lipid homeostasis,BP,
14428,GO:0055089,1,0.919938416099288,0,12,fatty acid homeostasis,BP,
14429,GO:0055090,1,0.86537655252368,0,25,acylglycerol homeostasis,BP,
14430,GO:0055091,1,0.951392171673301,0,8,phospholipid homeostasis,BP,
14431,GO:0055092,1,0.718367361873573,0,52,sterol homeostasis,BP,
14432,GO:0055093,1,0.878374825126584,0,20,response to hyperoxia,BP,
14433,GO:0055094,1,0.867456767184188,0,21,response to lipoprotein particle,BP,
14434,GO:0055095,1,0.979598681603099,0,3,lipoprotein particle mediated signaling,BP,
14435,GO:0055096,1,0.979598681603099,0,3,low-density lipoprotein particle mediated signaling,BP,
14436,GO:0055100,1,0.97943695721163,0,3,adiponectin binding,MF,
14437,GO:0055102,1,0.952001345607701,0,11,lipase inhibitor activity,MF,
14438,GO:0055103,1,0.992635692460644,0,1,ligase regulator activity,MF,
14439,GO:0055105,1,0.978707546751468,0,6,ubiquitin-protein transferase inhibitor activity,MF,
14440,GO:0055106,1,0.92020148871371,0,16,ubiquitin-protein transferase regulator activity,MF,
14441,GO:0055108,1,0.994687371047303,0,1,Golgi to transport vesicle transport,BP,
14442,GO:0055111,1,0.991740013114587,0,1,ingression involved in gastrulation with mouth forming second,BP,
14443,GO:0055113,1,0.988612422490634,0,1,epiboly involved in gastrulation with mouth forming second,BP,
14446,GO:0055118,1,0.957209293018678,0,6,negative regulation of cardiac muscle contraction,BP,
14447,GO:0055119,1,0.888178224657814,0,17,relaxation of cardiac muscle,BP,
14448,GO:0055120,1,0.996793076521281,0,1,striated muscle dense body,CC,
14450,GO:0055129,1,0.977664672114957,0,4,L-proline biosynthetic process,BP,
14451,GO:0055130,1,0.995570989438816,0,1,D-alanine catabolic process,BP,
14452,GO:0055131,1,0.963909938085931,0,6,C3HC4-type RING finger domain binding,MF,
14453,GO:0060001,1,0.989905553411287,0,1,minus-end directed microfilament motor activity,MF,
14454,GO:0060002,1,0.980095960868564,0,2,plus-end directed microfilament motor activity,MF,
14455,GO:0060003,1,0.981407554015502,0,2,copper ion export,BP,
14457,GO:0060005,1,0.970046489497399,0,4,vestibular reflex,BP,
14458,GO:0060007,1,0.992442757765342,0,1,linear vestibuloocular reflex,BP,
14459,GO:0060008,1,0.888415841271692,0,17,Sertoli cell differentiation,BP,
14460,GO:0060009,1,0.912040194177092,0,13,Sertoli cell development,BP,
14461,GO:0060010,1,0.992600947524926,0,1,Sertoli cell fate commitment,BP,
14462,GO:0060011,1,0.981902008446122,0,3,Sertoli cell proliferation,BP,
14463,GO:0060012,1,0.954664174344298,0,7,synaptic transmission, glycinergic,BP,
14464,GO:0060013,1,0.940310756062753,0,8,righting reflex,BP,
14465,GO:0060014,1,0.992898862820728,0,1,granulosa cell differentiation,BP,
14466,GO:0060017,1,0.958061588165605,0,6,parathyroid gland development,BP,
14467,GO:0060018,1,0.977540529992424,0,3,astrocyte fate commitment,BP,
14468,GO:0060019,1,0.933816558340947,0,12,radial glial cell differentiation,BP,
14469,GO:0060020,1,0.948624343038618,0,8,Bergmann glial cell differentiation,BP,
14470,GO:0060021,1,0.54483642571875,0,83,roof of mouth development,BP,
14471,GO:0060022,1,0.955026006265079,0,6,hard palate development,BP,
14472,GO:0060023,1,0.962293300808595,0,5,soft palate development,BP,
14473,GO:0060024,1,0.970917365453574,0,4,rhythmic synaptic transmission,BP,
14474,GO:0060025,1,0.976899588754956,0,3,regulation of synaptic activity,BP,
14475,GO:0060026,1,0.900077839076528,0,15,convergent extension,BP,
14476,GO:0060027,1,0.943081097966095,0,8,convergent extension involved in gastrulation,BP,
14477,GO:0060028,1,0.952563998021592,0,7,convergent extension involved in axis elongation,BP,
14478,GO:0060029,1,0.960950255082639,0,6,convergent extension involved in organogenesis,BP,
14479,GO:0060031,1,0.986476270988903,0,2,mediolateral intercalation,BP,
14480,GO:0060032,1,0.983656228241193,0,2,notochord regression,BP,
14481,GO:0060033,1,0.933933641744365,0,10,anatomical structure regression,BP,
14482,GO:0060037,1,0.845545907681084,0,24,pharyngeal system development,BP,
14484,GO:0060039,1,0.85680740954549,0,19,pericardium development,BP,
14485,GO:0060040,1,0.978791295816494,0,4,retinal bipolar neuron differentiation,BP,
14490,GO:0060045,1,0.846123158011901,0,22,positive regulation of cardiac muscle cell proliferation,BP,
14491,GO:0060046,1,0.941043700769981,0,12,regulation of acrosome reaction,BP,
14494,GO:0060049,1,0.915860680940842,0,13,regulation of protein glycosylation,BP,
14495,GO:0060050,1,0.937504492707084,0,9,positive regulation of protein glycosylation,BP,
14496,GO:0060051,1,0.988350343049681,0,2,negative regulation of protein glycosylation,BP,
14497,GO:0060052,1,0.961090417021256,0,6,neurofilament cytoskeleton organization,BP,
14498,GO:0060053,1,0.98479610260041,0,2,neurofilament cytoskeleton,CC,
14499,GO:0060054,1,0.978085321746746,0,4,positive regulation of epithelial cell proliferation involved in wound healing,BP,
14500,GO:0060055,1,0.879265730656648,0,19,angiogenesis involved in wound healing,BP,
14501,GO:0060056,1,0.949103961216667,0,8,mammary gland involution,BP,
14502,GO:0060057,1,0.982084759338733,0,3,apoptotic process involved in mammary gland involution,BP,
14503,GO:0060058,1,0.982084759338733,0,3,positive regulation of apoptotic process involved in mammary gland involution,BP,
14504,GO:0060059,1,0.940320623273647,0,7,embryonic retina morphogenesis in camera-type eye,BP,
14505,GO:0060060,1,0.990824261314217,0,1,post-embryonic retina morphogenesis in camera-type eye,BP,
14506,GO:0060061,1,0.987021598805995,0,2,Spemann organizer formation,BP,
14507,GO:0060064,1,0.995809200936825,0,1,Spemann organizer formation at the anterior end of the primitive streak,BP,
14508,GO:0060065,1,0.866684208122048,0,19,uterus development,BP,
14509,GO:0060066,1,0.987909964673881,0,2,oviduct development,BP,
14510,GO:0060067,1,0.991622634195076,0,1,cervix development,BP,
14511,GO:0060068,1,0.936667919585313,0,9,vagina development,BP,
14514,GO:0060072,1,0.991351449257679,0,1,large conductance calcium-activated potassium channel activity,MF,
14515,GO:0060073,1,0.950284461843861,0,7,micturition,BP,
14516,GO:0060074,1,0.873078572239883,0,17,synapse maturation,BP,
14517,GO:0060075,1,0.947917823911527,0,7,regulation of resting membrane potential,BP,
14519,GO:0060077,1,0.898703567542089,0,15,inhibitory synapse,CC,
14522,GO:0060080,1,0.893792741131476,0,15,inhibitory postsynaptic potential,BP,
14523,GO:0060081,1,0.930621970450405,0,11,membrane hyperpolarization,BP,
14524,GO:0060083,1,0.976616225415068,0,3,smooth muscle contraction involved in micturition,BP,
14525,GO:0060084,1,0.978711264081572,0,3,synaptic transmission involved in micturition,BP,
14526,GO:0060086,1,0.98583584767216,0,2,circadian temperature homeostasis,BP,
14527,GO:0060087,1,0.973768848292319,0,5,relaxation of vascular smooth muscle,BP,
14528,GO:0060088,1,0.933180627136843,0,10,auditory receptor cell stereocilium organization,BP,
14531,GO:0060091,1,0.955911861495517,0,7,kinocilium,CC,
14532,GO:0060092,1,0.992649030422308,0,1,regulation of synaptic transmission, glycinergic,BP,
14533,GO:0060099,1,0.927375707110436,0,11,regulation of phagocytosis, engulfment,BP,
14534,GO:0060100,1,0.938514279402072,0,9,positive regulation of phagocytosis, engulfment,BP,
14535,GO:0060101,1,0.994898364058571,0,1,negative regulation of phagocytosis, engulfment,BP,
14536,GO:0060112,1,0.992521776221006,0,2,generation of ovulation cycle rhythm,BP,
14538,GO:0060117,1,0.882874738046051,0,17,auditory receptor cell development,BP,
14540,GO:0060120,1,0.968009757292688,0,5,inner ear receptor cell fate commitment,BP,
14542,GO:0060123,1,0.933321797902195,0,11,regulation of growth hormone secretion,BP,
14543,GO:0060124,1,0.960291812163633,0,8,positive regulation of growth hormone secretion,BP,
14544,GO:0060125,1,0.982837696708422,0,2,negative regulation of growth hormone secretion,BP,
14545,GO:0060126,1,0.982761914368179,0,3,somatotropin secreting cell differentiation,BP,
14546,GO:0060127,1,0.994092217431797,0,1,prolactin secreting cell differentiation,BP,
14547,GO:0060128,1,0.989512070040062,0,2,corticotropin hormone secreting cell differentiation,BP,
14548,GO:0060129,1,0.982075842681478,0,3,thyroid-stimulating hormone-secreting cell differentiation,BP,
14549,GO:0060133,1,0.99608818763211,0,1,somatotropin secreting cell development,BP,
14552,GO:0060136,1,0.962377619673829,0,6,embryonic process involved in female pregnancy,BP,
14553,GO:0060137,1,0.948742259084203,0,8,maternal process involved in parturition,BP,
14554,GO:0060139,1,0.988877440650483,0,2,positive regulation of apoptotic process by virus,BP,
14555,GO:0060142,1,0.900637591602153,0,18,regulation of syncytium formation by plasma membrane fusion,BP,
14556,GO:0060143,1,0.908576007566911,0,16,positive regulation of syncytium formation by plasma membrane fusion,BP,
14559,GO:0060149,1,0.904347032059096,0,14,negative regulation of posttranscriptional gene silencing,BP,
14560,GO:0060151,1,0.984781874987096,0,2,peroxisome localization,BP,
14561,GO:0060152,1,0.984781874987096,0,2,microtubule-based peroxisome localization,BP,
14562,GO:0060154,1,0.982561454852253,0,3,cellular process regulating host cell cycle in response to virus,BP,
14563,GO:0060155,1,0.953240253036248,0,8,platelet dense granule organization,BP,
14565,GO:0060157,1,0.969510744040027,0,5,urinary bladder development,BP,
14566,GO:0060158,1,0.946508732725738,0,9,phospholipase C-activating dopamine receptor signaling pathway,BP,
14568,GO:0060160,1,0.986322010291736,0,2,negative regulation of dopamine receptor signaling pathway,BP,
14570,GO:0060163,1,0.990052568126512,0,2,subpallium neuron fate commitment,BP,
14571,GO:0060164,1,0.982225051587706,0,3,regulation of timing of neuron differentiation,BP,
14572,GO:0060165,1,0.993587012283989,0,1,regulation of timing of subpallium neuron differentiation,BP,
14573,GO:0060166,1,0.982211350514532,0,3,olfactory pit development,BP,
14576,GO:0060169,1,0.99571435540411,0,1,negative regulation of adenosine receptor signaling pathway,BP,
14577,GO:0060170,1,0.601239412551244,0,71,ciliary membrane,CC,
14578,GO:0060171,1,0.980077546296339,0,2,stereocilium membrane,CC,
14580,GO:0060174,1,0.924164418682707,0,11,limb bud formation,BP,
14581,GO:0060175,1,0.990835125729457,0,1,brain-derived neurotrophic factor-activated receptor activity,MF,
14582,GO:0060177,1,0.992583653886802,0,1,regulation of angiotensin metabolic process,BP,
14583,GO:0060178,1,0.994040986541587,0,1,regulation of exocyst localization,BP,
14584,GO:0060179,1,0.973289735854853,0,4,male mating behavior,BP,
14585,GO:0060180,1,0.959714032494361,0,6,female mating behavior,BP,
14586,GO:0060183,1,0.992649030422308,0,1,apelin receptor signaling pathway,BP,
14587,GO:0060184,1,0.992818852022948,0,1,cell cycle switching,BP,
14588,GO:0060187,1,0.984260983840892,0,2,cell pole,CC,
14590,GO:0060192,1,0.938467616422949,0,11,negative regulation of lipase activity,BP,
14592,GO:0060197,1,0.982353576735327,0,3,cloacal septation,BP,
14595,GO:0060200,1,0.981823689650805,0,3,clathrin-sculpted acetylcholine transport vesicle,CC,
14596,GO:0060201,1,0.981823689650805,0,3,clathrin-sculpted acetylcholine transport vesicle membrane,CC,
14599,GO:0060211,1,0.920784688252797,0,11,regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
14600,GO:0060212,1,0.995059387970464,0,1,negative regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
14601,GO:0060213,1,0.920784688252797,0,11,positive regulation of nuclear-transcribed mRNA poly(A) tail shortening,BP,
14602,GO:0060214,1,0.977803241019534,0,4,endocardium formation,BP,
14603,GO:0060215,1,0.944802291068152,0,8,primitive hemopoiesis,BP,
14604,GO:0060216,1,0.858155189713672,0,21,definitive hemopoiesis,BP,
14605,GO:0060217,1,0.992119717382285,0,1,hemangioblast cell differentiation,BP,
14608,GO:0060221,1,0.981067235255754,0,3,retinal rod cell differentiation,BP,
14609,GO:0060228,1,0.991651790626768,0,3,phosphatidylcholine-sterol O-acyltransferase activator activity,MF,
14610,GO:0060229,1,0.943899643367835,0,10,lipase activator activity,MF,
14611,GO:0060230,1,0.993943238210836,0,2,lipoprotein lipase activator activity,MF,
14612,GO:0060231,1,0.881545616828092,0,20,mesenchymal to epithelial transition,BP,
14613,GO:0060232,1,0.980543890449646,0,3,delamination,BP,
14614,GO:0060235,1,0.966489709926616,0,4,lens induction in camera-type eye,BP,
14615,GO:0060236,1,0.766922582484175,0,36,regulation of mitotic spindle organization,BP,
14616,GO:0060242,1,0.947964346466335,0,8,contact inhibition,BP,
14617,GO:0060243,1,0.992428812355931,0,1,negative regulation of cell growth involved in contact inhibition,BP,
14618,GO:0060244,1,0.980783913721261,0,3,negative regulation of cell proliferation involved in contact inhibition,BP,
14619,GO:0060245,1,0.992502896428707,0,1,detection of cell density,BP,
14620,GO:0060246,1,0.992502896428707,0,1,detection of cell density by contact stimulus,BP,
14621,GO:0060248,1,0.992502896428707,0,1,detection of cell density by contact stimulus involved in contact inhibition,BP,
14624,GO:0060252,1,0.925789552459225,0,11,positive regulation of glial cell proliferation,BP,
14626,GO:0060254,1,0.995075918256662,0,1,regulation of N-terminal protein palmitoylation,BP,
14628,GO:0060259,1,0.900735538613163,0,17,regulation of feeding behavior,BP,
14629,GO:0060260,1,0.838729644486173,0,27,regulation of transcription initiation from RNA polymerase II promoter,BP,
14630,GO:0060261,1,0.881432141861477,0,20,positive regulation of transcription initiation from RNA polymerase II promoter,BP,
14631,GO:0060262,1,0.995075918256662,0,1,negative regulation of N-terminal protein palmitoylation,BP,
14632,GO:0060263,1,0.944770265413343,0,10,regulation of respiratory burst,BP,
14633,GO:0060264,1,0.986377176682267,0,3,regulation of respiratory burst involved in inflammatory response,BP,
14634,GO:0060265,1,0.992255180100494,0,2,positive regulation of respiratory burst involved in inflammatory response,BP,
14635,GO:0060266,1,0.991303368606686,0,2,negative regulation of respiratory burst involved in inflammatory response,BP,
14636,GO:0060267,1,0.976796247238045,0,4,positive regulation of respiratory burst,BP,
14637,GO:0060268,1,0.9823624253318,0,3,negative regulation of respiratory burst,BP,
14638,GO:0060271,1,0.0899774188658154,0,338,cilium assembly,BP,
14639,GO:0060272,1,0.927382705065928,0,12,embryonic skeletal joint morphogenesis,BP,
14640,GO:0060278,1,0.980921211367271,0,3,regulation of ovulation,BP,
14641,GO:0060279,1,0.986939214174673,0,2,positive regulation of ovulation,BP,
14642,GO:0060280,1,0.993903156509167,0,1,negative regulation of ovulation,BP,
14643,GO:0060281,1,0.935261107063478,0,10,regulation of oocyte development,BP,
14644,GO:0060282,1,0.972589668930309,0,4,positive regulation of oocyte development,BP,
14645,GO:0060283,1,0.974463194801104,0,4,negative regulation of oocyte development,BP,
14647,GO:0060285,1,0.806709281988108,0,30,cilium-dependent cell motility,BP,
14648,GO:0060287,1,0.941628057878108,0,9,epithelial cilium movement involved in determination of left/right asymmetry,BP,
14649,GO:0060290,1,0.963328957288183,0,5,transdifferentiation,BP,
14652,GO:0060293,1,0.908482680651149,0,14,germ plasm,CC,
14653,GO:0060294,1,0.91413800972419,0,16,cilium movement involved in cell motility,BP,
14654,GO:0060295,1,0.966459673816147,0,5,regulation of cilium movement involved in cell motility,BP,
14655,GO:0060296,1,0.966459673816147,0,5,regulation of cilium beat frequency involved in ciliary motility,BP,
14656,GO:0060297,1,0.95693418223594,0,5,regulation of sarcomere organization,BP,
14657,GO:0060298,1,0.977626922280982,0,3,positive regulation of sarcomere organization,BP,
14658,GO:0060300,1,0.976618745637503,0,4,regulation of cytokine activity,BP,
14659,GO:0060301,1,0.99356547104577,0,1,positive regulation of cytokine activity,BP,
14660,GO:0060302,1,0.990430255324097,0,2,negative regulation of cytokine activity,BP,
14661,GO:0060304,1,0.951207955756032,0,6,regulation of phosphatidylinositol dephosphorylation,BP,
14662,GO:0060305,1,0.992965609817527,0,1,regulation of cell diameter,BP,
14665,GO:0060309,1,0.997366574054577,0,1,elastin catabolic process,BP,
14666,GO:0060310,1,0.997366574054577,0,1,regulation of elastin catabolic process,BP,
14667,GO:0060311,1,0.997366574054577,0,1,negative regulation of elastin catabolic process,BP,
14668,GO:0060312,1,0.946277628335908,0,8,regulation of blood vessel remodeling,BP,
14669,GO:0060313,1,0.980434853387901,0,3,negative regulation of blood vessel remodeling,BP,
14670,GO:0060314,1,0.848884180368981,0,25,regulation of ryanodine-sensitive calcium-release channel activity,BP,
14671,GO:0060315,1,0.940248974696518,0,11,negative regulation of ryanodine-sensitive calcium-release channel activity,BP,
14672,GO:0060316,1,0.951058098024691,0,8,positive regulation of ryanodine-sensitive calcium-release channel activity,BP,
14673,GO:0060317,1,0.811473257578124,0,31,cardiac epithelial to mesenchymal transition,BP,
14674,GO:0060318,1,0.965524010602462,0,5,definitive erythrocyte differentiation,BP,
14675,GO:0060319,1,0.973856640283375,0,4,primitive erythrocyte differentiation,BP,
14677,GO:0060323,1,0.784910130508026,0,34,head morphogenesis,BP,
14678,GO:0060324,1,0.713536232347821,0,46,face development,BP,
14679,GO:0060325,1,0.808782298926837,0,29,face morphogenesis,BP,
14681,GO:0060327,1,0.993106507431301,0,1,cytoplasmic actin-based contraction involved in cell motility,BP,
14682,GO:0060330,1,0.870967988332838,0,22,regulation of response to interferon-gamma,BP,
14683,GO:0060331,1,0.967268509667937,0,6,negative regulation of response to interferon-gamma,BP,
14684,GO:0060332,1,0.96279200146316,0,5,positive regulation of response to interferon-gamma,BP,
14686,GO:0060334,1,0.870967988332838,0,22,regulation of interferon-gamma-mediated signaling pathway,BP,
14687,GO:0060335,1,0.96279200146316,0,5,positive regulation of interferon-gamma-mediated signaling pathway,BP,
14688,GO:0060336,1,0.967268509667937,0,6,negative regulation of interferon-gamma-mediated signaling pathway,BP,
14690,GO:0060338,1,0.809484966939694,0,30,regulation of type I interferon-mediated signaling pathway,BP,
14692,GO:0060340,1,0.929686872725207,0,10,positive regulation of type I interferon-mediated signaling pathway,BP,
14694,GO:0060342,1,0.988035395238478,0,2,photoreceptor inner segment membrane,CC,
14695,GO:0060343,1,0.852143875312256,0,23,trabecula formation,BP,
14696,GO:0060345,1,0.992586444087196,0,1,spleen trabecula formation,BP,
14697,GO:0060346,1,0.925303801758852,0,10,bone trabecula formation,BP,
14698,GO:0060347,1,0.927877021709192,0,12,heart trabecula formation,BP,
14702,GO:0060351,1,0.851632076025938,0,23,cartilage development involved in endochondral bone morphogenesis,BP,
14703,GO:0060352,1,0.959563204723564,0,7,cell adhesion molecule production,BP,
14704,GO:0060353,1,0.974126071009918,0,5,regulation of cell adhesion molecule production,BP,
14705,GO:0060354,1,0.997109972288868,0,1,negative regulation of cell adhesion molecule production,BP,
14706,GO:0060355,1,0.976950144456244,0,4,positive regulation of cell adhesion molecule production,BP,
14708,GO:0060363,1,0.949439181075458,0,8,cranial suture morphogenesis,BP,
14709,GO:0060364,1,0.971480816789248,0,4,frontal suture morphogenesis,BP,
14710,GO:0060366,1,0.990179116344062,0,1,lambdoid suture morphogenesis,BP,
14711,GO:0060367,1,0.990179116344062,0,1,sagittal suture morphogenesis,BP,
14712,GO:0060368,1,0.960779894602672,0,6,regulation of Fc receptor mediated stimulatory signaling pathway,BP,
14713,GO:0060369,1,0.972711852143276,0,4,positive regulation of Fc receptor mediated stimulatory signaling pathway,BP,
14714,GO:0060370,1,0.988477686632346,0,2,susceptibility to T cell mediated cytotoxicity,BP,
14716,GO:0060372,1,0.947577530978304,0,7,regulation of atrial cardiac muscle cell membrane repolarization,BP,
14718,GO:0060374,1,0.961986513964744,0,5,mast cell differentiation,BP,
14719,GO:0060375,1,0.984812867264724,0,2,regulation of mast cell differentiation,BP,
14720,GO:0060377,1,0.992635692460644,0,1,negative regulation of mast cell differentiation,BP,
14721,GO:0060378,1,0.985625750981059,0,2,regulation of brood size,BP,
14722,GO:0060379,1,0.926238119486313,0,10,cardiac muscle cell myoblast differentiation,BP,
14723,GO:0060380,1,0.994487128084414,0,1,regulation of single-stranded telomeric DNA binding,BP,
14724,GO:0060381,1,0.994487128084414,0,1,positive regulation of single-stranded telomeric DNA binding,BP,
14725,GO:0060382,1,0.98376443856344,0,2,regulation of DNA strand elongation,BP,
14726,GO:0060383,1,0.99245941573831,0,1,positive regulation of DNA strand elongation,BP,
14729,GO:0060386,1,0.991690137192055,0,1,synapse assembly involved in innervation,BP,
14730,GO:0060389,1,0.674868684144655,0,59,pathway-restricted SMAD protein phosphorylation,BP,
14731,GO:0060390,1,0.887646816047746,0,17,regulation of SMAD protein signal transduction,BP,
14732,GO:0060391,1,0.909094792418381,0,13,positive regulation of SMAD protein signal transduction,BP,
14733,GO:0060392,1,0.984203328599142,0,3,negative regulation of SMAD protein signal transduction,BP,
14734,GO:0060393,1,0.6915069816382,0,56,regulation of pathway-restricted SMAD protein phosphorylation,BP,
14735,GO:0060394,1,0.937681901152476,0,10,negative regulation of pathway-restricted SMAD protein phosphorylation,BP,
14736,GO:0060395,1,0.659161033764168,0,60,SMAD protein signal transduction,BP,
14737,GO:0060396,1,0.873807272524699,0,18,growth hormone receptor signaling pathway,BP,
14738,GO:0060397,1,0.917043108707545,0,11,JAK-STAT cascade involved in growth hormone signaling pathway,BP,
14739,GO:0060398,1,0.973491564233185,0,4,regulation of growth hormone receptor signaling pathway,BP,
14740,GO:0060399,1,0.981055357857866,0,3,positive regulation of growth hormone receptor signaling pathway,BP,
14741,GO:0060400,1,0.99229161415358,0,1,negative regulation of growth hormone receptor signaling pathway,BP,
14742,GO:0060401,1,0.36348627581217,0,141,cytosolic calcium ion transport,BP,
14743,GO:0060402,1,0.391802300788548,0,131,calcium ion transport into cytosol,BP,
14744,GO:0060404,1,0.992513702219898,0,1,axonemal microtubule depolymerization,BP,
14745,GO:0060405,1,0.965368408031191,0,5,regulation of penile erection,BP,
14746,GO:0060406,1,0.97770247064606,0,3,positive regulation of penile erection,BP,
14747,GO:0060407,1,0.99571435540411,0,1,negative regulation of penile erection,BP,
14748,GO:0060411,1,0.628154319203552,0,63,cardiac septum morphogenesis,BP,
14749,GO:0060412,1,0.77351918034127,0,35,ventricular septum morphogenesis,BP,
14750,GO:0060413,1,0.899384161169448,0,14,atrial septum morphogenesis,BP,
14751,GO:0060414,1,0.975322356094198,0,3,aorta smooth muscle tissue morphogenesis,BP,
14752,GO:0060415,1,0.580743810889847,0,72,muscle tissue morphogenesis,BP,
14753,GO:0060416,1,0.804107168970232,0,29,response to growth hormone,BP,
14756,GO:0060421,1,0.782460783633576,0,33,positive regulation of heart growth,BP,
14757,GO:0060422,1,0.993959570720588,0,1,peptidyl-dipeptidase inhibitor activity,MF,
14758,GO:0060423,1,0.979719796412643,0,3,foregut regionalization,BP,
14759,GO:0060424,1,0.979719796412643,0,3,lung field specification,BP,
14760,GO:0060425,1,0.718884126146902,0,49,lung morphogenesis,BP,
14761,GO:0060426,1,0.968662898234807,0,5,lung vasculature development,BP,
14762,GO:0060428,1,0.799686131704296,0,33,lung epithelium development,BP,
14764,GO:0060430,1,0.959672685335807,0,6,lung saccule development,BP,
14765,GO:0060431,1,0.967748840694157,0,5,primary lung bud formation,BP,
14766,GO:0060432,1,0.9976720550329,0,1,lung pattern specification process,BP,
14767,GO:0060433,1,0.939734760340864,0,10,bronchus development,BP,
14768,GO:0060434,1,0.985754762967066,0,2,bronchus morphogenesis,BP,
14769,GO:0060435,1,0.993861730179727,0,2,bronchiole development,BP,
14770,GO:0060436,1,0.9976720550329,0,1,bronchiole morphogenesis,BP,
14771,GO:0060437,1,0.969293406238327,0,5,lung growth,BP,
14772,GO:0060438,1,0.876857482644829,0,19,trachea development,BP,
14773,GO:0060439,1,0.929227411221949,0,11,trachea morphogenesis,BP,
14774,GO:0060440,1,0.961414165265803,0,6,trachea formation,BP,
14775,GO:0060441,1,0.829812905777032,0,28,epithelial tube branching involved in lung morphogenesis,BP,
14776,GO:0060442,1,0.918113619331109,0,12,branching involved in prostate gland morphogenesis,BP,
14777,GO:0060443,1,0.728447700565777,0,43,mammary gland morphogenesis,BP,
14778,GO:0060444,1,0.844198292024167,0,22,branching involved in mammary gland duct morphogenesis,BP,
14779,GO:0060445,1,0.855325087607117,0,22,branching involved in salivary gland morphogenesis,BP,
14780,GO:0060447,1,0.983911481258665,0,3,bud outgrowth involved in lung branching,BP,
14781,GO:0060448,1,0.976341793649375,0,3,dichotomous subdivision of terminal units involved in lung branching,BP,
14782,GO:0060449,1,0.958604505347603,0,7,bud elongation involved in lung branching,BP,
14783,GO:0060452,1,0.937963024043384,0,11,positive regulation of cardiac muscle contraction,BP,
14784,GO:0060453,1,0.944858047645945,0,10,regulation of gastric acid secretion,BP,
14785,GO:0060454,1,0.985125897203,0,2,positive regulation of gastric acid secretion,BP,
14786,GO:0060455,1,0.980064598220518,0,5,negative regulation of gastric acid secretion,BP,
14787,GO:0060456,1,0.947429713555791,0,10,positive regulation of digestive system process,BP,
14788,GO:0060457,1,0.930032416569159,0,13,negative regulation of digestive system process,BP,
14789,GO:0060458,1,0.989088185815838,0,2,right lung development,BP,
14790,GO:0060459,1,0.984244831230848,0,3,left lung development,BP,
14791,GO:0060460,1,0.988562780865106,0,2,left lung morphogenesis,BP,
14792,GO:0060461,1,0.993427169554927,0,1,right lung morphogenesis,BP,
14793,GO:0060462,1,0.959284886466068,0,6,lung lobe development,BP,
14794,GO:0060463,1,0.959284886466068,0,6,lung lobe morphogenesis,BP,
14795,GO:0060465,1,0.985189300809954,0,2,pharynx development,BP,
14796,GO:0060466,1,0.99103494315388,0,1,activation of meiosis involved in egg activation,BP,
14797,GO:0060467,1,0.990132545110315,0,2,negative regulation of fertilization,BP,
14798,GO:0060474,1,0.99259123599096,0,1,positive regulation of flagellated sperm motility involved in capacitation,BP,
14799,GO:0060478,1,0.976472313668438,0,4,acrosomal vesicle exocytosis,BP,
14800,GO:0060479,1,0.878163641107895,0,20,lung cell differentiation,BP,
14801,GO:0060480,1,0.987403315660119,0,3,lung goblet cell differentiation,BP,
14802,GO:0060481,1,0.979982023400985,0,4,lobar bronchus epithelium development,BP,
14803,GO:0060482,1,0.972615848707579,0,5,lobar bronchus development,BP,
14804,GO:0060484,1,0.949320189502002,0,8,lung-associated mesenchyme development,BP,
14806,GO:0060486,1,0.970945150062401,0,4,Clara cell differentiation,BP,
14807,GO:0060487,1,0.884751800575947,0,19,lung epithelial cell differentiation,BP,
14808,GO:0060488,1,0.980403887707006,0,2,orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,
14809,GO:0060489,1,0.980403887707006,0,2,planar dichotomous subdivision of terminal units involved in lung branching morphogenesis,BP,
14810,GO:0060490,1,0.980403887707006,0,2,lateral sprouting involved in lung morphogenesis,BP,
14812,GO:0060492,1,0.979719796412643,0,3,lung induction,BP,
14813,GO:0060495,1,0.9976720550329,0,1,cell-cell signaling involved in lung development,BP,
14814,GO:0060496,1,0.9976720550329,0,1,mesenchymal-epithelial cell signaling involved in lung development,BP,
14815,GO:0060501,1,0.958433975569798,0,6,positive regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
14816,GO:0060502,1,0.931120809143153,0,10,epithelial cell proliferation involved in lung morphogenesis,BP,
14817,GO:0060503,1,0.995148968087614,0,1,bud dilation involved in lung branching,BP,
14818,GO:0060509,1,0.959938331325411,0,5,Type I pneumocyte differentiation,BP,
14819,GO:0060510,1,0.971221559829901,0,5,Type II pneumocyte differentiation,BP,
14820,GO:0060512,1,0.83296746796643,0,26,prostate gland morphogenesis,BP,
14821,GO:0060513,1,0.9371081941954,0,10,prostatic bud formation,BP,
14822,GO:0060514,1,0.992771866788736,0,1,prostate induction,BP,
14823,GO:0060515,1,0.992771866788736,0,1,prostate field specification,BP,
14824,GO:0060516,1,0.988148527654341,0,2,primary prostatic bud elongation,BP,
14825,GO:0060517,1,0.992483430475493,0,1,epithelial cell proliferation involved in prostatic bud elongation,BP,
14826,GO:0060520,1,0.992771866788736,0,1,activation of prostate induction by androgen receptor signaling pathway,BP,
14827,GO:0060523,1,0.979534230184143,0,3,prostate epithelial cord elongation,BP,
14828,GO:0060525,1,0.923864036256218,0,10,prostate glandular acinus development,BP,
14829,GO:0060526,1,0.954663553914872,0,6,prostate glandular acinus morphogenesis,BP,
14830,GO:0060527,1,0.954663553914872,0,6,prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis,BP,
14831,GO:0060528,1,0.975271152896695,0,3,secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development,BP,
14832,GO:0060529,1,0.984809084446246,0,2,squamous basal epithelial stem cell differentiation involved in prostate gland acinus development,BP,
14833,GO:0060532,1,0.984946600757195,0,2,bronchus cartilage development,BP,
14834,GO:0060534,1,0.942425279160025,0,8,trachea cartilage development,BP,
14835,GO:0060535,1,0.970775421617796,0,4,trachea cartilage morphogenesis,BP,
14836,GO:0060536,1,0.927620231122712,0,11,cartilage morphogenesis,BP,
14839,GO:0060539,1,0.953820778785947,0,7,diaphragm development,BP,
14841,GO:0060542,1,0.991661391349946,0,1,regulation of strand invasion,BP,
14842,GO:0060544,1,0.88413930178093,0,20,regulation of necroptotic process,BP,
14843,GO:0060545,1,0.98734110793176,0,2,positive regulation of necroptotic process,BP,
14844,GO:0060546,1,0.933544036562644,0,10,negative regulation of necroptotic process,BP,
14845,GO:0060547,1,0.92565379452824,0,13,negative regulation of necrotic cell death,BP,
14847,GO:0060556,1,0.953415603311622,0,8,regulation of vitamin D biosynthetic process,BP,
14848,GO:0060557,1,0.991240869766744,0,2,positive regulation of vitamin D biosynthetic process,BP,
14849,GO:0060558,1,0.96323809704793,0,6,regulation of calcidiol 1-monooxygenase activity,BP,
14850,GO:0060559,1,0.991240869766744,0,2,positive regulation of calcidiol 1-monooxygenase activity,BP,
14852,GO:0060561,1,0.854766666522508,0,23,apoptotic process involved in morphogenesis,BP,
14855,GO:0060566,1,0.988593461709096,0,1,positive regulation of DNA-templated transcription, termination,BP,
14857,GO:0060572,1,0.895477589102698,0,17,morphogenesis of an epithelial bud,BP,
14858,GO:0060573,1,0.935208760014759,0,10,cell fate specification involved in pattern specification,BP,
14859,GO:0060574,1,0.978595383157325,0,4,intestinal epithelial cell maturation,BP,
14860,GO:0060575,1,0.903411371795713,0,16,intestinal epithelial cell differentiation,BP,
14861,GO:0060576,1,0.944806997049648,0,10,intestinal epithelial cell development,BP,
14862,GO:0060577,1,0.98969252077318,0,2,pulmonary vein morphogenesis,BP,
14863,GO:0060578,1,0.994092217431797,0,1,superior vena cava morphogenesis,BP,
14864,GO:0060579,1,0.910386762468544,0,14,ventral spinal cord interneuron fate commitment,BP,
14865,GO:0060580,1,0.994463725794407,0,1,ventral spinal cord interneuron fate determination,BP,
14866,GO:0060581,1,0.910386762468544,0,14,cell fate commitment involved in pattern specification,BP,
14867,GO:0060582,1,0.994463725794407,0,1,cell fate determination involved in pattern specification,BP,
14868,GO:0060584,1,0.983222012277739,0,3,regulation of prostaglandin-endoperoxide synthase activity,BP,
14869,GO:0060585,1,0.983222012277739,0,3,positive regulation of prostaglandin-endoperoxide synthase activity,BP,
14870,GO:0060586,1,0.94832602140598,0,8,multicellular organismal iron ion homeostasis,BP,
14874,GO:0060590,1,0.782819905457511,0,40,ATPase regulator activity,MF,
14875,GO:0060591,1,0.971692479315903,0,4,chondroblast differentiation,BP,
14876,GO:0060592,1,0.953705476480778,0,7,mammary gland formation,BP,
14877,GO:0060594,1,0.980423220980921,0,3,mammary gland specification,BP,
14878,GO:0060595,1,0.990148310367733,0,2,fibroblast growth factor receptor signaling pathway involved in mammary gland specification,BP,
14879,GO:0060596,1,0.977497023659019,0,3,mammary placode formation,BP,
14880,GO:0060598,1,0.996384339139669,0,1,dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis,BP,
14881,GO:0060599,1,0.984454453483017,0,2,lateral sprouting involved in mammary gland duct morphogenesis,BP,
14882,GO:0060600,1,0.926940933415261,0,10,dichotomous subdivision of an epithelial terminal unit,BP,
14883,GO:0060601,1,0.911798587391326,0,13,lateral sprouting from an epithelium,BP,
14884,GO:0060602,1,0.878673832836496,0,19,branch elongation of an epithelium,BP,
14885,GO:0060603,1,0.796807619937699,0,30,mammary gland duct morphogenesis,BP,
14886,GO:0060605,1,0.968084407907351,0,5,tube lumen cavitation,BP,
14888,GO:0060611,1,0.993676910461691,0,1,mammary gland fat development,BP,
14889,GO:0060612,1,0.788211529827838,0,35,adipose tissue development,BP,
14890,GO:0060613,1,0.959035018284457,0,6,fat pad development,BP,
14891,GO:0060615,1,0.990148310367733,0,2,mammary gland bud formation,BP,
14892,GO:0060620,1,0.993058458973322,0,1,regulation of cholesterol import,BP,
14893,GO:0060623,1,0.986980741443011,0,2,regulation of chromosome condensation,BP,
14895,GO:0060628,1,0.918186983010245,0,12,regulation of ER to Golgi vesicle-mediated transport,BP,
14896,GO:0060629,1,0.992973063262185,0,1,regulation of homologous chromosome segregation,BP,
14897,GO:0060631,1,0.951849375204366,0,7,regulation of meiosis I,BP,
14898,GO:0060632,1,0.855356103328447,0,23,regulation of microtubule-based movement,BP,
14899,GO:0060633,1,0.964839875270782,0,5,negative regulation of transcription initiation from RNA polymerase II promoter,BP,
14900,GO:0060638,1,0.950021546674811,0,8,mesenchymal-epithelial cell signaling,BP,
14901,GO:0060644,1,0.892937288597659,0,16,mammary gland epithelial cell differentiation,BP,
14902,GO:0060648,1,0.985155126855248,0,3,mammary gland bud morphogenesis,BP,
14903,GO:0060661,1,0.991929164870311,0,2,submandibular salivary gland formation,BP,
14904,GO:0060662,1,0.968084407907351,0,5,salivary gland cavitation,BP,
14905,GO:0060664,1,0.974065862700896,0,5,epithelial cell proliferation involved in salivary gland morphogenesis,BP,
14906,GO:0060665,1,0.97670649887666,0,4,regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling,BP,
14907,GO:0060666,1,0.958583884188891,0,5,dichotomous subdivision of terminal units involved in salivary gland branching,BP,
14908,GO:0060667,1,0.990148310367733,0,2,branch elongation involved in salivary gland morphogenesis,BP,
14909,GO:0060668,1,0.992519441264015,0,1,regulation of branching involved in salivary gland morphogenesis by extracellular matrix-epithelial cell signaling,BP,
14910,GO:0060669,1,0.855747789975279,0,23,embryonic placenta morphogenesis,BP,
14911,GO:0060670,1,0.938467153909665,0,10,branching involved in labyrinthine layer morphogenesis,BP,
14912,GO:0060671,1,0.987941492628211,0,2,epithelial cell differentiation involved in embryonic placenta development,BP,
14913,GO:0060672,1,0.987941492628211,0,2,epithelial cell morphogenesis involved in placental branching,BP,
14914,GO:0060674,1,0.813748305281362,0,29,placenta blood vessel development,BP,
14915,GO:0060675,1,0.658786176102678,0,59,ureteric bud morphogenesis,BP,
14916,GO:0060676,1,0.962838628104714,0,6,ureteric bud formation,BP,
14917,GO:0060677,1,0.944222698635321,0,7,ureteric bud elongation,BP,
14918,GO:0060678,1,0.994032123914288,0,1,dichotomous subdivision of terminal units involved in ureteric bud branching,BP,
14919,GO:0060681,1,0.972524936423691,0,4,branch elongation involved in ureteric bud branching,BP,
14920,GO:0060683,1,0.993076100442706,0,1,regulation of branching involved in salivary gland morphogenesis by epithelial-mesenchymal signaling,BP,
14921,GO:0060684,1,0.966420374993759,0,6,epithelial-mesenchymal cell signaling,BP,
14922,GO:0060685,1,0.960052543110571,0,6,regulation of prostatic bud formation,BP,
14923,GO:0060686,1,0.971288047303656,0,4,negative regulation of prostatic bud formation,BP,
14924,GO:0060687,1,0.950523542810719,0,7,regulation of branching involved in prostate gland morphogenesis,BP,
14925,GO:0060688,1,0.712179111421609,0,51,regulation of morphogenesis of a branching structure,BP,
14926,GO:0060689,1,0.978129490066395,0,3,cell differentiation involved in salivary gland development,BP,
14927,GO:0060690,1,0.995093615990103,0,1,epithelial cell differentiation involved in salivary gland development,BP,
14928,GO:0060691,1,0.995093615990103,0,1,epithelial cell maturation involved in salivary gland development,BP,
14929,GO:0060693,1,0.945124116160836,0,9,regulation of branching involved in salivary gland morphogenesis,BP,
14930,GO:0060694,1,0.994973034818595,0,1,regulation of cholesterol transporter activity,BP,
14931,GO:0060696,1,0.96800653571883,0,6,regulation of phospholipid catabolic process,BP,
14932,GO:0060697,1,0.990545879181554,0,2,positive regulation of phospholipid catabolic process,BP,
14933,GO:0060698,1,0.985237185185765,0,2,endoribonuclease inhibitor activity,MF,
14934,GO:0060699,1,0.975198816736791,0,4,regulation of endoribonuclease activity,BP,
14935,GO:0060700,1,0.944150560835143,0,9,regulation of ribonuclease activity,BP,
14936,GO:0060701,1,0.985237185185765,0,2,negative regulation of ribonuclease activity,BP,
14937,GO:0060702,1,0.985237185185765,0,2,negative regulation of endoribonuclease activity,BP,
14938,GO:0060703,1,0.993162364409317,0,1,deoxyribonuclease inhibitor activity,MF,
14939,GO:0060706,1,0.864440531298774,0,22,cell differentiation involved in embryonic placenta development,BP,
14940,GO:0060707,1,0.929154539656025,0,11,trophoblast giant cell differentiation,BP,
14941,GO:0060708,1,0.982014811010318,0,3,spongiotrophoblast differentiation,BP,
14942,GO:0060709,1,0.992953371278489,0,1,glycogen cell differentiation involved in embryonic placenta development,BP,
14943,GO:0060710,1,0.954004666051907,0,7,chorio-allantoic fusion,BP,
14944,GO:0060711,1,0.748942105919328,0,43,labyrinthine layer development,BP,
14945,GO:0060712,1,0.910244793836402,0,14,spongiotrophoblast layer development,BP,
14946,GO:0060713,1,0.883880767392375,0,19,labyrinthine layer morphogenesis,BP,
14947,GO:0060715,1,0.978999034781034,0,3,syncytiotrophoblast cell differentiation involved in labyrinthine layer development,BP,
14948,GO:0060716,1,0.882213636907655,0,19,labyrinthine layer blood vessel development,BP,
14949,GO:0060717,1,0.949770740786235,0,7,chorion development,BP,
14950,GO:0060718,1,0.96215670397799,0,5,chorionic trophoblast cell differentiation,BP,
14951,GO:0060720,1,0.987356635353896,0,2,spongiotrophoblast cell proliferation,BP,
14952,GO:0060721,1,0.987356635353896,0,2,regulation of spongiotrophoblast cell proliferation,BP,
14953,GO:0060722,1,0.987356635353896,0,2,cell proliferation involved in embryonic placenta development,BP,
14954,GO:0060723,1,0.987356635353896,0,2,regulation of cell proliferation involved in embryonic placenta development,BP,
14955,GO:0060729,1,0.966066614870628,0,5,intestinal epithelial structure maintenance,BP,
14956,GO:0060730,1,0.98597315836464,0,2,regulation of intestinal epithelial structure maintenance,BP,
14957,GO:0060731,1,0.992618000628388,0,1,positive regulation of intestinal epithelial structure maintenance,BP,
14958,GO:0060732,1,0.937460045067998,0,10,positive regulation of inositol phosphate biosynthetic process,BP,
14959,GO:0060733,1,0.984365289533278,0,2,regulation of eIF2 alpha phosphorylation by amino acid starvation,BP,
14960,GO:0060734,1,0.992284422491857,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
14961,GO:0060735,1,0.996099248617713,0,1,regulation of eIF2 alpha phosphorylation by dsRNA,BP,
14962,GO:0060736,1,0.916406583565285,0,11,prostate gland growth,BP,
14963,GO:0060737,1,0.972169977012525,0,4,prostate gland morphogenetic growth,BP,
14964,GO:0060738,1,0.995632596003417,0,1,epithelial-mesenchymal signaling involved in prostate gland development,BP,
14965,GO:0060739,1,0.990534112115178,0,1,mesenchymal-epithelial cell signaling involved in prostate gland development,BP,
14966,GO:0060740,1,0.834661048185796,0,25,prostate gland epithelium morphogenesis,BP,
14967,GO:0060741,1,0.991847173211488,0,2,prostate gland stromal morphogenesis,BP,
14968,GO:0060742,1,0.926854635102444,0,10,epithelial cell differentiation involved in prostate gland development,BP,
14969,GO:0060743,1,0.986261328764966,0,2,epithelial cell maturation involved in prostate gland development,BP,
14970,GO:0060744,1,0.968724227552157,0,5,mammary gland branching involved in thelarche,BP,
14971,GO:0060745,1,0.947734009081484,0,6,mammary gland branching involved in pregnancy,BP,
14972,GO:0060746,1,0.911396484594883,0,13,parental behavior,BP,
14973,GO:0060748,1,0.973031646771354,0,3,tertiary branching involved in mammary gland duct morphogenesis,BP,
14974,GO:0060749,1,0.888638948863193,0,17,mammary gland alveolus development,BP,
14975,GO:0060750,1,0.969863595402243,0,4,epithelial cell proliferation involved in mammary gland duct elongation,BP,
14976,GO:0060751,1,0.964206347754699,0,5,branch elongation involved in mammary gland duct branching,BP,
14977,GO:0060752,1,0.993229158668432,0,1,intestinal phytosterol absorption,BP,
14978,GO:0060753,1,0.967400180296919,0,6,regulation of mast cell chemotaxis,BP,
14979,GO:0060754,1,0.971411217191104,0,5,positive regulation of mast cell chemotaxis,BP,
14980,GO:0060759,1,0.379905009353991,0,149,regulation of response to cytokine stimulus,BP,
14981,GO:0060760,1,0.737638208156764,0,46,positive regulation of response to cytokine stimulus,BP,
14982,GO:0060761,1,0.745342570074938,0,48,negative regulation of response to cytokine stimulus,BP,
14983,GO:0060762,1,0.974440639750454,0,4,regulation of branching involved in mammary gland duct morphogenesis,BP,
14984,GO:0060763,1,0.985002544580726,0,2,mammary duct terminal end bud growth,BP,
14985,GO:0060764,1,0.988253901627839,0,2,cell-cell signaling involved in mammary gland development,BP,
14986,GO:0060765,1,0.846096838586984,0,25,regulation of androgen receptor signaling pathway,BP,
14987,GO:0060766,1,0.928855973156626,0,11,negative regulation of androgen receptor signaling pathway,BP,
14988,GO:0060767,1,0.930463450402142,0,11,epithelial cell proliferation involved in prostate gland development,BP,
14989,GO:0060768,1,0.937514875673565,0,10,regulation of epithelial cell proliferation involved in prostate gland development,BP,
14990,GO:0060769,1,0.981083610407736,0,3,positive regulation of epithelial cell proliferation involved in prostate gland development,BP,
14991,GO:0060770,1,0.965700536501073,0,6,negative regulation of epithelial cell proliferation involved in prostate gland development,BP,
14992,GO:0060775,1,0.986476270988903,0,2,planar cell polarity pathway involved in gastrula mediolateral intercalation,BP,
14993,GO:0060781,1,0.995632596003417,0,1,mesenchymal cell proliferation involved in prostate gland development,BP,
14994,GO:0060782,1,0.995632596003417,0,1,regulation of mesenchymal cell proliferation involved in prostate gland development,BP,
14995,GO:0060783,1,0.995632596003417,0,1,mesenchymal smoothened signaling pathway involved in prostate gland development,BP,
14996,GO:0060784,1,0.992483430475493,0,1,regulation of cell proliferation involved in tissue homeostasis,BP,
14997,GO:0060788,1,0.906238200122269,0,14,ectodermal placode formation,BP,
14998,GO:0060789,1,0.964244194209873,0,6,hair follicle placode formation,BP,
15000,GO:0060796,1,0.98969995525194,0,2,regulation of transcription involved in primary germ layer cell fate commitment,BP,
15001,GO:0060800,1,0.979812660917231,0,3,regulation of cell differentiation involved in embryonic placenta development,BP,
15002,GO:0060802,1,0.994438031540948,0,1,epiblast cell-extraembryonic ectoderm cell signaling involved in anterior/posterior axis specification,BP,
15003,GO:0060803,1,0.995824952987269,0,1,BMP signaling pathway involved in mesodermal cell fate specification,BP,
15004,GO:0060804,1,0.992692623517792,0,1,positive regulation of Wnt signaling pathway by BMP signaling pathway,BP,
15005,GO:0060806,1,0.995370752595169,0,1,negative regulation of cell differentiation involved in embryonic placenta development,BP,
15006,GO:0060807,1,0.993849579949817,0,1,regulation of transcription from RNA polymerase II promoter involved in definitive endodermal cell fate specification,BP,
15007,GO:0060809,1,0.984809923111667,0,2,mesodermal to mesenchymal transition involved in gastrulation,BP,
15008,GO:0060816,1,0.981498583167609,0,2,random inactivation of X chromosome,BP,
15009,GO:0060819,1,0.982630571575331,0,2,inactivation of X chromosome by genetic imprinting,BP,
15010,GO:0060821,1,0.989892835047208,0,1,inactivation of X chromosome by DNA methylation,BP,
15011,GO:0060823,1,0.985089779449536,0,2,canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
15012,GO:0060825,1,0.99035238093586,0,2,fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
15013,GO:0060827,1,0.99246323137792,0,1,regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
15015,GO:0060829,1,0.99246323137792,0,1,negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
15016,GO:0060830,1,0.981929755289523,0,3,ciliary receptor clustering involved in smoothened signaling pathway,BP,
15017,GO:0060831,1,0.904648815354176,0,13,smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
15018,GO:0060836,1,0.939405008082328,0,8,lymphatic endothelial cell differentiation,BP,
15019,GO:0060837,1,0.939866235831549,0,9,blood vessel endothelial cell differentiation,BP,
15020,GO:0060838,1,0.978541724025242,0,3,lymphatic endothelial cell fate commitment,BP,
15021,GO:0060839,1,0.952224684281269,0,7,endothelial cell fate commitment,BP,
15022,GO:0060840,1,0.55474490169679,0,76,artery development,BP,
15023,GO:0060841,1,0.881766534769451,0,16,venous blood vessel development,BP,
15024,GO:0060842,1,0.958509716877796,0,6,arterial endothelial cell differentiation,BP,
15025,GO:0060843,1,0.989543829144195,0,1,venous endothelial cell differentiation,BP,
15026,GO:0060844,1,0.986471555740257,0,2,arterial endothelial cell fate commitment,BP,
15027,GO:0060846,1,0.980123214163316,0,3,blood vessel endothelial cell fate commitment,BP,
15028,GO:0060847,1,0.980123214163316,0,3,endothelial cell fate specification,BP,
15029,GO:0060849,1,0.985288881837529,0,2,regulation of transcription involved in lymphatic endothelial cell fate commitment,BP,
15031,GO:0060853,1,0.992603270400501,0,1,Notch signaling pathway involved in arterial endothelial cell fate commitment,BP,
15032,GO:0060856,1,0.935523027130735,0,10,establishment of blood-brain barrier,BP,
15033,GO:0060857,1,0.993999018411445,0,1,establishment of glial blood-brain barrier,BP,
15034,GO:0060872,1,0.93647599510408,0,9,semicircular canal development,BP,
15035,GO:0060873,1,0.990179116344062,0,1,anterior semicircular canal development,BP,
15036,GO:0060875,1,0.990179116344062,0,1,lateral semicircular canal development,BP,
15037,GO:0060876,1,0.991339349361376,0,2,semicircular canal formation,BP,
15038,GO:0060879,1,0.9976720550329,0,1,semicircular canal fusion,BP,
15039,GO:0060896,1,0.934832375346173,0,9,neural plate pattern specification,BP,
15040,GO:0060897,1,0.952150763057635,0,7,neural plate regionalization,BP,
15041,GO:0060900,1,0.909553911655081,0,12,embryonic camera-type eye formation,BP,
15042,GO:0060901,1,0.99241567941278,0,1,regulation of hair cycle by canonical Wnt signaling pathway,BP,
15043,GO:0060903,1,0.97270521743482,0,4,positive regulation of meiosis I,BP,
15044,GO:0060904,1,0.992478271476717,0,1,regulation of protein folding in endoplasmic reticulum,BP,
15045,GO:0060907,1,0.955539798252306,0,7,positive regulation of macrophage cytokine production,BP,
15046,GO:0060911,1,0.93993458749308,0,10,cardiac cell fate commitment,BP,
15047,GO:0060912,1,0.986950308158492,0,2,cardiac cell fate specification,BP,
15048,GO:0060913,1,0.983656169913365,0,3,cardiac cell fate determination,BP,
15049,GO:0060914,1,0.869460605508635,0,22,heart formation,BP,
15050,GO:0060915,1,0.990148310367733,0,2,mesenchymal cell differentiation involved in lung development,BP,
15051,GO:0060916,1,0.963881008158664,0,5,mesenchymal cell proliferation involved in lung development,BP,
15054,GO:0060922,1,0.986560159980816,0,2,atrioventricular node cell differentiation,BP,
15055,GO:0060923,1,0.962241129738919,0,6,cardiac muscle cell fate commitment,BP,
15057,GO:0060927,1,0.994822455267186,0,1,cardiac pacemaker cell fate commitment,BP,
15058,GO:0060928,1,0.986560159980816,0,2,atrioventricular node cell development,BP,
15059,GO:0060929,1,0.994822455267186,0,1,atrioventricular node cell fate commitment,BP,
15061,GO:0060932,1,0.987103489664279,0,2,His-Purkinje system cell differentiation,BP,
15062,GO:0060935,1,0.977651529963914,0,3,cardiac fibroblast cell differentiation,BP,
15063,GO:0060936,1,0.977651529963914,0,3,cardiac fibroblast cell development,BP,
15064,GO:0060938,1,0.977651529963914,0,3,epicardium-derived cardiac fibroblast cell differentiation,BP,
15065,GO:0060939,1,0.977651529963914,0,3,epicardium-derived cardiac fibroblast cell development,BP,
15066,GO:0060940,1,0.986276499820798,0,2,epithelial to mesenchymal transition involved in cardiac fibroblast development,BP,
15067,GO:0060947,1,0.942375047839598,0,8,cardiac vascular smooth muscle cell differentiation,BP,
15068,GO:0060948,1,0.97550953797439,0,3,cardiac vascular smooth muscle cell development,BP,
15069,GO:0060956,1,0.956022914270496,0,6,endocardial cell differentiation,BP,
15070,GO:0060957,1,0.992847632417209,0,1,endocardial cell fate commitment,BP,
15072,GO:0060965,1,0.919322378908304,0,12,negative regulation of gene silencing by miRNA,BP,
15074,GO:0060967,1,0.904347032059096,0,14,negative regulation of gene silencing by RNA,BP,
15076,GO:0060969,1,0.848064873100905,0,22,negative regulation of gene silencing,BP,
15077,GO:0060971,1,0.971346590700336,0,4,embryonic heart tube left/right pattern formation,BP,
15078,GO:0060972,1,0.862267465532143,0,21,left/right pattern formation,BP,
15080,GO:0060974,1,0.993359378517449,0,2,cell migration involved in heart formation,BP,
15081,GO:0060975,1,0.996555366104087,0,1,cardioblast migration to the midline involved in heart field formation,BP,
15082,GO:0060976,1,0.728930381918399,0,41,coronary vasculature development,BP,
15083,GO:0060977,1,0.881471283919176,0,15,coronary vasculature morphogenesis,BP,
15084,GO:0060978,1,0.976731983693454,0,3,angiogenesis involved in coronary vascular morphogenesis,BP,
15085,GO:0060979,1,0.964541705243405,0,4,vasculogenesis involved in coronary vascular morphogenesis,BP,
15086,GO:0060980,1,0.99251470947205,0,1,cell migration involved in coronary vasculogenesis,BP,
15087,GO:0060981,1,0.991688888021103,0,1,cell migration involved in coronary angiogenesis,BP,
15088,GO:0060982,1,0.927383941498056,0,9,coronary artery morphogenesis,BP,
15089,GO:0060986,1,0.761604904235828,0,43,endocrine hormone secretion,BP,
15090,GO:0060987,1,0.993903156509167,0,1,lipid tube,CC,
15091,GO:0060988,1,0.986383513921345,0,2,lipid tube assembly,BP,
15092,GO:0060992,1,0.921316965423617,0,11,response to fungicide,BP,
15094,GO:0060994,1,0.98769214444055,0,2,regulation of transcription from RNA polymerase II promoter involved in kidney development,BP,
15095,GO:0060995,1,0.984785638511809,0,2,cell-cell signaling involved in kidney development,BP,
15096,GO:0060996,1,0.523950554885794,0,84,dendritic spine development,BP,
15097,GO:0060997,1,0.686974165007356,0,48,dendritic spine morphogenesis,BP,
15098,GO:0060998,1,0.614055277620875,0,63,regulation of dendritic spine development,BP,
15099,GO:0060999,1,0.737560694514202,0,39,positive regulation of dendritic spine development,BP,
15100,GO:0061000,1,0.917390947668515,0,11,negative regulation of dendritic spine development,BP,
15101,GO:0061001,1,0.765655311404748,0,34,regulation of dendritic spine morphogenesis,BP,
15102,GO:0061002,1,0.956298035674648,0,6,negative regulation of dendritic spine morphogenesis,BP,
15103,GO:0061003,1,0.871900124094341,0,17,positive regulation of dendritic spine morphogenesis,BP,
15105,GO:0061005,1,0.698392105708688,0,50,cell differentiation involved in kidney development,BP,
15107,GO:0061009,1,0.971501843254343,0,5,common bile duct development,BP,
15108,GO:0061010,1,0.978285294001994,0,3,gall bladder development,BP,
15109,GO:0061011,1,0.995212341837907,0,1,hepatic duct development,BP,
15110,GO:0061013,1,0.338123728243616,0,169,regulation of mRNA catabolic process,BP,
15111,GO:0061014,1,0.745870075061733,0,39,positive regulation of mRNA catabolic process,BP,
15112,GO:0061015,1,0.992097742393828,0,2,snRNA import into nucleus,BP,
15113,GO:0061017,1,0.995212341837907,0,1,hepatoblast differentiation,BP,
15116,GO:0061026,1,0.988120014668766,0,1,cardiac muscle tissue regeneration,BP,
15117,GO:0061027,1,0.987224344563637,0,2,umbilical cord development,BP,
15118,GO:0061028,1,0.760279887559403,0,38,establishment of endothelial barrier,BP,
15120,GO:0061030,1,0.982116229173233,0,3,epithelial cell differentiation involved in mammary gland alveolus development,BP,
15121,GO:0061031,1,0.984136554946579,0,3,endodermal digestive tract morphogenesis,BP,
15122,GO:0061032,1,0.986659677381655,0,2,visceral serous pericardium development,BP,
15123,GO:0061033,1,0.990171679619646,0,2,secretion by lung epithelial cell involved in lung growth,BP,
15124,GO:0061034,1,0.984482552653143,0,2,olfactory bulb mitral cell layer development,BP,
15126,GO:0061036,1,0.817543971081212,0,27,positive regulation of cartilage development,BP,
15127,GO:0061037,1,0.864610247561701,0,22,negative regulation of cartilage development,BP,
15128,GO:0061038,1,0.953593060244302,0,6,uterus morphogenesis,BP,
15129,GO:0061040,1,0.989857033990238,0,1,female gonad morphogenesis,BP,
15131,GO:0061042,1,0.943478612335494,0,9,vascular wound healing,BP,
15132,GO:0061043,1,0.97576653432023,0,4,regulation of vascular wound healing,BP,
15133,GO:0061044,1,0.992683518576315,0,1,negative regulation of vascular wound healing,BP,
15135,GO:0061046,1,0.963204279242788,0,6,regulation of branching involved in lung morphogenesis,BP,
15136,GO:0061047,1,0.97496617197177,0,4,positive regulation of branching involved in lung morphogenesis,BP,
15137,GO:0061048,1,0.995421640886495,0,1,negative regulation of branching involved in lung morphogenesis,BP,
15138,GO:0061049,1,0.890610492235063,0,17,cell growth involved in cardiac muscle cell development,BP,
15139,GO:0061050,1,0.927566668125049,0,11,regulation of cell growth involved in cardiac muscle cell development,BP,
15140,GO:0061051,1,0.952931362204808,0,7,positive regulation of cell growth involved in cardiac muscle cell development,BP,
15141,GO:0061052,1,0.97339511022569,0,4,negative regulation of cell growth involved in cardiac muscle cell development,BP,
15143,GO:0061054,1,0.987189161852435,0,2,dermatome development,BP,
15145,GO:0061056,1,0.977734675453685,0,4,sclerotome development,BP,
15147,GO:0061072,1,0.93497044695626,0,9,iris morphogenesis,BP,
15148,GO:0061073,1,0.979520422185309,0,3,ciliary body morphogenesis,BP,
15149,GO:0061074,1,0.967153973952307,0,5,regulation of neural retina development,BP,
15150,GO:0061075,1,0.987980382263189,0,2,positive regulation of neural retina development,BP,
15151,GO:0061076,1,0.992699999157039,0,1,negative regulation of neural retina development,BP,
15152,GO:0061077,1,0.645796140892061,0,71,chaperone-mediated protein folding,BP,
15153,GO:0061078,1,0.997807301551196,0,1,positive regulation of prostaglandin secretion involved in immune response,BP,
15154,GO:0061081,1,0.936755722535833,0,11,positive regulation of myeloid leukocyte cytokine production involved in immune response,BP,
15155,GO:0061082,1,0.869873740796058,0,22,myeloid leukocyte cytokine production,BP,
15156,GO:0061083,1,0.973060223886108,0,4,regulation of protein refolding,BP,
15157,GO:0061084,1,0.973060223886108,0,4,negative regulation of protein refolding,BP,
15158,GO:0061085,1,0.938947828840499,0,9,regulation of histone H3-K27 methylation,BP,
15159,GO:0061086,1,0.97310471992819,0,4,negative regulation of histone H3-K27 methylation,BP,
15160,GO:0061087,1,0.958812908648715,0,6,positive regulation of histone H3-K27 methylation,BP,
15162,GO:0061090,1,0.993732150252834,0,1,positive regulation of sequestering of zinc ion,BP,
15163,GO:0061091,1,0.974931700927941,0,3,regulation of phospholipid translocation,BP,
15164,GO:0061092,1,0.974931700927941,0,3,positive regulation of phospholipid translocation,BP,
15165,GO:0061097,1,0.626807696432796,0,67,regulation of protein tyrosine kinase activity,BP,
15166,GO:0061098,1,0.763765965012328,0,38,positive regulation of protein tyrosine kinase activity,BP,
15167,GO:0061099,1,0.852281602242823,0,24,negative regulation of protein tyrosine kinase activity,BP,
15168,GO:0061100,1,0.993587012283989,0,1,lung neuroendocrine cell differentiation,BP,
15169,GO:0061101,1,0.956059304469206,0,8,neuroendocrine cell differentiation,BP,
15170,GO:0061102,1,0.989520948193913,0,2,stomach neuroendocrine cell differentiation,BP,
15171,GO:0061103,1,0.993587012283989,0,1,carotid body glomus cell differentiation,BP,
15172,GO:0061104,1,0.986639050157939,0,2,adrenal chromaffin cell differentiation,BP,
15173,GO:0061105,1,0.995907955243566,0,1,regulation of stomach neuroendocrine cell differentiation,BP,
15174,GO:0061106,1,0.995907955243566,0,1,negative regulation of stomach neuroendocrine cell differentiation,BP,
15175,GO:0061107,1,0.981922837687207,0,3,seminal vesicle development,BP,
15176,GO:0061108,1,0.994033230959954,0,1,seminal vesicle epithelium development,BP,
15177,GO:0061110,1,0.977068683927232,0,3,dense core granule biogenesis,BP,
15178,GO:0061113,1,0.977554386584237,0,3,pancreas morphogenesis,BP,
15179,GO:0061114,1,0.992750120792518,0,1,branching involved in pancreas morphogenesis,BP,
15180,GO:0061115,1,0.9976720550329,0,1,lung proximal/distal axis specification,BP,
15182,GO:0061133,1,0.972875560191313,0,6,endopeptidase activator activity,MF,
15187,GO:0061140,1,0.952831308550222,0,9,lung secretory cell differentiation,BP,
15188,GO:0061141,1,0.979915060890637,0,3,lung ciliated cell differentiation,BP,
15189,GO:0061143,1,0.992974313593734,0,1,alveolar primary septum development,BP,
15190,GO:0061145,1,0.984946600757195,0,2,lung smooth muscle development,BP,
15191,GO:0061146,1,0.980095891846228,0,3,Peyer's patch morphogenesis,BP,
15192,GO:0061149,1,0.995148968087614,0,1,BMP signaling pathway involved in ureter morphogenesis,BP,
15193,GO:0061150,1,0.995148968087614,0,1,renal system segmentation,BP,
15194,GO:0061151,1,0.995148968087614,0,1,BMP signaling pathway involved in renal system segmentation,BP,
15195,GO:0061152,1,0.989066124498065,0,2,trachea submucosa development,BP,
15196,GO:0061153,1,0.989066124498065,0,2,trachea gland development,BP,
15197,GO:0061154,1,0.908804783185094,0,15,endothelial tube morphogenesis,BP,
15198,GO:0061155,1,0.995148968087614,0,1,pulmonary artery endothelial tube morphogenesis,BP,
15199,GO:0061156,1,0.95229872502626,0,6,pulmonary artery morphogenesis,BP,
15200,GO:0061157,1,0.842909757070232,0,22,mRNA destabilization,BP,
15201,GO:0061158,1,0.908308875345426,0,12,3'-UTR-mediated mRNA destabilization,BP,
15202,GO:0061162,1,0.868753087081137,0,19,establishment of monopolar cell polarity,BP,
15203,GO:0061178,1,0.732140932703849,0,49,regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
15204,GO:0061179,1,0.953513233281867,0,9,negative regulation of insulin secretion involved in cellular response to glucose stimulus,BP,
15205,GO:0061180,1,0.627529365142889,0,64,mammary gland epithelium development,BP,
15206,GO:0061181,1,0.992429062863843,0,1,regulation of chondrocyte development,BP,
15207,GO:0061183,1,0.987189161852435,0,2,regulation of dermatome development,BP,
15208,GO:0061184,1,0.992485744980242,0,1,positive regulation of dermatome development,BP,
15209,GO:0061185,1,0.994663717220603,0,1,negative regulation of dermatome development,BP,
15210,GO:0061187,1,0.983457534783851,0,2,regulation of chromatin silencing at rDNA,BP,
15211,GO:0061188,1,0.983457534783851,0,2,negative regulation of chromatin silencing at rDNA,BP,
15212,GO:0061189,1,0.995632596003417,0,1,positive regulation of sclerotome development,BP,
15213,GO:0061190,1,0.995632596003417,0,1,regulation of sclerotome development,BP,
15214,GO:0061193,1,0.996903467990892,0,1,taste bud development,BP,
15215,GO:0061196,1,0.957458308910367,0,6,fungiform papilla development,BP,
15216,GO:0061197,1,0.963225907350025,0,5,fungiform papilla morphogenesis,BP,
15217,GO:0061198,1,0.978237246450704,0,3,fungiform papilla formation,BP,
15218,GO:0061200,1,0.951039685361515,0,8,clathrin-sculpted gamma-aminobutyric acid transport vesicle,CC,
15219,GO:0061202,1,0.951039685361515,0,8,clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane,CC,
15220,GO:0061205,1,0.985512327601426,0,2,paramesonephric duct development,BP,
15221,GO:0061209,1,0.974789922415017,0,4,cell proliferation involved in mesonephros development,BP,
15222,GO:0061213,1,0.876127136735092,0,20,positive regulation of mesonephros development,BP,
15223,GO:0061216,1,0.995148968087614,0,1,regulation of transcription from RNA polymerase II promoter involved in mesonephros development,BP,
15224,GO:0061217,1,0.862090010289599,0,23,regulation of mesonephros development,BP,
15225,GO:0061218,1,0.968443617645443,0,5,negative regulation of mesonephros development,BP,
15226,GO:0061227,1,0.990067112779632,0,2,pattern specification involved in mesonephros development,BP,
15227,GO:0061245,1,0.73148416052231,0,45,establishment or maintenance of bipolar cell polarity,BP,
15228,GO:0061289,1,0.984785638511809,0,2,Wnt signaling pathway involved in kidney development,BP,
15229,GO:0061290,1,0.984785638511809,0,2,canonical Wnt signaling pathway involved in metanephric kidney development,BP,
15230,GO:0061298,1,0.880138453917097,0,16,retina vasculature development in camera-type eye,BP,
15231,GO:0061299,1,0.935687080737284,0,9,retina vasculature morphogenesis in camera-type eye,BP,
15232,GO:0061300,1,0.986472958181865,0,2,cerebellum vasculature development,BP,
15233,GO:0061301,1,0.990678709386881,0,1,cerebellum vasculature morphogenesis,BP,
15235,GO:0061303,1,0.950805602787325,0,8,cornea development in camera-type eye,BP,
15236,GO:0061304,1,0.966351764068911,0,4,retinal blood vessel morphogenesis,BP,
15237,GO:0061307,1,0.936493728401783,0,11,cardiac neural crest cell differentiation involved in heart development,BP,
15238,GO:0061308,1,0.936493728401783,0,11,cardiac neural crest cell development involved in heart development,BP,
15239,GO:0061309,1,0.948386412410781,0,9,cardiac neural crest cell development involved in outflow tract morphogenesis,BP,
15240,GO:0061311,1,0.849989484993385,0,24,cell surface receptor signaling pathway involved in heart development,BP,
15241,GO:0061312,1,0.964890938207852,0,6,BMP signaling pathway involved in heart development,BP,
15242,GO:0061314,1,0.93353033895742,0,9,Notch signaling involved in heart development,BP,
15243,GO:0061316,1,0.981598944491653,0,3,canonical Wnt signaling pathway involved in heart development,BP,
15244,GO:0061317,1,0.988954874003068,0,2,canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
15245,GO:0061318,1,0.896148652662385,0,15,renal filtration cell differentiation,BP,
15246,GO:0061323,1,0.902249207648828,0,15,cell proliferation involved in heart morphogenesis,BP,
15247,GO:0061324,1,0.992562739064772,0,1,canonical Wnt signaling pathway involved in positive regulation of cardiac outflow tract cell proliferation,BP,
15248,GO:0061325,1,0.975831510899541,0,4,cell proliferation involved in outflow tract morphogenesis,BP,
15252,GO:0061339,1,0.868753087081137,0,19,establishment or maintenance of monopolar cell polarity,BP,
15253,GO:0061341,1,0.983613439270556,0,2,non-canonical Wnt signaling pathway involved in heart development,BP,
15254,GO:0061343,1,0.96832005568904,0,4,cell adhesion involved in heart morphogenesis,BP,
15255,GO:0061346,1,0.983613439270556,0,2,planar cell polarity pathway involved in heart morphogenesis,BP,
15256,GO:0061347,1,0.991622634195076,0,1,planar cell polarity pathway involved in outflow tract morphogenesis,BP,
15257,GO:0061348,1,0.991622634195076,0,1,planar cell polarity pathway involved in ventricular septum morphogenesis,BP,
15258,GO:0061349,1,0.991622634195076,0,1,planar cell polarity pathway involved in cardiac right atrium morphogenesis,BP,
15259,GO:0061350,1,0.991622634195076,0,1,planar cell polarity pathway involved in cardiac muscle tissue morphogenesis,BP,
15261,GO:0061354,1,0.991622634195076,0,1,planar cell polarity pathway involved in pericardium morphogenesis,BP,
15262,GO:0061355,1,0.973481737604824,0,4,Wnt protein secretion,BP,
15263,GO:0061356,1,0.973481737604824,0,4,regulation of Wnt protein secretion,BP,
15264,GO:0061357,1,0.978418675469964,0,3,positive regulation of Wnt protein secretion,BP,
15265,GO:0061358,1,0.994955265031546,0,1,negative regulation of Wnt protein secretion,BP,
15266,GO:0061360,1,0.992456292901894,0,1,optic chiasma development,BP,
15267,GO:0061364,1,0.975792841194378,0,3,apoptotic process involved in luteolysis,BP,
15268,GO:0061365,1,0.966891819801561,0,7,positive regulation of triglyceride lipase activity,BP,
15269,GO:0061366,1,0.980932864525303,0,3,behavioral response to chemical pain,BP,
15270,GO:0061368,1,0.980932864525303,0,3,behavioral response to formalin induced pain,BP,
15271,GO:0061369,1,0.992485744980242,0,1,negative regulation of testicular blood vessel morphogenesis,BP,
15272,GO:0061370,1,0.968315280524941,0,6,testosterone biosynthetic process,BP,
15274,GO:0061373,1,0.989628102769887,0,1,mammillary axonal complex development,BP,
15275,GO:0061377,1,0.888638948863193,0,17,mammary gland lobule development,BP,
15276,GO:0061383,1,0.711353902407856,0,46,trabecula morphogenesis,BP,
15277,GO:0061384,1,0.798322205256023,0,31,heart trabecula morphogenesis,BP,
15278,GO:0061386,1,0.9813696935216,0,2,closure of optic fissure,BP,
15280,GO:0061394,1,0.989857032952389,0,2,regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,
15281,GO:0061395,1,0.995302240164312,0,1,positive regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance,BP,
15282,GO:0061400,1,0.993058458973322,0,1,positive regulation of transcription from RNA polymerase II promoter in response to calcium ion,BP,
15283,GO:0061402,1,0.98686141198153,0,2,positive regulation of transcription from RNA polymerase II promoter in response to acidic pH,BP,
15284,GO:0061408,1,0.981011678430336,0,3,positive regulation of transcription from RNA polymerase II promoter in response to heat stress,BP,
15285,GO:0061418,1,0.664669093135354,0,74,regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
15286,GO:0061419,1,0.962080117730743,0,5,positive regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
15287,GO:0061428,1,0.974031989386799,0,4,negative regulation of transcription from RNA polymerase II promoter in response to hypoxia,BP,
15288,GO:0061430,1,0.902630453137047,0,13,bone trabecula morphogenesis,BP,
15289,GO:0061433,1,0.99476079763154,0,1,cellular response to caloric restriction,BP,
15290,GO:0061436,1,0.898802934524961,0,16,establishment of skin barrier,BP,
15291,GO:0061437,1,0.851794060382622,0,23,renal system vasculature development,BP,
15292,GO:0061438,1,0.954757394915916,0,6,renal system vasculature morphogenesis,BP,
15293,GO:0061439,1,0.954757394915916,0,6,kidney vasculature morphogenesis,BP,
15294,GO:0061440,1,0.851794060382622,0,23,kidney vasculature development,BP,
15295,GO:0061441,1,0.985701312389167,0,2,renal artery morphogenesis,BP,
15296,GO:0061443,1,0.984423730927019,0,2,endocardial cushion cell differentiation,BP,
15297,GO:0061444,1,0.991516019436392,0,1,endocardial cushion cell development,BP,
15298,GO:0061445,1,0.992847632417209,0,1,endocardial cushion cell fate commitment,BP,
15300,GO:0061450,1,0.943957708458972,0,10,trophoblast cell migration,BP,
15302,GO:0061459,1,0.990564505868844,0,1,L-arginine transmembrane transporter activity,MF,
15304,GO:0061469,1,0.944743664040424,0,8,regulation of type B pancreatic cell proliferation,BP,
15305,GO:0061470,1,0.969137898043768,0,4,T follicular helper cell differentiation,BP,
15306,GO:0061474,1,0.993453041736638,0,1,phagolysosome membrane,CC,
15307,GO:0061476,1,0.962961483318247,0,5,response to anticoagulant,BP,
15309,GO:0061481,1,0.997227134670758,0,1,response to TNF agonist,BP,
15310,GO:0061484,1,0.970631816598152,0,4,hematopoietic stem cell homeostasis,BP,
15311,GO:0061485,1,0.990609279379774,0,1,memory T cell proliferation,BP,
15312,GO:0061495,1,0.993058458973322,0,1,gamma-tubulin small complex, mitotic spindle pole body,CC,
15313,GO:0061502,1,0.967102979116478,0,4,early endosome to recycling endosome transport,BP,
15314,GO:0061505,1,0.983757141597064,0,2,DNA topoisomerase II activity,MF,
15315,GO:0061507,1,0.9953661177185,0,1,cyclic-GMP-AMP binding,MF,
15316,GO:0061508,1,0.993058458973322,0,1,CDP phosphorylation,BP,
15317,GO:0061511,1,0.973279306401326,0,4,centriole elongation,BP,
15318,GO:0061512,1,0.800005163962972,0,33,protein localization to cilium,BP,
15319,GO:0061513,1,0.979683146978749,0,3,glucose 6-phosphate:inorganic phosphate antiporter activity,MF,
15321,GO:0061517,1,0.986295837177796,0,2,macrophage proliferation,BP,
15322,GO:0061518,1,0.986295837177796,0,2,microglial cell proliferation,BP,
15323,GO:0061519,1,0.992523613767206,0,1,macrophage homeostasis,BP,
15324,GO:0061523,1,0.992513702219898,0,1,cilium disassembly,BP,
15325,GO:0061525,1,0.941285025432228,0,8,hindgut development,BP,
15326,GO:0061526,1,0.973875883230378,0,4,acetylcholine secretion,BP,
15327,GO:0061528,1,0.992162690456213,0,1,aspartate secretion,BP,
15328,GO:0061534,1,0.987862387037057,0,1,gamma-aminobutyric acid secretion, neurotransmission,BP,
15329,GO:0061535,1,0.972737743014375,0,3,glutamate secretion, neurotransmission,BP,
15330,GO:0061536,1,0.992649030422308,0,1,glycine secretion,BP,
15331,GO:0061537,1,0.992649030422308,0,1,glycine secretion, neurotransmission,BP,
15332,GO:0061542,1,0.996318964210472,0,1,3-demethylubiquinone-n 3-O-methyltransferase activity,MF,
15333,GO:0061547,1,0.985308262440519,0,2,glycogen synthase activity, transferring glucose-1-phosphate,MF,
15334,GO:0061548,1,0.915523469391575,0,12,ganglion development,BP,
15335,GO:0061549,1,0.942844882617204,0,8,sympathetic ganglion development,BP,
15336,GO:0061550,1,0.963010822486551,0,5,cranial ganglion development,BP,
15337,GO:0061551,1,0.970228838835186,0,4,trigeminal ganglion development,BP,
15338,GO:0061552,1,0.99356547104577,0,1,ganglion morphogenesis,BP,
15340,GO:0061565,1,0.993058458973322,0,1,dAMP phosphorylation,BP,
15341,GO:0061566,1,0.993058458973322,0,1,CMP phosphorylation,BP,
15342,GO:0061567,1,0.993058458973322,0,1,dCMP phosphorylation,BP,
15343,GO:0061568,1,0.993058458973322,0,1,GDP phosphorylation,BP,
15344,GO:0061569,1,0.993058458973322,0,1,UDP phosphorylation,BP,
15345,GO:0061570,1,0.993058458973322,0,1,dCDP phosphorylation,BP,
15346,GO:0061571,1,0.993058458973322,0,1,TDP phosphorylation,BP,
15348,GO:0061574,1,0.980963461551683,0,3,ASAP complex,CC,
15349,GO:0061575,1,0.985455108111745,0,4,cyclin-dependent protein serine/threonine kinase activator activity,MF,
15350,GO:0061577,1,0.919058694597108,0,11,calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
15351,GO:0061578,1,0.928318795550921,0,10,Lys63-specific deubiquitinase activity,MF,
15352,GO:0061580,1,0.99245419202513,0,1,colon epithelial cell migration,BP,
15353,GO:0061582,1,0.983858304010164,0,2,intestinal epithelial cell migration,BP,
15354,GO:0061588,1,0.96319224343255,0,5,calcium activated phospholipid scrambling,BP,
15355,GO:0061589,1,0.971405157066035,0,4,calcium activated phosphatidylserine scrambling,BP,
15356,GO:0061590,1,0.96319224343255,0,5,calcium activated phosphatidylcholine scrambling,BP,
15357,GO:0061591,1,0.96319224343255,0,5,calcium activated galactosylceramide scrambling,BP,
15358,GO:0061598,1,0.992420809289738,0,1,molybdopterin adenylyltransferase activity,MF,
15359,GO:0061599,1,0.992420809289738,0,1,molybdopterin molybdotransferase activity,MF,
15360,GO:0061604,1,0.993626621426091,0,1,molybdopterin-synthase sulfurtransferase activity,MF,
15361,GO:0061605,1,0.993626621426091,0,1,molybdopterin-synthase adenylyltransferase activity,MF,
15362,GO:0061608,1,0.944141343652725,0,9,nuclear import signal receptor activity,MF,
15363,GO:0061609,1,0.993674882758611,0,1,fructose-1-phosphate aldolase activity,MF,
15364,GO:0061611,1,0.99517012130739,0,1,mannose to fructose-6-phosphate metabolic process,BP,
15365,GO:0061614,1,0.759229998080837,0,37,pri-miRNA transcription by RNA polymerase II,BP,
15366,GO:0061615,1,0.860498042058609,0,25,glycolytic process through fructose-6-phosphate,BP,
15367,GO:0061617,1,0.958411618483563,0,8,MICOS complex,CC,
15368,GO:0061618,1,0.988358578116796,0,1,sublamina densa,CC,
15369,GO:0061620,1,0.860498042058609,0,25,glycolytic process through glucose-6-phosphate,BP,
15370,GO:0061621,1,0.863866970890729,0,24,canonical glycolysis,BP,
15371,GO:0061622,1,0.988787132550751,0,2,glycolytic process through glucose-1-phosphate,BP,
15372,GO:0061623,1,0.99610588168743,0,1,glycolytic process from galactose,BP,
15373,GO:0061624,1,0.974648699192126,0,4,fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate,BP,
15374,GO:0061626,1,0.956131478453956,0,7,pharyngeal arch artery morphogenesis,BP,
15375,GO:0061627,1,0.994649534375166,0,1,S-methylmethionine-homocysteine S-methyltransferase activity,MF,
15377,GO:0061629,1,0.96972547098277,0,5,RNA polymerase II sequence-specific DNA binding transcription factor binding,MF,
15378,GO:0061630,1,0.221352869850367,0,212,ubiquitin protein ligase activity,MF,
15379,GO:0061631,1,0.845803675165747,0,27,ubiquitin conjugating enzyme activity,MF,
15380,GO:0061635,1,0.958105266429968,0,7,regulation of protein complex stability,BP,
15381,GO:0061640,1,0.584393998737853,0,77,cytoskeleton-dependent cytokinesis,BP,
15382,GO:0061641,1,0.851888907468094,0,30,CENP-A containing chromatin organization,BP,
15383,GO:0061642,1,0.991622634195076,0,1,chemoattraction of axon,BP,
15384,GO:0061643,1,0.977227169990592,0,3,chemorepulsion of axon,BP,
15385,GO:0061645,1,0.948408436511747,0,7,endocytic patch,CC,
15386,GO:0061646,1,0.99214890728012,0,1,positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization,BP,
15387,GO:0061647,1,0.742451635668788,0,40,histone H3-K9 modification,BP,
15388,GO:0061649,1,0.978130752118877,0,3,ubiquitin modification-dependent histone binding,MF,
15389,GO:0061650,1,0.84280476748907,0,28,ubiquitin-like protein conjugating enzyme activity,MF,
15390,GO:0061656,1,0.996460308534979,0,1,SUMO conjugating enzyme activity,MF,
15391,GO:0061659,1,0.214358152582506,0,217,ubiquitin-like protein ligase activity,MF,
15392,GO:0061663,1,0.990684704996628,0,1,NEDD8 ligase activity,MF,
15393,GO:0061665,1,0.968865665763174,0,5,SUMO ligase activity,MF,
15394,GO:0061668,1,0.95969393596762,0,6,mitochondrial ribosome assembly,BP,
15395,GO:0061669,1,0.973546867397119,0,3,spontaneous neurotransmitter secretion,BP,
15396,GO:0061670,1,0.995797939836702,0,1,evoked neurotransmitter secretion,BP,
15397,GO:0061673,1,0.964260094688199,0,5,mitotic spindle astral microtubule,CC,
15398,GO:0061676,1,0.959448154649215,0,6,importin-alpha family protein binding,MF,
15399,GO:0061682,1,0.993860240929273,0,1,seminal vesicle morphogenesis,BP,
15400,GO:0061684,1,0.92424327986372,0,12,chaperone-mediated autophagy,BP,
15401,GO:0061685,1,0.993058458973322,0,1,diphthine methylesterase activity,MF,
15402,GO:0061687,1,0.957011079256377,0,13,detoxification of inorganic compound,BP,
15403,GO:0061689,1,0.972226928255954,0,4,tricellular tight junction,CC,
15404,GO:0061690,1,0.996529489746992,0,1,lipoamidase activity,MF,
15406,GO:0061697,1,0.992690646028277,0,1,protein-glutaryllysine deglutarylase activity,MF,
15407,GO:0061698,1,0.992690646028277,0,1,protein deglutarylation,BP,
15408,GO:0061699,1,0.992690646028277,0,1,peptidyl-lysine deglutarylation,BP,
15409,GO:0061700,1,0.941753933742142,0,9,GATOR2 complex,CC,
15410,GO:0061702,1,0.933388921913883,0,12,inflammasome complex,CC,
15411,GO:0061709,1,0.991101436147855,0,1,reticulophagy,BP,
15412,GO:0061711,1,0.989613975846321,0,2,N(6)-L-threonylcarbamoyladenine synthase activity,MF,
15413,GO:0061712,1,0.992618468743188,0,1,tRNA (N(6)-L-threonylcarbamoyladenosine(37)-C(2))-methylthiotransferase,MF,
15414,GO:0061713,1,0.996793076521281,0,1,anterior neural tube closure,BP,
15415,GO:0061714,1,0.993436548812617,0,2,folic acid receptor activity,MF,
15416,GO:0061718,1,0.863866970890729,0,24,glucose catabolic process to pyruvate,BP,
15417,GO:0061723,1,0.984794110821325,0,2,glycophagy,BP,
15418,GO:0061724,1,0.954999074766061,0,6,lipophagy,BP,
15419,GO:0061726,1,0.591608901310941,0,80,mitochondrion disassembly,BP,
15420,GO:0061727,1,0.988503962609357,0,2,methylglyoxal catabolic process to lactate,BP,
15421,GO:0061731,1,0.977575275840088,0,3,ribonucleoside-diphosphate reductase activity,MF,
15422,GO:0061732,1,0.960834447712271,0,6,mitochondrial acetyl-CoA biosynthetic process from pyruvate,BP,
15423,GO:0061733,1,0.683969745958804,0,52,peptide-lysine-N-acetyltransferase activity,MF,
15424,GO:0061734,1,0.957637132790345,0,5,parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
15425,GO:0061736,1,0.991701063807511,0,1,engulfment of target by autophagosome,BP,
15426,GO:0061737,1,0.973854854636047,0,5,leukotriene signaling pathway,BP,
15427,GO:0061738,1,0.981459910715464,0,3,late endosomal microautophagy,BP,
15428,GO:0061739,1,0.977744224084117,0,3,protein lipidation involved in autophagosome assembly,BP,
15429,GO:0061740,1,0.980125208396832,0,3,protein targeting to lysosome involved in chaperone-mediated autophagy,BP,
15430,GO:0061741,1,0.987569887796063,0,2,chaperone-mediated protein transport involved in chaperone-mediated autophagy,BP,
15431,GO:0061743,1,0.976517567151558,0,4,motor learning,BP,
15432,GO:0061744,1,0.973232375417112,0,5,motor behavior,BP,
15433,GO:0061749,1,0.98405572271886,0,2,forked DNA-dependent helicase activity,MF,
15434,GO:0061750,1,0.993892387500742,0,1,acid sphingomyelin phosphodiesterase activity,MF,
15435,GO:0061752,1,0.987762481382826,0,2,telomeric repeat-containing RNA binding,MF,
15436,GO:0061753,1,0.991701063807511,0,1,substrate localization to autophagosome,BP,
15437,GO:0061756,1,0.840644140173254,0,27,leukocyte adhesion to vascular endothelial cell,BP,
15438,GO:0061757,1,0.988332122949365,0,2,leukocyte adhesion to arterial endothelial cell,BP,
15439,GO:0061760,1,0.990332409277634,0,2,antifungal innate immune response,BP,
15440,GO:0061762,1,0.973733025158503,0,3,CAMKK-AMPK signaling cascade,BP,
15441,GO:0061763,1,0.986407287896898,0,2,multivesicular body-lysosome fusion,BP,
15442,GO:0061767,1,0.991577996294273,0,1,negative regulation of lung blood pressure,BP,
15443,GO:0061768,1,0.992191623755324,0,1,magnesium:sodium antiporter activity,MF,
15444,GO:0061769,1,0.986164624597214,0,2,ribosylnicotinate kinase activity,MF,
15445,GO:0061770,1,0.994264454123425,0,1,translation elongation factor binding,MF,
15446,GO:0061771,1,0.983325079826511,0,3,response to caloric restriction,BP,
15447,GO:0061772,1,0.992565193809675,0,1,drug transport across blood-nerve barrier,BP,
15448,GO:0061778,1,0.876803325861852,0,18,intracellular chloride channel activity,MF,
15449,GO:0061780,1,0.989076230734225,0,1,mitotic cohesin loading,BP,
15450,GO:0061782,1,0.99245977317499,0,1,vesicle fusion with vesicle,BP,
15451,GO:0061783,1,0.987197085163379,0,4,peptidoglycan muralytic activity,MF,
15452,GO:0061789,1,0.970998341155227,0,3,dense core granule priming,BP,
15453,GO:0061792,1,0.976626502078067,0,3,secretory granule maturation,BP,
15454,GO:0061798,1,0.99244581380195,0,1,GTP 3',8'-cyclase activity,MF,
15455,GO:0061799,1,0.99244581380195,0,1,cyclic pyranopterin monophosphate synthase activity,MF,
15456,GO:0061809,1,0.991669392789779,0,2,NAD+ nucleotidase, cyclic ADP-ribose generating,MF,
15457,GO:0061811,1,0.995838442268978,0,1,ADP-ribosyl cyclase activity,MF,
15458,GO:0061812,1,0.995838442268978,0,1,cyclic ADP-ribose hydrolase,MF,
15459,GO:0061817,1,0.976519816374499,0,3,endoplasmic reticulum-plasma membrane tethering,BP,
15460,GO:0061819,1,0.978176510280173,0,3,telomeric DNA-containing double minutes formation,BP,
15461,GO:0061820,1,0.942342776716838,0,8,telomeric D-loop disassembly,BP,
15462,GO:0061821,1,0.969300965250371,0,4,telomeric D-loop binding,MF,
15463,GO:0061825,1,0.992482867306063,0,1,podosome core,CC,
15464,GO:0061827,1,0.969784070648415,0,5,sperm head,CC,
15465,GO:0061828,1,0.990515360610157,0,1,apical tubulobulbar complex,CC,
15466,GO:0061829,1,0.990515360610157,0,1,basal tubulobulbar complex,CC,
15467,GO:0061832,1,0.990408814022038,0,1,basal ectoplasmic specialization,CC,
15468,GO:0061833,1,0.986563857877223,0,2,protein localization to tricellular tight junction,BP,
15469,GO:0061842,1,0.825354602610027,0,24,microtubule organizing center localization,BP,
15471,GO:0061845,1,0.99263010078286,0,1,neuron projection branch point,CC,
15472,GO:0061846,1,0.99263010078286,0,1,dendritic spine cytoplasm,CC,
15473,GO:0061847,1,0.993931277811386,0,1,response to cholecystokinin,BP,
15474,GO:0061849,1,0.98405572271886,0,2,telomeric G-quadruplex DNA binding,MF,
15475,GO:0061850,1,0.997133032599985,0,1,growth cone leading edge,CC,
15476,GO:0061851,1,0.993153112760472,0,1,leading edge of lamellipodium,CC,
15477,GO:0061853,1,0.992114422505465,0,1,regulation of neuroblast migration,BP,
15478,GO:0061855,1,0.992114422505465,0,1,negative regulation of neuroblast migration,BP,
15479,GO:0061857,1,0.985599230852549,0,2,endoplasmic reticulum stress-induced pre-emptive quality control,BP,
15480,GO:0061880,1,0.995338277902724,0,1,regulation of anterograde axonal transport of mitochondrion,BP,
15481,GO:0061881,1,0.995338277902724,0,1,positive regulation of anterograde axonal transport of mitochondrion,BP,
15482,GO:0061884,1,0.994548150917564,0,1,regulation of mini excitatory postsynaptic potential,BP,
15483,GO:0061885,1,0.994548150917564,0,1,positive regulation of mini excitatory postsynaptic potential,BP,
15484,GO:0061888,1,0.9717862423769,0,4,regulation of astrocyte activation,BP,
15485,GO:0061889,1,0.991966839034353,0,1,negative regulation of astrocyte activation,BP,
15486,GO:0061890,1,0.979657599443868,0,3,positive regulation of astrocyte activation,BP,
15487,GO:0061896,1,0.992271484700902,0,1,all-trans retinol 3,4-desaturase activity,MF,
15488,GO:0061897,1,0.992271484700902,0,1,all-trans retinal 3,4-desaturase activity,MF,
15489,GO:0061898,1,0.992271484700902,0,1,all-trans retinoic acid 3,4-desaturase activity,MF,
15490,GO:0061899,1,0.992271484700902,0,1,11-cis-retinal 3,4-desaturase activity,MF,
15492,GO:0061901,1,0.994737097928544,0,1,regulation of 1-phosphatidylinositol-3-kinase activity,BP,
15493,GO:0061903,1,0.994737097928544,0,1,positive regulation of 1-phosphatidylinositol-3-kinase activity,BP,
15494,GO:0061912,1,0.748589101425009,0,40,selective autophagy,BP,
15496,GO:0061920,1,0.989851265375405,0,1,protein propionyltransferase activity,MF,
15497,GO:0061921,1,0.989851265375405,0,1,peptidyl-lysine propionylation,BP,
15498,GO:0061930,1,0.992035648124119,0,1,regulation of erythrocyte enucleation,BP,
15499,GO:0061931,1,0.992035648124119,0,1,positive regulation of erythrocyte enucleation,BP,
15500,GO:0061944,1,0.992401381268823,0,1,negative regulation of protein K48-linked ubiquitination,BP,
15501,GO:0061945,1,0.98086352971428,0,3,regulation of protein K48-linked ubiquitination,BP,
15502,GO:0061951,1,0.763839983519413,0,39,establishment of protein localization to plasma membrane,BP,
15503,GO:0061953,1,0.980826199804542,0,3,mRNA (adenine-N1-)-methyltransferase activity,MF,
15505,GO:0061980,1,0.808012547957703,0,30,regulatory RNA binding,MF,
15506,GO:0061981,1,0.99583057491786,0,1,3-hydroxykynureninase activity,MF,
15507,GO:0061982,1,0.522784056037414,0,98,meiosis I cell cycle process,BP,
15508,GO:0061983,1,0.951405279937707,0,8,meiosis II cell cycle process,BP,
15509,GO:0061986,1,0.993709531925352,0,1,negative regulation of transcription by glucose,BP,
15510,GO:0061987,1,0.993709531925352,0,1,negative regulation of transcription from RNA polymerase II promoter by glucose,BP,
15511,GO:0062009,1,0.927960827535241,0,10,secondary palate development,BP,
15514,GO:0062014,1,0.520418418765819,0,99,negative regulation of small molecule metabolic process,BP,
15515,GO:0065001,1,0.973420707406997,0,4,specification of axis polarity,BP,
15516,GO:0065002,1,0.75693981913794,0,49,intracellular protein transmembrane transport,BP,
15518,GO:0065004,1,0.314178372750335,0,192,protein-DNA complex assembly,BP,
15519,GO:0065005,1,0.859089315426359,0,24,protein-lipid complex assembly,BP,
15524,GO:0065010,1,0.972210243115035,0,5,extracellular membrane-bounded organelle,CC,
15525,GO:0070001,1,0.895519222907993,0,18,aspartic-type peptidase activity,MF,
15526,GO:0070003,1,0.939962367517636,0,18,threonine-type peptidase activity,MF,
15527,GO:0070004,1,0.993058458973322,0,1,cysteine-type exopeptidase activity,MF,
15528,GO:0070006,1,0.871421317347193,0,19,metalloaminopeptidase activity,MF,
15529,GO:0070008,1,0.921718129613266,0,12,serine-type exopeptidase activity,MF,
15531,GO:0070012,1,0.986768610439634,0,2,oligopeptidase activity,MF,
15533,GO:0070016,1,0.924999246035133,0,10,armadillo repeat domain binding,MF,
15534,GO:0070022,1,0.968949132843804,0,4,transforming growth factor beta receptor complex,CC,
15535,GO:0070025,1,0.993347995930623,0,1,carbon monoxide binding,MF,
15536,GO:0070026,1,0.990345344942455,0,2,nitric oxide binding,MF,
15537,GO:0070032,1,0.977662065357691,0,4,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin I complex,CC,
15538,GO:0070033,1,0.981042560540104,0,3,synaptobrevin 2-SNAP-25-syntaxin-1a-complexin II complex,CC,
15539,GO:0070034,1,0.862340485034557,0,22,telomerase RNA binding,MF,
15540,GO:0070035,1,0.519089026198673,0,91,purine NTP-dependent helicase activity,MF,
15541,GO:0070037,1,0.996784560141772,0,1,rRNA (pseudouridine) methyltransferase activity,MF,
15542,GO:0070039,1,0.992036210342068,0,1,rRNA (guanosine-2'-O-)-methyltransferase activity,MF,
15543,GO:0070042,1,0.992777398744391,0,1,rRNA (uridine-N3-)-methyltransferase activity,MF,
15544,GO:0070044,1,0.976351066642412,0,4,synaptobrevin 2-SNAP-25-syntaxin-1a complex,CC,
15546,GO:0070051,1,0.977772537653591,0,3,fibrinogen binding,MF,
15547,GO:0070052,1,0.984382299033298,0,2,collagen V binding,MF,
15548,GO:0070053,1,0.979875189364294,0,3,thrombospondin receptor activity,MF,
15549,GO:0070054,1,0.97905249016939,0,3,mRNA splicing, via endonucleolytic cleavage and ligation,BP,
15550,GO:0070055,1,0.97905249016939,0,3,mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
15551,GO:0070059,1,0.707463244128252,0,54,intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress,BP,
15552,GO:0070060,1,0.989652081548275,0,1,'de novo' actin filament nucleation,BP,
15553,GO:0070061,1,0.969007696231869,0,5,fructose binding,MF,
15555,GO:0070063,1,0.68996379827395,0,54,RNA polymerase binding,MF,
15556,GO:0070064,1,0.87434974351665,0,18,proline-rich region binding,MF,
15557,GO:0070069,1,0.906979935933752,0,25,cytochrome complex,CC,
15558,GO:0070070,1,0.924037720562426,0,10,proton-transporting V-type ATPase complex assembly,BP,
15559,GO:0070071,1,0.903725897896111,0,14,proton-transporting two-sector ATPase complex assembly,BP,
15560,GO:0070072,1,0.924037720562426,0,10,vacuolar proton-transporting V-type ATPase complex assembly,BP,
15561,GO:0070075,1,0.9976720550329,0,1,tear secretion,BP,
15562,GO:0070076,1,0.815019581237884,0,25,histone lysine demethylation,BP,
15563,GO:0070077,1,0.992518804425241,0,1,histone arginine demethylation,BP,
15564,GO:0070078,1,0.992518804425241,0,1,histone H3-R2 demethylation,BP,
15565,GO:0070079,1,0.992518804425241,0,1,histone H4-R3 demethylation,BP,
15566,GO:0070080,1,0.989331026117197,0,2,titin Z domain binding,MF,
15567,GO:0070081,1,0.970462310450367,0,5,clathrin-sculpted monoamine transport vesicle,CC,
15568,GO:0070083,1,0.970462310450367,0,5,clathrin-sculpted monoamine transport vesicle membrane,CC,
15570,GO:0070086,1,0.976754443002413,0,4,ubiquitin-dependent endocytosis,BP,
15571,GO:0070087,1,0.948944727494478,0,6,chromo shadow domain binding,MF,
15572,GO:0070091,1,0.961124730186589,0,7,glucagon secretion,BP,
15573,GO:0070092,1,0.964500336876631,0,6,regulation of glucagon secretion,BP,
15574,GO:0070093,1,0.9859939005231,0,3,negative regulation of glucagon secretion,BP,
15575,GO:0070094,1,0.99337998496374,0,1,positive regulation of glucagon secretion,BP,
15576,GO:0070095,1,0.982195749551758,0,3,fructose-6-phosphate binding,MF,
15577,GO:0070096,1,0.992576689408957,0,1,mitochondrial outer membrane translocase complex assembly,BP,
15578,GO:0070097,1,0.951114321431892,0,6,delta-catenin binding,MF,
15580,GO:0070099,1,0.951721404964278,0,7,regulation of chemokine-mediated signaling pathway,BP,
15581,GO:0070100,1,0.967451687080327,0,4,negative regulation of chemokine-mediated signaling pathway,BP,
15582,GO:0070101,1,0.983745834081732,0,3,positive regulation of chemokine-mediated signaling pathway,BP,
15583,GO:0070102,1,0.881278928580156,0,17,interleukin-6-mediated signaling pathway,BP,
15584,GO:0070103,1,0.984591022176185,0,3,regulation of interleukin-6-mediated signaling pathway,BP,
15585,GO:0070104,1,0.995333632824751,0,1,negative regulation of interleukin-6-mediated signaling pathway,BP,
15586,GO:0070105,1,0.989207528436467,0,2,positive regulation of interleukin-6-mediated signaling pathway,BP,
15588,GO:0070110,1,0.979913468912787,0,3,ciliary neurotrophic factor receptor complex,CC,
15589,GO:0070119,1,0.992452128295228,0,1,ciliary neurotrophic factor binding,MF,
15590,GO:0070120,1,0.964245051054374,0,5,ciliary neurotrophic factor-mediated signaling pathway,BP,
15591,GO:0070121,1,0.991799783217798,0,1,Kupffer's vesicle development,BP,
15592,GO:0070122,1,0.965225286486519,0,5,isopeptidase activity,MF,
15593,GO:0070123,1,0.991256220273894,0,1,transforming growth factor beta receptor activity, type III,MF,
15594,GO:0070124,1,0.989911073287987,0,2,mitochondrial translational initiation,BP,
15595,GO:0070125,1,0.713985621778989,0,84,mitochondrial translational elongation,BP,
15596,GO:0070126,1,0.705730830336737,0,86,mitochondrial translational termination,BP,
15597,GO:0070127,1,0.948210555097052,0,8,tRNA aminoacylation for mitochondrial protein translation,BP,
15598,GO:0070129,1,0.895635883009785,0,18,regulation of mitochondrial translation,BP,
15599,GO:0070130,1,0.993058458973322,0,1,negative regulation of mitochondrial translation,BP,
15600,GO:0070131,1,0.935407325773937,0,11,positive regulation of mitochondrial translation,BP,
15601,GO:0070137,1,0.967749624698361,0,4,ubiquitin-like protein-specific endopeptidase activity,MF,
15602,GO:0070138,1,0.97756070221863,0,3,ubiquitin-like protein-specific isopeptidase activity,MF,
15603,GO:0070139,1,0.967749624698361,0,4,SUMO-specific endopeptidase activity,MF,
15604,GO:0070140,1,0.97756070221863,0,3,SUMO-specific isopeptidase activity,MF,
15606,GO:0070142,1,0.9631061592833,0,5,synaptic vesicle budding,BP,
15607,GO:0070143,1,0.992221005015368,0,1,mitochondrial alanyl-tRNA aminoacylation,BP,
15608,GO:0070145,1,0.992584948142418,0,1,mitochondrial asparaginyl-tRNA aminoacylation,BP,
15609,GO:0070150,1,0.988709697401966,0,2,mitochondrial glycyl-tRNA aminoacylation,BP,
15610,GO:0070159,1,0.993769487930932,0,1,mitochondrial threonyl-tRNA aminoacylation,BP,
15613,GO:0070162,1,0.957981513200217,0,6,adiponectin secretion,BP,
15614,GO:0070163,1,0.957981513200217,0,6,regulation of adiponectin secretion,BP,
15615,GO:0070164,1,0.971959473690583,0,4,negative regulation of adiponectin secretion,BP,
15616,GO:0070165,1,0.985622840593808,0,2,positive regulation of adiponectin secretion,BP,
15617,GO:0070166,1,0.933700945706227,0,9,enamel mineralization,BP,
15619,GO:0070168,1,0.919574129784505,0,13,negative regulation of biomineral tissue development,BP,
15621,GO:0070170,1,0.973105894265655,0,4,regulation of tooth mineralization,BP,
15622,GO:0070171,1,0.984938550585924,0,2,negative regulation of tooth mineralization,BP,
15623,GO:0070172,1,0.987988213286764,0,2,positive regulation of tooth mineralization,BP,
15624,GO:0070176,1,0.995111298923854,0,1,DRM complex,CC,
15625,GO:0070178,1,0.989174402041407,0,2,D-serine metabolic process,BP,
15626,GO:0070179,1,0.993575240739539,0,1,D-serine biosynthetic process,BP,
15627,GO:0070180,1,0.997770470052686,0,1,large ribosomal subunit rRNA binding,MF,
15628,GO:0070181,1,0.964235308795198,0,8,small ribosomal subunit rRNA binding,MF,
15629,GO:0070182,1,0.897089322402705,0,16,DNA polymerase binding,MF,
15630,GO:0070183,1,0.993010929094048,0,1,mitochondrial tryptophanyl-tRNA aminoacylation,BP,
15631,GO:0070184,1,0.994264454123425,0,1,mitochondrial tyrosyl-tRNA aminoacylation,BP,
15632,GO:0070187,1,0.962302719798061,0,6,shelterin complex,CC,
15633,GO:0070189,1,0.962615884854854,0,7,kynurenine metabolic process,BP,
15634,GO:0070191,1,0.98787292203371,0,2,methionine-R-sulfoxide reductase activity,MF,
15635,GO:0070192,1,0.685389388334529,0,55,chromosome organization involved in meiotic cell cycle,BP,
15636,GO:0070193,1,0.883283109182063,0,19,synaptonemal complex organization,BP,
15637,GO:0070194,1,0.987358627666956,0,2,synaptonemal complex disassembly,BP,
15638,GO:0070195,1,0.992393189410449,0,1,growth hormone receptor complex,CC,
15639,GO:0070197,1,0.966163431541637,0,5,meiotic attachment of telomere to nuclear envelope,BP,
15640,GO:0070198,1,0.827160081610076,0,27,protein localization to chromosome, telomeric region,BP,
15641,GO:0070199,1,0.864505316178861,0,23,establishment of protein localization to chromosome,BP,
15642,GO:0070200,1,0.904640971898038,0,15,establishment of protein localization to telomere,BP,
15644,GO:0070202,1,0.934387362905737,0,11,regulation of establishment of protein localization to chromosome,BP,
15645,GO:0070203,1,0.940922781886553,0,10,regulation of establishment of protein localization to telomere,BP,
15646,GO:0070206,1,0.729091763858638,0,48,protein trimerization,BP,
15647,GO:0070207,1,0.837883099390288,0,28,protein homotrimerization,BP,
15648,GO:0070208,1,0.923598392424213,0,11,protein heterotrimerization,BP,
15649,GO:0070209,1,0.99259143139985,0,1,ASTRA complex,CC,
15650,GO:0070212,1,0.968639593277982,0,4,protein poly-ADP-ribosylation,BP,
15651,GO:0070213,1,0.967127530764106,0,4,protein auto-ADP-ribosylation,BP,
15652,GO:0070221,1,0.983592365413252,0,4,sulfide oxidation, using sulfide:quinone oxidoreductase,BP,
15653,GO:0070227,1,0.682807878109945,0,63,lymphocyte apoptotic process,BP,
15654,GO:0070228,1,0.751234747809049,0,48,regulation of lymphocyte apoptotic process,BP,
15655,GO:0070229,1,0.847119706705895,0,27,negative regulation of lymphocyte apoptotic process,BP,
15656,GO:0070230,1,0.925198432826478,0,14,positive regulation of lymphocyte apoptotic process,BP,
15657,GO:0070231,1,0.775641168634713,0,43,T cell apoptotic process,BP,
15658,GO:0070232,1,0.843475984955254,0,29,regulation of T cell apoptotic process,BP,
15659,GO:0070233,1,0.901703076339825,0,17,negative regulation of T cell apoptotic process,BP,
15660,GO:0070234,1,0.947143128823375,0,10,positive regulation of T cell apoptotic process,BP,
15661,GO:0070235,1,0.969991328015205,0,5,regulation of activation-induced cell death of T cells,BP,
15662,GO:0070236,1,0.975050221557865,0,4,negative regulation of activation-induced cell death of T cells,BP,
15663,GO:0070238,1,0.995407779536441,0,1,activated T cell autonomous cell death,BP,
15664,GO:0070239,1,0.995407779536441,0,1,regulation of activated T cell autonomous cell death,BP,
15665,GO:0070241,1,0.995407779536441,0,1,positive regulation of activated T cell autonomous cell death,BP,
15666,GO:0070242,1,0.899093210567916,0,17,thymocyte apoptotic process,BP,
15667,GO:0070243,1,0.929417998157444,0,12,regulation of thymocyte apoptotic process,BP,
15668,GO:0070244,1,0.959517249080721,0,7,negative regulation of thymocyte apoptotic process,BP,
15669,GO:0070245,1,0.968643601784862,0,5,positive regulation of thymocyte apoptotic process,BP,
15670,GO:0070246,1,0.996253344696241,0,1,natural killer cell apoptotic process,BP,
15671,GO:0070247,1,0.996253344696241,0,1,regulation of natural killer cell apoptotic process,BP,
15672,GO:0070251,1,0.99391611389164,0,1,pristanate-CoA ligase activity,MF,
15674,GO:0070253,1,0.985467466743938,0,4,somatostatin secretion,BP,
15675,GO:0070254,1,0.942221641529953,0,10,mucus secretion,BP,
15676,GO:0070255,1,0.944644104634308,0,9,regulation of mucus secretion,BP,
15677,GO:0070256,1,0.988728522250398,0,2,negative regulation of mucus secretion,BP,
15678,GO:0070257,1,0.961947735507919,0,6,positive regulation of mucus secretion,BP,
15679,GO:0070259,1,0.985625339970197,0,2,tyrosyl-DNA phosphodiesterase activity,MF,
15680,GO:0070260,1,0.993058458973322,0,1,5'-tyrosyl-DNA phosphodiesterase activity,MF,
15681,GO:0070262,1,0.906901793872385,0,16,peptidyl-serine dephosphorylation,BP,
15682,GO:0070265,1,0.757888470697858,0,48,necrotic cell death,BP,
15683,GO:0070266,1,0.795595185447849,0,36,necroptotic process,BP,
15684,GO:0070267,1,0.992524667028015,0,1,oncosis,BP,
15686,GO:0070269,1,0.952334412545238,0,9,pyroptosis,BP,
15687,GO:0070273,1,0.858282015473483,0,22,phosphatidylinositol-4-phosphate binding,MF,
15688,GO:0070274,1,0.990376183227505,0,2,RES complex,CC,
15689,GO:0070278,1,0.966678939066184,0,5,extracellular matrix constituent secretion,BP,
15690,GO:0070279,1,0.749481024645463,0,45,vitamin B6 binding,MF,
15691,GO:0070280,1,0.992493728080011,0,1,pyridoxal binding,MF,
15692,GO:0070283,1,0.995399687780569,0,1,radical SAM enzyme activity,MF,
15693,GO:0070286,1,0.802435218547625,0,29,axonemal dynein complex assembly,BP,
15694,GO:0070287,1,0.992517709297307,0,1,ferritin receptor activity,MF,
15695,GO:0070288,1,0.993582692531095,0,2,ferritin complex,CC,
15696,GO:0070290,1,0.965549491376178,0,5,N-acylphosphatidylethanolamine-specific phospholipase D activity,MF,
15697,GO:0070291,1,0.980151057542483,0,3,N-acylethanolamine metabolic process,BP,
15698,GO:0070292,1,0.984798584334961,0,2,N-acylphosphatidylethanolamine metabolic process,BP,
15699,GO:0070293,1,0.912688487963176,0,15,renal absorption,BP,
15700,GO:0070294,1,0.97168159358665,0,4,renal sodium ion absorption,BP,
15701,GO:0070295,1,0.981939694746205,0,3,renal water absorption,BP,
15702,GO:0070296,1,0.796432212727181,0,31,sarcoplasmic reticulum calcium ion transport,BP,
15704,GO:0070301,1,0.590384654381462,0,82,cellular response to hydrogen peroxide,BP,
15706,GO:0070303,1,0.763753809256027,0,39,negative regulation of stress-activated protein kinase signaling cascade,BP,
15707,GO:0070304,1,0.386982009699952,0,137,positive regulation of stress-activated protein kinase signaling cascade,BP,
15708,GO:0070305,1,0.952518631659571,0,6,response to cGMP,BP,
15709,GO:0070306,1,0.831826439459708,0,26,lens fiber cell differentiation,BP,
15710,GO:0070307,1,0.92928178763955,0,11,lens fiber cell development,BP,
15711,GO:0070309,1,0.973024718224444,0,4,lens fiber cell morphogenesis,BP,
15712,GO:0070314,1,0.96012083845874,0,6,G1 to G0 transition,BP,
15713,GO:0070315,1,0.985363826690613,0,2,G1 to G0 transition involved in cell differentiation,BP,
15714,GO:0070316,1,0.749613145870575,0,40,regulation of G0 to G1 transition,BP,
15715,GO:0070317,1,0.770122989665539,0,36,negative regulation of G0 to G1 transition,BP,
15716,GO:0070318,1,0.973436615607831,0,4,positive regulation of G0 to G1 transition,BP,
15717,GO:0070320,1,0.993229974828245,0,1,inward rectifier potassium channel inhibitor activity,MF,
15718,GO:0070324,1,0.959603757108207,0,7,thyroid hormone binding,MF,
15719,GO:0070325,1,0.854474501409185,0,21,lipoprotein particle receptor binding,MF,
15720,GO:0070326,1,0.973187986220263,0,4,very-low-density lipoprotein particle receptor binding,MF,
15721,GO:0070327,1,0.956991872304778,0,7,thyroid hormone transport,BP,
15722,GO:0070328,1,0.86537655252368,0,25,triglyceride homeostasis,BP,
15723,GO:0070329,1,0.987421175502056,0,2,tRNA seleno-modification,BP,
15724,GO:0070330,1,0.908144425698834,0,16,aromatase activity,MF,
15725,GO:0070335,1,0.990818831094352,0,1,aspartate binding,MF,
15726,GO:0070336,1,0.984777159196683,0,2,flap-structured DNA binding,MF,
15727,GO:0070337,1,0.991661391349946,0,1,3'-flap-structured DNA binding,MF,
15728,GO:0070339,1,0.962929072281307,0,6,response to bacterial lipopeptide,BP,
15729,GO:0070340,1,0.977315679694232,0,3,detection of bacterial lipopeptide,BP,
15730,GO:0070341,1,0.943602697313242,0,9,fat cell proliferation,BP,
15731,GO:0070343,1,0.986416917354015,0,3,white fat cell proliferation,BP,
15732,GO:0070344,1,0.943602697313242,0,9,regulation of fat cell proliferation,BP,
15733,GO:0070345,1,0.963190440801606,0,5,negative regulation of fat cell proliferation,BP,
15734,GO:0070346,1,0.987161332792865,0,3,positive regulation of fat cell proliferation,BP,
15735,GO:0070350,1,0.986416917354015,0,3,regulation of white fat cell proliferation,BP,
15736,GO:0070352,1,0.993958067804248,0,2,positive regulation of white fat cell proliferation,BP,
15737,GO:0070358,1,0.961442228994785,0,6,actin polymerization-dependent cell motility,BP,
15738,GO:0070365,1,0.922794099722089,0,13,hepatocyte differentiation,BP,
15739,GO:0070366,1,0.991124452712833,0,2,regulation of hepatocyte differentiation,BP,
15740,GO:0070367,1,0.994550502627417,0,1,negative regulation of hepatocyte differentiation,BP,
15741,GO:0070368,1,0.996555366104087,0,1,positive regulation of hepatocyte differentiation,BP,
15742,GO:0070369,1,0.975349888409891,0,3,beta-catenin-TCF7L2 complex,CC,
15743,GO:0070370,1,0.974347906959903,0,5,cellular heat acclimation,BP,
15746,GO:0070373,1,0.673834901835079,0,58,negative regulation of ERK1 and ERK2 cascade,BP,
15748,GO:0070375,1,0.978728348113004,0,3,ERK5 cascade,BP,
15749,GO:0070376,1,0.992916869061981,0,1,regulation of ERK5 cascade,BP,
15750,GO:0070377,1,0.992916869061981,0,1,negative regulation of ERK5 cascade,BP,
15751,GO:0070381,1,0.985121392323828,0,2,endosome to plasma membrane transport vesicle,CC,
15753,GO:0070383,1,0.957495248237439,0,8,DNA cytosine deamination,BP,
15754,GO:0070384,1,0.975899426070488,0,4,Harderian gland development,BP,
15755,GO:0070390,1,0.995312711829602,0,1,transcription export complex 2,CC,
15756,GO:0070391,1,0.939432257549296,0,11,response to lipoteichoic acid,BP,
15757,GO:0070392,1,0.996782430484662,0,1,detection of lipoteichoic acid,BP,
15758,GO:0070401,1,0.989539909474878,0,2,NADP+ binding,MF,
15759,GO:0070402,1,0.924185306062814,0,13,NADPH binding,MF,
15760,GO:0070403,1,0.920436131846691,0,14,NAD+ binding,MF,
15761,GO:0070404,1,0.986372251010084,0,3,NADH binding,MF,
15762,GO:0070405,1,0.692240674587907,0,59,ammonium ion binding,MF,
15763,GO:0070407,1,0.992709673893517,0,1,oxidation-dependent protein catabolic process,BP,
15764,GO:0070408,1,0.99167451769715,0,1,carbamoyl phosphate metabolic process,BP,
15765,GO:0070409,1,0.99167451769715,0,1,carbamoyl phosphate biosynthetic process,BP,
15766,GO:0070410,1,0.90809160572441,0,12,co-SMAD binding,MF,
15767,GO:0070411,1,0.916263539793866,0,11,I-SMAD binding,MF,
15768,GO:0070412,1,0.832441773289452,0,23,R-SMAD binding,MF,
15769,GO:0070413,1,0.992851164494148,0,1,trehalose metabolism in response to stress,BP,
15770,GO:0070417,1,0.951091683036878,0,7,cellular response to cold,BP,
15771,GO:0070418,1,0.992024362753079,0,1,DNA-dependent protein kinase complex,CC,
15772,GO:0070419,1,0.950027070248534,0,7,nonhomologous end joining complex,CC,
15773,GO:0070423,1,0.793791690612727,0,33,nucleotide-binding oligomerization domain containing signaling pathway,BP,
15774,GO:0070424,1,0.940733668512741,0,8,regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
15775,GO:0070425,1,0.985228105757099,0,2,negative regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
15776,GO:0070426,1,0.979079169131248,0,3,positive regulation of nucleotide-binding oligomerization domain containing signaling pathway,BP,
15777,GO:0070427,1,0.973392767345923,0,4,nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15778,GO:0070428,1,0.984174780766495,0,2,regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15779,GO:0070429,1,0.992371143331572,0,1,negative regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15780,GO:0070430,1,0.991741257029872,0,1,positive regulation of nucleotide-binding oligomerization domain containing 1 signaling pathway,BP,
15781,GO:0070431,1,0.933947803287175,0,10,nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15782,GO:0070432,1,0.964613281425908,0,5,regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15783,GO:0070433,1,0.985228105757099,0,2,negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15784,GO:0070434,1,0.979079169131248,0,3,positive regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway,BP,
15786,GO:0070436,1,0.985087676060412,0,2,Grb2-EGFR complex,CC,
15787,GO:0070442,1,0.996066043553681,0,1,integrin alphaIIb-beta3 complex,CC,
15788,GO:0070444,1,0.938906794088023,0,8,oligodendrocyte progenitor proliferation,BP,
15789,GO:0070445,1,0.938906794088023,0,8,regulation of oligodendrocyte progenitor proliferation,BP,
15790,GO:0070446,1,0.99476079763154,0,1,negative regulation of oligodendrocyte progenitor proliferation,BP,
15791,GO:0070447,1,0.973242161454735,0,3,positive regulation of oligodendrocyte progenitor proliferation,BP,
15794,GO:0070460,1,0.992489152328139,0,1,thyroid-stimulating hormone secretion,BP,
15795,GO:0070461,1,0.855187082486712,0,23,SAGA-type complex,CC,
15796,GO:0070462,1,0.992513702219898,0,1,plus-end specific microtubule depolymerization,BP,
15797,GO:0070463,1,0.99254900681805,0,1,tubulin-dependent ATPase activity,MF,
15798,GO:0070469,1,0.736246978001051,0,81,respiratory chain,CC,
15799,GO:0070470,1,0.980803667126547,0,4,plasma membrane respiratory chain,CC,
15800,GO:0070471,1,0.948491455442108,0,8,uterine smooth muscle contraction,BP,
15801,GO:0070472,1,0.954806620520627,0,7,regulation of uterine smooth muscle contraction,BP,
15802,GO:0070473,1,0.994748946424566,0,1,negative regulation of uterine smooth muscle contraction,BP,
15803,GO:0070474,1,0.959848900308141,0,6,positive regulation of uterine smooth muscle contraction,BP,
15804,GO:0070475,1,0.961052143712552,0,7,rRNA base methylation,BP,
15805,GO:0070476,1,0.997770470052686,0,1,rRNA (guanine-N7)-methylation,BP,
15806,GO:0070478,1,0.99243937474803,0,1,nuclear-transcribed mRNA catabolic process, 3'-5' exonucleolytic nonsense-mediated decay,BP,
15807,GO:0070481,1,0.992894448348162,0,1,nuclear-transcribed mRNA catabolic process, non-stop decay,BP,
15809,GO:0070483,1,0.992669230765027,0,1,detection of hypoxia,BP,
15810,GO:0070486,1,0.930106857602556,0,12,leukocyte aggregation,BP,
15811,GO:0070487,1,0.965441001085621,0,5,monocyte aggregation,BP,
15812,GO:0070488,1,0.995901720361979,0,2,neutrophil aggregation,BP,
15813,GO:0070489,1,0.987286382505374,0,2,T cell aggregation,BP,
15814,GO:0070491,1,0.655976825364465,0,62,repressing transcription factor binding,MF,
15815,GO:0070492,1,0.94844970076386,0,9,oligosaccharide binding,MF,
15816,GO:0070493,1,0.917277167372672,0,12,thrombin-activated receptor signaling pathway,BP,
15817,GO:0070494,1,0.979458830510873,0,3,regulation of thrombin-activated receptor signaling pathway,BP,
15818,GO:0070495,1,0.979458830510873,0,3,negative regulation of thrombin-activated receptor signaling pathway,BP,
15819,GO:0070498,1,0.576976868197776,0,96,interleukin-1-mediated signaling pathway,BP,
15820,GO:0070506,1,0.986503983543532,0,2,high-density lipoprotein particle receptor activity,MF,
15821,GO:0070507,1,0.307155461332963,0,162,regulation of microtubule cytoskeleton organization,BP,
15822,GO:0070508,1,0.960720226260293,0,7,cholesterol import,BP,
15823,GO:0070509,1,0.624488924896059,0,64,calcium ion import,BP,
15824,GO:0070510,1,0.990828787509672,0,1,regulation of histone H4-K20 methylation,BP,
15825,GO:0070512,1,0.990828787509672,0,1,positive regulation of histone H4-K20 methylation,BP,
15826,GO:0070513,1,0.953386341781841,0,9,death domain binding,MF,
15827,GO:0070522,1,0.971384965511913,0,4,ERCC4-ERCC1 complex,CC,
15828,GO:0070524,1,0.996000544923602,0,1,11-beta-hydroxysteroid dehydrogenase (NADP+) activity,MF,
15829,GO:0070525,1,0.928492021159003,0,13,tRNA threonylcarbamoyladenosine metabolic process,BP,
15831,GO:0070528,1,0.833891214602785,0,27,protein kinase C signaling,BP,
15832,GO:0070530,1,0.88224659520112,0,17,K63-linked polyubiquitin modification-dependent protein binding,MF,
15833,GO:0070531,1,0.964020544319462,0,5,BRCA1-A complex,CC,
15834,GO:0070534,1,0.752277067623282,0,42,protein K63-linked ubiquitination,BP,
15835,GO:0070535,1,0.96078862426192,0,5,histone H2A K63-linked ubiquitination,BP,
15836,GO:0070536,1,0.835231100759194,0,24,protein K63-linked deubiquitination,BP,
15837,GO:0070537,1,0.979228609773687,0,3,histone H2A K63-linked deubiquitination,BP,
15838,GO:0070538,1,0.992676724667824,0,2,oleic acid binding,MF,
15839,GO:0070539,1,0.992539097270522,0,1,linoleic acid binding,MF,
15840,GO:0070541,1,0.979656253325462,0,3,response to platinum ion,BP,
15841,GO:0070542,1,0.611860700913089,0,75,response to fatty acid,BP,
15842,GO:0070543,1,0.994466064188805,0,1,response to linoleic acid,BP,
15843,GO:0070544,1,0.938589258004993,0,8,histone H3-K36 demethylation,BP,
15844,GO:0070545,1,0.980410156126527,0,3,PeBoW complex,CC,
15845,GO:0070547,1,0.993087571229264,0,1,L-tyrosine aminotransferase activity,MF,
15846,GO:0070548,1,0.982785840502929,0,2,L-glutamine aminotransferase activity,MF,
15847,GO:0070550,1,0.989076230734225,0,1,rDNA condensation,BP,
15848,GO:0070551,1,0.993058458973322,0,1,endoribonuclease activity, cleaving siRNA-paired mRNA,MF,
15849,GO:0070552,1,0.980200764542426,0,3,BRISC complex,CC,
15850,GO:0070553,1,0.993058458973322,0,1,nicotinic acid receptor activity,MF,
15851,GO:0070554,1,0.986622292321676,0,2,synaptobrevin 2-SNAP-25-syntaxin-3-complexin complex,CC,
15852,GO:0070555,1,0.37596818250425,0,166,response to interleukin-1,BP,
15853,GO:0070557,1,0.990349675944121,0,2,PCNA-p21 complex,CC,
15855,GO:0070561,1,0.936979890752416,0,9,vitamin D receptor signaling pathway,BP,
15856,GO:0070562,1,0.957807639959333,0,6,regulation of vitamin D receptor signaling pathway,BP,
15857,GO:0070563,1,0.986528435250619,0,2,negative regulation of vitamin D receptor signaling pathway,BP,
15858,GO:0070564,1,0.987916589967314,0,2,positive regulation of vitamin D receptor signaling pathway,BP,
15859,GO:0070566,1,0.830119978911473,0,27,adenylyltransferase activity,MF,
15860,GO:0070567,1,0.945782832549488,0,9,cytidylyltransferase activity,MF,
15861,GO:0070568,1,0.969538066147984,0,5,guanylyltransferase activity,MF,
15862,GO:0070569,1,0.954171738525941,0,7,uridylyltransferase activity,MF,
15863,GO:0070570,1,0.83339769631421,0,26,regulation of neuron projection regeneration,BP,
15864,GO:0070571,1,0.90309160459704,0,14,negative regulation of neuron projection regeneration,BP,
15865,GO:0070572,1,0.953210243447137,0,8,positive regulation of neuron projection regeneration,BP,
15866,GO:0070573,1,0.98110883623553,0,3,metallodipeptidase activity,MF,
15867,GO:0070574,1,0.972459763997186,0,4,cadmium ion transmembrane transport,BP,
15868,GO:0070576,1,0.986060303959266,0,2,vitamin D 24-hydroxylase activity,MF,
15869,GO:0070577,1,0.868224776944696,0,17,lysine-acetylated histone binding,MF,
15870,GO:0070578,1,0.941303828341306,0,9,RISC-loading complex,CC,
15871,GO:0070579,1,0.961422030866408,0,4,methylcytosine dioxygenase activity,MF,
15872,GO:0070584,1,0.880994778898609,0,21,mitochondrion morphogenesis,BP,
15873,GO:0070585,1,0.345995876301387,0,177,protein localization to mitochondrion,BP,
15877,GO:0070589,1,0.99517012130739,0,1,cellular component macromolecule biosynthetic process,BP,
15878,GO:0070593,1,0.983004524342243,0,2,dendrite self-avoidance,BP,
15879,GO:0070601,1,0.935957506848401,0,10,centromeric sister chromatid cohesion,BP,
15880,GO:0070602,1,0.974852374281851,0,4,regulation of centromeric sister chromatid cohesion,BP,
15882,GO:0070611,1,0.993287443236099,0,1,histone methyltransferase activity (H3-R2 specific),MF,
15883,GO:0070612,1,0.993287443236099,0,1,histone methyltransferase activity (H2A-R3 specific),MF,
15885,GO:0070615,1,0.992461094797854,0,1,nucleosome-dependent ATPase activity,MF,
15886,GO:0070618,1,0.993203299420269,0,1,Grb2-Sos complex,CC,
15887,GO:0070625,1,0.994445033866488,0,1,zymogen granule exocytosis,BP,
15888,GO:0070626,1,0.995845182606778,0,1,(S)-2-(5-amino-1-(5-phospho-D-ribosyl)imidazole-4-carboxamido)succinate AMP-lyase (fumarate-forming) activity,MF,
15889,GO:0070627,1,0.992443860497474,0,1,ferrous iron import,BP,
15890,GO:0070628,1,0.884182160770477,0,21,proteasome binding,MF,
15891,GO:0070631,1,0.993058458973322,0,1,spindle pole body localization,BP,
15892,GO:0070632,1,0.993058458973322,0,1,establishment of spindle pole body localization,BP,
15893,GO:0070633,1,0.899189492797766,0,15,transepithelial transport,BP,
15894,GO:0070634,1,0.985796264301393,0,2,transepithelial ammonium transport,BP,
15895,GO:0070637,1,0.99370748335756,0,1,pyridine nucleoside metabolic process,BP,
15896,GO:0070638,1,0.99370748335756,0,1,pyridine nucleoside catabolic process,BP,
15897,GO:0070640,1,0.980952242722176,0,3,vitamin D3 metabolic process,BP,
15898,GO:0070643,1,0.995536655506774,0,1,vitamin D 25-hydroxylase activity,MF,
15899,GO:0070644,1,0.976675077617371,0,3,vitamin D response element binding,MF,
15900,GO:0070646,1,0.16816975730481,0,264,protein modification by small protein removal,BP,
15902,GO:0070649,1,0.975960711731305,0,3,formin-nucleated actin cable assembly,BP,
15903,GO:0070651,1,0.992894448348162,0,1,nonfunctional rRNA decay,BP,
15904,GO:0070652,1,0.951875468246758,0,8,HAUS complex,CC,
15905,GO:0070653,1,0.997109972288868,0,1,high-density lipoprotein particle receptor binding,MF,
15907,GO:0070662,1,0.976847985916337,0,3,mast cell proliferation,BP,
15910,GO:0070665,1,0.491839593652255,0,121,positive regulation of leukocyte proliferation,BP,
15911,GO:0070666,1,0.984707889313395,0,2,regulation of mast cell proliferation,BP,
15912,GO:0070667,1,0.99275372321051,0,1,negative regulation of mast cell proliferation,BP,
15913,GO:0070668,1,0.984707889313395,0,2,positive regulation of mast cell proliferation,BP,
15914,GO:0070669,1,0.915019829164038,0,13,response to interleukin-2,BP,
15915,GO:0070670,1,0.830137527007397,0,30,response to interleukin-4,BP,
15916,GO:0070671,1,0.767439357528418,0,46,response to interleukin-12,BP,
15917,GO:0070672,1,0.904769168611238,0,14,response to interleukin-15,BP,
15918,GO:0070673,1,0.931856165176423,0,11,response to interleukin-18,BP,
15919,GO:0070676,1,0.985289452723802,0,3,intralumenal vesicle formation,BP,
15920,GO:0070678,1,0.993214551051892,0,1,preprotein binding,MF,
15921,GO:0070679,1,0.894900719544071,0,13,inositol 1,4,5 trisphosphate binding,MF,
15922,GO:0070681,1,0.983704527496903,0,3,glutaminyl-tRNAGln biosynthesis via transamidation,BP,
15923,GO:0070682,1,0.982317745379634,0,3,proteasome regulatory particle assembly,BP,
15924,GO:0070684,1,0.996602713522715,0,1,seminal clot liquefaction,BP,
15925,GO:0070685,1,0.994374038936943,0,1,macropinocytic cup,CC,
15926,GO:0070694,1,0.993058458973322,0,1,deoxyribonucleoside 5'-monophosphate N-glycosidase activity,MF,
15927,GO:0070695,1,0.959095540112398,0,5,FHF complex,CC,
15928,GO:0070696,1,0.892274463377689,0,17,transmembrane receptor protein serine/threonine kinase binding,MF,
15929,GO:0070697,1,0.967716049708999,0,5,activin receptor binding,MF,
15930,GO:0070698,1,0.987418261753865,0,2,type I activin receptor binding,MF,
15931,GO:0070699,1,0.985258672558824,0,2,type II activin receptor binding,MF,
15932,GO:0070700,1,0.922066170992408,0,12,BMP receptor binding,MF,
15933,GO:0070704,1,0.985485708380348,0,2,sterol desaturase activity,MF,
15934,GO:0070715,1,0.992618000628388,0,1,sodium-dependent organic cation transport,BP,
15935,GO:0070717,1,0.846833190002957,0,23,poly-purine tract binding,MF,
15936,GO:0070722,1,0.992543282067169,0,1,Tle3-Aes complex,CC,
15937,GO:0070723,1,0.853008837172364,0,20,response to cholesterol,BP,
15938,GO:0070724,1,0.992692623517792,0,1,BMP receptor complex,CC,
15940,GO:0070728,1,0.950189466278114,0,7,leucine binding,MF,
15941,GO:0070733,1,0.995460844898659,0,1,protein adenylyltransferase activity,MF,
15943,GO:0070735,1,0.992568030712992,0,1,protein-glycine ligase activity,MF,
15944,GO:0070736,1,0.992568030712992,0,1,protein-glycine ligase activity, initiating,MF,
15945,GO:0070739,1,0.95205608301822,0,7,protein-glutamic acid ligase activity,MF,
15946,GO:0070740,1,0.95205608301822,0,7,tubulin-glutamic acid ligase activity,MF,
15947,GO:0070741,1,0.788297853228543,0,35,response to interleukin-6,BP,
15948,GO:0070742,1,0.904011744714458,0,14,C2H2 zinc finger domain binding,MF,
15949,GO:0070743,1,0.996805844367504,0,1,interleukin-23 complex,CC,
15950,GO:0070757,1,0.926744044923927,0,11,interleukin-35-mediated signaling pathway,BP,
15951,GO:0070761,1,0.969944360879653,0,5,pre-snoRNP complex,CC,
15952,GO:0070762,1,0.993058458973322,0,1,nuclear pore transmembrane ring,CC,
15953,GO:0070765,1,0.962004058175027,0,6,gamma-secretase complex,CC,
15954,GO:0070772,1,0.99272040386425,0,1,PAS complex,CC,
15955,GO:0070773,1,0.996136801278012,0,1,protein-N-terminal glutamine amidohydrolase activity,MF,
15956,GO:0070774,1,0.992384031824099,0,1,phytoceramidase activity,MF,
15957,GO:0070775,1,0.949585517603595,0,7,H3 histone acetyltransferase complex,CC,
15958,GO:0070776,1,0.949585517603595,0,7,MOZ/MORF histone acetyltransferase complex,CC,
15959,GO:0070777,1,0.965975233634082,0,4,D-aspartate transport,BP,
15960,GO:0070778,1,0.959205869626528,0,6,L-aspartate transmembrane transport,BP,
15961,GO:0070779,1,0.965975233634082,0,4,D-aspartate import across plasma membrane,BP,
15962,GO:0070780,1,0.989098103478281,0,2,dihydrosphingosine-1-phosphate phosphatase activity,MF,
15963,GO:0070781,1,0.987005469849327,0,2,response to biotin,BP,
15964,GO:0070782,1,0.994271335668092,0,1,phosphatidylserine exposure on apoptotic cell surface,BP,
15965,GO:0070813,1,0.972241298950451,0,5,hydrogen sulfide metabolic process,BP,
15966,GO:0070814,1,0.975199930835579,0,4,hydrogen sulfide biosynthetic process,BP,
15967,GO:0070815,1,0.970919195496777,0,4,peptidyl-lysine 5-dioxygenase activity,MF,
15968,GO:0070816,1,0.905928184137249,0,15,phosphorylation of RNA polymerase II C-terminal domain,BP,
15969,GO:0070818,1,0.995236914498508,0,1,protoporphyrinogen oxidase activity,MF,
15971,GO:0070821,1,0.623620011128316,0,69,tertiary granule membrane,CC,
15972,GO:0070822,1,0.898884386681792,0,15,Sin3-type complex,CC,
15973,GO:0070826,1,0.992443860497474,0,1,paraferritin complex,CC,
15974,GO:0070827,1,0.968591643129241,0,4,chromatin maintenance,BP,
15975,GO:0070828,1,0.89881030962858,0,15,heterochromatin organization,BP,
15976,GO:0070829,1,0.983145269021004,0,2,heterochromatin maintenance,BP,
15978,GO:0070831,1,0.939997515173234,0,8,basement membrane assembly,BP,
15980,GO:0070837,1,0.97771566845516,0,3,dehydroascorbic acid transport,BP,
15982,GO:0070839,1,0.98513176408618,0,2,divalent metal ion export,BP,
15983,GO:0070840,1,0.850053338416492,0,20,dynein complex binding,MF,
15984,GO:0070841,1,0.868918822118617,0,20,inclusion body assembly,BP,
15985,GO:0070842,1,0.974561391474331,0,4,aggresome assembly,BP,
15986,GO:0070843,1,0.99245419202513,0,1,misfolded protein transport,BP,
15987,GO:0070844,1,0.99245419202513,0,1,polyubiquitinated protein transport,BP,
15988,GO:0070845,1,0.99245419202513,0,1,polyubiquitinated misfolded protein transport,BP,
15989,GO:0070846,1,0.99245419202513,0,1,Hsp90 deacetylation,BP,
15990,GO:0070847,1,0.958529240092303,0,8,core mediator complex,CC,
15993,GO:0070851,1,0.492980850019344,0,107,growth factor receptor binding,MF,
15994,GO:0070852,1,0.954647500217318,0,6,cell body fiber,CC,
15995,GO:0070853,1,0.981311062430091,0,2,myosin VI binding,MF,
15996,GO:0070856,1,0.991468791263616,0,1,myosin VI light chain binding,MF,
15997,GO:0070857,1,0.946961736464325,0,8,regulation of bile acid biosynthetic process,BP,
15998,GO:0070858,1,0.980225805166215,0,3,negative regulation of bile acid biosynthetic process,BP,
15999,GO:0070859,1,0.980464545152935,0,3,positive regulation of bile acid biosynthetic process,BP,
16000,GO:0070860,1,0.993933448167693,0,1,RNA polymerase I core factor complex,CC,
16001,GO:0070861,1,0.846870459670673,0,23,regulation of protein exit from endoplasmic reticulum,BP,
16002,GO:0070862,1,0.936111044789878,0,10,negative regulation of protein exit from endoplasmic reticulum,BP,
16003,GO:0070863,1,0.919879561557006,0,11,positive regulation of protein exit from endoplasmic reticulum,BP,
16004,GO:0070873,1,0.818976814864209,0,26,regulation of glycogen metabolic process,BP,
16005,GO:0070874,1,0.961264189921692,0,5,negative regulation of glycogen metabolic process,BP,
16006,GO:0070875,1,0.890265190543684,0,14,positive regulation of glycogen metabolic process,BP,
16007,GO:0070876,1,0.971818789139959,0,4,SOSS complex,CC,
16008,GO:0070877,1,0.985476596623959,0,2,microprocessor complex,CC,
16009,GO:0070878,1,0.93864855128149,0,8,primary miRNA binding,MF,
16010,GO:0070883,1,0.968975813859736,0,5,pre-miRNA binding,MF,
16011,GO:0070884,1,0.887890042711348,0,16,regulation of calcineurin-NFAT signaling cascade,BP,
16012,GO:0070885,1,0.976205051046001,0,3,negative regulation of calcineurin-NFAT signaling cascade,BP,
16013,GO:0070886,1,0.938671856503309,0,9,positive regulation of calcineurin-NFAT signaling cascade,BP,
16016,GO:0070889,1,0.987159345686532,0,2,platelet alpha granule organization,BP,
16017,GO:0070890,1,0.990928293703605,0,1,sodium-dependent L-ascorbate transmembrane transporter activity,MF,
16018,GO:0070891,1,0.980167025473965,0,4,lipoteichoic acid binding,MF,
16019,GO:0070892,1,0.994466064188805,0,1,lipoteichoic acid receptor activity,MF,
16020,GO:0070893,1,0.984998774932635,0,2,transposon integration,BP,
16021,GO:0070894,1,0.984998774932635,0,2,regulation of transposon integration,BP,
16022,GO:0070895,1,0.984998774932635,0,2,negative regulation of transposon integration,BP,
16023,GO:0070897,1,0.761546247065453,0,42,DNA-templated transcriptional preinitiation complex assembly,BP,
16024,GO:0070898,1,0.988553975744481,0,1,RNA polymerase III transcriptional preinitiation complex assembly,BP,
16025,GO:0070899,1,0.992804884205147,0,1,mitochondrial tRNA wobble uridine modification,BP,
16026,GO:0070900,1,0.949988656077618,0,9,mitochondrial tRNA modification,BP,
16027,GO:0070901,1,0.977213709281733,0,4,mitochondrial tRNA methylation,BP,
16028,GO:0070902,1,0.995419331557463,0,1,mitochondrial tRNA pseudouridine synthesis,BP,
16029,GO:0070903,1,0.994708674507553,0,1,mitochondrial tRNA thio-modification,BP,
16030,GO:0070904,1,0.990928293703605,0,1,transepithelial L-ascorbic acid transport,BP,
16031,GO:0070905,1,0.980546008484407,0,3,serine binding,MF,
16032,GO:0070911,1,0.826064395046357,0,32,global genome nucleotide-excision repair,BP,
16033,GO:0070914,1,0.930434154503695,0,11,UV-damage excision repair,BP,
16034,GO:0070915,1,0.970321430359767,0,5,lysophosphatidic acid receptor activity,MF,
16037,GO:0070922,1,0.937641277781817,0,9,small RNA loading onto RISC,BP,
16038,GO:0070925,1,0.00503674413136764,0,747,organelle assembly,BP,
16039,GO:0070926,1,0.992489571294925,0,1,regulation of ATP:ADP antiporter activity,BP,
16040,GO:0070931,1,0.99168795109272,0,1,Golgi-associated vesicle lumen,CC,
16041,GO:0070932,1,0.86838175942337,0,20,histone H3 deacetylation,BP,
16042,GO:0070933,1,0.935992901333966,0,9,histone H4 deacetylation,BP,
16043,GO:0070934,1,0.970370414270101,0,4,CRD-mediated mRNA stabilization,BP,
16044,GO:0070935,1,0.898470798770254,0,15,3'-UTR-mediated mRNA stabilization,BP,
16045,GO:0070936,1,0.717286760987208,0,49,protein K48-linked ubiquitination,BP,
16046,GO:0070937,1,0.963044663629812,0,5,CRD-mediated mRNA stability complex,CC,
16047,GO:0070938,1,0.918299996390283,0,11,contractile ring,CC,
16048,GO:0070939,1,0.976632668540028,0,3,Dsl1/NZR complex,CC,
16049,GO:0070940,1,0.96681269536937,0,5,dephosphorylation of RNA polymerase II C-terminal domain,BP,
16050,GO:0070942,1,0.96741788481278,0,7,neutrophil mediated cytotoxicity,BP,
16051,GO:0070943,1,0.978548948341447,0,5,neutrophil mediated killing of symbiont cell,BP,
16052,GO:0070944,1,0.982565963356696,0,4,neutrophil mediated killing of bacterium,BP,
16053,GO:0070945,1,0.985447452744056,0,3,neutrophil mediated killing of gram-negative bacterium,BP,
16054,GO:0070947,1,0.992979718643963,0,2,neutrophil mediated killing of fungus,BP,
16055,GO:0070948,1,0.977630258654673,0,4,regulation of neutrophil mediated cytotoxicity,BP,
16056,GO:0070949,1,0.988877633563167,0,2,regulation of neutrophil mediated killing of symbiont cell,BP,
16057,GO:0070950,1,0.992936619507467,0,1,regulation of neutrophil mediated killing of bacterium,BP,
16058,GO:0070951,1,0.992936619507467,0,1,regulation of neutrophil mediated killing of gram-negative bacterium,BP,
16059,GO:0070953,1,0.99591242959171,0,1,regulation of neutrophil mediated killing of fungus,BP,
16060,GO:0070960,1,0.988877633563167,0,2,positive regulation of neutrophil mediated cytotoxicity,BP,
16061,GO:0070961,1,0.988877633563167,0,2,positive regulation of neutrophil mediated killing of symbiont cell,BP,
16062,GO:0070962,1,0.992936619507467,0,1,positive regulation of neutrophil mediated killing of bacterium,BP,
16063,GO:0070963,1,0.992936619507467,0,1,positive regulation of neutrophil mediated killing of gram-negative bacterium,BP,
16064,GO:0070965,1,0.99591242959171,0,1,positive regulation of neutrophil mediated killing of fungus,BP,
16065,GO:0070966,1,0.9769326001654,0,3,nuclear-transcribed mRNA catabolic process, no-go decay,BP,
16066,GO:0070970,1,0.925826630517191,0,10,interleukin-2 secretion,BP,
16067,GO:0070971,1,0.885166759377623,0,17,endoplasmic reticulum exit site,CC,
16068,GO:0070972,1,0.574274996685449,0,129,protein localization to endoplasmic reticulum,BP,
16069,GO:0070973,1,0.95554671000352,0,6,protein localization to endoplasmic reticulum exit site,BP,
16070,GO:0070974,1,0.992771866788736,0,1,POU domain binding,MF,
16071,GO:0070975,1,0.990679908378419,0,1,FHA domain binding,MF,
16072,GO:0070976,1,0.993167017903249,0,1,TIR domain binding,MF,
16074,GO:0070979,1,0.85853233382338,0,27,protein K11-linked ubiquitination,BP,
16075,GO:0070981,1,0.993888087308069,0,1,L-asparagine biosynthetic process,BP,
16076,GO:0070982,1,0.993888087308069,0,1,L-asparagine metabolic process,BP,
16077,GO:0070984,1,0.992444516122591,0,1,SET domain binding,MF,
16078,GO:0070985,1,0.991830897236838,0,2,TFIIK complex,CC,
16079,GO:0070986,1,0.908887357585459,0,13,left/right axis specification,BP,
16080,GO:0070987,1,0.8984250959302,0,18,error-free translesion synthesis,BP,
16081,GO:0070988,1,0.648156388587146,0,59,demethylation,BP,
16082,GO:0070989,1,0.91987194167984,0,12,oxidative demethylation,BP,
16083,GO:0070990,1,0.972891624640587,0,6,snRNP binding,MF,
16084,GO:0070991,1,0.979371573843338,0,3,medium-chain-acyl-CoA dehydrogenase activity,MF,
16085,GO:0070992,1,0.990954821858642,0,2,translation initiation complex,CC,
16086,GO:0070993,1,0.984851736251577,0,2,translation preinitiation complex,CC,
16087,GO:0070995,1,0.979181707262137,0,3,NADPH oxidation,BP,
16088,GO:0070996,1,0.987798463635682,0,3,type 1 melanocortin receptor binding,MF,
16090,GO:0071000,1,0.988866941509817,0,2,response to magnetism,BP,
16091,GO:0071001,1,0.98289932840077,0,3,U4/U6 snRNP,CC,
16092,GO:0071004,1,0.899832134729274,0,17,U2-type prespliceosome,CC,
16093,GO:0071005,1,0.994189150138512,0,1,U2-type precatalytic spliceosome,CC,
16094,GO:0071006,1,0.980419462784324,0,3,U2-type catalytic step 1 spliceosome,CC,
16095,GO:0071007,1,0.852170841745591,0,29,U2-type catalytic step 2 spliceosome,CC,
16096,GO:0071008,1,0.975448709446228,0,4,U2-type post-mRNA release spliceosomal complex,CC,
16097,GO:0071010,1,0.876399840406242,0,22,prespliceosome,CC,
16098,GO:0071011,1,0.838148722197152,0,31,precatalytic spliceosome,CC,
16099,GO:0071012,1,0.961714701899949,0,6,catalytic step 1 spliceosome,CC,
16100,GO:0071013,1,0.546633580981075,0,97,catalytic step 2 spliceosome,CC,
16101,GO:0071014,1,0.946939641585917,0,9,post-mRNA release spliceosomal complex,CC,
16102,GO:0071020,1,0.990537865624364,0,2,post-spliceosomal complex,CC,
16103,GO:0071021,1,0.995322013720195,0,1,U2-type post-spliceosomal complex,CC,
16104,GO:0071025,1,0.923365632880583,0,15,RNA surveillance,BP,
16105,GO:0071026,1,0.993567422063829,0,1,cytoplasmic RNA surveillance,BP,
16106,GO:0071027,1,0.936003315787508,0,13,nuclear RNA surveillance,BP,
16107,GO:0071028,1,0.936003315787508,0,13,nuclear mRNA surveillance,BP,
16108,GO:0071029,1,0.972224604310887,0,6,nuclear ncRNA surveillance,BP,
16109,GO:0071030,1,0.988409151365588,0,2,nuclear mRNA surveillance of spliceosomal pre-mRNA splicing,BP,
16110,GO:0071031,1,0.990779669528142,0,2,nuclear mRNA surveillance of mRNA 3'-end processing,BP,
16111,GO:0071033,1,0.974703436468967,0,5,nuclear retention of pre-mRNA at the site of transcription,BP,
16112,GO:0071034,1,0.9745877572918,0,4,CUT catabolic process,BP,
16113,GO:0071035,1,0.972224604310887,0,6,nuclear polyadenylation-dependent rRNA catabolic process,BP,
16114,GO:0071038,1,0.979025401578039,0,5,nuclear polyadenylation-dependent tRNA catabolic process,BP,
16115,GO:0071042,1,0.980535507351441,0,4,nuclear polyadenylation-dependent mRNA catabolic process,BP,
16116,GO:0071043,1,0.9745877572918,0,4,CUT metabolic process,BP,
16117,GO:0071044,1,0.91970512472761,0,11,histone mRNA catabolic process,BP,
16118,GO:0071045,1,0.995472355960302,0,1,nuclear histone mRNA catabolic process,BP,
16119,GO:0071046,1,0.972224604310887,0,6,nuclear polyadenylation-dependent ncRNA catabolic process,BP,
16120,GO:0071047,1,0.980535507351441,0,4,polyadenylation-dependent mRNA catabolic process,BP,
16121,GO:0071048,1,0.988409151365588,0,2,nuclear retention of unspliced pre-mRNA at the site of transcription,BP,
16122,GO:0071049,1,0.990779669528142,0,2,nuclear retention of pre-mRNA with aberrant 3'-ends at the site of transcription,BP,
16123,GO:0071051,1,0.98029083650282,0,5,polyadenylation-dependent snoRNA 3'-end processing,BP,
16124,GO:0071062,1,0.980112418792801,0,3,alphav-beta3 integrin-vitronectin complex,CC,
16125,GO:0071065,1,0.98558572581802,0,2,alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex,CC,
16126,GO:0071071,1,0.921063731381471,0,13,regulation of phospholipid biosynthetic process,BP,
16127,GO:0071072,1,0.971334564496639,0,4,negative regulation of phospholipid biosynthetic process,BP,
16128,GO:0071073,1,0.954104644502914,0,8,positive regulation of phospholipid biosynthetic process,BP,
16129,GO:0071074,1,0.994843805190933,0,1,eukaryotic initiation factor eIF2 binding,MF,
16130,GO:0071077,1,0.980305153810067,0,3,adenosine 3',5'-bisphosphate transmembrane transporter activity,MF,
16132,GO:0071104,1,0.976918897322691,0,4,response to interleukin-9,BP,
16133,GO:0071105,1,0.989319877908614,0,2,response to interleukin-11,BP,
16134,GO:0071106,1,0.980305153810067,0,3,adenosine 3',5'-bisphosphate transmembrane transport,BP,
16136,GO:0071108,1,0.823637045465756,0,24,protein K48-linked deubiquitination,BP,
16137,GO:0071109,1,0.980156113325144,0,2,superior temporal gyrus development,BP,
16138,GO:0071110,1,0.991511043527596,0,1,histone biotinylation,BP,
16139,GO:0071133,1,0.992691303580234,0,1,alpha9-beta1 integrin-ADAM8 complex,CC,
16140,GO:0071139,1,0.984729807531627,0,2,resolution of recombination intermediates,BP,
16141,GO:0071140,1,0.984729807531627,0,2,resolution of mitotic recombination intermediates,BP,
16142,GO:0071141,1,0.933397445724238,0,8,SMAD protein complex,CC,
16143,GO:0071144,1,0.980584954835325,0,2,heteromeric SMAD protein complex,CC,
16144,GO:0071148,1,0.981516943452116,0,2,TEAD-1-YAP complex,CC,
16145,GO:0071149,1,0.986248779437349,0,2,TEAD-2-YAP complex,CC,
16146,GO:0071156,1,0.50724431522303,0,107,regulation of cell cycle arrest,BP,
16147,GO:0071157,1,0.882747702142997,0,21,negative regulation of cell cycle arrest,BP,
16148,GO:0071158,1,0.579874641677732,0,84,positive regulation of cell cycle arrest,BP,
16149,GO:0071159,1,0.990635151477034,0,2,NF-kappaB complex,CC,
16150,GO:0071163,1,0.984542417241863,0,3,DNA replication preinitiation complex assembly,BP,
16151,GO:0071164,1,0.992508194970706,0,1,RNA trimethylguanosine synthase activity,MF,
16152,GO:0071166,1,0.444546246958473,0,123,ribonucleoprotein complex localization,BP,
16153,GO:0071168,1,0.875834294176181,0,20,protein localization to chromatin,BP,
16154,GO:0071169,1,0.962359893270372,0,7,establishment of protein localization to chromatin,BP,
16155,GO:0071173,1,0.809514598974333,0,31,spindle assembly checkpoint,BP,
16156,GO:0071174,1,0.809514598974333,0,31,mitotic spindle checkpoint,BP,
16157,GO:0071203,1,0.962871947047339,0,5,WASH complex,CC,
16158,GO:0071204,1,0.964960558992321,0,6,histone pre-mRNA 3'end processing complex,CC,
16161,GO:0071207,1,0.987615360601797,0,2,histone pre-mRNA stem-loop binding,MF,
16162,GO:0071208,1,0.985345355255041,0,4,histone pre-mRNA DCP binding,MF,
16163,GO:0071209,1,0.986750025056073,0,3,U7 snRNA binding,MF,
16164,GO:0071211,1,0.971989586768658,0,4,protein targeting to vacuole involved in autophagy,BP,
16166,GO:0071215,1,0.99239595615167,0,1,cellular response to abscisic acid stimulus,BP,
16168,GO:0071217,1,0.992475485630838,0,1,cellular response to external biotic stimulus,BP,
16169,GO:0071218,1,0.86616839757564,0,21,cellular response to misfolded protein,BP,
16171,GO:0071220,1,0.962929072281307,0,6,cellular response to bacterial lipoprotein,BP,
16172,GO:0071221,1,0.962929072281307,0,6,cellular response to bacterial lipopeptide,BP,
16174,GO:0071223,1,0.939432257549296,0,11,cellular response to lipoteichoic acid,BP,
16175,GO:0071224,1,0.968696234508207,0,5,cellular response to peptidoglycan,BP,
16176,GO:0071225,1,0.963835328691941,0,5,cellular response to muramyl dipeptide,BP,
16177,GO:0071226,1,0.985462169209114,0,2,cellular response to molecule of fungal origin,BP,
16178,GO:0071228,1,0.996694918055396,0,1,cellular response to tumor cell,BP,
16181,GO:0071231,1,0.993436548812617,0,2,cellular response to folic acid,BP,
16182,GO:0071233,1,0.930229860447139,0,9,cellular response to leucine,BP,
16185,GO:0071242,1,0.703364631912756,0,53,cellular response to ammonium ion,BP,
16186,GO:0071243,1,0.91686347707182,0,16,cellular response to arsenic-containing substance,BP,
16187,GO:0071245,1,0.992515812703208,0,1,cellular response to carbon monoxide,BP,
16188,GO:0071247,1,0.996689569348466,0,1,cellular response to chromate,BP,
16190,GO:0071250,1,0.991319662364429,0,1,cellular response to nitrite,BP,
16192,GO:0071256,1,0.985284670280573,0,4,translocon complex,CC,
16193,GO:0071257,1,0.919860617078645,0,12,cellular response to electrical stimulus,BP,
16194,GO:0071258,1,0.992450517902719,0,1,cellular response to gravity,BP,
16195,GO:0071259,1,0.988866941509817,0,2,cellular response to magnetism,BP,
16197,GO:0071262,1,0.984365289533278,0,2,regulation of translational initiation in response to starvation,BP,
16198,GO:0071264,1,0.984365289533278,0,2,positive regulation of translational initiation in response to starvation,BP,
16199,GO:0071265,1,0.955515594883047,0,8,L-methionine biosynthetic process,BP,
16200,GO:0071266,1,0.995239252591955,0,1,'de novo' L-methionine biosynthetic process,BP,
16201,GO:0071267,1,0.960088192837519,0,7,L-methionine salvage,BP,
16202,GO:0071268,1,0.993966123633487,0,1,homocysteine biosynthetic process,BP,
16203,GO:0071275,1,0.994285115658647,0,1,cellular response to aluminum ion,BP,
16206,GO:0071279,1,0.981538724041691,0,3,cellular response to cobalt ion,BP,
16207,GO:0071280,1,0.926276767460454,0,18,cellular response to copper ion,BP,
16208,GO:0071281,1,0.937468355389391,0,10,cellular response to iron ion,BP,
16209,GO:0071283,1,0.991361218831936,0,2,cellular response to iron(III) ion,BP,
16210,GO:0071284,1,0.967979747033989,0,4,cellular response to lead ion,BP,
16211,GO:0071285,1,0.939896446896751,0,11,cellular response to lithium ion,BP,
16212,GO:0071286,1,0.947739324642102,0,6,cellular response to magnesium ion,BP,
16213,GO:0071287,1,0.937121100696079,0,9,cellular response to manganese ion,BP,
16214,GO:0071288,1,0.993103570478837,0,1,cellular response to mercury ion,BP,
16215,GO:0071294,1,0.931748630356882,0,17,cellular response to zinc ion,BP,
16216,GO:0071295,1,0.835728145988143,0,27,cellular response to vitamin,BP,
16217,GO:0071298,1,0.992563042505725,0,1,cellular response to L-ascorbic acid,BP,
16218,GO:0071300,1,0.645771574483827,0,64,cellular response to retinoic acid,BP,
16219,GO:0071301,1,0.990684704996628,0,1,cellular response to vitamin B1,BP,
16220,GO:0071305,1,0.886186058051359,0,18,cellular response to vitamin D,BP,
16221,GO:0071306,1,0.986554192026243,0,2,cellular response to vitamin E,BP,
16222,GO:0071307,1,0.986215294744148,0,2,cellular response to vitamin K,BP,
16224,GO:0071312,1,0.800803918145207,0,31,cellular response to alkaloid,BP,
16225,GO:0071313,1,0.924542331010289,0,8,cellular response to caffeine,BP,
16226,GO:0071314,1,0.984429039626682,0,3,cellular response to cocaine,BP,
16227,GO:0071315,1,0.977382750941635,0,4,cellular response to morphine,BP,
16228,GO:0071316,1,0.954539384780815,0,8,cellular response to nicotine,BP,
16229,GO:0071317,1,0.977382750941635,0,4,cellular response to isoquinoline alkaloid,BP,
16230,GO:0071318,1,0.916410150763689,0,13,cellular response to ATP,BP,
16232,GO:0071321,1,0.952518631659571,0,6,cellular response to cGMP,BP,
16234,GO:0071324,1,0.992118131476958,0,1,cellular response to disaccharide stimulus,BP,
16236,GO:0071329,1,0.992118131476958,0,1,cellular response to sucrose stimulus,BP,
16238,GO:0071332,1,0.967212999348662,0,5,cellular response to fructose stimulus,BP,
16240,GO:0071335,1,0.991929164870311,0,2,hair follicle cell proliferation,BP,
16241,GO:0071336,1,0.991929164870311,0,2,regulation of hair follicle cell proliferation,BP,
16242,GO:0071338,1,0.991929164870311,0,2,positive regulation of hair follicle cell proliferation,BP,
16243,GO:0071339,1,0.824088047144114,0,28,MLL1 complex,CC,
16244,GO:0071340,1,0.941118085541124,0,9,skeletal muscle acetylcholine-gated channel clustering,BP,
16245,GO:0071344,1,0.991837320920442,0,2,diphosphate metabolic process,BP,
16248,GO:0071347,1,0.427660242805004,0,146,cellular response to interleukin-1,BP,
16249,GO:0071348,1,0.992228291227347,0,1,cellular response to interleukin-11,BP,
16250,GO:0071349,1,0.778174507710981,0,44,cellular response to interleukin-12,BP,
16251,GO:0071350,1,0.9120581125685,0,13,cellular response to interleukin-15,BP,
16252,GO:0071351,1,0.951507632097521,0,8,cellular response to interleukin-18,BP,
16253,GO:0071352,1,0.91771192614828,0,12,cellular response to interleukin-2,BP,
16254,GO:0071353,1,0.839255585685765,0,28,cellular response to interleukin-4,BP,
16255,GO:0071354,1,0.805115037383794,0,31,cellular response to interleukin-6,BP,
16256,GO:0071355,1,0.979791218395524,0,3,cellular response to interleukin-9,BP,
16257,GO:0071356,1,0.237770997354032,0,250,cellular response to tumor necrosis factor,BP,
16260,GO:0071360,1,0.917253527125975,0,13,cellular response to exogenous dsRNA,BP,
16261,GO:0071361,1,0.911967836848241,0,13,cellular response to ethanol,BP,
16262,GO:0071362,1,0.964021499369746,0,5,cellular response to ether,BP,
16265,GO:0071371,1,0.886990193646934,0,16,cellular response to gonadotropin stimulus,BP,
16266,GO:0071372,1,0.926648380354476,0,10,cellular response to follicle-stimulating hormone stimulus,BP,
16267,GO:0071373,1,0.986315335698088,0,2,cellular response to luteinizing hormone stimulus,BP,
16270,GO:0071376,1,0.967037663322132,0,5,cellular response to corticotropin-releasing hormone stimulus,BP,
16271,GO:0071377,1,0.793553047698707,0,35,cellular response to glucagon stimulus,BP,
16272,GO:0071378,1,0.867885050596088,0,19,cellular response to growth hormone stimulus,BP,
16273,GO:0071379,1,0.85724773045414,0,21,cellular response to prostaglandin stimulus,BP,
16274,GO:0071380,1,0.89097924913314,0,16,cellular response to prostaglandin E stimulus,BP,
16278,GO:0071386,1,0.974520198527085,0,3,cellular response to corticosterone stimulus,BP,
16279,GO:0071387,1,0.992008435392823,0,1,cellular response to cortisol stimulus,BP,
16280,GO:0071389,1,0.953582969533928,0,7,cellular response to mineralocorticoid stimulus,BP,
16281,GO:0071391,1,0.917184571922584,0,12,cellular response to estrogen stimulus,BP,
16284,GO:0071394,1,0.942209066554988,0,9,cellular response to testosterone stimulus,BP,
16285,GO:0071395,1,0.984840674027201,0,4,cellular response to jasmonic acid stimulus,BP,
16287,GO:0071397,1,0.907536318591084,0,12,cellular response to cholesterol,BP,
16288,GO:0071398,1,0.708284840073537,0,49,cellular response to fatty acid,BP,
16289,GO:0071400,1,0.98535169679726,0,2,cellular response to oleic acid,BP,
16290,GO:0071401,1,0.993971591098376,0,1,cellular response to triglyceride,BP,
16291,GO:0071402,1,0.854778465362213,0,23,cellular response to lipoprotein particle stimulus,BP,
16292,GO:0071403,1,0.98540512079898,0,2,cellular response to high density lipoprotein particle stimulus,BP,
16293,GO:0071404,1,0.897422864186907,0,16,cellular response to low-density lipoprotein particle stimulus,BP,
16295,GO:0071409,1,0.977608736811515,0,3,cellular response to cycloheximide,BP,
16296,GO:0071412,1,0.9939880296475,0,1,cellular response to genistein,BP,
16297,GO:0071413,1,0.9939880296475,0,1,cellular response to hydroxyisoflavone,BP,
16298,GO:0071415,1,0.916752931539366,0,9,cellular response to purine-containing compound,BP,
16300,GO:0071418,1,0.996116930952928,0,1,cellular response to amine stimulus,BP,
16301,GO:0071420,1,0.946692148980574,0,7,cellular response to histamine,BP,
16302,GO:0071421,1,0.970715103082643,0,4,manganese ion transmembrane transport,BP,
16303,GO:0071422,1,0.980140898643121,0,3,succinate transmembrane transport,BP,
16304,GO:0071423,1,0.994895992285313,0,1,malate transmembrane transport,BP,
16305,GO:0071424,1,0.993058458973322,0,1,rRNA (cytosine-N4-)-methyltransferase activity,MF,
16306,GO:0071425,1,0.877740132243578,0,19,hematopoietic stem cell proliferation,BP,
16307,GO:0071426,1,0.447165602885602,0,122,ribonucleoprotein complex export from nucleus,BP,
16308,GO:0071427,1,0.494285970981031,0,104,mRNA-containing ribonucleoprotein complex export from nucleus,BP,
16309,GO:0071428,1,0.922012674346571,0,15,rRNA-containing ribonucleoprotein complex export from nucleus,BP,
16310,GO:0071431,1,0.801203394259312,0,31,tRNA-containing ribonucleoprotein complex export from nucleus,BP,
16311,GO:0071435,1,0.925207301829928,0,12,potassium ion export,BP,
16312,GO:0071437,1,0.902618872141258,0,14,invadopodium,CC,
16313,GO:0071438,1,0.966539145591363,0,5,invadopodium membrane,CC,
16314,GO:0071439,1,0.937531276284087,0,9,clathrin complex,CC,
16315,GO:0071440,1,0.959728687646063,0,6,regulation of histone H3-K14 acetylation,BP,
16316,GO:0071441,1,0.992492016498709,0,1,negative regulation of histone H3-K14 acetylation,BP,
16317,GO:0071442,1,0.973752402815955,0,4,positive regulation of histone H3-K14 acetylation,BP,
16318,GO:0071444,1,0.998517372187304,0,1,cellular response to pheromone,BP,
16320,GO:0071449,1,0.997070086016987,0,1,cellular response to lipid hydroperoxide,BP,
16321,GO:0071450,1,0.880545031308414,0,24,cellular response to oxygen radical,BP,
16322,GO:0071451,1,0.880545031308414,0,24,cellular response to superoxide,BP,
16323,GO:0071453,1,0.272395032591391,0,204,cellular response to oxygen levels,BP,
16324,GO:0071454,1,0.990651749312105,0,1,cellular response to anoxia,BP,
16325,GO:0071455,1,0.958547426931758,0,6,cellular response to hyperoxia,BP,
16326,GO:0071456,1,0.318459235629962,0,182,cellular response to hypoxia,BP,
16327,GO:0071458,1,0.967350370872396,0,5,integral component of cytoplasmic side of endoplasmic reticulum membrane,CC,
16328,GO:0071459,1,0.881927158487758,0,20,protein localization to chromosome, centromeric region,BP,
16329,GO:0071460,1,0.992739587599964,0,2,cellular response to cell-matrix adhesion,BP,
16330,GO:0071461,1,0.989483263194319,0,2,cellular response to redox state,BP,
16331,GO:0071462,1,0.977233904398722,0,3,cellular response to water stimulus,BP,
16332,GO:0071464,1,0.992085420122243,0,1,cellular response to hydrostatic pressure,BP,
16335,GO:0071468,1,0.939486991369825,0,9,cellular response to acidic pH,BP,
16336,GO:0071469,1,0.987565800908386,0,2,cellular response to alkaline pH,BP,
16337,GO:0071470,1,0.80449125773224,0,32,cellular response to osmotic stress,BP,
16338,GO:0071471,1,0.992348248037886,0,1,cellular response to non-ionic osmotic stress,BP,
16339,GO:0071472,1,0.938882240042421,0,9,cellular response to salt stress,BP,
16340,GO:0071474,1,0.930443260296646,0,11,cellular hyperosmotic response,BP,
16341,GO:0071475,1,0.975576414096429,0,4,cellular hyperosmotic salinity response,BP,
16342,GO:0071476,1,0.949783063066294,0,7,cellular hypotonic response,BP,
16343,GO:0071477,1,0.983361910374799,0,2,cellular hypotonic salinity response,BP,
16344,GO:0071478,1,0.334344053982508,0,164,cellular response to radiation,BP,
16345,GO:0071479,1,0.642122538245069,0,66,cellular response to ionizing radiation,BP,
16346,GO:0071480,1,0.835602121532652,0,27,cellular response to gamma radiation,BP,
16347,GO:0071481,1,0.905949627608069,0,13,cellular response to X-ray,BP,
16348,GO:0071482,1,0.492816865431737,0,106,cellular response to light stimulus,BP,
16349,GO:0071483,1,0.985131488431315,0,2,cellular response to blue light,BP,
16350,GO:0071484,1,0.984640396784781,0,2,cellular response to light intensity,BP,
16351,GO:0071485,1,0.992612484295299,0,1,cellular response to absence of light,BP,
16352,GO:0071486,1,0.991969172784861,0,1,cellular response to high light intensity,BP,
16353,GO:0071492,1,0.979934976402077,0,3,cellular response to UV-A,BP,
16354,GO:0071493,1,0.956008395349669,0,8,cellular response to UV-B,BP,
16355,GO:0071494,1,0.971016964732996,0,4,cellular response to UV-C,BP,
16358,GO:0071498,1,0.886545398244715,0,18,cellular response to fluid shear stress,BP,
16359,GO:0071499,1,0.956475087353793,0,7,cellular response to laminar fluid shear stress,BP,
16360,GO:0071500,1,0.964243871264242,0,6,cellular response to nitrosative stress,BP,
16361,GO:0071501,1,0.938022482998133,0,9,cellular response to sterol depletion,BP,
16362,GO:0071502,1,0.970103429202188,0,5,cellular response to temperature stimulus,BP,
16363,GO:0071503,1,0.970015254190973,0,4,response to heparin,BP,
16364,GO:0071504,1,0.970015254190973,0,4,cellular response to heparin,BP,
16365,GO:0071505,1,0.985690968107285,0,2,response to mycophenolic acid,BP,
16366,GO:0071506,1,0.985690968107285,0,2,cellular response to mycophenolic acid,BP,
16367,GO:0071514,1,0.857243677942762,0,22,genetic imprinting,BP,
16368,GO:0071526,1,0.773336102750809,0,32,semaphorin-plexin signaling pathway,BP,
16369,GO:0071527,1,0.993809324488368,0,1,semaphorin-plexin signaling pathway involved in outflow tract morphogenesis,BP,
16370,GO:0071528,1,0.992487675545079,0,1,tRNA re-export from nucleus,BP,
16371,GO:0071529,1,0.993381778579818,0,1,cementum mineralization,BP,
16372,GO:0071532,1,0.960593931367978,0,5,ankyrin repeat binding,MF,
16373,GO:0071535,1,0.974351427063389,0,4,RING-like zinc finger domain binding,MF,
16374,GO:0071538,1,0.993931277811386,0,1,SH2 domain-mediated complex assembly,BP,
16375,GO:0071539,1,0.807953652636791,0,27,protein localization to centrosome,BP,
16376,GO:0071540,1,0.99193982175588,0,1,eukaryotic translation initiation factor 3 complex, eIF3e,CC,
16377,GO:0071541,1,0.964851502982484,0,7,eukaryotic translation initiation factor 3 complex, eIF3m,CC,
16378,GO:0071542,1,0.822487206089942,0,30,dopaminergic neuron differentiation,BP,
16379,GO:0071543,1,0.976974422612972,0,4,diphosphoinositol polyphosphate metabolic process,BP,
16380,GO:0071544,1,0.996136801278012,0,1,diphosphoinositol polyphosphate catabolic process,BP,
16381,GO:0071545,1,0.919412961838635,0,12,inositol phosphate catabolic process,BP,
16382,GO:0071546,1,0.95701792829809,0,6,pi-body,CC,
16383,GO:0071547,1,0.966954328069943,0,5,piP-body,CC,
16386,GO:0071550,1,0.950717283994795,0,9,death-inducing signaling complex assembly,BP,
16387,GO:0071553,1,0.984167066118025,0,3,G-protein coupled pyrimidinergic nucleotide receptor activity,MF,
16388,GO:0071554,1,0.978095511656257,0,5,cell wall organization or biogenesis,BP,
16390,GO:0071557,1,0.960058027150139,0,5,histone H3-K27 demethylation,BP,
16391,GO:0071558,1,0.960058027150139,0,5,histone demethylase activity (H3-K27 specific),MF,
16394,GO:0071561,1,0.992091923542588,0,1,nucleus-vacuole junction,CC,
16395,GO:0071564,1,0.920229465062312,0,12,npBAF complex,CC,
16396,GO:0071565,1,0.904888826565856,0,14,nBAF complex,CC,
16397,GO:0071566,1,0.992860363226105,0,1,UFM1 activating enzyme activity,MF,
16398,GO:0071567,1,0.990722366296636,0,2,UFM1 hydrolase activity,MF,
16399,GO:0071568,1,0.989712250211884,0,2,UFM1 transferase activity,MF,
16400,GO:0071569,1,0.967575345034024,0,6,protein ufmylation,BP,
16401,GO:0071573,1,0.99287447827936,0,1,shelterin complex assembly,BP,
16403,GO:0071578,1,0.952828951427521,0,7,zinc ion import across plasma membrane,BP,
16404,GO:0071579,1,0.987606873750496,0,2,regulation of zinc ion transport,BP,
16405,GO:0071580,1,0.994599959152636,0,1,regulation of zinc ion transmembrane transport,BP,
16406,GO:0071581,1,0.994599959152636,0,1,regulation of zinc ion transmembrane import,BP,
16407,GO:0071582,1,0.994599959152636,0,1,negative regulation of zinc ion transport,BP,
16408,GO:0071583,1,0.994599959152636,0,1,negative regulation of zinc ion transmembrane transport,BP,
16409,GO:0071584,1,0.994599959152636,0,1,negative regulation of zinc ion transmembrane import,BP,
16410,GO:0071585,1,0.994599959152636,0,1,detoxification of cadmium ion,BP,
16411,GO:0071586,1,0.988579186240195,0,2,CAAX-box protein processing,BP,
16412,GO:0071593,1,0.974852224490824,0,4,lymphocyte aggregation,BP,
16413,GO:0071595,1,0.986164624597214,0,2,Nem1-Spo7 phosphatase complex,CC,
16414,GO:0071596,1,0.972948693938787,0,3,ubiquitin-dependent protein catabolic process via the N-end rule pathway,BP,
16415,GO:0071598,1,0.968521241208985,0,5,neuronal ribonucleoprotein granule,CC,
16416,GO:0071599,1,0.907684808375949,0,15,otic vesicle development,BP,
16417,GO:0071600,1,0.942666836213841,0,10,otic vesicle morphogenesis,BP,
16418,GO:0071602,1,0.992384031824099,0,1,phytosphingosine biosynthetic process,BP,
16419,GO:0071603,1,0.970928958627908,0,4,endothelial cell-cell adhesion,BP,
16420,GO:0071604,1,0.824446312044547,0,28,transforming growth factor beta production,BP,
16422,GO:0071606,1,0.99468027294805,0,1,chemokine (C-C motif) ligand 4 production,BP,
16423,GO:0071608,1,0.972946997058698,0,4,macrophage inflammatory protein-1 alpha production,BP,
16424,GO:0071609,1,0.932356288254076,0,10,chemokine (C-C motif) ligand 5 production,BP,
16425,GO:0071610,1,0.993515266373982,0,1,chemokine (C-C motif) ligand 1 production,BP,
16426,GO:0071611,1,0.96938979938116,0,5,granulocyte colony-stimulating factor production,BP,
16427,GO:0071612,1,0.988204938321775,0,1,IP-10 production,BP,
16428,GO:0071613,1,0.989953557569459,0,2,granzyme B production,BP,
16429,GO:0071614,1,0.994967112333128,0,1,linoleic acid epoxygenase activity,MF,
16430,GO:0071616,1,0.726259500658481,0,46,acyl-CoA biosynthetic process,BP,
16431,GO:0071617,1,0.878027468460026,0,18,lysophospholipid acyltransferase activity,MF,
16432,GO:0071619,1,0.994006724496386,0,1,phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
16433,GO:0071621,1,0.638150312087529,0,83,granulocyte chemotaxis,BP,
16434,GO:0071622,1,0.798131780452826,0,43,regulation of granulocyte chemotaxis,BP,
16435,GO:0071623,1,0.985242258931905,0,2,negative regulation of granulocyte chemotaxis,BP,
16436,GO:0071624,1,0.867428673087914,0,30,positive regulation of granulocyte chemotaxis,BP,
16437,GO:0071625,1,0.869451011061645,0,17,vocalization behavior,BP,
16438,GO:0071626,1,0.996314597249943,0,1,mastication,BP,
16439,GO:0071629,1,0.995472355960302,0,1,cytoplasm protein quality control by the ubiquitin-proteasome system,BP,
16440,GO:0071630,1,0.976015651136807,0,3,nuclear protein quality control by the ubiquitin-proteasome system,BP,
16441,GO:0071633,1,0.992968085068105,0,1,dihydroceramidase activity,MF,
16442,GO:0071634,1,0.830842490548196,0,27,regulation of transforming growth factor beta production,BP,
16443,GO:0071635,1,0.954017206895254,0,7,negative regulation of transforming growth factor beta production,BP,
16444,GO:0071636,1,0.893709053451752,0,17,positive regulation of transforming growth factor beta production,BP,
16447,GO:0071639,1,0.961754441821461,0,7,positive regulation of monocyte chemotactic protein-1 production,BP,
16448,GO:0071640,1,0.972946997058698,0,4,regulation of macrophage inflammatory protein 1 alpha production,BP,
16449,GO:0071641,1,0.987261412984179,0,2,negative regulation of macrophage inflammatory protein 1 alpha production,BP,
16450,GO:0071642,1,0.985502730645329,0,2,positive regulation of macrophage inflammatory protein 1 alpha production,BP,
16451,GO:0071643,1,0.99468027294805,0,1,regulation of chemokine (C-C motif) ligand 4 production,BP,
16452,GO:0071644,1,0.99468027294805,0,1,negative regulation of chemokine (C-C motif) ligand 4 production,BP,
16453,GO:0071649,1,0.936677872319699,0,9,regulation of chemokine (C-C motif) ligand 5 production,BP,
16454,GO:0071650,1,0.98389719105267,0,3,negative regulation of chemokine (C-C motif) ligand 5 production,BP,
16455,GO:0071651,1,0.952015475513913,0,6,positive regulation of chemokine (C-C motif) ligand 5 production,BP,
16456,GO:0071652,1,0.993515266373982,0,1,regulation of chemokine (C-C motif) ligand 1 production,BP,
16457,GO:0071654,1,0.993515266373982,0,1,positive regulation of chemokine (C-C motif) ligand 1 production,BP,
16458,GO:0071655,1,0.973994975479666,0,4,regulation of granulocyte colony-stimulating factor production,BP,
16459,GO:0071656,1,0.993901000600317,0,1,negative regulation of granulocyte colony-stimulating factor production,BP,
16460,GO:0071657,1,0.979973036166495,0,3,positive regulation of granulocyte colony-stimulating factor production,BP,
16461,GO:0071658,1,0.988204938321775,0,1,regulation of IP-10 production,BP,
16462,GO:0071660,1,0.988204938321775,0,1,positive regulation of IP-10 production,BP,
16463,GO:0071661,1,0.989953557569459,0,2,regulation of granzyme B production,BP,
16464,GO:0071663,1,0.989953557569459,0,2,positive regulation of granzyme B production,BP,
16465,GO:0071664,1,0.96811260163201,0,4,catenin-TCF7L2 complex,CC,
16466,GO:0071665,1,0.992581647518425,0,1,gamma-catenin-TCF7L2 complex,CC,
16467,GO:0071670,1,0.952184493623692,0,8,smooth muscle cell chemotaxis,BP,
16468,GO:0071671,1,0.967215258343589,0,6,regulation of smooth muscle cell chemotaxis,BP,
16469,GO:0071672,1,0.981710234053541,0,4,negative regulation of smooth muscle cell chemotaxis,BP,
16470,GO:0071673,1,0.982917446054426,0,3,positive regulation of smooth muscle cell chemotaxis,BP,
16471,GO:0071674,1,0.741326317670123,0,55,mononuclear cell migration,BP,
16472,GO:0071675,1,0.812940720467119,0,34,regulation of mononuclear cell migration,BP,
16473,GO:0071676,1,0.95848077493859,0,6,negative regulation of mononuclear cell migration,BP,
16474,GO:0071677,1,0.909614598674725,0,17,positive regulation of mononuclear cell migration,BP,
16475,GO:0071678,1,0.990484143896796,0,1,olfactory bulb axon guidance,BP,
16476,GO:0071679,1,0.937708424206461,0,8,commissural neuron axon guidance,BP,
16477,GO:0071680,1,0.96128724333927,0,5,response to indole-3-methanol,BP,
16478,GO:0071681,1,0.96128724333927,0,5,cellular response to indole-3-methanol,BP,
16480,GO:0071684,1,0.992632621830319,0,1,organism emergence from protective structure,BP,
16481,GO:0071688,1,0.896778773201014,0,13,striated muscle myosin thick filament assembly,BP,
16482,GO:0071691,1,0.990943455048479,0,1,cardiac muscle thin filament assembly,BP,
16483,GO:0071692,1,0.95603259172235,0,6,protein localization to extracellular region,BP,
16484,GO:0071694,1,0.95603259172235,0,6,maintenance of protein location in extracellular region,BP,
16486,GO:0071696,1,0.900401259823404,0,15,ectodermal placode development,BP,
16487,GO:0071697,1,0.906238200122269,0,14,ectodermal placode morphogenesis,BP,
16488,GO:0071698,1,0.970254785222843,0,4,olfactory placode development,BP,
16489,GO:0071699,1,0.970254785222843,0,4,olfactory placode morphogenesis,BP,
16490,GO:0071701,1,0.992194073412866,0,1,regulation of MAPK export from nucleus,BP,
16495,GO:0071707,1,0.996314597249943,0,1,immunoglobulin heavy chain V-D-J recombination,BP,
16497,GO:0071711,1,0.867040970236596,0,19,basement membrane organization,BP,
16498,GO:0071712,1,0.924291071798198,0,12,ER-associated misfolded protein catabolic process,BP,
16499,GO:0071713,1,0.992262244678278,0,1,para-aminobenzoyl-glutamate hydrolase activity,MF,
16500,GO:0071714,1,0.992430555781127,0,1,icosanoid transmembrane transporter activity,MF,
16502,GO:0071723,1,0.954533978602265,0,7,lipopeptide binding,MF,
16503,GO:0071724,1,0.974475000364072,0,4,response to diacyl bacterial lipopeptide,BP,
16504,GO:0071725,1,0.981258759716165,0,3,response to triacyl bacterial lipopeptide,BP,
16505,GO:0071726,1,0.974475000364072,0,4,cellular response to diacyl bacterial lipopeptide,BP,
16506,GO:0071727,1,0.981258759716165,0,3,cellular response to triacyl bacterial lipopeptide,BP,
16507,GO:0071731,1,0.893378448044039,0,18,response to nitric oxide,BP,
16509,GO:0071733,1,0.973613332321363,0,4,transcriptional activation by promoter-enhancer looping,BP,
16510,GO:0071763,1,0.958764216090944,0,6,nuclear membrane organization,BP,
16511,GO:0071765,1,0.992433730604815,0,1,nuclear inner membrane organization,BP,
16512,GO:0071772,1,0.340343769283608,0,150,response to BMP,BP,
16513,GO:0071773,1,0.340343769283608,0,150,cellular response to BMP stimulus,BP,
16515,GO:0071782,1,0.884641726604623,0,18,endoplasmic reticulum tubular network,CC,
16516,GO:0071786,1,0.90149567114531,0,15,endoplasmic reticulum tubular network organization,BP,
16517,GO:0071787,1,0.974221267811125,0,4,endoplasmic reticulum tubular network formation,BP,
16518,GO:0071789,1,0.993058458973322,0,1,spindle pole body localization to nuclear envelope,BP,
16519,GO:0071790,1,0.993058458973322,0,1,establishment of spindle pole body localization to nuclear envelope,BP,
16520,GO:0071791,1,0.985812633145353,0,2,chemokine (C-C motif) ligand 5 binding,MF,
16521,GO:0071796,1,0.996264298514217,0,1,K6-linked polyubiquitin modification-dependent protein binding,MF,
16522,GO:0071797,1,0.97409732250794,0,4,LUBAC complex,CC,
16523,GO:0071798,1,0.967924285798978,0,5,response to prostaglandin D,BP,
16524,GO:0071799,1,0.967924285798978,0,5,cellular response to prostaglandin D stimulus,BP,
16525,GO:0071800,1,0.869835838777408,0,20,podosome assembly,BP,
16526,GO:0071801,1,0.912578772677506,0,13,regulation of podosome assembly,BP,
16527,GO:0071802,1,0.992438684740905,0,1,negative regulation of podosome assembly,BP,
16528,GO:0071803,1,0.938214198041854,0,9,positive regulation of podosome assembly,BP,
16531,GO:0071806,1,0.737662709777932,0,54,protein transmembrane transport,BP,
16532,GO:0071812,1,0.992705487785486,0,1,positive regulation of fever generation by positive regulation of prostaglandin secretion,BP,
16533,GO:0071813,1,0.86707085970483,0,21,lipoprotein particle binding,MF,
16534,GO:0071814,1,0.86707085970483,0,21,protein-lipid complex binding,MF,
16535,GO:0071816,1,0.977374684989301,0,4,tail-anchored membrane protein insertion into ER membrane,BP,
16536,GO:0071817,1,0.973028110951856,0,5,MMXD complex,CC,
16537,GO:0071818,1,0.981535354227572,0,3,BAT3 complex,CC,
16538,GO:0071819,1,0.990326249058277,0,2,DUBm complex,CC,
16539,GO:0071820,1,0.995907955243566,0,1,N-box binding,MF,
16540,GO:0071821,1,0.987884898141034,0,2,FANCM-MHF complex,CC,
16543,GO:0071825,1,0.780342951920997,0,39,protein-lipid complex subunit organization,BP,
16544,GO:0071826,1,0.276970621154838,0,207,ribonucleoprotein complex subunit organization,BP,
16545,GO:0071827,1,0.791140601572945,0,37,plasma lipoprotein particle organization,BP,
16546,GO:0071830,1,0.96047245576867,0,7,triglyceride-rich lipoprotein particle clearance,BP,
16547,GO:0071837,1,0.888851483129596,0,17,HMG box domain binding,MF,
16548,GO:0071838,1,0.959188475278194,0,6,cell proliferation in bone marrow,BP,
16549,GO:0071839,1,0.976219191420805,0,4,apoptotic process in bone marrow,BP,
16551,GO:0071846,1,0.997604218332917,0,1,actin filament debranching,BP,
16552,GO:0071847,1,0.985108998058946,0,2,TNFSF11-mediated signaling pathway,BP,
16553,GO:0071848,1,0.992705487785486,0,1,positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling,BP,
16554,GO:0071850,1,0.912890432416095,0,14,mitotic cell cycle arrest,BP,
16555,GO:0071855,1,0.903808415624377,0,23,neuropeptide receptor binding,MF,
16556,GO:0071863,1,0.959067854028206,0,6,regulation of cell proliferation in bone marrow,BP,
16557,GO:0071864,1,0.959067854028206,0,6,positive regulation of cell proliferation in bone marrow,BP,
16558,GO:0071865,1,0.975084397184206,0,4,regulation of apoptotic process in bone marrow,BP,
16559,GO:0071866,1,0.975084397184206,0,4,negative regulation of apoptotic process in bone marrow,BP,
16560,GO:0071867,1,0.772059352563672,0,35,response to monoamine,BP,
16561,GO:0071868,1,0.786492981932259,0,32,cellular response to monoamine stimulus,BP,
16562,GO:0071869,1,0.772059352563672,0,35,response to catecholamine,BP,
16563,GO:0071870,1,0.786492981932259,0,32,cellular response to catecholamine stimulus,BP,
16564,GO:0071871,1,0.891622163485323,0,15,response to epinephrine,BP,
16565,GO:0071872,1,0.908266816097681,0,12,cellular response to epinephrine stimulus,BP,
16566,GO:0071873,1,0.97764968911876,0,3,response to norepinephrine,BP,
16567,GO:0071874,1,0.986211520463618,0,2,cellular response to norepinephrine stimulus,BP,
16568,GO:0071875,1,0.860917054373312,0,21,adrenergic receptor signaling pathway,BP,
16569,GO:0071877,1,0.996136801278012,0,1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,
16570,GO:0071878,1,0.982389699910836,0,2,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
16571,GO:0071879,1,0.977631622025489,0,3,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
16572,GO:0071880,1,0.875931028274453,0,18,adenylate cyclase-activating adrenergic receptor signaling pathway,BP,
16573,GO:0071881,1,0.988655097830976,0,2,adenylate cyclase-inhibiting adrenergic receptor signaling pathway,BP,
16574,GO:0071882,1,0.992489571294925,0,1,phospholipase C-activating adrenergic receptor signaling pathway,BP,
16575,GO:0071885,1,0.990102725431807,0,2,N-terminal protein N-methyltransferase activity,MF,
16576,GO:0071886,1,0.984963950482958,0,2,1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding,MF,
16577,GO:0071887,1,0.564630701648427,0,93,leukocyte apoptotic process,BP,
16578,GO:0071888,1,0.943691509572887,0,9,macrophage apoptotic process,BP,
16579,GO:0071889,1,0.836069863013413,0,25,14-3-3 protein binding,MF,
16580,GO:0071890,1,0.991998695008564,0,1,bicarbonate binding,MF,
16581,GO:0071893,1,0.995148968087614,0,1,BMP signaling pathway involved in nephric duct formation,BP,
16582,GO:0071894,1,0.986929412953391,0,2,histone H2B conserved C-terminal lysine ubiquitination,BP,
16583,GO:0071895,1,0.959804395423141,0,6,odontoblast differentiation,BP,
16584,GO:0071896,1,0.964885567448969,0,4,protein localization to adherens junction,BP,
16586,GO:0071898,1,0.981082573182003,0,3,regulation of estrogen receptor binding,BP,
16587,GO:0071899,1,0.981082573182003,0,3,negative regulation of estrogen receptor binding,BP,
16589,GO:0071901,1,0.438137992747967,0,125,negative regulation of protein serine/threonine kinase activity,BP,
16591,GO:0071907,1,0.948447076685273,0,7,determination of digestive tract left/right asymmetry,BP,
16592,GO:0071908,1,0.991897525981382,0,1,determination of intestine left/right asymmetry,BP,
16593,GO:0071909,1,0.991897525981382,0,1,determination of stomach left/right asymmetry,BP,
16594,GO:0071910,1,0.955271248033051,0,6,determination of liver left/right asymmetry,BP,
16595,GO:0071914,1,0.985031122860786,0,2,prominosome,CC,
16596,GO:0071918,1,0.973094012425814,0,4,urea transmembrane transport,BP,
16597,GO:0071920,1,0.987761821511768,0,2,cleavage body,CC,
16598,GO:0071921,1,0.96320656555657,0,5,cohesin loading,BP,
16599,GO:0071922,1,0.969941500984056,0,4,regulation of cohesin loading,BP,
16600,GO:0071926,1,0.971251651891167,0,4,endocannabinoid signaling pathway,BP,
16601,GO:0071929,1,0.985816844346409,0,2,alpha-tubulin acetylation,BP,
16602,GO:0071930,1,0.977257524909727,0,3,negative regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
16603,GO:0071931,1,0.982067900248157,0,3,positive regulation of transcription involved in G1/S transition of mitotic cell cycle,BP,
16604,GO:0071933,1,0.946672553922476,0,8,Arp2/3 complex binding,MF,
16605,GO:0071934,1,0.980611873451649,0,3,thiamine transmembrane transport,BP,
16607,GO:0071938,1,0.992974313593734,0,1,vitamin A transport,BP,
16608,GO:0071939,1,0.992974313593734,0,1,vitamin A import,BP,
16609,GO:0071941,1,0.921767103280668,0,14,nitrogen cycle metabolic process,BP,
16610,GO:0071942,1,0.981800926028154,0,3,XPC complex,CC,
16612,GO:0071947,1,0.977457853924356,0,3,protein deubiquitination involved in ubiquitin-dependent protein catabolic process,BP,
16613,GO:0071949,1,0.846718322023587,0,25,FAD binding,MF,
16614,GO:0071951,1,0.993109452947755,0,1,conversion of methionyl-tRNA to N-formyl-methionyl-tRNA,BP,
16615,GO:0071953,1,0.974548269671141,0,4,elastic fiber,CC,
16616,GO:0071954,1,0.992545224030108,0,1,chemokine (C-C motif) ligand 11 production,BP,
16617,GO:0071955,1,0.983181283028017,0,2,recycling endosome to Golgi transport,BP,
16618,GO:0071960,1,0.997133032599985,0,1,maintenance of mitotic sister chromatid cohesion, centromeric,BP,
16619,GO:0071962,1,0.984760530328328,0,3,mitotic sister chromatid cohesion, centromeric,BP,
16620,GO:0071963,1,0.995235745311178,0,1,establishment or maintenance of cell polarity regulating cell shape,BP,
16621,GO:0071971,1,0.954576523809065,0,7,extracellular exosome assembly,BP,
16622,GO:0071976,1,0.992611134078856,0,1,cell gliding,BP,
16623,GO:0071985,1,0.831973022355074,0,28,multivesicular body sorting pathway,BP,
16624,GO:0071986,1,0.959441100743117,0,6,Ragulator complex,CC,
16625,GO:0071987,1,0.969320713947567,0,4,WD40-repeat domain binding,MF,
16626,GO:0071988,1,0.990783868118484,0,1,protein localization to spindle pole body,BP,
16627,GO:0071997,1,0.99126790998446,0,1,glutathione S-conjugate-transporting ATPase activity,MF,
16629,GO:0072003,1,0.980945998303816,0,3,kidney rudiment formation,BP,
16630,GO:0072004,1,0.985001542988399,0,2,kidney field specification,BP,
16632,GO:0072007,1,0.955184971987655,0,7,mesangial cell differentiation,BP,
16633,GO:0072008,1,0.960089547228212,0,6,glomerular mesangial cell differentiation,BP,
16635,GO:0072010,1,0.877443996459306,0,18,glomerular epithelium development,BP,
16636,GO:0072011,1,0.98859049646958,0,2,glomerular endothelium development,BP,
16637,GO:0072012,1,0.864168449654656,0,21,glomerulus vasculature development,BP,
16638,GO:0072014,1,0.962807203693313,0,5,proximal tubule development,BP,
16639,GO:0072015,1,0.931198162377386,0,9,glomerular visceral epithelial cell development,BP,
16640,GO:0072016,1,0.993289142355086,0,1,glomerular parietal epithelial cell development,BP,
16641,GO:0072017,1,0.913032105664255,0,11,distal tubule development,BP,
16642,GO:0072019,1,0.994310435915199,0,1,proximal convoluted tubule development,BP,
16643,GO:0072021,1,0.975046195684369,0,3,ascending thin limb development,BP,
16644,GO:0072023,1,0.995804697462269,0,1,thick ascending limb development,BP,
16645,GO:0072024,1,0.995804697462269,0,1,macula densa development,BP,
16646,GO:0072025,1,0.974458405404226,0,4,distal convoluted tubule development,BP,
16647,GO:0072027,1,0.993466096989706,0,1,connecting tubule development,BP,
16649,GO:0072033,1,0.935309881932605,0,8,renal vesicle formation,BP,
16650,GO:0072034,1,0.977901232030926,0,3,renal vesicle induction,BP,
16651,GO:0072036,1,0.992502896428707,0,1,mesenchymal to epithelial transition involved in renal vesicle formation,BP,
16652,GO:0072038,1,0.967992336808067,0,5,mesenchymal stem cell maintenance involved in nephron morphogenesis,BP,
16653,GO:0072039,1,0.977582897392629,0,3,regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
16654,GO:0072040,1,0.977582897392629,0,3,negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
16655,GO:0072044,1,0.91317897977618,0,12,collecting duct development,BP,
16656,GO:0072046,1,0.995883323984961,0,1,establishment of planar polarity involved in nephron morphogenesis,BP,
16659,GO:0072049,1,0.97178508599362,0,5,comma-shaped body morphogenesis,BP,
16660,GO:0072050,1,0.957153671823295,0,7,S-shaped body morphogenesis,BP,
16661,GO:0072051,1,0.995804697462269,0,1,juxtaglomerular apparatus development,BP,
16662,GO:0072053,1,0.985102948930511,0,2,renal inner medulla development,BP,
16663,GO:0072054,1,0.985102948930511,0,2,renal outer medulla development,BP,
16664,GO:0072055,1,0.992085420122243,0,1,renal cortex development,BP,
16665,GO:0072059,1,0.992085420122243,0,1,cortical collecting duct development,BP,
16666,GO:0072060,1,0.992484872212748,0,1,outer medullary collecting duct development,BP,
16667,GO:0072061,1,0.981482419397926,0,3,inner medullary collecting duct development,BP,
16668,GO:0072069,1,0.980868539444084,0,3,DCT cell differentiation,BP,
16670,GO:0072071,1,0.990822262655392,0,2,kidney interstitial fibroblast differentiation,BP,
16672,GO:0072074,1,0.883796552912286,0,18,kidney mesenchyme development,BP,
16673,GO:0072075,1,0.904876191686434,0,14,metanephric mesenchyme development,BP,
16674,GO:0072076,1,0.976538292333128,0,3,nephrogenic mesenchyme development,BP,
16675,GO:0072077,1,0.88271084363333,0,18,renal vesicle morphogenesis,BP,
16681,GO:0072087,1,0.878197770484287,0,19,renal vesicle development,BP,
16685,GO:0072092,1,0.970906166378225,0,3,ureteric bud invasion,BP,
16686,GO:0072093,1,0.963625044064347,0,4,metanephric renal vesicle formation,BP,
16687,GO:0072095,1,0.979880707580653,0,3,regulation of branch elongation involved in ureteric bud branching,BP,
16688,GO:0072096,1,0.995148968087614,0,1,negative regulation of branch elongation involved in ureteric bud branching,BP,
16689,GO:0072097,1,0.995148968087614,0,1,negative regulation of branch elongation involved in ureteric bud branching by BMP signaling pathway,BP,
16690,GO:0072098,1,0.990067112779632,0,2,anterior/posterior pattern specification involved in kidney development,BP,
16691,GO:0072099,1,0.995148968087614,0,1,anterior/posterior pattern specification involved in ureteric bud development,BP,
16692,GO:0072100,1,0.995148968087614,0,1,specification of ureteric bud anterior/posterior symmetry,BP,
16693,GO:0072101,1,0.995148968087614,0,1,specification of ureteric bud anterior/posterior symmetry by BMP signaling pathway,BP,
16694,GO:0072102,1,0.945662839577586,0,7,glomerulus morphogenesis,BP,
16695,GO:0072103,1,0.968611652670311,0,4,glomerulus vasculature morphogenesis,BP,
16696,GO:0072104,1,0.968611652670311,0,4,glomerular capillary formation,BP,
16697,GO:0072106,1,0.975136752139907,0,4,regulation of ureteric bud formation,BP,
16698,GO:0072107,1,0.975136752139907,0,4,positive regulation of ureteric bud formation,BP,
16699,GO:0072108,1,0.975214449197549,0,4,positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis,BP,
16700,GO:0072109,1,0.909790360341499,0,14,glomerular mesangium development,BP,
16701,GO:0072110,1,0.940934162936104,0,9,glomerular mesangial cell proliferation,BP,
16702,GO:0072111,1,0.885759771470667,0,18,cell proliferation involved in kidney development,BP,
16703,GO:0072112,1,0.896148652662385,0,15,glomerular visceral epithelial cell differentiation,BP,
16704,GO:0072114,1,0.991799783217798,0,1,pronephros morphogenesis,BP,
16705,GO:0072124,1,0.948824069577141,0,8,regulation of glomerular mesangial cell proliferation,BP,
16706,GO:0072125,1,0.980548851010848,0,3,negative regulation of glomerular mesangial cell proliferation,BP,
16707,GO:0072126,1,0.967652145561396,0,5,positive regulation of glomerular mesangial cell proliferation,BP,
16708,GO:0072127,1,0.994032123914288,0,1,renal capsule development,BP,
16709,GO:0072128,1,0.994032123914288,0,1,renal capsule morphogenesis,BP,
16710,GO:0072129,1,0.994032123914288,0,1,renal capsule formation,BP,
16711,GO:0072130,1,0.994032123914288,0,1,renal capsule specification,BP,
16712,GO:0072131,1,0.971338912679804,0,4,kidney mesenchyme morphogenesis,BP,
16713,GO:0072132,1,0.734614746263463,0,45,mesenchyme morphogenesis,BP,
16714,GO:0072133,1,0.971338912679804,0,4,metanephric mesenchyme morphogenesis,BP,
16715,GO:0072134,1,0.982402184180354,0,2,nephrogenic mesenchyme morphogenesis,BP,
16716,GO:0072135,1,0.980750046978959,0,3,kidney mesenchymal cell proliferation,BP,
16717,GO:0072136,1,0.980750046978959,0,3,metanephric mesenchymal cell proliferation involved in metanephros development,BP,
16718,GO:0072137,1,0.961681843855466,0,4,condensed mesenchymal cell proliferation,BP,
16719,GO:0072138,1,0.98190876199419,0,3,mesenchymal cell proliferation involved in ureteric bud development,BP,
16720,GO:0072139,1,0.985821955428121,0,2,glomerular parietal epithelial cell differentiation,BP,
16721,GO:0072141,1,0.990822262655392,0,2,renal interstitial fibroblast development,BP,
16722,GO:0072143,1,0.961767459962577,0,6,mesangial cell development,BP,
16723,GO:0072144,1,0.966705493966823,0,5,glomerular mesangial cell development,BP,
16725,GO:0072156,1,0.970707303914224,0,3,distal tubule morphogenesis,BP,
16726,GO:0072160,1,0.900951062993031,0,13,nephron tubule epithelial cell differentiation,BP,
16727,GO:0072161,1,0.955707394769083,0,7,mesenchymal cell differentiation involved in kidney development,BP,
16728,GO:0072162,1,0.972643422805826,0,4,metanephric mesenchymal cell differentiation,BP,
16731,GO:0072165,1,0.994893620462238,0,1,anterior mesonephric tubule development,BP,
16732,GO:0072166,1,0.987736250225781,0,2,posterior mesonephric tubule development,BP,
16733,GO:0072167,1,0.994893620462238,0,1,specification of mesonephric tubule identity,BP,
16734,GO:0072168,1,0.994893620462238,0,1,specification of anterior mesonephric tubule identity,BP,
16735,GO:0072169,1,0.994893620462238,0,1,specification of posterior mesonephric tubule identity,BP,
16736,GO:0072170,1,0.852253207359985,0,22,metanephric tubule development,BP,
16737,GO:0072171,1,0.655408121358562,0,60,mesonephric tubule morphogenesis,BP,
16738,GO:0072172,1,0.953975006611589,0,8,mesonephric tubule formation,BP,
16739,GO:0072173,1,0.925345779975228,0,11,metanephric tubule morphogenesis,BP,
16740,GO:0072174,1,0.959264176958762,0,6,metanephric tubule formation,BP,
16742,GO:0072176,1,0.909520275058122,0,13,nephric duct development,BP,
16743,GO:0072177,1,0.959274890047682,0,6,mesonephric duct development,BP,
16744,GO:0072178,1,0.933746246435031,0,10,nephric duct morphogenesis,BP,
16745,GO:0072179,1,0.976444385041749,0,4,nephric duct formation,BP,
16746,GO:0072180,1,0.984812359625746,0,3,mesonephric duct morphogenesis,BP,
16747,GO:0072181,1,0.995883323984961,0,1,mesonephric duct formation,BP,
16748,GO:0072182,1,0.916066248342028,0,11,regulation of nephron tubule epithelial cell differentiation,BP,
16749,GO:0072183,1,0.987458978414222,0,2,negative regulation of nephron tubule epithelial cell differentiation,BP,
16750,GO:0072184,1,0.994893620462238,0,1,renal vesicle progenitor cell differentiation,BP,
16751,GO:0072185,1,0.988740538935304,0,2,metanephric cap development,BP,
16752,GO:0072186,1,0.988740538935304,0,2,metanephric cap morphogenesis,BP,
16753,GO:0072189,1,0.912662738668056,0,13,ureter development,BP,
16754,GO:0072190,1,0.982624463924137,0,3,ureter urothelium development,BP,
16755,GO:0072191,1,0.976677627206891,0,4,ureter smooth muscle development,BP,
16756,GO:0072192,1,0.995148968087614,0,1,ureter epithelial cell differentiation,BP,
16757,GO:0072193,1,0.976677627206891,0,4,ureter smooth muscle cell differentiation,BP,
16758,GO:0072194,1,0.98270777986878,0,3,kidney smooth muscle tissue development,BP,
16759,GO:0072195,1,0.995632596003417,0,1,kidney smooth muscle cell differentiation,BP,
16760,GO:0072197,1,0.980525706860564,0,3,ureter morphogenesis,BP,
16761,GO:0072198,1,0.98407568386983,0,3,mesenchymal cell proliferation involved in ureter development,BP,
16762,GO:0072199,1,0.98407568386983,0,3,regulation of mesenchymal cell proliferation involved in ureter development,BP,
16763,GO:0072200,1,0.995148968087614,0,1,negative regulation of mesenchymal cell proliferation involved in ureter development,BP,
16764,GO:0072201,1,0.946771043710722,0,8,negative regulation of mesenchymal cell proliferation,BP,
16765,GO:0072202,1,0.853583437483397,0,23,cell differentiation involved in metanephros development,BP,
16766,GO:0072203,1,0.932983287820507,0,10,cell proliferation involved in metanephros development,BP,
16767,GO:0072204,1,0.984785638511809,0,2,cell-cell signaling involved in metanephros development,BP,
16768,GO:0072205,1,0.944928942760297,0,7,metanephric collecting duct development,BP,
16769,GO:0072206,1,0.995804697462269,0,1,metanephric juxtaglomerular apparatus development,BP,
16770,GO:0072207,1,0.839014154044217,0,24,metanephric epithelium development,BP,
16771,GO:0072208,1,0.987019053767798,0,2,metanephric smooth muscle tissue development,BP,
16772,GO:0072209,1,0.986143551136693,0,2,metanephric mesangial cell differentiation,BP,
16774,GO:0072213,1,0.994032123914288,0,1,metanephric capsule development,BP,
16775,GO:0072214,1,0.992085420122243,0,1,metanephric cortex development,BP,
16776,GO:0072215,1,0.871095965688118,0,20,regulation of metanephros development,BP,
16777,GO:0072216,1,0.922208705832464,0,12,positive regulation of metanephros development,BP,
16778,GO:0072217,1,0.955898544858816,0,7,negative regulation of metanephros development,BP,
16779,GO:0072218,1,0.975046195684369,0,3,metanephric ascending thin limb development,BP,
16780,GO:0072219,1,0.992085420122243,0,1,metanephric cortical collecting duct development,BP,
16781,GO:0072221,1,0.974458405404226,0,4,metanephric distal convoluted tubule development,BP,
16782,GO:0072223,1,0.963822736300959,0,5,metanephric glomerular mesangium development,BP,
16783,GO:0072224,1,0.920559063507205,0,11,metanephric glomerulus development,BP,
16784,GO:0072227,1,0.995804697462269,0,1,metanephric macula densa development,BP,
16785,GO:0072229,1,0.994310435915199,0,1,metanephric proximal convoluted tubule development,BP,
16786,GO:0072233,1,0.995804697462269,0,1,metanephric thick ascending limb development,BP,
16787,GO:0072234,1,0.868280304297848,0,19,metanephric nephron tubule development,BP,
16788,GO:0072235,1,0.954140537691069,0,6,metanephric distal tubule development,BP,
16789,GO:0072236,1,0.967716756028101,0,4,metanephric loop of Henle development,BP,
16790,GO:0072237,1,0.981351213597623,0,2,metanephric proximal tubule development,BP,
16791,GO:0072239,1,0.950415408217472,0,7,metanephric glomerulus vasculature development,BP,
16792,GO:0072240,1,0.980868539444084,0,3,metanephric DCT cell differentiation,BP,
16793,GO:0072243,1,0.860997805912156,0,20,metanephric nephron epithelium development,BP,
16794,GO:0072244,1,0.991624508921087,0,1,metanephric glomerular epithelium development,BP,
16795,GO:0072248,1,0.991624508921087,0,1,metanephric glomerular visceral epithelial cell differentiation,BP,
16796,GO:0072249,1,0.991624508921087,0,1,metanephric glomerular visceral epithelial cell development,BP,
16797,GO:0072254,1,0.986143551136693,0,2,metanephric glomerular mesangial cell differentiation,BP,
16798,GO:0072255,1,0.992937210169218,0,1,metanephric glomerular mesangial cell development,BP,
16799,GO:0072257,1,0.941536496826751,0,7,metanephric nephron tubule epithelial cell differentiation,BP,
16800,GO:0072258,1,0.994893620462238,0,1,metanephric interstitial fibroblast differentiation,BP,
16801,GO:0072259,1,0.994893620462238,0,1,metanephric interstitial fibroblast development,BP,
16802,GO:0072262,1,0.977368672377095,0,3,metanephric glomerular mesangial cell proliferation involved in metanephros development,BP,
16803,GO:0072265,1,0.994032123914288,0,1,metanephric capsule morphogenesis,BP,
16804,GO:0072266,1,0.994032123914288,0,1,metanephric capsule formation,BP,
16805,GO:0072267,1,0.994032123914288,0,1,metanephric capsule specification,BP,
16808,GO:0072273,1,0.837453235857424,0,25,metanephric nephron morphogenesis,BP,
16809,GO:0072274,1,0.991624508921087,0,1,metanephric glomerular basement membrane development,BP,
16810,GO:0072275,1,0.982917842253003,0,2,metanephric glomerulus morphogenesis,BP,
16811,GO:0072276,1,0.982917842253003,0,2,metanephric glomerulus vasculature morphogenesis,BP,
16812,GO:0072277,1,0.982917842253003,0,2,metanephric glomerular capillary formation,BP,
16813,GO:0072278,1,0.979464509200901,0,3,metanephric comma-shaped body morphogenesis,BP,
16814,GO:0072282,1,0.942732981855089,0,8,metanephric nephron tubule morphogenesis,BP,
16815,GO:0072283,1,0.902679139040592,0,15,metanephric renal vesicle morphogenesis,BP,
16816,GO:0072284,1,0.964718625887151,0,5,metanephric S-shaped body morphogenesis,BP,
16817,GO:0072285,1,0.992502896428707,0,1,mesenchymal to epithelial transition involved in metanephric renal vesicle formation,BP,
16818,GO:0072286,1,0.993466096989706,0,1,metanephric connecting tubule development,BP,
16819,GO:0072287,1,0.986967361416371,0,1,metanephric distal tubule morphogenesis,BP,
16820,GO:0072289,1,0.970525923122837,0,4,metanephric nephron tubule formation,BP,
16821,GO:0072298,1,0.970466185960497,0,4,regulation of metanephric glomerulus development,BP,
16822,GO:0072299,1,0.992806261113875,0,1,negative regulation of metanephric glomerulus development,BP,
16823,GO:0072300,1,0.977499656775272,0,3,positive regulation of metanephric glomerulus development,BP,
16824,GO:0072301,1,0.985560965202864,0,2,regulation of metanephric glomerular mesangial cell proliferation,BP,
16825,GO:0072302,1,0.992806261113875,0,1,negative regulation of metanephric glomerular mesangial cell proliferation,BP,
16826,GO:0072303,1,0.992702730269534,0,1,positive regulation of glomerular metanephric mesangial cell proliferation,BP,
16827,GO:0072304,1,0.985001542988399,0,2,regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
16828,GO:0072305,1,0.985001542988399,0,2,negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
16829,GO:0072307,1,0.941536496826751,0,7,regulation of metanephric nephron tubule epithelial cell differentiation,BP,
16830,GO:0072308,1,0.992527580310158,0,1,negative regulation of metanephric nephron tubule epithelial cell differentiation,BP,
16831,GO:0072309,1,0.985001542988399,0,2,mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis,BP,
16832,GO:0072310,1,0.924944585709682,0,10,glomerular epithelial cell development,BP,
16833,GO:0072311,1,0.890128153719101,0,16,glomerular epithelial cell differentiation,BP,
16834,GO:0072312,1,0.991624508921087,0,1,metanephric glomerular epithelial cell differentiation,BP,
16835,GO:0072313,1,0.991624508921087,0,1,metanephric glomerular epithelial cell development,BP,
16836,GO:0072318,1,0.956959583800171,0,6,clathrin coat disassembly,BP,
16837,GO:0072319,1,0.951420347698853,0,7,vesicle uncoating,BP,
16838,GO:0072320,1,0.972165018176421,0,4,volume-sensitive chloride channel activity,MF,
16839,GO:0072321,1,0.951018259549069,0,10,chaperone-mediated protein transport,BP,
16840,GO:0072329,1,0.467415994010597,0,122,monocarboxylic acid catabolic process,BP,
16843,GO:0072332,1,0.607385415221265,0,79,intrinsic apoptotic signaling pathway by p53 class mediator,BP,
16844,GO:0072334,1,0.991787624528082,0,2,UDP-galactose transmembrane transport,BP,
16845,GO:0072337,1,0.888165183193259,0,17,modified amino acid transport,BP,
16846,GO:0072338,1,0.956804019972273,0,6,cellular lactam metabolic process,BP,
16847,GO:0072340,1,0.995349884203026,0,1,cellular lactam catabolic process,BP,
16849,GO:0072343,1,0.991277702913634,0,2,pancreatic stellate cell proliferation,BP,
16850,GO:0072344,1,0.974546303575298,0,4,rescue of stalled ribosome,BP,
16851,GO:0072345,1,0.958260902293957,0,6,NAADP-sensitive calcium-release channel activity,MF,
16853,GO:0072348,1,0.810679910239203,0,30,sulfur compound transport,BP,
16854,GO:0072349,1,0.912192342279859,0,13,modified amino acid transmembrane transporter activity,MF,
16855,GO:0072350,1,0.803739865172782,0,36,tricarboxylic acid metabolic process,BP,
16856,GO:0072354,1,0.995319688798766,0,1,histone kinase activity (H3-T3 specific),MF,
16857,GO:0072355,1,0.995319688798766,0,1,histone H3-T3 phosphorylation,BP,
16858,GO:0072356,1,0.992470257377452,0,1,chromosome passenger complex localization to kinetochore,BP,
16859,GO:0072357,1,0.951485729104329,0,7,PTW/PP1 phosphatase complex,CC,
16862,GO:0072361,1,0.979596748600962,0,2,regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter,BP,
16863,GO:0072362,1,0.990336105700147,0,1,regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter,BP,
16864,GO:0072363,1,0.989156891021747,0,1,regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter,BP,
16865,GO:0072364,1,0.979190565047257,0,2,regulation of cellular ketone metabolic process by regulation of transcription from RNA polymerase II promoter,BP,
16866,GO:0072365,1,0.989925513699865,0,1,regulation of cellular ketone metabolic process by negative regulation of transcription from RNA polymerase II promoter,BP,
16867,GO:0072366,1,0.989156891021747,0,1,regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter,BP,
16868,GO:0072367,1,0.965208314833101,0,4,regulation of lipid transport by regulation of transcription from RNA polymerase II promoter,BP,
16869,GO:0072368,1,0.982815707096472,0,2,regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter,BP,
16870,GO:0072369,1,0.982087818969697,0,2,regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter,BP,
16871,GO:0072376,1,0.672385054099075,0,66,protein activation cascade,BP,
16872,GO:0072378,1,0.882821101111369,0,21,blood coagulation, fibrin clot formation,BP,
16873,GO:0072379,1,0.981535354227572,0,3,ER membrane insertion complex,CC,
16874,GO:0072382,1,0.986851394274971,0,1,minus-end-directed vesicle transport along microtubule,BP,
16875,GO:0072383,1,0.942781975227777,0,7,plus-end-directed vesicle transport along microtubule,BP,
16876,GO:0072384,1,0.605340856245841,0,69,organelle transport along microtubule,BP,
16877,GO:0072385,1,0.964270076474851,0,4,minus-end-directed organelle transport along microtubule,BP,
16878,GO:0072386,1,0.93492030045742,0,8,plus-end-directed organelle transport along microtubule,BP,
16879,GO:0072387,1,0.987228949530589,0,2,flavin adenine dinucleotide metabolic process,BP,
16880,GO:0072388,1,0.994700388265012,0,1,flavin adenine dinucleotide biosynthetic process,BP,
16881,GO:0072389,1,0.992489152328139,0,1,flavin adenine dinucleotide catabolic process,BP,
16882,GO:0072393,1,0.911205547923368,0,11,microtubule anchoring at microtubule organizing center,BP,
16883,GO:0072395,1,0.610355935080292,0,74,signal transduction involved in cell cycle checkpoint,BP,
16884,GO:0072396,1,0.961405326894267,0,5,response to cell cycle checkpoint signaling,BP,
16885,GO:0072401,1,0.616618214963071,0,73,signal transduction involved in DNA integrity checkpoint,BP,
16886,GO:0072402,1,0.961405326894267,0,5,response to DNA integrity checkpoint signaling,BP,
16887,GO:0072413,1,0.667732164884337,0,62,signal transduction involved in mitotic cell cycle checkpoint,BP,
16888,GO:0072414,1,0.990861101073973,0,1,response to mitotic cell cycle checkpoint signaling,BP,
16889,GO:0072422,1,0.616618214963071,0,73,signal transduction involved in DNA damage checkpoint,BP,
16890,GO:0072423,1,0.961405326894267,0,5,response to DNA damage checkpoint signaling,BP,
16891,GO:0072425,1,0.918851807080485,0,11,signal transduction involved in G2 DNA damage checkpoint,BP,
16892,GO:0072428,1,0.994948155266244,0,1,signal transduction involved in intra-S DNA damage checkpoint,BP,
16893,GO:0072429,1,0.980765009648057,0,3,response to intra-S DNA damage checkpoint signaling,BP,
16894,GO:0072431,1,0.672578606569416,0,61,signal transduction involved in mitotic G1 DNA damage checkpoint,BP,
16895,GO:0072432,1,0.990861101073973,0,1,response to G1 DNA damage checkpoint signaling,BP,
16896,GO:0072434,1,0.981459040200817,0,2,signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
16897,GO:0072487,1,0.972158819403795,0,4,MSL complex,CC,
16898,GO:0072488,1,0.933871969659504,0,11,ammonium transmembrane transport,BP,
16899,GO:0072492,1,0.995219366830879,0,1,host cell mitochondrial intermembrane space,CC,
16900,GO:0072497,1,0.94042661980331,0,8,mesenchymal stem cell differentiation,BP,
16901,GO:0072498,1,0.917160903819502,0,14,embryonic skeletal joint development,BP,
16902,GO:0072501,1,0.954807818517028,0,6,cellular divalent inorganic anion homeostasis,BP,
16903,GO:0072502,1,0.954807818517028,0,6,cellular trivalent inorganic anion homeostasis,BP,
16905,GO:0072505,1,0.933263315267557,0,9,divalent inorganic anion homeostasis,BP,
16906,GO:0072506,1,0.933263315267557,0,9,trivalent inorganic anion homeostasis,BP,
16909,GO:0072510,1,0.978134117813301,0,3,trivalent inorganic cation transmembrane transporter activity,MF,
16911,GO:0072512,1,0.792105222879329,0,38,trivalent inorganic cation transport,BP,
16912,GO:0072513,1,0.975724909029378,0,4,positive regulation of secondary heart field cardioblast proliferation,BP,
16913,GO:0072517,1,0.992558446435096,0,1,host cell viral assembly compartment,CC,
16914,GO:0072518,1,0.991255605191299,0,1,Rho-dependent protein serine/threonine kinase activity,MF,
16915,GO:0072520,1,0.926084108831002,0,11,seminiferous tubule development,BP,
16918,GO:0072523,1,0.723327454003712,0,49,purine-containing compound catabolic process,BP,
16919,GO:0072524,1,0.341676540728148,0,162,pyridine-containing compound metabolic process,BP,
16920,GO:0072525,1,0.434024696050758,0,122,pyridine-containing compound biosynthetic process,BP,
16921,GO:0072526,1,0.970627725785825,0,6,pyridine-containing compound catabolic process,BP,
16922,GO:0072527,1,0.640097493940591,0,77,pyrimidine-containing compound metabolic process,BP,
16923,GO:0072528,1,0.807918124547959,0,39,pyrimidine-containing compound biosynthetic process,BP,
16924,GO:0072529,1,0.821355294262028,0,34,pyrimidine-containing compound catabolic process,BP,
16925,GO:0072530,1,0.951679758361937,0,8,purine-containing compound transmembrane transport,BP,
16926,GO:0072531,1,0.944756339062155,0,9,pyrimidine-containing compound transmembrane transport,BP,
16927,GO:0072534,1,0.982285687968028,0,2,perineuronal net,CC,
16929,GO:0072536,1,0.994667264080108,0,1,interleukin-23 receptor complex,CC,
16930,GO:0072537,1,0.936973464593799,0,9,fibroblast activation,BP,
16931,GO:0072538,1,0.894272878737957,0,17,T-helper 17 type immune response,BP,
16932,GO:0072539,1,0.900927025191586,0,16,T-helper 17 cell differentiation,BP,
16933,GO:0072540,1,0.944524563766021,0,10,T-helper 17 cell lineage commitment,BP,
16934,GO:0072542,1,0.95789192495381,0,7,protein phosphatase activator activity,MF,
16935,GO:0072544,1,0.99534524277805,0,1,L-DOPA binding,MF,
16936,GO:0072545,1,0.989636128416895,0,2,tyrosine binding,MF,
16937,GO:0072546,1,0.932182290910033,0,10,ER membrane protein complex,CC,
16938,GO:0072553,1,0.958287443610581,0,6,terminal button organization,BP,
16939,GO:0072554,1,0.986443089323677,0,2,blood vessel lumenization,BP,
16940,GO:0072556,1,0.992440287823366,0,1,other organism presynaptic membrane,CC,
16941,GO:0072557,1,0.982022450366425,0,4,IPAF inflammasome complex,CC,
16942,GO:0072558,1,0.982212528038339,0,4,NLRP1 inflammasome complex,CC,
16943,GO:0072559,1,0.958587089744368,0,8,NLRP3 inflammasome complex,CC,
16944,GO:0072560,1,0.989378879486233,0,2,type B pancreatic cell maturation,BP,
16945,GO:0072562,1,0.588273119912898,0,92,blood microparticle,CC,
16946,GO:0072563,1,0.988291983666947,0,2,endothelial microparticle,CC,
16947,GO:0072564,1,0.989912788840421,0,2,blood microparticle formation,BP,
16948,GO:0072566,1,0.987868169689496,0,2,chemokine (C-X-C motif) ligand 1 production,BP,
16950,GO:0072570,1,0.992637506708155,0,1,ADP-D-ribose binding,MF,
16951,GO:0072572,1,0.994308131096673,0,1,poly-ADP-D-ribose binding,MF,
16952,GO:0072573,1,0.992371143331572,0,1,tolerance induction to lipopolysaccharide,BP,
16953,GO:0072574,1,0.911214766767394,0,14,hepatocyte proliferation,BP,
16954,GO:0072575,1,0.911214766767394,0,14,epithelial cell proliferation involved in liver morphogenesis,BP,
16955,GO:0072576,1,0.903035061349604,0,15,liver morphogenesis,BP,
16956,GO:0072577,1,0.725113677286755,0,46,endothelial cell apoptotic process,BP,
16957,GO:0072578,1,0.923954849672698,0,10,neurotransmitter-gated ion channel clustering,BP,
16958,GO:0072579,1,0.992420809289738,0,1,glycine receptor clustering,BP,
16959,GO:0072583,1,0.750187525527788,0,38,clathrin-dependent endocytosis,BP,
16960,GO:0072584,1,0.939952432087686,0,9,caveolin-mediated endocytosis,BP,
16961,GO:0072586,1,0.992344203487146,0,1,DNA topoisomerase (ATP-hydrolyzing) regulator activity,MF,
16962,GO:0072587,1,0.992344203487146,0,1,DNA topoisomerase (ATP-hydrolyzing) activator activity,MF,
16963,GO:0072588,1,0.981399633808129,0,5,box H/ACA RNP complex,CC,
16964,GO:0072589,1,0.985236834801277,0,4,box H/ACA scaRNP complex,CC,
16965,GO:0072590,1,0.980566238315733,0,2,N-acetyl-L-aspartate-L-glutamate ligase activity,MF,
16966,GO:0072591,1,0.991625758802834,0,1,citrate-L-glutamate ligase activity,MF,
16967,GO:0072592,1,0.975595208331138,0,5,oxygen metabolic process,BP,
16970,GO:0072595,1,0.7658429709599,0,40,maintenance of protein localization in organelle,BP,
16971,GO:0072599,1,0.682741430937554,0,104,establishment of protein localization to endoplasmic reticulum,BP,
16972,GO:0072602,1,0.960266545845611,0,6,interleukin-4 secretion,BP,
16973,GO:0072603,1,0.960872575992418,0,6,interleukin-5 secretion,BP,
16976,GO:0072608,1,0.956720117475692,0,8,interleukin-10 secretion,BP,
16977,GO:0072610,1,0.947431496801632,0,9,interleukin-12 secretion,BP,
16978,GO:0072611,1,0.95758025596647,0,7,interleukin-13 secretion,BP,
16979,GO:0072615,1,0.988997774242212,0,2,interleukin-17 secretion,BP,
16980,GO:0072616,1,0.992473963019799,0,1,interleukin-18 secretion,BP,
16981,GO:0072619,1,0.992529000303621,0,1,interleukin-21 secretion,BP,
16982,GO:0072641,1,0.944647372194917,0,7,type I interferon secretion,BP,
16983,GO:0072642,1,0.951353380329704,0,6,interferon-alpha secretion,BP,
16984,GO:0072643,1,0.903228582375354,0,15,interferon-gamma secretion,BP,
16985,GO:0072655,1,0.353765974709423,0,174,establishment of protein localization to mitochondrion,BP,
16986,GO:0072656,1,0.967355958423062,0,5,maintenance of protein location in mitochondrion,BP,
16988,GO:0072658,1,0.989191759965915,0,1,maintenance of protein location in membrane,BP,
16990,GO:0072660,1,0.989191759965915,0,1,maintenance of protein location in plasma membrane,BP,
16991,GO:0072662,1,0.892862885078239,0,17,protein localization to peroxisome,BP,
16992,GO:0072663,1,0.892862885078239,0,17,establishment of protein localization to peroxisome,BP,
16995,GO:0072669,1,0.966881846538599,0,7,tRNA-splicing ligase complex,CC,
16996,GO:0072671,1,0.993440989855558,0,1,mitochondria-associated ubiquitin-dependent protein catabolic process,BP,
16997,GO:0072672,1,0.953161537434078,0,7,neutrophil extravasation,BP,
16999,GO:0072674,1,0.964940975604903,0,4,multinuclear osteoclast differentiation,BP,
17000,GO:0072675,1,0.964940975604903,0,4,osteoclast fusion,BP,
17002,GO:0072677,1,0.933299495525855,0,14,eosinophil migration,BP,
17004,GO:0072679,1,0.973569077756963,0,5,thymocyte migration,BP,
17005,GO:0072680,1,0.992691303580234,0,1,extracellular matrix-dependent thymocyte migration,BP,
17006,GO:0072681,1,0.992691303580234,0,1,fibronectin-dependent thymocyte migration,BP,
17007,GO:0072682,1,0.992567076119753,0,1,eosinophil extravasation,BP,
17008,GO:0072683,1,0.980901900921525,0,4,T cell extravasation,BP,
17009,GO:0072684,1,0.992494560037644,0,1,mitochondrial tRNA 3'-trailer cleavage, endonucleolytic,BP,
17010,GO:0072686,1,0.535166429471978,0,85,mitotic spindle,CC,
17011,GO:0072687,1,0.967117200043708,0,5,meiotic spindle,CC,
17012,GO:0072695,1,0.987321203198508,0,2,regulation of DNA recombination at telomere,BP,
17013,GO:0072697,1,0.922811663193561,0,11,protein localization to cell cortex,BP,
17014,GO:0072698,1,0.714848001322513,0,43,protein localization to microtubule cytoskeleton,BP,
17015,GO:0072702,1,0.991750891076956,0,1,response to methyl methanesulfonate,BP,
17016,GO:0072703,1,0.991750891076956,0,1,cellular response to methyl methanesulfonate,BP,
17017,GO:0072706,1,0.993406159157069,0,1,response to sodium dodecyl sulfate,BP,
17018,GO:0072707,1,0.993406159157069,0,1,cellular response to sodium dodecyl sulfate,BP,
17019,GO:0072708,1,0.968998409992894,0,5,response to sorbitol,BP,
17020,GO:0072709,1,0.982437719246106,0,3,cellular response to sorbitol,BP,
17021,GO:0072710,1,0.93959369823533,0,8,response to hydroxyurea,BP,
17022,GO:0072711,1,0.946165162753051,0,7,cellular response to hydroxyurea,BP,
17023,GO:0072714,1,0.995249769378109,0,1,response to selenite ion,BP,
17024,GO:0072715,1,0.995249769378109,0,1,cellular response to selenite ion,BP,
17025,GO:0072716,1,0.975105121363946,0,4,response to actinomycin D,BP,
17026,GO:0072717,1,0.981922415416055,0,3,cellular response to actinomycin D,BP,
17027,GO:0072718,1,0.938846781255245,0,9,response to cisplatin,BP,
17028,GO:0072719,1,0.960233416364153,0,6,cellular response to cisplatin,BP,
17029,GO:0072720,1,0.986164624597214,0,2,response to dithiothreitol,BP,
17030,GO:0072721,1,0.993058458973322,0,1,cellular response to dithiothreitol,BP,
17031,GO:0072733,1,0.982511631239364,0,3,response to staurosporine,BP,
17032,GO:0072734,1,0.982511631239364,0,3,cellular response to staurosporine,BP,
17033,GO:0072737,1,0.987686492745924,0,2,response to diamide,BP,
17034,GO:0072738,1,0.987686492745924,0,2,cellular response to diamide,BP,
17035,GO:0072739,1,0.987980106156051,0,2,response to anisomycin,BP,
17036,GO:0072740,1,0.994886504719633,0,1,cellular response to anisomycin,BP,
17037,GO:0072741,1,0.977684815872658,0,3,protein localization to cell division site,BP,
17038,GO:0072749,1,0.995087718336798,0,1,cellular response to cytochalasin B,BP,
17039,GO:0072750,1,0.996277433952069,0,1,cellular response to leptomycin B,BP,
17040,GO:0072752,1,0.991148832282024,0,1,cellular response to rapamycin,BP,
17041,GO:0072755,1,0.992500645009124,0,1,cellular response to benomyl,BP,
17042,GO:0072757,1,0.972266903913642,0,4,cellular response to camptothecin,BP,
17043,GO:0075044,1,0.968319910800728,0,4,autophagy of host cells involved in interaction with symbiont,BP,
17044,GO:0075071,1,0.968319910800728,0,4,autophagy involved in symbiotic interaction,BP,
17045,GO:0075109,1,0.992003285188543,0,1,modulation by symbiont of host receptor-mediated signal transduction,BP,
17046,GO:0075111,1,0.992003285188543,0,1,negative regulation by symbiont of host receptor-mediated signal transduction,BP,
17047,GO:0075112,1,0.992003285188543,0,1,modulation by symbiont of host transmembrane receptor-mediated signal transduction,BP,
17048,GO:0075114,1,0.992003285188543,0,1,negative regulation by symbiont of host transmembrane receptor-mediated signal transduction,BP,
17049,GO:0075136,1,0.966752764072485,0,5,response to host,BP,
17050,GO:0075341,1,0.993958479426141,0,1,host cell PML body,CC,
17052,GO:0075519,1,0.997527977053139,0,1,microtubule-dependent intracellular transport of viral material,BP,
17053,GO:0075521,1,0.997527977053139,0,1,microtubule-dependent intracellular transport of viral material towards nucleus,BP,
17054,GO:0075522,1,0.933738466166435,0,10,IRES-dependent viral translational initiation,BP,
17055,GO:0075525,1,0.971113722096629,0,5,viral translational termination-reinitiation,BP,
17056,GO:0075528,1,0.986218198019591,0,2,modulation by virus of host immune response,BP,
17057,GO:0075606,1,0.997527977053139,0,1,transport of viral material towards nucleus,BP,
17058,GO:0075713,1,0.953625737826998,0,8,establishment of integrated proviral latency,BP,
17059,GO:0075732,1,0.984120792322059,0,2,viral penetration into host nucleus,BP,
17060,GO:0075733,1,0.701019777817593,0,53,intracellular transport of virus,BP,
17061,GO:0080008,1,0.793068226228271,0,34,Cul4-RING E3 ubiquitin ligase complex,CC,
17062,GO:0080009,1,0.939851450040164,0,10,mRNA methylation,BP,
17063,GO:0080019,1,0.986406915242731,0,2,fatty-acyl-CoA reductase (alcohol-forming) activity,MF,
17064,GO:0080023,1,0.986164624597214,0,2,3R-hydroxyacyl-CoA dehydratase activity,MF,
17065,GO:0080025,1,0.857377152377024,0,22,phosphatidylinositol-3,5-bisphosphate binding,MF,
17066,GO:0080033,1,0.991319662364429,0,1,response to nitrite,BP,
17067,GO:0080048,1,0.993058458973322,0,1,GDP-D-glucose phosphorylase activity,MF,
17068,GO:0080058,1,0.996112512123046,0,1,protein deglutathionylation,BP,
17069,GO:0080084,1,0.96122792634049,0,5,5S rDNA binding,MF,
17071,GO:0080101,1,0.99690558516184,0,1,phosphatidyl-N-dimethylethanolamine N-methyltransferase activity,MF,
17072,GO:0080111,1,0.860450691550438,0,22,DNA demethylation,BP,
17073,GO:0080120,1,0.988579186240195,0,2,CAAX-box protein maturation,BP,
17074,GO:0080121,1,0.986770020443027,0,2,AMP transport,BP,
17075,GO:0080122,1,0.980305153810067,0,3,AMP transmembrane transporter activity,MF,
17076,GO:0080129,1,0.996694918055396,0,1,proteasome core complex assembly,BP,
17080,GO:0080144,1,0.987353883918656,0,2,amino acid homeostasis,BP,
17081,GO:0080146,1,0.995239252591955,0,1,L-cysteine desulfhydrase activity,MF,
17082,GO:0080147,1,0.997356194534619,0,1,root hair cell development,BP,
17083,GO:0080154,1,0.919705508526704,0,16,regulation of fertilization,BP,
17084,GO:0080163,1,0.993749732191475,0,1,regulation of protein serine/threonine phosphatase activity,BP,
17085,GO:0080171,1,0.678119807426199,0,58,lytic vacuole organization,BP,
17086,GO:0080182,1,0.895315710056491,0,16,histone H3-K4 trimethylation,BP,
17088,GO:0085018,1,0.993103570478837,0,1,maintenance of symbiont-containing vacuole by host,BP,
17089,GO:0085020,1,0.959885550318727,0,7,protein K6-linked ubiquitination,BP,
17090,GO:0085029,1,0.804294464642953,0,30,extracellular matrix assembly,BP,
17091,GO:0085032,1,0.992618938164342,0,1,modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade,BP,
17097,GO:0086006,1,0.96298753582422,0,5,voltage-gated sodium channel activity involved in cardiac muscle cell action potential,MF,
17098,GO:0086007,1,0.954066152362924,0,5,voltage-gated calcium channel activity involved in cardiac muscle cell action potential,MF,
17099,GO:0086008,1,0.922641037382975,0,12,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization,MF,
17102,GO:0086011,1,0.847687743729509,0,24,membrane repolarization during action potential,BP,
17103,GO:0086012,1,0.847815721079825,0,20,membrane depolarization during cardiac muscle cell action potential,BP,
17104,GO:0086013,1,0.865860319474729,0,21,membrane repolarization during cardiac muscle cell action potential,BP,
17106,GO:0086015,1,0.925020831418094,0,8,SA node cell action potential,BP,
17107,GO:0086016,1,0.919174157526402,0,9,AV node cell action potential,BP,
17108,GO:0086017,1,0.978910961415487,0,3,Purkinje myocyte action potential,BP,
17109,GO:0086018,1,0.925020831418094,0,8,SA node cell to atrial cardiac muscle cell signaling,BP,
17111,GO:0086020,1,0.990523394996428,0,1,gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling,MF,
17112,GO:0086021,1,0.990523394996428,0,1,SA node cell to atrial cardiac muscle cell communication by electrical coupling,BP,
17113,GO:0086023,1,0.94919703024931,0,6,adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
17114,GO:0086024,1,0.99023308023085,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in positive regulation of heart rate,BP,
17116,GO:0086027,1,0.919174157526402,0,9,AV node cell to bundle of His cell signaling,BP,
17117,GO:0086028,1,0.957520271736801,0,6,bundle of His cell to Purkinje myocyte signaling,BP,
17118,GO:0086029,1,0.958494713776132,0,5,Purkinje myocyte to ventricular cardiac muscle cell signaling,BP,
17119,GO:0086030,1,0.994531698198617,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in cardiac muscle relaxation,BP,
17120,GO:0086036,1,0.94730546528796,0,8,regulation of cardiac muscle cell membrane potential,BP,
17121,GO:0086037,1,0.992528523012615,0,1,sodium:potassium-exchanging ATPase activity involved in regulation of cardiac muscle cell membrane potential,MF,
17122,GO:0086038,1,0.993058458973322,0,1,calcium:sodium antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
17123,GO:0086039,1,0.990165646669906,0,1,calcium-transporting ATPase activity involved in regulation of cardiac muscle cell membrane potential,MF,
17124,GO:0086040,1,0.992317355438081,0,1,sodium:proton antiporter activity involved in regulation of cardiac muscle cell membrane potential,MF,
17125,GO:0086041,1,0.99076821290995,0,1,voltage-gated potassium channel activity involved in SA node cell action potential depolarization,MF,
17127,GO:0086043,1,0.957520271736801,0,6,bundle of His cell action potential,BP,
17128,GO:0086045,1,0.95361689595268,0,5,membrane depolarization during AV node cell action potential,BP,
17129,GO:0086046,1,0.95294456350619,0,5,membrane depolarization during SA node cell action potential,BP,
17130,GO:0086047,1,0.978910961415487,0,3,membrane depolarization during Purkinje myocyte cell action potential,BP,
17131,GO:0086048,1,0.975176752859539,0,3,membrane depolarization during bundle of His cell action potential,BP,
17132,GO:0086050,1,0.992959461926035,0,1,membrane repolarization during bundle of His cell action potential,BP,
17133,GO:0086052,1,0.992959461926035,0,1,membrane repolarization during SA node cell action potential,BP,
17134,GO:0086053,1,0.990523394996428,0,1,AV node cell to bundle of His cell communication by electrical coupling,BP,
17135,GO:0086056,1,0.970551883378528,0,3,voltage-gated calcium channel activity involved in AV node cell action potential,MF,
17136,GO:0086057,1,0.992490718507675,0,1,voltage-gated calcium channel activity involved in bundle of His cell action potential,MF,
17137,GO:0086059,1,0.981106942246922,0,2,voltage-gated calcium channel activity involved SA node cell action potential,MF,
17138,GO:0086060,1,0.990018622880227,0,1,voltage-gated sodium channel activity involved in AV node cell action potential,MF,
17139,GO:0086061,1,0.990018622880227,0,1,voltage-gated sodium channel activity involved in bundle of His cell action potential,MF,
17140,GO:0086062,1,0.986345839442325,0,2,voltage-gated sodium channel activity involved in Purkinje myocyte action potential,MF,
17141,GO:0086063,1,0.990018622880227,0,1,voltage-gated sodium channel activity involved in SA node cell action potential,MF,
17145,GO:0086067,1,0.910456211861088,0,10,AV node cell to bundle of His cell communication,BP,
17146,GO:0086068,1,0.958494713776132,0,5,Purkinje myocyte to ventricular cardiac muscle cell communication,BP,
17148,GO:0086070,1,0.916247985873452,0,9,SA node cell to atrial cardiac muscle cell communication,BP,
17149,GO:0086072,1,0.993590947659061,0,1,AV node cell-bundle of His cell adhesion involved in cell communication,BP,
17152,GO:0086077,1,0.990523394996428,0,1,gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling,MF,
17154,GO:0086082,1,0.993590947659061,0,1,cell adhesive protein binding involved in AV node cell-bundle of His cell communication,MF,
17156,GO:0086087,1,0.992959461926035,0,1,voltage-gated potassium channel activity involved in bundle of His cell action potential repolarization,MF,
17157,GO:0086089,1,0.971801973215432,0,4,voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,MF,
17158,GO:0086090,1,0.992959461926035,0,1,voltage-gated potassium channel activity involved in SA node cell action potential repolarization,MF,
17160,GO:0086092,1,0.987672643761845,0,2,regulation of the force of heart contraction by cardiac conduction,BP,
17161,GO:0086096,1,0.996136801278012,0,1,adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
17162,GO:0086097,1,0.986269396505483,0,2,phospholipase C-activating angiotensin-activated signaling pathway,BP,
17163,GO:0086098,1,0.985746556980039,0,2,angiotensin-activated signaling pathway involved in heart process,BP,
17164,GO:0086100,1,0.984966626169303,0,2,endothelin receptor signaling pathway,BP,
17165,GO:0086103,1,0.928454854644062,0,10,G-protein coupled receptor signaling pathway involved in heart process,BP,
17166,GO:0089700,1,0.969596446576183,0,4,protein kinase D signaling,BP,
17167,GO:0089701,1,0.975994929094546,0,5,U2AF,CC,
17168,GO:0089709,1,0.980603962746435,0,3,L-histidine transmembrane transport,BP,
17169,GO:0089717,1,0.92206422071249,0,10,spanning component of membrane,CC,
17170,GO:0089718,1,0.870015261912058,0,19,amino acid import across plasma membrane,BP,
17171,GO:0089720,1,0.958330505893103,0,9,caspase binding,MF,
17172,GO:0090009,1,0.941314411629227,0,9,primitive streak formation,BP,
17173,GO:0090010,1,0.994438031540948,0,1,transforming growth factor beta receptor signaling pathway involved in primitive streak formation,BP,
17174,GO:0090022,1,0.842763215778063,0,34,regulation of neutrophil chemotaxis,BP,
17175,GO:0090023,1,0.870210284741651,0,29,positive regulation of neutrophil chemotaxis,BP,
17176,GO:0090024,1,0.985242258931905,0,2,negative regulation of neutrophil chemotaxis,BP,
17177,GO:0090025,1,0.897943685701708,0,18,regulation of monocyte chemotaxis,BP,
17178,GO:0090026,1,0.929852269579607,0,13,positive regulation of monocyte chemotaxis,BP,
17179,GO:0090027,1,0.972759596270258,0,4,negative regulation of monocyte chemotaxis,BP,
17180,GO:0090030,1,0.937839819269165,0,9,regulation of steroid hormone biosynthetic process,BP,
17181,GO:0090031,1,0.978875420217498,0,3,positive regulation of steroid hormone biosynthetic process,BP,
17182,GO:0090032,1,0.965537818240073,0,5,negative regulation of steroid hormone biosynthetic process,BP,
17183,GO:0090034,1,0.988053730148088,0,2,regulation of chaperone-mediated protein complex assembly,BP,
17184,GO:0090035,1,0.988053730148088,0,2,positive regulation of chaperone-mediated protein complex assembly,BP,
17185,GO:0090036,1,0.895571727726971,0,15,regulation of protein kinase C signaling,BP,
17186,GO:0090037,1,0.947439173675172,0,8,positive regulation of protein kinase C signaling,BP,
17187,GO:0090038,1,0.985258500497617,0,2,negative regulation of protein kinase C signaling,BP,
17188,GO:0090042,1,0.93867652609573,0,9,tubulin deacetylation,BP,
17189,GO:0090043,1,0.950801391559521,0,7,regulation of tubulin deacetylation,BP,
17190,GO:0090044,1,0.995566416067967,0,1,positive regulation of tubulin deacetylation,BP,
17191,GO:0090045,1,0.944465816759789,0,8,positive regulation of deacetylase activity,BP,
17192,GO:0090049,1,0.790072345381525,0,34,regulation of cell migration involved in sprouting angiogenesis,BP,
17193,GO:0090050,1,0.885856546616794,0,18,positive regulation of cell migration involved in sprouting angiogenesis,BP,
17194,GO:0090051,1,0.898629665060607,0,15,negative regulation of cell migration involved in sprouting angiogenesis,BP,
17195,GO:0090063,1,0.971450298100278,0,4,positive regulation of microtubule nucleation,BP,
17196,GO:0090065,1,0.992473353745584,0,1,regulation of production of siRNA involved in RNA interference,BP,
17198,GO:0090067,1,0.992331782807655,0,1,regulation of thalamus size,BP,
17199,GO:0090068,1,0.188033063241404,0,244,positive regulation of cell cycle process,BP,
17200,GO:0090069,1,0.912165419150454,0,13,regulation of ribosome biogenesis,BP,
17201,GO:0090070,1,0.948311749465331,0,8,positive regulation of ribosome biogenesis,BP,
17202,GO:0090071,1,0.969679505979085,0,4,negative regulation of ribosome biogenesis,BP,
17203,GO:0090073,1,0.941904732500858,0,9,positive regulation of protein homodimerization activity,BP,
17204,GO:0090074,1,0.964432082523638,0,5,negative regulation of protein homodimerization activity,BP,
17205,GO:0090075,1,0.838878306652254,0,27,relaxation of muscle,BP,
17206,GO:0090076,1,0.984499431713666,0,2,relaxation of skeletal muscle,BP,
17207,GO:0090077,1,0.816884381154812,0,29,foam cell differentiation,BP,
17208,GO:0090079,1,0.845412412940383,0,24,translation regulator activity, nucleic acid binding,MF,
17209,GO:0090080,1,0.983926397836349,0,2,positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway,BP,
17210,GO:0090081,1,0.991673939615846,0,2,regulation of heart induction by regulation of canonical Wnt signaling pathway,BP,
17211,GO:0090082,1,0.991673939615846,0,2,positive regulation of heart induction by negative regulation of canonical Wnt signaling pathway,BP,
17212,GO:0090083,1,0.899127436092726,0,15,regulation of inclusion body assembly,BP,
17213,GO:0090084,1,0.926796333919112,0,10,negative regulation of inclusion body assembly,BP,
17214,GO:0090085,1,0.931634462030926,0,11,regulation of protein deubiquitination,BP,
17215,GO:0090086,1,0.988140705861653,0,3,negative regulation of protein deubiquitination,BP,
17217,GO:0090088,1,0.988703966357826,0,2,regulation of oligopeptide transport,BP,
17218,GO:0090089,1,0.988703966357826,0,2,regulation of dipeptide transport,BP,
17220,GO:0090091,1,0.96057920473933,0,5,positive regulation of extracellular matrix disassembly,BP,
17222,GO:0090094,1,0.988740538935304,0,2,metanephric cap mesenchymal cell proliferation involved in metanephros development,BP,
17223,GO:0090095,1,0.993815653211834,0,1,regulation of metanephric cap mesenchymal cell proliferation,BP,
17224,GO:0090096,1,0.993815653211834,0,1,positive regulation of metanephric cap mesenchymal cell proliferation,BP,
17225,GO:0090100,1,0.51302160966902,0,96,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,BP,
17229,GO:0090107,1,0.979626917711147,0,3,regulation of high-density lipoprotein particle assembly,BP,
17230,GO:0090108,1,0.994468402997698,0,1,positive regulation of high-density lipoprotein particle assembly,BP,
17232,GO:0090110,1,0.907632639697884,0,13,cargo loading into COPII-coated vesicle,BP,
17233,GO:0090113,1,0.994243844117059,0,1,regulation of ER to Golgi vesicle-mediated transport by GTP hydrolysis,BP,
17234,GO:0090114,1,0.626793029773836,0,69,COPII-coated vesicle budding,BP,
17235,GO:0090116,1,0.976960289494875,0,3,C-5 methylation of cytosine,BP,
17236,GO:0090118,1,0.962508413218871,0,5,receptor-mediated endocytosis involved in cholesterol transport,BP,
17237,GO:0090119,1,0.986973433043387,0,2,vesicle-mediated cholesterol transport,BP,
17238,GO:0090122,1,0.994597601201436,0,1,cholesterol ester hydrolysis involved in cholesterol transport,BP,
17239,GO:0090128,1,0.924083274963056,0,10,regulation of synapse maturation,BP,
17240,GO:0090129,1,0.938685435141105,0,8,positive regulation of synapse maturation,BP,
17242,GO:0090131,1,0.973809964882474,0,5,mesenchyme migration,BP,
17244,GO:0090133,1,0.996796269237842,0,1,mesendoderm migration,BP,
17245,GO:0090134,1,0.996796269237842,0,1,cell migration involved in mesendoderm migration,BP,
17246,GO:0090135,1,0.980950783014968,0,3,actin filament branching,BP,
17248,GO:0090138,1,0.992512023534277,0,1,regulation of actin cytoskeleton organization by cell-cell adhesion,BP,
17249,GO:0090140,1,0.857277363368212,0,21,regulation of mitochondrial fission,BP,
17250,GO:0090141,1,0.90937142982389,0,14,positive regulation of mitochondrial fission,BP,
17252,GO:0090149,1,0.986265732456859,0,2,mitochondrial membrane fission,BP,
17254,GO:0090151,1,0.948050983273706,0,12,establishment of protein localization to mitochondrial membrane,BP,
17255,GO:0090153,1,0.9246256409518,0,13,regulation of sphingolipid biosynthetic process,BP,
17256,GO:0090154,1,0.950260531986637,0,8,positive regulation of sphingolipid biosynthetic process,BP,
17257,GO:0090155,1,0.977148276255885,0,4,negative regulation of sphingolipid biosynthetic process,BP,
17258,GO:0090156,1,0.984969925866194,0,3,cellular sphingolipid homeostasis,BP,
17259,GO:0090158,1,0.961095560481195,0,6,endoplasmic reticulum membrane organization,BP,
17260,GO:0090160,1,0.944622992735609,0,8,Golgi to lysosome transport,BP,
17261,GO:0090161,1,0.919077507735393,0,11,Golgi ribbon formation,BP,
17262,GO:0090162,1,0.814605908366397,0,28,establishment of epithelial cell polarity,BP,
17263,GO:0090164,1,0.983836088564435,0,2,asymmetric Golgi ribbon formation,BP,
17264,GO:0090166,1,0.963702402701684,0,6,Golgi disassembly,BP,
17265,GO:0090168,1,0.973815907973594,0,4,Golgi reassembly,BP,
17266,GO:0090169,1,0.830408047125606,0,25,regulation of spindle assembly,BP,
17267,GO:0090170,1,0.976278899249424,0,4,regulation of Golgi inheritance,BP,
17268,GO:0090171,1,0.992493312849118,0,1,chondrocyte morphogenesis,BP,
17271,GO:0090176,1,0.991758651804326,0,1,microtubule cytoskeleton organization involved in establishment of planar polarity,BP,
17273,GO:0090178,1,0.898648657755607,0,14,regulation of establishment of planar polarity involved in neural tube closure,BP,
17274,GO:0090179,1,0.905625180399306,0,13,planar cell polarity pathway involved in neural tube closure,BP,
17275,GO:0090181,1,0.704227991837544,0,51,regulation of cholesterol metabolic process,BP,
17276,GO:0090182,1,0.990156589220292,0,2,regulation of secretion of lysosomal enzymes,BP,
17277,GO:0090183,1,0.723071896019014,0,48,regulation of kidney development,BP,
17278,GO:0090184,1,0.792536936698384,0,35,positive regulation of kidney development,BP,
17279,GO:0090185,1,0.908228943294489,0,15,negative regulation of kidney development,BP,
17280,GO:0090186,1,0.953483952382402,0,7,regulation of pancreatic juice secretion,BP,
17281,GO:0090187,1,0.992381150615365,0,2,positive regulation of pancreatic juice secretion,BP,
17282,GO:0090188,1,0.960807118279913,0,5,negative regulation of pancreatic juice secretion,BP,
17283,GO:0090189,1,0.878969913112495,0,20,regulation of branching involved in ureteric bud morphogenesis,BP,
17284,GO:0090190,1,0.893279090201386,0,17,positive regulation of branching involved in ureteric bud morphogenesis,BP,
17285,GO:0090191,1,0.975516573975614,0,4,negative regulation of branching involved in ureteric bud morphogenesis,BP,
17286,GO:0090192,1,0.929519065485573,0,11,regulation of glomerulus development,BP,
17287,GO:0090193,1,0.947967889221674,0,8,positive regulation of glomerulus development,BP,
17288,GO:0090194,1,0.980548851010848,0,3,negative regulation of glomerulus development,BP,
17292,GO:0090198,1,0.992936619507467,0,1,negative regulation of chemokine secretion,BP,
17293,GO:0090199,1,0.788339742056279,0,42,regulation of release of cytochrome c from mitochondria,BP,
17294,GO:0090200,1,0.857620444123503,0,28,positive regulation of release of cytochrome c from mitochondria,BP,
17295,GO:0090201,1,0.913981559876237,0,15,negative regulation of release of cytochrome c from mitochondria,BP,
17296,GO:0090202,1,0.973613332321363,0,4,gene looping,BP,
17297,GO:0090204,1,0.983882639799399,0,3,protein localization to nuclear pore,BP,
17298,GO:0090205,1,0.956699444476082,0,6,positive regulation of cholesterol metabolic process,BP,
17299,GO:0090206,1,0.973983119168808,0,5,negative regulation of cholesterol metabolic process,BP,
17300,GO:0090207,1,0.862341496523379,0,24,regulation of triglyceride metabolic process,BP,
17301,GO:0090208,1,0.914166129335505,0,15,positive regulation of triglyceride metabolic process,BP,
17302,GO:0090209,1,0.961423784485941,0,6,negative regulation of triglyceride metabolic process,BP,
17303,GO:0090210,1,0.98579738889843,0,2,regulation of establishment of blood-brain barrier,BP,
17304,GO:0090212,1,0.98579738889843,0,2,negative regulation of establishment of blood-brain barrier,BP,
17305,GO:0090214,1,0.987356635353896,0,2,spongiotrophoblast layer developmental growth,BP,
17307,GO:0090219,1,0.978871201824977,0,3,negative regulation of lipid kinase activity,BP,
17308,GO:0090220,1,0.928846904435596,0,10,chromosome localization to nuclear envelope involved in homologous chromosome segregation,BP,
17309,GO:0090222,1,0.981493044206568,0,2,centrosome-templated microtubule nucleation,BP,
17310,GO:0090224,1,0.748973610760256,0,39,regulation of spindle organization,BP,
17311,GO:0090226,1,0.997252166295856,0,1,regulation of microtubule nucleation by Ran protein signal transduction,BP,
17312,GO:0090230,1,0.969612706896145,0,4,regulation of centromere complex assembly,BP,
17313,GO:0090231,1,0.905527979268324,0,15,regulation of spindle checkpoint,BP,
17314,GO:0090232,1,0.946859797137751,0,8,positive regulation of spindle checkpoint,BP,
17315,GO:0090233,1,0.993217783511225,0,1,negative regulation of spindle checkpoint,BP,
17316,GO:0090234,1,0.977212960217444,0,3,regulation of kinetochore assembly,BP,
17317,GO:0090235,1,0.942079207874328,0,7,regulation of metaphase plate congression,BP,
17318,GO:0090237,1,0.967562321085782,0,5,regulation of arachidonic acid secretion,BP,
17319,GO:0090238,1,0.975267013130915,0,4,positive regulation of arachidonic acid secretion,BP,
17320,GO:0090239,1,0.928350623792881,0,12,regulation of histone H4 acetylation,BP,
17321,GO:0090240,1,0.958952008128354,0,7,positive regulation of histone H4 acetylation,BP,
17322,GO:0090241,1,0.971566999877651,0,5,negative regulation of histone H4 acetylation,BP,
17323,GO:0090244,1,0.971527713311481,0,4,Wnt signaling pathway involved in somitogenesis,BP,
17324,GO:0090245,1,0.966165503728345,0,4,axis elongation involved in somitogenesis,BP,
17325,GO:0090246,1,0.992359736600904,0,1,convergent extension involved in somitogenesis,BP,
17326,GO:0090247,1,0.993367477867485,0,1,cell motility involved in somitogenic axis elongation,BP,
17327,GO:0090249,1,0.993367477867485,0,1,regulation of cell motility involved in somitogenic axis elongation,BP,
17328,GO:0090251,1,0.988387209416912,0,1,protein localization involved in establishment of planar polarity,BP,
17330,GO:0090258,1,0.976416248592088,0,3,negative regulation of mitochondrial fission,BP,
17331,GO:0090259,1,0.963929229745787,0,5,regulation of retinal ganglion cell axon guidance,BP,
17332,GO:0090260,1,0.984658278973857,0,2,negative regulation of retinal ganglion cell axon guidance,BP,
17333,GO:0090261,1,0.979508974936034,0,4,positive regulation of inclusion body assembly,BP,
17334,GO:0090263,1,0.449201997686957,0,126,positive regulation of canonical Wnt signaling pathway,BP,
17335,GO:0090264,1,0.989125488593042,0,2,regulation of immune complex clearance by monocytes and macrophages,BP,
17336,GO:0090265,1,0.993536383049275,0,1,positive regulation of immune complex clearance by monocytes and macrophages,BP,
17337,GO:0090266,1,0.91227253710338,0,14,regulation of mitotic cell cycle spindle assembly checkpoint,BP,
17338,GO:0090267,1,0.953909045236185,0,7,positive regulation of mitotic cell cycle spindle assembly checkpoint,BP,
17339,GO:0090269,1,0.955485693158081,0,6,fibroblast growth factor production,BP,
17340,GO:0090270,1,0.955485693158081,0,6,regulation of fibroblast growth factor production,BP,
17341,GO:0090271,1,0.975241224774951,0,3,positive regulation of fibroblast growth factor production,BP,
17342,GO:0090272,1,0.979747950484941,0,3,negative regulation of fibroblast growth factor production,BP,
17343,GO:0090273,1,0.99059460979173,0,2,regulation of somatostatin secretion,BP,
17344,GO:0090274,1,0.99059460979173,0,2,positive regulation of somatostatin secretion,BP,
17347,GO:0090278,1,0.77236073951145,0,40,negative regulation of peptide hormone secretion,BP,
17348,GO:0090279,1,0.84614975483531,0,27,regulation of calcium ion import,BP,
17349,GO:0090280,1,0.918429960623174,0,14,positive regulation of calcium ion import,BP,
17350,GO:0090281,1,0.978462169344957,0,5,negative regulation of calcium ion import,BP,
17351,GO:0090282,1,0.992793133926616,0,1,positive regulation of transcription involved in G2/M transition of mitotic cell cycle,BP,
17352,GO:0090283,1,0.979215521977875,0,3,regulation of protein glycosylation in Golgi,BP,
17353,GO:0090284,1,0.990758584424964,0,1,positive regulation of protein glycosylation in Golgi,BP,
17354,GO:0090285,1,0.988350343049681,0,2,negative regulation of protein glycosylation in Golgi,BP,
17355,GO:0090286,1,0.947636312314645,0,6,cytoskeletal anchoring at nuclear membrane,BP,
17358,GO:0090289,1,0.981736528013203,0,3,regulation of osteoclast proliferation,BP,
17359,GO:0090290,1,0.996807971560297,0,1,positive regulation of osteoclast proliferation,BP,
17360,GO:0090291,1,0.984880775062323,0,2,negative regulation of osteoclast proliferation,BP,
17361,GO:0090292,1,0.96992315794296,0,3,nuclear matrix anchoring at nuclear membrane,BP,
17362,GO:0090293,1,0.994287414484928,0,1,nitrogen catabolite regulation of transcription,BP,
17363,GO:0090294,1,0.994287414484928,0,1,nitrogen catabolite activation of transcription,BP,
17364,GO:0090296,1,0.974402545012035,0,4,regulation of mitochondrial DNA replication,BP,
17365,GO:0090297,1,0.996292746081189,0,1,positive regulation of mitochondrial DNA replication,BP,
17366,GO:0090298,1,0.978029153186698,0,3,negative regulation of mitochondrial DNA replication,BP,
17367,GO:0090299,1,0.995428566727141,0,1,regulation of neural crest formation,BP,
17368,GO:0090301,1,0.995428566727141,0,1,negative regulation of neural crest formation,BP,
17372,GO:0090306,1,0.96974228028891,0,4,spindle assembly involved in meiosis,BP,
17373,GO:0090307,1,0.644267368393937,0,62,mitotic spindle assembly,BP,
17374,GO:0090308,1,0.945708221212599,0,7,regulation of methylation-dependent chromatin silencing,BP,
17375,GO:0090309,1,0.969807193886596,0,4,positive regulation of methylation-dependent chromatin silencing,BP,
17376,GO:0090310,1,0.982510996309018,0,2,negative regulation of methylation-dependent chromatin silencing,BP,
17377,GO:0090311,1,0.77489349846533,0,36,regulation of protein deacetylation,BP,
17378,GO:0090312,1,0.86792784427707,0,20,positive regulation of protein deacetylation,BP,
17380,GO:0090314,1,0.838387164855744,0,27,positive regulation of protein targeting to membrane,BP,
17382,GO:0090316,1,0.296728687041146,0,179,positive regulation of intracellular protein transport,BP,
17385,GO:0090323,1,0.997807301551196,0,1,prostaglandin secretion involved in immune response,BP,
17386,GO:0090324,1,0.967222693742636,0,5,negative regulation of oxidative phosphorylation,BP,
17387,GO:0090325,1,0.978465948866247,0,3,regulation of locomotion involved in locomotory behavior,BP,
17388,GO:0090326,1,0.992611582878955,0,1,positive regulation of locomotion involved in locomotory behavior,BP,
17389,GO:0090327,1,0.99244581380195,0,1,negative regulation of locomotion involved in locomotory behavior,BP,
17390,GO:0090329,1,0.733017521310459,0,45,regulation of DNA-dependent DNA replication,BP,
17392,GO:0090331,1,0.927921028838823,0,11,negative regulation of platelet aggregation,BP,
17393,GO:0090335,1,0.917568212357408,0,12,regulation of brown fat cell differentiation,BP,
17394,GO:0090336,1,0.96087802161377,0,6,positive regulation of brown fat cell differentiation,BP,
17395,GO:0090340,1,0.994468402997698,0,1,positive regulation of secretion of lysosomal enzymes,BP,
17396,GO:0090341,1,0.995664442842841,0,1,negative regulation of secretion of lysosomal enzymes,BP,
17397,GO:0090342,1,0.764817601735849,0,39,regulation of cell aging,BP,
17398,GO:0090343,1,0.945671833800858,0,10,positive regulation of cell aging,BP,
17399,GO:0090344,1,0.856873462890197,0,21,negative regulation of cell aging,BP,
17400,GO:0090345,1,0.989154802741785,0,2,cellular organohalogen metabolic process,BP,
17401,GO:0090346,1,0.989154802741785,0,2,cellular organofluorine metabolic process,BP,
17402,GO:0090347,1,0.995607527026098,0,1,regulation of cellular organohalogen metabolic process,BP,
17403,GO:0090348,1,0.995607527026098,0,1,regulation of cellular organofluorine metabolic process,BP,
17404,GO:0090349,1,0.995607527026098,0,1,negative regulation of cellular organohalogen metabolic process,BP,
17405,GO:0090350,1,0.995607527026098,0,1,negative regulation of cellular organofluorine metabolic process,BP,
17406,GO:0090360,1,0.981328799836914,0,3,platelet-derived growth factor production,BP,
17407,GO:0090361,1,0.981328799836914,0,3,regulation of platelet-derived growth factor production,BP,
17408,GO:0090362,1,0.986776427424532,0,2,positive regulation of platelet-derived growth factor production,BP,
17409,GO:0090365,1,0.994211890902552,0,1,regulation of mRNA modification,BP,
17410,GO:0090367,1,0.994211890902552,0,1,negative regulation of mRNA modification,BP,
17411,GO:0090370,1,0.980339071802612,0,3,negative regulation of cholesterol efflux,BP,
17412,GO:0090381,1,0.991673939615846,0,2,regulation of heart induction,BP,
17413,GO:0090382,1,0.786325763640219,0,40,phagosome maturation,BP,
17414,GO:0090383,1,0.865099935173581,0,26,phagosome acidification,BP,
17415,GO:0090385,1,0.957852035579212,0,7,phagosome-lysosome fusion,BP,
17416,GO:0090386,1,0.982980267402241,0,2,phagosome maturation involved in apoptotic cell clearance,BP,
17417,GO:0090387,1,0.982980267402241,0,2,phagolysosome assembly involved in apoptotic cell clearance,BP,
17418,GO:0090389,1,0.990515955648412,0,1,phagosome-lysosome fusion involved in apoptotic cell clearance,BP,
17419,GO:0090394,1,0.927612341299126,0,10,negative regulation of excitatory postsynaptic potential,BP,
17420,GO:0090398,1,0.679785363853488,0,58,cellular senescence,BP,
17421,GO:0090399,1,0.909726122166928,0,13,replicative senescence,BP,
17422,GO:0090400,1,0.94619089043052,0,8,stress-induced premature senescence,BP,
17423,GO:0090402,1,0.987726880223828,0,2,oncogene-induced cell senescence,BP,
17424,GO:0090403,1,0.971615415091185,0,4,oxidative stress-induced premature senescence,BP,
17426,GO:0090409,1,0.99397268531889,0,1,malonyl-CoA synthetase activity,MF,
17427,GO:0090410,1,0.99397268531889,0,1,malonate catabolic process,BP,
17428,GO:0090416,1,0.993414354368861,0,1,nicotinate transmembrane transporter activity,MF,
17429,GO:0090420,1,0.996017221888988,0,1,naphthalene-containing compound metabolic process,BP,
17430,GO:0090422,1,0.988773075413266,0,2,thiamine pyrophosphate transmembrane transporter activity,MF,
17431,GO:0090425,1,0.992750120792518,0,1,acinar cell differentiation,BP,
17432,GO:0090427,1,0.980121083084123,0,3,activation of meiosis,BP,
17433,GO:0090435,1,0.958052624172188,0,7,protein localization to nuclear envelope,BP,
17434,GO:0090461,1,0.992414853997043,0,1,glutamate homeostasis,BP,
17435,GO:0090472,1,0.992439832277321,0,1,dibasic protein processing,BP,
17436,GO:0090480,1,0.97690660619821,0,3,purine nucleotide-sugar transmembrane transport,BP,
17437,GO:0090481,1,0.934830077090499,0,11,pyrimidine nucleotide-sugar transmembrane transport,BP,
17438,GO:0090482,1,0.865036357440711,0,22,vitamin transmembrane transporter activity,MF,
17439,GO:0090493,1,0.938459686383487,0,11,catecholamine uptake,BP,
17440,GO:0090494,1,0.938459686383487,0,11,dopamine uptake,BP,
17441,GO:0090498,1,0.978461768973085,0,3,extrinsic component of Golgi membrane,CC,
17442,GO:0090500,1,0.969511133280337,0,5,endocardial cushion to mesenchymal transition,BP,
17443,GO:0090501,1,0.455003230993948,0,129,RNA phosphodiester bond hydrolysis,BP,
17444,GO:0090502,1,0.69122607124758,0,62,RNA phosphodiester bond hydrolysis, endonucleolytic,BP,
17445,GO:0090503,1,0.794552142914458,0,35,RNA phosphodiester bond hydrolysis, exonucleolytic,BP,
17446,GO:0090504,1,0.815028884562413,0,28,epiboly,BP,
17447,GO:0090505,1,0.824435213780714,0,27,epiboly involved in wound healing,BP,
17448,GO:0090520,1,0.927424519197032,0,12,sphingolipid mediated signaling pathway,BP,
17449,GO:0090521,1,0.970409522414657,0,4,glomerular visceral epithelial cell migration,BP,
17451,GO:0090529,1,0.994993164821226,0,1,cell septum assembly,BP,
17452,GO:0090533,1,0.917032047129928,0,14,cation-transporting ATPase complex,CC,
17453,GO:0090534,1,0.995319688798766,0,1,calcium ion-transporting ATPase complex,CC,
17454,GO:0090537,1,0.98426276203068,0,2,CERF complex,CC,
17455,GO:0090541,1,0.985498010194621,0,2,MIT domain binding,MF,
17456,GO:0090543,1,0.829689192156028,0,26,Flemming body,CC,
17458,GO:0090554,1,0.965013185959489,0,4,phosphatidylcholine-translocating ATPase activity,MF,
17459,GO:0090555,1,0.982931257443107,0,2,phosphatidylethanolamine-translocating ATPase activity,MF,
17460,GO:0090556,1,0.980002814002865,0,2,phosphatidylserine-translocating ATPase activity,MF,
17461,GO:0090557,1,0.937014875436846,0,8,establishment of endothelial intestinal barrier,BP,
17462,GO:0090558,1,0.997356194534619,0,1,plant epidermis development,BP,
17464,GO:0090560,1,0.994270188349298,0,1,2-(3-amino-3-carboxypropyl)histidine synthase activity,MF,
17466,GO:0090571,1,0.975742059567704,0,4,RNA polymerase II transcription repressor complex,CC,
17467,GO:0090575,1,0.377943516867245,0,146,RNA polymerase II transcription factor complex,CC,
17468,GO:0090576,1,0.941895709129335,0,8,RNA polymerase III transcription factor complex,CC,
17469,GO:0090579,1,0.973613332321363,0,4,dsDNA loop formation,BP,
17470,GO:0090594,1,0.95747987672378,0,7,inflammatory response to wounding,BP,
17472,GO:0090598,1,0.982358827734912,0,3,male anatomical structure morphogenesis,BP,
17473,GO:0090599,1,0.959940190843252,0,5,alpha-glucosidase activity,MF,
17474,GO:0090600,1,0.99248541887796,0,1,alpha-1,3-glucosidase activity,MF,
17475,GO:0090601,1,0.992035648124119,0,1,enucleation,BP,
17476,GO:0090611,1,0.969394592995609,0,5,ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway,BP,
17477,GO:0090615,1,0.987171961559009,0,2,mitochondrial mRNA processing,BP,
17478,GO:0090616,1,0.992307720971646,0,1,mitochondrial mRNA 3'-end processing,BP,
17479,GO:0090624,1,0.993058458973322,0,1,endoribonuclease activity, cleaving miRNA-paired mRNA,MF,
17480,GO:0090625,1,0.993058458973322,0,1,mRNA cleavage involved in gene silencing by siRNA,BP,
17481,GO:0090627,1,0.997356194534619,0,1,plant epidermal cell differentiation,BP,
17482,GO:0090630,1,0.561999022758029,0,79,activation of GTPase activity,BP,
17483,GO:0090634,1,0.995764108068102,0,1,microglial cell mediated cytotoxicity,BP,
17484,GO:0090646,1,0.93094256464382,0,12,mitochondrial tRNA processing,BP,
17485,GO:0090647,1,0.95225963794173,0,7,modulation of age-related behavioral decline,BP,
17486,GO:0090648,1,0.991370295221435,0,1,response to environmental enrichment,BP,
17487,GO:0090649,1,0.960575540909227,0,5,response to oxygen-glucose deprivation,BP,
17488,GO:0090650,1,0.960575540909227,0,5,cellular response to oxygen-glucose deprivation,BP,
17489,GO:0090651,1,0.991055358264972,0,1,apical cytoplasm,CC,
17490,GO:0090656,1,0.901474764790415,0,14,t-circle formation,BP,
17491,GO:0090657,1,0.928867605323628,0,10,telomeric loop disassembly,BP,
17493,GO:0090661,1,0.985236834801277,0,4,box H/ACA telomerase RNP complex,CC,
17494,GO:0090662,1,0.841026997513892,0,29,ATP hydrolysis coupled transmembrane transport,BP,
17495,GO:0090663,1,0.99283011075546,0,2,galanin-activated signaling pathway,BP,
17497,GO:0090666,1,0.977444503803825,0,4,scaRNA localization to Cajal body,BP,
17498,GO:0090667,1,0.99038662091338,0,1,cell chemotaxis to vascular endothelial growth factor,BP,
17499,GO:0090668,1,0.99038662091338,0,1,endothelial cell chemotaxis to vascular endothelial growth factor,BP,
17500,GO:0090669,1,0.974099979557881,0,4,telomerase RNA stabilization,BP,
17501,GO:0090670,1,0.896103198963696,0,19,RNA localization to Cajal body,BP,
17502,GO:0090671,1,0.896103198963696,0,19,telomerase RNA localization to Cajal body,BP,
17503,GO:0090672,1,0.896103198963696,0,19,telomerase RNA localization,BP,
17504,GO:0090673,1,0.9906991011123,0,1,endothelial cell-matrix adhesion,BP,
17505,GO:0090675,1,0.992428812355931,0,1,intermicrovillar adhesion,BP,
17506,GO:0090677,1,0.987937162504371,0,2,reversible differentiation,BP,
17507,GO:0090678,1,0.987937162504371,0,2,cell dedifferentiation involved in phenotypic switching,BP,
17508,GO:0090685,1,0.896103198963696,0,19,RNA localization to nucleus,BP,
17509,GO:0090694,1,0.982209767071976,0,2,Scc2-Scc4 cohesin loading complex,CC,
17510,GO:0090713,1,0.9598010192903,0,6,immunological memory process,BP,
17511,GO:0090715,1,0.9598010192903,0,6,immunological memory formation process,BP,
17512,GO:0090722,1,0.976174445835274,0,4,receptor-receptor interaction,MF,
17513,GO:0090723,1,0.908142092669662,0,14,growth cone part,CC,
17514,GO:0090724,1,0.980651462091905,0,3,central region of growth cone,CC,
17515,GO:0090725,1,0.997133032599985,0,1,peripheral region of growth cone,CC,
17516,GO:0090731,1,0.996510058796768,0,1,cellular response to very-low-density lipoprotein particle stimulus,BP,
17517,GO:0090734,1,0.789316718996386,0,33,site of DNA damage,CC,
17518,GO:0090735,1,0.938399163519219,0,10,DNA repair complex assembly,BP,
17519,GO:0090737,1,0.901474764790415,0,14,telomere maintenance via telomere trimming,BP,
17520,GO:0090741,1,0.940915255032247,0,11,pigment granule membrane,CC,
17521,GO:0093001,1,0.99265292550742,0,1,glycolysis from storage polysaccharide through glucose-1-phosphate,BP,
17522,GO:0095500,1,0.873493346710391,0,21,acetylcholine receptor signaling pathway,BP,
17524,GO:0097003,1,0.986846083662047,0,2,adipokinetic hormone receptor activity,MF,
17525,GO:0097006,1,0.623573238068174,0,73,regulation of plasma lipoprotein particle levels,BP,
17526,GO:0097009,1,0.887119455818022,0,18,energy homeostasis,BP,
17527,GO:0097010,1,0.978121747713046,0,3,eukaryotic translation initiation factor 4F complex assembly,BP,
17528,GO:0097011,1,0.947645036553026,0,8,cellular response to granulocyte macrophage colony-stimulating factor stimulus,BP,
17529,GO:0097012,1,0.947645036553026,0,8,response to granulocyte macrophage colony-stimulating factor,BP,
17531,GO:0097014,1,0.468986304862249,0,100,ciliary plasm,CC,
17532,GO:0097016,1,0.978272725120362,0,4,L27 domain binding,MF,
17533,GO:0097017,1,0.98669653992466,0,2,renal protein absorption,BP,
17534,GO:0097018,1,0.993522923901973,0,1,renal albumin absorption,BP,
17535,GO:0097020,1,0.992582737757818,0,1,COPII adaptor activity,MF,
17536,GO:0097021,1,0.981648500500277,0,3,lymphocyte migration into lymphoid organs,BP,
17537,GO:0097022,1,0.994241557377807,0,1,lymphocyte migration into lymph node,BP,
17538,GO:0097025,1,0.970443553879736,0,5,MPP7-DLG1-LIN7 complex,CC,
17539,GO:0097026,1,0.979335324495364,0,4,dendritic cell dendrite assembly,BP,
17540,GO:0097027,1,0.960583520085285,0,7,ubiquitin-protein transferase activator activity,MF,
17541,GO:0097028,1,0.81468558879301,0,37,dendritic cell differentiation,BP,
17542,GO:0097029,1,0.981741655420089,0,4,mature conventional dendritic cell differentiation,BP,
17544,GO:0097036,1,0.995939249581314,0,1,regulation of plasma membrane sterol distribution,BP,
17545,GO:0097037,1,0.992559757346675,0,1,heme export,BP,
17546,GO:0097038,1,0.924811788111988,0,11,perinuclear endoplasmic reticulum,CC,
17547,GO:0097039,1,0.96310645563849,0,5,protein linear polyubiquitination,BP,
17548,GO:0097045,1,0.992227121076383,0,1,phosphatidylserine exposure on blood platelet,BP,
17549,GO:0097048,1,0.943123435737668,0,10,dendritic cell apoptotic process,BP,
17551,GO:0097050,1,0.917659632588871,0,12,type B pancreatic cell apoptotic process,BP,
17552,GO:0097051,1,0.97553704497351,0,3,establishment of protein localization to endoplasmic reticulum membrane,BP,
17553,GO:0097052,1,0.983664477365638,0,3,L-kynurenine metabolic process,BP,
17554,GO:0097053,1,0.99583057491786,0,1,L-kynurenine catabolic process,BP,
17555,GO:0097055,1,0.987274027966991,0,2,agmatine biosynthetic process,BP,
17556,GO:0097056,1,0.976605262549311,0,4,selenocysteinyl-tRNA(Sec) biosynthetic process,BP,
17557,GO:0097057,1,0.990983463325571,0,2,TRAF2-GSTP1 complex,CC,
17559,GO:0097059,1,0.989806712748121,0,2,CNTFR-CLCF1 complex,CC,
17561,GO:0097061,1,0.60293460873611,0,66,dendritic spine organization,BP,
17562,GO:0097062,1,0.883601282440147,0,17,dendritic spine maintenance,BP,
17563,GO:0097064,1,0.779212086503105,0,36,ncRNA export from nucleus,BP,
17564,GO:0097065,1,0.958532310829705,0,6,anterior head development,BP,
17565,GO:0097066,1,0.849335728624074,0,24,response to thyroid hormone,BP,
17566,GO:0097067,1,0.893129271513051,0,16,cellular response to thyroid hormone stimulus,BP,
17567,GO:0097068,1,0.963491121640753,0,5,response to thyroxine,BP,
17568,GO:0097069,1,0.985303075321928,0,2,cellular response to thyroxine stimulus,BP,
17569,GO:0097070,1,0.962740402070215,0,5,ductus arteriosus closure,BP,
17570,GO:0097084,1,0.950668767984934,0,8,vascular smooth muscle cell development,BP,
17571,GO:0097086,1,0.992513136053713,0,1,amniotic stem cell differentiation,BP,
17572,GO:0097089,1,0.989367626546264,0,2,methyl-branched fatty acid metabolic process,BP,
17574,GO:0097091,1,0.930350143558858,0,9,synaptic vesicle clustering,BP,
17575,GO:0097094,1,0.897485748091659,0,15,craniofacial suture morphogenesis,BP,
17576,GO:0097100,1,0.971071082882653,0,5,supercoiled DNA binding,MF,
17577,GO:0097101,1,0.980123214163316,0,3,blood vessel endothelial cell fate specification,BP,
17578,GO:0097102,1,0.986215863401133,0,2,endothelial tip cell fate specification,BP,
17579,GO:0097104,1,0.912496576014167,0,11,postsynaptic membrane assembly,BP,
17580,GO:0097105,1,0.922659751049241,0,10,presynaptic membrane assembly,BP,
17581,GO:0097106,1,0.881075707581506,0,15,postsynaptic density organization,BP,
17582,GO:0097107,1,0.937857267445651,0,7,postsynaptic density assembly,BP,
17583,GO:0097108,1,0.975606036078284,0,3,hedgehog family protein binding,MF,
17584,GO:0097109,1,0.960979820888739,0,5,neuroligin family protein binding,MF,
17586,GO:0097111,1,0.982306495067485,0,2,endoplasmic reticulum-Golgi intermediate compartment organization,BP,
17587,GO:0097112,1,0.985243992079447,0,2,gamma-aminobutyric acid receptor clustering,BP,
17588,GO:0097113,1,0.948932052196009,0,7,AMPA glutamate receptor clustering,BP,
17589,GO:0097114,1,0.968123863321634,0,4,NMDA glutamate receptor clustering,BP,
17590,GO:0097115,1,0.992161676171263,0,1,neurexin clustering involved in presynaptic membrane assembly,BP,
17591,GO:0097116,1,0.973317278718375,0,3,gephyrin clustering involved in postsynaptic density assembly,BP,
17592,GO:0097117,1,0.990808577627167,0,1,guanylate kinase-associated protein clustering,BP,
17593,GO:0097118,1,0.964621754933969,0,4,neuroligin clustering involved in postsynaptic membrane assembly,BP,
17594,GO:0097119,1,0.927941728718108,0,9,postsynaptic density protein 95 clustering,BP,
17596,GO:0097123,1,0.988963661273249,0,2,cyclin A1-CDK2 complex,CC,
17597,GO:0097124,1,0.987153371363649,0,2,cyclin A2-CDK2 complex,CC,
17598,GO:0097125,1,0.98968143959427,0,2,cyclin B1-CDK1 complex,CC,
17599,GO:0097129,1,0.983520800772489,0,3,cyclin D2-CDK4 complex,CC,
17600,GO:0097134,1,0.989047358271141,0,2,cyclin E1-CDK2 complex,CC,
17601,GO:0097135,1,0.987253571560556,0,2,cyclin E2-CDK2 complex,CC,
17602,GO:0097136,1,0.962844865546711,0,6,Bcl-2 family protein complex,CC,
17603,GO:0097144,1,0.997289666042589,0,1,BAX complex,CC,
17604,GO:0097145,1,0.994186879981186,0,1,BAK complex,CC,
17605,GO:0097149,1,0.977793785062654,0,3,centralspindlin complex,CC,
17606,GO:0097150,1,0.844481829827841,0,21,neuronal stem cell population maintenance,BP,
17607,GO:0097151,1,0.944103524397895,0,7,positive regulation of inhibitory postsynaptic potential,BP,
17608,GO:0097152,1,0.926354733415481,0,12,mesenchymal cell apoptotic process,BP,
17609,GO:0097153,1,0.93561428192536,0,13,cysteine-type endopeptidase activity involved in apoptotic process,MF,
17611,GO:0097155,1,0.972584040862625,0,3,fasciculation of sensory neuron axon,BP,
17612,GO:0097156,1,0.983788829503916,0,2,fasciculation of motor neuron axon,BP,
17613,GO:0097157,1,0.944404356730473,0,8,pre-mRNA intronic binding,MF,
17614,GO:0097158,1,0.995474657112284,0,1,pre-mRNA intronic pyrimidine-rich binding,MF,
17616,GO:0097161,1,0.991298700908345,0,1,DH domain binding,MF,
17617,GO:0097162,1,0.992619880935046,0,1,MADS box domain binding,MF,
17619,GO:0097165,1,0.967617242481993,0,5,nuclear stress granule,CC,
17620,GO:0097166,1,0.984638054665805,0,2,lens epithelial cell proliferation,BP,
17621,GO:0097167,1,0.97355313473307,0,4,circadian regulation of translation,BP,
17622,GO:0097168,1,0.98664435858241,0,2,mesenchymal stem cell proliferation,BP,
17623,GO:0097169,1,0.982396113117238,0,5,AIM2 inflammasome complex,CC,
17624,GO:0097176,1,0.978489846889325,0,4,epoxide metabolic process,BP,
17625,GO:0097177,1,0.984957341225163,0,3,mitochondrial ribosome binding,MF,
17626,GO:0097178,1,0.805209567691375,0,34,ruffle assembly,BP,
17627,GO:0097179,1,0.983687809476258,0,4,protease inhibitor complex,CC,
17628,GO:0097180,1,0.989413185078758,0,2,serine protease inhibitor complex,CC,
17629,GO:0097181,1,0.993920441312131,0,1,protein C inhibitor-coagulation factor V complex,CC,
17630,GO:0097182,1,0.993920441312131,0,1,protein C inhibitor-coagulation factor Xa complex,CC,
17631,GO:0097183,1,0.993920441312131,0,1,protein C inhibitor-coagulation factor XI complex,CC,
17632,GO:0097186,1,0.889117875680582,0,16,amelogenesis,BP,
17633,GO:0097187,1,0.980257086981107,0,3,dentinogenesis,BP,
17637,GO:0097193,1,0.181592496223963,0,269,intrinsic apoptotic signaling pathway,BP,
17638,GO:0097194,1,0.605705915142339,0,77,execution phase of apoptosis,BP,
17639,GO:0097195,1,0.981085139972312,0,3,pilomotor reflex,BP,
17640,GO:0097196,1,0.987870567231822,0,2,Shu complex,CC,
17641,GO:0097197,1,0.954430452387549,0,7,tetraspanin-enriched microdomain,CC,
17642,GO:0097198,1,0.982919881905713,0,2,histone H3-K36 trimethylation,BP,
17643,GO:0097199,1,0.969193144123306,0,6,cysteine-type endopeptidase activity involved in apoptotic signaling pathway,MF,
17644,GO:0097200,1,0.940520486154321,0,11,cysteine-type endopeptidase activity involved in execution phase of apoptosis,MF,
17645,GO:0097201,1,0.924346220815564,0,12,negative regulation of transcription from RNA polymerase II promoter in response to stress,BP,
17646,GO:0097202,1,0.917552502241167,0,13,activation of cysteine-type endopeptidase activity,BP,
17648,GO:0097208,1,0.963700795369796,0,6,alveolar lamellar body,CC,
17649,GO:0097209,1,0.973475036056117,0,4,epidermal lamellar body,CC,
17650,GO:0097210,1,0.967382495231689,0,5,response to gonadotropin-releasing hormone,BP,
17651,GO:0097211,1,0.967382495231689,0,5,cellular response to gonadotropin-releasing hormone,BP,
17652,GO:0097212,1,0.986592904574101,0,3,lysosomal membrane organization,BP,
17653,GO:0097213,1,0.991862733811359,0,2,regulation of lysosomal membrane permeability,BP,
17654,GO:0097214,1,0.997766375234452,0,1,positive regulation of lysosomal membrane permeability,BP,
17655,GO:0097222,1,0.992307720971646,0,1,mitochondrial mRNA polyadenylation,BP,
17657,GO:0097224,1,0.990184167818362,0,2,sperm connecting piece,CC,
17658,GO:0097225,1,0.916585774772707,0,15,sperm midpiece,CC,
17659,GO:0097226,1,0.993981447760105,0,1,sperm mitochondrial sheath,CC,
17660,GO:0097227,1,0.965937117780834,0,5,sperm annulus,CC,
17661,GO:0097228,1,0.889966827392651,0,17,sperm principal piece,CC,
17662,GO:0097229,1,0.996178672883269,0,1,sperm end piece,CC,
17663,GO:0097231,1,0.995305731548576,0,1,cell motility in response to calcium ion,BP,
17664,GO:0097232,1,0.983776814887459,0,2,lamellar body membrane,CC,
17665,GO:0097233,1,0.983776814887459,0,2,alveolar lamellar body membrane,CC,
17667,GO:0097238,1,0.993061157165495,0,2,cellular response to methylglyoxal,BP,
17668,GO:0097240,1,0.966163431541637,0,5,chromosome attachment to the nuclear envelope,BP,
17669,GO:0097241,1,0.987533173313263,0,2,hematopoietic stem cell migration to bone marrow,BP,
17670,GO:0097242,1,0.85855615919747,0,19,amyloid-beta clearance,BP,
17671,GO:0097252,1,0.979550356573978,0,3,oligodendrocyte apoptotic process,BP,
17672,GO:0097254,1,0.994367080541708,0,1,renal tubular secretion,BP,
17673,GO:0097255,1,0.970788523479169,0,6,R2TP complex,CC,
17674,GO:0097258,1,0.992814146848517,0,1,20-hydroxy-leukotriene B4 omega oxidase activity,MF,
17675,GO:0097259,1,0.992814146848517,0,1,20-aldehyde-leukotriene B4 20-monooxygenase activity,MF,
17676,GO:0097260,1,0.993206504305061,0,1,eoxin A4 synthase activity,MF,
17677,GO:0097264,1,0.95774208278706,0,6,self proteolysis,BP,
17678,GO:0097267,1,0.972704279159023,0,4,omega-hydroxylase P450 pathway,BP,
17679,GO:0097272,1,0.987157630553712,0,2,ammonia homeostasis,BP,
17680,GO:0097273,1,0.99166389187976,0,1,creatinine homeostasis,BP,
17681,GO:0097274,1,0.984277001405772,0,2,urea homeostasis,BP,
17682,GO:0097275,1,0.99166389187976,0,1,cellular ammonia homeostasis,BP,
17683,GO:0097276,1,0.99166389187976,0,1,cellular creatinine homeostasis,BP,
17684,GO:0097277,1,0.99166389187976,0,1,cellular urea homeostasis,BP,
17685,GO:0097278,1,0.982865732185816,0,3,complement-dependent cytotoxicity,BP,
17686,GO:0097283,1,0.969618586670594,0,5,keratinocyte apoptotic process,BP,
17687,GO:0097284,1,0.922908216278991,0,12,hepatocyte apoptotic process,BP,
17688,GO:0097286,1,0.917072185568981,0,13,iron ion import,BP,
17689,GO:0097291,1,0.994625913819046,0,1,renal phosphate ion absorption,BP,
17690,GO:0097296,1,0.925139698604788,0,13,activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
17691,GO:0097298,1,0.992482867306063,0,1,regulation of nucleus size,BP,
17692,GO:0097300,1,0.778372910148143,0,41,programmed necrotic cell death,BP,
17693,GO:0097305,1,0.324275194179774,0,171,response to alcohol,BP,
17694,GO:0097306,1,0.673139189936246,0,53,cellular response to alcohol,BP,
17695,GO:0097309,1,0.986164624597214,0,2,cap1 mRNA methylation,BP,
17696,GO:0097310,1,0.993058458973322,0,1,cap2 mRNA methylation,BP,
17698,GO:0097322,1,0.953050376459514,0,7,7SK snRNA binding,MF,
17699,GO:0097323,1,0.990109175268208,0,2,B cell adhesion,BP,
17700,GO:0097324,1,0.981729318699681,0,2,melanocyte migration,BP,
17701,GO:0097325,1,0.984717454050677,0,2,melanocyte proliferation,BP,
17702,GO:0097326,1,0.992019259254054,0,1,melanocyte adhesion,BP,
17704,GO:0097329,1,0.914292715291513,0,12,response to antimetabolite,BP,
17705,GO:0097332,1,0.981935628172133,0,3,response to antipsychotic drug,BP,
17706,GO:0097338,1,0.984921376977696,0,2,response to clozapine,BP,
17707,GO:0097340,1,0.911408211373057,0,13,inhibition of cysteine-type endopeptidase activity,BP,
17708,GO:0097341,1,0.911408211373057,0,13,zymogen inhibition,BP,
17709,GO:0097342,1,0.960791913576685,0,6,ripoptosome,CC,
17710,GO:0097343,1,0.975153633331093,0,3,ripoptosome assembly,BP,
17711,GO:0097344,1,0.988451939984914,0,2,Rix1 complex,CC,
17713,GO:0097346,1,0.870109860153582,0,23,INO80-type complex,CC,
17714,GO:0097350,1,0.967301036383585,0,5,neutrophil clearance,BP,
17715,GO:0097352,1,0.809605103947616,0,33,autophagosome maturation,BP,
17716,GO:0097354,1,0.945704204082036,0,8,prenylation,BP,
17717,GO:0097359,1,0.980901744294669,0,2,UDP-glucosylation,BP,
17718,GO:0097360,1,0.969219309007457,0,4,chorionic trophoblast cell proliferation,BP,
17719,GO:0097361,1,0.976954788531106,0,4,CIA complex,CC,
17720,GO:0097362,1,0.986157065989638,0,2,MCM8-MCM9 complex,CC,
17721,GO:0097363,1,0.984956335179926,0,2,protein O-GlcNAc transferase activity,MF,
17722,GO:0097366,1,0.756123156045434,0,42,response to bronchodilator,BP,
17724,GO:0097368,1,0.972766314329059,0,4,establishment of Sertoli cell barrier,BP,
17725,GO:0097371,1,0.948721785629681,0,7,MDM2/MDM4 family protein binding,MF,
17726,GO:0097372,1,0.995301076185118,0,1,NAD-dependent histone deacetylase activity (H3-K18 specific),MF,
17727,GO:0097374,1,0.99356547104577,0,1,sensory neuron axon guidance,BP,
17728,GO:0097376,1,0.98995866466405,0,2,interneuron axon guidance,BP,
17729,GO:0097377,1,0.993955207019507,0,1,spinal cord interneuron axon guidance,BP,
17730,GO:0097378,1,0.993955207019507,0,1,dorsal spinal cord interneuron axon guidance,BP,
17731,GO:0097380,1,0.993955207019507,0,1,dorsal spinal cord interneuron anterior axon guidance,BP,
17732,GO:0097381,1,0.904571895500918,0,15,photoreceptor disc membrane,CC,
17733,GO:0097382,1,0.991503892523375,0,1,deoxynucleoside-diphosphatase activity,MF,
17734,GO:0097383,1,0.991503892523375,0,1,dIDP diphosphatase activity,MF,
17735,GO:0097384,1,0.95705605385966,0,7,cellular lipid biosynthetic process,BP,
17736,GO:0097386,1,0.895519647296633,0,16,glial cell projection,CC,
17737,GO:0097393,1,0.988529945830477,0,1,telomeric repeat-containing RNA transcription,BP,
17738,GO:0097394,1,0.988529945830477,0,1,telomeric repeat-containing RNA transcription by RNA polymerase II,BP,
17739,GO:0097396,1,0.966846700429024,0,5,response to interleukin-17,BP,
17740,GO:0097398,1,0.966846700429024,0,5,cellular response to interleukin-17,BP,
17741,GO:0097400,1,0.966846700429024,0,5,interleukin-17-mediated signaling pathway,BP,
17743,GO:0097402,1,0.985665194933604,0,2,neuroblast migration,BP,
17744,GO:0097403,1,0.992792243560688,0,1,cellular response to raffinose,BP,
17745,GO:0097409,1,0.994733543956073,0,1,glial cytoplasmic inclusion,CC,
17746,GO:0097411,1,0.964925388726664,0,5,hypoxia-inducible factor-1alpha signaling pathway,BP,
17747,GO:0097413,1,0.959894054656205,0,7,Lewy body,CC,
17748,GO:0097414,1,0.994733543956073,0,1,classical Lewy body,CC,
17749,GO:0097418,1,0.963120018803777,0,5,neurofibrillary tangle,CC,
17751,GO:0097422,1,0.965885390179232,0,5,tubular endosome,CC,
17752,GO:0097425,1,0.971654774943952,0,5,smooth endoplasmic reticulum part,CC,
17753,GO:0097427,1,0.958185742103224,0,6,microtubule bundle,CC,
17754,GO:0097428,1,0.960208572798854,0,10,protein maturation by iron-sulfur cluster transfer,BP,
17755,GO:0097431,1,0.827438419769984,0,25,mitotic spindle pole,CC,
17756,GO:0097433,1,0.968400716513821,0,5,dense body,CC,
17758,GO:0097440,1,0.88722453745161,0,15,apical dendrite,CC,
17759,GO:0097441,1,0.961980755150134,0,5,basal dendrite,CC,
17760,GO:0097442,1,0.975807269525833,0,3,CA3 pyramidal cell dendrite,CC,
17761,GO:0097443,1,0.954915042874367,0,6,sorting endosome,CC,
17762,GO:0097444,1,0.992046016899726,0,1,spine apparatus,CC,
17764,GO:0097449,1,0.935651036740649,0,10,astrocyte projection,CC,
17765,GO:0097450,1,0.976523748709029,0,4,astrocyte end-foot,CC,
17766,GO:0097451,1,0.984985979120119,0,2,glial limiting end-foot,CC,
17767,GO:0097452,1,0.976172835415346,0,4,GAIT complex,CC,
17769,GO:0097454,1,0.977998638225773,0,3,Schwann cell microvillus,CC,
17770,GO:0097457,1,0.972971940752656,0,3,hippocampal mossy fiber,CC,
17772,GO:0097462,1,0.994733543956073,0,1,Lewy neurite,CC,
17773,GO:0097466,1,0.970814248191043,0,4,ubiquitin-dependent glycoprotein ERAD pathway,BP,
17774,GO:0097468,1,0.929826316645885,0,12,programmed cell death in response to reactive oxygen species,BP,
17775,GO:0097470,1,0.959622774274356,0,5,ribbon synapse,CC,
17776,GO:0097472,1,0.799128162403895,0,35,cyclin-dependent protein kinase activity,MF,
17777,GO:0097473,1,0.991969172784861,0,1,retinal rod cell apoptotic process,BP,
17778,GO:0097475,1,0.959169100048182,0,5,motor neuron migration,BP,
17779,GO:0097476,1,0.981719642800532,0,2,spinal cord motor neuron migration,BP,
17780,GO:0097477,1,0.981719642800532,0,2,lateral motor column neuron migration,BP,
17781,GO:0097479,1,0.416402109814043,0,122,synaptic vesicle localization,BP,
17782,GO:0097480,1,0.441010876646444,0,115,establishment of synaptic vesicle localization,BP,
17783,GO:0097484,1,0.81058992562278,0,29,dendrite extension,BP,
17785,GO:0097486,1,0.981102690762375,0,5,multivesicular body lumen,CC,
17788,GO:0097490,1,0.970074425768084,0,4,sympathetic neuron projection extension,BP,
17789,GO:0097491,1,0.970074425768084,0,4,sympathetic neuron projection guidance,BP,
17790,GO:0097493,1,0.856486887993667,0,17,structural molecule activity conferring elasticity,MF,
17791,GO:0097494,1,0.973153740708483,0,4,regulation of vesicle size,BP,
17792,GO:0097497,1,0.992686411033338,0,1,blood vessel endothelial cell delamination,BP,
17793,GO:0097498,1,0.986471609465609,0,2,endothelial tube lumen extension,BP,
17794,GO:0097499,1,0.948647903980573,0,8,protein localization to non-motile cilium,BP,
17795,GO:0097500,1,0.972500367657944,0,4,receptor localization to non-motile cilium,BP,
17796,GO:0097501,1,0.95739701496725,0,13,stress response to metal ion,BP,
17797,GO:0097502,1,0.835221340483529,0,29,mannosylation,BP,
17799,GO:0097504,1,0.927462525126944,0,12,Gemini of coiled bodies,CC,
17800,GO:0097505,1,0.991680141828044,0,1,Rad6-Rad18 complex,CC,
17801,GO:0097506,1,0.974825163249299,0,5,deaminated base DNA N-glycosylase activity,MF,
17802,GO:0097510,1,0.99451408896489,0,1,base-excision repair, AP site formation via deaminated base removal,BP,
17803,GO:0097512,1,0.969400003283172,0,6,cardiac myofibril,CC,
17804,GO:0097513,1,0.972351725518049,0,3,myosin II filament,CC,
17805,GO:0097517,1,0.678985379175786,0,52,contractile actin filament bundle,CC,
17806,GO:0097524,1,0.975992945674333,0,3,sperm plasma membrane,CC,
17807,GO:0097525,1,0.700374920417649,0,61,spliceosomal snRNP complex,CC,
17808,GO:0097526,1,0.863642970192091,0,28,spliceosomal tri-snRNP complex,CC,
17809,GO:0097527,1,0.964562451582092,0,6,necroptotic signaling pathway,BP,
17810,GO:0097529,1,0.438949747046682,0,143,myeloid leukocyte migration,BP,
17811,GO:0097530,1,0.594315530579617,0,94,granulocyte migration,BP,
17812,GO:0097531,1,0.933323114162324,0,11,mast cell migration,BP,
17813,GO:0097532,1,0.988041609965981,0,2,stress response to acid chemical,BP,
17814,GO:0097533,1,0.988041609965981,0,2,cellular stress response to acid chemical,BP,
17815,GO:0097534,1,0.990484143896796,0,1,lymphoid lineage cell migration,BP,
17816,GO:0097535,1,0.990484143896796,0,1,lymphoid lineage cell migration into thymus,BP,
17817,GO:0097536,1,0.994367080541708,0,1,thymus epithelium morphogenesis,BP,
17818,GO:0097539,1,0.922145320309557,0,10,ciliary transition fiber,CC,
17819,GO:0097541,1,0.993058458973322,0,1,axonemal basal plate,CC,
17820,GO:0097542,1,0.744553704290154,0,43,ciliary tip,CC,
17821,GO:0097543,1,0.984906224653779,0,2,ciliary inversin compartment,CC,
17822,GO:0097546,1,0.828939857307758,0,27,ciliary base,CC,
17823,GO:0097550,1,0.966784801191968,0,6,transcriptional preinitiation complex,CC,
17824,GO:0097553,1,0.432623749368658,0,115,calcium ion transmembrane import into cytosol,BP,
17825,GO:0097573,1,0.996112512123046,0,1,glutathione oxidoreductase activity,MF,
17826,GO:0097574,1,0.983622109328001,0,2,lateral part of cell,CC,
17827,GO:0097575,1,0.983622109328001,0,2,lateral cell cortex,CC,
17828,GO:0097576,1,0.985719433303622,0,2,vacuole fusion,BP,
17829,GO:0097577,1,0.988242749287663,0,3,sequestering of iron ion,BP,
17831,GO:0097598,1,0.985005702260134,0,2,sperm cytoplasmic droplet,CC,
17832,GO:0097602,1,0.895955774686321,0,17,cullin family protein binding,MF,
17833,GO:0097603,1,0.987571073990158,0,2,temperature-gated ion channel activity,MF,
17834,GO:0097604,1,0.99508299905701,0,1,temperature-gated cation channel activity,MF,
17835,GO:0097617,1,0.911093046054674,0,13,annealing activity,MF,
17836,GO:0097621,1,0.993950847268195,0,1,monoamine oxidase activity,MF,
17837,GO:0097623,1,0.955235004020701,0,7,potassium ion export across plasma membrane,BP,
17838,GO:0097625,1,0.990564505868844,0,1,low-affinity basic amino acid transmembrane transporter activity,MF,
17839,GO:0097626,1,0.990564505868844,0,1,low-affinity L-arginine transmembrane transporter activity,MF,
17840,GO:0097627,1,0.990564505868844,0,1,high-affinity L-ornithine transmembrane transporter activity,MF,
17841,GO:0097629,1,0.966259971112599,0,5,extrinsic component of omegasome membrane,CC,
17842,GO:0097630,1,0.993058458973322,0,1,intrinsic component of omegasome membrane,CC,
17843,GO:0097631,1,0.993058458973322,0,1,integral component of omegasome membrane,CC,
17844,GO:0097632,1,0.985098401696185,0,2,extrinsic component of phagophore assembly site membrane,CC,
17845,GO:0097635,1,0.984330930604227,0,2,extrinsic component of autophagosome membrane,CC,
17846,GO:0097636,1,0.98539284660035,0,2,intrinsic component of autophagosome membrane,CC,
17847,GO:0097637,1,0.98539284660035,0,2,integral component of autophagosome membrane,CC,
17848,GO:0097638,1,0.969084803055062,0,4,L-arginine import across plasma membrane,BP,
17849,GO:0097639,1,0.984015236194849,0,2,L-lysine import across plasma membrane,BP,
17850,GO:0097640,1,0.990564505868844,0,1,L-ornithine import across plasma membrane,BP,
17851,GO:0097642,1,0.968808102807095,0,6,calcitonin family receptor activity,MF,
17852,GO:0097643,1,0.983209076284829,0,4,amylin receptor activity,MF,
17853,GO:0097644,1,0.979226864938322,0,4,calcitonin family binding,MF,
17854,GO:0097646,1,0.97147436123057,0,6,calcitonin family receptor signaling pathway,BP,
17855,GO:0097647,1,0.979193856985865,0,5,amylin receptor signaling pathway,BP,
17856,GO:0097648,1,0.951270962781246,0,8,G-protein coupled receptor complex,CC,
17857,GO:0097651,1,0.96877518733916,0,4,phosphatidylinositol 3-kinase complex, class I,CC,
17858,GO:0097655,1,0.993058458973322,0,1,serpin family protein binding,MF,
17860,GO:0097676,1,0.972748016396349,0,3,histone H3-K36 dimethylation,BP,
17861,GO:0097677,1,0.964262107061737,0,5,STAT family protein binding,MF,
17862,GO:0097679,1,0.991572723754108,0,2,other organism cytoplasm,CC,
17863,GO:0097680,1,0.978942948198671,0,3,double-strand break repair via classical nonhomologous end joining,BP,
17864,GO:0097681,1,0.977253665317571,0,2,double-strand break repair via alternative nonhomologous end joining,BP,
17865,GO:0097682,1,0.994386807986924,0,1,intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity,MF,
17866,GO:0097688,1,0.948932052196009,0,7,glutamate receptor clustering,BP,
17867,GO:0097689,1,0.992586444087196,0,1,iron channel activity,MF,
17868,GO:0097692,1,0.991364732513997,0,1,histone H3-K4 monomethylation,BP,
17869,GO:0097694,1,0.971828976257442,0,3,establishment of RNA localization to telomere,BP,
17870,GO:0097695,1,0.971828976257442,0,3,establishment of protein-containing complex localization to telomere,BP,
17872,GO:0097698,1,0.995820454003768,0,1,telomere maintenance via base-excision repair,BP,
17873,GO:0097699,1,0.99236079223624,0,1,vascular endothelial cell response to fluid shear stress,BP,
17874,GO:0097707,1,0.99701749609411,0,1,ferroptosis,BP,
17876,GO:0097709,1,0.961093038776757,0,6,connective tissue replacement,BP,
17877,GO:0097711,1,0.508533400208298,0,96,ciliary basal body-plasma membrane docking,BP,
17878,GO:0097712,1,0.993058458973322,0,1,vesicle targeting, trans-Golgi to periciliary membrane compartment,BP,
17880,GO:0097720,1,0.827061010143618,0,26,calcineurin-mediated signaling,BP,
17881,GO:0097722,1,0.679216978094327,0,60,sperm motility,BP,
17882,GO:0097724,1,0.995039300672811,0,1,sperm flagellum movement,BP,
17883,GO:0097726,1,0.996633855202208,0,1,LEM domain binding,MF,
17884,GO:0097729,1,0.681826092018386,0,61,9+2 motile cilium,CC,
17887,GO:0097732,1,0.955911861495517,0,7,9+2 non-motile cilium,CC,
17889,GO:0097734,1,0.893689076535449,0,18,extracellular exosome biogenesis,BP,
17890,GO:0097742,1,0.972308319850449,0,4,de novo centriole assembly,BP,
17891,GO:0097745,1,0.983472217376503,0,3,mitochondrial tRNA 5'-end processing,BP,
17893,GO:0097747,1,0.782696478561579,0,43,RNA polymerase activity,MF,
17894,GO:0097749,1,0.984482827822823,0,2,membrane tubulation,BP,
17895,GO:0097752,1,0.979305177621537,0,3,regulation of DNA stability,BP,
17896,GO:0097753,1,0.985685387529519,0,2,membrane bending,BP,
17899,GO:0098501,1,0.975485370358141,0,5,polynucleotide dephosphorylation,BP,
17900,GO:0098502,1,0.987467089540957,0,3,DNA dephosphorylation,BP,
17901,GO:0098503,1,0.995280108756433,0,1,DNA 3' dephosphorylation,BP,
17902,GO:0098504,1,0.995280108756433,0,1,DNA 3' dephosphorylation involved in DNA repair,BP,
17903,GO:0098505,1,0.935821500212993,0,10,G-rich strand telomeric DNA binding,MF,
17904,GO:0098506,1,0.995280108756433,0,1,polynucleotide 3' dephosphorylation,BP,
17905,GO:0098507,1,0.987867733151982,0,2,polynucleotide 5' dephosphorylation,BP,
17906,GO:0098508,1,0.987768911987559,0,2,endothelial to hematopoietic transition,BP,
17907,GO:0098518,1,0.983204536223084,0,3,polynucleotide phosphatase activity,MF,
17908,GO:0098519,1,0.967786720159858,0,5,nucleotide phosphatase activity, acting on free nucleotides,MF,
17909,GO:0098528,1,0.965897188867486,0,5,skeletal muscle fiber differentiation,BP,
17910,GO:0098530,1,0.991661391349946,0,1,positive regulation of strand invasion,BP,
17913,GO:0098533,1,0.867828300696282,0,21,ATPase dependent transmembrane transport complex,CC,
17914,GO:0098534,1,0.804003460796595,0,31,centriole assembly,BP,
17915,GO:0098535,1,0.972308319850449,0,4,de novo centriole assembly involved in multi-ciliated epithelial cell differentiation,BP,
17916,GO:0098536,1,0.972840512319152,0,4,deuterosome,CC,
17918,GO:0098543,1,0.921233186369713,0,11,detection of other organism,BP,
17919,GO:0098547,1,0.994058754267211,0,1,lumenal side of Golgi membrane,CC,
17922,GO:0098554,1,0.935478136725041,0,13,cytoplasmic side of endoplasmic reticulum membrane,CC,
17923,GO:0098556,1,0.987000484790695,0,5,cytoplasmic side of rough endoplasmic reticulum membrane,CC,
17924,GO:0098559,1,0.980362876615453,0,3,cytoplasmic side of early endosome membrane,CC,
17925,GO:0098560,1,0.986550042029244,0,2,cytoplasmic side of late endosome membrane,CC,
17928,GO:0098573,1,0.671860203752555,0,66,intrinsic component of mitochondrial membrane,CC,
17929,GO:0098574,1,0.968084224312323,0,5,cytoplasmic side of lysosomal membrane,CC,
17930,GO:0098575,1,0.988650414835292,0,2,lumenal side of lysosomal membrane,CC,
17931,GO:0098576,1,0.975475203090992,0,4,lumenal side of membrane,CC,
17932,GO:0098577,1,0.991012416566479,0,1,inactive sex chromosome,CC,
17933,GO:0098581,1,0.89805867657888,0,16,detection of external biotic stimulus,BP,
17934,GO:0098582,1,0.984132026074066,0,2,innate vocalization behavior,BP,
17935,GO:0098583,1,0.996314597249943,0,1,learned vocalization behavior,BP,
17936,GO:0098586,1,0.766750383212214,0,39,cellular response to virus,BP,
17940,GO:0098592,1,0.978006452476873,0,3,cytoplasmic side of apical plasma membrane,CC,
17941,GO:0098594,1,0.99743704668573,0,1,mucin granule,CC,
17942,GO:0098595,1,0.994065431553779,0,1,perivitelline space,CC,
17943,GO:0098596,1,0.935421142762793,0,7,imitative learning,BP,
17944,GO:0098597,1,0.92405984560067,0,8,observational learning,BP,
17945,GO:0098598,1,0.931971437773734,0,8,learned vocalization behavior or vocal learning,BP,
17946,GO:0098599,1,0.940741187013966,0,10,palmitoyl hydrolase activity,MF,
17947,GO:0098601,1,0.992568672128432,0,1,selenomethionine adenosyltransferase activity,MF,
17949,GO:0098619,1,0.994869900053123,0,1,selenocysteine-tRNA ligase activity,MF,
17950,GO:0098621,1,0.991739391090166,0,1,phosphoseryl-selenocysteinyl-tRNA selenium transferase activity,MF,
17951,GO:0098625,1,0.992496339368912,0,1,methylselenol reductase activity,MF,
17952,GO:0098626,1,0.992496339368912,0,1,methylseleninic acid reductase activity,MF,
17953,GO:0098629,1,0.993058458973322,0,1,trans-Golgi network membrane organization,BP,
17956,GO:0098633,1,0.993473592336188,0,1,collagen fibril binding,MF,
17957,GO:0098634,1,0.94883805880061,0,7,cell-matrix adhesion mediator activity,MF,
17958,GO:0098636,1,0.766831955409812,0,35,protein complex involved in cell adhesion,CC,
17959,GO:0098637,1,0.992482413000109,0,1,protein complex involved in cell-matrix adhesion,CC,
17960,GO:0098639,1,0.95985703457137,0,5,collagen binding involved in cell-matrix adhesion,MF,
17961,GO:0098640,1,0.988524865146958,0,2,integrin binding involved in cell-matrix adhesion,MF,
17962,GO:0098641,1,0.897994959732533,0,19,cadherin binding involved in cell-cell adhesion,MF,
17963,GO:0098642,1,0.939130982984898,0,7,network-forming collagen trimer,CC,
17964,GO:0098643,1,0.904953960705545,0,12,banded collagen fibril,CC,
17965,GO:0098644,1,0.840936683498913,0,20,complex of collagen trimers,CC,
17966,GO:0098645,1,0.939130982984898,0,7,collagen network,CC,
17967,GO:0098646,1,0.993305375845177,0,1,collagen sheet,CC,
17968,GO:0098647,1,0.978231657509789,0,3,collagen beaded filament,CC,
17969,GO:0098648,1,0.989567140448524,0,1,collagen anchoring fibril,CC,
17970,GO:0098651,1,0.931562789440335,0,8,basement membrane collagen trimer,CC,
17971,GO:0098652,1,0.989567140448524,0,1,collagen type VII anchoring fibril,CC,
17975,GO:0098659,1,0.707164441853533,0,48,inorganic cation import across plasma membrane,BP,
17979,GO:0098664,1,0.928264986600908,0,13,G-protein coupled serotonin receptor signaling pathway,BP,
17980,GO:0098679,1,0.979596748600962,0,2,regulation of carbohydrate catabolic process by regulation of transcription from RNA polymerase II promoter,BP,
17981,GO:0098680,1,0.992473353745584,0,1,template-free RNA nucleotidyltransferase,MF,
17982,GO:0098687,1,0.118483635901269,0,310,chromosomal region,CC,
17983,GO:0098693,1,0.727307369578575,0,42,regulation of synaptic vesicle cycle,BP,
17984,GO:0098698,1,0.937857267445651,0,7,postsynaptic specialization assembly,BP,
17986,GO:0098703,1,0.909925496053989,0,13,calcium ion import across plasma membrane,BP,
17987,GO:0098704,1,0.993903156509167,0,1,carbohydrate import across plasma membrane,BP,
17988,GO:0098705,1,0.992231324473278,0,1,copper ion import across plasma membrane,BP,
17989,GO:0098706,1,0.968893568752662,0,4,ferric iron import across plasma membrane,BP,
17990,GO:0098711,1,0.956583422303027,0,6,iron ion import across plasma membrane,BP,
17991,GO:0098712,1,0.92027254191381,0,11,L-glutamate import across plasma membrane,BP,
17992,GO:0098713,1,0.994027697980764,0,1,leucine import across plasma membrane,BP,
17993,GO:0098719,1,0.897954390694648,0,14,sodium ion import across plasma membrane,BP,
17994,GO:0098722,1,0.939758175873177,0,9,asymmetric stem cell division,BP,
17995,GO:0098725,1,0.993058458973322,0,1,symmetric cell division,BP,
17996,GO:0098727,1,0.345021436722033,0,149,maintenance of cell number,BP,
17997,GO:0098728,1,0.983086917173549,0,3,germline stem cell asymmetric division,BP,
17998,GO:0098732,1,0.47543340843135,0,106,macromolecule deacylation,BP,
17999,GO:0098734,1,0.940741187013966,0,10,macromolecule depalmitoylation,BP,
18000,GO:0098735,1,0.961069530200707,0,4,positive regulation of the force of heart contraction,BP,
18001,GO:0098736,1,0.989824462282673,0,1,negative regulation of the force of heart contraction,BP,
18002,GO:0098739,1,0.602307701191661,0,69,import across plasma membrane,BP,
18004,GO:0098743,1,0.893212922057207,0,17,cell aggregation,BP,
18005,GO:0098745,1,0.995245096186547,0,1,Dcp1-Dcp2 complex,CC,
18006,GO:0098746,1,0.992213406289889,0,1,fast, calcium ion-dependent exocytosis of neurotransmitter,BP,
18007,GO:0098748,1,0.926032510369323,0,11,endocytic adaptor activity,MF,
18008,GO:0098749,1,0.992299116546858,0,1,cerebellar neuron development,BP,
18011,GO:0098756,1,0.951057052217041,0,7,response to interleukin-21,BP,
18012,GO:0098757,1,0.951057052217041,0,7,cellular response to interleukin-21,BP,
18013,GO:0098758,1,0.979504338664428,0,3,response to interleukin-8,BP,
18014,GO:0098759,1,0.979504338664428,0,3,cellular response to interleukin-8,BP,
18015,GO:0098760,1,0.882221022621458,0,19,response to interleukin-7,BP,
18016,GO:0098761,1,0.882221022621458,0,19,cellular response to interleukin-7,BP,
18017,GO:0098770,1,0.980845957350358,0,2,FBXO family protein binding,MF,
18021,GO:0098779,1,0.944392990301719,0,8,positive regulation of mitophagy in response to mitochondrial depolarization,BP,
18022,GO:0098780,1,0.88678234754395,0,17,response to mitochondrial depolarisation,BP,
18023,GO:0098781,1,0.552594332107259,0,94,ncRNA transcription,BP,
18024,GO:0098782,1,0.99508299905701,0,1,mechanosensitived potassium channel activity,MF,
18025,GO:0098787,1,0.906655595041413,0,14,mRNA cleavage involved in mRNA processing,BP,
18026,GO:0098789,1,0.926069181123127,0,11,pre-mRNA cleavage required for polyadenylation,BP,
18028,GO:0098792,1,0.93136227856381,0,10,xenophagy,BP,
18031,GO:0098795,1,0.985633541813997,0,2,mRNA cleavage involved in gene silencing,BP,
18034,GO:0098798,1,0.381733225177105,0,217,mitochondrial protein complex,CC,
18035,GO:0098799,1,0.937918055400087,0,12,outer mitochondrial membrane protein complex,CC,
18036,GO:0098800,1,0.655343638657631,0,100,inner mitochondrial membrane protein complex,CC,
18039,GO:0098803,1,0.783181475610793,0,69,respiratory chain complex,CC,
18041,GO:0098808,1,0.987829373170214,0,2,mRNA cap binding,MF,
18042,GO:0098809,1,0.993347995930623,0,1,nitrite reductase activity,MF,
18043,GO:0098810,1,0.902962715000571,0,16,neurotransmitter reuptake,BP,
18044,GO:0098813,1,0.148639366135562,0,279,nuclear chromosome segregation,BP,
18045,GO:0098814,1,0.962573590609335,0,5,spontaneous synaptic transmission,BP,
18046,GO:0098815,1,0.749354270626518,0,38,modulation of excitatory postsynaptic potential,BP,
18047,GO:0098816,1,0.994548150917564,0,1,mini excitatory postsynaptic potential,BP,
18048,GO:0098821,1,0.960553438157746,0,5,BMP receptor activity,MF,
18049,GO:0098822,1,0.993626621426091,0,1,peptidyl-cysteine modification to L-cysteine persulfide,BP,
18050,GO:0098826,1,0.974108874700066,0,4,endoplasmic reticulum tubular network membrane,CC,
18052,GO:0098828,1,0.944103524397895,0,7,modulation of inhibitory postsynaptic potential,BP,
18053,GO:0098829,1,0.991219344568354,0,1,intestinal folate absorption,BP,
18054,GO:0098830,1,0.992207656350658,0,1,presynaptic endosome,CC,
18055,GO:0098831,1,0.911940846658568,0,9,presynaptic active zone cytoplasmic component,CC,
18056,GO:0098833,1,0.992145818172317,0,1,presynaptic endocytic zone,CC,
18057,GO:0098835,1,0.992145818172317,0,1,presynaptic endocytic zone membrane,CC,
18058,GO:0098837,1,0.981555921384606,0,3,postsynaptic recycling endosome,CC,
18059,GO:0098838,1,0.992985671165203,0,1,reduced folate transmembrane transport,BP,
18061,GO:0098840,1,0.971216512567399,0,4,protein transport along microtubule,BP,
18062,GO:0098842,1,0.987884842629117,0,2,postsynaptic early endosome,CC,
18063,GO:0098843,1,0.961065038563798,0,6,postsynaptic endocytic zone,CC,
18064,GO:0098844,1,0.975857846284119,0,3,postsynaptic endocytic zone membrane,CC,
18065,GO:0098845,1,0.962328068698928,0,6,postsynaptic endosome,CC,
18066,GO:0098847,1,0.918247407957901,0,13,sequence-specific single stranded DNA binding,MF,
18067,GO:0098850,1,0.99476079763154,0,1,extrinsic component of synaptic vesicle membrane,CC,
18069,GO:0098855,1,0.975447214604398,0,3,HCN channel complex,CC,
18070,GO:0098856,1,0.95227040394571,0,8,intestinal lipid absorption,BP,
18075,GO:0098869,1,0.648171049827474,0,82,cellular oxidant detoxification,BP,
18076,GO:0098870,1,0.959958989728232,0,6,action potential propagation,BP,
18077,GO:0098871,1,0.995356843606931,0,1,postsynaptic actin cytoskeleton,CC,
18078,GO:0098875,1,0.99224788121708,0,1,epididymosome,CC,
18079,GO:0098876,1,0.620051982275446,0,68,vesicle-mediated transport to the plasma membrane,BP,
18080,GO:0098877,1,0.933866989369954,0,10,neurotransmitter receptor transport to plasma membrane,BP,
18082,GO:0098881,1,0.973759028680515,0,4,exocytic insertion of neurotransmitter receptor to plasma membrane,BP,
18083,GO:0098883,1,0.995101869933184,0,1,synapse disassembly,BP,
18084,GO:0098884,1,0.975857846284119,0,3,postsynaptic neurotransmitter receptor internalization,BP,
18085,GO:0098885,1,0.990773028720735,0,1,modification of postsynaptic actin cytoskeleton,BP,
18086,GO:0098886,1,0.985159141152913,0,2,modification of dendritic spine,BP,
18087,GO:0098887,1,0.971802272622349,0,4,neurotransmitter receptor transport, endosome to postsynaptic membrane,BP,
18088,GO:0098888,1,0.990747156029711,0,1,extrinsic component of presynaptic membrane,CC,
18089,GO:0098889,1,0.97183038110343,0,4,intrinsic component of presynaptic membrane,CC,
18090,GO:0098890,1,0.990747156029711,0,1,extrinsic component of postsynaptic membrane,CC,
18091,GO:0098895,1,0.992438915237959,0,1,postsynaptic endosome membrane,CC,
18094,GO:0098902,1,0.970279861186788,0,4,regulation of membrane depolarization during action potential,BP,
18095,GO:0098903,1,0.940192027672543,0,8,regulation of membrane repolarization during action potential,BP,
18096,GO:0098904,1,0.979555533742056,0,2,regulation of AV node cell action potential,BP,
18097,GO:0098905,1,0.997252166295856,0,1,regulation of bundle of His cell action potential,BP,
18098,GO:0098907,1,0.976249264734766,0,2,regulation of SA node cell action potential,BP,
18099,GO:0098908,1,0.973927123551645,0,4,regulation of neuronal action potential,BP,
18100,GO:0098909,1,0.947000067102192,0,7,regulation of cardiac muscle cell action potential involved in regulation of contraction,BP,
18101,GO:0098910,1,0.95197263324297,0,5,regulation of atrial cardiac muscle cell action potential,BP,
18103,GO:0098912,1,0.970021008811154,0,3,membrane depolarization during atrial cardiac muscle cell action potential,BP,
18104,GO:0098914,1,0.956941116318391,0,6,membrane repolarization during atrial cardiac muscle cell action potential,BP,
18105,GO:0098915,1,0.920851830386025,0,12,membrane repolarization during ventricular cardiac muscle cell action potential,BP,
18107,GO:0098917,1,0.95067966999436,0,7,retrograde trans-synaptic signaling,BP,
18108,GO:0098918,1,0.995087718336798,0,1,structural constituent of synapse,MF,
18109,GO:0098920,1,0.984869786179943,0,2,retrograde trans-synaptic signaling by lipid,BP,
18110,GO:0098921,1,0.984869786179943,0,2,retrograde trans-synaptic signaling by endocannabinoid,BP,
18111,GO:0098923,1,0.990816418088595,0,1,retrograde trans-synaptic signaling by soluble gas,BP,
18112,GO:0098924,1,0.990816418088595,0,1,retrograde trans-synaptic signaling by nitric oxide,BP,
18113,GO:0098926,1,0.990931325152421,0,1,postsynaptic signal transduction,BP,
18114,GO:0098927,1,0.752657717721941,0,40,vesicle-mediated transport between endosomal compartments,BP,
18115,GO:0098928,1,0.971190706240784,0,2,presynaptic signal transduction,BP,
18116,GO:0098930,1,0.730152153535928,0,45,axonal transport,BP,
18117,GO:0098935,1,0.959355237790799,0,5,dendritic transport,BP,
18118,GO:0098936,1,0.921540586314607,0,10,intrinsic component of postsynaptic membrane,CC,
18119,GO:0098937,1,0.959355237790799,0,5,anterograde dendritic transport,BP,
18120,GO:0098939,1,0.991189273517624,0,1,dendritic transport of mitochondrion,BP,
18121,GO:0098942,1,0.992161676171263,0,1,retrograde trans-synaptic signaling by trans-synaptic protein complex,BP,
18123,GO:0098945,1,0.992388814474749,0,1,intrinsic component of presynaptic active zone membrane,CC,
18124,GO:0098948,1,0.963098711198777,0,4,intrinsic component of postsynaptic specialization membrane,CC,
18126,GO:0098957,1,0.971501752736538,0,4,anterograde axonal transport of mitochondrion,BP,
18128,GO:0098961,1,0.99093617632344,0,1,dendritic transport of ribonucleoprotein complex,BP,
18129,GO:0098963,1,0.99093617632344,0,1,dendritic transport of messenger ribonucleoprotein complex,BP,
18130,GO:0098964,1,0.99093617632344,0,1,anterograde dendritic transport of messenger ribonucleoprotein complex,BP,
18131,GO:0098967,1,0.973759028680515,0,4,exocytic insertion of neurotransmitter receptor to postsynaptic membrane,BP,
18132,GO:0098968,1,0.992003285188543,0,1,neurotransmitter receptor transport postsynaptic membrane to endosome,BP,
18133,GO:0098969,1,0.940822401587091,0,9,neurotransmitter receptor transport to postsynaptic membrane,BP,
18135,GO:0098971,1,0.967885782388074,0,4,anterograde dendritic transport of neurotransmitter receptor complex,BP,
18136,GO:0098972,1,0.991189273517624,0,1,anterograde dendritic transport of mitochondrion,BP,
18137,GO:0098973,1,0.995087718336798,0,1,structural constituent of postsynaptic actin cytoskeleton,MF,
18138,GO:0098974,1,0.995087718336798,0,1,postsynaptic actin cytoskeleton organization,BP,
18139,GO:0098976,1,0.935570791825268,0,8,excitatory chemical synaptic transmission,BP,
18140,GO:0098978,1,0.951543883789273,0,6,glutamatergic synapse,CC,
18141,GO:0098982,1,0.961841729629526,0,5,GABA-ergic synapse,CC,
18142,GO:0098983,1,0.968849766620872,0,4,symmetric, GABA-ergic, inhibitory synapse,CC,
18144,GO:0098985,1,0.951543883789273,0,6,asymmetric, glutamatergic, excitatory synapse,CC,
18145,GO:0098988,1,0.952635644478356,0,6,G-protein coupled glutamate receptor activity,MF,
18146,GO:0098989,1,0.986597072121429,0,2,NMDA selective glutamate receptor signaling pathway,BP,
18147,GO:0098992,1,0.993592917496461,0,1,neuronal dense core vesicle,CC,
18148,GO:0098993,1,0.951254372825287,0,9,anchored component of synaptic vesicle membrane,CC,
18149,GO:0098999,1,0.992438915237959,0,1,extrinsic component of postsynaptic endosome membrane,CC,
18151,GO:0099004,1,0.971611291989256,0,4,calmodulin dependent kinase signaling pathway,BP,
18152,GO:0099010,1,0.97606775487517,0,3,modification of postsynaptic structure,BP,
18153,GO:0099011,1,0.955889326422782,0,5,neuronal dense core vesicle exocytosis,BP,
18154,GO:0099022,1,0.988537912160147,0,2,vesicle tethering,BP,
18155,GO:0099023,1,0.615286492024567,0,69,tethering complex,CC,
18156,GO:0099024,1,0.711561344688273,0,53,plasma membrane invagination,BP,
18157,GO:0099038,1,0.992173775597837,0,1,ceramide-translocating ATPase activity,MF,
18158,GO:0099039,1,0.983509348020811,0,2,sphingolipid translocation,BP,
18159,GO:0099040,1,0.992173775597837,0,1,ceramide translocation,BP,
18160,GO:0099044,1,0.988537912160147,0,2,vesicle tethering to endoplasmic reticulum,BP,
18161,GO:0099046,1,0.99592584516889,0,1,clearance of foreign intracellular nucleic acids,BP,
18162,GO:0099050,1,0.993137858599587,0,1,vesicle scission,BP,
18163,GO:0099053,1,0.979542230234526,0,3,activating signal cointegrator 1 complex,CC,
18164,GO:0099054,1,0.868491770172989,0,18,presynapse assembly,BP,
18165,GO:0099055,1,0.921540586314607,0,10,integral component of postsynaptic membrane,CC,
18166,GO:0099056,1,0.97183038110343,0,4,integral component of presynaptic membrane,CC,
18167,GO:0099059,1,0.992388814474749,0,1,integral component of presynaptic active zone membrane,CC,
18168,GO:0099060,1,0.963098711198777,0,4,integral component of postsynaptic specialization membrane,CC,
18169,GO:0099061,1,0.970487472647785,0,3,integral component of postsynaptic density membrane,CC,
18170,GO:0099068,1,0.867764044524024,0,17,postsynapse assembly,BP,
18172,GO:0099073,1,0.984996790205355,0,2,mitochondrion-derived vesicle,CC,
18173,GO:0099074,1,0.985906565712686,0,2,mitochondrion to lysosome transport,BP,
18174,GO:0099075,1,0.985906565712686,0,2,mitochondrion-derived vesicle mediated transport,BP,
18175,GO:0099077,1,0.991666079756139,0,1,histone-dependent DNA binding,MF,
18176,GO:0099078,1,0.982428788340537,0,4,BORC complex,CC,
18179,GO:0099082,1,0.981937296712019,0,3,retrograde trans-synaptic signaling by neuropeptide,BP,
18180,GO:0099083,1,0.989398377318869,0,2,retrograde trans-synaptic signaling by neuropeptide, modulating synaptic transmission,BP,
18181,GO:0099084,1,0.881075707581506,0,15,postsynaptic specialization organization,BP,
18182,GO:0099086,1,0.819169720107828,0,31,synaptonemal structure,CC,
18183,GO:0099089,1,0.987963114460795,0,1,establishment of endoplasmic reticulum localization to postsynapse,BP,
18184,GO:0099093,1,0.984965418366895,0,2,calcium export from the mitochondrion,BP,
18187,GO:0099098,1,0.992645206224271,0,1,microtubule polymerization based movement,BP,
18188,GO:0099103,1,0.978235111150623,0,4,channel activator activity,MF,
18189,GO:0099104,1,0.978235111150623,0,4,potassium channel activator activity,MF,
18190,GO:0099106,1,0.571479399280466,0,86,ion channel regulator activity,MF,
18191,GO:0099111,1,0.37776687511785,0,137,microtubule-based transport,BP,
18192,GO:0099116,1,0.920690986695838,0,16,tRNA 5'-end processing,BP,
18193,GO:0099118,1,0.971216512567399,0,4,microtubule-based protein transport,BP,
18194,GO:0099122,1,0.977561120645235,0,3,RNA polymerase II C-terminal domain binding,MF,
18195,GO:0099130,1,0.994116876213623,0,1,estrogen binding,MF,
18196,GO:0099131,1,0.842912986131495,0,28,ATP hydrolysis coupled ion transmembrane transport,BP,
18197,GO:0099132,1,0.727494925001749,0,45,ATP hydrolysis coupled cation transmembrane transport,BP,
18198,GO:0099133,1,0.909621319236281,0,12,ATP hydrolysis coupled anion transmembrane transport,BP,
18199,GO:0099142,1,0.991427235493867,0,1,intracellularly ATP-gated ion channel activity,MF,
18200,GO:0099146,1,0.970487472647785,0,3,intrinsic component of postsynaptic density membrane,CC,
18201,GO:0099159,1,0.990773028720735,0,1,regulation of modification of postsynaptic structure,BP,
18202,GO:0099163,1,0.990816418088595,0,1,synaptic signaling by nitric oxide,BP,
18203,GO:0099170,1,0.978437172068578,0,3,postsynaptic modulation of chemical synaptic transmission,BP,
18204,GO:0099172,1,0.858091265291566,0,20,presynapse organization,BP,
18205,GO:0099173,1,0.488816639707944,0,95,postsynapse organization,BP,
18206,GO:0099174,1,0.962496253625687,0,5,regulation of presynapse organization,BP,
18207,GO:0099175,1,0.676654839102868,0,52,regulation of postsynapse organization,BP,
18209,GO:0099186,1,0.995087718336798,0,1,structural constituent of postsynapse,MF,
18210,GO:0099188,1,0.995087718336798,0,1,postsynaptic cytoskeleton organization,BP,
18211,GO:0099240,1,0.921540586314607,0,10,intrinsic component of synaptic membrane,CC,
18212,GO:0099243,1,0.990747156029711,0,1,extrinsic component of synaptic membrane,CC,
18213,GO:0099400,1,0.989575106505612,0,1,caveola neck,CC,
18214,GO:0099402,1,0.997356194534619,0,1,plant organ development,BP,
18215,GO:0099403,1,0.978026362525039,0,2,maintenance of mitotic sister chromatid cohesion, telomeric,BP,
18216,GO:0099404,1,0.978026362525039,0,2,mitotic sister chromatid cohesion, telomeric,BP,
18217,GO:0099500,1,0.906749728885585,0,16,vesicle fusion to plasma membrane,BP,
18221,GO:0099509,1,0.985348914042087,0,3,regulation of presynaptic cytosolic calcium ion concentration,BP,
18224,GO:0099514,1,0.900959799871975,0,17,synaptic vesicle cytoskeletal transport,BP,
18225,GO:0099515,1,0.918615253116941,0,10,actin filament-based transport,BP,
18226,GO:0099516,1,0.66507421274523,0,56,ion antiporter activity,MF,
18227,GO:0099517,1,0.900959799871975,0,17,synaptic vesicle transport along microtubule,BP,
18228,GO:0099518,1,0.711331743574295,0,46,vesicle cytoskeletal trafficking,BP,
18229,GO:0099519,1,0.993058458973322,0,1,dense core granule cytoskeletal transport,BP,
18230,GO:0099522,1,0.994555207012681,0,1,region of cytosol,CC,
18231,GO:0099523,1,0.994555207012681,0,1,presynaptic cytosol,CC,
18232,GO:0099524,1,0.994555207012681,0,1,postsynaptic cytosol,CC,
18233,GO:0099525,1,0.955889326422782,0,5,presynaptic dense core vesicle exocytosis,BP,
18234,GO:0099526,1,0.971190706240784,0,2,presynapse to nucleus signaling pathway,BP,
18235,GO:0099527,1,0.990931325152421,0,1,postsynapse to nucleus signaling pathway,BP,
18236,GO:0099528,1,0.84907033439588,0,26,G-protein coupled neurotransmitter receptor activity,MF,
18238,GO:0099530,1,0.981425368274374,0,2,G-protein coupled receptor activity involved in regulation of postsynaptic membrane potential,MF,
18240,GO:0099532,1,0.982576785559694,0,2,synaptic vesicle endosomal processing,BP,
18243,GO:0099538,1,0.972936332925157,0,4,synaptic signaling via neuropeptide,BP,
18244,GO:0099540,1,0.972936332925157,0,4,trans-synaptic signaling by neuropeptide,BP,
18245,GO:0099541,1,0.959967036360245,0,5,trans-synaptic signaling by lipid,BP,
18246,GO:0099542,1,0.959967036360245,0,5,trans-synaptic signaling by endocannabinoid,BP,
18247,GO:0099543,1,0.990816418088595,0,1,trans-synaptic signaling by soluble gas,BP,
18248,GO:0099545,1,0.984405334485288,0,2,trans-synaptic signaling by trans-synaptic complex,BP,
18249,GO:0099547,1,0.978437172068578,0,3,regulation of translation at synapse, modulating synaptic transmission,BP,
18250,GO:0099548,1,0.990816418088595,0,1,trans-synaptic signaling by nitric oxide,BP,
18251,GO:0099550,1,0.948067771244859,0,7,trans-synaptic signaling, modulating synaptic transmission,BP,
18252,GO:0099551,1,0.980329703685175,0,3,trans-synaptic signaling by neuropeptide, modulating synaptic transmission,BP,
18253,GO:0099552,1,0.974718479205655,0,3,trans-synaptic signaling by lipid, modulating synaptic transmission,BP,
18254,GO:0099553,1,0.974718479205655,0,3,trans-synaptic signaling by endocannabinoid, modulating synaptic transmission,BP,
18255,GO:0099557,1,0.992182993390367,0,1,trans-synaptic signaling by trans-synaptic complex, modulating synaptic transmission,BP,
18256,GO:0099558,1,0.99162457477163,0,2,maintenance of synapse structure,BP,
18257,GO:0099560,1,0.974633441607425,0,3,synaptic membrane adhesion,BP,
18258,GO:0099563,1,0.921850308801248,0,11,modification of synaptic structure,BP,
18260,GO:0099566,1,0.973261592770713,0,3,regulation of postsynaptic cytosolic calcium ion concentration,BP,
18262,GO:0099569,1,0.932174509784298,0,7,presynaptic cytoskeleton,CC,
18263,GO:0099571,1,0.995356843606931,0,1,postsynaptic cytoskeleton,CC,
18265,GO:0099578,1,0.978437172068578,0,3,regulation of translation at postsynapse, modulating synaptic transmission,BP,
18266,GO:0099580,1,0.983543108171029,0,2,ion antiporter activity involved in regulation of postsynaptic membrane potential,MF,
18267,GO:0099583,1,0.973261592770713,0,3,neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration,MF,
18268,GO:0099587,1,0.707164441853533,0,48,inorganic ion import across plasma membrane,BP,
18269,GO:0099589,1,0.928264986600908,0,13,serotonin receptor activity,MF,
18272,GO:0099602,1,0.963608113537256,0,7,neurotransmitter receptor regulator activity,MF,
18273,GO:0099604,1,0.791584260249994,0,27,ligand-gated calcium channel activity,MF,
18274,GO:0099606,1,0.989926381970271,0,1,microtubule plus-end directed mitotic chromosome migration,BP,
18275,GO:0099607,1,0.989926381970271,0,1,lateral attachment of mitotic spindle microtubules to kinetochore,BP,
18276,GO:0099609,1,0.983313878591955,0,2,microtubule lateral binding,MF,
18278,GO:0099617,1,0.992572606069046,0,1,matrix side of mitochondrial inner membrane,CC,
18281,GO:0099624,1,0.929217221201226,0,10,atrial cardiac muscle cell membrane repolarization,BP,
18284,GO:0099631,1,0.993119257349566,0,2,postsynaptic endocytic zone cytoplasmic component,CC,
18288,GO:0099638,1,0.964620146968977,0,5,endosome to plasma membrane protein transport,BP,
18289,GO:0099639,1,0.964620146968977,0,5,neurotransmitter receptor transport, endosome to plasma membrane,BP,
18290,GO:0099640,1,0.988076238963225,0,2,axo-dendritic protein transport,BP,
18291,GO:0099641,1,0.9971141667904,0,1,anterograde axonal protein transport,BP,
18293,GO:0099699,1,0.921540586314607,0,10,integral component of synaptic membrane,CC,
18294,GO:0099738,1,0.771322038751396,0,34,cell cortex region,CC,
18295,GO:0100001,1,0.991904122528462,0,1,regulation of skeletal muscle contraction by action potential,BP,
18296,GO:0100002,1,0.992953371278489,0,1,negative regulation of protein kinase activity by protein phosphorylation,BP,
18297,GO:0100012,1,0.991673939615846,0,2,regulation of heart induction by canonical Wnt signaling pathway,BP,
18298,GO:0100057,1,0.990532027818856,0,1,regulation of phenotypic switching by transcription from RNA polymerase II promoter,BP,
18299,GO:0101002,1,0.33720336507292,0,178,ficolin-1-rich granule,CC,
18300,GO:0101003,1,0.691427971017645,0,55,ficolin-1-rich granule membrane,CC,
18301,GO:0101005,1,0.514775752240742,0,88,ubiquitinyl hydrolase activity,MF,
18302,GO:0101006,1,0.984949604768676,0,3,protein histidine phosphatase activity,MF,
18303,GO:0101020,1,0.9835434621117,0,3,estrogen 16-alpha-hydroxylase activity,MF,
18304,GO:0101023,1,0.903415373453163,0,14,vascular endothelial cell proliferation,BP,
18305,GO:0101030,1,0.996161055383937,0,1,tRNA-guanine transglycosylation,BP,
18306,GO:0101031,1,0.928024482828307,0,12,chaperone complex,CC,
18307,GO:0102005,1,0.99577764952693,0,1,2-octaprenyl-6-methoxy-1,4-benzoquinone methylase activity,MF,
18308,GO:0102007,1,0.98723225065118,0,3,acyl-L-homoserine-lactone lactonohydrolase activity,MF,
18309,GO:0102008,1,0.992112829312494,0,1,cytosolic dipeptidase activity,MF,
18310,GO:0102009,1,0.994884132722821,0,1,proline dipeptidase activity,MF,
18311,GO:0102076,1,0.992961914196941,0,1,beta,beta-carotene-9',10'-cleaving oxygenase activity,MF,
18312,GO:0102077,1,0.989016742803312,0,2,oleamide hydrolase activity,MF,
18313,GO:0102084,1,0.986819882785499,0,2,L-dopa O-methyltransferase activity,MF,
18314,GO:0102092,1,0.983759943843758,0,2,5-diphosphoinositol pentakisphosphate 3-kinase activity,MF,
18315,GO:0102102,1,0.992479488058318,0,1,homocarnosine synthase activity,MF,
18316,GO:0102113,1,0.990959233724992,0,1,hypoxia-inducible factor-asparagine oxygenase activity,MF,
18317,GO:0102121,1,0.980302889692707,0,3,ceramidase activity,MF,
18318,GO:0102131,1,0.990019785722482,0,1,3-oxo-glutaryl-[acp] methyl ester reductase activity,MF,
18319,GO:0102132,1,0.990019785722482,0,1,3-oxo-pimeloyl-[acp] methyl ester reductase activity,MF,
18320,GO:0102148,1,0.98270511382752,0,3,N-acetyl-beta-D-galactosaminidase activity,MF,
18321,GO:0102158,1,0.972518779653678,0,4,very-long-chain 3-hydroxyacyl-CoA dehydratase activity,MF,
18322,GO:0102166,1,0.992047970804738,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-threonine O-N-acetyl-alpha-D-glucosaminase activity,MF,
18323,GO:0102167,1,0.992047970804738,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine O-N-acetyl-alpha-D-glucosaminase activity,MF,
18324,GO:0102200,1,0.992002712041438,0,1,N-acetylphosphatidylethanolamine-hydrolysing phospholipas activity,MF,
18325,GO:0102250,1,0.978177874817495,0,3,linear malto-oligosaccharide phosphorylase activity,MF,
18326,GO:0102279,1,0.992178770105001,0,1,lecithin:11-cis retinol acyltransferase activity,MF,
18327,GO:0102336,1,0.959687244086777,0,6,3-oxo-arachidoyl-CoA synthase activity,MF,
18328,GO:0102337,1,0.959687244086777,0,6,3-oxo-cerotoyl-CoA synthase activity,MF,
18329,GO:0102338,1,0.959687244086777,0,6,3-oxo-lignoceronyl-CoA synthase activity,MF,
18330,GO:0102339,1,0.993456763770416,0,1,3-oxo-arachidoyl-CoA reductase activity,MF,
18331,GO:0102340,1,0.993456763770416,0,1,3-oxo-behenoyl-CoA reductase activity,MF,
18332,GO:0102341,1,0.993456763770416,0,1,3-oxo-lignoceroyl-CoA reductase activity,MF,
18333,GO:0102342,1,0.993456763770416,0,1,3-oxo-cerotoyl-CoA reductase activity,MF,
18334,GO:0102343,1,0.972518779653678,0,4,3-hydroxy-arachidoyl-CoA dehydratase activity,MF,
18335,GO:0102344,1,0.972518779653678,0,4,3-hydroxy-behenoyl-CoA dehydratase activity,MF,
18336,GO:0102345,1,0.972518779653678,0,4,3-hydroxy-lignoceroyl-CoA dehydratase activity,MF,
18337,GO:0102389,1,0.993248879662176,0,1,polyprenol reductase activity,MF,
18338,GO:0102390,1,0.99327897546493,0,1,mycophenolic acid acyl-glucuronide esterase activity,MF,
18339,GO:0102391,1,0.950240659286933,0,7,decanoate-CoA ligase activity,MF,
18340,GO:0102420,1,0.984325800892163,0,2,sn-1-glycerol-3-phosphate C16:0-DCA-CoA acyl transferase activity,MF,
18341,GO:0102483,1,0.995378860140206,0,1,scopolin beta-glucosidase activity,MF,
18342,GO:0102485,1,0.975241803426312,0,3,dATP phosphohydrolase activity,MF,
18343,GO:0102486,1,0.975241803426312,0,3,dCTP phosphohydrolase activity,MF,
18344,GO:0102487,1,0.975241803426312,0,3,dUTP phosphohydrolase activity,MF,
18345,GO:0102488,1,0.975241803426312,0,3,dTTP phosphohydrolase activity,MF,
18346,GO:0102489,1,0.975241803426312,0,3,GTP phosphohydrolase activity,MF,
18347,GO:0102490,1,0.975241803426312,0,3,8-oxo-dGTP phosphohydrolase activity,MF,
18348,GO:0102491,1,0.975241803426312,0,3,dGTP phosphohydrolase activity,MF,
18349,GO:0102499,1,0.978177874817495,0,3,SHG alpha-glucan phosphorylase activity,MF,
18350,GO:0102500,1,0.990780254397619,0,1,beta-maltose 4-alpha-glucanotransferase activity,MF,
18351,GO:0102521,1,0.992593005126943,0,1,tRNA-4-demethylwyosine synthase activity,MF,
18352,GO:0102522,1,0.994141631997223,0,1,tRNA 4-demethylwyosine alpha-amino-alpha-carboxypropyltransferase activity,MF,
18353,GO:0102524,1,0.993058458973322,0,1,tRNAPhe (7-(3-amino-3-carboxypropyl)wyosine37-C2)-hydroxylase activity,MF,
18354,GO:0102555,1,0.996983772724596,0,1,octanoyl transferase activity (acting on glycine-cleavage complex H protein),MF,
18355,GO:0102567,1,0.91001173770366,0,15,phospholipase A2 activity (consuming 1,2-dipalmitoylphosphatidylcholine),MF,
18356,GO:0102568,1,0.91001173770366,0,15,phospholipase A2 activity consuming 1,2-dioleoylphosphatidylethanolamine),MF,
18357,GO:0102571,1,0.992047970804738,0,1,[protein]-3-O-(N-acetyl-D-glucosaminyl)-L-serine/L-threonine O-N-acetyl-alpha-D-glucosaminase activity,MF,
18358,GO:0102704,1,0.992905549610952,0,1,GDP-Man:Man2GlcNAc2-PP-dolichol alpha-1,6-mannosyltransferase activity,MF,
18359,GO:0102707,1,0.993429006919672,0,1,S-adenosyl-L-methionine:beta-alanine N-methyltransferase activity,MF,
18360,GO:0102751,1,0.987715276302503,0,2,UDP-alpha-D-glucose:glucosyl-glycogenin alpha-D-glucosyltransferase activity,MF,
18361,GO:0102752,1,0.992718951160495,0,1,1,4-alpha-glucan branching enzyme activity (using a glucosylated glycogenin as primer for glycogen synthesis),MF,
18362,GO:0102756,1,0.959687244086777,0,6,very-long-chain 3-ketoacyl-CoA synthase activity,MF,
18363,GO:0102758,1,0.996527331758697,0,1,very-long-chain enoyl-CoA reductase activity,MF,
18364,GO:0102769,1,0.995497649255634,0,1,dihydroceramide glucosyltransferase activity,MF,
18365,GO:0102773,1,0.992364284201856,0,1,dihydroceramide kinase activity,MF,
18366,GO:0102797,1,0.992140648859012,0,1,geranial:oxygen oxidoreductase activity,MF,
18367,GO:0102798,1,0.992140648859012,0,1,heptaldehyde:oxygen oxidoreductase activity,MF,
18368,GO:0102867,1,0.993128806149118,0,1,molybdenum cofactor sulfurtransferase activity,MF,
18369,GO:0102938,1,0.986819882785499,0,2,orcinol O-methyltransferase activity,MF,
18370,GO:0102953,1,0.98073557383568,0,3,hypoglycin A gamma-glutamyl transpeptidase activity,MF,
18371,GO:0102965,1,0.986406915242731,0,2,alcohol-forming fatty acyl-CoA reductase activity,MF,
18372,GO:0102991,1,0.969122540323778,0,6,myristoyl-CoA hydrolase activity,MF,
18373,GO:0103025,1,0.989737658285596,0,2,alpha-amylase activity (releasing maltohexaose),MF,
18374,GO:0103045,1,0.994463725794407,0,1,methione N-acyltransferase activity,MF,
18375,GO:0103046,1,0.992112829312494,0,1,alanylglutamate dipeptidase activity,MF,
18376,GO:0103053,1,0.990407178796978,0,2,1-ethyladenine demethylase activity,MF,
18377,GO:0103066,1,0.99557327560826,0,1,4alpha-carboxy-4beta-methyl-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-oxidoreductase (decarboxylating) activity,MF,
18378,GO:0103067,1,0.99557327560826,0,1,4alpha-carboxy-5alpha-cholesta-8-en-3beta-ol:NAD(P)+ 3-dehydrogenase (decarboxylating) activity,MF,
18379,GO:0103068,1,0.98073557383568,0,3,leukotriene C4 gamma-glutamyl transferase activity,MF,
18380,GO:0103073,1,0.989016742803312,0,2,anandamide amidohydrolase activity,MF,
18383,GO:0106001,1,0.957687041049021,0,6,intestinal hexose absorption,BP,
18384,GO:0106003,1,0.920235798473397,0,11,amyloid-beta complex,CC,
18385,GO:0106004,1,0.99149484035628,0,2,tRNA (guanine-N7)-methylation,BP,
18386,GO:0106005,1,0.991390703303505,0,1,RNA 5'-cap (guanine-N7)-methylation,BP,
18387,GO:0106014,1,0.989020866175939,0,2,regulation of inflammatory response to wounding,BP,
18388,GO:0106015,1,0.989020866175939,0,2,negative regulation of inflammatory response to wounding,BP,
18389,GO:0106017,1,0.970695868962481,0,4,phosphatidylinositol-3,4-bisphosphate phosphatase activity,MF,
18390,GO:0106018,1,0.885690146530023,0,15,phosphatidylinositol-3,5-bisphosphate phosphatase activity,MF,
18391,GO:0106019,1,0.925136256074393,0,10,phosphatidylinositol-4,5-bisphosphate phosphatase activity,MF,
18392,GO:0106020,1,0.98656937363748,0,2,regulation of vesicle docking,BP,
18393,GO:0106022,1,0.992484044239524,0,1,positive regulation of vesicle docking,BP,
18394,GO:0106027,1,0.588829876053373,0,69,neuron projection organization,BP,
18395,GO:0106028,1,0.992182993390367,0,1,neuron projection retraction,BP,
18397,GO:0106044,1,0.997032233810024,0,1,guanine deglycation,BP,
18398,GO:0106045,1,0.997032233810024,0,1,guanine deglycation, methylglyoxal removal,BP,
18399,GO:0106046,1,0.997032233810024,0,1,guanine deglycation, glyoxal removal,BP,
18400,GO:0106049,1,0.963702607901132,0,6,regulation of cellular response to osmotic stress,BP,
18401,GO:0106050,1,0.994732359360662,0,1,tRNA 2'-O-methyltransferase activity,MF,
18402,GO:0106056,1,0.887890042711348,0,16,regulation of calcineurin-mediated signaling,BP,
18403,GO:0106057,1,0.976205051046001,0,3,negative regulation of calcineurin-mediated signaling,BP,
18404,GO:0106058,1,0.938671856503309,0,9,positive regulation of calcineurin-mediated signaling,BP,
18405,GO:0106064,1,0.991662641627008,0,1,regulation of cobalamin metabolic process,BP,
18406,GO:0106068,1,0.969067842853532,0,6,SUMO ligase complex,CC,
18407,GO:0106070,1,0.931948579264355,0,10,regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
18408,GO:0106071,1,0.966742355390518,0,5,positive regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
18409,GO:0106072,1,0.955779442400126,0,7,negative regulation of adenylate cyclase-activating G-protein coupled receptor signaling pathway,BP,
18410,GO:0106073,1,0.981911381015002,0,2,dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity,MF,
18411,GO:0106074,1,0.927298315891607,0,11,aminoacyl-tRNA metabolism involved in translational fidelity,BP,
18412,GO:0106075,1,0.992708271854673,0,1,peptide N-succinyltransferase activity,MF,
18413,GO:0106077,1,0.970931562647634,0,4,histone succinylation,BP,
18414,GO:0106078,1,0.992708271854673,0,1,histone succinyltransferase activity,MF,
18415,GO:0106083,1,0.941054733056983,0,7,nuclear membrane protein complex,CC,
18416,GO:0106088,1,0.990984138029263,0,1,regulation of cell adhesion involved in sprouting angiogenesis,BP,
18417,GO:0106089,1,0.990984138029263,0,1,negative regulation of cell adhesion involved in sprouting angiogenesis,BP,
18418,GO:0106094,1,0.941054733056983,0,7,nuclear membrane microtubule tethering complex,CC,
18419,GO:0106101,1,0.995001450490178,0,1,ER-dependent peroxisome localization,BP,
18420,GO:0106104,1,0.976024906386391,0,3,regulation of glutamate receptor clustering,BP,
18421,GO:0110008,1,0.992763509482533,0,1,ncRNA deadenylation,BP,
18422,GO:0110009,1,0.975960711731305,0,3,formin-nucleated actin cable organization,BP,
18423,GO:0110011,1,0.956907151177701,0,5,regulation of basement membrane organization,BP,
18424,GO:0110017,1,0.992680948106692,0,2,cap-independent translational initiation of linear mRNA,BP,
18425,GO:0110020,1,0.55249070812225,0,81,regulation of actomyosin structure organization,BP,
18426,GO:0110021,1,0.979563949229851,0,3,cardiac muscle myoblast proliferation,BP,
18427,GO:0110022,1,0.979563949229851,0,3,regulation of cardiac muscle myoblast proliferation,BP,
18428,GO:0110024,1,0.979563949229851,0,3,positive regulation of cardiac muscle myoblast proliferation,BP,
18429,GO:0110025,1,0.992759808820661,0,1,DNA strand resection involved in replication fork processing,BP,
18430,GO:0110026,1,0.992759808820661,0,1,regulation of DNA strand resection involved in replication fork processing,BP,
18431,GO:0110028,1,0.990783868118484,0,1,positive regulation of mitotic spindle organization,BP,
18432,GO:0110029,1,0.992687382343135,0,1,negative regulation of meiosis I,BP,
18434,GO:0110057,1,0.991839975542571,0,1,regulation of blood vessel endothelial cell differentiation,BP,
18435,GO:0110059,1,0.991839975542571,0,1,negative regulation of blood vessel endothelial cell differentiation,BP,
18436,GO:0110075,1,0.99701749609411,0,1,regulation of ferroptosis,BP,
18437,GO:0110076,1,0.99701749609411,0,1,negative regulation of ferroptosis,BP,
18438,GO:0110095,1,0.986830846414303,0,3,cellular detoxification of aldehyde,BP,
18439,GO:0110096,1,0.977145248800987,0,5,cellular response to aldehyde,BP,
18440,GO:0120009,1,0.967184197456177,0,5,intermembrane lipid transfer,BP,
18441,GO:0120012,1,0.991888506608268,0,1,intermembrane sphingolipid transfer,BP,
18442,GO:0120013,1,0.967184197456177,0,5,intermembrane lipid transfer activity,MF,
18443,GO:0120016,1,0.991888506608268,0,1,intermembrane sphingolipid transfer activity,MF,
18444,GO:0120017,1,0.991888506608268,0,1,intermembrane ceramide transfer activity,MF,
18448,GO:0120033,1,0.880781711700057,0,20,negative regulation of plasma membrane bounded cell projection assembly,BP,
18449,GO:0120034,1,0.562967903867175,0,81,positive regulation of plasma membrane bounded cell projection assembly,BP,
18454,GO:0120043,1,0.992245150660355,0,1,stereocilium shaft,CC,
18455,GO:0120044,1,0.992245150660355,0,1,stereocilium base,CC,
18456,GO:0120048,1,0.993058458973322,0,1,U6 snRNA (adenine-(43)-N(6))-methyltransferase activity,MF,
18457,GO:0120049,1,0.993058458973322,0,1,snRNA (adenine-N6)-methylation,BP,
18458,GO:0120054,1,0.997490814002907,0,1,intestinal motility,BP,
18459,GO:0120055,1,0.997490814002907,0,1,small intestinal transit,BP,
18460,GO:0120057,1,0.997490814002907,0,1,regulation of small intestinal transit,BP,
18461,GO:0120058,1,0.997490814002907,0,1,positive regulation of small intestinal transit,BP,
18462,GO:0120060,1,0.997281337658679,0,1,regulation of gastric emptying,BP,
18463,GO:0120061,1,0.997281337658679,0,1,negative regulation of gastric emptying,BP,
18464,GO:0120063,1,0.989322077190688,0,2,stomach smooth muscle contraction,BP,
18465,GO:0120064,1,0.992019259254054,0,1,stomach pylorus smooth muscle contraction,BP,
18466,GO:0120065,1,0.992019259254054,0,1,pyloric antrum smooth muscle contraction,BP,
18467,GO:0120068,1,0.997281337658679,0,1,regulation of stomach fundus smooth muscle contraction,BP,
18468,GO:0120069,1,0.997281337658679,0,1,positive regulation of stomach fundus smooth muscle contraction,BP,
18469,GO:0120071,1,0.992019259254054,0,1,regulation of pyloric antrum smooth muscle contraction,BP,
18470,GO:0120072,1,0.992019259254054,0,1,positive regulation of pyloric antrum smooth muscle contraction,BP,
18471,GO:0120077,1,0.990984138029263,0,1,angiogenic sprout fusion,BP,
18472,GO:0120078,1,0.990984138029263,0,1,cell adhesion involved in sprouting angiogenesis,BP,
18473,GO:0120092,1,0.992583103378401,0,1,crotonyl-CoA hydratase activity,MF,
18474,GO:0120093,1,0.992583103378401,0,1,regulation of peptidyl-lysine crotonylation,BP,
18475,GO:0120094,1,0.992583103378401,0,1,negative regulation of peptidyl-lysine crotonylation,BP,
18476,GO:0120103,1,0.933017800514191,0,9,centriolar subdistal appendage,CC,
18477,GO:0120108,1,0.994585815572028,0,1,DNA-3'-diphospho-5'-guanosine diphosphatase,MF,
18478,GO:0120111,1,0.626925472540739,0,67,neuron projection cytoplasm,CC,
18479,GO:0120114,1,0.627477698931943,0,79,Sm-like protein family complex,CC,
18480,GO:0140007,1,0.975794209759665,0,4,KICSTOR complex,CC,
18481,GO:0140009,1,0.985073950756221,0,2,L-aspartate import across plasma membrane,BP,
18482,GO:0140013,1,0.383646136886789,0,143,meiotic nuclear division,BP,
18486,GO:0140031,1,0.986839663417045,0,2,phosphorylation-dependent protein binding,MF,
18487,GO:0140033,1,0.868224776944696,0,17,acetylation-dependent protein binding,MF,
18489,GO:0140035,1,0.963574752797873,0,5,ubiquitination-like modification-dependent protein binding,MF,
18490,GO:0140036,1,0.963574752797873,0,5,ubiquitin-dependent protein binding,MF,
18491,GO:0140041,1,0.997032233810024,0,1,cellular detoxification of methylglyoxal,BP,
18492,GO:0140049,1,0.99543318216766,0,1,regulation of endocardial cushion to mesenchymal transition,BP,
18493,GO:0140051,1,0.99543318216766,0,1,positive regulation of endocardial cushion to mesenchymal transition,BP,
18494,GO:0140052,1,0.964660893110239,0,5,cellular response to oxidised low-density lipoprotein particle stimulus,BP,
18495,GO:0140053,1,0.468420271604078,0,151,mitochondrial gene expression,BP,
18497,GO:0140058,1,0.875932438429199,0,16,neuron projection arborization,BP,
18498,GO:0140059,1,0.965039962983866,0,5,dendrite arborization,BP,
18499,GO:0140064,1,0.989851265375405,0,1,peptide crotonyltransferase activity,MF,
18500,GO:0140065,1,0.989851265375405,0,1,peptide butyryltransferase activity,MF,
18501,GO:0140066,1,0.982508895863087,0,2,peptidyl-lysine crotonylation,BP,
18502,GO:0140067,1,0.989851265375405,0,1,peptidyl-lysine butyrylation,BP,
18503,GO:0140068,1,0.989851265375405,0,1,histone crotonyltransferase activity,MF,
18504,GO:0140069,1,0.989851265375405,0,1,histone butyryltransferase activity,MF,
18505,GO:0140074,1,0.99201812306414,0,1,cardiac endothelial to mesenchymal transition,BP,
18506,GO:0140078,1,0.949296184279631,0,10,class I DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
18507,GO:0140080,1,0.949296184279631,0,10,class III/IV DNA-(apurinic or apyrimidinic site) endonuclease activity,MF,
18509,GO:0140097,1,0.297853397402327,0,180,catalytic activity, acting on DNA,MF,
18510,GO:0140098,1,0.116026733282482,0,338,catalytic activity, acting on RNA,MF,
18511,GO:0140101,1,0.491844505209243,0,115,catalytic activity, acting on a tRNA,MF,
18512,GO:0140102,1,0.916052829598735,0,15,catalytic activity, acting on a rRNA,MF,
18514,GO:0140104,1,0.811211138619909,0,40,molecular carrier activity,MF,
18516,GO:0140112,1,0.88301562189859,0,20,extracellular vesicle biogenesis,BP,
18517,GO:0140115,1,0.866101380431471,0,22,export across plasma membrane,BP,
18518,GO:0140131,1,0.934931710320597,0,12,positive regulation of lymphocyte chemotaxis,BP,
18519,GO:0140135,1,0.973004705203299,0,4,mechanosensitive cation channel activity,MF,
18520,GO:0140142,1,0.882991208518563,0,18,nucleocytoplasmic carrier activity,MF,
18521,GO:0140161,1,0.955925477505783,0,8,monocarboxylate:sodium symporter activity,MF,
18522,GO:0140192,1,0.980733404693147,0,2,regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
18523,GO:0140193,1,0.996136801278012,0,1,regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
18524,GO:0140194,1,0.996136801278012,0,1,negative regulation of adenylate cyclase-inhibiting adrenergic receptor signaling pathway involved in heart process,BP,
18525,GO:0140196,1,0.990816418088595,0,1,positive regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
18526,GO:0140199,1,0.989824462282673,0,1,negative regulation of adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process,BP,
18527,GO:0140200,1,0.99023308023085,0,1,adenylate cyclase-activating adrenergic receptor signaling pathway involved in regulation of heart rate,BP,
18528,GO:0150003,1,0.970456277756207,0,4,regulation of spontaneous synaptic transmission,BP,
18529,GO:0150005,1,0.935735653269885,0,11,enzyme activator complex,CC,
18530,GO:0150011,1,0.945900031559466,0,7,regulation of neuron projection arborization,BP,
18531,GO:0150012,1,0.945900031559466,0,7,positive regulation of neuron projection arborization,BP,
18532,GO:0150018,1,0.977691088651477,0,3,basal dendrite development,BP,
18533,GO:0150019,1,0.977691088651477,0,3,basal dendrite morphogenesis,BP,
18534,GO:0150020,1,0.977691088651477,0,3,basal dendrite arborization,BP,
18535,GO:0150024,1,0.994466064188805,0,1,oxidised low-density lipoprotein particle clearance,BP,
18536,GO:0150025,1,0.994466064188805,0,1,oxidised low-density lipoprotein particle receptor activity,MF,
18537,GO:0150031,1,0.991255605191299,0,1,regulation of protein localization to lysosome,BP,
18538,GO:0150033,1,0.991255605191299,0,1,negative regulation of protein localization to lysosome,BP,
18541,GO:1900003,1,0.974167836901598,0,6,regulation of serine-type endopeptidase activity,BP,
18542,GO:1900004,1,0.974167836901598,0,6,negative regulation of serine-type endopeptidase activity,BP,
18543,GO:1900005,1,0.989540988123595,0,1,positive regulation of serine-type endopeptidase activity,BP,
18545,GO:1900010,1,0.995016832765426,0,1,regulation of corticotropin-releasing hormone receptor activity,BP,
18546,GO:1900011,1,0.995016832765426,0,1,negative regulation of corticotropin-releasing hormone receptor activity,BP,
18549,GO:1900017,1,0.919234818939199,0,13,positive regulation of cytokine production involved in inflammatory response,BP,
18555,GO:1900027,1,0.859669322495536,0,24,regulation of ruffle assembly,BP,
18556,GO:1900028,1,0.972343014271448,0,5,negative regulation of ruffle assembly,BP,
18557,GO:1900029,1,0.93188927156814,0,11,positive regulation of ruffle assembly,BP,
18559,GO:1900035,1,0.993158500568297,0,1,negative regulation of cellular response to heat,BP,
18560,GO:1900036,1,0.993870929392863,0,1,positive regulation of cellular response to heat,BP,
18561,GO:1900037,1,0.929243962612611,0,12,regulation of cellular response to hypoxia,BP,
18562,GO:1900038,1,0.955919763658726,0,7,negative regulation of cellular response to hypoxia,BP,
18563,GO:1900039,1,0.989111292461755,0,2,positive regulation of cellular response to hypoxia,BP,
18564,GO:1900040,1,0.947110359309162,0,7,regulation of interleukin-2 secretion,BP,
18565,GO:1900041,1,0.971755683468128,0,4,negative regulation of interleukin-2 secretion,BP,
18566,GO:1900042,1,0.974645519232325,0,3,positive regulation of interleukin-2 secretion,BP,
18567,GO:1900044,1,0.929530631592387,0,9,regulation of protein K63-linked ubiquitination,BP,
18568,GO:1900045,1,0.959773586965931,0,5,negative regulation of protein K63-linked ubiquitination,BP,
18570,GO:1900047,1,0.764620204023867,0,43,negative regulation of hemostasis,BP,
18572,GO:1900052,1,0.996406077437465,0,1,regulation of retinoic acid biosynthetic process,BP,
18573,GO:1900053,1,0.996406077437465,0,1,negative regulation of retinoic acid biosynthetic process,BP,
18574,GO:1900060,1,0.977148276255885,0,4,negative regulation of ceramide biosynthetic process,BP,
18575,GO:1900062,1,0.992505961596166,0,1,regulation of replicative cell aging,BP,
18576,GO:1900063,1,0.975327175710909,0,3,regulation of peroxisome organization,BP,
18577,GO:1900076,1,0.630808537311104,0,66,regulation of cellular response to insulin stimulus,BP,
18578,GO:1900077,1,0.799642550246769,0,33,negative regulation of cellular response to insulin stimulus,BP,
18579,GO:1900078,1,0.824497863306121,0,26,positive regulation of cellular response to insulin stimulus,BP,
18580,GO:1900081,1,0.989824462282673,0,1,regulation of arginine catabolic process,BP,
18581,GO:1900082,1,0.989824462282673,0,1,negative regulation of arginine catabolic process,BP,
18582,GO:1900084,1,0.954541706578981,0,6,regulation of peptidyl-tyrosine autophosphorylation,BP,
18583,GO:1900085,1,0.993229974828245,0,1,negative regulation of peptidyl-tyrosine autophosphorylation,BP,
18584,GO:1900086,1,0.961050618320603,0,5,positive regulation of peptidyl-tyrosine autophosphorylation,BP,
18585,GO:1900087,1,0.834645581335199,0,27,positive regulation of G1/S transition of mitotic cell cycle,BP,
18586,GO:1900094,1,0.960728755555021,0,7,regulation of transcription from RNA polymerase II promoter involved in determination of left/right symmetry,BP,
18587,GO:1900095,1,0.988833477997571,0,1,regulation of dosage compensation by inactivation of X chromosome,BP,
18588,GO:1900098,1,0.995093615990103,0,1,regulation of plasma cell differentiation,BP,
18589,GO:1900100,1,0.995093615990103,0,1,positive regulation of plasma cell differentiation,BP,
18590,GO:1900101,1,0.849553238473931,0,25,regulation of endoplasmic reticulum unfolded protein response,BP,
18591,GO:1900102,1,0.927260089376528,0,11,negative regulation of endoplasmic reticulum unfolded protein response,BP,
18592,GO:1900103,1,0.917457311433854,0,13,positive regulation of endoplasmic reticulum unfolded protein response,BP,
18593,GO:1900104,1,0.980468513726914,0,3,regulation of hyaluranon cable assembly,BP,
18594,GO:1900106,1,0.980468513726914,0,3,positive regulation of hyaluranon cable assembly,BP,
18595,GO:1900107,1,0.958451623552649,0,7,regulation of nodal signaling pathway,BP,
18596,GO:1900108,1,0.98468240501592,0,3,negative regulation of nodal signaling pathway,BP,
18597,GO:1900109,1,0.985335575722305,0,3,regulation of histone H3-K9 dimethylation,BP,
18598,GO:1900110,1,0.991730930776577,0,2,negative regulation of histone H3-K9 dimethylation,BP,
18599,GO:1900111,1,0.993551855093648,0,1,positive regulation of histone H3-K9 dimethylation,BP,
18600,GO:1900112,1,0.936376764358439,0,9,regulation of histone H3-K9 trimethylation,BP,
18601,GO:1900113,1,0.969345646497497,0,5,negative regulation of histone H3-K9 trimethylation,BP,
18602,GO:1900114,1,0.9839841317511,0,2,positive regulation of histone H3-K9 trimethylation,BP,
18603,GO:1900115,1,0.906279856467918,0,15,extracellular regulation of signal transduction,BP,
18604,GO:1900116,1,0.906279856467918,0,15,extracellular negative regulation of signal transduction,BP,
18605,GO:1900117,1,0.875755811897418,0,21,regulation of execution phase of apoptosis,BP,
18606,GO:1900118,1,0.95509629538469,0,7,negative regulation of execution phase of apoptosis,BP,
18607,GO:1900119,1,0.930882967620243,0,12,positive regulation of execution phase of apoptosis,BP,
18608,GO:1900120,1,0.883342696319675,0,20,regulation of receptor binding,BP,
18609,GO:1900121,1,0.933884450965867,0,11,negative regulation of receptor binding,BP,
18610,GO:1900122,1,0.951708697660427,0,8,positive regulation of receptor binding,BP,
18611,GO:1900125,1,0.948043270703324,0,7,regulation of hyaluronan biosynthetic process,BP,
18612,GO:1900126,1,0.976848187858461,0,3,negative regulation of hyaluronan biosynthetic process,BP,
18613,GO:1900127,1,0.970519189437711,0,4,positive regulation of hyaluronan biosynthetic process,BP,
18614,GO:1900130,1,0.992519843455163,0,1,regulation of lipid binding,BP,
18615,GO:1900131,1,0.992519843455163,0,1,negative regulation of lipid binding,BP,
18616,GO:1900133,1,0.978646686057706,0,3,regulation of renin secretion into blood stream,BP,
18617,GO:1900134,1,0.992495918880092,0,1,negative regulation of renin secretion into blood stream,BP,
18618,GO:1900135,1,0.986047098688597,0,2,positive regulation of renin secretion into blood stream,BP,
18619,GO:1900138,1,0.988137950233556,0,2,negative regulation of phospholipase A2 activity,BP,
18620,GO:1900139,1,0.992098394010898,0,1,negative regulation of arachidonic acid secretion,BP,
18621,GO:1900141,1,0.993522923901973,0,1,regulation of oligodendrocyte apoptotic process,BP,
18622,GO:1900142,1,0.993522923901973,0,1,negative regulation of oligodendrocyte apoptotic process,BP,
18623,GO:1900145,1,0.971042864975339,0,5,regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
18624,GO:1900146,1,0.99175446578911,0,2,negative regulation of nodal signaling pathway involved in determination of left/right asymmetry,BP,
18625,GO:1900147,1,0.983894902466278,0,2,regulation of Schwann cell migration,BP,
18626,GO:1900148,1,0.993058458973322,0,1,negative regulation of Schwann cell migration,BP,
18627,GO:1900149,1,0.990773028720735,0,1,positive regulation of Schwann cell migration,BP,
18628,GO:1900150,1,0.988822649029291,0,2,regulation of defense response to fungus,BP,
18629,GO:1900151,1,0.893711616832672,0,16,regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
18630,GO:1900152,1,0.995059387970464,0,1,negative regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
18631,GO:1900153,1,0.893711616832672,0,16,positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay,BP,
18632,GO:1900154,1,0.987846465186828,0,2,regulation of bone trabecula formation,BP,
18633,GO:1900155,1,0.987846465186828,0,2,negative regulation of bone trabecula formation,BP,
18635,GO:1900158,1,0.992452624809098,0,1,negative regulation of bone mineralization involved in bone maturation,BP,
18637,GO:1900161,1,0.993050114308619,0,1,regulation of phospholipid scramblase activity,BP,
18638,GO:1900163,1,0.993050114308619,0,1,positive regulation of phospholipid scramblase activity,BP,
18639,GO:1900164,1,0.960728755555021,0,7,nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18640,GO:1900165,1,0.950747980713619,0,7,negative regulation of interleukin-6 secretion,BP,
18641,GO:1900166,1,0.986458049079474,0,2,regulation of glial cell-derived neurotrophic factor secretion,BP,
18642,GO:1900168,1,0.986458049079474,0,2,positive regulation of glial cell-derived neurotrophic factor secretion,BP,
18643,GO:1900169,1,0.980540602295791,0,2,regulation of glucocorticoid mediated signaling pathway,BP,
18644,GO:1900170,1,0.993058458973322,0,1,negative regulation of glucocorticoid mediated signaling pathway,BP,
18645,GO:1900175,1,0.971042864975339,0,5,regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18646,GO:1900176,1,0.99175446578911,0,2,negative regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18649,GO:1900182,1,0.647789009987131,0,62,positive regulation of protein localization to nucleus,BP,
18650,GO:1900186,1,0.980434741538089,0,3,negative regulation of clathrin-dependent endocytosis,BP,
18653,GO:1900193,1,0.959816397877792,0,7,regulation of oocyte maturation,BP,
18654,GO:1900194,1,0.983563383708516,0,3,negative regulation of oocyte maturation,BP,
18655,GO:1900195,1,0.988881433801838,0,2,positive regulation of oocyte maturation,BP,
18656,GO:1900200,1,0.985001542988399,0,2,mesenchymal cell apoptotic process involved in metanephros development,BP,
18657,GO:1900204,1,0.985001542988399,0,2,apoptotic process involved in metanephric collecting duct development,BP,
18658,GO:1900205,1,0.985001542988399,0,2,apoptotic process involved in metanephric nephron tubule development,BP,
18659,GO:1900208,1,0.991268887387211,0,2,regulation of cardiolipin metabolic process,BP,
18660,GO:1900210,1,0.991268887387211,0,2,positive regulation of cardiolipin metabolic process,BP,
18661,GO:1900211,1,0.985001542988399,0,2,regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
18662,GO:1900212,1,0.985001542988399,0,2,negative regulation of mesenchymal cell apoptotic process involved in metanephros development,BP,
18663,GO:1900214,1,0.985001542988399,0,2,regulation of apoptotic process involved in metanephric collecting duct development,BP,
18664,GO:1900215,1,0.985001542988399,0,2,negative regulation of apoptotic process involved in metanephric collecting duct development,BP,
18665,GO:1900217,1,0.985001542988399,0,2,regulation of apoptotic process involved in metanephric nephron tubule development,BP,
18666,GO:1900218,1,0.985001542988399,0,2,negative regulation of apoptotic process involved in metanephric nephron tubule development,BP,
18667,GO:1900220,1,0.983157183086806,0,2,semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis,BP,
18668,GO:1900221,1,0.924336753920208,0,10,regulation of amyloid-beta clearance,BP,
18669,GO:1900222,1,0.979200406643376,0,3,negative regulation of amyloid-beta clearance,BP,
18670,GO:1900223,1,0.949827123164323,0,6,positive regulation of amyloid-beta clearance,BP,
18671,GO:1900224,1,0.983413596893723,0,2,positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry,BP,
18672,GO:1900225,1,0.923373687000562,0,11,regulation of NLRP3 inflammasome complex assembly,BP,
18673,GO:1900226,1,0.971921614442167,0,4,negative regulation of NLRP3 inflammasome complex assembly,BP,
18674,GO:1900227,1,0.956598239282515,0,6,positive regulation of NLRP3 inflammasome complex assembly,BP,
18677,GO:1900238,1,0.97786531322969,0,3,regulation of metanephric mesenchymal cell migration by platelet-derived growth factor receptor-beta signaling pathway,BP,
18678,GO:1900239,1,0.969792734933932,0,4,regulation of phenotypic switching,BP,
18679,GO:1900241,1,0.992937210169218,0,1,positive regulation of phenotypic switching,BP,
18680,GO:1900242,1,0.936877388363484,0,8,regulation of synaptic vesicle endocytosis,BP,
18681,GO:1900243,1,0.991982541142166,0,1,negative regulation of synaptic vesicle endocytosis,BP,
18682,GO:1900244,1,0.968816876965886,0,4,positive regulation of synaptic vesicle endocytosis,BP,
18683,GO:1900245,1,0.974686543091989,0,3,positive regulation of MDA-5 signaling pathway,BP,
18684,GO:1900246,1,0.958507256174071,0,5,positive regulation of RIG-I signaling pathway,BP,
18685,GO:1900247,1,0.933114570020659,0,10,regulation of cytoplasmic translational elongation,BP,
18686,GO:1900248,1,0.983464041638801,0,2,negative regulation of cytoplasmic translational elongation,BP,
18687,GO:1900259,1,0.994886504719633,0,1,regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
18688,GO:1900260,1,0.994886504719633,0,1,negative regulation of RNA-directed 5'-3' RNA polymerase activity,BP,
18689,GO:1900262,1,0.967575351291043,0,6,regulation of DNA-directed DNA polymerase activity,BP,
18690,GO:1900264,1,0.967575351291043,0,6,positive regulation of DNA-directed DNA polymerase activity,BP,
18692,GO:1900272,1,0.944534208881872,0,8,negative regulation of long-term synaptic potentiation,BP,
18695,GO:1900275,1,0.984366414789413,0,2,negative regulation of phospholipase C activity,BP,
18696,GO:1900276,1,0.992558446435096,0,1,regulation of proteinase activated receptor activity,BP,
18697,GO:1900279,1,0.992545224030108,0,1,regulation of CD4-positive, alpha-beta T cell costimulation,BP,
18698,GO:1900281,1,0.992545224030108,0,1,positive regulation of CD4-positive, alpha-beta T cell costimulation,BP,
18699,GO:1900363,1,0.919276169453647,0,12,regulation of mRNA polyadenylation,BP,
18700,GO:1900364,1,0.943760246735042,0,8,negative regulation of mRNA polyadenylation,BP,
18701,GO:1900365,1,0.978415009257529,0,3,positive regulation of mRNA polyadenylation,BP,
18702,GO:1900368,1,0.975753306585834,0,3,regulation of RNA interference,BP,
18703,GO:1900369,1,0.983724024908065,0,2,negative regulation of RNA interference,BP,
18704,GO:1900370,1,0.991898726480816,0,1,positive regulation of RNA interference,BP,
18706,GO:1900372,1,0.789883828526995,0,35,negative regulation of purine nucleotide biosynthetic process,BP,
18708,GO:1900376,1,0.947108479053834,0,7,regulation of secondary metabolite biosynthetic process,BP,
18709,GO:1900377,1,0.982703262209146,0,2,negative regulation of secondary metabolite biosynthetic process,BP,
18710,GO:1900378,1,0.963784903955709,0,5,positive regulation of secondary metabolite biosynthetic process,BP,
18712,GO:1900387,1,0.994410062983299,0,1,negative regulation of cell-cell adhesion by negative regulation of transcription from RNA polymerase II promoter,BP,
18713,GO:1900390,1,0.984793213418935,0,3,regulation of iron ion import,BP,
18714,GO:1900402,1,0.935652640143733,0,8,regulation of carbohydrate metabolic process by regulation of transcription from RNA polymerase II promoter,BP,
18715,GO:1900407,1,0.651203451033191,0,66,regulation of cellular response to oxidative stress,BP,
18716,GO:1900408,1,0.777904879313424,0,39,negative regulation of cellular response to oxidative stress,BP,
18717,GO:1900409,1,0.91116821739345,0,15,positive regulation of cellular response to oxidative stress,BP,
18718,GO:1900424,1,0.926204821352568,0,12,regulation of defense response to bacterium,BP,
18719,GO:1900425,1,0.967034499586245,0,5,negative regulation of defense response to bacterium,BP,
18720,GO:1900426,1,0.966871225315094,0,6,positive regulation of defense response to bacterium,BP,
18722,GO:1900450,1,0.992182993390367,0,1,negative regulation of glutamate receptor signaling pathway,BP,
18723,GO:1900451,1,0.931338308061319,0,9,positive regulation of glutamate receptor signaling pathway,BP,
18725,GO:1900453,1,0.981636948813248,0,3,negative regulation of long term synaptic depression,BP,
18727,GO:1900477,1,0.994452040128867,0,1,negative regulation of G1/S transition of mitotic cell cycle by negative regulation of transcription from RNA polymerase II promoter,BP,
18728,GO:1900533,1,0.995731334388177,0,1,palmitic acid metabolic process,BP,
18729,GO:1900535,1,0.995731334388177,0,1,palmitic acid biosynthetic process,BP,
18731,GO:1900543,1,0.74275300535029,0,45,negative regulation of purine nucleotide metabolic process,BP,
18733,GO:1900558,1,0.994702755566728,0,1,austinol metabolic process,BP,
18734,GO:1900560,1,0.994702755566728,0,1,austinol biosynthetic process,BP,
18735,GO:1900561,1,0.994702755566728,0,1,dehydroaustinol metabolic process,BP,
18736,GO:1900563,1,0.994702755566728,0,1,dehydroaustinol biosynthetic process,BP,
18737,GO:1900619,1,0.979592457432877,0,3,acetate ester metabolic process,BP,
18738,GO:1900620,1,0.993270554299511,0,1,acetate ester biosynthetic process,BP,
18739,GO:1900623,1,0.976872057302461,0,3,regulation of monocyte aggregation,BP,
18740,GO:1900625,1,0.976872057302461,0,3,positive regulation of monocyte aggregation,BP,
18741,GO:1900673,1,0.980038965859203,0,3,olefin metabolic process,BP,
18742,GO:1900719,1,0.992114422505465,0,1,regulation of uterine smooth muscle relaxation,BP,
18743,GO:1900721,1,0.992114422505465,0,1,positive regulation of uterine smooth muscle relaxation,BP,
18744,GO:1900736,1,0.981106317986507,0,4,regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
18745,GO:1900737,1,0.992558446435096,0,1,negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
18746,GO:1900738,1,0.988462869379799,0,3,positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway,BP,
18747,GO:1900739,1,0.835707848069339,0,30,regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
18748,GO:1900740,1,0.835707848069339,0,30,positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway,BP,
18749,GO:1900744,1,0.813215554669747,0,31,regulation of p38MAPK cascade,BP,
18751,GO:1900746,1,0.933459858358984,0,10,regulation of vascular endothelial growth factor signaling pathway,BP,
18752,GO:1900747,1,0.979972226116732,0,3,negative regulation of vascular endothelial growth factor signaling pathway,BP,
18753,GO:1900748,1,0.966291955221912,0,4,positive regulation of vascular endothelial growth factor signaling pathway,BP,
18755,GO:1900753,1,0.992395037898618,0,1,doxorubicin transport,BP,
18756,GO:1900756,1,0.983776023923714,0,2,protein processing in phagocytic vesicle,BP,
18757,GO:1900825,1,0.978945305232958,0,3,regulation of membrane depolarization during cardiac muscle cell action potential,BP,
18758,GO:1900827,1,0.989191759965915,0,1,positive regulation of membrane depolarization during cardiac muscle cell action potential,BP,
18759,GO:1900864,1,0.949988656077618,0,9,mitochondrial RNA modification,BP,
18760,GO:1901004,1,0.996303675081453,0,1,ubiquinone-6 metabolic process,BP,
18761,GO:1901006,1,0.996303675081453,0,1,ubiquinone-6 biosynthetic process,BP,
18762,GO:1901016,1,0.704379508428003,0,49,regulation of potassium ion transmembrane transporter activity,BP,
18763,GO:1901017,1,0.898990318256074,0,15,negative regulation of potassium ion transmembrane transporter activity,BP,
18764,GO:1901018,1,0.855221458941873,0,22,positive regulation of potassium ion transmembrane transporter activity,BP,
18765,GO:1901019,1,0.594935655178839,0,77,regulation of calcium ion transmembrane transporter activity,BP,
18766,GO:1901020,1,0.831665538747555,0,31,negative regulation of calcium ion transmembrane transporter activity,BP,
18767,GO:1901021,1,0.807677532826233,0,31,positive regulation of calcium ion transmembrane transporter activity,BP,
18768,GO:1901026,1,0.975153633331093,0,3,ripoptosome assembly involved in necroptotic process,BP,
18769,GO:1901028,1,0.761527764086924,0,46,regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,
18770,GO:1901029,1,0.956598274116854,0,8,negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,
18771,GO:1901030,1,0.800189065124281,0,37,positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway,BP,
18772,GO:1901031,1,0.797633687492039,0,35,regulation of response to reactive oxygen species,BP,
18773,GO:1901032,1,0.89585555176734,0,17,negative regulation of response to reactive oxygen species,BP,
18774,GO:1901033,1,0.955134236917278,0,8,positive regulation of response to reactive oxygen species,BP,
18775,GO:1901052,1,0.992604338498186,0,1,sarcosine metabolic process,BP,
18776,GO:1901053,1,0.992604338498186,0,1,sarcosine catabolic process,BP,
18777,GO:1901068,1,0.73073187071008,0,50,guanosine-containing compound metabolic process,BP,
18778,GO:1901069,1,0.995986077774223,0,1,guanosine-containing compound catabolic process,BP,
18779,GO:1901070,1,0.941584620557948,0,14,guanosine-containing compound biosynthetic process,BP,
18780,GO:1901071,1,0.867498577431248,0,22,glucosamine-containing compound metabolic process,BP,
18781,GO:1901072,1,0.949130451896638,0,9,glucosamine-containing compound catabolic process,BP,
18782,GO:1901073,1,0.984508579767,0,2,glucosamine-containing compound biosynthetic process,BP,
18783,GO:1901074,1,0.984260341382912,0,2,regulation of engulfment of apoptotic cell,BP,
18784,GO:1901076,1,0.990993256256924,0,1,positive regulation of engulfment of apoptotic cell,BP,
18785,GO:1901077,1,0.933802788816797,0,11,regulation of relaxation of muscle,BP,
18786,GO:1901078,1,0.979103621938184,0,3,negative regulation of relaxation of muscle,BP,
18787,GO:1901079,1,0.980542473564775,0,3,positive regulation of relaxation of muscle,BP,
18788,GO:1901080,1,0.992114422505465,0,1,regulation of relaxation of smooth muscle,BP,
18789,GO:1901082,1,0.992114422505465,0,1,positive regulation of relaxation of smooth muscle,BP,
18790,GO:1901086,1,0.99207833818527,0,1,benzylpenicillin metabolic process,BP,
18791,GO:1901090,1,0.987515194084316,0,2,regulation of protein tetramerization,BP,
18792,GO:1901091,1,0.987515194084316,0,2,negative regulation of protein tetramerization,BP,
18793,GO:1901093,1,0.987515194084316,0,2,regulation of protein homotetramerization,BP,
18794,GO:1901094,1,0.987515194084316,0,2,negative regulation of protein homotetramerization,BP,
18795,GO:1901096,1,0.93198850420185,0,9,regulation of autophagosome maturation,BP,
18796,GO:1901097,1,0.97820938499793,0,3,negative regulation of autophagosome maturation,BP,
18797,GO:1901098,1,0.951288676297505,0,6,positive regulation of autophagosome maturation,BP,
18802,GO:1901142,1,0.948486760498598,0,7,insulin metabolic process,BP,
18803,GO:1901143,1,0.984616911561264,0,2,insulin catabolic process,BP,
18804,GO:1901145,1,0.977582897392629,0,3,mesenchymal cell apoptotic process involved in nephron morphogenesis,BP,
18805,GO:1901147,1,0.985001542988399,0,2,mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis,BP,
18806,GO:1901159,1,0.975131983747371,0,5,xylulose 5-phosphate biosynthetic process,BP,
18807,GO:1901160,1,0.915807494959059,0,12,primary amino compound metabolic process,BP,
18808,GO:1901162,1,0.977079329250904,0,4,primary amino compound biosynthetic process,BP,
18809,GO:1901163,1,0.943957708458972,0,10,regulation of trophoblast cell migration,BP,
18810,GO:1901164,1,0.972947516239049,0,5,negative regulation of trophoblast cell migration,BP,
18811,GO:1901165,1,0.970212195918338,0,5,positive regulation of trophoblast cell migration,BP,
18812,GO:1901166,1,0.977992716590448,0,3,neural crest cell migration involved in autonomic nervous system development,BP,
18815,GO:1901186,1,0.797195308479641,0,34,positive regulation of ERBB signaling pathway,BP,
18816,GO:1901187,1,0.985169453558765,0,2,regulation of ephrin receptor signaling pathway,BP,
18817,GO:1901189,1,0.993823049830488,0,1,positive regulation of ephrin receptor signaling pathway,BP,
18818,GO:1901193,1,0.996619901427331,0,1,regulation of formation of translation preinitiation complex,BP,
18819,GO:1901194,1,0.996619901427331,0,1,negative regulation of formation of translation preinitiation complex,BP,
18820,GO:1901201,1,0.901550012010135,0,13,regulation of extracellular matrix assembly,BP,
18821,GO:1901202,1,0.993836823501135,0,1,negative regulation of extracellular matrix assembly,BP,
18822,GO:1901203,1,0.929711094659863,0,9,positive regulation of extracellular matrix assembly,BP,
18823,GO:1901207,1,0.985110292581891,0,2,regulation of heart looping,BP,
18824,GO:1901208,1,0.992577734060924,0,1,negative regulation of heart looping,BP,
18825,GO:1901210,1,0.992577734060924,0,1,regulation of cardiac chamber formation,BP,
18826,GO:1901211,1,0.992577734060924,0,1,negative regulation of cardiac chamber formation,BP,
18827,GO:1901213,1,0.919299498952035,0,12,regulation of transcription from RNA polymerase II promoter involved in heart development,BP,
18830,GO:1901216,1,0.598307719185636,0,75,positive regulation of neuron death,BP,
18831,GO:1901219,1,0.992577734060924,0,1,regulation of cardiac chamber morphogenesis,BP,
18832,GO:1901220,1,0.992577734060924,0,1,negative regulation of cardiac chamber morphogenesis,BP,
18834,GO:1901223,1,0.943960760765332,0,9,negative regulation of NIK/NF-kappaB signaling,BP,
18836,GO:1901228,1,0.976070168226415,0,3,positive regulation of transcription from RNA polymerase II promoter involved in heart development,BP,
18837,GO:1901229,1,0.993367477867485,0,1,regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
18838,GO:1901231,1,0.993367477867485,0,1,positive regulation of non-canonical Wnt signaling pathway via JNK cascade,BP,
18839,GO:1901232,1,0.993367477867485,0,1,regulation of convergent extension involved in axis elongation,BP,
18840,GO:1901233,1,0.993367477867485,0,1,negative regulation of convergent extension involved in axis elongation,BP,
18841,GO:1901246,1,0.989600002107392,0,2,regulation of lung ciliated cell differentiation,BP,
18842,GO:1901247,1,0.996286185390552,0,1,negative regulation of lung ciliated cell differentiation,BP,
18843,GO:1901248,1,0.993289142355086,0,1,positive regulation of lung ciliated cell differentiation,BP,
18844,GO:1901249,1,0.996286185390552,0,1,regulation of lung goblet cell differentiation,BP,
18845,GO:1901251,1,0.996286185390552,0,1,positive regulation of lung goblet cell differentiation,BP,
18846,GO:1901252,1,0.989433906385815,0,2,regulation of intracellular transport of viral material,BP,
18847,GO:1901253,1,0.997021707873429,0,1,negative regulation of intracellular transport of viral material,BP,
18848,GO:1901254,1,0.992389759215191,0,1,positive regulation of intracellular transport of viral material,BP,
18849,GO:1901255,1,0.986695107489798,0,2,nucleotide-excision repair involved in interstrand cross-link repair,BP,
18850,GO:1901256,1,0.966716349678225,0,5,regulation of macrophage colony-stimulating factor production,BP,
18851,GO:1901257,1,0.993901000600317,0,1,negative regulation of macrophage colony-stimulating factor production,BP,
18852,GO:1901258,1,0.979973036166495,0,3,positive regulation of macrophage colony-stimulating factor production,BP,
18855,GO:1901269,1,0.995228475299946,0,2,lipooligosaccharide metabolic process,BP,
18856,GO:1901271,1,0.995228475299946,0,2,lipooligosaccharide biosynthetic process,BP,
18857,GO:1901291,1,0.994837874525491,0,1,negative regulation of double-strand break repair via single-strand annealing,BP,
18858,GO:1901292,1,0.34115240741594,0,162,nucleoside phosphate catabolic process,BP,
18860,GO:1901295,1,0.988954874003068,0,2,regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
18861,GO:1901296,1,0.995101869933184,0,1,negative regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
18862,GO:1901297,1,0.993823049830488,0,1,positive regulation of canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment,BP,
18863,GO:1901298,1,0.938672521078998,0,10,regulation of hydrogen peroxide-mediated programmed cell death,BP,
18864,GO:1901299,1,0.96301278166689,0,6,negative regulation of hydrogen peroxide-mediated programmed cell death,BP,
18865,GO:1901300,1,0.974734288837366,0,4,positive regulation of hydrogen peroxide-mediated programmed cell death,BP,
18866,GO:1901301,1,0.985518517494755,0,2,regulation of cargo loading into COPII-coated vesicle,BP,
18867,GO:1901303,1,0.993162364409317,0,1,negative regulation of cargo loading into COPII-coated vesicle,BP,
18868,GO:1901304,1,0.995349884203026,0,1,regulation of spermidine biosynthetic process,BP,
18869,GO:1901307,1,0.995349884203026,0,1,positive regulation of spermidine biosynthetic process,BP,
18870,GO:1901314,1,0.974654757001541,0,3,regulation of histone H2A K63-linked ubiquitination,BP,
18871,GO:1901315,1,0.974654757001541,0,3,negative regulation of histone H2A K63-linked ubiquitination,BP,
18872,GO:1901317,1,0.960345113156999,0,8,regulation of flagellated sperm motility,BP,
18873,GO:1901318,1,0.994807037247671,0,1,negative regulation of flagellated sperm motility,BP,
18874,GO:1901321,1,0.991673939615846,0,2,positive regulation of heart induction,BP,
18875,GO:1901328,1,0.995087718336798,0,1,response to cytochalasin B,BP,
18876,GO:1901329,1,0.980246412084523,0,3,regulation of odontoblast differentiation,BP,
18877,GO:1901331,1,0.992683518576315,0,1,positive regulation of odontoblast differentiation,BP,
18878,GO:1901337,1,0.993248879662176,0,1,thioester transport,BP,
18879,GO:1901338,1,0.916995395221889,0,14,catecholamine binding,MF,
18880,GO:1901339,1,0.950885338962751,0,7,regulation of store-operated calcium channel activity,BP,
18881,GO:1901340,1,0.992452723726228,0,1,negative regulation of store-operated calcium channel activity,BP,
18882,GO:1901341,1,0.965178514976034,0,5,positive regulation of store-operated calcium channel activity,BP,
18884,GO:1901343,1,0.518175716256804,0,93,negative regulation of vasculature development,BP,
18885,GO:1901344,1,0.996277433952069,0,1,response to leptomycin B,BP,
18886,GO:1901350,1,0.99086805309887,0,1,cell-cell signaling involved in cell-cell junction organization,BP,
18887,GO:1901355,1,0.985465822021828,0,2,response to rapamycin,BP,
18889,GO:1901361,1,0.018471521018783,0,656,organic cyclic compound catabolic process,BP,
18892,GO:1901373,1,0.995977168526206,0,1,lipid hydroperoxide transport,BP,
18893,GO:1901374,1,0.961459137757516,0,6,acetate ester transport,BP,
18894,GO:1901375,1,0.98725352991757,0,2,acetate ester transmembrane transporter activity,MF,
18895,GO:1901376,1,0.99312430827893,0,1,organic heteropentacyclic compound metabolic process,BP,
18896,GO:1901377,1,0.99312430827893,0,1,organic heteropentacyclic compound catabolic process,BP,
18897,GO:1901379,1,0.614677930793775,0,69,regulation of potassium ion transmembrane transport,BP,
18898,GO:1901380,1,0.880353750022187,0,18,negative regulation of potassium ion transmembrane transport,BP,
18899,GO:1901381,1,0.794432644455135,0,32,positive regulation of potassium ion transmembrane transport,BP,
18900,GO:1901382,1,0.969219309007457,0,4,regulation of chorionic trophoblast cell proliferation,BP,
18901,GO:1901383,1,0.984393997944526,0,2,negative regulation of chorionic trophoblast cell proliferation,BP,
18902,GO:1901385,1,0.823764329444717,0,31,regulation of voltage-gated calcium channel activity,BP,
18903,GO:1901386,1,0.931593883211949,0,12,negative regulation of voltage-gated calcium channel activity,BP,
18904,GO:1901387,1,0.954646181853395,0,8,positive regulation of voltage-gated calcium channel activity,BP,
18905,GO:1901388,1,0.993451183141474,0,1,regulation of transforming growth factor beta activation,BP,
18906,GO:1901389,1,0.993451183141474,0,1,negative regulation of transforming growth factor beta activation,BP,
18907,GO:1901401,1,0.991662641627008,0,1,regulation of tetrapyrrole metabolic process,BP,
18908,GO:1901407,1,0.944660301049127,0,9,regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
18909,GO:1901409,1,0.958279888379918,0,7,positive regulation of phosphorylation of RNA polymerase II C-terminal domain,BP,
18910,GO:1901419,1,0.99239595615167,0,1,regulation of response to alcohol,BP,
18911,GO:1901421,1,0.99239595615167,0,1,positive regulation of response to alcohol,BP,
18912,GO:1901474,1,0.954386834484944,0,7,azole transmembrane transporter activity,MF,
18913,GO:1901475,1,0.974007783962165,0,4,pyruvate transmembrane transport,BP,
18914,GO:1901490,1,0.970193197505928,0,4,regulation of lymphangiogenesis,BP,
18915,GO:1901491,1,0.984121445608217,0,2,negative regulation of lymphangiogenesis,BP,
18916,GO:1901492,1,0.985849270331407,0,2,positive regulation of lymphangiogenesis,BP,
18917,GO:1901503,1,0.967974230464353,0,5,ether biosynthetic process,BP,
18918,GO:1901505,1,0.804939429315108,0,34,carbohydrate derivative transmembrane transporter activity,MF,
18919,GO:1901509,1,0.973930904680249,0,4,regulation of endothelial tube morphogenesis,BP,
18920,GO:1901522,1,0.848516542154864,0,23,positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus,BP,
18921,GO:1901523,1,0.9812540882801,0,3,icosanoid catabolic process,BP,
18922,GO:1901524,1,0.908638231105212,0,13,regulation of mitophagy,BP,
18923,GO:1901525,1,0.962161184251734,0,5,negative regulation of mitophagy,BP,
18924,GO:1901526,1,0.944392990301719,0,8,positive regulation of mitophagy,BP,
18925,GO:1901529,1,0.969461808966897,0,4,positive regulation of anion channel activity,BP,
18927,GO:1901533,1,0.959245580124314,0,7,negative regulation of hematopoietic progenitor cell differentiation,BP,
18928,GO:1901534,1,0.985090558390332,0,2,positive regulation of hematopoietic progenitor cell differentiation,BP,
18929,GO:1901535,1,0.956924236050797,0,5,regulation of DNA demethylation,BP,
18930,GO:1901536,1,0.985639910081985,0,2,negative regulation of DNA demethylation,BP,
18931,GO:1901537,1,0.970870105019072,0,3,positive regulation of DNA demethylation,BP,
18932,GO:1901538,1,0.955948860658215,0,6,changes to DNA methylation involved in embryo development,BP,
18933,GO:1901545,1,0.992792243560688,0,1,response to raffinose,BP,
18934,GO:1901550,1,0.922716378771583,0,12,regulation of endothelial cell development,BP,
18935,GO:1901551,1,0.992437291389907,0,1,negative regulation of endothelial cell development,BP,
18936,GO:1901552,1,0.967643322489195,0,5,positive regulation of endothelial cell development,BP,
18937,GO:1901555,1,0.990938602302629,0,1,response to paclitaxel,BP,
18938,GO:1901557,1,0.992475485630838,0,1,response to fenofibrate,BP,
18939,GO:1901558,1,0.986335899483722,0,2,response to metformin,BP,
18940,GO:1901561,1,0.992500645009124,0,1,response to benomyl,BP,
18941,GO:1901563,1,0.964545132900554,0,5,response to camptothecin,BP,
18945,GO:1901567,1,0.878483645342994,0,24,fatty acid derivative binding,MF,
18946,GO:1901568,1,0.449656682877998,0,132,fatty acid derivative metabolic process,BP,
18947,GO:1901569,1,0.95235048127532,0,8,fatty acid derivative catabolic process,BP,
18948,GO:1901570,1,0.636229955802884,0,75,fatty acid derivative biosynthetic process,BP,
18952,GO:1901580,1,0.988529945830477,0,1,regulation of telomeric RNA transcription from RNA pol II promoter,BP,
18953,GO:1901581,1,0.988529945830477,0,1,negative regulation of telomeric RNA transcription from RNA pol II promoter,BP,
18954,GO:1901582,1,0.988529945830477,0,1,positive regulation of telomeric RNA transcription from RNA pol II promoter,BP,
18955,GO:1901585,1,0.993005021553661,0,1,regulation of acid-sensing ion channel activity,BP,
18956,GO:1901588,1,0.992274097141352,0,1,dendritic microtubule,CC,
18957,GO:1901594,1,0.99245132719801,0,1,response to capsazepine,BP,
18960,GO:1901607,1,0.68513761025535,0,59,alpha-amino acid biosynthetic process,BP,
18961,GO:1901608,1,0.996176471697596,0,1,regulation of vesicle transport along microtubule,BP,
18962,GO:1901609,1,0.996176471697596,0,1,negative regulation of vesicle transport along microtubule,BP,
18963,GO:1901611,1,0.941012083358722,0,10,phosphatidylglycerol binding,MF,
18964,GO:1901612,1,0.957755833838549,0,7,cardiolipin binding,MF,
18965,GO:1901615,1,0.0554183895428004,0,433,organic hydroxy compound metabolic process,BP,
18966,GO:1901616,1,0.717995121504115,0,53,organic hydroxy compound catabolic process,BP,
18967,GO:1901617,1,0.246632924450198,0,214,organic hydroxy compound biosynthetic process,BP,
18968,GO:1901618,1,0.770328663552982,0,39,organic hydroxy compound transmembrane transporter activity,MF,
18969,GO:1901620,1,0.951750781075239,0,7,regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
18970,GO:1901621,1,0.96414665007802,0,5,negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
18971,GO:1901622,1,0.993381778579818,0,1,positive regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning,BP,
18972,GO:1901623,1,0.911786638659188,0,17,regulation of lymphocyte chemotaxis,BP,
18973,GO:1901624,1,0.985506036839917,0,3,negative regulation of lymphocyte chemotaxis,BP,
18974,GO:1901626,1,0.933770322313719,0,10,regulation of postsynaptic membrane organization,BP,
18975,GO:1901627,1,0.993868789516679,0,1,negative regulation of postsynaptic membrane organization,BP,
18976,GO:1901628,1,0.976352714488428,0,4,positive regulation of postsynaptic membrane organization,BP,
18977,GO:1901629,1,0.986846060255831,0,2,regulation of presynaptic membrane organization,BP,
18978,GO:1901630,1,0.996510058796768,0,1,negative regulation of presynaptic membrane organization,BP,
18979,GO:1901631,1,0.990302494540774,0,1,positive regulation of presynaptic membrane organization,BP,
18980,GO:1901639,1,0.991503892523375,0,1,XDP catabolic process,BP,
18981,GO:1901640,1,0.991503892523375,0,1,XTP binding,MF,
18982,GO:1901641,1,0.991503892523375,0,1,ITP binding,MF,
18983,GO:1901642,1,0.963626194959055,0,6,nucleoside transmembrane transport,BP,
18988,GO:1901656,1,0.978089233134635,0,3,glycoside transport,BP,
18989,GO:1901657,1,0.450126696963231,0,134,glycosyl compound metabolic process,BP,
18990,GO:1901658,1,0.823092559187072,0,35,glycosyl compound catabolic process,BP,
18991,GO:1901659,1,0.792401766566053,0,43,glycosyl compound biosynthetic process,BP,
18992,GO:1901660,1,0.938654506554126,0,8,calcium ion export,BP,
18993,GO:1901661,1,0.874720476073864,0,27,quinone metabolic process,BP,
18994,GO:1901662,1,0.989350250206725,0,2,quinone catabolic process,BP,
18995,GO:1901663,1,0.932137277638303,0,14,quinone biosynthetic process,BP,
18996,GO:1901664,1,0.982183714845112,0,3,regulation of NAD+ ADP-ribosyltransferase activity,BP,
18997,GO:1901666,1,0.982183714845112,0,3,positive regulation of NAD+ ADP-ribosyltransferase activity,BP,
18998,GO:1901668,1,0.980458742593015,0,4,regulation of superoxide dismutase activity,BP,
18999,GO:1901671,1,0.987313090335356,0,3,positive regulation of superoxide dismutase activity,BP,
19000,GO:1901673,1,0.875999712232079,0,19,regulation of mitotic spindle assembly,BP,
19001,GO:1901674,1,0.976813953195906,0,3,regulation of histone H3-K27 acetylation,BP,
19002,GO:1901675,1,0.99109257947265,0,1,negative regulation of histone H3-K27 acetylation,BP,
19003,GO:1901676,1,0.992484210638354,0,1,positive regulation of histone H3-K27 acetylation,BP,
19004,GO:1901678,1,0.930331433217332,0,11,iron coordination entity transport,BP,
19005,GO:1901679,1,0.951209013505494,0,8,nucleotide transmembrane transport,BP,
19006,GO:1901680,1,0.989356043494652,0,1,sulfur-containing amino acid secondary active transmembrane transporter activity,MF,
19008,GO:1901682,1,0.824313326570528,0,27,sulfur compound transmembrane transporter activity,MF,
19015,GO:1901702,1,0.983332280391838,0,3,salt transmembrane transporter activity,MF,
19016,GO:1901706,1,0.993371042688108,0,1,mesenchymal cell differentiation involved in bone development,BP,
19017,GO:1901707,1,0.996277433952069,0,1,leptomycin B binding,MF,
19018,GO:1901722,1,0.929703166715251,0,11,regulation of cell proliferation involved in kidney development,BP,
19019,GO:1901723,1,0.966775947512994,0,5,negative regulation of cell proliferation involved in kidney development,BP,
19020,GO:1901724,1,0.961665886766772,0,6,positive regulation of cell proliferation involved in kidney development,BP,
19021,GO:1901725,1,0.9345877458336,0,8,regulation of histone deacetylase activity,BP,
19022,GO:1901726,1,0.988663439355295,0,1,negative regulation of histone deacetylase activity,BP,
19023,GO:1901727,1,0.952504501620042,0,6,positive regulation of histone deacetylase activity,BP,
19025,GO:1901739,1,0.919079512045761,0,15,regulation of myoblast fusion,BP,
19026,GO:1901740,1,0.991271145942882,0,2,negative regulation of myoblast fusion,BP,
19027,GO:1901741,1,0.927178827677543,0,13,positive regulation of myoblast fusion,BP,
19028,GO:1901748,1,0.98073557383568,0,3,leukotriene D4 metabolic process,BP,
19029,GO:1901750,1,0.98073557383568,0,3,leukotriene D4 biosynthetic process,BP,
19030,GO:1901751,1,0.993807217231287,0,1,leukotriene A4 metabolic process,BP,
19032,GO:1901797,1,0.856363279948517,0,26,negative regulation of signal transduction by p53 class mediator,BP,
19035,GO:1901800,1,0.518367043189669,0,99,positive regulation of proteasomal protein catabolic process,BP,
19036,GO:1901804,1,0.993728026440238,0,1,beta-glucoside metabolic process,BP,
19037,GO:1901805,1,0.993728026440238,0,1,beta-glucoside catabolic process,BP,
19038,GO:1901810,1,0.993058458973322,0,1,beta-carotene metabolic process,BP,
19039,GO:1901825,1,0.993321774029604,0,1,zeaxanthin metabolic process,BP,
19040,GO:1901827,1,0.993321774029604,0,1,zeaxanthin biosynthetic process,BP,
19041,GO:1901834,1,0.995245096186547,0,1,regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
19042,GO:1901835,1,0.995245096186547,0,1,positive regulation of deadenylation-independent decapping of nuclear-transcribed mRNA,BP,
19043,GO:1901836,1,0.929482735162446,0,11,regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
19044,GO:1901837,1,0.989061657435979,0,2,negative regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
19045,GO:1901838,1,0.93976860181195,0,9,positive regulation of transcription of nucleolar large rRNA by RNA polymerase I,BP,
19046,GO:1901841,1,0.937079685997051,0,11,regulation of high voltage-gated calcium channel activity,BP,
19047,GO:1901842,1,0.980765272057744,0,4,negative regulation of high voltage-gated calcium channel activity,BP,
19048,GO:1901843,1,0.978159750686648,0,3,positive regulation of high voltage-gated calcium channel activity,BP,
19049,GO:1901844,1,0.940941055273084,0,9,regulation of cell communication by electrical coupling involved in cardiac conduction,BP,
19050,GO:1901846,1,0.992343092060361,0,1,positive regulation of cell communication by electrical coupling involved in cardiac conduction,BP,
19051,GO:1901856,1,0.986654660349343,0,2,negative regulation of cellular respiration,BP,
19052,GO:1901857,1,0.968152190552058,0,6,positive regulation of cellular respiration,BP,
19053,GO:1901858,1,0.958906719720154,0,6,regulation of mitochondrial DNA metabolic process,BP,
19054,GO:1901859,1,0.978029153186698,0,3,negative regulation of mitochondrial DNA metabolic process,BP,
19055,GO:1901860,1,0.987644268313883,0,2,positive regulation of mitochondrial DNA metabolic process,BP,
19059,GO:1901873,1,0.984238350997708,0,2,regulation of post-translational protein modification,BP,
19060,GO:1901874,1,0.984238350997708,0,2,negative regulation of post-translational protein modification,BP,
19061,GO:1901876,1,0.992809787681215,0,2,regulation of calcium ion binding,BP,
19062,GO:1901877,1,0.992809787681215,0,2,negative regulation of calcium ion binding,BP,
19065,GO:1901881,1,0.908265224983246,0,15,positive regulation of protein depolymerization,BP,
19068,GO:1901890,1,0.801184981549902,0,30,positive regulation of cell junction assembly,BP,
19069,GO:1901894,1,0.947522051115457,0,8,regulation of calcium-transporting ATPase activity,BP,
19070,GO:1901895,1,0.979312931909658,0,3,negative regulation of calcium-transporting ATPase activity,BP,
19071,GO:1901896,1,0.969990902033226,0,4,positive regulation of calcium-transporting ATPase activity,BP,
19072,GO:1901897,1,0.952222361912267,0,7,regulation of relaxation of cardiac muscle,BP,
19073,GO:1901898,1,0.982725994055701,0,2,negative regulation of relaxation of cardiac muscle,BP,
19074,GO:1901899,1,0.988336992106635,0,2,positive regulation of relaxation of cardiac muscle,BP,
19075,GO:1901906,1,0.976974422612972,0,4,diadenosine pentaphosphate metabolic process,BP,
19076,GO:1901907,1,0.976974422612972,0,4,diadenosine pentaphosphate catabolic process,BP,
19077,GO:1901908,1,0.976974422612972,0,4,diadenosine hexaphosphate metabolic process,BP,
19078,GO:1901909,1,0.976974422612972,0,4,diadenosine hexaphosphate catabolic process,BP,
19079,GO:1901910,1,0.976974422612972,0,4,adenosine 5'-(hexahydrogen pentaphosphate) metabolic process,BP,
19080,GO:1901911,1,0.976974422612972,0,4,adenosine 5'-(hexahydrogen pentaphosphate) catabolic process,BP,
19081,GO:1901917,1,0.993109452947755,0,1,regulation of exoribonuclease activity,BP,
19082,GO:1901919,1,0.993109452947755,0,1,positive regulation of exoribonuclease activity,BP,
19083,GO:1901950,1,0.993058458973322,0,1,dense core granule transport,BP,
19084,GO:1901962,1,0.994107897982335,0,1,S-adenosyl-L-methionine transmembrane transport,BP,
19085,GO:1901963,1,0.987747426705244,0,2,regulation of cell proliferation involved in outflow tract morphogenesis,BP,
19086,GO:1901964,1,0.995148968087614,0,1,positive regulation of cell proliferation involved in outflow tract morphogenesis,BP,
19087,GO:1901970,1,0.948645602448063,0,8,positive regulation of mitotic sister chromatid separation,BP,
19088,GO:1901976,1,0.809913498906601,0,32,regulation of cell cycle checkpoint,BP,
19089,GO:1901977,1,0.961900930126925,0,6,negative regulation of cell cycle checkpoint,BP,
19090,GO:1901978,1,0.933462430874201,0,10,positive regulation of cell cycle checkpoint,BP,
19091,GO:1901979,1,0.979783349149559,0,3,regulation of inward rectifier potassium channel activity,BP,
19092,GO:1901980,1,0.989123196194878,0,1,positive regulation of inward rectifier potassium channel activity,BP,
19094,GO:1901983,1,0.648921145220273,0,65,regulation of protein acetylation,BP,
19095,GO:1901984,1,0.864975775614063,0,23,negative regulation of protein acetylation,BP,
19096,GO:1901985,1,0.792948843618814,0,35,positive regulation of protein acetylation,BP,
19097,GO:1901986,1,0.996014999274804,0,1,response to ketamine,BP,
19100,GO:1901989,1,0.624695943066753,0,72,positive regulation of cell cycle phase transition,BP,
19103,GO:1901992,1,0.670986688834077,0,61,positive regulation of mitotic cell cycle phase transition,BP,
19104,GO:1901993,1,0.985651451371516,0,2,regulation of meiotic cell cycle phase transition,BP,
19105,GO:1901994,1,0.985651451371516,0,2,negative regulation of meiotic cell cycle phase transition,BP,
19106,GO:1901998,1,0.798350233213793,0,35,toxin transport,BP,
19107,GO:1902001,1,0.898006756780343,0,14,fatty acid transmembrane transport,BP,
19108,GO:1902003,1,0.876538100066781,0,18,regulation of amyloid-beta formation,BP,
19109,GO:1902004,1,0.931758937512839,0,10,positive regulation of amyloid-beta formation,BP,
19110,GO:1902010,1,0.992545470420504,0,1,negative regulation of translation in response to endoplasmic reticulum stress,BP,
19112,GO:1902018,1,0.941522687283968,0,9,negative regulation of cilium assembly,BP,
19113,GO:1902019,1,0.966459673816147,0,5,regulation of cilium-dependent cell motility,BP,
19114,GO:1902022,1,0.967168132170594,0,5,L-lysine transport,BP,
19115,GO:1902023,1,0.959141415486545,0,6,L-arginine transport,BP,
19116,GO:1902031,1,0.968012452097379,0,6,regulation of NADP metabolic process,BP,
19117,GO:1902033,1,0.954717642142376,0,7,regulation of hematopoietic stem cell proliferation,BP,
19118,GO:1902035,1,0.968468965105529,0,5,positive regulation of hematopoietic stem cell proliferation,BP,
19120,GO:1902037,1,0.979467183679226,0,3,negative regulation of hematopoietic stem cell differentiation,BP,
19121,GO:1902038,1,0.992557726312042,0,1,positive regulation of hematopoietic stem cell differentiation,BP,
19124,GO:1902043,1,0.885782218287301,0,17,positive regulation of extrinsic apoptotic signaling pathway via death domain receptors,BP,
19125,GO:1902044,1,0.986190861910842,0,2,regulation of Fas signaling pathway,BP,
19126,GO:1902045,1,0.993828341714919,0,1,negative regulation of Fas signaling pathway,BP,
19127,GO:1902047,1,0.966980267154807,0,6,polyamine transmembrane transport,BP,
19128,GO:1902065,1,0.927229800991961,0,11,response to L-glutamate,BP,
19129,GO:1902071,1,0.996514378549531,0,1,regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
19130,GO:1902073,1,0.996514378549531,0,1,positive regulation of hypoxia-inducible factor-1alpha signaling pathway,BP,
19131,GO:1902074,1,0.925012317770201,0,13,response to salt,BP,
19132,GO:1902075,1,0.960772808227007,0,7,cellular response to salt,BP,
19133,GO:1902076,1,0.988276939930579,0,1,regulation of lateral motor column neuron migration,BP,
19134,GO:1902078,1,0.988276939930579,0,1,positive regulation of lateral motor column neuron migration,BP,
19135,GO:1902080,1,0.995319688798766,0,1,regulation of calcium ion import into sarcoplasmic reticulum,BP,
19136,GO:1902081,1,0.995319688798766,0,1,negative regulation of calcium ion import into sarcoplasmic reticulum,BP,
19137,GO:1902083,1,0.959230497690313,0,5,negative regulation of peptidyl-cysteine S-nitrosylation,BP,
19138,GO:1902093,1,0.965359957662585,0,7,positive regulation of flagellated sperm motility,BP,
19139,GO:1902098,1,0.992258462460885,0,1,calcitriol binding,MF,
19140,GO:1902099,1,0.722409411500379,0,48,regulation of metaphase/anaphase transition of cell cycle,BP,
19141,GO:1902100,1,0.803431334388319,0,32,negative regulation of metaphase/anaphase transition of cell cycle,BP,
19142,GO:1902101,1,0.948645602448063,0,8,positive regulation of metaphase/anaphase transition of cell cycle,BP,
19143,GO:1902102,1,0.992781274983959,0,1,regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
19144,GO:1902103,1,0.992781274983959,0,1,negative regulation of metaphase/anaphase transition of meiotic cell cycle,BP,
19147,GO:1902107,1,0.46571413822205,0,118,positive regulation of leukocyte differentiation,BP,
19149,GO:1902109,1,0.986628333325437,0,3,negative regulation of mitochondrial membrane permeability involved in apoptotic process,BP,
19151,GO:1902115,1,0.339551274398754,0,149,regulation of organelle assembly,BP,
19152,GO:1902116,1,0.808699271770105,0,31,negative regulation of organelle assembly,BP,
19153,GO:1902117,1,0.644759304025075,0,58,positive regulation of organelle assembly,BP,
19154,GO:1902121,1,0.992258462460885,0,1,lithocholic acid binding,MF,
19155,GO:1902122,1,0.994287414484928,0,1,chenodeoxycholic acid binding,MF,
19156,GO:1902159,1,0.988760536918077,0,2,regulation of cyclic nucleotide-gated ion channel activity,BP,
19157,GO:1902161,1,0.991427235493867,0,1,positive regulation of cyclic nucleotide-gated ion channel activity,BP,
19158,GO:1902162,1,0.986302583431345,0,3,regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
19159,GO:1902164,1,0.986302583431345,0,3,positive regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator,BP,
19160,GO:1902165,1,0.930750094011039,0,14,regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
19161,GO:1902166,1,0.939557036533126,0,12,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
19162,GO:1902167,1,0.997762279923933,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator,BP,
19163,GO:1902170,1,0.887237984242502,0,18,cellular response to reactive nitrogen species,BP,
19164,GO:1902172,1,0.969618586670594,0,5,regulation of keratinocyte apoptotic process,BP,
19165,GO:1902174,1,0.981326762296614,0,3,positive regulation of keratinocyte apoptotic process,BP,
19166,GO:1902175,1,0.854464850826772,0,26,regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
19167,GO:1902176,1,0.900039618787435,0,18,negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
19168,GO:1902177,1,0.972041286530434,0,5,positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway,BP,
19171,GO:1902187,1,0.900962580298502,0,14,negative regulation of viral release from host cell,BP,
19173,GO:1902202,1,0.974913323464585,0,4,regulation of hepatocyte growth factor receptor signaling pathway,BP,
19174,GO:1902203,1,0.992134411744048,0,1,negative regulation of hepatocyte growth factor receptor signaling pathway,BP,
19175,GO:1902204,1,0.994610573227019,0,1,positive regulation of hepatocyte growth factor receptor signaling pathway,BP,
19176,GO:1902205,1,0.995333632824751,0,1,regulation of interleukin-2-mediated signaling pathway,BP,
19177,GO:1902206,1,0.995333632824751,0,1,negative regulation of interleukin-2-mediated signaling pathway,BP,
19178,GO:1902211,1,0.993058458973322,0,1,regulation of prolactin signaling pathway,BP,
19179,GO:1902213,1,0.993058458973322,0,1,positive regulation of prolactin signaling pathway,BP,
19180,GO:1902214,1,0.981123620130449,0,3,regulation of interleukin-4-mediated signaling pathway,BP,
19181,GO:1902215,1,0.995333632824751,0,1,negative regulation of interleukin-4-mediated signaling pathway,BP,
19182,GO:1902216,1,0.985724030944478,0,2,positive regulation of interleukin-4-mediated signaling pathway,BP,
19183,GO:1902217,1,0.996183074398141,0,1,erythrocyte apoptotic process,BP,
19184,GO:1902218,1,0.963702607901132,0,6,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
19185,GO:1902219,1,0.966904557317267,0,5,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
19186,GO:1902220,1,0.996689569348466,0,1,positive regulation of intrinsic apoptotic signaling pathway in response to osmotic stress,BP,
19187,GO:1902221,1,0.950315937288447,0,10,erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process,BP,
19188,GO:1902222,1,0.950315937288447,0,10,erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process,BP,
19189,GO:1902224,1,0.925141301704207,0,12,ketone body metabolic process,BP,
19190,GO:1902226,1,0.984849827932957,0,3,regulation of macrophage colony-stimulating factor signaling pathway,BP,
19191,GO:1902227,1,0.991117309737701,0,2,negative regulation of macrophage colony-stimulating factor signaling pathway,BP,
19192,GO:1902228,1,0.993676910461691,0,1,positive regulation of macrophage colony-stimulating factor signaling pathway,BP,
19193,GO:1902229,1,0.824834904829293,0,35,regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
19194,GO:1902230,1,0.854814637278109,0,28,negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
19195,GO:1902231,1,0.971929645133729,0,6,positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage,BP,
19196,GO:1902232,1,0.995333632824751,0,1,regulation of positive thymic T cell selection,BP,
19197,GO:1902233,1,0.995333632824751,0,1,negative regulation of positive thymic T cell selection,BP,
19198,GO:1902235,1,0.835098855529289,0,29,regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,
19199,GO:1902236,1,0.896493563771679,0,17,negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,
19200,GO:1902237,1,0.942587343988369,0,10,positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway,BP,
19201,GO:1902238,1,0.992438915237959,0,1,regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
19202,GO:1902239,1,0.992438915237959,0,1,negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
19203,GO:1902250,1,0.996183074398141,0,1,regulation of erythrocyte apoptotic process,BP,
19204,GO:1902251,1,0.996183074398141,0,1,negative regulation of erythrocyte apoptotic process,BP,
19205,GO:1902253,1,0.881743990338189,0,23,regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
19206,GO:1902254,1,0.90337521089293,0,17,negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
19207,GO:1902255,1,0.987037117451677,0,4,positive regulation of intrinsic apoptotic signaling pathway by p53 class mediator,BP,
19208,GO:1902256,1,0.980099005389561,0,3,regulation of apoptotic process involved in outflow tract morphogenesis,BP,
19209,GO:1902257,1,0.987992457948073,0,2,negative regulation of apoptotic process involved in outflow tract morphogenesis,BP,
19210,GO:1902259,1,0.904759257362182,0,15,regulation of delayed rectifier potassium channel activity,BP,
19211,GO:1902260,1,0.956720758580065,0,7,negative regulation of delayed rectifier potassium channel activity,BP,
19212,GO:1902261,1,0.971279794516774,0,4,positive regulation of delayed rectifier potassium channel activity,BP,
19213,GO:1902262,1,0.972368510097043,0,5,apoptotic process involved in blood vessel morphogenesis,BP,
19214,GO:1902263,1,0.979125694159944,0,3,apoptotic process involved in embryonic digit morphogenesis,BP,
19215,GO:1902267,1,0.974315363617582,0,5,regulation of polyamine transmembrane transport,BP,
19216,GO:1902268,1,0.988624609579043,0,3,negative regulation of polyamine transmembrane transport,BP,
19217,GO:1902269,1,0.985527754960996,0,2,positive regulation of polyamine transmembrane transport,BP,
19218,GO:1902271,1,0.992258462460885,0,1,D3 vitamins binding,MF,
19219,GO:1902275,1,0.316643246623211,0,157,regulation of chromatin organization,BP,
19220,GO:1902282,1,0.949311217209789,0,8,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,MF,
19221,GO:1902283,1,0.992471121987881,0,1,negative regulation of primary amine oxidase activity,BP,
19222,GO:1902284,1,0.766457842847705,0,32,neuron projection extension involved in neuron projection guidance,BP,
19223,GO:1902285,1,0.893272563172038,0,13,semaphorin-plexin signaling pathway involved in neuron projection guidance,BP,
19224,GO:1902287,1,0.900569985484619,0,12,semaphorin-plexin signaling pathway involved in axon guidance,BP,
19225,GO:1902292,1,0.99650789854135,0,1,cell cycle DNA replication initiation,BP,
19226,GO:1902296,1,0.992613390815465,0,1,DNA strand elongation involved in cell cycle DNA replication,BP,
19227,GO:1902298,1,0.98254106042881,0,2,cell cycle DNA replication maintenance of fidelity,BP,
19228,GO:1902299,1,0.983637094796707,0,3,pre-replicative complex assembly involved in cell cycle DNA replication,BP,
19229,GO:1902302,1,0.967380034047297,0,5,regulation of potassium ion export,BP,
19230,GO:1902303,1,0.985469607238791,0,2,negative regulation of potassium ion export,BP,
19231,GO:1902304,1,0.989454874921169,0,2,positive regulation of potassium ion export,BP,
19232,GO:1902305,1,0.687172792664458,0,55,regulation of sodium ion transmembrane transport,BP,
19233,GO:1902306,1,0.914974970025933,0,12,negative regulation of sodium ion transmembrane transport,BP,
19234,GO:1902307,1,0.884895607170183,0,18,positive regulation of sodium ion transmembrane transport,BP,
19235,GO:1902308,1,0.968258448915396,0,5,regulation of peptidyl-serine dephosphorylation,BP,
19236,GO:1902309,1,0.978752553703759,0,3,negative regulation of peptidyl-serine dephosphorylation,BP,
19237,GO:1902310,1,0.989280372910583,0,2,positive regulation of peptidyl-serine dephosphorylation,BP,
19238,GO:1902311,1,0.99517481828068,0,1,regulation of copper ion transmembrane transport,BP,
19239,GO:1902315,1,0.99650789854135,0,1,nuclear cell cycle DNA replication initiation,BP,
19240,GO:1902319,1,0.992613390815465,0,1,DNA strand elongation involved in nuclear cell cycle DNA replication,BP,
19241,GO:1902336,1,0.986151098080956,0,2,positive regulation of retinal ganglion cell axon guidance,BP,
19242,GO:1902337,1,0.94095136527466,0,9,regulation of apoptotic process involved in morphogenesis,BP,
19243,GO:1902338,1,0.965841884364479,0,5,negative regulation of apoptotic process involved in morphogenesis,BP,
19244,GO:1902339,1,0.982084759338733,0,3,positive regulation of apoptotic process involved in morphogenesis,BP,
19245,GO:1902356,1,0.994895992285313,0,1,oxaloacetate(2-) transmembrane transport,BP,
19246,GO:1902358,1,0.922869929381856,0,11,sulfate transmembrane transport,BP,
19247,GO:1902359,1,0.987608222085645,0,2,Notch signaling pathway involved in somitogenesis,BP,
19248,GO:1902362,1,0.99303706715562,0,1,melanocyte apoptotic process,BP,
19249,GO:1902363,1,0.990783868118484,0,1,regulation of protein localization to spindle pole body,BP,
19250,GO:1902365,1,0.990783868118484,0,1,positive regulation of protein localization to spindle pole body,BP,
19251,GO:1902366,1,0.987608222085645,0,2,regulation of Notch signaling pathway involved in somitogenesis,BP,
19252,GO:1902367,1,0.987608222085645,0,2,negative regulation of Notch signaling pathway involved in somitogenesis,BP,
19253,GO:1902369,1,0.73038384555353,0,44,negative regulation of RNA catabolic process,BP,
19254,GO:1902373,1,0.761901736223447,0,38,negative regulation of mRNA catabolic process,BP,
19255,GO:1902378,1,0.99356547104577,0,1,VEGF-activated neuropilin signaling pathway involved in axon guidance,BP,
19256,GO:1902379,1,0.991622634195076,0,1,chemoattractant activity involved in axon guidance,MF,
19257,GO:1902380,1,0.993689104376492,0,1,positive regulation of endoribonuclease activity,BP,
19258,GO:1902387,1,0.993058458973322,0,1,ceramide 1-phosphate binding,MF,
19259,GO:1902388,1,0.993058458973322,0,1,ceramide 1-phosphate transporter activity,MF,
19260,GO:1902389,1,0.993058458973322,0,1,ceramide 1-phosphate transport,BP,
19261,GO:1902396,1,0.992485091367061,0,1,protein localization to bicellular tight junction,BP,
19262,GO:1902400,1,0.672578606569416,0,61,intracellular signal transduction involved in G1 DNA damage checkpoint,BP,
19263,GO:1902402,1,0.667732164884337,0,62,signal transduction involved in mitotic DNA damage checkpoint,BP,
19264,GO:1902403,1,0.667732164884337,0,62,signal transduction involved in mitotic DNA integrity checkpoint,BP,
19265,GO:1902410,1,0.961541443804425,0,6,mitotic cytokinetic process,BP,
19266,GO:1902412,1,0.969465699545457,0,4,regulation of mitotic cytokinesis,BP,
19267,GO:1902414,1,0.939663838799588,0,8,protein localization to cell junction,BP,
19268,GO:1902415,1,0.946805045481127,0,9,regulation of mRNA binding,BP,
19269,GO:1902416,1,0.958199196768996,0,7,positive regulation of mRNA binding,BP,
19270,GO:1902423,1,0.985348385564488,0,2,regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
19271,GO:1902425,1,0.985348385564488,0,2,positive regulation of attachment of mitotic spindle microtubules to kinetochore,BP,
19272,GO:1902426,1,0.993217783511225,0,1,deactivation of mitotic spindle assembly checkpoint,BP,
19273,GO:1902430,1,0.935870942959101,0,9,negative regulation of amyloid-beta formation,BP,
19274,GO:1902442,1,0.992503126248236,0,1,regulation of ripoptosome assembly involved in necroptotic process,BP,
19275,GO:1902443,1,0.992503126248236,0,1,negative regulation of ripoptosome assembly involved in necroptotic process,BP,
19276,GO:1902444,1,0.996491688546935,0,1,riboflavin binding,MF,
19277,GO:1902445,1,0.988172041151993,0,3,regulation of mitochondrial membrane permeability involved in programmed necrotic cell death,BP,
19278,GO:1902455,1,0.959598435189911,0,6,negative regulation of stem cell population maintenance,BP,
19279,GO:1902459,1,0.946495051116009,0,7,positive regulation of stem cell population maintenance,BP,
19280,GO:1902460,1,0.992315764615738,0,1,regulation of mesenchymal stem cell proliferation,BP,
19281,GO:1902462,1,0.992315764615738,0,1,positive regulation of mesenchymal stem cell proliferation,BP,
19282,GO:1902463,1,0.991416534542108,0,2,protein localization to cell leading edge,BP,
19283,GO:1902464,1,0.992377833994214,0,1,regulation of histone H3-K27 trimethylation,BP,
19284,GO:1902466,1,0.992377833994214,0,1,positive regulation of histone H3-K27 trimethylation,BP,
19285,GO:1902473,1,0.942919056416026,0,8,regulation of protein localization to synapse,BP,
19286,GO:1902474,1,0.949513545314666,0,7,positive regulation of protein localization to synapse,BP,
19289,GO:1902480,1,0.993683001499415,0,1,protein localization to mitotic spindle,BP,
19290,GO:1902488,1,0.989856457056912,0,1,cholangiocyte apoptotic process,BP,
19291,GO:1902490,1,0.99468027294805,0,1,regulation of sperm capacitation,BP,
19292,GO:1902493,1,0.563547337919934,0,85,acetyltransferase complex,CC,
19295,GO:1902498,1,0.964003291539787,0,4,regulation of protein autoubiquitination,BP,
19296,GO:1902499,1,0.982623176821455,0,2,positive regulation of protein autoubiquitination,BP,
19297,GO:1902504,1,0.992822651878865,0,1,regulation of signal transduction involved in mitotic G2 DNA damage checkpoint,BP,
19298,GO:1902510,1,0.963424371251866,0,7,regulation of apoptotic DNA fragmentation,BP,
19299,GO:1902511,1,0.993162364409317,0,1,negative regulation of apoptotic DNA fragmentation,BP,
19300,GO:1902512,1,0.988185651530141,0,3,positive regulation of apoptotic DNA fragmentation,BP,
19301,GO:1902513,1,0.955498351521811,0,7,regulation of organelle transport along microtubule,BP,
19302,GO:1902514,1,0.937320363558052,0,9,regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
19303,GO:1902523,1,0.977820113351831,0,3,positive regulation of protein K63-linked ubiquitination,BP,
19304,GO:1902524,1,0.988374686991482,0,2,positive regulation of protein K48-linked ubiquitination,BP,
19305,GO:1902525,1,0.974376797776528,0,5,regulation of protein monoubiquitination,BP,
19306,GO:1902527,1,0.981733726766772,0,4,positive regulation of protein monoubiquitination,BP,
19307,GO:1902528,1,0.990066934750116,0,1,regulation of protein linear polyubiquitination,BP,
19308,GO:1902530,1,0.990066934750116,0,1,positive regulation of protein linear polyubiquitination,BP,
19312,GO:1902544,1,0.989881506082149,0,2,regulation of DNA N-glycosylase activity,BP,
19313,GO:1902546,1,0.997227134670758,0,1,positive regulation of DNA N-glycosylase activity,BP,
19314,GO:1902547,1,0.926112613494812,0,11,regulation of cellular response to vascular endothelial growth factor stimulus,BP,
19315,GO:1902548,1,0.97226261562663,0,4,negative regulation of cellular response to vascular endothelial growth factor stimulus,BP,
19317,GO:1902555,1,0.842626242383923,0,29,endoribonuclease complex,CC,
19318,GO:1902559,1,0.989048726133533,0,2,3'-phospho-5'-adenylyl sulfate transmembrane transport,BP,
19319,GO:1902560,1,0.990698150942483,0,2,GMP reductase complex,CC,
19320,GO:1902562,1,0.771506261520346,0,39,H4 histone acetyltransferase complex,CC,
19321,GO:1902563,1,0.933180803429107,0,10,regulation of neutrophil activation,BP,
19322,GO:1902564,1,0.973665492916807,0,4,negative regulation of neutrophil activation,BP,
19323,GO:1902565,1,0.971656282586284,0,4,positive regulation of neutrophil activation,BP,
19324,GO:1902566,1,0.977601058419515,0,4,regulation of eosinophil activation,BP,
19325,GO:1902567,1,0.988467393969032,0,2,negative regulation of eosinophil activation,BP,
19326,GO:1902568,1,0.989008154560891,0,2,positive regulation of eosinophil activation,BP,
19327,GO:1902569,1,0.994898364058571,0,1,negative regulation of activation of Janus kinase activity,BP,
19328,GO:1902570,1,0.943074641071312,0,10,protein localization to nucleolus,BP,
19329,GO:1902571,1,0.974167836901598,0,6,regulation of serine-type peptidase activity,BP,
19330,GO:1902572,1,0.974167836901598,0,6,negative regulation of serine-type peptidase activity,BP,
19331,GO:1902573,1,0.989540988123595,0,1,positive regulation of serine-type peptidase activity,BP,
19332,GO:1902576,1,0.973533561020684,0,4,negative regulation of nuclear cell cycle DNA replication,BP,
19334,GO:1902581,1,0.970990173398288,0,5,multi-organism cellular localization,BP,
19335,GO:1902583,1,0.970990173398288,0,5,multi-organism intracellular transport,BP,
19336,GO:1902594,1,0.984120792322059,0,2,multi-organism nuclear import,BP,
19337,GO:1902595,1,0.989225282969975,0,2,regulation of DNA replication origin binding,BP,
19339,GO:1902603,1,0.976644270829149,0,4,carnitine transmembrane transport,BP,
19340,GO:1902605,1,0.993119829403495,0,1,heterotrimeric G-protein complex assembly,BP,
19341,GO:1902606,1,0.993621530800084,0,2,regulation of large conductance calcium-activated potassium channel activity,BP,
19342,GO:1902608,1,0.993621530800084,0,2,positive regulation of large conductance calcium-activated potassium channel activity,BP,
19343,GO:1902612,1,0.993112407007883,0,1,regulation of anti-Mullerian hormone signaling pathway,BP,
19344,GO:1902613,1,0.993112407007883,0,1,negative regulation of anti-Mullerian hormone signaling pathway,BP,
19345,GO:1902616,1,0.994941044546944,0,1,acyl carnitine transmembrane transport,BP,
19346,GO:1902617,1,0.968406374365637,0,5,response to fluoride,BP,
19347,GO:1902618,1,0.991539046863078,0,1,cellular response to fluoride,BP,
19348,GO:1902622,1,0.824106938149708,0,37,regulation of neutrophil migration,BP,
19349,GO:1902623,1,0.985242258931905,0,2,negative regulation of neutrophil migration,BP,
19350,GO:1902624,1,0.850952513116477,0,32,positive regulation of neutrophil migration,BP,
19351,GO:1902626,1,0.990415265606563,0,3,assembly of large subunit precursor of preribosome,BP,
19352,GO:1902629,1,0.996099248617713,0,1,regulation of mRNA stability involved in cellular response to UV,BP,
19353,GO:1902630,1,0.982613686927922,0,2,regulation of membrane hyperpolarization,BP,
19354,GO:1902631,1,0.990921322927324,0,1,negative regulation of membrane hyperpolarization,BP,
19355,GO:1902636,1,0.990317057969927,0,2,kinociliary basal body,CC,
19356,GO:1902652,1,0.439391725897459,0,122,secondary alcohol metabolic process,BP,
19357,GO:1902653,1,0.654456395463227,0,63,secondary alcohol biosynthetic process,BP,
19358,GO:1902656,1,0.909925496053989,0,13,calcium ion import into cytosol,BP,
19359,GO:1902659,1,0.983720278334683,0,3,regulation of glucose mediated signaling pathway,BP,
19360,GO:1902661,1,0.983720278334683,0,3,positive regulation of glucose mediated signaling pathway,BP,
19361,GO:1902667,1,0.747400258481334,0,36,regulation of axon guidance,BP,
19362,GO:1902668,1,0.848238939456103,0,21,negative regulation of axon guidance,BP,
19363,GO:1902669,1,0.933137471972619,0,8,positive regulation of axon guidance,BP,
19366,GO:1902683,1,0.982691803825484,0,3,regulation of receptor localization to synapse,BP,
19367,GO:1902684,1,0.996176471697596,0,1,negative regulation of receptor localization to synapse,BP,
19368,GO:1902685,1,0.992418939044868,0,1,positive regulation of receptor localization to synapse,BP,
19371,GO:1902710,1,0.881936291087768,0,17,GABA receptor complex,CC,
19372,GO:1902711,1,0.88937501210774,0,16,GABA-A receptor complex,CC,
19373,GO:1902713,1,0.949894126670843,0,8,regulation of interferon-gamma secretion,BP,
19374,GO:1902714,1,0.987486912858592,0,2,negative regulation of interferon-gamma secretion,BP,
19375,GO:1902715,1,0.961935553807032,0,6,positive regulation of interferon-gamma secretion,BP,
19377,GO:1902723,1,0.978047078465504,0,3,negative regulation of skeletal muscle satellite cell proliferation,BP,
19378,GO:1902724,1,0.984150045723318,0,2,positive regulation of skeletal muscle satellite cell proliferation,BP,
19379,GO:1902725,1,0.97685603733504,0,3,negative regulation of satellite cell differentiation,BP,
19380,GO:1902728,1,0.984150045723318,0,2,positive regulation of growth factor dependent skeletal muscle satellite cell proliferation,BP,
19381,GO:1902730,1,0.978255305391338,0,3,positive regulation of proteoglycan biosynthetic process,BP,
19382,GO:1902731,1,0.973412961233782,0,3,negative regulation of chondrocyte proliferation,BP,
19384,GO:1902737,1,0.992389759215191,0,1,dendritic filopodium,CC,
19385,GO:1902739,1,0.951353380329704,0,6,regulation of interferon-alpha secretion,BP,
19386,GO:1902741,1,0.951353380329704,0,6,positive regulation of interferon-alpha secretion,BP,
19387,GO:1902742,1,0.815004599565399,0,29,apoptotic process involved in development,BP,
19389,GO:1902744,1,0.968906014911026,0,4,negative regulation of lamellipodium organization,BP,
19391,GO:1902746,1,0.978185601756498,0,3,regulation of lens fiber cell differentiation,BP,
19392,GO:1902747,1,0.994692103991625,0,1,negative regulation of lens fiber cell differentiation,BP,
19393,GO:1902748,1,0.989628102769887,0,1,positive regulation of lens fiber cell differentiation,BP,
19394,GO:1902749,1,0.273612066342118,0,202,regulation of cell cycle G2/M phase transition,BP,
19395,GO:1902750,1,0.581775085738939,0,96,negative regulation of cell cycle G2/M phase transition,BP,
19396,GO:1902751,1,0.848276846455106,0,25,positive regulation of cell cycle G2/M phase transition,BP,
19397,GO:1902766,1,0.991029820973585,0,2,skeletal muscle satellite cell migration,BP,
19398,GO:1902767,1,0.986315665145128,0,2,isoprenoid biosynthetic process via mevalonate,BP,
19399,GO:1902769,1,0.988630859643084,0,1,regulation of choline O-acetyltransferase activity,BP,
19400,GO:1902771,1,0.988630859643084,0,1,positive regulation of choline O-acetyltransferase activity,BP,
19401,GO:1902773,1,0.992775261717837,0,1,GTPase activator complex,CC,
19402,GO:1902774,1,0.952495417164946,0,7,late endosome to lysosome transport,BP,
19403,GO:1902775,1,0.976951768199011,0,3,mitochondrial large ribosomal subunit assembly,BP,
19404,GO:1902803,1,0.821148221829876,0,27,regulation of synaptic vesicle transport,BP,
19405,GO:1902804,1,0.976582604240377,0,4,negative regulation of synaptic vesicle transport,BP,
19406,GO:1902805,1,0.975955423971251,0,3,positive regulation of synaptic vesicle transport,BP,
19409,GO:1902808,1,0.798428822621179,0,34,positive regulation of cell cycle G1/S phase transition,BP,
19410,GO:1902809,1,0.981100761869414,0,3,regulation of skeletal muscle fiber differentiation,BP,
19411,GO:1902811,1,0.988085468776987,0,2,positive regulation of skeletal muscle fiber differentiation,BP,
19412,GO:1902816,1,0.97123586005355,0,4,regulation of protein localization to microtubule,BP,
19413,GO:1902817,1,0.97123586005355,0,4,negative regulation of protein localization to microtubule,BP,
19414,GO:1902822,1,0.973936612814489,0,4,regulation of late endosome to lysosome transport,BP,
19415,GO:1902823,1,0.982262950634118,0,2,negative regulation of late endosome to lysosome transport,BP,
19416,GO:1902824,1,0.991524822492966,0,2,positive regulation of late endosome to lysosome transport,BP,
19417,GO:1902838,1,0.992035648124119,0,1,regulation of nuclear migration along microtubule,BP,
19418,GO:1902846,1,0.990783868118484,0,1,positive regulation of mitotic spindle elongation,BP,
19419,GO:1902847,1,0.992976821212928,0,1,regulation of neuronal signal transduction,BP,
19420,GO:1902850,1,0.410351756642491,0,125,microtubule cytoskeleton organization involved in mitosis,BP,
19421,GO:1902855,1,0.933025933605136,0,10,regulation of non-motile cilium assembly,BP,
19422,GO:1902856,1,0.984607683435314,0,2,negative regulation of non-motile cilium assembly,BP,
19423,GO:1902857,1,0.953791308184874,0,7,positive regulation of non-motile cilium assembly,BP,
19424,GO:1902858,1,0.994310435915199,0,1,propionyl-CoA metabolic process,BP,
19425,GO:1902860,1,0.994310435915199,0,1,propionyl-CoA biosynthetic process,BP,
19426,GO:1902866,1,0.959864785563085,0,6,regulation of retina development in camera-type eye,BP,
19427,GO:1902867,1,0.992699999157039,0,1,negative regulation of retina development in camera-type eye,BP,
19428,GO:1902868,1,0.987980382263189,0,2,positive regulation of retina development in camera-type eye,BP,
19429,GO:1902869,1,0.980767255693758,0,3,regulation of amacrine cell differentiation,BP,
19430,GO:1902870,1,0.992699999157039,0,1,negative regulation of amacrine cell differentiation,BP,
19431,GO:1902871,1,0.987980382263189,0,2,positive regulation of amacrine cell differentiation,BP,
19432,GO:1902882,1,0.617644117445921,0,74,regulation of response to oxidative stress,BP,
19433,GO:1902883,1,0.766843609054611,0,41,negative regulation of response to oxidative stress,BP,
19434,GO:1902884,1,0.905613715060989,0,16,positive regulation of response to oxidative stress,BP,
19435,GO:1902889,1,0.991012416566479,0,1,protein localization to spindle microtubule,BP,
19436,GO:1902890,1,0.997356194534619,0,1,regulation of root hair elongation,BP,
19437,GO:1902891,1,0.997356194534619,0,1,negative regulation of root hair elongation,BP,
19438,GO:1902893,1,0.792271808968119,0,31,regulation of pri-miRNA transcription by RNA polymerase II,BP,
19439,GO:1902894,1,0.915107274384148,0,11,negative regulation of pri-miRNA transcription by RNA polymerase II,BP,
19440,GO:1902895,1,0.853217418575119,0,22,positive regulation of pri-miRNA transcription by RNA polymerase II,BP,
19441,GO:1902896,1,0.978463918504063,0,3,terminal web assembly,BP,
19442,GO:1902897,1,0.979671215896747,0,3,regulation of postsynaptic density protein 95 clustering,BP,
19443,GO:1902902,1,0.931911840318895,0,11,negative regulation of autophagosome assembly,BP,
19447,GO:1902908,1,0.98779587418151,0,2,regulation of melanosome transport,BP,
19448,GO:1902910,1,0.99241567941278,0,1,positive regulation of melanosome transport,BP,
19450,GO:1902912,1,0.993058458973322,0,1,pyruvate kinase complex,CC,
19451,GO:1902913,1,0.992683518576315,0,1,positive regulation of neuroepithelial cell differentiation,BP,
19452,GO:1902914,1,0.888705828270867,0,16,regulation of protein polyubiquitination,BP,
19453,GO:1902915,1,0.9524776531284,0,6,negative regulation of protein polyubiquitination,BP,
19454,GO:1902916,1,0.942058293636296,0,9,positive regulation of protein polyubiquitination,BP,
19455,GO:1902930,1,0.668066293923557,0,59,regulation of alcohol biosynthetic process,BP,
19456,GO:1902931,1,0.947137945093281,0,9,negative regulation of alcohol biosynthetic process,BP,
19457,GO:1902932,1,0.895367128256007,0,17,positive regulation of alcohol biosynthetic process,BP,
19459,GO:1902937,1,0.979427466655332,0,3,inward rectifier potassium channel complex,CC,
19460,GO:1902938,1,0.976609357278037,0,3,regulation of intracellular calcium activated chloride channel activity,BP,
19461,GO:1902939,1,0.992920307794521,0,1,negative regulation of intracellular calcium activated chloride channel activity,BP,
19462,GO:1902941,1,0.983941832087117,0,2,regulation of voltage-gated chloride channel activity,BP,
19463,GO:1902943,1,0.983941832087117,0,2,positive regulation of voltage-gated chloride channel activity,BP,
19464,GO:1902946,1,0.936460198535446,0,8,protein localization to early endosome,BP,
19465,GO:1902947,1,0.957928237003111,0,6,regulation of tau-protein kinase activity,BP,
19466,GO:1902948,1,0.988630859643084,0,1,negative regulation of tau-protein kinase activity,BP,
19467,GO:1902949,1,0.974196071563638,0,4,positive regulation of tau-protein kinase activity,BP,
19468,GO:1902950,1,0.942947591690609,0,9,regulation of dendritic spine maintenance,BP,
19469,GO:1902951,1,0.97928462777602,0,3,negative regulation of dendritic spine maintenance,BP,
19470,GO:1902952,1,0.981210559254053,0,3,positive regulation of dendritic spine maintenance,BP,
19471,GO:1902953,1,0.970263308237203,0,4,positive regulation of ER to Golgi vesicle-mediated transport,BP,
19472,GO:1902954,1,0.979285664958286,0,2,regulation of early endosome to recycling endosome transport,BP,
19473,GO:1902955,1,0.988630859643084,0,1,positive regulation of early endosome to recycling endosome transport,BP,
19474,GO:1902956,1,0.98304737207897,0,3,regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
19475,GO:1902957,1,0.992679397096388,0,1,negative regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
19476,GO:1902958,1,0.990297652745539,0,2,positive regulation of mitochondrial electron transport, NADH to ubiquinone,BP,
19477,GO:1902959,1,0.942696576218276,0,8,regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19478,GO:1902960,1,0.982602645666191,0,2,negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19479,GO:1902961,1,0.959394353191167,0,6,positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19480,GO:1902962,1,0.981211873974901,0,2,regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19481,GO:1902963,1,0.981211873974901,0,2,negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process,BP,
19482,GO:1902965,1,0.950130290272848,0,6,regulation of protein localization to early endosome,BP,
19483,GO:1902966,1,0.950130290272848,0,6,positive regulation of protein localization to early endosome,BP,
19484,GO:1902969,1,0.939986849502463,0,9,mitotic DNA replication,BP,
19485,GO:1902975,1,0.99650789854135,0,1,mitotic DNA replication initiation,BP,
19486,GO:1902977,1,0.994817711096688,0,1,mitotic DNA replication preinitiation complex assembly,BP,
19487,GO:1902983,1,0.992613390815465,0,1,DNA strand elongation involved in mitotic DNA replication,BP,
19488,GO:1902988,1,0.973503935928557,0,3,neurofibrillary tangle assembly,BP,
19489,GO:1902990,1,0.980966782475091,0,3,mitotic telomere maintenance via semi-conservative replication,BP,
19491,GO:1902992,1,0.922604542717488,0,11,negative regulation of amyloid precursor protein catabolic process,BP,
19492,GO:1902993,1,0.920531272019265,0,12,positive regulation of amyloid precursor protein catabolic process,BP,
19493,GO:1902994,1,0.987534435085022,0,2,regulation of phospholipid efflux,BP,
19494,GO:1902995,1,0.987534435085022,0,2,positive regulation of phospholipid efflux,BP,
19495,GO:1902996,1,0.981686738448549,0,2,regulation of neurofibrillary tangle assembly,BP,
19496,GO:1902997,1,0.988630859643084,0,1,negative regulation of neurofibrillary tangle assembly,BP,
19497,GO:1902998,1,0.992976821212928,0,1,positive regulation of neurofibrillary tangle assembly,BP,
19498,GO:1903000,1,0.996510058796768,0,1,regulation of lipid transport across blood brain barrier,BP,
19499,GO:1903002,1,0.996510058796768,0,1,positive regulation of lipid transport across blood brain barrier,BP,
19500,GO:1903003,1,0.959904184402232,0,6,positive regulation of protein deubiquitination,BP,
19501,GO:1903004,1,0.992489152328139,0,1,regulation of protein K63-linked deubiquitination,BP,
19502,GO:1903006,1,0.992489152328139,0,1,positive regulation of protein K63-linked deubiquitination,BP,
19503,GO:1903007,1,0.992489152328139,0,1,positive regulation of Lys63-specific deubiquitinase activity,BP,
19504,GO:1903008,1,0.516375240706482,0,100,organelle disassembly,BP,
19508,GO:1903015,1,0.990191949294809,0,2,regulation of exo-alpha-sialidase activity,BP,
19509,GO:1903016,1,0.994789249680222,0,1,negative regulation of exo-alpha-sialidase activity,BP,
19510,GO:1903017,1,0.995378860140206,0,1,positive regulation of exo-alpha-sialidase activity,BP,
19511,GO:1903018,1,0.778350173734289,0,40,regulation of glycoprotein metabolic process,BP,
19512,GO:1903019,1,0.93355267743212,0,12,negative regulation of glycoprotein metabolic process,BP,
19513,GO:1903020,1,0.868931714624148,0,21,positive regulation of glycoprotein metabolic process,BP,
19514,GO:1903025,1,0.949749072248203,0,9,regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
19515,GO:1903026,1,0.979703755240023,0,5,negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
19516,GO:1903027,1,0.984682628745034,0,2,regulation of opsonization,BP,
19517,GO:1903028,1,0.990548409793461,0,1,positive regulation of opsonization,BP,
19518,GO:1903031,1,0.988284229108496,0,2,regulation of microtubule plus-end binding,BP,
19519,GO:1903033,1,0.988284229108496,0,2,positive regulation of microtubule plus-end binding,BP,
19526,GO:1903044,1,0.949147567708903,0,8,protein localization to membrane raft,BP,
19527,GO:1903045,1,0.991730055604424,0,1,neural crest cell migration involved in sympathetic nervous system development,BP,
19528,GO:1903046,1,0.348140377895885,0,156,meiotic cell cycle process,BP,
19533,GO:1903053,1,0.811291746671373,0,28,regulation of extracellular matrix organization,BP,
19534,GO:1903054,1,0.964879353280047,0,6,negative regulation of extracellular matrix organization,BP,
19535,GO:1903055,1,0.893154987986014,0,15,positive regulation of extracellular matrix organization,BP,
19536,GO:1903056,1,0.985021144983131,0,2,regulation of melanosome organization,BP,
19537,GO:1903059,1,0.968099995132233,0,5,regulation of protein lipidation,BP,
19538,GO:1903060,1,0.995075918256662,0,1,negative regulation of protein lipidation,BP,
19539,GO:1903061,1,0.972891909102333,0,4,positive regulation of protein lipidation,BP,
19540,GO:1903069,1,0.945107322345134,0,9,regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
19541,GO:1903070,1,0.98251054106734,0,3,negative regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
19542,GO:1903071,1,0.956068437915023,0,7,positive regulation of ER-associated ubiquitin-dependent protein catabolic process,BP,
19543,GO:1903072,1,0.997032233810024,0,1,regulation of death-inducing signaling complex assembly,BP,
19544,GO:1903073,1,0.997032233810024,0,1,negative regulation of death-inducing signaling complex assembly,BP,
19546,GO:1903077,1,0.861883434263671,0,22,negative regulation of protein localization to plasma membrane,BP,
19548,GO:1903080,1,0.996782430484662,0,1,regulation of C-C chemokine receptor CCR7 signaling pathway,BP,
19549,GO:1903082,1,0.996782430484662,0,1,positive regulation of C-C chemokine receptor CCR7 signaling pathway,BP,
19550,GO:1903093,1,0.984226761236192,0,3,regulation of protein K48-linked deubiquitination,BP,
19551,GO:1903094,1,0.993307507823352,0,2,negative regulation of protein K48-linked deubiquitination,BP,
19552,GO:1903095,1,0.985476596623959,0,2,ribonuclease III complex,CC,
19553,GO:1903096,1,0.992781274983959,0,1,protein localization to meiotic spindle midzone,BP,
19554,GO:1903108,1,0.992060194717323,0,1,regulation of mitochondrial transcription,BP,
19555,GO:1903109,1,0.992060194717323,0,1,positive regulation of mitochondrial transcription,BP,
19557,GO:1903116,1,0.977468484336281,0,3,positive regulation of actin filament-based movement,BP,
19558,GO:1903119,1,0.977684815872658,0,3,protein localization to actin cytoskeleton,BP,
19559,GO:1903121,1,0.975422259236217,0,4,regulation of TRAIL-activated apoptotic signaling pathway,BP,
19560,GO:1903122,1,0.997032233810024,0,1,negative regulation of TRAIL-activated apoptotic signaling pathway,BP,
19561,GO:1903123,1,0.989575106505612,0,1,regulation of thioredoxin peroxidase activity,BP,
19562,GO:1903124,1,0.989575106505612,0,1,negative regulation of thioredoxin peroxidase activity,BP,
19563,GO:1903125,1,0.989575106505612,0,1,negative regulation of thioredoxin peroxidase activity by peptidyl-threonine phosphorylation,BP,
19564,GO:1903126,1,0.99432427702669,0,1,negative regulation of centriole-centriole cohesion,BP,
19565,GO:1903131,1,0.814309054269328,0,30,mononuclear cell differentiation,BP,
19566,GO:1903135,1,0.982735346490549,0,3,cupric ion binding,MF,
19567,GO:1903136,1,0.967458623690313,0,6,cuprous ion binding,MF,
19568,GO:1903140,1,0.922716378771583,0,12,regulation of establishment of endothelial barrier,BP,
19569,GO:1903141,1,0.992437291389907,0,1,negative regulation of establishment of endothelial barrier,BP,
19570,GO:1903142,1,0.967643322489195,0,5,positive regulation of establishment of endothelial barrier,BP,
19571,GO:1903143,1,0.985679003702621,0,3,adrenomedullin receptor complex,CC,
19572,GO:1903146,1,0.739338198179684,0,44,regulation of autophagy of mitochondrion,BP,
19573,GO:1903147,1,0.953171783217321,0,7,negative regulation of autophagy of mitochondrion,BP,
19574,GO:1903165,1,0.993192938376038,0,1,response to polycyclic arene,BP,
19575,GO:1903167,1,0.997032233810024,0,1,regulation of pyrroline-5-carboxylate reductase activity,BP,
19576,GO:1903168,1,0.997032233810024,0,1,positive regulation of pyrroline-5-carboxylate reductase activity,BP,
19577,GO:1903169,1,0.431464830692959,0,124,regulation of calcium ion transmembrane transport,BP,
19578,GO:1903170,1,0.811435950054939,0,34,negative regulation of calcium ion transmembrane transport,BP,
19579,GO:1903173,1,0.987464530146545,0,2,fatty alcohol metabolic process,BP,
19580,GO:1903176,1,0.997032233810024,0,1,regulation of tyrosine 3-monooxygenase activity,BP,
19581,GO:1903178,1,0.997032233810024,0,1,positive regulation of tyrosine 3-monooxygenase activity,BP,
19582,GO:1903179,1,0.989665524881716,0,2,regulation of dopamine biosynthetic process,BP,
19583,GO:1903181,1,0.989665524881716,0,2,positive regulation of dopamine biosynthetic process,BP,
19584,GO:1903182,1,0.996460308534979,0,1,regulation of SUMO transferase activity,BP,
19585,GO:1903184,1,0.997032233810024,0,1,L-dopa metabolic process,BP,
19586,GO:1903185,1,0.997032233810024,0,1,L-dopa biosynthetic process,BP,
19587,GO:1903189,1,0.997032233810024,0,1,glyoxal metabolic process,BP,
19588,GO:1903195,1,0.997032233810024,0,1,regulation of L-dopa biosynthetic process,BP,
19589,GO:1903197,1,0.997032233810024,0,1,positive regulation of L-dopa biosynthetic process,BP,
19590,GO:1903198,1,0.997032233810024,0,1,regulation of L-dopa decarboxylase activity,BP,
19591,GO:1903200,1,0.997032233810024,0,1,positive regulation of L-dopa decarboxylase activity,BP,
19592,GO:1903201,1,0.689440846315155,0,57,regulation of oxidative stress-induced cell death,BP,
19593,GO:1903202,1,0.777904879313424,0,39,negative regulation of oxidative stress-induced cell death,BP,
19594,GO:1903203,1,0.867153791027883,0,20,regulation of oxidative stress-induced neuron death,BP,
19595,GO:1903204,1,0.901997908456457,0,15,negative regulation of oxidative stress-induced neuron death,BP,
19596,GO:1903205,1,0.854891800039774,0,24,regulation of hydrogen peroxide-induced cell death,BP,
19597,GO:1903206,1,0.89585555176734,0,17,negative regulation of hydrogen peroxide-induced cell death,BP,
19598,GO:1903207,1,0.977906521159045,0,4,regulation of hydrogen peroxide-induced neuron death,BP,
19599,GO:1903208,1,0.977906521159045,0,4,negative regulation of hydrogen peroxide-induced neuron death,BP,
19600,GO:1903209,1,0.920145032205333,0,13,positive regulation of oxidative stress-induced cell death,BP,
19601,GO:1903210,1,0.991319662364429,0,1,glomerular visceral epithelial cell apoptotic process,BP,
19602,GO:1903214,1,0.595967069751807,0,82,regulation of protein targeting to mitochondrion,BP,
19603,GO:1903215,1,0.973053136239416,0,4,negative regulation of protein targeting to mitochondrion,BP,
19604,GO:1903216,1,0.9861404160696,0,2,regulation of protein processing involved in protein targeting to mitochondrion,BP,
19605,GO:1903217,1,0.9861404160696,0,2,negative regulation of protein processing involved in protein targeting to mitochondrion,BP,
19606,GO:1903223,1,0.968701952889912,0,4,positive regulation of oxidative stress-induced neuron death,BP,
19607,GO:1903224,1,0.966395319586671,0,5,regulation of endodermal cell differentiation,BP,
19608,GO:1903225,1,0.977648835289191,0,3,negative regulation of endodermal cell differentiation,BP,
19609,GO:1903232,1,0.97565321595037,0,5,melanosome assembly,BP,
19610,GO:1903233,1,0.982391000293928,0,2,regulation of calcium ion-dependent exocytosis of neurotransmitter,BP,
19611,GO:1903236,1,0.961502032837935,0,8,regulation of leukocyte tethering or rolling,BP,
19612,GO:1903237,1,0.986427855136564,0,4,negative regulation of leukocyte tethering or rolling,BP,
19613,GO:1903238,1,0.974734645679275,0,4,positive regulation of leukocyte tethering or rolling,BP,
19614,GO:1903242,1,0.93811704464393,0,8,regulation of cardiac muscle hypertrophy in response to stress,BP,
19615,GO:1903243,1,0.952506856417658,0,6,negative regulation of cardiac muscle hypertrophy in response to stress,BP,
19616,GO:1903244,1,0.984899980783645,0,2,positive regulation of cardiac muscle hypertrophy in response to stress,BP,
19617,GO:1903248,1,0.989824462282673,0,1,regulation of citrulline biosynthetic process,BP,
19618,GO:1903249,1,0.989824462282673,0,1,negative regulation of citrulline biosynthetic process,BP,
19619,GO:1903251,1,0.962947666263759,0,6,multi-ciliated epithelial cell differentiation,BP,
19620,GO:1903265,1,0.954488992209248,0,8,positive regulation of tumor necrosis factor-mediated signaling pathway,BP,
19621,GO:1903276,1,0.980493272740991,0,4,regulation of sodium ion export across plasma membrane,BP,
19622,GO:1903278,1,0.980493272740991,0,4,positive regulation of sodium ion export across plasma membrane,BP,
19623,GO:1903279,1,0.979228084570305,0,3,regulation of calcium:sodium antiporter activity,BP,
19624,GO:1903280,1,0.991848516624445,0,1,negative regulation of calcium:sodium antiporter activity,BP,
19625,GO:1903281,1,0.987276881441673,0,2,positive regulation of calcium:sodium antiporter activity,BP,
19626,GO:1903282,1,0.992679397096388,0,1,regulation of glutathione peroxidase activity,BP,
19627,GO:1903284,1,0.992679397096388,0,1,positive regulation of glutathione peroxidase activity,BP,
19628,GO:1903285,1,0.992679397096388,0,1,positive regulation of hydrogen peroxide catabolic process,BP,
19629,GO:1903286,1,0.974839057590821,0,4,regulation of potassium ion import,BP,
19630,GO:1903288,1,0.982593960878083,0,3,positive regulation of potassium ion import,BP,
19631,GO:1903292,1,0.985473540462138,0,2,protein localization to Golgi membrane,BP,
19632,GO:1903293,1,0.737365095507474,0,44,phosphatase complex,CC,
19633,GO:1903294,1,0.984691374972402,0,2,regulation of glutamate secretion, neurotransmission,BP,
19634,GO:1903296,1,0.984691374972402,0,2,positive regulation of glutamate secretion, neurotransmission,BP,
19635,GO:1903297,1,0.969808438572403,0,5,regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
19636,GO:1903298,1,0.969808438572403,0,5,negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway,BP,
19637,GO:1903299,1,0.946742651430078,0,9,regulation of hexokinase activity,BP,
19638,GO:1903300,1,0.977216398808857,0,4,negative regulation of hexokinase activity,BP,
19639,GO:1903301,1,0.968822841290344,0,5,positive regulation of hexokinase activity,BP,
19640,GO:1903305,1,0.451243840260051,0,116,regulation of regulated secretory pathway,BP,
19641,GO:1903306,1,0.873870126271897,0,20,negative regulation of regulated secretory pathway,BP,
19642,GO:1903307,1,0.740494311891292,0,46,positive regulation of regulated secretory pathway,BP,
19643,GO:1903311,1,0.168326845496733,0,271,regulation of mRNA metabolic process,BP,
19644,GO:1903312,1,0.620856529127706,0,68,negative regulation of mRNA metabolic process,BP,
19645,GO:1903313,1,0.646249176194489,0,62,positive regulation of mRNA metabolic process,BP,
19646,GO:1903314,1,0.994287414484928,0,1,regulation of nitrogen cycle metabolic process,BP,
19648,GO:1903318,1,0.788196670495924,0,35,negative regulation of protein maturation,BP,
19652,GO:1903322,1,0.475953821070581,0,114,positive regulation of protein modification by small protein conjugation or removal,BP,
19653,GO:1903332,1,0.957291859507841,0,7,regulation of protein folding,BP,
19654,GO:1903333,1,0.970926010498336,0,5,negative regulation of protein folding,BP,
19655,GO:1903335,1,0.973936612814489,0,4,regulation of vacuolar transport,BP,
19656,GO:1903336,1,0.982262950634118,0,2,negative regulation of vacuolar transport,BP,
19657,GO:1903337,1,0.991524822492966,0,2,positive regulation of vacuolar transport,BP,
19658,GO:1903347,1,0.970585894908897,0,4,negative regulation of bicellular tight junction assembly,BP,
19659,GO:1903348,1,0.978051925928108,0,3,positive regulation of bicellular tight junction assembly,BP,
19660,GO:1903349,1,0.959550344136347,0,6,omegasome membrane,CC,
19661,GO:1903350,1,0.912070480741865,0,13,response to dopamine,BP,
19662,GO:1903351,1,0.912070480741865,0,13,cellular response to dopamine,BP,
19663,GO:1903352,1,0.958336504408226,0,6,L-ornithine transmembrane transport,BP,
19664,GO:1903358,1,0.899401475647496,0,15,regulation of Golgi organization,BP,
19665,GO:1903361,1,0.963573626564843,0,7,protein localization to basolateral plasma membrane,BP,
19671,GO:1903371,1,0.967733065629039,0,4,regulation of endoplasmic reticulum tubular network organization,BP,
19672,GO:1903373,1,0.977040718580734,0,3,positive regulation of endoplasmic reticulum tubular network organization,BP,
19673,GO:1903375,1,0.98534821193752,0,2,facioacoustic ganglion development,BP,
19674,GO:1903376,1,0.953879624218704,0,7,regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19675,GO:1903377,1,0.97570821187483,0,4,negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19676,GO:1903378,1,0.985048080086074,0,2,positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19677,GO:1903381,1,0.992324049087638,0,1,regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19678,GO:1903382,1,0.992324049087638,0,1,negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway,BP,
19679,GO:1903383,1,0.990297652745539,0,2,regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
19680,GO:1903384,1,0.990297652745539,0,2,negative regulation of hydrogen peroxide-induced neuron intrinsic apoptotic signaling pathway,BP,
19681,GO:1903385,1,0.984570981386085,0,2,regulation of homophilic cell adhesion,BP,
19682,GO:1903387,1,0.991962163867704,0,1,positive regulation of homophilic cell adhesion,BP,
19685,GO:1903393,1,0.827679928118257,0,25,positive regulation of adherens junction organization,BP,
19686,GO:1903394,1,0.993836823501135,0,1,protein localization to kinetochore involved in kinetochore assembly,BP,
19687,GO:1903400,1,0.963079551372743,0,5,L-arginine transmembrane transport,BP,
19688,GO:1903401,1,0.967168132170594,0,5,L-lysine transmembrane transport,BP,
19689,GO:1903402,1,0.992488626920326,0,1,regulation of renal phosphate excretion,BP,
19690,GO:1903403,1,0.992488626920326,0,1,negative regulation of renal phosphate excretion,BP,
19691,GO:1903405,1,0.948639489576539,0,9,protein localization to nuclear body,BP,
19692,GO:1903406,1,0.992515812703208,0,1,regulation of sodium:potassium-exchanging ATPase activity,BP,
19693,GO:1903408,1,0.992515812703208,0,1,positive regulation of sodium:potassium-exchanging ATPase activity,BP,
19695,GO:1903412,1,0.986379829412782,0,3,response to bile acid,BP,
19696,GO:1903413,1,0.986379829412782,0,3,cellular response to bile acid,BP,
19697,GO:1903414,1,0.992586444087196,0,1,iron cation export,BP,
19698,GO:1903416,1,0.959086520898677,0,6,response to glycoside,BP,
19699,GO:1903420,1,0.991266679207539,0,1,protein localization to endoplasmic reticulum tubular network,BP,
19700,GO:1903421,1,0.890923190011878,0,15,regulation of synaptic vesicle recycling,BP,
19701,GO:1903422,1,0.984372143598395,0,2,negative regulation of synaptic vesicle recycling,BP,
19702,GO:1903423,1,0.945062209221026,0,7,positive regulation of synaptic vesicle recycling,BP,
19703,GO:1903426,1,0.656546224602009,0,65,regulation of reactive oxygen species biosynthetic process,BP,
19704,GO:1903427,1,0.878465054986632,0,21,negative regulation of reactive oxygen species biosynthetic process,BP,
19705,GO:1903428,1,0.758104308215073,0,42,positive regulation of reactive oxygen species biosynthetic process,BP,
19706,GO:1903429,1,0.874129538200379,0,20,regulation of cell maturation,BP,
19707,GO:1903430,1,0.961462083087686,0,7,negative regulation of cell maturation,BP,
19708,GO:1903431,1,0.947875015619866,0,7,positive regulation of cell maturation,BP,
19709,GO:1903432,1,0.845801265454128,0,25,regulation of TORC1 signaling,BP,
19710,GO:1903433,1,0.985575869096134,0,2,regulation of constitutive secretory pathway,BP,
19711,GO:1903434,1,0.992490406238745,0,1,negative regulation of constitutive secretory pathway,BP,
19712,GO:1903435,1,0.993033667586533,0,1,positive regulation of constitutive secretory pathway,BP,
19713,GO:1903436,1,0.98397665757088,0,2,regulation of mitotic cytokinetic process,BP,
19714,GO:1903438,1,0.98397665757088,0,2,positive regulation of mitotic cytokinetic process,BP,
19715,GO:1903439,1,0.975458242830809,0,5,calcitonin family receptor complex,CC,
19716,GO:1903440,1,0.983209076284829,0,4,amylin receptor complex,CC,
19717,GO:1903441,1,0.945955735635795,0,8,protein localization to ciliary membrane,BP,
19718,GO:1903442,1,0.992493728080011,0,1,response to lipoic acid,BP,
19719,GO:1903444,1,0.992686411033338,0,1,negative regulation of brown fat cell differentiation,BP,
19720,GO:1903445,1,0.985404396377233,0,3,protein transport from ciliary membrane to plasma membrane,BP,
19721,GO:1903450,1,0.989938541535042,0,1,regulation of G1 to G0 transition,BP,
19722,GO:1903452,1,0.989938541535042,0,1,positive regulation of G1 to G0 transition,BP,
19723,GO:1903461,1,0.992721863402914,0,1,Okazaki fragment processing involved in mitotic DNA replication,BP,
19724,GO:1903463,1,0.979367020415396,0,3,regulation of mitotic cell cycle DNA replication,BP,
19725,GO:1903464,1,0.987520648524249,0,2,negative regulation of mitotic cell cycle DNA replication,BP,
19726,GO:1903465,1,0.991744366024575,0,1,positive regulation of mitotic cell cycle DNA replication,BP,
19727,GO:1903487,1,0.98766295587765,0,2,regulation of lactation,BP,
19728,GO:1903489,1,0.995093615990103,0,1,positive regulation of lactation,BP,
19729,GO:1903490,1,0.98397665757088,0,2,positive regulation of mitotic cytokinesis,BP,
19730,GO:1903494,1,0.996937317313033,0,1,response to dehydroepiandrosterone,BP,
19731,GO:1903496,1,0.996937317313033,0,1,response to 11-deoxycorticosterone,BP,
19732,GO:1903504,1,0.91227253710338,0,14,regulation of mitotic spindle checkpoint,BP,
19738,GO:1903513,1,0.843404720802432,0,26,endoplasmic reticulum to cytosol transport,BP,
19739,GO:1903514,1,0.805299878889953,0,29,release of sequestered calcium ion into cytosol by endoplasmic reticulum,BP,
19740,GO:1903515,1,0.990165646669906,0,1,calcium ion transport from cytosol to endoplasmic reticulum,BP,
19741,GO:1903516,1,0.979889576534185,0,3,regulation of single strand break repair,BP,
19742,GO:1903517,1,0.992913450177408,0,1,negative regulation of single strand break repair,BP,
19743,GO:1903518,1,0.986884099753547,0,2,positive regulation of single strand break repair,BP,
19744,GO:1903519,1,0.982084759338733,0,3,regulation of mammary gland involution,BP,
19745,GO:1903521,1,0.982084759338733,0,3,positive regulation of mammary gland involution,BP,
19747,GO:1903523,1,0.82463076954529,0,27,negative regulation of blood circulation,BP,
19749,GO:1903525,1,0.960734286660279,0,5,regulation of membrane tubulation,BP,
19750,GO:1903526,1,0.984946162290386,0,2,negative regulation of membrane tubulation,BP,
19751,GO:1903527,1,0.975421750461863,0,3,positive regulation of membrane tubulation,BP,
19753,GO:1903531,1,0.361026791315391,0,158,negative regulation of secretion by cell,BP,
19756,GO:1903537,1,0.986833750741794,0,2,meiotic cell cycle process involved in oocyte maturation,BP,
19757,GO:1903538,1,0.986833750741794,0,2,regulation of meiotic cell cycle process involved in oocyte maturation,BP,
19758,GO:1903539,1,0.914391533147393,0,12,protein localization to postsynaptic membrane,BP,
19759,GO:1903540,1,0.940822401587091,0,9,establishment of protein localization to postsynaptic membrane,BP,
19760,GO:1903541,1,0.915699086907251,0,14,regulation of exosomal secretion,BP,
19761,GO:1903542,1,0.986717114788424,0,2,negative regulation of exosomal secretion,BP,
19762,GO:1903543,1,0.915699086907251,0,14,positive regulation of exosomal secretion,BP,
19763,GO:1903544,1,0.992565193809675,0,1,response to butyrate,BP,
19764,GO:1903545,1,0.992565193809675,0,1,cellular response to butyrate,BP,
19765,GO:1903546,1,0.959041587637367,0,6,protein localization to photoreceptor outer segment,BP,
19766,GO:1903547,1,0.99317425730572,0,2,regulation of growth hormone activity,BP,
19767,GO:1903551,1,0.961154860688422,0,6,regulation of extracellular exosome assembly,BP,
19768,GO:1903553,1,0.972260915821215,0,4,positive regulation of extracellular exosome assembly,BP,
19771,GO:1903557,1,0.663148966834484,0,66,positive regulation of tumor necrosis factor superfamily cytokine production,BP,
19773,GO:1903564,1,0.967145181243838,0,4,regulation of protein localization to cilium,BP,
19774,GO:1903565,1,0.992569967091373,0,1,negative regulation of protein localization to cilium,BP,
19775,GO:1903566,1,0.974386776626593,0,3,positive regulation of protein localization to cilium,BP,
19776,GO:1903567,1,0.986416471664239,0,2,regulation of protein localization to ciliary membrane,BP,
19777,GO:1903568,1,0.992569967091373,0,1,negative regulation of protein localization to ciliary membrane,BP,
19778,GO:1903569,1,0.993800902447866,0,1,positive regulation of protein localization to ciliary membrane,BP,
19779,GO:1903570,1,0.992538089810412,0,1,regulation of protein kinase D signaling,BP,
19780,GO:1903572,1,0.992538089810412,0,1,positive regulation of protein kinase D signaling,BP,
19781,GO:1903573,1,0.769048278739421,0,40,negative regulation of response to endoplasmic reticulum stress,BP,
19782,GO:1903575,1,0.988481586056312,0,2,cornified envelope assembly,BP,
19783,GO:1903576,1,0.994473081848742,0,1,response to L-arginine,BP,
19784,GO:1903578,1,0.560694438593626,0,83,regulation of ATP metabolic process,BP,
19785,GO:1903579,1,0.881755806066735,0,19,negative regulation of ATP metabolic process,BP,
19786,GO:1903580,1,0.818099368435043,0,29,positive regulation of ATP metabolic process,BP,
19787,GO:1903584,1,0.992386913179088,0,1,regulation of histone deubiquitination,BP,
19788,GO:1903586,1,0.992386913179088,0,1,positive regulation of histone deubiquitination,BP,
19789,GO:1903587,1,0.941058981528163,0,9,regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
19790,GO:1903588,1,0.973317178704598,0,4,negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
19791,GO:1903589,1,0.966866278252424,0,5,positive regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis,BP,
19792,GO:1903593,1,0.988160415338491,0,3,regulation of histamine secretion by mast cell,BP,
19793,GO:1903595,1,0.988160415338491,0,3,positive regulation of histamine secretion by mast cell,BP,
19794,GO:1903596,1,0.97203543183717,0,4,regulation of gap junction assembly,BP,
19795,GO:1903597,1,0.992583653886802,0,1,negative regulation of gap junction assembly,BP,
19796,GO:1903598,1,0.979299770736603,0,3,positive regulation of gap junction assembly,BP,
19797,GO:1903599,1,0.886740442688737,0,17,positive regulation of autophagy of mitochondrion,BP,
19798,GO:1903608,1,0.961412190291251,0,6,protein localization to cytoplasmic stress granule,BP,
19799,GO:1903609,1,0.993229974828245,0,1,negative regulation of inward rectifier potassium channel activity,BP,
19800,GO:1903610,1,0.994807037247671,0,1,regulation of calcium-dependent ATPase activity,BP,
19801,GO:1903611,1,0.994807037247671,0,1,negative regulation of calcium-dependent ATPase activity,BP,
19802,GO:1903613,1,0.991922331109302,0,1,regulation of protein tyrosine phosphatase activity,BP,
19803,GO:1903615,1,0.991922331109302,0,1,positive regulation of protein tyrosine phosphatase activity,BP,
19804,GO:1903618,1,0.992473353745584,0,1,regulation of transdifferentiation,BP,
19805,GO:1903620,1,0.992473353745584,0,1,positive regulation of transdifferentiation,BP,
19806,GO:1903621,1,0.994764353474589,0,1,protein localization to photoreceptor connecting cilium,BP,
19807,GO:1903624,1,0.947445794944694,0,9,regulation of DNA catabolic process,BP,
19808,GO:1903625,1,0.988004556051527,0,2,negative regulation of DNA catabolic process,BP,
19809,GO:1903626,1,0.97687458505582,0,4,positive regulation of DNA catabolic process,BP,
19810,GO:1903627,1,0.994807037247671,0,1,regulation of dUTP diphosphatase activity,BP,
19811,GO:1903629,1,0.994807037247671,0,1,positive regulation of dUTP diphosphatase activity,BP,
19812,GO:1903630,1,0.99125103282374,0,2,regulation of aminoacyl-tRNA ligase activity,BP,
19813,GO:1903631,1,0.994807037247671,0,1,negative regulation of aminoacyl-tRNA ligase activity,BP,
19814,GO:1903632,1,0.996425619401755,0,1,positive regulation of aminoacyl-tRNA ligase activity,BP,
19815,GO:1903633,1,0.994807037247671,0,1,regulation of leucine-tRNA ligase activity,BP,
19816,GO:1903634,1,0.994807037247671,0,1,negative regulation of leucine-tRNA ligase activity,BP,
19817,GO:1903636,1,0.997807301551196,0,1,regulation of protein import into mitochondrial outer membrane,BP,
19818,GO:1903638,1,0.997807301551196,0,1,positive regulation of protein import into mitochondrial outer membrane,BP,
19819,GO:1903639,1,0.997901254710568,0,1,regulation of gastrin-induced gastric acid secretion,BP,
19820,GO:1903640,1,0.997901254710568,0,1,negative regulation of gastrin-induced gastric acid secretion,BP,
19821,GO:1903644,1,0.991256082300143,0,2,regulation of chaperone-mediated protein folding,BP,
19822,GO:1903645,1,0.997807301551196,0,1,negative regulation of chaperone-mediated protein folding,BP,
19823,GO:1903649,1,0.866213257379121,0,20,regulation of cytoplasmic transport,BP,
19824,GO:1903650,1,0.993642415197,0,2,negative regulation of cytoplasmic transport,BP,
19825,GO:1903651,1,0.930813171381761,0,9,positive regulation of cytoplasmic transport,BP,
19826,GO:1903659,1,0.989761447066737,0,2,regulation of complement-dependent cytotoxicity,BP,
19827,GO:1903660,1,0.989761447066737,0,2,negative regulation of complement-dependent cytotoxicity,BP,
19828,GO:1903670,1,0.681551301949332,0,55,regulation of sprouting angiogenesis,BP,
19829,GO:1903671,1,0.844705488393723,0,23,negative regulation of sprouting angiogenesis,BP,
19830,GO:1903672,1,0.813420062225097,0,31,positive regulation of sprouting angiogenesis,BP,
19831,GO:1903673,1,0.994827199554952,0,1,mitotic cleavage furrow formation,BP,
19832,GO:1903674,1,0.994843805190933,0,1,regulation of cap-dependent translational initiation,BP,
19833,GO:1903676,1,0.994843805190933,0,1,positive regulation of cap-dependent translational initiation,BP,
19834,GO:1903677,1,0.982675157178844,0,3,regulation of cap-independent translational initiation,BP,
19835,GO:1903679,1,0.982675157178844,0,3,positive regulation of cap-independent translational initiation,BP,
19836,GO:1903689,1,0.945514088731872,0,6,regulation of wound healing, spreading of epidermal cells,BP,
19837,GO:1903690,1,0.964874972627602,0,4,negative regulation of wound healing, spreading of epidermal cells,BP,
19838,GO:1903691,1,0.979941395643838,0,2,positive regulation of wound healing, spreading of epidermal cells,BP,
19839,GO:1903697,1,0.992587577888548,0,1,negative regulation of microvillus assembly,BP,
19840,GO:1903699,1,0.988186385669017,0,1,tarsal gland development,BP,
19841,GO:1903701,1,0.992011575481171,0,1,substantia propria of cornea development,BP,
19842,GO:1903704,1,0.992473353745584,0,1,negative regulation of production of siRNA involved in RNA interference,BP,
19846,GO:1903709,1,0.988186385669017,0,1,uterine gland development,BP,
19847,GO:1903712,1,0.992504407295285,0,1,cysteine transmembrane transport,BP,
19848,GO:1903715,1,0.958678005797854,0,6,regulation of aerobic respiration,BP,
19849,GO:1903717,1,0.99167451769715,0,1,response to ammonia,BP,
19850,GO:1903718,1,0.99167451769715,0,1,cellular response to ammonia,BP,
19851,GO:1903719,1,0.983379891574883,0,3,regulation of I-kappaB phosphorylation,BP,
19852,GO:1903721,1,0.983379891574883,0,3,positive regulation of I-kappaB phosphorylation,BP,
19853,GO:1903722,1,0.989691584880709,0,2,regulation of centriole elongation,BP,
19854,GO:1903723,1,0.997093186593732,0,1,negative regulation of centriole elongation,BP,
19855,GO:1903724,1,0.992577036557618,0,1,positive regulation of centriole elongation,BP,
19857,GO:1903726,1,0.955891567330559,0,7,negative regulation of phospholipid metabolic process,BP,
19859,GO:1903729,1,0.926466045778098,0,11,regulation of plasma membrane organization,BP,
19860,GO:1903742,1,0.996176471697596,0,1,regulation of anterograde synaptic vesicle transport,BP,
19861,GO:1903743,1,0.996176471697596,0,1,negative regulation of anterograde synaptic vesicle transport,BP,
19862,GO:1903747,1,0.487574806463169,0,115,regulation of establishment of protein localization to mitochondrion,BP,
19863,GO:1903748,1,0.953597507289406,0,7,negative regulation of establishment of protein localization to mitochondrion,BP,
19864,GO:1903749,1,0.523214441943602,0,104,positive regulation of establishment of protein localization to mitochondrion,BP,
19865,GO:1903750,1,0.976914541160684,0,4,regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
19866,GO:1903751,1,0.976914541160684,0,4,negative regulation of intrinsic apoptotic signaling pathway in response to hydrogen peroxide,BP,
19867,GO:1903753,1,0.964700417961801,0,5,negative regulation of p38MAPK cascade,BP,
19868,GO:1903755,1,0.996460308534979,0,1,positive regulation of SUMO transferase activity,BP,
19869,GO:1903756,1,0.986119069208757,0,2,regulation of transcription from RNA polymerase II promoter by histone modification,BP,
19870,GO:1903758,1,0.986119069208757,0,2,negative regulation of transcription from RNA polymerase II promoter by histone modification,BP,
19871,GO:1903759,1,0.992686411033338,0,1,signal transduction involved in regulation of aerobic respiration,BP,
19872,GO:1903760,1,0.977119653889922,0,3,regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
19873,GO:1903762,1,0.984892516161635,0,2,positive regulation of voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization,BP,
19875,GO:1903764,1,0.982166214427163,0,3,regulation of potassium ion export across plasma membrane,BP,
19876,GO:1903765,1,0.9927525183413,0,1,negative regulation of potassium ion export across plasma membrane,BP,
19877,GO:1903766,1,0.997206255235835,0,1,positive regulation of potassium ion export across plasma membrane,BP,
19878,GO:1903767,1,0.993425333841069,0,1,sweet taste receptor complex,CC,
19879,GO:1903768,1,0.993425333841069,0,1,taste receptor complex,CC,
19880,GO:1903770,1,0.992913450177408,0,1,negative regulation of beta-galactosidase activity,BP,
19881,GO:1903772,1,0.972830761866013,0,5,regulation of viral budding via host ESCRT complex,BP,
19882,GO:1903774,1,0.983140631909819,0,3,positive regulation of viral budding via host ESCRT complex,BP,
19883,GO:1903775,1,0.986945825670603,0,2,regulation of DNA double-strand break processing,BP,
19884,GO:1903778,1,0.991288227354194,0,1,protein localization to vacuolar membrane,BP,
19885,GO:1903779,1,0.608757502990305,0,69,regulation of cardiac conduction,BP,
19886,GO:1903781,1,0.977453479338972,0,3,positive regulation of cardiac conduction,BP,
19887,GO:1903786,1,0.99312430827893,0,1,regulation of glutathione biosynthetic process,BP,
19888,GO:1903788,1,0.99312430827893,0,1,positive regulation of glutathione biosynthetic process,BP,
19889,GO:1903789,1,0.946260379202325,0,8,regulation of amino acid transmembrane transport,BP,
19890,GO:1903792,1,0.852126219843867,0,22,negative regulation of anion transport,BP,
19892,GO:1903795,1,0.951172097295832,0,6,regulation of inorganic anion transmembrane transport,BP,
19893,GO:1903796,1,0.98284786702365,0,2,negative regulation of inorganic anion transmembrane transport,BP,
19894,GO:1903797,1,0.983941832087117,0,2,positive regulation of inorganic anion transmembrane transport,BP,
19896,GO:1903799,1,0.939799295348641,0,8,negative regulation of production of miRNAs involved in gene silencing by miRNA,BP,
19898,GO:1903801,1,0.994027697980764,0,1,L-leucine import across plasma membrane,BP,
19899,GO:1903803,1,0.99480822318924,0,1,L-glutamine import across plasma membrane,BP,
19900,GO:1903804,1,0.992944939983508,0,1,glycine import across plasma membrane,BP,
19901,GO:1903814,1,0.997206255235835,0,1,regulation of collecting lymphatic vessel constriction,BP,
19902,GO:1903815,1,0.997206255235835,0,1,negative regulation of collecting lymphatic vessel constriction,BP,
19903,GO:1903817,1,0.9502408783471,0,8,negative regulation of voltage-gated potassium channel activity,BP,
19904,GO:1903818,1,0.909294095318379,0,13,positive regulation of voltage-gated potassium channel activity,BP,
19905,GO:1903823,1,0.992913450177408,0,1,telomere single strand break repair,BP,
19906,GO:1903824,1,0.992913450177408,0,1,negative regulation of telomere single strand break repair,BP,
19908,GO:1903826,1,0.958166710266602,0,6,arginine transmembrane transport,BP,
19912,GO:1903830,1,0.892218473113866,0,16,magnesium ion transmembrane transport,BP,
19913,GO:1903831,1,0.873493346710391,0,21,signal transduction involved in cellular response to ammonium ion,BP,
19914,GO:1903837,1,0.993587012283989,0,1,regulation of mRNA 3'-UTR binding,BP,
19915,GO:1903839,1,0.993587012283989,0,1,positive regulation of mRNA 3'-UTR binding,BP,
19918,GO:1903846,1,0.840339696514726,0,25,positive regulation of cellular response to transforming growth factor beta stimulus,BP,
19919,GO:1903847,1,0.982029672749507,0,2,regulation of aorta morphogenesis,BP,
19920,GO:1903849,1,0.982029672749507,0,2,positive regulation of aorta morphogenesis,BP,
19921,GO:1903850,1,0.993245573612002,0,1,regulation of cristae formation,BP,
19922,GO:1903852,1,0.993245573612002,0,1,positive regulation of cristae formation,BP,
19923,GO:1903859,1,0.863346164492266,0,20,regulation of dendrite extension,BP,
19924,GO:1903860,1,0.984336242426134,0,3,negative regulation of dendrite extension,BP,
19925,GO:1903861,1,0.877102781660621,0,17,positive regulation of dendrite extension,BP,
19926,GO:1903862,1,0.968093617917883,0,6,positive regulation of oxidative phosphorylation,BP,
19927,GO:1903867,1,0.937181496272558,0,9,extraembryonic membrane development,BP,
19928,GO:1903874,1,0.97746879184746,0,3,ferrous iron transmembrane transport,BP,
19929,GO:1903881,1,0.992506143966437,0,1,regulation of interleukin-17-mediated signaling pathway,BP,
19930,GO:1903883,1,0.992506143966437,0,1,positive regulation of interleukin-17-mediated signaling pathway,BP,
19931,GO:1903884,1,0.992506143966437,0,1,regulation of chemokine (C-C motif) ligand 20 production,BP,
19932,GO:1903886,1,0.992506143966437,0,1,positive regulation of chemokine (C-C motif) ligand 20 production,BP,
19933,GO:1903888,1,0.997356194534619,0,1,regulation of plant epidermal cell differentiation,BP,
19934,GO:1903889,1,0.997356194534619,0,1,negative regulation of plant epidermal cell differentiation,BP,
19935,GO:1903891,1,0.972139447237255,0,4,regulation of ATF6-mediated unfolded protein response,BP,
19936,GO:1903892,1,0.98587799960154,0,2,negative regulation of ATF6-mediated unfolded protein response,BP,
19937,GO:1903893,1,0.993540242089933,0,1,positive regulation of ATF6-mediated unfolded protein response,BP,
19938,GO:1903894,1,0.91898642466763,0,13,regulation of IRE1-mediated unfolded protein response,BP,
19939,GO:1903895,1,0.972092713803723,0,4,negative regulation of IRE1-mediated unfolded protein response,BP,
19940,GO:1903896,1,0.953680740682612,0,7,positive regulation of IRE1-mediated unfolded protein response,BP,
19941,GO:1903897,1,0.940395354976176,0,9,regulation of PERK-mediated unfolded protein response,BP,
19942,GO:1903898,1,0.967561421051229,0,5,negative regulation of PERK-mediated unfolded protein response,BP,
19943,GO:1903899,1,0.979299847561501,0,3,positive regulation of PERK-mediated unfolded protein response,BP,
19947,GO:1903903,1,0.977197810513751,0,3,regulation of establishment of T cell polarity,BP,
19948,GO:1903905,1,0.983959133717356,0,2,positive regulation of establishment of T cell polarity,BP,
19949,GO:1903906,1,0.993129557636053,0,1,regulation of plasma membrane raft polarization,BP,
19950,GO:1903909,1,0.944379095278123,0,8,regulation of receptor clustering,BP,
19951,GO:1903910,1,0.993868789516679,0,1,negative regulation of receptor clustering,BP,
19952,GO:1903911,1,0.974058293893522,0,4,positive regulation of receptor clustering,BP,
19953,GO:1903912,1,0.97281396105721,0,4,negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation,BP,
19954,GO:1903916,1,0.993777838898081,0,1,regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
19955,GO:1903917,1,0.993777838898081,0,1,positive regulation of endoplasmic reticulum stress-induced eIF2 alpha dephosphorylation,BP,
19956,GO:1903918,1,0.990582404295347,0,1,regulation of actin filament severing,BP,
19957,GO:1903919,1,0.990582404295347,0,1,negative regulation of actin filament severing,BP,
19958,GO:1903921,1,0.983776023923714,0,2,regulation of protein processing in phagocytic vesicle,BP,
19959,GO:1903923,1,0.983776023923714,0,2,positive regulation of protein processing in phagocytic vesicle,BP,
19960,GO:1903924,1,0.994116876213623,0,1,estradiol binding,MF,
19961,GO:1903925,1,0.994948155266244,0,1,response to bisphenol A,BP,
19962,GO:1903926,1,0.994948155266244,0,1,cellular response to bisphenol A,BP,
19963,GO:1903929,1,0.986535473334803,0,2,primary palate development,BP,
19964,GO:1903935,1,0.971022845440523,0,5,response to sodium arsenite,BP,
19965,GO:1903936,1,0.971022845440523,0,5,cellular response to sodium arsenite,BP,
19966,GO:1903937,1,0.992142202368947,0,1,response to acrylamide,BP,
19967,GO:1903939,1,0.99259143139985,0,1,regulation of TORC2 signaling,BP,
19968,GO:1903943,1,0.994729990264892,0,1,regulation of hepatocyte apoptotic process,BP,
19969,GO:1903944,1,0.994729990264892,0,1,negative regulation of hepatocyte apoptotic process,BP,
19970,GO:1903946,1,0.9927525183413,0,1,negative regulation of ventricular cardiac muscle cell action potential,BP,
19971,GO:1903947,1,0.984892516161635,0,2,positive regulation of ventricular cardiac muscle cell action potential,BP,
19972,GO:1903949,1,0.984996642784493,0,2,positive regulation of atrial cardiac muscle cell action potential,BP,
19973,GO:1903952,1,0.99247727662598,0,1,regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
19974,GO:1903954,1,0.99247727662598,0,1,positive regulation of voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization,BP,
19975,GO:1903955,1,0.626600776527257,0,74,positive regulation of protein targeting to mitochondrion,BP,
19976,GO:1903959,1,0.839352936916802,0,23,regulation of anion transmembrane transport,BP,
19977,GO:1903960,1,0.92046573333181,0,11,negative regulation of anion transmembrane transport,BP,
19978,GO:1903961,1,0.957294768224953,0,6,positive regulation of anion transmembrane transport,BP,
19979,GO:1903963,1,0.890437541940278,0,19,arachidonate transport,BP,
19980,GO:1903964,1,0.98140556642259,0,3,monounsaturated fatty acid metabolic process,BP,
19981,GO:1903965,1,0.996074904731686,0,1,monounsaturated fatty acid catabolic process,BP,
19982,GO:1903966,1,0.985273432184477,0,2,monounsaturated fatty acid biosynthetic process,BP,
19983,GO:1903969,1,0.984849827932957,0,3,regulation of response to macrophage colony-stimulating factor,BP,
19984,GO:1903970,1,0.991117309737701,0,2,negative regulation of response to macrophage colony-stimulating factor,BP,
19985,GO:1903971,1,0.993676910461691,0,1,positive regulation of response to macrophage colony-stimulating factor,BP,
19986,GO:1903972,1,0.984849827932957,0,3,regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
19987,GO:1903973,1,0.991117309737701,0,2,negative regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
19988,GO:1903974,1,0.993676910461691,0,1,positive regulation of cellular response to macrophage colony-stimulating factor stimulus,BP,
19989,GO:1903975,1,0.948556809711023,0,9,regulation of glial cell migration,BP,
19990,GO:1903976,1,0.978561658110844,0,4,negative regulation of glial cell migration,BP,
19991,GO:1903977,1,0.97814323307802,0,3,positive regulation of glial cell migration,BP,
19992,GO:1903978,1,0.936143739408483,0,9,regulation of microglial cell activation,BP,
19993,GO:1903979,1,0.988677428885469,0,2,negative regulation of microglial cell activation,BP,
19994,GO:1903980,1,0.954660306630978,0,7,positive regulation of microglial cell activation,BP,
19995,GO:1903984,1,0.978326340638657,0,3,positive regulation of TRAIL-activated apoptotic signaling pathway,BP,
19996,GO:1903988,1,0.992586444087196,0,1,ferrous iron export across plasma membrane,BP,
19997,GO:1903995,1,0.989999138360768,0,2,regulation of non-membrane spanning protein tyrosine kinase activity,BP,
19998,GO:1903997,1,0.989999138360768,0,2,positive regulation of non-membrane spanning protein tyrosine kinase activity,BP,
19999,GO:1903998,1,0.976811751999644,0,4,regulation of eating behavior,BP,
20000,GO:1903999,1,0.989305574518115,0,2,negative regulation of eating behavior,BP,
20001,GO:1904000,1,0.987372469163997,0,2,positive regulation of eating behavior,BP,
20002,GO:1904008,1,0.996014999274804,0,1,response to monosodium glutamate,BP,
20003,GO:1904009,1,0.996014999274804,0,1,cellular response to monosodium glutamate,BP,
20004,GO:1904010,1,0.996014999274804,0,1,response to Aroclor 1254,BP,
20005,GO:1904016,1,0.968768596690609,0,4,response to Thyroglobulin triiodothyronine,BP,
20006,GO:1904017,1,0.982452084000563,0,2,cellular response to Thyroglobulin triiodothyronine,BP,
20007,GO:1904018,1,0.331808317897177,0,161,positive regulation of vasculature development,BP,
20008,GO:1904019,1,0.546231227470317,0,86,epithelial cell apoptotic process,BP,
20009,GO:1904020,1,0.980880668706661,0,3,regulation of G-protein coupled receptor internalization,BP,
20010,GO:1904021,1,0.988145358250854,0,2,negative regulation of G-protein coupled receptor internalization,BP,
20011,GO:1904022,1,0.992649030422308,0,1,positive regulation of G-protein coupled receptor internalization,BP,
20012,GO:1904026,1,0.986576904721734,0,2,regulation of collagen fibril organization,BP,
20013,GO:1904027,1,0.993473592336188,0,1,negative regulation of collagen fibril organization,BP,
20014,GO:1904028,1,0.993058458973322,0,1,positive regulation of collagen fibril organization,BP,
20016,GO:1904030,1,0.807844667749109,0,32,negative regulation of cyclin-dependent protein kinase activity,BP,
20018,GO:1904035,1,0.651182553829669,0,63,regulation of epithelial cell apoptotic process,BP,
20019,GO:1904036,1,0.788213343778652,0,34,negative regulation of epithelial cell apoptotic process,BP,
20020,GO:1904037,1,0.842128873467256,0,26,positive regulation of epithelial cell apoptotic process,BP,
20021,GO:1904041,1,0.992612484295299,0,1,regulation of cystathionine beta-synthase activity,BP,
20022,GO:1904042,1,0.992612484295299,0,1,negative regulation of cystathionine beta-synthase activity,BP,
20023,GO:1904044,1,0.976761678224378,0,4,response to aldosterone,BP,
20024,GO:1904045,1,0.994146143205705,0,1,cellular response to aldosterone,BP,
20025,GO:1904046,1,0.992017493258829,0,2,negative regulation of vascular endothelial growth factor production,BP,
20026,GO:1904047,1,0.980943451619497,0,3,S-adenosyl-L-methionine binding,MF,
20027,GO:1904048,1,0.981518509484128,0,2,regulation of spontaneous neurotransmitter secretion,BP,
20028,GO:1904049,1,0.989107065278094,0,1,negative regulation of spontaneous neurotransmitter secretion,BP,
20029,GO:1904050,1,0.992328707776266,0,1,positive regulation of spontaneous neurotransmitter secretion,BP,
20030,GO:1904054,1,0.989856457056912,0,1,regulation of cholangiocyte proliferation,BP,
20031,GO:1904056,1,0.989856457056912,0,1,positive regulation of cholangiocyte proliferation,BP,
20032,GO:1904057,1,0.988886177591104,0,2,negative regulation of sensory perception of pain,BP,
20033,GO:1904058,1,0.968708413731074,0,5,positive regulation of sensory perception of pain,BP,
20034,GO:1904059,1,0.97956274904696,0,2,regulation of locomotor rhythm,BP,
20036,GO:1904063,1,0.639863769508799,0,69,negative regulation of cation transmembrane transport,BP,
20037,GO:1904064,1,0.457881749809939,0,116,positive regulation of cation transmembrane transport,BP,
20038,GO:1904071,1,0.982541769272025,0,2,presynaptic active zone assembly,BP,
20039,GO:1904073,1,0.990749260817457,0,1,regulation of trophectodermal cell proliferation,BP,
20040,GO:1904075,1,0.990749260817457,0,1,positive regulation of trophectodermal cell proliferation,BP,
20041,GO:1904090,1,0.983687809476258,0,4,peptidase inhibitor complex,CC,
20042,GO:1904098,1,0.980355501352691,0,3,regulation of protein O-linked glycosylation,BP,
20043,GO:1904100,1,0.980355501352691,0,3,positive regulation of protein O-linked glycosylation,BP,
20045,GO:1904115,1,0.758209488628885,0,40,axon cytoplasm,CC,
20046,GO:1904116,1,0.977087901589022,0,3,response to vasopressin,BP,
20047,GO:1904117,1,0.977087901589022,0,3,cellular response to vasopressin,BP,
20048,GO:1904118,1,0.992718951160495,0,1,regulation of otic vesicle morphogenesis,BP,
20049,GO:1904120,1,0.992718951160495,0,1,positive regulation of otic vesicle morphogenesis,BP,
20050,GO:1904121,1,0.978404141909949,0,3,phosphatidylethanolamine transporter activity,MF,
20051,GO:1904124,1,0.985343812477995,0,3,microglial cell migration,BP,
20052,GO:1904139,1,0.985343812477995,0,3,regulation of microglial cell migration,BP,
20053,GO:1904140,1,0.995764108068102,0,1,negative regulation of microglial cell migration,BP,
20054,GO:1904141,1,0.993676910461691,0,1,positive regulation of microglial cell migration,BP,
20055,GO:1904149,1,0.995764108068102,0,1,regulation of microglial cell mediated cytotoxicity,BP,
20056,GO:1904151,1,0.995764108068102,0,1,positive regulation of microglial cell mediated cytotoxicity,BP,
20057,GO:1904152,1,0.918749243096271,0,13,regulation of retrograde protein transport, ER to cytosol,BP,
20058,GO:1904153,1,0.942559724739015,0,9,negative regulation of retrograde protein transport, ER to cytosol,BP,
20059,GO:1904154,1,0.982081554772284,0,3,positive regulation of retrograde protein transport, ER to cytosol,BP,
20060,GO:1904155,1,0.99259123599096,0,1,DN2 thymocyte differentiation,BP,
20061,GO:1904156,1,0.99259123599096,0,1,DN3 thymocyte differentiation,BP,
20062,GO:1904158,1,0.975248679028462,0,3,axonemal central apparatus assembly,BP,
20063,GO:1904167,1,0.988891958579685,0,1,regulation of thyroid hormone receptor activity,BP,
20064,GO:1904168,1,0.988891958579685,0,1,negative regulation of thyroid hormone receptor activity,BP,
20065,GO:1904170,1,0.984978818012497,0,2,regulation of bleb assembly,BP,
20066,GO:1904172,1,0.984978818012497,0,2,positive regulation of bleb assembly,BP,
20067,GO:1904177,1,0.964068523202975,0,6,regulation of adipose tissue development,BP,
20068,GO:1904179,1,0.967581814944441,0,5,positive regulation of adipose tissue development,BP,
20069,GO:1904180,1,0.963748496715203,0,6,negative regulation of membrane depolarization,BP,
20071,GO:1904182,1,0.996529489746992,0,1,regulation of pyruvate dehydrogenase activity,BP,
20072,GO:1904192,1,0.989856457056912,0,1,regulation of cholangiocyte apoptotic process,BP,
20073,GO:1904193,1,0.989856457056912,0,1,negative regulation of cholangiocyte apoptotic process,BP,
20074,GO:1904195,1,0.989856457056912,0,1,regulation of granulosa cell proliferation,BP,
20075,GO:1904197,1,0.989856457056912,0,1,positive regulation of granulosa cell proliferation,BP,
20076,GO:1904199,1,0.99246323137792,0,1,positive regulation of regulation of vascular smooth muscle cell membrane depolarization,BP,
20077,GO:1904200,1,0.989856457056912,0,1,iodide transmembrane transport,BP,
20078,GO:1904201,1,0.989856457056912,0,1,regulation of iodide transport,BP,
20079,GO:1904202,1,0.989856457056912,0,1,negative regulation of iodide transport,BP,
20080,GO:1904204,1,0.981317094503151,0,2,regulation of skeletal muscle hypertrophy,BP,
20081,GO:1904205,1,0.991374004438938,0,1,negative regulation of skeletal muscle hypertrophy,BP,
20082,GO:1904206,1,0.989856457056912,0,1,positive regulation of skeletal muscle hypertrophy,BP,
20085,GO:1904210,1,0.996054960406973,0,1,VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
20086,GO:1904211,1,0.987317105585609,0,2,membrane protein proteolysis involved in retrograde protein transport, ER to cytosol,BP,
20087,GO:1904212,1,0.989856457056912,0,1,regulation of iodide transmembrane transport,BP,
20088,GO:1904213,1,0.989856457056912,0,1,negative regulation of iodide transmembrane transport,BP,
20089,GO:1904217,1,0.982212497383406,0,3,regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
20090,GO:1904219,1,0.982212497383406,0,3,positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity,BP,
20091,GO:1904220,1,0.975393209353874,0,4,regulation of serine C-palmitoyltransferase activity,BP,
20092,GO:1904222,1,0.982212497383406,0,3,positive regulation of serine C-palmitoyltransferase activity,BP,
20093,GO:1904226,1,0.994205061262777,0,1,regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
20094,GO:1904227,1,0.994205061262777,0,1,negative regulation of glycogen synthase activity, transferring glucose-1-phosphate,BP,
20095,GO:1904229,1,0.990805562801006,0,1,regulation of succinate dehydrogenase activity,BP,
20096,GO:1904231,1,0.990805562801006,0,1,positive regulation of succinate dehydrogenase activity,BP,
20097,GO:1904232,1,0.990805562801006,0,1,regulation of aconitate hydratase activity,BP,
20098,GO:1904234,1,0.990805562801006,0,1,positive regulation of aconitate hydratase activity,BP,
20099,GO:1904235,1,0.990076843592514,0,1,regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
20100,GO:1904237,1,0.990076843592514,0,1,positive regulation of substrate-dependent cell migration, cell attachment to substrate,BP,
20101,GO:1904238,1,0.955184971987655,0,7,pericyte cell differentiation,BP,
20102,GO:1904239,1,0.996054960406973,0,1,regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
20103,GO:1904240,1,0.996054960406973,0,1,negative regulation of VCP-NPL4-UFD1 AAA ATPase complex assembly,BP,
20104,GO:1904245,1,0.988023061782314,0,2,regulation of polynucleotide adenylyltransferase activity,BP,
20105,GO:1904246,1,0.995245096186547,0,1,negative regulation of polynucleotide adenylyltransferase activity,BP,
20106,GO:1904247,1,0.992743806358111,0,1,positive regulation of polynucleotide adenylyltransferase activity,BP,
20107,GO:1904251,1,0.93488221999072,0,10,regulation of bile acid metabolic process,BP,
20108,GO:1904252,1,0.980225805166215,0,3,negative regulation of bile acid metabolic process,BP,
20109,GO:1904253,1,0.980464545152935,0,3,positive regulation of bile acid metabolic process,BP,
20110,GO:1904259,1,0.956907151177701,0,5,regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,
20111,GO:1904261,1,0.956907151177701,0,5,positive regulation of basement membrane assembly involved in embryonic body morphogenesis,BP,
20112,GO:1904262,1,0.926780212090735,0,11,negative regulation of TORC1 signaling,BP,
20113,GO:1904263,1,0.944430323288118,0,9,positive regulation of TORC1 signaling,BP,
20114,GO:1904265,1,0.991358553302424,0,1,ubiquitin-specific protease activity involved in negative regulation of retrograde protein transport, ER to cytosol,MF,
20115,GO:1904266,1,0.990773028720735,0,1,regulation of Schwann cell chemotaxis,BP,
20116,GO:1904268,1,0.990773028720735,0,1,positive regulation of Schwann cell chemotaxis,BP,
20117,GO:1904271,1,0.993596861458281,0,1,L-proline import across plasma membrane,BP,
20118,GO:1904274,1,0.994119122781983,0,1,tricellular tight junction assembly,BP,
20119,GO:1904282,1,0.994763168170186,0,1,regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
20120,GO:1904283,1,0.994763168170186,0,1,negative regulation of antigen processing and presentation of endogenous peptide antigen via MHC class I,BP,
20121,GO:1904288,1,0.969599295353715,0,4,BAT3 complex binding,MF,
20122,GO:1904289,1,0.985211954818169,0,2,regulation of mitotic DNA damage checkpoint,BP,
20123,GO:1904290,1,0.992334833045192,0,1,negative regulation of mitotic DNA damage checkpoint,BP,
20124,GO:1904292,1,0.831117863477295,0,27,regulation of ERAD pathway,BP,
20125,GO:1904293,1,0.918962036445374,0,13,negative regulation of ERAD pathway,BP,
20126,GO:1904294,1,0.91269423718584,0,13,positive regulation of ERAD pathway,BP,
20127,GO:1904298,1,0.992450517902719,0,1,regulation of transcytosis,BP,
20128,GO:1904300,1,0.992450517902719,0,1,positive regulation of transcytosis,BP,
20129,GO:1904301,1,0.992450517902719,0,1,regulation of maternal process involved in parturition,BP,
20130,GO:1904303,1,0.992450517902719,0,1,positive regulation of maternal process involved in parturition,BP,
20131,GO:1904304,1,0.972588429260854,0,5,regulation of gastro-intestinal system smooth muscle contraction,BP,
20132,GO:1904306,1,0.972588429260854,0,5,positive regulation of gastro-intestinal system smooth muscle contraction,BP,
20133,GO:1904313,1,0.992478271476717,0,1,response to methamphetamine hydrochloride,BP,
20135,GO:1904316,1,0.992450517902719,0,1,response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
20136,GO:1904317,1,0.992450517902719,0,1,cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine,BP,
20139,GO:1904323,1,0.992907795971071,0,1,regulation of inhibitory G-protein coupled receptor phosphorylation,BP,
20140,GO:1904325,1,0.992907795971071,0,1,positive regulation of inhibitory G-protein coupled receptor phosphorylation,BP,
20141,GO:1904327,1,0.984199524222514,0,2,protein localization to cytosolic proteasome complex,BP,
20142,GO:1904328,1,0.993153112760472,0,1,regulation of myofibroblast contraction,BP,
20143,GO:1904338,1,0.945329631544561,0,9,regulation of dopaminergic neuron differentiation,BP,
20144,GO:1904339,1,0.986516970531754,0,2,negative regulation of dopaminergic neuron differentiation,BP,
20145,GO:1904340,1,0.979860637038187,0,4,positive regulation of dopaminergic neuron differentiation,BP,
20146,GO:1904341,1,0.992019259254054,0,1,regulation of colon smooth muscle contraction,BP,
20147,GO:1904343,1,0.992019259254054,0,1,positive regulation of colon smooth muscle contraction,BP,
20148,GO:1904344,1,0.997490814002907,0,1,regulation of gastric mucosal blood circulation,BP,
20149,GO:1904346,1,0.997490814002907,0,1,positive regulation of gastric mucosal blood circulation,BP,
20150,GO:1904347,1,0.989529898303092,0,2,regulation of small intestine smooth muscle contraction,BP,
20151,GO:1904349,1,0.989529898303092,0,2,positive regulation of small intestine smooth muscle contraction,BP,
20152,GO:1904350,1,0.928811782188489,0,9,regulation of protein catabolic process in the vacuole,BP,
20153,GO:1904351,1,0.979310457162443,0,3,negative regulation of protein catabolic process in the vacuole,BP,
20154,GO:1904352,1,0.954433911650937,0,5,positive regulation of protein catabolic process in the vacuole,BP,
20155,GO:1904353,1,0.829807273641855,0,26,regulation of telomere capping,BP,
20156,GO:1904354,1,0.936619609401377,0,8,negative regulation of telomere capping,BP,
20157,GO:1904355,1,0.893300850640493,0,17,positive regulation of telomere capping,BP,
20158,GO:1904356,1,0.663598174917472,0,58,regulation of telomere maintenance via telomere lengthening,BP,
20159,GO:1904357,1,0.826712294593798,0,25,negative regulation of telomere maintenance via telomere lengthening,BP,
20160,GO:1904358,1,0.786171123602843,0,36,positive regulation of telomere maintenance via telomere lengthening,BP,
20161,GO:1904373,1,0.995698491588033,0,1,response to kainic acid,BP,
20163,GO:1904376,1,0.849522603503474,0,24,negative regulation of protein localization to cell periphery,BP,
20165,GO:1904378,1,0.977976409464025,0,3,maintenance of unfolded protein involved in ERAD pathway,BP,
20166,GO:1904379,1,0.984199524222514,0,2,protein localization to cytosolic proteasome complex involved in ERAD pathway,BP,
20167,GO:1904380,1,0.873172583601367,0,20,endoplasmic reticulum mannose trimming,BP,
20168,GO:1904381,1,0.977177831179719,0,3,Golgi apparatus mannose trimming,BP,
20169,GO:1904382,1,0.970814248191043,0,4,mannose trimming involved in glycoprotein ERAD pathway,BP,
20170,GO:1904383,1,0.987246992759437,0,2,response to sodium phosphate,BP,
20172,GO:1904386,1,0.963491121640753,0,5,response to L-phenylalanine derivative,BP,
20173,GO:1904387,1,0.985303075321928,0,2,cellular response to L-phenylalanine derivative,BP,
20174,GO:1904389,1,0.995698491588033,0,1,rod bipolar cell differentiation,BP,
20175,GO:1904391,1,0.995698491588033,0,1,response to ciliary neurotrophic factor,BP,
20176,GO:1904393,1,0.979995805520108,0,3,regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
20177,GO:1904394,1,0.993868789516679,0,1,negative regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
20178,GO:1904395,1,0.986042285540697,0,2,positive regulation of skeletal muscle acetylcholine-gated channel clustering,BP,
20179,GO:1904396,1,0.949085717743938,0,7,regulation of neuromuscular junction development,BP,
20180,GO:1904397,1,0.989593391700434,0,2,negative regulation of neuromuscular junction development,BP,
20181,GO:1904398,1,0.976866965758374,0,3,positive regulation of neuromuscular junction development,BP,
20182,GO:1904399,1,0.995698491588033,0,1,heparan sulfate binding,MF,
20183,GO:1904400,1,0.992730389328597,0,1,response to Thyroid stimulating hormone,BP,
20184,GO:1904404,1,0.990684704996628,0,1,response to formaldehyde,BP,
20185,GO:1904406,1,0.926552086966698,0,12,negative regulation of nitric oxide metabolic process,BP,
20186,GO:1904407,1,0.793191963372288,0,35,positive regulation of nitric oxide metabolic process,BP,
20187,GO:1904408,1,0.996589812374165,0,1,melatonin binding,MF,
20188,GO:1904412,1,0.992518804425241,0,1,regulation of cardiac ventricle development,BP,
20189,GO:1904414,1,0.992518804425241,0,1,positive regulation of cardiac ventricle development,BP,
20190,GO:1904415,1,0.959372454367545,0,6,regulation of xenophagy,BP,
20191,GO:1904417,1,0.959372454367545,0,6,positive regulation of xenophagy,BP,
20192,GO:1904424,1,0.928068156652439,0,10,regulation of GTP binding,BP,
20193,GO:1904425,1,0.992499547453697,0,1,negative regulation of GTP binding,BP,
20194,GO:1904426,1,0.984398460412419,0,2,positive regulation of GTP binding,BP,
20195,GO:1904427,1,0.683365163236254,0,58,positive regulation of calcium ion transmembrane transport,BP,
20196,GO:1904428,1,0.976989544666513,0,3,negative regulation of tubulin deacetylation,BP,
20197,GO:1904429,1,0.95728097891553,0,6,regulation of t-circle formation,BP,
20198,GO:1904430,1,0.977950390361432,0,3,negative regulation of t-circle formation,BP,
20199,GO:1904431,1,0.978869219537407,0,3,positive regulation of t-circle formation,BP,
20200,GO:1904432,1,0.99170163812696,0,2,regulation of ferrous iron binding,BP,
20201,GO:1904434,1,0.99170163812696,0,2,positive regulation of ferrous iron binding,BP,
20202,GO:1904435,1,0.99170163812696,0,2,regulation of transferrin receptor binding,BP,
20203,GO:1904437,1,0.99170163812696,0,2,positive regulation of transferrin receptor binding,BP,
20204,GO:1904447,1,0.977520487320014,0,2,folic acid import across plasma membrane,BP,
20205,GO:1904448,1,0.992162690456213,0,1,regulation of aspartate secretion,BP,
20206,GO:1904450,1,0.992162690456213,0,1,positive regulation of aspartate secretion,BP,
20207,GO:1904454,1,0.990340827257099,0,1,ubiquitin-specific protease activity involved in positive regulation of ERAD pathway,MF,
20208,GO:1904455,1,0.983553001786514,0,2,ubiquitin-specific protease activity involved in negative regulation of ERAD pathway,MF,
20209,GO:1904456,1,0.994941044546944,0,1,negative regulation of neuronal action potential,BP,
20210,GO:1904457,1,0.993728026440238,0,1,positive regulation of neuronal action potential,BP,
20211,GO:1904464,1,0.995261445819626,0,1,regulation of matrix metallopeptidase secretion,BP,
20212,GO:1904465,1,0.995261445819626,0,1,negative regulation of matrix metallopeptidase secretion,BP,
20213,GO:1904467,1,0.894541262732319,0,17,regulation of tumor necrosis factor secretion,BP,
20214,GO:1904468,1,0.971911192688694,0,5,negative regulation of tumor necrosis factor secretion,BP,
20215,GO:1904469,1,0.9204157985745,0,12,positive regulation of tumor necrosis factor secretion,BP,
20216,GO:1904475,1,0.982474074567993,0,2,regulation of Ras GTPase binding,BP,
20217,GO:1904477,1,0.991298700908345,0,1,positive regulation of Ras GTPase binding,BP,
20218,GO:1904478,1,0.973727429122028,0,5,regulation of intestinal absorption,BP,
20219,GO:1904479,1,0.991328446024637,0,2,negative regulation of intestinal absorption,BP,
20220,GO:1904481,1,0.993616666346993,0,1,response to tetrahydrofolate,BP,
20221,GO:1904482,1,0.993616666346993,0,1,cellular response to tetrahydrofolate,BP,
20222,GO:1904491,1,0.980167202942011,0,4,protein localization to ciliary transition zone,BP,
20223,GO:1904492,1,0.993349758253345,0,1,Ac-Asp-Glu binding,MF,
20224,GO:1904493,1,0.993349758253345,0,1,tetrahydrofolyl-poly(glutamate) polymer binding,MF,
20225,GO:1904498,1,0.977684815872658,0,3,protein localization to mitotic actomyosin contractile ring,BP,
20226,GO:1904499,1,0.992562739064772,0,1,regulation of chromatin-mediated maintenance of transcription,BP,
20227,GO:1904501,1,0.992562739064772,0,1,positive regulation of chromatin-mediated maintenance of transcription,BP,
20228,GO:1904502,1,0.960672487457591,0,5,regulation of lipophagy,BP,
20229,GO:1904504,1,0.960672487457591,0,5,positive regulation of lipophagy,BP,
20230,GO:1904505,1,0.970659682969113,0,4,regulation of telomere maintenance in response to DNA damage,BP,
20231,GO:1904506,1,0.970659682969113,0,4,negative regulation of telomere maintenance in response to DNA damage,BP,
20232,GO:1904515,1,0.99259143139985,0,1,positive regulation of TORC2 signaling,BP,
20233,GO:1904526,1,0.941136508323954,0,9,regulation of microtubule binding,BP,
20234,GO:1904527,1,0.977933662574054,0,3,negative regulation of microtubule binding,BP,
20235,GO:1904528,1,0.963027278989186,0,6,positive regulation of microtubule binding,BP,
20236,GO:1904529,1,0.984533248165359,0,2,regulation of actin filament binding,BP,
20237,GO:1904530,1,0.99272665433335,0,1,negative regulation of actin filament binding,BP,
20238,GO:1904531,1,0.991747163125289,0,1,positive regulation of actin filament binding,BP,
20239,GO:1904533,1,0.978262809191954,0,3,regulation of telomeric loop disassembly,BP,
20240,GO:1904534,1,0.985837922697338,0,2,negative regulation of telomeric loop disassembly,BP,
20241,GO:1904535,1,0.992317156913836,0,1,positive regulation of telomeric loop disassembly,BP,
20242,GO:1904542,1,0.993245573612002,0,1,regulation of free ubiquitin chain polymerization,BP,
20243,GO:1904544,1,0.993245573612002,0,1,positive regulation of free ubiquitin chain polymerization,BP,
20244,GO:1904550,1,0.994475421885791,0,1,response to arachidonic acid,BP,
20245,GO:1904555,1,0.993596861458281,0,1,L-proline transmembrane transport,BP,
20246,GO:1904556,1,0.993596861458281,0,1,L-tryptophan transmembrane transport,BP,
20247,GO:1904562,1,0.981387478169789,0,2,phosphatidylinositol 5-phosphate metabolic process,BP,
20248,GO:1904565,1,0.99270722470751,0,1,response to 1-oleoyl-sn-glycerol 3-phosphate,BP,
20249,GO:1904566,1,0.99270722470751,0,1,cellular response to 1-oleoyl-sn-glycerol 3-phosphate,BP,
20250,GO:1904567,1,0.992800326150592,0,1,response to wortmannin,BP,
20251,GO:1904568,1,0.992800326150592,0,1,cellular response to wortmannin,BP,
20252,GO:1904569,1,0.995249769378109,0,1,regulation of selenocysteine incorporation,BP,
20253,GO:1904570,1,0.995249769378109,0,1,negative regulation of selenocysteine incorporation,BP,
20254,GO:1904572,1,0.995249769378109,0,1,negative regulation of mRNA binding,BP,
20255,GO:1904573,1,0.995249769378109,0,1,regulation of selenocysteine insertion sequence binding,BP,
20256,GO:1904574,1,0.995249769378109,0,1,negative regulation of selenocysteine insertion sequence binding,BP,
20257,GO:1904576,1,0.988460076930543,0,2,response to tunicamycin,BP,
20258,GO:1904577,1,0.988460076930543,0,2,cellular response to tunicamycin,BP,
20259,GO:1904578,1,0.982837530604468,0,3,response to thapsigargin,BP,
20260,GO:1904579,1,0.982837530604468,0,3,cellular response to thapsigargin,BP,
20261,GO:1904580,1,0.988071270947168,0,2,regulation of intracellular mRNA localization,BP,
20262,GO:1904582,1,0.988071270947168,0,2,positive regulation of intracellular mRNA localization,BP,
20263,GO:1904585,1,0.99426674733889,0,1,response to putrescine,BP,
20264,GO:1904586,1,0.99426674733889,0,1,cellular response to putrescine,BP,
20265,GO:1904587,1,0.960247843776826,0,6,response to glycoprotein,BP,
20266,GO:1904588,1,0.99636257431311,0,1,cellular response to glycoprotein,BP,
20269,GO:1904591,1,0.783832506514546,0,33,positive regulation of protein import,BP,
20270,GO:1904594,1,0.988593461709096,0,1,regulation of termination of RNA polymerase II transcription,BP,
20271,GO:1904595,1,0.988593461709096,0,1,positive regulation of termination of RNA polymerase II transcription,BP,
20272,GO:1904596,1,0.996154444087333,0,1,regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
20273,GO:1904597,1,0.996154444087333,0,1,negative regulation of connective tissue replacement involved in inflammatory response wound healing,BP,
20274,GO:1904599,1,0.996154444087333,0,1,advanced glycation end-product binding,MF,
20275,GO:1904602,1,0.989173952714235,0,2,serotonin-activated cation-selective channel complex,CC,
20276,GO:1904603,1,0.996154444087333,0,1,regulation of advanced glycation end-product receptor activity,BP,
20277,GO:1904604,1,0.996154444087333,0,1,negative regulation of advanced glycation end-product receptor activity,BP,
20278,GO:1904606,1,0.992563042505725,0,1,fat cell apoptotic process,BP,
20281,GO:1904616,1,0.984533248165359,0,2,regulation of actin binding,BP,
20282,GO:1904617,1,0.99272665433335,0,1,negative regulation of actin binding,BP,
20283,GO:1904618,1,0.991747163125289,0,1,positive regulation of actin binding,BP,
20284,GO:1904627,1,0.98905213448812,0,2,response to phorbol 13-acetate 12-myristate,BP,
20285,GO:1904628,1,0.98905213448812,0,2,cellular response to phorbol 13-acetate 12-myristate,BP,
20286,GO:1904631,1,0.994079925475322,0,1,response to glucoside,BP,
20287,GO:1904633,1,0.991319662364429,0,1,regulation of glomerular visceral epithelial cell apoptotic process,BP,
20288,GO:1904635,1,0.991319662364429,0,1,positive regulation of glomerular visceral epithelial cell apoptotic process,BP,
20289,GO:1904636,1,0.97263281171133,0,4,response to ionomycin,BP,
20290,GO:1904637,1,0.97263281171133,0,4,cellular response to ionomycin,BP,
20291,GO:1904638,1,0.991319662364429,0,1,response to resveratrol,BP,
20292,GO:1904639,1,0.991319662364429,0,1,cellular response to resveratrol,BP,
20293,GO:1904640,1,0.984587737058351,0,2,response to methionine,BP,
20294,GO:1904645,1,0.819089171181709,0,27,response to amyloid-beta,BP,
20295,GO:1904646,1,0.828428074422016,0,25,cellular response to amyloid-beta,BP,
20296,GO:1904647,1,0.989642657973999,0,1,response to rotenone,BP,
20297,GO:1904649,1,0.992563042505725,0,1,regulation of fat cell apoptotic process,BP,
20298,GO:1904651,1,0.992563042505725,0,1,positive regulation of fat cell apoptotic process,BP,
20299,GO:1904659,1,0.519775402032939,0,92,glucose transmembrane transport,BP,
20300,GO:1904666,1,0.908701793188978,0,19,regulation of ubiquitin protein ligase activity,BP,
20301,GO:1904667,1,0.975123860172945,0,7,negative regulation of ubiquitin protein ligase activity,BP,
20302,GO:1904668,1,0.931900070585825,0,12,positive regulation of ubiquitin protein ligase activity,BP,
20303,GO:1904672,1,0.963130914409905,0,5,regulation of somatic stem cell population maintenance,BP,
20304,GO:1904673,1,0.977582897392629,0,3,negative regulation of somatic stem cell population maintenance,BP,
20305,GO:1904674,1,0.985219940295228,0,2,positive regulation of somatic stem cell population maintenance,BP,
20306,GO:1904675,1,0.99287289100993,0,1,regulation of somatic stem cell division,BP,
20307,GO:1904677,1,0.99287289100993,0,1,positive regulation of somatic stem cell division,BP,
20308,GO:1904680,1,0.880882557200988,0,22,peptide transmembrane transporter activity,MF,
20309,GO:1904681,1,0.993192938376038,0,1,response to 3-methylcholanthrene,BP,
20311,GO:1904684,1,0.965780046620672,0,4,negative regulation of metalloendopeptidase activity,BP,
20313,GO:1904688,1,0.969416865559122,0,5,regulation of cytoplasmic translational initiation,BP,
20314,GO:1904689,1,0.996619901427331,0,1,negative regulation of cytoplasmic translational initiation,BP,
20315,GO:1904690,1,0.972705617449044,0,4,positive regulation of cytoplasmic translational initiation,BP,
20316,GO:1904691,1,0.994333515866912,0,1,negative regulation of type B pancreatic cell proliferation,BP,
20317,GO:1904692,1,0.992515001197605,0,1,positive regulation of type B pancreatic cell proliferation,BP,
20318,GO:1904693,1,0.975300485759425,0,3,midbrain morphogenesis,BP,
20319,GO:1904694,1,0.973915363226366,0,3,negative regulation of vascular smooth muscle contraction,BP,
20320,GO:1904695,1,0.994827199554952,0,1,positive regulation of vascular smooth muscle contraction,BP,
20321,GO:1904700,1,0.993353288176591,0,1,granulosa cell apoptotic process,BP,
20322,GO:1904701,1,0.995101869933184,0,1,Wnt-Frizzled-LRP5/6 complex assembly,BP,
20323,GO:1904705,1,0.778865311710347,0,36,regulation of vascular smooth muscle cell proliferation,BP,
20324,GO:1904706,1,0.916686578642553,0,14,negative regulation of vascular smooth muscle cell proliferation,BP,
20325,GO:1904707,1,0.845948858753809,0,23,positive regulation of vascular smooth muscle cell proliferation,BP,
20326,GO:1904708,1,0.993353288176591,0,1,regulation of granulosa cell apoptotic process,BP,
20327,GO:1904711,1,0.995101869933184,0,1,regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,
20328,GO:1904713,1,0.982705213902683,0,2,beta-catenin destruction complex binding,MF,
20329,GO:1904714,1,0.950108487860045,0,8,regulation of chaperone-mediated autophagy,BP,
20330,GO:1904715,1,0.981661780141426,0,3,negative regulation of chaperone-mediated autophagy,BP,
20331,GO:1904716,1,0.993805111137145,0,1,positive regulation of chaperone-mediated autophagy,BP,
20332,GO:1904717,1,0.976024906386391,0,3,regulation of AMPA glutamate receptor clustering,BP,
20333,GO:1904719,1,0.993642621526323,0,1,positive regulation of AMPA glutamate receptor clustering,BP,
20334,GO:1904720,1,0.986480588845941,0,2,regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
20335,GO:1904721,1,0.99274616084698,0,1,negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
20336,GO:1904722,1,0.993689104376492,0,1,positive regulation of mRNA endonucleolytic cleavage involved in unfolded protein response,BP,
20337,GO:1904723,1,0.995101869933184,0,1,negative regulation of Wnt-Frizzled-LRP5/6 complex assembly,BP,
20339,GO:1904729,1,0.982992537803676,0,3,regulation of intestinal lipid absorption,BP,
20340,GO:1904730,1,0.993229158668432,0,1,negative regulation of intestinal lipid absorption,BP,
20341,GO:1904732,1,0.988121361427826,0,2,regulation of electron transfer activity,BP,
20342,GO:1904734,1,0.998088491919711,0,1,positive regulation of electron transfer activity,BP,
20343,GO:1904738,1,0.878466616029552,0,16,vascular associated smooth muscle cell migration,BP,
20344,GO:1904742,1,0.971977910716538,0,4,regulation of telomeric DNA binding,BP,
20345,GO:1904743,1,0.980518572393977,0,2,negative regulation of telomeric DNA binding,BP,
20346,GO:1904744,1,0.991291355160281,0,2,positive regulation of telomeric DNA binding,BP,
20347,GO:1904746,1,0.965841884364479,0,5,negative regulation of apoptotic process involved in development,BP,
20348,GO:1904747,1,0.982084759338733,0,3,positive regulation of apoptotic process involved in development,BP,
20349,GO:1904748,1,0.94095136527466,0,9,regulation of apoptotic process involved in development,BP,
20350,GO:1904749,1,0.968859878486682,0,5,regulation of protein localization to nucleolus,BP,
20351,GO:1904750,1,0.991111518645563,0,1,negative regulation of protein localization to nucleolus,BP,
20352,GO:1904751,1,0.977550783988446,0,4,positive regulation of protein localization to nucleolus,BP,
20353,GO:1904752,1,0.878466616029552,0,16,regulation of vascular associated smooth muscle cell migration,BP,
20354,GO:1904753,1,0.963635918620485,0,5,negative regulation of vascular associated smooth muscle cell migration,BP,
20355,GO:1904754,1,0.91164794257753,0,11,positive regulation of vascular associated smooth muscle cell migration,BP,
20356,GO:1904760,1,0.976922004390027,0,3,regulation of myofibroblast differentiation,BP,
20357,GO:1904761,1,0.984331349293443,0,2,negative regulation of myofibroblast differentiation,BP,
20358,GO:1904762,1,0.992473895706169,0,1,positive regulation of myofibroblast differentiation,BP,
20359,GO:1904764,1,0.994555207012681,0,1,chaperone-mediated autophagy translocation complex disassembly,BP,
20360,GO:1904766,1,0.990963483725751,0,1,negative regulation of macroautophagy by TORC1 signaling,BP,
20361,GO:1904768,1,0.989401488159787,0,2,all-trans-retinol binding,MF,
20362,GO:1904772,1,0.993293398236355,0,1,response to tetrachloromethane,BP,
20363,GO:1904776,1,0.954289023179488,0,6,regulation of protein localization to cell cortex,BP,
20364,GO:1904777,1,0.993058458973322,0,1,negative regulation of protein localization to cell cortex,BP,
20365,GO:1904778,1,0.96096222742776,0,5,positive regulation of protein localization to cell cortex,BP,
20366,GO:1904779,1,0.946091366541215,0,7,regulation of protein localization to centrosome,BP,
20367,GO:1904781,1,0.952095110335024,0,6,positive regulation of protein localization to centrosome,BP,
20368,GO:1904782,1,0.992182993390367,0,1,negative regulation of NMDA glutamate receptor activity,BP,
20369,GO:1904783,1,0.985480842562848,0,2,positive regulation of NMDA glutamate receptor activity,BP,
20370,GO:1904784,1,0.991837531793709,0,1,NLRP1 inflammasome complex assembly,BP,
20371,GO:1904790,1,0.99287447827936,0,1,regulation of shelterin complex assembly,BP,
20372,GO:1904792,1,0.99287447827936,0,1,positive regulation of shelterin complex assembly,BP,
20373,GO:1904793,1,0.992562739064772,0,1,regulation of euchromatin binding,BP,
20374,GO:1904796,1,0.96541090079817,0,5,regulation of core promoter binding,BP,
20375,GO:1904797,1,0.99146506681211,0,1,negative regulation of core promoter binding,BP,
20376,GO:1904798,1,0.973723770130772,0,4,positive regulation of core promoter binding,BP,
20377,GO:1904799,1,0.992479608148959,0,1,regulation of neuron remodeling,BP,
20378,GO:1904800,1,0.992479608148959,0,1,negative regulation of neuron remodeling,BP,
20379,GO:1904803,1,0.997762279923933,0,1,regulation of translation involved in cellular response to UV,BP,
20380,GO:1904806,1,0.986164624597214,0,2,regulation of protein oxidation,BP,
20381,GO:1904808,1,0.986164624597214,0,2,positive regulation of protein oxidation,BP,
20382,GO:1904812,1,0.992479787768794,0,1,rRNA acetylation involved in maturation of SSU-rRNA,BP,
20383,GO:1904813,1,0.48898784642527,0,123,ficolin-1-rich granule lumen,CC,
20384,GO:1904814,1,0.922532208570378,0,13,regulation of protein localization to chromosome, telomeric region,BP,
20385,GO:1904815,1,0.987731104009212,0,2,negative regulation of protein localization to chromosome, telomeric region,BP,
20386,GO:1904816,1,0.933999128645284,0,11,positive regulation of protein localization to chromosome, telomeric region,BP,
20387,GO:1904823,1,0.981556516002149,0,3,purine nucleobase transmembrane transport,BP,
20388,GO:1904826,1,0.990532027818856,0,1,regulation of hydrogen sulfide biosynthetic process,BP,
20389,GO:1904828,1,0.990532027818856,0,1,positive regulation of hydrogen sulfide biosynthetic process,BP,
20390,GO:1904829,1,0.995239252591955,0,1,regulation of aortic smooth muscle cell differentiation,BP,
20391,GO:1904831,1,0.995239252591955,0,1,positive regulation of aortic smooth muscle cell differentiation,BP,
20392,GO:1904833,1,0.987313090335356,0,3,positive regulation of removal of superoxide radicals,BP,
20393,GO:1904835,1,0.99356547104577,0,1,dorsal root ganglion morphogenesis,BP,
20394,GO:1904837,1,0.792633504417311,0,34,beta-catenin-TCF complex assembly,BP,
20395,GO:1904842,1,0.994264454123425,0,1,response to nitroglycerin,BP,
20396,GO:1904843,1,0.994264454123425,0,1,cellular response to nitroglycerin,BP,
20397,GO:1904844,1,0.984286956324555,0,3,response to L-glutamine,BP,
20398,GO:1904845,1,0.984286956324555,0,3,cellular response to L-glutamine,BP,
20399,GO:1904847,1,0.967917256512691,0,5,regulation of cell chemotaxis to fibroblast growth factor,BP,
20400,GO:1904848,1,0.996460308534979,0,1,negative regulation of cell chemotaxis to fibroblast growth factor,BP,
20401,GO:1904849,1,0.978703581392683,0,3,positive regulation of cell chemotaxis to fibroblast growth factor,BP,
20402,GO:1904850,1,0.99287447827936,0,1,negative regulation of establishment of protein localization to telomere,BP,
20403,GO:1904851,1,0.947679107007079,0,9,positive regulation of establishment of protein localization to telomere,BP,
20404,GO:1904854,1,0.98650439701216,0,2,proteasome core complex binding,MF,
20406,GO:1904862,1,0.976701371458873,0,3,inhibitory synapse assembly,BP,
20407,GO:1904863,1,0.992496286735226,0,1,regulation of beta-catenin-TCF complex assembly,BP,
20408,GO:1904864,1,0.992496286735226,0,1,negative regulation of beta-catenin-TCF complex assembly,BP,
20409,GO:1904867,1,0.948639489576539,0,9,protein localization to Cajal body,BP,
20410,GO:1904868,1,0.978804958970206,0,2,telomerase catalytic core complex assembly,BP,
20411,GO:1904869,1,0.953434655559867,0,8,regulation of protein localization to Cajal body,BP,
20412,GO:1904871,1,0.953434655559867,0,8,positive regulation of protein localization to Cajal body,BP,
20413,GO:1904872,1,0.900635396977136,0,18,regulation of telomerase RNA localization to Cajal body,BP,
20414,GO:1904874,1,0.923020361313678,0,15,positive regulation of telomerase RNA localization to Cajal body,BP,
20415,GO:1904875,1,0.987322334282825,0,2,regulation of DNA ligase activity,BP,
20416,GO:1904876,1,0.992914587604173,0,1,negative regulation of DNA ligase activity,BP,
20417,GO:1904877,1,0.994368239949363,0,1,positive regulation of DNA ligase activity,BP,
20418,GO:1904878,1,0.988908463826096,0,1,negative regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
20419,GO:1904879,1,0.986345948970309,0,2,positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel,BP,
20420,GO:1904880,1,0.97843121543016,0,3,response to hydrogen sulfide,BP,
20421,GO:1904881,1,0.984774500340458,0,2,cellular response to hydrogen sulfide,BP,
20422,GO:1904882,1,0.978804958970206,0,2,regulation of telomerase catalytic core complex assembly,BP,
20423,GO:1904884,1,0.978804958970206,0,2,positive regulation of telomerase catalytic core complex assembly,BP,
20424,GO:1904885,1,0.95857667082552,0,5,beta-catenin destruction complex assembly,BP,
20425,GO:1904886,1,0.872412616301502,0,18,beta-catenin destruction complex disassembly,BP,
20426,GO:1904887,1,0.989575106505612,0,1,Wnt signalosome assembly,BP,
20427,GO:1904888,1,0.648888538455976,0,59,cranial skeletal system development,BP,
20428,GO:1904889,1,0.988403383970739,0,2,regulation of excitatory synapse assembly,BP,
20429,GO:1904891,1,0.988403383970739,0,2,positive regulation of excitatory synapse assembly,BP,
20431,GO:1904893,1,0.734961951341324,0,45,negative regulation of STAT cascade,BP,
20433,GO:1904895,1,0.995421640886495,0,1,ESCRT complex assembly,BP,
20434,GO:1904896,1,0.939503604325856,0,10,ESCRT complex disassembly,BP,
20435,GO:1904897,1,0.992600529140788,0,1,regulation of hepatic stellate cell proliferation,BP,
20436,GO:1904899,1,0.992600529140788,0,1,positive regulation of hepatic stellate cell proliferation,BP,
20437,GO:1904902,1,0.995421640886495,0,1,ESCRT III complex assembly,BP,
20438,GO:1904903,1,0.939503604325856,0,10,ESCRT III complex disassembly,BP,
20439,GO:1904907,1,0.978026362525039,0,2,regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
20440,GO:1904908,1,0.978026362525039,0,2,negative regulation of maintenance of mitotic sister chromatid cohesion, telomeric,BP,
20441,GO:1904910,1,0.99287447827936,0,1,regulation of establishment of RNA localization to telomere,BP,
20442,GO:1904911,1,0.99287447827936,0,1,negative regulation of establishment of RNA localization to telomere,BP,
20443,GO:1904913,1,0.99287447827936,0,1,regulation of establishment of protein-containing complex localization to telomere,BP,
20444,GO:1904914,1,0.99287447827936,0,1,negative regulation of establishment of protein-containing complex localization to telomere,BP,
20445,GO:1904923,1,0.918134561886353,0,12,regulation of autophagy of mitochondrion in response to mitochondrial depolarization,BP,
20446,GO:1904924,1,0.9937228787619,0,1,negative regulation of mitophagy in response to mitochondrial depolarization,BP,
20447,GO:1904925,1,0.923938812602673,0,11,positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization,BP,
20448,GO:1904928,1,0.981236377059378,0,2,coreceptor activity involved in canonical Wnt signaling pathway,MF,
20450,GO:1904933,1,0.991622634195076,0,1,regulation of cell proliferation in midbrain,BP,
20451,GO:1904934,1,0.991622634195076,0,1,negative regulation of cell proliferation in midbrain,BP,
20453,GO:1904938,1,0.957699786182336,0,5,planar cell polarity pathway involved in axon guidance,BP,
20454,GO:1904947,1,0.992786941542118,0,1,folic acid import into mitochondrion,BP,
20455,GO:1904948,1,0.902966933457098,0,15,midbrain dopaminergic neuron differentiation,BP,
20459,GO:1904953,1,0.933011084805057,0,10,Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
20460,GO:1904954,1,0.981428745964797,0,3,canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
20461,GO:1904955,1,0.991622634195076,0,1,planar cell polarity pathway involved in midbrain dopaminergic neuron differentiation,BP,
20462,GO:1904956,1,0.970228811473518,0,5,regulation of midbrain dopaminergic neuron differentiation,BP,
20463,GO:1904958,1,0.982946560089377,0,3,positive regulation of midbrain dopaminergic neuron differentiation,BP,
20464,GO:1904959,1,0.988121361427826,0,2,regulation of cytochrome-c oxidase activity,BP,
20465,GO:1904960,1,0.998088491919711,0,1,positive regulation of cytochrome-c oxidase activity,BP,
20467,GO:1904971,1,0.992297874244277,0,1,regulation of viral translation,BP,
20468,GO:1904973,1,0.992297874244277,0,1,positive regulation of viral translation,BP,
20469,GO:1904975,1,0.984572170708559,0,2,response to bleomycin,BP,
20470,GO:1904976,1,0.984572170708559,0,2,cellular response to bleomycin,BP,
20471,GO:1904977,1,0.992936619507467,0,1,lymphatic endothelial cell migration,BP,
20472,GO:1904978,1,0.977357112473399,0,3,regulation of endosome organization,BP,
20473,GO:1904979,1,0.994096693478931,0,1,negative regulation of endosome organization,BP,
20474,GO:1904980,1,0.990850223990872,0,1,positive regulation of endosome organization,BP,
20475,GO:1904983,1,0.994340450883261,0,1,glycine import into mitochondrion,BP,
20476,GO:1904990,1,0.993655686055414,0,1,regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
20477,GO:1904992,1,0.993655686055414,0,1,positive regulation of adenylate cyclase-inhibiting dopamine receptor signaling pathway,BP,
20478,GO:1904994,1,0.935762547147921,0,12,regulation of leukocyte adhesion to vascular endothelial cell,BP,
20479,GO:1904995,1,0.979401754457652,0,5,negative regulation of leukocyte adhesion to vascular endothelial cell,BP,
20480,GO:1904996,1,0.955452078487957,0,7,positive regulation of leukocyte adhesion to vascular endothelial cell,BP,
20481,GO:1904997,1,0.988332122949365,0,2,regulation of leukocyte adhesion to arterial endothelial cell,BP,
20482,GO:1904998,1,0.992878200428606,0,1,negative regulation of leukocyte adhesion to arterial endothelial cell,BP,
20483,GO:1904999,1,0.995421640886495,0,1,positive regulation of leukocyte adhesion to arterial endothelial cell,BP,
20484,GO:1905000,1,0.989993346924247,0,1,regulation of membrane repolarization during atrial cardiac muscle cell action potential,BP,
20485,GO:1905005,1,0.95682542101754,0,6,regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
20486,GO:1905006,1,0.986952641520923,0,2,negative regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
20487,GO:1905007,1,0.961731453623228,0,5,positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation,BP,
20488,GO:1905008,1,0.993388970162643,0,1,regulation of L-lysine import across plasma membrane,BP,
20489,GO:1905010,1,0.993388970162643,0,1,positive regulation of L-lysine import across plasma membrane,BP,
20490,GO:1905024,1,0.97003636504956,0,4,regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
20491,GO:1905025,1,0.9927525183413,0,1,negative regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
20492,GO:1905026,1,0.984892516161635,0,2,positive regulation of membrane repolarization during ventricular cardiac muscle cell action potential,BP,
20493,GO:1905030,1,0.991932129188522,0,1,voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential,MF,
20494,GO:1905031,1,0.960326613599679,0,5,regulation of membrane repolarization during cardiac muscle cell action potential,BP,
20495,GO:1905032,1,0.9927525183413,0,1,negative regulation of membrane repolarization during cardiac muscle cell action potential,BP,
20496,GO:1905033,1,0.984892516161635,0,2,positive regulation of membrane repolarization during cardiac muscle cell action potential,BP,
20497,GO:1905034,1,0.992881411540392,0,1,regulation of antifungal innate immune response,BP,
20498,GO:1905035,1,0.992881411540392,0,1,negative regulation of antifungal innate immune response,BP,
20499,GO:1905037,1,0.537965413884434,0,90,autophagosome organization,BP,
20500,GO:1905038,1,0.9246256409518,0,13,regulation of membrane lipid metabolic process,BP,
20502,GO:1905040,1,0.99356547104577,0,1,otic placode development,BP,
20503,GO:1905041,1,0.994076577534993,0,1,regulation of epithelium regeneration,BP,
20504,GO:1905042,1,0.994076577534993,0,1,negative regulation of epithelium regeneration,BP,
20505,GO:1905044,1,0.993058458973322,0,1,regulation of Schwann cell proliferation involved in axon regeneration,BP,
20506,GO:1905045,1,0.993058458973322,0,1,negative regulation of Schwann cell proliferation involved in axon regeneration,BP,
20508,GO:1905049,1,0.955736586766348,0,6,negative regulation of metallopeptidase activity,BP,
20510,GO:1905051,1,0.992419881185792,0,2,regulation of base-excision repair,BP,
20511,GO:1905053,1,0.992419881185792,0,2,positive regulation of base-excision repair,BP,
20512,GO:1905062,1,0.993171689752098,0,1,positive regulation of cardioblast proliferation,BP,
20513,GO:1905063,1,0.94412110952605,0,8,regulation of vascular smooth muscle cell differentiation,BP,
20514,GO:1905064,1,0.978836796120509,0,3,negative regulation of vascular smooth muscle cell differentiation,BP,
20515,GO:1905065,1,0.964541180018037,0,5,positive regulation of vascular smooth muscle cell differentiation,BP,
20516,GO:1905066,1,0.988954874003068,0,2,regulation of canonical Wnt signaling pathway involved in heart development,BP,
20517,GO:1905067,1,0.995101869933184,0,1,negative regulation of canonical Wnt signaling pathway involved in heart development,BP,
20518,GO:1905068,1,0.993823049830488,0,1,positive regulation of canonical Wnt signaling pathway involved in heart development,BP,
20519,GO:1905069,1,0.986751746129538,0,2,allantois development,BP,
20520,GO:1905071,1,0.976269583585749,0,3,occluding junction disassembly,BP,
20521,GO:1905073,1,0.976269583585749,0,3,regulation of occluding junction disassembly,BP,
20522,GO:1905075,1,0.976269583585749,0,3,positive regulation of occluding junction disassembly,BP,
20523,GO:1905076,1,0.99468027294805,0,1,regulation of interleukin-17 secretion,BP,
20524,GO:1905077,1,0.99468027294805,0,1,negative regulation of interleukin-17 secretion,BP,
20525,GO:1905089,1,0.987929911365083,0,1,regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
20526,GO:1905090,1,0.987929911365083,0,1,negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization,BP,
20527,GO:1905097,1,0.956305799419979,0,6,regulation of guanyl-nucleotide exchange factor activity,BP,
20528,GO:1905098,1,0.973369562396572,0,4,negative regulation of guanyl-nucleotide exchange factor activity,BP,
20529,GO:1905099,1,0.991298700908345,0,1,positive regulation of guanyl-nucleotide exchange factor activity,BP,
20530,GO:1905103,1,0.992473489815072,0,1,integral component of lysosomal membrane,CC,
20532,GO:1905123,1,0.984772797148474,0,2,regulation of glucosylceramidase activity,BP,
20533,GO:1905132,1,0.992781274983959,0,1,regulation of meiotic chromosome separation,BP,
20534,GO:1905133,1,0.992781274983959,0,1,negative regulation of meiotic chromosome separation,BP,
20535,GO:1905143,1,0.995678071347941,0,1,eukaryotic translation initiation factor 2 complex assembly,BP,
20536,GO:1905144,1,0.873493346710391,0,21,response to acetylcholine,BP,
20537,GO:1905145,1,0.873493346710391,0,21,cellular response to acetylcholine,BP,
20538,GO:1905146,1,0.924119906081314,0,10,lysosomal protein catabolic process,BP,
20539,GO:1905150,1,0.976742711991327,0,3,regulation of voltage-gated sodium channel activity,BP,
20540,GO:1905152,1,0.991578308151986,0,1,positive regulation of voltage-gated sodium channel activity,BP,
20541,GO:1905153,1,0.919934929146576,0,12,regulation of membrane invagination,BP,
20542,GO:1905154,1,0.986921400880676,0,2,negative regulation of membrane invagination,BP,
20543,GO:1905155,1,0.938514279402072,0,9,positive regulation of membrane invagination,BP,
20544,GO:1905161,1,0.991982541142166,0,1,protein localization to phagocytic vesicle,BP,
20545,GO:1905162,1,0.991982541142166,0,1,regulation of phagosome maturation,BP,
20546,GO:1905165,1,0.939220664353098,0,7,regulation of lysosomal protein catabolic process,BP,
20547,GO:1905166,1,0.979310457162443,0,3,negative regulation of lysosomal protein catabolic process,BP,
20548,GO:1905167,1,0.96512700487637,0,3,positive regulation of lysosomal protein catabolic process,BP,
20549,GO:1905168,1,0.99250669503576,0,1,positive regulation of double-strand break repair via homologous recombination,BP,
20550,GO:1905169,1,0.991982541142166,0,1,regulation of protein localization to phagocytic vesicle,BP,
20551,GO:1905171,1,0.991982541142166,0,1,positive regulation of protein localization to phagocytic vesicle,BP,
20552,GO:1905172,1,0.992297874244277,0,1,RISC complex binding,MF,
20553,GO:1905174,1,0.987937162504371,0,2,regulation of vascular smooth muscle cell dedifferentiation,BP,
20554,GO:1905176,1,0.992937210169218,0,1,positive regulation of vascular smooth muscle cell dedifferentiation,BP,
20555,GO:1905202,1,0.986006198283534,0,2,methylcrotonoyl-CoA carboxylase complex,CC,
20556,GO:1905203,1,0.98846993661139,0,2,regulation of connective tissue replacement,BP,
20557,GO:1905204,1,0.996154444087333,0,1,negative regulation of connective tissue replacement,BP,
20558,GO:1905205,1,0.992286123834156,0,1,positive regulation of connective tissue replacement,BP,
20559,GO:1905206,1,0.967411750501534,0,5,positive regulation of hydrogen peroxide-induced cell death,BP,
20562,GO:1905209,1,0.845548361270677,0,24,positive regulation of cardiocyte differentiation,BP,
20563,GO:1905214,1,0.930894876203552,0,11,regulation of RNA binding,BP,
20564,GO:1905215,1,0.995249769378109,0,1,negative regulation of RNA binding,BP,
20565,GO:1905216,1,0.950429808535106,0,8,positive regulation of RNA binding,BP,
20566,GO:1905217,1,0.992730389328597,0,1,response to astaxanthin,BP,
20567,GO:1905222,1,0.992700339107276,0,1,atrioventricular canal morphogenesis,BP,
20568,GO:1905223,1,0.991298084684562,0,1,epicardium morphogenesis,BP,
20569,GO:1905224,1,0.984370609113579,0,2,clathrin-coated pit assembly,BP,
20570,GO:1905225,1,0.989119142731869,0,2,response to thyrotropin-releasing hormone,BP,
20571,GO:1905226,1,0.996279622224939,0,1,regulation of adhesion of symbiont to host epithelial cell,BP,
20572,GO:1905229,1,0.99636257431311,0,1,cellular response to thyrotropin-releasing hormone,BP,
20573,GO:1905230,1,0.992475485630838,0,1,response to borneol,BP,
20574,GO:1905231,1,0.992475485630838,0,1,cellular response to borneol,BP,
20575,GO:1905232,1,0.963851688093316,0,5,cellular response to L-glutamate,BP,
20576,GO:1905233,1,0.992475485630838,0,1,response to codeine,BP,
20577,GO:1905235,1,0.992475485630838,0,1,response to quercetin,BP,
20578,GO:1905237,1,0.992475485630838,0,1,response to cyclosporin A,BP,
20579,GO:1905239,1,0.992108570220633,0,1,regulation of canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
20580,GO:1905240,1,0.992108570220633,0,1,negative regulation of canonical Wnt signaling pathway involved in osteoblast differentiation,BP,
20581,GO:1905242,1,0.985837910158492,0,2,response to 3,3',5-triiodo-L-thyronine,BP,
20582,GO:1905243,1,0.993211326445594,0,1,cellular response to 3,3',5-triiodo-L-thyronine,BP,
20583,GO:1905244,1,0.941167527869813,0,8,regulation of modification of synaptic structure,BP,
20584,GO:1905245,1,0.942696576218276,0,8,regulation of aspartic-type peptidase activity,BP,
20585,GO:1905246,1,0.982602645666191,0,2,negative regulation of aspartic-type peptidase activity,BP,
20586,GO:1905247,1,0.959394353191167,0,6,positive regulation of aspartic-type peptidase activity,BP,
20587,GO:1905255,1,0.991239618845105,0,1,regulation of RNA binding transcription factor activity,BP,
20588,GO:1905258,1,0.992750144152349,0,2,regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
20589,GO:1905259,1,0.992750144152349,0,2,negative regulation of nitrosative stress-induced intrinsic apoptotic signaling pathway,BP,
20590,GO:1905267,1,0.986639566405845,0,2,endonucleolytic cleavage involved in tRNA processing,BP,
20591,GO:1905268,1,0.719935944219832,0,45,negative regulation of chromatin organization,BP,
20592,GO:1905269,1,0.534161862017771,0,88,positive regulation of chromatin organization,BP,
20593,GO:1905271,1,0.997670001543501,0,1,regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,
20594,GO:1905273,1,0.997670001543501,0,1,positive regulation of proton-transporting ATP synthase activity, rotational mechanism,BP,
20595,GO:1905274,1,0.990773028720735,0,1,regulation of modification of postsynaptic actin cytoskeleton,BP,
20596,GO:1905276,1,0.876281748954307,0,18,regulation of epithelial tube formation,BP,
20597,GO:1905277,1,0.992751317537939,0,1,negative regulation of epithelial tube formation,BP,
20598,GO:1905278,1,0.975136752139907,0,4,positive regulation of epithelial tube formation,BP,
20599,GO:1905279,1,0.982705213902683,0,2,regulation of retrograde transport, endosome to Golgi,BP,
20600,GO:1905285,1,0.992518804425241,0,1,fibrous ring of heart morphogenesis,BP,
20601,GO:1905286,1,0.980417659061698,0,3,serine-type peptidase complex,CC,
20602,GO:1905288,1,0.954831980360321,0,6,vascular associated smooth muscle cell apoptotic process,BP,
20603,GO:1905289,1,0.989575106505612,0,1,regulation of CAMKK-AMPK signaling cascade,BP,
20604,GO:1905292,1,0.979770347117032,0,3,regulation of neural crest cell differentiation,BP,
20605,GO:1905294,1,0.979770347117032,0,3,positive regulation of neural crest cell differentiation,BP,
20606,GO:1905301,1,0.992328707776266,0,1,regulation of macropinocytosis,BP,
20607,GO:1905302,1,0.992328707776266,0,1,negative regulation of macropinocytosis,BP,
20608,GO:1905304,1,0.989857033990238,0,1,regulation of cardiac myofibril assembly,BP,
20609,GO:1905305,1,0.989857033990238,0,1,negative regulation of cardiac myofibril assembly,BP,
20610,GO:1905309,1,0.989076230734225,0,1,positive regulation of cohesin loading,BP,
20611,GO:1905310,1,0.979770347117032,0,3,regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
20612,GO:1905312,1,0.979770347117032,0,3,positive regulation of cardiac neural crest cell migration involved in outflow tract morphogenesis,BP,
20613,GO:1905313,1,0.994168744955213,0,1,transforming growth factor beta receptor signaling pathway involved in heart development,BP,
20614,GO:1905314,1,0.895087355029336,0,15,semi-lunar valve development,BP,
20615,GO:1905317,1,0.992281002971285,0,1,inferior endocardial cushion morphogenesis,BP,
20616,GO:1905319,1,0.993058458973322,0,1,mesenchymal stem cell migration,BP,
20617,GO:1905320,1,0.993058458973322,0,1,regulation of mesenchymal stem cell migration,BP,
20618,GO:1905322,1,0.993058458973322,0,1,positive regulation of mesenchymal stem cell migration,BP,
20619,GO:1905323,1,0.955491763444309,0,6,telomerase holoenzyme complex assembly,BP,
20620,GO:1905327,1,0.995632596003417,0,1,tracheoesophageal septum formation,BP,
20622,GO:1905331,1,0.879192577130907,0,18,negative regulation of morphogenesis of an epithelium,BP,
20623,GO:1905332,1,0.810058416224543,0,30,positive regulation of morphogenesis of an epithelium,BP,
20624,GO:1905333,1,0.990235691804271,0,3,regulation of gastric motility,BP,
20625,GO:1905335,1,0.987287396619876,0,1,regulation of aggrephagy,BP,
20626,GO:1905337,1,0.987287396619876,0,1,positive regulation of aggrephagy,BP,
20627,GO:1905340,1,0.975970159558161,0,4,regulation of protein localization to kinetochore,BP,
20628,GO:1905341,1,0.993217783511225,0,1,negative regulation of protein localization to kinetochore,BP,
20629,GO:1905342,1,0.975970159558161,0,4,positive regulation of protein localization to kinetochore,BP,
20630,GO:1905344,1,0.993058458973322,0,1,prostaglandin catabolic process,BP,
20631,GO:1905348,1,0.842626242383923,0,29,endonuclease complex,CC,
20632,GO:1905349,1,0.992027252421618,0,2,ciliary transition zone assembly,BP,
20633,GO:1905354,1,0.881154168086256,0,22,exoribonuclease complex,CC,
20634,GO:1905355,1,0.992046016899726,0,1,spine apparatus assembly,BP,
20635,GO:1905359,1,0.992781274983959,0,1,protein localization to meiotic spindle,BP,
20637,GO:1905365,1,0.994096693478931,0,1,regulation of intralumenal vesicle formation,BP,
20638,GO:1905366,1,0.994096693478931,0,1,negative regulation of intralumenal vesicle formation,BP,
20639,GO:1905368,1,0.651669441209279,0,83,peptidase complex,CC,
20640,GO:1905369,1,0.732377256193273,0,63,endopeptidase complex,CC,
20641,GO:1905370,1,0.9937228787619,0,1,serine-type endopeptidase complex,CC,
20642,GO:1905371,1,0.98725945755117,0,2,ceramide phosphoethanolamine metabolic process,BP,
20643,GO:1905373,1,0.98725945755117,0,2,ceramide phosphoethanolamine biosynthetic process,BP,
20644,GO:1905383,1,0.985369659447473,0,3,protein localization to presynapse,BP,
20645,GO:1905384,1,0.988221841760631,0,2,regulation of protein localization to presynapse,BP,
20646,GO:1905386,1,0.988221841760631,0,2,positive regulation of protein localization to presynapse,BP,
20647,GO:1905392,1,0.997356194534619,0,1,plant organ morphogenesis,BP,
20648,GO:1905394,1,0.978997162514498,0,3,retromer complex binding,MF,
20649,GO:1905395,1,0.982341263362705,0,3,response to flavonoid,BP,
20650,GO:1905397,1,0.99041269236881,0,2,activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20651,GO:1905402,1,0.99041269236881,0,2,regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20652,GO:1905403,1,0.99468027294805,0,1,negative regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20653,GO:1905404,1,0.995709824540287,0,1,positive regulation of activated CD8-positive, alpha-beta T cell apoptotic process,BP,
20654,GO:1905405,1,0.989076230734225,0,1,regulation of mitotic cohesin loading,BP,
20655,GO:1905406,1,0.989076230734225,0,1,positive regulation of mitotic cohesin loading,BP,
20656,GO:1905407,1,0.987546632247365,0,2,regulation of creatine transmembrane transporter activity,BP,
20657,GO:1905408,1,0.987546632247365,0,2,negative regulation of creatine transmembrane transporter activity,BP,
20658,GO:1905419,1,0.995039300672811,0,1,sperm flagellum movement involved in flagellated sperm motility,BP,
20659,GO:1905421,1,0.997356194534619,0,1,regulation of plant organ morphogenesis,BP,
20660,GO:1905422,1,0.997356194534619,0,1,negative regulation of plant organ morphogenesis,BP,
20661,GO:1905424,1,0.987785455684363,0,2,regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,
20662,GO:1905426,1,0.987785455684363,0,2,positive regulation of Wnt-mediated midbrain dopaminergic neuron differentiation,BP,
20663,GO:1905429,1,0.986914135296249,0,2,response to glycine,BP,
20664,GO:1905430,1,0.994454376412615,0,1,cellular response to glycine,BP,
20665,GO:1905432,1,0.99245977317499,0,1,regulation of retrograde trans-synaptic signaling by neuropeptide,BP,
20666,GO:1905433,1,0.99245977317499,0,1,negative regulation of retrograde trans-synaptic signaling by neuropeptide,BP,
20667,GO:1905435,1,0.993058458973322,0,1,regulation of histone H3-K4 trimethylation,BP,
20668,GO:1905437,1,0.993058458973322,0,1,positive regulation of histone H3-K4 trimethylation,BP,
20669,GO:1905438,1,0.987540101952117,0,2,non-canonical Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation,BP,
20670,GO:1905443,1,0.992347149773647,0,1,regulation of clathrin coat assembly,BP,
20671,GO:1905445,1,0.992347149773647,0,1,positive regulation of clathrin coat assembly,BP,
20672,GO:1905446,1,0.972902010533414,0,5,regulation of mitochondrial ATP synthesis coupled electron transport,BP,
20673,GO:1905447,1,0.992679397096388,0,1,negative regulation of mitochondrial ATP synthesis coupled electron transport,BP,
20674,GO:1905448,1,0.98007821347743,0,4,positive regulation of mitochondrial ATP synthesis coupled electron transport,BP,
20675,GO:1905449,1,0.986435699423365,0,2,regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
20676,GO:1905451,1,0.986435699423365,0,2,positive regulation of Fc-gamma receptor signaling pathway involved in phagocytosis,BP,
20677,GO:1905456,1,0.949684872231445,0,7,regulation of lymphoid progenitor cell differentiation,BP,
20678,GO:1905457,1,0.981786173294738,0,3,negative regulation of lymphoid progenitor cell differentiation,BP,
20679,GO:1905458,1,0.992477402077949,0,1,positive regulation of lymphoid progenitor cell differentiation,BP,
20680,GO:1905459,1,0.954831980360321,0,6,regulation of vascular associated smooth muscle cell apoptotic process,BP,
20681,GO:1905460,1,0.990749260817457,0,1,negative regulation of vascular associated smooth muscle cell apoptotic process,BP,
20682,GO:1905461,1,0.963750659253941,0,5,positive regulation of vascular associated smooth muscle cell apoptotic process,BP,
20683,GO:1905462,1,0.984214072623927,0,2,regulation of DNA duplex unwinding,BP,
20684,GO:1905463,1,0.991692635295332,0,1,negative regulation of DNA duplex unwinding,BP,
20685,GO:1905464,1,0.99245941573831,0,1,positive regulation of DNA duplex unwinding,BP,
20686,GO:1905468,1,0.991982541142166,0,1,regulation of clathrin-coated pit assembly,BP,
20687,GO:1905469,1,0.991982541142166,0,1,negative regulation of clathrin-coated pit assembly,BP,
20688,GO:1905474,1,0.995809200936825,0,1,canonical Wnt signaling pathway involved in stem cell proliferation,BP,
20692,GO:1905483,1,0.988276939930579,0,1,regulation of motor neuron migration,BP,
20693,GO:1905485,1,0.988276939930579,0,1,positive regulation of motor neuron migration,BP,
20694,GO:1905502,1,0.996481955681857,0,1,acetyl-CoA binding,MF,
20695,GO:1905508,1,0.800491646031429,0,28,protein localization to microtubule organizing center,BP,
20696,GO:1905512,1,0.993414354368861,0,1,regulation of short-term synaptic potentiation,BP,
20697,GO:1905513,1,0.993414354368861,0,1,negative regulation of short-term synaptic potentiation,BP,
20698,GO:1905515,1,0.723579911986731,0,47,non-motile cilium assembly,BP,
20699,GO:1905516,1,0.948413025483353,0,8,positive regulation of fertilization,BP,
20700,GO:1905517,1,0.830983954700705,0,33,macrophage migration,BP,
20701,GO:1905518,1,0.992161676171263,0,1,regulation of presynaptic active zone assembly,BP,
20702,GO:1905520,1,0.992161676171263,0,1,positive regulation of presynaptic active zone assembly,BP,
20703,GO:1905521,1,0.88666083737294,0,20,regulation of macrophage migration,BP,
20704,GO:1905522,1,0.975622523325102,0,5,negative regulation of macrophage migration,BP,
20705,GO:1905523,1,0.932353813688082,0,11,positive regulation of macrophage migration,BP,
20706,GO:1905524,1,0.990491572390632,0,1,negative regulation of protein autoubiquitination,BP,
20707,GO:1905535,1,0.991990635010017,0,1,regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
20708,GO:1905537,1,0.991990635010017,0,1,positive regulation of eukaryotic translation initiation factor 4F complex assembly,BP,
20709,GO:1905538,1,0.992297874244277,0,1,polysome binding,MF,
20710,GO:1905541,1,0.993388970162643,0,1,regulation of L-arginine import across plasma membrane,BP,
20711,GO:1905546,1,0.9939880296475,0,1,cellular response to phenylpropanoid,BP,
20712,GO:1905547,1,0.995486157582346,0,1,regulation of telomeric heterochromatin assembly,BP,
20713,GO:1905549,1,0.995486157582346,0,1,positive regulation of telomeric heterochromatin assembly,BP,
20714,GO:1905550,1,0.990021101071143,0,2,regulation of protein localization to endoplasmic reticulum,BP,
20715,GO:1905552,1,0.990021101071143,0,2,positive regulation of protein localization to endoplasmic reticulum,BP,
20716,GO:1905553,1,0.983479640856968,0,3,regulation of blood vessel branching,BP,
20717,GO:1905555,1,0.987270202275011,0,2,positive regulation blood vessel branching,BP,
20718,GO:1905562,1,0.903415373453163,0,14,regulation of vascular endothelial cell proliferation,BP,
20719,GO:1905563,1,0.978702912549324,0,3,negative regulation of vascular endothelial cell proliferation,BP,
20720,GO:1905564,1,0.923090065522839,0,11,positive regulation of vascular endothelial cell proliferation,BP,
20721,GO:1905572,1,0.992989499040312,0,1,ganglioside GM1 transport to membrane,BP,
20722,GO:1905573,1,0.987864380619065,0,2,ganglioside GM1 binding,MF,
20723,GO:1905574,1,0.992989499040312,0,1,ganglioside GM2 binding,MF,
20724,GO:1905575,1,0.992989499040312,0,1,ganglioside GM3 binding,MF,
20726,GO:1905577,1,0.992989499040312,0,1,ganglioside GP1c binding,MF,
20727,GO:1905578,1,0.993648644178067,0,1,regulation of ERBB3 signaling pathway,BP,
20728,GO:1905580,1,0.993648644178067,0,1,positive regulation of ERBB3 signaling pathway,BP,
20729,GO:1905581,1,0.995487307145082,0,1,positive regulation of low-density lipoprotein particle clearance,BP,
20730,GO:1905589,1,0.993388970162643,0,1,positive regulation of L-arginine import across plasma membrane,BP,
20731,GO:1905590,1,0.992704795922991,0,1,fibronectin fibril organization,BP,
20732,GO:1905594,1,0.996589812374165,0,1,resveratrol binding,MF,
20733,GO:1905595,1,0.988036483609702,0,2,regulation of low-density lipoprotein particle receptor binding,BP,
20734,GO:1905596,1,0.992515738361928,0,1,negative regulation of low-density lipoprotein particle receptor binding,BP,
20735,GO:1905597,1,0.995487307145082,0,1,positive regulation of low-density lipoprotein particle receptor binding,BP,
20736,GO:1905598,1,0.992515738361928,0,1,negative regulation of low-density lipoprotein receptor activity,BP,
20737,GO:1905599,1,0.995487307145082,0,1,positive regulation of low-density lipoprotein receptor activity,BP,
20738,GO:1905600,1,0.980992752292894,0,3,regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
20739,GO:1905601,1,0.992515738361928,0,1,negative regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
20740,GO:1905602,1,0.988390989649422,0,2,positive regulation of receptor-mediated endocytosis involved in cholesterol transport,BP,
20741,GO:1905603,1,0.992114422505465,0,1,regulation of maintenance of permeability of blood-brain barrier,BP,
20742,GO:1905604,1,0.992114422505465,0,1,negative regulation of maintenance of permeability of blood-brain barrier,BP,
20743,GO:1905606,1,0.969788068134745,0,4,regulation of presynapse assembly,BP,
20744,GO:1905608,1,0.992161676171263,0,1,positive regulation of presynapse assembly,BP,
20745,GO:1905610,1,0.991990635010017,0,1,regulation of mRNA cap binding,BP,
20746,GO:1905612,1,0.991990635010017,0,1,positive regulation of mRNA cap binding,BP,
20747,GO:1905616,1,0.985104139911256,0,2,regulation of miRNA mediated inhibition of translation,BP,
20748,GO:1905618,1,0.985104139911256,0,2,positive regulation of miRNA mediated inhibition of translation,BP,
20749,GO:1905634,1,0.960285437651473,0,5,regulation of protein localization to chromatin,BP,
20750,GO:1905636,1,0.996349502593585,0,1,positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding,BP,
20751,GO:1905642,1,0.993058458973322,0,1,negative regulation of DNA methylation,BP,
20752,GO:1905643,1,0.991542471803621,0,1,positive regulation of DNA methylation,BP,
20753,GO:1905647,1,0.993596861458281,0,1,proline import across plasma membrane,BP,
20754,GO:1905651,1,0.975408461773904,0,3,regulation of artery morphogenesis,BP,
20755,GO:1905653,1,0.975408461773904,0,3,positive regulation of artery morphogenesis,BP,
20756,GO:1905661,1,0.986818552732673,0,2,regulation of telomerase RNA reverse transcriptase activity,BP,
20757,GO:1905663,1,0.986818552732673,0,2,positive regulation of telomerase RNA reverse transcriptase activity,BP,
20758,GO:1905664,1,0.976467155804958,0,4,regulation of calcium ion import across plasma membrane,BP,
20759,GO:1905665,1,0.988700337547709,0,2,positive regulation of calcium ion import across plasma membrane,BP,
20760,GO:1905666,1,0.930469917604824,0,9,regulation of protein localization to endosome,BP,
20761,GO:1905668,1,0.930469917604824,0,9,positive regulation of protein localization to endosome,BP,
20762,GO:1905671,1,0.980732452851554,0,3,regulation of lysosome organization,BP,
20763,GO:1905672,1,0.994285115658647,0,1,negative regulation of lysosome organization,BP,
20764,GO:1905687,1,0.991666079756139,0,1,regulation of diacylglycerol kinase activity,BP,
20765,GO:1905689,1,0.991666079756139,0,1,positive regulation of diacylglycerol kinase activity,BP,
20766,GO:1905693,1,0.994287414484928,0,1,regulation of phosphatidic acid biosynthetic process,BP,
20767,GO:1905695,1,0.994287414484928,0,1,positive regulation of phosphatidic acid biosynthetic process,BP,
20768,GO:1905696,1,0.984349586980606,0,2,regulation of polysome binding,BP,
20769,GO:1905698,1,0.992297874244277,0,1,positive regulation of polysome binding,BP,
20770,GO:1905705,1,0.990938602302629,0,1,cellular response to paclitaxel,BP,
20771,GO:1905709,1,0.975179522513358,0,5,negative regulation of membrane permeability,BP,
20773,GO:1905711,1,0.992496392024204,0,1,response to phosphatidylethanolamine,BP,
20774,GO:1905719,1,0.986020986158204,0,2,protein localization to perinuclear region of cytoplasm,BP,
20775,GO:1905720,1,0.990783868118484,0,1,cytoplasmic microtubule bundle,CC,
20776,GO:1905747,1,0.996314597249943,0,1,negative regulation of saliva secretion,BP,
20777,GO:1905748,1,0.996314597249943,0,1,hard palate morphogenesis,BP,
20778,GO:1905764,1,0.978176510280173,0,3,regulation of protection from non-homologous end joining at telomere,BP,
20779,GO:1905765,1,0.978176510280173,0,3,negative regulation of protection from non-homologous end joining at telomere,BP,
20780,GO:1905767,1,0.991048652760241,0,1,regulation of double-stranded telomeric DNA binding,BP,
20781,GO:1905768,1,0.991048652760241,0,1,negative regulation of double-stranded telomeric DNA binding,BP,
20782,GO:1905770,1,0.964944028766493,0,6,regulation of mesodermal cell differentiation,BP,
20783,GO:1905771,1,0.980314152526523,0,4,negative regulation of mesodermal cell differentiation,BP,
20784,GO:1905773,1,0.976634180585007,0,3,8-hydroxy-2'-deoxyguanosine DNA binding,MF,
20785,GO:1905774,1,0.99245941573831,0,1,regulation of DNA helicase activity,BP,
20786,GO:1905776,1,0.99245941573831,0,1,positive regulation of DNA helicase activity,BP,
20787,GO:1905777,1,0.97904399488738,0,3,regulation of exonuclease activity,BP,
20788,GO:1905778,1,0.985837922697338,0,2,negative regulation of exonuclease activity,BP,
20789,GO:1905779,1,0.993109452947755,0,1,positive regulation of exonuclease activity,BP,
20790,GO:1905793,1,0.980757761000351,0,2,protein localization to pericentriolar material,BP,
20791,GO:1905794,1,0.989103173580698,0,1,response to puromycin,BP,
20792,GO:1905795,1,0.989103173580698,0,1,cellular response to puromycin,BP,
20793,GO:1905799,1,0.997573333461451,0,1,regulation of intraciliary retrograde transport,BP,
20794,GO:1905802,1,0.992969326151488,0,1,regulation of cellular response to manganese ion,BP,
20795,GO:1905809,1,0.851821233985297,0,22,negative regulation of synapse organization,BP,
20796,GO:1905818,1,0.688987020952278,0,55,regulation of chromosome separation,BP,
20797,GO:1905819,1,0.801412605513512,0,33,negative regulation of chromosome separation,BP,
20798,GO:1905820,1,0.939898174647634,0,9,positive regulation of chromosome separation,BP,
20799,GO:1905832,1,0.963398539472684,0,4,positive regulation of spindle assembly,BP,
20800,GO:1905838,1,0.985837922697338,0,2,regulation of telomeric D-loop disassembly,BP,
20801,GO:1905839,1,0.985837922697338,0,2,negative regulation of telomeric D-loop disassembly,BP,
20802,GO:1905843,1,0.988555056457097,0,1,regulation of cellular response to gamma radiation,BP,
20803,GO:1905853,1,0.996510058796768,0,1,regulation of heparan sulfate binding,BP,
20804,GO:1905855,1,0.996510058796768,0,1,positive regulation of heparan sulfate binding,BP,
20805,GO:1905858,1,0.996510058796768,0,1,regulation of heparan sulfate proteoglycan binding,BP,
20806,GO:1905860,1,0.996510058796768,0,1,positive regulation of heparan sulfate proteoglycan binding,BP,
20807,GO:1905863,1,0.982505965644348,0,2,invadopodium organization,BP,
20809,GO:1905874,1,0.972692243837002,0,4,regulation of postsynaptic density organization,BP,
20810,GO:1905875,1,0.992877667102885,0,1,negative regulation of postsynaptic density organization,BP,
20811,GO:1905878,1,0.989280182040423,0,1,invadopodium disassembly,BP,
20812,GO:1905879,1,0.935261107063478,0,10,regulation of oogenesis,BP,
20813,GO:1905880,1,0.974463194801104,0,4,negative regulation of oogenesis,BP,
20814,GO:1905881,1,0.972589668930309,0,4,positive regulation of oogenesis,BP,
20815,GO:1905890,1,0.996510058796768,0,1,regulation of cellular response to very-low-density lipoprotein particle stimulus,BP,
20816,GO:1905891,1,0.992976821212928,0,1,regulation of cellular response to thapsigargin,BP,
20817,GO:1905892,1,0.992976821212928,0,1,negative regulation of cellular response to thapsigargin,BP,
20818,GO:1905894,1,0.992976821212928,0,1,regulation of cellular response to tunicamycin,BP,
20819,GO:1905895,1,0.992976821212928,0,1,negative regulation of cellular response to tunicamycin,BP,
20820,GO:1905897,1,0.61943264099165,0,73,regulation of response to endoplasmic reticulum stress,BP,
20821,GO:1905898,1,0.795908869383671,0,35,positive regulation of response to endoplasmic reticulum stress,BP,
20822,GO:1905899,1,0.995632596003417,0,1,regulation of smooth muscle tissue development,BP,
20823,GO:1905900,1,0.995632596003417,0,1,negative regulation of smooth muscle tissue development,BP,
20824,GO:1905901,1,0.995632596003417,0,1,positive regulation of smooth muscle tissue development,BP,
20825,GO:1905902,1,0.964944028766493,0,6,regulation of mesoderm formation,BP,
20826,GO:1905903,1,0.980314152526523,0,4,negative regulation of mesoderm formation,BP,
20827,GO:1905906,1,0.958021481352964,0,7,regulation of amyloid fibril formation,BP,
20828,GO:1905907,1,0.982576401407331,0,3,negative regulation of amyloid fibril formation,BP,
20829,GO:1905908,1,0.973753295123836,0,4,positive regulation of amyloid fibril formation,BP,
20830,GO:1905912,1,0.995007367605537,0,1,regulation of calcium ion export across plasma membrane,BP,
20831,GO:1905913,1,0.995007367605537,0,1,negative regulation of calcium ion export across plasma membrane,BP,
20832,GO:1905918,1,0.994262161544125,0,1,regulation of CoA-transferase activity,BP,
20833,GO:1905920,1,0.994262161544125,0,1,positive regulation of CoA-transferase activity,BP,
20834,GO:1905927,1,0.989280182040423,0,1,regulation of invadopodium disassembly,BP,
20835,GO:1905929,1,0.989280182040423,0,1,positive regulation of invadopodium disassembly,BP,
20836,GO:1905936,1,0.98269495461297,0,4,regulation of germ cell proliferation,BP,
20837,GO:1905937,1,0.985714320634368,0,3,negative regulation of germ cell proliferation,BP,
20838,GO:1905938,1,0.996937317313033,0,1,positive regulation of germ cell proliferation,BP,
20839,GO:1905939,1,0.898066837171125,0,18,regulation of gonad development,BP,
20840,GO:1905940,1,0.967439373632494,0,5,negative regulation of gonad development,BP,
20841,GO:1905941,1,0.943678728472729,0,10,positive regulation of gonad development,BP,
20842,GO:1905942,1,0.993648644178067,0,1,regulation of formation of growth cone in injured axon,BP,
20843,GO:1905943,1,0.993648644178067,0,1,negative regulation of formation of growth cone in injured axon,BP,
20844,GO:1905952,1,0.493288410537147,0,109,regulation of lipid localization,BP,
20845,GO:1905953,1,0.809083270232647,0,31,negative regulation of lipid localization,BP,
20846,GO:1905954,1,0.654827044895793,0,66,positive regulation of lipid localization,BP,
20847,GO:1905957,1,0.99239595615167,0,1,regulation of cellular response to alcohol,BP,
20848,GO:1905959,1,0.99239595615167,0,1,positive regulation of cellular response to alcohol,BP,
20849,GO:1905961,1,0.950282883413309,0,8,protein-cysteine S-palmitoyltransferase complex,CC,
20850,GO:1990000,1,0.914382707618802,0,14,amyloid fibril formation,BP,
20851,GO:1990001,1,0.928180620197488,0,10,inhibition of cysteine-type endopeptidase activity involved in apoptotic process,BP,
20852,GO:1990003,1,0.991503892523375,0,1,IDP phosphatase activity,MF,
20853,GO:1990005,1,0.988405694008247,0,2,granular vesicle,CC,
20854,GO:1990008,1,0.995315037853685,0,1,neurosecretory vesicle,CC,
20855,GO:1990009,1,0.984537189210027,0,2,retinal cell apoptotic process,BP,
20857,GO:1990023,1,0.910265382744156,0,12,mitotic spindle midzone,CC,
20858,GO:1990026,1,0.984702368329673,0,2,hippocampal mossy fiber expansion,CC,
20859,GO:1990030,1,0.992484597321559,0,1,pericellular basket,CC,
20860,GO:1990031,1,0.992684479157823,0,1,pinceau fiber,CC,
20861,GO:1990032,1,0.992352424541461,0,1,parallel fiber,CC,
20862,GO:1990034,1,0.962789735733478,0,5,calcium ion export across plasma membrane,BP,
20863,GO:1990036,1,0.98553090626016,0,2,calcium ion import into sarcoplasmic reticulum,BP,
20864,GO:1990037,1,0.984342672811372,0,3,Lewy body core,CC,
20865,GO:1990038,1,0.994733543956073,0,1,Lewy body corona,CC,
20866,GO:1990046,1,0.996292746081189,0,1,stress-induced mitochondrial fusion,BP,
20867,GO:1990047,1,0.993992422323057,0,1,spindle matrix,CC,
20868,GO:1990048,1,0.993058458973322,0,1,anterograde neuronal dense core vesicle transport,BP,
20869,GO:1990050,1,0.982799752072866,0,4,phosphatidic acid transporter activity,MF,
20870,GO:1990051,1,0.984370973302901,0,2,activation of protein kinase C activity,BP,
20871,GO:1990070,1,0.997379024031002,0,1,TRAPPI protein complex,CC,
20872,GO:1990071,1,0.988318766914299,0,2,TRAPPII protein complex,CC,
20873,GO:1990072,1,0.99045549471192,0,2,TRAPPIII protein complex,CC,
20874,GO:1990074,1,0.992538872077278,0,1,polyuridylation-dependent mRNA catabolic process,BP,
20875,GO:1990075,1,0.965966750192477,0,4,periciliary membrane compartment,CC,
20876,GO:1990079,1,0.996897115199208,0,1,cartilage homeostasis,BP,
20877,GO:1990086,1,0.971287778525194,0,4,lens fiber cell apoptotic process,BP,
20878,GO:1990089,1,0.690497914313792,0,52,response to nerve growth factor,BP,
20879,GO:1990090,1,0.704240820087334,0,49,cellular response to nerve growth factor stimulus,BP,
20880,GO:1990108,1,0.983083990198846,0,2,protein linear deubiquitination,BP,
20881,GO:1990111,1,0.9808474100655,0,4,spermatoproteasome complex,CC,
20882,GO:1990112,1,0.986164624597214,0,2,RQC complex,CC,
20883,GO:1990116,1,0.986164624597214,0,2,ribosome-associated ubiquitin-dependent protein catabolic process,BP,
20884,GO:1990117,1,0.997289666042589,0,1,B cell receptor apoptotic signaling pathway,BP,
20885,GO:1990124,1,0.942371306340575,0,8,messenger ribonucleoprotein complex,CC,
20886,GO:1990126,1,0.895216393221778,0,16,retrograde transport, endosome to plasma membrane,BP,
20887,GO:1990127,1,0.992438915237959,0,1,intrinsic apoptotic signaling pathway in response to osmotic stress by p53 class mediator,BP,
20888,GO:1990130,1,0.967203054447606,0,5,GATOR1 complex,CC,
20889,GO:1990131,1,0.97799736267125,0,4,Gtr1-Gtr2 GTPase complex,CC,
20890,GO:1990134,1,0.992099200475851,0,1,epithelial cell apoptotic process involved in palatal shelf morphogenesis,BP,
20891,GO:1990136,1,0.993513355814362,0,1,linoleate 9S-lipoxygenase activity,MF,
20893,GO:1990144,1,0.965657500935481,0,6,intrinsic apoptotic signaling pathway in response to hypoxia,BP,
20894,GO:1990145,1,0.985277070025403,0,2,maintenance of translational fidelity,BP,
20895,GO:1990164,1,0.98577956592527,0,2,histone H2A phosphorylation,BP,
20896,GO:1990165,1,0.994585815572028,0,1,single-strand break-containing DNA binding,MF,
20897,GO:1990166,1,0.993816709009601,0,1,protein localization to site of double-strand break,BP,
20898,GO:1990167,1,0.982640242309548,0,2,protein K27-linked deubiquitination,BP,
20899,GO:1990168,1,0.983574633388645,0,2,protein K33-linked deubiquitination,BP,
20900,GO:1990169,1,0.96989457747883,0,11,stress response to copper ion,BP,
20901,GO:1990170,1,0.994599959152636,0,1,stress response to cadmium ion,BP,
20902,GO:1990172,1,0.991598275708435,0,1,G-protein coupled receptor catabolic process,BP,
20903,GO:1990173,1,0.941111376054884,0,10,protein localization to nucleoplasm,BP,
20904,GO:1990174,1,0.992490718507675,0,1,phosphodiesterase decapping endonuclease activity,MF,
20905,GO:1990175,1,0.99248264058292,0,1,EH domain binding,MF,
20906,GO:1990179,1,0.977684815872658,0,3,protein localization to actomyosin contractile ring,BP,
20907,GO:1990180,1,0.984134647005049,0,3,mitochondrial tRNA 3'-end processing,BP,
20908,GO:1990182,1,0.899851890602517,0,17,exosomal secretion,BP,
20909,GO:1990183,1,0.997206255235835,0,1,lymphatic vascular process in circulatory system,BP,
20910,GO:1990186,1,0.997206255235835,0,1,regulation of lymphatic vessel size,BP,
20911,GO:1990188,1,0.993307094251939,0,1,euchromatin binding,MF,
20912,GO:1990189,1,0.985563892967695,0,3,peptide-serine-N-acetyltransferase activity,MF,
20913,GO:1990190,1,0.992918166422528,0,2,peptide-glutamate-N-acetyltransferase activity,MF,
20914,GO:1990192,1,0.997206255235835,0,1,collecting lymphatic vessel constriction,BP,
20915,GO:1990204,1,0.630424779023563,0,95,oxidoreductase complex,CC,
20916,GO:1990226,1,0.963490788742878,0,6,histone methyltransferase binding,MF,
20918,GO:1990239,1,0.958211726384949,0,6,steroid hormone binding,MF,
20919,GO:1990246,1,0.972518779653678,0,4,uniplex complex,CC,
20920,GO:1990247,1,0.946763794875967,0,7,N6-methyladenosine-containing RNA binding,MF,
20921,GO:1990253,1,0.934966595023226,0,9,cellular response to leucine starvation,BP,
20922,GO:1990254,1,0.96752871118191,0,5,keratin filament binding,MF,
20923,GO:1990256,1,0.988170498263857,0,1,signal clustering,BP,
20924,GO:1990258,1,0.996531647484467,0,1,histone glutamine methylation,BP,
20925,GO:1990259,1,0.996531647484467,0,1,histone-glutamine methyltransferase activity,MF,
20926,GO:1990261,1,0.993058458973322,0,1,pre-mRNA catabolic process,BP,
20927,GO:1990262,1,0.993112407007883,0,1,anti-Mullerian hormone signaling pathway,BP,
20928,GO:1990264,1,0.986721125838656,0,2,peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity,BP,
20929,GO:1990266,1,0.656330875670081,0,78,neutrophil migration,BP,
20930,GO:1990267,1,0.992647930596004,0,1,response to transition metal nanoparticle,BP,
20931,GO:1990268,1,0.992647930596004,0,1,response to gold nanoparticle,BP,
20932,GO:1990269,1,0.986427928865613,0,2,RNA polymerase II C-terminal domain phosphoserine binding,MF,
20933,GO:1990275,1,0.992928991876176,0,1,preribosome binding,MF,
20934,GO:1990280,1,0.991012416566479,0,1,RNA localization to chromatin,BP,
20935,GO:1990298,1,0.994277074612634,0,1,bub1-bub3 complex,CC,
20936,GO:1990314,1,0.940443156211033,0,8,cellular response to insulin-like growth factor stimulus,BP,
20937,GO:1990316,1,0.938512847865013,0,8,Atg1/ULK1 kinase complex,CC,
20938,GO:1990332,1,0.992471121987881,0,1,Ire1 complex,CC,
20939,GO:1990349,1,0.994630636083079,0,1,gap junction-mediated intercellular transport,BP,
20941,GO:1990356,1,0.996460308534979,0,1,sumoylated E2 ligase complex,CC,
20942,GO:1990357,1,0.983223669821736,0,3,terminal web,CC,
20943,GO:1990379,1,0.990724944874471,0,2,lipid transport across blood brain barrier,BP,
20944,GO:1990380,1,0.939161343183207,0,7,Lys48-specific deubiquitinase activity,MF,
20945,GO:1990381,1,0.910807456578129,0,13,ubiquitin-specific protease binding,MF,
20946,GO:1990384,1,0.996290559458947,0,1,hyaloid vascular plexus regression,BP,
20947,GO:1990386,1,0.994687371047303,0,1,mitotic cleavage furrow ingression,BP,
20948,GO:1990390,1,0.992550573073969,0,1,protein K33-linked ubiquitination,BP,
20949,GO:1990391,1,0.78516920716612,0,33,DNA repair complex,CC,
20950,GO:1990393,1,0.963353812830855,0,5,3M complex,CC,
20951,GO:1990399,1,0.994076577534993,0,1,epithelium regeneration,BP,
20952,GO:1990401,1,0.993076100442706,0,1,embryonic lung development,BP,
20953,GO:1990402,1,0.994168744955213,0,1,embryonic liver development,BP,
20954,GO:1990403,1,0.931188313053996,0,10,embryonic brain development,BP,
20955,GO:1990404,1,0.987437341253057,0,2,protein ADP-ribosylase activity,MF,
20957,GO:1990406,1,0.98923191782299,0,2,CGRP receptor complex,CC,
20958,GO:1990407,1,0.997091087513256,0,1,calcitonin gene-related peptide binding,MF,
20959,GO:1990408,1,0.98923191782299,0,2,calcitonin gene-related peptide receptor signaling pathway,BP,
20960,GO:1990409,1,0.989486714199702,0,2,adrenomedullin binding,MF,
20961,GO:1990410,1,0.981653799240214,0,4,adrenomedullin receptor signaling pathway,BP,
20962,GO:1990414,1,0.970355741941683,0,4,replication-born double-strand break repair via sister chromatid exchange,BP,
20963,GO:1990415,1,0.980489803051693,0,3,Pex17p-Pex14p docking complex,CC,
20964,GO:1990416,1,0.941038911247723,0,8,cellular response to brain-derived neurotrophic factor stimulus,BP,
20965,GO:1990418,1,0.981104699683482,0,3,response to insulin-like growth factor stimulus,BP,
20966,GO:1990421,1,0.988529945830477,0,1,subtelomeric heterochromatin,CC,
20967,GO:1990423,1,0.976634400366939,0,3,RZZ complex,CC,
20968,GO:1990425,1,0.973683539225102,0,3,ryanodine receptor complex,CC,
20969,GO:1990426,1,0.98254106042881,0,2,mitotic recombination-dependent replication fork processing,BP,
20970,GO:1990427,1,0.990676311599433,0,1,stereocilia tip-link density,CC,
20971,GO:1990428,1,0.984847536345509,0,2,miRNA transport,BP,
20972,GO:1990429,1,0.980489803051693,0,3,peroxisomal importomer complex,CC,
20973,GO:1990430,1,0.969911424170338,0,4,extracellular matrix protein binding,MF,
20974,GO:1990435,1,0.990676311599433,0,1,upper tip-link density,CC,
20975,GO:1990439,1,0.992860879199155,0,1,MAP kinase serine/threonine phosphatase activity,MF,
20976,GO:1990440,1,0.935521892594616,0,11,positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,
20977,GO:1990441,1,0.974383661148922,0,4,negative regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress,BP,
20978,GO:1990442,1,0.989855856460344,0,3,intrinsic apoptotic signaling pathway in response to nitrosative stress,BP,
20979,GO:1990446,1,0.98212449429434,0,4,U1 snRNP binding,MF,
20980,GO:1990448,1,0.99113842723545,0,1,exon-exon junction complex binding,MF,
20981,GO:1990452,1,0.985204000933105,0,2,Parkin-FBXW7-Cul1 ubiquitin ligase complex,CC,
20982,GO:1990454,1,0.941097665911288,0,7,L-type voltage-gated calcium channel complex,CC,
20983,GO:1990456,1,0.992492690517144,0,1,mitochondrion-endoplasmic reticulum membrane tethering,BP,
20984,GO:1990459,1,0.955358999176704,0,7,transferrin receptor binding,MF,
20985,GO:1990460,1,0.97834413633008,0,3,leptin receptor binding,MF,
20986,GO:1990462,1,0.952418234836589,0,7,omegasome,CC,
20987,GO:1990478,1,0.994801107718406,0,1,response to ultrasound,BP,
20988,GO:1990481,1,0.976586644971912,0,4,mRNA pseudouridine synthesis,BP,
20989,GO:1990498,1,0.981059444345302,0,2,mitotic spindle microtubule,CC,
20990,GO:1990502,1,0.984047632008512,0,2,dense core granule maturation,BP,
20991,GO:1990504,1,0.947734339292071,0,6,dense core granule exocytosis,BP,
20992,GO:1990505,1,0.98254106042881,0,2,mitotic DNA replication maintenance of fidelity,BP,
20993,GO:1990511,1,0.971151809685688,0,4,piRNA biosynthetic process,BP,
20994,GO:1990518,1,0.992297874244277,0,1,single-stranded DNA-dependent ATP-dependent 3'-5' DNA helicase activity,MF,
20995,GO:1990519,1,0.98819992926779,0,2,pyrimidine nucleotide import into mitochondrion,BP,
20996,GO:1990523,1,0.972729811307545,0,4,bone regeneration,BP,
20997,GO:1990535,1,0.960018830843048,0,5,neuron projection maintenance,BP,
20998,GO:1990539,1,0.993903156509167,0,1,fructose import across plasma membrane,BP,
20999,GO:1990542,1,0.672824618588067,0,67,mitochondrial transmembrane transport,BP,
21000,GO:1990546,1,0.995566416067967,0,1,mitochondrial tricarboxylic acid transmembrane transport,BP,
21001,GO:1990564,1,0.97254521862491,0,5,protein polyufmylation,BP,
21002,GO:1990565,1,0.995403156215303,0,1,HSP90-CDC37 chaperone complex,CC,
21003,GO:1990569,1,0.985348369185324,0,2,UDP-N-acetylglucosamine transmembrane transport,BP,
21004,GO:1990570,1,0.993058458973322,0,1,GDP-mannose transmembrane transport,BP,
21005,GO:1990572,1,0.992473353745584,0,1,TERT-RMRP complex,CC,
21006,GO:1990573,1,0.941544101148279,0,9,potassium ion import across plasma membrane,BP,
21007,GO:1990575,1,0.986322410581798,0,2,mitochondrial L-ornithine transmembrane transport,BP,
21008,GO:1990578,1,0.991639510168091,0,1,perinuclear endoplasmic reticulum membrane,CC,
21009,GO:1990579,1,0.992471121987881,0,1,peptidyl-serine trans-autophosphorylation,BP,
21010,GO:1990583,1,0.994687371047303,0,1,phospholipase D activator activity,MF,
21011,GO:1990584,1,0.991371749526676,0,3,cardiac Troponin complex,CC,
21012,GO:1990589,1,0.984649315991342,0,2,ATF4-CREB1 transcription factor complex,CC,
21013,GO:1990590,1,0.988986431166161,0,2,ATF1-ATF4 transcription factor complex,CC,
21014,GO:1990592,1,0.97254521862491,0,5,protein K69-linked ufmylation,BP,
21015,GO:1990597,1,0.978958581314393,0,3,AIP1-IRE1 complex,CC,
21016,GO:1990599,1,0.978176510280173,0,3,3' overhang single-stranded DNA endodeoxyribonuclease activity,MF,
21017,GO:1990603,1,0.992612484295299,0,1,dark adaptation,BP,
21018,GO:1990604,1,0.978610145555683,0,3,IRE1-TRAF2-ASK1 complex,CC,
21019,GO:1990613,1,0.992537316659797,0,1,mitochondrial membrane fusion,BP,
21020,GO:1990617,1,0.99240058708741,0,2,CHOP-ATF4 complex,CC,
21021,GO:1990619,1,0.988011726720632,0,2,histone H3-K9 deacetylation,BP,
21022,GO:1990622,1,0.991629926823794,0,2,CHOP-ATF3 complex,CC,
21023,GO:1990630,1,0.992471121987881,0,1,IRE1-RACK1-PP2A complex,CC,
21024,GO:1990635,1,0.971833057850995,0,4,proximal dendrite,CC,
21025,GO:1990637,1,0.97891020075826,0,3,response to prolactin,BP,
21026,GO:1990641,1,0.985271014591665,0,3,response to iron ion starvation,BP,
21027,GO:1990646,1,0.992800326150592,0,1,cellular response to prolactin,BP,
21028,GO:1990654,1,0.992162436986367,0,1,sebum secreting cell proliferation,BP,
21029,GO:1990666,1,0.984542103693473,0,2,PCSK9-LDLR complex,CC,
21030,GO:1990667,1,0.988036483609702,0,2,PCSK9-AnxA2 complex,CC,
21031,GO:1990668,1,0.969123344854771,0,5,vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane,BP,
21032,GO:1990682,1,0.986197518595448,0,2,CSF1-CSF1R complex,CC,
21033,GO:1990696,1,0.982384510434491,0,2,USH2 complex,CC,
21034,GO:1990697,1,0.994121370149456,0,1,protein depalmitoleylation,BP,
21035,GO:1990698,1,0.987657750293927,0,2,palmitoleoyltransferase activity,MF,
21036,GO:1990699,1,0.994121370149456,0,1,palmitoleyl hydrolase activity,MF,
21037,GO:1990700,1,0.99248114509281,0,1,nucleolar chromatin organization,BP,
21038,GO:1990705,1,0.989856457056912,0,1,cholangiocyte proliferation,BP,
21039,GO:1990707,1,0.988529945830477,0,1,nuclear subtelomeric heterochromatin,CC,
21040,GO:1990708,1,0.992142202368947,0,1,conditioned place preference,BP,
21041,GO:1990709,1,0.978412343251988,0,3,presynaptic active zone organization,BP,
21042,GO:1990712,1,0.954854687625948,0,7,HFE-transferrin receptor complex,CC,
21043,GO:1990715,1,0.992465365368842,0,1,mRNA CDS binding,MF,
21044,GO:1990716,1,0.975620169666241,0,3,axonemal central apparatus,CC,
21045,GO:1990718,1,0.989320324781474,0,1,axonemal central pair projection,CC,
21046,GO:1990723,1,0.981085167098713,0,2,cytoplasmic periphery of the nuclear pore complex,CC,
21047,GO:1990726,1,0.983655178366873,0,5,Lsm1-7-Pat1 complex,CC,
21048,GO:1990729,1,0.994729990264892,0,1,primary miRNA modification,BP,
21049,GO:1990730,1,0.985076138788983,0,2,VCP-NSFL1C complex,CC,
21050,GO:1990736,1,0.99246323137792,0,1,regulation of vascular smooth muscle cell membrane depolarization,BP,
21051,GO:1990737,1,0.980160299313159,0,3,response to manganese-induced endoplasmic reticulum stress,BP,
21052,GO:1990739,1,0.989856457056912,0,1,granulosa cell proliferation,BP,
21053,GO:1990742,1,0.984765527586567,0,2,microvesicle,CC,
21054,GO:1990743,1,0.971357676862592,0,4,protein sialylation,BP,
21055,GO:1990744,1,0.994729990264892,0,1,primary miRNA methylation,BP,
21056,GO:1990745,1,0.977282574586054,0,3,EARP complex,CC,
21058,GO:1990751,1,0.990773028720735,0,1,Schwann cell chemotaxis,BP,
21059,GO:1990752,1,0.805866737471553,0,25,microtubule end,CC,
21060,GO:1990755,1,0.993058458973322,0,1,mitotic spindle microtubule depolymerization,BP,
21061,GO:1990756,1,0.982148804242334,0,3,protein binding, bridging involved in substrate recognition for ubiquitination,MF,
21062,GO:1990758,1,0.995028660144537,0,1,mitotic sister chromatid biorientation,BP,
21063,GO:1990761,1,0.975140844791062,0,3,growth cone lamellipodium,CC,
21064,GO:1990763,1,0.959388379126835,0,6,arrestin family protein binding,MF,
21065,GO:1990764,1,0.993153112760472,0,1,myofibroblast contraction,BP,
21066,GO:1990765,1,0.992019259254054,0,1,colon smooth muscle contraction,BP,
21067,GO:1990768,1,0.997490814002907,0,1,gastric mucosal blood circulation,BP,
21068,GO:1990769,1,0.981926774649265,0,3,proximal neuron projection,CC,
21069,GO:1990770,1,0.989529898303092,0,2,small intestine smooth muscle contraction,BP,
21070,GO:1990771,1,0.991460722374548,0,1,clathrin-dependent extracellular exosome endocytosis,BP,
21071,GO:1990773,1,0.995261445819626,0,1,matrix metallopeptidase secretion,BP,
21072,GO:1990774,1,0.887881482353196,0,18,tumor necrosis factor secretion,BP,
21074,GO:1990777,1,0.834953165026056,0,32,lipoprotein particle,CC,
21077,GO:1990784,1,0.992468630612233,0,1,response to dsDNA,BP,
21078,GO:1990785,1,0.974242237397481,0,3,response to water-immersion restraint stress,BP,
21079,GO:1990786,1,0.992468630612233,0,1,cellular response to dsDNA,BP,
21080,GO:1990791,1,0.978975509593605,0,3,dorsal root ganglion development,BP,
21081,GO:1990796,1,0.992863466887519,0,1,photoreceptor cell terminal bouton,CC,
21082,GO:1990809,1,0.974106706967364,0,4,endoplasmic reticulum tubular network membrane organization,BP,
21083,GO:1990812,1,0.97837764640371,0,3,growth cone filopodium,CC,
21084,GO:1990817,1,0.994001218984072,0,1,RNA adenylyltransferase activity,MF,
21085,GO:1990822,1,0.946640106764956,0,8,basic amino acid transmembrane transport,BP,
21086,GO:1990823,1,0.525897794439777,0,92,response to leukemia inhibitory factor,BP,
21087,GO:1990825,1,0.944512441952719,0,9,sequence-specific mRNA binding,MF,
21088,GO:1990828,1,0.99426674733889,0,1,hepatocyte dedifferentiation,BP,
21089,GO:1990829,1,0.994735913240326,0,1,C-rich single-stranded DNA binding,MF,
21090,GO:1990830,1,0.525897794439777,0,92,cellular response to leukemia inhibitory factor,BP,
21091,GO:1990832,1,0.994555207012681,0,1,slow axonal transport,BP,
21092,GO:1990833,1,0.994555207012681,0,1,clathrin-uncoating ATPase activity,MF,
21093,GO:1990834,1,0.973719688537364,0,4,response to odorant,BP,
21095,GO:1990839,1,0.986393071959613,0,2,response to endothelin,BP,
21097,GO:1990843,1,0.991319662364429,0,1,subsarcolemmal mitochondrion,CC,
21098,GO:1990844,1,0.991319662364429,0,1,interfibrillar mitochondrion,CC,
21099,GO:1990845,1,0.917930890505006,0,13,adaptive thermogenesis,BP,
21100,GO:1990851,1,0.974043587168384,0,3,Wnt-Frizzled-LRP5/6 complex,CC,
21101,GO:1990859,1,0.993931277811386,0,1,cellular response to endothelin,BP,
21102,GO:1990868,1,0.963528046445289,0,5,response to chemokine,BP,
21103,GO:1990869,1,0.963528046445289,0,5,cellular response to chemokine,BP,
21104,GO:1990874,1,0.778865311710347,0,36,vascular smooth muscle cell proliferation,BP,
21105,GO:1990876,1,0.991131697096888,0,1,cytoplasmic side of nuclear pore,CC,
21106,GO:1990879,1,0.986164624597214,0,2,CST complex,CC,
21107,GO:1990882,1,0.992479787768794,0,1,rRNA acetylation,BP,
21108,GO:1990883,1,0.992479787768794,0,1,rRNA cytidine N-acetyltransferase activity,MF,
21109,GO:1990884,1,0.992479787768794,0,1,RNA acetylation,BP,
21110,GO:1990889,1,0.994960004311046,0,1,H4K20me3 modified histone binding,MF,
21112,GO:1990907,1,0.916435885681334,0,11,beta-catenin-TCF complex,CC,
21113,GO:1990909,1,0.919851757853354,0,10,Wnt signalosome,CC,
21114,GO:1990910,1,0.98411214607973,0,3,response to hypobaric hypoxia,BP,
21116,GO:1990913,1,0.993451183141474,0,1,sperm head plasma membrane,CC,
21117,GO:1990917,1,0.993451183141474,0,1,ooplasm,CC,
21118,GO:1990918,1,0.985428614743787,0,2,double-strand break repair involved in meiotic recombination,BP,
21119,GO:1990922,1,0.992600529140788,0,1,hepatic stellate cell proliferation,BP,
21120,GO:1990923,1,0.981000783023349,0,3,PET complex,CC,
21121,GO:1990926,1,0.980379980904321,0,3,short-term synaptic potentiation,BP,
21122,GO:1990927,1,0.984378220241775,0,2,calcium ion regulated lysosome exocytosis,BP,
21123,GO:1990928,1,0.98370213130853,0,2,response to amino acid starvation,BP,
21124,GO:1990930,1,0.995632596003417,0,1,RNA N1-methyladenosine dioxygenase activity,MF,
21125,GO:1990931,1,0.992413469005246,0,1,RNA N6-methyladenosine dioxygenase activity,MF,
21126,GO:1990936,1,0.987937162504371,0,2,vascular smooth muscle cell dedifferentiation,BP,
21127,GO:1990938,1,0.992473489815072,0,1,peptidyl-aspartic acid autophosphorylation,BP,
21128,GO:1990939,1,0.656931801275485,0,48,ATP-dependent microtubule motor activity,MF,
21129,GO:1990948,1,0.984089710479164,0,5,ubiquitin ligase inhibitor activity,MF,
21130,GO:1990955,1,0.99245941573831,0,1,G-rich single-stranded DNA binding,MF,
21131,GO:1990962,1,0.992475485630838,0,1,drug transport across blood-brain barrier,BP,
21132,GO:1990963,1,0.992475485630838,0,1,establishment of blood-retinal barrier,BP,
21133,GO:1990966,1,0.974086788001931,0,4,ATP generation from poly-ADP-D-ribose,BP,
21134,GO:1990967,1,0.988296723732438,0,2,multi-organism toxin transport,BP,
21135,GO:1990968,1,0.991239618845105,0,1,modulation by host of RNA binding by virus,BP,
21136,GO:1990969,1,0.991239618845105,0,1,modulation by host of viral RNA-binding transcription factor activity,BP,
21137,GO:1990971,1,0.992482413000109,0,1,EMILIN complex,CC,
21138,GO:1990983,1,0.993376402884916,0,1,tRNA demethylation,BP,
21139,GO:1990984,1,0.993376402884916,0,1,tRNA demethylase activity,MF,
21140,GO:2000001,1,0.901048570882046,0,16,regulation of DNA damage checkpoint,BP,
21141,GO:2000002,1,0.968471410262191,0,5,negative regulation of DNA damage checkpoint,BP,
21142,GO:2000003,1,0.993058458973322,0,1,positive regulation of DNA damage checkpoint,BP,
21143,GO:2000004,1,0.995148968087614,0,1,regulation of metanephric S-shaped body morphogenesis,BP,
21144,GO:2000005,1,0.995148968087614,0,1,negative regulation of metanephric S-shaped body morphogenesis,BP,
21145,GO:2000006,1,0.995148968087614,0,1,regulation of metanephric comma-shaped body morphogenesis,BP,
21146,GO:2000007,1,0.995148968087614,0,1,negative regulation of metanephric comma-shaped body morphogenesis,BP,
21147,GO:2000008,1,0.798799983938772,0,33,regulation of protein localization to cell surface,BP,
21148,GO:2000009,1,0.923703942362143,0,12,negative regulation of protein localization to cell surface,BP,
21149,GO:2000010,1,0.913482513233304,0,13,positive regulation of protein localization to cell surface,BP,
21150,GO:2000011,1,0.994161956511822,0,1,regulation of adaxial/abaxial pattern formation,BP,
21151,GO:2000015,1,0.977634337727881,0,4,regulation of determination of dorsal identity,BP,
21152,GO:2000016,1,0.992056976259697,0,2,negative regulation of determination of dorsal identity,BP,
21153,GO:2000017,1,0.985463037779219,0,2,positive regulation of determination of dorsal identity,BP,
21154,GO:2000018,1,0.949371525914242,0,8,regulation of male gonad development,BP,
21155,GO:2000019,1,0.992485744980242,0,1,negative regulation of male gonad development,BP,
21156,GO:2000020,1,0.956562560707039,0,7,positive regulation of male gonad development,BP,
21159,GO:2000035,1,0.949819571642039,0,8,regulation of stem cell division,BP,
21161,GO:2000040,1,0.987063819250461,0,2,regulation of planar cell polarity pathway involved in axis elongation,BP,
21162,GO:2000041,1,0.987063819250461,0,2,negative regulation of planar cell polarity pathway involved in axis elongation,BP,
21163,GO:2000042,1,0.930850556849819,0,9,negative regulation of double-strand break repair via homologous recombination,BP,
21164,GO:2000043,1,0.993849579949817,0,1,regulation of cardiac cell fate specification,BP,
21166,GO:2000047,1,0.947427482857514,0,9,regulation of cell-cell adhesion mediated by cadherin,BP,
21167,GO:2000048,1,0.978906094922083,0,4,negative regulation of cell-cell adhesion mediated by cadherin,BP,
21168,GO:2000049,1,0.967849822303403,0,5,positive regulation of cell-cell adhesion mediated by cadherin,BP,
21169,GO:2000050,1,0.848522245216255,0,22,regulation of non-canonical Wnt signaling pathway,BP,
21170,GO:2000051,1,0.9524558032291,0,6,negative regulation of non-canonical Wnt signaling pathway,BP,
21171,GO:2000052,1,0.920133600019913,0,12,positive regulation of non-canonical Wnt signaling pathway,BP,
21172,GO:2000053,1,0.981549755447649,0,2,regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
21173,GO:2000054,1,0.992359736600904,0,1,negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
21174,GO:2000055,1,0.989107621297466,0,1,positive regulation of Wnt signaling pathway involved in dorsal/ventral axis specification,BP,
21175,GO:2000056,1,0.994922078489237,0,1,regulation of Wnt signaling pathway involved in digestive tract morphogenesis,BP,
21176,GO:2000057,1,0.994922078489237,0,1,negative regulation of Wnt signaling pathway involved in digestive tract morphogenesis,BP,
21178,GO:2000059,1,0.78850343006581,0,37,negative regulation of ubiquitin-dependent protein catabolic process,BP,
21180,GO:2000061,1,0.995632596003417,0,1,regulation of ureter smooth muscle cell differentiation,BP,
21181,GO:2000062,1,0.995632596003417,0,1,negative regulation of ureter smooth muscle cell differentiation,BP,
21182,GO:2000063,1,0.995632596003417,0,1,positive regulation of ureter smooth muscle cell differentiation,BP,
21183,GO:2000064,1,0.958072663710308,0,6,regulation of cortisol biosynthetic process,BP,
21184,GO:2000065,1,0.972834913042933,0,4,negative regulation of cortisol biosynthetic process,BP,
21185,GO:2000066,1,0.992485744980242,0,1,positive regulation of cortisol biosynthetic process,BP,
21186,GO:2000067,1,0.997356194534619,0,1,regulation of root morphogenesis,BP,
21187,GO:2000074,1,0.951251825888893,0,8,regulation of type B pancreatic cell development,BP,
21188,GO:2000077,1,0.98510237627277,0,2,negative regulation of type B pancreatic cell development,BP,
21189,GO:2000078,1,0.986103258802293,0,3,positive regulation of type B pancreatic cell development,BP,
21190,GO:2000079,1,0.992359736600904,0,1,regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
21191,GO:2000080,1,0.992359736600904,0,1,negative regulation of canonical Wnt signaling pathway involved in controlling type B pancreatic cell proliferation,BP,
21192,GO:2000095,1,0.914065761876752,0,13,regulation of Wnt signaling pathway, planar cell polarity pathway,BP,
21193,GO:2000096,1,0.946630717877229,0,8,positive regulation of Wnt signaling pathway, planar cell polarity pathway,BP,
21196,GO:2000101,1,0.99287289100993,0,1,regulation of mammary stem cell proliferation,BP,
21197,GO:2000103,1,0.99287289100993,0,1,positive regulation of mammary stem cell proliferation,BP,
21198,GO:2000104,1,0.872737216021532,0,19,negative regulation of DNA-dependent DNA replication,BP,
21199,GO:2000105,1,0.904112236170709,0,14,positive regulation of DNA-dependent DNA replication,BP,
21200,GO:2000106,1,0.630726169711443,0,75,regulation of leukocyte apoptotic process,BP,
21201,GO:2000107,1,0.768597763273896,0,43,negative regulation of leukocyte apoptotic process,BP,
21202,GO:2000108,1,0.862074204700739,0,24,positive regulation of leukocyte apoptotic process,BP,
21203,GO:2000109,1,0.954553831205537,0,7,regulation of macrophage apoptotic process,BP,
21204,GO:2000110,1,0.979710570804947,0,3,negative regulation of macrophage apoptotic process,BP,
21205,GO:2000111,1,0.980501513332793,0,3,positive regulation of macrophage apoptotic process,BP,
21208,GO:2000114,1,0.866806677118208,0,18,regulation of establishment of cell polarity,BP,
21211,GO:2000118,1,0.985339495919599,0,2,regulation of sodium-dependent phosphate transport,BP,
21212,GO:2000119,1,0.99283522256781,0,1,negative regulation of sodium-dependent phosphate transport,BP,
21213,GO:2000121,1,0.942417979150254,0,10,regulation of removal of superoxide radicals,BP,
21214,GO:2000124,1,0.986174747072608,0,2,regulation of endocannabinoid signaling pathway,BP,
21216,GO:2000136,1,0.898117058561999,0,15,regulation of cell proliferation involved in heart morphogenesis,BP,
21217,GO:2000137,1,0.983244530933557,0,2,negative regulation of cell proliferation involved in heart morphogenesis,BP,
21218,GO:2000138,1,0.96497277097725,0,5,positive regulation of cell proliferation involved in heart morphogenesis,BP,
21219,GO:2000142,1,0.783864489297542,0,36,regulation of DNA-templated transcription, initiation,BP,
21220,GO:2000143,1,0.957598895890812,0,6,negative regulation of DNA-templated transcription, initiation,BP,
21221,GO:2000144,1,0.836322536006995,0,27,positive regulation of DNA-templated transcription, initiation,BP,
21225,GO:2000152,1,0.981967595482385,0,4,regulation of ubiquitin-specific protease activity,BP,
21226,GO:2000156,1,0.985473710520545,0,2,regulation of retrograde vesicle-mediated transport, Golgi to ER,BP,
21227,GO:2000157,1,0.993307507823352,0,2,negative regulation of ubiquitin-specific protease activity,BP,
21228,GO:2000158,1,0.988584448938048,0,2,positive regulation of ubiquitin-specific protease activity,BP,
21229,GO:2000167,1,0.991897525981382,0,1,regulation of planar cell polarity pathway involved in neural tube closure,BP,
21230,GO:2000169,1,0.944834267137707,0,7,regulation of peptidyl-cysteine S-nitrosylation,BP,
21231,GO:2000170,1,0.98499808852994,0,2,positive regulation of peptidyl-cysteine S-nitrosylation,BP,
21232,GO:2000171,1,0.820728198989053,0,26,negative regulation of dendrite development,BP,
21233,GO:2000172,1,0.968759105121251,0,4,regulation of branching morphogenesis of a nerve,BP,
21234,GO:2000173,1,0.992479608148959,0,1,negative regulation of branching morphogenesis of a nerve,BP,
21235,GO:2000174,1,0.992477402077949,0,1,regulation of pro-T cell differentiation,BP,
21236,GO:2000176,1,0.992477402077949,0,1,positive regulation of pro-T cell differentiation,BP,
21238,GO:2000178,1,0.870058055872437,0,20,negative regulation of neural precursor cell proliferation,BP,
21240,GO:2000181,1,0.540019558258318,0,87,negative regulation of blood vessel morphogenesis,BP,
21241,GO:2000182,1,0.976493202901404,0,3,regulation of progesterone biosynthetic process,BP,
21242,GO:2000184,1,0.991319662364429,0,1,positive regulation of progesterone biosynthetic process,BP,
21243,GO:2000191,1,0.895485805354699,0,16,regulation of fatty acid transport,BP,
21244,GO:2000192,1,0.960215322727482,0,5,negative regulation of fatty acid transport,BP,
21245,GO:2000193,1,0.941717766462262,0,10,positive regulation of fatty acid transport,BP,
21246,GO:2000194,1,0.93199228539197,0,12,regulation of female gonad development,BP,
21247,GO:2000195,1,0.974765877622757,0,4,negative regulation of female gonad development,BP,
21248,GO:2000196,1,0.986537062945953,0,3,positive regulation of female gonad development,BP,
21249,GO:2000197,1,0.954973138161703,0,6,regulation of ribonucleoprotein complex localization,BP,
21250,GO:2000199,1,0.992727025883349,0,1,positive regulation of ribonucleoprotein complex localization,BP,
21251,GO:2000200,1,0.992727025883349,0,1,regulation of ribosomal subunit export from nucleus,BP,
21252,GO:2000202,1,0.992727025883349,0,1,positive regulation of ribosomal subunit export from nucleus,BP,
21253,GO:2000206,1,0.992727025883349,0,1,regulation of ribosomal small subunit export from nucleus,BP,
21254,GO:2000208,1,0.992727025883349,0,1,positive regulation of ribosomal small subunit export from nucleus,BP,
21255,GO:2000209,1,0.862573733423255,0,21,regulation of anoikis,BP,
21256,GO:2000210,1,0.968743601611924,0,6,positive regulation of anoikis,BP,
21257,GO:2000211,1,0.986429963918213,0,2,regulation of glutamate metabolic process,BP,
21258,GO:2000212,1,0.992097856076846,0,1,negative regulation of glutamate metabolic process,BP,
21259,GO:2000213,1,0.994287414484928,0,1,positive regulation of glutamate metabolic process,BP,
21260,GO:2000224,1,0.985782576610408,0,3,regulation of testosterone biosynthetic process,BP,
21261,GO:2000225,1,0.989338564517913,0,2,negative regulation of testosterone biosynthetic process,BP,
21262,GO:2000226,1,0.995907955243566,0,1,regulation of pancreatic A cell differentiation,BP,
21263,GO:2000227,1,0.995907955243566,0,1,negative regulation of pancreatic A cell differentiation,BP,
21264,GO:2000229,1,0.991277702913634,0,2,regulation of pancreatic stellate cell proliferation,BP,
21265,GO:2000230,1,0.994973034818595,0,1,negative regulation of pancreatic stellate cell proliferation,BP,
21266,GO:2000231,1,0.996286185390552,0,1,positive regulation of pancreatic stellate cell proliferation,BP,
21267,GO:2000232,1,0.92614591872022,0,11,regulation of rRNA processing,BP,
21268,GO:2000233,1,0.984532359889566,0,2,negative regulation of rRNA processing,BP,
21269,GO:2000234,1,0.948311749465331,0,8,positive regulation of rRNA processing,BP,
21270,GO:2000241,1,0.485600227033299,0,115,regulation of reproductive process,BP,
21271,GO:2000242,1,0.762464836171261,0,44,negative regulation of reproductive process,BP,
21273,GO:2000249,1,0.804056770538656,0,35,regulation of actin cytoskeleton reorganization,BP,
21274,GO:2000251,1,0.901522234266107,0,18,positive regulation of actin cytoskeleton reorganization,BP,
21275,GO:2000252,1,0.968460692018031,0,7,negative regulation of feeding behavior,BP,
21276,GO:2000253,1,0.96508939762185,0,5,positive regulation of feeding behavior,BP,
21277,GO:2000254,1,0.98269495461297,0,4,regulation of male germ cell proliferation,BP,
21278,GO:2000255,1,0.985714320634368,0,3,negative regulation of male germ cell proliferation,BP,
21279,GO:2000256,1,0.996937317313033,0,1,positive regulation of male germ cell proliferation,BP,
21280,GO:2000257,1,0.797098548897524,0,36,regulation of protein activation cascade,BP,
21281,GO:2000258,1,0.955094986754316,0,6,negative regulation of protein activation cascade,BP,
21282,GO:2000259,1,0.979738789173436,0,3,positive regulation of protein activation cascade,BP,
21283,GO:2000269,1,0.898478811040932,0,15,regulation of fibroblast apoptotic process,BP,
21284,GO:2000270,1,0.950521146620253,0,7,negative regulation of fibroblast apoptotic process,BP,
21285,GO:2000271,1,0.948838604052973,0,7,positive regulation of fibroblast apoptotic process,BP,
21286,GO:2000272,1,0.826445314856692,0,28,negative regulation of signaling receptor activity,BP,
21287,GO:2000273,1,0.81782941754593,0,29,positive regulation of signaling receptor activity,BP,
21288,GO:2000275,1,0.98097013951514,0,4,regulation of oxidative phosphorylation uncoupler activity,BP,
21289,GO:2000276,1,0.989639569684645,0,2,negative regulation of oxidative phosphorylation uncoupler activity,BP,
21290,GO:2000277,1,0.997032233810024,0,1,positive regulation of oxidative phosphorylation uncoupler activity,BP,
21293,GO:2000280,1,0.997356194534619,0,1,regulation of root development,BP,
21294,GO:2000282,1,0.986886593885683,0,2,regulation of cellular amino acid biosynthetic process,BP,
21295,GO:2000283,1,0.989824462282673,0,1,negative regulation of cellular amino acid biosynthetic process,BP,
21296,GO:2000284,1,0.997032233810024,0,1,positive regulation of cellular amino acid biosynthetic process,BP,
21297,GO:2000286,1,0.979351898703374,0,3,receptor internalization involved in canonical Wnt signaling pathway,BP,
21299,GO:2000288,1,0.943596761309998,0,9,positive regulation of myoblast proliferation,BP,
21301,GO:2000291,1,0.912964386965101,0,14,regulation of myoblast proliferation,BP,
21302,GO:2000295,1,0.986642889571502,0,3,regulation of hydrogen peroxide catabolic process,BP,
21303,GO:2000296,1,0.993919422627845,0,2,negative regulation of hydrogen peroxide catabolic process,BP,
21304,GO:2000297,1,0.977349170132887,0,3,negative regulation of synapse maturation,BP,
21305,GO:2000298,1,0.986376743150715,0,2,regulation of Rho-dependent protein serine/threonine kinase activity,BP,
21306,GO:2000299,1,0.992584206895236,0,1,negative regulation of Rho-dependent protein serine/threonine kinase activity,BP,
21307,GO:2000300,1,0.829922142240327,0,25,regulation of synaptic vesicle exocytosis,BP,
21308,GO:2000301,1,0.980331675037986,0,3,negative regulation of synaptic vesicle exocytosis,BP,
21309,GO:2000302,1,0.975955423971251,0,3,positive regulation of synaptic vesicle exocytosis,BP,
21310,GO:2000303,1,0.9246256409518,0,13,regulation of ceramide biosynthetic process,BP,
21311,GO:2000304,1,0.950260531986637,0,8,positive regulation of ceramide biosynthetic process,BP,
21314,GO:2000309,1,0.992691303580234,0,1,positive regulation of tumor necrosis factor (ligand) superfamily member 11 production,BP,
21317,GO:2000312,1,0.977267813093456,0,3,regulation of kainate selective glutamate receptor activity,BP,
21318,GO:2000313,1,0.99035238093586,0,2,regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
21319,GO:2000314,1,0.995428566727141,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in neural plate anterior/posterior pattern formation,BP,
21320,GO:2000316,1,0.943209622054782,0,9,regulation of T-helper 17 type immune response,BP,
21321,GO:2000317,1,0.965710278430784,0,5,negative regulation of T-helper 17 type immune response,BP,
21322,GO:2000318,1,0.976708441859775,0,4,positive regulation of T-helper 17 type immune response,BP,
21323,GO:2000319,1,0.950224149035133,0,8,regulation of T-helper 17 cell differentiation,BP,
21324,GO:2000320,1,0.965710278430784,0,5,negative regulation of T-helper 17 cell differentiation,BP,
21325,GO:2000321,1,0.983969552851459,0,3,positive regulation of T-helper 17 cell differentiation,BP,
21326,GO:2000322,1,0.945367968029938,0,8,regulation of glucocorticoid receptor signaling pathway,BP,
21327,GO:2000323,1,0.957785162394594,0,6,negative regulation of glucocorticoid receptor signaling pathway,BP,
21328,GO:2000324,1,0.987041064823223,0,2,positive regulation of glucocorticoid receptor signaling pathway,BP,
21329,GO:2000325,1,0.991408033413895,0,1,regulation of ligand-dependent nuclear receptor transcription coactivator activity,BP,
21330,GO:2000327,1,0.991408033413895,0,1,positive regulation of ligand-dependent nuclear receptor transcription coactivator activity,BP,
21331,GO:2000328,1,0.977758925413325,0,4,regulation of T-helper 17 cell lineage commitment,BP,
21332,GO:2000329,1,0.986152276286064,0,2,negative regulation of T-helper 17 cell lineage commitment,BP,
21333,GO:2000330,1,0.991489971730733,0,2,positive regulation of T-helper 17 cell lineage commitment,BP,
21334,GO:2000331,1,0.985149886697413,0,2,regulation of terminal button organization,BP,
21335,GO:2000332,1,0.989912788840421,0,2,regulation of blood microparticle formation,BP,
21336,GO:2000334,1,0.989912788840421,0,2,positive regulation of blood microparticle formation,BP,
21337,GO:2000338,1,0.987868169689496,0,2,regulation of chemokine (C-X-C motif) ligand 1 production,BP,
21338,GO:2000340,1,0.987868169689496,0,2,positive regulation of chemokine (C-X-C motif) ligand 1 production,BP,
21340,GO:2000342,1,0.986732222369217,0,2,negative regulation of chemokine (C-X-C motif) ligand 2 production,BP,
21342,GO:2000344,1,0.955971148905101,0,7,positive regulation of acrosome reaction,BP,
21343,GO:2000345,1,0.929272161183653,0,11,regulation of hepatocyte proliferation,BP,
21344,GO:2000346,1,0.97953868956297,0,3,negative regulation of hepatocyte proliferation,BP,
21345,GO:2000347,1,0.963117143662945,0,6,positive regulation of hepatocyte proliferation,BP,
21346,GO:2000348,1,0.963931834494075,0,6,regulation of CD40 signaling pathway,BP,
21347,GO:2000349,1,0.987042334454788,0,2,negative regulation of CD40 signaling pathway,BP,
21348,GO:2000350,1,0.996782430484662,0,1,positive regulation of CD40 signaling pathway,BP,
21349,GO:2000351,1,0.766652332886602,0,39,regulation of endothelial cell apoptotic process,BP,
21350,GO:2000352,1,0.839411273859052,0,25,negative regulation of endothelial cell apoptotic process,BP,
21351,GO:2000353,1,0.913466346403752,0,14,positive regulation of endothelial cell apoptotic process,BP,
21352,GO:2000354,1,0.965753848112958,0,6,regulation of ovarian follicle development,BP,
21353,GO:2000355,1,0.989395878936255,0,2,negative regulation of ovarian follicle development,BP,
21354,GO:2000356,1,0.995632596003417,0,1,regulation of kidney smooth muscle cell differentiation,BP,
21355,GO:2000357,1,0.995632596003417,0,1,negative regulation of kidney smooth muscle cell differentiation,BP,
21356,GO:2000358,1,0.995632596003417,0,1,positive regulation of kidney smooth muscle cell differentiation,BP,
21357,GO:2000359,1,0.990132545110315,0,2,regulation of binding of sperm to zona pellucida,BP,
21358,GO:2000360,1,0.990132545110315,0,2,negative regulation of binding of sperm to zona pellucida,BP,
21359,GO:2000361,1,0.984645070453086,0,2,regulation of prostaglandin-E synthase activity,BP,
21360,GO:2000363,1,0.984645070453086,0,2,positive regulation of prostaglandin-E synthase activity,BP,
21361,GO:2000367,1,0.990839356362489,0,2,regulation of acrosomal vesicle exocytosis,BP,
21362,GO:2000368,1,0.990839356362489,0,2,positive regulation of acrosomal vesicle exocytosis,BP,
21363,GO:2000369,1,0.87961575688001,0,16,regulation of clathrin-dependent endocytosis,BP,
21364,GO:2000370,1,0.97001087359043,0,4,positive regulation of clathrin-dependent endocytosis,BP,
21365,GO:2000371,1,0.964574855760556,0,5,regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,
21366,GO:2000373,1,0.964574855760556,0,5,positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity,BP,
21367,GO:2000374,1,0.989318068540298,0,3,regulation of oxygen metabolic process,BP,
21368,GO:2000376,1,0.994756817216189,0,2,positive regulation of oxygen metabolic process,BP,
21370,GO:2000378,1,0.755775155847825,0,45,negative regulation of reactive oxygen species metabolic process,BP,
21372,GO:2000380,1,0.914512919444895,0,15,regulation of mesoderm development,BP,
21373,GO:2000381,1,0.955256005542972,0,8,negative regulation of mesoderm development,BP,
21374,GO:2000382,1,0.976885734937535,0,4,positive regulation of mesoderm development,BP,
21375,GO:2000383,1,0.99249165342284,0,1,regulation of ectoderm development,BP,
21376,GO:2000384,1,0.99249165342284,0,1,negative regulation of ectoderm development,BP,
21377,GO:2000386,1,0.988539461626079,0,2,positive regulation of ovarian follicle development,BP,
21378,GO:2000387,1,0.996043869819361,0,1,regulation of antral ovarian follicle growth,BP,
21379,GO:2000388,1,0.996043869819361,0,1,positive regulation of antral ovarian follicle growth,BP,
21380,GO:2000389,1,0.977900407689883,0,3,regulation of neutrophil extravasation,BP,
21381,GO:2000391,1,0.977900407689883,0,3,positive regulation of neutrophil extravasation,BP,
21383,GO:2000393,1,0.985146887864647,0,2,negative regulation of lamellipodium morphogenesis,BP,
21385,GO:2000395,1,0.992604737666411,0,2,regulation of ubiquitin-dependent endocytosis,BP,
21386,GO:2000397,1,0.992604737666411,0,2,positive regulation of ubiquitin-dependent endocytosis,BP,
21389,GO:2000403,1,0.866737146044078,0,26,positive regulation of lymphocyte migration,BP,
21392,GO:2000406,1,0.883943591262037,0,22,positive regulation of T cell migration,BP,
21393,GO:2000407,1,0.983430956903397,0,3,regulation of T cell extravasation,BP,
21394,GO:2000409,1,0.988559235499603,0,2,positive regulation of T cell extravasation,BP,
21395,GO:2000410,1,0.983563989248392,0,3,regulation of thymocyte migration,BP,
21396,GO:2000412,1,0.989136322107589,0,2,positive regulation of thymocyte migration,BP,
21397,GO:2000413,1,0.992691303580234,0,1,regulation of fibronectin-dependent thymocyte migration,BP,
21398,GO:2000415,1,0.992691303580234,0,1,positive regulation of fibronectin-dependent thymocyte migration,BP,
21399,GO:2000416,1,0.973708200140096,0,4,regulation of eosinophil migration,BP,
21400,GO:2000417,1,0.987502983221085,0,2,negative regulation of eosinophil migration,BP,
21401,GO:2000418,1,0.986032385858968,0,2,positive regulation of eosinophil migration,BP,
21402,GO:2000419,1,0.992567076119753,0,1,regulation of eosinophil extravasation,BP,
21403,GO:2000420,1,0.992567076119753,0,1,negative regulation of eosinophil extravasation,BP,
21404,GO:2000422,1,0.993292546137503,0,1,regulation of eosinophil chemotaxis,BP,
21405,GO:2000424,1,0.993292546137503,0,1,positive regulation of eosinophil chemotaxis,BP,
21406,GO:2000425,1,0.9400433167239,0,9,regulation of apoptotic cell clearance,BP,
21407,GO:2000426,1,0.987801635820604,0,2,negative regulation of apoptotic cell clearance,BP,
21408,GO:2000427,1,0.953571465333595,0,7,positive regulation of apoptotic cell clearance,BP,
21409,GO:2000434,1,0.994534891080824,0,2,regulation of protein neddylation,BP,
21410,GO:2000435,1,0.994534891080824,0,2,negative regulation of protein neddylation,BP,
21411,GO:2000437,1,0.977219340561924,0,3,regulation of monocyte extravasation,BP,
21412,GO:2000438,1,0.99103494315388,0,1,negative regulation of monocyte extravasation,BP,
21413,GO:2000439,1,0.986060664577817,0,2,positive regulation of monocyte extravasation,BP,
21414,GO:2000446,1,0.992400188240257,0,1,regulation of macrophage migration inhibitory factor signaling pathway,BP,
21415,GO:2000449,1,0.983430956903397,0,3,regulation of CD8-positive, alpha-beta T cell extravasation,BP,
21416,GO:2000451,1,0.988559235499603,0,2,positive regulation of CD8-positive, alpha-beta T cell extravasation,BP,
21417,GO:2000452,1,0.989829488120235,0,2,regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
21418,GO:2000454,1,0.994990797134754,0,1,positive regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation,BP,
21419,GO:2000458,1,0.988721067149383,0,2,regulation of astrocyte chemotaxis,BP,
21420,GO:2000463,1,0.824647397742993,0,25,positive regulation of excitatory postsynaptic potential,BP,
21421,GO:2000464,1,0.993536383049275,0,1,positive regulation of astrocyte chemotaxis,BP,
21422,GO:2000465,1,0.95414638175275,0,6,regulation of glycogen (starch) synthase activity,BP,
21423,GO:2000466,1,0.97785983649579,0,3,negative regulation of glycogen (starch) synthase activity,BP,
21424,GO:2000467,1,0.977068568428115,0,3,positive regulation of glycogen (starch) synthase activity,BP,
21425,GO:2000468,1,0.982330064845964,0,2,regulation of peroxidase activity,BP,
21426,GO:2000469,1,0.989575106505612,0,1,negative regulation of peroxidase activity,BP,
21427,GO:2000470,1,0.992679397096388,0,1,positive regulation of peroxidase activity,BP,
21428,GO:2000471,1,0.985684541375694,0,2,regulation of hematopoietic stem cell migration,BP,
21429,GO:2000473,1,0.985684541375694,0,2,positive regulation of hematopoietic stem cell migration,BP,
21430,GO:2000474,1,0.986178650956792,0,2,regulation of opioid receptor signaling pathway,BP,
21431,GO:2000479,1,0.910461250494093,0,14,regulation of cAMP-dependent protein kinase activity,BP,
21432,GO:2000480,1,0.951327025885544,0,8,negative regulation of cAMP-dependent protein kinase activity,BP,
21433,GO:2000481,1,0.968245860039809,0,4,positive regulation of cAMP-dependent protein kinase activity,BP,
21434,GO:2000482,1,0.877430063649726,0,22,regulation of interleukin-8 secretion,BP,
21435,GO:2000483,1,0.956100234298487,0,7,negative regulation of interleukin-8 secretion,BP,
21436,GO:2000484,1,0.924173286725902,0,14,positive regulation of interleukin-8 secretion,BP,
21437,GO:2000485,1,0.986218829689024,0,2,regulation of glutamine transport,BP,
21438,GO:2000486,1,0.992563042505725,0,1,negative regulation of glutamine transport,BP,
21439,GO:2000487,1,0.993608727456903,0,1,positive regulation of glutamine transport,BP,
21440,GO:2000489,1,0.957548571304365,0,6,regulation of hepatic stellate cell activation,BP,
21441,GO:2000490,1,0.987297262168569,0,2,negative regulation of hepatic stellate cell activation,BP,
21442,GO:2000491,1,0.969872349534879,0,4,positive regulation of hepatic stellate cell activation,BP,
21443,GO:2000492,1,0.992822651878865,0,1,regulation of interleukin-18-mediated signaling pathway,BP,
21444,GO:2000494,1,0.992822651878865,0,1,positive regulation of interleukin-18-mediated signaling pathway,BP,
21445,GO:2000501,1,0.981616656798425,0,5,regulation of natural killer cell chemotaxis,BP,
21446,GO:2000502,1,0.993063390352774,0,2,negative regulation of natural killer cell chemotaxis,BP,
21447,GO:2000503,1,0.9884741120441,0,3,positive regulation of natural killer cell chemotaxis,BP,
21448,GO:2000504,1,0.98600144891581,0,2,positive regulation of blood vessel remodeling,BP,
21449,GO:2000508,1,0.960904001841729,0,8,regulation of dendritic cell chemotaxis,BP,
21450,GO:2000510,1,0.960904001841729,0,8,positive regulation of dendritic cell chemotaxis,BP,
21451,GO:2000511,1,0.99641910777211,0,1,regulation of granzyme A production,BP,
21452,GO:2000513,1,0.99641910777211,0,1,positive regulation of granzyme A production,BP,
21453,GO:2000514,1,0.778257533933499,0,39,regulation of CD4-positive, alpha-beta T cell activation,BP,
21454,GO:2000515,1,0.885131673789708,0,18,negative regulation of CD4-positive, alpha-beta T cell activation,BP,
21455,GO:2000516,1,0.859081308789873,0,25,positive regulation of CD4-positive, alpha-beta T cell activation,BP,
21456,GO:2000517,1,0.99641910777211,0,1,regulation of T-helper 1 cell activation,BP,
21457,GO:2000518,1,0.99641910777211,0,1,negative regulation of T-helper 1 cell activation,BP,
21458,GO:2000520,1,0.984234579347016,0,3,regulation of immunological synapse formation,BP,
21459,GO:2000521,1,0.989935642730043,0,2,negative regulation of immunological synapse formation,BP,
21460,GO:2000522,1,0.994241557377807,0,1,positive regulation of immunological synapse formation,BP,
21461,GO:2000523,1,0.986829282835659,0,2,regulation of T cell costimulation,BP,
21462,GO:2000525,1,0.986829282835659,0,2,positive regulation of T cell costimulation,BP,
21463,GO:2000526,1,0.994241557377807,0,1,positive regulation of glycoprotein biosynthetic process involved in immunological synapse formation,BP,
21464,GO:2000527,1,0.997153976623448,0,1,regulation of myeloid dendritic cell chemotaxis,BP,
21465,GO:2000529,1,0.997153976623448,0,1,positive regulation of myeloid dendritic cell chemotaxis,BP,
21466,GO:2000532,1,0.993522923901973,0,1,regulation of renal albumin absorption,BP,
21467,GO:2000533,1,0.993522923901973,0,1,negative regulation of renal albumin absorption,BP,
21468,GO:2000535,1,0.956989496042899,0,6,regulation of entry of bacterium into host cell,BP,
21469,GO:2000536,1,0.990939815390663,0,1,negative regulation of entry of bacterium into host cell,BP,
21470,GO:2000537,1,0.988843537936424,0,2,regulation of B cell chemotaxis,BP,
21471,GO:2000538,1,0.988843537936424,0,2,positive regulation of B cell chemotaxis,BP,
21472,GO:2000542,1,0.954489041694596,0,7,negative regulation of gastrulation,BP,
21473,GO:2000543,1,0.976206173535351,0,4,positive regulation of gastrulation,BP,
21474,GO:2000544,1,0.967917256512691,0,5,regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
21475,GO:2000545,1,0.996460308534979,0,1,negative regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
21476,GO:2000546,1,0.978703581392683,0,3,positive regulation of endothelial cell chemotaxis to fibroblast growth factor,BP,
21477,GO:2000547,1,0.988989379338996,0,3,regulation of dendritic cell dendrite assembly,BP,
21478,GO:2000548,1,0.997153976623448,0,1,negative regulation of dendritic cell dendrite assembly,BP,
21479,GO:2000549,1,0.997556848377653,0,1,positive regulation of dendritic cell dendrite assembly,BP,
21480,GO:2000551,1,0.95517379575409,0,8,regulation of T-helper 2 cell cytokine production,BP,
21481,GO:2000552,1,0.989338948092187,0,2,negative regulation of T-helper 2 cell cytokine production,BP,
21482,GO:2000553,1,0.965470327275771,0,6,positive regulation of T-helper 2 cell cytokine production,BP,
21483,GO:2000554,1,0.99641910777211,0,1,regulation of T-helper 1 cell cytokine production,BP,
21484,GO:2000556,1,0.99641910777211,0,1,positive regulation of T-helper 1 cell cytokine production,BP,
21485,GO:2000557,1,0.99641910777211,0,1,regulation of immunoglobulin production in mucosal tissue,BP,
21486,GO:2000558,1,0.99641910777211,0,1,positive regulation of immunoglobulin production in mucosal tissue,BP,
21487,GO:2000559,1,0.99103494315388,0,1,regulation of CD24 biosynthetic process,BP,
21488,GO:2000560,1,0.99103494315388,0,1,positive regulation of CD24 biosynthetic process,BP,
21489,GO:2000561,1,0.964766962741978,0,6,regulation of CD4-positive, alpha-beta T cell proliferation,BP,
21490,GO:2000562,1,0.979167558888183,0,4,negative regulation of CD4-positive, alpha-beta T cell proliferation,BP,
21491,GO:2000563,1,0.977258012825732,0,4,positive regulation of CD4-positive, alpha-beta T cell proliferation,BP,
21492,GO:2000564,1,0.984417545927332,0,3,regulation of CD8-positive, alpha-beta T cell proliferation,BP,
21493,GO:2000566,1,0.991827036596089,0,2,positive regulation of CD8-positive, alpha-beta T cell proliferation,BP,
21494,GO:2000567,1,0.994161956511822,0,1,regulation of memory T cell activation,BP,
21495,GO:2000568,1,0.994161956511822,0,1,positive regulation of memory T cell activation,BP,
21496,GO:2000569,1,0.992621782255615,0,1,regulation of T-helper 2 cell activation,BP,
21497,GO:2000570,1,0.992621782255615,0,1,positive regulation of T-helper 2 cell activation,BP,
21498,GO:2000571,1,0.992545224030108,0,1,regulation of interleukin-4-dependent isotype switching to IgE isotypes,BP,
21499,GO:2000572,1,0.992545224030108,0,1,positive regulation of interleukin-4-dependent isotype switching to IgE isotypes,BP,
21500,GO:2000573,1,0.659624702386667,0,63,positive regulation of DNA biosynthetic process,BP,
21501,GO:2000574,1,0.947513706362209,0,9,regulation of microtubule motor activity,BP,
21502,GO:2000576,1,0.968630965619042,0,6,positive regulation of microtubule motor activity,BP,
21503,GO:2000580,1,0.975403450635138,0,5,regulation of ATP-dependent microtubule motor activity, plus-end-directed,BP,
21504,GO:2000582,1,0.975403450635138,0,5,positive regulation of ATP-dependent microtubule motor activity, plus-end-directed,BP,
21505,GO:2000583,1,0.992491860916364,0,1,regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
21506,GO:2000584,1,0.992491860916364,0,1,negative regulation of platelet-derived growth factor receptor-alpha signaling pathway,BP,
21507,GO:2000586,1,0.920538137849926,0,10,regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
21508,GO:2000587,1,0.936311769178488,0,8,negative regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
21509,GO:2000588,1,0.9831644152724,0,2,positive regulation of platelet-derived growth factor receptor-beta signaling pathway,BP,
21510,GO:2000589,1,0.97786531322969,0,3,regulation of metanephric mesenchymal cell migration,BP,
21511,GO:2000591,1,0.97786531322969,0,3,positive regulation of metanephric mesenchymal cell migration,BP,
21512,GO:2000592,1,0.985001542988399,0,2,regulation of metanephric DCT cell differentiation,BP,
21513,GO:2000594,1,0.985001542988399,0,2,positive regulation of metanephric DCT cell differentiation,BP,
21514,GO:2000595,1,0.992456292901894,0,1,regulation of optic nerve formation,BP,
21515,GO:2000597,1,0.992456292901894,0,1,positive regulation of optic nerve formation,BP,
21516,GO:2000601,1,0.957455178141751,0,6,positive regulation of Arp2/3 complex-mediated actin nucleation,BP,
21517,GO:2000606,1,0.992751317537939,0,1,regulation of cell proliferation involved in mesonephros development,BP,
21518,GO:2000607,1,0.992751317537939,0,1,negative regulation of cell proliferation involved in mesonephros development,BP,
21519,GO:2000609,1,0.974833384730402,0,4,regulation of thyroid hormone generation,BP,
21520,GO:2000611,1,0.979819137545469,0,3,positive regulation of thyroid hormone generation,BP,
21521,GO:2000612,1,0.992489152328139,0,1,regulation of thyroid-stimulating hormone secretion,BP,
21522,GO:2000615,1,0.926844183446214,0,11,regulation of histone H3-K9 acetylation,BP,
21523,GO:2000616,1,0.986978684348606,0,2,negative regulation of histone H3-K9 acetylation,BP,
21524,GO:2000617,1,0.952117624293061,0,7,positive regulation of histone H3-K9 acetylation,BP,
21525,GO:2000618,1,0.964369034717684,0,5,regulation of histone H4-K16 acetylation,BP,
21526,GO:2000619,1,0.981589802957925,0,3,negative regulation of histone H4-K16 acetylation,BP,
21527,GO:2000620,1,0.982459476815216,0,2,positive regulation of histone H4-K16 acetylation,BP,
21528,GO:2000622,1,0.968953912571128,0,4,regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
21529,GO:2000623,1,0.968953912571128,0,4,negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay,BP,
21530,GO:2000625,1,0.985520625250057,0,2,regulation of miRNA catabolic process,BP,
21531,GO:2000627,1,0.985520625250057,0,2,positive regulation of miRNA catabolic process,BP,
21532,GO:2000628,1,0.954468731021392,0,7,regulation of miRNA metabolic process,BP,
21533,GO:2000630,1,0.96828499796314,0,5,positive regulation of miRNA metabolic process,BP,
21534,GO:2000631,1,0.992635692460644,0,1,regulation of pre-miRNA processing,BP,
21535,GO:2000632,1,0.992635692460644,0,1,negative regulation of pre-miRNA processing,BP,
21537,GO:2000638,1,0.98571624287758,0,2,regulation of SREBP signaling pathway,BP,
21538,GO:2000639,1,0.98571624287758,0,2,negative regulation of SREBP signaling pathway,BP,
21539,GO:2000641,1,0.891625848342773,0,17,regulation of early endosome to late endosome transport,BP,
21540,GO:2000642,1,0.993642415197,0,2,negative regulation of early endosome to late endosome transport,BP,
21541,GO:2000643,1,0.941523892437667,0,8,positive regulation of early endosome to late endosome transport,BP,
21542,GO:2000644,1,0.939174625505638,0,9,regulation of receptor catabolic process,BP,
21543,GO:2000645,1,0.980302994665098,0,3,negative regulation of receptor catabolic process,BP,
21544,GO:2000646,1,0.96505395255582,0,5,positive regulation of receptor catabolic process,BP,
21545,GO:2000647,1,0.930494349098144,0,10,negative regulation of stem cell proliferation,BP,
21547,GO:2000649,1,0.732653020240536,0,46,regulation of sodium ion transmembrane transporter activity,BP,
21548,GO:2000650,1,0.917272883848258,0,11,negative regulation of sodium ion transmembrane transporter activity,BP,
21549,GO:2000651,1,0.911105747363515,0,13,positive regulation of sodium ion transmembrane transporter activity,BP,
21550,GO:2000653,1,0.977908757096421,0,3,regulation of genetic imprinting,BP,
21551,GO:2000654,1,0.992492016498709,0,1,regulation of cellular response to testosterone stimulus,BP,
21552,GO:2000655,1,0.992492016498709,0,1,negative regulation of cellular response to testosterone stimulus,BP,
21553,GO:2000656,1,0.994922078489237,0,1,regulation of apolipoprotein binding,BP,
21554,GO:2000657,1,0.994922078489237,0,1,negative regulation of apolipoprotein binding,BP,
21555,GO:2000659,1,0.960173613306039,0,7,regulation of interleukin-1-mediated signaling pathway,BP,
21556,GO:2000660,1,0.972904832058496,0,5,negative regulation of interleukin-1-mediated signaling pathway,BP,
21557,GO:2000661,1,0.992165726805901,0,1,positive regulation of interleukin-1-mediated signaling pathway,BP,
21558,GO:2000662,1,0.960872575992418,0,6,regulation of interleukin-5 secretion,BP,
21559,GO:2000663,1,0.99251709430428,0,1,negative regulation of interleukin-5 secretion,BP,
21560,GO:2000664,1,0.968119259000968,0,5,positive regulation of interleukin-5 secretion,BP,
21561,GO:2000665,1,0.95758025596647,0,7,regulation of interleukin-13 secretion,BP,
21562,GO:2000666,1,0.98723677860516,0,2,negative regulation of interleukin-13 secretion,BP,
21563,GO:2000667,1,0.969963872686777,0,5,positive regulation of interleukin-13 secretion,BP,
21564,GO:2000668,1,0.943123435737668,0,10,regulation of dendritic cell apoptotic process,BP,
21565,GO:2000669,1,0.963060826177504,0,7,negative regulation of dendritic cell apoptotic process,BP,
21566,GO:2000670,1,0.979305604648503,0,3,positive regulation of dendritic cell apoptotic process,BP,
21569,GO:2000674,1,0.930816811129425,0,11,regulation of type B pancreatic cell apoptotic process,BP,
21570,GO:2000675,1,0.957901098074988,0,6,negative regulation of type B pancreatic cell apoptotic process,BP,
21571,GO:2000676,1,0.971737371357328,0,5,positive regulation of type B pancreatic cell apoptotic process,BP,
21572,GO:2000677,1,0.745760668784028,0,44,regulation of transcription regulatory region DNA binding,BP,
21573,GO:2000678,1,0.889626608540648,0,19,negative regulation of transcription regulatory region DNA binding,BP,
21574,GO:2000679,1,0.869935439467108,0,21,positive regulation of transcription regulatory region DNA binding,BP,
21575,GO:2000683,1,0.985800721914064,0,2,regulation of cellular response to X-ray,BP,
21576,GO:2000685,1,0.992999161121732,0,1,positive regulation of cellular response to X-ray,BP,
21577,GO:2000690,1,0.992424091422782,0,1,regulation of cardiac muscle cell myoblast differentiation,BP,
21578,GO:2000691,1,0.992424091422782,0,1,negative regulation of cardiac muscle cell myoblast differentiation,BP,
21579,GO:2000696,1,0.899645694161137,0,15,regulation of epithelial cell differentiation involved in kidney development,BP,
21580,GO:2000697,1,0.977240807069993,0,4,negative regulation of epithelial cell differentiation involved in kidney development,BP,
21581,GO:2000698,1,0.967881800095971,0,5,positive regulation of epithelial cell differentiation involved in kidney development,BP,
21582,GO:2000699,1,0.992751317537939,0,1,fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
21583,GO:2000701,1,0.992751317537939,0,1,glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
21584,GO:2000702,1,0.992751317537939,0,1,regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
21585,GO:2000703,1,0.992751317537939,0,1,negative regulation of fibroblast growth factor receptor signaling pathway involved in ureteric bud formation,BP,
21586,GO:2000705,1,0.977068683927232,0,3,regulation of dense core granule biogenesis,BP,
21587,GO:2000706,1,0.992513136053713,0,1,negative regulation of dense core granule biogenesis,BP,
21588,GO:2000707,1,0.984440204313661,0,2,positive regulation of dense core granule biogenesis,BP,
21589,GO:2000718,1,0.997133032599985,0,1,regulation of maintenance of mitotic sister chromatid cohesion, centromeric,BP,
21590,GO:2000719,1,0.997133032599985,0,1,negative regulation of maintenance of mitotic sister chromatid cohesion, centromeric,BP,
21591,GO:2000721,1,0.976137981226664,0,3,positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
21592,GO:2000722,1,0.97747728946571,0,3,regulation of cardiac vascular smooth muscle cell differentiation,BP,
21593,GO:2000723,1,0.993230791472838,0,1,negative regulation of cardiac vascular smooth muscle cell differentiation,BP,
21594,GO:2000724,1,0.984140200471109,0,2,positive regulation of cardiac vascular smooth muscle cell differentiation,BP,
21595,GO:2000725,1,0.824221874977165,0,27,regulation of cardiac muscle cell differentiation,BP,
21596,GO:2000726,1,0.919670126104567,0,11,negative regulation of cardiac muscle cell differentiation,BP,
21597,GO:2000727,1,0.896296887552741,0,16,positive regulation of cardiac muscle cell differentiation,BP,
21598,GO:2000729,1,0.988873276052195,0,2,positive regulation of mesenchymal cell proliferation involved in ureter development,BP,
21599,GO:2000733,1,0.992751317537939,0,1,regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
21600,GO:2000734,1,0.992751317537939,0,1,negative regulation of glial cell-derived neurotrophic factor receptor signaling pathway involved in ureteric bud formation,BP,
21602,GO:2000737,1,0.872705936862442,0,18,negative regulation of stem cell differentiation,BP,
21603,GO:2000738,1,0.886876711094674,0,17,positive regulation of stem cell differentiation,BP,
21604,GO:2000739,1,0.951623488948254,0,6,regulation of mesenchymal stem cell differentiation,BP,
21605,GO:2000740,1,0.992513136053713,0,1,negative regulation of mesenchymal stem cell differentiation,BP,
21606,GO:2000741,1,0.967362943041666,0,4,positive regulation of mesenchymal stem cell differentiation,BP,
21607,GO:2000742,1,0.994433365545022,0,1,regulation of anterior head development,BP,
21608,GO:2000744,1,0.994433365545022,0,1,positive regulation of anterior head development,BP,
21609,GO:2000752,1,0.993050114308619,0,1,regulation of glucosylceramide catabolic process,BP,
21610,GO:2000753,1,0.993050114308619,0,1,positive regulation of glucosylceramide catabolic process,BP,
21611,GO:2000754,1,0.993050114308619,0,1,regulation of sphingomyelin catabolic process,BP,
21612,GO:2000755,1,0.993050114308619,0,1,positive regulation of sphingomyelin catabolic process,BP,
21613,GO:2000756,1,0.679729580358427,0,57,regulation of peptidyl-lysine acetylation,BP,
21614,GO:2000757,1,0.87143903313136,0,21,negative regulation of peptidyl-lysine acetylation,BP,
21615,GO:2000758,1,0.82435532700515,0,29,positive regulation of peptidyl-lysine acetylation,BP,
21616,GO:2000759,1,0.992185715214004,0,1,regulation of N-terminal peptidyl-lysine acetylation,BP,
21617,GO:2000761,1,0.992185715214004,0,1,positive regulation of N-terminal peptidyl-lysine acetylation,BP,
21618,GO:2000763,1,0.993809324488368,0,1,positive regulation of transcription from RNA polymerase II promoter involved in norepinephrine biosynthetic process,BP,
21619,GO:2000764,1,0.993809324488368,0,1,positive regulation of semaphorin-plexin signaling pathway involved in outflow tract morphogenesis,BP,
21620,GO:2000765,1,0.857821051355269,0,22,regulation of cytoplasmic translation,BP,
21621,GO:2000766,1,0.949135168894306,0,7,negative regulation of cytoplasmic translation,BP,
21622,GO:2000767,1,0.951490311834813,0,7,positive regulation of cytoplasmic translation,BP,
21623,GO:2000768,1,0.992482867306063,0,1,positive regulation of nephron tubule epithelial cell differentiation,BP,
21624,GO:2000772,1,0.796319175739555,0,33,regulation of cellular senescence,BP,
21625,GO:2000773,1,0.88560343067466,0,16,negative regulation of cellular senescence,BP,
21626,GO:2000774,1,0.952631990434077,0,9,positive regulation of cellular senescence,BP,
21627,GO:2000775,1,0.994421708477763,0,1,histone H3-S10 phosphorylation involved in chromosome condensation,BP,
21628,GO:2000777,1,0.988598042016373,0,2,positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia,BP,
21630,GO:2000779,1,0.701982948100466,0,50,regulation of double-strand break repair,BP,
21631,GO:2000780,1,0.862919277222204,0,20,negative regulation of double-strand break repair,BP,
21632,GO:2000781,1,0.915354799512207,0,12,positive regulation of double-strand break repair,BP,
21633,GO:2000785,1,0.785435863798569,0,35,regulation of autophagosome assembly,BP,
21634,GO:2000786,1,0.925787250119913,0,10,positive regulation of autophagosome assembly,BP,
21635,GO:2000790,1,0.982778900745772,0,2,regulation of mesenchymal cell proliferation involved in lung development,BP,
21636,GO:2000791,1,0.982778900745772,0,2,negative regulation of mesenchymal cell proliferation involved in lung development,BP,
21637,GO:2000793,1,0.973547868360282,0,3,cell proliferation involved in heart valve development,BP,
21638,GO:2000794,1,0.941913742583688,0,8,regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
21639,GO:2000795,1,0.990214294717055,0,1,negative regulation of epithelial cell proliferation involved in lung morphogenesis,BP,
21640,GO:2000797,1,0.992513136053713,0,1,regulation of amniotic stem cell differentiation,BP,
21641,GO:2000798,1,0.992513136053713,0,1,negative regulation of amniotic stem cell differentiation,BP,
21642,GO:2000800,1,0.99543318216766,0,1,regulation of endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
21643,GO:2000802,1,0.99543318216766,0,1,positive regulation of endocardial cushion to mesenchymal transition involved in heart valve formation,BP,
21644,GO:2000804,1,0.988593461709096,0,1,regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
21645,GO:2000806,1,0.988593461709096,0,1,positive regulation of termination of RNA polymerase II transcription, poly(A)-coupled,BP,
21646,GO:2000807,1,0.943787564547402,0,7,regulation of synaptic vesicle clustering,BP,
21647,GO:2000808,1,0.991801323675887,0,1,negative regulation of synaptic vesicle clustering,BP,
21648,GO:2000809,1,0.960913106909784,0,5,positive regulation of synaptic vesicle clustering,BP,
21650,GO:2000811,1,0.895469545368426,0,15,negative regulation of anoikis,BP,
21651,GO:2000812,1,0.992488099351822,0,1,regulation of barbed-end actin filament capping,BP,
21652,GO:2000816,1,0.801412605513512,0,33,negative regulation of mitotic sister chromatid separation,BP,
21653,GO:2000818,1,0.988151296536952,0,2,negative regulation of myoblast proliferation,BP,
21654,GO:2000819,1,0.985766307362554,0,2,regulation of nucleotide-excision repair,BP,
21655,GO:2000820,1,0.978873798446667,0,3,negative regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation,BP,
21656,GO:2000821,1,0.967934623533606,0,5,regulation of grooming behavior,BP,
21658,GO:2000823,1,0.96791892447613,0,6,regulation of androgen receptor activity,BP,
21659,GO:2000824,1,0.986718011387672,0,2,negative regulation of androgen receptor activity,BP,
21660,GO:2000825,1,0.980950388642115,0,4,positive regulation of androgen receptor activity,BP,
21661,GO:2000826,1,0.800741224807019,0,32,regulation of heart morphogenesis,BP,
21662,GO:2000827,1,0.993567422063829,0,1,mitochondrial RNA surveillance,BP,
21663,GO:2000828,1,0.986676195290412,0,2,regulation of parathyroid hormone secretion,BP,
21664,GO:2000830,1,0.991744366024575,0,1,positive regulation of parathyroid hormone secretion,BP,
21665,GO:2000831,1,0.916263962313952,0,16,regulation of steroid hormone secretion,BP,
21666,GO:2000832,1,0.984028290223539,0,2,negative regulation of steroid hormone secretion,BP,
21667,GO:2000833,1,0.958057553933439,0,9,positive regulation of steroid hormone secretion,BP,
21668,GO:2000834,1,0.992619880935046,0,1,regulation of androgen secretion,BP,
21669,GO:2000836,1,0.992619880935046,0,1,positive regulation of androgen secretion,BP,
21670,GO:2000843,1,0.983641068126021,0,2,regulation of testosterone secretion,BP,
21671,GO:2000845,1,0.983641068126021,0,2,positive regulation of testosterone secretion,BP,
21672,GO:2000846,1,0.929986707809371,0,13,regulation of corticosteroid hormone secretion,BP,
21673,GO:2000847,1,0.984028290223539,0,2,negative regulation of corticosteroid hormone secretion,BP,
21674,GO:2000848,1,0.967142728714387,0,7,positive regulation of corticosteroid hormone secretion,BP,
21675,GO:2000849,1,0.955381277854589,0,9,regulation of glucocorticoid secretion,BP,
21676,GO:2000850,1,0.984028290223539,0,2,negative regulation of glucocorticoid secretion,BP,
21677,GO:2000851,1,0.980943817530772,0,5,positive regulation of glucocorticoid secretion,BP,
21678,GO:2000852,1,0.982734408134721,0,4,regulation of corticosterone secretion,BP,
21679,GO:2000854,1,0.992906931034547,0,2,positive regulation of corticosterone secretion,BP,
21680,GO:2000855,1,0.973431418089994,0,4,regulation of mineralocorticoid secretion,BP,
21681,GO:2000857,1,0.985933499133226,0,2,positive regulation of mineralocorticoid secretion,BP,
21682,GO:2000858,1,0.973431418089994,0,4,regulation of aldosterone secretion,BP,
21683,GO:2000860,1,0.985933499133226,0,2,positive regulation of aldosterone secretion,BP,
21684,GO:2000864,1,0.979380019476984,0,3,regulation of estradiol secretion,BP,
21685,GO:2000866,1,0.988005366631198,0,2,positive regulation of estradiol secretion,BP,
21686,GO:2000870,1,0.992580701990023,0,2,regulation of progesterone secretion,BP,
21687,GO:2000872,1,0.997974621707065,0,1,positive regulation of progesterone secretion,BP,
21688,GO:2000878,1,0.988703966357826,0,2,positive regulation of oligopeptide transport,BP,
21689,GO:2000880,1,0.988703966357826,0,2,positive regulation of dipeptide transport,BP,
21690,GO:2000896,1,0.992688683011616,0,1,amylopectin metabolic process,BP,
21691,GO:2000909,1,0.993058458973322,0,1,regulation of sterol import,BP,
21692,GO:2000969,1,0.959634621493779,0,5,positive regulation of AMPA receptor activity,BP,
21693,GO:2000970,1,0.993709531925352,0,1,regulation of detection of glucose,BP,
21694,GO:2000971,1,0.993709531925352,0,1,negative regulation of detection of glucose,BP,
21695,GO:2000973,1,0.956886301792254,0,6,regulation of pro-B cell differentiation,BP,
21696,GO:2000974,1,0.981786173294738,0,3,negative regulation of pro-B cell differentiation,BP,
21697,GO:2000977,1,0.977657520414114,0,4,regulation of forebrain neuron differentiation,BP,
21698,GO:2000978,1,0.992161193186937,0,2,negative regulation of forebrain neuron differentiation,BP,
21699,GO:2000979,1,0.992750120792518,0,1,positive regulation of forebrain neuron differentiation,BP,
21700,GO:2000980,1,0.954806871484361,0,7,regulation of inner ear receptor cell differentiation,BP,
21701,GO:2000981,1,0.974522836582114,0,4,negative regulation of inner ear receptor cell differentiation,BP,
21702,GO:2000983,1,0.993986670721789,0,2,regulation of ATP citrate synthase activity,BP,
21703,GO:2000984,1,0.993986670721789,0,2,negative regulation of ATP citrate synthase activity,BP,
21705,GO:2001012,1,0.955707394769083,0,7,mesenchymal cell differentiation involved in renal system development,BP,
21706,GO:2001013,1,0.968716500299055,0,4,epithelial cell proliferation involved in renal tubule morphogenesis,BP,
21707,GO:2001014,1,0.878560334908916,0,18,regulation of skeletal muscle cell differentiation,BP,
21708,GO:2001015,1,0.95768850420074,0,6,negative regulation of skeletal muscle cell differentiation,BP,
21709,GO:2001016,1,0.965402014863141,0,5,positive regulation of skeletal muscle cell differentiation,BP,
21711,GO:2001021,1,0.65810437378434,0,65,negative regulation of response to DNA damage stimulus,BP,
21713,GO:2001023,1,0.624375004766998,0,74,regulation of response to drug,BP,
21714,GO:2001024,1,0.84591520830636,0,25,negative regulation of response to drug,BP,
21715,GO:2001025,1,0.865636624240822,0,25,positive regulation of response to drug,BP,
21716,GO:2001026,1,0.892210260014951,0,16,regulation of endothelial cell chemotaxis,BP,
21717,GO:2001027,1,0.977798310287479,0,3,negative regulation of endothelial cell chemotaxis,BP,
21718,GO:2001028,1,0.919393450193709,0,12,positive regulation of endothelial cell chemotaxis,BP,
21719,GO:2001029,1,0.991814244539348,0,1,regulation of cellular glucuronidation,BP,
21720,GO:2001031,1,0.991814244539348,0,1,positive regulation of cellular glucuronidation,BP,
21721,GO:2001032,1,0.919422326152519,0,12,regulation of double-strand break repair via nonhomologous end joining,BP,
21722,GO:2001033,1,0.969818307323301,0,5,negative regulation of double-strand break repair via nonhomologous end joining,BP,
21723,GO:2001034,1,0.962065886877268,0,5,positive regulation of double-strand break repair via nonhomologous end joining,BP,
21724,GO:2001035,1,0.988085468776987,0,2,regulation of tongue muscle cell differentiation,BP,
21725,GO:2001037,1,0.988085468776987,0,2,positive regulation of tongue muscle cell differentiation,BP,
21726,GO:2001038,1,0.83536399832378,0,27,regulation of cellular response to drug,BP,
21727,GO:2001039,1,0.89585555176734,0,17,negative regulation of cellular response to drug,BP,
21728,GO:2001040,1,0.960694205143928,0,6,positive regulation of cellular response to drug,BP,
21730,GO:2001045,1,0.983954076649516,0,2,negative regulation of integrin-mediated signaling pathway,BP,
21732,GO:2001049,1,0.994656624862147,0,1,regulation of tendon cell differentiation,BP,
21733,GO:2001051,1,0.994656624862147,0,1,positive regulation of tendon cell differentiation,BP,
21734,GO:2001053,1,0.934269551571888,0,11,regulation of mesenchymal cell apoptotic process,BP,
21735,GO:2001054,1,0.94467786219126,0,9,negative regulation of mesenchymal cell apoptotic process,BP,
21736,GO:2001055,1,0.988988397406763,0,2,positive regulation of mesenchymal cell apoptotic process,BP,
21739,GO:2001065,1,0.996150035116935,0,1,mannan binding,MF,
21740,GO:2001069,1,0.986550221356848,0,2,glycogen binding,MF,
21741,GO:2001070,1,0.985536484173107,0,2,starch binding,MF,
21742,GO:2001074,1,0.987982772377576,0,2,regulation of metanephric ureteric bud development,BP,
21743,GO:2001076,1,0.987982772377576,0,2,positive regulation of metanephric ureteric bud development,BP,
21744,GO:2001106,1,0.982474074567993,0,2,regulation of Rho guanyl-nucleotide exchange factor activity,BP,
21745,GO:2001108,1,0.991298700908345,0,1,positive regulation of Rho guanyl-nucleotide exchange factor activity,BP,
21746,GO:2001109,1,0.984638054665805,0,2,regulation of lens epithelial cell proliferation,BP,
21747,GO:2001111,1,0.984638054665805,0,2,positive regulation of lens epithelial cell proliferation,BP,
21748,GO:2001112,1,0.992134411744048,0,1,regulation of cellular response to hepatocyte growth factor stimulus,BP,
21749,GO:2001113,1,0.992134411744048,0,1,negative regulation of cellular response to hepatocyte growth factor stimulus,BP,
21751,GO:2001136,1,0.992588721910978,0,1,negative regulation of endocytic recycling,BP,
21752,GO:2001137,1,0.96646108158454,0,4,positive regulation of endocytic recycling,BP,
21753,GO:2001138,1,0.949392327211022,0,8,regulation of phospholipid transport,BP,
21754,GO:2001140,1,0.949392327211022,0,8,positive regulation of phospholipid transport,BP,
21756,GO:2001142,1,0.993414354368861,0,1,nicotinate transport,BP,
21757,GO:2001144,1,0.994211890902552,0,1,regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
21758,GO:2001145,1,0.994211890902552,0,1,negative regulation of phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity,BP,
21759,GO:2001148,1,0.988703966357826,0,2,regulation of dipeptide transmembrane transport,BP,
21760,GO:2001150,1,0.988703966357826,0,2,positive regulation of dipeptide transmembrane transport,BP,
21761,GO:2001151,1,0.992649030422308,0,1,regulation of renal water transport,BP,
21762,GO:2001153,1,0.992649030422308,0,1,positive regulation of renal water transport,BP,
21763,GO:2001160,1,0.98890542337461,0,2,regulation of histone H3-K79 methylation,BP,
21764,GO:2001162,1,0.98890542337461,0,2,positive regulation of histone H3-K79 methylation,BP,
21765,GO:2001163,1,0.994006724496386,0,1,regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
21766,GO:2001165,1,0.994006724496386,0,1,positive regulation of phosphorylation of RNA polymerase II C-terminal domain serine 2 residues,BP,
21767,GO:2001166,1,0.965695783663663,0,5,regulation of histone H2B ubiquitination,BP,
21768,GO:2001168,1,0.971209707123039,0,4,positive regulation of histone H2B ubiquitination,BP,
21769,GO:2001169,1,0.612005259377806,0,69,regulation of ATP biosynthetic process,BP,
21770,GO:2001170,1,0.914045695878143,0,13,negative regulation of ATP biosynthetic process,BP,
21771,GO:2001171,1,0.840557226147406,0,24,positive regulation of ATP biosynthetic process,BP,
21772,GO:2001173,1,0.99432427702669,0,1,regulation of histone H2B conserved C-terminal lysine ubiquitination,BP,
21773,GO:2001176,1,0.987108662456525,0,2,regulation of mediator complex assembly,BP,
21774,GO:2001178,1,0.987108662456525,0,2,positive regulation of mediator complex assembly,BP,
21775,GO:2001179,1,0.963528406618142,0,7,regulation of interleukin-10 secretion,BP,
21776,GO:2001180,1,0.980502373502422,0,3,negative regulation of interleukin-10 secretion,BP,
21777,GO:2001181,1,0.982691884246378,0,4,positive regulation of interleukin-10 secretion,BP,
21778,GO:2001182,1,0.955256390718918,0,7,regulation of interleukin-12 secretion,BP,
21779,GO:2001183,1,0.98042142925823,0,3,negative regulation of interleukin-12 secretion,BP,
21780,GO:2001184,1,0.981672865694017,0,3,positive regulation of interleukin-12 secretion,BP,
21781,GO:2001185,1,0.957829658090729,0,7,regulation of CD8-positive, alpha-beta T cell activation,BP,
21782,GO:2001186,1,0.987754281759427,0,2,negative regulation of CD8-positive, alpha-beta T cell activation,BP,
21783,GO:2001187,1,0.98437195313356,0,3,positive regulation of CD8-positive, alpha-beta T cell activation,BP,
21784,GO:2001188,1,0.974645484247437,0,5,regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
21785,GO:2001189,1,0.98296043160044,0,3,negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
21786,GO:2001190,1,0.991542364201199,0,2,positive regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell,BP,
21787,GO:2001191,1,0.99295458484256,0,1,regulation of gamma-delta T cell activation involved in immune response,BP,
21788,GO:2001193,1,0.99295458484256,0,1,positive regulation of gamma-delta T cell activation involved in immune response,BP,
21789,GO:2001197,1,0.956907151177701,0,5,basement membrane assembly involved in embryonic body morphogenesis,BP,
21790,GO:2001198,1,0.947822362749678,0,10,regulation of dendritic cell differentiation,BP,
21791,GO:2001199,1,0.969949617478531,0,6,negative regulation of dendritic cell differentiation,BP,
21792,GO:2001200,1,0.976713515011352,0,4,positive regulation of dendritic cell differentiation,BP,
21793,GO:2001201,1,0.975266794905494,0,3,regulation of transforming growth factor-beta secretion,BP,
21794,GO:2001202,1,0.983100648886784,0,2,negative regulation of transforming growth factor-beta secretion,BP,
21795,GO:2001203,1,0.99203283408172,0,1,positive regulation of transforming growth factor-beta secretion,BP,
21798,GO:2001206,1,0.980598434931346,0,3,positive regulation of osteoclast development,BP,
21799,GO:2001207,1,0.992495604331318,0,1,regulation of transcription elongation from RNA polymerase I promoter,BP,
21800,GO:2001208,1,0.992495604331318,0,1,negative regulation of transcription elongation by RNA polymerase I,BP,
21801,GO:2001212,1,0.912658412080249,0,14,regulation of vasculogenesis,BP,
21802,GO:2001213,1,0.991678267239222,0,1,negative regulation of vasculogenesis,BP,
21803,GO:2001214,1,0.939744096776389,0,10,positive regulation of vasculogenesis,BP,
21804,GO:2001222,1,0.785823194139824,0,29,regulation of neuron migration,BP,
21805,GO:2001223,1,0.939817865952157,0,8,negative regulation of neuron migration,BP,
21806,GO:2001224,1,0.890718429550752,0,13,positive regulation of neuron migration,BP,
21807,GO:2001225,1,0.930904514059046,0,10,regulation of chloride transport,BP,
21808,GO:2001226,1,0.97835698896911,0,3,negative regulation of chloride transport,BP,
21809,GO:2001228,1,0.975984025421768,0,2,regulation of response to gamma radiation,BP,
21810,GO:2001229,1,0.987284878654552,0,1,negative regulation of response to gamma radiation,BP,
21813,GO:2001235,1,0.370630411332017,0,164,positive regulation of apoptotic signaling pathway,BP,
21816,GO:2001238,1,0.733654897033834,0,49,positive regulation of extrinsic apoptotic signaling pathway,BP,
21819,GO:2001241,1,0.929169108265526,0,12,positive regulation of extrinsic apoptotic signaling pathway in absence of ligand,BP,
21820,GO:2001242,1,0.429653182554058,0,144,regulation of intrinsic apoptotic signaling pathway,BP,
21821,GO:2001243,1,0.581235861263205,0,90,negative regulation of intrinsic apoptotic signaling pathway,BP,
21822,GO:2001244,1,0.769805249970285,0,48,positive regulation of intrinsic apoptotic signaling pathway,BP,
21823,GO:2001245,1,0.981679323365874,0,3,regulation of phosphatidylcholine biosynthetic process,BP,
21824,GO:2001246,1,0.992480085778328,0,1,negative regulation of phosphatidylcholine biosynthetic process,BP,
21825,GO:2001247,1,0.992406949361386,0,1,positive regulation of phosphatidylcholine biosynthetic process,BP,
21826,GO:2001248,1,0.994287414484928,0,1,regulation of ammonia assimilation cycle,BP,
21827,GO:2001250,1,0.994287414484928,0,1,positive regulation of ammonia assimilation cycle,BP,
21828,GO:2001251,1,0.432187771034592,0,116,negative regulation of chromosome organization,BP,
21829,GO:2001252,1,0.342987154927074,0,152,positive regulation of chromosome organization,BP,
21830,GO:2001253,1,0.992801233875787,0,1,regulation of histone H3-K36 trimethylation,BP,
21831,GO:2001256,1,0.926855759973935,0,12,regulation of store-operated calcium entry,BP,
21833,GO:2001258,1,0.805325377544393,0,36,negative regulation of cation channel activity,BP,
21834,GO:2001259,1,0.683126477554354,0,54,positive regulation of cation channel activity,BP,
21835,GO:2001260,1,0.993809324488368,0,1,regulation of semaphorin-plexin signaling pathway,BP,
21836,GO:2001262,1,0.993809324488368,0,1,positive regulation of semaphorin-plexin signaling pathway,BP,
21837,GO:2001267,1,0.874833691438476,0,23,regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
21838,GO:2001268,1,0.976659726715882,0,5,negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
21839,GO:2001269,1,0.895763856381422,0,18,positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway,BP,
21840,GO:2001270,1,0.975853098553715,0,4,regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
21841,GO:2001271,1,0.978567122919468,0,3,negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
21842,GO:2001272,1,0.997227134670758,0,1,positive regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis,BP,
21843,GO:2001273,1,0.862023016159334,0,20,regulation of glucose import in response to insulin stimulus,BP,
21844,GO:2001274,1,0.978435963699912,0,3,negative regulation of glucose import in response to insulin stimulus,BP,
21845,GO:2001275,1,0.887649098581423,0,16,positive regulation of glucose import in response to insulin stimulus,BP,
21846,GO:2001279,1,0.966455927631216,0,5,regulation of unsaturated fatty acid biosynthetic process,BP,
21847,GO:2001280,1,0.980922207524749,0,3,positive regulation of unsaturated fatty acid biosynthetic process,BP,
21848,GO:2001286,1,0.971094581436153,0,4,regulation of caveolin-mediated endocytosis,BP,
21849,GO:2001287,1,0.988285731144876,0,2,negative regulation of caveolin-mediated endocytosis,BP,
21850,GO:2001288,1,0.990066934750116,0,1,positive regulation of caveolin-mediated endocytosis,BP,
21851,GO:2001293,1,0.983807280514477,0,2,malonyl-CoA metabolic process,BP,
21852,GO:2001294,1,0.994186879981186,0,1,malonyl-CoA catabolic process,BP,
21853,GO:2001295,1,0.98956031487143,0,1,malonyl-CoA biosynthetic process,BP,
21854,GO:2001300,1,0.968681518806059,0,6,lipoxin metabolic process,BP,
21855,GO:2001301,1,0.968681518806059,0,6,lipoxin biosynthetic process,BP,
21856,GO:2001302,1,0.987055374168798,0,2,lipoxin A4 metabolic process,BP,
21857,GO:2001303,1,0.987055374168798,0,2,lipoxin A4 biosynthetic process,BP,
21858,GO:2001304,1,0.993807217231287,0,1,lipoxin B4 metabolic process,BP,
21859,GO:2001306,1,0.993807217231287,0,1,lipoxin B4 biosynthetic process,BP,
21860,GO:2001311,1,0.995078278770783,0,1,lysobisphosphatidic acid metabolic process,BP,
3291,GO:0006607,1,0.851895098771699,0,20,NLS-bearing protein import into nucleus,BP,
9679,GO:0035306,1,0.707603478311048,0,48,positive regulation of dephosphorylation,BP,
19111,GO:1902017,1.00000000000001,0.765177042431918,0,39,regulation of cilium assembly,BP,
1250,GO:0002755,1.00000000000001,0.791001574374345,0,35,MyD88-dependent toll-like receptor signaling pathway,BP,
21160,GO:2000036,1.00000000000001,0.836051206329995,0,24,regulation of stem cell population maintenance,BP,
6331,GO:0018279,1.00000000000001,0.777402933534782,0,42,protein N-linked glycosylation via asparagine,BP,
1101,GO:0002507,1.00000000000001,0.863241863760266,0,23,tolerance induction,BP,
16508,GO:0071732,1.00000000000001,0.909088773059211,0,15,cellular response to nitric oxide,BP,
693,GO:0001845,1.00000000000001,0.926030453312819,0,12,phagolysosome assembly,BP,
6660,GO:0019840,1.00000000000001,0.873150163251873,0,24,isoprenoid binding,MF,
14691,GO:0060339,1.00000000000001,0.951186877155308,0,7,negative regulation of type I interferon-mediated signaling pathway,BP,
